PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chittenden, CM; Jensen, JLA; Ewart, D; Anderson, S; Balfry, S; Downey, E; Eaves, A; Saksida, S; Smith, B; Vincent, S; Welch, D; McKinley, RS				Chittenden, Cedar M.; Jensen, Jenny L. A.; Ewart, David; Anderson, Shannon; Balfry, Shannon; Downey, Elan; Eaves, Alexandra; Saksida, Sonja; Smith, Brian; Vincent, Stephen; Welch, David; McKinley, R. Scott			Recent Salmon Declines: A Result of Lost Feeding Opportunities Due to Bad Timing?	PLOS ONE			English	Article							WILD COHO SALMON; ONCORHYNCHUS-KISUTCH; MARINE SURVIVAL; INTERANNUAL VARIABILITY; ATLANTIC SALMON; CLIMATE-CHANGE; WEST-COAST; HATCHERY; SMOLTS; MIGRATION	As the timing of spring productivity blooms in near-shore areas advances due to warming trends in global climate, the selection pressures on out-migrating salmon smolts are shifting. Species and stocks that leave natal streams earlier may be favoured over later-migrating fish. The low post-release survival of hatchery fish during recent years may be in part due to static release times that do not take the timing of plankton blooms into account. This study examined the effects of release time on the migratory behaviour and survival of wild and hatchery-reared coho salmon (Oncorhynchus kisutch) using acoustic and coded-wire telemetry. Plankton monitoring and near-shore seining were also conducted to determine which habitat and food sources were favoured. Acoustic tags (n = 140) and coded-wire tags (n = 266,692) were implanted into coho salmon smolts at the Seymour and Quinsam Rivers, in British Columbia, Canada. Differences between wild and hatchery fish, and early and late releases were examined during the entire lifecycle. Physiological sampling was also carried out on 30 fish from each release group. The smolt-to-adult survival of coho salmon released during periods of high marine productivity was 1.5- to 3-fold greater than those released both before and after, and the fish's degree of smoltification affected their downstream migration time and duration of stay in the estuary. Therefore, hatchery managers should consider having smolts fully developed and ready for release during the peak of the near-shore plankton blooms. Monitoring chlorophyll a levels and water temperature early in the spring could provide a forecast of the timing of these blooms, giving hatcheries time to adjust their release schedule.	[Chittenden, Cedar M.; Jensen, Jenny L. A.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Ewart, David; Anderson, Shannon] Fisheries & Oceans Canada, Campbell River, BC, Canada; [Chittenden, Cedar M.; Balfry, Shannon; McKinley, R. Scott] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Balfry, Shannon; McKinley, R. Scott] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Downey, Elan; Eaves, Alexandra; Saksida, Sonja] British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada; [Smith, Brian; Vincent, Stephen] Seymour Salmonid Soc, N Vancouver, BC, Canada; [Welch, David] Kintama Res Corp, Nanaimo, BC, Canada	UiT The Arctic University of Tromso; Fisheries & Oceans Canada; University of British Columbia; Fisheries & Oceans Canada	Chittenden, CM (corresponding author), Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway.	Cedar.M.Chittenden@uit.no			Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation; Natural Sciences and Engineering Research Council	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, the Pacific Salmon Foundation and a grant from Natural Sciences and Engineering Research Council to RSM. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of the first three organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Alvarez D, 2003, J FISH BIOL, V63, P1565, DOI 10.1111/j.1095-8649.2003.00267.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Beamish RJ, 2000, FISH OCEANOGR, V9, P114; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Beamish RJ, 2004, PROG OCEANOGR, V60, P355, DOI 10.1016/j.pocean.2004.02.009; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Bilton H. T, 1984, CAN TECH REP FISH AQ, V1306, P1; BOHLIN T, 1993, CAN J FISH AQUAT SCI, V50, P224, DOI 10.1139/f93-025; Carruth LL, 2002, INTEGR COMP BIOL, V42, P574, DOI 10.1093/icb/42.3.574; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Chittenden CM, 2009, ICES J MAR SCI, V66, P2195, DOI 10.1093/icesjms/fsp174; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Daly EA, 2009, T AM FISH SOC, V138, P1420, DOI 10.1577/T08-226.1; DORN MW, 1989, THESIS U WASHINGTON; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; *ENV CAN, 2008, ARCH HYDR DAT; Eslinger DL, 2001, FISH OCEANOGR, V10, P81, DOI 10.1046/j.1054-6006.2001.00036.x; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Hendrick L.J., 1952, COPEIA, V4, P265; HOLTBY LB, 1989, CAN J FISH AQUAT SCI, V46, P1396, DOI 10.1139/f89-179; Houston A.H., 1990, P273; HVIDSTEN NA, 1988, J FISH BIOL, V33, P121, DOI 10.1111/j.1095-8649.1988.tb05453.x; Jepsen N, 2006, FISHERIES MANAG ECOL, V13, P341, DOI 10.1111/j.1365-2400.2006.00509.x; JONSSON B, 1985, CAN J FISH AQUAT SCI, V42, P593, DOI 10.1139/f85-076; Li M, 2000, ESTUAR COAST SHELF S, V50, P467, DOI 10.1006/ecss.2000.0593; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Nichols T.L., 1990, MANUAL CODED WIRE TA; *NOAA PUBL AFF, 2007, NOAA REP 2006 WARM Y; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; SHRIMPTON JM, 1994, CAN J FISH AQUAT SCI, V51, P2179, DOI 10.1139/f94-219; Sweeting R. M., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P255; Tanasichuk RW, 2002, FISH OCEANOGR, V11, P18, DOI 10.1046/j.1365-2419.2002.00185.x	36	34	34	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12423	10.1371/journal.pone.0012423	http://dx.doi.org/10.1371/journal.pone.0012423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805978	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500006
J	Wang, X; Zhao, JP; Tang, SX; Ye, ZP; Hewlett, I				Wang, Xue; Zhao, Jiangqin; Tang, Shixing; Ye, Zhiping; Hewlett, Indira			Viremia Associated with Fatal Outcomes in Ferrets Infected with Avian H5N1 Influenza Virus	PLOS ONE			English	Article							PATHOGENESIS	Avian H5N1 influenza viruses cause severe disease and high mortality in infected humans. However, tissue tropism and underlying pathogenesis of H5N1 virus infection in humans needs further investigation. The objective of this work was to study viremia, tissue tropism and disease pathogenesis of H5N1 virus infection in the susceptible ferret animal model. To evaluate the relationship of morbidity and mortality with virus loads, we performed studies in ferrets infected with the H5N1 strain A/VN/1203/04 to assess clinical signs after infection and virus load in lung, brain, ileum, nasal turbinate, nasal wash, and blood. We observed that H5N1 infection in ferrets is characterized by high virus load in the brain and and low levels in the ileum using real-time PCR. In addition, viral RNA was frequently detected in blood one or two days before death and associated with symptoms of diarrhea. Our observations further substantiate pathogenicity of H5N1 and further indicate that viremia may be a bio-marker for fatal outcomes in H5N1 infection.	[Wang, Xue; Zhao, Jiangqin; Tang, Shixing; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA; [Ye, Zhiping] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Wang, X (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA.	xue.wang@fda.hhs.gov; indira.hewlett@fda.hhs.gov		Zhao, Jiangqin/0000-0003-4672-0735				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; REED LJ, 1938, AM J HYG, V27; Stanley E D, 1966, Trans Assoc Am Physicians, V79, P376; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Zhou JJ, 2009, VIRUS GENES, V39, P76, DOI 10.1007/s11262-009-0365-y	16	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12099	10.1371/journal.pone.0012099	http://dx.doi.org/10.1371/journal.pone.0012099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20730085	Green Published, Green Submitted, gold			2022-12-27	WOS:000280859700005
J	Chung, RS; Howells, C; Eaton, ED; Shabala, L; Zovo, K; Palumaa, P; Sillard, R; Woodhouse, A; Bennett, WR; Ray, S; Vickers, JC; West, AK				Chung, Roger S.; Howells, Claire; Eaton, Emma D.; Shabala, Lana; Zovo, Kairit; Palumaa, Peep; Sillard, Rannar; Woodhouse, Adele; Bennett, William R.; Ray, Shannon; Vickers, James C.; West, Adrian K.			The Native Copper- and Zinc- Binding Protein Metallothionein Blocks Copper-Mediated A beta Aggregation and Toxicity in Rat Cortical Neurons	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HYDROGEN-PEROXIDE; DOWN-REGULATION; NEURITE GROWTH; PEPTIDE; EXPRESSION; INJURY; BRAIN; PURIFICATION; POSTINJURY	Background: A major pathological hallmark of AD is the deposition of insoluble extracellular beta-amyloid (A beta) plaques. There are compelling data suggesting that A beta aggregation is catalysed by reaction with the metals zinc and copper. Methodology/Principal Findings: We now report that the major human-expressed metallothionein (MT) subtype, MT-2A, is capable of preventing the in vitro copper-mediated aggregation of A beta(1-40) and A beta(1-42). This action of MT-2A appears to involve a metal-swap between Zn(7)MT-2A and Cu(II)-A beta, since neither Cu(10)MT-2A or carboxymethylated MT-2A blocked Cu(II)-A beta aggregation. Furthermore, Zn7MT-2A blocked Cu(II)-A beta induced changes in ionic homeostasis and subsequent neurotoxicity of cultured cortical neurons. Conclusions/Significance: These results indicate that MTs of the type represented by MT-2A are capable of protecting against A beta aggregation and toxicity. Given the recent interest in metal-chelation therapies for AD that remove metal from A beta leaving a metal-free A beta that can readily bind metals again, we believe that MT-2A might represent a different therapeutic approach as the metal exchange between MT and A beta leaves the A beta in a Zn-bound, relatively inert form.	[Chung, Roger S.; Howells, Claire; Eaton, Emma D.; Shabala, Lana; Woodhouse, Adele; Bennett, William R.; Ray, Shannon; Vickers, James C.; West, Adrian K.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia; [Zovo, Kairit; Palumaa, Peep; Sillard, Rannar] Tallinn Univ Technol, Dept Gene Technol, EE-200108 Tallinn, Estonia	University of Tasmania; Menzies Institute for Medical Research; Tallinn University of Technology	Chung, RS (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas, Australia.	Roger.Chung@utas.edu.au	Palumaa, Peep/AAF-7617-2020; West, Adrian/AAR-8857-2021; Vickers, James C/J-7464-2014; Chung, Roger/ABF-8395-2020; Palumaa, Peep/B-4668-2019; Bennett, Bill/A-4039-2010	Palumaa, Peep/0000-0002-3505-3466; Vickers, James C/0000-0001-5671-4879; Palumaa, Peep/0000-0002-3505-3466; Bennett, Bill/0000-0002-1559-3027; Chung, Roger/0000-0002-9286-947X; Woodhouse, Adele/0000-0002-4246-7624; Zovo, Kairit/0000-0001-5834-5157; Shabala, Lana/0000-0002-5360-8496	Australian Research Council (ARC) [DP0556630, DP0984673, LP0774820]; National Health and Medical Research Council [490025, 544913]; Jack & Ethel Goldin Foundation	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jack & Ethel Goldin Foundation	This work was supported by research grants from the Australian Research Council (ARC, ID# DP0556630; DP0984673; LP0774820), National Health and Medical Research Council (ID# 490025, 544913) and Jack & Ethel Goldin Foundation. RSC holds an ARC Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 1998, NEUROBIOL DIS, V5, P349, DOI 10.1006/nbdi.1998.0203; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cardoso SM, 2005, NEUROTOX RES, V7, P273, DOI 10.1007/BF03033885; Carrasco J, 2006, NEUROSCIENCE, V143, P911, DOI 10.1016/j.neuroscience.2006.08.054; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, EXP NEUROL, V178, P1, DOI 10.1006/exnr.2002.8017; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; ERICKSON JC, 1994, BRAIN RES, V649, P297, DOI 10.1016/0006-8993(94)91076-6; Eriste E, 2003, PROTEIN EXPRES PURIF, V31, P161, DOI 10.1016/S1046-5928(03)00144-X; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1; HAASS C, 1992, NATURE, V359, P325; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Kagi J H, 1987, Experientia Suppl, V52, P25; Kelly EJ, 1996, NAT GENET, V13, P219, DOI 10.1038/ng0696-219; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Penkowa M, 1999, J NEUROSCI, V19, P2535; Pouokam E, 2009, EUR J PHARMACOL, V615, P40, DOI 10.1016/j.ejphar.2009.04.066; Richarz AN, 2002, ANAL BIOANAL CHEM, V372, P412, DOI 10.1007/s00216-001-1187-5; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shabala L, 2006, FEMS MICROBIOL REV, V30, P472, DOI 10.1111/j.1574-6976.2006.00019.x; Shabala L, 2001, J MICROBIOL METH, V46, P119, DOI 10.1016/S0167-7012(01)00270-6; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Townsend AT, 2000, FRESEN J ANAL CHEM, V367, P614, DOI 10.1007/s002160000416; TRENDELENBURG G, J NEUROSCI, V22, P5879; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Wake H, 2007, J NEUROSCI, V27, P1642, DOI 10.1523/JNEUROSCI.3104-06.2007; Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6	47	55	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12030	10.1371/journal.pone.0012030	http://dx.doi.org/10.1371/journal.pone.0012030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711450	Green Published, Green Submitted, gold			2022-12-27	WOS:000280849100007
J	Casorelli, I; Pannellini, T; De Luca, G; Degan, P; Chiera, F; Iavarone, I; Giuliani, A; Butera, A; Boirivant, M; Musiani, P; Bignami, M				Casorelli, Ida; Pannellini, Tania; De Luca, Gabriele; Degan, Paolo; Chiera, Federica; Iavarone, Ivano; Giuliani, Alessandro; Butera, Alessia; Boirivant, Monica; Musiani, Piero; Bignami, Margherita			The Mutyh Base Excision Repair Gene Influences the Inflammatory Response in a Mouse Model of Ulcerative Colitis	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; MICROSATELLITE INSTABILITY; INTESTINAL TUMORIGENESIS; COLON CARCINOGENESIS; COLORECTAL TUMORS; T-CELLS; MICE; MYH; PROTEIN; SUSCEPTIBILITY	Background: The Mutyh DNA glycosylase is involved in the repair of oxidized DNA bases. Mutations in the human MUTYH gene are responsible for colorectal cancer in familial adenomatous polyposis. Since defective DNA repair genes might contribute to the increased cancer risk associated with inflammatory bowel diseases, we compared the inflammatory response of wild-type and Mutyh(-/-) mice to oxidative stress. Methodology/Principal Findings: The severity of colitis, changes in expression of genes involved in DNA repair and inflammation, DNA 8-oxoguanine levels and microsatellite instability were analysed in colon of mice treated with dextran sulfate sodium (DSS). The Mutyh(-/-) phenotpe was associated with a significant accumulation of 8-oxoguanine in colon DNA of treated mice. A single DSS cycle induced severe acute ulcerative colitis in wild-type mice, whereas lesions were modest in Mutyh(-/-) mice, and this was associated with moderate variations in the expression of several cytokines. Eight DSS cycles caused chronic colitis in both wild-type and Mutyh(-/-) mice. Lymphoid hyperplasia and a significant reduction in Foxp3(+) regulatory T cells were observed only in Mutyh(-/-) mice. Conclusions: The findings indicate that, in this model of ulcerative colitis, Mutyh plays a major role in maintaining intestinal integrity by affecting the inflammatory response.	[Casorelli, Ida; De Luca, Gabriele; Chiera, Federica; Iavarone, Ivano; Giuliani, Alessandro; Bignami, Margherita] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Pannellini, Tania; Musiani, Piero] Gabriele DAnnunzio Univ Chieti, Aging Res Ctr, Chieti, Italy; [Degan, Paolo] Ist Tumori Genova, Genoa, Italy; [Butera, Alessia; Boirivant, Monica] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); G d'Annunzio University of Chieti-Pescara; Istituto Superiore di Sanita (ISS)	Casorelli, I (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	ida.casorelli@ospedalesantandrea.it; margherita.bignami@iss.it	Butera, Alessia/I-3399-2014; Giuliani, Alessandro/K-7589-2016; degan, paolo/AAB-4093-2019; Giuliani, Alessandro/AAF-1740-2020; BOIRIVANT, MONICA/B-9977-2016; de luca, gabriele/J-6655-2018; degan, paolo/AAB-6713-2019	Butera, Alessia/0000-0002-7659-4066; Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; BOIRIVANT, MONICA/0000-0003-3665-7058; de luca, gabriele/0000-0003-2918-0124; degan, paolo/0000-0003-0855-8896; Iavarone, Ivano/0000-0001-5856-9484	Association for International Cancer Research; Associazione Italiana Ricerca sul Cancro; Alleanza Contro il Cancro; Fondo per gli Investimenti della Ricerca di Base	Association for International Cancer Research; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from Association for International Cancer Research, Associazione Italiana Ricerca sul Cancro, Alleanza Contro il Cancro and Fondo per gli Investimenti della Ricerca di Base to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Ando K, 2008, NUCLEIC ACIDS RES, V36, P4327, DOI 10.1093/nar/gkn416; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Choi S, 2007, FREE RADICAL BIO MED, V43, P1594, DOI 10.1016/j.freeradbiomed.2007.08.022; D'Errico M, 2008, MUTAT RES-REV MUTAT, V659, P4, DOI 10.1016/j.mrrev.2007.10.003; D'Inca R, 2004, INFLAMM BOWEL DIS, V10, P23, DOI 10.1097/00054725-200401000-00003; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; De Zoeten EF, 2008, GASTROENTEROLOGY, V134, P2171, DOI 10.1053/j.gastro.2008.04.030; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Eijkelkamp N, 2007, GUT, V56, P847, DOI 10.1136/gut.2006.107094; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gushima M, 2009, J PATHOL, V219, P77, DOI 10.1002/path.2570; Hirano S, 2003, J BIOL CHEM, V278, P38121, DOI 10.1074/jbc.C300316200; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Kim HJ, 2007, FREE RADICAL RES, V41, P655, DOI 10.1080/10715760701250270; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohonen-Corish MRJ, 2002, CANCER RES, V62, P2092; Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427; Lipton L, 2003, CANCER RES, V63, P7595; LUO M, 2009, ANTIOXID REDOX SIGNA; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Risques RA, 2006, CURR OPIN GASTROEN, V22, P382, DOI 10.1097/01.mog.0000231812.95525.a7; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; *STATACORP, 2003, STAT STAT SOFTW REL; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Tardieu D, 1998, CANCER LETT, V134, P1, DOI 10.1016/S0304-3835(98)00228-6; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850	45	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12070	10.1371/journal.pone.0012070	http://dx.doi.org/10.1371/journal.pone.0012070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706593	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900029
J	Santoro, A; Balbi, V; Balducci, E; Pirazzini, C; Rosini, F; Tavano, F; Achilli, A; Siviero, P; Minicuci, N; Bellavista, E; Mishto, M; Salvioli, S; Marchegiani, F; Cardelli, M; Olivieri, F; Nacmias, B; Chiamenti, AM; Benussi, L; Ghidoni, R; Rose, G; Gabelli, C; Binetti, G; Sorbi, S; Crepaldi, G; Passarino, G; Torroni, A; Franceschi, C				Santoro, Aurelia; Balbi, Valentina; Balducci, Elisa; Pirazzini, Chiara; Rosini, Francesca; Tavano, Francesca; Achilli, Alessandro; Siviero, Paola; Minicuci, Nadia; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Marchegiani, Francesca; Cardelli, Maurizio; Olivieri, Fabiola; Nacmias, Benedetta; Chiamenti, Andrea Maria; Benussi, Luisa; Ghidoni, Roberta; Rose, Giuseppina; Gabelli, Carlo; Binetti, Giuliano; Sorbi, Sandro; Crepaldi, Gaetano; Passarino, Giuseppe; Torroni, Antonio; Franceschi, Claudio			Evidence for Sub-Haplogroup H5 of Mitochondrial DNA as a Risk Factor for Late Onset Alzheimer's Disease	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MTDNA HAPLOGROUPS; HUMAN-POPULATIONS; NEAR-EASTERN; EPIDEMIOLOGY; INVOLVEMENT; MUTATIONS; LONGEVITY; SELECTION; VARIANTS	Background: Alzheimer's Disease (AD) is the most common neurodegenerative disease and the leading cause of dementia among senile subjects. It has been proposed that AD can be caused by defects in mitochondrial oxidative phosphorylation. Given the fundamental contribution of the mitochondrial genome (mtDNA) for the respiratory chain, there have been a number of studies investigating the association between mtDNA inherited variants and multifactorial diseases, however no general consensus has been reached yet on the correlation between mtDNA haplogroups and AD. Methodology/Principal Findings: We applied for the first time a high resolution analysis (sequencing of displacement loop and restriction analysis of specific markers in the coding region of mtDNA) to investigate the possible association between mtDNA-inherited sequence variation and AD in 936 AD patients and 776 cognitively assessed normal controls from central and northern Italy. Among over 40 mtDNA sub-haplogroups analysed, we found that sub-haplogroup H5 is a risk factor for AD (OR = 1.85, 95% CI: 1.04-3.23) in particular for females (OR = 2.19, 95% CI: 1.06-4.51) and independently from the APOE genotype. Multivariate logistic regression revealed an interaction between H5 and age. When the whole sample is considered, the H5a subgroup of molecules, harboring the 4336 transition in the tRNA(Gln) gene, already associated to AD in early studies, was about threefold more represented in AD patients than in controls (2.0% vs 0.8%; p = 0.031), and it might account for the increased frequency of H5 in AD patients (4.2% vs 2.3%). The complete re-sequencing of the 56 mtDNAs belonging to H5 revealed that AD patients showed a trend towards a higher number (p = 0.052) of sporadic mutations in tRNA and rRNA genes when compared with controls. Conclusions: Our results indicate that high resolution analysis of inherited mtDNA sequence variation can help in identifying both ancient polymorphisms defining sub-haplogroups and the accumulation of sporadic mutations associated with complex traits such as AD.	[Santoro, Aurelia; Balbi, Valentina; Balducci, Elisa; Pirazzini, Chiara; Rosini, Francesca; Tavano, Francesca; Achilli, Alessandro; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Santoro, Aurelia; Bellavista, Elena; Mishto, Michele; Salvioli, Stefano; Franceschi, Claudio] Univ Bologna, CIG Interdept Ctr Biophys & Biocomplex Studies, Bologna, Italy; [Achilli, Alessandro; Torroni, Antonio] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dept Cell & Environm Biol, I-06100 Perugia, Italy; [Siviero, Paola; Minicuci, Nadia; Crepaldi, Gaetano] CNR, Inst Neurosci, Padua, Italy; [Mishto, Michele] Fac Med Charite, Inst Biochem, Berlin, Germany; [Marchegiani, Francesca; Cardelli, Maurizio; Olivieri, Fabiola] Italian Natl Res Ctr Aging INRCA, Ancona, Italy; [Olivieri, Fabiola] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Nacmias, Benedetta; Sorbi, Sandro] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Chiamenti, Andrea Maria; Gabelli, Carlo] Reg Ctr Cerebral Aging, Vicenza, Italy; [Benussi, Luisa; Ghidoni, Roberta; Binetti, Giuliano] Ctr S Giovanni di Dio Fatebenefratelli, NeuroBioGen Lab Memory Clin, Brescia, Italy; [Ghidoni, Roberta] Ctr S Giovanni di Dio Fatebenefratelli, Prote Unit, Brescia, Italy; [Rose, Giuseppina; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Cosenza, Italy	University of Bologna; University of Bologna; University of Pavia; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS INRCA; Marche Polytechnic University; University of Florence; IRCCS Fatebenefratelli; IRCCS Fatebenefratelli; University of Calabria	Santoro, A (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	aurelia.santoro@unibo.it	Binetti, Giuliano/K-4519-2016; Marchegiani, Francesca/AAB-8925-2019; Franceschi, Claudio/L-4484-2017; Tavano, Francesca/K-2203-2016; Pirazzini, Chiara/AAD-9318-2021; Nacmias, Benedetta/J-5084-2018; Olivieri, Fabiola/K-6465-2016; mishto, michele/A-5592-2010; Ghidoni, Roberta/K-4507-2016; Cardelli, Maurizio/I-5505-2014; Torroni, Antonio/E-1557-2011; BENUSSI, LUISA/K-4409-2016; Salvioli, Stefano/K-6663-2016; MINICUCI, NADIA/D-5237-2016; Achilli, Alessandro/I-9236-2012; pirazzini, chiara/K-2258-2018	Binetti, Giuliano/0000-0003-2759-5844; Franceschi, Claudio/0000-0001-9841-6386; Tavano, Francesca/0000-0002-8831-7349; Pirazzini, Chiara/0000-0001-8248-0295; Nacmias, Benedetta/0000-0001-9338-9040; Olivieri, Fabiola/0000-0002-9606-1144; mishto, michele/0000-0003-3042-2792; Ghidoni, Roberta/0000-0002-7691-1957; Cardelli, Maurizio/0000-0002-4480-2473; Torroni, Antonio/0000-0002-4163-4478; BENUSSI, LUISA/0000-0003-2836-8141; Salvioli, Stefano/0000-0002-6191-1225; MINICUCI, NADIA/0000-0002-0970-6531; Achilli, Alessandro/0000-0001-6871-3451; Santoro, Aurelia/0000-0002-7187-1116; sorbi, sandro/0000-0002-0380-6670; Rose, Giuseppina/0000-0002-4264-4184	Emilia-Romagna Region; University of Bologna [RFO ex 60%]; Programma Strategico [conv. PS39]; Ricerca Corrente; Italian Ministry of Health; Roberto and Cornelia Pallotti Legacy for Cancer Research	Emilia-Romagna Region(Regione Emilia Romagna); University of Bologna; Programma Strategico; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); Roberto and Cornelia Pallotti Legacy for Cancer Research	This work was supported by the "Promozione Regionale della Ricerca Industriale, dell'Innovazione e del Trasferimento Tecnologico'' (PRRIITT) program of the Emilia-Romagna Region, the University of Bologna Grant "Ricerca Fondamentale Orientata (RFO ex 60%) 2008'', the Programma Strategico 2007, conv. PS39, the Ricerca Corrente, Italian Ministry of Health Grant "An integrated approach to identify functional, biochemical and genetic markers in centenarians and Alzheimer's Disease patients'' and the Roberto and Cornelia Pallotti Legacy for Cancer Research Grants (to C. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X; BANDELT HJ, 1995, GENETICS, V141, P743; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8; Ferrucci L, 2008, RADIOL CLIN N AM, V46, P643, DOI 10.1016/j.rcl.2008.07.005; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gaweda-Walerych K, 2008, J NEURAL TRANSM, V115, P1521, DOI 10.1007/s00702-008-0121-9; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; HIXSON JE, 1990, J LIPID RES, V31, P545; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z; Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf; Petrozzi L, 2007, BIOSCIENCE REP, V27, P87, DOI 10.1007/s10540-007-9038-z; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; TORRONI A, 1994, J BIOENERG BIOMEMBR, V26, P261, DOI 10.1007/BF00763098; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van der Walt JM, 2005, HUM GENET, V118, P115, DOI 10.1007/s00439-005-0032-x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	54	88	90	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12037	10.1371/journal.pone.0012037	http://dx.doi.org/10.1371/journal.pone.0012037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700462	gold, Green Published			2022-12-27	WOS:000280687900021
J	Jackson, C; Welch, HC; Bellamy, TC				Jackson, Claire; Welch, Heidi C.; Bellamy, Tomas C.			Control of Cerebellar Long-Term Potentiation by P-Rex-Family Guanine-Nucleotide Exchange Factors and Phosphoinositide 3-Kinase	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; SMALL-MOLECULE INHIBITOR; PURKINJE-CELL; SYNAPTIC PLASTICITY; NITRIC-OXIDE; PHOSPHATIDYLINOSITOL 3-KINASE; MORPHOLOGICAL-CHANGES; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; PARALLEL	Background: Long-term potentiation (LTP) at the parallel fibre-Purkinje cell synapse in the cerebellum is a recently described and poorly characterized form of synaptic plasticity. The induction mechanism for LTP at this synapse is considered reciprocal to "classical'' LTP at hippocampal CA1 pyramidal neurons: kinases promote increased trafficking of AMPA receptors into the postsynaptic density in the hippocampus, whereas phosphatases decrease internalization of AMPA receptors in the cerebellum. In the hippocampus, LTP occurs in overlapping phases, with the transition from early to late phases requiring the consolidation of initial induction processes by structural re-arrangements at the synapse. Many signalling pathways have been implicated in this process, including PI3 kinases and Rho GTPases. Principal Findings: We hypothesized that analogous phases are present in cerebellar LTP, and took as the starting point for investigation our recent discovery that P-Rex - a Rac guanine nucleotide exchange factor which is activated by PtdIns(3,4,5)P(3) - is highly expressed in mouse cerebellar Purkinje neurons and plays a role in motor coordination. We found that LTP evoked at parallel fibre synapses by 1 Hz stimulation or by NO donors was not sustained beyond 30 min when P-Rex was eliminated or Rac inhibited, suggesting that cerebellar LTP exhibits a late phase analogous to hippocampal LTP. In contrast, inhibition of PI3 kinase activity eliminated LTP at the induction stage. Conclusions: Our data suggest that a PI3K/P-Rex/Rac pathway is required for late phase LTP in the mouse cerebellum, and that other PI3K targets, which remain to be discovered, control LTP induction.	[Jackson, Claire; Bellamy, Tomas C.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Jackson, Claire; Welch, Heidi C.] Babraham Inst, Inositide Lab, Cambridge, England; [Bellamy, Tomas C.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Nottingham	Jackson, C (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge, England.	tomas.bellamy@nottingham.ac.uk		Bellamy, Tomas/0000-0003-0204-7366; Welch, Heidi/0000-0001-7865-7000	Biotechnology and Biological Sciences Research Council, UK [BB/B500958/1]; Babraham Institute; Biotechnology and Biological Sciences Research Council [BB/B500958/1, BBS/E/B/0000C231] Funding Source: researchfish; BBSRC [BBS/E/B/0000C231] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK (grant number: BB/B500958/1), and a Synergy grant from the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Balakrishnan S, 2009, GLIA, V57, P393, DOI 10.1002/glia.20768; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Canepari M, 2003, J NEUROSCI, V23, P4066; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Donald S, 2008, P NATL ACAD SCI USA, V105, P4483, DOI 10.1073/pnas.0712324105; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; Lee KJ, 2007, NEUROBIOL LEARN MEM, V88, P445, DOI 10.1016/j.nlm.2007.06.001; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Opazo P, 2003, J NEUROSCI, V23, P3679; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sdrulla AD, 2007, NAT NEUROSCI, V10, P546, DOI 10.1038/nn1889; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11962	10.1371/journal.pone.0011962	http://dx.doi.org/10.1371/journal.pone.0011962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694145	Green Published, Green Submitted, gold			2022-12-27	WOS:000280574300014
J	Nair, R; Junankar, S; O'Toole, S; Shah, J; Borowsky, AD; Bishop, JM; Swarbrick, A				Nair, Radhika; Junankar, Simon; O'Toole, Sandra; Shah, Jaynish; Borowsky, Alexander D.; Bishop, J. Michael; Swarbrick, Alexander			Redefining the Expression and Function of the Inhibitor of Differentiation 1 in Mammary Gland Development	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; EPITHELIAL-CELLS; BREAST-CANCER; ID-1; ID1; CARCINOGENESIS; PROLIFERATION; PREGNANCY; PROSTATE; GENES	The accumulation of poorly differentiated cells is a hallmark of breast neoplasia and progression. Thus an understanding of the factors controlling mammary differentiation is critical to a proper understanding of breast tumourigenesis. The Inhibitor of Differentiation 1 (Id1) protein has well documented roles in the control of mammary epithelial differentiation and proliferation in vitro and breast cancer progression in vivo. However, it has not been determined whether Id1 expression is sufficient for the inhibition of mammary epithelial differentiation or the promotion of neoplastic transformation in vivo. We now show that Id1 is not commonly expressed by the luminal mammary epithelia, as previously reported. Generation and analysis of a transgenic mouse model of Id1 overexpression in the mammary gland reveals that Id1 is insufficient for neoplastic progression in virgin animals or to prevent terminal differentiation of the luminal epithelia during pregnancy and lactation. Together, these data demonstrate that there is no luminal cell-autonomous role for Id1 in mammary epithelial cell fate determination, ductal morphogenesis and terminal differentiation.	[Nair, Radhika; Junankar, Simon; O'Toole, Sandra; Shah, Jaynish; Swarbrick, Alexander] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [O'Toole, Sandra] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW 2050, Australia; [O'Toole, Sandra] Univ Sydney, Sch Clin, Sydney Med Sch, Sydney, NSW 2006, Australia; [Borowsky, Alexander D.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Bishop, J. Michael] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [O'Toole, Sandra; Swarbrick, Alexander] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2033, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Sydney; University of Sydney; University of California System; University of California Davis; University of California System; University of California San Francisco; University of New South Wales Sydney	Nair, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	a.swarbrick@garvan.org.au	Swarbrick, Alexander/E-6107-2010; Borowsky, Alexander D/S-5404-2017; Junankar, Simon/O-2009-2019; Junankar, Simon/B-7677-2019	Swarbrick, Alexander/0000-0002-3051-5676; Junankar, Simon/0000-0002-3965-8278; Shah, Jaynish/0000-0002-1089-7355; Nair, Radhika/0000-0002-6585-3384	Cancer Council NSW, Australia [RG-0812]; Cancer Institute NSW; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024037] Funding Source: NIH RePORTER	Cancer Council NSW, Australia(Cancer Council New South Wales); Cancer Institute NSW; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant RG-0812 from the Cancer Council NSW, Australia. AS is the recipient of a Cancer Institute NSW early career development fellowship. JS is a recipient of a Cancer Institute NSW research scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Caldon CE, 2008, CANCER RES, V68, P3026, DOI 10.1158/0008-5472.CAN-07-3079; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Itahana Y, 2003, CANCER RES, V63, P7098; Itahana Y, 2008, BIOCHEM BIOPH RES CO, V372, P826, DOI 10.1016/j.bbrc.2008.05.139; KHIDR L, ONCOGENE, V25, P5210; Lin CQ, 1999, ENDOCR-RELAT CANCER, V6, P49, DOI 10.1677/erc.0.0060049; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; OTOOLE S, 2009, EXPERT OPIN IN PRESS; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Salomon R, 2009, J HISTOCHEM CYTOCHEM, V57, P599, DOI 10.1369/jhc.2009.953182; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Uehara N, 2003, BREAST CANCER RES, V5, pR25, DOI 10.1186/bcr560	24	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11947	10.1371/journal.pone.0011947	http://dx.doi.org/10.1371/journal.pone.0011947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689821	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520500009
J	Scott, A; Powner, MB; Gandhi, P; Clarkin, C; Gutmann, DH; Johnson, RS; Ferrara, N; Fruttiger, M				Scott, Andrew; Powner, Michael B.; Gandhi, Pranita; Clarkin, Claire; Gutmann, David H.; Johnson, Randall S.; Ferrara, Napoleone; Fruttiger, Marcus			Astrocyte-Derived Vascular Endothelial Growth Factor Stabilizes Vessels in the Developing Retinal Vasculature	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; MESSENGER-RNA STABILITY; BLOOD-VESSELS; VEGF EXPRESSION; CELL; HYPOXIA; PREMATURITY; SURVIVAL; MOUSE; MICE	Vascular endothelial growth factor (VEGF) plays a critical role in normal development as well as retinal vasculature disease. During retinal vascularization, VEGF is most strongly expressed by not yet vascularized retinal astrocytes, but also by retinal astrocytes within the developing vascular plexus, suggesting a role for retinal astrocyte-derived VEGF in angiogenesis and vessel network maturation. To test the role of astrocyte-derived VEGF, we used Cre-lox technology in mice to delete VEGF in retinal astrocytes during development. Surprisingly, this only had a minor impact on retinal vasculature development, with only small decreases in plexus spreading, endothelial cell proliferation and survival observed. In contrast, astrocyte VEGF deletion had more pronounced effects on hyperoxia-induced vaso-obliteration and led to the regression of smooth muscle cell-coated radial arteries and veins, which are usually resistant to the vessel-collapsing effects of hyperoxia. These results suggest that VEGF production from retinal astrocytes is relatively dispensable during development, but performs vessel stabilizing functions in the retinal vasculature and might be relevant for retinopathy of prematurity in humans.	[Scott, Andrew; Powner, Michael B.; Gandhi, Pranita; Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England; [Clarkin, Claire] Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England; [Gutmann, David H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Johnson, Randall S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	University of London; University College London; University of London; King's College London; Washington University (WUSTL); University of California System; University of California San Diego; Roche Holding; Genentech	Scott, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	m.fruttiger@ucl.ac.uk	Johnson, Randall/AAM-1189-2021; Powner, Michael/CAG-7455-2022; Clarkin, Claire/AAC-2980-2019	Johnson, Randall/0000-0002-4084-6639; Fruttiger, Marcus/0000-0002-6962-5485; Gutmann, David/0000-0002-3127-5045; Powner, Michael/0000-0003-4913-1004	Fight for Sight, the Moorfields Biomedical Research Centre; Moorfields Special Trustees; Wellcome Trust; Genentech Inc	Fight for Sight, the Moorfields Biomedical Research Centre; Moorfields Special Trustees; Wellcome Trust(Wellcome TrustEuropean Commission); Genentech Inc(Roche HoldingGenentech)	This work was supported by grants from Fight for Sight, the Moorfields Biomedical Research Centre, Moorfields Special Trustees, the Wellcome Trust and Genentech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; with the exception of Genentech Inc. who supplied materials (Vegf-floxed mice) and were involved in the preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; CLAXTON S, 2005, OXYGEN MODIFIES ARTE; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Diez-Roux G, 1999, DEVELOPMENT, V126, P2141; DORRELL MI, 2009, MAINTAINING RETINAL; Downie LE, 2008, GLIA, V56, P1076, DOI 10.1002/glia.20680; ENGERMAN RL, 1965, AM J OPHTHALMOL, V60, P628, DOI 10.1016/0002-9394(65)92251-8; FAVARD C, 1991, BIOL CELL, V73, P1, DOI 10.1016/0248-4900(91)90002-5; Ferrara N, 1991, Growth Factors, V5, P141, DOI 10.3109/08977199109000278; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gerhardinger C, 1998, AM J PATHOL, V152, P1453; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gu XL, 2002, INVEST OPHTH VIS SCI, V43, P496; Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314; Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Levy AP, 1998, TRENDS CARDIOVAS MED, V8, P246, DOI 10.1016/S1050-1738(98)00020-6; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; MAGAUD JP, 1989, J HISTOCHEM CYTOCHEM, V37, P1517, DOI 10.1177/37.10.2476478; Meeson AP, 1999, DEVELOPMENT, V126, P1407; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; PEER J, 1995, LAB INVEST, V72, P638; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Provis JM, 2000, INVEST OPHTH VIS SCI, V41, P2827; Provis JM, 1997, EXP EYE RES, V65, P555, DOI 10.1006/exer.1997.0365; Ryan HE, 2000, CANCER RES, V60, P4010; SCHNITZER J, 1988, GLIA, V1, P74, DOI 10.1002/glia.440010109; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2004, GROWTH HORM IGF RES, V14, pS140, DOI 10.1016/j.ghir.2004.03.030; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2148; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Zhang L, 2002, BIOCHEM BIOPH RES CO, V292, P860, DOI 10.1006/bbrc.2002.6710	51	107	113	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11863	10.1371/journal.pone.0011863	http://dx.doi.org/10.1371/journal.pone.0011863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686684	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000280520200027
J	Thurstan, RH; Roberts, CM				Thurstan, Ruth H.; Roberts, Callum M.			Ecological Meltdown in the Firth of Clyde, Scotland: Two Centuries of Change in a Coastal Marine Ecosystem	PLOS ONE			English	Article							NEPHROPS FISHERY; SEA AREA; ESTUARY; DISTURBANCE; MANAGEMENT; COMMUNITY; ABUNDANCE; COLLAPSE; IMPACTS; BIOLOGY	Background: The Firth of Clyde is a large inlet of the sea that extends over 100 km into Scotland's west coast. Methods: We compiled detailed fisheries landings data for this area and combined them with historical accounts to build a picture of change due to fishing activity over the last 200 years. Findings: In the early 19(th) century, prior to the onset of industrial fishing, the Firth of Clyde supported diverse and productive fisheries for species such as herring (Clupea harengus, Clupeidae), cod (Gadus morhua, Gadidae), haddock (Melanogrammus aeglefinus, Gadidae), turbot (Psetta maxima, Scophthalmidae) and flounder (Platichthys flesus, Pleuronectidae). The 19(th) century saw increased demand for fish, which encouraged more indiscriminate methods of fishing such as bottom trawling. During the 1880s, fish landings began to decline, and upon the recommendation of local fishers and scientists, the Firth of Clyde was closed to large trawling vessels in 1889. This closure remained in place until 1962 when bottom trawling for Norway lobster (Nephrops norvegicus, Nephropidae) was approved in areas more than three nautical miles from the coast. During the 1960s and 1970s, landings of bottomfish increased as trawling intensified. The trawl closure within three nautical miles of the coast was repealed in 1984 under pressure from the industry. Thereafter, bottomfish landings went into terminal decline, with all species collapsing to zero or near zero landings by the early 21(st) century. Herring fisheries collapsed in the 1970s as more efficient mid-water trawls and fish finders were introduced, while a fishery for mid-water saithe (Pollachius virens, Gadidae) underwent a boom and bust shortly after discovery in the late 1960s. The only commercial fisheries that remain today are for Nephrops and scallops (Pecten maximus, Pectinidae). Significance: The Firth of Clyde is a marine ecosystem nearing the endpoint of overfishing, a time when no species remain that are capable of sustaining commercial catches. The evidence suggests that trawl closures helped maintain productive fisheries through the mid-20(th) century, and their reopening precipitated collapse of bottomfish stocks. We argue that continued intensive bottom trawling for Nephrops with fine mesh nets will prevent the recovery of other species. This once diverse and highly productive environment will only be restored if trawl closures or other protected areas are re-introduced. The Firth of Clyde represents at a small scale a process that is occurring ocean-wide today, and its experience serves as a warning to others.	[Thurstan, Ruth H.; Roberts, Callum M.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	University of York - UK	Thurstan, RH (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	cr10@york.ac.uk	Thurstan, Ruth/K-5551-2014	Thurstan, Ruth/0000-0002-8045-1631	Marine Conservation Biology Institute	Marine Conservation Biology Institute	This study was partly funded by a Mia Tegner Memorial Grant in Historical Ecology from the Marine Conservation Biology Institute (www.mcbi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1866, REPORT COMMISSIONERS; BAILEY N, 1986, P ROY SOC EDINB B, V90, P501, DOI 10.1017/S0269727000005194; BAILEY RS, 1986, P ROY SOC EDINB B, V90, P407, DOI 10.1017/S0269727000005121; BEAUFOY H, 1785, REPORTS COMMITTEES H, V10, P18; Beevers N., 2007, 8 INT C WORKSH LOBST; Bergmann M, 2002, FISH RES, V57, P169, DOI 10.1016/S0165-7836(01)00345-9; Bergmann M, 2002, MAR ECOL PROG SER, V233, P185, DOI 10.3354/meps233185; Bergmann M, 2001, ICES J MAR SCI, V58, P531, DOI 10.1006/jmsc.2001.1046; Bjornsson B, 2004, ICES J MAR SCI, V61, P983, DOI 10.1016/j.icesjms.2004.06.017; BLAKE G, 1952, FIRTH CLYDE; BOYD JM, 1986, P ROY SOC EDINB B, V90, P1; BOYD TJ, 1892, 10 FISH BOARD SCOT 1, P1; BOYD TJ, 2001, 8 FISH BOARD SCOT 1, P1; BOYD TJ, 1891, 9 FISH BOARD SCOTL 1, P1; Bradshaw C, 2002, J SEA RES, V47, P161, DOI 10.1016/S1385-1101(02)00096-5; BROOK G, 1985, 4 FISH BOARD SCOTL 1, P47; Carr MH, 2003, ECOL APPL, V13, pS90; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; *COAST, 2006, CAUGHT TIM COMM ARR; *DEP AGR FISH SCOT, 1978, FISH SCOTL REP 1977; *DEP AGR FISH SCOT, 1963, FISH SCOTL REP 1962; *DEP AGR FISH SCOT, 1981, FISH SCOTL REP 1980; *DEP AGR FISH SCOT, 1973, FISH SCOTL REP 1972; Duncan C, 2003, LAMLASH BAY SEASEARC; ESSLEMONT P, 1894, 12 FISH BOARD SCOT 1, P132; ESSLEMONT P, 1893, 11 FISH BOARD SCOT 1, P1; EWART JC, 1888, 6 FISH BOARD SCOTL 3, P25; EWART JC, 1888, FISHERY BOARD SCOTLA; EWART JC, 1888, FISHERY BOARD SCOTLA, P98; EWART JC, 1987, 6 FISH BOARD SCOT 3, P1; Fairfax D., 1998, BASKING SHARK SCOTLA; Fisher JAD, 2002, MAR ECOL PROG SER, V240, P249, DOI 10.3354/meps240249; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fulton Thomas W, 1911, SOVEREIGNTY SEA; FULTON TW, 1900, 18 FISH BOARD SCOT 3, P242; FULTON TW, 1994, 13 FISH BOARD SCOT 3, P17; GIBSON JA, 1986, P ROY SOC EDINB B, V90, P451, DOI 10.1017/S0269727000005157; HAIG AJN, 1986, P ROY SOC EDINB B, V90, P393, DOI 10.1017/S026972700000511X; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; HENDERSON AR, 1986, P ROY SOC EDINB B, V90, P157, DOI 10.1017/S0269727000004966; HISLOP JRG, 1986, P ROY SOC EDINB B, V90, P423, DOI 10.1017/S0269727000005133; HOGARTH G, 1937, 55 FISH BOARD SCOT; HOGARTH G, 1938, 56 FISH BOARD SCOTL; HOGARTH GED, 1936, 54 FISH BOARD SCOT; HOWDEN T, 2004, THESIS KINGS COLL LO; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; *ICES, 2008, REP WORKSH GROUP ASS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaworski A, 2006, ICES J MAR SCI, V63, P897, DOI 10.1016/j.icesjms.2006.03.001; JONES DT, 1923, 41 FISH BOARD SCOT; JONES DT, 1927, 45 FISH BOARD SCOT; JONES DT, 1924, 42 FISH BOARD SCOT 1; JONES DT, 1921, 39 FISH BOARD SCOT; Karagiannakos A, 1996, MAR POLICY, V20, P235, DOI 10.1016/0308-597X(96)86986-7; MAITLAND JRG, 1988, FISHERY BOARD SCOTLA, P3; MARTIN A, 2002, HERRING FISHERMEN KI; MCCRINDLE H, 2006, GLASGOW NATURALIST 4, V24, P77; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2003, PERFECT OCEAN STATE, P175; POLTE P, 2004, THESIS BREMEN U; RAE BB, 1959, SCOTTISH FISHERIES B, V14, P14; Roberts C., 2008, RETURN ABUNDANCE CAS; Roberts C., 2007, UNNATURAL HIST SEA F; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Robinson Gwen, 2018, NIKKEI ASIA; Robinson R, 2000, ENGLANDS SEA FISHERI, P72; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SAVILLE A, 1959, SCOTTISH FISHERIES B, V12, P9; *SCOTT HOM DEP, 1949, REP FISH SCOTL 1939; *SCOTT HOM DEP, 1958, REP FISH SCOTL 1957; SCOTT T, 1999, 18 FISH BOARD SCOT 3, P272; SKINNER J, 1898, 16 FISH BOARD SCOTL, P232; Smith Tim D., 2002, P61; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Stentiford GD, 2000, J EXP MAR BIOL ECOL, V247, P169, DOI 10.1016/S0022-0981(00)00146-5; STEVEN JM, 1971, SCOTTISH FISHERIES B, V35, P21; Stone HH, 2004, J SEA RES, V51, P261, DOI 10.1016/j.seares.2003.08.004; SUTHERLAND A, 1897, 15 FISH BOARD SCOT 1, P1; SUTHERLAND A, 1911, 29 FISH BOARD SCOT 1, P1; SUTHERLAND A, 1896, 14 FISH BOARD SCOT 1, P205; SUTHERLAND A, 1914, 32 FISH BOARD SCOT 1, P171; SUTHERLAND A, 2001, 17 FISH BOARD SCOT 1, P170; THOMSON D, 2001, 401 FOOD AGR ORG UN; TIVY J, 1986, P ROY SOC EDINB B, V90, P7, DOI 10.1017/S026972700000484X; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Wilson P., 1887, 5 FISH BOARD SCOT 1, P431; WOOD H, 1960, SCOTTISH FISHERIES B, V13, P23; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; YOUNG A, 1885, 3 FISH BOARD SCOTL, P91; 1756, J HOUSE COMMONS 1688, V27; [No title captured]	96	64	64	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11767	10.1371/journal.pone.0011767	http://dx.doi.org/10.1371/journal.pone.0011767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686614	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200005
J	Ovsyannikova, IG; Vierkant, RA; Pankratz, VS; Jacobson, RM; Poland, GA				Ovsyannikova, Inna G.; Vierkant, Robert A.; Pankratz, V. Shane; Jacobson, Robert M.; Poland, Gregory A.			Extended LTA, TNF, LST1 and HLA Gene Haplotypes and Their Association with Rubella Vaccine-Induced Immunity	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TUMOR-NECROSIS-FACTOR; E1 ENVELOPE PROTEIN; T-CELL; VIRUS-INFECTION; EMERGING FIELD; ALPHA PROMOTER; POLYMORPHISMS; DISEASE; SUSCEPTIBILITY	Background: Recent studies have suggested the importance of HLA genes in determining immune responses following rubella vaccine. The telomeric class III region of the HLA complex harbors several genes, including lymphotoxin alpha (LTA), tumor necrosis factor (TNF) and leukocyte specific transcript -1 (LST1) genes, located between the class I B and class II DRB1 loci. Apart from HLA, little is known about the effect of this extended genetic region on HLA haplotypic backgrounds as applied to immune responses. Methodology/Principal Findings: We examined the association between immune responses and extended class I-class II-class III haplotypes among 714 healthy children after two doses of rubella vaccination. These extended haplotypes were then compared to the HLA-only haplotypes. The most significant association was observed between haplotypes extending across the HLA class I region, ten-SNP haplotypes, and the HLA class II region (i.e. A-C-B-LTA-TNF-LST1-DRB1-DQA1-DQB1-DPA1-DPB1) and rubella-specific antibodies (global p-value of 0.03). Associations were found between both extended A*02-C*03-B*15-AAAACGGGGC-DRB1*04-DQA1*03-DQB1*03-DPA1*01-DPB1*04 (p = 0.002) and HLA-only *02-C*03-B*15-DRB1*04-DQA1*03-DQB1*03-DPA1*01-DPB1*04 haplotypes (p = 0.009) and higher levels of rubella antibodies. The class II HLA-only haplotype DRB1*13-DQA1*01-DQB1*06-DPA1*01-DPB1*04 (p = 0.04) lacking LTA-TNF-LST1 SNPs was associated with lower rubella antibody responses. Similarly, the class I-class II HLA-only A*01-C*07-B*08-DRB1*03-DQA1*05-DQB1*02DPA1*01-DPB1*04 haplotype was associated with increased TNF-alpha secretion levels (p = 0.009). In contrast, the extended AAAACGGGGC-DRB1*01-DQA1*01-DQB1*05-DPA1*01-DPB1*04 (p = 0.01) haplotype was found to trend with decreased rubella-specific IL-6 secretion levels. Conclusions/Significance: These data suggest the importance of examining both HLA genes and genes in the class III region as part of the extended haplotypes useful in understanding genomic drivers regulating immune responses to rubella vaccine.	[Ovsyannikova, Inna G.; Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Jacobson, Robert M.; Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Vierkant, Robert A.; Pankratz, V. Shane] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ovsyannikova, IG (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	ovsyannikova.inna@mayo.edu; poland.gregory@mayo.edu	Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221; Jacobson, Robert/0000-0002-6355-8752	National Center for Research Resources (NCRR), NIH [1 UL1 RR024150-01, AI 48793, AI 33144]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R01AI033144, R37AI048793] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI 48793 (to G. A. P.), AI 33144 (to G. A. P.) and 1 UL1 RR024150-01 from the National Center for Research Resources (NCRR), a component of the NIH, and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Kerr JR, 2003, J CLIN PATHOL, V56, P725, DOI 10.1136/jcp.56.10.725; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Mewar D, 2006, GENES IMMUN, V7, P625, DOI 10.1038/sj.gene.6364339; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nepom GT, 1997, VACCINE, V15, P648, DOI 10.1016/S0264-410X(96)00194-6; OU DW, 1994, HUM IMMUNOL, V39, P177, DOI 10.1016/0198-8859(94)90258-5; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2004, HUM IMMUNOL, V65, P1506, DOI 10.1016/j.humimm.2004.07.001; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Ovsyannikova IG, 2009, VACCINE, V27, P3359, DOI 10.1016/j.vaccine.2009.01.079; Ovsyannikova IG, 2009, VACCINE, V27, P3349, DOI 10.1016/j.vaccine.2009.01.080; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]; Posch PE, 2003, GENES IMMUN, V4, P547, DOI 10.1038/sj.gene.6364023; RAU H, 1995, EUR J IMMUNOGENET, V22, P277, DOI 10.1111/j.1744-313X.1995.tb00242.x; Robinson JH, 2002, IMMUNOLOGY, V105, P252, DOI 10.1046/j.0019-2805.2001.01358.x; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Tomoyose T, 2002, THYROID, V12, P673, DOI 10.1089/105072502760258640; Vejbaesya S, 2009, J INFECT DIS, V199, P1442, DOI 10.1086/597422; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yang Y, 1996, IMMUNOL RES, V15, P208, DOI 10.1007/BF02918250; 1997, VIROLOGY, V235, P286	32	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11806	10.1371/journal.pone.0011806	http://dx.doi.org/10.1371/journal.pone.0011806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668555	Green Published, gold, Green Submitted			2022-12-27	WOS:000280371800010
J	Das, ST; Rajagopalan, L; Guerrero-Plata, A; Sai, J; Richmond, A; Garofalo, RP; Rajarathnam, K				Das, Sandhya Thulasi; Rajagopalan, Lavanya; Guerrero-Plata, Antonieta; Sai, Jiqing; Richmond, Ann; Garofalo, Roberto P.; Rajarathnam, Krishna			Monomeric and Dimeric CXCL8 Are Both Essential for In Vivo Neutrophil Recruitment	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR1; HEPARAN-SULFATE; HOST-DEFENSE; INTERLEUKIN-8; BINDING; GLYCOSAMINOGLYCANS; OLIGOMERIZATION; ANTAGONISTS; ACTIVATION; RESPONSES	Rapid mobilization of neutrophils from vasculature to the site of bacterial/viral infections and tissue injury is a critical step in successful resolution of inflammation. The chemokine CXCL8 plays a central role in recruiting neutrophils. A characteristic feature of CXCL8 is its ability to reversibly exist as both monomers and dimers, but whether both forms exist in vivo, and if so, the relevance of each form for in vivo function is not known. In this study, using a 'trapped' non-associating monomer and a non-dissociating dimer, we show that (i) wild type (WT) CXCL8 exists as both monomers and dimers, (ii) the in vivo recruitment profiles of the monomer, dimer, and WT are distinctly different, and (iii) the dimer is essential for initial robust recruitment and the WT is most active for sustained recruitment. Using a microfluidic device, we also observe that recruitment is not only dependent on the total amount of CXCL8 but also on the steepness of the gradient, and the gradients created by different CXCL8 variants elicit different neutrophil migratory responses. CXCL8 mediates its function by binding to CXCR2 receptor on neutrophils and glycosaminoglycans (GAGs) on endothelial cells. On the basis of our data, we propose that dynamic equilibrium between CXCL8 monomers and dimers and their differential binding to CXCR2 and GAGs mediates and regulates in vivo neutrophil recruitment. Our finding that both CXCL8 monomer and dimer are functional in vivo is novel, and indicates that the CXCL8 monomer-dimer equilibrium and neutrophil recruitment are intimately linked in health and disease.	[Das, Sandhya Thulasi; Rajagopalan, Lavanya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Guerrero-Plata, Antonieta; Garofalo, Roberto P.; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Garofalo, Roberto P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX USA; [Sai, Jiqing; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Vet Affairs, Nashville, TN 37212 USA; [Sai, Jiqing; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Vanderbilt University; Vanderbilt University	Das, ST (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA.	krrajara@utmb.edu	DAS, SANDHYA/I-1763-2018; Garofalo, Roberto P./ABL-2322-2022; Sawant, Kirti V/H-3778-2013; Garofalo, Roberto P./AAF-7385-2022	Tripp, Ralph/0000-0002-2924-9956; RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health [AI-069152, CA34590]; Department of Veterans Affairs; McLaughlin Foundation; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); McLaughlin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health AI-069152 (K.R.) and CA34590 (A.R.) and the Department of Veterans Affairs (A.R.). S.T.D. and L.R. were supported in part by the McLaughlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Frevert CW, 2002, J IMMUNOL, V168, P3550, DOI 10.4049/jimmunol.168.7.3550; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HECHTMAN DH, 1991, J IMMUNOL, V147, P883; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LEE J, 1995, J IMMUNOL, V155, P2158; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; MOSER B, 1993, J BIOL CHEM, V268, P7125; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; RAJARATHNAM K, 1995, BIOCHEMISTRY-US, V34, P12983, DOI 10.1021/bi00040a008; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; SQUIER MKT, 1995, J LEUKOCYTE BIOL, V57, P2, DOI 10.1002/jlb.57.1.2; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; VANHAL PTW, 1995, CELL PROLIFERAT, V28, P533, DOI 10.1111/j.1365-2184.1995.tb00042.x; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	50	79	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11754	10.1371/journal.pone.0011754	http://dx.doi.org/10.1371/journal.pone.0011754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668677	Green Published, Green Submitted, gold			2022-12-27	WOS:000280297300004
J	Saito, S; Mukohara, K; Bito, S				Saito, Sayaka; Mukohara, Kei; Bito, Seiji			Japanese Practicing Physicians' Relationships with Pharmaceutical Representatives: A National Survey	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; SALES REPRESENTATIVES; MEDICINE RESIDENTS; INDUSTRY; ATTITUDES; COMPANIES; GIFTS; DOCTORS	Background: Previous surveys on the relationship between physicians and pharmaceutical representatives (PRs) have been of limited quality. The purpose of our survey of practicing physicians in Japan was to assess the extent of their involvement in pharmaceutical promotional activities, physician characteristics that predict such involvement, attitudes toward relationships with PRs, correlations between the extent of involvement and attitudes, and differences in the extent of involvement according to self-reported prescribing behaviors. Methods and Findings: From January to March 2008, we conducted a national survey of 2621 practicing physicians in seven specialties: internal medicine, general surgery, orthopedic surgery, pediatrics, obstetrics-gynecology, psychiatry, and ophthalmology. The response rate was 54%. Most physicians met with PRs (98%), received drug samples (85%) and stationery (96%), and participated in industry-sponsored continuing medical education (CME) events at the workplace (80%) and outside the workplace (93%). Half accepted meals outside the workplace (49%) and financial subsidies to attend CME events (49%). Rules at the workplace banning both meetings with PRs and gifts predicted less involvement of physicians in promotional activities. Physicians valued information from PRs. They believed that they were unlikely to be influenced by promotional activities, but that their colleagues were more susceptible to such influence than themselves. They were divided about the appropriateness of low-value gifts. The extent of physician involvement in promotional activities was positively correlated with the attitudes that PRs are a valuable source of information and that gifts are appropriate. The extent of such involvement was higher among physicians who prefer to ask PRs for information when a new medication becomes available, physicians who are not satisfied with patient encounters ending only with advice, and physicians who prefer to prescribe brand-name medications. Conclusions: Involvement in pharmaceutical promotional activities is widespread among practicing physicians in Japan. The extent of such involvement varies according to certain physician characteristics. As a group, they are at risk for influence by promotional activities.	[Saito, Sayaka] Tsukuba Med Ctr Hosp, Dept Gen Med & Primary Care, Ibaraki, Japan; [Mukohara, Kei] Natl Hosp Org Nagasaki Med Ctr, Dept Gen Internal Med, Nagasaki, Japan; [Bito, Seiji] Natl Hosp Org Tokyo Med Ctr, Div Clin Epidemiol, Tokyo, Japan		Saito, S (corresponding author), Tsukuba Med Ctr Hosp, Dept Gen Med & Primary Care, Ibaraki, Japan.	sayakasaitou@gmail.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This survey was partly supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldir R., 1996, J CONTIN EDUC HEALTH, V16, P25; Brett AS, 2003, ARCH INTERN MED, V163, P2213, DOI 10.1001/archinte.163.18.2213; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Ferguson RP, 1999, AM J MED, V107, P149, DOI 10.1016/S0002-9343(99)00192-8; Guldal D, 2000, INT J HEALTH SERV, V30, P585, DOI 10.2190/GYW9-XUMQ-M3K2-T31C; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; HAYES TM, 1990, BRIT J GEN PRACT, V40, P510; HODGES B, 1995, CAN MED ASSOC J, V153, P553; Madhavan S, 1997, J CLIN PHARM THER, V22, P207, DOI 10.1046/j.1365-2710.1997.94975949.x; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; *MIN HLTH LAB WELF, 2004, SURV PHYS DENT PHARM; Morgan MA, 2006, J MED ETHICS, V32, P559, DOI 10.1136/jme.2005.014480; REEDER M, 1993, ANN EMERG MED, V22, P1593, DOI 10.1016/S0196-0644(05)81266-1; Sergeant MD, 1996, CAN MED ASSOC J, V155, P1243; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Sigworth SK, 2001, JAMA-J AM MED ASSOC, V286, P1024, DOI 10.1001/jama.286.9.1024-a; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Strang D, 1996, Ann R Coll Physicians Surg Can, V29, P474; THOMSON AN, 1994, BRIT J GEN PRACT, V44, P220; Watkins C, 2003, BRIT MED J, V326, P1178, DOI 10.1136/bmj.326.7400.1178	23	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12193	10.1371/journal.pone.0012193	http://dx.doi.org/10.1371/journal.pone.0012193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730093	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200028
J	Zacchi, LF; Schulz, WL; Davis, DA				Zacchi, Lucia F.; Schulz, Wade L.; Davis, Dana A.			HOS2 and HDA1 Encode Histone Deacetylases with Opposing Roles in Candida albicans Morphogenesis	PLOS ONE			English	Article							FILAMENTOUS GROWTH; DISTINCT ROLES; PH RESPONSES; COMPLEX; RPD3; CELL; RECRUITMENT; REPRESSION; RESISTANCE; INHIBITORS	Epigenetic mechanisms regulate the expression of virulence traits in diverse pathogens, including protozoan and fungi. In the human fungal pathogen Candida albicans, virulence traits such as antifungal resistance, white-opaque switching, and adhesion to lung cells are regulated by histone deacetylases (HDACs). However, the role of HDACs in the regulation of the yeast-hyphal morphogenetic transitions, a critical virulence attribute of C. albicans, remains poorly explored. In this study, we wished to determine the relevance of other HDACs on C. albicans morphogenesis. We generated mutants in the HDACs HOS1, HOS2, RPD31, and HDA1 and determined their ability to filament in response to different environmental stimuli. We found that while HOS1 and RPD31 have no or a more limited role in morphogenesis, the HDACs HOS2 and HDA1 have opposite roles in the regulation of hyphal formation. Our results demonstrate an important role for HDACs on the regulation of yeast-hyphal transitions in the human pathogen C. albicans.	[Zacchi, Lucia F.; Schulz, Wade L.; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zacchi, LF (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	zacch002@umn.edu	Zacchi, Lucia/N-6484-2019; Schulz, Wade/A-5737-2013; Zacchi, Lucia/F-7494-2016	Zacchi, Lucia/0000-0001-6217-1380; Schulz, Wade/0000-0002-2048-4028; Zacchi, Lucia/0000-0001-6217-1380	Burroughs Wellcome Fund; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01-AI064054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064054] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund and by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases award R01-AI064054 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Adams A, 1997, METHODS YEAST GENETI; Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis DA, 2002, GENETICS, V162, P1573; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Hnisz D, 2009, MOL MICROBIOL, V74, P1, DOI 10.1111/j.1365-2958.2009.06772.x; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Khalaf RA, 2001, GENETICS, V157, P1503; Klar AJS, 2001, GENETICS, V158, P919; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2008, MOL BIOL CELL, V19, P4260, DOI 10.1091/mbc.E08-02-0173; Mai A, 2007, BIOORG MED CHEM LETT, V17, P1221, DOI 10.1016/j.bmcl.2006.12.028; Mao XM, 2006, FEBS LETT, V580, P2615, DOI 10.1016/j.febslet.2006.04.009; Niimi M, 2010, ODONTOLOGY, V98, P15, DOI 10.1007/s10266-009-0118-3; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3797, DOI 10.1128/JCM.00618-09; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Raman SB, 2006, MOL MICROBIOL, V60, P697, DOI 10.1111/j.1365-2958.2006.05121.x; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Romani L, 2004, INT IMMUNOL, V16, P149, DOI 10.1093/intimm/dxh012; Romani L, 2003, CURR OPIN MICROBIOL, V6, P338, DOI 10.1016/S1369-5274(03)00081-X; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Saville SP, 2008, INFECT IMMUN, V76, P97, DOI 10.1128/IAI.00982-07; Sciascia QL, 2004, CAN J MICROBIOL, V50, P1081, DOI [10.1139/w04-095, 10.1139/W04-095]; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Simonetti G, 2007, FEMS YEAST RES, V7, P1371, DOI 10.1111/j.1567-1364.2007.00276.x; Smith WL, 2002, ANTIMICROB AGENTS CH, V46, P3532, DOI 10.1128/AAC.46.11.3532-3539.2002; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tebarth B, 2003, J MOL BIOL, V329, P949, DOI 10.1016/S0022-2836(03)00505-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	60	26	31	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12171	10.1371/journal.pone.0012171	http://dx.doi.org/10.1371/journal.pone.0012171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730094	Green Submitted, Green Published, gold			2022-12-27	WOS:000280862200023
J	Briatore, F; Patrizi, A; Viltono, L; Sassoe-Pognetto, M; Wulff, P				Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco; Wulff, Peer			Quantitative Organization of GABAergic Synapses in the Molecular Layer of the Mouse Cerebellar Cortex	PLOS ONE			English	Article							GABA(A) RECEPTOR SUBTYPES; INHIBITORY SYNAPTIC CURRENTS; PURKINJE-CELLS; PARALLEL FIBER; STELLATE CELLS; SUBUNIT GENE; SPIKE OUTPUT; LUGARO CELL; A RECEPTORS; RAT	In the cerebellar cortex, interneurons of the molecular layer (stellate and basket cells) provide GABAergic input to Purkinje cells, as well as to each other and possibly to other interneurons. GABAergic inhibition in the molecular layer has mainly been investigated at the interneuron to Purkinje cell synapse. In this study, we used complementary subtractive strategies to quantitatively assess the ratio of GABAergic synapses on Purkinje cell dendrites versus those on interneurons. We generated a mouse model in which the GABA(A) receptor alpha 1 subunit (GABA(A)R alpha 1) was selectively removed from Purkinje cells using the Cre/loxP system. Deletion of the a1 subunit resulted in a complete loss of GABA(A)R aggregates from Purkinje cells, allowing us to determine the density of GABA(A)R clusters in interneurons. In a complementary approach, we determined the density of GABA synapses impinging on Purkinje cells using alpha-dystroglycan as a specific marker of inhibitory postsynaptic sites. Combining these inverse approaches, we found that synapses received by interneurons represent approximately 40% of all GABAergic synapses in the molecular layer. Notably, this proportion was stable during postnatal development, indicating synchronized synaptogenesis. Based on the pure quantity of GABAergic synapses onto interneurons, we propose that mutual inhibition must play an important, yet largely neglected, computational role in the cerebellar cortex.	[Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Briatore, Federica; Patrizi, Annarita; Viltono, Laura; Sassoe-Pognetto, Marco] Natl Inst Neurosci Italy, Turin, Italy; [Wulff, Peer] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Turin; University of Aberdeen	Briatore, F (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	marco.sassoe@unito.it	Sassoe-Pognetto, Marco/AAE-3536-2022	Wulff, Peer/0000-0002-0282-7832; Sassoe-Pognetto, Marco/0000-0001-8906-0613	Compagnia di San Paolo; Regione Piemonte [A218]; Royal Society [RG081195]; Medical Research Council [G0800399]; Fondazione CRT; Italian MUR; Medical Research Council [G0601498] Funding Source: researchfish; MRC [G0800399, G0601498] Funding Source: UKRI	Compagnia di San Paolo(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondazione CRT(Fondazione CRT); Italian MUR(Ministry of Education, Universities and Research (MIUR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Compagnia di San Paolo (2007) and Regione Piemonte (Ricerca Scientifica Applicata A218 and Ricerca Sanitaria Finalizzata 2006 and 2008) to M. S. P., and grants from The Royal Society (RG081195) and the Medical Research Council (G0800399) to P. W. F. B. received financial support from Fondazione CRT (Progetto Lagrange, Borse di Ricerca bando n. 6, 2007) and the Italian MUR (Assegno di Ricerca, XIII tornata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chavas J, 2003, J NEUROSCI, V23, P2019; Dean I, 2003, J NEUROSCI, V23, P4457; Dieudonne S, 2000, J NEUROSCI, V20, P1837; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Eccles JC, 1967, CEREBELLUM NEURONAL; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FOX FA, 1967, PROG BRAIN RES, V25, P174; Fritschy JM, 2006, CEREBELLUM, V5, P275, DOI 10.1080/14734220600962805; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Grady RM, 2006, J NEUROSCI, V26, P2841, DOI 10.1523/JNEUROSCI.4823-05.2006; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Howard CV, 2005, UNBIASED STEREOLOGY; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Laine J, 2002, NEUROSCIENCE, V115, P363, DOI 10.1016/S0306-4522(02)00421-9; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; Llinas R.R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.003.0007, DOI 10.1093/ACPR0F:0S0/9780195159561.003.0007, DOI 10.1093/ACPROF:OSO/9780195159561.003.0007]; Maex R, 2003, J NEUROSCI, V23, P10503; Maex R, 2005, PROG BRAIN RES, V148, P181, DOI 10.1016/S0079-6123(04)48015-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Nakanishi S, 2005, TRENDS NEUROSCI, V28, P93, DOI 10.1016/j.tins.2004.12.004; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Palay S. L., 1974, CEREBELLAR CORTEX CY; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEME N, VII; Rokni D, 2008, FRONT NEUROSCI-SWITZ, V2, P186, DOI 10.3389/neuro.01.036.2008; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Santamaria F, 2002, J COMPUT NEUROSCI, V13, P217, DOI 10.1023/A:1020266315730; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schilling K, 2008, HISTOCHEM CELL BIOL, V130, P601, DOI 10.1007/s00418-008-0483-y; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sillitoe RV, 2008, J NEUROSCI, V28, P2820, DOI 10.1523/JNEUROSCI.4145-07.2008; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Solinas S, 2003, NEUROCOMPUTING, V52-4, P97, DOI 10.1016/S0925-2312(02)00846-9; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sultan F, 1998, J COMP NEUROL, V393, P353; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Viltono L, 2008, J COMP NEUROL, V508, P579, DOI 10.1002/cne.21713; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102	69	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12119	10.1371/journal.pone.0012119	http://dx.doi.org/10.1371/journal.pone.0012119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711348	gold, Green Submitted, Green Published			2022-12-27	WOS:000280859700012
J	Meijaard, E; Welsh, A; Ancrenaz, M; Wich, S; Nijman, V; Marshall, AJ				Meijaard, Erik; Welsh, Alan; Ancrenaz, Marc; Wich, Serge; Nijman, Vincent; Marshall, Andrew J.			Declining Orangutan Encounter Rates from Wallace to the Present Suggest the Species Was Once More Abundant	PLOS ONE			English	Article							POPULATION-DENSITY; PONGO-PYGMAEUS; KALIMANTAN; FORESTS; INDONESIA; QUALITY	Background: Bornean orangutans (Pongo pygmaeus) currently occur at low densities and seeing a wild one is a rare event. Compared to present low encounter rates of orangutans, it is striking how many orangutan each day historic collectors like Alfred Russel Wallace were able to shoot continuously over weeks or even months. Does that indicate that some 150 years ago encounter rates with orangutans, or their densities, were higher than now? Methodology/Principal Findings: We test this hypothesis by quantifying encounter rates obtained from hunting accounts, museum collections, and recent field studies, and analysing whether there is a declining trend over time. Logistic regression analyses of our data support such a decline on Borneo between the mid-19th century and the present. Even when controlled for variation in the size of survey and hunting teams and the durations of expeditions, mean daily encounter rates appear to have declined about 6-fold in areas with little or no forest disturbance. Conclusions/Significance: This finding has potential consequences for our understanding of orangutans, because it suggests that Bornean orangutans once occurred at higher densities. We explore potential explanations-habitat loss and degradation, hunting, and disease-and conclude that hunting fits the observed patterns best. This suggests that hunting has been underestimated as a key causal factor of orangutan density and distribution, and that species population declines have been more severe than previously estimated based on habitat loss only. Our findings may require us to rethink the biology of orangutans, with much of our ecological understanding possibly being based on field studies of animals living at lower densities than they did historically. Our approach of quantifying species encounter rates from historic data demonstrates that this method can yield valuable information about the ecology and population density of species in the past, providing new insight into species' conservation needs.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Welsh, Alan] Australian Natl Univ, Inst Math Sci, Ctr Math & Its Applicat, Canberra, ACT, Australia; [Ancrenaz, Marc] Kinabatangan Orangutan Conservat Project, Sandakan, Sabah, Malaysia; [Wich, Serge] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Wich, Serge] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Nijman, Vincent] Zool Museum Amsterdam, Amsterdam, Netherlands; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA	People & Nature Consulting International; Australian National University; Australian National University; University of Zurich; University of Amsterdam; Oxford Brookes University; University of California System; University of California Davis; University of California System; University of California Davis	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@pnc-int.com	Nijman, Vincent/AHD-8685-2022; Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685; Nijman, Vincent/0000-0002-5600-4276; Wich, Serge/0000-0003-3954-5174; Welsh, Alan/0000-0002-3165-9559				[Anonymous], 2011, ROBUST STAT APPROACH; BANKS E, 1931, J MAL BR AS SOC, V9, P137; Beccari O., 1904, WANDERINGS GREAT FOR; BROOKE J, 1841, P ZOOL SOC LOND, P55; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DAVENPORT RK, 1967, ORYX, V20, P40; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; DERUITER LC, 1932, UIT BORNEOS WONDERWE; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Harrington D, 2000, SERV IND J, V20, P133; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; Hornaday William Temple, 1885, 2 YEARS JUNGLE EXPER; Hui C, 2006, ECOL MODEL, V192, P317, DOI 10.1016/j.ecolmodel.2005.07.001; Husson Simon J., 2009, P77; Johnson Osa., 1966, LAST ADVENTURE M JOH LAST ADVENTURE M JOH; Knapen Han, 2001, FORESTS FORTUNE ENV, P1600; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Lumholtz Carl, 1920, CENTRAL BORNEO ACCOU; MacKinnon Kathy, 1996, ECOLOGY KALIMANTAN I; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall Andrew J., 2009, P311; Marshall Andrew J., 2009, P97; MEIJAARD E, PLOSONE; MEIJAARD E, 2005, RAFFLES B ZOOL, V53, P121; MENGERSEN K, SIGNIFICANC IN PRESS; MOHNICKE O, 1883, BLICKE PFLANZEN THIE; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rijksen H. D, 1978, THESIS AGR U WAGENIN; Rijksen HD, 1999, OUR VANISHING RELATI; Russon Anne E., 2009, P327; SCHALLER GEORGE B., 1961, ZOOLOGICA [NEW YORK], V46, P73; SELENKA E, 1898, SITZ KONIGL PREUSS A, V16, P1; Singleton I., 2004, ORANGUTAN POPULATION; STEWARTOATEN A, 1995, ECOLOGY, V76, P2001, DOI 10.2307/1940736; Veth P.J., 1854, BORNEOS WESTER AFDEE; WALLACE AR, 1869, MALAY ARCHIPELAGO LA; WECHELTE G, 1911, TROP NAT, V1, P49; WEITZEL V, 1988, Raffles Bulletin of Zoology, V36, P1; Wich S, 2004, PRIMATES, V45, P177, DOI 10.1007/s10329-004-0080-1	43	27	27	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12042	10.1371/journal.pone.0012042	http://dx.doi.org/10.1371/journal.pone.0012042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711451	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000280849100008
J	Moran, AL; Woods, HA				Moran, Amy L.; Woods, H. Arthur			Limits to Diffusive O-2 Transport: Flow, Form, and Function in Nudibranch Egg Masses from Temperate and Polar Regions	PLOS ONE			English	Article							ANTARCTIC SEA-URCHIN; EMBRYONIC-DEVELOPMENT; OPISTHOBRANCH MOLLUSKS; ULTRAVIOLET-RADIATION; OXYGEN AVAILABILITY; AMBYSTOMA-MACULATUM; DEVELOPMENTAL MODE; MARINE GASTROPODS; PACIFIC-OCEAN; CLUTCH SIZE	Background: Many aquatic animals enclose embryos in gelatinous masses, and these embryos rely on diffusion to supply oxygen. Mass structure plays an important role in limiting or facilitating O-2 supply, but external factors such as temperature and photosynthesis can play important roles as well. Other external factors are less well understood. Methodology/Principal Findings: We first explored the effects of water flow on O-2 levels inside nudibranch embryo masses and compared the effects of flow on masses from temperate and polar regions. Water flow (still vs. vigorously bubbled) had a strong effect on central O-2 levels in all masses; in still water, masses were considerably more hypoxic than in bubbled water. This effect was stronger in temperate than in polar masses, likely due to the increased metabolic demand and O-2 consumption of temperate masses. Second, we made what are to our knowledge the first measurements of O-2 in invertebrate masses in the field. Consistent with laboratory experiments, O-2 in Antarctic masses was high in masses in situ, suggesting that boundary-layer effects do not substantially limit O-2 supply to polar embryos in the field. Conclusions/Significance: All else being equal, boundary layers are more likely to depress O-2 in masses in temperate or tropical regions; thus, selection on parents to choose high-flow sites for mass deposition is likely greater in warm water. Because of the large number of variables affecting diffusive O-2 supply to embryos in their natural environment, field observations are necessary to test hypotheses generated from laboratory experiments and mathematical modeling.	[Moran, Amy L.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Woods, H. Arthur] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Clemson University; University of Montana System; University of Montana	Moran, AL (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	moran@clemson.edu	Moran, Amy/F-7072-2011	Moran, Amy/0000-0002-0604-5096	National Science Foundation [ANT-0551969, ANT-0440577]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Office of Polar Programs (ANT-0551969 to ALM and ANT-0440577 to HAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancino JM, 2000, MAR ECOL PROG SER, V200, P141, DOI 10.3354/meps200141; CHAFFEE C, 1984, J EXP MAR BIOL ECOL, V84, P73, DOI 10.1016/0022-0981(84)90231-4; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Cohen CS, 1996, BIOL BULL, V190, P8, DOI 10.2307/1542671; Fernandez M, 2007, MAR ECOL PROG SER, V348, P229, DOI 10.3354/meps07032; Finelli CM, 2007, MAR ECOL PROG SER, V349, P103, DOI 10.3354/meps07101; Finelli CM, 2006, CORAL REEFS, V25, P47, DOI 10.1007/s00338-005-0055-8; GIORGI AE, 1984, ENVIRON BIOL FISH, V10, P15, DOI 10.1007/BF00001659; Goddard JHR, 2008, VELIGER, V50, P83; Goddard JHR, 2004, CAN J ZOOL, V82, P1954, DOI 10.1139/Z05-008; Lee CE, 1998, AM NAT, V151, P293, DOI 10.1086/286120; Marsh AG, 2000, MAR BIOL, V137, P215, DOI 10.1007/s002270000364; Marsh AG, 1999, J EXP BIOL, V202, P2041; Mills NE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P179, DOI 10.1086/316657; Mitchell NJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P60, DOI 10.1086/345486; Moran AL, 2007, J EXP BIOL, V210, P722, DOI 10.1242/jeb.02702; PATYLER, GENETICS, V201, P209; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2002, MAR BIOL, V141, P271, DOI 10.1007/s00227-002-0834-5; PINDER AW, 1994, J EXP BIOL, V197, P17; PINHEIRO JC, 2000, SPRINGER; PO R, 2007, SCIENCES, V362, P2233; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; RAWLINGS TA, 1994, EVOLUTION, V48, P1301, DOI 10.1111/j.1558-5646.1994.tb05314.x; Rawlings TA, 1996, MAR ECOL PROG SER, V136, P81, DOI 10.3354/meps136081; Rawlings TA, 1999, AM ZOOL, V39, P230; Steer MA, 2007, REV FISH BIOL FISHER, V17, P173, DOI 10.1007/s11160-006-9023-9; STRATHMANN MF, 1987, METHODS, P670; Strathmann RR, 2006, POLAR BIOL, V29, P495, DOI 10.1007/s00300-005-0080-7; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; STRATHMANN RR, 1995, J MAR BIOL ASSOC UK, V75, P413, DOI 10.1017/S0025315400018270; STRATHMANN RR, 1989, CONSTRAINTS; Thompson TE., 1976, BIOL OPISTHOBRANCH M, V1; Valls JH, 2007, J EXP BIOL, V210, P2430, DOI 10.1242/jeb.003541; von Dassow YJ, 2005, MAR ECOL PROG SER, V294, P23, DOI 10.3354/meps294023; Woods HA, 2008, J EXP BIOL, V211, P798, DOI 10.1242/jeb.014621; Woods HA, 2008, J EXP BIOL, V211, P790, DOI 10.1242/jeb.014613; Woods HA, 2007, BIOL BULL-US, V213, P88, DOI 10.2307/25066621; WOODS HA, 2009, SCIENCES, V276, P1069	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12113	10.1371/journal.pone.0012113	http://dx.doi.org/10.1371/journal.pone.0012113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711406	Green Submitted, gold, Green Published			2022-12-27	WOS:000280849100028
J	Politis, A; Park, AY; Hyung, SJ; Barsky, D; Ruotolo, BT; Robinson, CV				Politis, Argyris; Park, Ah Young; Hyung, Suk-Joon; Barsky, Daniel; Ruotolo, Brandon T.; Robinson, Carol V.			Integrating Ion Mobility Mass Spectrometry with Molecular Modelling to Determine the Architecture of Multiprotein Complexes	PLOS ONE			English	Article							DNA-POLYMERASE-III; INTACT PROTEIN COMPLEXES; N-TERMINAL DOMAIN; SUBUNIT ARCHITECTURE; CRYSTAL-STRUCTURE; SLIDING-CLAMP; HELICASE; HOLOENZYME; PEPTIDES; DYNAMICS	Current challenges in the field of structural genomics point to the need for new tools and technologies for obtaining structures of macromolecular protein complexes. Here, we present an integrative computational method that uses molecular modelling, ion mobility-mass spectrometry (IM-MS) and incomplete atomic structures, usually from X-ray crystallography, to generate models of the subunit architecture of protein complexes. We begin by analyzing protein complexes using IM-MS, and by taking measurements of both intact complexes and sub-complexes that are generated in solution. We then examine available high resolution structural data and use a suite of computational methods to account for missing residues at the subunit and/or domain level. High-order complexes and sub-complexes are then constructed that conform to distance and connectivity constraints imposed by IM-MS data. We illustrate our method by applying it to multimeric protein complexes within the Escherichia coli replisome: the sliding clamp, (beta(2)), the c complex (gamma(3)delta delta'), the DnaB helicase (DnaB(6)) and the Single-Stranded Binding Protein (SSB(4)).	[Politis, Argyris; Park, Ah Young; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford, England; [Hyung, Suk-Joon; Barsky, Daniel] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Ruotolo, Brandon T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Oxford; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Michigan System; University of Michigan	Politis, A (corresponding author), Univ Oxford, Dept Chem, Oxford, England.	carol.robinson@chem.ox.ac.uk	Politis, Argyris/R-4333-2019; Hyung, Suk-Joon/N-6449-2014; Ruotolo, Brandon/F-2669-2013	Hyung, Suk-Joon/0000-0001-6759-4219; Ruotolo, Brandon/0000-0002-6084-2328; Park, Ahyoung/0000-0002-5212-4369; robinson, carol/0000-0001-7829-5505	British Biotechnology and Biological Sciences Research Council [BB/G000360/1]; BBSRC [BB/G000360/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000360/1] Funding Source: researchfish	British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the British Biotechnology and Biological Sciences Research Council. Grant Reference: BB/G000360/1. URL: http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Clemmer DE, 1997, J MASS SPECTROM, V32, P577; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hoaglund-Hyzer CS, 1999, CHEM REV, V99, P3037, DOI 10.1021/cr980139g; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jarrold MF, 2000, ANNU REV PHYS CHEM, V51, P179, DOI 10.1146/annurev.physchem.51.1.179; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Kinnear BS, 2002, J AM CHEM SOC, V124, P4422, DOI 10.1021/ja012150v; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15673, DOI 10.1073/pnas.0907684106; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15667, DOI 10.1073/pnas.0907674106; Kundu S, 2004, PROTEINS, V57, P725, DOI 10.1002/prot.20268; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Lane LA, 2009, INT J MASS SPECTROM, V283, P169, DOI 10.1016/j.ijms.2009.03.006; Leary JA, 2009, J AM SOC MASS SPECTR, V20, P1699, DOI 10.1016/j.jasms.2009.05.003; Loo JA, 2005, J AM SOC MASS SPECTR, V16, P998, DOI 10.1016/j.jasms.2005.02.017; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; O'Donnell M, 2006, CURR OPIN STRUC BIOL, V16, P35, DOI 10.1016/j.sbi.2005.12.004; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P1192, DOI 10.1107/S0907444903009958; Park AY, 2010, STRUCTURE, V18, P285, DOI 10.1016/j.str.2010.01.009; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Pukala TL, 2009, STRUCTURE, V17, P1235, DOI 10.1016/j.str.2009.07.013; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2007, ANGEW CHEM INT EDIT, V46, P8001, DOI 10.1002/anie.200702161; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j; Wyttenbach T, 2007, ANNU REV PHYS CHEM, V58, P511, DOI 10.1146/annurev.physchem.58.032806.104515; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	50	108	108	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12080	10.1371/journal.pone.0012080	http://dx.doi.org/10.1371/journal.pone.0012080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711472	Green Submitted, Green Published, gold			2022-12-27	WOS:000280811900024
J	Hong, YJ; Marjoram, P; Shibata, D; Siegmund, KD				Hong, You Jin; Marjoram, Paul; Shibata, Darryl; Siegmund, Kimberly D.			Using DNA Methylation Patterns to Infer Tumor Ancestry	PLOS ONE			English	Article							COLORECTAL CANCERS; EVOLUTION	Background: Exactly how human tumors grow is uncertain because serial observations are impractical. One approach to reconstruct the histories of individual human cancers is to analyze the current genomic variation between its cells. The greater the variations, on average, the greater the time since the last clonal evolution cycle ("a molecular clock hypothesis''). Here we analyze passenger DNA methylation patterns from opposite sides of 12 primary human colorectal cancers (CRCs) to evaluate whether the variation (pairwise distances between epialleles) is consistent with a single clonal expansion after transformation. Methodology/Principal Findings: Data from 12 primary CRCs are compared to epigenomic data simulated under a single clonal expansion for a variety of possible growth scenarios. We find that for many different growth rates, a single clonal expansion can explain the population variation in 11 out of 12 CRCs. In eight CRCs, the cells from different glands are all equally distantly related, and cells sampled from the same tumor half appear no more closely related than cells sampled from opposite tumor halves. In these tumors, growth appears consistent with a single "symmetric'' clonal expansion. In three CRCs, the variation in epigenetic distances was different between sides, but this asymmetry could be explained by a single clonal expansion with one region of a tumor having undergone more cell division than the other. The variation in one CRC was complex and inconsistent with a simple single clonal expansion. Conclusions: Rather than a series of clonal expansion after transformation, these results suggest that the epigenetic variation of present-day cancer cells in primary CRCs can almost always be explained by a single clonal expansion.	[Hong, You Jin; Marjoram, Paul; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Hong, YJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	kims@usc.edu			National Cancer Institute (NCI) [2R01 CA097346]; NATIONAL CANCER INSTITUTE [R21CA149990, R01CA097346] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant number 2R01 CA097346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Anderson A., 2007, SINGLE CELL BASED MO; Beaumont MA, 2002, GENETICS, V162, P2025; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Gerlee P, 2009, J THEOR BIOL, V259, P67, DOI 10.1016/j.jtbi.2009.03.005; Lacey MR, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1489; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Siegmund KD, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1374; Siegmund KD, 2009, CELL CYCLE, V8, P2187, DOI 10.4161/cc.8.14.9151; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	13	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12002	10.1371/journal.pone.0012002	http://dx.doi.org/10.1371/journal.pone.0012002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711251	Green Published, gold, Green Submitted			2022-12-27	WOS:000280776800004
J	Johannesson, K; Saltin, SH; Duranovic, I; Havenhand, JN; Jonsson, PR				Johannesson, Kerstin; Saltin, Sara H.; Duranovic, Iris; Havenhand, Jon N.; Jonsson, Per R.			Indiscriminate Males: Mating Behaviour of a Marine Snail Compromised by a Sexual Conflict?	PLOS ONE			English	Article							LITTORINA-SAXATILIS OLIVI; INTERTIDAL SNAIL; EVOLUTION; PROSOBRANCHIA; DISCRIMINATION; POLYMORPHISM; DAMSELFLIES; POLYANDRY; PREDATION; SELECTION	Background: In promiscuous species, male fitness is expected to increase with repeated matings in an open-ended fashion (thereby increasing number of partners or probability of paternity) whereas female fitness should level out at some optimal number of copulations when direct and indirect benefits still outweigh the costs of courtship and copulation. After this fitness peak, additional copulations would incur female fitness costs and be under opposing selection. Hence, a sexual conflict over mating frequency may evolve in species where females are forced to engage in costly matings. Under such circumstance, if females could avoid male detection, significant fitness benefits from such avoidance strategies would be predicted. Methodology/Principal Findings: Among four Littorina species, one lives at very much higher densities and has a longer mating season than the other three species. Using video records of snail behaviour in a laboratory arena we show that males of the low-density species discriminate among male and female mucous trails, trailing females for copulations. In the high-density species, however, males fail to discriminate between male and female trails, not because males are unable to identify female trails (which we show using heterospecific females), but because females do not, as the other species, add a gender-specific cue to their trail. Conclusions/Significance: We conclude that there is likely a sexual conflict over mating frequency in the high-density species (L. saxatilis) owing to females most likely being less sperm-limited in this species. This has favoured the evolution of females that permanently or optionally do not release a cue in the mucus to decrease excessive and costly matings resulting in unusually high frequencies of male-male copulating attempts in the wild. This is one of few examples of masking gender identity to obtain fewer matings.	[Johannesson, Kerstin; Saltin, Sara H.; Duranovic, Iris; Havenhand, Jon N.; Jonsson, Per R.] Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden	University of Gothenburg	Johannesson, K (corresponding author), Univ Gothenburg, Dept Marine Ecol Tjarno, Stromstad, Sweden.	Kerstin.Johannesson@marecol.gu.se	Jonsson, Per R/E-6707-2013; Johannesson, Kerstin/B-5528-2013; Johannesson, Kerstin/X-7994-2019; Havenhand, Jon N/F-5435-2013	Johannesson, Kerstin/0000-0003-0176-7986; Johannesson, Kerstin/0000-0003-0176-7986; Havenhand, Jon N/0000-0003-0253-3428; Havenhand, Jonathan/0000-0001-6721-7763; Jonsson, Per/0000-0002-1793-5473	Swedish Research Councils	Swedish Research Councils(Swedish Research Council)	This study was performed at the Linnaeus Centre for Marine Evolutionary Biology (http://www.cemeb.science.gu/) and supported by grants from the Swedish Research Councils (VR and Formas) to KJ, JNH and PRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; Arnqvist G, 2002, EVOLUTION, V56, P936; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Buschbaum C, 1999, HELGOLAND MAR RES, V53, P56, DOI 10.1007/PL00012138; Byrne PG, 2009, P R SOC B, V276, P115, DOI 10.1098/rspb.2008.0794; Clifford KT, 2003, BEHAV NEUROSCI, V117, P1086, DOI 10.1037/0735-7044.117.5.1086; Cordero A, 1998, ANIM BEHAV, V55, P185, DOI 10.1006/anbe.1997.0603; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; Davies MS, 2007, P ROY SOC B-BIOL SCI, V274, P1233, DOI 10.1098/rspb.2007.0046; DAVIES MS, 1992, P 3 INT S LITT BIOL, P221; ERLANDSSON J, 1995, MAR BIOL, V122, P87, DOI 10.1007/BF00349281; Erlandsson J, 2002, INVERTEBR REPROD DEV, V41, P53, DOI 10.1080/07924259.2002.9652735; Fox CW, 2003, EVOL ECOL RES, V5, P273; Gaylord B, 1999, J EXP MAR BIOL ECOL, V239, P85, DOI 10.1016/S0022-0981(99)00031-3; Hanlon RT, 2005, NATURE, V433, P212, DOI 10.1038/433212a; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hollander J, 2005, ANIM BEHAV, V70, P1209, DOI 10.1016/j.anbehav.2005.03.014; JANSON K, 1982, J MOLLUS STUD, V48, P167; JOHANNESSON B, 1986, J EXP MAR BIOL ECOL, V102, P183, DOI 10.1016/0022-0981(86)90175-9; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; Kemppainen P, 2005, OECOLOGIA, V143, P402, DOI 10.1007/s00442-004-1819-5; Koch N, 2007, INVERTEBR BIOL, V126, P257, DOI 10.1111/j.1744-7410.2007.00095.x; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; RAFFAELLI D G, 1977, Veliger, V20, P75; Reid 0. G., 1986, LITTORINID MOLLUSCS; Reid DG, 1996, SYSTEMATICS EVOLUTIO, P463; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Saetre GP, 1996, AM NAT, V147, P981, DOI 10.1086/285889; Sarhan A, 2007, EVOLUTION, V61, P606, DOI 10.1111/j.1558-5646.2007.00053.x; SAUR M, 1990, DEV HYDROB, V56, P261, DOI 10.1007/BF00028082; Sirot LK, 2003, ANIM BEHAV, V66, P763, DOI 10.1006/anbe.2003.2279; Struhsaker J. W., 1966, Proceedings of the Malacological Society of London, V37, P137; Takeichi M, 2007, J MOLLUS STUD, V73, P275, DOI 10.1093/mollus/eym027; Winnepenninckx B, 1998, MOL PHYLOGENET EVOL, V9, P55, DOI 10.1006/mpev.1997.0439	37	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12005	10.1371/journal.pone.0012005	http://dx.doi.org/10.1371/journal.pone.0012005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711254	gold, Green Published			2022-12-27	WOS:000280776800006
J	O'Connell, RM; Balazs, AB; Rao, DS; Kivork, C; Yang, LL; Baltimore, D				O'Connell, Ryan M.; Balazs, Alejandro B.; Rao, Dinesh S.; Kivork, Christine; Yang, Lili; Baltimore, David			Lentiviral Vector Delivery of Human Interleukin-7 (hIL-7) to Human Immune System (HIS) Mice Expands T Lymphocyte Populations	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; GENE DELIVERY; SCID MICE; IL-7; HOMEOSTASIS; BLOOD; NAIVE; PROLIFERATION; TRANSDUCTION	Genetically modified mice carrying engrafted human tissues provide useful models to study human cell biology in physiologically relevant contexts. However, there remain several obstacles limiting the compatibility of human cells within their mouse hosts. Among these is inadequate cross-reactvitiy between certain mouse cytokines and human cellular receptors, depriving the graft of important survival and growth signals. To circumvent this problem, we utilized a lentivirus-based delivery system to express physiologically relevant levels of human interleukin-7 (hIL-7) in Rag2-/-gamma c-/-mice following a single intravenous injection. hIL-7 promoted homeostatic proliferation of both adoptively transferred and endogenously generated T-cells in Rag2-/-gamma c-/-Human Immune System (HIS) mice. Interestingly, we found that hIL-7 increased T lymphocyte numbers in the spleens of HIV infected HIS mice without affecting viral load. Taken together, our study unveils a versatile approach to deliver human cytokines to HIS mice, to both improve engraftment and determine the impact of cytokines on human diseases.	[O'Connell, Ryan M.; Balazs, Alejandro B.; Rao, Dinesh S.; Kivork, Christine; Yang, Lili; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	O'Connell, RM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	liyang@caltech.edu; baltimo@caltech.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Balazs, Alejandro/0000-0002-1767-3944	Bill and Melinda Gates Foundation (Seattle, WA) [37866]; National Heart, Lung and Blood Institute [K99HL102228]; amfAR fellowship [107756-47-RFVA]; NATIONAL CANCER INSTITUTE [K08CA133521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102228] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (Seattle, WA)(Bill & Melinda Gates Foundation); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); amfAR fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Bill and Melinda Gates Foundation (Seattle, WA) through the Grand Challenges in Global Health Initiative (awarded to D.B.) Grand Challenge Grant #37866 (http://www.grandchallenges.org/Pages/default.aspx). R.M.O. was funded by award number K99HL102228 from the National Heart, Lung and Blood Institute (http://www.nhlbi.nih.gov/). A.B.B. is supported by amfAR fellowship #107756-47-RFVA (http://www.amfar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; BOCK TA, 1995, J EXP MED, V182, P2037, DOI 10.1084/jem.182.6.2037; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	29	43	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12009	10.1371/journal.pone.0012009	http://dx.doi.org/10.1371/journal.pone.0012009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700454	gold, Green Published, Green Accepted			2022-12-27	WOS:000280687900009
J	Hayman, DTS; Emmerich, P; Yu, M; Wang, LF; Suu-Ire, R; Fooks, AR; Cunningham, AA; Wood, JLN				Hayman, David T. S.; Emmerich, Petra; Yu, Meng; Wang, Lin-Fa; Suu-Ire, Richard; Fooks, Anthony R.; Cunningham, Andrew A.; Wood, James L. N.			Long-Term Survival of an Urban Fruit Bat Seropositive for Ebola and Lagos Bat Viruses	PLOS ONE			English	Article							RABIES; PREVALENCE; MARBURG; ANTIBODIES	Ebolaviruses (EBOV) (family Filoviridae) cause viral hemorrhagic fevers in humans and non-human primates when they spill over from their wildlife reservoir hosts with case fatality rates of up to 90%. Fruit bats may act as reservoirs of the Filoviridae. The migratory fruit bat, Eidolon helvum, is common across sub-Saharan Africa and lives in large colonies, often situated in cities. We screened sera from 262 E. helvum using indirect fluorescent tests for antibodies against EBOV subtype Zaire. We detected a seropositive bat from Accra, Ghana, and confirmed this using western blot analysis. The bat was also seropositive for Lagos bat virus, a Lyssavirus, by virus neutralization test. The bat was fitted with a radio transmitter and was last detected in Accra 13 months after release post-sampling, demonstrating long-term survival. Antibodies to filoviruses have not been previously demonstrated in E. helvum. Radio-telemetry data demonstrates long-term survival of an individual bat following exposure to viruses of families that can be highly pathogenic to other mammal species. Because E. helvum typically lives in large urban colonies and is a source of bushmeat in some regions, further studies should determine if this species forms a reservoir for EBOV from which spillover infections into the human population may occur.	[Hayman, David T. S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Hayman, David T. S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.; Fooks, Anthony R.] Vet Labs Agcy, Rabies & Wildlife Zoonoses Grp, Weybridge, Surrey, England; [Emmerich, Petra] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Yu, Meng; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Suu-Ire, Richard] Ghana Forestry Commiss, Wildlife Div, Accra, Ghana; [Fooks, Anthony R.] Univ Liverpool, Natl Ctr Zoonoses Res, Liverpool L69 3BX, Merseyside, England	University of Cambridge; Zoological Society of London; Veterinary Laboratories Agency; Bernhard Nocht Institut fur Tropenmedizin; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Liverpool	Hayman, DTS (corresponding author), Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England.	dtsh2@cam.ac.uk	Cunningham, Andrew A/E-7536-2010; Wood, James/A-1626-2008; Fooks, Anthony R/F-5418-2010; wang, lin/GSE-3040-2022	Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Hayman, David/0000-0003-0087-3015	The Wellcome Trust, Defra [VT0105]; Science and Technology Directorate, Department of Homeland Security; The Lubee Foundation; UK Department for Environment, Food and Rural Affairs (Defra) [SEV3500]	The Wellcome Trust, Defra(Department for Environment, Food & Rural Affairs (DEFRA)Wellcome Trust); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); The Lubee Foundation; UK Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	The Wellcome Trust, Defra grant VT0105, Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, Department of Homeland Security, and The Lubee Foundation Luis F. Bacardi Bat Conservation and Research Fund supported the study. A.R.F. was funded by the UK Department for Environment, Food and Rural Affairs (Defra) by grant SEV3500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANGA J, 1980, AFRICAN J ECOLOGY, V20, P223; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; DEFREES SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Dimitrov DT, 2007, J THEOR BIOL, V245, P498, DOI 10.1016/j.jtbi.2006.11.001; Feller MJ, 1997, J AM VET MED ASSOC, V210, P195; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; LEROY EM, 2009, VECTOR BORNE ZOONOTI; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; PRICE JL, 1977, J WILDLIFE DIS, V13, P131, DOI 10.7589/0090-3558-13.2.131; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; STEECE R, 1989, J WILDLIFE DIS, V25, P490, DOI 10.7589/0090-3558-25.4.490; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; THOMAS DW, 1983, CAN J ZOOL, V61, P2266, DOI 10.1139/z83-299; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; VANDERGROEN G, 1983, LANCET, V1, P654; WACHARAPLUESADE.S, 2009, VECTOR BORNE ZOONOTI; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wang LF, 1997, ARCH VIROL, V142, P2269, DOI 10.1007/s007050050241	22	106	116	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11978	10.1371/journal.pone.0011978	http://dx.doi.org/10.1371/journal.pone.0011978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694141	gold, Green Submitted, Green Published			2022-12-27	WOS:000280574300018
J	Lopez, LC; Quinzii, CM; Area, E; Naini, A; Rahman, S; Schuelke, M; Salviati, L; DiMauro, S; Hirano, M				Lopez, Luis C.; Quinzii, Catarina M.; Area, Estela; Naini, Ali; Rahman, Shamima; Schuelke, Markus; Salviati, Leonardo; DiMauro, Salvatore; Hirano, Michio			Treatment of CoQ(10) Deficient Fibroblasts with Ubiquinone, CoQ Analogs, and Vitamin C: Time- and Compound-Dependent Effects	PLOS ONE			English	Article							COENZYME Q(10) DEFICIENCY; DIPHOSPHATE SYNTHASE SUBUNIT-2; RESPIRATORY-CHAIN DYSFUNCTION; MITOCHONDRIAL COMPLEX I; FRIEDREICH ATAXIA; CEREBELLAR-ATAXIA; OXIDATIVE STRESS; MUTATIONS; MUTANTS; NEPHROPATHY	Background: Coenzyme Q(10) (CoQ(10)) and its analogs are used therapeutically by virtue of their functions as electron carriers, antioxidant compounds, or both. However, published studies suggest that different ubiquinone analogs may produce divergent effects on oxidative phosphorylation and oxidative stress. Methodology/Principal Findings: To test these concepts, we have evaluated the effects of CoQ(10), coenzyme Q(2) (CoQ(2)), idebenone, and vitamin C on bioenergetics and oxidative stress in human skin fibroblasts with primary CoQ(10) deficiency. A final concentration of 5 mu M of each compound was chosen to approximate the plasma concentration of CoQ(10) of patients treated with oral ubiquinone. CoQ(10) supplementation for one week but not for 24 hours doubled ATP levels and ATP/ADP ratio in CoQ(10) deficient fibroblasts therein normalizing the bioenergetics status of the cells. Other compounds did not affect cellular bioenergetics. In COQ2 mutant fibroblasts, increased superoxide anion production and oxidative stress-induced cell death were normalized by all supplements. Conclusions/Significance: These results indicate that: 1) pharmacokinetics of CoQ(10) in reaching the mitochondrial respiratory chain is delayed; 2) short-tail ubiquinone analogs cannot replace CoQ(10) in the mitochondrial respiratory chain under conditions of CoQ(10) deficiency; and 3) oxidative stress and cell death can be counteracted by administration of lipophilic or hydrophilic antioxidants. The results of our in vitro experiments suggest that primary CoQ(10) deficiencies should be treated with CoQ(10) supplementation but not with short-tail ubiquinone analogs, such as idebenone or CoQ(2). Complementary administration of antioxidants with high bioavailability should be considered if oxidative stress is present.	[Lopez, Luis C.; Quinzii, Catarina M.; Area, Estela; Naini, Ali; DiMauro, Salvatore; Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA; [Rahman, Shamima] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Schuelke, Markus] Charite Virchow Univ Hosp, Dept Neuropediat, Berlin, Germany; [Salviati, Leonardo] Univ Padua, Dept Pediat, Serv Genet Clin & Epidemiol, Padua, Italy	Columbia University; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua	Lopez, LC (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.	mh29@columbia.edu	Rahman, Shamima/M-7904-2019; Salviati, Leonardo/L-1007-2016; Lopez, Luis Carlos/L-5129-2014; Lopez, Luis Carlos/AAP-9411-2020; Rahman, Shamima/C-5232-2008	Salviati, Leonardo/0000-0001-5642-9963; Lopez, Luis Carlos/0000-0003-3355-0298; Lopez, Luis Carlos/0000-0003-3355-0298; Rahman, Shamima/0000-0003-2088-730X; Schuelke, Markus/0000-0003-2824-3891; Area, Estela/0000-0002-0962-1570	U.S. National Institutes of Health (NIH) [HD32062, NS11766]; Muscular Dystrophy Association (MDA); Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain; Telethon [GGP09207]; MRC [G0200335] Funding Source: UKRI; Medical Research Council [G0200335] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1220] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, P01NS011766] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Telethon(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) grants HD32062 and NS11766, by grants from the Muscular Dystrophy Association (MDA), and by the Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF). LCL was supported by a post-doctoral fellowship from the Ministerio de Educacion y Ciencia, Spain. CMQ is supported by the MDA. LS is supported by Telethon grant GGP09207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aure K, 2004, NEUROLOGY, V63, P727, DOI 10.1212/01.WNL.0000134607.76780.B2; Beal F, 2004, METHOD ENZYMOL, V382, P473; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bhagavan HN, 2006, FREE RADICAL RES, V40, P445, DOI 10.1080/10715760600617843; Blanchard-Fillion B, 2006, J NEUROSCI, V26, P6124, DOI 10.1523/JNEUROSCI.1038-06.2006; CORNELL BA, 1987, BIOCHEMISTRY-US, V26, P7702, DOI 10.1021/bi00398a025; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Ferrante KL, 2005, NEUROLOGY, V65, P1834, DOI 10.1212/01.wnl.0000187070.35365.d7; Geromel V, 2002, MOL GENET METAB, V77, P21, DOI 10.1016/S1096-7192(02)00145-2; Gille L, 2008, BIOCHEM PHARMACOL, V76, P289, DOI 10.1016/j.bcp.2008.04.003; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; LENAZ G, 1992, BIOCHEM CELL BIOL, V70, P504, DOI 10.1139/o92-078; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; Miles MV, 2007, MITOCHONDRION, V7, pS72, DOI 10.1016/j.mito.2007.02.012; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; QUINZII CM, 2010, FASEB J IN PRESS; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Salviati L, 2005, NEUROLOGY, V65, P606, DOI 10.1212/01.wnl.0000172859.55579.a7; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; Schulz JB, 2009, J NEUROL, V256, P42, DOI 10.1007/s00415-009-1008-x; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; SODERBERG K, 1980, J CELL PHYSIOL, V103, P169, DOI 10.1002/jcp.1041030121; Takahashi M, 2008, MECH AGEING DEV, V129, P291, DOI 10.1016/j.mad.2008.01.008; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	52	81	83	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11897	10.1371/journal.pone.0011897	http://dx.doi.org/10.1371/journal.pone.0011897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689595	Green Published, gold			2022-12-27	WOS:000280520300012
J	Thrush, SF; Hewitt, JE; Cummings, VJ; Norkko, A; Chiantore, M				Thrush, Simon F.; Hewitt, Judi E.; Cummings, Vonda J.; Norkko, Alf; Chiantore, Mariachiara			beta-Diversity and Species Accumulation in Antarctic Coastal Benthos: Influence of Habitat, Distance and Productivity on Ecological Connectivity	PLOS ONE			English	Article							LATITUDINAL GRADIENTS; MCMURDO SOUND; PATTERNS; BIODIVERSITY; SCALE; RESILIENCE; RICHNESS; HOMOGENIZATION; VARIABILITY; RECRUITMENT	High Antarctic coastal marine environments are comparatively pristine with strong environmental gradients, which make them important places to investigate biodiversity relationships. Defining how different environmental features contribute to shifts in beta-diversity is especially important as these shifts reflect both spatio-temporal variations in species richness and the degree of ecological separation between local and regional species pools. We used complementary techniques (species accumulation models, multivariate variance partitioning and generalized linear models) to assess how the roles of productivity, bio-physical habitat heterogeneity and connectivity change with spatial scales from metres to 100's of km. Our results demonstrated that the relative importance of specific processes influencing species accumulation and beta-diversity changed with increasing spatial scale, and that patterns were never driven by only one factor. Bio-physical habitat heterogeneity had a strong influence on beta-diversity at scales <290 km, while the effects of productivity were low and significant only at scales >40 km. Our analysis supports the emphasis on the analysis of diversity relationships across multiple spatial scales and highlights the unequal connectivity of individual sites to the regional species pool. This has important implications for resilience to habitat loss and community homogenisation, especially for Antarctic benthic communities where rates of recovery from disturbance are slow, there is a high ratio of poor-dispersing and brooding species, and high biogenic habitat heterogeneity and spatio-temporal variability in primary production make the system vulnerable to disturbance. Consequently, large areas need to be included within marine protected areas for effective management and conservation of these special ecosystems in the face of increasing anthropogenic disturbance.	[Thrush, Simon F.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.; Chiantore, Mariachiara] Univ Genoa, DipTeRis, Genoa, Italy; [Cummings, Vonda J.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Norkko, Alf] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland; [Norkko, Alf] Univ Gothenburg, Dept Marine Ecol Kristineberg, Fiskebackskil, Sweden	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Genoa; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Finnish Environment Institute; University of Gothenburg	Thrush, SF (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	s.thrush@niwa.cri.nz	Norkko, Alf/K-2341-2019; Norkko, Alf/A-1856-2012; Norkko, Alf/L-8736-2019; Chiantore, Mariachiara/C-7070-2017	Norkko, Alf/0000-0002-9741-4458; Norkko, Alf/0000-0002-9741-4458; Chiantore, Mariachiara/0000-0002-5862-1470; Cummings, Vonda/0000-0003-1076-3995; Thrush, Simon/0000-0002-4005-3882	New Zealand Ministry of Fisheries [ZBD2001/02, ZBD2002/01, ZBD2006/03]; National Institute of Water and Atmospheric Research; NZ Foundation for Research Science and Technology [COX01707]; Marie Curie International Incoming Fellowship [FP7-PEOPLE-2007-4-2-IIF-ENV221065]	New Zealand Ministry of Fisheries; National Institute of Water and Atmospheric Research; NZ Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Marie Curie International Incoming Fellowship(European Commission)	This work has been funded by the New Zealand Ministry of Fisheries (ZBD2001/02, ZBD2002/01 and ZBD2006/03), National Institute of Water and Atmospheric Research-Non-Specific Output Funding and the NZ Foundation for Research Science and Technology International Polar Year project COX01707. Write up was partially funded by Marie Curie International Incoming Fellowship (FP7-PEOPLE-2007-4-2-IIF-ENV221065) to SFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2007, PHILOS T R SOC B, V362, P11, DOI 10.1098/rstb.2006.1951; BARRY JP, 1988, POLAR BIOL, V8, P377, DOI 10.1007/BF00442029; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; BELL SS, 1991, HABITAT STRUCTURE PH; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Crawley M.J., 1993, GLIM ECOLOGISTS; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cummings V, 2006, ANTARCT SCI, V18, P633, DOI 10.1017/S0954102006000666; DAYTON PK, 1986, POLAR BIOL, V6, P207, DOI 10.1007/BF00443397; Dayton PK, 2003, AM NAT, V162, P1, DOI 10.1086/376572; DAYTON PK, 1994, AM ZOOL, V34, P90; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Jobe RT, 2008, ECOLOGY, V89, P174, DOI 10.1890/06-1722.1; KNOX GA, 1994, BIOL SO OCEAN; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levin LA, 2002, ECOL APPL, V12, P1785, DOI 10.1890/1051-0761(2002)012[1785:NAMSOH]2.0.CO;2; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Lundquist CJ, 2006, MAR ECOL PROG SER, V324, P67, DOI 10.3354/meps324067; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Norkko A, 2007, ECOLOGY, V88, P2810, DOI 10.1890/06-1396.1; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; PEARSE JS, 1991, AM ZOOL, V31, P65; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SARTORY DP, 1982, 115163 TR HYDR RES I; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; StanwellSmith D, 1997, J EXP MAR BIOL ECOL, V212, P61, DOI 10.1016/S0022-0981(96)02754-2; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Thrush S, 2006, DEEP-SEA RES PT II, V53, P959, DOI 10.1016/j.dsr2.2006.02.006; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Welsch R, 1980, REGRESSION DIAGNOSTI; WHITTAKER R H, 1975, P385; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	57	49	50	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11899	10.1371/journal.pone.0011899	http://dx.doi.org/10.1371/journal.pone.0011899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689578	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300014
J	Kellett, DO; Fukunaga, I; Chen-Kubota, E; Dean, P; Yeo, CH				Kellett, Daniel O.; Fukunaga, Izumi; Chen-Kubota, Eva; Dean, Paul; Yeo, Christopher H.			Memory Consolidation in the Cerebellar Cortex	PLOS ONE			English	Article							CONDITIONED EYELID RESPONSES; NICTITATING-MEMBRANE RESPONSES; VESTIBULOOCULAR REFLEX; PURKINJE-CELL; INFERIOR OLIVE; MOTOR CONTROL; PLASTICITY; ACQUISITION; EXTINCTION; NUCLEI	Several forms of learning, including classical conditioning of the eyeblink, depend upon the cerebellum. In examining mechanisms of eyeblink conditioning in rabbits, reversible inactivations of the control circuitry have begun to dissociate aspects of cerebellar cortical and nuclear function in memory consolidation. It was previously shown that post-training cerebellar cortical, but not nuclear, inactivations with the GABA(A) agonist muscimol prevented consolidation but these findings left open the question as to how final memory storage was partitioned across cortical and nuclear levels. Memory consolidation might be essentially cortical and directly disturbed by actions of the muscimol, or it might be nuclear, and sensitive to the raised excitability of the nuclear neurons following the loss of cortical inhibition. To resolve this question, we simultaneously inactivated cerebellar cortical lobule HVI and the anterior interpositus nucleus of rabbits during the post-training period, so protecting the nuclei from disinhibitory effects of cortical inactivation. Consolidation was impaired by these simultaneous inactivations. Because direct application of muscimol to the nuclei alone has no impact upon consolidation, we can conclude that post-training, consolidation processes and memory storage for eyeblink conditioning have critical cerebellar cortical components. The findings are consistent with a recent model that suggests the distribution of learning-related plasticity across cortical and nuclear levels is task-dependent. There can be transfer to nuclear or brainstem levels for control of high-frequency responses but learning with lower frequency response components, such as in eyeblink conditioning, remains mainly dependent upon cortical memory storage.	[Kellett, Daniel O.; Fukunaga, Izumi; Chen-Kubota, Eva; Yeo, Christopher H.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Dean, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of Sheffield	Kellett, DO (corresponding author), Lilly UK, Surrey, England.	c.yeo@ucl.ac.uk			Biotechnology and Biological Sciences Research Council, UK [BBS/B/16984]; Biotechnology and Biological Sciences Research Council [BBS/B/16984] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK, http://www.bbsrc.ac.uk/, Grant No. BBS/B/16984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2000, PROG BRAIN RES, V124, P257; Aksenov D, 2004, J NEUROPHYSIOL, V91, P719, DOI 10.1152/jn.00859.2003; ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2001, J NEUROSCI, V21, P5715, DOI 10.1523/JNEUROSCI.21-15-05715.2001; Attwell PJE, 2002, ANN NY ACAD SCI, V978, P79, DOI 10.1111/j.1749-6632.2002.tb07557.x; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; Bengtsson F, 2004, EUR J NEUROSCI, V20, P2999, DOI 10.1111/j.1460-9568.2004.03789.x; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Bracha V, 2009, NEUROSCIENCE, V162, P787, DOI 10.1016/j.neuroscience.2008.12.042; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Cooke SF, 2004, J NEUROSCI, V24, P2934, DOI 10.1523/JNEUROSCI.5505-03.2004; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Delgado-Garcia JM, 2006, TRENDS NEUROSCI, V29, P330, DOI 10.1016/j.tins.2006.05.003; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; GORMEZANO I, 1962, SCIENCE, V138, P33, DOI 10.1126/science.138.3536.33; GRUART A, 1995, EXP BRAIN RES, V104, P431; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hesslow Germund, 2002, P86; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lepora NF, 2007, J NEUROPHYSIOL, V98, P2074, DOI 10.1152/jn.00210.2007; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; Ohyama T, 2006, J NEUROSCI, V26, P12656, DOI 10.1523/JNEUROSCI.4023-06.2006; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Porrill J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000085; Porrill J, 2007, PLOS COMPUT BIOL, V3, P1935, DOI 10.1371/journal.pcbi.0030197; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Welsh JP, 1998, EUR J NEUROSCI, V10, P3321, DOI 10.1046/j.1460-9568.1998.00400.x; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1992, EXP BRAIN RES, V88, P623; Yeo CH, 1997, LEARN MEMORY, V3, P557, DOI 10.1101/lm.3.6.557; Zbarska S, 2007, BEHAV BRAIN RES, V178, P128, DOI 10.1016/j.bbr.2006.12.012	49	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11737	10.1371/journal.pone.0011737	http://dx.doi.org/10.1371/journal.pone.0011737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686596	gold, Green Published, Green Accepted			2022-12-27	WOS:000280520200004
J	Yu, CH; Wu, HJ; Kaizuka, Y; Vale, RD; Groves, JT				Yu, Cheng-han; Wu, Hung-Jen; Kaizuka, Yoshihisa; Vale, Ronald D.; Groves, Jay T.			Altered Actin Centripetal Retrograde Flow in Physically Restricted Immunological Synapses	PLOS ONE			English	Article							T-CELL-RECEPTOR; GRADIENT VECTOR FLOW; ACTIVATION; MICROCLUSTERS; NETWORKS; CYTOSKELETON; MOLECULES; MEMBRANES; CLUSTER; SLP-76	Antigen recognition by T cells involves large scale spatial reorganization of numerous receptor, adhesion, and costimulatory proteins within the T cell-antigen presenting cell (APC) junction. The resulting patterns can be distinctive, and are collectively known as the immunological synapse. Dynamical assembly of cytoskeletal network is believed to play an important role in driving these assembly processes. In one experimental strategy, the APC is replaced with a synthetic supported membrane. An advantage of this configuration is that solid structures patterned onto the underlying substrate can guide immunological synapse assembly into altered patterns. Here, we use mobile anti-CD3 epsilon on the spatial-partitioned supported bilayer to ligate and trigger T cell receptor (TCR) in live Jurkat T cells. Simultaneous tracking of both TCR clusters and GFP-actin speckles reveals their dynamic association and individual flow patterns. Actin retrograde flow directs the inward transport of TCR clusters. Flow-based particle tracking algorithms allow us to investigate the velocity distribution of actin flow field across the whole synapse, and centripetal velocity of actin flow decreases as it moves toward the center of synapse. Localized actin flow analysis reveals that, while there is no influence on actin motion from substrate patterns directly, velocity differences of actin are observed over physically trapped TCR clusters. Actin flow regains its velocity immediately after passing through confined TCR clusters. These observations are consistent with a dynamic and dissipative coupling between TCR clusters and viscoelastic actin network.	[Yu, Cheng-han; Groves, Jay T.] Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117548, Singapore; [Yu, Cheng-han; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Kaizuka, Yoshihisa; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Kaizuka, Yoshihisa] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki, Japan; [Vale, Ronald D.; Groves, Jay T.] Howard Hughes Med Inst, Chevy Chase, MD USA	National University of Singapore; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National Institute for Materials Science; Howard Hughes Medical Institute	Yu, CH (corresponding author), Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117548, Singapore.	JTGroves@lbl.gov	KAIZUKA, Yoshihisa/H-2789-2011; Yu, Cheng-han/K-8732-2013; Wu, Hung-Jen/H-3769-2016	Yu, Cheng-han/0000-0002-8821-8877; Wu, Hung-Jen/0000-0003-3082-7431	U.S. Department of Energy [DE-AC02-05CH11231]; Sandler Foundation; National Science Council of Taiwan [NSC98-2917-I-564-165]	U.S. Department of Energy(United States Department of Energy (DOE)); Sandler Foundation; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	U.S. Department of Energy, Contract No. DE-AC02-05CH11231. (to J.T. Groves) Sandler Foundation (to R.D. Vale). National Science Council of Taiwan, Grant NSC98-2917-I-564-165 (to C. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; BROWN CM, 2006, PROBING INTEGRIN ACT, P5204; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Claessens MMAE, 2006, NAT PHYS, V2, P186, DOI 10.1038/nphys241; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m; GROVES JT, 1997, MICROPATTERNING FLUI, P651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; JONKMAN JEN, 2002, CONFOCAL 2 PHOTON MI, P101; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Parthasarathy R, 2006, LANGMUIR, V22, P5095, DOI 10.1021/la060390o; Rubinstein B, 2009, BIOPHYS J, V97, P1853, DOI 10.1016/j.bpj.2009.07.020; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Uhde J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061916; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu CY, 1998, SIGNAL PROCESS, V71, P131, DOI 10.1016/S0165-1684(98)00140-6; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	33	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11878	10.1371/journal.pone.0011878	http://dx.doi.org/10.1371/journal.pone.0011878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686692	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200040
J	Sepulveda, FJ; Parodi, J; Peoples, RW; Opazo, C; Aguayo, LG				Sepulveda, Fernando J.; Parodi, Jorge; Peoples, Robert W.; Opazo, Carlos; Aguayo, Luis G.			Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property	PLOS ONE			English	Article							ION CHANNELS; PROTEIN-KINASE; ALPHA-LATROTOXIN; COMMON MECHANISM; DISEASE; GLYCINE; PEPTIDE; OLIGOMERS; NEURONS; GABA	The mechanisms that induce Alzheimer's disease (AD) are largely unknown thereby deterring the development of disease-modifying therapies. One working hypothesis of AD is that A beta excess disrupts membranes causing pore formation leading to alterations in ionic homeostasis. However, it is largely unknown if this also occurs in native brain neuronal membranes. Here we show that similar to other pore forming toxins, A beta induces perforation of neuronal membranes causing an increase in membrane conductance, intracellular calcium and ethidium bromide influx. These data reveal that the target of A beta is not another membrane protein, but that A beta itself is the cellular target thereby explaining the failure of current therapies to interfere with the course of AD. We propose that this novel effect of A beta could be useful for the discovery of anti AD drugs capable of blocking these "A beta perforates". In addition, we demonstrate that peptides that block A beta neurotoxicity also slow or prevent the membrane-perforating action of A beta.	[Sepulveda, Fernando J.; Parodi, Jorge; Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; [Opazo, Carlos] Univ Concepcion, Dept Physiol, Lab Neurobiomet, Concepcion, Chile; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53233 USA; [Aguayo, Luis G.] Univ Concepcion, Ctr Invest Avanzada Educ, Concepcion, Chile	Universidad de Concepcion; Universidad de Concepcion; Marquette University; Universidad de Concepcion	Sepulveda, FJ (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile.	laguayo@udec.cl		Parodi, Jorge/0000-0002-9117-5433; Opazo, Carlos/0000-0003-3473-7548	FONDECYT [1060368, 1100502]; Ring of Research PBCT [ACT-04, CIE-05]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ring of Research PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by FONDECYT grant 1060368, FONDECYT grant 1100502, Ring of Research PBCT ACT-04, CIE-05 (L.G.A. and C.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2006, PEPTIDES, V27, P95, DOI 10.1016/j.peptides.2005.07.004; Andersen OS, 2005, IEEE T NANOBIOSCI, V4, P10, DOI 10.1109/TNB.2004.842470; Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Daniels WMU, 2001, METAB BRAIN DIS, V16, P175, DOI 10.1023/A:1012541011123; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B, 2001, ION CHANNELS EXCITAB, Vxviii, P814; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Le Foll F, 1998, J PHYSIOL-LONDON, V507, P55, DOI 10.1111/j.1469-7793.1998.055bu.x; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; MORALES A, 1994, P NATL ACAD SCI USA, V91, P3097, DOI 10.1073/pnas.91.8.3097; Orlova EV, 2000, NAT STRUCT BIOL, V7, P48, DOI 10.1038/71247; Pancetti F, 2004, NEUROTOXICOLOGY, V25, P817, DOI 10.1016/j.neuro.2004.01.008; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sepulveda FJ, 2009, MOL CELL NEUROSCI, V41, P420, DOI 10.1016/j.mcn.2009.04.012; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soto C, 2005, SUB CELL BIOCHEM, V38, P351; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Tajima Y, 1996, AM J PHYSIOL-CELL PH, V271, pC524, DOI 10.1152/ajpcell.1996.271.2.C524; Tapia JC, 2001, NEUROSCIENCE, V108, P493, DOI 10.1016/S0306-4522(01)00348-7; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Yavlovich A, 2010, BIOPHYS J, V98, p602A, DOI 10.1016/j.bpj.2009.12.3279; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095	42	113	113	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11820	10.1371/journal.pone.0011820	http://dx.doi.org/10.1371/journal.pone.0011820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676404	Green Published, gold			2022-12-27	WOS:000280371800019
J	King, BJ; Hoefel, D; Wong, PE; Monis, PT				King, Brendon J.; Hoefel, Daniel; Wong, Pao Ee; Monis, Paul T.			Solar Radiation Induces Non-Nuclear Perturbations and a False Start to Regulated Exocytosis in Cryptosporidium parvum	PLOS ONE			English	Article							UV-B PENETRATION; DNA-DAMAGE; OZONE DEPLETION; PYRIMIDINE DIMERS; GLIDING MOTILITY; FLOW-CYTOMETRY; CELL INVASION; MEMBRANE; CALCIUM; REPAIR	Stratospheric ozone depletion, climate warming and acidification of aquatic ecosystems have resulted in elevated levels of solar radiation reaching many aquatic environments with an increased deleterious impact on a wide range of living organisms. While detrimental effects on living organisms are thought to occur primarily through DNA damage, solar UV can also damage cellular proteins, lipids and signalling pathways. Cryptosporidium, a member of the eukaryotic phylum Apicomplexa, contain numerous vesicular secretory organelles and their discharge via regulated exocytosis is essential for the successful establishment of infection. Using flow cytometric techniques we demonstrate that solar UV rapidly induces sporozoite exocytosis resulting in a significant reduction in the ability of sporozoites to attach and invade host cells. We found that solar UV induced sporozoite membrane depolarization, resulting in reduced cellular ATP and increased cytosolic calcium. These changes were accompanied by a reduction in the internal granularity of sporozoites, indicative of apical organelle discharge, which was confirmed by analysis of sporozoites with an exocytosis-sensitive dye. The precise timing of apical organelle discharge in the presence of a compatible host cell is critical for sporozoite attachment and invasion. Our results demonstrate for the first time how solar UV radiation can interfere with exocytosis, a fundamental cellular process in all eukaryotic cells. We contend that not only may the forecast increases in solar radiation in both aquatic and terrestrial environments significantly affect members of the Apicomplexa, solar UV-induced membrane depolarizations resulting in cytosolic calcium perturbation may affect a wider range of eukaryotic organisms through antagonistic effects on a myriad of calcium dependant cellular functions.	[King, Brendon J.; Hoefel, Daniel; Monis, Paul T.] S Australian Water Corp, Australian Water Qual Ctr, Cooperat Res Ctr Water Qual & Treatment, Adelaide, SA, Australia; [Wong, Pao Ee] Flinders Univ S Australia, Sch Med, Dept Med Biotechnol, Adelaide, SA 5001, Australia	Flinders University South Australia	King, BJ (corresponding author), S Australian Water Corp, Australian Water Qual Ctr, Cooperat Res Ctr Water Qual & Treatment, Adelaide, SA, Australia.	brendon.king@sawater.com.au	Monis, Paul T/B-8539-2011	Monis, Paul T/0000-0002-9052-4742; King, Brendon/0000-0002-6114-0950	South Australian Water Corporation; Cooperative Research Centre for Water Quality and Treatment; Water Research Foundation (WRF)	South Australian Water Corporation; Cooperative Research Centre for Water Quality and Treatment(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Water Research Foundation (WRF)	The authors thank the South Australian Water Corporation, the Cooperative Research Centre for Water Quality and Treatment and the Water Research Foundation (WRF) for financial, technical, and administrative assistance in funding the project through which this information was discovered. SA Water Corporation is a wholly owned government water utility that has an interest in water quality issues and pathogen inactivation research as part of verifying water quality in South Australia. SA Water Corporation agreed to support this project by providing in-kind time for Brendon King, Paul Monis and Daniel Hoefel. However SA water had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of trade names or commercial products does not constitute WRF endorsement or recommendations for use. Similarly, omission of products or trade names indicates nothing concerning WRF's position regarding product effectiveness or applicability. The comments and views detailed herein may not necessarily reflect the views of the WRF, its officers, directors, affiliates or agents. The CRC AND WRF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO KR, 1994, MAR ECOL PROG SER, V114, P1, DOI 10.3354/meps114001; Ben Amor K, 2002, APPL ENVIRON MICROB, V68, P5209, DOI 10.1128/AEM.68.11.5209-5216.2002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BOONEN GJJC, 1994, CYTOMETRY, V15, P230, DOI 10.1002/cyto.990150308; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Chen XM, 2004, INFECT IMMUN, V72, P6806, DOI 10.1128/IAI.72.12.6806-6816.2004; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Connelly SJ, 2007, ENVIRON SCI TECHNOL, V41, P7101, DOI 10.1021/es071324r; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; FLETCHER MP, 1985, J LEUKOCYTE BIOL, V37, P431, DOI 10.1002/jlb.37.4.431; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gomez-Couso H, 2009, ACTA TROP, V112, P43, DOI 10.1016/j.actatropica.2009.06.004; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; HIDE I, 1993, J CELL BIOL, V123, P585, DOI 10.1083/jcb.123.3.585; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Keegan AR, 2003, APPL ENVIRON MICROB, V69, P2505, DOI 10.1128/AEM.69.5.2505-2511.2003; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; King BJ, 2009, PARASITOLOGY, V136, P953, DOI 10.1017/S0031182009006519; King BJ, 2005, APPL ENVIRON MICROB, V71, P3848, DOI 10.1128/AEM.71.7.3848-3857.2005; Koga T, 2002, BRAIN RES, V952, P282, DOI 10.1016/S0006-8993(02)03253-5; Li G, 1996, AM J PATHOL, V148, P1113; Malloy KD, 1997, P NATL ACAD SCI USA, V94, P1258, DOI 10.1073/pnas.94.4.1258; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Morita S, 2002, APPL ENVIRON MICROB, V68, P5387, DOI 10.1128/AEM.68.11.5387-5393.2002; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; Oguma K, 2001, APPL ENVIRON MICROB, V67, P4630, DOI 10.1128/AEM.67.10.4630-4637.2001; Peccia J, 2002, APPL ENVIRON MICROB, V68, P2542, DOI 10.1128/AEM.68.5.2542-2549.2002; Pienitz R, 2000, NATURE, V404, P484, DOI 10.1038/35006616; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; ROCHELLE PA, 2004, INVESTIGATION UV DIS; Rousseaux MC, 1999, P NATL ACAD SCI USA, V96, P15310, DOI 10.1073/pnas.96.26.15310; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; SINHA RP, 1995, ACTA PROTOZOOL, V34, P187; Sinha RP, 1996, PHOTOCHEM PHOTOBIOL, V64, P887, DOI 10.1111/j.1751-1097.1996.tb01852.x; Tetley L, 1998, MICROBIOL-SGM, V144, P3249, DOI 10.1099/00221287-144-12-3249; Wetzel DM, 2005, INFECT IMMUN, V73, P5379, DOI 10.1128/IAI.73.9.5379-5387.2005; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0; Zenoff VF, 2006, APPL ENVIRON MICROB, V72, P7857, DOI 10.1128/AEM.01333-06; Zimmer JL, 2003, WATER RES, V37, P3517, DOI 10.1016/S0043-1354(03)00238-0	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11773	10.1371/journal.pone.0011773	http://dx.doi.org/10.1371/journal.pone.0011773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668710	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243800035
J	Tanabe, H; Takayama, I; Nishiyama, T; Shimazaki, M; Kii, I; Li, MQ; Amizuka, N; Katsube, K; Kudo, A				Tanabe, Hideyuki; Takayama, Issei; Nishiyama, Takashi; Shimazaki, Masashi; Kii, Isao; Li, Minqi; Amizuka, Norio; Katsube, Ken-ichi; Kudo, Akira			Periostin Associates with Notch1 Precursor to Maintain Notch1 Expression under a Stress Condition in Mouse Cells	PLOS ONE			English	Article							OSTEOBLAST-SPECIFIC FACTOR; PERIODONTAL-LIGAMENT; EXTRACELLULAR-MATRIX; RESIDENT PROTEINS; SIGNALING PATHWAY; OXIDATIVE STRESS; RECEPTOR; DIFFERENTIATION; MATURATION; RETICULUM	Background: Matricellular proteins, including periostin, modulate cell-matrix interactions and cell functions by acting outside of cells. Methods and Findings: In this study, however, we reported that periostin physically associates with the Notch1 precursor at its EGF repeats in the inside of cells. Moreover, by using the periodontal ligament of molar from periostin-deficient adult mice (Pn(-/-) molar PDL), which is a constitutively mechanically stressed tissue, we found that periostin maintained the site-1 cleaved 120-kDa transmembrane domain of Notch1 (N1 (TM)) level without regulating Notch1 mRNA expression. N1 (TM) maintenance in vitro was also observed under such a stress condition as heat and H(2)O(2) treatment in periostin overexpressed cells. Furthermore, we found that the expression of a downstream effector of Notch signaling, Bcl-xL was decreased in the Pn(-)(-/) molar PDL, and in the molar movement, cell death was enhanced in the pressure side of Pn(-/-) molar PDL. Conclusion: These results suggest the possibility that periostin inhibits cell death through up-regulation of Bcl-xL expression by maintaining the Notch1 protein level under the stress condition, which is caused by its physical association with the Notch1 precursor.	[Tanabe, Hideyuki; Takayama, Issei; Nishiyama, Takashi; Shimazaki, Masashi; Kii, Isao; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Li, Minqi; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Div Oral Hlth Sci, Sapporo, Hokkaido, Japan; [Katsube, Ken-ichi] Tokyo Med & Dent Univ, Grad Sch, Dept Mol Pathol, Tokyo, Japan	Tokyo Institute of Technology; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Tanabe, H (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 227, Japan.	akudo@bio.titech.ac.jp	Amizuka, Norio/G-1397-2012; Kudo, Akira/C-7340-2015; KII, Isao/C-4117-2017; Nishiyama, Takashi/ABC-8965-2021	Kudo, Akira/0000-0001-6289-3391; KII, Isao/0000-0002-6153-6250; Nishiyama, Takashi/0000-0002-4496-240X	Ministry of Education, Science, Culture, and Sports of Japan; Ground-based Research Program for Space Utilization promoted by Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization promoted by Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan, and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gillan L, 2002, CANCER RES, V62, P5358; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Hecht JT, 2006, J HISTOCHEM CYTOCHEM, V54, P269, DOI 10.1369/jhc.5C6834.2005; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Kessler CB, 2007, ENDOCRINOLOGY, V148, P1666, DOI 10.1210/en.2006-0443; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; Van Der Vlies D, 2003, ANTIOXID REDOX SIGN, V5, P381, DOI 10.1089/152308603768295113; van der Vlies D, 2002, BIOCHEM J, V366, P825, DOI 10.1042/BJ20020618	29	44	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12234	10.1371/journal.pone.0012234	http://dx.doi.org/10.1371/journal.pone.0012234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805882	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600013
J	Laget, S; Joulie, M; Le Masson, F; Sasai, N; Christians, E; Pradhan, S; Roberts, RJ; Defossez, PA				Laget, Sophie; Joulie, Michael; Le Masson, Florent; Sasai, Nobuhiro; Christians, Elisabeth; Pradhan, Sriharsa; Roberts, Richard J.; Defossez, Pierre-Antoine			The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA	PLOS ONE			English	Article							PWWP DOMAIN; MECP2; INHERITANCE; PHENOTYPE; MEIOSIS; COMPLEX; FAMILY; KAISO; PLAY	Background: MBD5 and MBD6 are two uncharacterized mammalian proteins that contain a putative Methyl-Binding Domain (MBD). In the proteins MBD1, MBD2, MBD4, and MeCP2, this domain allows the specific recognition of DNA containing methylated cytosine; as a consequence, the proteins serve as interpreters of DNA methylation, an essential epigenetic mark. It is unknown whether MBD5 or MBD6 also bind methylated DNA; this question has interest for basic research, but also practical consequences for human health, as MBD5 deletions are the likely cause of certain cases of mental retardation. Principal Findings: Here we report the first functional characterization of MBD5 and MBD6. We have observed that the proteins colocalize with heterochromatin in cultured cells, and that this localization requires the integrity of their MBD. However, heterochromatic localization is maintained in cells with severely decreased levels of DNA methylation. In vitro, neither MBD5 nor MBD6 binds any of the methylated sequences DNA that were tested. Conclusions: Our data suggest that MBD5 and MBD6 are unlikely to be methyl-binding proteins, yet they may contribute to the formation or function of heterochromatin. One isoform of MBD5 is highly expressed in oocytes, which suggests a possible role in epigenetic reprogramming after fertilization.	[Laget, Sophie; Pradhan, Sriharsa; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA; [Laget, Sophie; Joulie, Michael; Sasai, Nobuhiro; Defossez, Pierre-Antoine] Univ Paris Diderot, CNRS, UMR7216, Paris, France; [Le Masson, Florent; Christians, Elisabeth] Univ Toulouse 3, CNRS, UMR 5547, F-31062 Toulouse, France	New England Biolabs; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Laget, S (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	Pierre-Antoine.Defossez@univ-paris-diderot.fr		Defossez, Pierre-Antoine/0000-0002-6463-9263; Roberts, Richard/0000-0002-4348-0169	Centre National de la Recherche Scientifique; New England Biolabs, Inc.; Institut National du Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); New England Biolabs, Inc.; Institut National du Cancer(Institut National du Cancer (INCA) France)	SL was supported in part by a doctoral fellowship from Centre National de la Recherche Scientifique. SL, SP and RJR acknowledge Don Comb and Jim Ellard for encouraging basic research and New England Biolabs, Inc. for funding. MJ was supported by a doctoral fellowship from Institut National du Cancer, and NS was supported by a postdoctoral fellowship from Institut National du Cancer. Work in the lab of PAD is supported by Association pour la Recherche contre le Cancer and Ligue Nationale contre le Cancer (Comite de Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication charges for open access are covered by New England Biolabs.	Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Carrell DT, 2010, MOL HUM REPROD, V16, P37, DOI 10.1093/molehr/gap090; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Grosso S, 2008, EPILEPSY RES, V79, P63, DOI 10.1016/j.eplepsyres.2007.12.011; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; SASAI N, 2010, NUCL ACIDS IN PRESS; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	45	67	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11982	10.1371/journal.pone.0011982	http://dx.doi.org/10.1371/journal.pone.0011982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700456	Green Published, gold, Green Submitted			2022-12-27	WOS:000280687900005
J	Kalapala, SK; Hobbie, SN; Bottger, EC; Shcherbakov, D				Kalapala, Sarath K.; Hobbie, Sven N.; Boettger, Erik C.; Shcherbakov, Dmitry			Mutation K42R in Ribosomal Protein S12 Does Not Affect Susceptibility of Mycobacterium smegmatis 16S rRNA A-Site Mutants to 2-Deoxystreptamines	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; STREPTOMYCIN; ANTIBIOTICS	Recent studies have suggested that ribosomal protein S12 modulates 16S rRNA function and susceptibility to 2-deoxystreptamine aminoglycosides. To study whether the non-restrictive K42R mutation in RpsL affects 2-deoxystreptamine susceptibility in Mycobacterium smegmatis, we studied the drug susceptibility pattern of various mutants with genetic alterations in the 16S rRNA decoding A-site in the context of wild-type and mutant protein S12. RpsL K42R substitution was found not to affect the drug resistance pattern associated with mutational alterations in 16S rRNA H44.	[Kalapala, Sarath K.; Hobbie, Sven N.; Boettger, Erik C.; Shcherbakov, Dmitry] Univ Zurich, Inst Med Mikrobiol, Zurich, Switzerland; [Hobbie, Sven N.] Singapore MIT Alliance Res & Technol SMART, Ctr Life Sci, Singapore, Singapore	University of Zurich; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Kalapala, SK (corresponding author), Univ Zurich, Inst Med Mikrobiol, Zurich, Switzerland.	dscherbakov@imm.uzh.ch	Böttger, Erik C./F-6175-2011	Scherbakov, Dimitri/0000-0001-5462-6584; Hobbie, Sven N./0000-0002-9205-0384	European Community [FP7-HEALTH-2009-241476]	European Community(European Commission)	This work was supported by grant from the European Community (PAR, FP7-HEALTH-2009-241476). URL of funder's website: http://cordis.europa.eu/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FUNATSU G, 1972, J MOL BIOL, V68, P547, DOI 10.1016/0022-2836(72)90108-8; Gromadski KB, 2004, NAT STRUCT MOL BIOL, V11, P316, DOI 10.1038/nsmb742; Hobbie SN, 2006, BIOCHIMIE, V88, P1033, DOI 10.1016/j.biochi.2006.04.008; Hobbie SN, 2005, ANTIMICROB AGENTS CH, V49, P5112, DOI 10.1128/AAC.49.12.5112-5118.2005; Kurland C.G., 1996, ESCHERICHIA COLI SAL, P979; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; OCONNOR M, 1991, BIOCHIMIE, V73, P1493, DOI 10.1016/0300-9084(91)90183-2; Pfister P, 2005, J MOL BIOL, V346, P467, DOI 10.1016/j.jmb.2004.11.073; Pfister P, 2003, CHEMBIOCHEM, V4, P1078, DOI 10.1002/cbic.200300657; Prammananan T, 1999, ANTIMICROB AGENTS CH, V43, P447, DOI 10.1128/AAC.43.3.447; SANDER P, 1995, MOL MICROBIOL, V16, P991, DOI 10.1111/j.1365-2958.1995.tb02324.x; Sander P, 1996, MOL MICROBIOL, V22, P841, DOI 10.1046/j.1365-2958.1996.01532.x; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Vila-Sanjurjo A, 2007, BBA-GENE STRUCT EXPR, V1769, P462, DOI 10.1016/j.bbaexp.2007.04.004	21	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11960	10.1371/journal.pone.0011960	http://dx.doi.org/10.1371/journal.pone.0011960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700526	Green Published, gold			2022-12-27	WOS:000280605400008
J	Olu, K; Cordes, EE; Fisher, CR; Brooks, JM; Sibuet, M; Desbruyeres, D				Olu, Karine; Cordes, Erik E.; Fisher, Charles R.; Brooks, James M.; Sibuet, Myriam; Desbruyeres, Daniel			Biogeography and Potential Exchanges Among the Atlantic Equatorial Belt Cold-Seep Faunas	PLOS ONE			English	Article							GULF-OF-MEXICO; HYDROTHERMAL VENT COMMUNITIES; BARBADOS ACCRETIONARY PRISM; DEEP-SEA VENT; BATHYMODIOLUS-CHILDRESSI; SPATIAL-DISTRIBUTION; GENETIC DIVERSITY; DISPERSAL; PATTERNS; RIDGE	Like hydrothermal vents along oceanic ridges, cold seeps are patchy and isolated ecosystems along continental margins, extending from bathyal to abyssal depths. The Atlantic Equatorial Belt (AEB), from the Gulf of Mexico to the Gulf of Guinea, was one focus of the Census of Marine Life ChEss (Chemosynthetic Ecosystems) program to study biogeography of seep and vent fauna. We present a review and analysis of collections from five seep regions along the AEB: the Gulf of Mexico where extensive faunal sampling has been conducted from 400 to 3300m, the Barbados accretionary prism, the Blake ridge diapir, and in the Eastern Atlantic from the Congo and Gabon margins and the recently explored Nigeria margin. Of the 72 taxa identified at the species level, a total of 9 species or species complexes are identified as amphi-Atlantic. Similarity analyses based on both Bray Curtis and Hellinger distances among 9 faunal collections, and principal component analysis based on presence/absence of megafauna species at these sites, suggest that within the AEB seep megafauna community structure is influenced primarily by depth rather than by geographic distance. Depth segregation is observed between 1000 and 2000m, with the middle slope sites either grouped with those deeper than 2000m or with the shallower sites. The highest level of community similarity was found between the seeps of the Florida escarpment and Congo margin. In the western Atlantic, the highest degree of similarity is observed between the shallowest sites of the Barbados prism and of the Louisiana slope. The high number of amphi-atlantic cold-seep species that do not cluster according to biogeographic regions, and the importance of depth in structuring AEB cold-seep communities are the major conclusions of this study. The hydrothermal vent sites along the Mid Atlantic Ridge (MAR) did not appear as "stepping stones" for dispersal of the AEB seep fauna, however, the south MAR and off axis regions should be further explored to more fully test this hypothesis.	[Olu, Karine; Desbruyeres, Daniel] IFREMER, DEEP, F-29280 Plouzane, France; [Cordes, Erik E.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Fisher, Charles R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Brooks, James M.] TDI Brooks Int, College Stn, TX USA; [Sibuet, Myriam] Inst Oceanograph, Paris, France	Ifremer; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Olu, K (corresponding author), IFREMER, DEEP, BP70, F-29280 Plouzane, France.	karine.olu@ifremer.fr	Fisher, Charles/H-7912-2012; Cordes, Erik E/B-3293-2009	Cordes, Erik E/0000-0002-6989-2348; Olu, Karine/0000-0002-4906-4131	Total; ANR [ANR06 BDV005]; Ifremer; US National Oceanic and Atmospheric Administration (NOAA) Mineral Management Service; National Science Foundation (NSF) [OCE 0117050]	Total(Total SA); ANR(French National Research Agency (ANR)); Ifremer; US National Oceanic and Atmospheric Administration (NOAA) Mineral Management Service(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	The Gulf of Guinea seeps off Congo, Angola and Gabon were investigated during the Biozaire program, partially funded by Total (P. I. M. Sibuet for Ifremer). Ifremer and Total oil company have supported the work in the Gulf of Guinea through a scientific partnership. Total contributed to finance data acquisition during oceanographic cruises. TDI-Brooks International were responsible for the collections of the scientific seep samples from the Nigerian margin. Data processing is supported by the French project ANR DeepOases (ANR06 BDV005) (https://aap.agencerecherche.fr/) and by Ifremer. Work at cold seeps in the Gulf of Mexico was supported by: US National Oceanic and Atmospheric Administration (NOAA) Mineral Management Service, and National Science Foundation (NSF) OCE 0117050. COML/ChEss (http://www.noc.soton.ac.uk/chess/) supported scientific exchanges (workshops) and publishing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AC, 2004, CAN J ZOOL, V82, P980, DOI 10.1139/Z04-049; Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; ARHAN M, 1998, DEEP SEA RES 1, V45; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; Bergquist DC, 2005, MAR ECOL PROG SER, V293, P99, DOI 10.3354/meps293099; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; BLACK MB, 1997, MAR BIOL, P1; Brooks J.M., 1990, EOS T AM GEOPHYS UNI, V71, P1772; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CARNEY RS, 1994, GEO-MAR LETT, V14, P149, DOI 10.1007/BF01203726; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Charlou JL, 2004, CHEM GEOL, V205, P405, DOI 10.1016/j.chemgeo.2003.12.033; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; CORDES EE, DEEP SEA 2 IN PRESS; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cordes EE, 2006, J EXP MAR BIOL ECOL, V339, P159, DOI 10.1016/j.jembe.2006.07.017; Cordes EE, 2010, MAR ECOL-EVOL PERSP, V31, P51, DOI 10.1111/j.1439-0485.2009.00334.x; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Eckelbarger KJ, 1999, MAR BIOL, V135, P635, DOI 10.1007/s002270050664; FISHER CR, 2007, OCEANOGRAPHY, V20; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Goffredi SK, 2002, MAR ECOL PROG SER, V225, P227, DOI 10.3354/meps225227; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Gooday AJ, 2004, DEEP-SEA RES PT II, V51, P1603, DOI 10.1016/j.dsr2.2004.06.025; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; HECKER B, 1985, BIOL SOC WASH B, V6, P465; JOLLIVET D, 1990, PROG OCEANOGR, V24, P25, DOI 10.1016/0079-6611(90)90017-V; Jollivet D, 1996, BIODIVERS CONSERV, V5, P1619, DOI 10.1007/BF00052119; Jones M., 1985, B BIOL SOC WASH, V6, P117; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; KENNICUTT MC, 1985, NATURE, V317, P351, DOI 10.1038/317351a0; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Kojima S, 2002, J OCEANOGR, V58, P343, DOI 10.1023/A:1015869927288; Kojima Shigeaki, 1997, Venus the Japanese Journal of Malacology, V56, P189; Komai T, 2005, ZOOTAXA, P27; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Krylova Elena M., 2006, Archiv fuer Molluskenkunde, V135, P231; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; LONSDALE P, 1977, DEEP-SEA RES, V24, P857, DOI 10.1016/0146-6291(77)90478-7; MacDonald IR, 2003, MAR GEOL, V198, P133, DOI 10.1016/S0025-3227(03)00098-7; MACDONALD IR, 1990, PROG OCEANOGR, V24, P15, DOI 10.1016/0079-6611(90)90016-U; MACDONALD IR, 1989, MAR BIOL, V101, P235, DOI 10.1007/BF00391463; Macpherson E, 2005, ZOOTAXA, P3; McClain CR, 2005, OIKOS, V109, P555, DOI 10.1111/j.0030-1299.2005.13529.x; McMullin ER, 2003, SYMBIOSIS, V34, P1; Menot L, 2010, MAR ECOL-EVOL PERSP, V31, P78, DOI 10.1111/j.1439-0485.2009.00340.x; MIGLIETTA MP, DEEP SEA 2 IN PRESS; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; Olu K, 1996, PROG OCEANOGR, V38, P347, DOI 10.1016/S0079-6611(97)00006-2; Olu K, 2009, DEEP-SEA RES PT II, V56, P2380, DOI 10.1016/j.dsr2.2009.04.017; Olu K, 1996, MAR ECOL PROG SER, V132, P109, DOI 10.3354/meps132109; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Rex M.A., 1983, DEEP SEA BIOL SEA, V8, P453; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2008, MAR GEOL, V249, P206, DOI 10.1016/j.margeo.2007.11.010; SCHELTEMA RUDOLF S., 1966, DEEP SEA RES, V13, P83, DOI 10.1016/0011-7471(66)90006-4; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sibuet M., 2002, OCEAN MARGIN SYSTEMS, P235, DOI DOI 10.1007/978-3-662-05127-6_15; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; TUNNICLIFFE V, 1988, PROC R SOC SER B-BIO, V233, P347, DOI 10.1098/rspb.1988.0025; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; Turnipseed M, 2004, MAR BIOL, V145, P121, DOI 10.1007/s00227-004-1304-z; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Tyler P, 2007, MAR BIOL, V150, P829, DOI 10.1007/s00227-006-0362-9; VACELET J, 1995, NATURE, V377, P296, DOI 10.1038/377296a0; Van Dover C.L., 1995, BULL BIOL SOC WASH, V6, P223; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VanDover CL, 1996, DEEP-SEA RES PT I, V43, P1509; VANGAEST AL, 2005, DEV ARVAL ECOLOGY CO, P53; Vermeij GJ, 2005, P ROY SOC B-BIOL SCI, V272, P2545, DOI 10.1098/rspb.2005.3177; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; Von Cosel R, 2008, ZOOSYSTEMA, V30, P929; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waren A, 2001, VELIGER, V44, P116; Waren A, 2009, DEEP-SEA RES PT II, V56, P2326, DOI 10.1016/j.dsr2.2009.04.013; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Won Y, 2003, MOL ECOL, V12, P169, DOI 10.1046/j.1365-294X.2003.01726.x; Won YJ, 2002, CAH BIOL MAR, V43, P387; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0; Young CM, 2003, ECOSY WORLD, V28, P381; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197; [No title captured]	106	57	58	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11967	10.1371/journal.pone.0011967	http://dx.doi.org/10.1371/journal.pone.0011967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700528	gold, Green Published, Green Submitted			2022-12-27	WOS:000280605400009
J	Perrotta, S; Cucciolla, V; Ferraro, M; Ronzoni, L; Tramontano, A; Rossi, F; Scudieri, AC; Borriello, A; Roberti, D; Nobili, B; Cappellini, MD; Oliva, A; Amendola, G; Migliaccio, AR; Mancuso, P; Martin-Padura, I; Bertolini, F; Yoon, D; Prchal, JT; Della Ragione, F				Perrotta, Silverio; Cucciolla, Valeria; Ferraro, Marcella; Ronzoni, Luisa; Tramontano, Annunziata; Rossi, Francesca; Scudieri, Anna Chiara; Borriello, Adriana; Roberti, Domenico; Nobili, Bruno; Cappellini, Maria Domenica; Oliva, Adriana; Amendola, Giovanni; Migliaccio, Anna Rita; Mancuso, Patrizia; Martin-Padura, Ines; Bertolini, Francesco; Yoon, Donghoon; Prchal, Josef T.; Della Ragione, Fulvio			EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34(+) Cell Differentiation and Increases Circulating Endothelial Precursors	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; FAMILIAL ERYTHROCYTOSIS; CANCER-CELLS; MUTATIONS; JAK2; GENE; DEGRADATION; EXPRESSION; ABSENCE	Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-erythroid tissues, although its physiological role is still undefined. Methodology/Principal Findings: We describe a family with polycythemia due to a heterozygous mutation of the EPOR gene that causes a G -> T change at nucleotide 1251 of exon 8. The novel EPOR G1251T mutation results in the replacement of a glutamate residue by a stop codon at amino acid 393. Differently from polycythemia vera, EPOR G1251T CD34(+) cells proliferate and differentiate towards the erythroid phenotype in the presence of minimal amounts of EPO. Moreover, the affected individuals show a 20-fold increase of circulating endothelial precursors. The analysis of erythroid precursor membranes demonstrates a heretofore undescribed accumulation of the truncated EPOR, probably due to the absence of residues involved in the EPO-dependent receptor internalization and degradation. Mutated receptor expression in EPOR-negative cells results in EPOR and Stat5 phosphorylation. Moreover, patient erythroid precursors present an increased activation of EPOR and its effectors, including Stat5 and Erk1/2 pathway. Conclusions/Significance: Our data provide an unanticipated mechanism for autosomal dominant inherited polycythemia due to a heterozygous EPOR mutation and suggest a regulatory role of EPO/EPOR pathway in human circulating endothelial precursors homeostasis.	[Perrotta, Silverio; Ferraro, Marcella; Rossi, Francesca; Roberti, Domenico; Nobili, Bruno; Oliva, Adriana] Univ Naples 2, Dept Pediat, Naples, Italy; [Cucciolla, Valeria; Tramontano, Annunziata; Scudieri, Anna Chiara; Borriello, Adriana; Della Ragione, Fulvio] Univ Naples 2, Dept Biochem & Biophys F Cedrangolo, Naples, Italy; [Ronzoni, Luisa; Cappellini, Maria Domenica] Univ Milan, IRCCS, Fdn Osped Maggiore Policlin, Milan, Italy; [Amendola, Giovanni] Osped Nocera Inferiore, Nocera Inferiore, Italy; [Migliaccio, Anna Rita] Mt Sinai Sch Med, New York, NY USA; [Mancuso, Patrizia; Martin-Padura, Ines; Bertolini, Francesco] European Inst Oncol, Lab Hematol Oncol, Milan, Italy; [Yoon, Donghoon; Prchal, Josef T.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT USA; [Yoon, Donghoon; Prchal, Josef T.] VAH, Salt Lake City, UT USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Icahn School of Medicine at Mount Sinai; IRCCS European Institute of Oncology (IEO); Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Perrotta, S (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	fulvio.dellaragione@unina2.it	bertolini, francesco/AAC-9780-2019; Migliaccio, Anna Rita/GWZ-9323-2022; Ronzoni, Luisa/AAR-2273-2021; CAPPELLINI, MARIA DOMENICA/B-4475-2017	bertolini, francesco/0000-0001-5660-3255; Ronzoni, Luisa/0000-0001-7820-6533; FRANCO MIGLIACCIO, ANNA RITA/0000-0003-1800-271X; Rossi, Francesca/0000-0003-2879-6277; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; Perrotta, Silverio/0000-0001-6149-6845	Progetti di Rilevante Interesse Nazionale (PRIN); Regione Campania, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC); NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER	Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Campania, Italy(Regione Campania); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from Progetti di Rilevante Interesse Nazionale (PRIN) to S.P. and F.D.R., Regione Campania, Italy to S.P. and F.D.R., and Associazione Italiana per la Ricerca sul Cancro (AIRC) to F.D. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sheikh M, 2008, HAEMATOL-HEMATOL J, V93, P1072, DOI 10.3324/haematol.12260; BARBER DL, 1992, SEMIN HEMATOL, V29, P293; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Borriello A, 2006, CANCER RES, V66, P4240, DOI 10.1158/0008-5472.CAN-05-2759; Bourantas LK, 2006, EUR J HAEMATOL, V76, P537, DOI 10.1111/j.1600-0609.2006.00653.x; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cucciolla V, 2008, CARCINOGENESIS, V29, P560, DOI 10.1093/carcin/bgn010; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Della Ragione F, 2007, J CLIN ONCOL, V25, P1812, DOI 10.1200/JCO.2006.09.7212; Divoky V, 2001, P NATL ACAD SCI USA, V98, P986, DOI 10.1073/pnas.98.3.986; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Furukawa T, 1997, BRIT J HAEMATOL, V99, P222, DOI 10.1046/j.1365-2141.1997.3583172.x; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Huang LJ, 2010, BRIT J HAEMATOL, V148, P844, DOI 10.1111/j.1365-2141.2009.08069.x; Kralovics R, 1997, BLOOD, V90, P2057, DOI 10.1182/blood.V90.5.2057; Kralovics R, 1998, J CLIN INVEST, V102, P124, DOI 10.1172/JCI2886; Leibundgut EO, 2006, HAEMATOLOGICA, V91, P1465; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Longmore GD, 2007, NEW ENGL J MED, V356, P2447, DOI 10.1056/NEJMp078112; Madeddu P, 2007, CIRC RES, V100, P599, DOI 10.1161/01.RES.0000261610.11754.b1; MALESE K, 2005, JAMA-J AM MED ASSOC, V293, P90; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Prchal JT, 2003, HEMATOL ONCOL CLIN N, V17, P1151, DOI 10.1016/S0889-8588(03)00090-X; PRCHAL JT, 1995, SCIENCE, V268, P1831, DOI 10.1126/science.7604250; QUEISSER W, 1988, DEUT MED WOCHENSCHR, V113, P851, DOI 10.1055/s-2008-1067733; Rives S, 2007, HAEMATOL-HEMATOL J, V92, P674, DOI 10.3324/haematol.10787; Ronzoni L, 2008, BLOOD CELL MOL DIS, V40, P148, DOI 10.1016/j.bcmd.2007.07.006; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; SOKOL L, 1995, BLOOD, V86, P15, DOI 10.1182/blood.V86.1.15.bloodjournal86115; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Van Maerken T, 2004, J PEDIAT HEMATOL ONC, V26, P407, DOI 10.1097/00043426-200407000-00002; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Watowich SS, 1999, BLOOD, V94, P2530, DOI 10.1182/blood.V94.7.2530.419k35_2530_2532; Wu H, 1999, DEVELOPMENT, V126, P3597; Yu XB, 2002, DEVELOPMENT, V129, P505; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156	43	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e12015	10.1371/journal.pone.0012015	http://dx.doi.org/10.1371/journal.pone.0012015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700488	gold, Green Published			2022-12-27	WOS:000280605400027
J	Zabaneh, D; Balding, DJ				Zabaneh, Delilah; Balding, David J.			A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men	PLOS ONE			English	Article							LOCI; RISK; POPULATION; VARIANT	We conducted a two-stage genome-wide association study to identify common genetic variation altering risk of the metabolic syndrome and related phenotypes in Indian Asian men, who have a high prevalence of these conditions. In Stage 1, approximately 317,000 single nucleotide polymorphisms were genotyped in 2700 individuals, from which 1500 SNPs were selected to be genotyped in a further 2300 individuals. Selection for inclusion in Stage 1 was based on four metabolic syndrome component traits: HDL-cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity measured by waist to hip ratio, and diastolic blood pressure. Association was tested with these four traits and a composite metabolic syndrome phenotype. Four SNPs reaching significance level p<5x10(-7) and with posterior probability of association >0.8 were found in genes CETP and LPL, associated with HDL-cholesterol. These associations have already been reported in Indian Asians and in Europeans. Five additional loci harboured SNPs significant at p<10(-6) and posterior probability >0.5 for HDL-cholesterol, type 2 diabetes or diastolic blood pressure. Our results suggest that the primary genetic determinants of metabolic syndrome are the same in Indian Asians as in other populations, despite the higher prevalence. Further, we found little evidence of a common genetic basis for metabolic syndrome traits in our sample of Indian Asian men.	[Zabaneh, Delilah; Balding, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England	Imperial College London	Zabaneh, D (corresponding author), UCL, UCL Genet Inst, London, England.	d.zabaneh@ucl.ac.uk	Balding, David/G-9898-2011	Balding, David/0000-0002-1480-6115	British Heart Foundation [SP/04/02]	British Heart Foundation(British Heart Foundation)	D. Zabaneh and stage one and two genotyping were funded by the British Heart Foundation [SP/04/02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hiura Y, 2009, CIRC J, V73, P1119, DOI 10.1253/circj.CJ-08-1101; Joy T, 2008, CURR DIABETES REP, V8, P141, DOI 10.1007/s11892-008-0025-y; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sjogren M, 2008, DIABETOLOGIA, V51, P2242, DOI 10.1007/s00125-008-1151-4; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; STEPHENS M, 2009, NATURE REV GENETICS, V10; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; World Health Organization, WHO DEF DIAGN CLASS; YU W, 2009, GENOPEDIA HUGE NAVIG; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; BLOOD, V285, P2486	26	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11961	10.1371/journal.pone.0011961	http://dx.doi.org/10.1371/journal.pone.0011961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694148	Green Published, gold			2022-12-27	WOS:000280574300013
J	Ahn, AC; Park, M; Shaw, JR; McManus, CA; Kaptchuk, TJ; Langevin, HM				Ahn, Andrew C.; Park, Min; Shaw, Jessica R.; McManus, Claire A.; Kaptchuk, Ted J.; Langevin, Helene M.			Electrical Impedance of Acupuncture Meridians: The Relevance of Subcutaneous Collagenous Bands	PLOS ONE			English	Article							HYPODERMICALLY INJECTED TC-99M; LAPLACE PLANE ANALYSIS; CONNECTIVE-TISSUE; RADIOACTIVE PATHWAYS; TRIGGER POINTS; INVASION; MECHANISMS; ULTRASOUND; NETWORK; HUMANS	Background: The scientific basis for acupuncture meridians is unknown. Past studies have suggested that acupuncture meridians are physiologically characterized by low electrical impedance and anatomically associated with connective tissue planes. We are interested in seeing whether acupuncture meridians are associated with lower electrical impedance and whether ultrasound-derived measures-specifically echogenic collagenous bands - can account for these impedance differences. Methods/Results: In 28 healthy subjects, we assessed electrical impedance of skin and underlying subcutaneous connective tissue using a four needle-electrode approach. The impedances were obtained at 10 kHz and 100 kHz frequencies and at three body sites - upper arm (Large Intestine meridian), thigh (Liver), and lower leg (Bladder). Meridian locations were determined by acupuncturists. Ultrasound images were obtained to characterize the anatomical features at each measured site. We found significantly reduced electrical impedance at the Large Intestine meridian compared to adjacent control for both frequencies. No significant decrease in impedance was found at the Liver or Bladder meridian. Greater subcutaneous echogenic densities were significantly associated with reduced impedances in both within-site (meridian vs. adjacent control) and between-site (arm vs. thigh vs. lower leg) analyses. This relationship remained significant in multivariable analyses which also accounted for gender, needle penetration depth, subcutaneous layer thickness, and other ultrasound-derived measures. Conclusion/Significance: Collagenous bands, represented by increased ultrasound echogenicity, are significantly associated with lower electrical impedance and may account for reduced impedances previously reported at acupuncture meridians. This finding may provide important insights into the nature of acupuncture meridians and the relevance of collagen in bioelectrical measurements.	[Ahn, Andrew C.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Ahn, Andrew C.; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Park, Min] P Pro Korea Co Ltd, Seoul, South Korea; [Shaw, Jessica R.] AltThera Hlth, Boston, MA USA; [McManus, Claire A.] Spaulding Rehabil Hosp, Dept Res & Training, Boston, MA USA; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Div Res & Educ Complementary & Integrat Med Thera, Boston, MA USA; [Langevin, Helene M.] Univ Vermont, Dept Neurol, Burlington, VT USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; University of Vermont	Ahn, AC (corresponding author), Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA.	aahn1@partners.org			National Center for Complementary Alternative Medicine (NCCAM) [K23-AT003238, P30AT005895, K24-AT004095]; Clinical Translational Science Award [UL1RR025758]; Bernard Osher Foundation; Beth Israel Deaconess Medical Center from the National Center for Research Resources; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT003238, P30AT005895] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	National Center for Complementary Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Clinical Translational Science Award; Bernard Osher Foundation; Beth Israel Deaconess Medical Center from the National Center for Research Resources; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant number K23-AT003238, P30AT005895, and K24-AT004095 of the National Center for Complementary Alternative Medicine (NCCAM) and supported in part by a gift from The Bernard Osher Foundation. The project described was supported by Clinical Translational Science Award UL1RR025758 to Harvard University and Beth Israel Deaconess Medical Center from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary Alternative Medicine or the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2008, BIOELECTROMAGNETICS, V29, P245, DOI 10.1002/bem.20403; Ahn Andrew C, 2005, BMC Complement Altern Med, V5, P10, DOI 10.1186/1472-6882-5-10; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; CHENG XM, 1995, ACUPUNCTURE REFERENC; Deadman P., 1998, J CHINESE MED PUBLIC; DEVERNEJOUL P, 1992, J NUCL MED, V33, P409; Grimnes S, 2007, J PHYS D APPL PHYS, V40, P9, DOI 10.1088/0022-3727/40/1/S02; HEINE H, 1988, Journal of Traditional Chinese Medicine, V8, P207; Ho MW, 1998, AM J CHINESE MED, V26, P251, DOI 10.1142/S0192415X98000294; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; KIM HJ, 2009, IEEE T MED IMAGING; KOVACS FM, 1993, EUR J NUCL MED, V20, P585; KOVACS FM, 1992, J NUCL MED, V33, P403; Kovacs FM, 2000, EUR RADIOL, V10, P1019, DOI 10.1007/s003300051056; Kovacs FM, 1996, AM J CHINESE MED, V24, P101; Langevin Helene M., 2002, Anatomical Record, V269, P257, DOI 10.1002/ar.10185; Langevin HM, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-25; Langevin HM, 2002, FASEB J, V16, P872, DOI 10.1096/fj.01-0925fje; Langevin HM, 2004, ULTRASOUND MED BIOL, V30, P1173, DOI 10.1016/j.ultrasmedbio.2004.07.010; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Langevin HM, 2001, J APPL PHYSIOL, V91, P2471, DOI 10.1152/jappl.2001.91.6.2471; MELZACK R, 1977, PAIN, V3, P3, DOI 10.1016/0304-3959(77)90032-X; MELZACK R, 1981, ARCH PHYS MED REHAB, V62, P114; Oschman J. L., 2000, ENERGY MED SCI BASIS; Osterman KS, 1999, ANN NY ACAD SCI, V873, P21, DOI 10.1111/j.1749-6632.1999.tb09445.x; RABISCHONG P, 1975, NOUV PRESSE MED, V4, P2021; Regling G, 2000, ELECTRO MAGNETOBIOL, V19, P149, DOI 10.3109/15368370009167833; REICHMANIS M, 1977, COMP MED EAST WEST, V5, P289, DOI 10.1142/S0147291777000416; REICHMANIS M, 1979, AM J CHINESE MED, V7, P188, DOI 10.1142/S0192415X79000167; REICHMANIS M, 1977, IEEE T BIO-MED ENG, V24, P402, DOI 10.1109/TBME.1977.326154; Schwartzman D, 1999, J INTERV CARD ELECTR, V3, P213, DOI 10.1023/A:1009887306055; SENELAR R, 1979, CHARACTERISTIQUES MO; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Tabel GM, 2006, ECHOCARDIOGR-J CARD, V23, P103, DOI 10.1111/j.1540-8175.2006.00178.x; TIBERIU R, 1981, AM J ACUPUNCTURE, V9, P251; VANDERSCHOT L, 1976, American Journal of Acupuncture, V4, P233	36	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11907	10.1371/journal.pone.0011907	http://dx.doi.org/10.1371/journal.pone.0011907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689594	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300021
J	Isomura, H; Stinski, MF; Murata, T; Nakayama, S; Chiba, S; Akatsuka, Y; Kanda, T; Tsurumi, T				Isomura, Hiroki; Stinski, Mark F.; Murata, Takayuki; Nakayama, Sanae; Chiba, Shigeki; Akatsuka, Yoshiki; Kanda, Teru; Tsurumi, Tatsuya			The Human Cytomegalovirus UL76 Gene Regulates the Level of Expression of the UL77 Gene	PLOS ONE			English	Article							OPEN READING FRAME; IMMEDIATE-EARLY PROMOTER; EARLY DISTAL ENHANCER; CIS-ACTING ELEMENTS; VIRAL REPLICATION; TRANSLATIONAL INHIBITION; PROXIMAL ENHANCER; TRANSCRIPTION; DNA; PROTEIN	Background: Human cytomegalovirus (HCMV) can be reactivated under immunosuppressive conditions causing several fatal pneumonitis, hepatitis, retinitis, and gastrointestinal diseases. HCMV also causes deafness and mental retardation in neonates when primary infection has occurred during pregnancy. In the genome of HCMV at least 194 known open reading frames (ORFs) have been predicted, and approximately one-quarter, or 41 ORFs, are required for viral replication in cell culture. In contrast, the majority of the predicted ORFs are nonessential for viral replication in cell culture. However, it is also possible that these ORFs are required for the efficient viral replication in the host. The UL77 gene of HCMV is essential for viral replication and has a role in viral DNA packaging. The function of the upstream UL76 gene in the HCMV-infected cells is not understood. UL76 and UL77 are cistons on the same viral mRNA and a conventional 59 mRNA for UL77 has not been detected. The vast majority of eukaryotic mRNAs are monocistronic, i.e., they encode only a single protein. Methodology/Principal Findings: To determine whether the UL76 ORF affects UL77 gene expression, we mutated UL76 by ORF frame-shifts, stop codons or deletion of the viral gene. The effect on UL77 protein expression was determined by either transfection of expression plasmids or infection with recombinant viruses. Mutation of UL76 ORF significantly increased the level of UL77 protein expression. However, deletion of UL76 upstream of the UL77 ORF had only marginal effects on viral growth. Conclusions/Significance: While UL76 is not essential for viral replication, the UL76 ORF is involved in regulation of the level of UL77 protein expression in a manner dependent on the translation re-initiation. UL76 may fine-tune the UL77 expression for the efficient viral replication in the HCMV-infected cells.	[Isomura, Hiroki; Murata, Takayuki; Nakayama, Sanae; Chiba, Shigeki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan; [Akatsuka, Yoshiki] Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan; [Stinski, Mark F.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	Aichi Cancer Center; Aichi Cancer Center; University of Iowa	Isomura, H (corresponding author), Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan.	hisomura@aichi-cc.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; akatsuka, yoshiki/0000-0003-3623-2826; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [20012056, 19041078, 20390137, 19590487]; Research on Health Sciences focusing on Drug Innovation [SH54412]; Ministry of Health, Labor and Welfare [19-01]; National Institutes of Health [AI-13562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI013562, R01AI013562] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Health Sciences focusing on Drug Innovation; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, Culture and Technology of Japan (20012056, 19041078, 20390137 to T.T., and 19590487 to H. I.), Research on Health Sciences focusing on Drug Innovation (SH54412 to H.I.), a Grant-in-aid for Cancer Research (19-01 to H.I.) from the Ministry of Health, Labor and Welfare, and grant AI-13562 from the National Institutes of Health (to M.F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM BL, 1995, J VIROL, V69, P5304, DOI 10.1128/JVI.69.9.5304-5310.1995; Akatsuka Y, 2002, TISSUE ANTIGENS, V59, P502, DOI 10.1034/j.1399-0039.2002.590607.x; Alderete JP, 1999, J VIROL, V73, P8330, DOI 10.1128/JVI.73.10.8330-8337.1999; BIEGALKE BJ, 1990, VIROLOGY, V177, P657, DOI 10.1016/0042-6822(90)90531-U; CAO JH, 1995, J VIROL, V69, P1030, DOI 10.1128/JVI.69.2.1030-1036.1995; Cao JH, 1996, MOL CELL BIOL, V16, P603; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; GEBALLE AP, 1988, J VIROL, V62, P3334, DOI 10.1128/JVI.62.9.3334-3340.1988; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hahn G, 2003, VIROLOGY, V307, P164, DOI 10.1016/S0042-6822(02)00061-2; Horn PA, 2002, BLOOD, V100, P3960, DOI 10.1182/blood-2002-05-1359; Isomura H, 2005, J VIROL, V79, P9597, DOI 10.1128/JVI.79.15.9597-9607.2005; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Isomura H, 2003, J VIROL, V77, P3602, DOI 10.1128/JVI.77.6.3602-3614.2003; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Isomura H, 2007, J VIROL, V81, P6197, DOI 10.1128/JVI.00089-07; LIU B, 1992, J VIROL, V66, P4434, DOI 10.1128/JVI.66.7.4434-4444.1992; Meier JL, 1997, J VIROL, V71, P1246, DOI 10.1128/JVI.71.2.1246-1255.1997; Meier JL, 2002, J VIROL, V76, P313, DOI 10.1128/JVI.76.1.313-326.2002; Meier JL, 2000, J VIROL, V74, P1602, DOI 10.1128/JVI.74.4.1602-1613.2000; Mitchell DP, 2009, J VIROL, V83, P10187, DOI 10.1128/JVI.00396-09; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; PARI GS, 1993, J VIROL, V67, P6979, DOI 10.1128/JVI.67.12.6979-6988.1993; SCHLEISS MR, 1991, J VIROL, V65, P6782, DOI 10.1128/JVI.65.12.6782-6789.1991; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; TENNEY DJ, 1991, VIROLOGY, V182, P199, DOI 10.1016/0042-6822(91)90663-V; Wang SK, 2000, J GEN VIROL, V81, P2407, DOI 10.1099/0022-1317-81-10-2407; Wang SK, 2004, J VIROL, V78, P9750, DOI 10.1128/JVI.78.18.9750-9762.2004; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; White EA, 2007, J VIROL, V81, P2573, DOI 10.1128/JVI.02454-06; WING BA, 1995, J VIROL, V69, P1521, DOI 10.1128/JVI.69.3.1521-1531.1995; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11901	10.1371/journal.pone.0011901	http://dx.doi.org/10.1371/journal.pone.0011901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689582	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300016
J	Muster, B; Kohl, W; Wittig, I; Strecker, V; Joos, F; Haase, W; Bereiter-Hahn, J; Busch, K				Muster, Britta; Kohl, Wladislaw; Wittig, Ilka; Strecker, Valentina; Joos, Friederike; Haase, Winfried; Bereiter-Hahn, Juergen; Busch, Karin			Respiratory Chain Complexes in Dynamic Mitochondria Display a Patchy Distribution in Life Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; QUALITY-CONTROL; FUSION PROTEINS; ATP SYNTHASE; CYTOCHROME-C; IN-VIVO; FISSION; MORPHOLOGY; DIVISION; CRISTAE	Background: Mitochondria, the main suppliers of cellular energy, are dynamic organelles that fuse and divide frequently. Constraining these processes impairs mitochondrial is closely linked to certain neurodegenerative diseases. It is proposed that functional mitochondrial dynamics allows the exchange of compounds thereby providing a rescue mechanism. Methodology/Principal Findings: The question discussed in this paper is whether fusion and fission of mitochondria in different cell lines result in re-localization of respiratory chain (RC) complexes and of the ATP synthase. This was addressed by fusing cells containing mitochondria with respiratory complexes labelled with different fluorescent proteins and resolving their time dependent re-localization in living cells. We found a complete reshuffling of RC complexes throughout the entire chondriome in single HeLa cells within 2-3 h by organelle fusion and fission. Polykaryons of fused cells completely re-mixed their RC complexes in 10-24 h in a progressive way. In contrast to the recently described homogeneous mixing of matrix-targeted proteins or outer membrane proteins, the distribution of RC complexes and ATP synthase in fused hybrid mitochondria, however, was not homogeneous but patterned. Thus, complete equilibration of respiratory chain complexes as integral inner mitochondrial membrane complexes is a slow process compared with matrix proteins probably limited by complete fusion. In co-expressing cells, complex II is more homogenously distributed than complex I and V, resp. Indeed, this result argues for higher mobility and less integration in supercomplexes. Conclusion/Significance: Our results clearly demonstrate that mitochondrial fusion and fission dynamics favours the re-mixing of all RC complexes within the chondriome. This permanent mixing avoids a static situation with a fixed composition of RC complexes per mitochondrion.	[Muster, Britta; Kohl, Wladislaw; Bereiter-Hahn, Juergen; Busch, Karin] Goethe Univ Frankfurt, Inst Kinemat Cell Res, Dept Biol, Frankfurt, Germany; [Kohl, Wladislaw; Busch, Karin] Univ Osnabrueck, Lab Mitochondrial Dynam, Dept Biol, Osnabruck, Germany; [Wittig, Ilka; Strecker, Valentina] Goethe Univ Frankfurt, Inst Mol Bioenerget, Sch Med, Frankfurt, Germany; [Joos, Friederike; Haase, Winfried] Max Planck Inst Biophys, Electron Facil, D-6000 Frankfurt, Germany	Goethe University Frankfurt; University Osnabruck; Goethe University Frankfurt; Max Planck Society	Muster, B (corresponding author), Goethe Univ Frankfurt, Inst Kinemat Cell Res, Dept Biol, Frankfurt, Germany.	busch_k@biologie.uni-osnabrueck.de	Busch, Karin/AAM-8374-2021; Busch, Karin/ABH-8594-2020	Busch, Karin/0000-0003-0525-0191	Deutsche Forschungsgemeinschaft [Bu2288/1, Sonderforschungsbereich 815, Z1]; Bundesministerium fuer Bildung und Forschung (BMBF) [01GM0863]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by a DFG grant (Bu2288/1) http://www.dfg.de. I.W. was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815, Project Z1 (Redox-Proteomics), and V. S. by the Bundesministerium fuer Bildung und Forschung (BMBF 01GM0863; mitoNET - Deutsches Netzwerk fuer mitochondriale Erkrankungen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; BEREITERHAHN J, 1983, CELL BIOCH AND FUNCT, V6, P1; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; CHANCE B, 1955, J BIOL CHEM, V217, P429; CHEN H, 2003, DEVELOPMENT, V70, P1; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Choksi KB, 2008, FREE RADICAL BIO MED, V44, P1795, DOI 10.1016/j.freeradbiomed.2008.01.032; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; JCELL B, 1960, J CELL BIOL, V189, P200; Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Keppler A, 2004, METHODS, V32, P437, DOI 10.1016/j.ymeth.2003.10.007; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kowald A, 2005, AGING CELL, V4, P273, DOI 10.1111/j.1474-9726.2005.00169.x; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Linford NJ, 2006, CANCER RES, V66, P2497, DOI 10.1158/0008-5472.CAN-05-3163; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Lu BW, 2009, CURR NEUROL NEUROSCI, V9, P212, DOI 10.1007/s11910-009-0032-7; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Molina AJA, 2009, METHOD ENZYMOL, V457, P289, DOI 10.1016/S0076-6879(09)05016-2; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Pickrell AM, 2009, J BIOENERG BIOMEMBR, V41, P453, DOI 10.1007/s10863-009-9245-3; Prescott M, 2003, J BIOL CHEM, V278, P251, DOI 10.1074/jbc.M204556200; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Ramadass R, 2008, BIOPHYS J, V95, P4068, DOI 10.1529/biophysj.108.135079; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Sato A, 2009, BIOFACTORS, V35, P130, DOI 10.1002/biof.14; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scorrano L, 2005, J BIOENERG BIOMEMBR, V37, P165, DOI 10.1007/s10863-005-6572-x; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sheahan MB, 2005, PLANT J, V44, P744, DOI 10.1111/j.1365-313X.2005.02561.x; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZINN AR, 1987, PLASMID, V17, P248, DOI 10.1016/0147-619X(87)90033-3	81	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11910	10.1371/journal.pone.0011910	http://dx.doi.org/10.1371/journal.pone.0011910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689601	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520300024
J	Rodrigue, S; Materna, AC; Timberlake, SC; Blackburn, MC; Malmstrom, RR; Alm, EJ; Chisholm, SW				Rodrigue, Sebastien; Materna, Arne C.; Timberlake, Sonia C.; Blackburn, Matthew C.; Malmstrom, Rex R.; Alm, Eric J.; Chisholm, Sallie W.			Unlocking Short Read Sequencing for Metagenomics	PLOS ONE			English	Article							GENOMIC DNA; SOLID-PHASE; PCR; AMPLIFICATION; GENERATION; LENGTH	Background: Different high-throughput nucleic acid sequencing platforms are currently available but a trade-off currently exists between the cost and number of reads that can be generated versus the read length that can be achieved. Methodology/Principal Findings: We describe an experimental and computational pipeline yielding millions of reads that can exceed 200 bp with quality scores approaching that of traditional Sanger sequencing. The method combines an automatable gel-less library construction step with paired-end sequencing on a short-read instrument. With appropriately sized library inserts, mate-pair sequences can overlap, and we describe the SHERA software package that joins them to form a longer composite read. Conclusions/Significance: This strategy is broadly applicable to sequencing applications that benefit from low-cost high-throughput sequencing, but require longer read lengths. We demonstrate that our approach enables metagenomic analyses using the Illumina Genome Analyzer, with low error rates, and at a fraction of the cost of pyrosequencing.	[Rodrigue, Sebastien; Materna, Arne C.; Timberlake, Sonia C.; Blackburn, Matthew C.; Malmstrom, Rex R.; Alm, Eric J.; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Rodrigue, S (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; chisholm@mit.edu	Malmstrom, Rex/K-7339-2012	Malmstrom, Rex/0000-0002-4758-7369; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foundation Marine Microbiology Initiative; Center for Microbial Oceanography; Department of Energy Genome-to-Life (DOE-GTL); Natural Science and Engineering Research Council of Canada (NSERC); Fonds Quebecois de Recherche sur la Nature et Technologies (FQRNT)	Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); Center for Microbial Oceanography; Department of Energy Genome-to-Life (DOE-GTL)(United States Department of Energy (DOE)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de Recherche sur la Nature et Technologies (FQRNT)(FQRNT)	This work was supported by funds from the Gordon and Betty Moore Foundation Marine Microbiology Initiative (www.moore.org), and the Center for Microbial Oceanography: Research and Education (C-MORE) (http://cmore.soest.hawaii.edu) awarded to S.W.C., and by funds from the Department of Energy Genome-to-Life (DOE-GTL) (http://genomicscience.energy.gov) program awarded to S.W.C. and E.J.A.S.R. is the recipient of postdoctoral fellowships from the Natural Science and Engineering Research Council of Canada (NSERC) (www.nserc-crsng.gc.ca) and from the Fonds Quebecois de Recherche sur la Nature et Technologies (FQRNT) (www.fqrnt.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hoff KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-217; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Krizova J, 2005, J CHROMATOGR A, V1064, P247, DOI 10.1016/j.chroma.2004.12.014; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mitra S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S12; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07	22	121	128	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11840	10.1371/journal.pone.0011840	http://dx.doi.org/10.1371/journal.pone.0011840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676378	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100016
J	Laguna-Torres, VA; Gomez, J; Aguilar, PV; Ampuero, JS; Munayco, C; Ocana, V; Perez, J; Gamero, ME; Arrasco, JC; Paz, I; Chavez, E; Cruz, R; Chavez, J; Mendocilla, S; Gomez, E; Antigoni, J; Gonzalez, S; Tejada, C; Chowell, G; Kochel, TJ				Alberto Laguna-Torres, Victor; Gomez, Jorge; Aguilar, Patricia V.; Ampuero, Julia S.; Munayco, Cesar; Ocana, Victor; Perez, Juan; Gamero, Maria E.; Carlos Arrasco, Juan; Paz, Irmia; Chavez, Edward; Cruz, Rollin; Chavez, Jaime; Mendocilla, Silvia; Gomez, Elizabeth; Antigoni, Juana; Gonzalez, Sofia; Tejada, Cesar; Chowell, Gerardo; Kochel, Tadeusz J.		Peru Influenza Working Grp	Changes in the Viral Distribution Pattern after the Appearance of the Novel Influenza A H1N1 (pH1N1) Virus in Influenza-Like Illness Patients in Peru	PLOS ONE			English	Article								Background: We describe the temporal variation in viral agents detected in influenza like illness (ILI) patients before and after the appearance of the ongoing pandemic influenza A (H1N1) (pH1N1) in Peru between 4-January and 13-July 2009. Methods: At the health centers, one oropharyngeal swab was obtained for viral isolation. From epidemiological week (EW) 1 to 18, at the US Naval Medical Research Center Detachment (NMRCD) in Lima, the specimens were inoculated into four cell lines for virus isolation. In addition, from EW 19 to 28, the specimens were also analyzed by real time-polymerase-chain-reaction (rRT-PCR). Results: We enrolled 2,872 patients: 1,422 cases before the appearance of the pH1N1 virus, and 1,450 during the pandemic. Non-pH1N1 influenza A virus was the predominant viral strain circulating in Peru through (EW) 18, representing 57.8% of the confirmed cases; however, this predominance shifted to pH1N1 (51.5%) from EW 19-28. During this study period, most of pH1N1 cases were diagnosed in the capital city (Lima) followed by other cities including Cusco and Trujillo. In contrast, novel influenza cases were essentially absent in the tropical rain forest (jungle) cities during our study period. The city of Iquitos (Jungle) had the highest number of influenza B cases and only one pH1N1 case. Conclusions: The viral distribution in Peru changed upon the introduction of the pH1N1 virus compared to previous months. Although influenza A viruses continue to be the predominant viral pathogen, the pH1N1 virus predominated over the other influenza A viruses.	[Alberto Laguna-Torres, Victor; Aguilar, Patricia V.; Ampuero, Julia S.; Perez, Juan; Gamero, Maria E.; Kochel, Tadeusz J.] US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru; [Gomez, Jorge; Munayco, Cesar; Carlos Arrasco, Juan] Minist Salud, Direcc Gen Epidemiol, Lima, Peru; [Ocana, Victor] Minist Salud, Direcc Reg Salud Piura, Piura, Peru; [Paz, Irmia] Univ Nacl San Agustin, Arequipa, Peru; [Chavez, Edward] Ctr Med Mil 32 Brigada Infanteri Ejercito, Trujillo, Peru; [Cruz, Rollin] Jefatura Salud Ejercito Peru, Lima, Peru; [Chavez, Jaime] Direcc Reg Salud Callao, Lima, Peru; [Mendocilla, Silvia] Minist Salud, Hosp Daniel Alcides Carr Callao, Callao, Peru; [Gomez, Elizabeth] Minist Salud, Direcc Reg Salud Puno, Puno, Peru; [Antigoni, Juana] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Gonzalez, Sofia] Ctr Med Naval, Callao, Peru; [Tejada, Cesar] Minist Salud, Hosp Santa Rosa Lima, Lima, Peru; [Chowell, Gerardo] Arizona State Univ, Math & Computat Modeling Sci Ctr, Sch Human Evolut & Social Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Div Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidad Nacional de San Agustin de Arequipa; Seguro Social de Salud del Peru; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Laguna-Torres, VA (corresponding author), US Naval Med Res Ctr Detachment, Dept Virol, Lima, Peru.	alberto.laguna@med.navy.mil	Munayco, Cesar/G-9990-2013; Chowell, Gerardo/F-5038-2012; Segura, Moises Apolaya/N-5239-2017; Gomez, Jorge/E-5258-2012	Munayco, Cesar/0000-0001-7872-8913; Chowell, Gerardo/0000-0003-2194-2251; Segura, Moises Apolaya/0000-0001-5650-9998; Paz, Irmia/0000-0003-3926-9982; Arrasco, Juan/0000-0002-4961-3858; Chavez-Cruzado, Edward/0000-0001-5379-8624; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ampuero, Julia/0000-0001-5486-1656; Gomez, Jorge/0000-0003-1342-3507	Ministry of Health of Peru; United States Dpartment of Defense [10107_09_LI];  [62787A.873.H.B000]	Ministry of Health of Peru; United States Dpartment of Defense; 	The study was funded by the Ministry of Health of Peru and the United States Dpartment of Defense Global Emerging Infections Systems grant number 10107_09_LI. The Naval Medical Research Center participation was under Protocol NMRCD.2002.0019 in compliance with all applicable federal regulations governing the protection of human subjects. This work was supported and funded by work unit number No. 62787A.873.H.B000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; ANDERSON RMM, 1991, INFECT DIS HUMANS, P3; Belshe RB, 2004, VIRUS RES, V103, P177, DOI 10.1016/j.virusres.2004.02.031; *CDC, 2009, INFLUENZA; *CHIL MOH, 2009, INFL GOV 2009 H1N1 P; *CHIL MOH, 2010, INFL PAND H1N1 2009; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; FRANK AL, 1983, J MED VIROL, V12, P17, DOI 10.1002/jmv.1890120103; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gomez J, 2009, EURO SURVEILL, V4; *MIN SAL P, 2005, PLAN NAC PREP RESP F; Munayco C, 2009, EURO SURVEILL, V14; Nishiura H, 2009, EUROSURVEILLANCE, V14; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7	15	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11719	10.1371/journal.pone.0011719	http://dx.doi.org/10.1371/journal.pone.0011719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668548	Green Submitted, gold, Green Published			2022-12-27	WOS:000280371800002
J	Fujiwara, Y; Kawato, M; Noda, C; Kinoshita, G; Yamanaka, T; Fujita, Y; Uematsu, K; Miyazaki, JI				Fujiwara, Yoshihiro; Kawato, Masaru; Noda, Chikayo; Kinoshita, Gin; Yamanaka, Toshiro; Fujita, Yuko; Uematsu, Katsuyuki; Miyazaki, Jun-Ichi			Extracellular and Mixotrophic Symbiosis in the Whale-Fall Mussel Adipicola pacifica: A Trend in Evolution from Extra- to Intracellular Symbiosis	PLOS ONE			English	Article							BACTERIAL ENDOSYMBIONTS; OLIGONUCLEOTIDE PROBES; BIVALVE MOLLUSKS; WOODEN STEPS; SP. NOV.; DEEP; ASSOCIATION; GILLS; ADAPTATIONS; DISPERSAL	Background: Deep-sea mussels harboring chemoautotrophic symbionts from hydrothermal vents and seeps are assumed to have evolved from shallow-water asymbiotic relatives by way of biogenic reducing environments such as sunken wood and whale falls. Such symbiotic associations have been well characterized in mussels collected from vents, seeps and sunken wood but in only a few from whale falls. Methodology/Principal Finding: Here we report symbioses in the gill tissues of two mussels, Adipicola crypta and Adipicola pacifica, collected from whale-falls on the continental shelf in the northwestern Pacific. The molecular, morphological and stable isotopic characteristics of bacterial symbionts were analyzed. A single phylotype of thioautotrophic bacteria was found in A. crypta gill tissue and two distinct phylotypes of bacteria (referred to as Symbiont A and Symbiont C) in A. pacifica. Symbiont A and the A. crypta symbiont were affiliated with thioautotrophic symbionts of bathymodiolin mussels from deep-sea reducing environments, while Symbiont C was closely related to free-living heterotrophic bacteria. The symbionts in A. crypta were intracellular within epithelial cells of the apical region of the gills and were extracellular in A. pacifica. No spatial partitioning was observed between the two phylotypes in A. pacifica in fluorescence in situ hybridization experiments. Stable isotopic analyses of carbon and sulfur indicated the chemoautotrophic nature of A. crypta and mixotrophic nature of A. pacifica. Molecular phylogenetic analyses of the host mussels showed that A. crypta constituted a monophyletic clade with other intracellular symbiotic (endosymbiotic) mussels and that A. pacifica was the sister group of all endosymbiotic mussels. Conclusions/Significance: These results strongly suggest that the symbiosis in A. pacifica is at an earlier stage in evolution than other endosymbiotic mussels. Whale falls and other modern biogenic reducing environments may act as refugia for primal chemoautotrophic symbioses between eukaryotes and prokaryotes since the extinction of ancient large marine vertebrates.	[Fujiwara, Yoshihiro; Kawato, Masaru] Japan Agcy Marine Earth Sci & Technol, Chemoecosyst Evolut Res ChEER Team, Yokosuka, Kanagawa 2370061, Japan; [Kinoshita, Gin] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [Yamanaka, Toshiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Fujita, Yuko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Uematsu, Katsuyuki] Marine Work Japan Ltd, Dept Tech Serv, Yokosuka, Kanagawa, Japan; [Miyazaki, Jun-Ichi] Univ Yamanashi, Fac Educ & Human Sci, Kofu, Yamanashi, Japan; [Noda, Chikayo] Keikyu Aburatsubo Marine Pk, Miura, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Hiroshima University; Okayama University; University of Tsukuba; University of Yamanashi	Fujiwara, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Chemoecosyst Evolut Res ChEER Team, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	fujiwara@jamstec.go.jp	YAMANAKA, Toshiro/B-2644-2011	YAMANAKA, Toshiro/0000-0002-6807-6904	Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Marine Work Japan Ltd; Keikyu Aburatsubo Marine Park (KAMP)	Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Marine Work Japan Ltd; Keikyu Aburatsubo Marine Park (KAMP)	This work was funded by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) (Grant number: ChEER, URL: www.jamstec.go.jp); Marine Work Japan Ltd (MWJ) (Grant number: N/A, URL: http://www.mwj.co.jp/en/); Keikyu Aburatsubo Marine Park (KAMP) (Grant number: N/A, URL: http://www.aburatsubo.co.jp/). Japan Agency for Marine-Earth Science and Technology had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marine Work Japan Ltd had a role in data collection. Marine Work Japan Ltd and Keikyu Aburatsubo Marine Park were funders due to employment of one author of this study from each company. One of the co-authors, Chikayo Noda from Keikyu Aburatsubo Marine Park, was a post-graduate student in Fujiwara's laboratory at the time of the study. Therefore, Keikyu Aburatsubo Marine Park has no commitment to this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amano K, 2005, PALAEOGEOGR PALAEOCL, V215, P345, DOI 10.1016/j.palaeo.2004.10.003; Baker P, 2007, J SHELLFISH RES, V26, P345, DOI 10.2983/0730-8000(2007)26[345:RADOAT]2.0.CO;2; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DISTEL DL, 1988, J BACTERIOL, V170, P2506, DOI 10.1128/jb.170.6.2506-2510.1988; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Dufour SC, 2005, BIOL BULL-US, V208, P200, DOI 10.2307/3593152; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FIALAMEDIONI A, 1986, J EXP MAR BIOL ECOL, V96, P191, DOI 10.1016/0022-0981(86)90242-X; FIALAMEDIONI A, 1987, SYMBIOSIS, V4, P63; FISHER CR, 1992, SYMBIOSIS, V12, P221; Fujiwara Y, 2001, MAR ECOL PROG SER, V214, P151, DOI 10.3354/meps214151; Fujiwara Y, 2000, MAR ECOL PROG SER, V208, P147, DOI 10.3354/meps208147; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Fujiwara Yoshihiro, 2009, Venus (Tokyo), V68, P27; Gros O, 2007, ZOOMORPHOLOGY, V126, P163, DOI 10.1007/s00435-007-0035-3; Gros O, 2007, CAH BIOL MAR, V48, P103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOGLER JA, 1994, PALAIOS, V9, P42, DOI 10.2307/3515077; Holloway MG, 2002, MAR ECOL PROG SER, V235, P43, DOI 10.3354/meps235043; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaim A, 2008, ACTA PALAEONTOL POL, V53, P97, DOI 10.4202/app.2008.0106; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Kiel S, 2006, PALAIOS, V21, P548, DOI 10.2110/palo.2005.p05-086r; Kyuno Akiko, 2009, Journal of Marine Biology, V2009, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; Le Pennec M, 1988, J SHELLFISH RES, V7, P483; LEPENNEC M, 1992, CAN J ZOOL, V70, P2298; LEPENNEC M, 1995, COMP BIOCHEM PHYS A, V111, P183, DOI 10.1016/0300-9629(94)00211-B; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; MARSHALL BA, 1994, NAUTILUS, V108, P1; MARTILL DM, 1991, NATURE, V351, P193, DOI 10.1038/351193a0; McKiness ZP, 2005, MAR BIOL, V148, P109, DOI 10.1007/s00227-005-0065-7; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; Mizota C, 1998, GEOCHEM J, V32, P421, DOI 10.2343/geochemj.32.421; Mizota Chitoshi, 2003, Japanese Journal of Benthology, V58, P56; Nogi Y, 2004, INT J SYST EVOL MICR, V54, P1627, DOI 10.1099/ijs.0.03049-0; Nylander JAA., 2004, BIOINFORMATICS; Okutani T., 2003, VENUS, V63, P61; PAGE HM, 1991, DEEP-SEA RES, V38, P1455, DOI 10.1016/0198-0149(91)90084-S; PAGE HM, 1990, MAR BIOL, V104, P251, DOI 10.1007/BF01313266; Rinke C, 2006, APPL ENVIRON MICROB, V72, P2014, DOI 10.1128/AEM.72.3.2014-2021.2006; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROSATI G, 2004, SYMBIOSIS MECH MODEL, P475; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; Skurikhina L. A., 2001, Genetika, V37, P1717; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SMITH DC, 1979, PROC R SOC SER B-BIO, V204, P115, DOI 10.1098/rspb.1979.0017; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; YANAGISAWA F, 1983, ANAL CHEM, V55, P985, DOI 10.1021/ac00257a046; Yumoto I, 1998, INT J SYST BACTERIOL, V48, P1357, DOI 10.1099/00207713-48-4-1357	67	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11808	10.1371/journal.pone.0011808	http://dx.doi.org/10.1371/journal.pone.0011808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676405	Green Submitted, Green Published, gold			2022-12-27	WOS:000280371800012
J	Kumper, S; Ridley, AJ				Kuemper, Sandra; Ridley, Anne J.			p120ctn and P-Cadherin but Not E-Cadherin Regulate Cell Motility and Invasion of DU145 Prostate Cancer Cells	PLOS ONE			English	Article							RHO-FAMILY GTPASES; EPITHELIAL-CELLS; ALPHA-CATENIN; BETA-CATENIN; TYROSINE PHOSPHORYLATION; INDEPENDENT MECHANISM; ADHESION PROTEINS; CARCINOMA-CELLS; DOWN-REGULATION; P120-CATENIN	Background: Adherens junctions consist of transmembrane cadherins, which interact intracellularly with p120ctn, beta-catenin and alpha-catenin. p120ctn is known to regulate cell-cell adhesion by increasing cadherin stability, but the effects of other adherens junction components on cell-cell adhesion have not been compared with that of p120ctn. Methodology/Principal Findings: We show that depletion of p120ctn by small interfering RNA (siRNA) in DU145 prostate cancer and MCF10A breast epithelial cells reduces the expression levels of the adherens junction proteins, E-cadherin, P-cadherin, beta-catenin and alpha-catenin, and induces loss of cell-cell adhesion. p120ctn-depleted cells also have increased migration speed and invasion, which correlates with increased Rap1 but not Rac1 or RhoA activity. Downregulation of P-cadherin, beta-catenin and alpha-catenin but not E-cadherin induces a loss of cell-cell adhesion, increased migration and enhanced invasion similar to p120ctn depletion. However, only p120ctn depletion leads to a decrease in the levels of other adherens junction proteins. Conclusions/Significance: Our data indicate that P-cadherin but not E-cadherin is important for maintaining adherens junctions in DU145 and MCF10A cells, and that depletion of any of the cadherin-associated proteins, p120ctn, beta-catenin or alpha-catenin, is sufficient to disrupt adherens junctions in DU145 cells and increase migration and cancer cell invasion.	[Kuemper, Sandra; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London	Kumper, S (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	anne.ridley@kcl.ac.uk		Kumper, Sandra/0000-0002-5478-0503; Ridley, Anne/0000-0001-8186-5708	Cancer Research UK; Bettencourt-Schueller Foundation; European Commission [LSHG-CT-2003-502935]; Kings College London School of Biomedical and Health Sciences	Cancer Research UK(Cancer Research UK); Bettencourt-Schueller Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Kings College London School of Biomedical and Health Sciences	This research was supported by Cancer Research UK, Bettencourt-Schueller Foundation, and a European Commission Framework 6 contract (LSHG-CT-2003-502935; MAIN). SK was supported by a PhD studentship from Kings College London School of Biomedical and Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Asuri S, 2008, J CELL BIOCHEM, V105, P1027, DOI 10.1002/jcb.21902; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Grosheva I, 2001, J CELL SCI, V114, P695; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Kallakury BVS, 2001, CANCER, V92, P2786, DOI 10.1002/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I; Kallakury BVS, 2001, HUM PATHOL, V32, P849, DOI 10.1053/hupa.2001.26463; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Luo J, 1999, CANCER RES, V59, P3552; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Noe V, 1999, J CELL SCI, V112, P127; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Parachoniak CA, 2009, J BIOL CHEM, V284, P8382, DOI 10.1074/jbc.M807607200; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perrin-Tricaud C, 2007, MOL CELL NEUROSCI, V35, P120, DOI 10.1016/j.mcn.2007.02.010; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Ridley AJ, 1999, BIOCHEM SOC SYMP, V65, P111; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sanders DSA, 1999, J CLIN PATHOL-MOL PA, V52, P151, DOI 10.1136/mp.52.3.151; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; SIMPSON KJ, 2008, NAT CELL BIOL; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	53	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11801	10.1371/journal.pone.0011801	http://dx.doi.org/10.1371/journal.pone.0011801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668551	gold, Green Published, Green Submitted			2022-12-27	WOS:000280371800007
J	Devun, F; Walter, L; Belliere, J; Cottet-Rousselle, C; Leverve, X; Fontaine, E				Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric			Ubiquinone Analogs: A Mitochondrial Permeability Transition Pore-Dependent Pathway to Selective Cell Death	PLOS ONE			English	Article							RESPIRATORY-CHAIN COMPLEX; CYCLOPHILIN-D; CYTOCHROME-C; IN-VITRO; SITE; PROGRESS; RELEASE; CALCIUM; TARGET	Background: Prolonged opening of the mitochondrial permeability transition pore (PTP) leads to cell death. Various ubiquinone analogs have been shown to regulate PTP opening but the outcome of PTP regulation by ubiquinone analogs on cell fate has not been studied yet. Methodology/Principal Findings: The effects of ubiquinone 0 (Ub(0)), ubiquinone 5 (Ub(5)), ubiquinone 10 (Ub(10)) and decylubiquinone (DUb) were studied in freshly isolated rat hepatocytes, cultured rat liver Clone-9 cells and cancerous rat liver MH1C1 cells. PTP regulation by ubiquinones differed significantly in permeabilized Clone-9 and MH1C1 cells from that previously reported in liver mitochondria. Ub0 inhibited PTP opening in isolated hepatocytes and Clone-9 cells, whereas it induced PTP opening in MH1C1 cells. Ub5 did not affect PTP opening in isolated hepatocytes and MH1C1 cells, but it induced PTP opening in Clone-9 cells. Ub10 regulated PTP in isolated hepatocytes, whereas it did not affect PTP opening in Clone-9 and MH1C1 cells. Only DUb displayed the same effect on PTP regulation in the three hepatocyte lines tested. Despite such modifications in PTP regulation, competition between ubiquinones still occurred in Clone-9 and MH1C1 cells. As expected, Ub5 induced a PTP-dependent cell death in Clone-9, while it did not affect MH1C1 cell viability. Ub0 induced a PTP-dependent cell death in MH1C1 cells, but was also slightly cytotoxic in Clone-9 by an oxidative stress-dependent mechanism. Conclusions/Significance: We found that various ubiquinone analogs regulate PTP in different ways depending on the cell studied. We took advantage of this unique property to develop a PTP opening-targeted strategy that leads to cell death specifically in cells where the ubiquinone analog used induces PTP opening, while sparing the cells in which it does not induce PTP opening.	[Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric] INSERM, U884, F-38041 Grenoble, France; [Devun, Flavien; Walter, Ludivine; Belliere, Julie; Cottet-Rousselle, Cecile; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Devun, F (corresponding author), INSERM, U884, F-38041 Grenoble, France.	eric.fontaine@ujf-grenoble.fr	Fontaine, Eric/ABA-8853-2020; Walter, Ludivine/S-4456-2017	Fontaine, Eric/0000-0002-5204-9477; Walter, Ludivine/0000-0001-7214-0676; COTTET-ROUSSELLE, Cecile/0000-0003-1208-8911	INSERM; Agence Nationale de la Recherche (QuinoMitEAO); Ministere de l'Enseignement de la Recherche et de la Technologie (MERT); Ligue Nationale contre le Cancer; Region Rhone-Alpes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (QuinoMitEAO)(French National Research Agency (ANR)); Ministere de l'Enseignement de la Recherche et de la Technologie (MERT); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from INSERM, Agence Nationale de la Recherche (QuinoMitEAO) and the Ministere de l'Enseignement de la Recherche et de la Technologie (MERT). FD was supported by fellowship from the Ligue Nationale contre le Cancer. LW was supported by fellowship from the Region Rhone-Alpes (programme Emergence). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; De Oliveira F, 2006, ONCOGENE, V25, P2646, DOI 10.1038/sj.onc.1209293; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nogueira V, 2005, J BIOENERG BIOMEMBR, V37, P25, DOI 10.1007/s10863-005-4120-3; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rousselle C, 2001, IN VITRO CELL DEV-AN, V37, P646; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	33	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11792	10.1371/journal.pone.0011792	http://dx.doi.org/10.1371/journal.pone.0011792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668684	Green Published, gold			2022-12-27	WOS:000280297300021
J	Kandan-Kulangara, F; Shah, RG; Affar, E; Shah, GM				Kandan-Kulangara, Febitha; Shah, Rashmi G.; Affar, El Bachir; Shah, Girish M.			Persistence of Different Forms of Transient RNAi during Apoptosis in Mammalian Cells	PLOS ONE			English	Article							VECTOR-BASED RNAI	Gene silencing by transient or stable RNA-interference (RNAi) is used for the study of apoptosis with an assumption that apoptotic events will not influence RNAi. However, we recently reported that stable RNAi, i.e., a permanent gene-knockdown mediated by shRNA-generating DNA vectors that are integrated in the genome, fails rapidly after induction of apoptosis due to caspase-3-mediated cleavage and inactivation of the endoribonuclease Dicer-1 that is required for conversion of shRNA to siRNA. Since apoptosis studies also increasingly employ transient RNAi models in which apoptosis is induced immediately after a gene is temporarily knocked down within a few days of transfection with RNAi-inducing agents, we examined the impact of apoptosis on various models of transient RNAi. We report here that unlike the stable RNAi, all forms of transient RNAi, whether Dicer-1-independent (by 21mer dsRNA) or Dicer-1-dependent (by 27mer dsRNA or shRNA-generating DNA vector), whether for an exogenous gene GFP or an endogenous gene poly(ADP-ribose) polymerase-1, do not fail for 2-3 days after onset of apoptosis. Our results reflect the differences in dynamics of achieving and maintaining RNAi during the early phase after transfection in the transient RNAi model and the late steady-state phase of gene-knockdown in stable RNAi model. Our results also sound a cautionary note that RNAi status should be frequently validated in the studies involving apoptosis and that while stable RNAi can be safely used for the study of early apoptotic events, transient RNAi is more suitable for the study of both early and late apoptotic events.	[Kandan-Kulangara, Febitha; Shah, Rashmi G.; Shah, Girish M.] Univ Laval, Hosp Res Ctr Laval Univ CHUL CHUQ, Fac Med, Dept Mol Biol Med Biochem & Pathol,Lab Skin Canc, Quebec City, PQ, Canada; [Affar, El Bachir] Univ Montreal, Dept Med, Fac Med, Hop Maison Neuve Rosemont,Res Ctr, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal	Kandan-Kulangara, F (corresponding author), Univ Laval, Hosp Res Ctr Laval Univ CHUL CHUQ, Fac Med, Dept Mol Biol Med Biochem & Pathol,Lab Skin Canc, Quebec City, PQ, Canada.	girish.shah@crchul.ulaval.ca		Shah, Girish/0000-0002-9291-1164	Natural Sciences and Engineering Research Council of Canada [155257-06]; NSERC; Fonds de la recherche en Sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by the research grant to G.M.S. from the Natural Sciences and Engineering Research Council of Canada (155257-06). F.K.K. was a recipient of the NSERC-Doctoral scholarship award. E.B.A. and G.M.S. were recipients of the FRSQ-Junior-1 and FRSQ-Senior Scholarship awards, respectively, from the Fonds de la recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp131; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Shah RG, 2005, BIOCHEM BIOPH RES CO, V331, P167, DOI 10.1016/j.bbrc.2005.03.135; Shi Y, 2003, TRENDS GENET, V19, P9, DOI 10.1016/S0168-9525(02)00005-7; Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020	9	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12263	10.1371/journal.pone.0012263	http://dx.doi.org/10.1371/journal.pone.0012263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805889	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600027
J	Bu, WY; Lim, KB; Yu, YH; Chou, AM; Sudhaharan, T; Ahmed, S				Bu, Wenyu; Lim, Kim Buay; Yu, Yuan Hong; Chou, Ai Mei; Sudhaharan, Thankiah; Ahmed, Sohail			Cdc42 Interaction with N-WASP and Toca-1 Regulates Membrane Tubulation, Vesicle Formation and Vesicle Motility: Implications for Endocytosis	PLOS ONE			English	Article							BAR-DOMAIN; ACTIN DYNAMICS; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; RHO-GTPASES; PROTEINS; COMPLEX; IRSP53; CELLS; INVAGINATIONS	Transducer of Cdc42-dependent actin assembly (Toca-1) consists of an F-BAR domain, a Cdc42 binding site and an SH3 domain. Toca-1 interacts with N-WASP, an activator of actin nucleation that binds Cdc42. Cdc42 may play an important role in regulating Toca-1 and N-WASP functions. We report here that the cellular expression of Toca-1 and N-WASP induces membrane tubulation and the formation of motile vesicles. Marker and uptake analysis suggests that the tubules and vesicles are associated with clathrin-mediated endocytosis. Forster resonance energy transfer (FRET) and Fluorescence Lifetime Imaging Microscopy (FLIM) analysis shows that Cdc42, N-WASP and Toca-1 form a trimer complex on the membrane tubules and vesicles and that Cdc42 interaction with N-WASP is critical for complex formation. Modulation of Cdc42 interaction with Toca-1 and/or N-WASP affects membrane tubulation, vesicle formation and vesicle motility. Thus Cdc42 may influence endocytic membrane trafficking by regulating the formation and activity of the Toca-1/N-WASP complex.	[Bu, Wenyu; Lim, Kim Buay; Yu, Yuan Hong; Chou, Ai Mei; Sudhaharan, Thankiah; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Bu, WY (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg			Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Fares H, 2001, GENETICS, V159, P133; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Futterer K, 2007, CELL, V129, P655, DOI 10.1016/j.cell.2007.05.006; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091	34	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12153	10.1371/journal.pone.0012153	http://dx.doi.org/10.1371/journal.pone.0012153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730103	Green Published, Green Submitted, gold			2022-12-27	WOS:000280862200012
J	Chen, H; Rangasamy, M; Tan, SY; Wang, HC; Siegfried, BD				Chen, Hong; Rangasamy, Murugesan; Tan, Sek Yee; Wang, Haichuan; Siegfried, Blair D.			Evaluation of Five Methods for Total DNA Extraction from Western Corn Rootworm Beetles	PLOS ONE			English	Article							GENOMIC DNA; MITOCHONDRIAL; COLEOPTERA; PCR	Background: DNA extraction is a routine step in many insect molecular studies. A variety of methods have been used to isolate DNA molecules from insects, and many commercial kits are available. Extraction methods need to be evaluated for their efficiency, cost, and side effects such as DNA degradation during extraction. Methodology/Principal Findings: From individual western corn rootworm beetles, Diabrotica virgifera virgifera, DNA extractions by the SDS method, CTAB method, DNAzol (R) reagent, Puregene (R) solutions and DNeasy (R) column were compared in terms of DNA quantity and quality, cost of materials, and time consumed. Although all five methods resulted in acceptable DNA concentrations and absorbance ratios, the SDS and CTAB methods resulted in higher DNA yield (ng DNA vs. mg tissue) at much lower cost and less degradation as revealed on agarose gels. The DNeasy (R) kit was most time-efficient but was the costliest among the methods tested. The effects of ethanol volume, temperature and incubation time on precipitation of DNA were also investigated. The DNA samples obtained by the five methods were tested in PCR for six microsatellites located in various positions of the beetle's genome, and all samples showed successful amplifications. Conclusion/Significance: These evaluations provide a guide for choosing methods of DNA extraction from western corn rootworm beetles based on expected DNA yield and quality, extraction time, cost, and waste control. The extraction conditions for this mid-size insect were optimized. The DNA extracted by the five methods was suitable for further molecular applications such as PCR and sequencing by synthesis.	[Chen, Hong; Rangasamy, Murugesan; Tan, Sek Yee; Wang, Haichuan; Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Chen, H (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	entomail@gmail.com; bsiegfried1@unl.edu						Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; [Anonymous], [No title captured]; BOYCE TM, 1989, GENETICS, V123, P825; Chen Min, 2008, Forestry Studies in China, V10, P189, DOI 10.1007/s11632-008-0035-5; Chomczynski P, 1997, BIOTECHNIQUES, V22, P550, DOI 10.2144/97223pf01; CHOMCZYNSKI P, 1998, ISOLATION GENOMIC DN, P185; Clark TL, 2001, INSECT MOL BIOL, V10, P303, DOI 10.1046/j.0962-1075.2001.00269.x; COEN ES, 1982, NATURE, V295, P564, DOI 10.1038/295564a0; Crouse J, 1987, FOCUS, V9, P3; *GENTR SYST, 2004, PUR GEN DNA PUR KIT; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Hammond JBW, 1996, ANAL BIOCHEM, V240, P298, DOI 10.1006/abio.1996.0360; Hoy MA, 2003, INSECT MOL GENETICS; HUNT GJ, 1992, THEOR APPL GENET, V85, P15, DOI 10.1007/BF00223839; Kim KS, 2008, ENVIRON ENTOMOL, V37, P293, DOI 10.1603/0046-225X(2008)37[293:ACSOMM]2.0.CO;2; Linton YM, 2001, SYST ENTOMOL, V26, P357, DOI 10.1046/j.1365-3113.2001.00153.x; Miller NJ, 2010, J APPL ENTOMOL, V134, P420, DOI 10.1111/j.1439-0418.2009.01448.x; Miller NJ, 2009, AGR FOREST ENTOMOL, V11, P47, DOI 10.1111/j.1461-9563.2008.00398.x; Milligan B., 1998, MOL GENETIC ANAL POP, P29; *MIN INC, 2005, MINITAB REL 14 20; MINITAB, 2005, LIFE SCI, V14, P20; *MOL RES CTR, 2008, DNAZOL GEN DNA IS RE; PHILLIPS AJ, 1995, ANN ENTOMOL SOC AM, V88, P281, DOI 10.1093/aesa/88.3.281; *QUAG, 2006, DNEASY BLOOD TISS HD; Roehrdanz RL, 2007, ANN ENTOMOL SOC AM, V100, P522, DOI 10.1603/0013-8746(2007)100[522:WBILTM]2.0.CO;2; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Sambrook J., 2001, MOL CLONING LAB MANU; SHAHJAHAN RM, 1995, BIOTECHNIQUES, V19, P332; Sheppard W.S., 1991, P89; STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/nar/23.13.2569-a; Waldschmidt AM, 1997, BRAZ J GENET, V20, P421, DOI 10.1590/S0100-84551997000300011; Zeugin JA Hartley JL., 1985, FOCUS, V7, P1, DOI DOI 10.1108/EB015969; 2010, LIFE SCI, P454; 2010, SOLID SYSTEMS; 2010, 454 LIF SCI	35	143	150	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e11963	10.1371/journal.pone.0011963	http://dx.doi.org/10.1371/journal.pone.0011963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730102	Green Published, gold			2022-12-27	WOS:000280862200001
J	Ma, WL; Kantarjian, H; Zhang, X; Wang, XQ; Zhang, Z; Yeh, CH; O'Brien, S; Giles, F; Bruey, JM; Albitar, M				Ma, Wanlong; Kantarjian, Hagop; Zhang, Xi; Wang, Xiuqiang; Zhang, Zhong; Yeh, Chen-Hsiung; O'Brien, Susan; Giles, Francis; Bruey, Jean Marie; Albitar, Maher			JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms	PLOS ONE			English	Article							PSEUDOKINASE DOMAIN; MUTATIONS; ACTIVATION; V617F	Background: The JAK2 V617F mutation in exon 14 is the most common mutation in chronic myeloproliferative neoplasms (MPNs); deletion of the entire exon 14 is rarely detected. In our previous study of >10,000 samples from patients with suspected MPNs tested for JAK2 mutations by reverse transcription-PCR (RT-PCR) with direct sequencing, complete deletion of exon 14 (Delta exon14) constituted <1% of JAK2 mutations. This appears to be an alternative splicing mutation, not detectable with DNA-based testing. Methodology/Principal Findings: We investigated the possibility that MPN patients may express the JAK2 Delta exon14 at low levels (<15% of total transcript) not routinely detectable by RT-PCR with direct sequencing. Using a sensitive RT-PCR-based fluorescent fragment analysis method to quantify JAK2 Delta exon14 mRNA expression relative to wild-type, we tested 61 patients with confirmed MPNs, 183 with suspected MPNs (93 V617F-positive, 90 V617F-negative), and 46 healthy control subjects. The Delta exon14 variant was detected in 9 of the 61 (15%) confirmed MPN patients, accounting for 3.96% to 33.85% (mean = 12.04%) of total JAK2 transcript. This variant was also detected in 51 of the 183 patients with suspected MPNs (27%), including 20 of the 93 (22%) with V617F (mean [ range] expression = 5.41% [ 2.13%-26.22%]) and 31 of the 90 (34%) without V617F (mean [ range] expression = 3.88% [ 2.08%-12.22%]). Immunoprecipitation studies demonstrated that patients expressing Delta exon14 mRNA expressed a corresponding truncated JAK2 protein. The Delta exon14 variant was not detected in the 46 control subjects. Conclusions/Significance: These data suggest that expression of the JAK2 Delta exon14 splice variant, leading to a truncated JAK2 protein, is common in patients with MPNs. This alternatively spliced transcript appears to be more frequent in MPN patients without V617F mutation, in whom it might contribute to leukemogenesis. This mutation is missed if DNA rather than RNA is used for testing.	[Ma, Wanlong; Zhang, Xi; Wang, Xiuqiang; Zhang, Zhong; Yeh, Chen-Hsiung; Bruey, Jean Marie; Albitar, Maher] Quest Diagnost Nichols Inst, Dept Hematol Oncol, San Juan Capistrano, CA USA; [Kantarjian, Hagop; O'Brien, Susan] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Giles, Francis] Univ Texas Hlth Sci Ctr, Canc Treatment & Res Ctr CTRC, San Antonio, TX USA	Nichols Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Ma, WL (corresponding author), Quest Diagnost Nichols Inst, Dept Hematol Oncol, San Juan Capistrano, CA USA.	maher.x.albitar@questdiagnostics.com						Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Ma W, 2006, BRIT J HAEMATOL, V134, P341, DOI 10.1111/j.1365-2141.2006.06174.x; Ma WL, 2007, HAEMATOLOGICA, V92, P170, DOI 10.3324/haematol.10360; Ma WL, 2009, J MOL DIAGN, V11, P49, DOI 10.2353/jmoldx.2009.080114; Morgani KJ, 2008, ANNU REV MED, V59, P213, DOI 10.1146/annurev.med.59.061506.154159; Nelson ME, 2006, LEUKEMIA LYMPHOMA, V47, P177, DOI 10.1080/10428190500301348; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Zhao LQ, 2010, BIOCHEM J, V426, P91, DOI 10.1042/BJ20090615	15	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12165	10.1371/journal.pone.0012165	http://dx.doi.org/10.1371/journal.pone.0012165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730051	gold, Green Submitted, Green Published			2022-12-27	WOS:000280862200020
J	Kang, DW; Min, DS				Kang, Dong Woo; Min, Do Sik			Positive Feedback Regulation between Phospholipase D and Wnt Signaling Promotes Wnt-Driven Anchorage-Independent Growth of Colorectal Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; COLON-CANCER; HUMAN BREAST; EXPRESSION; TARGET; ACTIVATION; GENE; MUTATIONS; ADHESION; OVEREXPRESSION	Background: Aberrant activation of the canonical Wnt/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival. Phopholipase D (PLD) has been implicated in progression of colorectal carcinoma However, an understanding of the targets and regulation of this important pathway remains incomplete and besides, relationship between Wnt signaling and PLD is not known. Methodology/Principal Findings: Here, we demonstrate that PLD isozymes, PLD1 and PLD2 are direct targets and positive feedback regulators of the Wnt/beta-catenin signaling. Wnt3a and Wnt mimetics significantly enhanced the expression of PLDs at a transcriptional level in HCT116 colorectal cancer cells, whereas silencing of beta-catenin gene expression or utilization of a dominant negative form of T cell factor-4 (TCF-4) inhibited expression of PLDs. Moreover, both PLD1 and PLD2 were highly induced in colon, liver and stomach tissues of mice after injection of LiCl, a Wnt mimetic. Wnt3a stimulated formation of the beta-catenin/TCF complexes to two functional TCF-4-binding elements within the PLD2 promoter as assessed by chromatin immunoprecipitation assay. Suppressing PLD using gene silencing or selective inhibitor blocked the ability of beta-catenin to transcriptionally activate PLD and other Wnt target genes by preventing formation of the beta-catenin/TCF-4 complex, whereas tactics to elevate intracellular levels of phosphatidic acid, the product of PLD activity, enhanced these effects. Here we show that PLD is necessary for Wnt3a-driven invasion and anchorage-independent growth of colon cancer cells. Conclusion/Significance: PLD isozyme acts as a novel transcriptional target and positive feedback regulator of Wnt signaling, and then promotes Wnt-driven anchorage-independent growth of colorectal cancer cells. We propose that therapeutic interventions targeting PLD may confer a clinical benefit in Wnt/beta-catenin-driven malignancies.	[Kang, Dong Woo; Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea	Pusan National University	Kang, DW (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan, South Korea.	minds@pusan.ac.kr			Ministry for Health, Welfare and Family Affairs, Republic of Korea [A080287]	Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A080287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Foster DA, 2003, MOL CANCER RES, V1, P789; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jaiswal AS, 2002, ONCOGENE, V21, P8414, DOI 10.1038/sj.onc.1205947; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Min DS, 2001, NEUROSCI LETT, V310, P125, DOI 10.1016/S0304-3940(01)02091-2; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Rodrik V, 2005, MOL CELL BIOL, V25, P7917, DOI 10.1128/MCB.25.17.7917-7925.2005; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Saito M, 2007, ONCOL REP, V18, P1329; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	48	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12109	10.1371/journal.pone.0012109	http://dx.doi.org/10.1371/journal.pone.0012109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711340	Green Published, Green Submitted, gold			2022-12-27	WOS:000280859700006
J	Levy, N; Pressman, A; Mussa-Ivaldi, FA; Karniel, A				Levy, Noa; Pressman, Assaf; Mussa-Ivaldi, Ferdinando A.; Karniel, Amir			Adaptation to Delayed Force Perturbations in Reaching Movements	PLOS ONE			English	Article							MOTOR CONTROL; INTERNAL-MODELS; ARM MOVEMENTS; REPRESENTATION; TIME; COMBINATION; PERCEPTION	Adaptation to deterministic force perturbations during reaching movements was extensively studied in the last few decades. Here, we use this methodology to explore the ability of the brain to adapt to a delayed velocity-dependent force field. Two groups of subjects preformed a standard reaching experiment under a velocity dependent force field. The force was either immediately proportional to the current velocity (Control) or lagged it by 50 ms (Test). The results demonstrate clear adaptation to the delayed force perturbations. Deviations from a straight line during catch trials were shifted in time compared to post-adaptation to a non-delayed velocity dependent field (Control), indicating expectation to the delayed force field. Adaptation to force fields is considered to be a process in which the motor system predicts the forces to be expected based on the state that a limb will assume in response to motor commands. This study demonstrates for the first time that the temporal window of this prediction needs not to be fixed. This is relevant to the ability of the adaptive mechanisms to compensate for variability in the transmission of information across the sensory-motor system.	[Levy, Noa; Pressman, Assaf; Karniel, Amir] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Pressman, Assaf; Mussa-Ivaldi, Ferdinando A.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	Ben Gurion University; Shirley Ryan AbilityLab	Levy, N (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	akarniel@bgu.ac.il	Karniel, Amir/F-2066-2012		United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel	United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation)	This research was supported by the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Cunningham DW, 2001, J VISION, V1, P88, DOI 10.1167/1.2.3; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Foulkes AJM, 2000, EXP BRAIN RES, V131, P101, DOI 10.1007/s002219900286; Gribble PL, 2000, EXP BRAIN RES, V135, P474, DOI 10.1007/s002210000547; INBAR GF, 1976, PROGR IN BRAIN RES, P337; Karniel A, 2000, IEEE T SYST MAN CY C, V30, P1, DOI 10.1109/5326.827449; Karniel A, 2003, BIOL CYBERN, V89, P10, DOI 10.1007/s00422-003-0397-7; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; Nisky I, 2010, J NEUROPHYSIOL, V103, P3017, DOI 10.1152/jn.00939.2009; Padoa-Schioppa C, 2004, J NEUROPHYSIOL, V91, P449, DOI 10.1152/jn.00876.2002; Pressman A, 2007, INT J ROBOT RES, V26, P1191, DOI 10.1177/0278364907082611; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SMITH WM, 1980, J MOTOR BEHAV, V12, P91; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	22	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12128	10.1371/journal.pone.0012128	http://dx.doi.org/10.1371/journal.pone.0012128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711461	gold, Green Published, Green Submitted			2022-12-27	WOS:000280849100031
J	van Etten, J; Hijmans, RJ				van Etten, Jacob; Hijmans, Robert J.			A Geospatial Modelling Approach Integrating Archaeobotany and Genetics to Trace the Origin and Dispersal of Domesticated Plants	PLOS ONE			English	Article							EVOLUTION; SPREAD; PHYLOGEOGRAPHY; CONSERVATION; CALIBRATION; DIVERGENCE; RESISTANCE; REGRESSION; DIVERSITY; FRAMEWORK	Background: The study of the prehistoric origins and dispersal routes of domesticated plants is often based on the analysis of either archaeobotanical or genetic data. As more data become available, spatially explicit models of crop dispersal can be used to combine different types of evidence. Methodology/Principal Findings: We present a model in which a crop disperses through a landscape that is represented by a conductance matrix. From this matrix, we derive least-cost distances from the geographical origin of the crop and use these to predict the age of archaeological crop remains and the heterozygosity of crop populations. We use measures of the overlap and divergence of dispersal trajectories to predict genetic similarity between crop populations. The conductance matrix is constructed from environmental variables using a number of parameters. Model parameters are determined with multiple-criteria optimization, simultaneously fitting the archaeobotanical and genetic data. The consilience reached by the model is the extent to which it converges around solutions optimal for both archaeobotanical and genetic data. We apply the modelling approach to the dispersal of maize in the Americas. Conclusions/Significance: The approach makes possible the integrative inference of crop dispersal processes, while controlling model complexity and computational requirements.	[van Etten, Jacob; Hijmans, Robert J.] Int Rice Res Inst, Los Banos, Philippines; [van Etten, Jacob] IE Univ, Segovia, Spain; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	CGIAR; International Rice Research Institute (IRRI); IE University; University of California System; University of California Davis	van Etten, J (corresponding author), Int Rice Res Inst, Los Banos, Philippines.	Jacob.vanEtten@ie.edu	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872; van Etten, Jacob/0000-0001-7554-2558	Consultative Group on International Agricultural Research (CGIAR)	Consultative Group on International Agricultural Research (CGIAR)(CGIAR)	This work was supported by the Global Public Goods II project of the System-wide Genetic Resources Program (SGRP) of the Consultative Group on International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2009, 2 FAO; Bellwood P., 2004, 1 FARMERS ORIGINS AG; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Chandra AK, 1997, COMPUT COMPLEX, V6, P312; Chung F., 1997, SPECTRAL GRAPH THEOR; Currat M, 2004, MOL ECOL NOTES, V4, P139, DOI 10.1046/j.1471-8286.2003.00582.x; Davis SM, 2007, HEALTH EDUC BEHAV, V34, P154, DOI 10.1177/1090198106288490; Davison K, 2006, J ARCHAEOL SCI, V33, P641, DOI 10.1016/j.jas.2005.09.017; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DOEBLEY JF, 1986, AM J BOT, V73, P64, DOI 10.2307/2444278; Doyle P.G., 1984, RANDOM WALKS ELECT N; EDMONSON MS, 1961, CURR ANTHROPOL, V2, P71, DOI 10.1086/200169; Emshwiller E, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P99; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fuller DQ, 2008, NAT GENET, V40, P1264, DOI 10.1038/ng1108-1264; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; HARRIS DR, 1987, PHILOS T R SOC A, V323, P23, DOI 10.1098/rsta.1987.0070; Hijmans RJ, 2010, RASTER PACKAGE READI; Jones M, 2000, HOLOCENE, V10, P769, DOI 10.1191/09596830095024; Kidd DM, 2008, MOL ECOL RESOUR, V8, P88, DOI 10.1111/j.1471-8286.2007.01925.x; Kidd DM, 2006, J BIOGEOGR, V33, P1851, DOI 10.1111/j.1365-2699.2006.01574.x; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Komuro R, 2006, ECOL MODEL, V197, P320, DOI 10.1016/j.ecolmodel.2006.03.033; Kwak M, 2009, CROP SCI, V49, P554, DOI 10.2135/cropsci2008.07.0421; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Montenegro A, 2008, J ARCHAEOL SCI, V35, P355, DOI 10.1016/j.jas.2007.04.004; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Saerens M, 2009, NEURAL COMPUT, V21, P2363, DOI 10.1162/neco.2009.11-07-643; Smith B.D., 1995, EMERGENCE AGR; STRUEVER S, 1968, AM ANTIQUITY, V33, P353, DOI 10.2307/278703; van Etten J, 2008, GENET RESOUR CROP EV, V55, P303, DOI 10.1007/s10722-007-9235-4; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; VANDIEPEN CA, 1989, SOIL USE MANAGE, V5, P16, DOI 10.1111/j.1475-2743.1989.tb00755.x; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; WILKES G, 2004, CORN ORIGIN HIST TEC, P3; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	65	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12060	10.1371/journal.pone.0012060	http://dx.doi.org/10.1371/journal.pone.0012060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711460	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100012
J	Cocco, E; Paladini, F; Macino, G; Fulci, V; Fiorillo, MT; Sorrentino, R				Cocco, Elisa; Paladini, Fabiana; Macino, Giuseppe; Fulci, Valerio; Fiorillo, Maria Teresa; Sorrentino, Rosa			The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p	PLOS ONE			English	Article							HUMAN MONOCYTIC CELLS; ALTERED EXPRESSION; GENE-EXPRESSION; TISSUE FACTOR; ACTIVATION; VIP; POLYMORPHISM; ASSOCIATION; POLYPEPTIDE; INHIBITION	Background: The human Vasoactive Intestinal Peptide (VIP) is a neurokine with effects on the immune system where it is involved in promoting tolerance. In this context, one of its receptors, VPAC1, has been found to be down-modulated in cells of the immune network in response to activating stimuli. In particular, the bacterial liposaccaride (LPS), a strong activator of the innate immune system, induces a rapid decrease of VPAC1 expression in monocytes and this event correlates with polymorphisms in the 3'-UTR of the gene. Methodology/Principal Findings: MicroRNA 525-5p, having as putative target the 3'-UTR region of VPAC1, has been analysed for its expression in monocytes and for its role in down-modulating VPAC1 expression. We report here that miR-525-5p is promptly up-regulated in LPS-treated monocytes. This microRNA, when co-transfected in 293T cells together with a construct containing the 3'-UTR of the VPAC1 gene, significantly reduced the luciferase activity in a standard expression assay. The U937 cell line as well as primary monocytes enforced to express miR-525-5p, both down-modulate VPAC1 expression at similar extent. Conclusions/Significance: Our results show that the response to an inflammatory stimulus elicits in monocytes a rapid increase of miR-525-5p that targets a signaling pathway involved in the control of the immune homeostasis.	[Cocco, Elisa; Paladini, Fabiana; Fiorillo, Maria Teresa; Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Macino, Giuseppe; Fulci, Valerio] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Cocco, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	rosa.sorrentino@uniroma1.it	Fulci, Valerio/J-1963-2015; Sorrentino, Rosa/G-5472-2012	Fulci, Valerio/0000-0002-1173-585X; Sorrentino, Rosa/0000-0002-9632-2383; FIORILLO, Maria Teresa/0000-0002-6859-5851; Paladini, Fabiana/0000-0003-1040-452X; Tripp, Ralph/0000-0002-2924-9956	Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy; Volkswagen Stingtuf Foundation, Germany	Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy; Volkswagen Stingtuf Foundation, Germany	This study was partially supported by Istituto Pasteur-Fondazione Cenci-Bolognetti, Sapienza, University of Rome, Italy and by Volkswagen Stingtuf Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBEZAT GO, 1971, SCIENCE, V174, P422, DOI 10.1126/science.174.4007.422; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; Gonzalez-Rey E, 2006, BLOOD, V107, P3632, DOI 10.1182/blood-2005-11-4497; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Kojima M, 2005, PANCREAS, V30, P62; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Leceta J, 2007, NEUROIMMUNOMODULAT, V14, P134, DOI 10.1159/000110636; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; MACKMAN N, 1994, J BIOL CHEM, V269, P26363; Makhlouf GM, 1997, CELL SIGNAL, V9, P269, DOI 10.1016/S0898-6568(96)00180-5; Martin AJ, 2009, NAT IMMUNOL, V10, P1229, DOI 10.1038/ni1209-1229; Miampamba M, 2002, REGUL PEPTIDES, V105, P145, DOI 10.1016/S0167-0115(02)00003-4; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Paladini F, 2009, NEUROGASTROENT MOTIL, V21, P597, DOI 10.1111/j.1365-2982.2009.01284.x; Paladini F, 2008, GENES IMMUN, V9, P659, DOI 10.1038/gene.2008.60; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pozo D, 2009, J IMMUNOL, V183, P4346, DOI 10.4049/jimmunol.0900400; Rigby RJ, 2008, CURR OPIN RHEUMATOL, V20, P526, DOI 10.1097/BOR.0b013e328304b45e; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; SREEDHARAN SP, 1995, P NATL ACAD SCI USA, V92, P2939, DOI 10.1073/pnas.92.7.2939; Stahl HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007158; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tili E, 2008, NAT CLIN PRACT RHEUM, V4, P534, DOI 10.1038/ncprheum0885; Toumi F, 2004, BIOCHEM BIOPH RES CO, V317, P187, DOI 10.1016/j.bbrc.2004.03.033; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999	42	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12067	10.1371/journal.pone.0012067	http://dx.doi.org/10.1371/journal.pone.0012067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706588	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900028
J	Murzyn, A; Krasowska, A; Stefanowicz, P; Dziadkowiec, D; Lukaszewicz, M				Murzyn, Anna; Krasowska, Anna; Stefanowicz, Piotr; Dziadkowiec, Dorota; Lukaszewicz, Marcin			Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; CELL-SURFACE HYDROPHOBICITY; PLACEBO-CONTROLLED TRIAL; CANDIDA-ALBICANS; SACCHAROMYCES-BOULARDII; ESCHERICHIA-COLI; FATTY-ACIDS; IN-VITRO; VIRULENCE; EXPRESSION	Candidiasis are life-threatening systemic fungal diseases, especially of gastro intestinal track, skin and mucous membranes lining various body cavities like the nostrils, the mouth, the lips, the eyelids, the ears or the genital area. Due to increasing resistance of candidiasis to existing drugs, it is very important to look for new strategies helping the treatment of such fungal diseases. One promising strategy is the use of the probiotic microorganisms, which when administered in adequate amounts confer a health benefit. Such a probiotic microorganism is yeast Saccharomyces boulardii, a close relative of baker yeast. Saccharomyces boulardii cells and their extract affect the virulence factors of the important human fungal pathogen C. albicans, its hyphae formation, adhesion and biofilm development. Extract prepared from S. boulardii culture filtrate was fractionated and GC-MS analysis showed that the active fraction contained, apart from 2-phenylethanol, caproic, caprylic and capric acid whose presence was confirmed by ESI-MS analysis. Biological activity was tested on C. albicans using extract and pure identified compounds. Our study demonstrated that this probiotic yeast secretes into the medium active compounds reducing candidal virulence factors. The chief compound inhibiting filamentous C. albicans growth comparably to S. boulardii extract was capric acid, which is thus responsible for inhibition of hyphae formation. It also reduced candidal adhesion and biofilm formation, though three times less than the extract, which thus contains other factors suppressing C. albicans adherence. The expression profile of selected genes associated with C. albicans virulence by real-time PCR showed a reduced expression of HWP1, INO1 and CSH1 genes in C. albicans cells treated with capric acid and S. boulardii extract. Hence capric acid secreted by S. boulardii is responsible for inhibition of C. albicans filamentation and partially also adhesion and biofilm formation.	[Murzyn, Anna; Krasowska, Anna; Dziadkowiec, Dorota; Lukaszewicz, Marcin] Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Stefanowicz, Piotr] Univ Wroclaw, Fac Chem, PL-50138 Wroclaw, Poland; [Lukaszewicz, Marcin] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; Wroclaw University of Science & Technology	Murzyn, A (corresponding author), Univ Wroclaw, Fac Biotechnol, PL-50138 Wroclaw, Poland.	lukasz@biotrans.uni.wroc.pl	Krasowska, Anna/I-5054-2019; Stefanowicz, Piotr/AAF-3445-2020; Łukaszewicz, Marcin/K-8441-2013; Stefanowicz, Piotr/A-4373-2009; Dziadkowiec, Dorota/H-1520-2012	Łukaszewicz, Marcin/0000-0002-1453-8376; Dziadkowiec, Dorota/0000-0003-0912-2111; Krasowska, Anna/0000-0002-1925-193X; Stefanowicz, Piotr/0000-0001-9581-2359	Biocodex, France; National Centre for Research and Development [KB/48/13639/IT1-B/U/08]; Institutional Research Concept [AV0Z50200510]	Biocodex, France; National Centre for Research and Development; Institutional Research Concept	This work was partly supported by a grant from Biocodex, France and by grant KB/48/13639/IT1-B/U/08 from the National Centre for Research and Development and by the Institutional Research Concept AV0Z50200510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG R, 1993, J INFECT DIS, V168, P1314, DOI 10.1093/infdis/168.5.1314; Bergsson G, 2001, ANTIMICROB AGENTS CH, V45, P3209, DOI 10.1128/AAC.45.11.3209-3212.2001; Bleichner G, 1997, INTENS CARE MED, V23, P517, DOI 10.1007/s001340050367; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Buts JP, 2006, PEDIATR RES, V60, P24, DOI 10.1203/01.pdr.0000220322.31940.29; BUTS JP, 1994, PEDIATR RES, V36, P522, DOI 10.1203/00006450-199410000-00019; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005; Castagliuolo I, 1999, INFECT IMMUN, V67, P302, DOI 10.1128/IAI.67.1.302-307.1999; Clement M, 2007, FEMS YEAST RES, V7, P276, DOI 10.1111/j.1567-1364.2006.00166.x; Czerucka D, 1999, DIGEST DIS SCI, V44, P2359, DOI 10.1023/A:1026689628136; Ells R, 2009, J ANTIMICROB CHEMOTH, V63, P124, DOI 10.1093/jac/dkn446; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Fidan I, 2009, MYCOSES, V52, P29, DOI 10.1111/j.1439-0507.2008.01545.x; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Konno N, 2006, BIOL PHARM BULL, V29, P923, DOI 10.1248/bpb.29.923; Kotowska M, 2005, ALIMENT PHARM THER, V21, P583, DOI 10.1111/j.1365-2036.2005.02356.x; Krasowska A, 2009, FEMS YEAST RES, V9, P1312, DOI 10.1111/j.1567-1364.2009.00559.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martins M, 2007, EUKARYOT CELL, V6, P2429, DOI 10.1128/EC.00252-07; McLain N, 2000, ANTIMICROB AGENTS CH, V44, P2873, DOI 10.1128/AAC.44.10.2873-2875.2000; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rogers PD, 2003, ANTIMICROB AGENTS CH, V47, P1220, DOI 10.1128/AAC.47.4.1220-1227.2003; SAINTMARC T, 1991, ANN MED INTERNE, V142, P64; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; Singleton DR, 2005, FEMS MICROBIOL LETT, V244, P373, DOI 10.1016/j.femsle.2005.02.010; Singleton DR, 2001, J BACTERIOL, V183, P3582, DOI 10.1128/JB.183.12.3582-3588.2001; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2	37	94	101	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12050	10.1371/journal.pone.0012050	http://dx.doi.org/10.1371/journal.pone.0012050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706577	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900013
J	Maher, AC; Akhtar, M; Vockley, J; Tarnopolsky, MA				Maher, Amy C.; Akhtar, Mahmood; Vockley, Jerry; Tarnopolsky, Mark A.			Women Have Higher Protein Content of beta-Oxidation Enzymes in Skeletal Muscle than Men	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PALMITOYLTRANSFERASE-I ACTIVITY; TISSUE GLYCOGEN-METABOLISM; MESSENGER-RNA EXPRESSION; ACTIVATED RECEPTOR-ALPHA; RAT-LIVER MITOCHONDRIA; MENSTRUAL-CYCLE PHASE; ENDURANCE EXERCISE; MODERATE-INTENSITY; GENDER-DIFFERENCES	It is well recognized that compared with men, women have better ultra-endurance capacity, oxidize more fat during endurance exercise, and are more resistant to fat oxidation defects i.e. diet-induced insulin resistance. Several groups have shown that the mRNA and protein transcribed and translated from genes related to transport of fatty acids into the muscle are greater in women than men; however, the mechanism(s) for the observed sex differences in fat oxidation remains to be determined. Muscle biopsies from the vastus lateralis were obtained from moderately active men (N = 12) and women (N = 11) at rest to examine mRNA and protein content of genes involved in lipid oxidation. Our results show that women have significantly higher protein content for tri-functional protein alpha (TFP alpha), very long chain acyl-CoA dehydrogenase (VLCAD), and medium chain acyl-CoA dehydrogenase (MCAD) (P<0.05). There was no significant sex difference in the expression of short-chain hydroxyacyl-CoA dehydrogenase (SCHAD), or peroxisome proliferator activated receptor alpha (PPAR alpha), or PPAR gamma, genes potentially involved in the transcriptional regulation of lipid metabolism. In conclusion, women have more protein content of the major enzymes involved in long and medium chain fatty acid oxidation which could account for the observed differences in fat oxidation during exercise.	[Maher, Amy C.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Akhtar, Mahmood; Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat & Med, Hamilton, ON, Canada; [Vockley, Jerry] Univ Pittsburgh, Sch Med Pediat, Pittsburgh, PA USA; [Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth Human Genet, Pittsburgh, PA USA	McMaster University; McMaster University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maher, AC (corresponding author), McMaster Univ, Dept Med Sci, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457	Natural Sciences and Engineering Research Council of Canada; National Institutes of Health [R01 DK78775]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078775] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is primarily funded through Natural Sciences and Engineering Research Council of Canada grant held by MT. AM was supported by a Natural Sciences and Engineering Research Council of Canada Doctoral Research Award. JV was funded in part by National Institutes of Health grant R01 DK78775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN RH, 2009, AM J PHYSL ENDOCRINO; Berthon PM, 1998, J APPL PHYSIOL, V85, P148, DOI 10.1152/jappl.1998.85.1.148; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Carter S, 2001, J APPL PHYSIOL, V90, P139, DOI 10.1152/jappl.2001.90.1.139; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Devries MC, 2005, J CLIN ENDOCR METAB, V90, P6218, DOI 10.1210/jc.2005-0926; Devries MC, 2006, AM J PHYSIOL-REG I, V291, pR1120, DOI 10.1152/ajpregu.00700.2005; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fredenrich A, 2005, DIABETES METAB, V31, P23, DOI 10.1016/S1262-3636(07)70162-3; Friedlander AL, 1998, J APPL PHYSIOL, V85, P1175, DOI 10.1152/jappl.1998.85.3.1175; Friedlander AL, 2007, AM J PHYSIOL-ENDOC M, V292, pE107, DOI 10.1152/ajpendo.00148.2006; Fu MHH, 2009, PHYSIOL GENOMICS, V40, P34, DOI 10.1152/physiolgenomics.00115.2009; Hamadeh MJ, 2005, J CLIN ENDOCR METAB, V90, P3592, DOI 10.1210/jc.2004-1743; HATTA H, 1988, HORM METAB RES, V20, P609, DOI 10.1055/s-2007-1010897; HAVEL RJ, 1963, J CLIN INVEST, V42, P1054, DOI 10.1172/JCI104791; HAVEL RJ, 1964, J APPL PHYSIOL, V19, P613, DOI 10.1152/jappl.1964.19.4.613; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Horton TJ, 1998, J APPL PHYSIOL, V85, P1823, DOI 10.1152/jappl.1998.85.5.1823; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Ingelsson E, 2009, J CLIN ENDOCR METAB, V94, P953, DOI 10.1210/jc.2008-1772; IZAI K, 1992, J BIOL CHEM, V267, P1027; KENDRICK ZV, 1987, J APPL PHYSIOL, V63, P492, DOI 10.1152/jappl.1987.63.2.492; KENDRICK ZV, 1991, J APPL PHYSIOL, V71, P1694, DOI 10.1152/jappl.1991.71.5.1694; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Knechtle B, 2004, INT J SPORTS MED, V25, P38, DOI 10.1055/s-2003-45232; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580; Mittendorfer B, 2002, AM J PHYSIOL-ENDOC M, V283, pE58, DOI 10.1152/ajpendo.00504.2001; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P3188, DOI 10.1210/jc.86.7.3188; PHILLIPS SM, 1993, J APPL PHYSIOL, V75, P2134, DOI 10.1152/jappl.1993.75.5.2134; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Riddell MC, 2003, INT J SPORT NUTR EXE, V13, P407, DOI 10.1123/ijsnem.13.4.407; Roepstorff C, 2005, EXERC SPORT SCI REV, V33, P182, DOI 10.1097/00003677-200510000-00006; Roepstorff C, 2005, ACTA PHYSIOL SCAND, V184, P215, DOI 10.1111/j.1365-201X.2005.01442.x; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Romijn JA, 2000, J APPL PHYSIOL, V88, P1707, DOI 10.1152/jappl.2000.88.5.1707; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Ruby BC, 1997, MED SCI SPORT EXER, V29, P1160, DOI 10.1097/00005768-199709000-00007; Spangenburg EE, 2009, MOL CELL BIOCHEM, V332, P225, DOI 10.1007/s11010-009-0195-1; TARNOPOLSKY LJ, 1990, J APPL PHYSIOL, V68, P302, DOI 10.1152/jappl.1990.68.1.302; TARNOPOLSKY MA, 1995, J APPL PHYSIOL, V78, P1360, DOI 10.1152/jappl.1995.78.4.1360; Tarnopolsky MA, 2000, CAN J APPL PHYSIOL, V25, P312, DOI 10.1139/h00-024; TARNOPOLSKY MA, 2006, AM J PHYSL REGUL INT; Tarnopolsky MA, 2008, MED SCI SPORT EXER, V40, P648, DOI 10.1249/MSS.0b013e31816212ff; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yang BZ, 1996, GENOMICS, V37, P141, DOI 10.1006/geno.1996.0533; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	63	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12025	10.1371/journal.pone.0012025	http://dx.doi.org/10.1371/journal.pone.0012025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700461	Green Published, Green Accepted, gold			2022-12-27	WOS:000280687900017
J	Menge, DNL; DeNoyer, JL; Lichstein, JW				Menge, Duncan N. L.; DeNoyer, Jeanne L.; Lichstein, Jeremy W.			Phylogenetic Constraints Do Not Explain the Rarity of Nitrogen-Fixing Trees in Late-Successional Temperate Forests	PLOS ONE			English	Article							PHOSPHORUS LIMITATION; FIXATION; EVOLUTION; ACCUMULATION; PRODUCTIVITY; ECOSYSTEMS; SATURATION; RESPONSES; COMPONENT; LEGUMES	Background: Symbiotic nitrogen (N)-fixing trees are rare in late-successional temperate forests, even though these forests are often N limited. Two hypotheses could explain this paradox. The 'phylogenetic constraints hypothesis' states that no late-successional tree taxa in temperate forests belong to clades that are predisposed to N fixation. Conversely, the 'selective constraints hypothesis' states that such taxa are present, but N-fixing symbioses would lower their fitness. Here we test the phylogenetic constraints hypothesis. Methodology/Principal Findings: Using U.S. forest inventory data, we derived successional indices related to shade tolerance and stand age for N-fixing trees, non-fixing trees in the 'potentially N-fixing clade' (smallest angiosperm clade that includes all N fixers), and non-fixing trees outside this clade. We then used phylogenetically independent contrasts (PICs) to test for associations between these successional indices and N fixation. Four results stand out from our analysis of U. S. trees. First, N fixers are less shade-tolerant than non-fixers both inside and outside of the potentially N-fixing clade. Second, N fixers tend to occur in younger stands in a given geographical region than non-fixers both inside and outside of the potentially N-fixing clade. Third, the potentially N-fixing clade contains numerous late-successional non-fixers. Fourth, although the N fixation trait is evolutionarily conserved, the successional traits are relatively labile. Conclusions/Significance: These results suggest that selective constraints, not phylogenetic constraints, explain the rarity of late-successional N-fixing trees in temperate forests. Because N-fixing trees could overcome N limitation to net primary production if they were abundant, this study helps to understand the maintenance of N limitation in temperate forests, and therefore the capacity of this biome to sequester carbon.	[Menge, Duncan N. L.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Menge, Duncan N. L.; DeNoyer, Jeanne L.; Lichstein, Jeremy W.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	National Center for Ecological Analysis & Synthesis; Princeton University	Menge, DNL (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA.	menge@nceas.ucsb.edu	Lichstein, Jeremy/GMW-6555-2022; Menge, Duncan/A-5417-2011	Menge, Duncan/0000-0003-4736-9844	National Science Foundation [DEB-0608267, EF-0553768]; University of California Santa Barbara; State of California; Princeton University Department of Ecology and Evolutionary Biology; Princeton Carbon Mitigation Initiative, BP and Ford; U.S. Forest Service Northern Research Station	National Science Foundation(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; Princeton University Department of Ecology and Evolutionary Biology(Princeton University); Princeton Carbon Mitigation Initiative, BP and Ford; U.S. Forest Service Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service)	D.N.L.M. was supported by a National Science Foundation Graduate Research Fellowship and a National Science Foundation Doctoral Dissertation Improvement Grant (DEB-0608267), and performed much of the work while a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California Santa Barbara, and the State of California. J.L.D. was supported by the Princeton University Department of Ecology and Evolutionary Biology. J.W.L. was supported by the Princeton Carbon Mitigation Initiative with funding from BP and Ford and by the U.S. Forest Service Northern Research Station. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; BARRON AR, 2007, THESIS PRINCETON U P; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BINKLEY D, 1992, ECOLOGY, V73, P2022, DOI 10.2307/1941452; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Boland DJ, 2006, FOREST TREES AUSTR; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; CHRISTENSEN EARL M., 1963, AMER MIDLAND NAT, V70, P133, DOI 10.2307/2422776; CLARKSON BD, 1990, NEW ZEAL J ECOL, V14, P59; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Crews TE, 1999, BIOGEOCHEMISTRY, V46, P233, DOI 10.1007/BF01007581; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Dawson J., 2000, NATURE GUIDE NZ FORE; DEBANO LF, 1978, ECOLOGY, V59, P489, DOI 10.2307/1936579; DEFARIA SM, 1989, NEW PHYTOL, V111, P607, DOI 10.1111/j.1469-8137.1989.tb02354.x; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; DYRNESS CT, 1973, ECOLOGY, V54, P57, DOI 10.2307/1934374; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Houlton BZ, 2008, NATURE, V454, P327, DOI 10.1038/nature07028; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; HussDanell K, 1997, NEW PHYTOL, V136, P375, DOI 10.1046/j.1469-8137.1997.00755.x; Kershaw L., 1998, PLANTS ROCKY MOUNTAI; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lesica P, 2001, WEST N AM NATURALIST, V61, P1; Lichstein JW, 2009, ECOL STUD-ANAL SYNTH, V207, P301, DOI 10.1007/978-3-540-92706-8_14; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Menge DNL, 2008, P NATL ACAD SCI USA, V105, P1573, DOI 10.1073/pnas.0711411105; Menge DNL, 2009, AM NAT, V174, P465, DOI 10.1086/605377; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pearson HL, 2001, ECOL APPL, V11, P1381, DOI 10.2307/3060927; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Pojar J., 1994, PLANTS PACIFIC NW CO; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; SCHLESINGER WH, 1981, ECOLOGY, V62, P762, DOI 10.2307/1937744; Sokal R.R., 2012, BIOMETRY; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sprent JI, 2009, LEGUME NODULATION GL, P183; Uliassi DD, 2002, ECOLOGY, V83, P88, DOI 10.1890/0012-9658(2002)083[0088:LTSNFI]2.0.CO;2; *USDA, 2005, FOR INV AN NAT COR F; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Vitousek PM, 1999, BIOGEOCHEMISTRY, V46, P179, DOI 10.1007/BF01007579; Walker L. R., 1993, PRIMARY SUCCESSION L, P249; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WARDLE P, 1980, NEW ZEAL J BOT, V18, P221, DOI 10.1080/0028825X.1980.10426921; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; ZAVITKOVSKI J, 1968, ECOLOGY, V49, P1134, DOI 10.2307/1934497	66	34	34	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12056	10.1371/journal.pone.0012056	http://dx.doi.org/10.1371/journal.pone.0012056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700466	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900025
J	Yadav, R; Bhowmick, S; Gorecki, P; O'Rourke, J; Cone, RE				Yadav, Rajwahrdhan; Bhowmick, Sourojit; Gorecki, Philip; O'Rourke, James; Cone, Robert E.			Paradoxical Effect of Pertussis Toxin on the Delayed Hypersensitivity Response to Autoantigens in Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ADJUVANT ACTION; CELLS; TH1; SENSITIZATION; BARRIER; ANTIGEN; BRAIN	Background: Pertussis toxin (PTX), an exotoxin of Bordetella pertussis, enhances the development of experimental autoimmune diseases such as experimental autoimmune uveitis (EAU) and experimental autoimmune encephalomyelitis (EAE) in rodent models. The mechanisms of the promotion of experimental autoimmune diseases by PTX may be based upon PTX-induced disruption of the blood eye/brain barriers facilitating the infiltration of inflammatory cells, the modulation of inflammatory cell migration and the enhancement of the activation of inflammatory cells. We hypothesized that the facilitation of experimental autoimmunity by PTX suggests that its influence on the in vivo immune response to auto-antigen may differ from its influence on non-self antigens. Methodology/Principal Findings: We have evaluated the effect of PTX on the simultaneous generation of delayed type hypersensitivity (DTH) responses and autoimmune responses to uveitogenic interphotoreceptor retinoid binding protein peptide (IRBP161-180), encephalitogenic myelin oligodendrocyte glycoprotein peptide (MOG(35-55)) or ovalbumin (OVA). PTX injection of mice immunized to IRBP peptide(161-180) led to (i) the development of EAU as shown by histopathology of the retina, (ii) pro-inflammatory cytokine production by splenocytes in response to IRBP peptide (161-180), and (iii) symptomatic EAE in mice immunized with encephalitogenic MOG peptide(35-55). However, mice that received PTX had a reduced DTH response to IRBP161-180 peptide or MOG peptide(35-55) when challenged distal to the site affected by autoreactive T cells. Moreover, footpad challenge with MOG(35-55) peptide reduced EAE in mice immunized with MOG peptide. In contrast, the use of PTX when immunizing with OVA protein or an OVA immunogenic peptide did not affect the DTH response to OVA. Conclusions/Significance: The results suggest that that the reduced DTH response in mice receiving PTX may be specific for autoantigens and autoantigen-reactive T cells are diverted away from ectopic sites that received the autoantigen and towards the tissue site of the autoantigen.	[Yadav, Rajwahrdhan; Bhowmick, Sourojit; Gorecki, Philip; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Dept Immunol, Connecticut Lions Vasc Vis Ctr, Ctr Hlth, Farmington, CT USA	University of Connecticut	Yadav, R (corresponding author), Univ Connecticut, Dept Immunol, Connecticut Lions Vasc Vis Ctr, Ctr Hlth, Farmington, CT USA.	cone@UCHC.EDU			NIH [EY017537, EY017289]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017289, R01EY017537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH EY017537, NIH EY017289, http://www.nih.gov/, Connecticut Lions Eye Research Foundation http://clerf.lionwap.org. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal RK, 2002, J NEUROIMMUNOL, V129, P133, DOI 10.1016/S0165-5728(02)00203-5; BO SS, 2001, J IMMUNOL, V167, P250; BO SS, 2003, J IMMUNOL, V171, P2314; CASPI R, 2003, CURRENT PROTOCOLS IM; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; CASPI RR, 2003, CURRENT PROTOCOLS S, V53; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Denkinger CM, 2007, CELL IMMUNOL, V246, P46, DOI 10.1016/j.cellimm.2007.05.004; Forrester John V, 2007, Chem Immunol Allergy, V92, P228, DOI 10.1159/000099274; GERY I, 1986, PROGR RETINAL RES, V5, P75; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x; KUNZ M, 2009, MEDIAT INFLAMM; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Millward JM, 2007, J IMMUNOL, V178, P8175, DOI 10.4049/jimmunol.178.12.8175; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ryan M, 1998, INT IMMUNOL, V10, P651, DOI 10.1093/intimm/10.5.651; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11983	10.1371/journal.pone.0011983	http://dx.doi.org/10.1371/journal.pone.0011983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700542	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400017
J	Caron, JM; Bannon, M; Rosshirt, L; Luis, J; Monteagudo, L; Caron, JM; Sternstein, GM				Caron, Joan McIntyre; Bannon, Marissa; Rosshirt, Lindsay; Luis, Jessica; Monteagudo, Luke; Caron, John M.; Sternstein, Gerson Marc			Methyl Sulfone Induces Loss of Metastatic Properties and Reemergence of Normal Phenotypes in a Metastatic Cloudman S-91 (M3) Murine Melanoma Cell Line	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; IN-VIVO; SENESCENCE; CANCER; DIMETHYLSULFOXIDE; METHYLSULFONYLMETHANE; CHEMOTHERAPY; CYTOTOXICITY; CULTURE	Background: The most deadly form of cancer is not lung or colon, breast or prostate; it is any cancer that has become metastatic. Mortality due to metastatic melanoma, one of the most aggressive and deadly cancers, has increased steadily over the last several decades. Unfortunately, the arsenal of chemotherapeutic agents available today is most often unsuccessful at extending and improving the life expectancy of afflicted individuals. We sought to identify an effective and nontoxic agent against metastatic melanoma. Methodology/Principal Findings: We chose to study Cloudman S-91 mouse melanoma cells (sub-clone M3, CCL53.1) because these cells are highly aggressive and metastatic, representing one of the deadliest types of cancer. Melanoma cells also had an experimental advantage because their morphology, which is easily monitored, relates to the physiology of metastatic cells and normal melanocytes. We chose to test methyl sulfone as a chemotherapeutic agent for two reasons. Because of its chemical structure, we speculated a potential anti-cancer activity by targeting microtubules. Equally important, methyl sulfone has a well-established safety profile in humans. Surprisingly, we found that malignant melanoma cells exposed to methyl sulfone demonstrated the loss of phenotypes characteristic of malignant cells, and the reemergence of phenotypes characteristic of healthy melanocytes. Briefly, over time methyl sulfone induced contact inhibition, loss of ability to migrate through an extracellular matrix, loss of anchorage-independent growth, proper wound healing followed by contact inhibition, irreversible senescence followed by arborization with melanosomes in arbors as seen in normal melanocytes. Conclusions/Significance: Methyl sulfone may have clinical potential as a non-toxic agent effective against metastatic melanoma. Additionally, methyl sulfone has promise as a tool to explore molecular mechanisms of metastatic transformation as well as fundamental processes such as cell migration, contact inhibition, wound healing and cellular senescence.	[Caron, Joan McIntyre; Bannon, Marissa; Rosshirt, Lindsay; Luis, Jessica; Monteagudo, Luke; Caron, John M.; Sternstein, Gerson Marc] Univ Connecticut, Ctr Hlth, Sch Med, Dept Cell Biol, Farmington, CT USA	University of Connecticut	Caron, JM (corresponding author), Univ Connecticut, Ctr Hlth, Sch Med, Dept Cell Biol, Farmington, CT USA.	caron@nso1.uchc.edu		Caron, Joan/0000-0002-8086-6175	Leas Foundation for Leukemia Research, Inc. [6-33616]; University of Connecticut Health Center	Leas Foundation for Leukemia Research, Inc.; University of Connecticut Health Center	This work was funded by the Leas Foundation for Leukemia Research, Inc., (http://www.leasfoundation.org, Grant Number: 6-33616) to JMC. LR, JL, and LM were funded by the University of Connecticut Health Center Summer Research Program, each for two summers. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Advani SH, 1999, AM J HEMATOL, V60, P87, DOI 10.1002/(SICI)1096-8652(199902)60:2<87::AID-AJH1>3.0.CO;2-5; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barrager E, 2002, J ALTERN COMPLEM MED, V8, P167, DOI 10.1089/107555302317371451; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; CASTAIGNE S, 1990, BLOOD, V76, P1704; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONOSO JA, 1977, BRAIN RES, V120, P287, DOI 10.1016/0006-8993(77)90907-6; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Haldar S, 1996, CANCER RES, V56, P1253; HASHIMOTO H, 1992, UROL RES, V20, P233, DOI 10.1007/BF00299723; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; KRUSE PF, 1965, J CELL BIOL, V27, P273, DOI 10.1083/jcb.27.2.273; Lanosa XA, 2008, NEURON GLIA BIOL, V4, P27, DOI 10.1017/S1740925X09000039; LLeonart ME, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-3; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nishikawa SI, 2005, E SCHERING RES FDN W, V54, P1; Roninson IB, 2003, CANCER RES, V63, P2705; Rose SE, 2000, MAGN RESON IMAGING, V18, P95, DOI 10.1016/S0730-725X(99)00110-1; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; *SOC AC, 1983, CA CANC J CLIN, V33; Steely JS, 1994, SULFUR COMPOUNDS FOO; STOKER MGP, 1967, NATURE, V215, P171, DOI 10.1038/215171a0; WALKER L, 1988, UROL RES, V16, P329, DOI 10.1007/BF00263647; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11788	10.1371/journal.pone.0011788	http://dx.doi.org/10.1371/journal.pone.0011788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694196	Green Published, Green Submitted, gold			2022-12-27	WOS:000280574300002
J	Planque, R; van den Berg, JB; Franks, NR				Planque, Robert; van den Berg, Jan Bouwe; Franks, Nigel R.			Recruitment Strategies and Colony Size in Ants	PLOS ONE			English	Article							DECISION-MAKING; HYMENOPTERA; ORGANIZATION; EVOLUTION; DIVERSIFICATION; FORMICIDAE; DYNAMICS; PATTERNS; BEHAVIOR; MODEL	Ants use a great variety of recruitment methods to forage for food or find new nests, including tandem running, group recruitment and scent trails. It has been known for some time that there is a loose correlation across many taxa between species-specific mature colony size and recruitment method. Very small colonies tend to use solitary foraging; small to medium sized colonies use tandem running or group recruitment whereas larger colonies use pheromone recruitment trails. Until now, explanations for this correlation have focused on the ants' ecology, such as food resource distribution. However, many species have colonies with a single queen and workforces that grow over several orders of magnitude, and little is known about how a colony's organization, including recruitment methods, may change during its growth. After all, recruitment involves interactions between ants, and hence the size of the colony itself may influence which recruitment method is used-even if the ants' behavioural repertoire remains unchanged. Here we show using mathematical models that the observed correlation can also be explained by recognizing that failure rates in recruitment depend differently on colony size in various recruitment strategies. Our models focus on the build up of recruiter numbers inside colonies and are not based on optimality arguments, such as maximizing food yield. We predict that ant colonies of a certain size should use only one recruitment method (and always the same one) rather than a mix of two or more. These results highlight the importance of the organization of recruitment and how it is affected by colony size. Hence these results should also expand our understanding of ant ecology.	[Planque, Robert; van den Berg, Jan Bouwe] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	Vrije Universiteit Amsterdam; University of Bristol	Planque, R (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	rplanque@few.vu.nl	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; van den Berg, Jan Bouwe/0000-0003-3503-7535; Planque, Robert/0000-0002-0489-5425	The Netherlands Organisation	The Netherlands Organisation(Netherlands Organization for Scientific Research (NWO))	RP's research was sponsored by the Nonlinear Dynamics of Natural System cluster of The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2009, ANIMAL BEHAV EVOLUTI; [Anonymous], 1971, INSECT SOC; ARON S, 1990, BIOL MOTION, P534; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Britton NF, 2002, P ROY SOC B-BIOL SCI, V269, P1383, DOI 10.1098/rspb.2002.2001; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; Franks NR, 1999, P ROY SOC B-BIOL SCI, V266, P1697, DOI 10.1098/rspb.1999.0834; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; FRANKS NR, 1991, J INSECT BEHAV, V4, P583, DOI 10.1007/BF01048072; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; GOTWALD WH, 1972, ANN ENTOMOL SOC AM, V65, P383, DOI 10.1093/aesa/65.2.383; HOLLDOBLER B, 1971, Z VERGL PHYSIOL, V75, P123; Holldobler B., 1990, pi; HOLLDOBLER B, 1995, J INSECT PHYSIOL, V41, P739, DOI 10.1016/0022-1910(95)00041-R; ITO F, 1993, J NAT HIST, V27, P1315, DOI 10.1080/00222939300770751; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Mallon EB, 2000, P ROY SOC B-BIOL SCI, V267, P765, DOI 10.1098/rspb.2000.1069; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MASUKO K, 1987, THESIS TOKYO METROPO; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Myerscough MR, 2003, P ROY SOC B-BIOL SCI, V270, P577, DOI 10.1098/rspb.2002.2293; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Richardson TO, 2007, CURR BIOL, V17, P1520, DOI 10.1016/j.cub.2007.08.032; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Sudd JH, 1987, BEHAV ECOLOGY ANTS; TOBIN JE, 1991, ANT - PLANT INTERACTIONS, P536; TOPOFF H, 1984, BEHAV ECOL SOCIOBIOL, V15, P273, DOI 10.1007/BF00292989; TRANIELLO JFA, 1980, NATURWISSENSCHAFTEN, V67, P361, DOI 10.1007/BF01106597; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; URBANI CB, 1993, INSECT SOC, V40, P233, DOI 10.1007/BF01242361; VERHAEGHE JC, 1983, INSECT SOC, V30, P347, DOI 10.1007/BF02223992; WEHNER R, 1983, AKAD WISS LIT MAI MN; Wilson E.O., 1975, P1; Wilson E.O, 1990, SUCCESS DOMINANCE EC; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912	48	33	34	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11664	10.1371/journal.pone.0011664	http://dx.doi.org/10.1371/journal.pone.0011664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694195	Green Published, Green Submitted, gold			2022-12-27	WOS:000280574300001
J	Rittenhouse, CD; Pidgeon, AM; Albright, TP; Culbert, PD; Clayton, MK; Flather, CH; Huang, CQ; Masek, JG; Stewart, SI; Radeloff, VC				Rittenhouse, Chadwick D.; Pidgeon, Anna M.; Albright, Thomas P.; Culbert, Patrick D.; Clayton, Murray K.; Flather, Curtis H.; Huang, Chengquan; Masek, Jeffrey G.; Stewart, Susan I.; Radeloff, Volker C.			Conservation of Forest Birds: Evidence of a Shifting Baseline in Community Structure	PLOS ONE			English	Article							SPECIES RICHNESS; NESTING SUCCESS; LAND-USE; FRAGMENTATION; HABITAT; DYNAMICS; BIODIVERSITY; ABUNDANCE; EXTINCTION; DIVERSITY	Background: Quantifying changes in forest bird diversity is an essential task for developing effective conservation actions. When subtle changes in diversity accumulate over time, annual comparisons may offer an incomplete perspective of changes in diversity. In this case, progressive change, the comparison of changes in diversity from a baseline condition, may offer greater insight because changes in diversity are assessed over longer periods of times. Our objectives were to determine how forest bird diversity has changed over time and whether those changes were associated with forest disturbance. Methodology/Principal Findings: We used North American Breeding Bird Survey data, a time series of Landsat images classified with respect to land cover change, and mixed-effects models to associate changes in forest bird community structure with forest disturbance, latitude, and longitude in the conterminous United States for the years 1985 to 2006. We document a significant divergence from the baseline structure for all birds of similar migratory habit and nest location, and all forest birds as a group from 1985 to 2006. Unexpectedly, decreases in progressive similarity resulted from small changes in richness (<1 species per route for the 22-year study period) and modest losses in abundance (-28.7--10.2 individuals per route) that varied by migratory habit and nest location. Forest disturbance increased progressive similarity for Neotropical migrants, permanent residents, ground nesting, and cavity nesting species. We also documented highest progressive similarity in the eastern United States. Conclusions/Significance: Contemporary forest bird community structure is changing rapidly over a relatively short period of time (e.g., similar to 22 years). Forest disturbance and forest regeneration are primary factors associated with contemporary forest bird community structure, longitude and latitude are secondary factors, and forest loss is a tertiary factor. Importantly, these findings suggest some regions of the United States may already fall below the habitat amount threshold where fragmentation effects become important predictors of forest bird community structure.	[Rittenhouse, Chadwick D.; Pidgeon, Anna M.; Albright, Thomas P.; Culbert, Patrick D.; Radeloff, Volker C.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Flather, Curtis H.] US Forest Serv, USDA, Rocky Mt Res Stn, Ft Collins, CO USA; [Huang, Chengquan] Univ Maryland, Dept Geog, College Pk, MD 20742 USA; [Masek, Jeffrey G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Stewart, Susan I.] US Forest Serv, USDA, No Res Stn, Evanston, IL USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Agriculture (USDA); United States Forest Service	Rittenhouse, CD (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	cdrittenhous@wisc.edu	Radeloff, Volker C/B-6124-2016; Flather, Curtis H/G-3577-2012; Flather, Curtis/GQA-5543-2022; Rittenhouse, Chadwick/G-7169-2012; Masek, Jeffrey/D-7673-2012	Radeloff, Volker C/0000-0001-9004-221X; Flather, Curtis H/0000-0002-0623-3126; Huang, Chengquan/0000-0003-0055-9798	NASA [NNX07AL14G]	NASA(National Aeronautics & Space Administration (NASA))	The NASA Biodiversity Program and Interdisciplinary Sciences Program (grant #NNX07AL14G) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bellamy PE, 1996, OECOLOGIA, V108, P64, DOI 10.1007/BF00333215; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; BYSTRAK D, 1981, STUD AVIAN BIOL, V6, P34; Campbell SP, 2007, CONSERV BIOL, V21, P1218, DOI 10.1111/j.1523-1739.2007.00768.x; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; Cavitt JF, 2002, STUD AVIAN BIOL-SER, P73; Doherty PF, 2002, ECOLOGY, V83, P844, DOI 10.1890/0012-9658(2002)083[0844:SOPRBI]2.0.CO;2; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Flather CH, 1996, ECOLOGY, V77, P28, DOI 10.2307/2265651; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gram WK, 2003, CONSERV BIOL, V17, P1324, DOI 10.1046/j.1523-1739.2003.02171.x; HABECK J R, 1973, Quaternary Research (Orlando), V3, P408, DOI 10.1016/0033-5894(73)90006-9; HEJL SJ, 2002, STUD AVIAN BIOL, V25, P115; HINSLEY SA, 1995, ECOGRAPHY, V18, P41, DOI 10.1111/j.1600-0587.1995.tb00117.x; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Huang CQ, 2009, INT J DIGIT EARTH, V2, P195, DOI 10.1080/17538940902801614; Huang CQ, 2009, REMOTE SENS ENVIRON, V113, P1430, DOI 10.1016/j.rse.2008.06.016; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; LYNCH JF, 1984, BIOL CONSERV, V28, P287, DOI 10.1016/0006-3207(84)90039-9; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Morrison ML, 2002, STUD AVIAN BIOL-SER, P65; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Philippi TE, 1998, ECOL APPL, V8, P300; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; R Core Development Team, 2006, R LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Rittenhouse CD, 2010, GLOBAL CHANGE BIOL, V16, P905, DOI 10.1111/j.1365-2486.2009.02101.x; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rusch D. H., 2000, BIRDS N AM; Sauer J.R., 2008, N AM BREEDING BIRD S; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; TURNER MG, 1994, LANDSCAPE ECOL, V9, P59, DOI 10.1007/BF00135079; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	54	21	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11938	10.1371/journal.pone.0011938	http://dx.doi.org/10.1371/journal.pone.0011938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689854	gold, Green Published			2022-12-27	WOS:000280520400015
J	Gartlehner, G; Chapman, A; Strobelberger, M; Thaler, K				Gartlehner, Gerald; Chapman, Andrea; Strobelberger, Michaela; Thaler, Kylie			Differences in Efficacy and Safety of Pharmaceutical Treatments between Men and Women: An Umbrella Review	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PLACEBO-CONTROLLED TRIAL; PERCUTANEOUS CORONARY INTERVENTION; MODERATELY EMETOGENIC CHEMOTHERAPY; CONVERTING ENZYME-INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; ONGOING METFORMIN THERAPY; IRRITABLE-BOWEL-SYNDROME; CISPLATIN-INDUCED EMESIS; DOSE ORAL GRANISETRON	Being male or female is an important determinant of risks for certain diseases, patterns of illness and life expectancy. Although differences in risks for and prognoses of several diseases have been well documented, sex-based differences in responses to pharmaceutical treatments and accompanying risks of adverse events are less clear. The objective of this umbrella review was to determine whether clinically relevant differences in efficacy and safety of commonly prescribed medications exist between men and women. We retrieved all available systematic reviews of the Oregon Drug Effectiveness Review Project published before January 2010. Two persons independently reviewed each report to identify relevant studies. We dually abstracted data from the original publications into standardized forms. We synthesized the available evidence for each drug class and rated its quality applying the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Findings, based on 59 studies and data of more than 250,000 patients suggested that for the majority of drugs no substantial differences in efficacy and safety exist between men and women. Some clinically important exceptions, however, were apparent: women experienced substantially lower response rates with newer antiemetics than men (45% vs. 58%; relative risk 1.49, 95% confidence interval 1.35-1.64); men had higher rates of sexual dysfunction than women while on paroxetine for major depressive disorder; women discontinued lovastatin more frequently than men because of adverse events. Overall, for the majority of drugs sex does not appear to be a factor that has to be taken into consideration when choosing a drug treatment. The available body of evidence, however, was limited in quality and quantity, confining the range and certainty of our conclusions.	[Gartlehner, Gerald; Chapman, Andrea; Strobelberger, Michaela; Thaler, Kylie] Danube Univ Krems, Dept Evidence Based Med & Clin Epidemiol, Krems, Austria; [Gartlehner, Gerald] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA	Danube University Krems; University of North Carolina; University of North Carolina Chapel Hill	Gartlehner, G (corresponding author), Danube Univ Krems, Dept Evidence Based Med & Clin Epidemiol, Krems, Austria.	gerald.gartlehner@donau-uni.ac.at	Gartlehner, Gerald/AAY-2801-2021	Gartlehner, Gerald/0000-0001-5531-3678; Chapman, Andrea/0000-0002-1010-7800				ANONYMOUS, 1997, J NEUROL SCI, V1, P77; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Audhuy B, 1996, EUR J CANCER, V32A, P807; Bardhan KD, 2000, ALIMENT PHARM THERAP, V14, P23; BARKLEY RA, 1989, J CHILD PSYCHOL PSYC, V30, P379, DOI 10.1111/j.1469-7610.1989.tb00253.x; Blonde L, 2002, DIABETES OBES METAB, V4, P368, DOI 10.1046/j.1463-1326.2002.00229.x; BRADFORD RH, 1993, ANN INTERN MED, V118, P850, DOI 10.7326/0003-4819-118-11-199306010-00004; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; CARSON S, 2008, DRUG CLASS REV INSOM; CHANDLER C, 2005, DRUG CLASS REV DRUGS; CHOU R, 2005, ENZYME, V1, P2010; Chou R, 2007, DRUG CLASS REV DRUGS; Chou R, 2005, DRUG CLASS REV SKELE; CHOU R, 2008, DRUG CLASS REV DRUGS; Chou R, 2007, DRUG CLASS REV PEGYL; Choudhry S, 2004, ICON-INT J CONST LAW, V2, P1, DOI 10.1093/icon/2.1.1; Clayton AH, 2006, ARCH WOMEN MENT HLTH, V9, P151, DOI 10.1007/s00737-005-0111-y; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Collins R, 2003, LANCET, V361, P2005; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; *CTR DRUG EV RES, 2007, MET MED REV; *CTR DRUG EV RES, 2007, MED REV NRP104; DAILEY JH, 2007, CLASSICAL REV, V1, P2010; Davidson MH, 2000, NUTR METAB CARDIOVAS, V10, P253; Deedwania P, 2007, CIRCULATION, V115, P700, DOI 10.1161/CIRCULATIONAHA.106.654756; Dekkers CPM, 1999, ALIMENT PHARM THERAP, V13, P179; DELFAVERO A, 1995, ANN ONCOL, V6, P805; Dmochowski R, 2007, EUR UROL, V51, P1054, DOI 10.1016/j.eururo.2006.10.005; Entsuah AR, 2001, J CLIN PSYCHIAT, V62, P869, DOI 10.4088/JCP.v62n1106; Fauser AA, 1996, EUR J CANCER, V32A, P1523, DOI 10.1016/0959-8049(96)00132-3; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Freedman RR, 2000, HYPERTENSION, V35, P795, DOI 10.1161/01.HYP.35.3.795; FURMAGA E, 2006, RECEPTOR, V1, P2010; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GARTLEHNER G, 2008, UPDATE, V1, P2010; Gartlehner G, 2009, FINAL REPORT UPDATE; Gartlehner G., 2007, DRUG CLASS REV CONST; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Gartlehner G, 2008, DRUG SAFETY, V31, P851, DOI 10.2165/00002018-200831100-00004; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Gralla RJ, 1998, J CLIN ONCOL, V16, P1568, DOI 10.1200/JCO.1998.16.4.1568; Gyulai L, 2003, NEUROPSYCHOPHARMACOL, V28, P1374, DOI 10.1038/sj.npp.1300190; HANSEN RA, 2006, DRUG CLASS REV INHAL; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; HELFAND M, 2009, UPDATE, V1, P2010; HELFAND M, 2009, DRUG CLASS REV TRIPT; HELFAND M, 2006, UPDATE, V1, P2010; Hesketh P, 1996, J CLIN ONCOL, V14, P2242, DOI 10.1200/JCO.1996.14.8.2242; Hirschfeld RMA, 2004, AM J PSYCHIAT, V161, P1057, DOI 10.1176/appi.ajp.161.6.1057; Holdcroft A, 2007, J ROY SOC MED, V100, P2, DOI 10.1258/jrsm.100.1.2; Hunninghake DB, 2003, CLIN CARDIOL, V26, P112, DOI 10.1002/clc.4960260304; *IMS C, 2010, GRADEPRO; JONAS DE, 2008, ASTHMA, V1, P2010; Kahrilas PJ, 2000, ALIMENT PHARM THER, V14, P1249, DOI 10.1046/j.1365-2036.2000.00856.x; Kennedy SH, 2006, CAN J PSYCHIAT, V51, P234, DOI 10.1177/070674370605100405; Kristensen LE, 2008, RHEUMATOLOGY, V47, P495, DOI 10.1093/rheumatology/ken002; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Layton D, 2001, DRUG SAFETY, V24, P703, DOI 10.2165/00002018-200124090-00005; Lee N. J., 2008, DRUG CLASS REV TOPIC; Lehmann MH, 1996, CIRCULATION, V94, P2535, DOI 10.1161/01.CIR.94.10.2535; LEIZOROVICZ A, 1988, EUR HEART J, V9, P8; LEW KH, 1993, CLIN PHARMACOL THER, V54, P402, DOI 10.1038/clpt.1993.167; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; McDonagh M, 2007, DRUG CLASS REV DIS M; MCDONAGH M, 2009, DRUG CLASS REV DRUGS; MCDONAGH M, 2008, UPDATE, V1, P2010; MCDONAGH M, 2007, DRUG CLASS REV FIXED; MCDONAGH MS, 2009, ATTENTION DEFICIT HY, V1, P2010; MCDONAGH SM, 2005, CALCIUM CHANNEL BLOC, V1, P2010; Meade T, 1999, EUR HEART J, V20, P725; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Michel MC, 2002, J UROLOGY, V168, P1027, DOI 10.1016/S0022-5347(05)64567-3; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; NAVARI R, 1995, J CLIN ONCOL, V13, P1242, DOI 10.1200/JCO.1995.13.5.1242; NIH, 1994, FED REGISTER, V59, P14508; Nonaka K, 2008, DIABETES RES CLIN PR, V79, P291, DOI 10.1016/j.diabres.2007.08.021; NORRIS S, 2008, ASTHMA, V1, P2010; NORRIS S, 2006, CLASSICAL REV, V1, P2010; Norris S.L., 2008, DRUG CLASS REV THIAZ; NORRIS SL, 2008, DRUG CLASS REV NEWER; Obrocea GV, 2002, BIOL PSYCHIAT, V51, P253, DOI 10.1016/S0006-3223(01)01206-9; OLSSON G, 1992, EUR HEART J, V13, P28, DOI 10.1093/oxfordjournals.eurheartj.a060043; *OR HLTH SCI U, 2001, PROD; *OR HLTH SCI U, 2001, HIST DERP; PELHAM WE, 1989, J AM ACAD CHILD PSY, V28, P773, DOI 10.1097/00004583-198909000-00021; Perez EA, 1998, J CLIN ONCOL, V16, P754, DOI 10.1200/JCO.1998.16.2.754; PETER K, 1909, UNTERSUCHUNGEN BAU E, V1, P1; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Robison RJ, 2008, J CLIN PSYCHIAT, V69, P213, DOI 10.4088/JCP.v69n0207; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Schneider L. S., 1998, INT J GERIATR PSYC S, V1, pS26; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x; Selover D, 2008, DRUG CLASS REV NASAL; Sharp WS, 1999, J AM ACAD CHILD PSY, V38, P40, DOI 10.1097/00004583-199901000-00018; Shekelle P, 2003, Evid Rep Technol Assess (Summ), P1; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; Smith MEB., 2009, DRUG CLASS REV HMG C; Sonuga-Barke EJS, 2007, J AM ACAD CHILD PSY, V46, P701, DOI 10.1097/chi.0b013e31804659f1; Spector, 1998, Oncologist, V3, P432; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stewart DE, 2006, J AFFECT DISORDERS, V94, P183, DOI 10.1016/j.jad.2006.04.006; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Thakurta S, 2009, DRUG CLASS REV PROTO; Thase ME, 2005, J WOMENS HEALTH, V14, P609, DOI 10.1089/jwh.2005.14.609; Tohen M, 2004, BRIT J PSYCHIAT, V184, P337, DOI 10.1192/bjp.184.4.337; Trenkwalder P, 2005, BLOOD PRESSURE, V14, P31, DOI 10.1080/08037050510008823; Wizemann T. M., 2001, EXPLORING BIOL CONTR; Yusuf S, 2001, NEW ENGL J MED, V345, P494	111	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11895	10.1371/journal.pone.0011895	http://dx.doi.org/10.1371/journal.pone.0011895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689584	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300010
J	Melchior, L; Lynnerup, N; Siegismund, HR; Kivisild, T; Dissing, J				Melchior, Linea; Lynnerup, Niels; Siegismund, Hans R.; Kivisild, Toomas; Dissing, Jorgen			Genetic Diversity among Ancient Nordic Populations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; HUMAN REMAINS; MTDNA; PHYLOGEOGRAPHY; CONTAMINATION; EVOLUTION; HISTORY; HUMANS; SINGLE	Using established criteria for work with fossil DNA we have analysed mitochondrial DNA from 92 individuals from 18 locations in Denmark ranging in time from the Mesolithic to the Medieval Age. Unequivocal assignment of mtDNA haplotypes was possible for 56 of the ancient individuals; however, the success rate varied substantially between sites; the highest rates were obtained with untouched, freshly excavated material, whereas heavy handling, archeological preservation and storage for many years influenced the ability to obtain authentic endogenic DNA. While the nucleotide diversity at two locations was similar to that among extant Danes, the diversity at four sites was considerably higher. This supports previous observations for ancient Britons. The overall occurrence of haplogroups did not deviate from extant Scandinavians, however, haplogroup I was significantly more frequent among the ancient Danes (average 13%) than among extant Danes and Scandinavians (similar to 2.5%) as well as among other ancient population samples reported. Haplogroup I could therefore have been an ancient Southern Scandinavian type "diluted" by later immigration events. Interestingly, the two Neolithic samples (4,200 YBP, Bell Beaker culture) that were typed were haplogroup U4 and U5a, respectively, and the single Bronze Age sample (3,300-3,500 YBP) was haplogroup U4. These two haplogroups have been associated with the Mesolithic populations of Central and Northern Europe. Therefore, at least for Southern Scandinavia, our findings do not support a possible replacement of a haplogroup U dominated hunter-gatherer population by a more haplogroup diverse Neolithic Culture.	[Melchior, Linea; Dissing, Jorgen] Univ Copenhagen, Res Lab, Fac Hlth Sci, Inst Forens Med, Copenhagen, Denmark; [Lynnerup, Niels] Univ Copenhagen, Anthropol Lab, Fac Hlth Sci, Inst Forens Med, Copenhagen, Denmark; [Siegismund, Hans R.] Univ Copenhagen, Dept Biol, Fac Nat Sci, Copenhagen, Denmark; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Cambridge	Melchior, L (corresponding author), Kennedy Ctr, Ctr Appl Human Mol Genet, Glostrup, Denmark.	lme@kennedy.dk; jdissing@mail.dk	Kivisild, Toomas/P-5889-2017; Siegismund, Hans R./K-4332-2014	Kivisild, Toomas/0000-0002-6297-7808; Siegismund, Hans R./0000-0001-5757-3131	VELUX FOUNDATION	VELUX FOUNDATION(Velux Fonden)	This work was supported by external funding from the VELUX FOUNDATION. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Budowle B, 2008, BIOTECHNIQUES, V44, P603, DOI 10.2144/000112806; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Dissing J, 2008, J ARCHAEOL SCI, V35, P1445, DOI 10.1016/j.jas.2007.10.009; ETHELBERG P, 2000, SKOVGAARDE BESTAUTTU; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HARRISON D, 2000, STORA DODEN; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Jensen J., 1995, PREHISTORY DENMARK, V2nd; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Kieffer-Olsen J, 1993, GRAV GRAVSKIK MIDDEL; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Lamers R, 2009, J MOL EVOL, V68, P40, DOI 10.1007/s00239-008-9184-3; LIEBGOTT NK, 1998, DANMARK MIDDELALDERE; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Melchior L, 2008, AM J PHYS ANTHROPOL, V135, P206, DOI 10.1002/ajpa.20721; Melchior L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002214; MIKKELSEN M, 2009, FORENSIC SC IN PRESS; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; NORDBERG M, 1987, DYNAMISKE MIDDELALDE; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Shennan S, 2009, HUM BIOL, V81, P339, DOI 10.3378/027.081.0312; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Topf AL, 2007, BIOL LETTERS, V3, P550, DOI 10.1098/rsbl.2007.0269; Topf AL, 2006, MOL BIOL EVOL, V23, P152, DOI 10.1093/molbev/msj013; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; WITTLE A, 1996, EUROPE NEOLITHIC CRE; ZIEGLER P, 1982, BLACK DEATH; [No title captured]	61	35	35	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11898	10.1371/journal.pone.0011898	http://dx.doi.org/10.1371/journal.pone.0011898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689597	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520300013
J	Chen, C; Shi, Q; Zhang, BY; Wang, GR; Zhou, W; Gao, C; Tian, C; Mei, GY; Han, YL; Han, J; Dong, XP				Chen, Cao; Shi, Qi; Zhang, Bao-Yun; Wang, Gui-Rong; Zhou, Wei; Gao, Chen; Tian, Chan; Mei, Guo-Yong; Han, Yan-Ling; Han, Jun; Dong, Xiao-Ping			The Prepared Tau Exon-Specific Antibodies Revealed Distinct Profiles of Tau in CSF of the Patients with Creutzfeldt-Jakob Disease	PLOS ONE			English	Article							HUMAN SPONGIFORM ENCEPHALOPATHIES; ALZHEIMERS-DISEASE; PRION DISEASES; CEREBROSPINAL-FLUID; PHOSPHORYLATED-TAU; PROTEIN-TAU; IN-VITRO; DIAGNOSIS; ISOFORMS; PRP	Background: The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD. Methodology/Principal Findings: Sequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients. Conclusions/Significance: Three exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD.	[Chen, Cao; Shi, Qi; Zhang, Bao-Yun; Wang, Gui-Rong; Zhou, Wei; Gao, Chen; Tian, Chan; Mei, Guo-Yong; Han, Yan-Ling; Han, Jun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, C (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	Chinese National Natural Science Foundation [30771914, 30800975]; National Science and Technology Task Force Project [2006BAD06A13-2]; Institution Technique RD [2008EG150300]; National Basic Research Program of China (973 Program) [2007CB310505]; China Mega-Project for Infectious Disease [2009ZX10004-101]; SKLID [2008SKLID102, 2008SKLID202]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Task Force Project; Institution Technique RD; National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Mega-Project for Infectious Disease; SKLID	This work was supported by Chinese National Natural Science Foundation Grants 30771914 and 30800975, National Science and Technology Task Force Project (2006BAD06A13-2), Institution Technique R&D Grant (2008EG150300), National Basic Research Program of China (973 Program) (2007CB310505), China Mega-Project for Infectious Disease (2009ZX10004-101) and the SKLID development Grant (2008SKLID102 and 2008SKLID202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cuadrado-Corrales N, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-25; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; LICHTENBERG B, 1988, NATURE, V334, P359, DOI 10.1038/334359a0; Ohkubo T, 2003, ANN NEUROL, V54, P553, DOI 10.1002/ana.10748; Otto M, 2002, NEUROLOGY, V58, P192, DOI 10.1212/WNL.58.2.192; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; Pevalova M, 2006, Bratisl Lek Listy, V107, P346; Satoh K, 2006, CELL MOL NEUROBIOL, V26, P45, DOI 10.1007/s10571-006-9370-z; Shi Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-360; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; Weber T, 1997, BIOMED PHARMACOTHER, V51, P381, DOI 10.1016/S0753-3322(97)89430-9; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; WILL RG, 1993, BRIT MED BULL, V49, P960, DOI 10.1093/oxfordjournals.bmb.a072655; World Health Organization, 1998, CONS CRIT SPOR CJD; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zhang FP, 2002, VIRUS RES, V87, P145, DOI 10.1016/S0168-1702(02)00089-8	28	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11886	10.1371/journal.pone.0011886	http://dx.doi.org/10.1371/journal.pone.0011886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686702	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520200045
J	Devney, CA; Caley, MJ; Congdon, BC				Devney, Carol A.; Caley, M. Julian; Congdon, Bradley C.			Plasticity of Noddy Parents and Offspring to Sea-Surface Temperature Anomalies	PLOS ONE			English	Article							GREAT-BARRIER-REEF; WEDGE-TAILED SHEARWATER; YELLOW-NOSED ALBATROSS; TERN STERNA-HIRUNDO; CLIMATE-CHANGE; ENVIRONMENTAL VARIABILITY; DEVELOPMENTAL PLASTICITY; REPRODUCTIVE SUCCESS; CALONECTRIS-DIOMEDEA; PUFFINUS-PACIFICUS	Behavioral and/or developmental plasticity is crucial for resisting the impacts of environmental stressors. We investigated the plasticity of adult foraging behavior and chick development in an offshore foraging seabird, the black noddy ( Anous minutus), during two breeding seasons. The first season had anomalously high sea-surface temperatures and 'low' prey availability, while the second was a season of below average sea-surface temperatures and 'normal' food availability. During the second season, supplementary feeding of chicks was used to manipulate offspring nutritional status in order to mimic conditions of high prey availability. When sea-surface temperatures were hotter than average, provisioning rates were significantly and negatively impacted at the day-to-day scale. Adults fed chicks during this low-food season smaller meals but at the same rate as chicks in the unfed treatment the following season. Supplementary feeding of chicks during the second season also resulted in delivery of smaller meals by adults, but did not influence feeding rate. Chick begging and parental responses to cessation of food supplementation suggested smaller meals fed to artificially supplemented chicks resulted from a decrease in chick demands associated with satiation, rather than adult behavioral responses to chick condition. During periods of low prey abundance, chicks maintained structural growth while sacrificing body condition and were unable to take advantage of periods of high prey abundance by increasing growth rates. These results suggest that this species expresses limited plasticity in provisioning behavior and offspring development. Consequently, responses to future changes in sea-surface temperature and other environmental variation may be limited.	[Devney, Carol A.] James Cook Univ, Sch Marine & Trop Biol, Australian Inst Marine Sci, Cairns, Qld, Australia; [Caley, M. Julian] JCU, AIMS, Townsville, Qld, Australia	Australian Institute of Marine Science; James Cook University; Australian Institute of Marine Science	Devney, CA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Australian Inst Marine Sci, Cairns, Qld, Australia.	carol.devney@jcu.edu.au	Caley, Julian/A-4042-2008; Congdon, Bradley C/J-9181-2012	Caley, Julian/0000-0001-5739-749X; Congdon, Bradley C/0000-0002-8751-0892	James Cook University; Stuart Leslie Bird Research Award; Birds Queensland Research Grant; GBRMPA; Australian Research Council [LP 0562157]; AIMS@JCU PhD Scholarship	James Cook University; Stuart Leslie Bird Research Award; Birds Queensland Research Grant; GBRMPA; Australian Research Council(Australian Research Council); AIMS@JCU PhD Scholarship	Data collection was financially supported by the following: James Cook University Graduate Research Support Scheme Grant, Stuart Leslie Bird Research Award, Birds Queensland Research Grant, GBRMPA Science for Management Award, Australian Research Council LP 0562157, and an, AIMS@JCU PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashmole N. P., 1967, Bulletin of the Peabody Museum of Natural History, V24, P1; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; ASHMOLE NP, 1962, IBIS B, V103, P255; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Bokony V, 2009, AM NAT, V173, P589, DOI 10.1086/597610; Chiaradia A, 2006, ARDEA, V94, P257; CONGDON BC, 1991, EMU, V91, P158, DOI 10.1071/MU9910158; Congdon BC, 2005, MAR ECOL PROG SER, V301, P293, DOI 10.3354/meps301293; Cooper RP, 1948, EMU, V48, P107; CROXALL JP, 1982, J ANIM ECOL, V63, P275; DIAMOND AW, 1983, STUD AVIAN BIOL, V8, P24; Duriez O, 2000, CAN J ZOOL, V78, P1275, DOI 10.1139/cjz-78-7-1275; Dyer PK, 2005, EMU, V105, P249, DOI 10.1071/MU04011; EMLEN ST, 1991, CONDOR, V93, P591, DOI 10.2307/1368191; Erikstad KE, 1998, ECOLOGY, V79, P1781; Erwin CA, 2007, MAR ECOL PROG SER, V331, P255, DOI 10.3354/meps331255; GAUGER VH, 1999, BIRDS N AM; GBRMPA, 2006, FIN BLEACH SUMM REP; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Hamer KC, 1999, ANIM BEHAV, V57, P627, DOI 10.1006/anbe.1998.0994; Hamer KC, 2006, BEHAV ECOL, V17, P132, DOI 10.1093/beheco/arj008; HAMER KC, 1993, J ANIM ECOL, V62, P441, DOI 10.2307/5193; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hedd A, 2002, MAR ECOL PROG SER, V229, P221, DOI 10.3354/meps229221; Higgins P. J., 1996, HDB AUSTR NZ ANTARCT, V3; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HULSMAN K., 1988, SEABIRDS OTHER MARIN; Konarzewski M, 2000, PHYSIOL BIOCHEM ZOOL, V73, P416, DOI 10.1086/317744; Konarzewski M, 1996, FUNCT ECOL, V10, P97, DOI 10.2307/2390267; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Mangel M, 2001, EVOL ECOL RES, V3, P583; MASSIAS A, 1990, ORNIS SCAND, V21, P187, DOI 10.2307/3676778; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; MONAGHAN P, 1992, Ardea, V80, P71; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; NISBET ICT, 1995, CONDOR, V97, P335, DOI 10.2307/1369019; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Peck DR, 2004, MAR ECOL PROG SER, V281, P259, DOI 10.3354/meps281259; PIANKA ER, 1976, AM ZOOL, V16, P775; Quilifeldt P, 2007, J AVIAN BIOL, V38, P298, DOI 10.1111/j.2007.0908-8857.03846.x; Quillfeldt P, 2007, BEHAV ECOL SOCIOBIOL, V61, P793, DOI 10.1007/s00265-006-0310-1; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; RICKLEFS RE, 1981, AUK, V98, P361; RICKLEFS RE, 1998, AVIAN GROWTH DEV EVO, P266; Robinson JA, 2002, IBIS, V144, P344, DOI 10.1046/j.1474-919X.2002.00061.x; Schew WA., 1998, AVIAN GROWTH DEV, P288; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Skirving W, 2002, SEA SURFACE TEMPERAT; Smithers BV, 2003, MAR FRESHWATER RES, V54, P973, DOI 10.1071/MF02137; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Surman CA, 2003, J ZOOL, V259, P219, DOI 10.1017/S0952836902003047; Takahashi A, 1999, ECOL RES, V14, P155, DOI 10.1046/j.1440-1703.1999.00285.x; Tilgar V, 2002, J AVIAN BIOL, V33, P407, DOI 10.1034/j.1600-048X.2002.02990.x; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; VANHEEZIK Y, 1990, IBIS, V132, P354; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch H, 2000, IBIS, V142, P103, DOI 10.1111/j.1474-919X.2000.tb07689.x; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; Wernham CV, 1998, J ANIM ECOL, V67, P25, DOI 10.1046/j.1365-2656.1998.00166.x; Wilkinson C, 2000, STATUS CORAL REEFS W	64	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11891	10.1371/journal.pone.0011891	http://dx.doi.org/10.1371/journal.pone.0011891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686693	Green Published, Green Accepted, gold			2022-12-27	WOS:000280520200049
J	Liu, YM; Bassham, DC				Liu, Yimo; Bassham, Diane C.			TOR Is a Negative Regulator of Autophagy in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; PROTEIN-KINASE; CHLAMYDOMONAS-REINHARDTII; PLANT AUTOPHAGY; RAPAMYCIN TOR; S6 KINASE; TARGET; STRESS; STARVATION	Background: Autophagy is a protein degradation process by which cells recycle cytoplasmic contents under stress conditions or during senescence; a basal level of housekeeping autophagy also occurs under non-stressed conditions. Although a number of genes that function in autophagy (ATG genes) have been identified in plants, the upstream components that regulate the plant autophagy pathway are still obscure. Target of rapamycin (TOR) is a negative regulator of autophagy in both yeast and animals, and homologs of TOR in plants control plant growth and protein synthesis. However, a role for TOR in regulation of autophagy in plants has not been demonstrated previously. Methodology/Principal Findings: In this paper we used RNA interference (RNAi) to generate transgenic plants with reduced AtTOR transcript level. By observing monodansylcadaverine- (MDC) and GFP-AtATG8e-labeled autophagosomes, these plants were demonstrated to have constitutive AtATG18a-dependent autophagy. Reverse transcriptase-PCR also showed increased expression of some AtATG genes in the RNAi-AtTOR plants. Unlike autophagy induced by starvation or salt stress, an NADPH oxidase inhibitor did not inhibit the constitutive autophagy in the RNAi-AtTOR lines, indicating that AtTOR is either downstream of or in a parallel pathway to NADPH oxidase. Conclusions/Significance: Together, our results provide evidence that TOR is a negative regulator of autophagy in plants.	[Liu, Yimo; Bassham, Diane C.] Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA; [Liu, Yimo; Bassham, Diane C.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Bassham, Diane C.] Iowa State Univ, Inst Plant Sci, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Liu, YM (corresponding author), Iowa State Univ, Interdept Genet Program, Ames, IA 50011 USA.	bassham@iastate.edu	Liu, Yimo/A-2910-2013		National Science Foundation [IOB-0515998]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant no. IOB-0515998 from the National Science Foundation (www.nsf.gov) to DCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GH, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-2; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Bassham DC, 2007, CURR OPIN PLANT BIOL, V10, P587, DOI 10.1016/j.pbi.2007.06.006; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; de la Cruz HR, 2004, BIOCHEMISTRY-US, V43, P533, DOI 10.1021/bi035222z; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Perez-Perez ME, 2010, PLANT PHYSIOL, V152, P1874, DOI 10.1104/pp.109.152520; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Honma Y, 2006, EMBO J, V25, P3832, DOI 10.1038/sj.emboj.7601262; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MY, 2002, PLANTA, V215, P1022, DOI 10.1007/s00425-002-0829-y; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Li L, 2007, J EXP BOT, V58, P3323, DOI 10.1093/jxb/erm180; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Matsuoka K, 1997, PLANT CELL, V9, P533; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Moriyasu Y, 1996, PLANT PHYSIOL, V111, P1233, DOI 10.1104/pp.111.4.1233; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shin JH, 2009, MOL CELLS, V27, P67, DOI 10.1007/s10059-009-0006-2; Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Xiang Y, 2007, AUTOPHAGY, V3, P257, DOI 10.4161/auto.3847; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	64	185	196	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11883	10.1371/journal.pone.0011883	http://dx.doi.org/10.1371/journal.pone.0011883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686696	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200042
J	Cantin, L; Lenoir, M; Augier, E; Vanhille, N; Dubreucq, S; Serre, F; Vouillac, C; Ahmed, SH				Cantin, Lauriane; Lenoir, Magalie; Augier, Eric; Vanhille, Nathalie; Dubreucq, Sarah; Serre, Fuschia; Vouillac, Caroline; Ahmed, Serge H.			Cocaine Is Low on the Value Ladder of Rats: Possible Evidence for Resilience to Addiction	PLOS ONE			English	Article							SELF-ADMINISTERED COCAINE; RHESUS-MONKEYS; FOOD ADDICTION; DRUG-ADDICTION; BEHAVIORAL SENSITIZATION; ALTERNATIVE REINFORCER; SUBJECTIVE RESPONSES; PARKINSONS-DISEASE; EXTENDED ACCESS; CHOICE	Background: Assessing the relative value of cocaine and how it changes with chronic drug use represents a long-standing goal in addiction research. Surprisingly, recent experiments in rats - by far the most frequently used animal model in this field - suggest that the value of cocaine is lower than previously thought. Methodology/Principal Findings: Here we report a series of choice experiments that better define the relative position of cocaine on the value ladder of rats (i.e., preference rank-ordering of different rewards). Rats were allowed to choose either taking cocaine or drinking water sweetened with saccharin - a nondrug alternative that is not biologically essential. By systematically varying the cost and concentration of sweet water, we found that cocaine is low on the value ladder of the large majority of rats, near the lowest concentrations of sweet water. In addition, a retrospective analysis of all experiments over the past 5 years revealed that no matter how heavy was past cocaine use most rats readily give up cocaine use in favor of the nondrug alternative. Only a minority, fewer than 15% at the heaviest level of past cocaine use, continued to take cocaine, even when hungry and offered a natural sugar that could relieve their need of calories. Conclusions/Significance: This pattern of results (cocaine abstinence in most rats; cocaine preference in few rats) maps well onto the epidemiology of human cocaine addiction and suggests that only a minority of rats would be vulnerable to cocaine addiction while the large majority would be resilient despite extensive drug use. Resilience to drug addiction has long been suspected in humans but could not be firmly established, mostly because it is difficult to control retrospectively for differences in drug self-exposure and/or availability in human drug users. This conclusion has important implications for preclinical research on the neurobiology of cocaine addiction and for future medication development.	Univ Victor Segalen Bordeaux 2, Inst Sante Publ Epidemiol & Dev, CNRS, UMR 5227, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Cantin, L (corresponding author), Univ Victor Segalen Bordeaux 2, Inst Sante Publ Epidemiol & Dev, CNRS, UMR 5227, Bordeaux, France.	sahmed@u-bordeaux2.fr	Lenoir, Magalie/E-5797-2019; SERRE, Fuschia/AAU-3161-2020; AHMED, Serge H/D-5236-2014	Lenoir, Magalie/0000-0001-7983-1824; SERRE, Fuschia/0000-0002-0228-3572; Ahmed, Serge/0000-0002-1225-9234	Centre National de la Recherche Scientifique (CNRS); Universite Victor-Segalen Bordeaux 2; Conseil Regional d'Aquitaine; National Research Agency (ANR); Fondation pour la Recherche Medicale (FRM); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Victor-Segalen Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); National Research Agency (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT)	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), the Universite Victor-Segalen Bordeaux 2, the Conseil Regional d'Aquitaine, the National Research Agency (ANR), the Fondation pour la Recherche Medicale (FRM) and the Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, NEUROPSYCHOPHARMACOL, V31, P563, DOI 10.1038/sj.npp.1300834; Ahmed SH, 2005, EUR J PHARMACOL, V526, P9, DOI 10.1016/j.ejphar.2005.09.036; Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; AHMED SH, 2010, NEUROSCI BI IN PRESS; AHMED SH, 2009, NEUROMETHOD IN PRESS; AIGNER TG, 1978, SCIENCE, V201, P534, DOI 10.1126/science.96531; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P224; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Brown G, 2002, BEHAV PHARMACOL, V13, P157, DOI 10.1097/00008877-200203000-00007; CARROLL ME, 1989, PSYCHOPHARMACOLOGY, V97, P23, DOI 10.1007/BF00443407; CARROLL ME, 1993, PSYCHOPHARMACOLOGY, V110, P5, DOI 10.1007/BF02246944; Carroll ME, 1997, PSYCHOPHARMACOLOGY, V129, P206, DOI 10.1007/s002130050182; Christensen CJ, 2008, PSYCHOPHARMACOLOGY, V198, P221, DOI 10.1007/s00213-008-1120-0; Christensen CJ, 2009, BEHAV NEUROSCI, V123, P165, DOI 10.1037/a0013736; Christensen CJ, 2008, PHARMACOL BIOCHEM BE, V91, P209, DOI 10.1016/j.pbb.2008.07.009; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; DAVIDSON ES, 1993, ADDICT BEHAV, V18, P445, DOI 10.1016/0306-4603(93)90062-E; Davis KL, 2002, NEUROPSYCHOPHARMACOL, P1557; Degenhardt L, 2008, DRUG ALCOHOL DEPEN, V93, P227, DOI 10.1016/j.drugalcdep.2007.09.024; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; ELSMORE TF, 1980, PHARMACOL BIOCHEM BE, V13, P729, DOI 10.1016/0091-3057(80)90018-0; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Evans AH, 2004, CURR OPIN NEUROL, V17, P393, DOI 10.1097/01.wco.0000137528.23126.41; FITCH TE, 1993, DRUG ALCOHOL DEPEN, V33, P119, DOI 10.1016/0376-8716(93)90053-S; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Goldstein RZ, 2010, J PSYCHOPHARMACOL, V24, P257, DOI 10.1177/0269881108096982; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; HAERTZEN CA, 1983, DRUG ALCOHOL DEPEN, V11, P147, DOI 10.1016/0376-8716(83)90076-5; Haney M, 2009, ADDICT BIOL, V14, P9, DOI 10.1111/j.1369-1600.2008.00121.x; HIGGINS ST, 1994, LIFE SCI, V55, P179, DOI 10.1016/0024-3205(94)00878-7; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HOLLARD V, 1971, J EXP ANAL BEHAV, V16, P375, DOI 10.1901/jeab.1971.16-375; Hughes JR, 2006, DRUG ALCOHOL DEPEN, V85, P91, DOI 10.1016/j.drugalcdep.2006.04.004; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kippin TE, 2006, PSYCHOPHARMACOLOGY, V187, P60, DOI 10.1007/s00213-006-0386-3; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Mantsch JR, 2004, PSYCHOPHARMACOLOGY, V175, P26, DOI 10.1007/s00213-004-1778-x; Martelle JL, 2008, BEHAV PHARMACOL, V19, P743, DOI 10.1097/FBP.0b013e3283123c6c; Mattson BJ, 2003, PSYCHOPHARMACOLOGY, V167, P1, DOI 10.1007/s00213-002-1351-4; Mattson BJ, 2001, BEHAV NEUROSCI, V115, P683, DOI 10.1037/0735-7044.115.3.683; MAZUR JE, 1991, TECHNIQUES BEHAV N 1, P219; MILLER HL, 1976, J EXP ANAL BEHAV, V26, P335, DOI 10.1901/jeab.1976.26-335; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Negus SS, 2005, PSYCHOPHARMACOLOGY, V181, P244, DOI 10.1007/s00213-005-2266-7; Negus SS, 2003, NEUROPSYCHOPHARMACOL, V28, P919, DOI 10.1038/sj.npp.1300096; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Pelchat ML, 2009, J NUTR, V139, P620, DOI 10.3945/jn.108.097816; PICKENS R, 1968, J PHARMACOL EXP THER, V161, P122; PONCELET M, 1983, PSYCHOPHARMACOLOGY, V80, P184, DOI 10.1007/BF00427967; Reboussin BA, 2006, NEUROPSYCHOPHARMACOL, V31, P2055, DOI 10.1038/sj.npp.1301037; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINS LN, 1993, ADDICTION, V88, P1041, DOI 10.1111/j.1360-0443.1993.tb02123.x; ROBINS LN, 1974, AM J EPIDEMIOL, V99, P235, DOI 10.1093/oxfordjournals.aje.a121608; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; Russ BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007834; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Seip KM, 2008, PSYCHOPHARMACOLOGY, V199, P119, DOI 10.1007/s00213-008-1140-9; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Sofuoglu M, 2000, AM J DRUG ALCOHOL AB, V26, P591, DOI 10.1081/ADA-100101897; SPEALMAN RD, 1979, SCIENCE, V204, P1231, DOI 10.1126/science.109920; Stafford D, 1998, PSYCHOPHARMACOLOGY, V139, P169, DOI 10.1007/s002130050702; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; VANDYKE C, 1982, SCI AM, V246, P128, DOI 10.1038/scientificamerican0382-128; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2002, SYNAPSE, V46, P79, DOI 10.1002/syn.10137; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Walsh SL, 2010, DRUG ALCOHOL DEPEN, V106, P28, DOI 10.1016/j.drugalcdep.2009.07.011; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Woolverton WL, 2002, J PHARMACOL EXP THER, V303, P211, DOI 10.1124/jpet.102.037812	81	127	127	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11592	10.1371/journal.pone.0011592	http://dx.doi.org/10.1371/journal.pone.0011592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676364	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100001
J	Rodriguez-Paris, J; Pique, L; Colen, T; Roberson, J; Gardner, P; Schrijver, I				Rodriguez-Paris, Juan; Pique, Lynn; Colen, Tahl; Roberson, Joseph; Gardner, Phyllis; Schrijver, Iris			Genotyping with a 198 Mutation Arrayed Primer Extension Array for Hereditary Hearing Loss: Assessment of Its Diagnostic Value for Medical Practice	PLOS ONE			English	Article							COCHLEAR MOTOR PROTEIN; PENDRED-SYNDROME; PHENOTYPE CORRELATION; RECESSIVE DEAFNESS; FREQUENCY; PRESTIN; GENE; PDS; IVS2-2A-GREATER-THAN-G; ENLARGEMENT	Molecular diagnostic testing of individuals with congenital sensorineural hearing loss typically begins with DNA sequencing of the GJB2 gene. If the cause of the hearing loss is not identified in GJB2, additional testing can be ordered. However, the step-wise analysis of several genes often results in a protracted diagnostic process. The more comprehensive Hereditary Hearing Loss Arrayed Primer Extension microarray enables analysis of 198 mutations across eight genes (GJB2, GJB6, GJB3, GJA1, SLC26A4, SLC26A5, MTRNR1 and MTTS1) in a single test. To evaluate the added diagnostic value of this microarray for our ethnically diverse patient population, we tested 144 individuals with congenital sensorineural hearing loss who were negative for biallelic GJB2 or GJB6 mutations. The array successfully detected all GJB2 changes previously identified in the study group, confirming excellent assay performance. Additional mutations were identified in the SLC26A4, SLC26A5 and MTRNR1 genes of 12/144 individuals (8.3%), four of whom (2.8%) had genotypes consistent with pathogenicity. These results suggest that the current format of this microarray falls short of adding diagnostic value beyond the customary testing of GJB2, perhaps reflecting the array's limitations on the number of mutations included for each gene, but more likely resulting from unknown genetic contributors to this phenotype. We conclude that mutations in other hearing loss associated genes should be incorporated in the array as knowledge of the etiology of hearing loss evolves. Such future modification of the flexible configuration of the Hereditary Hearing Loss Arrayed Primer Extension microarray would improve its impact as a diagnostic tool.	[Rodriguez-Paris, Juan; Pique, Lynn; Schrijver, Iris] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Colen, Tahl; Roberson, Joseph] Calif Ear Inst, Palo Alto, CA USA; [Gardner, Phyllis] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Schrijver, Iris] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Rodriguez-Paris, J (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ischrijver@stanfordmed.org			Pete and Arline Harman Pediatric Clinical Scholar grant	Pete and Arline Harman Pediatric Clinical Scholar grant	This work was generously funded by the Pete and Arline Harman Pediatric Clinical Scholar grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Cremers FPM, 2007, J MED GENET, V44, P153, DOI 10.1136/jmg.2006.044784; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Gardner P, 2006, PEDIATRICS, V118, P985, DOI 10.1542/peds.2005-2519; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Liu GP, 2000, INT J SYST SCI, V31, P63, DOI 10.1080/002077200291460; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Liu XZ, 2001, HUM MOL GENET, V10, P2945, DOI 10.1093/hmg/10.25.2945; LIU XZ, 2009, HUM GENET, V62, pCX26; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Tang HY, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-30; Teek R, 2009, INT J PEDIATR OTORHI, V73, P103, DOI 10.1016/j.ijporl.2008.10.003; TRANEBAERG L, 2008, INT J AUDIOL, V535, P45; Vele Oana, 2008, Expert Opin Med Diagn, V2, P231, DOI 10.1517/17530059.2.3.231; White KR, 2004, AM J MED GENET A, V130A, P29, DOI 10.1002/ajmg.a.30048	30	17	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11804	10.1371/journal.pone.0011804	http://dx.doi.org/10.1371/journal.pone.0011804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668687	Green Published, Green Submitted, gold			2022-12-27	WOS:000280297300027
J	Luo, LF; Ye, LZ; Liu, G; Shao, GC; Zheng, R; Ren, ZQ; Zuo, B; Xu, DQ; Lei, MG; Jiang, SW; Deng, CY; Xiong, YZ; Li, FG				Luo, Lifan; Ye, Lianzhi; Liu, Gang; Shao, Guochao; Zheng, Rong; Ren, Zhuqing; Zuo, Bo; Xu, Dequan; Lei, Minggang; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge			Microarray-Based Approach Identifies Differentially Expressed MicroRNAs in Porcine Sexually Immature and Mature Testes	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITES; RNAS; POLYMORPHISM; ASSOCIATION; ENCODES; TISSUES; PIRNAS; RNF4	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules which are proved to be involved in mammalian spermatogenesis. Their expression and function in the porcine germ cells are not fully understood. Methodology: We employed a miRNA microarray containing 1260 unique miRNA probes to evaluate the miRNA expression patterns between sexually immature (60-day) and mature (180-day) pig testes. One hundred and twenty nine miRNAs representing 164 reporter miRNAs were expressed differently (p<0.1). Fifty one miRNAs were significantly up-regulated and 78 miRNAs were down-regulated in mature testes. Nine of these differentially expressed miRNAs were validated using quantitative RT-PCR assay. Totally 15919 putative miRNA-target sites were detected by using RNA22 method to align 445 NCBI pig cDNA sequences with these 129 differentially expressed miRNAs, and seven putative target genes involved in spermatogenesis including DAZL, RNF4 gene were simply confirmed by quantitative RT-PCR. Conclusions: Overall, the results of this study indicated specific miRNAs expression in porcine testes and suggested that miRNAs had a role in regulating spermatogenesis.	[Luo, Lifan] Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China; Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Luo, LF (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China.	lifener@mail.hzau.edu.cn			National Natural Science Foundation of China [30700571]; Trans-gene Key Project of China [2009ZX08009-148B]; National High Technology Development Project [2007AA10Z162]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-gene Key Project of China; National High Technology Development Project(National High Technology Research and Development Program of China)	This work was supported financially by the National Natural Science Foundation of China (30700571), Trans-gene Key Project of China (2009ZX08009-148B), National High Technology Development Project (2007AA10Z162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; EGBUNIKE GN, 1976, ACTA ANAT, V104, P400; Feng Y, 2008, ANIM GENET, V39, P91, DOI 10.1111/j.1365-2052.2007.01685.x; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Fitzpatrick JM, 2005, MOL BIOCHEM PARASIT, V141, P1, DOI 10.1016/j.molbiopara.2005.01.007; Galili N, 2000, DEV DYNAM, V218, P102, DOI 10.1002/(SICI)1097-0177(200005)218:1<102::AID-DVDY9>3.3.CO;2-1; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Niu BY, 2009, ANIM REPROD SCI, V110, P283, DOI 10.1016/j.anireprosci.2008.01.020; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teng YN, 2002, J CLIN ENDOCR METAB, V87, P5258, DOI 10.1210/jc.2002-020016; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wester L, 2003, ARTHRITIS RES THER, V5, pR361, DOI 10.1186/ar993; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yan W, 2002, MECH DEVELOP, V118, P247, DOI 10.1016/S0925-4773(02)00261-7; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang YH, 2009, ANIM REPROD SCI, V112, P415, DOI 10.1016/j.anireprosci.2008.05.069	39	62	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11744	10.1371/journal.pone.0011744	http://dx.doi.org/10.1371/journal.pone.0011744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805883	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600002
J	Peng, XX; Song, SG; Sullivan, S; Qiu, JJ; Wang, W				Peng, Xiaoxia; Song, Shige; Sullivan, Sheena; Qiu, Jingjun; Wang, Wei			Ageing, the Urban-Rural Gap and Disability Trends: 19 Years of Experience in China-1987 to 2006	PLOS ONE			English	Article							HEALTH	Background: As the age of a population increases, so too does the rate of disability. In addition, disability is likely to be more common in rural compared with urban areas. The present study aimed to examine the influence of rapid population changes in terms of age and rural/urban residence on the prevalence of disability. Methods: Data from the 1987 and 2006 China Sampling Surveys on Disability were used to estimate the impacts of rapid ageing and the widening urban-rural gap on the prevalence of disability. Stratum specific rates of disability were estimated by 5-year age-group and type of residence. The decomposition of rates method was used to calculate the rate difference for each stratum between the two surveys. Results: The crude disability rate increased from 4.89% in 1987 to 6.39% in 2006, a 1.5% increase over the 19 year period. However, after the compositional effects from the overall rates of changing age-structure in 1987 and 2006 were eliminated by standardization, the disability rate in 1987 was 6.13%, which is higher than that in 2006 (5.91%). While in 1987 the excess due to rural residence compared with urban was <1.0%, this difference increased to >1.5% by 2006, suggesting a widening disparity by type of residence. When rates were decomposed, the bulk of the disability could be attributed to ageing, and very little to rural residence. However, a wider gap in prevalence between rural and urban areas could be observed in some age groups by 2006. Conclusion: The increasing number of elderly disabled persons in China and the widening discrepancy of disability prevalence between urban and rural areas may indicate that the most important priorities for disability prevention in China are to reinforce health promotion in older adults and improve health services in rural communities.	[Peng, Xiaoxia; Qiu, Jingjun; Wang, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Song, Shige] Chinese Acad Social Sci, Inst Sociol, Beijing, Peoples R China; [Sullivan, Sheena; Wang, Wei] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia; [Wang, Wei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Social Sciences; Edith Cowan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Peng, XX (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China.	wei6014@yahoo.com	liu, li/HGC-0900-2022	Sullivan, Sheena G./0000-0002-0856-0294; wang, wei/0000-0002-1430-1360	Office of the Second China National Sample Survey on Disability; 100-Chinese Merit Scientist Program; Chinese Academy of Sciences; Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [PHR201007112]	Office of the Second China National Sample Survey on Disability; 100-Chinese Merit Scientist Program; Chinese Academy of Sciences(Chinese Academy of Sciences); Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality	This work was supported by grants from the Office of the Second China National Sample Survey on Disability, the 100-Chinese Merit Scientist Program, the Chinese Academy of Sciences, and Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beydoun MA, 2005, SOC SCI MED, V60, P2045, DOI 10.1016/j.socscimed.2004.08.063; Brown GD, 2003, INT J OCCUP ENV HEAL, V9, P326, DOI 10.1179/oeh.2003.9.4.326; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Centre for Health Statistics and Information, 2004, RES NAT HLTH SERV AN; DASGUPTA P, 1993, STANDARDIZATION DECO, P55; *EUR COMM, 2001, EMPL SIT PEOPL DIS E; Giles LC, 2003, MED J AUSTRALIA, V179, P130, DOI 10.5694/j.1326-5377.2003.tb05470.x; Gu D., 2004, DEMOGR RES, V11, P1, DOI [10.4054/DemRes.2004.11.1, DOI 10.4054/DEMRES.2004.11.1]; HENDERSON G, 1995, SOC SCI MED, V41, P1119, DOI 10.1016/0277-9536(94)00420-X; Leading Group of the Second China National Sample Survey on Disability and National Bureau of Statistics of the People's Republic of China, 2006, COMM MAJ STAT 2 CHIN; LIAO TF, 1989, DEMOGRAPHY, V26, P717, DOI 10.2307/2061269; Liu JF, 2009, GERIATR GERONTOL INT, V9, P253, DOI 10.1111/j.1447-0594.2009.00529.x; MARTIN J, 1998, 1 OPCS SOC SURV DIV; Moss Margaret P, 2006, Int J Health Geogr, V5, P37, DOI 10.1186/1476-072X-5-37; National Bureau of Statistics of People's Republic of China, 2008, CHIN STAT YB 2008; *OFF 2 CHIN NAT SA, 2006, HDB MAIN DAT 2 CHIN; Office of China National Sample Survey on Disability, 1987, CHIN DAT 1987 SAMPL; PASCUAL M, 2007, J SOCIO-ECON, V2, P275; PENG XZ, 2002, CHANGING POPULATION; Raina P, 1998, ANN EPIDEMIOL, V8, P402, DOI 10.1016/S1047-2797(98)00006-4; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; Sicular T, 2007, REV INCOME WEALTH, V53, P93, DOI 10.1111/j.1475-4991.2007.00219.x; Simons LA, 2000, AGE AGEING, V29, P143, DOI 10.1093/ageing/29.2.143; Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293; TAYLOR S, 2008, BMJ-BRIT MED J, V337, P290; [United Nations Department of Economic and Social Affairs Population Division Population Estimates and Projections Section], WORLD POP PROSP 2008; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Xie ZH, 2008, J INTELL DISABIL RES, V52, P1029, DOI 10.1111/j.1365-2788.2008.01048.x; Zhao ZT, 2003, HEALTH PROMOT INT, V18, P247, DOI 10.1093/heapro/dag020; Zimmer Z, 2007, J GERONTOL B-PSYCHOL, V62, pS349, DOI 10.1093/geronb/62.5.S349	31	29	29	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12129	10.1371/journal.pone.0012129	http://dx.doi.org/10.1371/journal.pone.0012129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	638AP	20730089	Green Published, gold			2022-12-27	WOS:000280862200003
J	Ledesma, MA; Ochoa, SA; Cruz, A; Rocha-Ramirez, LM; Mas-Oliva, J; Eslava, CA; Giron, JA; Xicohtencatl-Cortes, J				Ledesma, Maria A.; Ochoa, Sara A.; Cruz, Ariadnna; Rocha-Ramirez, Luz M.; Mas-Oliva, Jaime; Eslava, Carlos A.; Giron, Jorge A.; Xicohtencatl-Cortes, Juan			The Hemorrhagic Coli Pilus (HCP) of Escherichia coli O157:H7 Is an Inducer of Proinflammatory Cytokine Secretion in Intestinal Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; HEMOLYTIC-UREMIC SYNDROME; GRAM-NEGATIVE FLAGELLIN; INNATE IMMUNE-RESPONSE; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; SHIGA TOXIN; IL-8 EXPRESSION; VIBRIO-CHOLERAE; INTERLEUKIN-8 PRODUCTION	Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7, the causative agent of hemorrhagic colitis and the hemolytic uremic syndrome (HUS), produces long bundles of type IV pili (TFP) called hemorrhagic coli pili (HCP). HCP are capable of mediating several phenomena associated with pathogenicity: i) adherence to human and bovine epithelial cells; ii) invasion of epithelial cells; iii) hemagglutination of rabbit erythrocytes; iv) biofilm formation; v) twitching motility; and vi) specific binding to laminin and fibronectin. HCP are composed of a 19 kDa pilin subunit (HcpA) encoded by the hcpA chromosomal gene (called prepilin peptidase-dependent gene [ppdD] in E. coli K-12). Methodology/Principal Findings: In this study we investigated the potential role of HCP of E. coli O157:H7 strain EDL933 in activating the release of pro-and anti-inflammatory cytokines from a variety of host epithelial cells. We found that purified HCP and a recombinant HcpA protein induced significant release of IL-8 and TNF-alpha, from cultured polarized intestinal cells (T84 and HT-29 cells) and non-intestinal HeLa cells. Levels of proinflammatory IL-8 and TNF-alpha, but not IL-2, IL6, or IL-10 cytokines, were increased in the presence of HCP and recombinant HcpA after 6 h of incubation with >= 50 ng/ml of protein, suggesting that stimulation of IL-8 and TNF-alpha are dose and time-dependent. In addition, we also demonstrated that flagella are potent inducers of cytokine production. Furthermore, MAPK activation kinetics studies showed that EHEC induces p38 phosphorylation under HCP-producing conditions, and ERK1/2 and JNK activation was detectable after 3 h of EHEC infection. HT-29 cells were stimulated with epidermal growth factor stimulation of HT-29 cells for 30 min leading to activation of three MAPKs. Conclusions/Significance: The HcpA pilin monomer of the HCP produced by EHEC O157:H7 is a potent inducer of IL-8 and TNF-alpha release, an event which could play a significant role in the pathogenesis of hemorrhagic colitis caused by this pathogen.	[Ledesma, Maria A.; Ochoa, Sara A.; Cruz, Ariadnna; Rocha-Ramirez, Luz M.; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico; [Mas-Oliva, Jaime] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Eslava, Carlos A.] Univ Nacl Autonoma Mexico, Dept Salud Publ, Fac Med, Mexico City 04510, DF, Mexico; [Giron, Jorge A.] Univ Florida, Dept Mol Genet & Microbiol, Emerging Pathogens Inst, Gainesville, FL USA	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; State University System of Florida; University of Florida	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Xicohtencatl-Cortes, Juan/ABD-5463-2020		Hospital Infantil de Mexico Federico Gomez [HIM/2008/051]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [47333/A-1]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [AI66012, AI61020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI061020, R01AI066012] Funding Source: NIH RePORTER	Hospital Infantil de Mexico Federico Gomez; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants No. HIM/2008/051 from Hospital Infantil de Mexico Federico Gomez and No. 47333/A-1 from Consejo Nacional de Ciencia y Tecnologia (CONACyT) to JM-O. The project described was also supported in part by Grant Numbers AI66012 and AI61020 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) to JAG and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2002, PEDIATR NEPHROL, V17, P293, DOI 10.1007/s00467-001-0783-0; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Ebel F, 1996, INFECT IMMUN, V64, P4472, DOI 10.1128/IAI.64.11.4472-4479.1996; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Edwards RA, 1997, MOL MICROBIOL, V25, P797, DOI 10.1046/j.1365-2958.1997.5161875.x; Elewaut D, 1999, J IMMUNOL, V163, P1457; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; GUINEE PAM, 1976, INFECT IMMUN, V13, P1369; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Isogai E, 1998, INFECT IMMUN, V66, P197, DOI 10.1128/IAI.66.1.197-202.1998; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111/j.1462-2920.2006.00995.x; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Paranjpye RN, 2005, INFECT IMMUN, V73, P1411, DOI 10.1128/IAI.73.3.1411-1422.2005; Patrone JB, 2006, J IMMUNOL, V177, P1314, DOI 10.4049/jimmunol.177.2.1314; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sambrook J., 2001, MOL CLONING LAB MANU; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Savkovic SD, 2003, AM J PHYSIOL-CELL PH, V285, pC512, DOI 10.1152/ajpcell.00444.2002; Savkovic SD, 2001, AM J PHYSIOL-GASTR L, V281, pG890, DOI 10.1152/ajpgi.2001.281.4.G890; Savkovic SD, 1997, AM J PHYSIOL-CELL PH, V273, pC1160, DOI 10.1152/ajpcell.1997.273.4.C1160; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Sharma SA, 1998, J IMMUNOL, V160, P2401; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003	61	30	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12127	10.1371/journal.pone.0012127	http://dx.doi.org/10.1371/journal.pone.0012127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711431	Green Published, gold			2022-12-27	WOS:000280859700019
J	Raychaudhuri, S				Raychaudhuri, Subhadip			A Minimal Model of Signaling Network Elucidates Cell-to-Cell Stochastic Variability in Apoptosis	PLOS ONE			English	Article							DEATH; EXPRESSION; SIMULATION; GENE	Background: Signaling networks are designed to sense an environmental stimulus and adapt to it. We propose and study a minimal model of signaling network that can sense and respond to external stimuli of varying strength in an adaptive manner. The structure of this minimal network is derived based on some simple assumptions on its differential response to external stimuli. Methodology: We employ stochastic differential equations and probability distributions obtained from stochastic simulations to characterize differential signaling response in our minimal network model. Gillespie's stochastic simulation algorithm (SSA) is used in this study. Conclusions/Significance: We show that the proposed minimal signaling network displays two distinct types of response as the strength of the stimulus is decreased. The signaling network has a deterministic part that undergoes rapid activation by a strong stimulus in which case cell-to-cell fluctuations can be ignored. As the strength of the stimulus decreases, the stochastic part of the network begins dominating the signaling response where slow activation is observed with characteristic large cell-to-cell stochastic variability. Interestingly, this proposed stochastic signaling network can capture some of the essential signaling behaviors of a complex apoptotic cell death signaling network that has been studied through experiments and large-scale computer simulations. Thus we claim that the proposed signaling network is an appropriate minimal model of apoptosis signaling. Elucidating the fundamental design principles of complex cellular signaling pathways such as apoptosis signaling remains a challenging task. We demonstrate how our proposed minimal model can help elucidate the effect of a specific apoptotic inhibitor Bcl-2 on apoptotic signaling in a cell-type independent manner. We also discuss the implications of our study in elucidating the adaptive strategy of cell death signaling pathways.	Univ Calif Davis, Dept Biomed Engn, Biophys Grad Grp, Immunol Grad Grp,Grad Grp Appl Math, Davis, CA 95616 USA	University of California System; University of California Davis	Raychaudhuri, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Biophys Grad Grp, Immunol Grad Grp,Grad Grp Appl Math, Davis, CA 95616 USA.	raychaudhuri@ucdavis.edu		Raychaudhuri, Subhadip/0000-0002-9873-6475; Raychaudhuri, Subhadip/0000-0003-3426-8382	National Institutes of Health (NIH) [R01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health (NIH) R01 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Gardiner C. W., 1990, HDB STOCHASTIC METHO; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldkorn T, 2005, ANTIOXID REDOX SIGN, V7, P119, DOI 10.1089/ars.2005.7.119; GOMPERTS BD, 2003, SIGNAL TRANSDUCTION; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Luo KQ, 2003, BIOCHEM BIOPH RES CO, V304, P217, DOI 10.1016/S0006-291X(03)00559-X; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PORWITMACDONALD A, 1995, LEUKEMIA, V9, P1191; Raychaudhuri S, 2008, BIOPHYS J, V95, P3559, DOI 10.1529/biophysj.108.135483; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SKOMMER J, 2010, APOPTOSIS IN PRESS; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; WATTERS D, 1999, SIGNALING PATHWAYS A	19	35	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11930	10.1371/journal.pone.0011930	http://dx.doi.org/10.1371/journal.pone.0011930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711445	Green Published, Green Submitted, gold			2022-12-27	WOS:000280849100002
J	Norgate, M; Boyd-Gerny, S; Simonov, V; Rosa, MGP; Heard, TA; Dyer, AG				Norgate, Melanie; Boyd-Gerny, Skye; Simonov, Vera; Rosa, Marcello G. P.; Heard, Tim A.; Dyer, Adrian G.			Ambient Temperature Influences Australian Native Stingless Bee (Trigona carbonaria) Preference for Warm Nectar	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; FLIGHT METABOLIC-RATE; POLLINATION; FLOWERS; THERMOREGULATION; BUMBLEBEES; DROSOPHILA; COLOR; MICROCLIMATE; HYMENOPTERA	The interaction between flowers and insect pollinators is an important aspect of the reproductive mechanisms of many plant species. Several laboratory and field studies indicate that raising flower temperature above ambient can be an advantage in attracting pollinators. Here we demonstrate that this preference for warmer flowers is, in fact, context-dependent. Using an Australian native bee as a model, we demonstrate for the first time a significant shift in behaviour when the ambient temperature reaches 34 degrees C, at which point bees prefer ambient temperature nectar over warmer nectar. We then use thermal imaging techniques to show warmer nectar maintains the flight temperature of bees during the period of rest on flowers at lower ambient temperatures but the behavioural switch is associated with the body temperature rising above that maintained during flight. These findings suggest that flower-pollinator interactions are dependent upon ambient temperature and may therefore alter in different thermal environments.	[Norgate, Melanie; Boyd-Gerny, Skye; Simonov, Vera] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Rosa, Marcello G. P.; Dyer, Adrian G.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Heard, Tim A.] CSIRO Entomol, Indooroopilly, Qld, Australia	Monash University; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	adrian.dyer@monash.edu	Heard, Tim/Q-7304-2019; Rosa, Marcello G/D-9278-2013; Heard, Tim A/B-1125-2008	Heard, Tim/0000-0003-4975-7314; Rosa, Marcello G/0000-0002-6620-6285; Heard, Tim A/0000-0003-4975-7314	Australian Research Council (ARC) [DP0772837, DP0878968]	Australian Research Council (ARC)(Australian Research Council)	Melanie Norgate is supported by the Australian Research Council (ARC http://www.arc.gov.au/) DP0772837. Adrian Dyer and Marcello Rosa are supported by ARC DP0878968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH FG, 1985, INSECTS FLOWERS BIOL, P1; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Choi HY, 2008, FIBER POLYM, V9, P355, DOI 10.1007/s12221-008-0057-6; COELHO JR, 1991, PHYSIOL ZOOL, V64, P823, DOI 10.1086/physzool.64.3.30158209; Comba L, 2000, PLANT CELL ENVIRON, V23, P639, DOI 10.1046/j.1365-3040.2000.00580.x; COOPER PD, 1985, J EXP BIOL, V114, P1; CORBET SA, 1978, ECOL ENTOMOL, V3, P25, DOI 10.1111/j.1365-2311.1978.tb00900.x; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARDER LD, 1986, OECOLOGIA, V69, P309, DOI 10.1007/BF00377639; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; HEARD TA, 1988, J AUST ENTOMOL SOC, V27, P303; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; HEARD TA, 1993, AUST J ZOOL, V41, P343, DOI 10.1071/ZO9930343; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; HEINRICH B, 1980, J EXP BIOL, V85, P61; HEINRICH B, 1979, J EXP BIOL, V80, P217; Heinrich B., 1979, BUMBLEBEE EC; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Kevan P.G., 1984, P607; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; Kevan PG, 2001, J EXP BIOL, V204, P2571; KINGSOLVER JG, 1983, ECOLOGY, V64, P534, DOI 10.2307/1939973; Lotz CN, 2003, J COMP PHYSIOL B, V173, P455, DOI 10.1007/s00360-003-0346-8; McKee J, 1998, BOT J LINN SOC, V128, P369; MICHENER CD, BEES WORLD; MOLGAARD P, 1989, ARCTIC ALPINE RES, V21, P83, DOI 10.2307/1551519; MORITZ RFA, 1988, EXPERIENTIA, V44, P1024, DOI 10.1007/BF01939912; Patino S, 2002, PLANT CELL ENVIRON, V25, P41, DOI 10.1046/j.0016-8025.2001.00801.x; Pereboom JJM, 2003, OECOLOGIA, V137, P42, DOI 10.1007/s00442-003-1324-2; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Reisenman CE, 2008, ARTHROPOD-PLANT INTE, V2, P137, DOI 10.1007/s11829-008-9041-8; Seymour RS, 1998, PHILOS T ROY SOC B, V353, P935, DOI 10.1098/rstb.1998.0258; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Seymour RS, 2001, BIOSCIENCE REP, V21, P223, DOI 10.1023/A:1013608627084; Sokal R. R, 1981, BIOMETRY; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Whitney HM, 2008, NATURWISSENSCHAFTEN, V95, P845, DOI 10.1007/s00114-008-0393-9; Woods WA, 2005, J EXP BIOL, V208, P1161, DOI 10.1242/jeb.01510	49	42	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12000	10.1371/journal.pone.0012000	http://dx.doi.org/10.1371/journal.pone.0012000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711250	Green Published, Green Submitted, gold			2022-12-27	WOS:000280776800003
J	Ioannoni, R; Beaudoin, J; Mercier, A; Labbe, S				Ioannoni, Raphael; Beaudoin, Jude; Mercier, Alexandre; Labbe, Simon			Copper-Dependent Trafficking of the Ctr4-Ctr5 Copper Transporting Complex	PLOS ONE			English	Article							ZRT1 ZINC TRANSPORTER; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FLUORESCENCE COMPLEMENTATION; BIOCHEMICAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; STIMULATED ENDOCYTOSIS; VACUOLAR DEGRADATION; YEAST; GENE	Background: In Schizosaccharomyces pombe, copper uptake is carried out by a heteromeric complex formed by the Ctr4 and Ctr5 proteins. Copper-induced differential subcellular localization may play a critical role with respect to fine tuning the number of Ctr4 and Ctr5 molecules at the cell surface. Methodology/Principal Findings: We have developed a bimolecular fluorescence complementation (BiFC) assay to analyze protein-protein interactions in vivo in S. pombe. The assay is based on the observation that N- and C-terminal subfragments of the Venus fluorescent protein can reconstitute a functional fluorophore only when they are brought into tight contact. Wild-type copies of the ctr4(+) and ctr5(+) genes were inserted downstream of and in-frame with the nonfluorescent C-terminal (VC) and N- terminal (VN) coding fragments of Venus, respectively. Co-expression of Ctr4-VC and Ctr5-VN fusion proteins allowed their detection at the plasma membrane of copper-limited cells. Similarly, cells co-expressing Ctr4-VN and Ctr4-VC in the presence of Ctr5-Myc(12) displayed a fluorescence signal at the plasma membrane. In contrast, Ctr5-VN and Ctr5-VC co-expressed in the presence of Ctr4-Flag(2) failed to be visualized at the plasma membrane, suggesting a requirement for a combination of two Ctr4 molecules with one Ctr5 molecule. We found that plasma membrane-located Ctr4-VC-Ctr5-VN fluorescent complexes were internalized when the cells were exposed to high levels of copper. The copper-induced internalization of Ctr4-VC-Ctr5-VN complexes was not dependent on de novo protein synthesis. When cells were transferred back from high to low copper levels, there was reappearance of the BiFC fluorescent signal at the plasma membrane. Significance: These findings reveal a copper-dependent internalization and recycling of the heteromeric Ctr4-Ctr5 complex as a function of copper availability.	[Ioannoni, Raphael; Beaudoin, Jude; Mercier, Alexandre; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Ioannoni, R (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research (CIHR) [MOP-36450]	Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	R.I. is the recipient of studentships from the Foundation of Stars for Children's Health Research and the Natural Sciences and Engineering Research Council of Canada. A.M. (Ph.D. student) and S.L. (Senior investigator) are recipients of scholarships from the Fonds de la Recherche en Sante du Quebec (FRSQ). This study was supported by a Canadian Institutes of Health Research (CIHR, http://www.cihr.ca/e/193.html) grant (MOP-36450) awarded to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST L, P186; Allen LE, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/01/006; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; KEENEY JB, 1994, GENETICS, V136, P849; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	41	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11964	10.1371/journal.pone.0011964	http://dx.doi.org/10.1371/journal.pone.0011964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694150	Green Submitted, Green Published, gold			2022-12-27	WOS:000280574300015
J	Kelly, WJ; Leahy, SC; Altermann, E; Yeoman, CJ; Dunne, JC; Kong, ZH; Pacheco, DM; Li, D; Noel, SJ; Moon, CD; Cookson, AL; Attwood, GT				Kelly, William J.; Leahy, Sinead C.; Altermann, Eric; Yeoman, Carl J.; Dunne, Jonathan C.; Kong, Zhanhao; Pacheco, Diana M.; Li, Dong; Noel, Samantha J.; Moon, Christina D.; Cookson, Adrian L.; Attwood, Graeme T.			The Glycobiome of the Rumen Bacterium Butyrivibrio proteoclasticus B316(T) Highlights Adaptation to a Polysaccharide-Rich Environment	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; CLOSTRIDIUM-PROTEOCLASTICUM; KYOTO ENCYCLOPEDIA; RUMINAL BACTERIUM; COLONIZATION; FIBRISOLVENS; DIVERSITY; STRAINS; FERMENTATION; METABOLISM	Determining the role of rumen microbes and their enzymes in plant polysaccharide breakdown is fundamental to understanding digestion and maximising productivity in ruminant animals. Butyrivibrio proteoclasticus B316(T) is a Gram-positive, butyrate-forming rumen bacterium with a key role in plant polysaccharide degradation. The 4.4Mb genome consists of 4 replicons; a chromosome, a chromid and two megaplasmids. The chromid is the smallest reported for all bacteria, and the first identified from the phylum Firmicutes. B316 devotes a large proportion of its genome to the breakdown and reassembly of complex polysaccharides and has a highly developed glycobiome when compared to other sequenced bacteria. The secretion of a range of polysaccharide-degrading enzymes which initiate the breakdown of pectin, starch and xylan, a subtilisin family protease active against plant proteins, and diverse intracellular enzymes to break down oligosaccharides constitute the degradative capability of this organism. A prominent feature of the genome is the presence of multiple gene clusters predicted to be involved in polysaccharide biosynthesis. Metabolic reconstruction reveals the absence of an identifiable gene for enolase, a conserved enzyme of the glycolytic pathway. To our knowledge this is the first report of an organism lacking an enolase. Our analysis of the B316 genome shows how one organism can contribute to the multi-organism complex that rapidly breaks down plant material in the rumen. It can be concluded that B316, and similar organisms with broad polysaccharide-degrading capability, are well suited to being early colonizers and degraders of plant polysaccharides in the rumen environment.	[Kelly, William J.; Leahy, Sinead C.; Altermann, Eric; Yeoman, Carl J.; Dunne, Jonathan C.; Kong, Zhanhao; Pacheco, Diana M.; Li, Dong; Noel, Samantha J.; Moon, Christina D.; Cookson, Adrian L.; Attwood, Graeme T.] Grasslands Res Ctr, Palmerston North, New Zealand; [Yeoman, Carl J.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Dunne, Jonathan C.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Dunne, Jonathan C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Massey University; Victoria University Wellington; Victoria University Wellington	Kelly, WJ (corresponding author), Grasslands Res Ctr, Palmerston North, New Zealand.	graeme.attwood@agresearch.co.nz	Cookson, Adrian/R-6617-2019; Noel, Samantha/AAM-4090-2021; Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Leahy, Sinead/0000-0002-5461-6738; Attwood, Graeme Trevor/0000-0002-6443-8760; Moon, Christina/0000-0001-9692-9559; Altermann, Eric/0000-0003-1376-1549	New Zealand Foundation for Research Science and Technology [C10X0314]; Tertiary Education Commission; Meat and Wool New Zealand	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Tertiary Education Commission; Meat and Wool New Zealand	This work was supported by the New Economy Research Fund of the New Zealand Foundation for Research Science and Technology (Contract C10X0314), and by an Enterprise Scholarship provided jointly by the Tertiary Education Commission and Meat and Wool New Zealand to CJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Attwood GT, 1996, INT J SYST BACTERIOL, V46, P753, DOI 10.1099/00207713-46-3-753; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Colombatto D, 2009, J ANIM SCI, V87, P1097, DOI 10.2527/jas.2008-1262; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Edwards JE, 2007, FEMS MICROBIOL ECOL, V62, P323, DOI 10.1111/j.1574-6941.2007.00392.x; Eun JS, 2005, J DAIRY SCI, V88, P2140, DOI 10.3168/jds.S0022-0302(05)72890-3; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; HESPELL RB, 1993, CAN J MICROBIOL, V39, P912, DOI 10.1139/m93-139; Jun HS, 2007, ASIAN AUSTRAL J ANIM, V20, P802, DOI 10.5713/ajas.2007.802; Kalmokoff ML, 2000, ANAEROBE, V6, P93, DOI 10.1006/anae.1999.0308; Kim EJ, 2005, J DAIRY SCI, V88, P3220, DOI 10.3168/jds.S0022-0302(05)73005-8; KISTNER A, 1973, CAN J MICROBIOL, V19, P1119, DOI 10.1139/m73-178; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Larue R, 2005, ENVIRON MICROBIOL, V7, P530, DOI 10.1111/j.1462-2920.2005.00721.x; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Liu YS, 2009, CELLULOSE, V16, P587, DOI 10.1007/s10570-009-9306-0; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Ludwig W., 2008, REVISED ROAD MAP PHY; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Moon CD, 2008, INT J SYST EVOL MICR, V58, P2041, DOI 10.1099/ijs.0.65845-0; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Paillard D, 2007, J APPL MICROBIOL, V103, P1251, DOI 10.1111/j.1365-2672.2007.03349.x; Ramsay AG, 2006, MICROBIOL-SGM, V152, P3281, DOI 10.1099/mic.0.29233-0; Reilly K, 1998, APPL ENVIRON MICROB, V64, P907; Russell JB, 1998, J ANIM SCI, V76, P1955; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SEWELL GW, 1988, APPL ENVIRON MICROB, V54, P1085, DOI 10.1128/AEM.54.5.1085-1090.1988; Shimoyama T, 2009, SCIENCE, V323, P1574, DOI 10.1126/science.1170086; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; STACK RJ, 1988, APPL ENVIRON MICROB, V54, P878, DOI 10.1128/AEM.54.4.878-883.1988; Staden R, 2000, Methods Mol Biol, V132, P115; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Wallace RJ, 2006, FEMS MICROBIOL LETT, V265, P195, DOI 10.1111/j.1574-6968.2006.00487.x	54	60	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11942	10.1371/journal.pone.0011942	http://dx.doi.org/10.1371/journal.pone.0011942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689770	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520500007
J	Fautin, D; Dalton, P; Incze, LS; Leong, JAC; Pautzke, C; Rosenberg, A; Sandifer, P; Sedberry, G; Tunnell, JW; Abbott, I; Brainard, RE; Brodeur, M; Eldredge, LG; Feldman, M; Moretzsohn, F; Vroom, PS; Wainstein, M; Wolff, N				Fautin, Daphne; Dalton, Penelope; Incze, Lewis S.; Leong, Jo-Ann C.; Pautzke, Clarence; Rosenberg, Andrew; Sandifer, Paul; Sedberry, George; Tunnell, John W., Jr.; Abbott, Isabella; Brainard, Russell E.; Brodeur, Melissa; Eldredge, Lucius G.; Feldman, Michael; Moretzsohn, Fabio; Vroom, Peter S.; Wainstein, Michelle; Wolff, Nicholas			An Overview of Marine Biodiversity in United States Waters	PLOS ONE			English	Review							INTERACTIONS SBI PROJECT; SOUTHEASTERN BERING-SEA; FRENCH-FRIGATE-SHOALS; CLIMATE-CHANGE; NORTH PACIFIC; CORAL-REEFS; COMMUNITY STRUCTURE; CAMPECHE BANK; COBSCOOK BAY; GEORGES BANK	Marine biodiversity of the United States (U.S.) is extensively documented, but data assembled by the United States National Committee for the Census of Marine Life demonstrate that even the most complete taxonomic inventories are based on records scattered in space and time. The best-known taxa are those of commercial importance. Body size is directly correlated with knowledge of a species, and knowledge also diminishes with distance from shore and depth. Measures of biodiversity other than species diversity, such as ecosystem and genetic diversity, are poorly documented. Threats to marine biodiversity in the U.S. are the same as those for most of the world: overexploitation of living resources; reduced water quality; coastal development; shipping; invasive species; rising temperature and concentrations of carbon dioxide in the surface ocean, and other changes that may be consequences of global change, including shifting currents; increased number and size of hypoxic or anoxic areas; and increased number and duration of harmful algal blooms. More information must be obtained through field and laboratory research and monitoring that involve innovative sampling techniques (such as genetics and acoustics), but data that already exist must be made accessible. And all data must have a temporal component so trends can be identified. As data are compiled, techniques must be developed to make certain that scales are compatible, to combine and reconcile data collected for various purposes with disparate gear, and to automate taxonomic changes. Information on biotic and abiotic elements of the environment must be interactively linked. Impediments to assembling existing data and collecting new data on marine biodiversity include logistical problems as well as shortages in finances and taxonomic expertise.	[Fautin, Daphne] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Dalton, Penelope; Wainstein, Michelle] Univ Washington, Seattle, WA 98195 USA; [Incze, Lewis S.; Wolff, Nicholas] Univ So Maine, Aquat Syst Grp, Portland, ME 04103 USA; [Leong, Jo-Ann C.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Pautzke, Clarence] N Pacific Res Board, Anchorage, AK USA; [Rosenberg, Andrew] Conservat Int, Arlington, VA USA; [Sandifer, Paul] Natl Ocean & Atmospher Adm, Hollings Marine Lab, Charleston, SC USA; [Sedberry, George] Grays Reef Natl Marine Sanctuary, Savannah, GA USA; [Tunnell, John W., Jr.; Moretzsohn, Fabio] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA; [Abbott, Isabella] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Brainard, Russell E.] Natl Ocean & Atmospher Adm Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Brodeur, Melissa; Feldman, Michael] Consortium Ocean Leadership, Washington, DC USA; [Eldredge, Lucius G.] Bernice P Bishop Museum, Honolulu, HI USA; [Vroom, Peter S.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	University of Kansas; University of Washington; University of Washington Seattle; University of Maine System; University of Southern Maine; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Texas A&M University System; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System	Fautin, D (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	fautin@ku.edu	Moretzsohn, Fabio/B-8142-2012; Leong, Jo-Ann/ABE-1443-2021	Wolff, Nicholas/0000-0003-1162-3556	Alfred P. Sloan Foundation; National Oceanic and Atmospheric Administration; Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi; National Centers for Coastal Ocean Science of NOAA	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi; National Centers for Coastal Ocean Science of NOAA	The Census of Marine Life U.S. National Committee (USNC) receives funding from the Alfred P. Sloan Foundation and the National Oceanic and Atmospheric Administration's Ocean Exploration and Research Program. Authors of the Northeast Continental Shelf Large Marine Ecosystem section gratefully acknowledge support from the Alfred P. Sloan Foundation through the Census of Marine Life Program. Initial funding for the project the Gulf of Mexico Large Marine Ecosystem section was based on was provided by the Harte Research Institute for Gulf of Mexico Studies at Texas A&M University-Corpus Christi. Later funding was provided by the National Centers for Coastal Ocean Science of NOAA and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I.A., 1999, MARINE RED ALGAE HAW; Abbott IA, 2004, MARINE GREEN BROWN A; ACIA, 2005, ARCT CLIM IMP ASS SC; *ACTC COUNC, 2009, ARCT MAR SHIPP ASS 2; AGASSIZ A, 1888, GULF MEXICO CARIBBEA, V1, P1; AINLEY DG, 1993, BEACHED MARINE BIRDS; Anderson, 2007, FORMATION FUTURE UPP; Andriashev A.P., 1995, VOP IKHTIOL, V35, P81; ANGLISS RP, 2009, NMFSAFSC193 US DEP C; [Anonymous], 2009, NOAATMNMFSSWFSC447; Archer A. W., 2003, GEOL SOC AM SPEC PAP, V370, P151, DOI DOI 10.1130/0-8137-2370-1.151; Arreguin-Sanchez F, 2000, REV BIOL TROP, V48, P323; ARREGUINSANCHEZ F, 1996, BIOL FISHERIES CULTU, P202; Atkinson LP, 1985, OCEANOGRAPHY SE US C; ATLAS RM, 1986, GULF ALASKA PHYSICAL, P221; Auster P. J, 2007, BIOREGIONAL CLASSIFI; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Azarovitz T. R., 1981, BOTTOM TRAWL SURVEYS, P62; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benson AJ, 2001, J SHELLFISH RES, V20, P21; Bigelow H.B., 1927, B US BUR FISH, V40, P511; Bigelow H.B., 1926, B BUR FISH WASH, V40, P1; BIGELOW HB, 1964, MEMOIR SEARS FDN MAR, V1; BIGELOW HB, 1953, FISH B US FISH WILDL, V74; BIGELOW HB, 1925, FISHES GULF MAINE; BLAKE JA, 1994, DEEP-SEA RES PT II, V41, P835, DOI 10.1016/0967-0645(94)90051-5; Bluhm BA, 2010, DEEP-SEA RES PT II, V57, P1, DOI 10.1016/j.dsr2.2009.08.001; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; BLUHM BA, 2008, BIOL UNSERER ZEIT, V38, P40; BLUHM BA, SEA ICE IN PRESS; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Bluhm BA, 2007, POLAR BIOL, V30, P1557, DOI 10.1007/s00300-007-0316-9; Botello AV, 2005, GOLFO MEXICO CONTAMI; BRAINARD R, 2009, 11 PAC SCI INT C PAP; BRAINARD RE, 2007, CR07007 NOAA PIFSC; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BROOKS J, 2008, 1 OCS MMS US DEP INT; Brown H, 2005, CONT SHELF RES, V25, P143, DOI 10.1016/j.csr.2004.07.028; BROWN WS, 1993, J MAR RES, V51, P53, DOI 10.1357/0022240933223828; BRUNEL P, 1998, PUBL SPEC CAN SCI HA, V126, P405; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; Burton ML, 2005, FISH B-NOAA, V103, P404; BYRNE CJ, 1981, BOTTOM TRAWL SURVEYS, P258; CAIRNS S D, 1984, Occasional Papers Bernice P. Bishop Museum, V25, P1; Calabretta CJ, 2008, MAR POLLUT BULL, V56, P1680, DOI 10.1016/j.marpolbul.2008.07.012; Carlton J.T., 2007, LIGHT SMITH MANUAL I, V4th ed. Berkeley, CA:; CARNEY RS, 1993, 930041 OCS MMS US DE; Carpenter KE, 2002, LIVING MARINE RESOUR; Carroll ML, 2003, BIOGEOCHEMISTRY MARI; Caruso JH, 2007, J FISH BIOL, V70, P1015, DOI 10.1111/j.1095-8649.2007.01360.x; Casazza TL, 2008, FISH B-NOAA, V106, P348; Caso M., 2004, DIAGNOSTICO AMBIENTA, V1; Catesby Mark, 1771, NATURAL HIST CAROLIN; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; CHAPMAN AS, 2008, GEOLOGICAL SURVEY CA, V5685, P47; CLAESSON SH, 2009, STELLWAGEN BANK MARI; COE WR, 2010, HARRIMAN ALASKA SERI, V11; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Collette B. B, 2002, BIGELOW SCHROEDERS F, V3rd; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Conklin KY, 2009, J PHYCOL, V45, P2; CONKLIN KY, 2009, J APPL PHYCOL ONLINE; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Cooney R. T., 1981, E BERING SEA SHELF O, V2, P947; COONEY RT, 1986, GULF ALASKA PHYS ENV, P285; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; Coyle K.O., 1996, P97; Coyle KO, 2005, DEEP-SEA RES PT II, V52, P217, DOI 10.1016/j.dsr2.2004.09.025; Coyle KO, 2003, FISH OCEANOGR, V12, P327, DOI 10.1046/j.1365-2419.2003.00256.x; Crandall Frank B., 2001, P1; *CSA INT INC, 2007, 2007044 OCS MMS US D; Dame R, 2000, ESTUARIES, V23, P793, DOI 10.2307/1352999; DARNELL RM, 1990, AM ZOOL, V30, P3; DAVIS RW, 2000, USGSBRDCR19990006, V2; Delegates of theWorld Conference onMarine Biodiversity,, 2008, VAL DECL PLEA PROT M; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; Dextrase AJ, 2006, BIOL INVASIONS, V8, P13, DOI 10.1007/s10530-005-0232-2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dunton Kenneth H., 2000, P371, DOI 10.1016/B978-012701235-3/50020-9; Edmondson C. H., 1933, Bishop Museum Special Publication Honolulu, V22; EDMONDSON CH, 1949, SEASHORE TREASURERS; EDMONDSON CH, 1925, TANAGER EXPEDITION P, V1; EDMONSON CH, 1946, BP BISHOP MUSEUM SPE, V22, P381; ELDREDGE LG, 1993, BISHOP MUSEUM OCCASI, V76, P1; ESCHMEYER WN, 1998, CATALOG FISHES, V2; Fahay M.P., 1983, J NW ATLANTIC FISHER, V4, P423; Feder HM, 2005, POLAR BIOL, V28, P402, DOI 10.1007/s00300-004-0683-4; Feder HM, 2007, POLAR BIOL, V30, P261, DOI 10.1007/s00300-006-0180-z; Felder D. L., 2009, GULF MEXICO ORIGIN W, V1, P1; Fenner D, 2004, CORAL REEFS, V23, P505, DOI 10.1007/s00338-004-0422-x; Fenner D., 2005, CORALS HAWAII FIELD; FIELDING A, 1987, UNDERWATER GUIDE HAW; FIORE CL, 2006, THESIS COLL CHARLEST; Firing June, 2006, Atoll Research Bulletin, P347; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; FOSTER NR, 2003, DATABASE MARINE INVE; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FRIEDLANDER AM, 2008, STATUS CORAL REEFS W; Gagaev SY, 2008, RUSS J MAR BIOL+, V34, P73, DOI 10.1134/S1063074008010100; GALTSOFF PS, 1954, US FISH WLD S FISH B, V55, P604; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gill R.E., 1981, E BERING SEA SHELF O, V2, P719; GODWIN S, 2008, MARINE INVERTEBRATE; GOODE GB, 1896, B US NAT MUS, V2, P553; Gosline W.A., 1960, HDB HAWAIIAN FISHES; GRACE MA, 2001, NOAA TECH REP NMFS, V153, P32; GRADINGER R, DEEP SEA 2 IN PRESS; GRADINGER R, LIFE WORLDS IN PRESS; GRADINGER R, 2005, 2005062 OCS MMS U AL; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2009, DEEP-SEA RES PT II, V56, P1137, DOI 10.1016/j.dsr2.2009.03.001; Grebmeier JM, 2005, DEEP-SEA RES PT II, V52, P3109, DOI 10.1016/j.dsr2.2005.10.004; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Greene CH, 2003, LIMNOL OCEANOGR, V48, P319, DOI 10.4319/lo.2003.48.1.0319; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Gulf of Mexico Alliance, 2006, GOV ACT PLAN HLTH RE; Hale SS, 2002, ECOLOGY, V83, P2942; Hale SS, 2008, ECOL INDIC, V8, P338, DOI 10.1016/j.ecolind.2007.04.004; Harasewych MG, 2006, NAUTILUS, V120, P39; HARE JA, NOAA CONS S IN PRESS; HARPER DEJ, 1991, 910063 OCS MMS US DE, V2; HARRISON P., 1983, SEABIRDS IDENTIFICAT; HATHAWAY JC, 1971, 7115 USGS, V2; Hawkins JP, 2000, ANIM CONSERV, V3, P81, DOI 10.1111/j.1469-1795.2000.tb00089.x; Hayes Derek, 2001, HIST ATLAS N PACIFIC; HEARD RW, 2007, NOAA PROFESSIONAL PA, V8, P30; Heifetz J, 2005, FISH OCEANOGR, V14, P131, DOI 10.1111/j.1365-2419.2005.00371.x; HERNANDEZ DF, 2005, EPOMEX C, V7, P496; Hester KC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034913; Hicks DW, 2002, MAR BIOL, V140, P1167, DOI 10.1007/s00227-002-0787-8; HICKS DW, 1995, AM MALACOL BULL, V11, P203; HICKS DW, 1993, VELIGER, V36, P92; Hodge Robert Parker, 2000, Herpetological Review, V31, P148; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holthuis L. B., 2006, HAWAIIS FISHES GUIDE; Hood D. W., 1986, GULF ALASKA PHYS ENV, P417; Hoover J. P., 1999, HAWAIIS SEA CREATURE; Hoover JP, 2008, ULTIMATE GUIDE HAWAI; Hopcroft R, 2008, ARCTIC OCEAN SYNTHES; HOPCROFT RR, 2002, SPINELESS WONDERS PE; HOPKINS TS, 1981, J MAR RES, V39, P465; Horner R., 1985, SEA ICE BIOTA; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; HUISMAN JM, 2006, HAWAIIAN REEF PLANTS; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Hunt GL, 1981, E BERING SEA SHELF O, P689; IKEN K, 2009, ESSENTIAL HABITATS O; IKEN K, 2003, P ARCT BIOD WORKSH N; JAY VJ, 2008, DISTRIBUTIONAL RESPO; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jennings RM, 2009, J HERED, V100, P86, DOI 10.1093/jhered/esn067; JEWETT SC, 1981, E BERING SEA SHELF O, V2, P1131; *JOCI, 2009, CHANG OC CHANG WORLD; JOKIEL PL, 1987, TRENDS ECOL EVOL, V2, P179, DOI 10.1016/0169-5347(87)90016-4; JORDAN DS, 1905, B US FISH COMMISSION; JUVIK SP, 1998, ATLAS HAWAII; Kaufman L, 1986, HDB PERCEPTION HUMAN, Vfirst, P1; Kawai H, 2008, J PHYCOL, V44, P1013, DOI 10.1111/j.1529-8817.2008.00548.x; Kay E.A., 1979, BP BISHOP MUSEUM SPE, V64, P1; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Konar B, 2006, BOT MAR, V49, P355, DOI 10.1515/BOT.2006.044; Konar B, 2009, PHYCOLOGIA, V48, P24, DOI 10.2216/08-12.1; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; KOSOBOKOVA KN, DEEP SEA 2 IN PRESS; Kozloff EN, 1996, MARINE INVERTEBRATES; Kraft GT, 2004, J PHYCOL, V40, P383, DOI 10.1111/j.1529-8817.2004.03115.x; Kramer KL, 2007, MAR ECOL PROG SER, V349, P111, DOI 10.3354/meps07083; Kumpf H., 1999, GULF MEXICO LARGE MA; Ladd C, 2005, FISH OCEANOGR, V14, P22, DOI 10.1111/j.1365-2419.2005.00373.x; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lamb A, 2005, MARINE LIFE PACIFIC; Lamb A., 1986, COASTAL FISHES PACIF; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lane PVZ, 2008, J MARINE SYST, V70, P97, DOI 10.1016/j.jmarsys.2007.04.001; Larsen PF, 2004, NORTHEAST NAT, V11, P13, DOI 10.1656/1092-6194(2004)11[13:NOTESA]2.0.CO;2; Lehnert RL, 2002, ESTUARIES, V25, P1015, DOI 10.1007/BF02691348; LEONG H, 2005, MARINE SYSTEMS ARCTI; Lindstrom SC, 2006, J APPL PHYCOL, V18, P637, DOI 10.1007/s10811-006-9076-0; Lindstrom SC, 2009, J BIOGEOGR, V36, P401, DOI 10.1111/j.1365-2699.2007.01855.x; LITWIN TS, 2005, HARRIMAN ALASKA EXPE; Logerwell EA, 2005, FISH OCEANOGR, V14, P93, DOI 10.1111/j.1365-2419.2005.00366.x; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Love JW, 2007, SOUTHEAST NAT, V6, P705, DOI 10.1656/1528-7092(2007)6[705:MFDACI]2.0.CO;2; MACDONALD IR, DEEP SEA 2 IN PRESS; Macklin S. A, 2004, NOAA COASTAL OCEAN P, V24; Magurran A.E, 2003, MEASURING BIOL DIVER; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Maragos J.E., 1977, Bernice P. Bishop Museum Special Publication, V64, P158; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; MARAGOS JE, 1995, MARINE COASTAL BIODI, V1; Martin JW, 2009, ZOOTAXA, P53; Martin JW, 2009, ZOOTAXA, P25; McCauley DJ, 2006, NATURE, V443, P27, DOI 10.1038/443027a; MCKAY M, 2001, GULF MEX MAR PROT SP; McLeod K., 2009, ECOSYSTEM BASED MANA; Mecklenburg Catherine W., 2007, Northwestern Naturalist, V88, P168, DOI 10.1898/1051-1733(2007)88[168:RLCOTA]2.0.CO;2; MECKLENBURG CW, 2008, ARCTIC OCEAN SYNTHES; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Metcalf V, 2008, ECOL APPL, V18, pS148, DOI 10.1890/06-0642.1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller G.C., 1980, Proceedings of the Gulf and Caribbean Fisheries Institute, V32, P114; Motoda S., 1974, OCEANOGRAPHY BERING, P207; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Mundy B. M., 2005, BISHOP MUSEUM B ZOOL, V6, P704; Mundy PR., 2005, GULF ALASKA BIOL OCE, P220; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; NAIDU AS, 1988, BERING CHUKCHI BEAUF; Nelson D, 1992, 10 ELMR NOAA NOS STR; Ning Z. H., 2003, PREPARING CHANGING C; Ning Zhu Hua, 2003, INTEGRATED ASSESSMEN; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; *NMSP, 2007, FLOR KEYS NAT MAR SA; *NOAA, 2008, CRUIS REP 2008 BEAUF; *NOAA, 1996, FLOR KEYS NAT MAR SA; *NOAA, 1988, W COAST N AM COAST O; *NOAA, 1991, FLOW GARD BANKS NAT; North Pacific Fisheries Management Council (NPFMC), 2008, STOCK ASS FISH EV RE; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; *NPFMC, 2009, ENV ASS REG IMP REV; *NPRB, 2005, NPRB SCI PLAN 2005; *NRC, 1996, BER SEA EC; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Obama B., 2009, MEMORANDUM HEADS EXE; ONEILL Dan, 2005, LAST GIANT BERINGIA; Orensanz J, 2004, CAL COOP OCEAN FISH, V45, P65; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; PATTILLO ME, DISTRIBUTION ABUNDAN, V2; PERRY RI, 2005, PICES SPECIAL PUBLIC, V2, P46; Piatt J.F., 2007, LONG TERM ECOLOGICAL, P522; *PICES, 2004, PICES SPEC PUBL, V1, P280; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; PIETSCH TW, 1997, AM SOC ICHTHY HERP S, V3, P409; Piraino S, 2008, J MAR BIOL ASSOC UK, V88, P1637, DOI 10.1017/S0025315408002166; POWELL AB, 1998, ICHTHYOPLANKTON ADJA; RABALAIS N, 2004, ENV ANAL GULF MEXICO; Rabalais Nancy N., 1999, P171; Ramirez-Rodriguez M, 2000, CIENC MAR, V26, P97; Randall J. E., 1995, MARINE COASTAL BIODI, V1, P193; Randall JE, 1998, ZOOL STUD, V37, P227; Randall JE, 2007, REEF SHORE FISHES HA; RASKOFF KA, DEEP SEA 2 IN PRESS; RATHBUN MJ, 1906, B US FISH COMM, V23, P827, DOI DOI 10.5962/BHL.TITLE.8992; Raven J, 2005, OCEAN ACIDIFICATION; Reed JK, 2002, HYDROBIOLOGIA, V471, P57, DOI 10.1023/A:1016593018389; Rezak R, 1972, TEXAS A M U OCEANOGR, V3, P263; Rezak R., 1985, REEFS BANKS NW GULF; Ricketts E.F., 1985, PACIFIC TIDES, VFifth; RISIEN J, 2009, W COAST REGIONAL MAR; Ritchie Kim B., 2008, MARINE SANCTUARIES C, VNMSP08- 04; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; ROBERTSON A, 2010, HARRIMAN ALASKA SERI, V11; Roe P, 2007, LIGHT SMITH MANUAL I, P182; Ross S. W., 2007, STATE DEEP CORAL ECO, P233; ROSS SW, 2002, CHECKLIST FISHES DOC; ROWE JJ, 2006, P GULF CARIB FISH I, V57, P9; *SAFMC, 1998, FIN HAB PLAN S ATL R; SANDIFER P, 2009, CONSERVING MARINE BI; SCHEUER P., 2004, MAR DRUGS, V2, P14, DOI DOI 10.3390/md201014; Schnabel KE, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2130.1.2; SEBENS KP, 1998, NOAA TECH REP NMFS, V141, P68; Sedberry George R., 2006, Proceedings of the Gulf and Caribbean Fisheries Institute, V57, P463; SEDBERRY GR, 1984, ENVIRON BIOL FISH, V11, P241, DOI 10.1007/BF00001372; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Selkoe KA, 2008, AQUAT CONSERV, V18, P1149, DOI 10.1002/aqc.961; SHERMAN K, 1993, LARGE MARINE ECOSYSTEMS, P3; Sherman K., 2004, NOAA FISHERIES SERVI; SHERWOOD AR, 2007, J PHYCOL S, V17; Sirenko B., 2001, EXPLORATIONS FAUNA S, V51; Sirenko BI, 2007, RUSS J MAR BIOL+, V33, P355, DOI 10.1134/S1063074007060016; Sirenko B. I., 2009, EXPLORATIONS FAUNA S, V61, P1; SIRENKO BI, 1994, BERICHTE POLARFORSCH, V144, P69; Smith WO, 2007, ELSEV OCEANOGR SERIE, V74, P1; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; SPIES RB, 2007, LONGT EC CHANG NO, P1; SPRINGER A, 2008, FINAL REPORT PROJECT; Stabeno PJ, 2008, DEEP-SEA RES PT II, V55, P1701, DOI 10.1016/j.dsr2.2008.03.006; STALLCUP R, 1994, OCEAN BIRDS N PACIFI; STEIMLE FW, 1995, MAR FISH REV, V57, P1; STOKER S., 1978, THESIS U ALASKA FAIR; Stroeve J, 2007, GEOPHYS RES LETT, V34; STURGES W, 2007, CIRCULATION GULF MEX; SWINGLE WE, 1990, RED DRUM AQUACULTURE, P22; TABRAH FL, 1970, SCIENCE, V170, P181, DOI 10.1126/science.170.3954.181; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; The National Science and Technology Council, 2003, ASS COAST HYP EUTR U; Theroux R.B., 1987, P283; THEROUX RB, 1998, QUANTITATIVE COMPOSI, P240; Thorsteinson LK, 2002, FISHES ALASKA; TOWNSEND DW, 2006, OCEANOGRAPHY NW ATLA, P119; Trott TJ, 2004, NORTHEAST NAT, V11, P261, DOI 10.1656/1092-6194(2004)11[261:CBIAHC]2.0.CO;2; Tunnel J.W., 1992, P 7 INT COR REEF S U, V1, P300; Tunnell J.W., 2007, CORAL REEFSO GULF; Tunnell J. W., 2002, LAGUNA MADRE TEXAS T; Tunnell Jr JW, 2009, OCEAN ILLUSTRATED AT, P136; TWILLEY RR, 2004, CONFRONTING CLIMATE; Upchurch S, 2008, J COASTAL RES, P200; *USCOP, 2004, OC BLUEPR 21 CENT FI; USHER MB, 2005, PRINCIPLES CONSERVIN; Vassilenko SV, 2009, ILLUSTRATED KEYS FRE, V1; VAUGHAN TW, 1907, B US NAT MUS, V59, P222; Verbruggen H, 2006, EUR J PHYCOL, V41, P337, DOI 10.1080/09670260600709315; Verrill A.E., 1914, MONOGRAPH SHALLOW WA, DOI [10.1126/science.40.1032.523, DOI 10.1126/SCIENCE.40.1032.523]; von Quillfeldt CH, 2003, POLAR BIOL, V26, P806, DOI 10.1007/s00300-003-0549-1; VONGRAVEN D, 2008, BACKGROUND PAPER CIR; Vroom PS, 2006, AM SCI, V94, P430, DOI 10.1511/2006.61.1004; Vroom PS, 2009, J PHYCOL, V45, P337, DOI 10.1111/j.1529-8817.2009.00666.x; Vroom PS, 2006, PAC SCI, V60, P81, DOI 10.1353/psc.2005.0063; Vroom PS, 2005, PHYCOLOGIA, V44, P572, DOI 10.2216/0031-8884(2005)44[572:DASNCR]2.0.CO;2; Vroom PS, 2004, PHYCOLOGIA, V43, P445, DOI 10.2216/i0031-8884-43-4-445.1; Vroom PS, 2004, PHYCOLOGIA, V43, P68, DOI 10.2216/i0031-8884-43-1-66.1; Walsh JJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002813; Wares JP, 2002, MOL ECOL, V11, P1131, DOI 10.1046/j.1365-294X.2002.01510.x; WATERS JR, 2003, REV U S COMMERCIAL R; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WENNER CA, 1983, FISH B-NOAA, V81, P537; WENNER CA, 1989, SPECIES COMPOSITION; WENNER EL, 1983, ESTUAR COAST SHELF S, V17, P143, DOI 10.1016/0272-7714(83)90059-8; Wenner EL, 1984, TEMPORAL SPATIAL STU; Wiencke C., 2007, Reviews in Environmental Science and Bio/Technology, V6, P95, DOI 10.1007/s11157-006-9106-z; WIGLEY RL, 1981, 529N GEOL SURV; WILIMOVSKY NJ, 1974, OCEANOGRAPHY BERING, P243; Williams A.B., 1984, SHRIMPS LOBSTERS CRA; Witherell D, 2005, MAR FISH REV, V67, P1; WITHERS K, 2008, SPECIAL PUBLICATION, V1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; WROBLEWSKI JS, 1984, CAN J FISH AQUAT SCI, V41, P294, DOI 10.1139/f84-034; Wursig B., 2000, MARINE MAMMALS GULF; Wynne Michael J., 2009, Algae, V24, P1; York A, 2009, SEA TECHNOL, V50, P41; Zimmerlam HM., 1986, GULF ALASKA PHYS ENV, P347; Zimmerman Todd L., 2004, Gulf and Caribbean Research, V16, P59; [No title captured]; [No title captured]; [No title captured]	352	93	97	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11914	10.1371/journal.pone.0011914	http://dx.doi.org/10.1371/journal.pone.0011914			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689852	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520400011
J	Schlesinger, A; Kramarsky-Winter, E; Rosenfeld, H; Armoza-Zvoloni, R; Loya, Y				Schlesinger, Ami; Kramarsky-Winter, Esti; Rosenfeld, Hanna; Armoza-Zvoloni, Rachel; Loya, Yossi			Sexual Plasticity and Self-Fertilization in the Sea Anemone Aiptasia diaphana	PLOS ONE			English	Article							CORAL STYLOPHORA-PISTILLATA; TROPICAL REEF CORALS; RED-SEA; HALIPLANELLA-LUCIAE; PEDAL LACERATION; REPRODUCTION; EVOLUTION; CNIDARIA; TEMPERATURE; VARIABILITY	Traits that influence reproductive success and contribute to reproductive isolation in animal and plant populations are a central focus of evolutionary biology. In the present study we used an experimental approach to demonstrate the occurrence of environmental effects on sexual and asexual reproduction, and provide evidence for sexual plasticity and inter-clonal fertilization in laboratory-cultured lines of the sea anemone Aiptasia diaphana. We showed that in A. diaphana, both asexual reproduction by pedal laceration, and sexual reproduction have seasonal components. The rate of pedal laceration was ten-fold higher under summer photoperiod and water temperature conditions than under winter conditions. The onset of gametogenesis coincided with the rising water temperatures occurring in spring, and spawning occurred under parameters that emulated summer photoperiod and temperature conditions. In addition, we showed that under laboratory conditions, asexually produced clones derived from a single founder individual exhibit sexual plasticity, resulting in the development of both male and female individuals. Moreover, a single female founder produced not only males and females but also hermaphrodite individuals. We further demonstrated that A. diaphana can fertilize within and between clone lines, producing swimming planula larvae. These diverse reproductive strategies may explain the species success as invader of artificial marine substrates. We suggest that these diverse reproductive strategies, together with their unique evolutionary position, make Aiptasia diaphana an excellent model for studying the evolution of sex.	[Schlesinger, Ami; Kramarsky-Winter, Esti; Armoza-Zvoloni, Rachel; Loya, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Rosenfeld, Hanna; Armoza-Zvoloni, Rachel] Natl Ctr Mariculture, Elat, Israel	Tel Aviv University	Schlesinger, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	wintere@post.tau.ac.il	Loya, Yossi/J-3039-2012; Kramarsky-Winter, Esti/H-2205-2012; Loya, Joseph/AAJ-9014-2020	Loya, Yossi/0000-0001-6870-9444; 	RAMOT (Horowitz Foundation) Tel Aviv University	RAMOT (Horowitz Foundation) Tel Aviv University	This work was funded by RAMOT (Horowitz Foundation) Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Brazeau DA, 1998, J EXP MAR BIOL ECOL, V231, P225, DOI 10.1016/S0022-0981(98)00097-5; Burt A, 2000, EVOLUTION, V54, P337; BUSS LW, 1983, P NATL ACAD SCI-BIOL, V80, P1387, DOI 10.1073/pnas.80.5.1387; Carlon DB, 1999, TRENDS ECOL EVOL, V14, P491, DOI 10.1016/S0169-5347(99)01709-7; Carre D, 2000, J EXP ZOOL, V287, P233, DOI 10.1002/1097-010X(20000801)287:3<233::AID-JEZ5>3.3.CO;2-6; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P361; Chen C, 2008, ZOOL STUD, V47, P37; CHEN CLA, 1995, ZOOL STUD, V34, P82; CLAYTON WS, 1985, MAR ECOL PROG SER, V21, P75, DOI 10.3354/meps021075; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; FAUTIN DG, 1997, 6 INT C COEL BIOL LE; FAUTIN DG, 1990, CNIDARIA REPROD BIOL, P31; Frank U, 2002, CAN J ZOOL, V80, P1723, DOI 10.1139/Z02-131; FUKUI Y, 1993, J MAR BIOL ASSOC UK, V73, P971, DOI 10.1017/S0025315400034858; GHISELIN MT, 1969, Q REV BIOL, V44, P189, DOI 10.1086/406066; GROSBERG RK, 1987, EVOLUTION, V41, P372, DOI 10.1111/j.1558-5646.1987.tb05804.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HUNTER T, 1984, J EXP MAR BIOL ECOL, V83, P127, DOI 10.1016/0022-0981(84)90041-8; Hyman LH., 1940, INVERTEBRATES; Kalisz S, 2004, NATURE, V430, P884, DOI 10.1038/nature02776; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Littlefield C. Lynne, 1994, Seminars in Developmental Biology, V5, P13, DOI 10.1006/sedb.1994.1003; Loya Y, 2004, MAR POLLUT BULL, V49, P344, DOI 10.1016/j.marpolbul.2004.06.011; Loya Y, 2008, P ROY SOC B-BIOL SCI, V275, P2335, DOI 10.1098/rspb.2008.0675; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; SCHLESINGER A, 2008, METHOD APPARATUS PRO; Schlesinger A, 2009, MAR BIOL, V156, P753, DOI 10.1007/s00227-009-1126-0; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; SHICK JM, 1977, BIOL BULL-US, V153, P604, DOI 10.2307/1540609; SOONG KY, 1992, BIOL BULL, V183, P418, DOI 10.2307/1542018; Stephenson T.A., 1928, BRIT SEA ANEMONES, VI; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Weismann A., 1889, ESSAYS HEREDITY KIND; [No title captured]	44	29	30	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11874	10.1371/journal.pone.0011874	http://dx.doi.org/10.1371/journal.pone.0011874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686700	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200036
J	Dasari, VR; Velpula, KK; Kaur, K; Fassett, D; Klopfenstein, JD; Dinh, DH; Gujrati, M; Rao, JS				Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Kaur, Kiranpreet; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP)	PLOS ONE			English	Article							CANCER-CELLS; IN-VIVO; BCL-2 FAMILY; NUDE-MICE; EXPRESSION; NECROSIS; RECEPTOR; DEATH; MITOCHONDRIA; LIGAND	Background: XIAP (X-linked inhibitor of apoptosis protein) is one of the most important members of the apoptosis inhibitor family. XIAP is upregulated in various malignancies, including human glioblastoma. It promotes invasion, metastasis, growth and survival of malignant cells. We hypothesized that downregulation of XIAP by human umbilical cord blood mesenchymal stem cells (hUCBSC) in glioma cells would cause them to undergo apoptotic death. Methodology/Principal Findings: We observed the effect of hUCBSC on two malignant glioma cell lines (SNB19 and U251) and two glioma xenograft cell lines (4910 and 5310). In co-cultures of glioma cells with hUCBSC, proliferation of glioma cells was significantly inhibited. This is associated with increased cytotoxicity of glioma cells, which led to glioma cell death. Stem cells induced apoptosis in glioma cells, which was evaluated by TUNEL assay, FACS analyses and immunoblotting. The induction of apoptosis is associated with inhibition of XIAP in co-cultures of hUCBSC. Similar results were obtained by the treatment of glioma cells with shRNA to downregulate XIAP (siXIAP). Downregulation of XIAP resulted in activation of caspase-3 and caspase-9 to trigger apoptosis in glioma cells. Apoptosis is characterized by the loss of mitochondrial membrane potential and upregulation of mitochondrial apoptotic proteins Bax and Bad. Cell death of glioma cells was marked by downregulation of Akt and phospho-Akt molecules. We observed similar results under in vivo conditions in U251- and 5310-injected nude mice brains, which were treated with hUCBSC. Under in vivo conditions, Smac/DIABLO was found to be colocalized in the nucleus, showing that hUCBSC induced apoptosis is mediated by inhibition of XIAP and activation of Smac/DIABLO. Conclusions/Significance: Our results indicate that downregulation of XIAP by hUCBSC treatment induces apoptosis, which led to the death of the glioma cells and xenograft cells. This study demonstrates the therapeutic potential of XIAP and hUCBSC to treat malignant gliomas.	[Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Kaur, Kiranpreet; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Dasari, VR (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Dasari, Venkata Ramesh/B-3098-2009; Kaur, Kiran/R-3535-2018	Dasari, Venkata Ramesh/0000-0003-0819-2935; Kaur, Kiran/0000-0002-7285-5513	National Institute of Neurological Disorders and Stroke (NINDS) [NS057529]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institute of Neurological Disorders and Stroke (NINDS), NS057529. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Ehtesham M, 2002, CANCER RES, V62, P7170; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; HAN L, 2009, MED ONCOL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao CH, 2001, CANCER RES, V61, P1162; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hassouna I, 1996, NEUROSCI LETT, V204, P85, DOI 10.1016/0304-3940(96)12323-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holcik M, 2000, ONCOGENE, V19, P4174, DOI 10.1038/sj.onc.1203765; Jeong JA, 2005, STEM CELLS, V23, P584, DOI 10.1634/stemcells.2004-0304; Kang SG, 2008, CHILD NERV SYST, V24, P293, DOI 10.1007/s00381-007-0515-2; Kim DS, 2009, STEM CELLS DEV, V18, P511, DOI 10.1089/scd.2008.0050; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus DC, 2004, ONCOGENE, V23, P8105, DOI 10.1038/sj.onc.1207967; Nagane M, 2000, CANCER RES, V60, P847; Naumann U, 2007, GENE THER, V14, P147, DOI 10.1038/sj.gt.3302845; PASTORINO JG, 1993, J BIOL CHEM, V268, P13791; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sasaki H, 2000, CANCER RES, V60, P5659; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Song JH, 2003, BRAIN PATHOL, V13, P539; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wrzesien-Kus A, 2004, APOPTOSIS, V9, P705, DOI 10.1023/B:APPT.0000045788.61012.b2; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zander T, 2002, J NEUROCHEM, V81, P1052, DOI 10.1046/j.1471-4159.2002.00899.x	59	62	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11813	10.1371/journal.pone.0011813	http://dx.doi.org/10.1371/journal.pone.0011813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676365	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520100006
J	O'Connor, RP; Madison, SD; Leveque, P; Roderick, HL; Bootman, MD				O'Connor, Rodney P.; Madison, Steve D.; Leveque, Philippe; Roderick, H. Llewelyn; Bootman, Martin D.			Exposure to GSM RF Fields Does Not Affect Calcium Homeostasis in Human Endothelial Cells, Rat Pheocromocytoma Cells or Rat Hippocampal Neurons	PLOS ONE			English	Article							FREQUENCY ELECTROMAGNETIC-FIELDS; MOBILE PHONE RADIATION; ION EFFLUX; RADIOFREQUENCY RADIATION; INTRACELLULAR CALCIUM; NEUROBLASTOMA-CELLS; BATTERY CURRENT; CA2+ RELEASE; BRAIN-TISSUE; PC12 CELLS	In the course of modern daily life, individuals are exposed to numerous sources of electromagnetic radiation that are not present in the natural environment. The strength of the electromagnetic fields from sources such as hairdryers, computer display units and other electrical devices is modest. However, in many home and office environments, individuals can experience perpetual exposure to an "electromagnetic smog", with occasional peaks of relatively high electromagnetic field intensity. This has led to concerns that such radiation can affect health. In particular, emissions from mobile phones or mobile phone masts have been invoked as a potential source of pathological electromagnetic radiation. Previous reports have suggested that cellular calcium (Ca2+) homeostasis is affected by the types of radiofrequency fields emitted by mobile phones. In the present study, we used a high-throughput imaging platform to monitor putative changes in cellular Ca2+ during exposure of cells to 900 MHz GSM fields of differing power (specific absorption rate 0.012-2 W/Kg), thus mimicking the type of radiation emitted by current mobile phone handsets. Data from cells experiencing the 900 Mhz GSM fields were compared with data obtained from paired experiments using continuous wave fields or no field. We employed three cell types (human endothelial cells, PC-12 neuroblastoma and primary hippocampal neurons) that have previously been suggested to be sensitive to radiofrequency fields. Experiments were designed to examine putative effects of radiofrequency fields on resting Ca2+, in addition to Ca2+ signals evoked by an InsP3-generating agonist. Furthermore, we examined putative effects of radiofrequency field exposure on Ca2+ store emptying and store-operated Ca2+ entry following application of the Ca2+ ATPase inhibitor thapsigargin. Multiple parameters (e. g., peak amplitude, integrated Ca2+ signal, recovery rates) were analysed to explore potential impact of radiofrequency field exposure on Ca2+ signals. Our data indicate that 900 MHz GSM fields do not affect either basal Ca2+ homeostasis or provoked Ca2+ signals. Even at the highest field strengths applied, which exceed typical phone exposure levels, we did not observe any changes in cellular Ca2+ signals. We conclude that under the conditions employed in our experiments, and using a highly-sensitive assay, we could not detect any consequence of RF exposure.	[O'Connor, Rodney P.; Madison, Steve D.; Roderick, H. Llewelyn; Bootman, Martin D.] Babraham Inst, Mol Signalling Lab, Cambridge, England; [Roderick, H. Llewelyn] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Leveque, Philippe] Univ Limoges, XLIM, Limoges, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Universite de Limoges	O'Connor, RP (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge, England.	martin.bootman@bbsrc.ac.uk	Bootman, Martin/AAB-3330-2019; LEVEQUE, Philippe/N-8749-2014	Bootman, Martin/0000-0002-6447-3451; LEVEQUE, Philippe/0000-0003-3687-436X; O'Connor, Rodney/0000-0002-3916-3101; Roderick, Hywel/0000-0001-7065-3523	Biotechnology and Biological Sciences Research Council; Mobile Telecommunications and Health Research Programme; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001116, BBS/E/B/0000C116] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Mobile Telecommunications and Health Research Programme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and the Mobile Telecommunications and Health Research Programme. HLR is a Royal Society Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; ALBERT EN, 1987, RADIAT RES, V109, P19, DOI 10.2307/3576863; BAWIN SM, 1975, ANN NY ACAD SCI, V247, P74, DOI 10.1111/j.1749-6632.1975.tb35984.x; BAWIN SM, 1984, BRAIN RES, V323, P227, DOI 10.1016/0006-8993(84)90293-2; Bennett DL, 1998, BIOCHEM J, V329, P349; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLACKMAN C F, 1980, Bioelectromagnetics, V1, P35, DOI 10.1002/bem.2250010104; BLACKMAN CF, 1991, BIOELECTROMAGNETICS, V12, P173, DOI 10.1002/bem.2250120305; BLACKMAN CF, 1985, BIOELECTROMAGNETICS, V6, P1, DOI 10.1002/bem.2250060102; Bootman MD, 2001, J CELL SCI, V114, P2213; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; DUTTA SK, 1984, BIOELECTROMAGNETICS, V5, P71, DOI 10.1002/bem.2250050108; DUTTA SK, 1989, BIOELECTROMAGNETICS, V10, P197, DOI 10.1002/bem.2250100208; Friedman J, 2007, BIOCHEM J, V405, P559, DOI 10.1042/BJ20061653; Green AC, 2005, INT J RADIAT BIOL, V81, P869, DOI 10.1080/09553000600555389; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Ilvonen S, 2005, BIOELECTROMAGNETICS, V26, P648, DOI 10.1002/bem.20159; Ivaschuk OI, 1997, BIOELECTROMAGNETICS, V18, P223, DOI 10.1002/(SICI)1521-186X(1997)18:3<223::AID-BEM4>3.0.CO;2-4; Jokela K, 2004, HEALTH PHYS, V86, P56, DOI 10.1097/00004032-200401000-00008; Koizumi S, 1999, J BIOL CHEM, V274, P33327, DOI 10.1074/jbc.274.47.33327; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; LIBURDY RP, 1988, RADIAT RES, V114, P500, DOI 10.2307/3577121; LIBURDY RP, 1992, FEBS LETT, V301, P53, DOI 10.1016/0014-5793(92)80209-Y; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MERRITT JH, 1982, BIOELECTROMAGNETICS, V3, P475, DOI 10.1002/bem.2250030411; Moisescu MG, 2008, BIOELECTROCHEMISTRY, V74, P9, DOI 10.1016/j.bioelechem.2007.11.003; Nylund R, 2004, PROTEOMICS, V4, P1359, DOI 10.1002/pmic.200300773; Nylund R, 2006, PROTEOMICS, V6, P4769, DOI 10.1002/pmic.200600076; Pessina GP, 2001, BIOELECTROMAGNETICS, V22, P503, DOI 10.1002/bem.79; Roderick HL, 2007, BIOCHEM SOC T, V35, P957, DOI 10.1042/BST0350957; SCHWARTZ JL, 1993, BIOELECTROMAGNETICS, V14, P521, DOI 10.1002/bem.2250140604; Selvam R, 2007, LIFE SCI, V80, P2403, DOI 10.1016/j.lfs.2007.03.019; Shahidain R, 2001, INT J RADIAT BIOL, V77, P241, DOI 10.1080/09553000010013779; SHELTON W W JR, 1981, Bioelectromagnetics, V2, P161, DOI 10.1002/bem.2250020207; Sisken JE, 2000, RADIAT RES, V153, P699, DOI 10.1667/0033-7587(2000)153[0699:PFEFAT]2.0.CO;2; Tattersall JEH, 2001, BRAIN RES, V904, P43, DOI 10.1016/S0006-8993(01)02434-9; Tonini R, 2001, BIOPHYS J, V81, P2580, DOI 10.1016/S0006-3495(01)75902-4; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Wolke S, 1996, BIOELECTROMAGNETICS, V17, P144, DOI 10.1002/(SICI)1521-186X(1996)17:2<144::AID-BEM9>3.0.CO;2-3; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	47	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11828	10.1371/journal.pone.0011828	http://dx.doi.org/10.1371/journal.pone.0011828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676401	gold, Green Published, Green Accepted			2022-12-27	WOS:000280371800022
J	Peters, R; Beckett, N; Beardmore, R; Pena-Miller, R; Rockwood, K; Mitnitski, A; Mt-Isa, S; Bulpitt, C				Peters, Ruth; Beckett, Nigel; Beardmore, Robert; Pena-Miller, Rafael; Rockwood, Kenneth; Mitnitski, Arnold; Mt-Isa, Shahrul; Bulpitt, Christopher			Modelling Cognitive Decline in the Hypertension in the Very Elderly Trial [HYVET] and Proposed Risk Tables for Population Use	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; INCIDENT DEMENTIA; BLOOD-PRESSURE; DOUBLE-BLIND; ACCUMULATION; TRANSITIONS; MORTALITY; PROTOCOL; OLDER; COG	Introduction: Although, on average, cognition declines with age, cognition in older adults is a dynamic process. Hypertension is associated with greater decline in cognition with age, but whether treatment of hypertension affects this is uncertain. Here, we modelled dynamics of cognition in relation to the treatment of hypertension, to see if treatment effects might better be discerned by a model that included baseline measures of cognition and consequent mortality Methodology/Principal Findings: This is a secondary analysis of the Hypertension in the Very Elderly Trial (HYVET), a double blind, placebo controlled trial of indapamide, with or without perindopril, in people aged 80+ years at enrollment. Cognitive states were defined in relation to errors on the Mini-Mental State Examination, with more errors signifying worse cognition. Change in cognitive state was evaluated using a dynamic model of cognitive transition. In the model, the probabilities of transitions between cognitive states is represented by a Poisson distribution, with the Poisson mean dependent on the baseline cognitive state. The dynamic model of cognitive transition was good (R(2) = 0.74) both for those on placebo and (0.86) for those on active treatment. The probability of maintaining cognitive function, based on baseline function, was slightly higher in the actively treated group (e. g., for those with the fewest baseline errors, the chance of staying in that state was 63% for those on treatment, compared with 60% for those on placebo). Outcomes at two and four years could be predicted based on the initial state and treatment. Conclusions/Significance: A dynamic model of cognition that allows all outcomes (cognitive worsening, stability improvement or death) to be categorized simultaneously detected small but consistent differences between treatment and control groups (in favour of treatment) amongst very elderly people treated for hypertension. The model showed good fit, and suggests that most change in cognition in very elderly people is small, and depends on their baseline state and on treatment. Additional work is needed to understand whether this modelling approach is well suited to the valuation of small effects, especially in the face of mortality differences between treatment groups.	[Peters, Ruth; Mt-Isa, Shahrul] Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, London, England; [Beardmore, Robert; Pena-Miller, Rafael] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Rockwood, Kenneth] Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada; [Mitnitski, Arnold] Dalhousie Univ, Dept Med, Halifax, NS, Canada	Imperial College London; Imperial College London; Dalhousie University; Dalhousie University	Peters, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, London, England.	r.peters@imperial.ac.uk	QQ, Simon/D-3888-2014; Rockwood, Kenneth/AAD-8951-2019; Peters, Ruth/D-4047-2011; Mt-Isa, Shahrul/F-1275-2010; Mitnitski, Arnold/C-7543-2012	Peters, Ruth/0000-0003-0148-3617; Mt-Isa, Shahrul/0000-0002-7163-8402; Beckett, Nigel/0000-0002-7736-3817	British Heart Foundation; Servier International; EPSRC [EP/I018263/1] Funding Source: UKRI; MRC [G0802611] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018263/1] Funding Source: researchfish; Medical Research Council [G0802611] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Servier International(Servier); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These authors have no support or funding to report. No funders were involved with the ideas, analyses or generation of this paper. The raw data used in these analyses was taken from the HYpertension in the Very Elderly Trial (HYVET) data sets. The HYVET trial was funded by the British Heart Foundation (http://www.bhf.org.uk/) and Servier International (http://www.servier.co.uk/). The funders of the HYVET trial had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew MK, 2008, J CLIN EPIDEMIOL, V61, P827, DOI 10.1016/j.jclinepi.2007.10.022; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bulpitt C, 2001, DRUG AGING, V18, P151, DOI 10.2165/00002512-200118030-00001; Davis HS, 2001, INT PSYCHOGERIATR, V13, P115, DOI 10.1017/S1041610202008050; Mitnitski A, 2006, EUR J NEUROL, V13, P514, DOI 10.1111/j.1468-1331.2006.01297.x; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2007, EXP GERONTOL, V42, P241, DOI 10.1016/j.exger.2006.10.001; Mitnitski Arnold, 2008, BMC Geriatr, V8, P3, DOI 10.1186/1471-2318-8-3; Moore MJ, 2001, J GERONTOL B-PSYCHOL, V56, pS219, DOI 10.1093/geronb/56.4.S219; Peters R, 2006, DRUG AGING, V23, P83, DOI 10.2165/00002512-200623010-00008; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Rockwood K, 2008, J AM GERIATR SOC, V56, P1213, DOI 10.1111/j.1532-5415.2008.01773.x; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Spreen O, 1998, COMPENDIUM NEUROPSYC; Strauss E, 2006, COMPENDIUM NEUROPSYC	16	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11775	10.1371/journal.pone.0011775	http://dx.doi.org/10.1371/journal.pone.0011775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630TN	20668673	Green Published, Green Submitted, gold			2022-12-27	WOS:000280297300010
J	Kapoor, A; Mehta, N; Esper, F; Poljsak-Prijatelj, M; Quan, PL; Qaisar, N; Delwart, E; Lipkin, WI				Kapoor, Amit; Mehta, Natasha; Esper, Frank; Poljsak-Prijatelj, Mateja; Quan, Phenix-Lan; Qaisar, Natasha; Delwart, Eric; Lipkin, W. Ian			Identification and Characterization of a New Bocavirus Species in Gorillas	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; HOSPITALIZED CHILDREN; PARVOVIRUS; CANINE; GASTROENTERITIS; SAMPLES; VIRUS; EMERGENCE; EVOLUTION; PATHOGEN	A novel parvovirus, provisionally named Gorilla Bocavirus species 1 (GBoV1), was identified in four stool samples from Western gorillas (Gorilla gorilla) with acute enteritis. The complete genomic sequence of the new parvovirus revealed three open reading frames (ORFs) with an organization similar to that of known bocaviruses. Phylogenetic analysis using complete capsid and non structural (NS) gene sequence suggested that the new parvovirus is most closely related to human bocaviruses (HBoV). However, the NS ORF is more similar in length to the NS ORF found in canine minute virus and bovine parvovirus than in HBoV. Comparative genetic analysis using GBoV and HBoV genomes enabled characterization of unique splice donor and acceptor sites that appear to be highly conserved among all four HBoV species, and provided evidence for expression of two different NS proteins in all primate bocaviruses. GBoV is the first non-human primate bocavirus identified and provides new insights into the genetic diversity and evolution of this highly prevalent and recently discovered group of parvoviruses.	[Kapoor, Amit; Mehta, Natasha; Quan, Phenix-Lan; Qaisar, Natasha; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Esper, Frank] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Poljsak-Prijatelj, Mateja] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA	Columbia University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Ljubljana; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute	Kapoor, A (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	ak3117@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Delwart, Eric/0000-0002-6296-4484; Qaisar, Natasha/0000-0001-6838-941X	Google.org; National Institutes of Health (Northeast Biodefense Center - Lipkin) [AI57158]; USAID Predict; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	Google.org; National Institutes of Health (Northeast Biodefense Center - Lipkin)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID Predict(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Google.org, National Institutes of Health award AI57158 (Northeast Biodefense Center - Lipkin), and USAID Predict. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Anderson LJ, 2007, CLIN INFECT DIS, V44, P911, DOI 10.1086/512438; Appel MJG, 1999, ADV VETER MED AP, V41, P309; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; CLAUDE M, 2004, VIRUS TAXONOMY 8 REP; DEVRIES JJ, 2009, J CLIN MICROBIOL; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; GAGLIARDI TB, 2009, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268808001842; Gerna G, 2007, NEW MICROBIOL, V30, P383; HOELZER K, VET RES, V41, P39; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; KAPOOR A, J INFECT DIS, V201, P1643; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; LEDERMAN M, 1984, J VIROL, V49, P315, DOI 10.1128/JVI.49.2.315-318.1984; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Patel JR, 2009, VACCINE, V27, P491, DOI 10.1016/j.vaccine.2008.11.027; Paul MA, 2006, J AM ANIM HOSP ASSOC, V42, P80, DOI 10.5326/0420080; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen O, 2007, EMERG INFECT DIS, V13, P1620, DOI 10.3201/eid1310.070436; Schultz RD, 2006, VET MICROBIOL, V117, P75, DOI 10.1016/j.vetmic.2006.04.013; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Vicente D, 2007, EMERG INFECT DIS, V13, P636, DOI 10.3201/eid1304.061501; Wellehan JFX, 2009, VET MICROBIOL, V133, P34, DOI 10.1016/j.vetmic.2008.06.011; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006	45	90	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11948	10.1371/journal.pone.0011948	http://dx.doi.org/10.1371/journal.pone.0011948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668709	Green Published, gold			2022-12-27	WOS:000280243800037
J	de Voer, RM; Mollema, L; Schepp, RM; de Greeff, SC; van Gageldonk, PGM; de Melker, HE; Sanders, EAM; Berbers, GAM; van der Klis, FRM				de Voer, Richarda M.; Mollema, Liesbeth; Schepp, Rutger M.; de Greeff, Sabine C.; van Gageldonk, Pieter G. M.; de Melker, Hester E.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.			Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine	PLOS ONE			English	Article							INFLUENZAE TYPE-B; SEROPREVALENCE; ANTIBODIES; PROTECTION; DIPHTHERIA; TETANUS; ABILITY; AGE	Background: In 2002 a Meningococcal serogroup C (MenC) conjugate vaccine, with tetanus toxoid as carrier protein, was introduced in the Netherlands as a single-dose at 14 months of age. A catch-up campaign was performed targeting all individuals aged 14 months to 18 years. We determined the MenC-specific immunity before and after introduction of the MenC conjugate (MenCC) vaccine. Methods and Findings: Two cross-sectional population-based serum banks, collected in 1995/1996 (n = 8539) and in 2006/2007 (n = 6386), were used for this study. The main outcome measurements were the levels of MenC polysaccharide(PS)specific IgG and serum bactericidal antibodies (SBA) after routine immunization, 4-5 years after catch-up immunization or by natural immunity. There was an increasing persistence of PS-specific IgG and SBA with age in the catch-up immunized cohorts 4-5 years after their MenCC immunization (MenC PS-specific IgG, 0.25 mu g/ml (95% CI: 0.19-0.31 mu g/ml) at age 6 years, gradually increasing to 2.34 mu g/ml,(95% CI: 1.70-3.32 mu g/ml) at age 21-22 years). A comparable pattern was found for antibodies against the carrier protein in children immunized above 9 years of age. In case of vaccination before the age of 5 years, PS-specific IgG was rapidly lost. For all age-cohorts together, SBA seroprevalence (>= 8) increased from 19.7% to 43.0% in the pre- and post-MenC introduction eras, respectively. In non-immunized adults the SBA seroprevalence was not significantly different between the pre- and post-MenC introduction periods, whereas PS-specific IgG was significantly lower in the post-MenC vaccination (GMT, age >= 25 years, 0.10 mu g/ml) era compared to the pre-vaccination (GMT, age >= 25 years, 0.43 mu g/ml) era. Conclusion: MenCC vaccination administered above 5 years of age induced high IgG levels compared to natural exposure, increasing with age. In children below 14 months of age and non-immunized cohorts lower IgG levels were observed compared to the pre-vaccination era, whereas functional levels remained similar in adults. Whether the lower IgG poses individuals at increased risk for MenC disease should be carefully monitored. Large-scale introduction of a MenCC vaccine has led to improved protection in adolescents, but in infants a single-dose schedule may not provide sufficient protection on the long-term and therefore a booster-dose early in adolescence should be considered.	[de Voer, Richarda M.; Schepp, Rutger M.; van Gageldonk, Pieter G. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [de Voer, Richarda M.] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands; [Mollema, Liesbeth; de Greeff, Sabine C.; de Melker, Hester E.] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	de Voer, RM (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	Fiona.van.der.Klis@rivm.nl	de Voer, Richarda M/GSD-6097-2022; de Voer, Richarda M/ABD-1525-2021; de Voer, Richarda/P-5728-2015	de Voer, Richarda M/0000-0002-8222-0343; van Gageldonk, Pieter/0000-0003-2753-9674	Ministry of Health, Welfare and Sport, The Hague, The Netherlands	Ministry of Health, Welfare and Sport, The Hague, The Netherlands	This study was supported by the Ministry of Health, Welfare and Sport, The Hague, The Netherlands. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Backhouse JL, 2007, VACCINE, V25, P1310, DOI 10.1016/j.vaccine.2006.09.087; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; BREDIUS RGM, 1992, INFECT IMMUN, V60, P4838, DOI 10.1128/IAI.60.11.4838-4847.1992; Cameron C, 2006, EUROSURVEILLANCE, V11; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Ceyhan M, 2007, VACCINE, V25, P7233, DOI 10.1016/j.vaccine.2007.07.019; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; de Voer RM, 2009, CLIN INFECT DIS, V49, P58, DOI 10.1086/599347; de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P148, DOI 10.1097/INF.0b013e3181b9a831; Feiring B, 2006, CLIN VACCINE IMMUNOL, V13, P790, DOI 10.1128/CVI.00047-06; *GEZ HLTH COUNC NE, 2002, 200127E GEZ HLTH COU; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; MYEROWITZ RL, 1973, INFECT IMMUN, V8, P896, DOI 10.1128/IAI.8.6.896-900.1973; NEPPELENBROEK SE, 2002, GOED GEDAAN WOORDVER; ODempsey TJD, 1996, ARCH DIS CHILD-FETAL, V74, pF43, DOI 10.1136/fn.74.1.F43; Pihlgren M, 2006, J IMMUNOL, V176, P165, DOI 10.4049/jimmunol.176.1.165; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; SNAPE MD, 2008, BMJ-BRIT MED J, V7659, P1487; Southern J, 2009, CLIN VACCINE IMMUNOL, V16, P194, DOI 10.1128/CVI.00420-08; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607	42	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12144	10.1371/journal.pone.0012144	http://dx.doi.org/10.1371/journal.pone.0012144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730091	Green Submitted, Green Published, gold			2022-12-27	WOS:000280862200006
J	Chow, AWM; Liang, JFT; Wong, JSC; Fu, Y; Tang, NLS; Ko, WH				Chow, Alison Wai-ming; Liang, Jocelyn Feng-ting; Wong, Janice Siu-chong; Fu, Yan; Tang, Nelson Leung-sang; Ko, Wing-hung			Polarized Secretion of Interleukin (IL)-6 and IL-8 by Human Airway Epithelia 16HBE14o-Cells in Response to Cationic Polypeptide Challenge	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; MAJOR BASIC-PROTEIN; POLY-L-ARGININE; CL-SECRETION; NUCLEAR TRANSLOCATION; MESOTHELIAL CELLS; P38 MAPK; IN-VIVO; EXPRESSION	Background: The airway epithelium participates in asthmatic inflammation in many ways. Target cells of the epithelium can respond to a variety of inflammatory mediators and cytokines. Damage to the surface epithelium occurs following the secretion of eosinophil-derived, highly toxic cationic proteins. Moreover, the surface epithelium itself is responsible for the synthesis and release of cytokines that cause the selective recruitment, retention, and accumulation of various inflammatory cells. To mimic the damage seen during asthmatic inflammation, the bronchial epithelium can be challenged with highly charged cationic polypeptides such as poly-L-arginine. Methodology/Principal Findings: In this study, human bronchial epithelial cells, 16HBE14o-cells, were "chemically injured'' by exposing them to poly-L-arginine as a surrogate of the eosinophil cationic protein. Cytokine antibody array data showed that seven inflammatory mediators were elevated out of the 40 tested, including marked elevation in interleukin (IL)-6 and IL-8 secretion. IL-6 and IL-8 mRNA expression levels were elevated as measured with real-time PCR. Cell culture supernatants from apical and basolateral compartments were collected, and the IL-6 and IL-8 production was quantified with ELISA. IL-6 and IL-8 secretion by 16HBE14o- epithelia into the apical compartment was significantly higher than that from the basolateral compartment. Using specific inhibitors, the production of IL-6 and IL-8 was found to be dependent on p38 MAPK, ERK1/2 MAPK, and NF-kappa B pathways. Conclusions/Significance: The results clearly demonstrate that damage to the bronchial epithelia by poly-L-arginine stimulates polarized IL-6 and IL-8 secretion. This apically directed secretion of cytokines may play an important role in orchestrating epithelial cell responses to inflammation.	[Chow, Alison Wai-ming; Liang, Jocelyn Feng-ting; Wong, Janice Siu-chong; Ko, Wing-hung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Fu, Yan; Tang, Nelson Leung-sang] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-sang; Ko, Wing-hung] Chinese Univ Hong Kong, KIZ CUHK Joint Lab Bioresource & Mol Res Common D, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chow, AWM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	whko@cuhk.edu.hk	Tang, Nelson L/P-5018-2017; Ko, Hung/R-1802-2018	Tang, Nelson L/0000-0002-3607-5819; Ko, Hung/0000-0002-2041-402X	Chinese University of Hong Kong [2041451]; Research Grant Council General Research Fund [2140595]	Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grant Council General Research Fund	The work was supported by a Direct Grant for Research, The Chinese University of Hong Kong (#2041451), and Research Grant Council General Research Fund (#2140595) awarded to W. H. Ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER KB, 1994, ANN NY ACAD SCI, V725, P128, DOI 10.1111/j.1749-6632.1994.tb00275.x; Arseneault D, 1999, INFLAMMATION, V23, P287; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Blau H, 2007, AM J PHYSIOL-LUNG C, V292, pL343, DOI 10.1152/ajplung.00030.2006; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Carolan EJ, 1997, AM J RESP CELL MOL, V17, P727, DOI 10.1165/ajrcmb.17.6.2745; Clark K, 2004, J LEUKOCYTE BIOL, V75, P1001, DOI 10.1189/jlb.0803391; Coyle AJ, 2000, PROG INFLAM RES, P147; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Donnelly LE, 2002, AM J RESP CELL MOL, V26, P144, DOI 10.1165/ajrcmb.26.1.4477; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Ebihara N, 2007, J IMMUNOL, V178, P3288, DOI 10.4049/jimmunol.178.5.3288; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Endo Y, 2007, CLIN EXP ALLERGY, V37, P219, DOI 10.1111/j.1365-2222.2007.02646.x; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Galietta Luis J V, 2004, Proc Am Thorac Soc, V1, P62, DOI 10.1513/pats.2306017; Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M412134200; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; HERBERT CA, 1991, BRIT J PHARMACOL, V104, P391, DOI 10.1111/j.1476-5381.1991.tb12441.x; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holtkamp GM, 1998, CLIN EXP IMMUNOL, V112, P34; Homma T, 2005, AM J PHYSIOL-LUNG C, V289, pL413, DOI 10.1152/ajplung.00059.2005; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Jeffery PK, 2000, PROG INFLAM RES, P1; KITA H, 1995, J IMMUNOL, V154, P4749; Kruger S, 2001, EXP NEPHROL, V9, P223; Kruger S, 2000, INFECT IMMUN, V68, P328, DOI 10.1128/IAI.68.1.328-334.2000; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Nasreen N, 2001, J INFECT DIS, V183, P1638, DOI 10.1086/320700; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Ohtake K, 2003, PHARMACEUT RES, V20, P153, DOI 10.1023/A:1022485816755; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Page SM, 1999, AM J RESP CELL MOL, V21, P230, DOI 10.1165/ajrcmb.21.2.3647; Parilla NW, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-84; Pearson AL, 2008, J NEPHROL, V21, P887; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; REED CE, 1994, ANN ALLERGY, V72, P376; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Sun Y, 2008, J IMMUNOL, V180, P4173, DOI 10.4049/jimmunol.180.6.4173; Toumi F, 2004, BIOCHEM BIOPH RES CO, V317, P187, DOI 10.1016/j.bbrc.2004.03.033; UCHIDA DA, 1993, AM REV RESPIR DIS, V147, P982, DOI 10.1164/ajrccm/147.4.982; Uchida DA, 1996, EXP LUNG RES, V22, P85, DOI 10.3109/01902149609074019; Wang CB, 2005, ALLERGY, V60, P1378, DOI 10.1111/j.1398-9995.2005.00884.x; White SR, 2008, AM J PHYSIOL-LUNG C, V295, pL1018, DOI 10.1152/ajplung.00065.2008; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Wong CHY, 2002, J BIOL CHEM, V277, P9016, DOI 10.1074/jbc.M111917200; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200; ZEILLEMAKER AM, 1995, IMMUNOLOGY, V84, P227	55	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12091	10.1371/journal.pone.0012091	http://dx.doi.org/10.1371/journal.pone.0012091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711426	Green Published, gold, Green Submitted			2022-12-27	WOS:000280859700004
J	Lancichinetti, A; Kivela, M; Saramaki, J; Fortunato, S				Lancichinetti, Andrea; Kivela, Mikko; Saramaki, Jari; Fortunato, Santo			Characterizing the Community Structure of Complex Networks	PLOS ONE			English	Article								Background: Community structure is one of the key properties of complex networks and plays a crucial role in their topology and function. While an impressive amount of work has been done on the issue of community detection, very little attention has been so far devoted to the investigation of communities in real networks. Methodology/Principal Findings: We present a systematic empirical analysis of the statistical properties of communities in large information, communication, technological, biological, and social networks. We find that the mesoscopic organization of networks of the same category is remarkably similar. This is reflected in several characteristics of community structure, which can be used as "fingerprints'' of specific network categories. While community size distributions are always broad, certain categories of networks consist mainly of tree-like communities, while others have denser modules. Average path lengths within communities initially grow logarithmically with community size, but the growth saturates or slows down for communities larger than a characteristic size. This behaviour is related to the presence of hubs within communities, whose roles differ across categories. Also the community embeddedness of nodes, measured in terms of the fraction of links within their communities, has a characteristic distribution for each category. Conclusions/Significance: Our findings, verified by the use of two fundamentally different community detection methods, allow for a classification of real networks and pave the way to a realistic modelling of networks' evolution.	[Lancichinetti, Andrea; Fortunato, Santo] ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Kivela, Mikko; Saramaki, Jari] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland	Aalto University	Lancichinetti, A (corresponding author), ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy.	fortunato@isi.it	Saramaki, Jari P/E-5226-2011; Fortunato, Santo/M-7912-2019; Kivelä, Mikko/G-6678-2011; Fortunato, Santo/C-3586-2009	Fortunato, Santo/0000-0002-9039-4730; Kivelä, Mikko/0000-0003-2049-1954; Fortunato, Santo/0000-0002-9039-4730	European Commission [238597]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors gratefully acknowledge ICTeCollective. The project ICTeCollective acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number 238597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 2007, LARGE SCALE STRUCTUR; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 1998, MODERN GRAPH THEORY; Caldarelli G., 2007, SCALE FREE NETWORKS; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Condon A, 2001, RANDOM STRUCT ALGOR, V18, P116, DOI 10.1002/1098-2418(200103)18:2<116::AID-RSA1001>3.0.CO;2-2; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gregory S, 2007, LECT NOTES ARTIF INT, V4702, P91; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leung IXY, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066107; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; ONNELA JP, 2010, 10065731 ARXIV; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sawardecker EN, 2009, EUR PHYS J B, V67, P277, DOI 10.1140/epjb/e2008-00418-0; Simon H. A., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023	36	158	164	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e11976	10.1371/journal.pone.0011976	http://dx.doi.org/10.1371/journal.pone.0011976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711338	gold, Green Published, Green Submitted			2022-12-27	WOS:000280859700001
J	Morice, A; Charreau, B; Neveu, B; Brouard, S; Soulillou, JP; Bonneville, M; Houssaint, E; Degauque, N				Morice, Alexis; Charreau, Beatrice; Neveu, Berangere; Brouard, Sophie; Soulillou, Jean-Paul; Bonneville, Marc; Houssaint, Elisabeth; Degauque, Nicolas			Cross-Reactivity of Herpesvirus-Specific CD8 T Cell Lines Toward Allogeneic Class I MHC Molecules	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYMPHOCYTE CTL; RECEPTOR USAGE; CYTOMEGALOVIRUS; MEMORY; PEPTIDE; RECOGNITION; RESPONSES; SELECTION; DISEASE	Although association between persistent viral infection and allograft rejection is well characterized, few examples of T-cell cross-reactivity between self-MHC/viral and allogeneic HLA molecules have been documented so far. We appraised in this study the alloreactivity of CD8 T cell lines specific for immunodominant epitopes from human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV). CD8 T cell lines were generated after sorting with immunomagnetic beads coated with either pp65(495-503)/A*0201, BMLF1(259-267)/A*0201, or BZLF1(54-64)/B*3501 multimeric complexes. Alloreactivity of the CD8 T cell lines against allogeneic class I MHC alleles was assessed by screening of (i) TNF-alpha production against COS-7 cells transfected with as many as 39 individual HLA class I-encoding cDNA, and (ii) cytotoxicity activity toward a large panel of HLA-typed EBV-transformed B lymphoblastoid cell lines. We identified several cross-reactive pp65/A*0201-specific T cell lines toward allogeneic HLA-A*3001, A*3101, or A*3201. Moreover, we described here cross-recognition of HLA-Cw*0602 by BZLF1/B*3501-specific T cells. It is noteworthy that these alloreactive CD8 T cell lines showed efficient recognition of endothelial cells expressing the relevant HLA class I allele, with high level TNF-alpha production and cytotoxicity activity. Taken together, our data support the notion that herpes virus-specific T cells recognizing allo-HLA alleles may promote solid organ rejection.	[Morice, Alexis; Neveu, Berangere; Bonneville, Marc; Houssaint, Elisabeth] Univ Nantes, Inst Rech Therapeut, INSERM, UMR892, Nantes, France; [Charreau, Beatrice; Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] INSERM, UMR 643, Nantes, France; [Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Brouard, Sophie; Soulillou, Jean-Paul; Degauque, Nicolas] Univ Nantes, Fac Med, Nantes, France; [Houssaint, Elisabeth] Univ Nantes, Fac Sci, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite	Morice, A (corresponding author), Univ Nantes, Inst Rech Therapeut, INSERM, UMR892, Nantes, France.	nicolas.degauque@univ-nantes.fr	CHARREAU, Beatrice/AAK-8186-2020; Degauque, Nicolas/R-4944-2017; brouard, sophie c/Q-1285-2016	CHARREAU, Beatrice/0000-0001-5870-4615; Degauque, Nicolas/0000-0003-2990-3513; 	Centre Hospitalier Universitaire de Nantes, ANR [A05130GS]; Ligue Nationale Contre le Cancer; INSERM; Xenome; European Commission [LSHB-CT-2006-037377]; la Fondation de l'Avenir [ET8-498]; ARC (Association pour la Recherche sur le Cancer)	Centre Hospitalier Universitaire de Nantes, ANR(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Xenome; European Commission(European CommissionEuropean Commission Joint Research Centre); la Fondation de l'Avenir; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from Centre Hospitalier Universitaire de Nantes, ANR (A05130GS), Ligue Nationale Contre le Cancer, and by institutional grants from INSERM, Xenome, a European Commission-funded Integrated Project, Life Sciences, Genomics and Biotechnology for Health LSHB-CT-2006-037377, and by a grant from la Fondation de l'Avenir (contrat ET8-498). A. Morice is funded by ARC (Association pour la Recherche sur le Cancer) and N. Degauque is a Transplantation Society (TTS) post-doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Burrows SR, 1997, EUR J IMMUNOL, V27, P1726, DOI 10.1002/eji.1830270720; Burrows SR, 1999, IMMUNOL TODAY, V20, P203, DOI 10.1016/S0167-5699(98)01429-7; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; DavidAmeline J, 1996, J IMMUNOL, V157, P4697; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; Doxiadis IIN, 1996, LANCET, V348, P850, DOI 10.1016/S0140-6736(96)02296-9; EPPERSON DE, 1994, J IMMUNOL, V153, P5402; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Finn O J, 1996, Int Rev Immunol, V13, P187, DOI 10.3109/08830189609061747; Gamadia LE, 2004, TRANSPLANTATION, V77, P1879, DOI 10.1097/01.tp.0000131158.81346.64; GASCHET J, 1995, BONE MARROW TRANSPL, V16, P427; GERTH UC, 1995, ANN NY ACAD SCI, V756, P12, DOI 10.1111/j.1749-6632.1995.tb44478.x; Grunewald J, 1999, SPRINGER SEMIN IMMUN, V21, P1, DOI 10.1007/BF00815174; Heemskerk MBA, 2005, HUM IMMUNOL, V66, P969, DOI 10.1016/j.humimm.2005.06.007; Hislop AD, 2001, J IMMUNOL, V167, P2019, DOI 10.4049/jimmunol.167.4.2019; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; KHANNA R, 1995, MICROBIOL REV, V59, P387, DOI 10.1128/MMBR.59.3.387-405.1995; Koelle DM, 2002, BLOOD, V99, P3844, DOI 10.1182/blood.V99.10.3844; Kreisel D, 2002, NAT MED, V8, P233, DOI 10.1038/nm0302-233; Landais E, 2006, J IMMUNOL, V177, P1427, DOI 10.4049/jimmunol.177.3.1427; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Le Bas-Bernardet S, 2003, AM J TRANSPLANT, V3, P167, DOI 10.1034/j.1600-6143.2003.00021.x; Maruya E, 1993, Clin Transpl, P511; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Moya-Quiles MR, 2003, LIVER TRANSPLANT, V9, P218, DOI 10.1053/jlts.2003.50043; Neveu B, 2006, INT IMMUNOL, V18, P1139, DOI 10.1093/intimm/dxl048; Pober JS, 1996, TRANSPLANTATION, V61, P343, DOI 10.1097/00007890-199602150-00001; Razonable Raymund R, 2003, Herpes, V10, P60; Saulquin X, 2000, EUR J IMMUNOL, V30, P2531, DOI 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O; Scotet E, 1999, EUR J IMMUNOL, V29, P973, DOI 10.1002/(SICI)1521-4141(199903)29:03<973::AID-IMMU973>3.3.CO;2-G; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Steven NM, 1996, J EXP MED, V184, P1801, DOI 10.1084/jem.184.5.1801; Steven NM, 1997, J EXP MED, V185, P1605, DOI 10.1084/jem.185.9.1605; Streblow DN, 2007, CURR OPIN IMMUNOL, V19, P577, DOI 10.1016/j.coi.2007.07.012; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tan LC, 1999, J IMMUNOL, V162, P1827; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	46	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12120	10.1371/journal.pone.0012120	http://dx.doi.org/10.1371/journal.pone.0012120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711433	Green Published, gold, Green Submitted			2022-12-27	WOS:000280859700013
J	Chen, C; Krishnan, R; Zhou, EH; Ramachandran, A; Tambe, D; Rajendran, K; Adam, RM; Deng, LH; Fredberg, JJ				Chen, Cheng; Krishnan, Ramaswamy; Zhou, Enhua; Ramachandran, Aruna; Tambe, Dhananjay; Rajendran, Kavitha; Adam, Rosalyn M.; Deng, Linhong; Fredberg, Jeffrey J.			Fluidization and Resolidification of the Human Bladder Smooth Muscle Cell in Response to Transient Stretch	PLOS ONE			English	Article							FOCAL ADHESIONS; ACTIN POLYMERIZATION; MYOSIN BINDING; SLOW DYNAMICS; ZYXIN; EXPRESSION; LOCOMOTION; MECHANICS; WORMLIKE; STRESSES	Background: Cells resident in certain hollow organs are subjected routinely to large transient stretches, including every adherent cell resident in lungs, heart, great vessels, gut, and bladder. We have shown recently that in response to a transient stretch the adherent eukaryotic cell promptly fluidizes and then gradually resolidifies, but mechanism is not yet understood. Principal Findings: In the isolated human bladder smooth muscle cell, here we applied a 10% transient stretch while measuring cell traction forces, elastic modulus, F-actin imaging and the F-actin/G-actin ratio. Immediately after a transient stretch, F-actin levels and cell stiffness were lower by about 50%, and traction forces were lower by about 70%, both indicative of prompt fluidization. Within 5min, F-actin levels recovered completely, cell stiffness recovered by about 90%, and traction forces recovered by about 60%, all indicative of resolidification. The extent of the fluidization response was uninfluenced by a variety of signaling inhibitors, and, surprisingly, was localized to the unstretch phase of the stretch-unstretch maneuver in a manner suggestive of cytoskeletal catch bonds. When we applied an "unstretch-restretch'' (transient compression), rather than a "stretch-unstretch'' (transient stretch), the cell did not fluidize and the actin network did not depolymerize. Conclusions: Taken together, these results implicate extremely rapid actin disassembly in the fluidization response, and slow actin reassembly in the resolidification response. In the bladder smooth muscle cell, the fluidization response to transient stretch occurs not through signaling pathways, but rather through release of increased tensile forces that drive acute disassociation of actin.	[Chen, Cheng; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Chen, Cheng; Krishnan, Ramaswamy; Zhou, Enhua; Tambe, Dhananjay; Rajendran, Kavitha; Deng, Linhong; Fredberg, Jeffrey J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Ramachandran, Aruna; Adam, Rosalyn M.] Harvard Univ, Sch Med, Urol Dis Res Ctr, Dept Urol,Childrens Hosp Boston, Boston, MA USA; [Ramachandran, Aruna; Adam, Rosalyn M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Chongqing University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Chen, C (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China.	denglh@cqu.edu.cn	Ladoux, Benoit/A-9879-2013; Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Fredberg, Jeffrey/M-9877-2019; Tambe, Dhananjay/E-3511-2010	Deng, Linhong/0000-0003-1970-8239; Tambe, Dhananjay/0000-0002-6534-6577; Chen, Cheng/0000-0002-7323-1104	National Natural Science Foundation of China [30670516, 30770529]; Chongqing Natural Science Foundation (CSTC) [2010BA5001]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077195] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the National Natural Science Foundation of China (Grant No. 30670516 and Grant No. 30770529 to LD) and Chongqing Natural Science Foundation (Project No. CSTC, 2010BA5001). CC is supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2004, PHYSIOL GENOMICS, V20, P36, DOI 10.1152/physiolgenomics.00181.2004; Adam RM, 2006, NEPHRON EXP NEPHROL, V102, pE1, DOI 10.1159/000088310; Adam RM, 2003, J UROLOGY, V169, P2388, DOI 10.1097/01.ju.0000063980.99368.35; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Borer JG, 1999, LAB INVEST, V79, P1335; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kroy K, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/416; Kroy K, 2008, SOFT MATTER, V4, P2323, DOI 10.1039/b807018k; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lenormand G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041901; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PENDER N, 1991, J CELL SCI, V100, P187; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; PRATUSEVICH VR, 1995, J GEN PHYSIOL, V105, P73, DOI 10.1085/jgp.105.1.73; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Tolic-Norrelykke IM, 2002, AM J PHYSIOL-CELL PH, V283, pC1254, DOI 10.1152/ajpcell.00169.2002; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wille JJ, 2004, J BIOMECH ENG-T ASME, V126, P545, DOI 10.1115/1.1798053; Wolff L, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053024; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	48	83	85	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12035	10.1371/journal.pone.0012035	http://dx.doi.org/10.1371/journal.pone.0012035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700509	gold, Green Published, Green Submitted			2022-12-27	WOS:000280687900020
J	Grietens, KP; Gies, S; Coulibaly, SO; Ky, C; Somda, J; Toomer, E; Ribera, JM; D'Alessandro, U				Grietens, Koen Peeters; Gies, Sabine; Coulibaly, Sheick Oumar; Ky, Clotilde; Somda, Judith; Toomer, Elizabeth; Ribera, Joan Muela; D'Alessandro, Umberto			Bottlenecks for High Coverage of Intermittent Preventive Treatment in Pregnancy: The Case of Adolescent Pregnancies in Rural Burkina Faso	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SULFADOXINE-PYRIMETHAMINE; ANTENATAL CARE; POLICY CHANGE; MALARIA; WOMEN; KENYA; KNOWLEDGE; DISEASE; BURDEN	Background: While IPTp-SP is currently being scaled up in sub-Saharan Africa (SSA), the coverage with the required >= 2 doses of SP remains considerably short of the Roll Back Malaria (RBM) goal of 80%, not to mention of the recently advocated universal coverage. Methods: The study triangulates quantitative data from a health center randomized community-based trial on IPTp-SP effectiveness and the additional benefit of a promotional campaign with qualitative data from focused ethnography. Findings: In rural Burkina Faso, despite the significantly higher risk of malaria infection among adolescent primigravidae (PG) (OR 2.44 95% CI 1.81-3.28, p<0.001), making them primary target beneficiaries of IPTp-SP, adolescents adhered to the required three or more ANC visits significantly less (PG: 46.6%; SG 43.7%) than adults (PG: 61.9%; SG 54.9%) and had lower SP uptake during the malaria transmission season, further showing the difficulty of reaching this age group. Adolescents' structural constraints (such as their social position and household labor requirements) and needs (such as anonymity in the health encounter) leave them highly vulnerable during their pregnancies and, especially, during the high malaria transmission season. Conclusion: Our study shows that adolescents need to be targeted specifically, prior to their first pregnancy and with measures adapted to their social context, addressing their structural constraints and needs and going beyond standard health promotion campaigns. Unless such specific measures are taken, adolescents' social vulnerability will present a serious bottleneck for the effectiveness of IPTi-SP.	[Grietens, Koen Peeters; Gies, Sabine; D'Alessandro, Umberto] Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; [Grietens, Koen Peeters; Toomer, Elizabeth; Ribera, Joan Muela] PASS Int, Tessenderlo, Belgium; [Coulibaly, Sheick Oumar] Univ Ouagadougou, UFR Sci Sante, Ouagadougou, Burkina Faso; [Coulibaly, Sheick Oumar; Ky, Clotilde; Somda, Judith] Lab Natl Sante Publ, Ouagadougou, Burkina Faso	Institute of Tropical Medicine (ITM)	Grietens, KP (corresponding author), Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium.	kpeeters@itg.be	D'Alessandro, Umberto/D-3457-2015; Peeters Grietens, Koen/G-7028-2019; Ribera, JM/B-8181-2009	D'Alessandro, Umberto/0000-0001-6341-5009; Peeters Grietens, Koen/0000-0001-6570-9887; Ribera, JM/0000-0003-1042-6024; muela ribera, joan/0000-0003-2111-6275	European Union [IC4-CT-2002-10022]; Belgian cooperation (Directorate-General for Development Cooperation, DGDC); Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso; SOFI-A	European Union(European Commission); Belgian cooperation (Directorate-General for Development Cooperation, DGDC); Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso; SOFI-A	This work was supported by the European Union INCO-DEV program (contract IC4-CT-2002-10022). SG was partly supported by the Belgian cooperation (Directorate-General for Development Cooperation, DGDC) through the framework agreement of the Institute for Tropical Medicine, Antwerp - Center Muraz, Bobo-Dioulasso and the SOFI-A research fund. Neither funding source had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Anthropological Association, 2018, COD ETH AM ANTHR ASS; American Anthropological Association, AM ANTHR ASS STAT ET; [Anonymous], GLOB MAL ACT PLAN; [Anonymous], 2005, GLOB STRAT PLAN 2005; [Anonymous], 2008, WORLD MAL REP 2008; Brabin L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-2; Brabin L, 1998, ACTA OBSTET GYN SCAN, V77, P402, DOI 10.1034/j.1600-0412.1998.770408.x; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; BRADY M, 2007, TRANSITIONS ADULTHOO, V9; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; DELACRUZ AC, 1996, J PHILIPP MED ASSOC, V71, P255; Gies S, 2009, AM J TROP MED HYG, V80, P460, DOI 10.4269/ajtmh.2009.80.460; Gies S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-180; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hounton SH, 2008, SCAND J PUBLIC HEALT, V36, P310, DOI 10.1177/1403494807085361; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Marchant T, 2002, TROP MED INT HEALTH, V7, P149, DOI 10.1046/j.1365-3156.2002.00840.x; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Newman RD, 2006, TROP MED INT HEALTH, V11, P462, DOI 10.1111/j.1365-3156.2006.01593.x; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Nikiema B, 2008, WORLD DEV, V36, P608, DOI 10.1016/j.worlddev.2007.04.019; OJENGBEDE O A, 1987, African Journal of Medicine and Medical Sciences, V16, P89; OKONOFUA FE, 1992, J TROP MED HYG, V95, P309; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; *RBM, 2005, MON EV REF GROUP MER; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; SCHULTZ LJ, 1994, TROP MED PARASITOL, V45, P65; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Stokes E, 2008, BJOG-INT J OBSTET GY, V115, P1641, DOI 10.1111/j.1471-0528.2008.01950.x; van Eijk AM, 2005, TROP MED INT HEALTH, V10, P1134, DOI 10.1111/j.1365-3156.2005.01497.x; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; *WHO, 2004, AD PREGN	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12013	10.1371/journal.pone.0012013	http://dx.doi.org/10.1371/journal.pone.0012013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	635WK	20700460	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900012
J	Leadbeater, E; Carruthers, JM; Green, JP; van Heusden, J; Field, J				Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; van Heusden, Jasper; Field, Jeremy			Unrelated Helpers in a Primitively Eusocial Wasp: Is Helping Tailored Towards Direct Fitness?	PLOS ONE			English	Article							POLISTES-DOMINULUS; ANIMAL SOCIETIES; PAPER WASP; GENETIC-MARKERS; FUTURE FITNESS; HYMENOPTERA; RECIPROCITY; HIERARCHY; VESPIDAE; DISCRIMINATION	The paper wasp Polistes dominulus is unique among the social insects in that nearly one-third of co-foundresses are completely unrelated to the dominant individual whose offspring they help to rear and yet reproductive skew is high. These unrelated subordinates stand to gain direct fitness through nest inheritance, raising the question of whether their behaviour is adaptively tailored towards maximizing inheritance prospects. Unusually, in this species, a wealth of theory and empirical data allows us to predict how unrelated subordinates should behave. Based on these predictions, here we compare helping in subordinates that are unrelated or related to the dominant wasp across an extensive range of field-based behavioural contexts. We find no differences in foraging effort, defense behaviour, aggression or inheritance rank between unrelated helpers and their related counterparts. Our study provides no evidence, across a number of behavioural scenarios, that the behaviour of unrelated subordinates is adaptively modified to promote direct fitness interests.	[Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; van Heusden, Jasper; Field, Jeremy] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Carruthers, Jonathan M.] Univ Sheffield, Nat Environm Res Council NERC, Biomol Anal Facil, Sheffield, S Yorkshire, England	University of Sussex; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield	Leadbeater, E (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	e.leadbeater@sussex.ac.uk			Natural Environment Research Council (NERC) [NE/E017894/1]; NERC [NBAF010001, NE/E017894/1] Funding Source: UKRI; Natural Environment Research Council [NE/E017894/1, NBAF010001] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by Natural Environment Research Council (NERC) grant NE/E017894/1 to Jeremy Field. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, SOCIAL BIOL WASPS; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Cant MA, 2006, P ROY SOC B-BIOL SCI, V273, P2977, DOI 10.1098/rspb.2006.3669; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Cant MA, 2006, AM NAT, V167, P837, DOI 10.1086/503445; CHANDRASHEKARA K, 1992, J INSECT BEHAV, V5, P193, DOI 10.1007/BF01049289; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Cronin AL, 2007, BEHAV ECOL, V18, P331, DOI 10.1093/beheco/arl091; Dani FR, 2004, P ROY SOC B-BIOL SCI, V271, P745, DOI 10.1098/rspb.2003.2646; Dapporto L, 2004, BEHAV ECOL SOCIOBIOL, V56, P315, DOI 10.1007/s00265-004-0800-y; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; Field J, 2007, BEHAV PROCESS, V76, P160, DOI 10.1016/j.beproc.2007.01.019; Field J, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P305, DOI 10.1017/CBO9780511641954.013; Field J, 2009, PHILOS T R SOC B, V364, P3181, DOI 10.1098/rstb.2009.0110; Gamboa George J., 1996, P161; GAMBOA GJ, 1978, SCIENCE, V199, P1463, DOI 10.1126/science.199.4336.1463; GLOOR GB, 1993, GENETICS, V135, P81; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Henshaw MT, 2000, MOL ECOL, V9, P2155, DOI 10.1046/j.1365-294X.2000.01053.x; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Liebert AE, 2006, ANIM BEHAV, V71, P913, DOI 10.1016/j.anbehav.2005.09.005; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; POST DC, 1982, BEHAV ECOL SOCIOBIOL, V11, P283, DOI 10.1007/BF00299305; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; RABENOLD KN, 1985, BEHAV ECOL SOCIOBIOL, V17, P1, DOI 10.1007/BF00299422; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Starks PT, 2003, ANN ZOOL FENN, V40, P53; TURILLAZZI S, 1977, MONIT ZOOL ITAL, V11, P101; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x; [No title captured]	37	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11997	10.1371/journal.pone.0011997	http://dx.doi.org/10.1371/journal.pone.0011997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700463	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000280687900007
J	Gherardini, PF; Ausiello, G; Helmer-Citterich, M				Gherardini, Pier Federico; Ausiello, Gabriele; Helmer-Citterich, Manuela			Superpose3D: A Local Structural Comparison Program That Allows for User-Defined Structure Representations	PLOS ONE			English	Article							PROTEIN-STRUCTURE ALIGNMENT; METHIONINE AMINOPEPTIDASE; FUNCTION PREDICTION; CRYSTAL-STRUCTURE; BINDING-SITE; SEQUENCE; DATABASE; MOTIFS; RECOGNITION; EVOLUTION	Local structural comparison methods can be used to find structural similarities involving functional protein patches such as enzyme active sites and ligand binding sites. The outcome of such analyses is critically dependent on the representation used to describe the structure. Indeed different categories of functional sites may require the comparison program to focus on different characteristics of the protein residues. We have therefore developed superpose3D, a novel structural comparison software that lets users specify, with a powerful and flexible syntax, the structure description most suited to the requirements of their analysis. Input proteins are processed according to the user's directives and the program identifies sets of residues (or groups of atoms) that have a similar 3D position in the two structures. The advantages of using such a general purpose program are demonstrated with several examples. These test cases show that no single representation is appropriate for every analysis, hence the usefulness of having a flexible program that can be tailored to different needs. Moreover we also discuss how to interpret the results of a database screening where a known structural motif is searched against a large ensemble of structures. The software is written in C++ and is released under the open source GPL license. Superpose3D does not require any external library, runs on Linux, Mac OSX, Windows and is available at http://cbm.bio.uniroma2.it/superpose3D.	[Gherardini, Pier Federico; Ausiello, Gabriele; Helmer-Citterich, Manuela] Univ Roma Tor Vergata, Dept Biol, Ctr Mol Bioinformat, I-00173 Rome, Italy	University of Rome Tor Vergata	Gherardini, PF (corresponding author), Univ Roma Tor Vergata, Dept Biol, Ctr Mol Bioinformat, I-00173 Rome, Italy.	gabriele.ausiello@uniroma2.it		Helmer-Citterich, Manuela/0000-0001-9530-7504	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the LEISHDRUG European Commission Framework Programme 7 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Ausiello G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S5; Betancourt MR, 2001, BIOPOLYMERS, V59, P305, DOI 10.1002/1097-0282(20011015)59:5<305::AID-BIP1027>3.3.CO;2-Y; Binda C, 2007, J MED CHEM, V50, P5848, DOI 10.1021/jm070677y; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Chang DTH, 2004, NUCLEIC ACIDS RES, V32, pW76, DOI 10.1093/nar/gkh425; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Davies JR, 2007, BIOINFORMATICS, V23, P3001, DOI 10.1093/bioinformatics/btm470; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; Evdokimov AG, 2007, PROTEINS, V66, P538, DOI 10.1002/prot.21207; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FISCHER D, 1992, J BIOMOL STRUCT DYN, V9, P769, DOI 10.1080/07391102.1992.10507955; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Gherardini Pier Federico, 2008, Briefings in Functional Genomics & Proteomics, V7, P291, DOI 10.1093/bfgp/eln030; Goto M, 2002, J BIOL CHEM, V277, P15890, DOI 10.1074/jbc.M112430200; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kack H, 1998, P NATL ACAD SCI USA, V95, P5495, DOI 10.1073/pnas.95.10.5495; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Lowther WT, 1999, BIOCHEMISTRY-US, V38, P14810, DOI 10.1021/bi991711g; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pennec X, 1998, BIOINFORMATICS, V14, P516, DOI 10.1093/bioinformatics/14.6.516; Pollegioni L, 2002, J MOL BIOL, V324, P535, DOI 10.1016/S0022-2836(02)01062-8; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Springate-Baginski O., 2003, Journal of Forest and Livelihood, V3, P21; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yamauchi T, 2009, J BIOCHEM, V145, P421, DOI 10.1093/jb/mvp010	39	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11988	10.1371/journal.pone.0011988	http://dx.doi.org/10.1371/journal.pone.0011988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700534	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400021
J	Nie, HS; Crooijmans, RPMA; Lammers, A; van Schothorst, EM; Keijer, J; Neerincx, PBT; Leunissen, JAM; Megens, HJ; Groenen, MAM				Nie, Haisheng; Crooijmans, Richard P. M. A.; Lammers, Aart; van Schothorst, Evert M.; Keijer, Jaap; Neerincx, Pieter B. T.; Leunissen, Jack A. M.; Megens, Hendrik-Jan; Groenen, Martien A. M.			Gene Expression in Chicken Reveals Correlation with Structural Genomic Features and Conserved Patterns of Transcription in the Terrestrial Vertebrates	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; SALMONELLA INFECTION; RESPONSES; SELECTION; CLUSTERS; LINES	Background: The chicken is an important agricultural and avian-model species. A survey of gene expression in a range of different tissues will provide a benchmark for understanding expression levels under normal physiological conditions in birds. With expression data for birds being very scant, this benchmark is of particular interest for comparative expression analysis among various terrestrial vertebrates. Methodology/Principal Findings: We carried out a gene expression survey in eight major chicken tissues using whole genome microarrays. A global picture of gene expression is presented for the eight tissues, and tissue specific as well as common gene expression were identified. A Gene Ontology (GO) term enrichment analysis showed that tissue-specific genes are enriched with GO terms reflecting the physiological functions of the specific tissue, and housekeeping genes are enriched with GO terms related to essential biological functions. Comparisons of structural genomic features between tissue-specific genes and housekeeping genes show that housekeeping genes are more compact. Specifically, coding sequence and particularly introns are shorter than genes that display more variation in expression between tissues, and in addition intergenic space was also shorter. Meanwhile, housekeeping genes are more likely to co-localize with other abundantly or highly expressed genes on the same chromosomal regions. Furthermore, comparisons of gene expression in a panel of five common tissues between birds, mammals and amphibians showed that the expression patterns across tissues are highly similar for orthologuous genes compared to random gene pairs within each pair-wise comparison, indicating a high degree of functional conservation in gene expression among terrestrial vertebrates. Conclusions: The housekeeping genes identified in this study have shorter gene length, shorter coding sequence length, shorter introns, and shorter intergenic regions, there seems to be selection pressure on economy in genes with a wide tissue distribution, i.e. these genes are more compact. A comparative analysis showed that the expression patterns of orthologous genes are conserved in the terrestrial vertebrates during evolution.	[Nie, Haisheng; Crooijmans, Richard P. M. A.; Megens, Hendrik-Jan; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Lammers, Aart] Wageningen Univ, Adaptat Physiol Grp, Wageningen, Netherlands; [Neerincx, Pieter B. T.; Leunissen, Jack A. M.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Nie, HS (corresponding author), Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands.	martien.groenen@wur.nl	Megens, Hendrik-Jan/E-9676-2010; Crooijmans, Richard PMA/E-2492-2012; Groenen, Martien/D-8408-2012; Megens, Hendrik-Jan/M-5300-2019; Keijer, Jaap/J-8089-2013	Megens, Hendrik-Jan/0000-0002-3619-7533; Groenen, Martien/0000-0003-0484-4545; Megens, Hendrik-Jan/0000-0002-3619-7533; Keijer, Jaap/0000-0002-9720-7491; van Schothorst, Evert/0000-0002-3036-5903	European Union [FOOD-CT-2004-506416]	European Union(European Commission)	This work was financed by European Union grant FOOD-CT-2004-506416 (EADGENE), website: www.eadgene.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huber W, 2002, BIOINFORMATICS, V18, pS96; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kim DK, 2008, POULTRY SCI, V87, P433, DOI 10.3382/ps.2007-00383; Kim DK, 2008, DEV BIOLOGICALS, V132, P131, DOI 10.1159/000317153; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Morgan RW, 2001, J VIROL, V75, P533, DOI 10.1128/JVI.75.1.533-539.2001; Neerincx Pieter B T, 2009, BMC Proc, V3 Suppl 4, pS4, DOI 10.1186/1753-6561-3-S4-S4; Nie HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-28; R Core Team, 2018, R LANG ENV STAT COMP; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Van Hemert S, 2007, VET RES, V38, P51, DOI 10.1051/vetres:2006048; van Hemert S, 2006, VET IMMUNOL IMMUNOP, V114, P247, DOI 10.1016/j.vetimm.2006.08.007; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	26	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11990	10.1371/journal.pone.0011990	http://dx.doi.org/10.1371/journal.pone.0011990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700537	Green Submitted, gold, Green Published			2022-12-27	WOS:000280605400022
J	Laporte, I; Muhly, TB; Pitt, JA; Alexander, M; Musiani, M				Laporte, Isabelle; Muhly, Tyler B.; Pitt, Justin A.; Alexander, Mike; Musiani, Marco			Effects of Wolves on Elk and Cattle Behaviors: Implications for Livestock Production and Wolf Conservation	PLOS ONE			English	Article							GROUP-SIZE; CERVUS-ELAPHUS; PREDATION RISK; HABITAT USE; HEART-RATE; VIGILANCE; RESPONSES; PATTERNS; PREY; FEAR	Background: In many areas, livestock are grazed within wolf (Canis lupus) range. Predation and harassment of livestock by wolves creates conflict and is a significant challenge for wolf conservation. Wild prey, such as elk (Cervus elaphus), perform anti-predator behaviors. Artificial selection of cattle (Bos taurus) might have resulted in attenuation or absence of anti-predator responses, or in erratic and inconsistent responses. Regardless, such responses might have implications on stress and fitness. Methodology/Principal Findings: We compared elk and cattle anti-predator responses to wolves in southwest Alberta, Canada within home ranges and livestock pastures, respectively. We deployed satellite- and GPS-telemetry collars on wolves, elk, and cattle (n = 16, 10 and 78, respectively) and measured seven prey response variables during periods of wolf presence and absence (speed, path sinuosity, time spent head-up, distance to neighboring animals, terrain ruggedness, slope and distance to forest). During independent periods of wolf presence (n = 72), individual elk increased path sinuosity (Z = -2.720, P = 0.007) and used more rugged terrain (Z = -2.856, P = 0.004) and steeper slopes (Z = -3.065, P = 0.002). For cattle, individual as well as group behavioral analyses were feasible and these indicated increased path sinuosity (Z = -2.720, P = 0.007) and decreased distance to neighbors (Z = -2.551, P = 0.011). In addition, cattle groups showed a number of behavioral changes concomitant to wolf visits, with variable direction in changes. Conclusions/Significance: Our results suggest both elk and cattle modify their behavior in relation to wolf presence, with potential energetic costs. Our study does not allow evaluating the efficacy of anti-predator behaviors, but indicates that artificial selection did not result in their absence in cattle. The costs of wolf predation on livestock are often compensated considering just the market value of the animal killed. However, society might consider refunding some additional costs (e.g., weight loss and reduced reproduction) that might be associated with the changes in cattle behaviors that we documented.	[Laporte, Isabelle; Muhly, Tyler B.; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Pitt, Justin A.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2M7, Canada; [Alexander, Mike] Alberta Sustainable Resource Dev, Lands Div, Pincher Creek, AB, Canada	University of Calgary; University of Alberta	Laporte, I (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	tmuhly@ucalgary.ca	Musiani, Marco/ABB-9387-2021	Musiani, Marco/0000-0002-6097-5841	Alberta Beef Producers; Alberta Community Development; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Bob Creek Ranch; Defenders of Wildlife; Parks Canada; Institute for Sustainable Energy; Environment and the Economy; Natural Science and Engineering Research Council of Canada; The Rocky Mountain Forest Range Association; Shell Canada; Southern Alberta Land Trust Society	Alberta Beef Producers; Alberta Community Development; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Bob Creek Ranch; Defenders of Wildlife; Parks Canada; Institute for Sustainable Energy; Environment and the Economy; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); The Rocky Mountain Forest Range Association; Shell Canada; Southern Alberta Land Trust Society	Funding sources: Alberta Beef Producers, Alberta Community Development, Alberta Conservation Association, Alberta Tourism, Parks and Recreation, Bob Creek Ranch, Defenders of Wildlife, Parks Canada, the Institute for Sustainable Energy, Environment and the Economy, the Natural Science and Engineering Research Council of Canada, The Rocky Mountain Forest Range Association, Shell Canada, and the Southern Alberta Land Trust Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALCOCK J, 2005, ANIMAL BEHAV EVOLUTI; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bleich VC, 1999, J MAMMAL, V80, P283, DOI 10.2307/1383228; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Chabot D, 1996, J CHEM ECOL, V22, P839, DOI 10.1007/BF02033590; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Coppinger R., 2001, DOGS NEW UNDERSTANDI; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; DICKE M, 1988, PHYSIOL ENTOMOL, V13, P393, DOI 10.1111/j.1365-3032.1988.tb01122.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FARIES FC, 1997, CONTROLLING BOVINE T; FIEBERG J, 2010, PHILOS T B IN PRESS; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Fritts Steven H., 2003, P289; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; *GOV ALB, 2003, BOB CREEK WILDL BLAC; Grandin T, 1997, J ANIM SCI, V75, P249; GRANDIN T, 1998, CAN ACTING PREDATOR; Grandin T, 2007, LIVESTOCK HANDLING AND TRANSPORT, 3RD EDITION, P44, DOI 10.1079/9781845932190.0044; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hebblewhite M, 2006, WILDLIFE SOC B, V34, P1280, DOI 10.2193/0091-7648(2006)34[1280:ITMBOM]2.0.CO;2; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Howery L. D., 2004, Sheep & Goat Research Journal, V19, P53; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Johnsson JI, 2001, CAN J FISH AQUAT SCI, V58, P788, DOI 10.1139/cjfas-58-4-788; Kilgour RJ, 2006, APPL ANIM BEHAV SCI, V99, P21, DOI 10.1016/j.applanim.2005.09.012; Kluever BM, 2009, BEHAV PROCESS, V81, P85, DOI 10.1016/j.beproc.2009.02.004; KONDO S, 1988, CAN J ANIM SCI, V68, P339, DOI 10.4141/cjas88-038; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEHMKUHLER J, 2007, EFFECTS WOLVES OTHER; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x; LYON LJ, 1979, J FOREST, V77, P658; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MCDERMID GJ, 2009, FOR ECOL MANAGE; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; Merrill SB, 2003, WILDLIFE SOC B, V31, P947; Millspaugh JJ, 2004, WILDLIFE SOC B, V32, P506, DOI 10.2193/0091-7648(2004)32[506:HOOCEI]2.0.CO;2; MUEGGLER WALTER F., 1965, J RANGE MANAGE, V18, P255, DOI 10.2307/3895492; MUHLY T, 2010, WORLD WOLVE IN PRESS; MUHLY TB, 2010, OIKOS IN PRESS; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; Musiani M, 2005, WILDLIFE SOC B, V33, P876, DOI 10.2193/0091-7648(2005)33[876:SARODA]2.0.CO;2; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Oakleaf JK, 2003, J WILDLIFE MANAGE, V67, P299, DOI 10.2307/3802771; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Price E. O., 2002, Animal domestication and behavior, P107, DOI 10.1079/9780851995977.0107; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; ROATH LR, 1982, J RANGE MANAGE, V35, P332, DOI 10.2307/3898312; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Skovlin Jon M., 2002, P531; Turchin Peter, 1998; TURNER LW, 2002, CANADIAN J ANIMAL SC, V80, P406; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Voisinet BD, 1997, J ANIM SCI, V75, P892; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Welp T, 2004, APPL ANIM BEHAV SCI, V87, P1, DOI 10.1016/j.applanim.2003.12.013; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x	78	56	56	5	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11954	10.1371/journal.pone.0011954	http://dx.doi.org/10.1371/journal.pone.0011954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694139	Green Published, gold, Green Submitted			2022-12-27	WOS:000280574300010
J	Dehmer, M; Mueller, LAJ; Graber, A				Dehmer, Matthias; Mueller, Laurin A. J.; Graber, Armin			New Polynomial-Based Molecular Descriptors with Low Degeneracy	PLOS ONE			English	Article							DISTANCE; NETWORKS; INDEXES; ENTROPY; GRAPHS	In this paper, we introduce a novel graph polynomial called the 'information polynomial' of a graph. This graph polynomial can be derived by using a probability distribution of the vertex set. By using the zeros of the obtained polynomial, we additionally define some novel spectral descriptors. Compared with those based on computing the ordinary characteristic polynomial of a graph, we perform a numerical study using real chemical databases. We obtain that the novel descriptors do have a high discrimination power.	[Dehmer, Matthias; Mueller, Laurin A. J.; Graber, Armin] Private Univ Med Informat & Tech UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria		Dehmer, M (corresponding author), Private Univ Med Informat & Tech UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at			COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria represented by the Styrian Business Promotion Agency (SFG); University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG	COMET Center ONCOTYROL; Federal Ministry for Transport Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Tiroler Zukunftsstiftung (TZS); State of Styria represented by the Styrian Business Promotion Agency (SFG); University for Health Sciences, Medical Informatics and Technology; BIOCRATES Life Sciences AG	This work was supported by the COMET Center ONCOTYROL and funded by the Federal Ministry for Transport Innovation and Technology (BMVIT) and the Federal Ministry of Economics and Labour/Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ), the Tiroler Zukunftsstiftung (TZS), and the State of Styria represented by the Styrian Business Promotion Agency (SFG) (and supported by the University for Health Sciences, Medical Informatics and Technology and BIOCRATES Life Sciences AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorath J., 2004, CHEMOINFORMATICS CON; Balaban A.T, 1999, TOPOLOGICAL INDICES, P59; BangJensen Jorgen, 2002, DIGRAPHS THEORY ALGO; Basak SC, 2000, J CHEM INF COMP SCI, V40, P927, DOI 10.1021/ci990119v; Basak SC, 1999, TOPOLOGICAL INDICES, P563; BONCHEV D, 1995, THEOCHEM-J MOL STRUC, V336, P137, DOI 10.1016/0166-1280(94)04081-3; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 1991, CHEM GRAPH THEORY IN, DOI [10.1201/9781315139104, DOI 10.1201/9781315139104]; Bonchev D, 1983, INFORM THEORETIC IND; Bretscher O., 2004, LINEAR ALGEBRA APPL; Chen SJ, 1996, J CHEM PHYS, V104, P5964, DOI 10.1063/1.471328; Cover TM., 2006, WILEY SERIES TELECOM; CVETKOVIC DM, 1997, SPECTRA GRAPHS; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Devillers J., 1999, TOPOLOGICAL INDICES; Diudea M.V., 2001, MOL TOPOLOGY; Dong F. M., 2005, CHROMATIC POLYNOMIAL; ELLISMONAGHAN JA, 2010, STRUCTURAL IN PRESS; Emmert-Streib F, 2006, J COMPUT BIOL, V13, P1503, DOI 10.1089/cmb.2006.13.1503; Estrada E, 2002, BIOINFORMATICS, V18, P697, DOI 10.1093/bioinformatics/18.5.697; FUKUI M, 1984, NUMBER THEORY COMBIN, P97; Gasteiger J., 2003, CHEMOINFORMATICS TXB; Gutman I, 1991, CHEM GRAPH THEORY IN, P133; HANSEN K, 2009, J CHEM INF MODEL; HOSOYA H, 1988, DISCRETE APPL MATH, V19, P239, DOI 10.1016/0166-218X(88)90017-0; Ivanciuc O., 1999, ROUM CHEM Q REV, V7, P41; Jackson B., 2003, J GEOMETRY, V76, P95; KAMAE T, 1983, J MATH ANAL APPL, V97, P355, DOI 10.1016/0022-247X(83)90202-0; Konstantinova EV, 2006, LECT NOTES COMPUT SC, V4123, P831; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; Kovse M., 2009, ANAL COMPLEX NETWORK, P323; Lovasz L, 1973, PERIOD MATH HUNG, V3, P175, DOI 10.1007/bf02018473; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mignotte M., 1999, POLYNOMIALS ALGORITH; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; Pachter L., 2005, ALGEBRAIC STAT COMPU; *R DEV COR TEAM FD, 2008, R SOFTW LANG ENV STA; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Randic M., 2001, QSPR QSAR STUDIES MO QSPR QSAR STUDIES MO, P93; Robles-Kelly A, 2005, IEEE T PATTERN ANAL, V27, P365, DOI 10.1109/TPAMI.2005.56; Schwaighofer A, 2008, J CHEM INF MODEL, V48, P785, DOI 10.1021/ci700142c; SCSIBRANY H, 2004, SOFTWARE SUBMAT; Shannon CE, 1997, MATH THEORY COMMUNIC; STEIN SE, 1998, NIST MASS SPECTRAL D; Todeschini R, 1999, CHEMOMETR INTELL LAB, V46, P13, DOI 10.1016/S0169-7439(98)00124-5; TODESCHINI R, 1992, CHEMOMETR INTELL LAB, V15, P51, DOI 10.1016/0169-7439(92)80026-Z; Todeschini R., 2002, HDB MOL DESCRIPTORS; Trinajstic N., 2018, CHEM GRAPH THEORY; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; WOODALL DR, 1992, DISCRETE MATH, V101, P333, DOI 10.1016/0012-365X(92)90614-L	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11393	10.1371/journal.pone.0011393	http://dx.doi.org/10.1371/journal.pone.0011393			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689599	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300002
J	De Feo, G; Signoriello, S; Bryce, JC; Del Giudice, A; Canzanella, G; Crudele, F; Romano, F; de Matteis, G; Florio, M; Falasconi, F; Savio, A; Giordano, P; Daniele, G; Iaccarino, M; Piccirillo, MC; Di Maio, M; Morabito, A; Gallo, C; Perrone, F				De Feo, Gianfranco; Signoriello, Simona; Bryce, Jane C.; Del Giudice, Antonia; Canzanella, Giuliana; Crudele, Federika; Romano, Fiorella; de Matteis, Giovanni; Florio, Manuela; Falasconi, Fabiano; Savio, Alfonso; Giordano, Pasqualina; Daniele, Gennaro; Iaccarino, Mario; Piccirillo, Maria Carmela; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco			Time Spent for Activation of Non-Profit Studies in Oncology in Italy	PLOS ONE			English	Article							CLINICAL-TRIALS; BARRIERS; IMPACT	Aim: The aim of this paper is to describe the time spent to activate oncological non-profit clinical trials promoted in Italy by the National Cancer Institute of Naples, following the implementation of recent European laws. Methodology: Data about the process of activation of 5 non-profit multicentre clinical trials were prospectively collected through a web-based system. The impact of European guidelines was assessed by comparing the efficiency of the process between applications started before and after the decree introducing in Italy the Clinical Trial Application form (MD-CTA). Outcomes of the descriptive analyses were the time to EC opinion, the time to administrative agreement signature after a positive EC opinion, and the cumulative percentage of submissions that came to closure (either positive or negative) within four subsequent time cohorts. Principal Findings: From March 2007 to October 2009, 202 applications were submitted to 107 centres. Forty-four (59%) applications of those submitted before were successful, compared to 71 (55%) of those submitted after MD-CTA. Most of the failures were due to missing EC response (27% and 22%) or administrative reasons (10% and 16%, before and after, respectively); very few (4% and 7%) were due to EC refusal. The impact of the MD-CTA on time to EC opinion looked positive (median 4.1 vs 2.4 months, before and after, respectively) but a subgroup analysis revealed that the impact was limited to a comparison biased by the selection of EC. After a positive EC opinion, there was no difference before and after MD-CTA in the time to administrative agreement signature (median 3.6 and 3.8 months, respectively). A trend to shortening time to closure of the whole submission process over the time was evident, with 58% of the applications coming to closure within 6 months from submission in the most recent cohort. Conclusions: In our experience there is reassuring evidence of a trend toward shortening the time spent to activate non-profit clinical trials in Italy, but the whole process still remains inefficient. Efforts should be made to improve the process, also focusing on administrative procedures.	[De Feo, Gianfranco; Bryce, Jane C.; Del Giudice, Antonia; Canzanella, Giuliana; Crudele, Federika; Romano, Fiorella; de Matteis, Giovanni; Florio, Manuela; Falasconi, Fabiano; Savio, Alfonso; Giordano, Pasqualina; Daniele, Gennaro; Iaccarino, Mario; Piccirillo, Maria Carmela; Di Maio, Massimo; Morabito, Alessandro; Perrone, Francesco] Natl Canc Inst, Naples, Italy; [Signoriello, Simona; Gallo, Ciro] Univ Naples 2, Dept Med & Publ Hlth, Naples, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	De Feo, G (corresponding author), Natl Canc Inst, Naples, Italy.	francesco.perrone@usc-intnapoli.net	Perrone, Francesco/AAB-8283-2022; Gallo, Ciro/AAA-9241-2019; Di Maio, Massimo/K-9990-2016; Daniele, Gennaro/AAC-1927-2019; Morabito, A./J-4814-2018; DI MAIO, Massimo/AAB-6074-2019	Perrone, Francesco/0000-0002-9738-0526; Gallo, Ciro/0000-0002-7939-3104; Di Maio, Massimo/0000-0001-8906-3785; Morabito, A./0000-0002-1319-9608; DI MAIO, Massimo/0000-0001-8906-3785; Daniele, Gennaro/0000-0001-5360-1895; Bryce, Jane/0000-0002-1371-8172				Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Dilts DM, 2009, J CLIN ONCOL, V27, P1761, DOI 10.1200/JCO.2008.19.9133; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; *EUR PARL, 2005, DET GUID REQ AUTH CL; *EUR PARL, 2007, GUID INV MED PROD IM; *EUR PARL, 2006, DET GUID APPL FORM D; *IT MED AG, 2008, 7 B CLIN TRIALS DRUG; *MIN SAL REP IT, 2007, MOD IN RICH AUT AUT; *MIN SAL REP IT, 2004, DECR MIN 17 DIC 2004; Porcu L, 2008, J MED ETHICS, V34, P747, DOI 10.1136/jme.2007.022178; Stewart DJ, 2010, J CLIN ONCOL, V28, P2925, DOI 10.1200/JCO.2009.27.5404; 2000, 8 B CLIN TRIALS DRUG	12	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11864	10.1371/journal.pone.0011864	http://dx.doi.org/10.1371/journal.pone.0011864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686686	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520200028
J	Li, XY; Swaggerty, CL; Kogut, MH; Chiang, HI; Wang, Y; Genovese, KJ; He, HQ; Zhou, HJ				Li, Xianyao; Swaggerty, Christina L.; Kogut, Michael H.; Chiang, Hsin-I; Wang, Ying; Genovese, Kenneth J.; He, Haiqi; Zhou, Huaijun			Gene Expression Profiling of the Local Cecal Response of Genetic Chicken Lines That Differ in Their Susceptibility to Campylobacter jejuni Colonization	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINE; MESSENGER-RNA EXPRESSION; CIRCADIAN CLOCK; SALMONELLA INFECTION; HETEROPHILS; CELLS; NUTRITION; RESISTANT; IMMUNITY; IDENTIFICATION	Campylobacter jejuni (C. jejuni) is one of the most common causes of human bacterial enteritis worldwide primarily due to contaminated poultry products. Previously, we found a significant difference in C. jejuni colonization in the ceca between two genetically distinct broiler lines (Line A (resistant) has less colony than line B (susceptible) on day 7 post inoculation). We hypothesize that different mechanisms between these two genetic lines may affect their ability to resist C. jejuni colonization in chickens. The molecular mechanisms of the local host response to C. jejuni colonization in chickens have not been well understood. In the present study, to profile the cecal gene expression in the response to C. jejuni colonization and to compare differences between two lines at the molecular level, RNA of ceca from two genetic lines of chickens (A and B) were applied to a chicken whole genome microarray for a pair-comparison between inoculated (I) and non-inoculated (N) chickens within each line and between lines. Our results demonstrated that metabolism process and insulin receptor signaling pathways are key contributors to the different response to C. jejuni colonization between lines A and B. With C. jejuni inoculation, lymphocyte activation and lymphoid organ development functions are important for line A host defenses, while cell differentiation, communication and signaling pathways are important for line B. Interestingly, circadian rhythm appears play a critical role in host response of the more resistant A line to C. jejuni colonization. A dramatic differential host response was observed between these two lines of chickens. The more susceptible line B chickens responded to C. jejuni inoculation with a dramatic up-regulation in lipid, glucose, and amino acid metabolism, which is undoubtedly for use in the response to the colonization with little or no change in immune host defenses. However, in more resistant line A birds the host defense responses were characterized by an up-regulation lymphocyte activation, probably by regulatory T cells and an increased expression of the NLR recognition receptor NALP1. To our knowledge, this is the first time each of these responses has been observed in the avian response to an intestinal bacterial pathogen.	[Li, Xianyao; Chiang, Hsin-I; Wang, Ying; Zhou, Huaijun] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA; [Swaggerty, Christina L.; Kogut, Michael H.; Genovese, Kenneth J.; He, Haiqi] ARS, So Plains Agr Res Ctr, USDA, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA)	Li, XY (corresponding author), Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA.	michael.kogut@ars.usda.gov; hjzhou@poultry.tamu.edu	Kogut, Michael H./Z-3119-2019; Chiang, Hsin-I/AAF-6578-2020	Chiang, Hsin-I/0000-0002-2815-4314; Kogut, Michael/0000-0001-5821-3728	United States Department of Agriculture (USDA) [2007-35604-17903]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This project was supported by National Research Initiative Grant no. 2007-35604-17903 from the United States Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service Animal Genome program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; ASCHOFF J, 1976, BRAIN RES, V101, P1, DOI 10.1016/0006-8993(76)90983-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; BERMAN A, 1978, J PHYSIOL-LONDON, V282, P419, DOI 10.1113/jphysiol.1978.sp012472; Born J, 1997, J IMMUNOL, V158, P4454; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; Bumstead N., 2003, Poultry genetics, breeding and biotechnology, P311, DOI 10.1079/9780851996608.0311; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; BUZBY JC, 1997, ESTIMATED ANN COSTS; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chiang HI, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-526; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cormican P, 2008, IMMUNOGENETICS, V60, P147, DOI 10.1007/s00251-007-0269-8; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Ferro PJ, 2004, EPIDEMIOL INFECT, V132, P1029, DOI 10.1017/S0950268804002687; Floyd RA, 1997, NEUROREPORT, V8, P915, DOI 10.1097/00001756-199703030-00020; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klasing KC, 2007, BRIT POULTRY SCI, V48, P525, DOI 10.1080/00071660701671336; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Kogut MH, 2009, J APPL POULTRY RES, V18, P111, DOI 10.3382/japr.2008-00081; Kogut MH, 2009, J APPL POULTRY RES, V18, P103, DOI 10.3382/japr.2008-00080; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Li X, 2008, POULTRY SCI, V87, P1742, DOI 10.3382/ps.2008-00136; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Monteleone Giovanni, 2006, Dig Liver Dis, V38 Suppl 2, pS256, DOI 10.1016/S1590-8658(07)60005-X; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Panteleeva NG, 2004, B EXP BIOL MED+, V137, P288, DOI 10.1023/B:BEBM.0000031572.40934.c5; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosenberger CM, 2001, MICROBES INFECT, V3, P1353, DOI 10.1016/S1286-4579(01)01497-6; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sick C, 2000, CYTOKINE, V12, P181, DOI 10.1006/cyto.1999.0543; Smith CK, 2005, INFECT IMMUN, V73, P2094, DOI 10.1128/IAI.73.4.2094-2100.2005; Smith J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-49; Smith J, 2004, IMMUNOGENETICS, V56, P122, DOI 10.1007/s00251-004-0669-y; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Swaggerty CL, 2008, VET IMMUNOL IMMUNOP, V126, P35, DOI 10.1016/j.vetimm.2008.06.005; Swaggerty CL, 2005, FOOD AGR IMMUNOL, V16, P1, DOI 10.1080/01421590400029780; Swaggerty CL, 2005, FEMS IMMUNOL MED MIC, V43, P149, DOI 10.1016/j.femsim.2004.07.013; Swaggerty CL, 2004, IMMUNOLOGY, V113, P139, DOI 10.1111/j.1365-2567.2004.01939.x; Swaggerty CL, 2003, AVIAN PATHOL, V32, P483, DOI 10.1080/0307945031000154071; Swaggerty CL, 2003, AVIAN PATHOL, V32, P95, DOI 10.1080/0307945021000070769; Tazawa H, 2002, COMP BIOCHEM PHYS A, V132, P675, DOI 10.1016/S1095-6433(02)00125-3; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Van Hemert S, 2007, VET RES, V38, P51, DOI 10.1051/vetres:2006048; van Hemert S, 2006, VET IMMUNOL IMMUNOP, V114, P247, DOI 10.1016/j.vetimm.2006.08.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhou H, 2007, CYTOGENET GENOME RES, V117, P131, DOI 10.1159/000103173; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005	65	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11827	10.1371/journal.pone.0011827	http://dx.doi.org/10.1371/journal.pone.0011827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676366	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100010
J	Romano, CM; de Matos, AM; Araujo, ESA; Villas-Boas, LS; da Silva, WC; Oliveira, OMNPF; Carvalho, KI; de Souza, ACM; Rodrigues, CL; Levi, JE; Kallas, EG; Pannuti, CS				Romano, Camila Malta; de Matos, Andreia Manso; Araujo, Evaldo Stanislau A.; Villas-Boas, Lucy Santos; da Silva, Wanessa Cardoso; Oliveira, Olimpia M. N. P. F.; Carvalho, Karina I.; Mamana de Souza, Ana Carolina; Rodrigues, Celia L.; Levi, Jose Eduardo; Kallas, Esper G.; Pannuti, Claudio Sergio			Characterization of Dengue Virus Type 2: New Insights on the 2010 Brazilian Epidemic	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SEROTYPES; OUTBREAK; AMERICA; STATE	Dengue viruses (DENV) serotypes 1, 2, and 3 have been causing yearly outbreaks in Brazil. In this study, we report the reintroduction of DENV2 in the coast of Sao Paulo State. Partial envelope viral genes were sequenced from eighteen patients with dengue fever during the 2010 epidemic. Phylogenetic analysis showed this strain belongs to the American/Asian genotype and was closely related to the virus that circulated in Rio de Janeiro in 2007 and 2008. The phylogeny also showed no clustering by clinical presentation, suggesting that the disease severity could not be explained by distinct variants or genotypes. The time of the most recent common ancestor of American/Asian genotype and the Sao Paulo and Rio de Janeiro (SP/RJ) monophyletic cluster was estimated to be around 40 and 10 years, respectively. Since this virus was first identified in Brazil in 2007, we suggest that it was already circulating in the country before causing the first documented outbreak. This is the first description of the 2010 outbreak in the State of Sao Paulo, Brazil, and should contribute to efforts to control and monitor the spread of DENVs in endemic areas.	[Romano, Camila Malta; Villas-Boas, Lucy Santos; da Silva, Wanessa Cardoso; Mamana de Souza, Ana Carolina; Rodrigues, Celia L.; Levi, Jose Eduardo; Pannuti, Claudio Sergio] Univ Sao Paulo, Dept Molestias Infecciosas & Parasitarias, LIMHC, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; [de Matos, Andreia Manso; Carvalho, Karina I.; Kallas, Esper G.] Univ Sao Paulo, Fac Med, Disciplina Imunol Clin & Alergia LIM 60, Sao Paulo, Brazil; [Araujo, Evaldo Stanislau A.; Oliveira, Olimpia M. N. P. F.] Hosp Ana Costa, Santos, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Romano, CM (corresponding author), Univ Sao Paulo, Dept Molestias Infecciosas & Parasitarias, LIMHC, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.	cmromano@usp.br	Carvalho, Karina IL/J-6789-2012; Kallas, Esper G/C-9539-2012; Pannuti, Claudio/B-7649-2012; Romano, Camila/ABC-2883-2020; Romano, Camila M/C-8185-2013	Carvalho, Karina IL/0000-0002-7763-8139; Romano, Camila/0000-0003-4550-1987; Kallas, Esper/0000-0003-2026-6925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education; Brazilian Ministry of Science and Technology (CNPq) [476088/2009-7]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education; Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazilian Ministry of Science and Technology (CNPq, grant #476088/2009-7 to EGK). AMM and EGK's scholarships were supported by CNPq. KIC's scholarship was supported by the Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior, Brazilian Ministry of Education. URL of CNPq: URL www.cnpq.br; URL of CAPES: www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390; DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Messer William B., 2002, American Journal of Tropical Medicine and Hygiene, V66, P765; Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; PAHO, 2008, NUMB REP CAS DENG DE; de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	29	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11811	10.1371/journal.pone.0011811	http://dx.doi.org/10.1371/journal.pone.0011811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676363	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100005
J	Collino, F; Deregibus, MC; Bruno, S; Sterpone, L; Aghemo, G; Viltono, L; Tetta, C; Camussi, G				Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Sterpone, Luca; Aghemo, Giulia; Viltono, Laura; Tetta, Ciro; Camussi, Giovanni			Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs	PLOS ONE			English	Article							MICRORNA EXPRESSION; CELLULAR MICROPARTICLES; MULTIVESICULAR BODIES; HORIZONTAL TRANSFER; MEDIATED TRANSFER; STRESS GRANULES; MESSENGER-RNA; GENE; LUNG; MECHANISM	Background: Cell-derived microvesicles (MVs) have been described as a new mechanism of cell-to-cell communication. MVs after internalization within target cells may deliver genetic information. Human bone marrow derived mesenchymal stem cells (MSCs) and liver resident stem cells (HLSCs) were shown to release MVs shuttling functional mRNAs. The aim of the present study was to evaluate whether MVs derived from MSCs and HLSCs contained selected micro-RNAs (miRNAs). Methodology/Principal Findings: MVs were isolated from MSCs and HLSCs. The presence in MVs of selected ribonucleoproteins involved in the traffic and stabilization of RNA was evaluated. We observed that MVs contained TIA, TIAR and HuR multifunctional proteins expressed in nuclei and stress granules, Stau1 and 2 implicated in the transport and stability of mRNA and Ago2 involved in miRNA transport and processing. RNA extracted from MVs and cells of origin was profiled for 365 known human mature miRNAs by real time PCR. Hierarchical clustering and similarity analysis of miRNAs showed 41 co-expressed miRNAs in MVs and cells. Some miRNAs were accumulated within MVs and absent in the cells after MV release; others were retained within the cells and not secreted in MVs. Gene ontology analysis of predicted and validated targets showed that the high expressed miRNAs in cells and MVs could be involved in multi-organ development, cell survival and differentiation. Few selected miRNAs shuttled by MVs were also associated with the immune system regulation. The highly expressed miRNAs in MVs were transferred to target cells after MV incorporation. Conclusions: This study demonstrated that MVs contained ribonucleoproteins involved in the intracellular traffic of RNA and selected pattern of miRNAs, suggesting a dynamic regulation of RNA compartmentalization in MVs. The observation that MV-highly expressed miRNAs were transferred to target cells, rises the possibility that the biological effect of stem cells may, at least in part, depend on MV-shuttled miRNAs. Data generated from this study, stimulate further functional investigations on the predicted target genes and pathways involved in the biological effect of human adult stem cells.	[Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Aghemo, Giulia; Viltono, Laura; Camussi, Giovanni] Univ Turin, Dept Internal Med, Turin, Italy; [Collino, Federica; Deregibus, Maria Chiara; Bruno, Stefania; Aghemo, Giulia; Viltono, Laura; Camussi, Giovanni] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Sterpone, Luca] Politecn Torino, Dept Automat & Informat, Turin, Italy; [Bruno, Stefania] SiS Ter SpA, Palazzo Pignano, Crema, Italy; [Tetta, Ciro] Fresenius Med Care, Bad Homburg, Germany	University of Turin; University of Turin; Polytechnic University of Turin	Collino, F (corresponding author), Univ Turin, Dept Internal Med, Turin, Italy.	giovanni.camussi@unito.it	Sterpone, Luca/AAL-2464-2020; Collino, Federica/B-9956-2018; Camussi, Giovanni/J-7624-2016	Collino, Federica/0000-0002-3619-7701; Camussi, Giovanni/0000-0003-2795-232X; BRUNO, Stefania/0000-0002-8879-9536; Sterpone, Luca/0000-0002-3080-2560	Associazione Italiana per la Ricerca sul Cancro (AIRC) [CT 8912]; Ministero Universita e Ricerca Scientifica; Regione Piemonte; Piattaforme Biotecnologiche; Progetto PiSTEM; Sis-Ter; Fresenius Medical Care	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Universita e Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte); Piattaforme Biotecnologiche; Progetto PiSTEM; Sis-Ter; Fresenius Medical Care	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) CT 8912, Ministero Universita e Ricerca Scientifica, PRIN and by Grants from Regione Piemonte, Piattaforme Biotecnologiche, Progetto PiSTEM, Sis-Ter and Fresenius Medical Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Deregibus MC, 2010, HISTOL HISTOPATHOL, V25, P397, DOI 10.14670/HH-25.397; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dooner MS, 2008, STEM CELLS DEV, V17, P207, DOI 10.1089/scd.2007.0195; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Doublier S, 2005, INT J MOL MED, V16, P49; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; GEORGE JN, 1982, BLOOD, V60, P834; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Heijnen Harry F. G., 1999, Blood, V94, P3791; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; HERRERA MB, 2009, J CELL MOL MED; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Masaki Shizuka, 2008, Rinsho Byori, V56, P1086; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Rozmyslowicz T, 2003, AIDS, V17, P33, DOI 10.1097/00002030-200301030-00006; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh Shree Ram, 2008, V450, P45, DOI 10.1007/978-1-60327-214-8_3; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; STERPONE L, ADV EXPT ME IN PRESS; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; ZHU W, 2010, INT J CANC	67	454	487	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11803	10.1371/journal.pone.0011803	http://dx.doi.org/10.1371/journal.pone.0011803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668554	Green Published, Green Submitted, gold			2022-12-27	WOS:000280371800009
J	Ikmi, A; Gibson, MC				Ikmi, Aissam; Gibson, Matthew C.			Identification and In Vivo Characterization of NvFP-7R, a Developmentally Regulated Red Fluorescent Protein of Nematostella vectensis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; GENOME REVEALS; EVOLUTION; COMPLEXITY; DIVERSITY; ORIGINS; FAMILY	Background: In recent years, the sea anemone Nematostella vectensis has emerged as a critical model organism for comparative genomics and developmental biology. Although Nematostella is a member of the anthozoan cnidarians (known for producing an abundance of diverse fluorescent proteins (FPs)), endogenous patterns of Nematostella fluorescence have not been described and putative FPs encoded by the genome have not been characterized. Methodology/Principal Findings: We described the spatiotemporal expression of endogenous red fluorescence during Nematostella development. Spatially, there are two patterns of red fluorescence, both restricted to the oral endoderm in developing polyps. One pattern is found in long fluorescent domains associated with the eight mesenteries and the other is found in short fluorescent domains situated between tentacles. Temporally, the long domains appear simultaneously at the 12-tentacle stage. In contrast, the short domains arise progressively between the 12- and 16-tentacle stage. To determine the source of the red fluorescence, we used bioinformatic approaches to identify all possible putative Nematostella FPs and a Drosophila S2 cell culture assay to validate NvFP-7R, a novel red fluorescent protein. We report that both the mRNA expression pattern and spectral signature of purified NvFP-7R closely match that of the endogenous red fluorescence. Strikingly, the red fluorescent pattern of NvFP-7R exhibits asymmetric expression along the directive axis, indicating that the nvfp-7r locus senses the positional information of the body plan. At the tissue level, NvFP-7R exhibits an unexpected subcellular localization and a complex complementary expression pattern in apposed epithelia sheets comprising each endodermal mesentery. Conclusions/Significance: These experiments not only identify NvFP-7R as a novel red fluorescent protein that could be employed as a research tool; they also uncover an unexpected spatio-temporal complexity of gene expression in an adult cnidarian. Perhaps most importantly, our results define Nematostella as a new model organism for understanding the biological function of fluorescent proteins in vivo.	[Ikmi, Aissam; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO USA; [Gibson, Matthew C.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Ikmi, A (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	mg2@stowers.org		Gibson, Matthew/0000-0001-5588-8842; Ikmi, Aissam/0000-0001-6310-8404	Stowers Institute for Medical Research; Burroughs Wellcome Fund	Stowers Institute for Medical Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Stowers Institute for Medical Research (www.stowers-institute.org) and the Burroughs Wellcome Fund Career Award in Biological Sciences (http://www.bwfund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Burton PM, 2009, DEV GENES EVOL, V219, P79, DOI 10.1007/s00427-009-0271-2; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; GENIKHOVICH G, 2009, CSH PROTOC; HAND C, 1992, BIOL BULL, P169; Kao HT, 2007, MAR BIOTECHNOL, V9, P733, DOI 10.1007/s10126-007-9025-1; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Mavrakis M, 2010, DEVELOPMENT, V137, P373, DOI 10.1242/dev.031690; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Miller DJ, 2008, TRENDS GENET, V24, P1, DOI 10.1016/j.tig.2007.10.002; Miyawaki A, 2002, CELL STRUCT FUNCT, V27, P343, DOI 10.1247/csf.27.343; Murate M, 1996, CELL TISSUE RES, V283, P455, DOI 10.1007/s004410050556; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Rentzsch F, 2008, DEVELOPMENT, V135, P1761, DOI 10.1242/dev.020784; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sun Y, 2004, FEBS LETT, V570, P175, DOI 10.1016/j.febslet.2004.06.043; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	39	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11807	10.1371/journal.pone.0011807	http://dx.doi.org/10.1371/journal.pone.0011807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668556	Green Published, Green Submitted, gold			2022-12-27	WOS:000280371800011
J	Koh, YS; Koo, JE; Biswas, A; Kobayashi, KS				Koh, Young-Sang; Koo, Jung-Eun; Biswas, Amlan; Kobayashi, Koichi S.			MyD88-Dependent Signaling Contributes to Host Defense against Ehrlichial Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; ANIMAL-MODEL; ADAPTIVE IMMUNITY; COXIELLA-BURNETII; DENDRITIC CELLS; MICE DEFICIENT; STRANDED-RNA; IFN-GAMMA; RECOGNITION	The ehrlichiae are small Gram-negative obligate intracellular bacteria in the family Anaplasmataceae. Ehrlichial infection in an accidental host may result in fatal diseases such as human monocytotropic ehrlichiosis, an emerging, tick-borne disease. Although the role of adaptive immune responses in the protection against ehrlichiosis has been well studied, the mechanism by which the innate immune system is activated is not fully understood. Using Ehrlichia muris as a model organism, we show here that MyD88-dependent signaling pathways play a pivotal role in the host defense against ehrlichial infection. Upon E. muris infection, MyD88-deficient mice had significantly impaired clearance of E. muris, as well as decreased inflammation, characterized by reduced splenomegaly and recruitment of macrophages and neutrophils. Furthermore, MyD88-deficient mice produced markedly lower levels of IL-12, which correlated well with an impaired Th1 immune response. In vitro, dendritic cells, but not macrophages, efficiently produced IL-12 upon E. muris infection through a MyD88-dependent mechanism. Therefore, MyD88-dependent signaling is required for controlling ehrlichial infection by playing an essential role in the immediate activation of the innate immune system and inflammatory cytokine production, as well as in the activation of the adaptive immune system at a later stage by providing for optimal Th1 immune responses.	[Koh, Young-Sang; Biswas, Amlan; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Koh, Young-Sang; Biswas, Amlan; Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Koh, Young-Sang; Koo, Jung-Eun] Jeju Natl Univ, Sch Med, Dept Microbiol, Cheju, Jeju Do, South Korea; [Koh, Young-Sang; Koo, Jung-Eun] Jeju Natl Univ, Sch Med, Brain Korea Program 21, Cheju, Jeju Do, South Korea	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Jeju National University; Jeju National University	Koh, YS (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	Koichi_Kobayashi@dfci.harvard.edu		Kobayashi, Koichi/0000-0003-2930-0114	NIH [R01DK074738]; Cancer Research Institute; Claudia Adams Barr Award; Korea Research Foundation [KRF-2008-313-C00807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Claudia Adams Barr Award; Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the NIH (R01DK074738) to KSK. KSK is a recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award, and YSK is a recipient of and was supported by the Korea Research Foundation Grant (KRF-2008-313-C00807). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; EWING SA, 1995, J MED ENTOMOL, V32, P368, DOI 10.1093/jmedent/32.3.368; Feng HM, 2004, INFECT IMMUN, V72, P966, DOI 10.1128/IAI.72.2.966-971.2004; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FICHTENBAUM CJ, 1993, AM J MED, V95, P351, DOI 10.1016/0002-9343(93)90302-6; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glimcher LH, 2000, GENE DEV, V14, P1693; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Kawahara M, 1996, MICROBIOL IMMUNOL, V40, P575, DOI 10.1111/j.1348-0421.1996.tb01111.x; KAWAHARA M, 1993, J CLIN MICROBIOL, V31, P89, DOI 10.1128/JCM.31.1.89-96.1993; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LAMKANFI M, 2007, J LEUKOC BIOL; Li JSY, 2001, J IMMUNOL, V166, P1855; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McQuiston JH, 1999, EMERG INFECT DIS, V5, P635, DOI 10.3201/eid0505.990504; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nandi B, 2007, INFECT IMMUN, V75, P5453, DOI 10.1128/IAI.00713-07; Nandi B, 2009, INFECT IMMUN, V77, P4643, DOI 10.1128/IAI.01433-08; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; PADDOCK CD, 1993, NEW ENGL J MED, V329, P1164, DOI 10.1056/NEJM199310143291605; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Uematsu Satoshi, 2008, V183, P1; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	67	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11758	10.1371/journal.pone.0011758	http://dx.doi.org/10.1371/journal.pone.0011758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668698	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800027
J	Vanreusel, A; De Groote, A; Gollner, S; Bright, M				Vanreusel, Ann; De Groote, Annelies; Gollner, Sabine; Bright, Monika			Ecology and Biogeography of Free-Living Nematodes Associated with Chemosynthetic Environments in the Deep Sea: A Review	PLOS ONE			English	Review							EAST FLOWER GARDEN; MOSBY-MUD-VOLCANO; HYDROTHERMAL VENT COMMUNITIES; COLD-SEEP COMMUNITIES; MARINE NEMATODES; VERTICAL-DISTRIBUTION; NORTH-ATLANTIC; MUSSEL AGGREGATIONS; SPATIAL VARIABILITY; FATTY-ACIDS	Background: Here, insight is provided into the present knowledge on free-living nematodes associated with chemosynthetic environments in the deep sea. It was investigated if the same trends of high standing stock, low diversity, and the dominance of a specialized fauna, as observed for macro-invertebrates, are also present in the nematodes in both vents and seeps. Methodology: This review is based on existing literature, in combination with integrated analysis of datasets, obtained through the Census of Marine Life program on Biogeography of Deep-Water Chemosynthetic Ecosystems (ChEss). Findings: Nematodes are often thriving in the sulphidic sediments of deep cold seeps, with standing stock values ocassionaly exceeding largely the numbers at background sites. Vents seem not characterized by elevated densities. Both chemosynthetic driven ecosystems are showing low nematode diversity, and high dominance of single species. Genera richness seems inversely correlated to vent and seep fluid emissions, associated with distinct habitat types. Deep-sea cold seeps and hydrothermal vents are, however, highly dissimilar in terms of community composition and dominant taxa. There is no unique affinity of particular nematode taxa with seeps or vents. Conclusions: It seems that shallow water relatives, rather than typical deep-sea taxa, have successfully colonized the reduced sediments of seeps at large water depth. For vents, the taxonomic similarity with adjacent regular sediments is much higher, supporting rather the importance of local adaptation, than that of long distance distribution. Likely the ephemeral nature of vents, its long distance offshore and the absence of pelagic transport mechanisms, have prevented so far the establishment of a successful and typical vent nematode fauna. Some future perspectives in meiofauna research are provided in order to get a more integrated picture of vent and seep biological processes, including all components of the marine ecosystem.	[Vanreusel, Ann; De Groote, Annelies] Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Gollner, Sabine; Bright, Monika] Univ Vienna, Dept Marine Biol, Vienna, Austria	Ghent University; University of Vienna	Vanreusel, A (corresponding author), Univ Ghent, Marine Biol Res Grp, B-9000 Ghent, Belgium.	ann.vanreusel@ugent.be	Bright, Monika/AAA-7015-2021; Bright, Monika/I-5542-2012	Bright, Monika/0000-0001-7066-1363; 	FWO-Vlaanderen, Belgium [3G0346 -'07'- 10]; Austrian Science Fund [FWF P16774-B03, FWF P20190-B17]	FWO-Vlaanderen, Belgium(FWO); Austrian Science Fund(Austrian Science Fund (FWF))	The networking was financed by http://www.noc.soton.ac.uk/chess/. Individual research grants include project (no 3G0346 -'07'- 10) provided by the FWO-Vlaanderen, Belgium (PI A. Vanreusel) and by Austrian Science Fund grants FWF P16774-B03, FWF P20190-B17 (PI M. Bright). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgen C. A., 1947, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening, V110, P65; ALLGEN C. A., 1959, Further zoological results of the Swedish Antarctic Expedition 1901-1903. Volume 5, No. 2, P1; ALONGI DM, 1987, MAR ECOL PROG SER, V40, P103, DOI 10.3354/meps040103; AUSTEN MC, 1993, J MAR BIOL ASSOC UK, V73, P627, DOI 10.1017/S0025315400033166; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Bernhard JM, 2001, DEEP-SEA RES PT I, V48, P2233, DOI 10.1016/S0967-0637(01)00017-6; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Boetius A, 2004, CHEM GEOL, V205, P291, DOI 10.1016/j.chemgeo.2003.12.034; Boyd SE, 2000, ESTUAR COAST SHELF S, V51, P805, DOI 10.1006/ecss.2000.0722; Bright M, 2010, DEEP-SEA RES PT II, V57, P1982, DOI 10.1016/j.dsr2.2010.05.003; Buck KR, 1998, CAH BIOL MAR, V39, P333; Burgess Robert, 2005, Meiofauna Marina, V14, P157; Chen GT, 1999, HYDROBIOLOGIA, V405, P95, DOI 10.1023/A:1003752619953; Chinnadurai G, 2007, ESTUAR COAST SHELF S, V72, P329, DOI 10.1016/j.ecss.2006.11.004; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; DANDO PR, 1993, MAR ECOL PROG SER, V100, P265, DOI 10.3354/meps100265; DANDO PR, 1991, MAR ECOL PROG SER, V70, P49, DOI 10.3354/meps070049; Danovaro R, 2002, MAR ECOL PROG SER, V230, P159, DOI 10.3354/meps230159; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; De Leonardis C, 2008, SCI MAR, V72, P5; Debenham NJ, 2004, DEEP-SEA RES PT I, V51, P701, DOI 10.1016/j.dsr.2004.02.004; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Dinet A, 1988, OCEANOL ACTA, V85, P7; Ditlevsen H, 1921, VIDENSKABELIGE MEDDE, V73, P1; Fernandez M, 2000, ECOL LETT, V3, P487, DOI 10.1046/j.1461-0248.2000.00172.x; Fisher R, 2003, HYDROBIOLOGIA, V495, P143, DOI 10.1023/A:1025406624390; Flint HC, 2006, CAH BIOL MAR, V47, P365; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fonseca G, 2009, POLAR BIOL, V32, P1345, DOI 10.1007/s00300-009-0631-4; FRICKE H, 1989, MAR BIOL, V102, P425, DOI 10.1007/BF00428495; Gad G, 2004, ARCH FISH MAR RES, V51, P43; Gad G, 2004, ARCH FISH MAR RES, V51, P30; Gage JD, 1996, J EXP MAR BIOL ECOL, V200, P257, DOI 10.1016/S0022-0981(96)02638-X; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gollner S, 2007, MAR ECOL PROG SER, V337, P39, DOI 10.3354/meps337039; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HENDELBERG M, 1993, OPHELIA, V37, P83, DOI 10.1080/00785326.1993.10429909; Hentschel U, 1999, MAR ECOL PROG SER, V183, P149, DOI 10.3354/meps183149; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; Ingels J, 2009, DEEP-SEA RES PT I, V56, P1521, DOI 10.1016/j.dsr.2009.04.010; JENNINGS JB, 1970, J ZOOL, V161, P211, DOI 10.1111/j.1469-7998.1970.tb02036.x; JENSEN P, 1981, CAH BIOL MAR, V22, P231; JENSEN P, 1984, HYDROBIOLOGIA, V108, P201, DOI 10.1007/BF00006329; JENSEN P, 1987, OECOLOGIA, V71, P564, DOI 10.1007/BF00379298; JENSEN P, 1992, MAR ECOL PROG SER, V83, P103, DOI 10.3354/meps083103; JENSEN P, 1986, MAR BIOL, V92, P489, DOI 10.1007/BF00392509; KAMENEV GM, 1993, NEW ZEAL J MAR FRESH, V27, P407, DOI 10.1080/00288330.1993.9516582; KHARLAMENKO VI, 1995, MAR ECOL PROG SER, V120, P231, DOI 10.3354/meps120231; Lambshead PJD, 2000, MAR ECOL PROG SER, V194, P159, DOI 10.3354/meps194159; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lampadariou N, 2006, PROG OCEANOGR, V69, P19, DOI 10.1016/j.pocean.2006.02.013; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2003, MAR ECOL PROG SER, V265, P123, DOI 10.3354/meps265123; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Modig H, 1998, J EXP MAR BIOL ECOL, V229, P133, DOI 10.1016/S0022-0981(98)00043-4; Mokievsky VO, 2005, OCEANOLOGY+, V45, P689; MONTAGNA PA, 1985, MAR ENVIRON RES, V16, P231, DOI 10.1016/0141-1136(85)90021-2; MONTAGNA PA, 1987, J MAR RES, V45, P761, DOI 10.1357/002224087788326894; MONTAGNA PA, 1989, J MAR RES, V47, P657, DOI 10.1357/002224089785076226; Moodley L, 1997, MAR ECOL PROG SER, V158, P151, DOI 10.3354/meps158151; Netto SA, 2005, DEEP-SEA RES PT I, V52, P845, DOI 10.1016/j.dsr.2004.11.009; NICHOLAS WL, 1991, HYDROBIOLOGIA, V209, P13, DOI 10.1007/BF00006714; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; Orcutt B, 2008, ENVIRON MICROBIOL, V10, P1108, DOI 10.1111/j.1462-2920.2007.01526.x; OTT JA, 1991, PSZNI MAR ECOL, V12, P261; Palmer MA, 1988, OIL CHEM POLL, V4, P179; Pastor de Ward C. T., 1984, CONTRIBUCIONES CTR N, V86, P1; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; POLZ MF, 1992, MICROBIAL ECOL, V24, P313, DOI 10.1007/BF00167789; POWELL EN, 1983, MAR BIOL, V73, P269, DOI 10.1007/BF00392253; POWELL EN, 1981, INT REV GES HYDROBIO, V66, P675, DOI 10.1002/iroh.19810660504; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; REISE K, 1979, MAR BIOL, V54, P225, DOI 10.1007/BF00395785; Renaud PE, 2006, J EXP MAR BIOL ECOL, V330, P297, DOI 10.1016/j.jembe.2005.12.035; Rex M.A., 2010, DEEP SEA BIODIVERSIT, P354; Robinson CA, 2004, MAR ECOL-P S Z N I, V25, P313, DOI 10.1111/j.1439-0485.2004.00034.x; Saito H, 2007, LIMNOL OCEANOGR, V52, P1910, DOI 10.4319/lo.2007.52.5.1910; SCHIEMER F, 1990, MAR BIOL, V106, P129, DOI 10.1007/BF02114683; Sebastian S, 2007, DEEP-SEA RES PT II, V54, P1727, DOI 10.1016/j.dsr2.2007.07.004; Sergeeva N.G., 1991, Ekologiya Morya, V39, P70; Sergeeva NG, 2007, MAR ECOL-EVOL PERSP, V28, P152, DOI 10.1111/j.1439-0485.2006.00143.x; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; SHIRAYAMA Y, 1992, DEEP-SEA RES, P287; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SOETAERT K, 1989, DEEP-SEA RES, V36, P93, DOI 10.1016/0198-0149(89)90020-4; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soltwedel T, 2005, J MARINE SYST, V55, P271, DOI 10.1016/j.jmarsys.2004.09.001; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Sommer S, 2007, MAR ECOL PROG SER, V337, P27, DOI 10.3354/meps337027; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Steyaert M, 1999, J MAR BIOL ASSOC UK, V79, P253, DOI 10.1017/S0025315498000289; Steyaert M, 2007, J EXP MAR BIOL ECOL, V345, P175, DOI 10.1016/j.jembe.2007.03.001; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; THIEL H, 1993, DEEP-SEA RES PT I, V40, P419, DOI 10.1016/0967-0637(93)90012-R; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Thiermann F., 1994, Vie et Milieu, V44, P215; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; Van Dover CL, 2004, J EXP MAR BIOL ECOL, V300, P273, DOI 10.1016/j.jembe.2003.12.024; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Gaever S, 2004, J MAR BIOL ASSOC UK, V84, P547, DOI 10.1017/S0025315404009555h; Van Gaever S, 2006, MAR ECOL PROG SER, V321, P143, DOI 10.3354/meps321143; Van Gaever S, 2009, DEEP-SEA RES PT II, V56, P2259, DOI 10.1016/j.dsr2.2009.04.008; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; Vanhove S, 1999, MAR ECOL PROG SER, V181, P237, DOI 10.3354/meps181237; VANREUSEL A, 1995, INT REV GES HYDROBIO, V80, P287, DOI 10.1002/iroh.19950800215; Vanreusel A, 2000, DEEP-SEA RES PT I, V47, P1855, DOI 10.1016/S0967-0637(00)00007-8; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; VANREUSEL A, 1990, CAH BIOL MAR, V31, P439; VANREUSEL A, 2010, PSZN 1, V31, P6; Veit-Kohler G, 2009, DEEP-SEA RES PT II, V56, P1093, DOI 10.1016/j.dsr2.2008.09.013; Verschelde D, 1998, J MAR BIOL ASSOC UK, V78, P75, DOI 10.1017/S0025315400039977; VINCX M, 1986, HYDROBIOLOGIA, V140, P255, DOI 10.1007/BF00007440; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9; VITIELLO P, 1974, ANN I OCEANOGR PARIS, V50, P145; VRANKEN G, 1989, MAR ENVIRON RES, V27, P127, DOI 10.1016/0141-1136(89)90004-4; VRANKEN G, 1988, OECOLOGIA, V77, P296, DOI 10.1007/BF00378033; WARWICK RM, 1984, MAR ECOL PROG SER, V18, P97, DOI 10.3354/meps018097; Wetzel MA, 2002, MAR BIOL, V141, P679, DOI 10.1007/s00227-002-0863-0; Wetzel MA, 1995, MAR BIOL, V124, P301, DOI 10.1007/BF00347134; Zekely J, 2006, DEEP-SEA RES PT I, V53, P1363, DOI 10.1016/j.dsr.2006.05.010; Zekely J, 2006, CAH BIOL MAR, V47, P477; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140; ZHANG Z, 1994, J OCEAN U QINGDAO, V24, P241	134	74	78	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12449	10.1371/journal.pone.0012449	http://dx.doi.org/10.1371/journal.pone.0012449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805986	Green Published, gold			2022-12-27	WOS:000281301500015
J	Sinkkonen, L; Hugenschmidt, T; Filipowicz, W; Svoboda, P				Sinkkonen, Lasse; Hugenschmidt, Tabea; Filipowicz, Witold; Svoboda, Petr			Dicer Is Associated with Ribosomal DNA Chromatin in Mammalian Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POLYMERASE-I TRANSCRIPTION; RNA GENES; FISSION YEAST; INTERGENIC TRANSCRIPTS; METHYLATION; PROMOTER; HETEROCHROMATIN; INTERFERENCE; HYPERMETHYLATION	Background: RNA silencing is a common term for pathways utilizing small RNAs as sequence-specific guides to repress gene expression. Components of the RNA silencing machinery are involved in different aspects of chromatin function in numerous organisms. However, association of RNA silencing with chromatin in mammalian cells remains unclear. Methodology/Principal Findings: Immunostaining of mitotic chromosomes with antibodies visualizing either endogenous or ectopically expressed Dicer in mammalian cells revealed association of the protein with ribosomal DNA (rDNA) repeats. Chromatin immunoprecipitations and bisulfite sequencing experiments indicated that Dicer is associated with transcribed regions of both active and silenced genes in rDNA arrays of interphase chromosomes. Metabolic labeling of the mouse embryonic stem (ES) cells lacking Dicer did not reveal apparent defect in rRNA biogenesis though pre-rRNA synthesis in these cells was decreased, likely as a consequence of their slower growth caused by the loss of miRNAs. We analyzed in detail chromatin structure of rDNA but did not find any epigenetic changes at rDNA loci in Dicer(-/-) ES cells. Instead, we found that rDNA methylation is rather low in primary tissues, contrasting with rDNA methylation patterns in transformed cell lines. Conclusion/Significance: We found that Dicer, a key component of RNA silencing pathways, can be detected in association with rDNA chromatin in mammalian cells. The role of this particular localization of Dicer is not readily apparent since the enzyme is associated with rDNA genes regardless of their transcriptional activity. However, localization of Dicer to the transcribed region suggests that transcription may contribute to the Dicer deposition at rDNA chromatin. We hypothesize that Dicer functions in maintaining integrity of rDNA arrays.	[Sinkkonen, Lasse; Hugenschmidt, Tabea; Filipowicz, Witold; Svoboda, Petr] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Sinkkonen, L (corresponding author), Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg.	filipowi@fmi.ch; svobodap@img.cas.cz	Sinkkonen, Lasse/AAL-7906-2021; Svoboda, Petr/G-3890-2012	Sinkkonen, Lasse/0000-0002-4223-3027; Svoboda, Petr/0000-0002-4370-3705	Novartis Research Foundation; European Community; European Molecular Biology Organization (EMBO) [1488]; GACR [P305/10/2215]; Purkynje Fellowship	Novartis Research Foundation; European Community(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); GACR(Grant Agency of the Czech Republic); Purkynje Fellowship	Friedrich Miescher Institute is supported by the Novartis Research Foundation. Work in WF laboratory is supported by the European Community FP7 Integrated Project "Sirocco". PS work is supported by the European Molecular Biology Organization Strategic Development Installation Grant (EMBO SDIG) program #1488, GACR P305/10/2215, and the Purkynje Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Calabrese JM, 2006, RNA, V12, P2092, DOI 10.1261/rna.224606; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; FRITZ J, 2009, MOL CELL BIOL; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kochanek S, 1996, FEBS LETT, V388, P192, DOI 10.1016/0014-5793(96)00506-6; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Reddy KS, 1998, HUM GENET, V102, P653, DOI 10.1007/s004390050758; Riddle NC, 2008, CURR TOP MICROBIOL, V320, P185; ROUSSEL P, 1993, J CELL SCI, V104, P327; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Svoboda P, 2004, CYTOGENET GENOME RES, V105, P422, DOI 10.1159/000078215; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	51	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12175	10.1371/journal.pone.0012175	http://dx.doi.org/10.1371/journal.pone.0012175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730047	Green Submitted, gold, Green Published			2022-12-27	WOS:000280862200026
J	Fieberg, JR; Shertzer, KW; Conn, PB; Noyce, KV; Garshelis, DL				Fieberg, John R.; Shertzer, Kyle W.; Conn, Paul B.; Noyce, Karen V.; Garshelis, David L.			Integrated Population Modeling of Black Bears in Minnesota: Implications for Monitoring and Management	PLOS ONE			English	Article							RECONSTRUCTION; ABUNDANCE; ACCURACY	Background: Wildlife populations are difficult to monitor directly because of costs and logistical challenges associated with collecting informative abundance data from live animals. By contrast, data on harvested individuals (e. g., age and sex) are often readily available. Increasingly, integrated population models are used for natural resource management because they synthesize various relevant data into a single analysis. Methodology/Principal Findings: We investigated the performance of integrated population models applied to black bears (Ursus americanus) in Minnesota, USA. Models were constructed using sex-specific age-at-harvest matrices (1980-2008), data on hunting effort and natural food supplies (which affects hunting success), and statewide mark-recapture estimates of abundance (1991, 1997, 2002). We compared this approach to Downing reconstruction, a commonly used population monitoring method that utilizes only age-at-harvest data. We first conducted a large-scale simulation study, in which our integrated models provided more accurate estimates of population trends than did Downing reconstruction. Estimates of trends were robust to various forms of model misspecification, including incorrectly specified cub and yearling survival parameters, age-related reporting biases in harvest data, and unmodeled temporal variability in survival and harvest rates. When applied to actual data on Minnesota black bears, the model predicted that harvest rates were negatively correlated with food availability and positively correlated with hunting effort, consistent with independent telemetry data. With no direct data on fertility, the model also correctly predicted 2-point cycles in cub production. Model-derived estimates of abundance for the most recent years provided a reasonable match to an empirical population estimate obtained after modeling efforts were completed. Conclusions/Significance: Integrated population modeling provided a reasonable framework for synthesizing age-at-harvest data, periodic large-scale abundance estimates, and measured covariates thought to affect harvest rates of black bears in Minnesota. Collection and analysis of these data appear to form the basis of a robust and viable population monitoring program.	[Fieberg, John R.; Garshelis, David L.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fieberg, John R.] Minnesota Dept Nat Resources, Biometr Unit, Forest Lake, MN USA; [Shertzer, Kyle W.; Conn, Paul B.] Natl Marine Fisheries Serv, SE Fisheries Sci Ctr, Beaufort, NC USA; [Noyce, Karen V.; Garshelis, David L.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Grand Rapids, MI USA	University of Minnesota System; University of Minnesota Twin Cities; National Oceanic Atmospheric Admin (NOAA) - USA	Fieberg, JR (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	john.fieberg@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021; Shertzer, Kyle/0000-0001-7196-5959				Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; BATES DM, 2004, SPLINES VERSION 1 9; BERKSON J, 1980, ANN STAT, V8, P457, DOI 10.1214/aos/1176345003; Besbeas P, 2002, BIOMETRICS, V58, P540, DOI 10.1111/j.0006-341X.2002.00540.x; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Conn PB, 2009, ENVIRON ECOL STAT SE, V3, P965, DOI 10.1007/978-0-387-78151-8_44; Conn PB, 2008, BIOMETRICS, V64, P1170, DOI 10.1111/j.1541-0420.2008.00987.x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Davis ML, 2007, J WILDLIFE MANAGE, V71, P2297, DOI 10.2193/2006-427; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Diefenbach DR, 1998, J WILDLIFE MANAGE, V62, P1292, DOI 10.2307/3801993; Downing R., 1980, WILDLIFE MANAGEMENT, P247; Fournier David, 2009, AD MOD BUILD AUT DIF; GARSHELIS D.L, 1991, E WORKSH BLACK BEAR, V10, P120; Garshelis DL, 2006, J WILDLIFE MANAGE, V70, P1634, DOI 10.2193/0022-541X(2006)70[1634:DBIALS]2.0.CO;2; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Garshelis DL, 1997, J WILDLIFE MANAGE, V61, P466, DOI 10.2307/3802605; Garshelis DL, 2008, FRONTIERS WILDLIFE S, P139; Gilbert BA, 2007, J WILDLIFE MANAGE, V71, P144, DOI 10.2193/2005-567; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Harshyne WA, 1998, J WILDLIFE MANAGE, V62, P1281, DOI 10.2307/3801992; Methot R.D., 1990, INPFC B, V50, P259; METHOT RD, 1989, AM FISH SOC S, V6, P66; MILLER SD, 1990, INT C BEAR, V8, P357; Newman KB, 2006, ECOL APPL, V16, P74, DOI 10.1890/04-0592; Noyce KV, 1997, J WILDLIFE MANAGE, V61, P1067, DOI 10.2307/3802103; R Core Team, 2020, R LANG ENV STAT COMP; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; Trenkel VM, 2000, J AM STAT ASSOC, V95, P363, DOI 10.2307/2669373; White GC, 2002, J WILDLIFE MANAGE, V66, P300, DOI 10.2307/3803162; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	39	39	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12114	10.1371/journal.pone.0012114	http://dx.doi.org/10.1371/journal.pone.0012114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711344	Green Submitted, Green Published, gold			2022-12-27	WOS:000280859700009
J	Drager, LF; Lopes, HF; Maki-Nunes, C; Trombetta, IC; Toschi-Dias, E; Alves, MJNN; Fraga, RF; Jun, JC; Negrao, CE; Krieger, EM; Polotsky, VY; Lorenzi, G				Drager, Luciano F.; Lopes, Heno F.; Maki-Nunes, Cristiane; Trombetta, Ivani C.; Toschi-Dias, Edgar; Alves, Maria Janieire N. N.; Fraga, Raffael F.; Jun, Jonathan C.; Negrao, Carlos E.; Krieger, Eduardo M.; Polotsky, Vsevolod Y.; Lorenzi-Filho, Geraldo			The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; URIC-ACID LEVELS; INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; DAYTIME SLEEPINESS; RISK; POPULATION; MORTALITY; OBESITY; ATHEROSCLEROSIS	Background: Obstructive Sleep Apnea (OSA) is tightly linked to some components of Metabolic Syndrome (MetS). However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS. Methodology/Principal Findings: We studied 152 consecutive patients (age 48 +/- 9 years, body mass index 32.3 +/- 3.4 Kg/m(2)) newly diagnosed with MetS (Adult Treatment Panel III). All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements (glucose, lipid profile, uric acid and C-reactive protein). The prevalence of OSA (apnea-hypopnea index >= 15 events per hour of sleep) was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol/HDL ratio, triglycerides/HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 (1.47-7.21) and glucose: OR: 2.31 (1.12-4.80). OSA was also independently associated with increased cholesterol/HDL ratio: OR: 2.38 (1.08-5.24), uric acid: OR: 4.19 (1.70-10.35) and C-reactive protein: OR: 6.10 (2.64-14.11). Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol/HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters. Conclusions/Significance: Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness.	[Drager, Luciano F.; Lopes, Heno F.; Maki-Nunes, Cristiane; Trombetta, Ivani C.; Toschi-Dias, Edgar; Alves, Maria Janieire N. N.; Fraga, Raffael F.; Negrao, Carlos E.; Krieger, Eduardo M.; Lorenzi-Filho, Geraldo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Drager, Luciano F.; Jun, Jonathan C.; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA	Universidade de Sao Paulo; Johns Hopkins University	Drager, LF (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil.	luciano.drager@incor.usp.br	Lopes, Heno/H-9825-2013; Lorenzi-Filho, Geraldo GLF/E-1062-2012; Toschi-Dias, Edgar/AAP-9528-2020; Toschi-Dias, Edgar/C-9685-2013; KRIEGER, EDUARDO M/E-5883-2012; Alves, Janieire/G-4548-2010; Drager, Luciano F/A-1535-2014; Negrao, Carlos E/C-4281-2012; Trombetta, Ivani C/G-5839-2012	Lopes, Heno/0000-0002-9591-3093; Lorenzi-Filho, Geraldo GLF/0000-0002-7011-7373; Toschi-Dias, Edgar/0000-0002-5226-2956; Toschi-Dias, Edgar/0000-0002-5226-2956; Alves, Janieire/0000-0003-3207-623X; Trombetta, Ivani C/0000-0002-0979-0091; Negrao, Carlos Eduardo/0000-0003-4652-1226	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [200032/2009-7]; Fundacao Zerbini, Brazil; National Sleep Foundation/American Lung Association Pickwick [SF-78568 N]; National Institutes of Health (NIH) [HL07534, R01 HL80105, 5P50HL084945]; American Heart Association [0765293U]; United States Israel Binational Science Foundation [2005265]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL080105, T32HL007534] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Zerbini, Brazil; National Sleep Foundation/American Lung Association Pickwick; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Zerbini, Brazil. Dr. Drager is supported by the CNPq (# 200032/2009-7) and Fundacao Zerbini, Brazil. Dr. Jun is supported by the National Sleep Foundation/American Lung Association Pickwick Grant (SF-78568 N) and National Institutes of Health (NIH) T32 training grant (HL07534). Dr. Polotsky is supported by NIH (R01 HL80105, 5P50HL084945), the American Heart Association (grant 0765293U) and United States Israel Binational Science Foundation (grant BSF No. 2005265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chin K, 2010, SLEEP, V33, P89, DOI 10.1093/sleep/33.1.89; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Drager LF, 2010, ATHEROSCLEROSIS, V208, P490, DOI 10.1016/j.atherosclerosis.2009.08.016; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gruber A, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-22; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kano M, 2007, CHEST, V131, P1387, DOI 10.1378/chest.06-1807; Lam JCM, 2006, RESP MED, V100, P980, DOI 10.1016/j.rmed.2005.10.003; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Lewington S, 2008, LANCET, V372, P292; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; LINN S, 1991, AM J PUBLIC HEALTH, V81, P1038, DOI 10.2105/AJPH.81.8.1038; Lorenzi-Filho G., 2009, J CARDIOMETAB SYNDR, V4, P89, DOI DOI 10.1111/J.1559-4572.2008.00046.X; Lui, 2009, CHEST, V135, P1406; Lui MMS, 2009, CHEST, V135, P950, DOI 10.1378/chest.08-1798; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Nock NL, 2009, SLEEP, V32, P615, DOI 10.1093/sleep/32.5.615; PARISH JM, 2007, J CLIN SLEEP MED, V13, P355; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ruggiero C, 2007, AM J CARDIOL, V100, P115, DOI 10.1016/j.amjcard.2007.02.065; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Santos RD, 2007, AM J CARDIOL, V99, P42, DOI 10.1016/j.amjcard.2006.07.057; Sasanabe R, 2006, HYPERTENS RES, V29, P315, DOI 10.1291/hypres.29.315; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Steiropoulos P, 2009, SLEEP, V32, P537, DOI 10.1093/sleep/32.4.537; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Venkateswaran S, 2007, POSTGRAD MED J, V83, P329, DOI 10.1136/pgmj.2006.051805; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071	43	171	179	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12065	10.1371/journal.pone.0012065	http://dx.doi.org/10.1371/journal.pone.0012065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711453	gold, Green Submitted, Green Published			2022-12-27	WOS:000280849100013
J	Farenhorst, M; Knols, BGJ; Thomas, MB; Howard, AFV; Takken, W; Rowland, M; N'Guessan, R				Farenhorst, Marit; Knols, Bart G. J.; Thomas, Matthew B.; Howard, Annabel F. V.; Takken, Willem; Rowland, Mark; N'Guessan, Raphael			Synergy in Efficacy of Fungal Entomopathogens and Permethrin against West African Insecticide-Resistant Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; CULEX-QUINQUEFASCIATUS; PYRETHROID RESISTANCE; INFECTION; VECTORS; DEUTEROMYCOTINA; BIOPESTICIDES; COLEOPTERA; KNOCKDOWN; STRAIN	Background: Increasing incidences of insecticide resistance in malaria vectors are threatening the sustainable use of contemporary chemical vector control measures. Fungal entomopathogens provide a possible additional tool for the control of insecticide-resistant malaria mosquitoes. This study investigated the compatibility of the pyrethroid insecticide permethrin and two mosquito-pathogenic fungi, Beauveria bassiana and Metarhizium anisopliae, against a laboratory colony and field population of West African insecticide-resistant Anopheles gambiae s.s. mosquitoes. Methodology/Findings: A range of fungus-insecticide combinations was used to test effects of timing and sequence of exposure. Both the laboratory-reared and field-collected mosquitoes were highly resistant to permethrin but susceptible to B. bassiana and M. anisopliae infection, inducing 100% mortality within nine days. Combinations of insecticide and fungus showed synergistic effects on mosquito survival. Fungal infection increased permethrin-induced mortality rates in wild An. gambiae s.s. mosquitoes and reciprocally, exposure to permethrin increased subsequent fungal-induced mortality rates in both colonies. Simultaneous co-exposure induced the highest mortality; up to 70.3 +/- 2% for a combined Beauveria and permethrin exposure within a time range of one gonotrophic cycle (4 days). Conclusions/Significance: Combining fungi and permethrin induced a higher impact on mosquito survival than the use of these control agents alone. The observed synergism in efficacy shows the potential for integrated fungus-insecticide control measures to dramatically reduce malaria transmission and enable control at more moderate levels of coverage even in areas where insecticide resistance has rendered pyrethroids essentially ineffective.	[Farenhorst, Marit; Howard, Annabel F. V.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Knols, Bart G. J.] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Thomas, Matthew B.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rowland, Mark; N'Guessan, Raphael] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England; [N'Guessan, Raphael] Ctr Rech Entomol Cotonou, Lab Natl Minist Sante, Cotonou, Benin	Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Farenhorst, M (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	marit.farenhorst@wur.nl	Knols, Bart/C-5765-2017		Adessium Foundation (Reeuwijk); Royal Dutch Academy of Arts and Sciences [AFD/SSA/125]	Adessium Foundation (Reeuwijk); Royal Dutch Academy of Arts and Sciences	This work has received financial support from the Adessium Foundation (Reeuwijk) and the Royal Dutch Academy of Arts and Sciences (KNAW-DJA travel grant AFD/SSA/125, awarded to Bart G. J. Knols). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahiense TC, 2006, VET PARASITOL, V141, P319, DOI 10.1016/j.vetpar.2006.05.011; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Blanford S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-72; BURT PE, 1974, PESTIC SCI, V5, P625, DOI 10.1002/ps.2780050514; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; COX DR, 1972, J R STAT SOC B, V187, P220; Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; FARENHORST M, 2010, MALAR J, V9; Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hiromori H, 2001, APPL ENTOMOL ZOOL, V36, P231, DOI 10.1303/aez.2001.231; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jaramillo J, 2005, BIOL CONTROL, V34, P12, DOI 10.1016/j.biocontrol.2005.03.021; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Kikankie CK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-71; Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI [10.2217/fmb.10.11, 10.2217/FMB.10.11]; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Koppenhofer AM, 1998, J ECON ENTOMOL, V91, P618, DOI 10.1093/jee/91.3.618; LACEY CM, 1988, J INVERTEBR PATHOL, V52, P108, DOI 10.1016/0022-2011(88)90109-7; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mnyone LL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-309; Mnyone LL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-59; Morales-Rodriguez A, 2009, BIOL CONTROL, V51, P169, DOI 10.1016/j.biocontrol.2009.06.008; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406; Neves Pedro M. O. J., 2001, Neotropical Entomology, V30, P263, DOI 10.1590/S1519-566X2001000200009; Pachamuthu P, 2000, J ECON ENTOMOL, V93, P60, DOI 10.1603/0022-0493-93.1.60; Quintela ED, 1998, J ECON ENTOMOL, V91, P110, DOI 10.1093/jee/91.1.110; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Sanyang S, 2000, INT J PEST MANAGE, V46, P165, DOI 10.1080/096708700415481; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; *WHO, 1998, 9812 WHOCDSCPCMAL; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	49	74	87	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12081	10.1371/journal.pone.0012081	http://dx.doi.org/10.1371/journal.pone.0012081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711409	Green Published, gold, Green Accepted			2022-12-27	WOS:000280849100019
J	Vitureira, N; Andres, R; Perez-Martinez, E; Martinez, A; Bribian, A; Blasi, J; Chelliah, S; Lopez-Domenech, G; De Castro, F; Burgaya, F; McNagny, K; Soriano, E				Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Blasi, Juan; Chelliah, Shierley; Lopez-Domenech, Guillermo; De Castro, Fernando; Burgaya, Ferran; McNagny, Kelly; Soriano, Eduardo			Podocalyxin Is a Novel Polysialylated Neural Adhesion Protein with Multiple Roles in Neural Development and Synapse Formation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NEURONAL MIGRATION; MICE LACKING; MOUSE-BRAIN; MOLECULE; EXPRESSION; REORGANIZATION; GROWTH; NCAM; CAM	Neural development and plasticity are regulated by neural adhesion proteins, including the polysialylated form of NCAM (PSA-NCAM). Podocalyxin (PC) is a renal PSA-containing protein that has been reported to function as an anti-adhesin in kidney podocytes. Here we show that PC is widely expressed in neurons during neural development. Neural PC interacts with the ERM protein family, and with NHERF1/2 and RhoA/G. Experiments in vitro and phenotypic analyses of podxl-deficient mice indicate that PC is involved in neurite growth, branching and axonal fasciculation, and that PC loss-offunction reduces the number of synapses in the CNS and in the neuromuscular system. We also show that whereas some of the brain PC functions require PSA, others depend on PC per se. Our results show that PC, the second highly sialylated neural adhesion protein, plays multiple roles in neural development.	[Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] Inst Res Biomed, Barcelona, Spain; [Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] CIBERNED, Barcelona, Spain; [Vitureira, Nathalia; Andres, Rosa; Perez-Martinez, Esther; Martinez, Albert; Bribian, Ana; Lopez-Domenech, Guillermo; Burgaya, Ferran; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Bribian, Ana; De Castro, Fernando] Hosp Nacl Paraplejicos, Grp Neurobiol Desarrollo GNDe, Toledo, OH USA; [Blasi, Juan] Univ Barcelona, Dept Expt Pathol, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Chelliah, Shierley; McNagny, Kelly] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBERNED; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of British Columbia	Vitureira, N (corresponding author), Inst Res Biomed, Parc Cient Barcelona, Barcelona, Spain.	eduardo.soriano@irbbarcelona.org	de Castro, Fernando/Q-8624-2018; McNagny, Kelly/P-5239-2014; Andres, Rosa/A-7236-2012; Blasi, Juan/K-7943-2014; IBSAL, Secretaría/H-3719-2011; López Doménech, Guillermo López Doménech/X-6075-2018; Soriano, Eduardo/AAB-3216-2019; Bribian, Ana/M-2978-2014	de Castro, Fernando/0000-0002-7018-8032; McNagny, Kelly/0000-0003-4737-3499; Blasi, Juan/0000-0002-0482-9444; López Doménech, Guillermo López Doménech/0000-0002-3114-2082; Soriano, Eduardo/0000-0002-3204-9285; Vitureira, Nathalia/0000-0003-1196-4094; Martinez, Albert/0000-0003-0831-9916; Andres, Rosa/0000-0002-6818-5203	Ministerio de Ciencia e Innovacion [BFU2008-3980]; La Caixa Foundation; Comunidad de Castilla-La Mancha; Canadian Institute for Heart Research; Heart and Stroke Foundation of BC and Yukon; FIS	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); La Caixa Foundation(La Caixa Foundation); Comunidad de Castilla-La Mancha; Canadian Institute for Heart Research; Heart and Stroke Foundation of BC and Yukon; FIS(Instituto de Salud Carlos III)	This work was supported by grants from Ministerio de Ciencia e Innovacion (BFU2008-3980) and La Caixa Foundation to ES, and the Comunidad de Castilla-La Mancha to FdeC, and FIS to FB. KMM is an MSFHR Scholar. This work was partially funded by a Canadian Institute for Heart Research grant and a Grant-in-Aid from the Heart and Stroke Foundation of BC and Yukon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 2000, DEVELOPMENT, V127, P1359; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Garcia-Frigola C, 2004, MOL BRAIN RES, V122, P133, DOI 10.1016/j.molbrainres.2003.12.014; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; KERSHAW DB, 1995, J BIOL CHEM, V270, P29439, DOI 10.1074/jbc.270.49.29439; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mann F, 2007, PROG NEUROBIOL, V82, P57, DOI 10.1016/j.pneurobio.2007.02.011; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; Miettinen A, 1999, AM J PATHOL, V154, P813, DOI 10.1016/S0002-9440(10)65328-X; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Packard M, 2003, CURR OPIN NEUROBIOL, V13, P527, DOI 10.1016/j.conb.2003.09.008; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Rodriguez RB, 2006, TISSUE ANTIGENS, V68, P407, DOI 10.1111/j.1399-0039.2006.00692.x; Rolf B, 2002, J NEUROSCI, V22, P8357; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P1565, DOI 10.1177/39.11.1918930; Sotelo C, 2005, PROG BRAIN RES, V148, P3, DOI 10.1016/S0079-6123(04)48001-7; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Takeda Tetsuro, 2003, Clin Exp Nephrol, V7, P260, DOI 10.1007/s10157-003-0257-8; TAN P, 2010, CELL MIGRATION; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Vitureira N, 2005, GENE EXPR PATTERNS, V5, P349, DOI 10.1016/j.modgep.2004.10.002; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	64	57	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12003	10.1371/journal.pone.0012003	http://dx.doi.org/10.1371/journal.pone.0012003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706633	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900003
J	Glaser, C; Demmelmair, H; Koletzko, B				Glaser, Claudia; Demmelmair, Hans; Koletzko, Berthold			High-Throughput Analysis of Total Plasma Fatty Acid Composition with Direct In Situ Transesterification	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; ADIPOSE-TISSUE; LIPID ANALYSIS; WHOLE-BLOOD; FISH-OIL; HUMANS; PHOSPHOLIPIDS; EXTRACTION; BIOMARKER; DEATH	Background: Plasma fatty acid (FA) composition reflects dietary intake and endogenous turnover and is associated with health outcomes on a short and long term basis. The total plasma FA pool represents the composition of all FA containing lipid fractions. We developed a simplified and affordable high-throughput method for the analysis of total plasma FA composition, suitable for large studies. Methodology/Principal Findings: The total lipid FA from 100 mu l plasma is transferred in situ into methyl esters, avoiding initial extraction and drying steps. The fatty acid methyl esters are extracted once and analyzed by gas chromatography. For the new direct in situ transesterification method optimal, reaction parameters were determined. Intra-assay analysis (n = 8) revealed coefficients of variation below 4% for FA contributing more than 1% to total FA. Conclusions/Significance: The results show good agreement with FA concentrations obtained by a reference method. The new direct in situ transesterification method is robust and simple. Sample preparation time and analysis costs are reduced to a minimum. This method is an economically and ecologically superior alternative to conventional methods for assessing plasma FA status in large studies.	[Glaser, Claudia; Demmelmair, Hans; Koletzko, Berthold] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany	University of Munich	Glaser, C (corresponding author), Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Div Metab & Nutr Med, Munich, Germany.	office.koletzko@med.uni-muenchen.de			Kompetenznetz Adipositas Competence Network for Adiposity; German Federal Ministry of Education and Research [01GI0826]; Munich Center of Health Sciences; Bristol-Myers Squibb Foundation, New York, New York, USA	Kompetenznetz Adipositas Competence Network for Adiposity; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences; Bristol-Myers Squibb Foundation, New York, New York, USA(Bristol-Myers Squibb)	This work was supported financially in part by the Kompetenznetz Adipositas Competence Network for Adiposity (www.kn-adipositas.de) funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826), and by the Munich Center of Health Sciences. Berthold Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Bailey-Hall E, 2008, LIPIDS, V43, P181, DOI 10.1007/s11745-007-3140-7; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; Beblo S, 2007, J PEDIATR-US, V150, P479, DOI 10.1016/j.jpeds.2006.12.011; Belo L, 2002, EUR J HAEMATOL, V69, P145, DOI 10.1034/j.1600-0609.2002.02788.x; Carrapiso AI, 2000, LIPIDS, V35, P1167, DOI 10.1007/s11745-000-0633-8; CIRILLO M, 1992, HYPERTENSION, V20, P319, DOI 10.1161/01.HYP.20.3.319; Fekete K, 2009, AM J CLIN NUTR, V89, p2070S, DOI 10.3945/ajcn.2009.27230I; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Indarti E, 2005, J FOOD COMPOS ANAL, V18, P161, DOI 10.1016/j.jfca.2003.12.007; Jopling J, 2009, PEDIATRICS, V123, pE333, DOI 10.1542/peds.2008-2654; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Kompauer I, 2005, BRIT J NUTR, V93, P529, DOI 10.1079/BJN20041387; Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3; Leaf A, 2006, FUND CLIN PHARMACOL, V20, P525, DOI 10.1111/j.1472-8206.2006.00438.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Marangoni F, 2004, ANAL BIOCHEM, V326, P267, DOI 10.1016/j.ab.2003.12.016; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Masood MA, 2008, LIPIDS, V43, P171, DOI 10.1007/s11745-007-3130-9; Muskiet FAJ, 2006, J NUTR BIOCHEM, V17, P717, DOI 10.1016/j.jnutbio.2006.02.001; PHILLIPS GB, 1967, J LIPID RES, V8, P676; Rise P, 2007, PROSTAG LEUKOTR ESS, V76, P363, DOI 10.1016/j.plefa.2007.05.003; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y	26	63	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12045	10.1371/journal.pone.0012045	http://dx.doi.org/10.1371/journal.pone.0012045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711501	Green Published, Green Submitted, gold			2022-12-27	WOS:000280776800017
J	Rutherford, M; Alisjahbana, B; Maharani, W; Sampurno, H; van Crevel, R; Hill, PC				Rutherford, Merrin; Alisjahbana, Bachti; Maharani, Winni; Sampurno, Hedy; van Crevel, Reinout; Hill, Philip C.			Sensitivity of the Quantiferon-Gold In-Tube Assay in Sputum Smear Positive TB Cases in Indonesia	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; SKIN-TEST; DIAGNOSIS; GAMBIA	Background: As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infection we compared its sensitivity to the tuberculin skin test (TST) in confirmed adult TB cases in Indonesia. Smear-positive TB disease was used as a proxy gold standard for latent TB infection. Methods and Findings: We compared the sensitivity of QFT-IT and TST in 98 sputum smear and chest x-ray positive TB cases and investigated risk factors for negative and discordant results in both tests. Both tests showed high sensitivity; (QFT-IT; 88.7%: TST; 94.9%), not significantly different from each other (p value 0.11). Very high sensitivity was seen when tests were combined (98.9%). There were no variables significantly associated with discordant results or with a negative TST. For QFT-IT which particular staff member collected blood was significantly associated with test positivity (p value 0.01). Study limitations include small sample size and lack of culture confirmation or HIV test results. Conclusions: The QFT-IT has similar sensitivity in Indonesian TB cases as in other locations. However, QFT-IT, like the TST cannot distinguish active TB disease from LTBI. In countries such as Indonesia, with high background rates of LTBI, test specificity for TB disease will likely be low. While our study was not designed to evaluate the QFT-IT in the diagnosis of active TB disease in TB suspects, the data suggest that a combination of TST and QFT-IT may prove useful for ruling out TB disease. Further research is required to explore the clinical role of QFT-IT in combination with other TB diagnostic tests.	[Rutherford, Merrin; Hill, Philip C.] Univ Otago, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand; [Alisjahbana, Bachti; Maharani, Winni] Padjadjaran State Univ, Hlth Res Unit, Bandung, Indonesia; [Sampurno, Hedy] Bandung Community Lung Clin, Bandung, Indonesia; [van Crevel, Reinout] Radboud Univ Nijmegen, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	University of Otago; Universitas Padjadjaran; Radboud University Nijmegen	Rutherford, M (corresponding author), Univ Otago, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand.	merrin.rutherford@gmail.com	van Crevel, reinout/A-6636-2010; Maharani, Winni/ABE-1323-2020	van Crevel, reinout/0000-0002-6233-6410; Maharani, Winni/0000-0003-0469-6247	University of Otago	University of Otago	Research was funded by the University of Otago (www.otago.ac.nz). Kits were donated by Cellestis (www.cellestis.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Bartu V, 2008, J INT MED RES, V36, P434, DOI 10.1177/147323000803600307; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; FALK A, 1978, CHEST, V73, P44, DOI 10.1378/chest.73.1.44; HERRERA V, 2010, J CLIN MICROBIOL; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Miranda C, 2009, INFECT CONT HOSP EP, V30, P296, DOI 10.1086/595732; Organization WH, 2008, GLOB TUB CONTR SURV; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; 1999, AM J RESP CRIT CARE, V161, P1376	19	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12020	10.1371/journal.pone.0012020	http://dx.doi.org/10.1371/journal.pone.0012020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711257	Green Published, Green Submitted, gold			2022-12-27	WOS:000280776800011
J	Weaver, EA				Weaver, Eric A.			A Detailed Phylogenetic Analysis of FIV in the United States	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; GENETIC DIVERSITY; NUCLEOTIDE-SEQUENCE; IN-VIVO; CATS; INFECTION; LENTIVIRUS; PREVALENCE; SUBTYPE; REPLICATION	Background: Feline immunodeficiency virus (FIV) is a lentivirus associated with AIDS-like illnesses in cats and has been used as a model for the study of human immunodeficiency virus (HIV). A feature of HIV and FIV infection is the continually increasing divergence among viral isolates between different individuals, as well as within the same individuals. Methodology/Principal Findings: The goal of this study was to determine the phylogenetic patterns of viral isolates obtained within the United States (U.S.) by focusing on the variable, V3-V4, region of the FIV envelope gene. Conclusions/Significance: Data indicate that FIV, from within the U.S., localize to four viral clades, A, B, C, and F. Also shown is the geographic isolation of strains where clade A and clade B are found predominately on the west coast; however, clade B is also found throughout the U.S. and represents the predominant clade. This study presents a complete and conclusive analysis of FIV isolates from within the U.S. and may be used as the essential basis for the development of an effective multi-clade vaccine.	Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA	Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Dept Internal Med, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu			Texas A&M University College of Veterinary Medicine, Department of Pathobiology	Texas A&M University College of Veterinary Medicine, Department of Pathobiology	Funding for this project was supplied by Texas A&M University College of Veterinary Medicine, Department of Pathobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MH, 1997, J VIROL, V71, P4241, DOI 10.1128/JVI.71.6.4241-4253.1997; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; BROWN WC, 1991, J VIROL, V65, P3359, DOI 10.1128/JVI.65.6.3359-3364.1991; BRUNNER D, 1989, J VIROL, V63, P5483, DOI 10.1128/JVI.63.12.5483-5488.1989; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Duarte A, 2006, VET MICROBIOL, V114, P25, DOI 10.1016/j.vetmic.2005.11.056; Duarte A, 2002, ARCH VIROL, V147, P1061, DOI 10.1007/s00705-002-0785-7; ELDER JH, 1993, INFECT AGENT DIS, V2, P361; ENGLISH RV, 1994, J INFECT DIS, V170, P543, DOI 10.1093/infdis/170.3.543; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GREENE WK, 1993, ARCH VIROL, V132, P369, DOI 10.1007/BF01309546; GREENE WK, 1993, ARCH VIROL, V133, P51, DOI 10.1007/BF01309743; Hartmann K, 1997, ANTIVIR RES, V36, P11, DOI 10.1016/S0166-3542(97)00030-2; HOSIE MJ, 1989, VET REC, V125, P293, DOI 10.1136/vr.125.11.293; Hosie MJ, 2000, J VIROL, V74, P9403, DOI 10.1128/JVI.74.20.9403-9411.2000; Inada G, 1997, ARCH VIROL, V142, P1459, DOI 10.1007/s007050050172; KAKINUMA S, 1995, J VIROL, V69, P3639, DOI 10.1128/JVI.69.6.3639-3646.1995; Kashiwase H, 2000, J VET MED SCI, V62, P499, DOI 10.1292/jvms.62.499; LANGLEY RJ, 1994, VIROLOGY, V202, P853, DOI 10.1006/viro.1994.1407; Mergia A, 1997, AIDS RES HUM RETROV, V13, P1333, DOI 10.1089/aid.1997.13.1333; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P2448, DOI 10.1073/pnas.86.7.2448; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Pecoraro MR, 1996, J GEN VIROL, V77, P2031, DOI 10.1099/0022-1317-77-9-2031; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; PHILPOTT MS, 1992, VET IMMUNOL IMMUNOP, V35, P155, DOI 10.1016/0165-2427(92)90128-D; Pistello M, 1997, J GEN VIROL, V78, P2247, DOI 10.1099/0022-1317-78-9-2247; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; Pu RY, 2001, AIDS, V15, P1225, DOI 10.1097/00002030-200107060-00004; RIGBY MA, 1993, J GEN VIROL, V74, P425, DOI 10.1099/0022-1317-74-3-425; SODORA DL, 1994, J VIROL, V68, P2230, DOI 10.1128/JVI.68.4.2230-2238.1994; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weaver EA, 2004, J VIROL, V78, P2158, DOI 10.1128/JVI.78.4.2158-2163.2004; YAMADA H, 1995, ARCH VIROL, V140, P41, DOI 10.1007/BF01309722; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; Yang JS, 1996, J VIROL, V70, P3011, DOI 10.1128/JVI.70.5.3011-3017.1996; ZENGER E, 1995, GLIA, V13, P92, DOI 10.1002/glia.440130203	41	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12004	10.1371/journal.pone.0012004	http://dx.doi.org/10.1371/journal.pone.0012004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711253	Green Published, gold			2022-12-27	WOS:000280776800005
J	Bugaysen, J; Bronfeld, M; Tischler, H; Bar-Gad, I; Korngreen, A				Bugaysen, Jenia; Bronfeld, Maya; Tischler, Hadass; Bar-Gad, Izhar; Korngreen, Alon			Electrophysiological Characteristics of Globus Pallidus Neurons	PLOS ONE			English	Article							MPTP-INDUCED PARKINSONISM; BASAL GANGLIA; BRAIN-SLICES; IN-VITRO; RAT; STIMULATION; RESPONSES; RECORDINGS; MORPHOLOGY; MOVEMENT	Extracellular recordings in primates have identified two types of neurons in the external segment of the globus pallidus (GPe): high frequency pausers (HFP) and low frequency bursters (LFB). The aim of the current study was to test whether the properties of HFP and LFB neurons recorded extracellularly in the primate GPe are linked to cellular mechanisms underlying the generation of action potential (AP) firing. Thus, we recorded from primate and rat globus pallidus neurons. Extracellular recordings in primates revealed that in addition to differences in firing patterns the APs of neurons in these two groups have different widths (AP(ex)). To quantitatively investigate this difference and to explore the heterogeneity of pallidal neurons we carried out cell-attached and whole-cell recordings from acute slices of the rat globus pallidus (GP, the rodent homolog of the primate GPe), examining both spontaneous and evoked activity. Several parameters related to the extracellular activity were extracted in order to subdivide the population of recorded GP neurons into groups. Statistical analysis showed that the GP neurons in the rodents may be differentiated along six cellular parameters into three subgroups. Combining two of these groups allowed a better separation of the population along nine parameters. Four of these parameters (F(max), AP(amp), AP(hw), and AHP(s) amplitude) form a subset, suggesting that one group of neurons may generate APs at significantly higher frequencies than the other group. This may suggest that the differences between the HFP and LFB neurons in the primate are related to fundamental underlying differences in their cellular properties.	[Bugaysen, Jenia; Bronfeld, Maya; Tischler, Hadass; Bar-Gad, Izhar; Korngreen, Alon] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Bugaysen, Jenia; Bar-Gad, Izhar; Korngreen, Alon] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Bugaysen, J (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.	korngra@mail.biu.ac.il		Bar-Gad, Izhar/0000-0002-2999-4083; Bronfeld, Maya/0000-0001-9797-5418; Korngreen, Alon/0000-0002-2036-6160	Israel Science Foundation [1000-05, 1698-07]; Tourette Syndrome Association	Israel Science Foundation(Israel Science Foundation); Tourette Syndrome Association	This study was supported in part by grants from the Israel Science Foundation (no. 1000-05) and the Tourette Syndrome Association to IB and Israel Science Foundation Converging Technologies grant 1698-07 (to AK and IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Bellman R., 1961, ADAPTIVE CONTROL PRO; Chang JY, 2006, EXP BRAIN RES, V172, P193, DOI 10.1007/s00221-005-0312-7; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; FILION M, 1991, BRAIN RES, V547, P142; FILION M, 1991, BRAIN RES, V547, P152; GARDINER TW, 1992, EXP BRAIN RES, V88, P517; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; KELLAND MD, 1995, SYNAPSE, V20, P338, DOI 10.1002/syn.890200407; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; KITA H, 1994, BRAIN RES, V636, P308, DOI 10.1016/0006-8993(94)91030-8; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; MILLHOUSE OE, 1986, J COMP NEUROL, V254, P209, DOI 10.1002/cne.902540206; Nambu A, 1997, J COMP NEUROL, V377, P85; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949	23	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12001	10.1371/journal.pone.0012001	http://dx.doi.org/10.1371/journal.pone.0012001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700458	Green Submitted, Green Published, gold			2022-12-27	WOS:000280687900008
J	Petermann, JS; Muller, CB; Roscher, C; Weigelt, A; Weisser, WW; Schmid, B				Petermann, Jana S.; Mueller, Christine B.; Roscher, Christiane; Weigelt, Alexandra; Weisser, Wolfgang W.; Schmid, Bernhard			Plant Species Loss Affects Life-History Traits of Aphids and Their Parasitoids	PLOS ONE			English	Article							PEA APHID; TROPHIC CASCADES; HOST-PLANT; BOTTOM-UP; SEX-RATIO; NITROGEN; BIODIVERSITY; HERBIVORE; ENDOSYMBIONTS; RESISTANCE	The consequences of plant species loss are rarely assessed in a multi-trophic context and especially effects on life-history traits of organisms at higher trophic levels have remained largely unstudied. We used a grassland biodiversity experiment and measured the effects of two components of plant diversity, plant species richness and the presence of nitrogen-fixing legumes, on several life-history traits of naturally colonizing aphids and their primary and secondary parasitoids in the field. We found that, irrespective of aphid species identity, the proportion of winged aphid morphs decreased with increasing plant species richness, which was correlated with decreasing host plant biomass. Similarly, emergence proportions of parasitoids decreased with increasing plant species richness. Both, emergence proportions and proportions of female parasitoids were lower in plots with legumes, where host plants had increased nitrogen concentrations. This effect of legume presence could indicate that aphids were better defended against parasitoids in high-nitrogen environments. Body mass of emerged individuals of the two most abundant primary parasitoid species was, however, higher in plots with legumes, suggesting that once parasitoids could overcome aphid defenses, they could profit from larger or more nutritious hosts. Our study demonstrates that cascading effects of plant species loss on higher trophic levels such as aphids, parasitoids and secondary parasitoids begin with changed life-history traits of these insects. Thus, life-history traits of organisms at higher trophic levels may be useful indicators of bottom-up effects of plant diversity on the biodiversity of consumers.	[Petermann, Jana S.; Mueller, Christine B.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Roscher, Christiane] Max Planck Inst Biogeochem, Jena, Germany; [Weigelt, Alexandra; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany	University of Zurich; Max Planck Society; Friedrich Schiller University of Jena	Petermann, JS (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	petermann@zoology.ubc.ca	Weisser, Wolfgang W/B-9718-2014; Petermann, Jana/AAK-9787-2020; Petermann, Jana/E-2130-2013; Schmid, Bernhard/C-8625-2009	Weisser, Wolfgang W/0000-0002-2757-8959; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Schmid, Bernhard/0000-0002-8430-3214	German Research Foundation [FOR 456]; Friedrich-Schiller-University of Jena; Max-Planck-Institute for Biogeochemistry, Jena; Swiss National Science Foundation [31-65224-01]	German Research Foundation(German Research Foundation (DFG)); Friedrich-Schiller-University of Jena; Max-Planck-Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Research Foundation (FOR 456, www.dfg.de) and supported by the Friedrich-Schiller-University of Jena (www.uni-jena.de) and the Max-Planck-Institute for Biogeochemistry, Jena (www.bgc-jena.mpg.de). Additional support was provided by the Swiss National Science Foundation (grant no. 31-65224-01 to BS, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Ashouri A, 2001, BIOCONTROL, V46, P401, DOI 10.1023/A:1014123712776; BARBOSA P, 1991, ECOLOGY, V72, P1567, DOI 10.2307/1940956; Belshaw R, 1999, EVOLUTION, V53, P1189, DOI [10.2307/2640822, 10.1111/j.1558-5646.1999.tb04532.x]; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Buhler C, 2001, J APPL ECOL, V38, P689, DOI 10.1046/j.1365-2664.2001.00640.x; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; Cohen JE, 2005, P NATL ACAD SCI USA, V102, P684, DOI 10.1073/pnas.0408780102; DAVIDSON AW, 1995, J ECON ENTOMOL, V88, P367, DOI 10.1093/jee/88.2.367; de Sassi C, 2006, P R SOC B, V273, P1301, DOI 10.1098/rspb.2005.3442; Dixon AF G, 1998, APHID ECOLOGY; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Dyer LA, 2003, BASIC APPL ECOL, V4, P423, DOI 10.1078/1439-1791-00191; Fagan WF, 2002, AM NAT, V160, P784, DOI 10.1086/343879; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Francis F, 2001, J CHEM ECOL, V27, P243, DOI 10.1023/A:1005672220342; Gange AC, 2003, ECOL LETT, V6, P1051, DOI 10.1046/j.1461-0248.2003.00540.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Harri SA, 2008, OECOLOGIA, V157, P399, DOI 10.1007/s00442-008-1094-y; Harri SA, 2008, P R SOC B, V275, P2627, DOI 10.1098/rspb.2008.0594; Harvey JA, 2003, J ANIM ECOL, V72, P520, DOI 10.1046/j.1365-2656.2003.00722.x; HUNTER MD, 1992, ECOLOGY, V73, P724; HUNTER MD, 2003, ECOL LETT, V5, P1; Kagata H, 2006, ECOL RES, V21, P26, DOI 10.1007/s11284-005-0124-z; Kempel A, 2009, OIKOS, V118, P634, DOI 10.1111/j.1600-0706.2009.17418.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; LAWTON JH, 1979, POPULATION DYNAMICS, P223; Li S, 2002, J INSECT PHYSIOL, V48, P971, DOI 10.1016/S0022-1910(02)00176-2; LYONS PC, 1986, SCIENCE, V232, P487, DOI 10.1126/science.3008328; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pfisterer AB, 2003, OECOLOGIA, V135, P234, DOI 10.1007/s00442-002-1169-0; R Core Team, 2018, R LANG ENV STAT COMP; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; ROTHMALER R, 2002, EXKURSIONSFLORA DEUT; Schmid Bernhard, 2009, P14; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sloggett JJ, 2002, OIKOS, V98, P323, DOI 10.1034/j.1600-0706.2002.980213.x; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; STRESEMANN E, 1994, EXKURSIONSFAUNA DEUT; SUTHERLA.OR, 1967, NATURE, V216, P387, DOI 10.1038/216387a0; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Ueno T, 1999, RES POPUL ECOL, V41, P47, DOI 10.1007/PL00011982; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Volkl W, 2007, APHIDS AS CROP PESTS, P187, DOI 10.1079/9780851998190.0187; Wacker L, 2009, J PLANT ECOL-UK, V2, P95, DOI 10.1093/jpe/rtp010; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wurst S, 2003, PEDOBIOLOGIA, V47, P91, DOI 10.1078/0031-4056-00173; Zust T, 2008, ECOL ENTOMOL, V33, P80, DOI 10.1111/j.1365-2311.2007.00940.x	60	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12053	10.1371/journal.pone.0012053	http://dx.doi.org/10.1371/journal.pone.0012053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700511	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900023
J	Coll, M; Piroddi, C; Steenbeek, J; Kaschner, K; Lasram, FB; Aguzzi, J; Ballesteros, E; Bianchi, CN; Corbera, J; Dailianis, T; Danovaro, R; Estrada, M; Froglia, C; Galil, BS; Gasol, JM; Gertwagen, R; Gil, J; Guilhaumon, F; Kesner-Reyes, K; Kitsos, MS; Koukouras, A; Lampadariou, N; Laxamana, E; de la Cuadra, CMLF; Lotze, HK; Martin, D; Mouillot, D; Oro, D; Raicevich, S; Rius-Barile, J; Saiz-Salinas, JI; San Vicente, C; Somot, S; Templado, J; Turon, X; Vafidis, D; Villanueva, R; Voultsiadou, E				Coll, Marta; Piroddi, Chiara; Steenbeek, Jeroen; Kaschner, Kristin; Lasram, Frida Ben Rais; Aguzzi, Jacopo; Ballesteros, Enric; Bianchi, Carlo Nike; Corbera, Jordi; Dailianis, Thanos; Danovaro, Roberto; Estrada, Marta; Froglia, Carlo; Galil, Bella S.; Gasol, Josep M.; Gertwagen, Ruthy; Gil, Joao; Guilhaumon, Francois; Kesner-Reyes, Kathleen; Kitsos, Miltiadis-Spyridon; Koukouras, Athanasios; Lampadariou, Nikolaos; Laxamana, Elijah; Lopez-Fe de la Cuadra, Carlos M.; Lotze, Heike K.; Martin, Daniel; Mouillot, David; Oro, Daniel; Raicevich, Sasa; Rius-Barile, Josephine; Ignacio Saiz-Salinas, Jose; San Vicente, Carles; Somot, Samuel; Templado, Jose; Turon, Xavier; Vafidis, Dimitris; Villanueva, Roger; Voultsiadou, Eleni			The Biodiversity of the Mediterranean Sea: Estimates, Patterns, and Threats	PLOS ONE			English	Review							SMALL PELAGIC FISH; BEAKED COMMON DOLPHINS; LONG-TERM CHANGES; DEEP-SEA; AEGEAN SEA; ADRIATIC SEA; MARINE-INVERTEBRATES; COMMUNITY STRUCTURE; MONACHUS-MONACHUS; SPECIES-DIVERSITY	The Mediterranean Sea is a marine biodiversity hot spot. Here we combined an extensive literature analysis with expert opinions to update publicly available estimates of major taxa in this marine ecosystem and to revise and update several species lists. We also assessed overall spatial and temporal patterns of species diversity and identified major changes and threats. Our results listed approximately 17,000 marine species occurring in the Mediterranean Sea. However, our estimates of marine diversity are still incomplete as yet-undescribed species will be added in the future. Diversity for microbes is substantially underestimated, and the deep-sea areas and portions of the southern and eastern region are still poorly known. In addition, the invasion of alien species is a crucial factor that will continue to change the biodiversity of the Mediterranean, mainly in its eastern basin that can spread rapidly northwards and westwards due to the warming of the Mediterranean Sea. Spatial patterns showed a general decrease in biodiversity from northwestern to southeastern regions following a gradient of production, with some exceptions and caution due to gaps in our knowledge of the biota along the southern and eastern rims. Biodiversity was also generally higher in coastal areas and continental shelves, and decreases with depth. Temporal trends indicated that overexploitation and habitat loss have been the main human drivers of historical changes in biodiversity. At present, habitat loss and degradation, followed by fishing impacts, pollution, climate change, eutrophication, and the establishment of alien species are the most important threats and affect the greatest number of taxonomic groups. All these impacts are expected to grow in importance in the future, especially climate change and habitat degradation. The spatial identification of hot spots highlighted the ecological importance of most of the western Mediterranean shelves (and in particular, the Strait of Gibraltar and the adjacent Alboran Sea), western African coast, the Adriatic, and the Aegean Sea, which show high concentrations of endangered, threatened, or vulnerable species. The Levantine Basin, severely impacted by the invasion of species, is endangered as well.	[Coll, Marta; Aguzzi, Jacopo; Estrada, Marta; Gasol, Josep M.; Villanueva, Roger] Sci Spanish Council ICM CSIC, Inst Ciencias Mar, Barcelona, Spain; [Coll, Marta; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Piroddi, Chiara; Steenbeek, Jeroen] Univ British Columbia, Fisheries Ctr, Aquat Ecosyst Res Lab, Vancouver, BC V5Z 1M9, Canada; [Kaschner, Kristin] Univ Freiburg, Evolutionary Biol & Ecol Lab, Freiburg, Germany; [Lasram, Frida Ben Rais; Guilhaumon, Francois; Mouillot, David] Univ Montpellier 2, Lab Ecosyst Lagunaires UMR 5119, Montpellier, France; [Lasram, Frida Ben Rais] Inst Natl Agron Tunisie, Lab Ecosyst & Ressources Aquat UR03AGRO1, Tunis, Tunisia; [Ballesteros, Enric; Gil, Joao; Martin, Daniel; Turon, Xavier] Sci Spanish Council CEAB CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Bianchi, Carlo Nike] Univ Genoa, Dipartimento Studio Terr & Sue Risorse, Genoa, Italy; [Corbera, Jordi] Carrer Gran, Argentona, Spain; [Dailianis, Thanos; Kitsos, Miltiadis-Spyridon; Koukouras, Athanasios; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Dept Zool, GR-54006 Thessaloniki, Greece; [Dailianis, Thanos] Inst Marine Biol & Genet, Hellen Ctr Marine Res, Iraklion, Greece; [Danovaro, Roberto] Polytech Univ Marche, Dipartimento Sci Mare, Ancona, Italy; [Froglia, Carlo] CNR, Ist Sci Marine, Ancona, Italy; [Galil, Bella S.] Natl Inst Oceanog, IL-31080 Haifa, Israel; [Gertwagen, Ruthy] Univ Haifa, IL-31999 Haifa, Israel; [Gertwagen, Ruthy] Oranim Acad Coll, Haifa, Israel; [Kesner-Reyes, Kathleen; Laxamana, Elijah; Rius-Barile, Josephine] WorldFish Ctr, Philippine Off, Los Banos, Philippines; [Lampadariou, Nikolaos] Hellen Ctr Marine Res, Inst Oceanog, Iraklion, Greece; [Lopez-Fe de la Cuadra, Carlos M.] Univ Seville, Dept Fisiol & Zool, Lab Biol Marina, Seville, Spain; [Oro, Daniel] Sci Spanish Council IMEDEA CSIC, Mediterranean Inst Adv Studies, Esporles, Spain; [Raicevich, Sasa] Ist Super Ric & Protez Ambientale, Chioggia, Italy; [Ignacio Saiz-Salinas, Jose] Univ Basque Country, Dept Zool, Bilbao, Spain; [San Vicente, Carles] Carrer Nou, Creixell, Spain; [Somot, Samuel] Meteo France, Ctr Natl Rech Meteorol, Toulouse, France; [Templado, Jose] CSIC, Museo Nacl Ciencias Nat, Sci Spanish Council, E-28006 Madrid, Spain; [Vafidis, Dimitris] Univ Thessaly, Dept Ichthyol & Aquat Environm, Nea Ionia, Greece	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Dalhousie University; University of British Columbia; University of Freiburg; Universite de Montpellier; Universite de Carthage; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Genoa; Aristotle University of Thessaloniki; Hellenic Centre for Marine Research; Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Israel Oceanographic & Limnological Research Institute; University of Haifa; CGIAR; Worldfish; Hellenic Centre for Marine Research; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); University of Basque Country; Meteo France; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Thessaly	Coll, M (corresponding author), Sci Spanish Council ICM CSIC, Inst Ciencias Mar, Barcelona, Spain.	mcoll@icm.csic.es	Estrada, Marta/L-6207-2014; Steenbeek, Jeroen/F-9936-2016; López-Fé, Carlos M./I-6342-2018; Martin, Daniel/G-5232-2010; Guilhaumon, francois/GPX-7180-2022; Gasol, Josep M M/B-1709-2008; Ballesteros, Enric/K-6497-2012; Voultsiadou, Eleni/P-9890-2017; Templado, José/Z-2319-2019; Piroddi, Chiara/AAD-8895-2019; Dailianis, Thanos/G-9145-2011; Aguzzi, Jacopo/D-6574-2012; Turon, Xavier/J-9211-2012; Coll, Marta/A-9488-2012; Lampadariou, Nikolaos/H-1201-2011; Kaschner, Kristin/GQQ-6475-2022; Somot, Samuel/A-7585-2008; Guilhaumon, François/C-3240-2009; Oro, Daniel/H-4208-2012; Corbera, Jordi/AAI-3207-2020; Villanueva, Roger/D-6911-2011; Saiz Salinas, Jose Ignacio/I-5216-2015; CNR, Ismar/P-1247-2014	Estrada, Marta/0000-0001-5769-9498; Steenbeek, Jeroen/0000-0002-7878-8075; López-Fé, Carlos M./0000-0003-2284-7037; Martin, Daniel/0000-0001-6350-7384; Guilhaumon, francois/0000-0003-4707-8932; Gasol, Josep M M/0000-0001-5238-2387; Voultsiadou, Eleni/0000-0003-3429-6754; Templado, José/0000-0002-6571-4720; Dailianis, Thanos/0000-0002-4102-9331; Aguzzi, Jacopo/0000-0002-1484-8219; Turon, Xavier/0000-0002-9229-5541; Coll, Marta/0000-0001-6235-5868; Oro, Daniel/0000-0003-4782-3007; Corbera, Jordi/0000-0003-3583-3929; Villanueva, Roger/0000-0001-8122-3449; Saiz Salinas, Jose Ignacio/0000-0002-6245-7589; Raicevich, Sasa/0000-0002-9323-031X; CNR, Ismar/0000-0001-5351-1486; FROGLIA, Carlo/0000-0003-0447-7802; Gil, Joao/0000-0002-1856-3333; Lotze, Heike/0000-0001-6258-1304; Somot, Samuel/0000-0002-5066-2921; Ben Rais Lasram, Frida/0000-0003-3327-908X; Lampadariou, Nikolaos/0000-0003-2171-7150; Bianchi, Carlo Nike/0000-0003-1071-3285; Piroddi, Chiara/0000-0003-2168-5830; VAFIDIS, DIMITRIS/0000-0002-8454-6937	European Census of Marine Life; Total Foundation; Alfred P. Sloan Foundation; European Commission [FP7-PEOPLE-2007-4-1-IOF]; Dalhousie University (Halifax, Canada); Spanish Ministry of Science and Innovation [C5D2007-00067]; Ministry of Science and Innovation of Spain [CGL2008-05407-C03-03, CTM2007-66635]; Generalitat de Catalunya [2009SRG665, 2009SGR484]; Italian Ministry of the Environment	European Census of Marine Life; Total Foundation(Total SA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Dalhousie University (Halifax, Canada); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Italian Ministry of the Environment	The authors gratefully acknowledge the support given by the European Census of Marine Life, the Total Foundation and the Alfred P. Sloan Foundation. MC was supported financially by the European Commission Marie Curie Postdoctoral Fellowship through the International Outgoing Fellowships (Call FP7-PEOPLE-2007-4-1-IOF) for the ECOFUN project and by Dalhousie University (Halifax, Canada). EB acknowledges financial support from GRACCIE project C5D2007-00067 funded by the Spanish Ministry of Science and Innovation. BG thanks the support of SESAME funded by the European Commission's Sixth Framework Program on Sustainable Development, Global Change and Ecosystems. JISS acknowledges ECOLIFE (CGL2008-05407-C03-03) funds of the Ministry of Science and Innovation of Spain. The present paper is a contribution of JG, DM and XT to the projects 2009SRG665 and 2009SGR484 of the "Generalitat de Catalunya'', and of DM and XT to project CTM2007-66635 funded by the Ministry of Science and Innovation of Spain. Research by C. N. Bianchi on Mediterranean Sea biodiversity is partly supported by the project "The impacts of biological invasions and climate change on the biodiversity of the Mediterranean Sea'' (Italy-Israel co-operation) funded by the Italian Ministry of the Environment. The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Abello P, 2002, SCI MAR, V66, P183, DOI 10.3989/scimar.2002.66s2183; ABELLO P, 1992, MAR BIOL, V114, P109; Acik S, 2008, TURK J ZOOL, V32, P443; Acinas SG, 1997, FEMS MICROBIOL ECOL, V24, P27, DOI 10.1111/j.1574-6941.1997.tb00420.x; Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; ADENSAMER T, 1898, BERICHTE COMMISSION, V65, P597; AGUILAR A, 1993, AMBIO, V22, P524; Aguilar A, 1999, STATUS MEDITERRANEAN; AGUILAR JS, 1993, P 2 PAN MED SEAB S C; AGUZZI J, 2009, PSZNI MAR ECOL, V30, P366; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alcover JA., 2000, TROPICS, V10, P103, DOI [10.3759/tropics.10.103, DOI 10.3759/TR0PICS.10.103]; Alcover JA, 2008, J WORLD PREHIST, V21, P19, DOI 10.1007/s10963-008-9010-2; Alegret JL, 1999, EUROPE'S SOUTHERN WATERS: MANAGEMENT ISSUES AND PRACTICE, P55; Alfaro Giner C, 2008, PURPUREAE VESTES S I, P195; Alongi G, 2008, BOT MAR, V51, P145, DOI 10.1515/BOT.2008.024; Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; [Anonymous], NATL STRATEGY ACTION; Antoniadou C, 2008, CAH BIOL MAR, V49, P97; Arcos JM, 2008, AM FISH S S, V49, P1471; Arndt H, 2003, MAR ECOL PROG SER, V256, P45, DOI 10.3354/meps256045; Arvanitidis C, 2002, MAR ECOL PROG SER, V244, P139, DOI 10.3354/meps244139; ASTRALDI M, 1995, OCEANOL ACTA, V18, P139; AVELLA FJ, 1984, 2 INT C MONK SEALS L, P60; Azzurro E, 2008, CIESM WORKSHOP MONOG, P39; Bahamon N, 2009, ICES J MAR SCI, V66, P2211, DOI 10.1093/icesjms/fsp190; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BALLESTEROS E, 1990, Scientia Marina, V54, P217; BALLESTEROS E, 1994, PSZNI MAR ECOL, V15, P233; BALLESTEROS E, 1992, ARXIUS SECCIO CIENCI, V101; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; BARMAWIDJAJA DM, 1995, MAR GEOL, V122, P367, DOI 10.1016/0025-3227(94)00121-Z; BAS C, 2002, MAR MEDITERRANCO REC; Bas C., 2003, VARIACIONS DEMOGRAFI; Bas C., 2009, CONTRIBUTIONS SCI, V5, P25, DOI DOI 10.2436/20.7010.01.57; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Bearzi Giovanni, 2008, Endangered Species Research, V5, P1, DOI 10.3354/esr00103; Bearzi G, 2009, MAMMAL REV, V39, P92, DOI 10.1111/j.1365-2907.2008.00133.x; BEKKERNIELSEN T, 2006, REPORT PILOT STUDY F, P52; Bellan-Santini D., 1992, OEBALIA S, V17, P21; Bellan-Santini D., 1994, BIOCENOSES MARINES L; BELLANSANTINI D, 1990, PROG OCEANOGR, V24, P275, DOI 10.1016/0079-6611(90)90037-3; BELLANSANTINI D, 2000, BIOL MARINA MEDITERR, P67; BELLANSANTINI D, 1982, MEMOIRES I OCEANOGRA, V13, P364; BELLO G, 2004, BIOGEOGRAPHIA, V24, P201; BERNARD C, 1994, MAR ECOL PROG SER, V108, P295, DOI 10.3354/meps108295; BETHOUX JP, 1979, OCEANOL ACTA, V2, P157; Bianchi C.N., 1997, P ITALIAN ASS OCEANO, V12, P3; Bianchi C. N., 1994, B MUS I BIOL U GEN, V58-59, P181; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi Carlo Nike, 1993, Porcupine Newsletter, V5, P156; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bianchi CN, 2001, ESTUAR COAST SHELF S, V53, P215, DOI 10.1006/ecss.2001.0793; BIANCHI CN, 2000, LIFE MARINE SCI A S2, V2, P145; BIANCHI CN, 2003, BIOGEOGRAPHIA, V24, P319; Bianchi CN, 2004, OCEAN CHALLENGE, V13, P32; BLONDEL J, 2005, BIOL WILDLIFE MEDITE, V1; Blumel M, 2007, AQUAT MICROB ECOL, V46, P209, DOI 10.3354/ame046209; Boero F, 2001, TRENDS ECOL EVOL, V16, P266, DOI 10.1016/S0169-5347(01)02133-4; Boero F, 2003, STATE KNOWLEDGE MARI; BOERO F, 2001, CIESM WORKSHOP SERIE, P44; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P134, DOI 10.1111/j.1439-0485.2007.00171.x; Bombace G, 2001, ARCH OCEANOGRAFIA LI, V22, P67; BOMBACE G, 2007, NOTIZIARIO SOC ITALI, V51, P29; Borrell A, 1997, MAR POLLUT BULL, V34, P505, DOI 10.1016/S0025-326X(97)00151-3; Bosc E, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002034; BOUCHET P, 1992, DEEP-SEA RES, V39, P169, DOI 10.1016/0198-0149(92)90103-Z; Bouchet Philippe, 2006, P31; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; BOUDOURESQUE CF, 1991, ESPECES MARINES PROT; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bourgeois K, 2008, ORYX, V42, P187, DOI 10.1017/S0030605308006467; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; Bozzano A, 2002, ICES J MAR SCI, V59, P15, DOI 10.1006/jmsc.2001.1142; BRESC H, 2001, PECHE HABITAT MEDITE, P525; BRESC H, 2000, CORALLO IERI CORALLO, V25, P41; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; Bucciarelli G, 2002, J EXP MAR BIOL ECOL, V273, P143, DOI 10.1016/S0022-0981(02)00138-7; BULLOCK A, 2008, SCARUS ANTICHI STORI, V1, P94; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; CAMINAS JA, 2004, EXP CONS INT SEA TUR, P27; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; Canals M, 2009, OCEANOGRAPHY, V22, P26, DOI 10.5670/oceanog.2009.03; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cartes JE, 2009, J SEA RES, V61, P244, DOI 10.1016/j.seares.2009.01.005; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; CEBRIAN CB, 2002, MISIDACEOS CRUSTACEA; Cerino F, 2006, EUR J PHYCOL, V41, P363, DOI 10.1080/09670260600839450; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2009, ECOL STUD-ANAL SYNTH, V206, P295, DOI 10.1007/978-3-540-92704-4_21; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; CHRETIENNOTDINE.M, 2007, VIE MILIEU, V47, P317; *CIESM, 2009, CIESM GUID MAR RES I; CIESM, 2009, CIESM ATL EX SPEC ME; CIESM, 2002, CIESM WORKSH MON, P136; *CIESM, 1997, CIESM WORKSH MON, V1; CIESM, 2008, CIESM WORKSH MON, V35; Coll M, 2008, ECOSYSTEMS, V11, P939, DOI 10.1007/s10021-008-9171-y; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coll M, 2009, ECOL MODEL, V220, P2088, DOI 10.1016/j.ecolmodel.2009.04.049; COMPAGNO LJV, 2001, SHARKS WORLD AN ANNO, V2; COSTA OG, 1836, CROSTACEI ARACNEIDI; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; COSTELLO MJ, 2001, PATRIMOINES NATURELS, V50, P463; Craig OE, 2006, J MEDITERR STUD, V16, P63; Cros L, 2002, SCI MAR, V66, P5; Cros L, 2000, MAR MICROPALEONTOL, V39, P1, DOI 10.1016/S0377-8398(00)00010-4; Cros L., 2002, PLANKTONIC COCCOLITH; Cuttelod A., 2008, 2008 REV IUCN RED LI; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2007, CHEM ECOL, V23, P347, DOI 10.1080/02757540701653384; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Davis AR, 1999, TRZS NSW, P325; DCOZ CDU, 1999, PATRIMOINES NATURELS, V40, P1; DELAROSA J, 2008, LIBRO ROJO INVERTEBR, P639; DELAUGERRE M, 1987, Vie et Milieu, V37, P243; Dendrinos Panagiotis, 2008, Aquatic Mammals, V34, P355, DOI 10.1578/AM.34.3.2008.355; DENICOLO L, 2008, MARE COME ERA, P35; Desse J, 1994, FISH EXPLOITATION, V274, P69; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; DISCIARA GN, 2004, SC56BC10 SCI COMM IN; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Dorigo U, 2005, WATER RES, V39, P2207, DOI 10.1016/j.watres.2005.04.007; Dov Por Francis, 2009, BioRisk, V3, P5; Dulcic J, 2008, J APPL ICHTHYOL, V24, P101, DOI 10.1111/j.1439-0426.2007.01022.x; EMIG C, 2005, QBIO0507003V1 ARXIV; EMIG C, 2004, NOTEBOOKS GEOLOGY; EMIG CC, 1997, BATHYAL ZONES MEDITE, P23; Estrada M, 1996, SCI MAR, V60, P55; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; FACCIA I, 2009, AQUAT INVASIONS, V4, P381; FAO Nations F.a.A.O.o.t.U., 2004, STAT WORLD FISH AQ; FEINGERSCH R, 2009, ISME J; FERAL JP, 2008, CLIMATE WARMING RELA, P79; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fischer W, 1987, MEDITERRANEE MER NOI, VII; *FISHB, 2009, GLOB IFN SYST FISH; Fishelson L, 2000, ITAL J ZOOL, V67, P393, DOI 10.1080/11250000009356345; Fishelson L, 2001, COPEIA, P556; Fontanier C, 2008, DEEP-SEA RES PT I, V55, P1532, DOI 10.1016/j.dsr.2008.07.003; FORTIBUONI T, 2008, ICES ANN SCI C HAL C; FOWLER SW, 2008, IMPACTS ACIDIFICATIO, P23; Francour P, 2008, CYBIUM, V32, P275; FRANGOUDES K, 2008, MARE COME ERA, P46; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Fredj G., 1992, Bulletin de l'Institut Oceanographique (Monaco), P133; FREDJ G, 1987, Cybium, V11, P217; FREDJ G, 1983, MEDITERRANEAN MARINE, P109; Fredj G., 1974, MEM I OCEANOGR MONAC, V7, P1; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Gaertner JC, 2007, MAR ECOL PROG SER, V341, P191, DOI 10.3354/meps341191; Gage J.D., 1992, DEEP SEA BIOL NATURA; GALAND P, LIMNOLOGY O IN PRESS; Galil BS, 2008, HYDROBIOLOGIA, V606, P105, DOI 10.1007/s10750-008-9342-z; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Galil Bella S., 2006, V83, P207, DOI 10.1007/978-1-4020-5047-3_6; Galil Bella S., 2009, V3, P93; Galil Bella S., 2007, Aquatic Invasions, V2, P281, DOI 10.3391/ai.2007.2.4.2; Galil BS, 2006, ENVIRONM POLLUT SER, V10, P39, DOI 10.1007/1-4020-4504-2_3; Galil Bella S., 1994, Senckenbergiana Maritima, V25, P41; Galil BS, 2004, SCI MAR, V68, P63, DOI 10.3989/scimar.2004.68s363; GALLARDO T, 1993, BOT MAR, V36, P399, DOI 10.1515/botm.1993.36.5.399; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; GAMBI MC, 2008, JMBA2 BIODIVERSITY R, V7; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; Garibaldi Fulvio, 2008, Aquatic Invasions, V3, P471, DOI 10.3391/ai.2008.3.4.21; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; GARRIDO A, 2008, MARE COMERA, P116; Garthe S, 2004, J APPL ECOL, V41, P724, DOI 10.1111/j.0021-8901.2004.00918.x; GERTWAGEN R, 2008, P 2 HMAP MED BLACK S; Ghiglione JF, 2005, AQUAT MICROB ECOL, V40, P229, DOI 10.3354/ame040229; Giangrande A, 2005, MAR POLLUT BULL, V50, P1153, DOI 10.1016/j.marpolbul.2005.08.003; GIGLIOLI EH, 1882, ANN SCI NATURELLES, V6, P1; Gili JM, 1998, SCI MAR, V62, P113; GOLANI D., 2002, CIESM ATLAS EXOTIC S, V1; Gomez F, 2003, BOT MAR, V46, P215, DOI 10.1515/BOT.2003.021; Gonzalez L.M., 1989, Ecologia (Madrid), V3, P157; Gooday AJ, 1998, DEEP-SEA RES PT II, V45, P165, DOI 10.1016/S0967-0645(97)00041-6; Goren M, 2005, J APPL ICHTHYOL, V21, P364, DOI 10.1111/j.1439-0426.2005.00674.x; Goren M, 2001, MAR ECOL-P S Z N I, V22, P369, DOI 10.1046/j.1439-0485.2001.01750.x; Goren M, 1997, ISRAEL J ZOOL, V43, P197; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Grbec B, 2002, CLIMATE RES, V20, P241, DOI 10.3354/cr020241; Green E.P., 2003, WORLD ATLAS SEAGRASS; Groombridge B, 2002, WORLD ATLAS BIODIVER; Groombridge B., 1990, NATURE ENV SERIES, V48, P80; Grubelic I, 2004, J MAR BIOL ASSOC UK, V84, P599, DOI 10.1017/S0025315404009609h; Gruvel A., 1936, Memoires Institut d'Egypte, V29, P1; Guclusoy H., 2004, EGE UNIVESITY J FISH, V21, P201; Guclusoy Harun, 2003, Zoology in the Middle East, V28, P5; Gucu AC, 2004, BIOL CONSERV, V116, P417, DOI 10.1016/S0006-3207(03)00234-9; Guidetti P, 2004, CONSERV BIOL, V18, P1417, DOI 10.1111/j.1523-1739.2004.00343.x; Guidetti P, 2003, MAR ECOL PROG SER, V253, P269, DOI 10.3354/meps253269; Guidetti P, 2002, J MAR BIOL ASSOC UK, V82, P495, DOI 10.1017/S0025315402005775; Guidetti P, 2001, J MAR BIOL ASSOC UK, V81, P717, DOI 10.1017/S0025315401004507; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harwood John, 1996, P241; Hassan M, 2003, J EXP MAR BIOL ECOL, V291, P219, DOI 10.1016/S0022-0981(03)00139-4; Heads M, 2005, BIOL J LINN SOC, V84, P675, DOI 10.1111/j.1095-8312.2005.00466.x; Heller C., 1863, CRUSTACEEN SUDLICHEN; Higgins R.P., 1988, P1; HOFRICHTER R, 2002, MAR MEDITERRANEO FLO, V2; HOFRICHTER R, 2001, MAR MEDITERRA  NEO F; HOPKINS TS, 1985, KEY ENV W MEDITERRAN, P100; Hughes J.Donald, 1994, PANS TRAVAIL ENV PRO; HUMMON WD, 1990, MAR POLLUT BULL, V21, P241, DOI 10.1016/0025-326X(90)90342-6; *ICTIMED, 2009, MED SEA FISH DAT; International Union for Conservation of Nature (IUCN), 1984, IUCN B, V15, P10; IUCN, 2014, IUCN RED LIST THREAT; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JAHNKE RA, 1996, GLOBAL BIOGEOCHEMICA, V10; JOHNSON WM, 2009, MEDITERRANEAN MONK S; JOHNSTON WH, 1999, MOL MICROBIAL ECOLOG, P1; Jukic-Peladic S, 2001, FISH RES, V53, P95, DOI 10.1016/S0165-7836(00)00232-0; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; KASCHNER K, 2009, AQUAMAPS PREDICTED R; KIMOR B, 1975, MAR BIOL, V29, P321, DOI 10.1007/BF00388852; Klein J, 2005, MAR ECOL PROG SER, V290, P79, DOI 10.3354/meps290079; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Koukouras A, 2007, J BIOL RES-THESSALON, V7, P67; Koukouras Athanasios, 2001, Bios (Thessaloniki), V6, P61; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Lambshead PJD, 2000, MAR ECOL PROG SER, V194, P159, DOI 10.3354/meps194159; Lambshead PJD, 2002, MAR ECOL PROG SER, V236, P129, DOI 10.3354/meps236129; Lampadariou N, 2006, PROG OCEANOGR, V69, P19, DOI 10.1016/j.pocean.2006.02.013; Lascaratos A, 1999, PROG OCEANOGR, V44, P5, DOI 10.1016/S0079-6611(99)00019-1; Lasram FBR, 2008, MAR ECOL PROG SER, V363, P273, DOI 10.3354/meps07474; LASRAM FB, GLOBAL CHANGE UNPUB; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lasram FB, 2009, BIOL INVASIONS, V11, P697, DOI 10.1007/s10530-008-9284-4; Laubier Lucien, 1993, P397; Lejeusne C, 2005, MAR ECOL PROG SER, V287, P189, DOI 10.3354/meps287189; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 1998, DEEP-SEA RES PT II, V45, P129, DOI 10.1016/S0967-0645(97)00085-4; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Logan A, 2004, SCI MAR, V68, P163, DOI 10.3989/scimar.2004.68s1163; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Louzao M, 2008, ACTA OECOL, V34, P186, DOI 10.1016/j.actao.2008.05.007; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; MacKenzie Brian R., 2009, Conservation Letters, V2, P26, DOI 10.1111/j.1755-263X.2008.00039.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maldonado A., 1985, KEY ENV W MEDITERRAN, P17; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; MARGALEF R, 1969, INVEST PESQ, V33, P345; MARGALEF R, 1987, Investigacion Pesquera (Barcelona), V51, P121; Margalef R., 1985, KEY ENV W MEDITERRAN; MARGARITOULIS D, 2000, P 5 MEDM S GOZ MALT, P262; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Massuti M., 1950, INTRO ESTUDIO PLANCT; Mavidis M, 2005, CRUSTACEANA, V78, P19, DOI 10.1163/1568540054024538; Meinesz A., 2002, KILLER ALGAE TRUE TA; Millot C, 2005, SCI MAR, V69, P5, DOI 10.3989/scimar.2005.69s15; MILNEEDWARDS A, 1882, ARCH MISSIONS SCI LI, V9, P1; Mineur F, 2007, MAR BIOL, V151, P1299, DOI 10.1007/s00227-006-0567-y; Minguez Eduardo, 2003, Scientia Marina, V67, P1; Mo Giulia, 2007, Rapport du Congress de la CIESM, V38, P542; Modigh M, 2002, AQUAT MICROB ECOL, V28, P299, DOI 10.3354/ame028299; Moeseneder MM, 2001, LIMNOL OCEANOGR, V46, P95, DOI 10.4319/lo.2001.46.1.0095; Molinero Juan Carlos, 2009, Annales Series Historia Naturalis, V19, P11; Montefalcone M, 2007, ESTUAR COAST SHELF S, V75, P63, DOI 10.1016/j.ecss.2007.03.034; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Morri C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P375; Morri C, 2009, J MAR BIOL ASSOC UK, V89, P49, DOI 10.1017/S0025315408002749; Munilla T, 2005, ACTA OECOL, V27, P81, DOI 10.1016/j.actao.2004.09.006; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYLONA D, 2007, THESIS U SOUTHAMPTON; Nardo G.D., 1847, SINONIMIA MODERNA SP; *NOAA, 2007, HAWKSB SEA TURTL ER; *NOAA, 2009, LARG MAR EC; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Notarbartolo di Sciara, 2002, CETACEANS MEDITERRAN; Occhipinti-Ambrogi Anna, 2002, CIESM Workshop Monographs, V20, P69; Olivi G., 1792, ZOOLOGIA ADRIATICA, DOI [10.5962/bhl.title.60887, DOI 10.5962/BHL.TITLE.60887]; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Oro D, 1997, ICES J MAR SCI, V54, P695, DOI 10.1006/jmsc.1997.0246; Oro D, 2004, BIOL CONSERV, V116, P93, DOI 10.1016/S0006-3207(03)00180-0; ORO D, 2000, MONITORING CONSERVAT, P69; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; OVCHINNIKOV IM, 1966, OCEANOLOGY-USSR, V6, P48; Ozcan Tahir, 2006, Aquatic Invasions, V1, P286; OZSOY E, 1993, DEEP-SEA RES PT II, V40, P1075, DOI 10.1016/0967-0645(93)90063-S; Pancucci-Papadopoulou MA, 1999, MONOGR MAR SCI, V2, P1; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; PANOU A, 1993, BIOL CONSERV, V64, P129, DOI 10.1016/0006-3207(93)90649-L; Papaconstantinou C., 2000, Mediterranean Marine Science, V1, P5; Park O, 1941, ECOLOGY, V22, P164, DOI 10.2307/1932211; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PEDROSALIO C, PATTERNS SPATI UNPUB; Peirano A, 2004, GLOBAL PLANET CHANGE, V40, P195, DOI 10.1016/S0921-8181(03)00110-3; Peres J. M., 1967, Oceanography and Marine Biology, V5, P449; Peres J. M., 1985, W MEDITERRANEAN, P198; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Pesta O, 1918, DECAPODENFAUNA ADRIA; Pinardi N., 2006, SEA, P1243; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Pipitone C, 2003, ITAL J ZOOL, V70, P69, DOI 10.1080/11250000309356498; Por F.D., 1978, Ecological Studies, V23, P1; Por F.O., 1989, MONOGRAPHIAE BIOL, P1; Por FD, 2006, MARE NOSTRUM NEOGENE; Potter D, 1997, BIODIVERS CONSERV, V6, P99, DOI 10.1023/A:1018379716868; Pronzato R, 2008, MAR ECOL-EVOL PERSP, V29, P146, DOI 10.1111/j.1439-0485.2008.00235.x; PUJOL C, 1995, MAR MICROPALEONTOL, V25, P187, DOI 10.1016/0377-8398(95)00002-I; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Quignard J.-P., 1993, Vie et Milieu, V43, P191; Quignard J.P., 2000, Biologia Marina Mediterranea, V7, P1; Quignard J.-P., 1978, Bollettino di Zoologia, V45, P23; Raffaelli D, 2003, J EXP MAR BIOL ECOL, V285, P191, DOI 10.1016/S0022-0981(02)00527-0; RAICEVICH S, 2008, P 2 HMAP MED BLACK S, P183; RAMIREZLLODRA E, BIOGEOSCIENCES; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Razek F.A.A., 1987, Acta Adriatica, V28, P143; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Reeves R.R., 2006, STATUS DISTRIBUTION; Reijnders P., 1997, STATUS PINNIPEDS REL, VDLO; Reijnders PJH, 1988, MAR MAMM ACT PLAN SE, P1; Relini M, 2000, SCI MAR, V64, P337, DOI 10.3989/scimar.2000.64n3337; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; RIBERA MA, 1992, BOT MAR, V35, P109, DOI 10.1515/botm.1992.35.2.109; Riedl R., 1983, FAUNA FLORA MEDITERR; Risso A., 1826, HIST NATURELLE PRINC, Vtroisieme, DOI DOI 10.5962/BHL.TITLE.58984; ROBINSON AR, 1992, EARTH-SCI REV, V32, P285, DOI 10.1016/0012-8252(92)90002-B; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Rodriguez-Prieto C, 2009, EUR J PHYCOL, V44, P107, DOI 10.1080/09670260802357111; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Rueda JL, 2008, HELGOLAND MAR RES, V62, P227, DOI 10.1007/s10152-008-0111-1; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Sabates A, 2006, GLOBAL CHANGE BIOL, V12, P2209, DOI 10.1111/j.1365-2486.2006.01246.x; Safriel U., 1966, Proceedings of the Malacological Society of London, V37, P27; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Salat J., 2002, CIESM WORKSHOP SERIE, V16, P29; Sangiorgi F, 2004, ESTUAR COAST SHELF S, V60, P69, DOI 10.1016/j.ecss.2003.12.001; Sanpera C, 2007, MAR POLLUT BULL, V54, P691, DOI 10.1016/j.marpolbul.2007.01.016; SANVICENTE C, 1996, CONTRIBUCION CONOCIM; SANVICENTE C, 1999, ATZAVARA, V8, P33; SANZAGUILAR A, 2008, LIFE HIST TRAITS CON; Sara M, 1985, MEDITERRANEAN MARINE, P1; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sarda F, 2003, J SHELLFISH RES, V22, P569; Sarda F, 2009, REV FISH BIOL FISHER, V19, P329, DOI 10.1007/s11160-009-9105-6; Sarda F, 1998, SCI MAR, V62, P295; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Schneider A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028842; Serena F., 2005, FIELD IDENTIFICATION, P97; *SIBM, 2009, CHECKL MAR FAUN IT S; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Stefani M, 2005, MAR GEOL, V222, P19, DOI 10.1016/j.margeo.2005.06.029; Streftaris N, 2005, OCEANOGR MAR BIOL, V43, P419; Streftaris N, 2006, MEDITERR MAR SCI, V7, P87, DOI 10.12681/mms.180; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Tavecchia G, 2007, OIKOS, V116, P1481, DOI 10.1111/j.2007.0030-1299.15791.x; Taviani M., 2002, Biologia Marina Mediterranea, V9, P445; TEMPLADO J, 2004, PRADERAS BOSQUES MAR, P89; Templado J., 2004, GUIA INVERTEBRADOS P; Templado J., 2006, FLORA FAUNA RESERVA; THEOCHARIS A, 1993, DEEP-SEA RES PT II, V40, P1121, DOI 10.1016/0967-0645(93)90064-T; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thorpe JP, 2000, HYDROBIOLOGIA, V420, P165, DOI 10.1023/A:1003987117508; Tomas J, 2001, J ZOOL, V255, P525, DOI 10.1017/S0952836901001613; TOMAS J, 2009, MARINE BIODIVERSITY, V1, P1; Tortonese E., 1985, MEDITERRANEAN MARINE, P57, DOI 10.1007/978-1-4899-2248-9_4; Trakadas A, 2006, J MEDITERR STUD, V16, P259; TRAKADAS LA, 2008, MARE COME ERA, P26; TRAVERS M, 1975, ANN I OCEANOGR PARIS, V51, P51; Tregouboff G., 1957, MANUEL PLANCTONOLOGI; Tselepides A, 2004, SCI MAR, V68, P39, DOI 10.3989/scimar.2004.68s339; TSIKLIRAS AC, 2007, FISHERIES CTR RES RE, V15, P121; Tsounis G, 2007, ECOSYSTEMS, V10, P975, DOI 10.1007/s10021-007-9072-5; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; Tudela S., 2004, GFCM STUD REV, V74, P1; Tudela Sergi, 2004, General Fisheries Council for the Mediterranean Studies and Reviews, V74, pi; Turley CM, 1999, PROG OCEANOGR, V44, P387, DOI 10.1016/S0079-6611(99)00033-6; Van Andel T.H., 1986, GEOARCHAEOLOGY, V1, P127; Vaque D, 1997, AQUAT MICROB ECOL, V12, P71, DOI 10.3354/ame012071; Velasquez Z., 1997, THESIS U POLITECNICA; Velasquez ZR, 1995, VIE MILIEU, V45, P249; Venizelos L, 2005, BELG J ZOOL, V135, P271; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verlaque M, 2001, OCEANOL ACTA, V24, P29, DOI 10.1016/S0399-1784(00)01127-0; VOULTSIADOU E, 2010, J BIOL RES IN PRESS; Voultsiadou E, 2007, J MAR BIOL ASSOC UK, V87, P1757, DOI 10.1017/S0025315407057773; Voultsiadou E, 2007, CONTRIB ZOOL, V76, P103, DOI 10.1163/18759866-07602004; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Whitehead Peter J. P, 1986, FISHES N E ATLANTIC; WHITTAKER RH, 1960, ECOLOGICAL MONOGRAPH, V26; Winter C, 2009, LIMNOL OCEANOGR, V54, P160, DOI 10.4319/lo.2009.54.1.0160; Wittmann K J., 1999, CRUSTACEANS BIODIVER, V1, P511; Wittmann KJ, 2001, MAR ECOL-P S Z N I, V22, P85, DOI 10.1046/j.1439-0485.2001.00741.x; *WORMS, 2009, WORLD REG MAR SPEC D; Yakimov MM, 2007, ISME J, V1, P743, DOI 10.1038/ismej.2007.83; YESOU P, 2000, P 5 MEDMARAVIS PAN M; Yokes Baki, 2006, Aquatic Invasions, V1, P188; ZABALA M, 1988, TREBALLS MUSEU ZOOLO, V4, P1; Zabala Mikel., 1993, Scientia Marina, V57, P65; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x; Zavatarelli M, 1998, J MARINE SYST, V18, P227, DOI 10.1016/S0924-7963(98)00014-1; Zenetos A, 2005, MEDITERR MAR SCI, V6, P63, DOI 10.12681/mms.186; Zenetos A, 2008, MEDITERR MAR SCI, V9, P119, DOI 10.12681/mms.146; Zenetos A., 2004, CIESM ATLAS EXOTIC S, V3; Zenetos A, 2009, J BIOL RES-THESSALON, V12, P135; Zibrowius H, 1980, MEMOIRES I OCEANOGRA, V11, P1; Zibrowius Helmut, 1991, Mesogee, V51, P83; Zohar I, 1997, INT J OSTEOARCHAEOL, V7, P150; Zotier R, 1999, J BIOGEOGR, V26, P297, DOI 10.1046/j.1365-2699.1999.00260.x; [No title captured]; [No title captured]	432	945	985	11	449	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11842	10.1371/journal.pone.0011842	http://dx.doi.org/10.1371/journal.pone.0011842			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689844	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520400008
J	Kott, O; Sumbera, R; Nemec, P				Kott, Ondrej; Sumbera, Radim; Nemec, Pavel			Light Perception in Two Strictly Subterranean Rodents: Life in the Dark or Blue?	PLOS ONE			English	Article							BLIND MOLE-RAT; VISUAL-SYSTEM; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; COLOR-VISION; CRYPTOMYS-ANSELLI; SPALAX-EHRENBERGI; SOLITARY; EYE; PHOTORECEPTOR	Background: The African mole-rats (Bathyergidae, Rodentia) are strictly subterranean, congenitally microphthalmic rodents that are hardly ever exposed to environmental light. Because of the lack of an overt behavioural reaction to light, they have long been considered to be blind. However, recent anatomical studies have suggested retention of basic visual capabilities. In this study, we employed behavioural tests to find out if two mole-rat species are able to discriminate between light and dark, if they are able to discriminate colours and, finally, if the presence of light in burrows provokes plugging behaviour, which is assumed to have a primarily anti-predatory function. Methodology/Principal Finding: We used a binary choice test to show that the silvery mole-rat Heliophobius argenteocinereus and the giant mole-rat Fukomys mechowii exhibit a clear photoavoidance response to full-spectrum ("white"), blue and green-yellow light, but no significant reaction to ultraviolet or red light during nest building. The mole-rats thus retain dark/light discrimination capabilities and a capacity to perceive short to medium-wavelength light in the photopic range of intensities. These findings further suggest that the mole-rat S opsin has its absorption maximum in the violet/blue part of the spectrum. The assay did not yield conclusive evidence regarding colour discrimination. To test the putative role of vision in bathyergid anti-predatory behaviour, we examined the reaction of mole-rats to the incidence of light in an artificial burrow system. The presence of light in the burrow effectively induced plugging of the illuminated tunnel. Conclusion/Significance: Our findings suggest that the photopic vision is conserved and that low acuity residual vision plays an important role in predator avoidance and tunnel maintenance in the African mole-rats.	[Kott, Ondrej; Sumbera, Radim] Univ S Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic; [Nemec, Pavel] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	University of South Bohemia Ceske Budejovice; Charles University Prague	Kott, O (corresponding author), Univ S Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic.	sumbera@prf.jcu.cz	Šumbera, Radim/D-9072-2016; Nemec, Pavel/K-1163-2012	Šumbera, Radim/0000-0001-8658-9378; Nemec, Pavel/0000-0003-0277-0239	University of South Bohemia [SGA 11/2006]; Academy of Sciences of the Czech Republic [IAA601410802]; Czech Science Foundation [206/09/1364]; Ministry of Education, Youth and Sport of the Czech Republic [6007665801, 0021620828]	University of South Bohemia; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Supported by the Grant Agency of the University of South Bohemia (SGA 11/2006, to OK), the Grant Agency of the Academy of Sciences of the Czech Republic IAA601410802 (to RS, gaav.cz), the Czech Science Foundation (206/09/1364, to PN, gacr.cz) and the Ministry of Education, Youth and Sport of the Czech Republic 6007665801 (to RS, msmt.cz) and 0021620828 (to PN, msmt.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Begall S., 2007, SUBTERRANEAN RODENTS; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BURDA H, 1990, PROG CLIN BIOL RES, V335, P269; Carmona FD, 2010, P ROY SOC B-BIOL SCI, V277, P1513, DOI 10.1098/rspb.2009.1744; Carmona FD, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-44; Cernuda-Cernuda R, 2003, EUR J NEUROSCI, V17, P709, DOI 10.1046/j.1460-9568.2003.02485.x; Cernuda-Cernuda R, 2002, INVEST OPHTH VIS SCI, V43, P2374; COOPER HM, 1993, J COMP NEUROL, V328, P313, DOI 10.1002/cne.903280302; Crish SD, 2006, ANAT REC PART A, V288A, P205, DOI 10.1002/ar.a.20288; David-Gray ZK, 2002, EUR J NEUROSCI, V16, P1186, DOI 10.1046/j.1460-9568.2002.02161.x; de Vries JL, 2008, J ZOOL, V276, P343, DOI 10.1111/j.1469-7998.2008.00496.x; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; ELOFF G, 1958, S AFR J SCI, V54, P292; Glosmann M, 2008, J VISION, V8, DOI 10.1167/8.4.23; Hart L, 2004, PHYSIOL BEHAV, V82, P563, DOI 10.1016/j.physbeh.2004.05.008; Hetling JR, 2005, J COMP PHYSIOL A, V191, P317, DOI 10.1007/s00359-004-0584-6; Hood D. C., 1986, HDB PERCEPTION HUMAN, V1; Hunt DM, 2007, PHOTOCHEM PHOTOBIOL, V83, P303, DOI 10.1562/2006-06-27-IR-952; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JOHANNESSONGROSS K, 1988, Z SAUGETIERKD, V53, P193; Kawalika M, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P205, DOI 10.1007/978-3-540-69276-8_15; Lacey EA, 2000, LIFE UNDERGROUND BIO; Land MF, 2002, ANIMAL EYES; LOVEGROVE BG, 1995, PHYSIOL BEHAV, V58, P679, DOI 10.1016/0031-9384(95)00106-S; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; LUND RD, 1965, EXP NEUROL, V13, P302, DOI 10.1016/0014-4886(65)90118-4; LUND RD, 1966, J ZOOL, V149, P95; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; MCFARLAND WN, 1975, LIGHT ECOLOGICAL FAC, P00249; Mills SL, 2004, VISUAL NEUROSCI, V21, P107, DOI 10.1017/S0952523804043020; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; Negroni J, 2003, BRAIN RES, V967, P48, DOI 10.1016/S0006-8993(02)04208-7; Nemec P, 2004, EUR J NEUROSCI, V20, P757, DOI 10.1111/j.1460-9568.2004.03510.x; Nemec P, 2008, BRAIN RES BULL, V75, P356, DOI 10.1016/j.brainresbull.2007.10.055; Nemec P, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P129, DOI 10.1007/978-3-540-69276-8_11; Nevo, 1999, MOSAIC EVOLUTION SUB; Nikitina NV, 2004, ANAT REC PART A, V277A, P317, DOI 10.1002/ar.a.20025; Oelschlager HHA, 2000, BRAIN BEHAV EVOLUT, V55, P209, DOI 10.1159/000006653; Oosthuizen MK, 2005, NEUROSCIENCE, V133, P555, DOI 10.1016/j.neuroscience.2005.01.017; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; RADO R, 1992, ISRAEL J ZOOL, V38, P323; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; SANYAL S, 1990, INVEST OPHTH VIS SCI, V31, P1398; Schottner K, 2006, PHYSIOL BEHAV, V89, P205, DOI 10.1016/j.physbeh.2006.06.014; Skliba J, 2008, J ETHOL, V26, P249, DOI 10.1007/s10164-007-0056-x; Skliba J, 2007, J MAMMAL, V88, P1009, DOI 10.1644/06-MAMM-A-235R1.1; Skliba J, 2009, ETHOLOGY, V115, P217, DOI 10.1111/j.1439-0310.2008.01604.x; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Sumbera R, 2003, NATURWISSENSCHAFTEN, V90, P370, DOI 10.1007/s00114-003-0439-y; Sumbera R, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P221, DOI 10.1007/978-3-540-69276-8_16; Vasicek CA, 2005, PHYSIOL BEHAV, V84, P181, DOI 10.1016/j.physbeh.2004.11.005; Wegner RE, 2006, ANIM BEHAV, V72, P1021, DOI 10.1016/j.anbehav.2006.02.018; Werner SJ, 2005, PHYSIOL BEHAV, V85, P340, DOI 10.1016/j.physbeh.2005.04.024; Williams GA, 2005, J COMP PHYSIOL A, V191, P125, DOI 10.1007/s00359-004-0578-4; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326	67	31	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11810	10.1371/journal.pone.0011810	http://dx.doi.org/10.1371/journal.pone.0011810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676369	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520100004
J	Cherrington, BD; Morency, E; Struble, AM; Coonrod, SA; Wakshlag, JJ				Cherrington, Brian D.; Morency, Eric; Struble, Angela M.; Coonrod, Scott A.; Wakshlag, Joseph J.			Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones	PLOS ONE			English	Article							ESTROUS-CYCLE; EXPRESSION; MOUSE; PROTEINS; ENZYMES; MODELS; GENES; GLAND	Peptidylarginine Deiminases (PADs) convert arginine residues on substrate proteins to citrulline. Previous reports have documented that PAD2 expression and activity varies across the estrous cycle in the rodent uterus and pituitary gland, however, the expression and function of PAD2 in mammary tissue has not been previously reported. To gain more insight into potential reproductive roles for PAD2, in this study we evaluated PAD2 expression and localization throughout the estrous cycle in canine mammary tissue and then identified possible PAD2 enzymatic targets. Immunohistochemical and immunofluorescence analysis found PAD2 expression is low in anestrus, limited to a distinct, yet sparse, subset of epithelial cells within ductal alveoli during estrus/early diestrus, and encompasses the entire epithelium of the mammary duct in late diestrus. At the subcellular level, PAD2 is expressed in the cytoplasm, and to a lesser extent, the nucleus of these epithelial cells. Surprisingly, stimulation of canine mammary tumor cells (CMT25) shows that EGF, but not estrogen or progesterone, upregulates PAD2 transcription and translation suggesting EGF regulation of PAD2 and possibly citrullination in vivo. To identify potential PAD2 targets, anti-pan citrulline western blots were performed and results showed that citrullination activity is limited to diestrus with histones appearing to represent major enzymatic targets. Use of site-specific anti-citrullinated histone antibodies found that the N-terminus of histone H3, but not H4, appears to be the primary target of PAD activity in mammary epithelium. This observation supports the hypothesis that PAD2 may play a regulatory role in the expression of lactation related genes via histone citrullination during diestrus.	[Cherrington, Brian D.; Morency, Eric; Coonrod, Scott A.] Cornell Univ, Coll Vet Med, JA Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Struble, Angela M.; Wakshlag, Joseph J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cherrington, BD (corresponding author), Cornell Univ, Coll Vet Med, JA Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	Jw37@cornell.edu		Cherrington, Brian/0000-0001-5847-2295	Department of Defense (DOD) [W81XWH-07-1-0372]	Department of Defense (DOD)(United States Department of Defense)	This work was supported by the Department of Defense (DOD) Era of Hope Scholar Award W81XWH-07-1-0372, Scott A. Coonrod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TE, 1996, AM J VET RES, V57, P693; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Cardiff RD, 2001, MICROSC RES TECHNIQ, V52, P224, DOI 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.3.CO;2-1; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; DONNAY I, 1995, VET RES COMMUN, V19, P101, DOI 10.1007/BF01839276; Gama A, 2003, VET PATHOL, V40, P412, DOI 10.1354/vp.40-4-412; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Munson Linda, 2007, Breast Dis, V28, P7; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Rehm S, 2007, BIRTH DEFECTS RES B, V80, P233, DOI 10.1002/bdrb.20121; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; SENSHU T, 1989, ENDOCRINOLOGY, V124, P2666, DOI 10.1210/endo-124-6-2666; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; TAKAHARA H, 1989, J BIOL CHEM, V264, P13361; TAKAHARA H, 1992, J BIOL CHEM, V267, P520; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; WOLFE LG, 1986, J NATL CANCER I, V77, P783, DOI 10.1093/jnci/77.3.783; Wood DD, 2008, LAB INVEST, V88, P354, DOI 10.1038/labinvest.3700748	23	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11768	10.1371/journal/pone.0011768	http://dx.doi.org/10.1371/journal/pone.0011768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668670				2022-12-27	WOS:000280297300007
J	Danovi, D; Cremona, CA; Machado-da-Silva, G; Basu, S; Noon, LA; Parrinello, S; Lloyd, AC				Danovi, Davide; Cremona, Catherine A.; Machado-da-Silva, Gisela; Basu, Sreya; Noon, Luke A.; Parrinello, Simona; Lloyd, Alison C.			A Genetic Screen for Anchorage-Independent Proliferation in Mammalian Cells Identifies a Membrane-Bound Neuregulin	PLOS ONE			English	Article							NERVE SHEATH TUMORS; SCHWANN-CELL; SIGNALING PATHWAY; GROWTH-FACTORS; SENESCENCE; CANCER; DIFFERENTIATION; TRANSFORMATION; TUMORIGENESIS; ACCUMULATION	Anchorage-independent proliferation is a hallmark of oncogenic transformation and is thought to be conducive to proliferation of cancer cells away from their site of origin. We have previously reported that primary Schwann cells expressing the SV40 Large T antigen (LT) are not fully transformed in that they maintain a strict requirement for attachment, requiring a further genetic change, such as oncogenic Ras, to gain anchorage-independence. Using the LT-expressing cells, we performed a genetic screen for anchorage-independent proliferation and identified Sensory and Motor Neuron Derived Factor (SMDF), a transmembrane class III isoform of Neuregulin 1. In contrast to oncogenic Ras, SMDF induced enhanced proliferation in normal primary Schwann cells but did not trigger cellular senescence. In cooperation with LT, SMDF drove anchorage-independent proliferation, loss of contact inhibition and tumourigenicity. This transforming ability was shared with membrane-bound class III but not secreted class I isoforms of Neuregulin, indicating a distinct mechanism of action. Importantly, we show that despite being membrane-bound signalling molecules, class III neuregulins transform via a cell intrinsic mechanism, as a result of constitutive, elevated levels of ErbB signalling at high cell density and in anchorage-free conditions. This novel transforming mechanism may provide new targets for cancer therapy.	UCL, MRC Lab Mol Cell Biol, London, England; UCL, UCL Canc Inst, London, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Danovi, D (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	alison.lloyd@ucl.ac.uk	Danovi, Davide/P-2874-2019; Noon, Luke A/H-4141-2014	Danovi, Davide/0000-0003-4119-5337; Noon, Luke A/0000-0002-0502-4322; Cremona, Catherine/0000-0002-5962-7399	Cancer Research UK; European Molecular Biology Organization; Dorothy Hodgkin Fellowship; Medical Research Council; Fundacao para a Ciencia e a Tecnologia; Cancer Research UK [11244] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dorothy Hodgkin Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Programme Grant. Davide Danovi was supported by an European Molecular Biology Organization fellowship. Simona Parrinello was supported by a Dorothy Hodgkin Fellowship. Catherine Cremona was supported by a Medical Research Council PHD programme. Gisela Machado da Silva was supported by a studentship from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Carroll SL, 2004, J NEUROPATH EXP NEUR, V63, P1115, DOI 10.1093/jnen/63.11.1115; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cockerill S, 2001, BIOORG MED CHEM LETT, V11, P1401, DOI 10.1016/S0960-894X(01)00219-0; Cremona CA, 2009, J CELL SCI, V122, P3272, DOI 10.1242/jcs.047126; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frohnert PW, 2003, GLIA, V43, P104, DOI 10.1002/glia.10232; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gomez-Sanchez JA, 2009, J NEUROSCI, V29, P11304, DOI 10.1523/JNEUROSCI.1753-09.2009; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansen JR, 2006, GLIA, V53, P593, DOI 10.1002/glia.20316; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; Huijbregts RPH, 2003, J NEUROSCI, V23, P7269; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; LOTTI LV, 1992, EXP CELL RES, V202, P274, DOI 10.1016/0014-4827(92)90075-J; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; McClatchey AI, 2007, ANNU REV PATHOL-MECH, V2, P191, DOI 10.1146/annurev.pathol.2.010506.091940; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Mitchell PJ, 2003, MOL CELL BIOL, V23, P2530, DOI 10.1128/MCB.23.7.2530-2542.2003; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stonecypher MS, 2006, J NEUROPATH EXP NEUR, V65, P162, DOI 10.1097/01.jnen.0000199575.93794.2f; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11774	10.1371/journal.pone.0011774	http://dx.doi.org/10.1371/journal.pone.0011774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668675	gold, Green Submitted, Green Published			2022-12-27	WOS:000280297300009
J	Ge, XC; Kitten, T; Munro, CL; Conrad, DH; Xu, P				Ge, Xiuchun; Kitten, Todd; Munro, Cindy L.; Conrad, Daniel H.; Xu, Ping			Pooled Protein Immunization for Identification of Cell Surface Antigens in Streptococcus sanguinis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; VACCINE CANDIDATE ANTIGENS; ANTIBODY-MEDIATED IMMUNITY; GROUP-B STREPTOCOCCUS; INFECTIVE ENDOCARDITIS; PROTECTIVE IMMUNITY; PARASANGUIS ENDOCARDITIS; INTRANASAL IMMUNIZATION; PNEUMONIAE INFECTION; REVERSE VACCINOLOGY	Background: Available bacterial genomes provide opportunities for screening vaccines by reverse vaccinology. Efficient identification of surface antigens is required to reduce time and animal cost in this technology. We developed an approach to identify surface antigens rapidly in Streptococcus sanguinis, a common infective endocarditis causative species. Methods and Findings: We applied bioinformatics for antigen prediction and pooled antigens for immunization. Forty-seven surface-exposed proteins including 28 lipoproteins and 19 cell wall-anchored proteins were chosen based on computer algorithms and comparative genomic analyses. Eight proteins among these candidates and 2 other proteins were pooled together to immunize rabbits. The antiserum reacted strongly with each protein and with S. sanguinis whole cells. Affinity chromatography was used to purify the antibodies to 9 of the antigen pool components. Competitive ELISA and FACS results indicated that these 9 proteins were exposed on S. sanguinis cell surfaces. The purified antibodies had demonstrable opsonic activity. Conclusions: The results indicate that immunization with pooled proteins, in combination with affinity purification, and comprehensive immunological assays may facilitate cell surface antigen identification to combat infectious diseases.	[Ge, Xiuchun; Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Kitten, Todd; Xu, Ping] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Kitten, Todd; Conrad, Daniel H.; Xu, Ping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Virginia Commonwealth Univ, Dept Adult Hlth Nursing, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ge, XC (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	pxu@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	National Institutes of Health [R01DE018138, R01AI47841, K02AI05490]; AD Williams Fund [646541]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AD Williams Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 (PX), R01AI47841 (TK), K02AI05490 (TK) from the National Institutes of Health and 646541 from the AD Williams Fund (PX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; AUSUBLE FM, 2000, CURRENT PROTOCALS MO; BAKER CJ, 1988, NEW ENGL J MED, V319, P1180, DOI 10.1056/NEJM198811033191802; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Bryksin AV, 2005, CLIN DIAGN LAB IMMUN, V12, P935, DOI 10.1128/CDLI.12.8.935-940.2005; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Casadevall A, 2004, INFECT IMMUN, V72, P6191, DOI 10.1128/IAI.72.11.6191-6196.2004; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Cron LE, 2009, MICROBIOL-SGM, V155, P2401, DOI 10.1099/mic.0.026765-0; CROWTHER JR, 2000, METHOD MOL BIOL, V149, P413; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Encheva V, 2009, MICROBIOL-SGM, V155, P2429, DOI 10.1099/mic.0.026138-0; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; Flock M, 2004, INFECT IMMUN, V72, P3228, DOI 10.1128/IAI.72.6.3228-3236.2004; Ford I, 1997, PLATELETS, V8, P285; Gan WJ, 2010, PARASITOL RES, V106, P873, DOI 10.1007/s00436-010-1729-x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Gor DO, 2005, INFECT IMMUN, V73, P1304, DOI 10.1128/IAI.73.3.1304-1312.2005; Haake DA, 1999, INFECT IMMUN, V67, P6572; Hajishengallis G, 1998, INFECT IMMUN, V66, P1740, DOI 10.1128/IAI.66.4.1740-1743.1998; Hamilton A, 2006, INFECT IMMUN, V74, P6907, DOI 10.1128/IAI.01116-06; Herzberg MC, 2005, J PERIODONTOL, V76, P2101, DOI 10.1902/jop.2005.76.11-S.2101; Herzberg MC, 1996, CRIT REV ORAL BIOL M, V7, P222, DOI 10.1177/10454411960070030201; Huang Y, 2001, INFECT IMMUN, V69, P2154, DOI 10.1128/IAI.69.4.2154-2161.2001; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KELLY CG, 1995, INFECT IMMUN, V63, P3649, DOI 10.1128/IAI.63.9.3649-3658.1995; Kitten T, 2002, INFECT IMMUN, V70, P422, DOI 10.1128/IAI.70.1.422-425.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kucknoor AS, 2007, CELL MICROBIOL, V9, P2586, DOI 10.1111/j.1462-5822.2007.00979.x; Lei BF, 2004, J INFECT DIS, V189, P79, DOI 10.1086/380491; Lindberg J, 1999, SCAND J INFECT DIS, V31, P409, DOI 10.1080/00365549950163888; Liu L, 2009, CURR MICROBIOL, V58, P11, DOI 10.1007/s00284-008-9258-x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MUNRO CL, 1993, MOL MICROBIOL, V8, P133, DOI 10.1111/j.1365-2958.1993.tb01210.x; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Seo JY, 2002, INFECT IMMUN, V70, P1143, DOI 10.1128/IAI.70.3.1143-1149.2002; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; SULLAM PM, 1985, AM J MED, V78, P110, DOI 10.1016/0002-9343(85)90373-0; Talkington DF, 1996, MICROB PATHOGENESIS, V21, P17, DOI 10.1006/mpat.1996.0038; TELFORD JL, 2004, GENOMICS PROTEOMICS, P203; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; TURNER LS, 2009, INFECT IMMUN; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; XU P, 2007, J BACTERIOL; Yang XL, 2008, MICROBES INFECT, V10, P1300, DOI 10.1016/j.micinf.2008.07.029; ZHAO YG, 2005, VACCINE	67	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11666	10.1371/journal.pone.0011666	http://dx.doi.org/10.1371/journal.pone.0011666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668678	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300002
J	Braithwaite, EK; Kedar, PS; Stumpo, DJ; Bertocci, B; Freedman, JH; Samson, LD; Wilson, SH				Braithwaite, Elena K.; Kedar, Padmini S.; Stumpo, Deborah J.; Bertocci, Barbara; Freedman, Jonathan H.; Samson, Leona D.; Wilson, Samuel H.			DNA Polymerases beta and lambda Mediate Overlapping and Independent Roles in Base Excision Repair in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; DAMAGE; IOTA; HYPERMUTATION; GLYCOSYLASE; DEFICIENT; BYPASS; SITES	Base excision repair (BER) is a DNA repair pathway designed to correct small base lesions in genomic DNA. While DNA polymerase beta (pol beta) is known to be the main polymerase in the BER pathway, various studies have implicated other DNA polymerases in back-up roles. One such polymerase, DNA polymerase lambda (pol lambda), was shown to be important in BER of oxidative DNA damage. To further explore roles of the X-family DNA polymerases lambda and beta in BER, we prepared a mouse embryonic fibroblast cell line with deletions in the genes for both pol beta and pol lambda. Neutral red viability assays demonstrated that pol lambda and pol beta double null cells were hypersensitive to alkylating and oxidizing DNA damaging agents. In vitro BER assays revealed a modest contribution of pol lambda to single-nucleotide BER of base lesions. Additionally, using co-immunoprecipitation experiments with purified enzymes and whole cell extracts, we found that both pol lambda and pol beta interact with the upstream DNA glycosylases for repair of alkylated and oxidized DNA bases. Such interactions could be important in coordinating roles of these polymerases during BER.	[Braithwaite, Elena K.; Kedar, Padmini S.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Braithwaite, Elena K.; Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA; [Stumpo, Deborah J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Bertocci, Barbara] INSERM, Fac Med Paris Descartes, U783, Paris, France; [Samson, Leona D.] MIT, Biol Engn Dept, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT)	Braithwaite, EK (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; Bertocci, Barbara/L-9115-2018	Wilson, Samuel H/0000-0002-1702-5293; 	National Institutes of Health (NIH) [ES050158, ES050159, CA055042, HHSN273200700046U]; NATIONAL CANCER INSTITUTE [R01CA055042, R01CA075576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102045, ZIAES050159, Z01ES050159, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) grants ES050158 and ES050159 from the Intramural Research Program and by NIH grant CA055042 (to L.S.). P.K.'s contribution was supported in whole with funds from NIH, under delivery order HHSN273200700046U to Constella/SRA, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Crespan E, 2007, NUCLEIC ACIDS RES, V35, P5173, DOI 10.1093/nar/gkm568; Fortini P, 2000, NUCLEIC ACIDS RES, V28, P3040, DOI 10.1093/nar/28.16.3040; Harlow E., 1988, ANTIBODIES LAB MANUA; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Poltoratsky V, 2008, DNA REPAIR, V7, P830, DOI 10.1016/j.dnarep.2008.02.013; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Shimazaki N, 2005, GENES CELLS, V10, P705, DOI 10.1111/j.1365-2443.2005.00868.x; Sobol RW, 2007, DNA REPAIR, V6, P3, DOI 10.1016/j.dnarep.2006.08.005; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; SRIVASTAVA DK, 1995, J BIOL CHEM, V270, P16402, DOI 10.1074/jbc.270.27.16402; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tano K, 2007, DNA REPAIR, V6, P869, DOI 10.1016/j.dnarep.2007.01.011; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	24	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12229	10.1371/journal.pone.0012229	http://dx.doi.org/10.1371/journal.pone.0012229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805875	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600011
J	Nogues, C; Leh, H; Langendorf, CG; Law, RHP; Buckle, AM; Buckle, M				Nogues, Claude; Leh, Herve; Langendorf, Christopher G.; Law, Ruby H. P.; Buckle, Ashley M.; Buckle, Malcolm			Characterisation of Peptide Microarrays for Studying Antibody-Antigen Binding Using Surface Plasmon Resonance Imagery	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; REAL-TIME; AUTOANTIBODY; EPITOPE; IDENTIFICATION; ADSORPTION; PROTEINS; OXIDE); GAD	Background: Non-specific binding to biosensor surfaces is a major obstacle to quantitative analysis of selective retention of analytes at immobilized target molecules. Although a range of chemical antifouling monolayers has been developed to address this problem, many macromolecular interactions still remain refractory to analysis due to the prevalent high degree of non-specific binding. We describe how we use the dynamic process of the formation of self assembling monolayers and optimise physical and chemical properties thus reducing considerably non-specific binding and allowing analysis of specific binding of analytes to immobilized target molecules. Methodology/Principal Findings: We illustrate this approach by the production of specific protein arrays for the analysis of interactions between the 65kDa isoform of human glutamate decarboxylase (GAD65) and a human monoclonal antibody. Our data illustrate that we have effectively eliminated non-specific interactions with the surface containing the immobilised GAD65 molecules. The findings have several implications. First, this approach obviates the dubious process of background subtraction and gives access to more accurate kinetic and equilibrium values that are no longer contaminated by multiphase non-specific binding. Second, an enhanced signal to noise ratio increases not only the sensitivity but also confidence in the use of SPR to generate kinetic constants that may then be inserted into van't Hoff type analyses to provide comparative Delta G, Delta S and Delta H values, making this an efficient, rapid and competitive alternative to ITC measurements used in drug and macromolecular-interaction mechanistic studies. Third, the accuracy of the measurements allows the application of more intricate interaction models than simple Langmuir monophasic binding. Conclusions: The detection and measurement of antibody binding by the type 1 diabetes autoantigen GAD65 represents an example of an antibody-antigen interaction where good structural, mechanistic and immunological data are available. Using SPRi we were able to characterise the kinetics of the interaction in greater detail than ELISA/RIA methods. Furthermore, our data indicate that SPRi is well suited to a multiplexed immunoassay using GAD65 proteins, and may be applicable to other biomarkers.	[Nogues, Claude; Leh, Herve; Buckle, Malcolm] Ecole Normale Super, Lab Biol & Pharmacol Appl, UMR 8113, CNRS,Inst Alembert, Cachan, France; [Langendorf, Christopher G.; Law, Ruby H. P.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Monash University	Nogues, C (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol Appl, UMR 8113, CNRS,Inst Alembert, Cachan, France.	ashley.buckle@monash.edu; buckle@lbpa.ens-cachan.fr	Nogues, claude/B-7215-2012; Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Langendorf, Christopher/0000-0002-9049-5283; law, ruby/0000-0001-5432-5781	National Health & Medical Research Council (NHMRC, Australia); Australian Research Council; ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces); ANR (National Research Agency); IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes)	National Health & Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces); ANR (National Research Agency)(French National Research Agency (ANR)); IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes)	The authors thank the National Health & Medical Research Council (NHMRC, Australia), and Australian Research Council for funding and support. AMB is an NHMRC Senior Research Fellow. CN and MB thank Eurotransbio (QUBIS) (Targeted functional genomics based on Mass Spectrometry (MS), Surface Plasmon Resonance imaging (SPRi) and Stable Isotope(SI)-labelling: Application towards the understanding of the function of PDZ-domains as switch board for signal transduction), ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces) and ANR (National Research Agency) IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes) for financial aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat Y, 2009, MOL IMMUNOL, V47, P493, DOI 10.1016/j.molimm.2009.08.022; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Bouffartigues E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm030; Buckle M, 1996, P NATL ACAD SCI USA, V93, P889, DOI 10.1073/pnas.93.2.889; Cherif B, 2006, CLIN CHEM, V52, P255, DOI 10.1373/clinchem.2005.085727; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fenalti G, 2007, MOL IMMUNOL, V44, P1178, DOI 10.1016/j.molimm.2006.06.025; Fenalti G, 2010, AUTOIMMUN REV, V9, P148, DOI 10.1016/j.autrev.2009.05.003; Frederix F, 2004, J BIOCHEM BIOPH METH, V58, P67, DOI 10.1016/S0165-022X(03)00150-7; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; Lee JW, 2005, BIOSENS BIOELECTRON, V20, P1422, DOI 10.1016/j.bios.2004.04.017; Powell M, 1996, CLIN CHIM ACTA, V256, P175, DOI 10.1016/S0009-8981(96)06422-4; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Primo ME, 2003, CLIN IMMUNOL, V108, P38, DOI 10.1016/S1521-6616(03)00061-5; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Teoh KL, 1998, AUTOIMMUNITY, V28, P259, DOI 10.3109/08916939808995374; TUOMILEHTO J, 1994, LANCET, V343, P1383, DOI 10.1016/S0140-6736(94)92521-6	18	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12152	10.1371/journal.pone.0012152	http://dx.doi.org/10.1371/journal.pone.0012152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730101	Green Submitted, Green Published, gold			2022-12-27	WOS:000280862200011
J	de Oliveira, IFF; Borges, AD; Kooij, V; Bartosiak-Jentys, J; Luirink, J; Scheffers, DJ				Fernandes de Oliveira, Ines Filipa; Borges, Anabela de Sousa; Kooij, Viola; Bartosiak-Jentys, Jeremy; Luirink, Joen; Scheffers, Dirk-Jan			Characterization of ftsZ Mutations that Render Bacillus subtilis Resistant to MinC	PLOS ONE			English	Article							DIVISION INHIBITOR SULA; SITE SELECTION SYSTEM; TO-POLE OSCILLATION; C-TERMINAL TAIL; CELL-DIVISION; ESCHERICHIA-COLI; Z-RING; CRYSTAL-STRUCTURE; ASSEMBLY DYNAMICS; GTPASE ACTIVITY	Background: Cell division in Bacillus subtilis occurs precisely at midcell. Positional control of cell division is exerted by two mechanisms: nucleoid occlusion, through Noc, which prevents division through nucleoids, and the Min system, where the combined action of the MinC, D and J proteins prevents formation of the FtsZ ring at cell poles or recently completed division sites. Methodology/Principal Findings: We used a genetic screen to identify mutations in ftsZ that confer resistance to the lethal overexpression of the MinC/MinD division inhibitor. The FtsZ mutants were purified and found to polymerize to a similar or lesser extent as wild type FtsZ, and all mutants displayed reduced GTP hydrolysis activity indicative of a reduced polymerization turnover. We found that even though the mutations conferred in vivo resistance to MinC/D, the purified FtsZ mutants did not display strong resistance to MinC in vitro. Conclusions/Significance: Our results show that in B. subtilis, overproduction of MinC can be countered by mutations that alter FtsZ polymerization dynamics. Even though it would be very likely that the FtsZ mutants found depend on other Z-ring stabilizing proteins such as ZapA, FtsA or SepF, we found this not to be the case. This indicates that the cell division process in B. subtilis is extremely robust.	[Fernandes de Oliveira, Ines Filipa; Borges, Anabela de Sousa; Scheffers, Dirk-Jan] Univ Nova Lisboa, Bacterial Membrane Prote Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Kooij, Viola; Luirink, Joen; Scheffers, Dirk-Jan] Vrije Univ Amsterdam, Dept Mol Microbiol, Amsterdam, Netherlands; [Bartosiak-Jentys, Jeremy; Scheffers, Dirk-Jan] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Universidade Nova de Lisboa; Vrije Universiteit Amsterdam; University of Oxford	de Oliveira, IFF (corresponding author), Univ Nova Lisboa, Bacterial Membrane Prote Lab, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal.	djscheffers@itqb.unl.pt	Luirink, Joen/AAB-8658-2021; Scheffers, Dirk-Jan/B-9475-2008	Scheffers, Dirk-Jan/0000-0002-9439-9168; Luirink, J./0000-0001-8431-0804	ITQB; Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/098637/2008]; BBSRC; European Framework Program [F3-2009-223431]; Netherlands Organisation for Scientific Research	ITQB; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Framework Program; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Work done at the Instituto de Tecnologia Quimica e Biologica was funded by an ITQB start-up grant, and by the Fundacao para a Ciencia e Tecnologia (FCT) through a Ciencia2007 fellowship and project grant PTDC/BIA-MIC/098637/2008 (to DJS). Work done in the Sir William Dunn School of Pathology was supported by a BBSRC grant to Jeff Errington. Work done at VU University Amsterdam was supported by European Framework Program DIVINOCELL HEALTH-F3-2009-223431 (to JL) and a VENI grant from the Netherlands Organisation for Scientific Research (to DJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders' websites: FCT (http://alfa.fct.mctes.pt/), BBSRC (http://www.bbsrc.ac.uk/), EU (http://cordis.europa.eu/fp7/home_en.html), NWO (www.nwo.nl).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; BI E, 1990, J BACTERIOL, V172, P5610, DOI 10.1128/jb.172.10.5610-5616.1990; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Cordell SC, 2003, P NATL ACAD SCI USA, V100, P7889, DOI 10.1073/pnas.1330742100; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2003, J BACTERIOL, V185, P196, DOI 10.1128/JB.185.1.196-203.2003; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 2002, MOL CLONING LAB MANU; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12048	10.1371/journal.pone.0012048	http://dx.doi.org/10.1371/journal.pone.0012048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711458	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100009
J	Cornelissen, M; Zorgdrager, F; Blom, P; Jurriaans, S; Repping, S; van Leeuwen, E; Bakker, M; Berkhout, B; van der Kuyl, AC				Cornelissen, Marion; Zorgdrager, Fokla; Blom, Petra; Jurriaans, Suzanne; Repping, Sjoerd; van Leeuwen, Elisabeth; Bakker, Margreet; Berkhout, Ben; van der Kuyl, Antoinette C.			Lack of Detection of XMRV in Seminal Plasma from HIV-1 Infected Men in The Netherlands	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; PROSTATE-CANCER; GAMMARETROVIRUS XMRV; BLOOD-CELLS; RETROVIRUS; INFECTION; ABSENCE; PREVALENCE; SAMPLES	Background: Xenotropic murine leukaemia virus-related virus (XMRV) is a recently discovered human gammaretrovirus with yet unknown prevalence and transmission route(s). Its presence in prostate stromal fibroblasts and prostatic secretions suggests that XMRV might be sexually transmitted. We chose to study a compartment closely connected to the prostate, a location where XMRV was detected in independent studies. Seminal plasma samples from HIV-1 infected men were examined as they have an increased probability of acquiring sexually transmitted pathogens. Methodology/Principal Findings: We studied the prevalence of XMRV in 93 seminal plasma samples of 54 HIV-1 infected men living in The Netherlands with a nested PCR amplification specifically targeting the XMRV gag gene. As a control for the presence and integrity of retrovirus particles, HIV-1 was amplified from the same samples with a PCR amplification targeting the env gene of the virus, or HIV-1 was quantified with a real-time PCR amplifying part of the pol gene. Conclusions/Significance: Although HIV-1 was amplified from 25% of the seminal plasma samples, no XMRV was detected, suggesting that either the prevalence of XMRV is very low in The Netherlands, or that XMRV is not naturally present in the seminal plasma.	[Cornelissen, Marion; Zorgdrager, Fokla; Bakker, Margreet; Berkhout, Ben; van der Kuyl, Antoinette C.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Blom, Petra; Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Repping, Sjoerd; van Leeuwen, Elisabeth] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cornelissen, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands.	a.c.vanderkuyl@amc.uva.nl	Van der Kuyl, Antoinette/T-9369-2019	Repping, Sjoerd/0000-0002-6959-149X; van Leeuwen, Elisabeth/0000-0003-2463-9127				Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Calis JCJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-26; Contreras-Galindo R, 2006, J VIROL METHODS, V136, P51, DOI 10.1016/j.jviromet.2006.03.029; DELWART EL, 1995, PCR METH APPL, V4, pS202; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; van Leeuwen E, 2009, NETH J MED, V67, P322; van Leeuwen E, 2008, FERTIL STERIL, V90, P636, DOI 10.1016/j.fertnstert.2007.06.102	25	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12040	10.1371/journal.pone.0012040	http://dx.doi.org/10.1371/journal.pone.0012040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706581	Green Submitted, Green Published, gold			2022-12-27	WOS:000280811900008
J	Douville, RN; Lissitsyn, Y; Hirschfeld, AF; Becker, AB; Kozyrskyj, AL; Liem, J; Bastien, N; Li, Y; Victor, RE; Sekhon, M; Turvey, SE; HayGlass, KT				Douville, Renee N.; Lissitsyn, Yuriy; Hirschfeld, Aaron F.; Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; Bastien, Nathalie; Li, Yan; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.; HayGlass, Kent T.			TLR4 Asp299Gly and Thr399Ile Polymorphisms: No Impact on Human Immune Responsiveness to LPS or Respiratory Syncytial Virus	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; FUNCTIONAL CONSEQUENCES; RESPONSES; LIPOPOLYSACCHARIDE; INFECTION; CHILDREN; DISEASE; ASTHMA	Background: A broad variety of natural environmental stimuli, genotypic influences and timing all contribute to expression of protective versus maladaptive immune responses and the resulting clinical outcomes in humans. The role of commonly co-segregating Toll-like receptor 4 (TLR4) non-synonymous single nucleotide polymorphisms Asp299Gly and Thr399Ile in this process remains highly controversial. Moreover, what differential impact these polymorphisms might have in at risk populations with respiratory dysfunction, such as current asthma or a history of infantile bronchiolitis, has never been examined. Here we determine the importance of these polymorphisms in modulating LPS and respiratory syncytial virus (RSV)-driven cytokine responses. We focus on both healthy children and those with clinically relevant respiratory dysfunction. Methodology: To elucidate the impact of TLR4 Asp299Gly and Thr399Ile on cytokine production, we assessed multiple immune parameters in over 200 pediatric subjects aged 7-9. Genotyping was followed by quantification of pro-and anti-inflammatory cytokine responses by fresh peripheral blood mononuclear cells upon acute exposure to LPS or RSV. Principal Findings: In contrast to early reports, neither SNP influenced immune responses evoked by LPS exposure or RSV infection, as measured by the intermediate phenotype of pro-and anti-inflammatory cytokine responses to these ubiquitous agents. There is no evidence of altered sensitivity in populations with "at risk" clinical phenotypes. Conclusions/Significance: Genomic medicine seeks to inform clinical practice. Determination of the TLR4 Asp299Gly/Thr399Ile haplotype is of no clinical benefit in predicting the nature or intensity of cytokine production in children whether currently healthy or among specific at-risk groups characterized by prior infantile broncholitis or current asthma.	[Douville, Renee N.; Lissitsyn, Yuriy; Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; Turvey, Stuart E.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, CIHR Natl Training Program Allergy & Asthma Res, Winnipeg, MB, Canada; [Li, Yan; HayGlass, Kent T.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kozyrskyj, Anita L.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Becker, Allan B.; Kozyrskyj, Anita L.; Liem, Joel; HayGlass, Kent T.] Univ Manitoba, Dept Pediat Child Hlth, Winnipeg, MB, Canada; [Bastien, Nathalie; Li, Yan] Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB, Canada; [Hirschfeld, Aaron F.; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, BC Childrens Hosp, Vancouver, BC V6T 1W5, Canada; [Hirschfeld, Aaron F.; Victor, Rachel E.; Sekhon, Mehtab; Turvey, Stuart E.] Child & Family Res Inst, Vancouver, BC, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Canadian Science Centre for Human & Animal Health; BC Childrens Hospital; University of British Columbia; Child & Family Research Institute	Douville, RN (corresponding author), Univ Manitoba, Dept Immunol, CIHR Natl Training Program Allergy & Asthma Res, Winnipeg, MB, Canada.	sturvey@cw.bc.ca; hayglass@cc.umanitoba.ca	Turvey, Stuart/HGV-1191-2022	Douville, Renee/0000-0002-7854-007X; HayGlass, Kent/0000-0002-4621-7737; Turvey, Stuart/0000-0003-1599-1065	Canadian Institutes for Health Research (CIHR); Canadian Immunodeficiency Society; Canadian Child Health Clinician Scientist Program (CCHCSP); CIHR Team in Mutagenesis and Infectious Diseases	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Immunodeficiency Society; Canadian Child Health Clinician Scientist Program (CCHCSP); CIHR Team in Mutagenesis and Infectious Diseases(Canadian Institutes of Health Research (CIHR))	This work was supported by fellowships and grants from the Canadian Institutes for Health Research (CIHR). R.N.D. was also supported by the Mindel and Tom Olenick Award in Immunology and as a member of the CIHR National Training Program in Allergy and Asthma. S. E. T. is supported by a Chaim Roifman Scholar Award from the Canadian Immunodeficiency Society, a Career Development Award from the Canadian Child Health Clinician Scientist Program (CCHCSP)-a CIHR Strategic Training Program, and the CIHR Team in Mutagenesis and Infectious Diseases. K. T. H. holds the Canada Research Chair in Immune Regulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Bell J, 2004, NATURE, V429, P453, DOI 10.1038/nature02624; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Custovic A, 2006, PAEDIATR RESPIR REV, V7, pS90, DOI 10.1016/j.prrv.2006.04.164; Cyr SL, 2009, VACCINE, V27, P421, DOI 10.1016/j.vaccine.2008.10.073; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Faisca P, 2006, MICROBES INFECT, V8, P621, DOI 10.1016/j.micinf.2005.08.010; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hirschfeld AF, 2007, CLIN IMMUNOL, V122, P271, DOI 10.1016/j.clim.2006.10.012; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moore ML, 2006, PHARMACOL THERAPEUT, V112, P405, DOI 10.1016/j.pharmthera.2006.04.008; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Pulendran B, 2007, NEW ENGL J MED, V356, P1776, DOI 10.1056/NEJMcibr070454; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; REIJMERINK NE, ALLERGY, V65, P199; Scagnolari C, 2009, CLIN VACCINE IMMUNOL, V16, P816, DOI 10.1128/CVI.00445-08; Stefura William P., 2008, V138, P107, DOI 10.1007/978-1-59745-366-0_10; Stinson Monique, 2008, V138, P121, DOI 10.1007/978-1-59745-366-0_11; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tantisira K, 2009, CURR ALLERGY ASTHM R, V9, P10, DOI 10.1007/s11882-009-0002-9; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; van der Graaf C, 2005, CYTOKINE, V30, P264, DOI 10.1016/j.cyto.2005.02.001; von Aulock S, 2003, J INFECT DIS, V188, P938, DOI 10.1086/378095	38	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12087	10.1371/journal.pone.0012087	http://dx.doi.org/10.1371/journal.pone.0012087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711470	Green Submitted, gold, Green Published			2022-12-27	WOS:000280811900027
J	Griffiths, CL; Robinson, TB; Lange, L; Mead, A				Griffiths, Charles L.; Robinson, Tamara B.; Lange, Louise; Mead, Angela			Marine Biodiversity in South Africa: An Evaluation of Current States of Knowledge	PLOS ONE			English	Review							LONG-TERM TRENDS; CAPE PROVINCE; EAST-COAST; WEST-COAST; SELECTION; BENGUELA; OCEAN; BIOGEOGRAPHY; CONSERVATION; ATLANTIC	Continental South Africa has a coastline of some 3,650 km and an Exclusive Economic Zone (EEZ) of just over 1 million km(2). Waters in the EEZ extend to a depth of 5,700 m, with more than 65% deeper than 2,000 m. Despite its status as a developing nation, South Africa has a relatively strong history of marine taxonomic research and maintains comprehensive and well-curated museum collections totaling over 291,000 records. Over 3 million locality records from more than 23,000 species have been lodged in the regional AfrOBIS (African Ocean Biogeographic Information System) data center (which stores data from a wider African region). A large number of regional guides to the marine fauna and flora are also available and are listed. The currently recorded marine biota of South Africa numbers at least 12,914 species, although many taxa, particularly those of small body size, remain poorly documented. The coastal zone is relatively well sampled with some 2,500 samples of benthic invertebrate communities have been taken by grab, dredge, or trawl. Almost none of these samples, however, were collected after 1980, and over 99% of existing samples are from depths shallower than 1,000 m-indeed 83% are from less than 100 m. The abyssal zone thus remains almost completely unexplored. South Africa has a fairly large industrial fishing industry, of which the largest fisheries are the pelagic (pilchard and anchovy) and demersal (hake) sectors, both focused on the west and south coasts. The east coast has fewer, smaller commercial fisheries, but a high coastal population density, resulting in intense exploitation of inshore resources by recreational and subsistence fishers, and this has resulted in the overexploitation of many coastal fish and invertebrate stocks. South Africa has a small aquaculture industry rearing mussels, oysters, prawns, and abalone-the latter two in land-based facilities. Compared with many other developing countries, South Africa has a well-conserved coastline, 23% of which is under formal protection, however deeper waters are almost entirely excluded from conservation areas. Marine pollution is confined mainly to the densely populated KwaZulu-Natal coast and the urban centers of Cape Town and Port Elizabeth. Over 120 introduced or cryptogenic marine species have been recorded, but most of these are confined to the few harbors and sheltered sites along the coast.	[Griffiths, Charles L.; Robinson, Tamara B.; Lange, Louise; Mead, Angela] Univ Cape Town, Dept Zool, Marine Biol Res Ctr, ZA-7700 Rondebosch, South Africa; [Griffiths, Charles L.] Univ Cape Town, Dept Zool, Ctr Invas Biol, ZA-7700 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Griffiths, CL (corresponding author), Univ Cape Town, Dept Zool, Marine Biol Res Ctr, ZA-7700 Rondebosch, South Africa.	Charles.Griffiths@uct.ac.za	Robinson, Tamara B/I-1806-2019	Robinson, Tamara B/0000-0001-5515-1445	South African National Research Foundation (NRF); Census of Marine Life (CoML)	South African National Research Foundation (NRF)(National Research Foundation - South Africa); Census of Marine Life (CoML)	This work was funded by the South African National Research Foundation (NRF) and the Census of Marine Life (CoML). While the funders had no direct role in study design, data collection and analysis or preparation of the manuscript, the decision to publish in this journal was prescribed by CoML, as this is a carefully structured collection.	Awad AA, 2002, DIVERS DISTRIB, V8, P129, DOI 10.1046/j.1472-4642.2002.00132.x; BAILEY GW, 1991, GEOL SOC SPEC PUBL, P171, DOI 10.1144/GSL.SP.1991.058.01.12; BALLY R, 1984, S AFR J SCI, V80, P500; Bolton J. J., 1997, P348; Bolton JJ, 2004, MAR BIOL, V144, P51, DOI 10.1007/s00227-003-1182-9; Bolton JJ, 2002, S AFR J MARINE SCI, V24, P9, DOI 10.2989/025776102784528402; Branch GM, 2010, 2 OCEANS GUIDE MARIN; BROWN AC, 1978, BIOGEOGRAPHY ECOLOGY, P1237; Bustamante RH, 1996, J BIOGEOGR, V23, P339, DOI 10.1046/j.1365-2699.1996.00026.x; Cockcroft AC, 2008, AFR J MAR SCI, V30, P149, DOI 10.2989/AJMS.2008.30.1.15.465; Cockcroft AC, 2001, MAR FRESHWATER RES, V52, P1085, DOI 10.1071/MF01100; Crawford RJM, 2008, AFR J MAR SCI, V30, P177, DOI 10.2989/AJMS.2008.30.1.18.468; DAY JH, 1977, HIST SCI ENDEAVOUR S, P86; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; *DEP ENV AFF TOUR, 2009, STAT ENV 2005; Durham B, 2000, SUMMARY MARINE BIODI; EMANUEL BP, 1992, S AFR J MARINE SCI, V12, P341; Field JG., 1991, INTERTIDAL LITTORAL, V24, P323; Florence Wayne K., 2007, African Natural History, V3, P1; Gibbons MJ, 1999, S AFR J SCI, V95, P8; Gr³ndlingh M.L., 1983, S AFR GEOGR J, V65, P49, DOI [10.1080/03736245.1983.10559671, DOI 10.1080/03736245.1983.10559671]; Griffiths Charles L., 2009, V204, P393; Griffiths CL, 2005, INDIAN J MAR SCI, V34, P35; Griffiths CL, 2004, OCEANOGR MAR BIOL, V42, P303; Griffiths MH, 2000, S AFR J MARINE SCI, V22, P81, DOI 10.2989/025776100784125663; Grundlingh ML, 2007, S AFR J SCI, V103, P91; Jackson L.F., 1984, COASTAL SENSITIVITY; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; LESLIE RW, 2000, SUMMARY MARINE BIODI, P13; Linder HP, 1999, T ROY SOC S AFR, V54, P1, DOI 10.1080/00359199909520399; Lombard A. T., 2004, MARINE COMPONENT NAT; Lutjeharms J. R. E., 1998, FIELD GUIDE E SO CAP, P50; Lutjeharms JRE, 2000, CONT SHELF RES, V20, P737, DOI 10.1016/S0278-4343(99)00092-8; LUTJEHARMS JRE, 1988, J PHYS OCEANOGR, V18, P1570, DOI 10.1175/1520-0485(1988)018<1570:TROTAC>2.0.CO;2; Monniot Claude, 2001, Annals of the South African Museum, V108, P1; Penney AJ, 1999, S AFR J MARINE SCI, V21, P51; SAMAAI T, 2005, AFR NAT HIST, V1, P96; SANTELICES B, 1994, ROCKY SHORES EXPLOIT, P33; SCHUMANN EH, 1987, T ROY SOC S AFR, V46, P215, DOI 10.1080/00359198709520125; SCHUMANN EH, 1984, T ROY SOC S AFR, V45, P191, DOI 10.1080/00359198409519483; Shannon L.V., 1996, BENGUELA LARGE SCALE; SHANNON LV, 1992, S AFR J MARINE SCI, V12, P271; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; SHILLINGTON FA, 1978, SURFACE WAVES NEAR C, V31, P67; Sink KJ, 2001, THESIS U CAPE TOWN; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; STEGENGA H, 1992, BOT MAR, V35, P99, DOI 10.1515/botm.1992.35.2.99; STEGENGA H, 1997, CONTRIBUTIONS BOLUS, V18, P1; Stephenson T. A., 1939, Journal of the Linnean Society Zoology, V40, P487; STEPHENSON T. A., 1948, ANN NATAL MUS, V11, P207; STEPHENSON T. A., 1944, ANN NATAL MUS, V10, P261; Stephenson T.A., 1972, LIFE TIDEMARKS ROCKY; STUTTAFORD M, 1996, S AFRICAN FISHING IN; TAUNTONCLARK J, 1988, S AFR J MARINE SCI, V6, P97, DOI 10.2989/025776188784480654; Turpie JK, 2000, BIOL CONSERV, V92, P59, DOI 10.1016/S0006-3207(99)00063-4; *UN FOA, 2009, FISH AQ COUNTR PROF; Whitfield AK, 1998, FIELD GUIDE E SO CAP, P216; WORLD CONSERVATION MONITORING CENTRE, 1992, DEV NAT BIOD IND DIS	58	161	167	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e12008	10.1371/journal.pone.0012008	http://dx.doi.org/10.1371/journal.pone.0012008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689849	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520400018
J	Ghosal, K; Stathopoulos, A; Pimplikar, SW				Ghosal, Kaushik; Stathopoulos, Andrea; Pimplikar, Sanjay W.			APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; LONG-TERM-MEMORY; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; MOUSE MODEL; BETA; HYPOTHESIS; HOMEOSTASIS; ACTIVATION	Background: A devastating aspect of Alzheimer's disease (AD) is the progressive deterioration of memory due to neuronal loss. Amyloid precursor protein (APP) occupies a central position in AD and APP-derived amyloid-beta (A beta) peptides are thought to play a pivotal role in disease pathogenesis. Nonetheless, it is becoming clear that AD etiology is highly complex and that factors other than A beta also contribute to AD pathogenesis. APP intracellular domain (AICD) is generated together with A beta and we recently showed that AICD transgenic mice recapitulate pathological features of AD such as tau hyperphosphorylation, memory deficits and neurodegeneration without increasing the A beta levels. Since impaired adult neurogenesis is shown to augment memory deficits in AD mouse models, here we examined the status of adult neurogenesis in AICD transgenic mice. Methodology/Principal Finding: We previously generated transgenic mice co-expressing 59-residue long AICD fragment and its binding partner Fe65. Hippocampal progenitor cell proliferation was determined by BrdU incorporation at 1.5, 3 and 12 months of age. Only male transgenic and their respective wilt type littermate control mice were used. We find age-dependent decrease in BrdU incorporation and doublecortin-positive cells in the dentate gyrus of AICD transgenic mice suggesting impaired adult neurogenesis. This deficit resulted from decreased proliferation and survival, whereas neuronal differentiation remained unaffected. Importantly, this impairment was independent of A beta since APP-KO mice expressing AICD also exhibit reduced neurogenesis. The defects in adult neurogenesis are prevented by long-term treatment with the non-steroidal anti-inflammatory agents ibuprofen or naproxen suggesting that neuroinflammation is critically involved in impaired adult neurogenesis in AICD transgenic mice. Conclusion/Significance: Since adult neurogenesis is crucial for spatial memory, which is particularly vulnerable in AD, these findings suggest that AICD can exacerbate memory defects in AD by impairing adult neurogenesis. Our findings further establish that AICD, in addition to A beta, contributes to AD pathology and that neuroinflammation plays a much broader role in AD pathogenesis than previously thought.	[Ghosal, Kaushik; Stathopoulos, Andrea; Pimplikar, Sanjay W.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ghosal, K (corresponding author), Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	pimplis@ccf.org			National Institutes of Health [R01-AG026146]; Alzheimer's Association; CART-Rotary Funds; NATIONAL INSTITUTE ON AGING [R01AG026146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); CART-Rotary Funds; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01-AG026146 and funding from Alzheimer's Association and CART-Rotary Funds to SWP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; DEMARS M, J NEUROSCI RES; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Ghosal K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.020; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GLASS CK, CELL, V140, P918; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Lamb BT, 1999, NAT NEUROSCI, V2, P695, DOI 10.1038/11154; LAZAROV O, 2009, EXP NEUROL; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VOGT DL, 2009, NEUROBIOL AGING; WANG JM, P NATL ACAD SCI US, V107, P6498; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; WHITNEY NP, J NEUROCHEM, V108, P1343; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	48	78	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11866	10.1371/journal.pone.0011866	http://dx.doi.org/10.1371/journal.pone.0011866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689579	gold, Green Published			2022-12-27	WOS:000280520300007
J	Ohms, VR; Snelderwaard, PC; ten Cate, C; Beckers, GJL				Ohms, Verena R.; Snelderwaard, Peter Ch.; ten Cate, Carel; Beckers, Gabriel J. L.			Vocal Tract Articulation in Zebra Finches	PLOS ONE			English	Article							OSCINE BIRD SOUND; TRACHEAL ELONGATION; SONG PRODUCTION; BEAK MOVEMENTS; MECHANISMS; RESONANCES; FREQUENCY; SPARROWS; DYNAMICS; SYRINX	Background: Birdsong and human vocal communication are both complex behaviours which show striking similarities mainly thought to be present in the area of development and learning. Recent studies, however, suggest that there are also parallels in vocal production mechanisms. While it has been long thought that vocal tract filtering, as it occurs in human speech, only plays a minor role in birdsong there is an increasing number of studies indicating the presence of sound filtering mechanisms in bird vocalizations as well. Methodology/Principal Findings: Correlating high-speed X-ray cinematographic imaging of singing zebra finches (Taeniopygia guttata) to song structures we identified beak gape and the expansion of the oropharyngeal-esophageal cavity (OEC) as potential articulators. We subsequently manipulated both structures in an experiment in which we played sound through the vocal tract of dead birds. Comparing acoustic input with acoustic output showed that OEC expansion causes an energy shift towards lower frequencies and an amplitude increase whereas a wide beak gape emphasizes frequencies around 5 kilohertz and above. Conclusion: These findings confirm that birds can modulate their song by using vocal tract filtering and demonstrate how OEC and beak gape contribute to this modulation.	[Ohms, Verena R.; Snelderwaard, Peter Ch.; ten Cate, Carel] Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; [ten Cate, Carel] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Beckers, Gabriel J. L.] Max Planck Inst Ornithol, Seewiesen, Germany	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Max Planck Society	Ohms, VR (corresponding author), Leiden Univ, Inst Biol Leiden, Leiden, Netherlands.	v.r.ohms@biology.leidenuniv.nl	Cate, Carel ten/G-2075-2012		Netherlands Organization for Scientific Research (NWO) [815.02.011]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding was provided by the Netherlands Organization for Scientific Research (NWO). Grant Number 815.02.011. http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, COURSE PHONETICS; Ballintijn MR, 1998, J EXP BIOL, V201, P1637; Beckers GJL, 2004, CURR BIOL, V14, P1592, DOI 10.1016/j.cub.2004.08.057; Boersma Paul, 2002, GLOT INT, V5, P341; CLENCH MH, 1978, CONDOR, V80, P423, DOI 10.2307/1367193; Daley M, 2004, J NEUROBIOL, V59, P319, DOI 10.1002/neu.10332; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Fletcher NH, 1999, J ACOUST SOC AM, V105, P35, DOI 10.1121/1.424620; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 2004, J NEUROBIOL, V59, P289, DOI 10.1002/neu.10327; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; HAUSBERGER M, 1991, ANIM BEHAV, V42, P319, DOI 10.1016/S0003-3472(05)80565-2; HEIDWEILLER J, 1990, CONDOR, V92, P1, DOI 10.2307/1368379; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Jones E., 2001, LEAST SQUARE REGRESS; Nelson BS, 2005, J EXP BIOL, V208, P297, DOI 10.1242/jeb.01378; NOWICKI S, 1986, SCIENCE, V231, P1297, DOI 10.1126/science.3945824; NOWICKI S, 1987, NATURE, V325, P53, DOI 10.1038/325053a0; Plummer EM, 2008, J EXP BIOL, V211, P66, DOI 10.1242/jeb.011908; Podos J, 2004, J EXP BIOL, V207, P607, DOI 10.1242/jeb.00770; PODOS J, 1995, ANIM BEHAV, V50, P1287, DOI 10.1016/0003-3472(95)80044-1; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2004, J EXP BIOL, V207, P4025, DOI 10.1242/jeb.01256; Riede T, 2009, J COMP PHYSIOL A, V195, P183, DOI 10.1007/s00359-008-0397-0; Snelderwaard PC, 2002, J BIOMECH, V35, P1007, DOI 10.1016/S0021-9290(02)00035-0; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0; Titze I. R., 2000, PRINCIPLES VOICE PRO; WESTNEAT MW, 1993, J EXP BIOL, V182, P147; Williams H, 2001, J EXP BIOL, V204, P3497; Zollinger SA, 2008, J EXP BIOL, V211, P1978, DOI 10.1242/jeb.014092	34	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11923	10.1371/journal.pone.0011923	http://dx.doi.org/10.1371/journal.pone.0011923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689831	Green Published, gold			2022-12-27	WOS:000280520300032
J	Caicedo-Carvajal, CE; Shinbrot, T; Foty, RA				Caicedo-Carvajal, Carlos E.; Shinbrot, Troy; Foty, Ramsey A.			alpha 5 beta 1 Integrin-Fibronectin Interactions Specify Liquid to Solid Phase Transition of 3D Cellular Aggregates	PLOS ONE			English	Article							EMBRYONIC-TISSUES; QUANTITATIVE DIFFERENCES; XENOPUS FIBRILLIN; SURFACE TENSIONS; MATRIX STIFFNESS; ADHESION; CELLS; FIBROBLASTS; EXPRESSION; DETACHMENT	Background: Tissue organization during embryonic development and wound healing depends on the ability of cells on the one hand to exchange adhesive bonds during active rearrangement and on the other to become fixed in place as tissue homeostasis is reached. Cells achieve these contradictory tasks by regulating either cell-cell adhesive bonds, mediated by cadherins, or cell-extracellular matrix (ECM) connections, regulated by integrins. Integrin alpha 5 beta 1 and soluble fibronectin (sFN) are key players in cell-ECM force generation and in ECM polymerization. Here, we explore the interplay between integrin alpha 5 beta 1 and sFN and its influence on tissue mechanical properties and cell sorting behavior. Methodology/Principal Findings: We generated a series of cell lines varying in alpha 5 beta 1 receptor density. We then systematically explored the effects of different sFN concentrations on aggregate biomechanical properties using tissue surface tensiometry. We found previously unreported complex behaviors including the observation that interactions between fibronectin and integrin alpha 5 beta 1 generates biphasic tissue cohesion profiles. Specifically, we show that at constant sFn concentration, aggregate cohesion increases linearly as alpha 5 beta 1 receptor density is increased from low to moderate levels, producing a transition from viscoelastic-liquid to pseudo viscoelastic-solid behavior. However, further increase in receptor density causes an abrupt drop in tissue cohesion and a transition back to viscoelastic-liquid properties. We propose that this may be due to depletion of sFn below a critical value in the aggregate microenvironment at high alpha 5 beta 1 levels. We also show that differential expression of alpha 5 beta 1 integrin can promote phase-separation between cells. Conclusions/Significance: The interplay between alpha 5-integrin and sFn contributes significantly to tissue cohesion and, depending on their level of expression, can mediate a shift from liquid to elastic behavior. This interplay represents a tunable level of control between integrins and the ECM that can influence tissue cohesion and other mechanical properties, which may translate to the specification of tissue structure and function. These studies provide insights into important biological processes such as embryonic development, wound healing, and for tissue engineering applications.	[Caicedo-Carvajal, Carlos E.; Shinbrot, Troy] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Foty, Ramsey A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Caicedo-Carvajal, CE (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	fotyra@umdnj.edu			National Institutes of Health (NIH) [1R01CA118755]; NATIONAL CANCER INSTITUTE [R01CA118755] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by National Institutes of Health (NIH) grant # 1R01CA118755 to RAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG PB, 1981, J CELL SCI, V50, P121; ARMSTRONG PB, 1980, J CELL SCI, V44, P263; ARMSTRONG PB, 2000, BIOCHIM BIOPHYS ACTA, V1470, P9; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; BEFFARA V, 2006, POLYM PINNING RANDOM; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; Damon BJ, 2008, DEV BIOL, V321, P319, DOI 10.1016/j.ydbio.2008.06.018; Davies J.T., 1963, INTERFACIAL PHENOMEN; Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741; Downie SA, 1995, DEV BIOL, V172, P519, DOI 10.1006/dbio.1995.8068; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; LIU AJ, 2010, ANN REV COND MAT PHY; NEWMAN SA, 1985, SCIENCE, V228, P885, DOI 10.1126/science.4001925; Newman SA, 2004, PHYS BIOL, V1, P100, DOI 10.1088/1478-3967/1/2/006; Palecek SP, 1996, J CELL SCI, V109, P941; Palecek SP, 1998, J CELL SCI, V111, P929; PHILLIPS HM, 1978, J CELL SCI, V30, P1; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Rozario T, 2009, DEV BIOL, V327, P386, DOI 10.1016/j.ydbio.2008.12.025; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Skoglund P, 2006, DEV DYNAM, V235, P1974, DOI 10.1002/dvdy.20818; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1992, DYNAMICAL PHENOMENA, P3; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; WISEMAN LL, 1972, DEV BIOL, V28, P498, DOI 10.1016/0012-1606(72)90033-4; YAMADA KM, 1975, P NATL ACAD SCI USA, V72, P3158, DOI 10.1073/pnas.72.8.3158; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235	42	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11830	10.1371/journal.pone.0011830	http://dx.doi.org/10.1371/journal.pone.0011830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686611	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200009
J	Stanhope, SA				Stanhope, Stephen A.			Occupancy Modeling, Maximum Contig Size Probabilities and Designing Metagenomics Experiments	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENOMIC ANALYSIS; VIRAL COMMUNITY; GUT MICROBIOME; DIVERSITY; MARINE; COVERAGE; VIRUSES; ARCHAEA; CULTIVATION	Mathematical aspects of coverage and gaps in genome assembly have received substantial attention by bioinformaticians. Typical problems under consideration suppose that reads can be experimentally obtained from a single genome and that the number of reads will be set to cover a large percentage of that genome at a desired depth. In metagenomics experiments genomes from multiple species are simultaneously analyzed and obtaining large numbers of reads per genome is unlikely. We propose the probability of obtaining at least one contig of a desired minimum size from each novel genome in the pool without restriction based on depth of coverage as a metric for metagenomic experimental design. We derive an approximation to the distribution of maximum contig size for single genome assemblies using relatively few reads. This approximation is verified in simulation studies and applied to a number of different metagenomic experimental design problems, ranging in difficulty from detecting a single novel genome in a pool of known species to detecting each of a random number of novel genomes collectively sized and with abundances corresponding to given distributions in a single pool.	Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago	Stanhope, SA (corresponding author), Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA.	sstanhop@bsd.uchicago.edu						Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Aldous D., 1989, PROBABILITY APPROXIM; Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; ARRATIA R, 1991, GENOMICS, V11, P806, DOI 10.1016/0888-7543(91)90004-X; Arratia R., 1990, STAT SCI, P403, DOI [10.1214/ss/1177012015, DOI 10.1214/SS/1177012015]; Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Ewens W.J., 2001, STAT METHODS BIOINFO; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Filippini M, 2007, FEMS MICROBIOL ECOL, V60, P397, DOI 10.1111/j.1574-6941.2007.00298.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hugenholtz P, 2002, GENOME BIOL, V3; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LANDER E S, 1988, Genomics, V2, P231; Leadbetter JR, 2003, CURR OPIN MICROBIOL, V6, P274, DOI 10.1016/S1369-5274(03)00041-9; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Moriarty J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-70; Pride DT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-420; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wendl MC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-245; Wendl MC, 2006, B MATH BIOL, V68, P179, DOI 10.1007/s11538-005-9021-4; Wendl MC, 2001, GENOME RES, V11, P274, DOI 10.1101/gr.GR-1339R; Wendl MC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-239; Wendl MC, 2006, J COMPUT BIOL, V13, P1177, DOI 10.1089/cmb.2006.13.1177; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	48	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11652	10.1371/journal.pone.0011652	http://dx.doi.org/10.1371/journal.pone.0011652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686599	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200002
J	Tang, JY; Li, S; Li, ZH; Zhang, ZJ; Hu, GA; Cheang, LCV; Alex, D; Hoi, MPM; Kwan, YW; Chan, SW; Leung, GPH; Lee, SMY				Tang, Jing Yan; Li, Shang; Li, Zhen Hua; Zhang, Zai Jun; Hu, Guang; Cheang, Lorita Chi Veng; Alex, Deepa; Hoi, Maggie Pui Man; Kwan, Yiu Wa; Chan, Shun Wan; Leung, George Pak Heng; Lee, Simon Ming Yuen			Calycosin Promotes Angiogenesis Involving Estrogen Receptor and Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Zebrafish and HUVEC	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHINESE HERBAL DECOCTION; RADIX ANGELICAE SINENSIS; IN-VITRO; NITRIC-OXIDE; BIOLOGICAL ASSESSMENT; CORONARY-ARTERY; BREAST-CANCER; CELLS; ASTRAGALI	Background: Angiogenesis plays an important role in a wide range of physiological processes, and many diseases are associated with the dysregulation of angiogenesis. Radix Astragali is a Chinese medicinal herb commonly used for treating cardiovascular disorders and has been shown to possess angiogenic effect in previous studies but its active constituent and underlying mechanism remain unclear. The present study investigates the angiogenic effects of calycosin, a major isoflavonoid isolated from Radix Astragali, in vitro and in vivo. Methodology: Tg(fli1:EGFP) and Tg(fli1:nEGFP) transgenic zebrafish embryos were treated with different concentrations of calycosin (10, 30, 100 mu M) from 72 hpf to 96 hpf prior morphological observation and angiogenesis phenotypes assessment. Zebrafish embryos were exposed to calycosin (10, 100 mu M) from 72 hpf to 78 hpf before gene-expression analysis. The effects of VEGFR tyrosine kinase inhibitor on calycosin-induced angiogenesis were studied using 72 hpf Tg(fli1:EGFP) and Tg(fli1:nEGFP) zebrafish embryos. The pro-angiogenic effects of calycosin were compared with raloxifene and tamoxifen in 72 hpf Tg(fli1:EGFP) zebrafish embryos. The binding affinities of calycosin to estrogen receptors (ERs) were evaluated by cell-free and cell-based estrogen receptor binding assays. Human umbilical vein endothelial cell cultures (HUVEC) were pretreated with different concentrations of calycosin (3, 10, 30, 100 mu M) for 48 h then tested for cell viability and tube formation. The role of MAPK signaling in calycosin-induced angiogenesis was evaluated using western blotting. Conclusion: Calycosin was shown to induce angiogenesis in human umbilical vein endothelial cell cultures (HUVEC) in vitro and zebrafish embryos in vivo via the up-regulation of vascular endothelial growth factor (VEGF), VEGFR1 and VEGFR2 mRNA expression. It was demonstrated that calycosin acted similar to other selective estrogen receptor modulators (SERMs), such as raloxifene and tamoxifen, by displaying selective potency and affinity to estrogen receptors ER alpha and ER beta. Our results further indicated that calycosin promotes angiogenesis via activation of MAPK with the involvement of ERK1/2 and ER. Together, this study revealed, for the first time, that calycosin acts as a selective estrogen receptor modulator (SERM) to promote angiogenesis, at least in part through VEGF-VEGFR2 and MAPK signaling pathways.	[Tang, Jing Yan; Li, Shang; Li, Zhen Hua; Zhang, Zai Jun; Hu, Guang; Cheang, Lorita Chi Veng; Alex, Deepa; Hoi, Maggie Pui Man; Lee, Simon Ming Yuen] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chinese Med & Mol Pharmacol, Hong Kong, Hong Kong, Peoples R China; [Leung, George Pak Heng] Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	University of Macau; Chinese University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Tang, JY (corresponding author), Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China.	SimonLee@umac.mo	Philippot, Laurent/G-5598-2011; tang, jing/HHR-9815-2022; Kwan, Yiu Wa/R-6468-2018; Chan, Shun-Wan/K-9363-2013; Hoi, Maggie Pui Man/AAY-5962-2021; Leung, George Pak Heng/B-4529-2009	Philippot, Laurent/0000-0003-3461-4492; Kwan, Yiu Wa/0000-0002-9024-1275; Chan, Shun-Wan/0000-0001-8238-798X; Leung, George Pak Heng/0000-0003-3529-9367; Hoi, Maggie Pui Man/0000-0003-2630-3707	Science and Technology Development Fund of Macau SAR [045/2007/A3]; Research Committee, University of Macau [RG085, UL017/09-Y1]	Science and Technology Development Fund of Macau SAR; Research Committee, University of Macau	This study is supported by grant from the Science and Technology Development Fund of Macau SAR (Ref. No. 045/2007/A3) and Research Committee, University of Macau (Ref. No. RG085 and UL017/09-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003; Bracamonte MP, 2002, J CARDIOVASC PHARM, V39, P704, DOI 10.1097/00005344-200205000-00011; Cai Xiao-yan, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P443; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chan CM, 2007, J ETHNOPHARMACOL, V109, P10, DOI 10.1016/j.jep.2006.06.003; Chen X, 1997, Zhongguo Zhong Yao Za Zhi, V22, P432; Chen XJ, 2006, AM J CHINESE MED, V34, P493, DOI 10.1142/S0192415X06004028; Choi R CY, 2009, EVID BASED COMPLEMEN, DOI 10.1093/ecam/nen085; Cid MC, 2002, ANN NY ACAD SCI, V966, P143, DOI 10.1111/j.1749-6632.2002.tb04211.x; Conner P, 2008, CLIN OBSTET GYNECOL, V51, P592, DOI 10.1097/GRF.0b013e318180b8ed; Dong TTX, 2006, J AGR FOOD CHEM, V54, P2767, DOI 10.1021/jf053163l; Doshida M, 2006, J BIOL CHEM, V281, P24270, DOI 10.1074/jbc.M513251200; Fan TP, 2006, TRENDS PHARMACOL SCI, V27, P297, DOI 10.1016/j.tips.2006.04.006; Fan Y, 2003, EUR J PHARMACOL, V481, P33, DOI 10.1016/j.ejphar.2003.09.007; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Fong TAT, 1999, CANCER RES, V59, P99; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Furet P, 2003, BIOORG MED CHEM LETT, V13, P2967, DOI 10.1016/S0960-894X(03)00626-7; Gao QT, 2007, FEBS LETT, V581, P233, DOI 10.1016/j.febslet.2006.12.018; Geraldes P, 2003, CIRC RES, V93, P399, DOI 10.1161/01.RES.0000088640.18462.42; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; He J, 1999, Zhonghua Yi Xue Za Zhi, V79, P654; Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035; Johns A, 1996, ENDOCRINOLOGY, V137, P4511, DOI 10.1210/en.137.10.4511; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kim KH, 2008, STEROIDS, V73, P864, DOI 10.1016/j.steroids.2008.01.008; KimSchulze S, 1996, CIRCULATION, V94, P1402, DOI 10.1161/01.CIR.94.6.1402; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Kostelac D, 2003, J AGR FOOD CHEM, V51, P7632, DOI 10.1021/jf034427b; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Leung FP, 2007, BRIT J PHARMACOL, V152, P223, DOI 10.1038/sj.bjp.0707387; Leung HS, 2006, BRIT J PHARMACOL, V149, P703, DOI 10.1038/sj.bjp.0706921; Liu K, 1990, Zhong Xi Yi Jie He Za Zhi, V10, P330; LIU K, 1990, ZHONG XI YI JIE HE Z, V10, P323; Liu L, 2006, J DERMATOL SCI, V44, P48, DOI 10.1016/j.jdermsci.2006.05.009; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Merchan JR, 2003, J NATL CANCER I, V95, P388, DOI 10.1093/jnci/95.5.388; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Pages G, 2000, ANN NY ACAD SCI, V902, P187; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pinna C, 2006, J PHARMACOL EXP THER, V319, P1444, DOI 10.1124/jpet.106.106062; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Seng Wen Lin, 2004, Angiogenesis, V7, P243, DOI 10.1007/s10456-004-4181-7; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Zi-Yi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P779; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Song JZ, 2008, J PHARMACEUT BIOMED, V47, P399, DOI 10.1016/j.jpba.2007.12.036; Song ZH, 2004, PLANTA MED, V70, P1222, DOI 10.1055/s-2004-835855; Suzuma I, 1999, INVEST OPHTH VIS SCI, V40, P2122; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Valachovicova T, 2004, MINI-REV MED CHEM, V4, P881, DOI 10.2174/1389557043403387; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilkinson JM, 2008, J BIOMOL SCREEN, V13, P755, DOI 10.1177/1087057108322155; Wong CM, 2008, BRIT J PHARMACOL, V155, P326, DOI 10.1038/bjp.2008.262; Wren BG, 2009, MED J AUSTRALIA, V190, P321, DOI 10.5694/j.1326-5377.2009.tb02423.x; Xi Sichuan, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P303; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Xu XL, 2008, PHYTOTHER RES, V22, P389, DOI 10.1002/ptr.2332; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zhang Y, 2009, PHYTOTHER RES, V23, P1205, DOI 10.1002/ptr.2479; Zhao Zhuanyou, 2009, Chin Med, V4, P6, DOI 10.1186/1749-8546-4-6	64	102	109	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11822	10.1371/journal.pone.0011822	http://dx.doi.org/10.1371/journal.pone.0011822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686605	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200007
J	Vempati, P; Mac Gabhann, F; Popel, AS				Vempati, Prakash; Mac Gabhann, Feilim; Popel, Aleksander S.			Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL ARTERIAL-DISEASE; METALLOPROTEINASE MMP 2; CELL-SURFACE; TISSUE INHIBITOR; BRANCHING MORPHOGENESIS; PLASMINOGEN-ACTIVATOR; ANGIOGENIC SWITCH; COMPARTMENT MODEL; BASEMENT-MEMBRANE	Background: VEGF proteolysis by plasmin or matrix metalloproteinases (MMPs) is believed to play an important role in regulating vascular patterning in vivo by releasing VEGF from the extracellular matrix (ECM). However, a quantitative understanding of the kinetics of VEGF cleavage and the efficiency of cell-mediated VEGF release is currently lacking. To address these uncertainties, we develop a molecular-detailed quantitative model of VEGF proteolysis, used here in the context of an endothelial sprout. Methodology and Findings: To study a cell's ability to cleave VEGF, the model captures MMP secretion, VEGF-ECM binding, VEGF proteolysis from VEGF(165) to VEGF(114) (the expected MMP cleavage product of VEGF165) and VEGF receptor-mediated recapture. Using experimental data, we estimated the effective bimolecular rate constant of VEGF(165) cleavage by plasmin to be 328 M(-1)s(-1) at 25 degrees C, which is relatively slow compared to typical MMP-ECM proteolysis reactions. While previous studies have implicated cellular proteolysis in growth factor processing, we show that single cells do not individually have the capacity to cleave VEGF to any appreciable extent (less than 0.1% conversion). In addition, we find that a tip cell's receptor system will not efficiently recapture the cleaved VEGF due to an inability of cleaved VEGF to associate with Neuropilin-1. Conclusions: Overall, VEGF(165) cleavage in vivo is likely to be mediated by the combined effect of numerous cells, instead of behaving in a single-cell-directed, autocrine manner. We show that heparan sulfate proteoglycans (HSPGs) potentiate VEGF cleavage by increasing the VEGF clearance time in tissues. In addition, we find that the VEGF-HSPG complex is more sensitive to proteases than is soluble VEGF, which may imply its potential relevance in receptor signaling. Finally, according to our calculations, experimentally measured soluble protease levels are approximately two orders of magnitude lower than that needed to reconcile levels of VEGF cleavage seen in pathological situations.	[Vempati, Prakash; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Vempati, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	pvempat1@jhu.edu	Mac Gabhann, Feilim/A-3436-2010; Popel, Aleksander S/A-6724-2009	Mac Gabhann, Feilim/0000-0003-3481-7740; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health (NIH) [R01 CA138264, R01 HL101200, U54 CA143868, R00 HL093219]; NATIONAL CANCER INSTITUTE [R01CA138264, U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093219, R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: the National Institutes of Health (NIH) grants, R01 CA138264, R01 HL101200, and U54 CA143868 (ASP), and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGELER J, 1984, J CELL BIOL, V98, P1656, DOI 10.1083/jcb.98.5.1656; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Buczek-Thomas JA, 2004, AM J RESP CELL MOL, V31, P344, DOI 10.1165/rcmb.2003-0420OC; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002; ELKAREH AW, 1993, BIOPHYS J, V64, P1638, DOI 10.1016/S0006-3495(93)81532-7; Filion RJ, 2005, AM J PHYSIOL-HEART C, V288, pH263, DOI 10.1152/ajpheart.00205.2004; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Furuya M, 2000, GYNECOL ONCOL, V78, P106, DOI 10.1006/gyno.2000.5856; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Gronski TJ, 1997, J BIOL CHEM, V272, P12189, DOI 10.1074/jbc.272.18.12189; GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974; Gutierrez J, 2008, CLIN CHEM, V54, P597, DOI 10.1373/clinchem.2007.096099; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; HERRON GS, 1986, J BIOL CHEM, V261, P2810; Herve MA, 2008, AM J PATHOL, V172, P167, DOI 10.2353/ajpath.2008.070181; Homandberg GA, 1997, BIOCHEM J, V321, P751, DOI 10.1042/bj3210751; Hornebeck W, 1999, ANN NY ACAD SCI, V878, P625, DOI 10.1111/j.1749-6632.1999.tb07745.x; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Ji JW, 2007, AM J PHYSIOL-HEART C, V293, pH3740, DOI 10.1152/ajpheart.00009.2007; Johnson EM, 1996, BIOPHYS J, V70, P1017, DOI 10.1016/S0006-3495(96)79645-5; Jung S, 2006, J NEURO-ONCOL, V76, P257, DOI 10.1007/s11060-005-6876-z; Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008; Karagiannis ED, 2006, J THEOR BIOL, V238, P124, DOI 10.1016/j.jtbi.2005.05.020; Karagiannis ED, 2004, J BIOL CHEM, V279, P39105, DOI 10.1074/jbc.M403627200; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KURTAGIC E, 2009, AM J PHYSL LUNG CELL; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lauer G, 2002, FEBS LETT, V531, P309, DOI 10.1016/S0014-5793(02)03545-7; LAUFFENBURGER DA, 1993, RECEPTORS MODELS BIN, P144; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lundkvist A, 2007, NOVART FDN SYMP, V283, P201; Lundkvist A, 2007, NOVART FDN SYMP, V283, P238; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Magalhaes J, 2005, BASIC APPL MYOL, V15, P29; Maquoi E, 2000, EXP CELL RES, V261, P348, DOI 10.1006/excr.2000.5063; Michizono K, 2001, NEUROLOGY, V56, P807, DOI 10.1212/WNL.56.6.807; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Mineur P, 2007, J CELL BIOL, V179, P1261, DOI 10.1083/jcb.200703052; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Osawa T, 2003, J ELECTRON MICROSC, V52, P435, DOI 10.1093/jmicro/52.4.435; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Paczek L, 2008, AGE AGEING, V37, P318, DOI 10.1093/ageing/afn039; Paczek L, 2009, AGING CLIN EXP RES, V21, P9; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Partridge CA, 1997, AM J PHYSIOL-LUNG C, V272, pL813, DOI 10.1152/ajplung.1997.272.5.L813; Plouet J, 1997, J BIOL CHEM, V272, P13390, DOI 10.1074/jbc.272.20.13390; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Press WH., 2002, NUMERICAL RECIPES C, V2; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Reinhardt D, 2002, HEART, V88, P525, DOI 10.1136/heart.88.5.525; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Small AR, 2008, J THEOR BIOL, V252, P593, DOI 10.1016/j.jtbi.2008.02.009; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Staack Andrea, 2006, BMC Urol, V6, P19, DOI 10.1186/1471-2490-6-19; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Vempati P, 2007, J BIOL CHEM, V282, P37585, DOI 10.1074/jbc.M611500200; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Wu FTH, 2009, PHYSIOL GENOMICS, V38, P29, DOI 10.1152/physiolgenomics.00031.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Yao C, 2006, BIOMATERIALS, V27, P1608, DOI 10.1016/j.biomaterials.2005.08.037; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163; Yuan F, 2001, ANN BIOMED ENG, V29, P1150, DOI 10.1114/1.1424915; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje	99	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11860	10.1371/journal.pone.0011860	http://dx.doi.org/10.1371/journal.pone.0011860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686621	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200024
J	Zeng, H; Guo, M; Martins-Taylor, K; Wang, XF; Zhang, Z; Park, JW; Zhan, SN; Kronenberg, MS; Lichtler, A; Liu, HX; Chen, FP; Yue, LX; Li, XJ; Xu, RH				Zeng, Hui; Guo, Min; Martins-Taylor, Kristen; Wang, Xiaofang; Zhang, Zheng; Park, Jung Woo; Zhan, Shuning; Kronenberg, Mark S.; Lichtler, Alexander; Liu, Hui-Xia; Chen, Fang-Ping; Yue, Lixia; Li, Xue-Jun; Xu, Ren-He			Specification of Region-Specific Neurons Including Forebrain Glutamatergic Neurons from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; FIBROBLAST-GROWTH-FACTOR; SPINAL MOTOR-NEURONS; NEURAL PRECURSORS; DIRECTED DIFFERENTIATION; IPS CELLS; HUMAN ES; INDUCTION; SIGNALS; CONVERSION	Background: Directed differentiation of human induced pluripotent stem cells (hiPSC) into functional, region-specific neural cells is a key step to realizing their therapeutic promise to treat various neural disorders, which awaits detailed elucidation. Methodology/Principal Findings: We analyzed neural differentiation from various hiPSC lines generated by others and ourselves. Although heterogeneity in efficiency of neuroepithelial (NE) cell differentiation was observed among different hiPSC lines, the NE differentiation process resembles that from human embryonic stem cells (hESC) in morphology, timing, transcriptional profile, and requirement for FGF signaling. NE cells differentiated from hiPSC, like those from hESC, can also form rostral phenotypes by default, and form the midbrain or spinal progenitors upon caudalization by morphogens. The rostrocaudal neural progenitors can further mature to develop forebrain glutamatergic projection neurons, midbrain dopaminergic neurons, and spinal motor neurons, respectively. Typical ion channels and action potentials were recorded in the hiPSC-derived neurons. Conclusions/Significance: Our results demonstrate that hiPSC, regardless of how they were derived, can differentiate into a spectrum of rostrocaudal neurons with functionality, which supports the considerable value of hiPSC for study and treatment of patient-specific neural disorders.	[Zeng, Hui; Martins-Taylor, Kristen; Wang, Xiaofang; Park, Jung Woo; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA; [Guo, Min; Li, Xue-Jun] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Neurosci, Farmington, CT USA; [Zeng, Hui; Chen, Fang-Ping] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China; [Guo, Min; Liu, Hui-Xia] Cent S Univ, Xiang Ya Hosp, Dept Geriatr, Changsha, Hunan, Peoples R China; [Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Zhan, Shuning; Kronenberg, Mark S.; Lichtler, Alexander] Univ Connecticut, Ctr Hlth, Dept Regenerat Sci, Farmington, CT USA	University of Connecticut; University of Connecticut; Central South University; Central South University; University of Connecticut; University of Connecticut	Zeng, H (corresponding author), Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA.	xjli@uchc.edu; renhexu@uchc.edu	Xu, Ren-He/M-3125-2016; Park, Jung Woo/R-6263-2019; Xu, Ren-He/AAK-7392-2021	Park, Jung Woo/0000-0003-0657-7401; LI, XUEJUN/0000-0003-1899-9134; Martins-Taylor, Kristen/0000-0002-7004-5867	National Institutes of Health [R21 NS055261]; Connecticut Stem Cell Research [06SCD02, 06SCB14]; University of Connecticut Health Center; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Stem Cell Research; University of Connecticut Health Center; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Ren-He Xu: Connecticut Stem Cell Research Grants (http://www.ct.gov/dph/cwp/view.asp?a=3142&q = 389700, #06SCD02 and 06SCB14). Xue-Jun Li: National Institutes of Health grant (http://grants.nih.gov/grants/funding/r21.htm, #R21 NS055261) and University of Connecticut Health Center start-up funds. Hui Zeng and Min Guo: China Scholarship Council funds (http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kim GJ, 2001, DEV GROWTH DIFFER, V43, P521; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; LAVAUTE TM, 2009, STEM CELLS; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2006, METH MOL B, V331, P169; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Martins-Taylor K, 2010, J CELL BIOCHEM, V109, P16, DOI 10.1002/jcb.22402; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Shinya M, 2001, DEVELOPMENT, V128, P4153; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; XU RH, 1995, BIOCHEM BIOPH RES CO, V212, P212, DOI 10.1006/bbrc.1995.1958; Xu RH, 1997, J NEUROSCI, V17, P6892; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	51	151	156	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11853	10.1371/journal.pone.0011853	http://dx.doi.org/10.1371/journal.pone.0011853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686615	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200018
J	Sapin, E; Berod, A; Leger, L; Herman, PA; Luppi, PH; Peyron, C				Sapin, Emilie; Berod, Anne; Leger, Lucienne; Herman, Paul A.; Luppi, Pierre-Herve; Peyron, Christelle			A Very Large Number of GABAergic Neurons Are Activated in the Tuberal Hypothalamus during Paradoxical (REM) Sleep Hypersomnia	PLOS ONE			English	Article							C-FOS EXPRESSION; GLUTAMIC-ACID DECARBOXYLASE; EYE-MOVEMENT SLEEP; RAT-BRAIN; WAKING DISCHARGE; DEPRIVATION; LOCALIZATION; RAPHE; GENE; MICROINJECTION	We recently discovered, using Fos immunostaining, that the tuberal and mammillary hypothalamus contain a massive population of neurons specifically activated during paradoxical sleep (PS) hypersomnia. We further showed that some of the activated neurons of the tuberal hypothalamus express the melanin concentrating hormone (MCH) neuropeptide and that icv injection of MCH induces a strong increase in PS quantity. However, the chemical nature of the majority of the neurons activated during PS had not been characterized. To determine whether these neurons are GABAergic, we combined in situ hybridization of GAD(67) mRNA with immunohistochemical detection of Fos in control, PS deprived and PS hypersomniac rats. We found that 74% of the very large population of Fos-labeled neurons located in the tuberal hypothalamus after PS hypersomnia were GAD-positive. We further demonstrated combining MCH immunohistochemistry and GAD(67) in situ hybridization that 85% of the MCH neurons were also GAD-positive. Finally, based on the number of Fos-ir/GAD(+), Fos-ir/ MCH+, and GAD(+)/MCH+ double-labeled neurons counted from three sets of double-staining, we uncovered that around 80% of the large number of the Fos-ir/GAD(+) neurons located in the tuberal hypothalamus after PS hypersomnia do not contain MCH. Based on these and previous results, we propose that the non-MCH Fos/GABAergic neuronal population could be involved in PS induction and maintenance while the Fos/MCH/GABAergic neurons could be involved in the homeostatic regulation of PS. Further investigations will be needed to corroborate this original hypothesis.	[Sapin, Emilie; Leger, Lucienne; Herman, Paul A.; Luppi, Pierre-Herve; Peyron, Christelle] Univ Lyon 1, CNRS, UMR5167, F-69365 Lyon, France; [Berod, Anne] Univ Lyon 1, CNRS, EAC5006, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Sapin, E (corresponding author), Univ Lyon 1, CNRS, UMR5167, F-69365 Lyon, France.	christelle.peyron@univ-lyon1.fr	Luppi, Pierre-Hervé/C-4333-2014; Peyron, Christelle/H-6223-2017	Luppi, Pierre-Hervé/0000-0002-0503-423X; Peyron, Christelle/0000-0002-9317-3546	CNRS; Universite de Lyon; Universite Claude Bernard Lyon 1	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; Universite Claude Bernard Lyon 1	This work was supported by CNRS, Universite de Lyon, Universite Claude Bernard Lyon 1 and a fellowship to E.S. from the "Association Francaise de Narcolepsie-Cataplexie et d'Hypersomnie" and UCB Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnaou A, 2008, EUR J PHARMACOL, V579, P177, DOI 10.1016/j.ejphar.2007.10.017; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; CURRAN T, 1987, ONCOGENE, V2, P79; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Goutagny R, 2005, NEUROREPORT, V16, P1069, DOI 10.1097/00001756-200507130-00008; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; JOUVET M, 1962, Arch Ital Biol, V100, P125; JOUVET M, 1965, INT J NEUROL, V5, P131; JOUVET M, 1959, CR SOC BIOL, V153, P422; JULIEN JF, 1987, NEUROSCI LETT, V73, P173, DOI 10.1016/0304-3940(87)90013-9; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Lagos P, 2009, BRAIN RES, V1265, P103, DOI 10.1016/j.brainres.2009.02.010; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Leger L, 2009, J CHEM NEUROANAT, V37, P149, DOI 10.1016/j.jchemneu.2008.12.008; Leriche M, 2008, NEUROSCIENCE, V153, P259, DOI 10.1016/j.neuroscience.2008.01.069; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2004, SLEEP CIRCUITS FUNCT, P272; Maloney KJ, 1999, J NEUROSCI, V19, P3057; Maloney KJ, 2002, EUR J NEUROSCI, V15, P774, DOI 10.1046/j.1460-9568.2002.01907.x; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; McDermott CM, 2003, J NEUROSCI, V23, P9687; MENDELSON W, 1974, J NEUROCHEM, V22, P1157, DOI 10.1111/j.1471-4159.1974.tb04353.x; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Morales FR, 2006, NEUROSCIENCE, V142, P37, DOI 10.1016/j.neuroscience.2006.05.066; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schmidt MH, 1999, SLEEP, V22, P409, DOI 10.1093/sleep/22.4.409; Semba K, 2001, BEHAV BRAIN RES, V120, P75, DOI 10.1016/S0166-4328(00)00362-4; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Verret L, 2005, EUR J NEUROSCI, V21, P2488, DOI 10.1111/j.1460-9568.2005.04060.x; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19	51	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11766	10.1371/journal.pone.0011766	http://dx.doi.org/10.1371/journal.pone.0011766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668680	Green Published, gold, Green Submitted			2022-12-27	WOS:000280297300006
J	Zhao, SW; Li, S				Zhao, Shiwen; Li, Shao			Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification	PLOS ONE			English	Article							PREDICTION; PERFORMANCE; CETIRIZINE; SIMILARITY; MOLECULES; DISCOVERY; THERAPY; DISEASE; GENES	Background: Identifying drug targets is a critical step in pharmacology. Drug phenotypic and chemical indexes are two important indicators in this field. However, in previous studies, the indexes were always isolated and the candidate proteins were often limited to a small subset of the human genome. Methodology/Principal Findings: Based on the correlations observed in pharmacological and genomic spaces, we develop a computational framework, drugCIPHER, to infer drug-target interactions in a genome-wide scale. Three linear regression models are proposed, which respectively relate drug therapeutic similarity, chemical similarity and their combination to the relevance of the targets on the basis of a protein-protein interaction network. Typically, the model integrating both drug therapeutic similarity and chemical similarity, drugCIPHER-MS, achieved an area under the Receiver Operating Characteristic (ROC) curve of 0.988 in the training set and 0.935 in the test set. Based on drugCIPHER-MS, a genome-wide map of drug biological fingerprints for 726 drugs is constructed, within which unexpected drug-drug relations emerged in 501 cases, implying possible novel applications or side effects. Conclusions/Significance: Our findings demonstrate that the integration of phenotypic and chemical indexes in pharmacological space and protein-protein interactions in genomic space can not only speed the genome-wide identification of drug targets but also find new applications for the existing drugs.	[Li, Shao] Tsinghua Univ, MOE Key Lab Bioinformat, Dept Automat, TNLIST, Beijing 100084, Peoples R China; Tsinghua Univ, Bioinformat Div, Dept Automat, TNLIST, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Li, S (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Dept Automat, TNLIST, Beijing 100084, Peoples R China.	shaoli@mail.tsinghua.edu.cn	Li, Shao/GPX-5473-2022	Li, Shao/0000-0002-8709-9167	National Natural Science Foundation of China [60934004, 30873464, 60721003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (Nos. 60934004, 30873464 and 60721003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANATOMICAL THERAPEUT; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cleves AE, 2006, J MED CHEM, V49, P2921, DOI 10.1021/jm051139t; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Ho SM, 2004, J CELL BIOCHEM, V91, P491, DOI 10.1002/jcb.10759; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khouzam H R, 2000, J Psychosoc Nurs Ment Health Serv, V38, P20; Koutras A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-109; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Lin D., 1998, ICML, V98, P296; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nigsch F, 2008, J CHEM INF MODEL, V48, P2313, DOI 10.1021/ci800079x; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Portnoy JM, 2004, EXPERT OPIN PHARMACO, V5, P125, DOI 10.1517/14656566.5.1.125; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rognan D, 2007, BRIT J PHARMACOL, V152, P38, DOI 10.1038/sj.bjp.0707307; Roth BL, 2000, NEUROSCIENTIST, V6, P252, DOI 10.1177/107385840000600408; Schuffenhauer A, 2003, J CHEM INF COMP SCI, V43, P391, DOI 10.1021/ci025569t; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Theunissen EL, 2006, BRIT J CLIN PHARMACO, V61, P79, DOI 10.1111/j.1365-2125.2005.02524.x; Tom N, 2010, INT J BIOCHEM CELL B, V42, P202, DOI 10.1016/j.biocel.2009.10.008; WILLETT P, 1986, J CHEM INF COMP SCI, V26, P36, DOI 10.1021/ci00049a008; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	40	181	206	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11764	10.1371/journal.pone.0011764	http://dx.doi.org/10.1371/journal.pone.0011764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668676	Green Published, gold, Green Submitted			2022-12-27	WOS:000280297300005
J	Cui, L; Ohuchida, K; Mizumoto, K; Moriyama, T; Onimaru, M; Nakata, K; Nabae, T; Ueki, T; Sato, N; Tominaga, Y; Tanaka, M				Cui, Lin; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Moriyama, Taiki; Onimaru, Manabu; Nakata, Kohei; Nabae, Toshinaga; Ueki, Takashi; Sato, Norihiro; Tominaga, Yohei; Tanaka, Masao			Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(-) Cancer Cells	PLOS ONE			English	Article							PANCREATIC-CANCER; STEM-CELLS; PROGENITOR CELLS; STROMAL CELLS; CLINICAL-IMPLICATION; HEMATOPOIETIC STEM; LYMPHOID-CELLS; EXPRESSION; METASTASIS; INVASION	Although CD133 has been reported to be a promising colon cancer stem cell marker, the biological functions of CD133(+) colon cancer cells remain controversial. In the present study, we investigated the biological differences between CD133(+) and CD133(-) colon cancer cells, with a particular focus on their interactions with cancer-associated fibroblasts, especially CD10(+) fibroblasts. We used 19 primary colon cancer tissues, 30 primary cultures of fibroblasts derived from colon cancer tissues and 6 colon cancer cell lines. We isolated CD133(+) and CD133(-) subpopulations from the colon cancer tissues and cultured cells. In vitro analyses revealed that the two populations showed similar biological behaviors in their proliferation and chemosensitivity. In vivo analyses revealed that CD133(+) cells showed significantly greater tumor growth than CD133(-) cells (P = 0.007). Moreover, in cocultures with primary fibroblasts derived from colon cancer tissues, CD133(+) cells exhibited significantly more invasive behaviors than CD133(-) cells (P<0.001), especially in cocultures with CD10(+) fibroblasts (P<0.0001). Further in vivo analyses revealed that CD10(+) fibroblasts enhanced the tumor growth of CD133(+) cells significantly more than CD10(-) fibroblasts (P<0.05). These data demonstrate that the in vitro invasive properties and in vivo tumor growth of CD133(+) colon cancer cells are enhanced in the presence of specific cancer-associated fibroblasts, CD10(+) fibroblasts, suggesting that the interactions between these specific cell populations have important roles in cancer progression. Therefore, these specific interactions may be promising targets for new colon cancer therapies.	[Cui, Lin; Ohuchida, Kenoki; Mizumoto, Kazuhiro; Moriyama, Taiki; Onimaru, Manabu; Nakata, Kohei; Nabae, Toshinaga; Ueki, Takashi; Tominaga, Yohei; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Ohuchida, Kenoki; Onimaru, Manabu] Kyushu Univ, Grad Sch Med Sci, Dept Adv Med Initiat, Fukuoka 812, Japan; [Sato, Norihiro] Kyushu Univ, Grad Sch Med Sci, Dept Canc Therapy & Res, Fukuoka 812, Japan; [Mizumoto, Kazuhiro] Kyushu Univ Hosp, Ctr Canc, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Cui, L (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan.	kenoki@med.kyushu-u.ac.jp; mizumoto@med.kyushu-u.ac.jp		Ohuchida, Kenoki/0000-0003-4792-1168	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Japanese Society of Gastroenterology; Uehara Memorial Foundation; Nakajima Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Uehara Memorial Foundation(Uehara Memorial Foundation); Nakajima Foundation	Supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Takeda Science Foundation, the Japanese Society of Gastroenterology, the Uehara Memorial Foundation, and the Nakajima Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Chung L W, 1997, Hinyokika Kiyo, V43, P815; Deschauer M, 2006, MOL GENET METAB, V88, P146, DOI 10.1016/j.ymgme.2006.01.007; GREAVES MF, 1983, BLOOD, V61, P628; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjco/hyi076; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; IMAI K, 1992, HUM REPROD, V7, P1326, DOI 10.1093/oxfordjournals.humrep.a137849; Iwaya K, 2002, VIRCHOWS ARCH, V440, P589, DOI 10.1007/s00428-002-0639-4; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kondo Toru, 2007, Cancer Biomarkers, V3, P245; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Martin M, 1996, PATHOL RES PRACT, V192, P712, DOI 10.1016/S0344-0338(96)80093-8; McIntosh GG, 1999, AM J PATHOL, V154, P77, DOI 10.1016/S0002-9440(10)65253-4; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; MOREAU I, 1993, BLOOD, V82, P2396; Nomura S, 2008, BRIT J CANCER, V99, P305, DOI 10.1038/sj.bjc.6604473; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ogawa H, 2002, HUM PATHOL, V33, P806, DOI 10.1053/hupa.2002.125773; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Oshima Y, 2007, GASTROENTEROLOGY, V132, P720, DOI 10.1053/j.gastro.2006.11.027; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Sato N, 2000, CANCER LETT, V155, P153, DOI 10.1016/S0304-3835(00)00421-3; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Sreerama L, 2001, CANCER CHEMOTH PHARM, V47, P255, DOI 10.1007/s002800000208; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Ueda T, 2000, STEM CELLS, V18, P204, DOI 10.1634/stemcells.18-3-204; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	39	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12121	10.1371/journal.pone.0012121	http://dx.doi.org/10.1371/journal.pone.0012121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711432	gold, Green Submitted, Green Published			2022-12-27	WOS:000280859700014
J	Lu, S; Xu, X; Zhao, WX; Wu, WW; Yuan, H; Shen, HB; Zhou, CH; Li, S; Ma, L				Lu, Shuai; Xu, Xing; Zhao, Wenxiu; Wu, Weiwei; Yuan, Hang; Shen, Huaibin; Zhou, Changhua; Li, Song; Ma, Lan			Targeting of Embryonic Stem Cells by Peptide-Conjugated Quantum Dots	PLOS ONE			English	Article							PHAGE DISPLAY; ENDOTHELIAL-CELLS; SELECTION; VECTORS; NANOPARTICLES; CYTOTOXICITY; OUTGROWTH; ANTIGENS; THERAPY; MARROW	Background: Targeting stem cells holds great potential for studying the embryonic stem cell and development of stem cell-based regenerative medicine. Previous studies demonstrated that nanoparticles can serve as a robust platform for gene delivery, non-invasive cell imaging, and manipulation of stem cell differentiation. However specific targeting of embryonic stem cells by peptide-linked nanoparticles has not been reported. Methodology/Principal Findings: Here, we developed a method for screening peptides that specifically recognize rhesus macaque embryonic stem cells by phage display and used the peptides to facilitate quantum dot targeting of embryonic stem cells. Through a phage display screen, we found phages that displayed an APWHLSSQYSRT peptide showed high affinity and specificity to undifferentiated primate embryonic stem cells in an enzyme-linked immunoabsorbent assay. These results were subsequently confirmed by immunofluoresence microscopy. Additionally, this binding could be completed by the chemically synthesized APWHLSSQYSRT peptide, indicating that the binding capability was specific and conferred by the peptide sequence. Through the ligation of the peptide to CdSe-ZnS core-shell nanocrystals, we were able to, for the first time, target embryonic stem cells through peptide-conjugated quantum dots. Conclusions/Significance: These data demonstrate that our established method of screening for embryonic stem cell specific binding peptides by phage display is feasible. Moreover, the peptide-conjugated quantum dots may be applicable for embryonic stem cell study and utilization.	[Lu, Shuai; Wu, Weiwei] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Lu, Shuai; Zhao, Wenxiu; Wu, Weiwei; Yuan, Hang; Ma, Lan] Tsinghua Univ, Div Life Sci, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Xu, Xing] Yunnan Univ, Kunming Yunda Monoclonal Antibody Technol Ctr, Kunming 650091, Peoples R China; [Yuan, Hang] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China; [Shen, Huaibin; Zhou, Changhua; Li, Song] Henan Univ, Key Lab Special Funct Mat, Minist Educ, Kaifeng, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Yunnan University; Jilin University; Henan University	Lu, S (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	malan@sz.tsinghua.edu.cn			Chinese Ministry of Science and Technology [2006AA03Z359]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by the Chinese Ministry of Science and Technology 863 projects 2006AA03Z359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Baskar S, 2009, BLOOD, V114, P4494, DOI 10.1182/blood-2009-05-222786; Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218; Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q; Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665; Gur D, 2009, BIOTECHNOL PROGR, V25, P1780, DOI 10.1002/btpr.285; HENNING TD, 2008, J VIS EXP; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Letchford J, 2006, J IMMUNOL METHODS, V308, P124, DOI 10.1016/j.jim.2005.10.015; LI SC, 2010, STEM CELL REV; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Meng XL, 2007, ENDOCRINOLOGY, V148, P5865, DOI 10.1210/en.2007-0941; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Morita Y, 2006, BIOTECHNOL PROGR, V22, P974, DOI 10.1021/bp060112f; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Paschke M, 2006, APPL MICROBIOL BIOT, V70, P2, DOI 10.1007/s00253-005-0270-9; Petty NK, 2007, TRENDS BIOTECHNOL, V25, P7, DOI 10.1016/j.tibtech.2006.11.003; Pi QM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-36; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1; Veleva AN, 2007, BIOTECHNOL BIOENG, V98, P306, DOI 10.1002/bit.21420; Westerlund-Wikstrom B, 2000, INT J MED MICROBIOL, V290, P223; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Woo DG, 2009, BIOMATERIALS, V30, P5631, DOI 10.1016/j.biomaterials.2009.07.026; YAMADA M, 2008, J VIS EXP; Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182; Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Yukawa H, 2009, CELL TRANSPLANT, V18, P591, DOI 10.1177/096368970901805-615; ZHAO W, 2010, J BIOMOL SCREEN	44	28	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12075	10.1371/journal.pone.0012075	http://dx.doi.org/10.1371/journal.pone.0012075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711469	gold, Green Submitted, Green Published			2022-12-27	WOS:000280811900022
J	van Leeuwen, TM; Petersson, KM; Hagoort, P				van Leeuwen, Tessa M.; Petersson, Karl Magnus; Hagoort, Peter			Synaesthetic Colour in the Brain: Beyond Colour Areas. A Functional Magnetic Resonance Imaging Study of Synaesthetes and Matched Controls	PLOS ONE			English	Article							WORD FORM AREA; SYNESTHETIC COLOR; PARIETAL; HEARING; BINDING; PERCEPTION; ACTIVATION; MECHANISMS; ATTENTION; REAL	Background: In synaesthesia, sensations in a particular modality cause additional experiences in a second, unstimulated modality (e. g., letters elicit colour). Understanding how synaesthesia is mediated in the brain can help to understand normal processes of perceptual awareness and multisensory integration. In several neuroimaging studies, enhanced brain activity for grapheme-colour synaesthesia has been found in ventral-occipital areas that are also involved in real colour processing. Our question was whether the neural correlates of synaesthetically induced colour and real colour experience are truly shared. Methodology/Principal Findings: First, in a free viewing functional magnetic resonance imaging (fMRI) experiment, we located main effects of synaesthesia in left superior parietal lobule and in colour related areas. In the left superior parietal lobe, individual differences between synaesthetes (projector-associator distinction) also influenced brain activity, confirming the importance of the left superior parietal lobe for synaesthesia. Next, we applied a repetition suppression paradigm in fMRI, in which a decrease in the BOLD (blood-oxygenated-level-dependent) response is generally observed for repeated stimuli. We hypothesized that synaesthetically induced colours would lead to a reduction in BOLD response for subsequently presented real colours, if the neural correlates were overlapping. We did find BOLD suppression effects induced by synaesthesia, but not within the colour areas. Conclusions/Significance: Because synaesthetically induced colours were not able to suppress BOLD effects for real colour, we conclude that the neural correlates of synaesthetic colour experience and real colour experience are not fully shared. We propose that synaesthetic colour experiences are mediated by higher-order visual pathways that lie beyond the scope of classical, ventral-occipital visual areas. Feedback from these areas, in which the left parietal cortex is likely to play an important role, may induce V4 activation and the percept of synaesthetic colour.	[van Leeuwen, Tessa M.; Petersson, Karl Magnus; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Petersson, Karl Magnus; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society	van Leeuwen, TM (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	t.vanleeuwen@donders.ru.nl	Petersson, Karl Magnus/E-8188-2012; van Leeuwen, Tessa M./K-2718-2015; Petersson, Karl Magnus/HDO-0143-2022; GNC, GNC/B-5716-2013; Hagoort, Peter/B-7417-2012	Petersson, Karl Magnus/0000-0002-8245-0392; van Leeuwen, Tessa M./0000-0001-7810-6348; Petersson, Karl Magnus/0000-0002-8245-0392; 	Volkswagen-Foundation [I/80 743]	Volkswagen-Foundation(Volkswagen)	This study was supported by a research grant from the Volkswagen-Foundation [grant number I/80 743]. URL: http://www.volkswagen-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargary G, 2008, TRENDS NEUROSCI, V31, P335, DOI 10.1016/j.tins.2008.03.007; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; Beeli G, 2008, CEREB CORTEX, V18, P379, DOI 10.1093/cercor/bhm072; Brett M., 2002, 8 INT C FUNCT MAPP H; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Esterman M, 2006, J COGNITIVE NEUROSCI, V18, P1570, DOI 10.1162/jocn.2006.18.9.1570; Flowers DL, 2004, NEUROIMAGE, V21, P829, DOI 10.1016/j.neuroimage.2003.10.002; Garrett AS, 2000, NEUROIMAGE, V11, P111, DOI 10.1006/nimg.1999.0528; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hochel M, 2008, COGN NEUROPSYCHOL, V25, P93, DOI 10.1080/02643290701822815; Hong SW, 2008, VISION RES, V48, P1018, DOI 10.1016/j.visres.2008.01.024; Horner AJ, 2008, NEUROPSYCHOLOGIA, V46, P1979, DOI 10.1016/j.neuropsychologia.2008.01.018; Hubbard Edward M, 2007, Curr Psychiatry Rep, V9, P193, DOI 10.1007/s11920-007-0018-6; Hubbard EM, 2007, NAT NEUROSCI, V10, P671, DOI 10.1038/nn0607-671; Hubbard EM, 2006, CORTEX, V42, P184, DOI 10.1016/S0010-9452(08)70343-5; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kadosh RC, 2007, J COGNITIVE NEUROSCI, V19, P2050, DOI 10.1162/jocn.2007.19.12.2050; Kim CY, 2006, CORTEX, V42, P195, DOI 10.1016/S0010-9452(08)70344-7; Kim CY, 2005, PERCEPTION, V34, P1501, DOI 10.1068/p5422; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; MAURER D, 1996, SYNAESTHESIA CLASSIC, P224; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Nikolic D, 2007, PSYCHOL SCI, V18, P481, DOI 10.1111/j.1467-9280.2007.01925.x; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Pernet C, 2005, NEUROIMAGE, V28, P738, DOI 10.1016/j.neuroimage.2005.06.046; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2006, NEUROPSYCHOLOGIA, V44, P2918, DOI 10.1016/j.neuropsychologia.2006.06.024; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Sagiv N, 2006, CORTEX, V42, P232, DOI 10.1016/S0010-9452(08)70348-4; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Sperling JM, 2006, CORTEX, V42, P295, DOI 10.1016/S0010-9452(08)70355-1; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Ward J, 2007, CONSCIOUS COGN, V16, P913, DOI 10.1016/j.concog.2006.09.012; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Weiss PH, 2005, NEUROIMAGE, V28, P859, DOI 10.1016/j.neuroimage.2005.06.052; Wollen KA, 1983, J MENT IMAG, V7, P83	57	46	46	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12074	10.1371/journal.pone.0012074	http://dx.doi.org/10.1371/journal.pone.0012074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711467	gold, Green Published			2022-12-27	WOS:000280811900021
J	Gienapp, P; Merila, J				Gienapp, Phillip; Merila, Juha			High Fidelity - No Evidence for Extra-Pair Paternity in Siberian Jays (Perisoreus infaustus)	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; DELAYED DISPERSAL; CORVUS-MONEDULA; FAIRY-WRENS; BIRDS; BEHAVIOR; FERTILIZATIONS; HYPOTHESIS; MONOGAMY; CARE	Extra-pair paternity (EPP) in birds is related to a number of ecological and social factors. For example, it has been found to be positively related with breeding density, negatively with the amount of paternal care and especially high rates have been observed in group-living species. Siberian jays (Perisoreous infaustus) breed at low densities and have extended parental care, which leads to the expectation of low rates of EPP. On the other hand, Siberian jays live in groups which can include also unrelated individuals, and provide opportunities for extra-pair matings. To assess the potential occurrence of EPP in Siberian jays, we analysed a large data pool (n = 1029 offspring) covering ca. 30 years of samples from a Finnish Siberian jay population. Paternities were assigned based on up to 21 polymorphic microsatellite markers with the additional information from field observations. We were unable to find any evidence for occurrence of EPP in this species. Our findings are in line with earlier studies and confirm the generally low rates of EPP in related Corvid species. These results suggest that ecological factors may be more important than social factors (group living) in determining costs and benefits of extra-pair paternity.	[Gienapp, Phillip; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Gienapp, P (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	phillip.gienapp@helsinki.fi	Merila, Juha/A-4061-2008; Gienapp, Phillip/A-2261-2014	Merila, Juha/0000-0001-9614-0072; Gienapp, Phillip/0000-0002-9368-8769	Academy of Finland; Kone Foundation; Maj and Tor Nessling Foundation	Academy of Finland(Academy of Finland); Kone Foundation; Maj and Tor Nessling Foundation	This work was funded by research grants from the Academy of Finland to PG and JM, from the Kone Foundation to PG and the Maj and Tor Nessling Foundation to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 1996, J WILDLIFE MANAGE, V60, P265, DOI 10.2307/3802224; Bennet P. M., 2002, EVOLUTIONARY ECOLOGY; BERGHOLM T, 2007, KUUKKELIN PERISOREUS; Blomgren A., 1964, LAVSKRIKA; Double M, 2000, P ROY SOC B-BIOL SCI, V267, P465, DOI 10.1098/rspb.2000.1023; EKMAN J, 1994, BEHAV ECOL, V5, P245, DOI 10.1093/beheco/5.3.245; Ekman J, 1999, P ROY SOC B-BIOL SCI, V266, P911, DOI 10.1098/rspb.1999.0723; Ekman J, 2002, ANIM BEHAV, V64, P453, DOI 10.1006/anbe.2002.3075; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GIENAPP P, 2010, BEHAV ECOLO IN PRESS; GOWATY PA, 1991, ANIM BEHAV, V41, P661, DOI 10.1016/S0003-3472(05)80904-2; Griesser M, 2005, ANIM BEHAV, V69, P345, DOI 10.1016/j.anbehav.2004.05.013; Griesser M, 2003, BEHAV ECOL, V14, P246, DOI 10.1093/beheco/14.2.246; Griesser M, 2006, P R SOC B, V273, P1881, DOI 10.1098/rspb.2006.3527; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hall ML, 2000, BEHAV ECOL SOCIOBIOL, V47, P180, DOI 10.1007/s002650050009; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Henderson IG, 2000, J AVIAN BIOL, V31, P177, DOI 10.1034/j.1600-048X.2000.310209.x; Hoi-Leitner M, 1999, P ROY SOC B-BIOL SCI, V266, P1021, DOI 10.1098/rspb.1999.0738; Jaari S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Li SH, 2000, ANIM BEHAV, V60, P867, DOI 10.1006/anbe.2000.1554; Liebers D, 1998, ARDEA, V86, P221; Lillandt B.-G., 1993, LAVSKRIKANS PERISORE; Lillandt BG, 2003, CONDOR, V105, P505, DOI 10.1650/7117; Lillandt BG, 2002, HEREDITAS, V137, P157, DOI 10.1034/j.1601-5223.2002.01675.x; Lillandt Bo-Goran, 2001, Avian Science, V1, P3; Moller AP, 2000, BEHAV ECOL, V11, P161, DOI 10.1093/beheco/11.2.161; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Quinn JS, 1999, BEHAV ECOL SOCIOBIOL, V45, P1, DOI 10.1007/s002650050534; Sandvik H, 2001, J FIELD ORNITHOL, V72, P30, DOI 10.1648/0273-8570-72.1.30; SLEPKOVYCH B, 1997, BEHAV ECOL SOCIOBIOL, V40, P287; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	37	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12006	10.1371/journal.pone.0012006	http://dx.doi.org/10.1371/journal.pone.0012006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711255	Green Published, gold, Green Submitted			2022-12-27	WOS:000280776800007
J	Demongeot, J; Goles, E; Morvan, M; Noual, M; Sene, S				Demongeot, Jacques; Goles, Eric; Morvan, Michel; Noual, Mathilde; Sene, Sylvain			Attraction Basins as Gauges of Robustness against Boundary Conditions in Biological Complex Systems	PLOS ONE			English	Article							REGULATORY NETWORKS; FLOWER DEVELOPMENT; PHASE-TRANSITIONS; ARABIDOPSIS; MODEL; DYNAMICS; GROWTH; ALGORITHMS; EPIGENESIS; EXPRESSION	One fundamental concept in the context of biological systems on which researches have flourished in the past decade is that of the apparent robustness of these systems, i.e., their ability to resist to perturbations or constraints induced by external or boundary elements such as electromagnetic fields acting on neural networks, micro-RNAs acting on genetic networks and even hormone flows acting both on neural and genetic networks. Recent studies have shown the importance of addressing the question of the environmental robustness of biological networks such as neural and genetic networks. In some cases, external regulatory elements can be given a relevant formal representation by assimilating them to or modeling them by boundary conditions. This article presents a generic mathematical approach to understand the influence of boundary elements on the dynamics of regulation networks, considering their attraction basins as gauges of their robustness. The application of this method on a real genetic regulation network will point out a mathematical explanation of a biological phenomenon which has only been observed experimentally until now, namely the necessity of the presence of gibberellin for the flower of the plant Arabidopsis thaliana to develop normally.	[Demongeot, Jacques] Univ Grenoble 1, TIMC IMAG, CNRS, UMR 5525, La Tronche, France; [Goles, Eric] Univ Adolfo Ibanez, Santiago, Chile; [Goles, Eric] Complex Syst Inst Valparaiso, ISCV, Valparaiso, Chile; [Morvan, Michel] Veolia Environm Res & Innovat, Rueil Malmaison, France; [Morvan, Michel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Noual, Mathilde] Univ Lyon, ENS Lyon, CNRS, UMR 5668, Lyon, France; [Sene, Sylvain] Univ Evry, IBISC, CNRS, FRE 3190, Evry, France; [Noual, Mathilde; Sene, Sylvain] Rhone Alpes Complex Syst Inst, IXXI, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Universidad Adolfo Ibanez; Veolia; The Santa Fe Institute; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Demongeot, J (corresponding author), Univ Grenoble 1, TIMC IMAG, CNRS, UMR 5525, La Tronche, France.	Sylvain.Sene@ibisc.univ-evry.fr	Demongeot, Jacques/GQI-1558-2022; Demongeot, Jacques/AAZ-2539-2020	Demongeot, Jacques/0000-0002-8335-9240	Fondecyt [1100003]; Anillo-ACT88; CMM-BASAL	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo-ACT88(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); CMM-BASAL(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL)	This work has been supported in part by Fondecyt 1100003, Anillo-ACT88 and CMM-BASAL, and the authors are indebted to CNRS for granting E. Goles as foreign senior visitor at TIMC-IMAG Grenoble and at IXXI Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ahmad J, 2009, BIOSYSTEMS, V98, P149, DOI 10.1016/j.biosystems.2009.05.002; Amor HB, 2008, LECT NOTES ARTIF INT, V5317, P973, DOI 10.1007/978-3-540-88636-5_92; Aracena J, 2004, THEOR COMPUT SCI, V322, P237, DOI 10.1016/j.tcs.2004.03.010; Aracena J, 2003, IEEE T SYST MAN CY B, V33, P825, DOI 10.1109/TSMCB.2003.816928; Aracena J, 2008, B MATH BIOL, V70, P1398, DOI 10.1007/s11538-008-9304-7; Barnat J, 2008, ELECTRON NOTES THEOR, V194, P35, DOI 10.1016/j.entcs.2007.12.001; Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRYANT RE, 1986, IEEE T COMPUT, V35, P677, DOI 10.1109/TC.1986.1676819; BRYANT RE, 1992, ACM COMPUT SURV, V24, P293, DOI DOI 10.1145/136035.136043; Chaouiya C, 2008, J DISCRET ALGORITHMS, V6, P165, DOI 10.1016/j.jda.2007.06.003; COSNARD M, 1985, LECT NOTES MATH, V1163, P23; COSNARD M, 1985, CR ACAD SCI I-MATH, V300, P551; DEMONGEOT J, 2009, WAINA, P908; DEMONGEOT J, 2010, WAINA, P782; Demongeot J, 2008, NEURAL NETWORKS, V21, P971, DOI 10.1016/j.neunet.2008.04.003; Demongeot J, 2008, NEURAL NETWORKS, V21, P962, DOI 10.1016/j.neunet.2008.04.005; Demongeot J, 2008, ACTA BIOTHEOR, V56, P27, DOI 10.1007/s10441-008-9029-x; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Elena A, 2008, CISIS 2008: THE SECOND INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS, PROCEEDINGS, P682, DOI 10.1109/CISIS.2008.31; Elena A., 2009, THESIS U J FOURIER G; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Fanchon E, 2005, LECT NOTES COMPUT SC, V3082, P104; Faraut T, 2000, CYTOGENET CELL GENET, V88, P15, DOI 10.1159/000015476; Fates N, 2004, LECT NOTES COMPUT SC, V3305, P111; Fates NA, 2005, COMPLEX SYST, V16, P1; FOGELMAN F, 1983, DISCRETE APPL MATH, V6, P95, DOI 10.1016/0166-218X(83)90105-1; Forest L, 2004, ACTA BIOTHEOR, V52, P415, DOI 10.1023/B:ACBI.0000046607.17817.20; Forest L, 2006, B MATH BIOL, V68, P753, DOI 10.1007/s11538-005-9004-5; Forest L, 2006, J THEOR BIOL, V241, P241, DOI 10.1016/j.jtbi.2005.11.029; Goles E, 2008, THEOR COMPUT SCI, V396, P247, DOI 10.1016/j.tcs.2007.09.008; GOLES E, 1981, DISCRETE APPL MATH, V3, P93, DOI 10.1016/0166-218X(81)90034-2; GOLES E, 1982, SIAM J ALGEBRA DISCR, V3, P529, DOI 10.1137/0603054; Goles E., 1990, NEURAL AUTOMATA NETW, DOI 10.1007/978-94-009-0529-0; Goto N, 1999, CAN J BOT, V77, P944, DOI 10.1139/cjb-77-7-944; Guespin-Michel JF, 2004, ACTA BIOTHEOR, V52, P379, DOI 10.1023/B:ACBI.0000046604.18092.a7; Harary F., 1969, GRAPH THEORY; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Junier I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000678; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUFFMAN SA, 1970, THEORETICAL BIOL, V3, P18; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mendoza L, 1998, J THEOR BIOL, V193, P307, DOI 10.1006/jtbi.1998.0701; Richard A, 2007, DISCRETE APPL MATH, V155, P2403, DOI 10.1016/j.dam.2007.04.019; SENE S, 2008, THESIS U J FOURIER G; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Tonnelier A, 1999, NEURAL NETWORKS, V12, P1213, DOI 10.1016/S0893-6080(99)00068-4; Toulouse T, 2005, COMPLEXITY, V11, P45, DOI 10.1002/cplx.20099; Troncale S, 2009, PATTERN RECOGN, V42, P562, DOI 10.1016/j.patcog.2008.09.019; Wilhelm Emmanuelle, 2008, BMC Res Notes, V1, P94, DOI 10.1186/1756-0500-1-94; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101	61	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11793	10.1371/journal.pone.0011793	http://dx.doi.org/10.1371/journal.pone.0011793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700525	Green Published, gold, Green Submitted			2022-12-27	WOS:000280605400002
J	Kang, KS; Wen, YJ; Yamabe, N; Fukui, M; Bishop, SC; Zhu, BT				Kang, Ki Sung; Wen, Yujing; Yamabe, Noriko; Fukui, Masayuki; Bishop, Stephanie C.; Zhu, Bao Ting			Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; GREEN TEA POLYPHENOL; PARKINSONS-DISEASE; EPIGALLOCATECHIN GALLATE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; L-DOPA; INHIBITION; 3-O-METHYLDOPA	Background: A combination of levodopa (L-DOPA) and carbidopa is the most commonly-used treatment for symptom management in Parkinson's disease. Studies have shown that concomitant use of a COMT inhibitor is highly beneficial in controlling the wearing-off phenomenon by improving L-DOPA bioavailability as well as brain entry. The present study sought to determine whether (-)-epigallocatechin-3-gallate (EGCG), a common tea polyphenol, can serve as a naturally-occurring COMT inhibitor that also possesses neuroprotective actions. Methodology/Principal Findings: Using both in vitro and in vivo models, we investigated the modulating effects of EGCG on L-DOPA methylation as well as on chemically induced oxidative neuronal damage and degeneration. EGCG strongly inhibited human liver COMT-mediated O-methylation of L-DOPA in a concentration-dependent manner in vitro, with an average IC50 of 0.36 mu M. Oral administration of EGCG moderately lowered the accumulation of 3-O-methyldopa in the plasma and striatum of rats treated with L-DOPA + carbidopa. In addition, EGCG also reduced glutamate-induced oxidative cytotoxicity in cultured HT22 mouse hippocampal neuronal cells through inactivation of the nuclear factor kappa B-signaling pathway. Under in vivo conditions, administration of EGCG exerted a strong protective effect against kainic acid-induced oxidative neuronal death in the hippocampus of rats. Conclusions/Significance: These observations suggest that oral administration of EGCG may have significant beneficial effects in Parkinson's patients treated with L-DOPA and carbidopa by exerting a modest inhibition of L-DOPA methylation plus a strong neuroprotection against oxidative damage and degeneration.	[Kang, Ki Sung; Wen, Yujing; Yamabe, Noriko; Fukui, Masayuki; Bishop, Stephanie C.; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kang, KS (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	Bishop, Stephanie/AAU-7712-2021		National Institutes of Health (NIH) [ES015242, P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in part, by National Institutes of Health (NIH) grants (ES015242 and P20RR021940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACQUAS E, 1992, J NEUROCHEM, V59, P326, DOI 10.1111/j.1471-4159.1992.tb08907.x; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Bai HW, 2007, CHEM RES TOXICOL, V20, P1409, DOI 10.1021/tx700174w; BARTHOLINI G, 1975, PHARMACOL THER PT B, V1, P407, DOI 10.1016/0306-039X(75)90047-1; Benabou Reina, 2003, Expert Opin Drug Saf, V2, P263, DOI 10.1517/14740338.2.3.263; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; DAPRADA M, 1984, EXPERIENTIA, V40, P1165; Dingemanse J, 2000, NEUROLOGY, V55, pS24; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FEUERSTEIN C, 1977, ACTA NEUROL SCAND, V56, P508; Floreani M, 1997, FASEB J, V11, P1309, DOI 10.1096/fasebj.11.14.9409550; Fu Y, 2006, NEUROTOX RES, V10, P23, DOI 10.1007/BF03033331; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69; Heikkinen H, 2001, CLIN NEUROPHARMACOL, V24, P150, DOI 10.1097/00002826-200105000-00006; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003; KAAKKOLA S, 1993, J NEUROCHEM, V60, P137, DOI 10.1111/j.1471-4159.1993.tb05831.x; Kandinov B, 2009, PARKINSONISM RELAT D, V15, P41, DOI 10.1016/j.parkreldis.2008.02.011; Karimi M, 2006, J CHROMATOGR B, V836, P120, DOI 10.1016/j.jchromb.2006.03.027; KERANEN T, 1993, CLIN NEUROPHARMACOL, V16, P145, DOI 10.1097/00002826-199304000-00007; Koller WC, 1999, NEUROLOGY, V53, P1012, DOI 10.1212/WNL.53.5.1012; Lang AE, 2002, MOV DISORD S4, V17, pS45; Leaver KR, 2009, BRAIN RES BULL, V80, P397, DOI 10.1016/j.brainresbull.2009.08.013; Lee ESY, 2008, NEUROCHEM RES, V33, P401, DOI 10.1007/s11064-007-9442-6; Lee JW, 2009, J NUTR, V139, P1987, DOI 10.3945/jn.109.109785; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Mabley JG, 2001, BRIT J PHARMACOL, V133, P909, DOI 10.1038/sj.bjp.0704156; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Matsuoka Y, 1999, EXP BRAIN RES, V124, P215, DOI 10.1007/s002210050616; Morgan John C, 2006, Expert Opin Emerg Drugs, V11, P403, DOI 10.1517/14728214.11.3.403; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nagai M, 2004, DRUG METAB DISPOS, V32, P497, DOI 10.1124/dmd.32.5.497; Nalder J.V., 1980, J COMP NEUROL, V192, P333; Napolitano A, 2003, PARKINSONISM RELAT D, V9, P145, DOI 10.1016/S1353-8020(02)00016-0; NISSINEN E, 1992, N-S ARCH PHARMACOL, V346, P262; Padovani A, 2006, NEUROL SCI, V27, pS40, DOI 10.1007/s10072-006-0546-6; RECHES A, 1981, ANN NEUROL, V10, P94; Schapira AHV, 2000, NEUROLOGY, V55, pS65; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sedek G, 1997, CLIN NEUROPHARMACOL, V20, P531, DOI 10.1097/00002826-199712000-00005; SHARPLES.NS, 1972, CLIN CHIM ACTA, V37, P359, DOI 10.1016/0009-8981(72)90456-1; Shin EJ, 2009, J NEUROSCI RES, V87, P710, DOI 10.1002/jnr.21880; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Tan SL, 1998, J NEUROCHEM, V71, P95; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; TOHGI H, 1991, NEUROSCI LETT, V132, P19, DOI 10.1016/0304-3940(91)90422-P; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; WAGNER J, 1982, J NEUROCHEM, V38, P1241, DOI 10.1111/j.1471-4159.1982.tb07897.x; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023; Zhu BT, 2008, XENOBIOTICA, V38, P130, DOI [10.1080/00498250701744641, 10.1080/00498250701744641 ]; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu BT, 1998, J STEROID BIOCHEM, V64, P207, DOI 10.1016/S0960-0760(97)00163-5; Zhu BT, 2004, INT J MOL MED, V13, P343; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	65	57	57	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11951	10.1371/journal.pone.0011951	http://dx.doi.org/10.1371/journal.pone.0011951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700524	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400006
J	Dees, ND; Bahar, S				Dees, Nathan D.; Bahar, Sonya			Mutation Size Optimizes Speciation in an Evolutionary Model	PLOS ONE			English	Article							RATES; EVOLVABILITY; POPULATIONS; ADJUSTMENT; ADAPTATION; SELECTION; COSTS	The role of mutation rate in optimizing key features of evolutionary dynamics has recently been investigated in various computational models. Here, we address the related question of how maximum mutation size affects the formation of species in a simple computational evolutionary model. We find that the number of species is maximized for intermediate values of a mutation size parameter mu; the result is observed for evolving organisms on a randomly changing landscape as well as in a version of the model where negative feedback exists between the local population size and the fitness provided by the landscape. The same result is observed for various distributions of mutation values within the limits set by mu. When organisms with various values of mu compete against each other, those with intermediate m values are found to survive. The surviving values of mu from these competition simulations, however, do not necessarily coincide with the values that maximize the number of species. These results suggest that various complex factors are involved in determining optimal mutation parameters for any population, and may also suggest approaches for building a computational bridge between the (micro) dynamics of mutations at the level of individual organisms and (macro) evolutionary dynamics at the species level.	[Dees, Nathan D.] Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; Univ Missouri, Ctr Neurodynam, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis; University of Missouri System; University of Missouri Saint Louis	Dees, ND (corresponding author), Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA.	bahars@umsl.edu						Bak P., 1996, NATURE WORKS SCI SEL; Bedau MA, 2003, BIOSYSTEMS, V69, P143, DOI 10.1016/S0303-2647(02)00137-5; Bell G, 2005, HEREDITY, V94, P1, DOI 10.1038/sj.hdy.6800608; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burger R, 2006, EVOLUTION, V60, P2185; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; de Aguiar MAM, 2009, NATURE, V460, P384, DOI 10.1038/nature08168; De Cara MAR, 2008, AM NAT, V171, P580, DOI 10.1086/587062; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; DRAKE JW, 1969, NATURE, V221, P1128, DOI 10.1038/2211128a0; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Fisher RA, 1930, GENETICAL THEORY NAT; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gould S. J., 1989, WONDERFUL LIFE BURGE; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Kauffman S.A., 1993, ORIGINS ORDER; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Kondrashov AS, 1998, P ROY SOC B-BIOL SCI, V265, P2273, DOI 10.1098/rspb.1998.0570; Kopp M, 2008, J EVOLUTION BIOL, V21, P1005, DOI 10.1111/j.1420-9101.2008.01547.x; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; NOTHEL H, 1987, P NATL ACAD SCI USA, V84, P1045, DOI 10.1073/pnas.84.4.1045; Otto SP, 2008, GENETICS, V179, P2091, DOI 10.1534/genetics.107.084418; Pennings PS, 2008, AM NAT, V171, pE44, DOI 10.1086/523952; Pennisi E, 2008, SCIENCE, V321, P196, DOI 10.1126/science.321.5886.196; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Pigliucci M, 2007, EVOLUTION, V61, P2743, DOI 10.1111/j.1558-5646.2007.00246.x; Schaaper RM, 1998, GENETICS, V148, P1579; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Sturtevant AH, 1937, Q REV BIOL, V12, P464, DOI 10.1086/394543; Szathmary E, 1995, MAJOR TRANSITIONS EV	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11952	10.1371/journal.pone.0011952	http://dx.doi.org/10.1371/journal.pone.0011952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689827	Green Published, gold			2022-12-27	WOS:000280520500010
J	Read, SW; DeGrezia, M; Ciccone, EJ; DerSimonian, R; Higgins, J; Adelsberger, JW; Starling, JM; Rehm, C; Sereti, I				Read, Sarah W.; DeGrezia, Mary; Ciccone, Emily J.; DerSimonian, Rebecca; Higgins, Jeanette; Adelsberger, Joseph W.; Starling, Judith M.; Rehm, Catherine; Sereti, Irini			The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LYMPHATIC TISSUE FIBROSIS; HIV-1 INFECTION; IMMUNE ACTIVATION; MYCOPHENOLATE-MOFETIL; LYMPHOCYTE-ACTIVATION; DISEASE; CD4(+); APOPTOSIS; A77-1726	Background: The pathogenesis of immunodeficiency due to human immunodeficiency virus (HIV)-1 is incompletely understood, but immune activation is believed to play a central role. Immunomodulatory agents that decrease immune activation may be useful in the treatment of HIV-1 infection. Methodology: A randomized, double blind, placebo-controlled pilot study of leflunomide for 28 days was performed in participants with HIV-1 infection who were not receiving antiretroviral therapy. Participants randomized to leflunomide were subsequently treated with cholestyramine until leflunomide levels were below detection limit. Findings: Treatment with leflunomide was well tolerated with mostly low-grade adverse events. Leflunomide administration reduced cycling of CD4 T cells (by ex vivo bromodeoxyuridine uptake and Ki67 expression) and decreased expression of activation markers (HLA-DR/CD38 co-expression) on CD8 T cells in peripheral blood. In addition, decreased expression of HIV-1 co-receptors was observed in both CD4 and CD8 T cells in the leflunomide group. There were no significant changes in naive and memory T cell subsets, apoptosis of T cells or markers of microbial translocation. Conclusions: Leflunomide was effective in reducing immune activation in the setting of chronic HIV-1 infection suggesting that targeting immune activation with immunomodulatory agents may be a feasible strategy.	[Read, Sarah W.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [DerSimonian, Rebecca] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Higgins, Jeanette; Adelsberger, Joseph W.] NCI, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA; [Starling, Judith M.] NIH, Dept Pharm, Ctr Clin, Bethesda, MD 20892 USA; [DeGrezia, Mary; Ciccone, Emily J.; Rehm, Catherine; Sereti, Irini] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Read, SW (corresponding author), NIAID, Div Aids, NIH, Bethesda, MD 20892 USA.	isereti@niaid.nih.gov		Sereti, Irini/0000-0002-0076-0224; Ciccone, Emily/0000-0003-2445-8473	National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001121] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract N01-CO-12400. This research was also supported in part by the Intramural Program of NIH, National Institute of Allergy and Infectious Diseases. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; BIRON F, 1995, J ACQ IMMUN DEF SYND, V10, P36; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chan V, 2005, BRIT J CLIN PHARMACO, V60, P257, DOI 10.1111/j.1365-2125.2005.02415.x; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; Coull JJ, 2001, J ACQ IMMUN DEF SYND, V26, P423, DOI 10.1097/00126334-200104150-00004; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; Fox RI, 1998, J RHEUMATOL, V25, P20; Gougeon ML, 1996, J IMMUNOL, V156, P3509; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Hossain MM, 2001, J ACQ IMMUN DEF SYND, V28, P199, DOI 10.1097/00126334-200110010-00016; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; John GT, 2005, TRANSPL P, V37, P4303, DOI 10.1016/j.transproceed.2005.10.116; Josephson MA, 2006, TRANSPLANTATION, V81, P704, DOI 10.1097/01.tp.0000181149.76113.50; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lederman MM, 2006, J INFECT DIS, V194, P1677, DOI 10.1086/509261; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Margolis DM, 2002, JAIDS-J ACQ IMM DEF, V31, P45, DOI 10.1097/00126334-200209010-00006; Paiardini M, 2009, ANNU REV MED, V60, P485, DOI 10.1146/annurev.med.60.041807.123753; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Sailaja G, 2007, VIROLOGY, V362, P331, DOI 10.1016/j.virol.2006.12.014; Schacker TW, 2006, CLIN VACCINE IMMUNOL, V13, P556, DOI 10.1128/CVI.13.5.556-560.2006; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schlapfer E, 2003, AIDS, V17, P1613, DOI [10.1097/00002030-200307250-00005, 10.1097/01.aids.0000072664.21517.ad]; Sereti I, 2001, AIDS, V15, P1765, DOI 10.1097/00002030-200109280-00004; Shattock RJ, 1996, J INFECT DIS, V174, P54, DOI 10.1093/infdis/174.1.54; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Simonelli C, 1996, J ACQ IMMUN DEF SYND, V13, P462, DOI 10.1097/00042560-199612150-00011; van Roon EN, 2005, ANN RHEUM DIS, V64, P569, DOI 10.1136/ard.2004.025205; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Yun ZB, 2003, J VIROL METHODS, V110, P73, DOI 10.1016/S0166-0934(03)00103-4	36	33	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11937	10.1371/journal.pone.0011937	http://dx.doi.org/10.1371/journal.pone.0011937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689824	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520500005
J	Fakhry, C; Sugar, E; D'Souza, G; Gillison, M				Fakhry, Carole; Sugar, Elizabeth; D'Souza, Gypsyamber; Gillison, Maura			Two-Week versus Six-Month Sampling Interval in a Short-Term Natural History Study of Oral HPV Infection in an HIV-Positive Cohort	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; RISK-FACTOR; HEAD; GENOTYPES; LESIONS	Background: Oral HPV infections detected six-months apart were compared to those detected bi-weekly, in an HIV-positive cohort, during the intervening months to elucidate systematic biases introduced into natural history studies by sampling interval. Methods: Fourteen consecutive oral rinse samples were collected every two weeks for six months from an HIV-positive cohort (n = 112) and evaluated for the presence of 37 HPV types. The cumulative probability of type-specific HPV detection at visits 1 through 14 was determined as a function of infection categorized at visits 1 and 14 as persistent, newly detected, cleared or absent. Transition models were used to evaluate the effect of HPV viral load (measured by RT-PCR for HPV 16, 18, 31, 33, 35) on infection persistence. Results: The average point prevalence of oral HPV infection was similar at two-week and six-month sampling intervals (45% vs. 47%, p = 0.52), but cumulative prevalence was higher with the former (82% vs. 53%, p<0.001) as was the cumulative prevalence of type-specific infections (9.3% vs 3.8%, p<0.0001). Type-specific infections persistent under a six-month sampling interval had a high probability (0.93, 95% CI 0.83-0.98) of detection at 50% or more of the intervening visits and infections that were absent had a high probability (0.94, 95% CI 0.93-0.95) of no interval detection. The odds of detection at any visit significantly increased for each unit increase in HPV viral load at the previous visit. Conclusions: Six-month sampling is appropriate to model factors associated with type-specific oral HPV infection persistence but may misclassify HPV-exposed individuals as unexposed.	[Fakhry, Carole] Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Sugar, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [D'Souza, Gypsyamber] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gillison, Maura] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Fakhry, C (corresponding author), Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA.	Maura.gillison@osumc.edu			National Institute of Dental and Craniofacial Research (NIDCR) [DE016631]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Institute of Dental and Craniofacial Research (NIDCR grant number DE016631 to Maura L. Gillison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN D, 2005, LONGITUDINAL STUDY G, P182; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gravitt PE, 2007, INT J CANCER, V121, P2787, DOI 10.1002/ijc.23012; Gravitt PE, 2003, CANCER EPIDEM BIOMAR, V12, P477; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Yuan CC, 2001, J VIROL METHODS, V91, P109	15	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11918	10.1371/journal.pone.0011918	http://dx.doi.org/10.1371/journal.pone.0011918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689835	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300028
J	Jung, J; Kang, H; Cho, YS; Oh, JH; Ryu, MH; Chung, HW; Seo, JS; Lee, JE; Oh, B; Bhak, J; Kim, HL				Jung, Jongsun; Kang, Hoyoung; Cho, Yoon Shin; Oh, Ji Hee; Ryu, Min Hyung; Chung, Hye Won; Seo, Jeong-Sun; Lee, Jong-Eun; Oh, Bermseok; Bhak, Jong; Kim, Hyung-Lae			Gene Flow between the Korean Peninsula and Its Neighboring Countries	PLOS ONE			English	Article							POPULATION-STRUCTURE; INDIVIDUALS	SNP markers provide the primary data for population structure analysis. In this study, we employed whole-genome autosomal SNPs as a marker set (54,836 SNP markers) and tested their possible effects on genetic ancestry using 320 subjects covering 24 regional groups including Northern (= 16) and Southern (= 3) Asians, Amerindians (= 1), and four HapMap populations (YRI, CEU, JPT, and CHB). Additionally, we evaluated the effectiveness and robustness of 50K autosomal SNPs with various clustering methods, along with their dependencies on recombination hotspots (RH), linkage disequilibrium (LD), missing calls and regional specific markers. The RH- and LD-free multi-dimensional scaling (MDS) method showed a broad picture of human migration from Africa to North-East Asia on our genome map, supporting results from previous haploid DNA studies. Of the Asian groups, the East Asian group showed greater differentiation than the Northern and Southern Asian groups with respect to Fst statistics. By extension, the analysis of monomorphic markers implied that nine out of ten historical regions in South Korea, and Tokyo in Japan, showed signs of genetic drift caused by the later settlement of East Asia (South Korea, Japan and China), while Gyeongju in South East Korea showed signs of the earliest settlement in East Asia. In the genome map, the gene flow to the Korean Peninsula from its neighboring countries indicated that some genetic signals from Northern populations such as the Siberians and Mongolians still remain in the South East and West regions, while few signals remain from the early Southern lineages.	[Jung, Jongsun] Syntekabio Inc, Seoul, South Korea; [Jung, Jongsun; Lee, Jong-Eun] DNA Link Inc, Seoul, South Korea; [Kang, Hoyoung; Bhak, Jong] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea; [Kang, Hoyoung] Univ Sci & Technol, Taejon, South Korea; [Jung, Jongsun; Cho, Yoon Shin; Oh, Ji Hee; Ryu, Min Hyung; Kim, Hyung-Lae] Korea Natl Inst Hlth, Ctr Genome Sci, Div Struct & Funct Genom, Seoul, South Korea; [Chung, Hye Won] Ewha Womans Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Oh, Bermseok] Kyung Hee Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea	DNA Link, Inc.; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Ewha Womans University; Seoul National University (SNU); Kyung Hee University	Jung, J (corresponding author), Syntekabio Inc, Seoul, South Korea.	hyung@ewha.ac.kr	Seo, Jeong-Sun/J-2763-2012		Syntekabio Inc.; DNA link Inc.	Syntekabio Inc.; DNA link Inc.	Syntekabio Inc. and DNA link Inc. were funders due to employment of Jongsun Jung of this study. The funders therefore played a role in study design, analysis, and preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; EXCOFFIER L, 1992, GENETICS, V131, P479; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8; Lell JT, 2002, AM J HUM GENET, V70, P1380, DOI 10.1086/340389; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Press W., 1992, NUMERICAL RECIPES FO; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROSS MT, 2005, NATURE, V325, P37; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Watanabe RM, 1999, HUM HERED, V49, P159, DOI 10.1159/000022865; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; 2006, AFFYMETRIX TECHNICAL	25	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11855	10.1371/journal.pone.0011855	http://dx.doi.org/10.1371/journal.pone.0011855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686617	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200020
J	Angel, M; Yanik, MF				Angel, Matthew; Yanik, Mehmet Fatih			Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PLURIPOTENT STEM-CELLS; RIG-I HELICASE; 5'-TRIPHOSPHATE RNA; MESSENGER-RNA; RECOGNITION; LET-7; HMGA2; GENERATION; EXPRESSION	Background: Generating autologous pluripotent stem cells for therapeutic applications will require the development of efficient DNA-free reprogramming techniques. Transfecting cells with in vitro-transcribed, protein-encoding RNA is a straightforward method of directly expressing high levels of reprogramming proteins without genetic modification. However, long-RNA transfection triggers a potent innate immune response characterized by growth inhibition and the production of inflammatory cytokines. As a result, repeated transfection with protein-encoding RNA causes cell death. Methodology/Principal Findings: RNA viruses have evolved methods of disrupting innate immune signaling by destroying or inhibiting specific proteins to enable persistent infection. Starting from a list of known viral targets, we performed a combinatorial screen to identify siRNA cocktails that could desensitize cells to exogenous RNA. We show that combined knockdown of interferon-beta (Ifnb1), Eif2ak2, and Stat2 rescues cells from the innate immune response triggered by frequent long-RNA transfection. Using this technique, we were able to transfect primary human fibroblasts every 24 hours with RNA encoding the reprogramming proteins Oct4, Sox2, Klf4, and Utf1. We provide evidence that the encoded protein is active, and we show that expression can be maintained for many days, through multiple rounds of cell division. Conclusions/Significance: Our results demonstrate that suppressing innate immunity enables frequent transfection with protein-encoding RNA. This technique represents a versatile tool for investigating expression dynamics and protein interactions by enabling precise control over levels and timing of protein expression. Our finding also opens the door for the development of reprogramming and directed-differentiation methods based on long-RNA transfection.	[Angel, Matthew; Yanik, Mehmet Fatih] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Yanik, Mehmet Fatih] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Angel, M (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	yanik@mit.edu		Tripp, Ralph/0000-0002-2924-9956; Yanik, Mehmet/0000-0002-8963-2893	Packard Award; Alfred P. Sloan Award	Packard Award; Alfred P. Sloan Award	This project was funded by a Packard Award and by an Alfred P. Sloan Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ANGEL M, 2008, THESIS MIT CAMBRIDGE; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; DAS HK, 1981, J BIOL CHEM, V256, P6491; De Martino I, 2007, ENDOCR-RELAT CANCER, V14, P875, DOI 10.1677/ERC-07-0036; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; JIA F, 2007, NAT METHODS, V7, P197; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; KILBOURNE E, 1961, NATURE, V190, P650, DOI 10.1038/190650a0; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LEVIN DH, 1981, J BIOL CHEM, V256, P7638; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PATERSON BM, 1979, NATURE, V279, P692, DOI 10.1038/279692a0; Russell JE, 1996, BLOOD, V87, P5314, DOI 10.1182/blood.V87.12.5314.bloodjournal87125314; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	51	67	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11756	10.1371/journal.pone.0011756	http://dx.doi.org/10.1371/journal.pone.0011756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668695	Green Submitted, Green Published, gold			2022-12-27	WOS:000280243800025
J	Das, S; Saha, S; Majumder, GC; Dungdung, SR				Das, Sujoy; Saha, Sudipta; Majumder, Gopal Chandra; Dungdung, Sandhya Rekha			Purification and Characterization of a Sperm Motility Inhibiting Factor from Caprine Epididymal Plasma	PLOS ONE			English	Article							SEMINAL PLASMA; POLYACRYLAMIDE GELS; SPERMATOZOA; INITIATION; GLYCOPROTEIN; PROTEINS; IDENTIFICATION; POPULATION; MATURATION; PARAMETERS	Several studies have been reported on the occurrence of sperm motility inhibiting factors in the male reproductive fluids of different mammalian species, but these proteins have not been adequately purified and characterized. A novel sperm motility inhibiting factor (MIF-II) has been purified from caprine epididymal plasma (EP) by Hydroxylapatite gel adsorption chromatography, DEAE-Cellulose ion-exchange chromatography and chromatofocusing. The MIF-II has been purified to apparent homogeneity and the molecular weight estimated by Sephacryl S-300 gel filtration is 160 kDa. MIF-II is a dimeric protein, made up of two subunits each having a molecular mass of 80 kDa as shown by SDS-PAGE. The isoelectric point of MIF-II is 5.1 as determined by chromatofocusing and isoelectric focusing. It is a heat labile protein and maximal active at the pH 6.9 to 7.5. The sperm motility inhibiting protein factor at 2 mu g/ml (12.5 nM) level showed maximal motility-inhibiting activity. The observation that the epididymal plasma factor lowered the intracellular cAMP level of spermatozoa in a concentration-dependent manner suggests that it may block the motility of caprine cauda spermatozoa by interfering the cAMP dependent motility function. The results revealed that the purified protein factor has the potential of sperm motility inhibition and may serve as a vaginal contraceptive. The antibody raised against the MIF-II has the potential for enhancement of forward motility of cauda-spermatozoa. This antibody may thus be useful for solving some of the problems of male infertility due to low sperm motility.	[Das, Sujoy; Saha, Sudipta; Dungdung, Sandhya Rekha] Indian Inst Chem Biol, Kolkata, India; [Majumder, Gopal Chandra] Jadavpur Univ, Ctr Rural & Cryogen Technol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Das, S (corresponding author), Indian Inst Chem Biol, Kolkata, India.	srdungdung@iicb.res.in	Saha, Sudipta/I-9614-2017; Saha, Sudipta/AAF-9307-2019	Saha, Sudipta/0000-0003-0903-0997; Saha, Sudipta/0000-0003-0903-0997	Indian Council of Medical Research (ICMR), New Delhi, India [5/10/3/2005-RHN]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	The research work was supported by Indian Council of Medical Research (ICMR), New Delhi, India (www.icmr.nic.in) Grant Number 5/10/3/2005-RHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; BASS JW, 1983, J REPROD FERTIL, V68, P275; Boone William R, 2007, J S C Med Assoc, V103, P8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASCIERI M, 1976, J BIOL CHEM, V251, P787; Chandra Abhishek, 2007, Journal of Ecophysiology and Occupational Health, V7, P201; CORNWALL GA, 2007, SPERM MATURATION EPI, P211; Curi SM, 2003, ARCH ANDROLOGY, V49, P343, DOI 10.1080/01485010390219656; DELAMIRANDE E, 1984, ANN NY ACAD SCI, V438, P125, DOI 10.1111/j.1749-6632.1984.tb38281.x; DEVI LG, 1994, MOL REPROD DEV, V38, P94, DOI 10.1002/mrd.1080380116; Dungdung S. R., 1995, MOL ANDROL, V7, P247; Dungdung SR, 2003, CELL MOL BIOL, V49, P413; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; IWAMOTO T, 1988, J ANDROL, V9, P377; IWAMOTO T, 1992, MOL REPROD DEV, V31, P55, DOI 10.1002/mrd.1080310110; Jaiswal BS, 2010, J CELL PHYSIOL, V222, P254, DOI 10.1002/jcp.21947; Jaiswal BS, 1996, BIOCHEM CELL BIOL, V74, P669, DOI 10.1139/o96-072; Jaiswal BS, 1998, REPROD FERT DEVELOP, V10, P299, DOI 10.1071/R98003; JENG H, 1993, BIOCHEM BIOPH RES CO, V191, P435, DOI 10.1006/bbrc.1993.1236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; MAJUMDER GC, 1984, J REPROD FERTIL, V70, P235, DOI 10.1530/jrf.0.0700235; MANDAL M, 1991, MOL ANDROL, V3, P161; Mandal M, 2006, J CELL PHYSIOL, V209, P353, DOI 10.1002/jcp.20734; Morton B E, 1979, Fertil Steril, V32, P822; PEITZ B, 1988, J REPROD FERTIL, V83, P169, DOI 10.1530/jrf.0.0830169; Robert M, 1996, BIOL REPROD, V55, P813, DOI 10.1095/biolreprod55.4.813; ROY N, 1985, ANDROLOGIA, V17, P200; Saha S, 2007, CYTOM PART A, V71A, P308, DOI 10.1002/cyto.a.20382; SLUYTERMAN LAA, 1978, J CHROMATOGR, V150, P17, DOI 10.1016/S0021-9673(01)92092-8; Tijssen P., 1985, PRACTICE THEORY ENZ; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER TT, 1982, AM J PHYSIOL, V242, P199; USSELMAN MC, 1983, BIOL REPROD, V29, P1241, DOI 10.1095/biolreprod29.5.1241; WISDOM GB, 1976, CLIN CHEM, V22, P1243; WOLLNY E, 1984, J BIOL CHEM, V259, P2484; WONG PYD, 1983, BIOL REPROD, V28, P206, DOI 10.1095/biolreprod28.1.206; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	38	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12039	10.1371/journal.pone.0012039	http://dx.doi.org/10.1371/journal.pone.0012039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706623	gold, Green Submitted, Green Published			2022-12-27	WOS:000280811900007
J	Beziat, V; Descours, B; Parizot, C; Debre, P; Vieillard, V				Beziat, Vivien; Descours, Benjamin; Parizot, Christophe; Debre, Patrice; Vieillard, Vincent			NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs	PLOS ONE			English	Article							HLA-E; INHIBITORY RECEPTORS; CD94/NKG2A; EXPRESSION; EDUCATION; INTERFACE; TOLERANCE; COMPLEX; INNATE; MHC	Background: Terminal differentiation of NK cells is crucial in maintaining broad responsiveness to pathogens and discriminating normal cells from cells in distress. Although it is well established that KIRs, in conjunction with NKG2A, play a major role in the NK cell education that determines whether cells will end up competent or hyporesponsive, the events underlying the differentiation are still debated. Methodology/Principal Findings: A combination of complementary approaches to assess the kinetics of the appearance of each subset during development allowed us to obtain new insights into these terminal stages of differentiation, characterising their gene expression profiles at a pan-genomic level, their distinct surface receptor patterns and their prototypic effector functions. The present study supports the hypothesis that CD56(dim) cells derive from the CD56(bright) subset and suggests that NK cell responsiveness is determined by persistent inhibitory signals received during their education. We report here the inverse correlation of NKG2A expression with KIR expression and explore whether this correlation bestows functional competence on NK cells. We show that CD56(dim)NKG2A(-)KIR(+) cells display the most differentiated phenotype associated to their unique ability to respond against HLA-E+ target cells. Importantly, after IL-12 + IL-18 stimulation, reacquisition of NKG2A strongly correlates with IFN-gamma production in CD56(dim)NKG2A(-) NK cells. Conclusions/Significance: Together, these findings call for the reclassification of mature human NK cells into distinct subsets and support a new model, in which the NK cell differentiation and functional fate are based on a stepwise decrease of NKG2A and acquisition of KIRs.	[Beziat, Vivien; Descours, Benjamin; Debre, Patrice; Vieillard, Vincent] Hop La Pitie Salpetriere, INSERM, UMR S 945, Paris, France; [Beziat, Vivien; Descours, Benjamin; Debre, Patrice; Vieillard, Vincent] Univ Paris 06, Paris, France; [Parizot, Christophe; Debre, Patrice] Lab Immunol Cellulaire & Tissulaire, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Beziat, V (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR S 945, Paris, France.	vincent.vieillard@upmc.fr	Béziat, Vivien/G-2971-2011; Béziat, Vivien/AAT-4097-2021	Béziat, Vivien/0000-0002-4020-824X; Béziat, Vivien/0000-0002-4020-824X; PARIZOT, Christophe/0000-0001-5723-4471	Institut National de la Sante et de la Recherche Medicale (INSERM) [P060206-AOM06206]; association Cent pour Sang la Vie; Agence de la BioMedecine	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); association Cent pour Sang la Vie; Agence de la BioMedecine	This work was supported in part by national funds from the Institut National de la Sante et de la Recherche Medicale (INSERM) under contract PHRC "Minicord'' (P060206-AOM06206), by the association Cent pour Sang la Vie and the Agence de la BioMedecine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Beziat V, 2009, LEUKEMIA, V23, P721, DOI 10.1038/leu.2008.343; Borrego F, 2005, MOL IMMUNOL, V42, P485, DOI 10.1016/j.molimm.2004.07.031; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carrega P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008132; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Gustafson KS, 1996, J BIOL CHEM, V271, P20035, DOI 10.1074/jbc.271.33.20035; Held W, 2008, EUR J IMMUNOL, V38, P2930, DOI 10.1002/eji.200838755; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Juelke K, 2009, EUR J IMMUNOL, V39, P2548, DOI 10.1002/eji.200939307; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lopez-Botet M, 2000, HUM IMMUNOL, V61, P7, DOI 10.1016/S0198-8859(99)00161-5; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Nguyen S, 2005, BLOOD, V105, P4135, DOI 10.1182/blood-2004-10-4113; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Ouyang Q, 2007, ANN NY ACAD SCI, V1106, P240, DOI 10.1196/annals.1392.001; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vago L, 2008, BLOOD, V112, P3488, DOI 10.1182/blood-2007-07-103325; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	41	146	149	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11966	10.1371/journal.pone.0011966	http://dx.doi.org/10.1371/journal.pone.0011966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700504	Green Submitted, Green Published, gold			2022-12-27	WOS:000280687900003
J	Lettner, T; Zeidler, U; Gimona, M; Hauser, M; Breitenbach, M; Bito, A				Lettner, Thomas; Zeidler, Ute; Gimona, Mario; Hauser, Michael; Breitenbach, Michael; Bito, Arnold			Candida albicans AGE3, the Ortholog of the S. cerevisiae ARF-GAP-Encoding Gene GCS1, Is Required for Hyphal Growth and Drug Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; ACTIN CYTOSKELETON; ANTIFUNGAL AGENTS; STATIONARY-PHASE; POLARIZED GROWTH; CELL POLARITY	Background: Hyphal growth and multidrug resistance of C. albicans are important features for virulence and antifungal therapy of this pathogenic fungus. Methodology/Principal Findings: Here we show by phenotypic complementation analysis that the C. albicans gene AGE3 is the functional ortholog of the yeast ARF-GAP-encoding gene GCS1. The finding that the gene is required for efficient endocytosis points to an important functional role of Age3p in endosomal compartments. Most C. albicans age3 Delta mutant cells which grew as cell clusters under yeast growth conditions showed defects in filamentation under different hyphal growth conditions and were almost completely disabled for invasive filamentous growth. Under hyphal growth conditions only a fraction of age3 Delta cells shows a wild-type-like polarization pattern of the actin cytoskeleton and lipid rafts. Moreover, age3 Delta cells were highly susceptible to several unrelated toxic compounds including antifungal azole drugs. Irrespective of the AGE3 genotype, C-terminal fusions of GFP to the drug efflux pumps Cdr1p and Mdr1p were predominantly localized in the plasma membrane. Moreover, the plasma membranes of wild-type and age3 Delta mutant cells contained similar amounts of Cdr1p, Cdr2p and Mdr1p. Conclusions/Significance: The results indicate that the defect in sustaining filament elongation is probably caused by the failure of age3 Delta cells to polarize the actin cytoskeleton and possibly of inefficient endocytosis. The high susceptibility of age3 Delta cells to azoles is not caused by inefficient transport of efflux pumps to the cell membrane. A possible role of a vacuolar defect of age3 Delta cells in drug susceptibility is proposed and discussed. In conclusion, our study shows that the ARF-GAP Age3p is required for hyphal growth which is an important virulence factor of C. albicans and essential for detoxification of azole drugs which are routinely used for antifungal therapy. Thus, it represents a promising antifungal drug target.	[Lettner, Thomas; Gimona, Mario; Breitenbach, Michael; Bito, Arnold] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Zeidler, Ute] Inst Pasteur, Unite Biol & Pathogenicite Fong, Paris, France; [Hauser, Michael] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Salzburg University	Bito, A (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	arnold.bito@sbg.ac.at	Hauser, Michael/P-6148-2017	Hauser, Michael/0000-0001-6558-755X; Lettner, Thomas/0000-0002-8130-8394	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg [05/01/001]	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg	Forschungsfoerderungsfonds der Paracelsus Medizinische Privatuniversitaet (PMU) Salzburg ( grant no 05/01/001). http://www.pmu.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI T, 1994, MICROBIOL-SGM, V140, P271, DOI 10.1099/13500872-140-2-271; Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; BENYAACOV R, 1994, ANTIMICROB AGENTS CH, V38, P648, DOI 10.1128/AAC.38.4.648; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Bernardo SM, 2008, FUNGAL GENET BIOL, V45, P861, DOI 10.1016/j.fgb.2008.01.001; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blackburn AS, 2003, ANTIMICROB AGENTS CH, V47, P676, DOI 10.1128/AAC.47.2.676-681.2003; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; Brachmann CB, 1998, YEAST, V14, P115; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; BUNICK FJ, 1982, BIOCHEMISTRY-US, V21, P4285, DOI 10.1021/bi00261a017; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Cornet M, 2006, ANTIMICROB AGENTS CH, V50, P3492, DOI 10.1128/AAC.00391-06; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414; de Micheli M, 2002, MOL MICROBIOL, V43, P1197, DOI 10.1046/j.1365-2958.2002.02814.x; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DREBOT MA, 1987, P NATL ACAD SCI USA, V84, P7948, DOI 10.1073/pnas.84.22.7948; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Harry JB, 2005, ANTIMICROB AGENTS CH, V49, P2785, DOI 10.1128/AAC.49.7.2785-2792.2005; Hazan I, 2002, EUKARYOT CELL, V1, P856, DOI 10.1128/EC.1.6.856-864.2002; Huang CF, 2002, J CELL SCI, V115, P275; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; IRELAND LS, 1994, EMBO J, V13, P3812, DOI 10.1002/j.1460-2075.1994.tb06692.x; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Li CR, 2005, J CELL SCI, V118, P2637, DOI 10.1242/jcs.02393; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Maebashi K, 2002, MICROBIOL IMMUNOL, V46, P317, DOI 10.1111/j.1348-0421.2002.tb02702.x; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Moran GP, 1998, ANTIMICROB AGENTS CH, V42, P1819, DOI 10.1128/AAC.42.7.1819; Morschhauser J, 2002, BBA-MOL BASIS DIS, V1587, P240, DOI 10.1016/S0925-4439(02)00087-X; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Palmer GE, 2005, EUKARYOT CELL, V4, P1677, DOI 10.1128/EC.4.10.1677-1686.2005; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pasrija R, 2005, J ANTIMICROB CHEMOTH, V55, P905, DOI 10.1093/jac/dki112; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Prasad R, 2005, INT REV CYTOL, V242, P215; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Pruyne D, 2000, J CELL SCI, V113, P571; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832; Sakane H, 2006, CELL STRUCT FUNCT, V31, P87, DOI 10.1247/csf.06021; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Theiss S, 2002, MOL MICROBIOL, V43, P571, DOI 10.1046/j.1365-2958.2002.02769.x; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Ushinsky SC, 2002, EUKARYOT CELL, V1, P95, DOI 10.1128/EC.1.1.95-104.2002; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wirsching S, 2000, MOL MICROBIOL, V36, P856, DOI 10.1046/j.1365-2958.2000.01899.x; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966; Zheng XD, 2003, MOL MICROBIOL, V49, P1391, DOI 10.1046/j.1365-2958.2003.03646.x	81	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11993	10.1371/journal.pone.0011993	http://dx.doi.org/10.1371/journal.pone.0011993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700541	gold, Green Published, Green Submitted			2022-12-27	WOS:000280605400025
J	Costello, MJ; Coll, M; Danovaro, R; Halpin, P; Ojaveer, H; Miloslavich, P				Costello, Mark John; Coll, Marta; Danovaro, Roberto; Halpin, Pat; Ojaveer, Henn; Miloslavich, Patricia			A Census of Marine Biodiversity Knowledge, Resources, and Future Challenges	PLOS ONE			English	Article							CLIMATE-CHANGE; INVENTORY; OCEAN; ERA	The Census of Marine Life (2000-2010) was the largest global research programme on marine biodiversity. This paper integrated the findings of reviews of major world regions by the Census and provides a global perspective on what is known and what are the major scientific gaps. Study metrics were regional species richness, numbers of endemic and alien species, numbers of species identification guides and taxonomic experts, and a state-of-knowledge index. The threats to biodiversity were classified across the regions. A poor to moderate correlation between species richness and seabed area, and sea volume, and no correlations with topographic variation, were attributed to sparse, uneven and unrepresentative sampling in much of the global marine environment. Many habitats have been poorly sampled, particularly in deeper seas, and several species-rich taxonomic groups, especially of smaller organisms, remain poorly studied. Crustacea, Mollusca, and Pisces comprised approximately half of all known species across the regions. The proportion that these and other taxa comprised of all taxa varied sufficiently to question whether the relative number of species within phyla and classes are constant throughout the world. Over-fishing and pollution were identified as the main threats to biodiversity across all regions, followed by alien species, altered temperature, acidification, and hypoxia, although their relative importance varied among regions. The findings were replicated worldwide, in both developed and developing countries: i.e. major gaps exist in sampling effort and taxonomic expertise that impair society's ability to discover new species and identify and understand species of economic and ecological importance. There was a positive relationship between the availability of species identification guides and knowledge of biodiversity, including the number of species and alien species. Available taxonomic guides and experts correlated negatively with endemic species, suggesting that the more we study the ocean the fewer endemic species are evident. There is a need to accelerate the discovery of marine biodiversity, since much of it may be lost without even being known. We discuss how international collaboration between developed and developing countries is essential for improving productivity in the discovery and management of marine biodiversity, and how various sectors may contribute to this.	[Costello, Mark John] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; [Coll, Marta] Dalhousie Univ, Halifax, NS, Canada; [Coll, Marta] Inst Marine Sci ICM CSIC, Barcelona, Spain; [Danovaro, Roberto] Polytech Univ Marche, Dept Marine Sci, Ancona, Italy; [Halpin, Pat] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Miloslavich, Patricia] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Miloslavich, Patricia] Univ Simon Bolivar, Ctr Biodiversidad Marina, Caracas, Venezuela	University of Auckland; Dalhousie University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Marche Polytechnic University; Duke University; University of Tartu; Estonian Marine Institute; Simon Bolivar University; Simon Bolivar University	Costello, MJ (corresponding author), Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand.	m.costello@auckland.ac.nz	Ojaveer, Henn/K-2160-2016; Coll, Marta/A-9488-2012; Costello, Mark/C-9267-2013	Ojaveer, Henn/0000-0003-2742-6063; Coll, Marta/0000-0001-6235-5868; Costello, Mark/0000-0003-2362-0328; Miloslavich, Patricia/0000-0001-5409-1401	Estonian Ministry of Education and Research [SF0180005s10]; European Commission [FP7-PEOPLE-2007-4-1-IOF]; Dalhousie University, Canada; EU; MIUR, Italy; Decanato de Investigacion y Desarrollo, Universidad Simon Bolivar	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Commission(European CommissionEuropean Commission Joint Research Centre); Dalhousie University, Canada; EU(European Commission); MIUR, Italy(Ministry of Education, Universities and Research (MIUR)); Decanato de Investigacion y Desarrollo, Universidad Simon Bolivar	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contribution of HO was financed by research grant from the Estonian Ministry of Education and Research (no. SF0180005s10). MC was supported financially by the European Commission Marie Curie Post-doctoral Fellowship through the International Outgoing Fellowships (Call FP7-PEOPLE-2007-4-1-IOF) for the ECOFUN project and by Dalhousie University, Canada. RD was supported by the projects HERMIONE (EU-FPVII), VECTOR and OBAMA (MIUR, Italy). PM was supported by the Decanato de Investigacion y Desarrollo, Universidad Simon Bolivar.	[Anonymous], 1953, ZOOGEOGRAPHY SEA; ARCHAMBAULT P, 2010, PLOS ONE IN PRESS; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Boero Ferdinando, 2010, Diversity, V2, P115; BOUCHET P, 2006, EXPLORATION MARINE B, P33; Boxshall G., 2010, HARPACTICOIDA; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Costello MJ, 1996, J MAR BIOL ASSOC UK, V76, P255, DOI 10.1017/S0025315400029234; COSTELLO MJ, 2010, GLOBAL ECOL IN PRESS; COSTELLO MJ, 2001, PATRIMOINES NATURELS, V50, P1; COSTELLO MJ, TOPOGRAPHY STA UNPUB; Crist D. T., 2009, WORLD OCEAN CENSUS; CRIST DT, COMMUNICATION; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Eschmeyer WN, 2010, ZOOTAXA, P19; Fautin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011914; Forbes E, 1844, REPORT 13 M BRIT ASS, V13, ppp130; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010905; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths CL, 2005, INDIAN J MAR SCI, V34, P35; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; do Sul JAI, 2007, MAR POLLUT BULL, V54, P1087, DOI 10.1016/j.marpolbul.2007.05.004; do Sul JAI, 2009, MAR POLLUT BULL, V58, P1236, DOI [10.1016/j.marpolbul.2008.05.004, 10.1016/j.marpolbul.2009.05.004]; Knowlton Nancy., 2010, CITIZENS SEA WONDROU; LEE YH, 2010, COMMUNICATION; Liu J.Y, 2008, CHECKLIST MARINE BIO; Miloslavich P, 2007, CIENC MAR, V33, P319, DOI 10.7773/cm.v33i3.1147; MILOSLAVICH P, 2010, MARINE BIODIVERSITY; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; NARAYANASWAMY BE, 2010, COMMUNICATION; O'Dor R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011871; OJAVEER H, 2010, PLOS ONE IN PRESS; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; RISSO A, 1816, HIST NATURELLE CRUST; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; Thresher RE, 2007, P NATL ACAD SCI USA, V104, P7461, DOI 10.1073/pnas.0610546104; WAFAR M, 2010, COMMUNICATION; Wilson SP, 2005, J R STAT SOC C-APPL, V54, P897, DOI 10.1111/j.1467-9876.2005.00513.x; Zenetos A, 2010, BIOL INVASIONS, V12, P3379, DOI 10.1007/s10530-009-9679-x	48	387	409	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e12110	10.1371/journal.pone.0012110	http://dx.doi.org/10.1371/journal.pone.0012110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689850	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520400019
J	Li, JO; Olsen, J; Vestergaard, M; Obel, C; Baker, JL; Sorensen, TIA				Li, Jiong; Olsen, Jorn; Vestergaard, Mogens; Obel, Carsten; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Prenatal Stress Exposure Related to Maternal Bereavement and Risk of Childhood Overweight	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ENDOCRINE DISRUPTORS; BODY-MASS; IN-UTERO; OBESITY; PREGNANCY; WEIGHT; COHORT; PREVENTION; ORIGINS	Background: It has been suggested that prenatal stress contributes to the risk of obesity later in life. In a population-based cohort study, we examined whether prenatal stress related to maternal bereavement during pregnancy was associated with the risk of overweight in offspring during school age. Methodology/Principal Findings: We followed 65,212 children born in Denmark from 1970-1989 who underwent health examinations from 7 to 13 years of age in public or private schools in Copenhagen. We identified 459 children as exposed to prenatal stress, defined by being born to mothers who were bereaved by death of a close family member from one year before pregnancy until birth of the child. We compared the prevalence of overweight between the exposed and the unexposed. Body mass index (BMI) values and prevalence of overweight were higher in the exposed children, but not significantly so until from 10 years of age and onwards, as compared with the unexposed children. For example, the adjusted odds ratio (OR) for overweight was 1.68 (95% confidence interval [CI] 1.08-2.61) at 12 years of age and 1.63 (95% CI 1.00-2.61) at 13 years of age. The highest ORs were observed when the death occurred in the period from 6 to 0 month before pregnancy (OR 3.31, 95% CI 1.71-6.42 at age 12, and OR 2.31, 95% CI 1.08-4.97 at age 13). Conclusions/Significance: Our results suggest that severe pre-pregnancy stress is associated with an increased risk of overweight in the offspring in later childhood.	[Li, Jiong; Olsen, Jorn] Univ Aarhus, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Vestergaard, Mogens] Univ Aarhus, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens; Obel, Carsten] Univ Aarhus, Sch Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark	Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University; University of Copenhagen	Li, JO (corresponding author), Univ Aarhus, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark.	jl@soci.au.dk	Ferraro, Alexandre A/G-6440-2013; li, jiong/L-6534-2014; Baker, Jennifer/F-1917-2010; Olsen, Jørn/F-8801-2015; Vestergaard, Mogens/M-9333-2014; Baker, Jennifer L./AAH-4693-2020; Obel, Carsten/H-9605-2016	Ferraro, Alexandre A/0000-0003-1439-8091; li, jiong/0000-0002-1716-8067; Baker, Jennifer/0000-0002-9649-6615; Olsen, Jørn/0000-0001-7462-5140; Vestergaard, Mogens/0000-0001-8830-2174; Baker, Jennifer L./0000-0002-9649-6615; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	Danish National Science Foundation; Danish Medical Research Council [271-05-0616, 271-07-0437, 09-072986]; Nordic Cancer Union; NordForsk [070331]	Danish National Science Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nordic Cancer Union; NordForsk	The study was supported by the Danish National Science Foundation, Danish Medical Research Council (projects no. 271-05-0616, no. 271-07-0437, no. 09-072986), Nordic Cancer Union (2008), and NordForsk (070331). This study was part of the research activities in the Danish Obesity Research Centre (DanORC, see www.danorc.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; *AM I STRESS, 2009, AM HLTH PROBL WHY IS; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; Denmark Statistics, 1991, IDA AN INT DAT LAB M; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Huang JS, 2007, MATERN CHILD HLTH J, V11, P461, DOI 10.1007/s10995-006-0141-8; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Khashan AS, 2009, HUM REPROD, V24, P429, DOI 10.1093/humrep/den418; Knudsen LB, 1998, DAN MED BULL, V45, P320; Labayen I, 2006, J NUTR, V136, P147, DOI 10.1093/jn/136.1.147; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; MATTHEWS KA, 1992, PSYCHOPHYSIOLOGY, V29, P232, DOI 10.1111/j.1469-8986.1992.tb01691.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MONROE SM, 1990, STRESS MEDICINE, V6, P209, DOI 10.1002/smi.2460060306; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pedersen CB, 2006, DAN MED BULL, V53, P441; Philipsen NM, 2008, J PERINAT EDUC, V17, P44, DOI 10.1624/105812408X266296; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Roy JR, 2009, MED SCI MONITOR, V15, pRA137; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; SCHULTE HM, 1990, CLIN ENDOCRINOL, V33, P99, DOI 10.1111/j.1365-2265.1990.tb00470.x; Sharma AJ, 2008, AM J EPIDEMIOL, V168, P995, DOI 10.1093/aje/kwn223; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; SKODOL AE, 1989, AM J PSYCHIAT, V146, P61; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3	44	107	109	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11896	10.1371/journal.pone.0011896	http://dx.doi.org/10.1371/journal.pone.0011896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689593	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300011
J	Choi, MS; Yoo, AS; Greenwald, I				Choi, Min Sung; Yoo, Andrew S.; Greenwald, Iva			sel-11 and cdc-42, Two Negative Modulators of LIN-12/Notch Activity in C. elegans	PLOS ONE			English	Article							MEDIATED DOWN-REGULATION; UBIQUITIN-LIGASE; CAENORHABDITIS-ELEGANS; TUMOR-SUPPRESSOR; RHO GTPASES; NOTCH; REGULATOR; GLP-1; TRAFFICKING; DEGRADATION	Background: LIN-12/Notch signaling is important for cell-cell interactions during development, and mutations resulting in constitutive LIN-12/Notch signaling can cause cancer. Loss of negative regulators of lin-12/Notch activity has the potential for influencing cell fate decisions during development and the genesis or aggressiveness of cancer. Methodology/Principal Findings: We describe two negative modulators of lin-12 activity in C. elegans. One gene, sel-11, was initially defined as a suppressor of a lin-12 hypomorphic allele; the other gene, cdc-42, is a well-studied Rho GTPase. Here, we show that SEL-11 corresponds to yeast Hrd1p and mammalian Synoviolin. We also show that cdc-42 has the genetic properties consistent with negative regulation of lin-12 activity during vulval precursor cell fate specification. Conclusions/Significance: Our results underscore the multiplicity of negative regulatory mechanisms that impact on lin-12/Notch activity and suggest novel mechanisms by which constitutive lin-12/Notch activity might be exacerbated in cancer.	[Choi, Min Sung] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA; [Yoo, Andrew S.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Integrated Program Cellular Mol & Biophys Studies, New York, NY USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Choi, MS (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10027 USA.	isg4@columbia.edu		Yoo, Andrew/0000-0002-0304-3247	National Institutes of Health [R01CA095389]; NATIONAL CANCER INSTITUTE [R01CA095389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant to I.G. from the National Institutes of Health (R01CA095389). I.G. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baron M, 2000, MOL GEN GENET, V264, P98, DOI 10.1007/s004380000287; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 1996, GENETICS, V143, P237; Green Iain, 2005, P1; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levitan D, 1998, DEVELOPMENT, V125, P3101; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Sasagawa Y, 2007, GENES CELLS, V12, P1063, DOI 10.1111/j.1365-2443.2007.01108.x; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Stetak A, 2006, EMBO J, V25, P2347, DOI 10.1038/sj.emboj.7601137; SUNDARAM M, 1993, GENETICS, V135, P755; SUNDARAM M, 1993, GENETICS, V135, P765; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	48	11	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11885	10.1371/journal.pone.0011885	http://dx.doi.org/10.1371/journal.pone.0011885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686701	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520200044
J	Fuentealba, RA; Liu, QA; Zhang, JA; Kanekiyo, T; Hu, XY; Lee, JM; LaDu, MJ; Bu, GJ				Fuentealba, Rodrigo A.; Liu, Qiang; Zhang, Juan; Kanekiyo, Takahisa; Hu, Xiaoyan; Lee, Jin-Moo; LaDu, Mary Jo; Bu, Guojun			Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Mediates Neuronal A beta 42 Uptake and Lysosomal Trafficking	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; SPORADIC ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; LDL RECEPTOR; A-BETA; PRECURSOR PROTEIN; TRANSGENIC MICE; HUMAN BRAIN; INTRACELLULAR ACCUMULATION; MOLECULAR CHAPERONE	Background: Alzheimer's disease (AD) is characterized by the presence of early intraneuronal deposits of amyloid-beta 42 (A beta 42) that precede extracellular amyloid deposition in vulnerable brain regions. It has been hypothesized that endosomal/lysosomal dysfunction might be associated with the pathological accumulation of intracellular A beta 42 in the brain. Our previous findings suggest that the LDL receptor-related protein 1 (LRP1), a major receptor for apolipoprotein E, facilitates intraneuronal A beta 42 accumulation in mouse brain. However, direct evidence of neuronal endocytosis of A beta 42 through LRP1 is lacking. Methodology/Principal Findings: Here we show that LRP1 endocytic function is required for neuronal A beta 42 uptake. Overexpression of a functional LRP1 minireceptor, mLRP4, increases A beta 42 uptake and accumulation in neuronal lysosomes. Conversely, knockdown of LRP1 expression significantly decreases neuronal A beta 42 uptake. Disruptions of LRP1 endocytic function by either clathrin knockdown or by removal of its cytoplasmic tail decreased both uptake and accumulation of A beta 42 in neurons. Finally, we show that LRP1-mediated neuronal accumulation of A beta 42 is associated with increased cellular toxicity. Conclusions/Significance: These results demonstrate that LRP1 endocytic function plays an important role in the uptake and accumulation of A beta 42 in neuronal lysosomes. These findings emphasize the central function of LRP1 in neuronal A beta metabolism.	[Fuentealba, Rodrigo A.; Liu, Qiang; Zhang, Juan; Kanekiyo, Takahisa; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Fuentealba, Rodrigo A.; Hu, Xiaoyan; Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Fuentealba, RA (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	bu@wustl.edu	Zhang, Juan/GRX-2638-2022; Liu, Qiang/E-9245-2011; Lee, Jin-Moo/K-2024-2015	LaDu, Mary Jo/0000-0003-2141-1450; Fuentealba, Rodrigo/0000-0001-8724-091X; Lee, Jin-Moo/0000-0002-3979-0906	National Institutes of Health (NIH) [R01AG027924, R01AG19121, P01AG021184]; Alzheimer's Association; NIH Neuroscience Blueprint Interdisciplinary Center [P30NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924, R01AG035355, P01AG030128, P01AG021184, R01AG019121] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NIH Neuroscience Blueprint Interdisciplinary Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01AG027924 (to G.B.), R01AG19121 (to M.J.L.) and P01AG021184 (to G.B. and M.J.L.), Zenith Fellows Awards from the Alzheimer's Association (to G.B. and M.J.L.), and the NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30NS057105 (to Washington University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr BA, 1998, J COMP NEUROL, V397, P139; BELINSON H, 2009, J ALZHEIMERS DIS; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1994, J BIOL CHEM, V269, P18521; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Eslami P, 2008, BRAIN RES, V1241, P176, DOI 10.1016/j.brainres.2008.08.086; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris-White ME, 2004, J NEUROSCI RES, V77, P217, DOI 10.1002/jnr.20149; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Li YH, 2001, MOL NEUROBIOL, V23, P53; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu JC, 2007, IET SIGNAL PROCESS, V1, P66, DOI 10.1049/iet-spr:20060260; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Roses AD, 2006, J ALZHEIMERS DIS, V9, P361; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Van Uden E, 2000, MICROSC RES TECHNIQ, V50, P268, DOI 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1; Van Uden E, 2002, J NEUROSCI, V22, P9298; WILLIAMS JK, 1994, HIGH TEMP CHEM PROCE, V3, P719; WOLF BB, 1992, AM J PATHOL, V141, P37; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101	63	76	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11884	10.1371/journal.pone.0011884	http://dx.doi.org/10.1371/journal.pone.0011884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686698	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520200043
J	Matthews, QL; Fatima, A; Tang, YZ; Perry, BA; Tsuruta, Y; Komarova, S; Timares, L; Zhao, CX; Makarova, N; Borovjagin, AV; Stewart, PL; Wu, HJ; Blackwell, JL; Curiel, DT				Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Perry, Brian A.; Tsuruta, Yuko; Komarova, Svetlana; Timares, Laura; Zhao, Chunxia; Makarova, Natalia; Borovjagin, Anton V.; Stewart, Phoebe L.; Wu, Hongju; Blackwell, Jerry L.; Curiel, David T.			HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach	PLOS ONE			English	Article							VIRUS TYPE-1 HIV-1; IMMUNE-RESPONSES; NEUTRALIZING RESPONSES; GENE-TRANSFER; FIBER KNOB; VECTORS; TRANSGENE; EPITOPE; EXPRESSION; ANTIBODY	Adenoviral (Ad) vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed to express antigens through transgene expression of a given antigen. However, in some cases these conventional Ad-based vaccines have had sub-optimal clinical results. These sub-optimal results are attributed in part to pre-existing Ad serotype 5 (Ad5) immunity. In order to circumvent the need for antigen expression via transgene incorporation, the "antigen capsid-incorporation" strategy has been developed and used for Ad-based vaccine development in the context of a few diseases. This strategy embodies the incorporation of antigenic peptides within the capsid structure of viral vectors. The major capsid protein hexon has been utilized for these capsid incorporation strategies due to hexon's natural role in the generation of anti-Ad immune response and its numerical representation within the Ad virion. Using this strategy, we have developed the means to incorporate heterologous peptide epitopes specifically within the major surface-exposed domains of the Ad capsid protein hexon. Our study herein focuses on generation of multivalent vaccine vectors presenting HIV antigens within the Ad capsid protein hexon, as well as expressing an HIV antigen as a transgene. These novel vectors utilize HVR2 as an incorporation site for a twenty-four amino acid region of the HIV membrane proximal ectodomain region (MPER), derived from HIV glycoprotein gp41 (gp41). Our study herein illustrates that our multivalent anti-HIV vectors elicit a cellular anti-HIV response. Furthermore, vaccinations with these vectors, which present HIV antigens at HVR2, elicit a HIV epitope-specific humoral immune response.	[Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Dept Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Matthews, Qiana L.; Fatima, Aiman; Tang, Yizhe; Komarova, Svetlana; Wu, Hongju; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Matthews, Qiana L.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL 35294 USA; [Tang, Yizhe] Univ Alabama Birmingham, Vis Sci Grad Program, Birmingham, AL 35294 USA; [Perry, Brian A.] Davidson Coll, Davidson, NC 28036 USA; [Tsuruta, Yuko; Timares, Laura] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Zhao, Chunxia; Makarova, Natalia; Blackwell, Jerry L.] Emory Univ, Atlanta, GA 30322 USA; [Borovjagin, Anton V.] Univ Alabama Birmingham, Inst Oral Hlth Res, Sch Dent, Birmingham, AL 35294 USA; [Stewart, Phoebe L.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Davidson College; University of Alabama System; University of Alabama Birmingham; Emory University; University of Alabama System; University of Alabama Birmingham; Vanderbilt University	Matthews, QL (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	curiel@uab.edu	Matthews, Qiana/P-9624-2019; Tang, Yizhe/A-8682-2014	Tang, Yizhe/0000-0001-5354-478X	National Institutes of Health [4R33AI076096-03, 2P30AI027767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076096, R21AI076096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health: 4R33AI076096-03 (Dr. David T. Curiel) and 2P30AI027767 [Supplement] (Drs. Michael Saag and Qiana L. Matthews). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Arnold GF, 1996, INTERVIROLOGY, V39, P72; Barnett BG, 2002, BBA-GENE STRUCT EXPR, V1575, P1, DOI 10.1016/S0167-4781(02)00249-X; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Blackwell JL, 2000, HUM GENE THER, V11, P1657, DOI 10.1089/10430340050111313; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Challacombe S J, 2006, Adv Dent Res, V19, P29; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Curiel DT, 1999, ANN NY ACAD SCI, V886, P158, DOI 10.1111/j.1749-6632.1999.tb09409.x; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Gomez-Roman Victor Raul, 2003, AIDS Reviews, V5, P178; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; KassEisler A, 1996, GENE THER, V3, P154; KASSEISLER A, 1994, GENE THER, V1, P395; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Li J, 2005, VIROLOGY, V338, P247, DOI 10.1016/j.virol.2005.04.005; Liu M, 2004, P NATL ACAD SCI USA, V101, P14567, DOI 10.1073/pnas.0404845101; Liu RY, 2005, VIRUS RES, V112, P24, DOI 10.1016/j.virusres.2005.02.009; Lowenstein PR, 2002, METHOD ENZYMOL, V346, P292; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; McConnell MJ, 2006, J VIROL, V80, P5361, DOI 10.1128/JVI.00256-06; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pereboev A, 2001, J VIROL, V75, P7107, DOI 10.1128/JVI.75.15.7107-7113.2001; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; Qin LZ, 2004, J VIROL, V78, P7016, DOI 10.1128/JVI.78.13.7016-7022.2004; RESNICK DA, 1995, J VIROL, V69, P2406, DOI 10.1128/JVI.69.4.2406-2411.1995; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SMITH AD, 1994, J VIROL, V68, P575, DOI 10.1128/JVI.68.1.575-579.1994; Smith AD, 1998, J VIROL, V72, P651, DOI 10.1128/JVI.72.1.651-659.1998; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Tang YZ, 2008, VIROLOGY, V377, P391, DOI 10.1016/j.virol.2008.04.023; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; Umana P, 2001, NAT BIOTECHNOL, V19, P582, DOI 10.1038/89349; Vigne E, 1999, J VIROL, V73, P5156, DOI 10.1128/JVI.73.6.5156-5161.1999; WEAVER EA, 2008, HUM GENE THER; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Worgall S, 2004, J VIROL, V78, P2572, DOI 10.1128/JVI.78.5.2572-2580.2004; Worgall S, 2007, J VIROL, V81, P13801, DOI 10.1128/JVI.01246-07; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Xiong WD, 2006, J VIROL, V80, P27, DOI 10.1128/JVI.80.1.27-37.2006; Xiong W, 2008, MOL THER, V16, P343, DOI 10.1038/sj.mt.6300375; Zhang AQ, 1999, BIOL CHEM, V380, P365, DOI 10.1515/BC.1999.048; Zhang HG, 2005, MOL THER, V11, P866, DOI 10.1016/j.ymthe.2005.02.014; Zhao CX, 2009, J VIROL METHODS, V160, P101, DOI 10.1016/j.jviromet.2009.04.028	59	37	43	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11815	10.1371/journal.pone.0011815	http://dx.doi.org/10.1371/journal.pone.0011815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676400	gold, Green Published, Green Submitted			2022-12-27	WOS:000280371800016
J	Xia, B; Joubert, A; Groves, B; Vo, K; Ashraf, D; Djavaherian, D; Awe, J; Xiong, Y; Cherfils, J; Ma, D				Xia, Bin; Joubert, Alexandra; Groves, Benjamin; Vo, Kevin; Ashraf, Davin; Djavaherian, Derek; Awe, Jason; Xiong, Ying; Cherfils, Jacqueline; Ma, Dzwokai			Modulation of Cell Adhesion and Migration by the Histone Methyltransferase Subunit mDpy-30 and Its Interacting Proteins	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; BREFELDIN-A; DISTINCT FUNCTIONS; BIG2; LOCALIZATION; INTEGRINS; DOMAINS; KINASE	We have previously shown that a subset of mDpy-30, an accessory subunit of the nuclear histone H3 lysine 4 methyltransferase (H3K4MT) complex, also localizes at the trans-Golgi network (TGN), where its recruitment is mediated by the TGN-localized ARF guanine nucleotide exchange factor (ArfGEF) BIG1. Depletion of mDpy-30 inhibits the endosome-to-TGN transport of internalized CIMPR receptors and concurrently promotes their accumulation at the cell protrusion. These observations suggest mDpy-30 may play a novel role at the crossroads of endosomal trafficking, nuclear transcription and adhesion/migration. Here we provide novel mechanistic and functional insight into this association. First, we demonstrate a direct interaction between mDpy-30 and BIG1 and locate the binding region in the N-terminus of BIG1. Second, we provide evidence that the depletion or overexpression of mDpy-30 enhances or inhibits cellular adhesion/migration of glioma cells in vitro, respectively. A similar increase in cell adhesion/migration is observed in cells with reduced levels of BIG1 or other H3K4MT subunits. Third, knockdown of mDpy-30, BIG1, or the RbBP5 H3K4MT subunit increases the targeting of beta 1 integrin to cell protrusions, and suppression of H3K4MT activity by depleting mDpy-30 or RbBP5 leads to increased protein and mRNA levels of beta 1 integrin. Moreover, stimulation of cell adhesion/migration via mDpy-30 knockdown is abolished after treating cells with a function-blocking antibody to beta 1 integrin. Taken together, these data indicate that mDpy-30 and its interacting proteins function as a novel class of cellular adhesion/migration modulators partially by affecting the subcellular distribution of endosomal compartments as well as the expression of key adhesion/migration proteins such as beta 1 integrin.	[Xia, Bin; Xiong, Ying] Sichuan Univ, W China Univ Hosp 2, Dept Pediat, Chengdu 610064, Peoples R China; [Xia, Bin; Groves, Benjamin; Vo, Kevin; Ashraf, Davin; Djavaherian, Derek; Awe, Jason; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Joubert, Alexandra; Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	Sichuan University; University of California System; University of California Santa Barbara; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Santa Barbara	Xia, B (corresponding author), Sichuan Univ, W China Univ Hosp 2, Dept Pediat, Chengdu 610064, Peoples R China.	ma@lifesci.ucsb.edu	Ashraf, Davin/AAP-4556-2021	Ashraf, Davin/0000-0001-7945-9516; /0000-0002-6129-2938	Cancer Research Coordinating Committee (CRCC) [8-597000-36240]	Cancer Research Coordinating Committee (CRCC)	A small grant from the Cancer Research Coordinating Committee (CRCC, the fund number is as follows: 8-597000-36240), along with the authors' startup funds allowed them to perform this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal R, 2008, PHARMACOL THERAPEUT, V120, P81, DOI 10.1016/j.pharmthera.2008.07.002; Blaschke F, 2002, BIOCHEM BIOPH RES CO, V296, P890, DOI 10.1016/S0006-291X(02)02033-8; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Faruque OM, 2009, AM J PHYSIOL-CELL PH, V296, pC306, DOI 10.1152/ajpcell.00216.2008; FLETCHER SJ, TRENDS CELL BIOL; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HSU DR, 1994, GENETICS, V137, P999; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jones HD, 2005, METHOD ENZYMOL, V404, P174, DOI 10.1016/S0076-6879(05)04017-6; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Mukhopadhyay NK, 2004, ANN THORAC SURG, V78, P450, DOI 10.1016/j.athoracsur.2004.01.042; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; SOUTH PF, 2009, J BIOL CHEM; WANG X, 2009, J MOL BIOL; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	28	14	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11771	10.1371/journal.pone.0011771	http://dx.doi.org/10.1371/journal.pone.0011771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668708	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800034
J	Cafini, F; Yuste, J; Gimenez, MJ; Sevillano, D; Aguilar, L; Alou, L; Ramos-Sevillano, E; Torrico, M; Gonzalez, N; Garcia, E; Coronel, P; Prieto, J				Cafini, Fabio; Yuste, Jose; Gimenez, Maria-Jose; Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Ramos-Sevillano, Elisa; Torrico, Martha; Gonzalez, Natalia; Garcia, Ernesto; Coronel, Pilar; Prieto, Jose			Enhanced In Vivo Activity of Cefditoren in Pre-Immunized Mice against Penicillin-Resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a Sepsis Model	PLOS ONE			English	Article							INVASIVE STREPTOCOCCUS-PNEUMONIAE; ACUTE OTITIS-MEDIA; RETICULOENDOTHELIAL CLEARANCE; PHARMACODYNAMIC PROFILE; PNEUMOCOCCAL CARRIAGE; NON-SUSCEPTIBILITY; ANTIBODIES; COMPLEMENT; OPSONIZATION; BACTEREMIA	Background: Specific antibodies are likely to be present before S. pneumoniae infection. We explored cefditoren (CDN) total and free values of serum concentrations exceeding the MIC (t>MIC) related to efficacy in a mice sepsis model, and the effect of specific gammaglobulins on in-vitro phagocytosis and in-vivo efficacy. Methodology/Principal Findings: We used three pneumococcal isolates (serotype, MIC of CDN): Strain 1 (6B, 1 mu g/ml), Strain 2 (19F, 2 mu g/ml) and Strain 3 (23F, 4 mu g/ml). Hyperimmune serum (HS) was obtained from mice immunized with heat-inactivated strains. In-vitro, phagocytosis by HS diluted 1/10 in presence/absence of sub-inhibitory concentrations was measured by flow cytometry including fluorescent bacteria and a neutrophil cell line. In-vivo dose-ranging experiments with HS (dilutions 1/2-1/16) and CDN (6.25 mg/kg-100 mg/kg tid for 48 h) were performed to determine the minimal protective dilution/dose (highest survival) and the non-protective highest dilution/dose (highest mortality: HS-np dilution and CDN-np dose) over 7 days. Efficacy of CDN-np in animals pre-immunized with HS-np (combined strategy) was explored and blood bacterial clearance determined. The CDN measured protein binding was 86.9%. In-vitro, CDN significantly increased phagocytosis (vs. HS 1/10). In non pre-immunized animals, t>MIC values for CDN of approximate to 35% (total) and approximate to 19% (free) were associated with 100% survival. Significant differences in survival were found between HS-np alone (<= 20%) or CDN-np alone (<= 20%) vs. the combined strategy (90%, 60% and 60% for Stains 1, 2 and 3), with t>MIC (total/free) of 22.8%/14.3%, 26.8%/16.0%, and 22.4%/12.7% for Strains 1, 2 and 3, respectively. Prior to the second dose (8 h), median bacterial counts were significantly lower in animals surviving vs. dead at day 7. Conclusions/Significance: In mice (CDN protein binding similar to humans) total t. MIC values of approximate to 35% (approximate to 19% free) were efficacious, with a decrease in the required values in pre-immunized animals. This reinforces that immunoprotection to overcome resistance may provide lifesaving strategies.	[Cafini, Fabio; Gimenez, Maria-Jose; Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Torrico, Martha; Gonzalez, Natalia; Prieto, Jose] Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Dept Sci, Madrid, Spain; [Yuste, Jose; Ramos-Sevillano, Elisa; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Yuste, Jose; Ramos-Sevillano, Elisa; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cafini, F (corresponding author), Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Prieto, José/G-5644-2010; YUSTE, JOSE/ABG-9851-2020; Alou, Luis/B-8170-2011; Gimenez, Maria Jose/GXF-2237-2022; Sevillano, David/G-5661-2010; Hidalgo, Natalia González/X-6840-2018; Cafini, Fabio/AAA-7938-2020; Sevillano, Elisa Ramos/J-4824-2016	Alou, Luis/0000-0002-0859-008X; Gimenez, Maria Jose/0000-0003-0830-4095; Hidalgo, Natalia González/0000-0002-6874-954X; Cafini, Fabio/0000-0002-5442-1674; Sevillano, Elisa Ramos/0000-0003-0803-2755; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; Sevillano Fernandez, David/0000-0003-0212-2194; YUSTE, JOSE/0000-0001-7996-0837	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. Tedec-Meiji Farma S.A. had a role in providing reagents, materials and analysis tools.	BROWN EJ, 1981, J RETICULOENDOTH SOC, V30, P23; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; CRAIG W. A., 1991, ANTIBIOTICS LAB MED, P367, DOI Williams & Wilkins; CRAIG WA, 2000, 40 ICAAC 2000 SEPT 1; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fenoll A, 2008, J ANTIMICROB CHEMOTH, V62, P1430, DOI 10.1093/jac/dkn413; Fenoll A, 2008, EUR J CLIN MICROBIOL, V27, P75, DOI 10.1007/s10096-007-0402-5; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; Fenoll A, 2007, J ANTIMICROB CHEMOTH, V60, P323, DOI 10.1093/jac/dkm209; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Fukuoka T, 1998, ANTIMICROB AGENTS CH, V42, P23, DOI 10.1128/AAC.42.1.23; Granizo JJ, 2008, INT J ANTIMICROB AG, V31, P396, DOI 10.1016/j.ijantimicag.2007.10.024; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; LUJAN M, 2010, EUR RESP J      0211; Martinez JE, 1999, CLIN DIAGN LAB IMMUN, V6, P581, DOI 10.1128/CDLI.6.4.581-586.1999; Nicasio AM, 2009, ANTIMICROB AGENTS CH, V53, P2756, DOI 10.1128/AAC.01678-08; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Rodriguez-Cerrato V, 2010, DIAGN MICR INFEC DIS, V66, P336, DOI 10.1016/j.diagmicrobio.2009.10.015; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Yuste J, 2002, J ANTIMICROB CHEMOTH, V49, P331, DOI 10.1093/jac/49.2.331; Yuste J, 2002, CLIN EXP IMMUNOL, V128, P411, DOI 10.1046/j.1365-2249.2002.01860.x; Yuste J, 2002, ANTIMICROB AGENTS CH, V46, P4043, DOI 10.1128/AAC.46.12.4043-4044.2002; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	31	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12041	10.1371/journal.pone.0012041	http://dx.doi.org/10.1371/journal.pone.0012041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706584	gold, Green Published, Green Submitted			2022-12-27	WOS:000280811900009
J	Negri, M; Recanatini, M; Hartmann, RW				Negri, Matthias; Recanatini, Maurizio; Hartmann, Rolf W.			Insights in 17 beta-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation	PLOS ONE			English	Article							17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1 17-BETA-HSD1; HUMAN ESTROGENIC 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; SELECTIVE NONSTEROIDAL INHIBITORS; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; HYDROXYSTEROID DEHYDROGENASES; BIOLOGICAL EVALUATION; MOLECULAR-DYNAMICS; BREAST-CANCER; ESTRONE REDUCTION; CRYSTAL-STRUCTURE	Background: Bisubstrate enzymes, such as 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1), exist in solution as an ensemble of conformations. 17 beta-HSD1 catalyzes the last step of the biosynthesis of estradiol and, thus, it is a potentially attractive target for breast cancer treatment. Methodology/Principal Findings: To elucidate the conformational transitions of its catalytic cycle, a structural analysis of all available crystal structures was performed and representative conformations were assigned to each step of the putative kinetic mechanism. To cover most of the conformational space, all-atom molecular dynamic simulations were performed using the four crystallographic structures best describing apoform, opened, occluded and closed state of 17 beta-HSD1 as starting structures. With three of them, binary and ternary complexes were built with NADPH and NADPH-estrone, respectively, while two were investigated as apoform. Free energy calculations were performed in order to judge more accurately which of the MD complexes describes a specific kinetic step. Conclusions/Significance: Remarkably, the analysis of the eight long range trajectories resulting from this multi-trajectory/complex approach revealed an essential role played by the backbone and side chain motions, especially of the beta FaG'-loop, in cofactor and substrate binding. Thus, a selected-fit mechanism is suggested for 17 beta-HSD1, where ligand-binding induced concerted motions of the FG-segment and the C-terminal part guide the enzyme along its preferred catalytic pathway. Overall, we could assign different enzyme conformations to the five steps of the random bi-bi kinetic cycle of 17 beta-HSD1 and we could postulate a preferred pathway for it. This study lays the basis for more-targeted biochemical studies on 17 beta-HSD1, as well as for the design of specific inhibitors of this enzyme. Moreover, it provides a useful guideline for other enzymes, also characterized by a rigid core and a flexible region directing their catalysis.	[Negri, Matthias; Hartmann, Rolf W.] Univ Saarland, D-6600 Saarbrucken, Germany; [Recanatini, Maurizio] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Negri, Matthias; Hartmann, Rolf W.] Helmholtz Inst Pharmaceut Res Saarland, Saarbrucken, Germany	Saarland University; University of Bologna; Helmholtz Association; Helmholtz-Center for Infection Research	Negri, M (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	rwh@mx.uni-saarland.de	Recanatini, Maurizio/GXH-1338-2022; Recanatini, Maurizio/AAU-3319-2021	Recanatini, Maurizio/0000-0002-0039-0518				Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ G, 1971, J BIOL CHEM, V246, P2063; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Brozic P, 2008, CURR MED CHEM, V15, P137; Case D, 2006, AMBER 9; Cooper WC, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703414200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; Gangloff A, 2002, FASEB J, V16, P274, DOI 10.1096/fj.02-0397fje; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Ghosh D, 2001, CHEM-BIOL INTERACT, V130, P637, DOI 10.1016/S0009-2797(00)00255-6; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Han Q, 2000, J BIOL CHEM, V275, P1105, DOI 10.1074/jbc.275.2.1105; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibarra CA, 2003, J BIOL CHEM, V278, P19257, DOI 10.1074/jbc.M301566200; Jin JZ, 1999, BIOCHEM BIOPH RES CO, V259, P489, DOI 10.1006/bbrc.1999.0704; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karkola S, 2008, CHEMMEDCHEM, V3, P461, DOI 10.1002/cmdc.200700271; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruchten P, 2009, J STEROID BIOCHEM, V114, P200, DOI 10.1016/j.jsbmb.2009.02.006; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Lerner MG, 2007, J CHEM INF MODEL, V47, P2358, DOI 10.1021/ci700167n; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; MAZUMDAR M, 2009, 17BETA HSD1 STIMULAT, DOI DOI 10.2210/PDB3DEY/PDB; Mazumdar M, 2009, BIOCHEM J, V424, P357, DOI 10.1042/BJ20091020; Mazza C, 1998, J BIOL CHEM, V273, P8145, DOI 10.1074/jbc.273.14.8145; Mazza C, 1997, HUMAN TYPE 1 17 BETA, DOI [10.2210/pdb1a27/pdb, DOI 10.2210/PDB1A27/PDB]; Messinger J, 2006, MOL CELL ENDOCRINOL, V248, P192, DOI 10.1016/j.mce.2005.11.044; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Miyoshi Y, 2001, INT J CANCER, V94, P685, DOI 10.1002/ijc.1525; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Poirier D, 2005, J MED CHEM, V48, P8134, DOI 10.1021/jm058235e; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Prehn C, 2009, J STEROID BIOCHEM, V114, P72, DOI 10.1016/j.jsbmb.2008.12.024; Puranen T, 1997, MOL ENDOCRINOL, V11, P77, DOI 10.1210/me.11.1.77; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasano H, 1996, J CLIN ENDOCR METAB, V81, P4042, DOI 10.1210/jc.81.11.4042; Sawicki MW, 1999, P NATL ACAD SCI USA, V96, P840, DOI 10.1073/pnas.96.3.840; Sherbet DP, 2007, MOL CELL ENDOCRINOL, V265, P83, DOI 10.1016/j.mce.2006.12.021; Sherbet DP, 2009, ENDOCRINOLOGY, V150, P4154, DOI 10.1210/en.2008-1817; Shi R, 2004, J BIOL CHEM, V279, P16778, DOI 10.1074/jbc.M313156200; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; THORPE MF, CASE DA RIGIDITY THE, P329; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223	59	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12026	10.1371/journal.pone.0012026	http://dx.doi.org/10.1371/journal.pone.0012026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706575	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900004
J	Hobaiter, C; Byrne, RW				Hobaiter, Catherine; Byrne, Richard W.			Able-Bodied Wild Chimpanzees Imitate a Motor Procedure Used by a Disabled Individual to Overcome Handicap	PLOS ONE			English	Article							TOOL USE; CAPUCHIN MONKEYS; PAN-TROGLODYTES; CULTURE; EVOLUTION; CHILDREN; ANIMALS; COMPLEXITY; CONFORMITY; BEHAVIOR	Chimpanzee culture has generated intense recent interest, fueled by the technical complexity of chimpanzee tool-using traditions; yet it is seriously doubted whether chimpanzees are able to learn motor procedures by imitation under natural conditions. Here we take advantage of an unusual chimpanzee population as a 'natural experiment' to identify evidence for imitative learning of this kind in wild chimpanzees. The Sonso chimpanzee community has suffered from high levels of snare injury and now has several manually disabled members. Adult male Tinka, with near-total paralysis of both hands, compensates inability to scratch his back manually by employing a distinctive technique of holding a growing liana taut while making side-to-side body movements against it. We found that seven able-bodied young chimpanzees also used this 'liana-scratch' technique, although they had no need to. The distribution of the liana-scratch technique was statistically associated with individuals' range overlap with Tinka and the extent of time they spent in parties with him, confirming that the technique is acquired by social learning. The motivation for able-bodied chimpanzees copying his variant is unknown, but the fact that they do is evidence that the imitative learning of motor procedures from others is a natural trait of wild chimpanzees.	[Hobaiter, Catherine] Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Hobaiter, C (corresponding author), Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	rwb@st-andrews.ac.uk		Hobaiter, Cat/0000-0002-3893-0524; Byrne, Richard/0000-0001-9862-9373	Wenner-Gren Foundation; Russell Trust	Wenner-Gren Foundation; Russell Trust	Fieldwork of CH was generously supported by grants from the Wenner-Gren Foundation (http://wennergren.org) and the Russell Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates LA, 2010, WIRES COGN SCI, V1, P685, DOI 10.1002/wcs.77; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boesch C, 2000, CHIMPANZEES TAI FORE; Boyd R., 1985, CULTURE EVOLUTIONARY; Byrne R., 2006, INT J PSYCHOL PSYCHO, V6, P215; Byrne R.W., 1994, P223; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Byrne Richard W., 1999, Animal Cognition, V2, P63, DOI 10.1007/s100710050025; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; Byrne Richard W., 1999, Symposia of the Zoological Society of London, V72, P333; BYRNE RW, 1993, AM J PRIMATOL, V31, P241, DOI 10.1002/ajp.1350310402; Byrne RW, 2004, TRENDS COGN SCI, V8, P341, DOI 10.1016/j.tics.2004.06.002; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Byrne RW, 2003, PHILOS T R SOC B, V358, P529, DOI 10.1098/rstb.2002.1219; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Byrne RW, 2001, BEHAVIOUR, V138, P525, DOI 10.1163/156853901750382142; BYRNE RW, 2006, ROOTS HUMAN SOCIALIT, P478; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Corp N, 2002, ETHOLOGY, V108, P673, DOI 10.1046/j.1439-0310.2002.00801.x; Corp N, 2002, BEHAVIOUR, V139, P137, DOI 10.1163/15685390252902328; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Fox Elizabeth A., 1999, P99, DOI 10.1017/CBO9780511542305.005; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; Galef Bennett G. Jr, 2003, P159, DOI 10.1017/CBO9780511584022.007; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Goodall J., 1986, CHIMPANZEES GOMBE PA; Greenberg R, 2009, AM J PRIMATOL, V71, P80; Gruber T, 2009, CURR BIOL, V19, P1806, DOI 10.1016/j.cub.2009.08.060; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hoppitt WJE, 2008, TRENDS ECOL EVOL, V23, P486, DOI 10.1016/j.tree.2008.05.008; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Huffman MA, 1996, SOCIAL LEARNING ANIM; KAWAI M, 1992, PRIMATE REP, V32, P143; Kohler W., 1925, MENTALITY APES; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KevinN., 2003, ENCY COGNITIVE SCI, V2, P268; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; Mannu M, 2009, AM J PRIMATOL, V71, P242, DOI 10.1002/ajp.20642; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; NISHIDA T, 1986, PRIMATE SOC, P462; Perry S, 2003, EVOL ANTHROPOL, V12, P71, DOI 10.1002/evan.10105; Premack D., 1994, COMPANION ENCY ANTHR, P350; Quiatt D, 2002, AFR J ECOL, V40, P303, DOI 10.1046/j.1365-2028.2002.00356.x; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Reynolds V., 2005, CHIMPANZEES BUDONGO; Russon AE, 1998, PRIMATES, V39, P485, DOI 10.1007/BF02557571; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Stokes Emma J., 2001, Animal Cognition, V4, P11, DOI 10.1007/s100710100082; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M, 1998, BEHAV BRAIN SCI, V21, P703, DOI 10.1017/S0140525X98441748; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M, 1997, PRIMATE COGNITION; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; Want SC, 2002, DEVELOPMENTAL SCI, V5, P1, DOI 10.1111/1467-7687.00194; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wood D., 1989, INTERACTION HUMAN DE, P59; Zuberbuhler K., 2005, SONSO CHIMPANZEE DAT	77	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11959	10.1371/journal.pone.0011959	http://dx.doi.org/10.1371/journal.pone.0011959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700527	Green Published, gold, Green Submitted			2022-12-27	WOS:000280605400007
J	Lin, KY; Cheng, CP; Chang, BCH; Wang, WC; Huang, YW; Lee, YS; Huang, HD; Hsu, YH; Lin, NS				Lin, Kuan-Yu; Cheng, Chi-Ping; Chang, Bill Chia-Han; Wang, Wei-Chi; Huang, Ying-Wen; Lee, Yun-Shien; Huang, Hsien-Da; Hsu, Yau-Heiu; Lin, Na-Sheng			Global Analyses of Small Interfering RNAs Derived from Bamboo mosaic virus and Its Associated Satellite RNAs in Different Plants	PLOS ONE			English	Article							DICER-LIKE PROTEINS; TRANS-ACTING SIRNAS; TRIPLE-GENE-BLOCK; SUBCELLULAR-LOCALIZATION; SILENCING PATHWAYS; DOWN-REGULATION; GC PREFERENCE; ARABIDOPSIS; DEFENSE; BIOGENESIS	Background: Satellite RNAs (satRNAs), virus parasites, are exclusively associated with plant virus infection and have attracted much interest over the last 3 decades. Upon virus infection, virus-specific small interfering RNAs (vsiRNAs) are produced by dicer-like (DCL) endoribonucleases for anti-viral defense. The composition of vsiRNAs has been studied extensively; however, studies of satRNA-derived siRNAs (satsiRNAs) or siRNA profiles after satRNA co-infection are limited. Here, we report on the small RNA profiles associated with infection with Bamboo mosaic virus (BaMV) and its two satellite RNAs (satBaMVs) in Nicotiana benthamiana and Arabidopsis thaliana. Methodology/Principal Findings: Leaves of N. benthamiana or A. thaliana inoculated with water, BaMV alone or coinoculated with interfering or noninterfering satBaMV were collected for RNA extraction, then large-scale Solexa sequencing. Up to about 20% of total siRNAs as BaMV-specific siRNAs were accumulated in highly susceptible N. benthamiana leaves inoculated with BaMV alone or co-inoculated with noninterfering satBaMV; however, only about 0.1% of vsiRNAs were produced in plants co-infected with interfering satBaMV. The abundant region of siRNA distribution along BaMV and satBaMV genomes differed by host but not by co-infection with satBaMV. Most of the BaMV and satBaMV siRNAs were 21 or 22 nt, of both (+) and (-) polarities; however, a higher proportion of 22-nt BaMV and satBaMV siRNAs were generated in N. benthamiana than in A. thaliana. Furthermore, the proportion of non-viral 24-nt siRNAs was greatly increased in N. benthamiana after virus infection. Conclusions/Significance: The overall composition of vsiRNAs and satsiRNAs in the infected plants reflect the combined action of virus, satRNA and different DCLs in host plants. Our findings suggest that the structure and/or sequence demands of various DCLs in different hosts may result in differential susceptibility to the same virus. DCL2 producing 24-nt siRNAs under biotic stresses may play a vital role in the antiviral mechanism in N. benthamiana.	[Lin, Kuan-Yu; Lin, Na-Sheng] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Cheng, Chi-Ping] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chang, Bill Chia-Han; Lin, Na-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Wei-Chi; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Ying-Wen; Hsu, Yau-Heiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Tao Yuan, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Cheng Kung University; Tzu Chi University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Chung Hsing University; Ming Chuan University; National Yang Ming Chiao Tung University	Lin, KY (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan.	nslin@sinica.edu.tw	Huang, Hsien-Da/AAA-7376-2019	Chang, Bill Chia-Han/0000-0001-5313-4852	National Science Council [NSC-95-2323-B-001-029-]; Academia Sinica, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This research was supported in part by grants from the National Science Council (NSC-95-2323-B-001-029-) and from Academia Sinica (Investigator Award Project), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2003, VIROLOGY, V311, P229, DOI 10.1016/S0042-6822(03)00178-8; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe D, 1999, ARCH VIROL, P189; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chang BY, 1997, J GEN VIROL, V78, P1175, DOI 10.1099/0022-1317-78-5-1175; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HC, 2007, VIROLOGY, V365, P271, DOI 10.1016/j.virol.2007.03.050; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; DONAIRE L, 2009, VIROLOGY; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Havelda Z, 2005, J VIROL, V79, P450, DOI 10.1128/JVI.79.1.450-457.2005; Herr AJ, 2004, COLD SPRING HARB SYM, V69, P363, DOI 10.1101/sqb.2004.69.363; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Ho T, 2006, J VIROL METHODS, V136, P217, DOI 10.1016/j.jviromet.2006.05.016; Hsu YH, 2006, J VIROL, V80, P2566, DOI 10.1128/JVI.80.5.2566-2574.2006; Hsu YH, 1998, MOL PLANT MICROBE IN, V11, P1207, DOI 10.1094/MPMI.1998.11.12.1207; Huang YW, 2009, VIROLOGY, V386, P139, DOI 10.1016/j.virol.2009.01.019; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jones L, 2002, TRENDS PLANT SCI, V7, P473, DOI 10.1016/S1360-1385(02)02361-0; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lin MK, 2004, J GEN VIROL, V85, P251, DOI 10.1099/vir.0.19442-0; LIN NS, 1994, VIROLOGY, V202, P707, DOI 10.1006/viro.1994.1392; Lin NS, 1996, P NATL ACAD SCI USA, V93, P3138, DOI 10.1073/pnas.93.7.3138; LIN NS, 1993, PLANT DIS, V77, P448, DOI 10.1094/PD-77-0448; LIN NS, 1994, J GEN VIROL, V75, P2513, DOI 10.1099/0022-1317-75-9-2513; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Markarian N, 2004, ARCH VIROL, V149, P397, DOI 10.1007/s00705-003-0215-5; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Palani PV, 2006, MOL PLANT MICROBE IN, V19, P758, DOI 10.1094/MPMI-19-0758; Palani PV, 2009, J GEN VIROL, V90, P507, DOI 10.1099/vir.0.004994-0; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; SCHOEMAKER HJ, 1974, J MOL BIOL, V84, P503, DOI 10.1016/0022-2836(74)90112-0; St-Pierre P, 2009, VIROLOGY, V383, P178, DOI 10.1016/j.virol.2008.11.008; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Waterhouse PM, 2006, SCIENCE, V313, P54, DOI 10.1126/science.1130818; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yeh WB, 2004, VIROLOGY, V330, P105, DOI 10.1016/j.virol.2004.09.025; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07	64	34	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11928	10.1371/journal.pone.0011928	http://dx.doi.org/10.1371/journal.pone.0011928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689857	Green Published, gold			2022-12-27	WOS:000280520400014
J	Butler, KL; Ambravaneswaran, V; Agrawal, N; Bilodeau, M; Toner, M; Tompkins, RG; Fagan, S; Irimia, D				Butler, Kathryn L.; Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel			Burn Injury Reduces Neutrophil Directional Migration Speed in Microfluidic Devices	PLOS ONE			English	Article							LEUKOCYTE CHEMOTAXIS INVITRO; POLYMORPHONUCLEAR LEUKOCYTES; CELL-MIGRATION; GRADIENT GENERATOR; THERMAL-INJURY; EARLY EXCISION; ORGAN FAILURE; INFECTION; COMPLEMENT; EXPRESSION	Thermal injury triggers a fulminant inflammatory cascade that heralds shock, end-organ failure, and ultimately sepsis and death. Emerging evidence points to a critical role for the innate immune system, and several studies had documented concurrent impairment in neutrophil chemotaxis with these post-burn inflammatory changes. While a few studies suggest that a link between neutrophil motility and patient mortality might exist, so far, cumbersome assays have prohibited exploration of the prognostic and diagnostic significance of chemotaxis after burn injury. To address this need, we developed a microfluidic device that is simple to operate and allows for precise and robust measurements of chemotaxis speed and persistence characteristics at single-cell resolution. Using this assay, we established a reference set of migration speed values for neutrophils from healthy subjects. Comparisons with samples from burn patients revealed impaired directional migration speed starting as early as 24 hours after burn injury, reaching a minimum at 72-120 hours, correlated to the size of the burn injury and potentially serving as an early indicator for concurrent infections. Further characterization of neutrophil chemotaxis using this new assay may have important diagnostic implications not only for burn patients but also for patients afflicted by other diseases that compromise neutrophil functions.	[Butler, Kathryn L.; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA; [Butler, Kathryn L.; Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Bilodeau, Maryelizabeth; Toner, Mehmet; Tompkins, Ronald G.; Fagan, Shawn; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Ambravaneswaran, Vijayakrishnan; Agrawal, Nitin; Toner, Mehmet; Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, Ctr Engn Med & Surg Serv, BioMEMS Resource Ctr, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Butler, KL (corresponding author), Shriners Hosp Children, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA.	dirimia@hms.harvard.edu	Irimia, Daniel/A-4095-2008; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082	National Institutes of Health [R01M092804]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from the National Institutes of Health (R01M092804) and the Shriners Hospitals for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Adams JM, 2001, J TRAUMA, V51, P452, DOI 10.1097/00005373-200109000-00005; Agrawal N, 2008, LAB CHIP, V8, P2054, DOI 10.1039/b813588f; Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; BABCOCK GF, 1990, CLIN IMMUNOL IMMUNOP, V54, P117, DOI 10.1016/0090-1229(90)90011-E; BJERKNES R, 1990, BLOOD CELLS, V16, P127; BJORNSON AB, 1993, J INFECT DIS, V168, P120, DOI 10.1093/infdis/168.1.120; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BRANSKI LK, 2009, ANN SURG; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Cheng XH, 2007, LAB CHIP, V7, P170, DOI 10.1039/b612966h; Chung BG, 2006, LAB CHIP, V6, P764, DOI 10.1039/b512667c; DAVIGNON LC, BURNS; DECHALAIN TMB, 1994, BURNS, V20, P416, DOI 10.1016/0305-4179(94)90033-7; DEITCH EA, 1990, J TRAUMA, V30, P259, DOI 10.1097/00005373-199003000-00003; Frevert CW, 2006, LAB CHIP, V6, P849, DOI 10.1039/b515560f; GERISCH G, 1981, J CELL SCI, V52, P1; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; HARTMAN RS, 1994, BIOPHYS J, V67, P2535, DOI 10.1016/S0006-3495(94)80743-X; Hasslen Sharon R., 1993, Journal of Burn Care and Rehabilitation, V14, P303, DOI 10.1097/00004630-199305000-00001; HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Ipaktchi K, 2006, CRIT CARE MED, V34, pS239, DOI 10.1097/01.CCM.0000232625.63460.D4; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Keenan TM, 2010, LAB CHIP, V10, P116, DOI 10.1039/b913494h; Kim D, 2009, LAB CHIP, V9, P1797, DOI 10.1039/b901613a; KIM Y, 1989, BURNS, V15, P93, DOI 10.1016/0305-4179(89)90137-X; Lakshman R, 2001, J CLIN PATHOL, V54, P7, DOI 10.1136/jcp.54.1.7; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu YX, 2008, BIOMED MICRODEVICES, V10, P499, DOI 10.1007/s10544-007-9158-z; Malawista SE, 1997, P NATL ACAD SCI USA, V94, P11577, DOI 10.1073/pnas.94.21.11577; MANKTELOW A, 1986, J TRAUMA, V26, P143, DOI 10.1097/00005373-198602000-00008; Mileski W., 1993, Journal of Burn Care and Rehabilitation, V14, P610, DOI 10.1097/00004630-199311000-00005; MILESKI WJ, 1994, EUR J PEDIATR SURG, V4, P225, DOI 10.1055/s-2008-1066110; MILESKI WJ, 1993, J SURG RES, V54, P349, DOI 10.1006/jsre.1993.1056; MOORE FD, 1986, NEW ENGL J MED, V314, P948, DOI 10.1056/NEJM198604103141503; Murray CK, 2007, ARCH SURG-CHICAGO, V142, P639, DOI 10.1001/archsurg.142.7.639; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; NELSON RD, 1975, J IMMUNOL, V115, P1650; NWARIAKU FE, 1995, J TRAUMA, V39, P285, DOI 10.1097/00005373-199508000-00016; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Ong YS, 2006, BURNS, V32, P145, DOI 10.1016/j.burns.2005.09.005; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Pereira Clifford T, 2005, Adv Surg, V39, P245, DOI 10.1016/j.yasu.2005.05.005; RANSJO U, 1977, BURNS, V3, P171, DOI 10.1016/0305-4179(77)90006-7; Russom A, 2008, CLIN CHEM, V54, P891, DOI 10.1373/clinchem.2007.099150; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Saffle JR, 2007, J BURN CARE RES, V28, P382, DOI 10.1097/BCR.0B013E318053D3A1; Salinas J, 2008, J TRAUMA, V64, pS321, DOI 10.1097/TA.0b013e31816bf4f7; SOLOMKIN JS, 1990, J TRAUMA, V30, pS80; SOLOMKIN JS, 1984, ANN SURG, V200, P742, DOI 10.1097/00000658-198412000-00012; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; TOMPKINS RG, 1988, ANN SURG, V208, P577, DOI 10.1097/00000658-198811000-00006; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; WARDEN GD, 1975, ANN SURG, V181, P363, DOI 10.1097/00000658-197503000-00019; WARDEN GD, 1974, J CLIN INVEST, V54, P1001, DOI 10.1172/JCI107815; White CE, 2008, CRIT CARE MED, V36, pS318, DOI 10.1097/CCM.0b013e31817e2d64; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Wu XW, 2002, ARCH SURG-CHICAGO, V137, P1049, DOI 10.1001/archsurg.137.9.1049; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	66	89	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11921	10.1371/journal.pone.0011921	http://dx.doi.org/10.1371/journal.pone.0011921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689600	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520300030
J	Paungfoo-Lonhienne, C; Rentsch, D; Robatzek, S; Webb, RI; Sagulenko, E; Nasholm, T; Schmidt, S; Lonhienne, TGA				Paungfoo-Lonhienne, Chanyarat; Rentsch, Doris; Robatzek, Silke; Webb, Richard I.; Sagulenko, Evgeny; Nasholm, Torgny; Schmidt, Susanne; Lonhienne, Thierry G. A.			Turning the Table: Plants Consume Microbes as a Source of Nutrients	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ROOT; GROWTH; NITROGEN; COLONIZATION; INFECTION; PROTEIN; EXPRESSION; EVOLUTION; SEEDLINGS	Interactions between plants and microbes in soil, the final frontier of ecology, determine the availability of nutrients to plants and thereby primary production of terrestrial ecosystems. Nutrient cycling in soils is considered a battle between autotrophs and heterotrophs in which the latter usually outcompete the former, although recent studies have questioned the unconditional reign of microbes on nutrient cycles and the plants' dependence on microbes for breakdown of organic matter. Here we present evidence indicative of a more active role of plants in nutrient cycling than currently considered. Using fluorescent-labeled non-pathogenic and non-symbiotic strains of a bacterium and a fungus (Escherichia coli and Saccharomyces cerevisiae, respectively), we demonstrate that microbes enter root cells and are subsequently digested to release nitrogen that is used in shoots. Extensive modifications of root cell walls, as substantiated by cell wall outgrowth and induction of genes encoding cell wall synthesizing, loosening and degrading enzymes, may facilitate the uptake of microbes into root cells. Our study provides further evidence that the autotrophy of plants has a heterotrophic constituent which could explain the presence of root-inhabiting microbes of unknown ecological function. Our discovery has implications for soil ecology and applications including future sustainable agriculture with efficient nutrient cycles.	[Paungfoo-Lonhienne, Chanyarat; Schmidt, Susanne; Lonhienne, Thierry G. A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Robatzek, Silke] Sainsbury Lab, Norwich, Norfolk, England; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Sagulenko, Evgeny] Univ Queensland, Sch Biochem & Mol Biosci, Brisbane, Qld, Australia; [Nasholm, Torgny] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	University of Queensland; University of Bern; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Queensland; University of Queensland; Swedish University of Agricultural Sciences	Paungfoo-Lonhienne, C (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	Chanyarat@uq.edu.au	Schmidt, Susanne/B-2780-2009; Robatzek, Silke/B-6844-2013; Lonhienne, Thierry/A-5828-2011; Paungfoo-Lonhienne, Chanyarat/A-5816-2011	Schmidt, Susanne/0000-0001-8369-1238; Paungfoo-Lonhienne, Chanyarat/0000-0002-8361-2058; Rentsch, Doris/0000-0003-4313-7683; Nasholm, Torgny/0000-0002-2275-2030	Australian Research Council [DP0986495]; The University of Queensland	Australian Research Council(Australian Research Council); The University of Queensland(University of Queensland)	This research was funded by the Australian Research Council (DP0986495 to SS, DR, TN, and SR) and The University of Queensland (to CPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 2006, PLANT-ASSOCIATED BACTERIA, P155; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BAJWA R, 1985, NEW PHYTOL, V101, P469, DOI 10.1111/j.1469-8137.1985.tb02853.x; BARON C, 1995, TRENDS BIOTECHNOL, V13, P356, DOI 10.1016/S0167-7799(00)88981-7; BERG RH, 1988, J ELECTRON MICR TECH, V8, P371, DOI 10.1002/jemt.1060080406; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; Coleman DJ, 2007, ANAL BIOCHEM, V371, P146, DOI 10.1016/j.ab.2007.08.027; ENGLISH PD, 1971, PLANT PHYSIOL, V47, P1, DOI 10.1104/pp.47.1.1; Ferguson BJ, 2010, J INTEGR PLANT BIOL, V52, P61, DOI 10.1111/j.1744-7909.2010.00899.x; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; James EK, 2002, MOL PLANT MICROBE IN, V15, P894, DOI 10.1094/MPMI.2002.15.9.894; JONES DL, 1994, PLANT SOIL, V158, P183, DOI 10.1007/BF00009493; Kovtunovych G, 1999, PLANT SOIL, V215, P1, DOI 10.1023/A:1004790122353; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; McCurdy DW, 2008, CURR OPIN PLANT BIOL, V11, P653, DOI 10.1016/j.pbi.2008.08.005; MENDGEN K, 1993, NEW PHYTOL, V124, P193, DOI 10.1111/j.1469-8137.1993.tb03809.x; Morgan JA, 2002, SCIENCE, V298, P1903, DOI 10.1126/science.1079808; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Paungfoo-Lonhienne C, 2010, PLANT PHYSIOL, V153, P799, DOI 10.1104/pp.110.154963; Puente ME, 1999, FEMS MICROBIOL ECOL, V29, P283, DOI 10.1111/j.1574-6941.1999.tb00619.x; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; Reinhold-Hurek B., 2007, P427, DOI 10.1007/978-1-4020-5843-1_30; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Robledo M, 2008, P NATL ACAD SCI USA, V105, P7064, DOI 10.1073/pnas.0802547105; Rothballer M, 2008, FEMS MICROBIOL ECOL, V66, P85, DOI 10.1111/j.1574-6941.2008.00582.x; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Triplett EW, 1996, PLANT SOIL, V186, P29, DOI 10.1007/BF00035052; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Zhu YM, 2003, PLANT PHYSIOL, V133, P1000, DOI 10.1104/pp.103.030726	51	92	94	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11915	10.1371/journal.pone.0011915	http://dx.doi.org/10.1371/journal.pone.0011915			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689833	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520300026
J	Lescai, F; Franceschi, C				Lescai, Francesco; Franceschi, Claudio			The Impact of Phenocopy on the Genetic Analysis of Complex Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR-DIMENSIONALITY REDUCTION; SUSCEPTIBILITY LOCUS; EPISTASIS; PATTERNS; DISEASE; REPLICATION; DISCOVERY; FAMILY; CANCER	A consistent debate is ongoing on genome-wide association studies (GWAs). A key point is the capability to identify low-penetrance variations across the human genome. Among the phenomena reducing the power of these analyses, phenocopy level (PE) hampers very seriously the investigation of complex diseases, as well known in neurological disorders, cancer, and likely of primary importance in human ageing. PE seems to be the norm, rather than the exception, especially when considering the role of epigenetics and environmental factors towards phenotype. Despite some attempts, no recognized solution has been proposed, particularly to estimate the effects of phenocopies on the study planning or its analysis design. We present a simulation, where we attempt to define more precisely how phenocopy impacts on different analytical methods under different scenarios. With our approach the critical role of phenocopy emerges, and the more the PE level increases the more the initial difficulty in detecting gene-gene interactions is amplified. In particular, our results show that strong main effects are not hampered by the presence of an increasing amount of phenocopy in the study sample, despite progressively reducing the significance of the association, if the study is sufficiently powered. On the opposite, when purely epistatic effects are simulated, the capability of identifying the association depends on several parameters, such as the strength of the interaction between the polymorphic variants, the penetrance of the polymorphism and the alleles (minor or major) which produce the combined effect and their frequency in the population. We conclude that the neglect of the possible presence of phenocopies in complex traits heavily affects the analysis of their genetic data.	[Lescai, Francesco] UCL, Div Res Strategy, London, England; [Lescai, Francesco; Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Ctr L Galvani Biocomplex, Bologna, Italy; [Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Dept Expt Pathol, Bologna, Italy	University of London; University College London; University of Bologna; University of Bologna	Lescai, F (corresponding author), UCL, Div Res Strategy, London, England.	f.lescai@ucl.ac.uk	Lescai, Francesco/F-8680-2010; Franceschi, Claudio/L-4484-2017	Franceschi, Claudio/0000-0001-9841-6386; Lescai, Francesco/0000-0002-6399-9101				Bass MP, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P93; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; BUTCHER LM, 2008, BEHAV GENET; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Curtis D, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-30; DEBENEDICTIS G, 2006, SCI AGING KNOWLEDGE, pPE20, DOI DOI 10.1126/SAGEKE.2006.10.PE20; Dong CZ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001262; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; EDWARDS TL, 2007, 2007 ANN M AM SOC HU; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451; Guthery SL, 2007, AM J HUM GENET, V81, P1221, DOI 10.1086/522239; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ionita-Laza I, 2007, AM J HUM GENET, V81, P607, DOI 10.1086/519748; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Kingsmore SF, 2008, NAT REV DRUG DISCOV, V7, P221, DOI 10.1038/nrd2519; Kooperberg C, 2001, GENET EPIDEMIOL, V21, pS626, DOI 10.1002/gepi.2001.21.s1.s626; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; LI C, 2008, GENET EPIDEMIOL; LI M, 2008, EUR J HUM GENET; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Moore JH, 2007, HUM HERED, V63, P120, DOI 10.1159/000099184; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, APPL SOFT COMPUT, V4, P79, DOI 10.1016/j.asoc.2003.08.003; Motsinger-Reif Alison A, 2008, BMC Res Notes, V1, P65, DOI 10.1186/1756-0500-1-65; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Schmidt M, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1133; Schwender H, 2008, BIOSTATISTICS, V9, P187, DOI 10.1093/biostatistics/kxm024; Singh SM, 2004, CLIN GENET, V65, P435, DOI 10.1111/j.1399-0004.2004.00269.x; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wider C, 2008, NEUROLOGY, V70, P1377, DOI 10.1212/01.wnl.0000275527.35752.c5; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wongseree W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-294; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Zeggini E, 2008, NAT GENET; Zubenko GS, 2001, MOL PSYCHIATR, V6, P413, DOI 10.1038/sj.mp.4000900	57	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11876	10.1371/journal.pone.0011876	http://dx.doi.org/10.1371/journal.pone.0011876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686705	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200038
J	Li, P; Harris, D; Liu, ZM; Liu, J; Keating, M; Estrov, Z				Li, Ping; Harris, David; Liu, Zhiming; Liu, Jie; Keating, Michael; Estrov, Zeev			Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							BRACHYDACTYLY TYPE-B; NF-KAPPA-B; RECESSIVE ROBINOW-SYNDROME; MULTIPLE-MYELOMA CELLS; WNT SIGNALING PATHWAY; EMBRYONIC STEM-CELLS; DNA-BINDING; CONSTITUTIVE ACTIVATION; THERAPEUTIC TARGET; RNAI SCREEN	Background: The receptor tyrosine kinase like orphan receptor (ROR)-1 gene is overexpressed in chronic lymphocytic leukemia (CLL). Because Stat3 is constitutively activated in CLL and sequence analysis revealed that the ROR1 promoter harbors gamma-interferon activation sequence-like elements typically activated by Stat3, we hypothesized that Stat3 activates ROR1. Methodology/Principal Findings: Because IL-6 induced Stat3 phosphorylation and upregulated Ror1 protein levels in MM1 cells, we used these cells as a model. We transfected MM1 cells with truncated ROR1 promoter luciferase reporter constructs and found that IL-6 induced luciferase activity of ROR1-195 and upstream constructs. Co-transfection with Stat3 siRNA reduced the IL-6-induced luciferase activity, suggesting that IL-6 induced luciferase activity by activating Stat3. EMSA and the ChIP assay confirmed that Stat3 binds ROR1, and EMSA studies identified two Stat3 binding sites. In CLL cells, EMSA and ChIP studies determined that phosphorylated Stat3 bound to the ROR1 promoter at those two ROR1 promoter sites, and ChIP analysis showed that Stat3 co-immunoprecipitated DNA of STAT3, ROR1, and several Stat3-regulated genes. Finally, like STAT3-siRNA in MM1 cells, STAT3-shRNA downregulated STAT3, ROR1, and STAT3-regulated genes and Stat3 and Ror1 protein levels in CLL cells. Conclusion/Significance: Our data suggest that constitutively activated Stat3 binds to the ROR1 promoter and activates ROR1 in CLL cells.	[Li, Ping; Harris, David; Liu, Zhiming; Liu, Jie; Keating, Michael; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Li, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org			CLL Global Foundation	CLL Global Foundation	Funding for the project was received from the CLL Global Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Amit-Vazina M, 2005, BRIT J CANCER, V93, P70, DOI 10.1038/sj.bjc.6602637; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Bueso-Ramos Carlos E, 2004, Hematology, V9, P279, DOI 10.1080/10245330410001727046; Chatterjee M, 2002, BLOOD, V100, P3311, DOI 10.1182/blood-2002-01-0102; Chim CS, 2008, J CLIN PATHOL, V61, P1214, DOI 10.1136/jcp.2008.060152; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Ermakov S, 2007, OSTEOPOROSIS INT, V18, P1683, DOI 10.1007/s00198-007-0401-5; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fujio Y, 2004, FEBS LETT, V573, P202, DOI 10.1016/j.febslet.2004.07.082; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Jin GY, 2009, BIOORG MED CHEM LETT, V19, P606, DOI 10.1016/j.bmcl.2008.12.067; Katoh M, 2007, INT J MOL MED, V19, P699; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kim WB, 2007, J ENDOCRINOL, V193, P93, DOI 10.1677/JOE-06-0025; Liu TH, 2006, CANCER RES, V66, P653, DOI 10.1158/0008-5472.CAN-05-3712; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI200523409; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; WeberNordt RM, 1996, BLOOD, V88, P809; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yee KWL, 2006, MAYO CLIN PROC, V81, P1105, DOI 10.4065/81.8.1105; Yu CL, 1997, J IMMUNOL, V159, P5206; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466	50	47	50	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11859	10.1371/journal.pone.0011859	http://dx.doi.org/10.1371/journal.pone.0011859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686606	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200023
J	Manthey, GM; Bailis, AM				Manthey, Glenn M.; Bailis, Adam M.			Rad51 Inhibits Translocation Formation by Non-Conservative Homologous Recombination in Saccharomyces cerevisiae	PLOS ONE			English	Article							DOUBLE-STRAND-BREAK; REPLICATION PROTEIN-A; DIRECT REPEAT RECOMBINATION; HUMAN GENOME ARCHITECTURE; NONHOMOLOGOUS DNA ENDS; COPY NUMBER VARIATION; CHROMOSOMAL TRANSLOCATIONS; PRESYNAPTIC FILAMENT; GENE CONVERSION; REPAIR GENE	Chromosomal translocations are a primary biological response to ionizing radiation (IR) exposure, and are likely to result from the inappropriate repair of the DNA double-strand breaks (DSBs) that are created. An abundance of repetitive sequences in eukaryotic genomes provides ample opportunity for such breaks to be repaired by homologous recombination (HR) between non-allelic repeats. Interestingly, in the budding yeast, Saccharomyces cerevisiae the central strand exchange protein, Rad51 that is required for DSB repair by gene conversion between unlinked repeats that conserves genomic structure also suppresses translocation formation by several HR mechanisms. In particular, Rad51 suppresses translocation formation by single-strand annealing (SSA), perhaps the most efficient mechanism for translocation formation by HR in both yeast and mammalian cells. Further, the enhanced translocation formation that emerges in the absence of Rad51 displays a distinct pattern of genetic control, suggesting that this occurs by a separate mechanism. Since hypomorphic mutations in RAD51 in mammalian cells also reduce DSB repair by conservative gene conversion and stimulate non-conservative repair by SSA, this mechanism may also operate in humans and, perhaps contribute to the genome instability that propels the development of cancer.	[Manthey, Glenn M.; Bailis, Adam M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Manthey, GM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	National Institutes of Health [GM057484]; Department of Defense/Department of the Interior [1435-04-06-GT-63257]; Beckman Research Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense/Department of the Interior(United States Department of Defense); Beckman Research Institute of the City of Hope; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health (GM057484 to AMB), the Department of Defense/Department of the Interior (1435-04-06-GT-63257 to GMM), and the Beckman Research Institute of the City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZUMA K, 1984, MOL CELL BIOL, V4, P2735, DOI 10.1128/MCB.4.12.2735; Aguilera A, 2001, TRENDS GENET, V17, P318, DOI 10.1016/S0168-9525(01)02309-5; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Asleson EN, 1999, GENETICS, V153, P681; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; BAILIS AM, 1995, MOL CELL BIOL, V15, P3998; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BEZZUBOVA O, 1993, NUCLEIC ACIDS RES, V21, P1577, DOI 10.1093/nar/21.7.1577; BEZZUBOVA OY, 1993, NUCLEIC ACIDS RES, V21, P5945, DOI 10.1093/nar/21.25.5945; BLANCK S, 2009, NUCL ACIDS RES; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Carvalho CMB, 2008, GENOME RES, V18, P1724, DOI 10.1101/gr.080697.108; CHENG R, 1993, MUTAT RES, V294, P223, DOI 10.1016/0921-8777(93)90005-2; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Colaiacovo MP, 1999, GENETICS, V151, P1409; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Davis AP, 2001, GENETICS, V159, P515; Fasullo M, 2005, MUTAT RES-FUND MOL M, V578, P158, DOI 10.1016/j.mrfmmm.2005.05.003; FASULLO M, 1994, MUTAT RES, V314, P121, DOI 10.1016/0921-8777(94)90076-0; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; GENBAUFFE FS, 1984, J BIOL CHEM, V259, P518; GOLDBERG RB, 1978, BIOCHEM GENET, V16, P45, DOI 10.1007/BF00484384; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; HERSHFIELD B, 1990, CHROMOSOMA, V99, P125, DOI 10.1007/BF01735328; HO KSY, 1975, MUTAT RES, V30, P327, DOI 10.1016/0165-1218(75)90058-0; Iadonato S P, 1996, Methods Mol Biol, V54, P75; Ivanov EL, 1996, GENETICS, V142, P693; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; KNIGHT W, 2006, 95 CONFIDENCE INTERV; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Larminat F, 2002, ONCOGENE, V21, P5188, DOI 10.1038/sj.onc.1205659; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LIN FLM, 1990, MOL CELL BIOL, V10, P113, DOI 10.1128/MCB.10.1.113; Luria SE, 1943, GENETICS, V28, P491; Lyndaker AM, 2008, GENETICS, V179, P1807, DOI 10.1534/genetics.108.090654; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; MAESHIMA K, 1995, GENE, V160, P195, DOI 10.1016/0378-1119(95)00148-Y; MANIATIS TE, 1989, MOL CLONING LAB MANU, P2; Manthey GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007488; MARYON E, 1991, MOL CELL BIOL, V11, P3278, DOI 10.1128/MCB.11.6.3278; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; MCDONALD JP, 1994, GENETICS, V137, P393; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; MOORE CW, 1978, MUTAT RES, V58, P41, DOI 10.1016/0165-1218(78)90094-0; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Osakabe K, 2002, PLANT MOL BIOL, V50, P71, DOI 10.1023/A:1016047231597; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Pannunzio NR, 2010, CURR GENET, V56, P87, DOI 10.1007/s00294-009-0282-6; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; PRADO F, 1995, GENETICS, V139, P109; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; Preston CR, 2002, GENETICS, V161, P711; Resnick M A, 1975, Basic Life Sci, V5B, P549; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; RONG L, 1993, J BIOL CHEM, V268, P1252; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; SAEKI T, 1980, MUTAT RES, V73, P251, DOI 10.1016/0027-5107(80)90192-X; Sakuraba Y, 2000, MOL GEN GENET, V264, P392, DOI 10.1007/s004380000342; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; SCHIESTL RH, 1989, CARCINOGENESIS, V10, P1445, DOI 10.1093/carcin/10.8.1445; SCHILD D, 1983, CURR GENET, V7, P85, DOI 10.1007/BF00365631; SCHILD D, 1983, CELLULAR RESPONSES D; Schildkraut E, 2005, NUCLEIC ACIDS RES, V33, P1574, DOI 10.1093/nar/gki295; SCHMIDTKE J, 1980, HUM GENET, V55, P1, DOI 10.1007/BF00329120; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Seong KY, 1997, MOL CELLS, V7, P284; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; SHEN ZY, 1995, GENOMICS, V25, P199, DOI 10.1016/0888-7543(95)80126-7; Sherman F., 1986, METHODS YEAST GENETI; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1995, NATURE, V373, P84, DOI 10.1038/373084a0; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SUNG P, 1993, J BIOL CHEM, V268, P26391; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; TOMKINSON AE, 1994, BIOCHEMISTRY-US, V33, P5305, DOI 10.1021/bi00183a038; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; Tsukamoto M, 2003, GENETICS, V165, P1703; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wu Y, 2008, J BIOL CHEM, V283, P14883, DOI 10.1074/jbc.M801097200; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Wu Y, 2006, J BIOL CHEM, V281, P40001, DOI 10.1074/jbc.M608071200; YOSHIMURA Y, 1993, NUCLEIC ACIDS RES, V21, P1665, DOI 10.1093/nar/21.7.1665; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	120	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11889	10.1371/journal.pone.0011889	http://dx.doi.org/10.1371/journal.pone.0011889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686691	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520200048
J	Hughes, SF; Hendricks, BD; Edwards, DR; Middleton, JF				Hughes, Stephen F.; Hendricks, Beverly D.; Edwards, David R.; Middleton, Jim F.			Tourniquet-Applied Upper Limb Orthopaedic Surgery Results in Increased Inflammation and Changes to Leukocyte, Coagulation and Endothelial Markers	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-C; ISCHEMIA; ACTIVATION; DAMAGE	Purpose: During this pilot clinical study, patients scheduled for elective tourniquet-applied upper limb orthopaedic surgery were recruited to investigate the effects of surgery on various biological markers (n = 10 patients). Methods: Three venous blood samples were collected from the arm at the ante-cubital fossa, at baseline (pre-operatively), 5 and 15 minutes after reperfusion (post-operatively). Neutrophil and monocyte leukocyte sub-populations were isolated by density gradient centrifugation techniques. Leukocyte activation was investigated by measuring the cell surface expression of CD62L (L-selectin), CD11b (Mac-1) and the intracellular production of hydrogen peroxide (H2O2), via flow cytometry. C-reactive protein (CRP) was measured using a clinical chemistry analyser. Plasma concentrations of protein C and von Willebrand factor (vWF) were measured using enzyme-linked fluorescent assays (ELFA). Results: Following tourniquet-applied upper limb orthopaedic surgery, there was a decrease in neutrophil CD62L expression (p = 0.001), an increase in CD11b expression and in the intracellular production of H2O2 by neutrophils and monocytes (p<0.05). An increase in CRP concentration (p<0.001), a decrease in protein C concentration (p = 0.004), with a trend towards elevated vWF levels (p = 0.232) were also observed during this time. Conclusions: Conventionally, patients undergoing orthopaedic surgery have been monitored in the peri-operative period by means of CRP, which is a non-specific marker of inflammation. This test cannot differentiate between inflammation due to current or pre-existing disease processes and the development of ischaemia-reperfusion injury surgery. The findings from this study suggest that markers such as CD11b, protein C and H2O2 may provide alternative ways of assessing leukocyte and coagulation activation peri-operatively. It is proposed that by allowing orthopaedic surgeons access to laboratory markers such as CD11b, protein C and H2O2, an accurate assessment of the extent of inflammation due to surgery per se could be made.	[Hughes, Stephen F.] Univ Chester, Dept Biol Sci, Chester, Cheshire, England; [Hendricks, Beverly D.] Glan Clwyd Gen Hosp, Dept Haematol, Conwy, Wales; [Edwards, David R.] Gwynedd Hosp, Dept Haematol, Bangor, Gwynedd, Wales; [Hughes, Stephen F.; Middleton, Jim F.] Keele Univ, Leopold Muller Arthrit Res Ctr, Robert Jones & Agnes Hunt Orthopaed Hosp, Sch Med, Keele, Staffs, England	University of Chester; Keele University	Hughes, SF (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	stephen.hughes@chester.ac.uk			Institute of Biomedical Science (IBMS); North Wales Research Committee (NWRC); Medical Research Council [G0401634] Funding Source: researchfish; MRC [G0401634] Funding Source: UKRI	Institute of Biomedical Science (IBMS); North Wales Research Committee (NWRC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thankfully acknowledge the Institute of Biomedical Science (IBMS) and the North Wales Research Committee (NWRC) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIOR BM, 1992, NOUV REV FR HEMATOL, V34, pS29; BASS DA, 1983, J IMMUNOL, V130, P1910; BLANN AD, 1994, EUR J VASCULAR SURG, V8, P10, DOI 10.1016/S0950-821X(05)80112-4; Blann AD, 1996, EUR J VASC ENDOVASC, V12, P218, DOI 10.1016/S1078-5884(96)80110-9; BRADBURY AW, 1993, BRIT J SURG, V80, P1503, DOI 10.1002/bjs.1800801204; ENGLER RL, 1989, AM J CARDIOL, V63, pE19, DOI 10.1016/0002-9149(89)90225-7; Foster W, 2009, RHEUMATOLOGY, V48, P285, DOI 10.1093/rheumatology/ken486; Hughes SF, 2006, BRIT J BIOMED SCI, V63, P166, DOI 10.1080/09674845.2006.11732743; Hughes Stephen F, 2007, J Inflamm (Lond), V4, P12, DOI 10.1186/1476-9255-4-12; JANG YS, 1994, J AM COLL CARDIOL, V24, P1591, DOI 10.1016/0735-1097(94)90162-7; Kirkpatrick U J, 2000, Int J Surg Investig, V2, P151; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Lan W, 2004, EUR J ANAESTH, V21, P892, DOI 10.1017/S0265021504000249; LEFF JA, 1990, BLOOD CELLS, V16, P183; LENNIE SE, 1987, CLIN HEMORHEOL, V7, P811; MARLAR RA, 1989, HUM PATHOL, V20, P1040, DOI 10.1016/0046-8177(89)90221-9; Norwood MGA, 2004, EUR J VASC ENDOVASC, V28, P234, DOI 10.1016/j.ejvs.2004.03.026; Orrego M, 2005, REV MED CHILE, V133, P1341; Pahl MV, 2005, J NATL MED ASSOC, V97, P172; Parslew R, 1997, BRIT J DERMATOL, V136, P734, DOI 10.1111/j.1365-2133.1997.tb03661.x; PRICE CP, 1987, J IMMUNOL METHODS, V99, P205, DOI 10.1016/0022-1759(87)90129-3; SCHMIDSCHONBEIN GW, 1990, BIORHEOLOGY, V27, P859; Seekamp A, 2001, SHOCK, V15, P254, DOI 10.1097/00024382-200115040-00002; SEKAMP A, 1993, AGENTS ACTIONS S, V41, P137; Sutter PM, 1997, WORLD J SURG, V21, P179, DOI 10.1007/s002689900212; SUTTER PM, 1997, WORLD J SURG, P185; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; ten Raa S, 2006, J SURG RES, V136, P45, DOI 10.1016/j.jss.2006.05.006	28	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11846	10.1371/journal.pone.0011846	http://dx.doi.org/10.1371/journal.pone.0011846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676375	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100018
J	White, AP; Weljie, AM; Apel, D; Zhang, P; Shaykhutdinov, R; Vogel, HJ; Surette, MG				White, Aaron P.; Weljie, Aalim M.; Apel, Dmitry; Zhang, Ping; Shaykhutdinov, Rustem; Vogel, Hans J.; Surette, Michael G.			A Global Metabolic Shift Is Linked to Salmonella Multicellular Development	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SIGMA(S)-DEPENDENT GENE-EXPRESSION; LONG-TERM SURVIVAL; ESCHERICHIA-COLI; BIOFILM FORMATION; AGGREGATIVE FIMBRIAE; RDAR MORPHOTYPE; GLYCINE BETAINE; PERSISTENCE; PROTEIN	Bacteria can elaborate complex patterns of development that are dictated by temporally ordered patterns of gene expression, typically under the control of a master regulatory pathway. For some processes, such as biofilm development, regulators that initiate the process have been identified but subsequent phenotypic changes such as stress tolerance do not seem to be under the control of these same regulators. A hallmark feature of biofilms is growth within a self-produced extracellular matrix. In this study we used metabolomics to compare Salmonella cells in rdar colony biofilms to isogenic csgD deletion mutants that do not produce an extracellular matrix. The two populations show distinct metabolite profiles. Even though CsgD controls only extracellular matrix production, metabolite signatures associated with cellular adaptations associated with stress tolerances were present in the wild type but not the mutant cells. To further explore these differences we examine the temporal gene expression of genes implicated in biofilm development and stress adaptations. In wild type cells, genes involved in a metabolic shift to gluconeogenesis and various stress-resistance pathways exhibited an ordered expression profile timed with multicellular development even though they are not CsgD regulated. In csgD mutant cells, the ordered expression was lost. We conclude that the induction of these pathways results from production of, and growth within, a self produced matrix rather than elaboration of a defined genetic program. These results predict that common physiological properties of biofilms are induced independently of regulatory pathways that initiate biofilm formation.	[White, Aaron P.; Apel, Dmitry; Surette, Michael G.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Weljie, Aalim M.; Zhang, Ping; Shaykhutdinov, Rustem; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	White, AP (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	surette@ucalgary.ca	Weljie, Aalim/V-6952-2019; Surette, Michael G/AAE-8825-2020; Weljie, Aalim M/B-6203-2012	Weljie, Aalim/0000-0002-7145-4494; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) to MGS and HJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Apel D, 2009, APPL ENVIRON MICROB, V75, P4923, DOI 10.1128/AEM.00363-09; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Checroun C, 2004, FEMS MICROBIOL LETT, V236, P221, DOI 10.1016/j.femsle.2004.05.046; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FRAENKEL DG, 1996, ESCHERICHIA COLI SAL, P189; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Ghigo JM, 2003, RES MICROBIOL, V154, P1, DOI 10.1016/S0923-2508(02)00012-8; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gjersing EL, 2007, ANAL CHEM, V79, P8037, DOI 10.1021/ac070800t; GOVONS S, 1969, J BACTERIOL, V97, P970, DOI 10.1128/JB.97.2.970-972.1969; Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; GUTIERREZ JA, 1995, J BACTERIOL, V177, P390, DOI 10.1128/jb.177.2.390-400.1995; Hamilton S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-599; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; LUCHT JM, 1994, FEMS MICROBIOL REV, V14, P3, DOI 10.1016/0168-6445(94)90008-6; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MALOY SR, 1996, GENETIC ANAL PATHOGE, P466; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; McMeechan A, 2005, MICROBIOL-SGM, V151, P3969, DOI 10.1099/mic.0.28292-0; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993, DOI 10.1128/JB.181.19.5993-6002.1999; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stocki SL, 2007, POULTRY SCI, V86, P2375, DOI 10.3382/ps.2007-00121; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tremoulet F, 2002, FEMS MICROBIOL LETT, V215, P7, DOI 10.1016/S0378-1097(02)00879-0; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; UNDERWOOD AH, 1965, BIOCHEM J, V95, P767, DOI 10.1042/bj0950767; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2008, INFECT IMMUN, V76, P1048, DOI 10.1128/IAI.01383-07; White AP, 2006, J BACTERIOL, V188, P8395, DOI 10.1128/JB.00798-06; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	84	62	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11814	10.1371/journal.pone.0011814	http://dx.doi.org/10.1371/journal.pone.0011814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676398	gold, Green Submitted, Green Published			2022-12-27	WOS:000280371800015
J	Stern, MD				Stern, Michael D.			Patrimony and the Evolution of Risk-Taking	PLOS ONE			English	Article							GAMBLING BEHAVIOR	The propensity to make risky choices has a genetic component, and recent studies have identified several specific genes that contribute to this trait. Since risk-taking often appears irrational or maladaptive, the question arises how (or if) natural selection favors risk-taking. Here we show, using a stochastic simulation of selection between two hypothetical species, "R'' (risk-seeking) and "A'' (risk-averse) that, when expected reproductive fitness of the individual is unaffected by the making of the risky choice (winnings balanced by losses) natural selection (taken to the point of extinction) favors the risk-averse species. However, the situation is entirely reversed if offspring are permitted to inherit a small fraction of the parent's increased or decreased fitness acquired through risk-taking. This seemingly Lamarckian form of inheritance actually corresponds to the human situation when property or culture are transmitted in families. In the presence of this "cultural inheritance'', the long-shot risk-taking species was overwhelmingly favored, even when 90% of individuals were rendered sterile by a losing choice. Given this strong effect in a minimal model, it is important to consider the co-evolution of genes and culture when interpreting the genetics of risk-taking. This conclusion applies, in principle, to any species where parental resources can directly affect the fecundity of offspring. It might also be relevant to the effects of epigenetic inheritance, if the epigenetic state of zygotes can be affected by parental experiences.	NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stern, MD (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	sternm@grc.nia.nih.gov		Stern, Michael/0000-0003-4476-7425	National Institute on Aging of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000241] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely supported by the Intramual Research Program of the National Institute on Aging of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bednekoff PA, 1996, AM ZOOL, V36, P471; Bell AM, 2009, ADV GENET, V68, P83, DOI 10.1016/S0065-2660(09)68004-4; Bloomfield AN, 2006, MEM COGNITION, V34, P929, DOI 10.3758/BF03193438; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Cooney CA, 2002, J NUTR, V132, p2393S; Dekel E, 1999, J ECON THEORY, V87, P125, DOI 10.1006/jeth.1999.2537; Eisen SA, 1998, ADDICTION, V93, P1375; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; HOUSTON AI, 1991, J EXP ANAL BEHAV, V56, P585, DOI 10.1901/jeab.1991.56-585; Juhasz G, 2010, NEUROPSYCHOPHARMACOL, V35, P1109, DOI 10.1038/npp.2009.216; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Madden GJ, 2007, J GAMBL STUD, V23, P63, DOI 10.1007/s10899-006-9041-5; NEUMANN JV, 1944, THEORIES GAMES EC BE; PETERS H, 2010, J GAMBL STU IN PRESS; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; Poethke Hans J., 2008, BMC Ecology, V8, P2, DOI 10.1186/1472-6785-8-2; ROOS P, 2009, 6 C EUR SOC SIM ASS; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van den Bos R, 2006, BEHAV RES METHODS, V38, P470, DOI 10.3758/BF03192801; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	27	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11656	10.1371/journal.pone.0011656	http://dx.doi.org/10.1371/journal.pone.0011656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	627TK	20668653	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600018
J	Bush, SL; Schul, J				Bush, Sarah L.; Schul, Johannes			Evolution of Novel Signal Traits in the Absence of Female Preferences in Neoconocephalus Katydids (Orthoptera, Tettigoniidae)	PLOS ONE			English	Article							NEBRASCENSIS ORTHOPTERA; SEXUAL SELECTION; CALL RECOGNITION; RECEIVER BIASES; SONG; POPULATION; PHONOTAXIS; FREQUENCY; PREDATION; TREEFROGS	Background Significance: Communication signals that function to bring together the sexes are important for maintaining reproductive isolation in many taxa. Changes in male calls are often attributed to sexual selection, in which female preferences initiate signal divergence. Natural selection can also influence signal traits if calls attract predators or parasitoids, or if calling is energetically costly. Neutral evolution is often neglected in the context of acoustic communication. Methodology/Principal Findings: We describe a signal trait that appears to have evolved in the absence of either sexual or natural selection. In the katydid genus Neoconocephalus, calls with a derived pattern in which pulses are grouped into pairs have evolved five times independently. We have previously shown that in three of these species, females require the double pulse pattern for call recognition, and hence the recognition system of the females is also in a derived state. Here we describe the remaining two species and find that although males produce the derived call pattern, females use the ancestral recognition mechanism in which no pulse pattern is required. Females respond equally well to the single and double pulse calls, indicating that the derived trait is selectively neutral in the context of mate recognition. Conclusions/Significance: These results suggest that 1) neutral changes in signal traits could be important in the diversification of communication systems, and 2) males rather than females may be responsible for initiating signal divergence.	[Bush, Sarah L.; Schul, Johannes] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Bush, SL (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	schulj@missouri.edu		Schul, Johannes/0000-0003-4059-7123	National Science Foundation [IOB-0445286]	National Science Foundation(National Science Foundation (NSF))	The work was funded by the National Science Foundation (www.nsf.gov) through one grant to JS & SLB (IOB-0445286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Beckers OM, 2008, P ROY SOC B-BIOL SCI, V275, P1243, DOI 10.1098/rspb.2007.1765; BENTLEY DR, 1972, ANIM BEHAV, V20, P478, DOI 10.1016/S0003-3472(72)80012-5; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; Bush SL, 2009, J EXP BIOL, V212, P648, DOI 10.1242/jeb.024786; Bush SL, 2006, J COMP PHYSIOL A, V192, P113, DOI 10.1007/s00359-005-0053-x; Bush SL, 2002, ANIM BEHAV, V63, P7, DOI 10.1006/anbe.2001.1880; Deily JA, 2004, J EXP BIOL, V207, P3523, DOI 10.1242/jeb.01179; Deily JA, 2009, J COMP PHYSIOL A, V195, P31, DOI 10.1007/s00359-008-0379-2; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENQUIST M, 1993, NATURE, V361, P446, DOI 10.1038/361446a0; FORREST TG, 1994, AM ZOOL, V34, P644; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Greenfield M.D., 1990, P71; GREENFIELD MD, 1993, NATURWISSENSCHAFTEN, V80, P570, DOI 10.1007/BF01149275; Greenfield MD, 2005, ADV STUD BEHAV, V35, P1, DOI 10.1016/S0065-3454(05)35001-7; GREENFIELD MD, 1983, ANIM BEHAV, V31, P102, DOI 10.1016/S0003-3472(83)80178-X; Greenfield MD, 2002, SIGNALERS RECEIVERS; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; HELLER KG, 1988, BIOACOUSTICS EUROPEA; Henry CS, 1999, EVOLUTION, V53, P1165, DOI [10.2307/2640820, 10.1111/j.1558-5646.1999.tb04530.x]; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Lehmann GUC, 1998, BEHAV ECOL SOCIOBIOL, V43, P239, DOI 10.1007/s002650050488; LLOYD JE, 1984, FLA ENTOMOL, V67, P228, DOI 10.2307/3493942; MEIXNER AJ, 1986, ANN ENTOMOL SOC AM, V79, P554, DOI 10.1093/aesa/79.4.554; Otte D., 1989, P482; Roff DA, 1999, EVOLUTION, V53, P216, DOI 10.1111/j.1558-5646.1999.tb05347.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Schul J, 2003, J EXP BIOL, V206, P141, DOI 10.1242/jeb.00070; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; Shaw KL, 1996, EVOLUTION, V50, P256, DOI 10.1111/j.1558-5646.1996.tb04489.x; SNYDER RL, 2009, THESIS U MISSOURI CO; Snyder RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007203; TALWAR M, 2007, THESIS U MISSOURI CO; von Helversen Otto, 1994, Progress in Zoology, V39, P253; Walker T.J., 1983, Transactions of the American Entomological Society (Philadelphia), V109, P357; WALKER TJ, 1975, J INSECT PHYSIOL, V21, P595, DOI 10.1016/0022-1910(75)90163-8; WALKER TJ, 1974, AM ZOOL, V14, P1137; WALKER TJ, 2008, SINGING INSECTS N AM; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	46	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12457	10.1371/journal.pone.0012457	http://dx.doi.org/10.1371/journal.pone.0012457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805980	gold, Green Submitted, Green Published			2022-12-27	WOS:000281301500023
J	Lubell, Y; Mills, AJ; Whitty, CJM; Staedke, SG				Lubell, Yoel; Mills, Anne J.; Whitty, Christopher J. M.; Staedke, Sarah G.			An Economic Evaluation of Home Management of Malaria in Uganda: An Interactive Markov Model	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; SULFADOXINE-PYRIMETHAMINE; COST-EFFECTIVENESS; VECTOR CONTROL; CHILDREN; TRANSMISSION; ARTESUNATE; BURDEN	Background: Home management of malaria (HMM), promoting presumptive treatment of febrile children in the community, is advocated to improve prompt appropriate treatment of malaria in Africa. The cost-effectiveness of HMM is likely to vary widely in different settings and with the antimalarial drugs used. However, no data on the cost-effectiveness of HMM programmes are available. Methods/Principal Findings: A Markov model was constructed to estimate the cost-effectiveness of HMM as compared to conventional care for febrile illnesses in children without HMM. The model was populated with data from Uganda, but is designed to be interactive, allowing the user to adjust certain parameters, including the antimalarials distributed. The model calculates the cost per disability adjusted life year averted and presents the incremental cost-effectiveness ratio compared to a threshold value. Model output is stratified by level of malaria transmission and the probability that a child would receive appropriate care from a health facility, to indicate the circumstances in which HMM is likely to be cost-effective. The model output suggests that the cost-effectiveness of HMM varies with malaria transmission, the probability of appropriate care, and the drug distributed. Where transmission is high and the probability of appropriate care is limited, HMM is likely to be cost-effective from a provider perspective. Even with the most effective antimalarials, HMM remains an attractive intervention only in areas of high malaria transmission and in medium transmission areas with a lower probability of appropriate care. HMM is generally not cost-effective in low transmission areas, regardless of which antimalarial is distributed. Considering the analysis from the societai perspective decreases the attractiveness of HMM. Conclusion: Syndromic HMM for children with fever may be a useful strategy for higher transmission settings with limited health care and diagnosis, but is not appropriate for all settings. HMM may need to be tailored to specific settings, accounting for local malaria transmission intensity and availability of health services.	[Lubell, Yoel] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Lubell, Yoel; Mills, Anne J.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Whitty, Christopher J. M.; Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lubell, Y (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	yoel@tropmedres.ac	Whitty, Christopher/C-7740-2012	Lubell, Yoel/0000-0002-0237-1070; Mills, Anne/0000-0001-9863-9950; Whitty, Christopher/0000-0002-6076-5027	Medical Research Council (UK); ACT Consortium; Bill & Melinda Gates Foundation	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ACT Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was carried out as a part of a PhD thesis funded by the Medical Research Council (UK) (http://www.mrc.ac.uk/index.htm). This research is supported by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (http://www.actconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2004, SCAL HOM BAS MAN MAL; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Checchi F, 2004, TROP MED INT HEALTH, V9, P445, DOI 10.1111/j.1365-3156.2004.01217.x; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; D'Alessandro U, 2005, TROP MED INT HEALTH, V10, P1, DOI 10.1111/j.1365-3156.2004.01375.x; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Drummond MF, 2015, METHODS EC EVALUATIO; Edejer T, 2003, MAKING CHOICES HLTH; Fapohunda B, 2004, HOME BASED MANAGEMEN; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hodel EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008184; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kager PA, 2002, TROP MED INT HEALTH, V7, P1042, DOI 10.1046/j.1365-3156.2002.00981.x; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kallander Karin, 2006, BMC Int Health Hum Rights, V6, P2, DOI 10.1186/1472-698X-6-2; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Kolaczinski JH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-40; LUBELL Y, LIKELY HLTH IN PRESS; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-60; Malimbo M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-124; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mathers CD., 2002, GLOBAL BURDEN DIS 20; Moerman F, 2003, LANCET INFECT DIS, V3, P99, DOI 10.1016/S1473-3099(03)00518-8; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Nsabagasani X, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-11; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Pagnoni F, 2005, TROP MED INT HEALTH, V10, P621; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; ROCAFELTRER A, 2008, TROP MED INT HLTH, V13; Sachs J, 2002, MACROECONOMICS HLTH; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; TRAPE JF, 1987, AM J EPIDEMIOL, V126, P193, DOI 10.1093/aje/126.2.193; Tren R, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-305; *UN STAT DIV, UN STAT DIV WORLD ST; WHO, 2010, GUID TREATM MAL, V2nd; *WHO STAT INF SYST, 2007, WORLD HLTH STAT 2007; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; *WORLD BANK, 2007, GNI PER CAP 2005 ATL; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	62	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12439	10.1371/journal.pone.0012439	http://dx.doi.org/10.1371/journal.pone.0012439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805977	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000281301500008
J	Hummelen, R; Fernandes, AD; Macklaim, JM; Dickson, RJ; Changalucha, J; Gloor, GB; Reid, G				Hummelen, Ruben; Fernandes, Andrew D.; Macklaim, Jean M.; Dickson, Russell J.; Changalucha, John; Gloor, Gregory B.; Reid, Gregor			Deep Sequencing of the Vaginal Microbiota of Women with HIV	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; IDENTIFICATION; ASSOCIATION; GENERATION; DIVERSITY	Background: Women living with HIV and co-infected with bacterial vaginosis (BV) are at higher risk for transmitting HIV to a partner or newborn. It is poorly understood which bacterial communities constitute BV or the normal vaginal microbiota among this population and how the microbiota associated with BV responds to antibiotic treatment. Methods and Findings: The vaginal microbiota of 132 HIV positive Tanzanian women, including 39 who received metronidazole treatment for BV, were profiled using Illumina to sequence the V6 region of the 16S rRNA gene. Of note, Gardnerella vaginalis and Lactobacillus iners were detected in each sample constituting core members of the vaginal microbiota. Eight major clusters were detected with relatively uniform microbiota compositions. Two clusters dominated by L. iners or L. crispatus were strongly associated with a normal microbiota. The L. crispatus dominated microbiota were associated with low pH, but when L. crispatus was not present, a large fraction of L. iners was required to predict a low pH. Four clusters were strongly associated with BV, and were dominated by Prevotella bivia, Lachnospiraceae, or a mixture of different species. Metronidazole treatment reduced the microbial diversity and perturbed the BV-associated microbiota, but rarely resulted in the establishment of a lactobacilli-dominated microbiota. Conclusions: Illumina based microbial profiling enabled high though-put analyses of microbial samples at a high phylogenetic resolution. The vaginal microbiota among women living with HIV in Sub-Saharan Africa constitutes several profiles associated with a normal microbiota or BV. Recurrence of BV frequently constitutes a different BV-associated profile than before antibiotic treatment.	[Hummelen, Ruben; Macklaim, Jean M.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Hummelen, Ruben] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Fernandes, Andrew D.; Macklaim, Jean M.; Dickson, Russell J.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Changalucha, John] Natl Inst Med Res, Mwanza Res Ctr, Mwanza, Tanzania; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Erasmus University Rotterdam; Erasmus MC; Western University (University of Western Ontario); Western University (University of Western Ontario); National Institute of Medical Research; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hummelen, R (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	gregor@uwo.ca	Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020; Hummelen, Ruben/ABG-5746-2021	Reid, Gregor/0000-0001-9658-5696; Gloor, Gregory/0000-0001-5803-3380	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Partial funding of this project from the Natural Sciences and Engineering Research Council of Canada (NSERC) is acknowledged. AF is supported by an NSERC post-doctoral fellowship and RD is supported by an NSERC CGS-D scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], TEACHING STAT; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Artinez RCRM, 2008, APPL ENVIRON MICROB, V74, P4539, DOI 10.1128/AEM.00284-08; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; CHAO A, 1984, SCAND J STAT, V11, P265; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; David H. A., 2003, ORDER STAT, P458; EDGAR RC, UCLUST VERSION 2 0; Farquhar C, 2010, AIDS, V24, P153, DOI 10.1097/QAD.0b013e32832326d8; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hillier SL, 2005, NEW ENGL J MED, V353, P1886, DOI 10.1056/NEJMp058191; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; JOUSIMIESSOMER H, 1997, CLIN INFECT DIS   S2, V25, P78; Kass R.E., 1989, STAT SCI, V4, P188, DOI [10.1214/ss/1177012480, DOI 10.1214/SS/1177012480]; Krebs C. J, 1989, ECOLOGICAL METHODOLO; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Kullback S., 1959, INFORM THEORY STAT, P395; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Msuya Sia E, 2009, Reprod Health, V6, P4, DOI 10.1186/1742-4755-6-4; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; Noether G.E., 1981, TEACH STAT, V3, P41, DOI [10.1111/j.1467-9639.1981.tb00422.x, DOI 10.1111/J.1467-9639.1981.TB00422.X]; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; OCONNOR TJ, 1995, INT J STD AIDS, V6, P267, DOI 10.1177/095646249500600409; OKSANEN J, 2010, L P O B VEGAN COMMUN; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; RAVEL J, 2010, P NAT ACAD SCI U JUN, P1; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Spear GT, 2008, J INFECT DIS, V198, P1131, DOI 10.1086/591942; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Taha Taha E, 2007, PLoS Clin Trials, V2, pe10, DOI 10.1371/journal.pctr.0020010; Tamrakar R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-128; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	36	179	190	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12078	10.1371/journal.pone.0012078	http://dx.doi.org/10.1371/journal.pone.0012078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711427	Green Submitted, Green Published, gold			2022-12-27	WOS:000280859700003
J	Chow, J; Klein, EY; Laxminarayan, R				Chow, Jeffrey; Klein, Eili Y.; Laxminarayan, Ramanan			Cost-Effectiveness of "Golden Mustard" for Treating Vitamin A Deficiency in India	PLOS ONE			English	Article							MORTALITY; RICE; HEALTH; TRIAL; SUPPLEMENTATION; INTERVENTIONS; CHILDREN; IMPACT	Background: Vitamin A deficiency (VAD) is an important nutritional problem in India, resulting in an increased risk of severe morbidity and mortality. Periodic, high-dose vitamin A supplementation is the WHO-recommended method to prevent VAD, since a single dose can compensate for reduced dietary intake or increased need over a period of several months. However, in India only 34 percent of targeted children currently receive the two doses per year, and new strategies are urgently needed. Methodology: Recent advancements in biotechnology permit alternative strategies for increasing the vitamin A content of common foods. Mustard (Brassica juncea), which is consumed widely in the form of oil by VAD populations, can be genetically modified to express high levels of beta-carotene, a precursor to vitamin A. Using estimates for consumption, we compare predicted costs and benefits of genetically modified (GM) fortification of mustard seed with high-dose vitamin A supplementation and industrial fortification of mustard oil during processing to alleviate VAD by calculating the avertable health burden in terms of disability-adjusted life years (DALY). Principal Findings: We found that all three interventions potentially avert significant numbers of DALYs and deaths. Expanding vitamin A supplementation to all areas was the least costly intervention, at $23-$50 per DALY averted and $1,000-$6,100 per death averted, though cost-effectiveness varied with prevailing health subcenter coverage. GM fortification could avert 5 million-6 million more DALYs and 8,000-46,000 more deaths, mainly because it would benefit the entire population and not just children. However, the costs associated with GM fortification were nearly five times those of supplementation. Industrial fortification was dominated by both GM fortification and supplementation. The cost-effectiveness ratio of each intervention decreased with the prevalence of VAD and was sensitive to the efficacy rate of averted mortality. Conclusions: Although supplementation is the least costly intervention, our findings also indicate that GM fortification could reduce the VAD disease burden to a substantially greater degree because of its wider reach. Given the difficulties in expanding supplementation to areas without health subcenters, GM fortification of mustard seed is an attractive alternative, and further exploration of this technology is warranted.	[Chow, Jeffrey] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Klein, Eili Y.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Klein, Eili Y.; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA	Yale University; Princeton University; Princeton University	Chow, J (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	Ramanan@rff.org	Laxminarayan, Ramanan/ABD-5050-2021; Klein, Eili/C-3745-2012	Chow, Jeffrey/0000-0002-3351-7730; Klein, Eili/0000-0002-1304-5289	International Center for Tropical Agriculture (CIAT), Colombia	International Center for Tropical Agriculture (CIAT), Colombia	The report was produced under a grant from the International Center for Tropical Agriculture (CIAT), Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2004, Indian Pediatr, V41, P377; ARROYAVE G, 1981, AM J CLIN NUTR, V34, P41, DOI 10.1093/ajcn/34.1.41; Awasthi S, 2007, 6 MONTHLY VITAMIN A; Barwale R. B., 2004, AgBioForum, V7, P23; BEATON G, 1994, FOOD NUTR B, V15; Bhushan Chandra, 2006, FRONTLINE, V23; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chakravarty I, 2000, J Indian Med Assoc, V98, P539; *CHAND NAT INF CEN, 2007, CHAND FIG EC IND 200; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Christian P, 2002, J NUTR, V132, p2884S, DOI 10.1093/jn/132.9.2884S; COHEN N, 1987, AM J CLIN NUTR, V45, P970, DOI 10.1093/ajcn/45.5.970; DARY O, 1997, C 16 INT C NUTR S RE; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; Dawe D, 2002, FOOD POLICY, V27, P541, DOI 10.1016/S0306-9192(02)00065-9; Egana Nilva E., 2003, Journal of Nutritional & Environmental Medicine (Abingdon), V13, P169, DOI 10.1080/13590840310001619414; Fiedler JL, 2000, SOC SCI MED, V51, P223, DOI 10.1016/S0277-9536(99)00449-9; GEORGE C, 2005, COMMUNICATION   1202; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; HOUSTON R, 2003, WHY THEY WORK ANAL 3; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; *IND COUNC MED RES, 2004, REC NAT WORKSH MICR; Kapil U, 2001, Indian Pediatr, V38, P37; Katz J, 2000, AM J CLIN NUTR, V71, P1570; LAKSHMAN A, 2006, COMMUNICATION   O630; MANORAMA R, 1991, FOOD CHEM, V42, P253, DOI 10.1016/0308-8146(91)90068-Y; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Meenakshi JV, 2007, 2 HARVESTPLUS; *MI, 2006, IND MICR NAT INV PLA; *MICH STAT U, 2003, AGR BIOT SUPP PROJ; *MICR IN, 2005, CONTR VIT MIN DEF IN; Mora J.O., 2000, VITAMIN A SUGAR FORT; *NAT RES COUNC, 2004, BIOL CONF GEN ENG OR; National Nutrition Monitoring Bureau (NNMB), 2003, 22 NNMB; *NICH PIR IND LTD, 2006, HUM NUTR HLTH FORT; *NICH PIR IND LTD, 2006, PAMPHL NICORICH OIL; *NIN, 2001, ANN REP NIN HYD; *NNMB, 1999, REP 2 REP SURV RUR; NNMB, 2002, DIET NUTR STAT RUR P; *NRHM, ANN REP 2005 2006 GO; *NSS, 2001, NSS 55 ROUND; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Phillips M, 1996, SOC SCI MED, V42, P1661, DOI 10.1016/0277-9536(95)00317-7; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; RAO B. R. H., 1961, INDIAN JOUR PEDIATRICS, V28, P39, DOI 10.1007/BF02751166; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; SOLON F, 1979, AM J CLIN NUTR, V32, P1445, DOI 10.1093/ajcn/32.7.1445; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Stein AJ, 2006, NAT BIOTECHNOL, V24, P1200, DOI 10.1038/nbt1006-1200b; Swami H. M., 2002, Indian Journal of Pediatrics, V69, P675, DOI 10.1007/BF02722703; SWAMINATHAN MC, 1970, AM J CLIN NUTR, V23, P119; *TERI, 2006, VIT A SOC REV; Toteja G, 2001, MICRONUTRIENT DEFI 1; Toteja GS, 2004, MICRONUTRIENT PROFIL; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; VIJAYARAGHAVAN K, 2006, MICRONUTRIENT POLICI; West K. P. Jr., 2001, Nutrition and health in developing countries, P267; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; World Bank, 1993, WORLD DEV REP INV HL; Zimmermann R, 2004, FOOD POLICY, V29, P147, DOI 10.1016/j.foodpol.2004.03.001	66	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12046	10.1371/journal.pone.0012046	http://dx.doi.org/10.1371/journal.pone.0012046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637IW	20706590	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900010
J	Hegele, M; Heuer, H				Hegele, Mathias; Heuer, Herbert			The Impact of Augmented Information on Visuo-Motor Adaptation in Younger and Older Adults	PLOS ONE			English	Article							SENSORIMOTOR ADAPTATION; PRISM ADAPTATION; EXPOSURE; MECHANISMS; CONCURRENT; COMPONENTS; STRATEGY; ERROR; LOCUS; TASK	Background: Adjustment to a visuo-motor rotation is known to be affected by ageing. According to previous studies, the age-related differences primarily pertain to the use of strategic corrections and the generation of explicit knowledge on which strategic corrections are based, whereas the acquisition of an (implicit) internal model of the novel visuo-motor transformation is unaffected. The present study aimed to assess the impact of augmented information on the age-related variation of visuo-motor adjustments. Methodology/ Principal Findings: Participants performed aiming movements controlling a cursor on a computer screen. Visual feedback of direction of cursor motion was rotated 75u relative to the direction of hand motion. Participants had to adjust to this rotation in the presence and absence of an additional hand-movement target that explicitly depicted the input-output relations of the visuo-motor transformation. An extensive set of tests was employed in order to disentangle the contributions of different processes to visuo-motor adjustment. Results show that the augmented information failed to affect the age-related variations of explicit knowledge, adaptive shifts, and aftereffects in a substantial way, whereas it clearly affected initial direction errors during practice and proprioceptive realignment. Conclusions: Contrary to expectations, older participants apparently made no use of the augmented information, whereas younger participants used the additional movement target to reduce initial direction errors early during practice. However, after a first block of trials errors increased, indicating a neglect of the augmented information, and only slowly declined thereafter. A hypothetical dual-task account of these findings is discussed. The use of the augmented information also led to a selective impairment of proprioceptive realignment in the younger group. The mere finding of proprioceptive realignment in adaptation to a visuo-motor rotation in a computer-controlled setup is noteworthy since visual and proprioceptive information pertain to different objects.	[Hegele, Mathias; Heuer, Herbert] IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Hegele, M (corresponding author), Univ Giessen, Dept Psychol & Sport Sci, Giessen, Germany.	mathias.hegele@sport.uni-giessen.de	Hegele, Mathias/D-1728-2014	Hegele, Mathias/0000-0002-1707-5506; Lauwereyns, Jan/0000-0003-0551-2550; Heuer, Herbert/0000-0002-0488-2878	Deutsche Forschungsgmeinschaft [He 1187/15-2]	Deutsche Forschungsgmeinschaft	The research reported in this paper was supported by grant He 1187/15-2 of the Deutsche Forschungsgmeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Abeele S, 2001, EXP BRAIN RES, V139, P248, DOI 10.1007/s002210100768; Amthauer R., 1953, I S T INTELLIGENZ ST; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; BOCK O, 1992, BEHAV BRAIN RES, V51, P41, DOI 10.1016/S0166-4328(05)80310-9; Bock O, 1997, BEHAV BRAIN RES, V89, P267, DOI 10.1016/S0166-4328(97)00069-7; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; COHEN MM, 1974, PERCEPT MOTOR SKILL, V38, P1202, DOI 10.2466/pms.1974.38.3c.1202; COHEN MM, 1967, PERCEPT MOTOR SKILL, V24, P1295, DOI 10.2466/pms.1967.24.3c.1295; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; HEGELE M, 2010, CONSCIOUS C IN PRESS; Hegele M, 2010, PSYCHOL RES-PSYCH FO, V74, P21, DOI 10.1007/s00426-008-0221-z; Heuer H, 2007, ERGONOMICS, V50, P979, DOI 10.1080/00140130701240828; HEUER H, 1983, NEURAL NETWORKS, V11, P1317; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishihara S., 2005, ISHIHARAS TESTS COLO; JAKOBSON LS, 1989, EXP BRAIN RES, V78, P575; KELSO JAS, 1975, J EXP PSYCHOL HUMAN, V1, P237, DOI 10.1037/0096-1523.1.3.237; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pennel I, 2002, ERGONOMICS, V45, P1047, DOI 10.1080/00140130210166906; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; REDDING GM, 1988, PERCEPT PSYCHOPHYS, V44, P59, DOI 10.3758/BF03207476; Riby LM, 2004, EUR J COGN PSYCHOL, V16, P863, DOI 10.1080/09541440340000402; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Schoppe K.J, 1974, DIAGNOSTICA, V20, P43; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; SUELZENBRUECK S, 2010, OCCUP ERGON IN PRESS; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Tewes U., 1994, HAMBURG WECHSLER INT; UHLARIK JJ, 1973, J EXP PSYCHOL, V98, P223, DOI 10.1037/h0034364; UHLARIK JJ, 1971, J EXP PSYCHOL, V91, P233, DOI 10.1037/h0031786; Vercruyssen M., 1997, HDB HUMAN FACTORS OL, P55; Welch R. B., 1978, PERCEPTUAL MODIFICAT; Wong T, 2009, J NEUROPHYSIOL, V101, P614, DOI 10.1152/jn.90544.2008	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12071	10.1371/journal.pone.0012071	http://dx.doi.org/10.1371/journal.pone.0012071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636XC	20711507	gold, Green Published			2022-12-27	WOS:000280776800019
J	Ma, SG; Liu, AN; Carr, J; Post, W; Kronmal, R				Ma, Shuangge; Liu, Anna; Carr, Jeffrey; Post, Wendy; Kronmal, Richard			Statistical Modeling of Agatston Score in Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; COMPUTED-TOMOGRAPHY; YOUNG-ADULTS; CARDIA	The MESA (Multi-Ethnic Study of Atherosclerosis) is an ongoing study of the prevalence, risk factors, and progression of subclinical cardiovascular disease in a multi-ethnic cohort. It provides a valuable opportunity to examine the development and progression of CAC (coronary artery calcium), which is an important risk factor for the development of coronary heart disease. In MESA, about half of the CAC scores are zero and the rest are continuously distributed. Such data has been referred to as "zero-inflated data'' and may be described using two-part models. Existing two-part model studies have limitations in that they usually consider parametric models only, make the assumption of known forms of the covariate effects, and focus only on the estimation property of the models. In this article, we investigate statistical modeling of CAC in MESA. Building on existing studies, we focus on two-part models. We investigate both parametric and semiparametric, and both proportional and nonproportional models. For various models, we study their estimation as well as prediction properties. We show that, to fully describe the relationship between covariates and CAC development, the semiparametric model with nonproportional covariate effects is needed. In contrast, for the purpose of prediction, the parametric model with proportional covariate effects is sufficient. This study provides a statistical basis for describing the behaviors of CAC and insights into its biological mechanisms.	[Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Liu, Anna] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Carr, Jeffrey] Wake Forest Univ Hlth Sci, Div Radiol Sci, Winston Salem, NC USA; [Post, Wendy] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA; [Kronmal, Richard] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Yale University; University of Massachusetts System; University of Massachusetts Amherst; Wake Forest University; Wake Forest University School of Medicine; Johns Hopkins University; University of Washington; University of Washington Seattle	Ma, SG (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Shuangge.ma@yale.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237	National Science Foundation [DMS 0805984]; National Heart, Lung and Blood Institute [N01-HC-95159, N01-HC-95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study has been supported by DMS 0805984 from the National Science Foundation (Ma) and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung and Blood Institute (Carr, Post, Kronmal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Berk KN, 2002, STAT METHODS MED RES, V11, P303, DOI 10.1191/0962280202sm293ra; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Budoff MJ, 2005, AM HEART J, V149, P695, DOI 10.1016/j.ahj.2004.07.034; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Gardin JM, 2005, AM J CARDIOL, V95, P626, DOI 10.1016/j.amjcard.2004.11.010; Han C, 2006, COMMUN STAT-THEOR M, V35, P99, DOI 10.1080/03610920500438614; Jamjoum Lama S, 2002, Med Sci Monit, V8, pCR775; KRONMAL R, 2005, RECOMMENDATION ANAL; LIU A, 2009, SEMIPARAMETRIC 2 PAR; Mazzone T, 2007, DIABETES, V56, P849, DOI 10.2337/db06-0935; McCullagh P, 1989, GEN LINEAR MODELS; Peyser PA, 2002, CIRCULATION, V106, P304, DOI 10.1161/01.CIR.0000022664.21832.5D; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Silverman B.W., 1986, DENSITY ESTIMATION S; VANDEVAART A, 1998, ASYMPTOTIC STAT; Wahba G., 1990, CBMS NSF REGIONAL C	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12036	10.1371/journal.pone.0012036	http://dx.doi.org/10.1371/journal.pone.0012036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711503	Green Published, gold			2022-12-27	WOS:000280776800016
J	Tripathi, SC; Matta, A; Kaur, J; Grigull, J; Chauhan, SS; Thakar, A; Shukla, NK; Duggal, R; DattaGupta, S; Ralhan, R; Siu, KWM				Tripathi, Satyendra Chandra; Matta, Ajay; Kaur, Jatinder; Grigull, Jorg; Chauhan, Shyam Singh; Thakar, Alok; Shukla, Nootan Kumar; Duggal, Ritu; DattaGupta, Siddhartha; Ralhan, Ranju; Siu, K. W. Michael			Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; INVASIVE BREAST-CANCER; PSORIASIN S100A7; ORAL-CANCER; DIFFERENTIAL EXPRESSION; PRECANCEROUS LESIONS; GENE FAMILY; IDENTIFICATION	Background: Tissue proteomic analysis of head and neck squamous cell carcinoma (HNSCC) and normal oral mucosa using iTRAQ (isobaric tag for relative and absolute quantitation) labeling and liquid chromatography-mass spectrometry, led to the identification of a panel of biomarkers including S100A7. In the multi-step process of head and neck tumorigenesis, the presence of dysplastic areas in the epithelium is proposed to be associated with a likely progression to cancer; however there are no established biomarkers to predict their potential of malignant transformation. This study aimed to determine the clinical significance of S100A7 overexpression in HNSCC. Methodology: Immunohistochemical analysis of S100A7 expression in HNSCC (100 cases), oral lesions (166 cases) and 100 histologically normal tissues was carried out and correlated with clinicopathological parameters and disease prognosis over 7 years for HNSCC patients. Overexpression of S100A7 protein was significant in oral lesions (squamous cell hyperplasia/dysplasia) and sustained in HNSCC in comparison with oral normal mucosa (p(trend)<0.001). Significant increase in nuclear S100A7 was observed in HNSCC as compared to dysplastic lesions (p = 0.005) and associated with well differentiated squamous cell carcinoma (p = 0.031). Notably, nuclear accumulation of S100A7 also emerged as an independent predictor of reduced disease free survival (p = 0.006, Hazard ratio (HR = 7.6), 95% CI = 1.3-5.1) in multivariate analysis underscoring its relevance as a poor prognosticator of HNSCC patients. Conclusions: Our study demonstrated nuclear accumulation of S100A7 may serve as predictor of poor prognosis in HNSCC patients. Further, increased nuclear accumulation of S100A7 in HNSCC as compared to dysplastic lesions warrants a large-scale longitudinal study of patients with dysplasia to evaluate its potential as a determinant of increased risk of transformation of oral premalignant lesions.	[Tripathi, Satyendra Chandra; Kaur, Jatinder; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Matta, Ajay; Ralhan, Ranju; Siu, K. W. Michael] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Grigull, Jorg] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Thakar, Alok] All India Inst Med Sci, Dept Otorhinolaryngol, New Delhi 110029, India; [Shukla, Nootan Kumar] All India Inst Med Sci, Dr BRA Inst, Rotary Canc Hosp, Dept Surg, New Delhi 110029, India; [Duggal, Ritu] All India Inst Med Sci, Dept Dent Surg, New Delhi 110029, India; [DattaGupta, Siddhartha] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; York University - Canada; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tripathi, SC (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	ralhanr@yorku.ca; kwmsiu@yorku.ca	Thakar, Alok/V-7701-2019; Bhurji, Jatinder K/B-6767-2013; MATTA, AJAY/AFT-2977-2022; Tripathi, Satyendra Chandra/L-9352-2017	Tripathi, Satyendra Chandra/0000-0003-3917-9645; Kaur, Jatinder/0000-0003-1650-0707	Indian Council of Medical Research (ICMR), New Delhi, India; Ontario Institute for Cancer Research (OICR); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR); Ontario Research and Development Challenge Fund; Applied Biosystems/MDS Analytical Technologies	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Ontario Institute for Cancer Research (OICR); Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Temmy Latner/Dynacare Family Foundation, Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); Applied Biosystems/MDS Analytical Technologies	SCT is a recipient of a Senior Research Fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. RR gratefully acknowledges support from the Ontario Institute for Cancer Research (OICR), Joseph and Mildred Sonshine Centre for Head and Neck Diseases and Temmy Latner/Dynacare Family Foundation, Canada. KWMS acknowledges infrastructural support from the Canadian Institutes of Health Research (CIHR), Ontario Research and Development Challenge Fund and Applied Biosystems/MDS Analytical Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Anderson KS, 2009, BRIT J DERMATOL, V160, P325, DOI 10.1111/j.1365-2133.2008.08904.x; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Banerjee AG, 2005, MOL CANCER THER, V4, P865, DOI 10.1158/1535-7163.MCT-05-0033; Bettendorf O, 2004, ORAL ONCOL, V40, P110, DOI 10.1016/j.oraloncology.2003.08.010; Broome AM, 2003, J HISTOCHEM CYTOCHEM, V51, P675, DOI 10.1177/002215540305100513; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Celis JE, 2007, MOL ONCOL, V1, P97, DOI 10.1016/j.molonc.2007.02.005; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; El-Rifai W, 2002, CANCER RES, V62, P6823; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Enerback C, 2002, CANCER RES, V62, P43; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2004, J CANCER RES CLIN, V130, P480, DOI 10.1007/s00432-004-0555-x; Jiang WG, 2004, INT J ONCOL, V25, P81; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Leon R, 2009, BIOCHEMISTRY-US, V48, P10591, DOI 10.1021/bi901330g; Leygue E, 1996, CANCER RES, V56, P4606; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Matta A, 2008, J PROTEOME RES, V7, P2078, DOI 10.1021/pr7007797; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Moriyama-Kita M, 2005, CANCER LETT, V230, P211, DOI 10.1016/j.canlet.2004.12.046; Moriyama-Kita M, 2004, ORAL ONCOL, V40, P496, DOI 10.1016/j.oraloncology.2003.10.003; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sapkota D, 2008, J ORAL PATHOL MED, V37, P607, DOI 10.1111/j.1600-0714.2008.00683.x; Suzuki F, 2005, ONCOL REP, V14, P1493; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Tsai ST, 2005, ORAL ONCOL, V41, P349, DOI 10.1016/j.oraloncology.2004.09.006; Uma RS, 2007, ORAL ONCOL, V43, P27, DOI 10.1016/j.oraloncology.2005.12.024; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6; Webb M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-17; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Zhang H, 2008, THORAX, V63, P352, DOI 10.1136/thx.2007.087015; Zhang H, 2007, LUNG CANCER, V57, P37, DOI 10.1016/j.lungcan.2007.02.020; Zhou G, 2008, ONCOGENE, V27, P3527, DOI 10.1038/sj.onc.1211015	52	49	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11939	10.1371/journal.pone.0011939	http://dx.doi.org/10.1371/journal.pone.0011939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689826	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520500006
J	Vermeij, WP; Backendorf, C				Vermeij, Wilbert P.; Backendorf, Claude			Skin Cornification Proteins Provide Global Link between ROS Detoxification and Cell Migration during Wound Healing	PLOS ONE			English	Article							PROLINE-RICH PROTEINS; CORNIFIED ENVELOPE; BARRIER FUNCTION; EXPRESSION; REGENERATION; MECHANISMS; PRECURSOR; STRESS; FAMILY; INJURY	Wound healing is a complex dynamic process characterised by a uniform flow of events in nearly all types of tissue damage, from a small skin scratch to myocardial infarction. Reactive oxygen species (ROS) are essential during the healing process at multiple stages, ranging from the initial signal that instigates the immune response, to the triggering of intracellular redox-dependent signalling pathways and the defence against invading bacteria. Excessive ROS in the wound milieu nevertheless impedes new tissue formation. Here we identify small proline-rich (SPRR) proteins as essential players in this latter process, as they directly link ROS detoxification with cell migration. A literature-based meta-analysis revealed their up-regulation in various forms of tissue injury, ranging from heart infarction and commensal-induced gut responses to nerve regeneration and burn injury. Apparently, SPRR proteins have a far more widespread role in wound healing and tissue remodelling than their established function in skin cornification. It is inferred that SPRR proteins provide injured tissue with an efficient, finely tuneable antioxidant barrier specifically adapted to the tissue involved and the damage inflicted. Their recognition as novel cell protective proteins combining ROS detoxification with cell migration will provide new venues to study and manage tissue repair and wound healing at a molecular level.	[Vermeij, Wilbert P.; Backendorf, Claude] Leiden Univ, Mol Genet Lab, Fac Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Vermeij, WP (corresponding author), Leiden Univ, Mol Genet Lab, Fac Sci, Leiden, Netherlands.	backendo@chem.leidenuniv.nl		Vermeij, Wilbert/0000-0002-9690-1385	Leiden Institute of Chemistry	Leiden Institute of Chemistry	The research has been solely funded by the Leiden Institute of Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIA A, 2003, Patent No. 03075903; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cabral A, 2001, J CELL SCI, V114, P3837; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Collins AR, 1996, ENVIRON HEALTH PERSP, V104, P465, DOI 10.2307/3432805; Cooper L, 2005, GENOME BIOL, V6; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Demetris AJ, 2008, J HEPATOL, V48, P276, DOI 10.1016/j.jhep.2007.09.019; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; Feezor RJ, 2004, PHYSIOL GENOMICS, V16, P341, DOI 10.1152/physiolgenomics.00101.2003; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KOCHEVAR IE, 2004, SCI STKE, DOI DOI 10.1126/STKE.2212004PE7; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Morris JS, 2006, J CELL PHYSIOL, V206, P16, DOI 10.1002/jcp.20427; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200	31	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11957	10.1371/journal.pone.0011957	http://dx.doi.org/10.1371/journal.pone.0011957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689819	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520500011
J	Greenwald, R; Fitzpatrick, AM; Gaston, B; Marozkina, NV; Erzurum, S; Teague, WG				Greenwald, Roby; Fitzpatrick, Anne M.; Gaston, Benjamin; Marozkina, Nadzeya V.; Erzurum, Serpil; Teague, W. Gerald			Breath Formate Is a Marker of Airway S-Nitrosothiol Depletion in Severe Asthma	PLOS ONE			English	Article							NITROSOGLUTATHIONE REDUCTASE; SMOOTH-MUSCLE; NITRIC-OXIDE; BRONCHODILATOR; NITROSYLATION; CONDENSATE; GLUTATHIONE; RELAXATION; CHILDREN; EVENTS	Background: Children with severe asthma have poor symptom control and elevated markers of airway oxidative and nitrosative stress. Paradoxically, they have decreased airway levels of S-nitrosothiols (SNOs), a class of endogenous airway smooth muscle relaxants. This deficiency results from increased activity of an enzyme that both reduces SNOs to ammonia and oxidizes formaldehyde to formic acid, a volatile carboxylic acid that is more easily detected in exhaled breath condensate (EBC) than SNOs. We therefore hypothesize that depletion of airway SNOs is related to asthma pathology, and breath formate concentration may be a proxy measure of SNO catabolism. Methods and Findings: We collected EBC samples from children and adolescents, including 38 with severe asthma, 46 with mild-to-moderate asthma and 16 healthy adolescent controls, and the concentration of ionic constituents was quantified using ion chromatography. The concentrations of EBC components with volatile conjugates were log-normally distributed. Formate was the principal ion that displayed a significant difference between asthma status classifications. The mean EBC formate concentration was 40% higher in samples collected from all asthmatics than from healthy controls (mean = 5.7 mu M, mean +/- standard deviation = 3.1-10.3 mu M vs. 4.0, 2.8-5.8 mu M, p = 0.05). EBC formate was higher in severe asthmatics than in mild-to-moderate asthmatics (6.8, 3.7-12.3 mu M vs. 4.9, 2.8-8.7 mu M, p = 0.012). In addition, formate concentration was negatively correlated with methacholine PC(20) (r = -0.39, p = 0.002, asthmatics only), and positively correlated with the NO-derived ion nitrite (r = 0.46, p<0.0001) as well as with total serum IgE (r = 0.28, p = 0.016, asthmatics only). Furthermore, formate was not significantly correlated with other volatile organic acids nor with inhaled corticosteroid dose. Conclusions: We conclude that EBC formate concentration is significantly higher in the breath of children with asthma than in those without asthma. In addition, amongst asthmatics, formate is elevated in the breath of those with severe asthma compared to those with mild-to-moderate asthma. We suggest that this difference is related to asthma pathology and may be a product of increased catabolism of endogenous S-nitrosothiols.	[Greenwald, Roby] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA; [Gaston, Benjamin; Marozkina, Nadzeya V.; Teague, W. Gerald] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Erzurum, Serpil] Cleveland Clin, Dept Med & Pathobiol, Cleveland, OH 44106 USA	Emory University; Rollins School Public Health; Emory University; University of Virginia; Cleveland Clinic Foundation	Greenwald, R (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	roby.greenwald@emory.edu; wgt2p@virginia.edu		Fitzpatrick, Anne/0000-0002-2933-5926	U.S. Centers for Disease Control and Prevention [5 U48 DP000043-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000043] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the U.S. Centers for Disease Control and Prevention (award 5 U48 DP000043-02 to WGT), http://www.cdc.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; DEBLEY JS, 2010, CHEST, V138; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Dwyer TM, 2004, LUNG, V182, P241, DOI 10.1007/s00408-004-2506-3; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; FERDINANDS JM, 2008, ENV HLTH, V7; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Greenwald R, 2009, PEDIATR PULM, V44, P768, DOI 10.1002/ppul.21055; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hedberg JJ, 2003, EUR J BIOCHEM, V270, P1249, DOI 10.1046/j.1432-1033.2003.03486.x; Henderson EM, 2005, TRENDS MOL MED, V11, P481, DOI 10.1016/j.molmed.2005.09.009; Hoog JO, 2003, CHEM-BIOL INTERACT, V143, P175, DOI 10.1016/S0009-2797(02)00225-9; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Malashenko A, 2009, J AEROSOL MED PULM D, V22, P341, DOI 10.1089/jamp.2008.0696; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Palmer LA, 2008, METHOD ENZYMOL, V440, P157, DOI 10.1016/S0076-6879(07)00809-9; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Thompson CM, 2008, J TOXICOL ENV HEAL A, V71, P244, DOI 10.1080/15287390701598259; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	33	36	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11919	10.1371/journal.pone.0011919	http://dx.doi.org/10.1371/journal.pone.0011919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689836	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520300029
J	Low, SK; Kuchiba, A; Zembutsu, H; Saito, A; Takahashi, A; Kubo, M; Daigo, Y; Kamatani, N; Chiku, S; Totsuka, H; Ohnami, S; Hirose, H; Shimada, K; Okusaka, T; Yoshida, T; Nakamura, Y; Sakamoto, H				Low, Siew-Kee; Kuchiba, Aya; Zembutsu, Hitoshi; Saito, Akira; Takahashi, Atsushi; Kubo, Michiaki; Daigo, Yataro; Kamatani, Naoyuki; Chiku, Suenori; Totsuka, Hirohiko; Ohnami, Sumiko; Hirose, Hiroshi; Shimada, Kazuaki; Okusaka, Takuji; Yoshida, Teruhiko; Nakamura, Yusuke; Sakamoto, Hiromi			Genome-Wide Association Study of Pancreatic Cancer in Japanese Population	PLOS ONE			English	Article							AFFECT TELOMERE LENGTH; TUMOR-SUPPRESSOR GENE; DUCTAL ADENOCARCINOMA; RISK; SUSCEPTIBILITY; MUTATIONS; CARCINOMA; RELATIVES; VARIANTS; YEAST	Pancreatic cancer shows very poor prognosis and is the fifth leading cause of cancer death in Japan. Previous studies indicated some genetic factors contributing to the development and progression of pancreatic cancer; however, there are limited reports for common genetic variants to be associated with this disease, especially in the Asian population. We have conducted a genome-wide association study (GWAS) using 991 invasive pancreatic ductal adenocarcinoma cases and 5,209 controls, and identified three loci showing significant association (P-value, 5 x 10(-7)) with susceptibility to pancreatic cancer. The SNPs that showed significant association carried estimated odds ratios of 1.29, 1.32, and 3.73 with 95% confidence intervals of 1.17-1.43, 1.19-1.47, and 2.24-6.21; P-value of 3.30 x 10(-7), 3.30 x 10(-7), and 4.41 x 10(-7); located on chromosomes 6p25.3, 12p11.21 and 7q36.2, respectively. These associated SNPs are located within linkage disequilibrium blocks containing genes that have been implicated some roles in the oncogenesis of pancreatic cancer.	[Low, Siew-Kee; Zembutsu, Hitoshi; Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Low, Siew-Kee; Daigo, Yataro] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kuchiba, Aya; Saito, Akira; Chiku, Suenori; Totsuka, Hirohiko; Ohnami, Sumiko; Yoshida, Teruhiko; Sakamoto, Hiromi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Kanagawa, Japan; [Saito, Akira] StaGen Co Ltd, Stat Genet Anal Div, Tokyo, Japan; [Chiku, Suenori] Mizuho Informat & Res Inst Inc, Sci Solut Div, Tokyo, Japan; [Totsuka, Hirohiko] Hitachi Govt & Publ Corp Syst Engn Ltd, Ctr Res & Dev, Bioinfomat Grp, Tokyo, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Shimada, Kazuaki] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; RIKEN; RIKEN; Mizuho Research & Technologies, Ltd.; Hitachi Limited; Keio University; National Cancer Center - Japan; National Cancer Center - Japan	Low, SK (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	tyoshida@ncc.go.jp; yusuke@ims.u-tokyo.ac.jp	Hirose, Hiroshi/F-8556-2014; Kubo, Michiaki/N-7947-2015	Daigo, Yataro/0000-0002-0915-3025; Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government; Center for Genomic Medicine, RIKEN, Japan; National Institute of Biomedical Innovation (NiBio)	Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Genomic Medicine, RIKEN, Japan; National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	This work was conducted as a part of Biobank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology from the Japanese Government and Center for Genomic Medicine, RIKEN, Japan. It was also supported in part by the program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson KE, 2006, CANC EPIDEMIOLOGY PR, P721; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; BARTON CM, 1991, BRIT J CANCER, V64, P1076, DOI 10.1038/bjc.1991.467; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Buchler P, 2001, PANCREAS, V22, P331, DOI 10.1097/00006676-200105000-00001; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; Catanzaro A, 2003, GASTROINTEST ENDOSC, V58, P836, DOI 10.1016/S0016-5107(03)02301-0; Del Chiaro M, 2007, PANCREATOLOGY, V7, P459, DOI 10.1159/000108963; FERNANDEZ E, 1994, CANCER EPIDEM BIOMAR, V3, P209; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hruban RH, 2001, CANCER J, V7, P251; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Kobitsu K, 1997, MOL CARCINOGEN, V18, P153, DOI 10.1002/(SICI)1098-2744(199703)18:3<153::AID-MC4>3.0.CO;2-G; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; MacLeod SL, 2006, WORLD J GASTROENTERO, V12, P7433, DOI 10.3748/wjg.v12.i46.7433; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McWilliams RR, 2005, CANCER, V104, P388, DOI 10.1002/cncr.21166; Milne RL, 2009, PANCREATOLOGY, V9, P206, DOI 10.1159/000210261; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; Stevens RJ, 2007, BRIT J CANCER, V96, P507, DOI 10.1038/sj.bjc.6603571; Tersmette AC, 2001, CLIN CANCER RES, V7, P738; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Heek NT, 2002, AM J PATHOL, V161, P1541, DOI 10.1016/S0002-9440(10)64432-X; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wong T, 2001, PANCREATOLOGY, V1, P486, DOI 10.1159/000055852; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yan L, 2005, GASTROENTEROLOGY, V128, P2124, DOI 10.1053/j.gastro.2005.03.006; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	39	103	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11824	10.1371/journal.pone.0011824	http://dx.doi.org/10.1371/journal.pone.0011824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686608	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520200008
J	Franckhauser, C; Mamaeva, D; Heron-Milhavet, L; Fernandez, A; Lamb, NJC				Franckhauser, Celine; Mamaeva, Daria; Heron-Milhavet, Lisa; Fernandez, Anne; Lamb, Ned J. C.			Distinct Pools of cdc25C Are Phosphorylated on Specific TP Sites and Differentially Localized in Human Mitotic Cells	PLOS ONE			English	Article							POLO-LIKE KINASE; PROTEIN-KINASE; MAMMALIAN-CELLS; NUCLEAR TRANSLOCATION; PHASE-TRANSITION; CYCLE REGULATION; PHOSPHATASE; MITOSIS; ACTIVATION; PLK1	Background: The dual specificity phosphatase cdc25C was the first human cdc25 family member found to be essential in the activation of cdk1/cyclin B1 that takes place at the entry into mitosis. Human cdc25C is phosphorylated on Proline-dependent SP and TP sites when it becomes active at mitosis and the prevalent model is that this phosphorylation/ activation of cdc25C would be part of an amplification loop with cdk1/cyclin B1. Methodology/Principal Findings: Using highly specific antibodies directed against cdc25C phospho-epitopes, pT67 and pT130, we show here that these two phospho-forms of cdc25C represent distinct pools with differential localization during human mitosis. Phosphorylation on T67 occurs from prophase and the cdc25C-pT67 phospho-isoform closely localizes with condensed chromosomes throughout mitosis. The phospho-T130 form of cdc25C arises in late G2 and associates predominantly with centrosomes from prophase to anaphase B where it colocalizes with Plk1. As shown by immunoprecipitation of each isoform, these two phospho-forms are not simultaneously phosphorylated on the other mitotic TP sites or associated with one another. Phospho-T67 cdc25C co-precipitates with MPM2-reactive proteins while pT130-cdc25C is associated with Plk1. Interaction and colocalization of phosphoT130-cdc25C with Plk1 demonstrate in living cells, that the sequence around pT130 acts as a true Polo Box Domain (PBD) binding site as previously identified from in vitro peptide screening studies. Overexpression of non-phosphorylatable alanine mutant forms for each isoform, but not wild type cdc25C, strongly impairs mitotic progression showing the functional requirement for each site-specific phosphorylation of cdc25C at mitosis. Conclusions/Significance: These results show for the first time that in human mitosis, distinct phospho-isoforms of cdc25C exist with different localizations and interacting partners, thus implying that the long-standing model of a cdc25C/cdk1 multi-site auto amplification loop is implausible.	[Franckhauser, Celine; Mamaeva, Daria; Heron-Milhavet, Lisa; Fernandez, Anne; Lamb, Ned J. C.] CNRS UPR1142, Inst Genet Humain, Cell Biol Unit, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Franckhauser, C (corresponding author), CNRS UPR1142, Inst Genet Humain, Cell Biol Unit, Montpellier, France.	Ned.Lamb@igh.cnrs.fr	Heron-Milhavet, Lisa/O-4339-2017	Heron-Milhavet, Lisa/0000-0002-7099-0850	Aventis-SA; Association Francaise contre le Myopathie (AFM); Association pour la Recherche Contre le Cancer (ARC) [3976]	Aventis-SA; Association Francaise contre le Myopathie (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche Contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	Association Francaise contre le Myopathie (AFM, http://www.afm-telethon.fr/) to Anne Fernandez, Association pour la Recherche Contre le Cancer (ARC 3976 http://www.arc-cancer.net/) to Ned Lamb and a grant in aid from Aventis-SA to Ned Lamb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahassi ELM, 2004, ONCOGENE, V23, P2658, DOI 10.1038/sj.onc.1207425; Bonnet J, 2008, CELL CYCLE, V7, P1991, DOI 10.4161/cc.7.13.6095; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Bureik M, 2000, INT J ONCOL, V17, P1251; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; GIRARD F, 1992, J CELL BIOL, V118, P785, DOI 10.1083/jcb.118.4.785; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hutchins JRA, 2004, CELL CYCLE, V3, P41; IZUMI T, 1995, MOL BIOL CELL, V6, P215, DOI 10.1091/mbc.6.2.215; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; Lamb NJC, 1997, METHOD ENZYMOL, V283, P72; Lammer C, 1998, J CELL SCI, V111, P2445; Li MG, 2006, CELL SIGNAL, V18, P1318, DOI 10.1016/j.cellsig.2005.10.020; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Myer DL, 2005, ONCOGENE, V24, P299, DOI 10.1038/sj.onc.1208278; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Peterson, 2002, TECH KNEE SURG, V1, P2; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Roshak AK, 2000, CELL SIGNAL, V12, P405, DOI 10.1016/S0898-6568(00)00080-2; SADHU K, 1990, P NATL ACAD SCI USA, V87, P5139, DOI 10.1073/pnas.87.13.5139; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Varmeh S, 2008, MOL CANCER THER, V7, P3789, DOI 10.1158/1535-7163.MCT-08-0838; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wegener S, 2000, EUR J CELL BIOL, V79, P810, DOI 10.1078/0171-9335-00115; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	47	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11798	10.1371/journal.pone.0011798	http://dx.doi.org/10.1371/journal.pone.0011798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668692	Green Published, gold, Green Submitted			2022-12-27	WOS:000280297300024
J	Goitre, L; Balzac, F; Degani, S; Degan, P; Marchi, S; Pinton, P; Retta, SF				Goitre, Luca; Balzac, Fiorella; Degani, Simona; Degan, Paolo; Marchi, Saverio; Pinton, Paolo; Retta, Saverio Francesco			KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; FORKHEAD TRANSCRIPTION FACTORS; BLOOD-BRAIN-BARRIER; HUMAN CEREBROVASCULAR MALFORMATIONS; MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS-RESPONSE; CELL-CYCLE REGULATION; ENDOTHELIAL-CELLS; VASCULAR DYSFUNCTION; NADPH OXIDASE	KRIT1 is a gene responsible for Cerebral Cavernous Malformations (CCM), a major cerebrovascular disease characterized by abnormally enlarged and leaky capillaries that predispose to seizures, focal neurological deficits, and fatal intracerebral hemorrhage. Comprehensive analysis of the KRIT1 gene in CCM patients has suggested that KRIT1 functions need to be severely impaired for pathogenesis. However, the molecular and cellular functions of KRIT1 as well as CCM pathogenesis mechanisms are still research challenges. We found that KRIT1 plays an important role in molecular mechanisms involved in the maintenance of the intracellular Reactive Oxygen Species (ROS) homeostasis to prevent oxidative cellular damage. In particular, we demonstrate that KRIT1 loss/down-regulation is associated with a significant increase in intracellular ROS levels. Conversely, ROS levels in KRIT1(-/-) cells are significantly and dose-dependently reduced after restoration of KRIT1 expression. Moreover, we show that the modulation of intracellular ROS levels by KRIT1 loss/restoration is strictly correlated with the modulation of the expression of the antioxidant protein SOD2 as well as of the transcriptional factor FoxO1, a master regulator of cell responses to oxidative stress and a modulator of SOD2 levels. Furthermore, we show that the KRIT1-dependent maintenance of low ROS levels facilitates the downregulation of cyclin D1 expression required for cell transition from proliferative growth to quiescence. Finally, we demonstrate that the enhanced ROS levels in KRIT1(-/-) cells are associated with an increased cell susceptibility to oxidative DNA damage and a marked induction of the DNA damage sensor and repair gene Gadd45 alpha, as well as with a decline of mitochondrial energy metabolism. Taken together, our results point to a new model where KRIT1 limits the accumulation of intracellular oxidants and prevents oxidative stress-mediated cellular dysfunction and DNA damage by enhancing the cell capacity to scavenge intracellular ROS through an antioxidant pathway involving FoxO1 and SOD2, thus providing novel and useful insights into the understanding of KRIT1 molecular and cellular functions.	[Goitre, Luca; Balzac, Fiorella; Degani, Simona; Retta, Saverio Francesco] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy; [Degan, Paolo] Natl Inst Canc Res, IST, Dept Translat Oncol, Genoa, Italy; [Marchi, Saverio; Pinton, Paolo] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Ferrara	Goitre, L (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy.	francesco.retta@unito.it	Marchi, Saverio/AAK-3308-2021; degan, paolo/AAB-6713-2019; degan, paolo/AAB-4093-2019; Retta, Saverio Francesco/Q-4770-2019; Pinton, Paolo/J-8025-2012; Marchi, Saverio/K-5997-2016	Marchi, Saverio/0000-0003-2708-1843; degan, paolo/0000-0003-0855-8896; Retta, Saverio Francesco/0000-0001-9761-2959; Pinton, Paolo/0000-0001-7108-6508; Marchi, Saverio/0000-0003-2708-1843	Fondazione Telethon [GGP06222]	Fondazione Telethon(Fondazione TelethonEuropean Commission)	Fondazione Telethon (grant n. GGP06222). http://www.telethon.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Adam O, 2008, ARCH TOXICOL, V82, P885, DOI 10.1007/s00204-008-0344-4; Aird WC, 2006, CIRC RES, V98, P159, DOI 10.1161/01.RES.0000204553.32549.a7; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Belik J, 2009, AM J PHYSIOL-LUNG C, V297, pL1170, DOI 10.1152/ajplung.00168.2009; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Childs EW, 2008, AM J PHYSIOL-HEART C, V294, pH2285, DOI 10.1152/ajpheart.01361.2007; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Denier C, 2002, MECH DEVELOP, V117, P363, DOI 10.1016/S0925-4773(02)00209-5; Di Lisa F, 2009, BASIC RES CARDIOL, V104, P131, DOI 10.1007/s00395-009-0008-4; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; DYPBUKT JM, 1994, J BIOL CHEM, V269, P30553; Ekshyyan O, 2005, CELL DEATH DIFFER, V12, P1066, DOI 10.1038/sj.cdd.4401650; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Evans MD, 2006, GENOME DYN, V1, P53, DOI 10.1159/000092500; Evans MD, 2004, MUTAT RES-REV MUTAT, V567, P1, DOI 10.1016/j.mrrev.2003.11.001; Faraci FM, 2006, J APPL PHYSIOL, V100, P2089, DOI 10.1152/japplphysiol.00939.2005; Faraci FM, 2005, STROKE, V36, P186, DOI 10.1161/01.STR.0000153067.27288.8b; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Felbor U, 2006, ZBL NEUROCHIR, V67, P110, DOI 10.1055/s-2006-933537; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Gault J, 2009, NEUROSURGERY, V65, P138, DOI 10.1227/01.NEU.0000348049.81121.C1; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Girouard H, 2007, ARTERIOSCL THROM VAS, V27, P303, DOI 10.1161/01.ATV.0000253885.41509.25; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iadecola C, 2009, STROKE, V40, pS40, DOI 10.1161/STROKEAHA.108.533638; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jung KH, 2003, ARCH NEUROL-CHICAGO, V60, P1613, DOI 10.1001/archneur.60.11.1613; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kehrer-Sawatzki H, 2002, ACTA NEUROPATHOL, V104, P231, DOI 10.1007/s00401-002-0552-6; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Kuhlmann CRW, 2008, LIFE SCI, V82, P1281, DOI 10.1016/j.lfs.2008.04.017; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Machida S, 2003, J CELL PHYSIOL, V196, P523, DOI 10.1002/jcp.10339; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mattila J, 2008, P NATL ACAD SCI USA, V105, P14873, DOI 10.1073/pnas.0803022105; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miller AA, 2006, ANTIOXID REDOX SIGN, V8, P1113, DOI 10.1089/ars.2006.8.1113; Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Napoli C, 1999, CIRCULATION, V99, P2003, DOI 10.1161/01.CIR.99.15.2003; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; PACHER P, 2007, PHYSIOL REV, V315, P424; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARK SH, 2009, BIOCH BIOPHYS RES CO; Petit N, 2006, GENE EXPR PATTERNS, V6, P495, DOI 10.1016/j.modgep.2005.11.001; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Retta SF, 2004, GENE, V325, P63, DOI 10.1016/j.gene.2003.09.046; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Schroeter ML, 2001, NEUROREPORT, V12, P2513, DOI 10.1097/00001756-200108080-00045; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Shah AM, 2006, CARDIOVASC RES, V71, P191, DOI 10.1016/j.cardiores.2006.05.018; Shenkar R, 2008, NEUROSURGERY, V63, P782, DOI 10.1227/01.NEU.0000325490.80694.A2; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Sure U, 2001, J NEUROSURG, V94, P970, DOI 10.3171/jns.2001.94.6.0972; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Thum T, 2008, J BIOL CHEM, V283, P19456, DOI 10.1074/jbc.M708309200; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uranishi R, 2001, NEUROSURGERY, V48, P359, DOI 10.1097/00006123-200102000-00024; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958	130	87	95	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11786	10.1371/journal.pone.0011786	http://dx.doi.org/10.1371/journal.pone.0011786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668652	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300018
J	Houck, SA; Clark, JI				Houck, Scott A.; Clark, John I.			Dynamic Subunit Exchange and the Regulation of Microtubule Assembly by the Stress Response Protein Human alpha B Crystallin	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; INTERACTIVE DOMAINS; TUBULIN AGGREGATION; OLIGOMER; BINDING; POLYMERIZATION; DISSOCIATION; CYTOSKELETON; INSTABILITY	Background: The small heat shock protein (sHSP), human alpha B crystallin, forms large, polydisperse complexes that modulate the tubulin-microtubule equilibrium using a dynamic mechanism that is poorly understood. The interactive sequences in alpha B crystallin for tubulin are surface exposed, and correspond to interactive sites for the formation of alpha B crystallin complexes. Methodology/Principal Findings: There is sequence homology between tubulin and the interactive domains in the beta 8-strand of the core domain and the C-terminal extension of alpha B crystallin. This study investigated the hypothesis that the formation of tubulin and alpha B crystallin quaternary structures was regulated through common interactive domains that alter the dynamics of their assembly. Size exclusion chromatography (SEC), SDS-PAGE, microtubule assembly assays, aggregation assays, multiple sequence alignment, and molecular modeling characterized the dynamic response of tubulin assembly to increasing concentrations of alpha B crystallin. Low molar ratios of alpha B crystallin: tubulin were favorable for microtubule assembly and high molar ratios of alpha B crystallin: tubulin were unfavorable for microtubule assembly. Interactions between alpha B crystallin and unassembled tubulin were observed using SEC and SDS-PAGE. Conclusions/Significance: Subunits of alpha B crystallin that exchange dynamically with the alpha B crystallin complex can interact with tubulin subunits to regulate the equilibrium between tubulin and microtubules.	[Houck, Scott A.] Univ N Carolina, Med Adm, Chapel Hill, NC 27515 USA; [Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Houck, SA (corresponding author), Univ N Carolina, Med Adm, Chapel Hill, NC 27515 USA.	clarkji@u.washington.edu			National Eye Institute [EY04542]; NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by Grant EY04542 from the National Eye Institute: http://www.nei.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, CELL STRUCT FUNCT, V22, P539, DOI 10.1247/csf.22.539; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bauer NG, 2006, J MOL NEUROSCI, V29, P153, DOI 10.1385/JMN:29:2:153; BERKOWITZ SA, 1981, J BIOL CHEM, V256, P1216; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COLNAGO LA, 1987, BIOCHEMISTRY-US, V26, P847, DOI 10.1021/bi00377a028; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Ghosh JG, 2007, INT J BIOCHEM CELL B, V39, P1804, DOI 10.1016/j.biocel.2007.04.027; Ghosh JG, 2006, CELL STRESS CHAPERON, V11, P187, DOI 10.1379/CSC-186.1; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P9878, DOI 10.1021/bi060970k; Gopalakrishnan S., 1993, Transactions of the Kansas Academy of Science, V96, P7, DOI 10.2307/3628308; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Head MW, 2000, NEUROREPORT, V11, P361, DOI 10.1097/00001756-200002070-00028; Husain Mustafa M, 2008, Neuropsychiatr Dis Treat, V4, P765; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jee H, 2009, J PHYSIOL SCI, V59, P149, DOI 10.1007/s12576-008-0014-6; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kato K, 1996, J BIOL CHEM, V271, P26989, DOI 10.1074/jbc.271.43.26989; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Krushelnitsky A, 2008, Open Biochem J, V2, P116, DOI 10.2174/1874091X00802010116; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Liu LY, 2006, ANAL BIOCHEM, V350, P186, DOI 10.1016/j.ab.2005.12.019; Mitra G, 2007, PROTEINS, V67, P112, DOI 10.1002/prot.21286; Muchowski PJ, 1999, J MOL BIOL, V289, P397, DOI 10.1006/jmbi.1999.2759; Murugesan R, 2008, MOL VIS, V14, P1835; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Oosawa F, 1977, J Mechanochem Cell Motil, V4, P63; Pasta SY, 2004, MOL VIS, V10, P655; Prescott AR, 1996, OPHTHALMIC RES, V28, P58, DOI 10.1159/000267946; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Srinivas V, 2005, MOL VIS, V11, P249; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com	52	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11795	10.1371/journal.pone.0011795	http://dx.doi.org/10.1371/journal.pone.0011795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668689	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300023
J	Degrange, FJ; Tambussi, CP; Moreno, K; Witmer, LM; Wroe, S				Degrange, Federico J.; Tambussi, Claudia P.; Moreno, Karen; Witmer, Lawrence M.; Wroe, Stephen			Mechanical Analysis of Feeding Behavior in the Extinct "Terror Bird'' Andalgalornis steulleti (Gruiformes: Phorusrhacidae)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; MAXIMAL BITE FORCE; PREDATORY BEHAVIOR; CRANIAL MECHANICS; DARWINS FINCHES; PERFORMANCE; MORPHOLOGY; EVOLUTION; KINEMATICS; KINESIS	The South American phorusrhacid bird radiation comprised at least 18 species of small to gigantic terrestrial predators for which there are no close modern analogs. Here we perform functional analyses of the skull of the medium-sized (similar to 40 kg) patagornithine phorusrhacid Andalgalornis steulleti (upper Miocene-lower Pliocene, Andalgala Formation, Catamarca, Argentina) to assess its mechanical performance in a comparative context. Based on computed tomographic (CT) scanning and morphological analysis, the skull of Andalgalornis steulleti is interpreted as showing features reflecting loss of intracranial immobility. Discrete anatomical attributes permitting such cranial kinesis are widespread phorusrhacids outgroups, but this is the first clear evidence of loss of cranial kinesis in a gruiform bird and may be among the best documented cases among all birds. This apomorphic loss is interpreted as an adaptation for enhanced craniofacial rigidity, particularly with regard to sagittal loading. We apply a Finite Element approach to a three-dimensional (3D) model of the skull. Based on regression analysis we estimate the bite force of Andalgalornis at the bill tip to be 133 N. Relative to results obtained from Finite Element Analysis of one of its closest living relatives (seriema) and a large predatory bird (eagle), the phorusrhacid's skull shows relatively high stress under lateral loadings, but low stress where force is applied dorsoventrally (sagittally) and in "pullback'' simulations. Given the relative weakness of the skull mediolaterally, it seems unlikely that Andalgalornis engaged in potentially risky behaviors that involved subduing large, struggling prey with its beak. We suggest that it either consumed smaller prey that could be killed and consumed more safely (e. g., swallowed whole) or that it used multiple well-targeted sagittal strikes with the beak in a repetitive attack-and-retreat strategy.	[Degrange, Federico J.; Tambussi, Claudia P.] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Museo La Plata, CONICET,Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Moreno, Karen] Univ Austral Chile, Inst Geociencias, Lab Paleontol, Valdivia, Chile; [Moreno, Karen; Wroe, Stephen] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidad Austral de Chile; University of New South Wales Sydney; University System of Ohio; Ohio University	Degrange, FJ (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Museo La Plata, CONICET,Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina.	fjdegrange@fcnym.unlp.edu.ar	Wroe, Stephen/A-4462-2010; Moreno, Karen/B-6127-2009	Wroe, Stephen/0000-0002-5813-9182; Moreno, Karen/0000-0002-5949-133X; Witmer, Lawrence/0000-0002-7610-0118; Wroe, Stephen/0000-0002-6365-5915	Australian Research Council (ARC) [DP0666374, DP098785]; Australian Pacific Science Foundation (APSF); University of New South Wales; Agencia Nacional de Investigaciones Cientificas y Tecnicas [PICT 32617]; National Science Foundation (NSF) [IBN-0343744, IBN-0517257]	Australian Research Council (ARC)(Australian Research Council); Australian Pacific Science Foundation (APSF); University of New South Wales; Agencia Nacional de Investigaciones Cientificas y Tecnicas; National Science Foundation (NSF)(National Science Foundation (NSF))	Funding was provided by Australian Research Council (ARC) Discovery Grants (DP0666374, DP098785), an Australian Pacific Science Foundation (APSF) and a University of New South Wales Internal Strategic Grant (to S.W.), Agencia Nacional de Investigaciones Cientificas y Tecnicas PICT 32617 (to C.P.T.), and National Science Foundation (NSF) IBN-0343744 and NSF IBN-0517257 to L.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2005, ORNITOL NEOTROP, V16, P471; Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Andrews C.W., 1901, T ZOOLOGICAL SOC LON, V15, P55; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Blanco RE, 2005, P ROY SOC B-BIOL SCI, V272, P1769, DOI 10.1098/rspb.2005.3133; Bout RG, 2001, COMP BIOCHEM PHYS A, V131, P197, DOI 10.1016/S1095-6433(01)00470-6; Campbell Kenneth E. Jr, 1992, Natural History Museum of Los Angeles County Science Series, V36, P395; Chiappe LM, 2006, NATURE, V443, P929, DOI 10.1038/443929a; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; DEGRANGE FJ, 2008, 3 C LAT PAL VERT S M, P76; Gussekloo SWS, 2005, J EXP BIOL, V208, P3409, DOI 10.1242/jeb.01768; Gussekloo SWS, 2001, J EXP BIOL, V204, P1735; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 2005, J EVOLUTION BIOL, V18, P669, DOI 10.1111/j.1420-9101.2004.00857.x; Hofling E., 1984, Gegenbaurs Morphologisches Jahrbuch, V130, P235; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; JIMENEZ J E, 1990, Hornero, V13, P97; Kraglievich L., 1931, Physis Buenos Aires, V10, P304; Livezey BC, 1998, PHILOS T R SOC B, V353, P2077, DOI 10.1098/rstb.1998.0353; Mayr Gerald, 2002, Palaeontologische Zeitschrift, V76, P305; McDOWELL SAM, 1948, AUK, V65, P520; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Patterson B., 1960, Publ Mus Cienc nat Mar del Plata, V1, P1; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reid JR., 1835, P ZOOL SOC LOND, V3, P132; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; SCHOONEES J., 1963, ANN UNIV STELLENBOSCH, V38, P215; SIMS SW, 1955, B BRIT MUSEUM ZOOL, V2, P371; SINCLAIR WILLIAM J., 1932, REPT PRINCETON UNIV EXPED PATAGONIA 1896 1899, V7, P157; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Tambussi C, 1999, J VERTEBR PALEONTOL, V19, P404, DOI 10.1080/02724634.1999.10011154; Tambussi Claudia, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P245; TAMBUSSI CP, 1997, AMEGHINIANA, V34, P541; Tizzard A, 2005, PHYSIOL MEAS, V26, pS251, DOI 10.1088/0967-3334/26/2/024; van der Meij MAA, 2006, J EXP BIOL, V209, P3329, DOI 10.1242/jeb.02379; van der Meij MAA, 2004, J EXP BIOL, V207, P2745, DOI 10.1242/jeb.01091; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2004, P ROY SOC B-BIOL SCI, V271, P1203, DOI 10.1098/rspb.2004.2694; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594; ZUSI RL, 1993, SKULL, V2, P391	52	56	61	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11856	10.1371/journal.pone.0011856	http://dx.doi.org/10.1371/journal.pone.0011856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805872	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600003
J	Lenting, PJ; Westerlaken, GHA; Denis, CV; Akkerman, JW; Meyaard, L				Lenting, Peter J.; Westerlaken, Geertje H. A.; Denis, Cecile V.; Akkerman, Jan Willem; Meyaard, Linde			Efficient Inhibition of Collagen-Induced Platelet Activation and Adhesion by LAIR-2, a Soluble Ig-Like Receptor Family Member	PLOS ONE			English	Article							BINDING-SITE; LIGANDS; GPVI	LAIR-1 (Leukocyte Associated Ig-like Receptor-1) is a collagen receptor that functions as an inhibitory receptor on immune cells. It has a soluble family member, LAIR-2, that also binds collagen and can interfere with LAIR-1/collagen interactions. Collagen is a main initiator for platelet adhesion and aggregation. Here, we explored the potential of soluble LAIR proteins to inhibit thrombus formation in vitro. LAIR-2/Fc but not LAIR-1/Fc inhibited collagen-induced platelet aggregation. In addition, LAIR-2/Fc also interfered with platelet adhesion to collagen at low shear rate (300 s(-1); IC50 = 18 mu g/ml) and high shear rate (1500 s(-1); IC50 = 30 mu g/ml). Additional experiments revealed that LAIR-2/Fc leaves interactions between collagen and alpha 2 beta 1 unaffected, but efficiently prevents binding of collagen to Glycoprotein VI and von Willebrand factor. Thus, LAIR-2/Fc has the capacity to interfere with platelet-collagen interactions mediated by Glycoprotein VI and the VWF/Glycoprotein Ib axis.	[Lenting, Peter J.; Denis, Cecile V.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Lenting, Peter J.; Denis, Cecile V.] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Lenting, Peter J.; Akkerman, Jan Willem] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Lenting, PJ (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	l.meyaard@umcutrecht.nl	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019; Denis, Cecile/A-7649-2011	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Denis, Cecile/0000-0001-5152-9156; Meyaard, Linde/0000-0003-0707-4793	Division of Laboratory and Pharmacy at the UMC Utrecht	Division of Laboratory and Pharmacy at the UMC Utrecht	This study was funded by a seeding grant from the Division of Laboratory and Pharmacy at the UMC Utrecht to PJL and LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Farndale RW, 2007, J THROMB HAEMOST, V5, P220, DOI 10.1111/j.1538-7836.2007.02521.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; LEBBINK RJ, 2009, MATRIX BIOL IN PRESS; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ouyang WM, 2003, BIOCHEM BIOPH RES CO, V310, P1236, DOI 10.1016/j.bbrc.2003.09.152; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Sixma JJ, 1998, THROMB RES, V92, pS43, DOI 10.1016/S0049-3848(98)00159-5; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Van de Walle GR, 2005, J BIOL CHEM, V280, P36873, DOI 10.1074/jbc.M508148200; Verbrugge A, 2006, J LEUKOCYTE BIOL, V79, P828, DOI 10.1189/jlb.0705370	24	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12174	10.1371/journal.pone.0012174	http://dx.doi.org/10.1371/journal.pone.0012174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730098	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200025
J	Burra, PV; Kalmar, L; Tompa, P				Burra, Prasad V.; Kalmar, Lajos; Tompa, Peter			Reduction in Structural Disorder and Functional Complexity in the Thermal Adaptation of Prokaryotes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; AMINO-ACID-COMPOSITION; TRANSCRIPTION FACTORS; ENERGY CONTENT; LINEAR MOTIFS; LEA PROTEINS; RECOGNITION; BACTERIA; REGIONS; BINDING	Genomic correlates of evolutionary adaptation to very low or very high optimal growth temperature (OGT) values have been the subject of many studies. Whereas these provided a protein-structural rationale of the activity and stability of globular proteins/enzymes, the point has been neglected that adaptation to extreme temperatures could also have resulted from an increased use of intrinsically disordered proteins (IDPs), which are resistant to these conditions in vitro. Contrary to these expectations, we found a conspicuously low level of structural disorder in bacteria of very high (and very low) OGT values. This paucity of disorder does not reflect phylogenetic relatedness, i.e. it is a result of genuine adaptation to extreme conditions. Because intrinsic disorder correlates with important regulatory functions, we asked how these bacteria could exist without IDPs by studying transcription factors, known to harbor a lot of function-related intrinsic disorder. Hyperthermophiles have much less transcription factors, which have reduced disorder compared to their mesophilic counterparts. On the other hand, we found by systematic categorization of proteins with long disordered regions that there are certain functions, such as translation and ribosome biogenesis that depend on structural disorder even in hyperthermophiles. In all, our observations suggest that adaptation to extreme conditions is achieved by a significant functional simplification, apparent at both the level of the genome and individual genes/proteins.	[Burra, Prasad V.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kalmar, Lajos; Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary	University of California System; University of California San Diego; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Burra, PV (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	tompa@enzim.hu	Kalmar, Lajos/C-3040-2014	Kalmar, Lajos/0000-0003-3691-8350	Hungarian Scientific Research [OTKA K60694, NK71582]; Hungarian Ministry of Health [ETT 245/2006]	Hungarian Scientific Research(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health	This research was supported by grants OTKA K60694 and NK71582 from the Hungarian Scientific Research Fund and ETT 245/2006 from the Hungarian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Berezovsky IN, 2007, PLOS COMPUT BIOL, V3, P498, DOI 10.1371/journal.pcbi.0030052; Blochl E, 1997, EXTREMOPHILES, V1, P14; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; CHEN X, 2009, J MOL BIOL; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; Goldstein RA, 2007, PROTEIN SCI, V16, P1887, DOI 10.1110/ps.072947007; Huang SL, 2004, BIOINFORMATICS, V20, P276, DOI 10.1093/bioinformatics/btg403; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kalthoff C, 2003, J CHROMATOGR B, V786, P247, DOI 10.1016/S1570-0232(02)00908-X; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Minezaki Y, 2005, DNA RES, V12, P269, DOI 10.1093/dnares/dsi016; Mizuguchi K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S15; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Pasamontes A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-257; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Plaxco KW, 1997, NATURE, V386, P657, DOI 10.1038/386657a0; Puigbo P, 2008, TRENDS GENET, V24, P10, DOI 10.1016/j.tig.2007.10.005; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RAJASEKAR K, 2010, J BIOL CHEM; Schroder O, 2002, BIOL CHEM, V383, P945, DOI 10.1515/BC.2002.101; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sharma AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007159; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Singh J, 2009, PROTEIN EXPRES PURIF, V67, P15, DOI 10.1016/j.pep.2009.04.003; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Subramanyam MB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-141; Suhre K, 2003, J BIOL CHEM, V278, P17198, DOI 10.1074/jbc.M301327200; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tantos A, 2009, FEBS LETT, V583, P465, DOI 10.1016/j.febslet.2008.12.054; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2009, STRUCTURE FUNCTION I; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	64	57	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12069	10.1371/journal.pone.0012069	http://dx.doi.org/10.1371/journal.pone.0012069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711457	Green Submitted, gold, Green Published			2022-12-27	WOS:000280849100015
J	Ek, CJ; Habgood, MD; Callaway, JK; Dennis, R; Dziegielewska, KM; Johansson, PA; Potter, A; Wheaton, B; Saunders, NR				Ek, C. Joakim; Habgood, Mark D.; Callaway, Jennifer K.; Dennis, Ross; Dziegielewska, Katarzyna M.; Johansson, Pia A.; Potter, Ann; Wheaton, Benjamin; Saunders, Norman R.			Spatio-Temporal Progression of Grey and White Matter Damage Following Contusion Injury in Rat Spinal Cord	PLOS ONE			English	Article							BLOOD-FLOW; PATHOPHYSIOLOGY; LOCOMOTION; RECOVERY; BRAIN; TRAUMA; LESION; IMPACT; DISPLACEMENT; OUTCOMES	Cellular mechanisms of secondary damage progression following spinal cord injury remain unclear. We have studied the extent of tissue damage from 15 min to 10 weeks after injury using morphological and biochemical estimates of lesion volume and surviving grey and white matter. This has been achieved by semi-quantitative immunocytochemical methods for a range of cellular markers, quantitative counts of white matter axonal profiles in semi-thin sections and semi-quantitative Western blot analysis, together with behavioural tests (BBB scores, ledged beam, random rung horizontal ladder and DigiGait (TM) analysis). We have developed a new computer-controlled electronic impactor based on a linear motor that allows specification of the precise nature, extent and timing of the impact. Initial (15 min) lesion volumes showed very low variance (1.92 +/- 0.23 mm(3), mean +/- SD, n = 5). Although substantial tissue clearance continued for weeks after injury, loss of grey matter was rapid and complete by 24 hours, whereas loss of white matter extended up to one week. No change was found between one and 10 weeks after injury for almost all morphological and biochemical estimates of lesion size or behavioural methods. These results suggest that previously reported apparent ongoing injury progression is likely to be due, to a large extent, to clearance of tissue damaged by the primary impact rather than continuing cell death. The low variance of the impactor and the comprehensive assessment methods described in this paper provide an improved basis on which the effects of potential treatment regimes for spinal cord injury can be assessed.	[Ek, C. Joakim; Habgood, Mark D.; Callaway, Jennifer K.; Dennis, Ross; Dziegielewska, Katarzyna M.; Johansson, Pia A.; Potter, Ann; Wheaton, Benjamin; Saunders, Norman R.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Melbourne	Ek, CJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	n.saunders@unimelb.edu.au	Wheaton, Ben/AAC-7037-2021	Wheaton, Benjamin/0000-0003-0619-4777; Johansson, Pia/0000-0002-6938-4060; Saunders, Norman/0000-0001-6660-7639	Victorian Neurotrauma Initiative [DP048]	Victorian Neurotrauma Initiative	This work was supported by the Victorian Neurotrauma Initiative (Grant #DP048). For more information about this research fund, go to http://www.vni.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AR, 1911, JAMA 57, P878, DOI [10.1001/jama.1911.04260090100008, DOI 10.1001/JAMA.1911.04260090100008]; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; BALENTINE JD, 1978, LAB INVEST, V39, P236; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; EDGERTON VR, 1992, J NEUROTRAUM, V9, pS119; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Kim JH, 2009, J NEUROTRAUM, V26, P1395, DOI [10.1089/neu.2008.0728, 10.1089/neu.2008-0728]; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; KOYANAGI I, 1993, NEUROSURGERY, V32, P260, DOI 10.1227/00006123-199302000-00015; KOYANAGI I, 1993, NEUROSURGERY, V33, P277; LANGE W, 1978, ANAT EMBRYOL, V152, P325, DOI 10.1007/BF00350528; Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; NOYES DH, 1987, EXP NEUROL, V95, P535, DOI 10.1016/0014-4886(87)90298-6; Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52; Oschipok LW, 2008, NEUROSCI LETT, V434, P113, DOI 10.1016/j.neulet.2008.01.048; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Rossignol S, 1993, J Am Paraplegia Soc, V16, P190; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Schallert T, 2000, PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000, P329; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1992, J NEUROTRAUM, V9, P139, DOI 10.1089/neu.1992.9.139; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; WALLACE MC, 1986, NEUROSURGERY, V18, P433; Wannier-Morino P, 2008, BRAIN RES, V1217, P96, DOI 10.1016/j.brainres.2007.11.019; WOOLLAM DHM, 1955, J NEUROL NEUROSUR PS, V18, P97, DOI 10.1136/jnnp.18.2.97; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Yeo J D, 1984, Cent Nerv Syst Trauma, V1, P161; Young W, 2002, PROG BRAIN RES, V137, P231; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	58	68	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12021	10.1371/journal.pone.0012021	http://dx.doi.org/10.1371/journal.pone.0012021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711496	Green Published, gold			2022-12-27	WOS:000280776800012
J	Gautier, M; Hocking, TD; Foulley, JL				Gautier, Mathieu; Hocking, Toby Dylan; Foulley, Jean-Louis			A Bayesian Outlier Criterion to Detect SNPs under Selection in Large Data Sets	PLOS ONE			English	Article							ADAPTIVE GENETIC-DIVERGENCE; LOCI; POLYMORPHISM; FREQUENCY; SIGNATURES; INFERENCE; MARKERS; MODEL; SCAN; MAP	Background: The recent advent of high-throughput SNP genotyping technologies has opened new avenues of research for population genetics. In particular, a growing interest in the identification of footprints of selection, based on genome scans for adaptive differentiation, has emerged. Methodology/Principal Findings: The purpose of this study is to develop an efficient model-based approach to perform Bayesian exploratory analyses for adaptive differentiation in very large SNP data sets. The basic idea is to start with a very simple model for neutral loci that is easy to implement under a Bayesian framework and to identify selected loci as outliers via Posterior Predictive P-values (PPP-values). Applications of this strategy are considered using two different statistical models. The first one was initially interpreted in the context of populations evolving respectively under pure genetic drift from a common ancestral population while the second one relies on populations under migration-drift equilibrium. Robustness and power of the two resulting Bayesian model-based approaches to detect SNP under selection are further evaluated through extensive simulations. An application to a cattle data set is also provided. Conclusions/Significance: The procedure described turns out to be much faster than former Bayesian approaches and also reasonably efficient especially to detect loci under positive selection.	[Gautier, Mathieu; Hocking, Toby Dylan; Foulley, Jean-Louis] INRA, GABI UMR1313, Jouy En Josas, France; [Gautier, Mathieu] INRA, CBGP UMR1031, Montferrier Sur Lez, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD)	Gautier, M (corresponding author), INRA, GABI UMR1313, Jouy En Josas, France.	mathieu.gautier@jouy.inra.fr	gautier, mathieu/F-7429-2010; gautier, mathieu/AAU-8789-2020	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880	French National Institute of Agronomic Research (INRA)	French National Institute of Agronomic Research (INRA)	This work was supported by the French National Institute of Agronomic Research (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Bayarri MJ, 2007, STAT SCI, V22, P322, DOI 10.1214/07-STS235; BAZIN E, 2010, LIKELIHOOD IN PRESS; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Guillot G, 2009, BIOINFORMATICS, V25, P552, DOI 10.1093/bioinformatics/btn665; Guo F, 2009, J AM STAT ASSOC, V104, P142, DOI 10.1198/jasa.2009.0010; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LEWONTIN RC, 1973, GENETICS, V74, P175; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; ROBERTSON A, 1975, GENETICS, V81, P775; RUBIN DB, 1984, ANN STAT, V12, P1151, DOI 10.1214/aos/1176346785; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Vitalis R, 2001, GENETICS, V158, P1811; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	31	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11913	10.1371/journal.pone.0011913	http://dx.doi.org/10.1371/journal.pone.0011913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689851	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520400010
J	O'Dor, R; Miloslavich, P; Yarincik, K				O'Dor, Ron; Miloslavich, Patricia; Yarincik, Kristen			Marine Biodiversity and Biogeography - Regional Comparisons of Global Issues, an Introduction	PLOS ONE			English	Review							CENSUS; LIFE	The Census of Marine Life grew out of a series of global concept meetings, following a 1995 U. S. National Research Council report indicating that no nation in the world could list the species that live in its offshore exclusive economic zone, as required under the Convention on Biological Diversity. A series of "Known, Unknown, Unknowable'' meetings convened in every ocean region enabled the Census Scientific Steering Committee to compile information and enlist people from around the world to form a network of National and Regional Implementation Committees in support of a global effort to resolve this knowledge void. This collection represents the assembled results of their activities. As these data are incorporated into the Census' Ocean Biogeographic Information System and made available through its new home at the UN's Intergovernmental Oceanographic Commission, they will be the best records of most countries' marine biodiversity. The people, technologies, and associations of the Census will play a key role the UN General Assembly's future Regular Marine Assessments. This collection is a major legacy of the Census' US$650 million "Decade of Discovery'' to be released in London in October 2010.	[O'Dor, Ron; Yarincik, Kristen] Consortium Ocean Leadership, Census Marine Life Secretariat, Washington, DC USA; [Miloslavich, Patricia] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela	Simon Bolivar University	O'Dor, R (corresponding author), Consortium Ocean Leadership, Census Marine Life Secretariat, Washington, DC USA.	kyarincik@oceanleadership.org		Miloslavich, Patricia/0000-0001-5409-1401	Alfred P. Sloan Foundation [2008-3-8]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The Census of Marine Life program is primarily funded by the Alfred P. Sloan Foundation (2008-3-8: www.sloan.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel J.H., 1999, OCEANOGRAPHY, V12, P4, DOI [10.5670/oceanog.1999.17, DOI 10.5670/OCEANOG.1999.17]; Ausubel JH, 2001, FISHERIES, V26, P33; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; DECKER C, 2003, P MAR BIOD SUBS KNOW; Gallardo Víctor Ariel, 2003, Gayana (Concepc.), V67, P139; GRADINGER R, 2010, MARINE LIFE IN PRESS; IKEN K, 2003, P ARCT BIOD WORKSH N; *IUCN, 2010, GLOB OC BIOD IN WORK; Liu RY., 2008, CHECKLIST MARINE BIO; McIntyre A., 2010, LIFE WORLDS OCEANS D; Miloslavich P, 2005, CARIBBEAN MARINE BIO; *NAT RES COUNC COM, 1995, UND MAR BIOD; O'Dor R, 2005, SCI MAR, V69, P181, DOI 10.3989/scimar.2005.69s1181; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; UNEP IOC/UNESCO, 2009, ASS ASS FIND GROUP E; VERMUELEN N, 2009, SUPERSIZING SCI BUIL; Wafar M, 2005, INDIAN J MAR SCI, V34, P7; WAGEY T, 2008, MARINE BIODIVERSITY; Yarincik K, 2005, SCI MAR, V69, P201, DOI 10.3989/scimar.2005.69s1201; ZWANENBURG KCT, 2002, 2432 FISH AQ SCI, V2432	22	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11871	10.1371/journal.pone.0011871	http://dx.doi.org/10.1371/journal.pone.0011871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689843	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520400009
J	de Herve, MGD; Gonzales, E; Hendel-Chavez, H; Decline, JL; Mourier, O; Abbed, K; Jacquemin, E; Taoufik, Y				de Herve, Marie-Ghislaine de Goer; Gonzales, Emmanuel; Hendel-Chavez, Houria; Decline, Jean-Luc; Mourier, Olivia; Abbed, Karim; Jacquemin, Emmanuel; Taoufik, Yassine			CD25 Appears Non Essential for Human Peripheral T-reg Maintenance In Vivo	PLOS ONE			English	Article							FOOD ALLERGY; LIVER-TRANSPLANTATION; STRUCTURAL BASIS; CELLS; INTERLEUKIN-2; TACROLIMUS; EXPRESSION; FOXP3; BASILIXIMAB; CHILDREN	Background: IL-2 has been reported to be critical for peripheral T-reg survival in mouse models. Here, we examined T-reg maintenance in a series of paediatric liver transplant recipients who received basiliximab, a therapeutic anti-CD25 monoclonal antibody. Methodology/Principal Findings: FoxP3(+) CD4 T cells were analyzed by flow cytometry before liver grafting and more than 9 months later. We found that in vivo CD25 blockade did not lead to Treg depletion: the proportion of FoxP3(+) cells among CD4 T cells and the level of FoxP3 expression were both unchanged. IL-2R beta expression was enhanced in FoxP3(+) cells both before and after basiliximab treatment, while the level of IL-2R gamma expression was similar in T-regs and non-T-regs. No significant change in the weak or absent expression of IL-7R alpha and IL-15R alpha expression on FoxP3(+) cells was observed. Although the proportion of FoxP3(+) cells among CD4 T cells did not vary, food allergies occurred more rapidly after liver grafting in patients who received basiliximab, raising questions as to T-reg functionality in vivo in the absence of functional CD25. Conclusions: CD25 appears non essential for human T-reg peripheral maintenance in vivo. However, our results raise questions as to T-reg functionality after therapeutic CD25 targeting.	[de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Abbed, Karim; Taoufik, Yassine] CHU Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Hendel-Chavez, Houria; Taoufik, Yassine] INSERM 10 12, Fac Med, Le Kremlin Bicetre, France; [de Herve, Marie-Ghislaine de Goer; Taoufik, Yassine] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Gonzales, Emmanuel; Decline, Jean-Luc; Mourier, Olivia; Jacquemin, Emmanuel] CHU Bicetre, Serv Hepatol Pediat, Le Kremlin Bicetre, France; [Gonzales, Emmanuel; Decline, Jean-Luc; Mourier, Olivia; Jacquemin, Emmanuel] CHU Bicetre, Ctr Reference Natl Atresie Voies Biliaires, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	de Herve, MGD (corresponding author), CHU Bicetre, Unite Immunol Biol, Le Kremlin Bicetre, France.	yassine.taoufik@bct.aphp.fr	jacquemin, emmanuel/J-8673-2013; Gonzales, Emmanuel/J-8730-2013	GONZALES, Emmanuel/0000-0002-1546-3193	Assistance Publique-Hopitaux de Paris (AP-HP)	Assistance Publique-Hopitaux de Paris (AP-HP)	Funding was provided by Assistance Publique-Hopitaux de Paris (AP-HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2009, CURR OPIN IMMUNOL, V21, P700, DOI 10.1016/j.coi.2009.07.012; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Arikan C, 2003, TRANSPLANT P, V35, P3039, DOI 10.1016/j.transproceed.2003.10.033; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Binder M, 2007, CANCER RES, V67, P3518, DOI 10.1158/0008-5472.CAN-06-3919; Bluestone JA, 2008, AM J TRANSPLANT, V8, P2086, DOI 10.1111/j.1600-6143.2008.02377.x; Boyle RJ, 2005, LIVER TRANSPLANT, V11, P326, DOI 10.1002/lt.20368; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dell-Olio D, 2009, PEDIATR TRANSPLANT, V13, P670, DOI 10.1111/j.1399-3046.2009.01184.x; Du JM, 2010, J IMMUNOL, V184, P1361, DOI 10.4049/jimmunol.0903178; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gabe SM, 1998, GASTROENTEROLOGY, V115, P67, DOI 10.1016/S0016-5085(98)70366-X; Kahan BD, 1999, TRANSPLANTATION, V67, P276, DOI 10.1097/00007890-199901270-00016; Kelly D, 2004, LANCET, V364, P1054, DOI 10.1016/S0140-6736(04)17060-8; Levy Y, 2009, PEDIATR TRANSPLANT, V13, P63, DOI 10.1111/j.1399-3046.2007.00883.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pescovitz MD, 2008, CURR OPIN ORGAN TRAN, V13, P495, DOI 10.1097/MOT.0b013e328310b0ba; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Fueyo A, 2007, TRANSPL INT, V20, P534, DOI 10.1111/j.1432-2277.2007.00470.x; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; von Boehmer H, 2003, J EXP MED, V198, P845, DOI 10.1084/jem.20031358; VONDRAN FW, 2009, TRANSPL INT; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wang Z, 2009, CLIN EXP IMMUNOL, V155, P496, DOI 10.1111/j.1365-2249.2008.03847.x	37	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11784	10.1371/journal.pone.0011784	http://dx.doi.org/10.1371/journal.pone.0011784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689592	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520300006
J	Hanin, A; Sava, I; Bao, YY; Huebner, J; Hartke, A; Auffray, Y; Sauvageot, N				Hanin, Aurelie; Sava, Irina; Bao, YinYin; Huebner, Johannes; Hartke, Axel; Auffray, Yanick; Sauvageot, Nicolas			Screening of In Vivo Activated Genes in Enterococcus faecalis during Insect and Mouse Infections and Growth in Urine	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; EXPRESSION TECHNOLOGY; STREPTOCOCCUS-PNEUMONIAE; PATHOGENICITY ISLAND; LACTOCOCCUS-LACTIS; VIRULENCE GENES; TRANSCRIPTIONAL REGULATOR; PSEUDOMONAS-AERUGINOSA; LISTERIA-MONOCYTOGENES; AGGREGATION SUBSTANCE	Enterococcus faecalis is part of the commensal microbiota of humans and its main habitat is the gastrointestinal tract. Although harmless in healthy individuals, E. faecalis has emerged as a major cause of nosocomial infections. In order to better understand the transformation of a harmless commensal into a life-threatening pathogen, we developed a Recombination-based In Vivo Expression Technology for E. faecalis. Two R-IVET systems with different levels of sensitivity have been constructed in a E. faecalis V583 derivative strain and tested in the insect model Galleria mellonella, during growth in urine, in a mouse bacteremia and in a mouse peritonitis model. Our combined results led to the identification of 81 in vivo activated genes. Among them, the ef_3196/7 operon was shown to be strongly induced in the insect host model. Deletion of this operonic structure demonstrated that this two-component system was essential to the E. faecalis pathogenic potential in Galleria. Gene ef_0377, induced in insect and mammalian models, has also been further analyzed and it has been demonstrated that this ankyrin-encoding gene was also involved in E. faecalis virulence. Thus these R-IVET screenings led to the identification of new E. faecalis factors implied in in vivo persistence and pathogenic potential of this opportunistic pathogen.	[Hanin, Aurelie; Hartke, Axel; Auffray, Yanick; Sauvageot, Nicolas] Univ Caen, Lab Microbiol Environm, USC INRA 2017 EA956, F-14032 Caen, France; [Sava, Irina; Bao, YinYin; Huebner, Johannes] Univ Med Ctr, Dept Med, Div Infect Dis, Freiburg, Germany	INRAE; Universite de Caen Normandie; University of Freiburg	Hanin, A (corresponding author), Univ Caen, Lab Microbiol Environm, USC INRA 2017 EA956, F-14032 Caen, France.	nicolas.sauvageot@unicaen.fr	Hanin, Aurélie/AAQ-1072-2021	Hanin, Aurélie/0000-0003-4469-537X; Huebner, Johannes/0000-0003-1232-4646	French Ministre de l'Enseignement suparieur et de la Recherche; Agence Nationale de la Recherche [ANR-06-PATHO-008-01]	French Ministre de l'Enseignement suparieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR))	Auralie Hanin is a PhD student whose thesis was granted by the French Ministre de l'Enseignement suparieur et de la Recherche. This work was partly supported by grants from the Agence Nationale de la Recherche in the frame of a transnational ERA-NET PathoGenoMics program (ANR-06-PATHO-008-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Angelichio MJ, 2002, INFECT IMMUN, V70, P6518, DOI 10.1128/IAI.70.12.6518-6523.2002; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BACHMANN H, 2010, ENV MICROBIOL; Bachmann H, 2008, APPL ENVIRON MICROB, V74, P4727, DOI 10.1128/AEM.00297-08; Ballering KS, 2009, J BACTERIOL, V191, P2806, DOI 10.1128/JB.01688-08; Benachour A, 2007, CURR MICROBIOL, V54, P342, DOI 10.1007/s00284-006-0358-1; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Castillo AR, 2008, INFECT IMMUN, V76, P5632, DOI 10.1128/IAI.00627-08; Charpentier E, 2000, MOL MICROBIOL, V37, P717, DOI 10.1046/j.1365-2958.2000.02011.x; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2008, INFECT IMMUN, V76, P5668, DOI 10.1128/IAI.00930-08; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Gahan CGM, 2000, MOL MICROBIOL, V36, P498, DOI 10.1046/j.1365-2958.2000.01869.x; Gaspar F, 2009, MICROBIOL-SGM, V155, P3564, DOI 10.1099/mic.0.030775-0; Giard JC, 2003, REC RES DEV MICROBIO, V7, P325; Haas W, 2002, NATURE, V415, P84, DOI 10.1038/415084a; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; HANCOCK LE, 2000, PATHOGENICITY ENTERO, P251; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Ibrahim YM, 2005, INFECT IMMUN, V73, P730, DOI 10.1128/IAI.73.2.730-740.2005; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; KONARSKAKOZLOWSKA M, 1981, GENE, V14, P195, DOI 10.1016/0378-1119(81)90115-3; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; MAHAN MJ, 1995, P NATL ACAD SCI USA, V92, P669, DOI 10.1073/pnas.92.3.669; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Nair S, 2000, INFECT IMMUN, V68, P7061, DOI 10.1128/IAI.68.12.7061-7068.2000; Osorio CG, 2005, INFECT IMMUN, V73, P972, DOI 10.1128/IAI.73.2.972-980.2005; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park SY, 2007, INFECT IMMUN, V75, P1861, DOI 10.1128/IAI.01473-06; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Rainey PB, 2000, CURR OPIN BIOTECH, V11, P440, DOI 10.1016/S0958-1669(00)00132-4; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Shankar N, 2004, INT J MED MICROBIOL, V293, P609, DOI 10.1078/1438-4221-00301; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Sood S, 2008, INDIAN J MED RES, V128, P111; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660	58	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11879	10.1371/journal.pone.0011879	http://dx.doi.org/10.1371/journal.pone.0011879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686694	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520200041
J	Moore, N; Messina, J				Moore, Nathan; Messina, Joseph			A Landscape and Climate Data Logistic Model of Tsetse Distribution in Kenya	PLOS ONE			English	Article							GLOSSINA-PALLIDIPES; LAND-COVER; POPULATION; FLIES; TRYPANOSOMOSIS; DENSITY	Background: Trypanosoma spp, biologically transmitted by the tsetse fly in Africa, are a major cause of illness resulting in both high morbidity and mortality among humans, cattle, wild ungulates, and other species. However, tsetse fly distributions change rapidly due to environmental changes, and fine-scale distribution maps are few. Due to data scarcity, most presence/absence estimates in Kenya prior to 2000 are a combination of local reports, entomological knowledge, and topographic information. The availability of tsetse fly abundance data are limited, or at least have not been collected into aggregate, publicly available national datasets. Despite this limitation, other avenues exist for estimating tsetse distributions including remotely sensed data, climate information, and statistical tools. Methodology/Principal Findings: Here we present a logistic regression model of tsetse abundance. The goal of this model is to estimate the distribution of tsetse fly in Kenya in the year 2000, and to provide a method by which to anticipate their future distribution. Multiple predictor variables were tested for significance and for predictive power; ultimately, a parsimonious subset of variables was identified and used to construct the regression model with the 1973 tsetse map. These data were validated against year 2000 Food and Agriculture Organization (FAO) estimates. Mapcurves Goodness-Of-Fit scores were used to evaluate the modeled fly distribution against FAO estimates and against 1973 presence/absence data, each driven by appropriate climate data. Conclusions/Significance: Logistic regression can be effectively used to produce a model that projects fly abundance under elevated greenhouse gas scenarios. This model identifies potential areas for tsetse abandonment and expansion.	[Moore, Nathan] Zhejiang Univ, Dept Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Moore, Nathan; Messina, Joseph] Michigan State Univ, Dept Geog, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA	Zhejiang University; Michigan State University	Moore, N (corresponding author), Zhejiang Univ, Dept Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	moorena@msu.edu		Messina, Joseph/0000-0002-1978-0778	National Institutes of Health; National Institutes of Health, Office of the Director, Roadmap Initiative; NIGMS [RGM084704A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM084704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Office of the Director, Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by The National Institutes of Health, Office of the Director, Roadmap Initiative, and NIGMS: award # RGM084704A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2005, AFRICA BUSINESS APR; Bett B, 2008, VET PARASITOL, V155, P287, DOI 10.1016/j.vetpar.2008.05.028; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cecchi G, 2008, MED VET ENTOMOL, V22, P364, DOI 10.1111/j.1365-2915.2008.00747.x; Cotton WR, 2003, METEOROL ATMOS PHYS, V82, P5, DOI 10.1007/s00703-001-0584-9; Curran PJ, 2000, ADV PARASIT, V47, P37, DOI 10.1016/S0065-308X(00)47006-5; FAO, 2005, LIV SECT BRIEF; Ford J., 1971, ROLE TRYPANOSOMIASES; GILBERT M, 1999, P JUB M INT SCI COUN; Goovaerts P, 2000, J HYDROL, V228, P113, DOI 10.1016/S0022-1694(00)00144-X; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; Hargrove JW, 2001, ENTOMOL EXP APPL, V100, P151, DOI 10.1023/A:1019271727810; Hargrove WW, 2006, J GEOGR SYST, V8, P187, DOI 10.1007/s10109-006-0025-x; Hendrickx G, 2000, PARASITOLOGY, V120, P121, DOI 10.1017/S0031182099005338; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; LEAK SGA, 2008, COLLECTION BASELINE; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; MCDERMOTT JJ, 2001, AFRICAN TRYPANOSOMES; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Moore N, 2010, INT J CLIMATOL, V30, P1954, DOI 10.1002/joc.2011; Nash TAM, 1933, J ANIM ECOL, V2, P197, DOI 10.2307/957; Pollock J. N., 1982, TRAINING MANUAL TSET, V2; RANDOLPH SE, 1991, MED VET ENTOMOL, V5, P335, DOI 10.1111/j.1365-2915.1991.tb00559.x; Reid RS, 2000, AGR ECOSYST ENVIRON, V77, P227, DOI 10.1016/S0167-8809(99)00103-6; ROGERS D, 1979, J ANIM ECOL, V48, P825, DOI 10.2307/4197; Rogers D., 2000, PREDICTED DISTRIBUTI, P1; ROGERS DJ, 1990, INSECT SCI APPL, V11, P331, DOI 10.1017/S1742758400012753; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; WILLIAMS B, 1992, J APPL ECOL, V29, P163, DOI 10.2307/2404359; Wint W., 2001, KILOMETRE RESOLUTION	35	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11809	10.1371/journal.pone.0011809	http://dx.doi.org/10.1371/journal.pone.0011809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676406	gold, Green Published, Green Submitted			2022-12-27	WOS:000280371800013
J	Kanodia, S; Wieder, E; Lu, SJ; Talpaz, M; Alatrash, G; Clise-Dwyer, K; Molldrem, JJ				Kanodia, Shreya; Wieder, Eric; Lu, Sijie; Talpaz, Moshe; Alatrash, Gheath; Clise-Dwyer, Karen; Molldrem, Jeffrey J.			PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ABL GENOMIC REARRANGEMENT; IN-VITRO; IMATINIB MESYLATE; ALPHA THERAPY; STEM-CELLS; SERINE-PROTEASE; DENDRITIC CELLS; CD34(+) CELLS; LYMPHOCYTES	Background: Interferon-alpha (IFN) induces complete cytogenetic remission (CCR) in 20-25% CML patients and in a small minority of patients; CCR persists after IFN is stopped. IFN induces CCR in part by increasing cytotoxic T lymphocytes (CTL) specific for PR1, the HLA-A2-restricted 9-mer peptide from proteinase 3 and neutrophil elastase, but it is unknown how CCR persists after IFN is stopped. Principal Findings: We reasoned that PR1-CTL persist and mediate CML-specific immunity in patients that maintain CCR after IFN withdrawal. We found that PR1-CTL were increased in peripheral blood of 7/7 HLA-A2+ patients during unmaintained CCR from 3 to 88 months after IFN withdrawal, as compared to no detectable PR1-CTL in 2/2 IFN-treated CML patients not in CCR. Unprimed PR1-CTL secreted IFN gamma and were predominantly CD45RA +/- CD28+CCR7+CD57-, consistent with functional naive and central memory (CM) T cells. Similarly, following stimulation, proliferation occurred predominantly in CM PR1-CTL, consistent with long-term immunity sustained by self-renewing CM T cells. PR1-CTL were functionally anergic in one patient 6 months prior to cytogenetic relapse at 26 months after IFN withdrawal, and in three relapsed patients PR1-CTL were undetectable but re-emerged 3-6 months after starting imatinib. Conclusion: These data support the hypothesis that IFN elicits CML-specific CM CTL that may contribute to continuous CCR after IFN withdrawal and suggest a role for T cell immune therapy with or without tyrosine kinase inhibitors as a strategy to prolong CR in CML.	[Kanodia, Shreya; Wieder, Eric; Lu, Sijie; Alatrash, Gheath; Clise-Dwyer, Karen; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Sect Transplant Immunol, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; [Talpaz, Moshe] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kanodia, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplant Immunol, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA.	jmolldre@mdanderson.org		Alatrash, Gheath/0000-0002-7648-4377; Talpaz, Moshe/0000-0003-3361-3981	National Institutes of Health [CA100632, CA049639]; Leukemia and Lymphoma Society [6031-07, 7262-08]; American Legion Auxiliary Foundation; National Institutes of Health through M. D. Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P01CA049639, P50CA100632, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Legion Auxiliary Foundation; National Institutes of Health through M. D. Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA100632, and CA049639 from the National Institutes of Health to JJM; and 6031-07 and 7262-08 from the Leukemia and Lymphoma Society to JJM. This work was also supported in part by the National Institutes of Health through M. D. Anderson's Cancer Center Support Grant CA016672. SK was supported, in part, by the American Legion Auxiliary Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, J EXP MED, V184, P485, DOI 10.1084/jem.184.2.485; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Appel S, 2004, BLOOD, V103, P538, DOI 10.1182/blood-2003-03-0975; Aswald JM, 2002, CYTOKINES CELL MOL T, V7, P143, DOI 10.1080/13684730210002319; BAGGIOLINI M, 1978, AGENTS ACTIONS, V8, P3, DOI 10.1007/BF01972395; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; BORIES D, 1989, CELL, V59, P959, DOI 10.1016/0092-8674(89)90752-6; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brizard F, 1998, LEUKEMIA, V12, P1076, DOI 10.1038/sj.leu.2401053; Burchert A, 2010, J CLIN ONCOL, V28, P1429, DOI 10.1200/JCO.2009.25.5075; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chomel JC, 2000, BLOOD, V95, P404, DOI 10.1182/blood.V95.2.404; Cornelissen JJ, 1998, J CLIN INVEST, V102, P976, DOI 10.1172/JCI2366; Cwynarski K, 2004, LEUKEMIA, V18, P1332, DOI 10.1038/sj.leu.2403401; DENGLER R, 1995, BRIT J HAEMATOL, V89, P250, DOI 10.1111/j.1365-2141.1995.tb03297.x; Dietz AB, 2004, BLOOD, V104, P1094, DOI 10.1182/blood-2003-12-4266; Gannage M, 2005, J IMMUNOL, V174, P8210, DOI 10.4049/jimmunol.174.12.8210; Guilhot F, 1998, HEMATOL CELL THER, V40, P237; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; KANTARJIAN HM, 1995, ANN INTERN MED, V122, P254, DOI 10.7326/0003-4819-122-4-199502150-00003; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V97, P1033, DOI 10.1002/cncr.11223; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Molldrem J, 1996, BLOOD, V88, P2450, DOI 10.1182/blood.V88.7.2450.bloodjournal8872450; Molldrem JJ, 2003, J CLIN INVEST, V111, P639, DOI 10.1172/JCI200316398; Molldrem JJ, 1999, CANCER RES, V59, P2675; Molldrem JJ, 1997, BLOOD, V90, P2529, DOI 10.1182/blood.V90.7.2529.2529_2529_2534; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Mollet L, 1998, INT IMMUNOL, V10, P311, DOI 10.1093/intimm/10.3.311; Nakayama S, 2007, INT J HEMATOL, V86, P208, DOI 10.1007/BF03006921; Sawyers CL, 2007, NAT MED, V13, P1144, DOI 10.1038/nm1007-1144; Seggewiss R, 2008, CYTOTHERAPY, V10, P633, DOI 10.1080/14653240802317639; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; TALPAZ M, 1994, J CLIN INVEST, V94, P1383, DOI 10.1172/JCI117473; TALPAZ M, 1986, BRIT J HAEMATOL, V64, P87, DOI 10.1111/j.1365-2141.1986.tb07576.x; TALPAZ M, 1983, BLOOD, V62, P689; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; Witko-Sarsat V, 2002, J BIOL CHEM, V277, P47338, DOI 10.1074/jbc.M202789200; Yee C, 1999, J IMMUNOL, V162, P2227; Yong ASM, 2007, BLOOD, V110, P770, DOI 10.1182/blood-2007-02-071738; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zeh HJ, 1999, J IMMUNOL, V162, P989; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	46	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11770	10.1371/journal.pone.0011770	http://dx.doi.org/10.1371/journal.pone.0011770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668669	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300008
J	Robles-Sikisaka, R; Bohonak, AJ; McClenaghan, LR; Dhar, AK				Robles-Sikisaka, Refugio; Bohonak, Andrew J.; McClenaghan, Leroy R., Jr.; Dhar, Arun K.			Genetic Signature of Rapid IHHNV (Infectious Hypodermal and Hematopoietic Necrosis Virus) Expansion in Wild Penaeus Shrimp Populations	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; MOLECULAR EVOLUTION; PHYLOGENETIC EVIDENCE; SELECTION; RATES; RECOMBINATION; STYLIROSTRIS; GENEALOGIES; PREVALENCE; PARVOVIRUS	Infectious hypodermal and hematopoietic necrosis virus (IHHNV) is a widely distributed single-stranded DNA parvovirus that has been responsible for major losses in wild and farmed penaeid shrimp populations on the northwestern Pacific coast of Mexico since the early 1990's. IHHNV has been considered a slow-evolving, stable virus because shrimp populations in this region have recovered to pre-epizootic levels, and limited nucleotide variation has been found in a small number of IHHNV isolates studied from this region. To gain insight into IHHNV evolutionary and population dynamics, we analyzed IHHNV capsid protein gene sequences from 89 Penaeus shrimp, along with 14 previously published sequences. Using Bayesian coalescent approaches, we calculated a mean rate of nucleotide substitution for IHHNV that was unexpectedly high (1.39610 24 substitutions/site/year) and comparable to that reported for RNA viruses. We found more genetic diversity than previously reported for IHHNV isolates and highly significant subdivision among the viral populations in Mexican waters. Past changes in effective number of infections that we infer from Bayesian skyline plots closely correspond to IHHNV epizootiological historical records. Given the high evolutionary rate and the observed regional isolation of IHHNV in shrimp populations in the Gulf of California, we suggest regular monitoring of wild and farmed shrimp and restriction of shrimp movement as preventative measures for future viral outbreaks.	[Robles-Sikisaka, Refugio; Bohonak, Andrew J.; McClenaghan, Leroy R., Jr.; Dhar, Arun K.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Robles-Sikisaka, R (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	refugio.robles1@gmail.com			California Sea Grant Fund [R/A-121]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	California Sea Grant Fund; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work presented in this manuscript was partially funded by a grant from the California Sea Grant Fund (Number R/A-121) to AKD. Partial funding was also provided through a graduate fellowship to RRS from Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Bohonak AJ, 2006, ARCH HYDROBIOL, V167, P183, DOI 10.1127/0003-9136/2006/0167-0183; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; BONAMI JR, 1990, J GEN VIROL, V71, P2657, DOI 10.1099/0022-1317-71-11-2657; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cordellier M, 2008, J BIOGEOGR, V35, P1580, DOI 10.1111/j.1365-2699.2008.01909.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Firth C, 2009, J VIROL, V83, P12813, DOI 10.1128/JVI.01719-09; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JUKES T H, 1969, P21; KALAGAYAN H, 1991, Journal of the World Aquaculture Society, V22, P235, DOI 10.1111/j.1749-7345.1991.tb00740.x; Kautsky N, 2000, AQUACULTURE, V191, P145, DOI 10.1016/S0044-8486(00)00424-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lightner D. V., 1999, Journal of Applied Aquaculture, V9, P27, DOI 10.1300/J028v09n02_03; LIGHTNER DV, 1983, J INVERTEBR PATHOL, V42, P62, DOI 10.1016/0022-2011(83)90202-1; LIGHTNER DV, 1992, ICES MAR SC, V194, P97; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Morales-Covarrubias MS, 1999, J AQUAT ANIM HEALTH, V11, P296, DOI 10.1577/1548-8667(1999)011&lt;0296:POIHAH&gt;2.0.CO;2; Nunan LM, 2000, MAR BIOTECHNOL, V2, P319; Pantoja CR, 1999, J AQUAT ANIM HEALTH, V11, P23, DOI 10.1577/1548-8667(1999)011&lt;0023:PAGDOI&gt;2.0.CO;2; Parsyan A, 2007, J GEN VIROL, V88, P428, DOI 10.1099/vir.0.82496-0; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2008, FIGTREE TREE FIGURE; Robles-Sikisaka R, 2002, J GEN VIROL, V83, P3123, DOI 10.1099/0022-1317-83-12-3123; ROBLESSIKISAKA R, 2008, THESIS U CALIFORNIA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; *SAGARPA, 2004, AN EST AC PESC; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Shike H, 2000, VIROLOGY, V277, P167, DOI 10.1006/viro.2000.0589; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tang KFJ, 2003, DIS AQUAT ORGAN, V53, P91, DOI 10.3354/dao053091; Tang KFJ, 2002, DIS AQUAT ORGAN, V49, P93, DOI 10.3354/dao049093; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	52	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11799	10.1371/journal.pone.0011799	http://dx.doi.org/10.1371/journal.pone.0011799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668694	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300025
J	Rajamaki, K; Lappalainen, J; Oorni, K; Valimaki, E; Matikainen, S; Kovanen, PT; Eklund, KK				Rajamaki, Kristiina; Lappalainen, Jani; Oorni, Katariina; Valimaki, Elina; Matikainen, Sampsa; Kovanen, Petri T.; Eklund, Kari K.			Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR-4; SMOOTH-MUSCLE CELLS; CATHEPSIN-B; NALP3 INFLAMMASOME; EPOXYSUCCINYL PEPTIDES; SELECTIVE INHIBITOR; GENE-EXPRESSION; FATTY STREAKS; CUTTING EDGE	Background: Chronic inflammation of the arterial wall is a key element in the pathogenesis of atherosclerosis, yet the factors that trigger and sustain the inflammation remain elusive. Inflammasomes are cytoplasmic caspase-1-activating protein complexes that promote maturation and secretion of the proinflammatory cytokines interleukin(IL)-1 beta and IL-18. The most intensively studied inflammasome, NLRP3 inflammasome, is activated by diverse substances, including crystalline and particulate materials. As cholesterol crystals are abundant in atherosclerotic lesions, and IL-1 beta has been linked to atherogenesis, we explored the possibility that cholesterol crystals promote inflammation by activating the inflammasome pathway. Principal Findings: Here we show that human macrophages avidly phagocytose cholesterol crystals and store the ingested cholesterol as cholesteryl esters. Importantly, cholesterol crystals induced dose-dependent secretion of mature IL-1 beta from human monocytes and macrophages. The cholesterol crystal-induced secretion of IL-1 beta was caspase-1-dependent, suggesting the involvement of an inflammasome-mediated pathway. Silencing of the NLRP3 receptor, the crucial component in NLRP3 inflammasome, completely abolished crystal-induced IL-1 beta secretion, thus identifying NLRP3 inflammasome as the cholesterol crystal-responsive element in macrophages. The crystals were shown to induce leakage of the lysosomal protease cathepsin B into the cytoplasm and inhibition of this enzyme reduced cholesterol crystal-induced IL-1 beta secretion, suggesting that NLRP3 inflammasome activation occurred via lysosomal destabilization. Conclusions: The cholesterol crystal-induced inflammasome activation in macrophages may represent an important link between cholesterol metabolism and inflammation in atherosclerotic lesions.	[Rajamaki, Kristiina; Lappalainen, Jani; Oorni, Katariina; Kovanen, Petri T.; Eklund, Kari K.] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Valimaki, Elina; Matikainen, Sampsa] Finnish Inst Occupat Hlth, Helsinki, Finland	Wihuri Research Institute; Finnish Institute of Occupational Health	Rajamaki, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	kristiina.rajamaki@helsinki.fi	Oorni, Katariina/G-2484-2011; Matikainen, Sampsa/AAH-8654-2021	Oorni, Katariina/0000-0002-9525-0250; Rajamaki, Kristiina/0000-0001-5151-1220	Jenny and Antti Wihuri Foundation	Jenny and Antti Wihuri Foundation	Wihuri Research Institute is maintained by the Jenny and Antti Wihuri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BOCAN TMA, 1986, AM J PATHOL, V123, P413; BORASCHI D, 1990, EUR J IMMUNOL, V20, P317, DOI 10.1002/eji.1830200213; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Dinarello C A, 1986, Year Immunol, V2, P68; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Erridge C, 2008, TRENDS CARDIOVAS MED, V18, P52, DOI 10.1016/j.tcm.2007.12.003; FENTON MJ, 1988, J IMMUNOL, V140, P2267; FENTON MJ, 1992, INT J IMMUNOPHARMACO, V14, P401, DOI 10.1016/0192-0561(92)90170-P; FLYNN GL, 1979, J PHARM SCI, V68, P1090, DOI 10.1002/jps.2600680908; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; GENG YJ, 1995, AM J PATHOL, V147, P251; GUYTON JR, 1993, AM J PATHOL, V143, P1444; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; Herman WH, 1999, TRANSPLANT P, V31, P1412, DOI 10.1016/S0041-1345(98)02109-5; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang H, 2006, ARCH PHARM RES, V29, P890, DOI 10.1007/BF02973911; KANNO K, 1993, HYPERTENSION, V22, P34, DOI 10.1161/01.HYP.22.1.34; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KNIGHT CG, 1980, BIOCHEM J, V189, P447, DOI 10.1042/bj1890447; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kovacs T, 2009, CYTOM PART A, V75A, P650, DOI 10.1002/cyto.a.20756; KRUTH HS, 1995, J CELL BIOL, V129, P133, DOI 10.1083/jcb.129.1.133; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOREE HM, 1994, ARTERIOSCLER THROMB, V14, P230, DOI 10.1161/01.ATV.14.2.230; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MCCONATHY WJ, 1989, ATHEROSCLEROSIS, V77, P221, DOI 10.1016/0021-9150(89)90085-3; MERRITT EA, 1994, MOL MICROBIOL, V13, P745, DOI 10.1111/j.1365-2958.1994.tb00467.x; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; Schoneveld AH, 2008, ATHEROSCLEROSIS, V197, P95, DOI 10.1016/j.atherosclerosis.2007.08.004; TANGIRALA RK, 1994, J LIPID RES, V35, P93; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; TOWATARI T, 1991, FEBS LETT, V280, P311, DOI 10.1016/0014-5793(91)80319-X; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B	57	653	679	6	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11765	10.1371/journal.pone.0011765	http://dx.doi.org/10.1371/journal.pone.0011765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668705	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800032
J	Emre, N; Vidal, JG; Elia, J; O'Connor, ED; Paramban, RI; Hefferan, MP; Navarro, R; Goldberg, DS; Varki, NM; Marsala, M; Carson, CT				Emre, Nil; Vidal, Jason G.; Elia, Jeanne; O'Connor, Eric D.; Paramban, Rosanto I.; Hefferan, Michael P.; Navarro, Roman; Goldberg, Danielle S.; Varki, Nissi M.; Marsala, Martin; Carson, Christian T.			The ROCK Inhibitor Y-27632 Improves Recovery of Human Embryonic Stem Cells after Fluorescence-Activated Cell Sorting with Multiple Cell Surface Markers	PLOS ONE			English	Article							IN-VITRO; HUMAN BLASTOCYSTS; SURVIVAL; LINES; DIFFERENTIATION; DERIVATION; CRYOPRESERVATION; PLURIPOTENCY; GENERATION; CULTURE	Background: Due to the inherent sensitivity of human embryonic stem cells (hESCs) to manipulations, the recovery and survival of hESCs after fluorescence-activated cell sorting (FACS) can be low. Additionally, a well characterized and robust methodology for performing FACS on hESCs using multiple-cell surface markers has not been described. The p160-Rho-associated coiled kinase (ROCK) inhibitor, Y-27632, previously has been identified as enhancing survival of hESCs upon single-cell dissociation, as well as enhancing recovery from cryopreservation. Here we examined the application of Y-27632 to hESCs after FACS to improve survival in both feeder-dependent and feeder-independent growth conditions. Methodology/Principal Findings: HESCs were sorted using markers for SSEA-3, TRA-1-81, and SSEA-1. Cells were plated after sorting for 24 hours in either the presence or the absence of Y-27632. In both feeder-dependent and feeder-independent conditions, cell survival was greater when Y-27632 was applied to the hESCs after sort. Specifically, treatment of cells with Y-27632 improved post-sort recovery up to four fold. To determine the long-term effects of sorting with and without the application of Y-27632, hESCs were further analyzed. Specifically, hESCs sorted with and without the addition of Y-27632 retained normal morphology, expressed hESC-specific markers as measured by immunocytochemistry and flow cytometry, and maintained a stable karyotype. In addition, the hESCs could differentiate into three germ layers in vitro and in vivo in both feeder-dependent and feeder-independent growth conditions. Conclusions/Significance: The application of Y-27632 to hESCs after cell sorting improves cell recovery with no observed effect on pluripotency, and enables the consistent recovery of hESCs by FACS using multiple surface markers. This improved methodology for cell sorting of hESCs will aid many applications such as removal of hESCs from secondary cell types, identification and isolation of stem cell subpopulations, and generation of single cell clones. Finally, these results demonstrate an additional application of ROCK inhibition to hESC research.	[Emre, Nil; Vidal, Jason G.; Elia, Jeanne; Paramban, Rosanto I.; Carson, Christian T.] BD Biosci, La Jolla, CA USA; [O'Connor, Eric D.] Univ Calif San Diego, Human Embryon Stem Cell Core Facil, La Jolla, CA 92093 USA; [Hefferan, Michael P.; Navarro, Roman; Goldberg, Danielle S.; Marsala, Martin] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Varki, Nissi M.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Emre, N (corresponding author), BD Biosci, La Jolla, CA USA.	chistian_carson@bd.com			BD Biosciences; California Institute for Regenerative Medicine [RC1-00131-1-M.M.]	BD Biosciences; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This study was funded by BD Biosciences and the California Institute for Regenerative Medicine (RC1-00131-1-M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BAHARVAND H, NAT PROTOC, V5, P588; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; BRAAM SR, ANN N Y ACAD SCI, V1188, P52; BUENO C, STEM CELL REV; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; CLAASSEN DA, 2009, MOL REPROD DEV; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; FONG CY, 2009, STEM CELL REV; HENG BC, 2009, TISSUE CELL; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; KING FW, 2009, STEM CELLS DEV; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; MOLLAMOHAMMADI S, 2009, HUM REPROD; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nicholas CR, 2007, STEM CELLS DEV, V16, P109, DOI 10.1089/scd.2006.0059; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; PAKZAD M, STEM CELL REV, V6, P96; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sidhu KS, 2006, STEM CELLS DEV, V15, P61, DOI 10.1089/scd.2006.15.61; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Takehara T, 2008, MOL HUM REPROD, V14, P627, DOI 10.1093/molehr/gan061; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468	45	48	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12148	10.1371/journal.pone.0012148	http://dx.doi.org/10.1371/journal.pone.0012148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730054	Green Submitted, gold, Green Published			2022-12-27	WOS:000280862200008
J	Ortigue, S; Sinigaglia, C; Rizzolatti, G; Grafton, ST				Ortigue, Stephanie; Sinigaglia, Corrado; Rizzolatti, Giacomo; Grafton, Scott T.			Understanding Actions of Others: The Electrodynamics of the Left and Right Hemispheres. A High-Density EEG Neuroimaging Study	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; AUTISM-SPECTRUM-DISORDERS; ELECTROMAGNETIC TOMOGRAPHY; SPATIOTEMPORAL DYNAMICS; MAGNETIC STIMULATION; ELECTRICAL-ACTIVITY; MOTOR FACILITATION; SOCIAL-INTERACTION; IDEOMOTOR APRAXIA; HAND ACTIONS	Background: When we observe an individual performing a motor act (e. g. grasping a cup) we get two types of information on the basis of how the motor act is done and the context: what the agent is doing (i.e. grasping) and the intention underlying it (i.e. grasping for drinking). Here we examined the temporal dynamics of the brain activations that follow the observation of a motor act and underlie the observer's capacity to understand what the agent is doing and why. Methodology/Principal Findings: Volunteers were presented with two-frame video-clips. The first frame (T0) showed an object with or without context; the second frame (T1) showed a hand interacting with the object. The volunteers were instructed to understand the intention of the observed actions while their brain activity was recorded with a high-density 128-channel EEG system. Visual event-related potentials (VEPs) were recorded time-locked with the frame showing the hand-object interaction (T1). The data were analyzed by using electrical neuroimaging, which combines a cluster analysis performed on the group-averaged VEPs with the localization of the cortical sources that give rise to different spatio-temporal states of the global electrical field. Electrical neuroimaging results revealed four major steps: 1) bilateral posterior cortical activations; 2) a strong activation of the left posterior temporal and inferior parietal cortices with almost a complete disappearance of activations in the right hemisphere; 3) a significant increase of the activations of the right temporo-parietal region with simultaneously co-active left hemispheric sources, and 4) a significant global decrease of cortical activity accompanied by the appearance of activation of the orbito-frontal cortex. Conclusions/Significance: We conclude that the early striking left hemisphere involvement is due to the activation of a lateralized action-observation/action execution network. The activation of this lateralized network mediates the understanding of the goal of object-directed motor acts (mirror mechanism). The successive right hemisphere activation indicates that this hemisphere plays an important role in understanding the intention of others.	[Ortigue, Stephanie; Grafton, Scott T.] Univ Calif Santa Barbara, Brain Electrodynam Lab 4D, Dept Pathol, Inst Collaborat Biotechnol,UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA; [Ortigue, Stephanie] Syracuse Univ, Dept Psychol, Lab Adv Translat Neurosc, Cent New York Med Ctr, Syracuse, NY USA; [Sinigaglia, Corrado] Univ Milan, Dept Philosophy, Milan, Italy; [Rizzolatti, Giacomo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Rizzolatti, Giacomo] Univ Parma, Ist Italiano Tecnol, I-43100 Parma, Italy	University of California System; University of California Santa Barbara; Syracuse University; University of Milan; University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Ortigue, S (corresponding author), Univ Calif Santa Barbara, Brain Electrodynam Lab 4D, Dept Pathol, Inst Collaborat Biotechnol,UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA.	giacomo.rizzolatti@unipr.it	SINIGAGLIA, CORRADO/AGY-7196-2022; sinigaglia, corrado/AAI-2220-2021	SINIGAGLIA, CORRADO/0000-0002-3365-7522; 	Institute for Collaborative Biotechnologies, U.S. Army Research Office [DAAD19-03-D-0004]; IUAP [5/04]; Ministero dell'Istruzione, dell'Universita e della Ricerca; dalla Regione Emilia-Romagna	Institute for Collaborative Biotechnologies, U.S. Army Research Office; IUAP; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); dalla Regione Emilia-Romagna	This study was supported in part by the Institute for Collaborative Biotechnologies through grant DAAD19-03-D-0004 from the U.S. Army Research Office to S. T. G., and by IUAP 5/04, and Ministero dell'Istruzione, dell'Universita e della Ricerca to G. R. and C. S., and dalla Regione Emilia-Romagna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Brandeis Daniel, 1995, Brain Topography, V8, P145, DOI 10.1007/BF01199778; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brown KS, 2010, NEUROIMAGE, V49, P2401, DOI 10.1016/j.neuroimage.2009.10.011; Carruthers P., 1996, THEORIES THEORIES MI, DOI 10.1017/CBO9780511597985; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; De Renzi E., 1999, CLIN EXPT NEUROPSYCH; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fecteau S, 2005, NEUROREPORT, V16, P1591, DOI 10.1097/01.wnr.0000179079.54906.1b; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Hamilton AFD, 2007, NEUROPSYCHOLOGIA, V45, P1859, DOI 10.1016/j.neuropsychologia.2006.11.022; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; HEILMAN KM, 1982, NEUROLOGY, V32, P342, DOI 10.1212/WNL.32.4.342; Heilman KM., 2003, INT J CLIN NEUROPSYC; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kilner JM, 2007, P NATL ACAD SCI USA, V104, P8683, DOI 10.1073/pnas.0702937104; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2008, NEUROIMAGE, V43, P784, DOI 10.1016/j.neuroimage.2008.08.007; Liepmann H, 1900, KRANKHEITSBILD APRAX; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Malle BF, 2001, INTENTIONS INTENTION; Michel C.M., 2009, ELECT NEUROIMAGING; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; Michel CM, 1999, J CLIN NEUROPHYSIOL, V16, P239, DOI 10.1097/00004691-199905000-00005; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortigue S, 2004, NEUROIMAGE, V21, P1242, DOI 10.1016/j.neuroimage.2003.11.007; Ortigue S., 2009, BMJ CASE REPORTS, V2009, DOI [10.1136/bcr.07.2008.0593, DOI 10.1136/BCR.07.2008.0593]; Ortigue S, 2008, NEUROIMAGE, V43, P337, DOI 10.1016/j.neuroimage.2008.07.059; Ortigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006962; Ortigue S, 2009, J SEX MED, V6, P1830, DOI 10.1111/j.1743-6109.2009.01271.x; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2009, EXP BRAIN RES; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rizzolatti Giacomo, 2008, MIRRORS BRAIN OUR MI; ROTHI LJG, 1985, J NEUROL NEUROSUR PS, V48, P207, DOI 10.1136/jnnp.48.3.207; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Southgate V, 2008, TRENDS COGN SCI, V12, P225, DOI 10.1016/j.tics.2008.03.005; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tunik E, 2008, J NEUROSCI, V28, P13615, DOI 10.1523/JNEUROSCI.3303-08.2008	78	81	84	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12160	10.1371/journal.pone.0012160	http://dx.doi.org/10.1371/journal.pone.0012160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730095	Green Published, gold			2022-12-27	WOS:000280862200016
J	Kim, J; Matthews, NL; Park, S				Kim, Jejoong; Matthews, Natasha L.; Park, Sohee			An Event-Related fMRI Study of Phonological Verbal Working Memory in Schizophrenia	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; ACTIVATION; TASK; PERFORMANCE; DYSFUNCTION; DEFICITS; RISPERIDONE; SYMPTOMS; PET	Background: While much is known about the role of prefrontal cortex (PFC) in working memory (WM) deficits of schizophrenia, the nature of the relationship between cognitive components of WM and brain activation patterns remains unclear. We aimed to elucidate the neural correlates of the maintenance component of verbal WM by examining correct and error trials with event-related fMRI. Methodology/Findings: Twelve schizophrenia patients (SZ) and thirteen healthy control participants (CO) performed a phonological delayed-matching-to-sample-task in which a memory set of three nonsense words was presented, followed by a 6-seconds delay after which a probe nonsense word appeared. Participants decided whether the probe matched one of the targets, and rated the confidence of their decision. Blood-oxygen-level-dependent (BOLD) activity during WM maintenance was analyzed in relation to performance (correct/error) and confidence ratings. Frontal and parietal regions exhibited increased activation on correct trials for both groups. Correct and error trials were further segregated into true memory, false memory, guess, and true error trials. True memory trials were associated with increased bilateral activation of frontal and parietal regions in both groups but only CO showed deactivation in PFC. There was very little maintenance-related cortical activity during guess trials. False memory was associated with increased left frontal and parietal activation in both groups. Conclusion: These findings suggest that a wider network of frontal and parietal regions support WM maintenance in correct trials compared with error trials in both groups. Furthermore, a more extensive and dynamic pattern of recruitment of the frontal and parietal networks for true memory was observed in healthy controls compared with schizophrenia patients. These results underscore the value of parsing the sources of memory errors in fMRI studies because of the non-linear nature of the brain-behavior relationship, and suggest that group comparisons need to be interpreted in more specific behavioral contexts.	[Kim, Jejoong; Matthews, Natasha L.; Park, Sohee] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Kim, Jejoong; Matthews, Natasha L.; Park, Sohee] Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA; [Park, Sohee] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37240 USA; [Kim, Jejoong] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Matthews, Natasha L.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	Vanderbilt University; Vanderbilt University; Vanderbilt University; Seoul National University (SNU); University of Queensland	Kim, J (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	sohee.park@vanderbilt.edu		Matthews, Natasha/0000-0001-5683-7289; Park, Sohee/0000-0003-3797-4776	Discovery Grant;  [MH-073028]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028] Funding Source: NIH RePORTER	Discovery Grant; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by MH-073028 and the Discovery Grant to Sohee Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; Andreasen N. C., 1984, SCALE ASSESSMENT POS; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Angrilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004507; Baddeley A. D, 1986, WORKING MEMORY; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Boulay Luc J, 2007, Cogn Neuropsychiatry, V12, P322, DOI 10.1080/13546800601069534; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Curtis CE, 2006, NEUROSCIENCE, V139, P173, DOI 10.1016/j.neuroscience.2005.04.070; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dietz NAE, 2005, HUM BRAIN MAPP, V26, P81, DOI 10.1002/hbm.20122; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GODLBERG TE, 2007, ARCH GEN PSYCHIAT, V64, P1115; Goldberg TE, 1998, NEUROIMAGE, V7, P296, DOI 10.1006/nimg.1998.0338; GOLDING AR, 1991, P AAAI 91, V1, P22; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Green MF, 1997, AM J PSYCHIAT, V154, P799; Green MF, 1996, AM J PSYCHIAT, V153, P321; Jansma JM, 2002, SCHIZOPHR RES, V53, P111; Karlsgodt KH, 2009, SCHIZOPHR RES, V108, P143, DOI 10.1016/j.schres.2008.12.025; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001760; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Leung Hoi-Chung, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P553, DOI 10.3758/CABN.4.4.553; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Park S, 1999, BIOL PSYCHIAT, V46, P392, DOI 10.1016/S0006-3223(98)00370-9; Park S.J., 2002, PRINCIPLES EXPT PSYC, P83; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray MK, 2008, CEREB CORTEX, V18, P1421, DOI 10.1093/cercor/bhm175; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith MR, 1996, CURR PROB CANCER, V20, P6, DOI 10.1016/S0147-0272(96)80303-5; Snyder PJ, 2008, PSYCHIAT RES, V160, P316, DOI 10.1016/j.psychres.2007.07.011; Surguladze SA, 2007, J CLIN PSYCHOPHARM, V27, P560, DOI 10.1097/jcp.0b013e31815a256c; Talairach J., 1988, COPLANAR STEREOTAXIC; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12068	10.1371/journal.pone.0012068	http://dx.doi.org/10.1371/journal.pone.0012068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725639	gold, Green Published, Green Submitted			2022-12-27	WOS:000280849100014
J	Brunskill, EW; Potter, SS				Brunskill, Eric W.; Potter, S. Steven			Gene Expression Programs of Mouse Endothelial Cells in Kidney Development and Disease	PLOS ONE			English	Article							BONE MORPHOGENIC PROTEIN-7; GROWTH-FACTOR-BETA; DIABETIC-NEPHROPATHY; NITRIC-OXIDE; BLOOD-PRESSURE; VASCULAR POLE; APELIN; MOLECULE-1; PROTECTS; INJURY	Endothelial cells are remarkably heterogeneous in both morphology and function, and they play critical roles in the formation of multiple organ systems. In addition endothelial cell dysfunction can contribute to disease processes, including diabetic nephropathy, which is a leading cause of end stage renal disease. In this report we define the comprehensive gene expression programs of multiple types of kidney endothelial cells, and analyze the differences that distinguish them. Endothelial cells were purified from Tie2-GFP mice by cell dissociation and fluorescent activated cell sorting. Microarrays were then used to provide a global, quantitative and sensitive measure of gene expression levels. We examined renal endothelial cells from the embryo and from the adult glomerulus, cortex and medulla compartments, as well as the glomerular endothelial cells of the db/db mutant mouse, which represents a model for human diabetic nephropathy. The results identified the growth factors, receptors and transcription factors expressed by these multiple endothelial cell types. Biological processes and molecular pathways were characterized in exquisite detail. Cell type specific gene expression patterns were defined, finding novel molecular markers and providing a better understanding of compartmental distinctions. Further, analysis of enriched, evolutionarily conserved transcription factor binding sites in the promoters of co-activated genes begins to define the genetic regulatory network of renal endothelial cell formation. Finally, the gene expression differences associated with diabetic nephropathy were defined, providing a global view of both the pathogenic and protective pathways activated. These studies provide a rich resource to facilitate further investigations of endothelial cell functions in kidney development, adult compartments, and disease.	[Brunskill, Eric W.; Potter, S. Steven] Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Brunskill, EW (corresponding author), Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	steve.potter@cchmc.org			National Institutes of Health (NIH) [UO1DK070251, RO1DK081489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070251, R01DK081489] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work was supported by grants UO1DK070251 and RO1DK081489 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Atkins RC, 2010, NEPHROL DIAL TRANSPL, V25, P331, DOI 10.1093/ndt/gfp757; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BOSSU JL, 1992, FEBS LETT, V299, P239, DOI 10.1016/0014-5793(92)80123-X; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Broxmeyer HE, 2007, MOL CELL BIOL, V27, P5275, DOI 10.1128/MCB.01967-05; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; Clark TG, 1999, DEVELOPMENT, V126, P2631; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Cohen MP, 1996, EXP NEPHROL, V4, P166; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Emerson GG, 2001, AM J PHYSIOL-HEART C, V280, pH160; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goldie LC, 2008, ORGANOGENESIS, V4, P257, DOI [DOI 10.4161/ORG.4.4.7416, DOI 10.4161/org.4.4.7416]; Goligorsky MS, 2001, HYPERTENSION, V37, P744, DOI 10.1161/01.HYP.37.2.744; Guo Y, 2003, BLOOD, V102, P2428, DOI 10.1182/blood-2003-02-0634; He P, 2000, AM J PHYSIOL-HEART C, V278, pH1124, DOI 10.1152/ajpheart.2000.278.4.H1124; Hirata K, 1998, DIABETOLOGIA, V41, P185, DOI 10.1007/s001250050888; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Jia Yue Xia, 2007, Peptides, V28, P2023, DOI 10.1016/j.peptides.2007.07.016; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kato H, 2008, DIABETES, V57, P1459, DOI 10.2337/db08-0365; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Knoll KE, 2005, PHYSIOL GENOMICS, V21, P222, DOI 10.1152/physiolgenomics.00231.2004; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; KOO BH, AM J PATHOL, P1495; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Liu N, 2004, FEBS LETT, V569, P49, DOI 10.1016/j.febslet.2004.05.061; Lopez MLSS, 2003, AM J PHYSIOL-REG I, V284, pR1126, DOI 10.1152/ajpregu.00543.2002; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; MIN W, 1993, VIRCHOWS ARCH A, V423, P201, DOI 10.1007/BF01614771; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nemer G, 2002, DEVELOPMENT, V129, P4045; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Osterby R, 1999, NEPHROL DIAL TRANSPL, V14, P348, DOI 10.1093/ndt/14.2.348; Osterby R, 1987, J Diabet Complications, V1, P122, DOI 10.1016/S0891-6632(87)80069-7; PALL AA, 1993, NEPHROL DIAL TRANSPL, V8, P1429; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Prabhakar SS, 2004, SEMIN NEPHROL, V24, P333, DOI 10.1016/j.semnephrol.2004.04.005; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Sassy-Prigent C, 2000, DIABETES, V49, P466, DOI 10.2337/diabetes.49.3.466; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sharghi-Namini S, 2008, BIOCHEM BIOPH RES CO, V371, P215, DOI 10.1016/j.bbrc.2008.04.047; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Shigematsu S, 1999, ENDOCR J, V46, pS59; Shin JW, 2008, BLOOD, V112, P2318, DOI 10.1182/blood-2008-05-156331; Skubitz KM, 2006, J LAB CLIN MED, V147, P250, DOI 10.1016/j.lab.2006.04.001; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Stojic J, 2008, NEUROSCI RES, V60, P40, DOI 10.1016/j.neures.2007.09.009; Stout LC, 2007, HUM PATHOL, V38, P1167, DOI 10.1016/j.humpath.2007.01.019; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Stuart RO, 2001, P NATL ACAD SCI USA, V98, P5649, DOI 10.1073/pnas.091110798; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Valdembri D, 2001, FASEB J, V15, P225, DOI 10.1096/fj.01-0633fje; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; Wada J, 2001, KIDNEY INT, V59, P1363, DOI 10.1046/j.1523-1755.2001.0590041363.x; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zent R, 2007, SEMIN NEPHROL, V27, P161, DOI 10.1016/j.semnephrol.2007.01.007; Zhong JC, 2007, REGUL PEPTIDES, V144, P109, DOI 10.1016/j.regpep.2007.06.010; Zhong JC, 2007, CARDIOVASC RES, V74, P388, DOI 10.1016/j.cardiores.2007.02.002; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	93	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12034	10.1371/journal.pone.0012034	http://dx.doi.org/10.1371/journal.pone.0012034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706631	gold, Green Published, Green Submitted			2022-12-27	WOS:000280811900005
J	Kuhbier, JW; Allmeling, C; Reimers, K; Hillmer, A; Kasper, C; Menger, B; Brandes, G; Guggenheim, M; Vogt, PM				Kuhbier, Joern W.; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Kasper, Cornelia; Menger, Bjoern; Brandes, Gudrun; Guggenheim, Merlin; Vogt, Peter M.			Interactions between Spider Silk and Cells - NIH/3T3 Fibroblasts Seeded on Miniature Weaving Frames	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; CLAVIPES DRAGLINE SILK; NEPHILA-CLAVIPES; IN-VITRO; FIBROIN; SCAFFOLDS; FIBERS; PROTEINS; PROLIFERATION; BIOMATERIALS	Background: Several materials have been used for tissue engineering purposes, since the ideal matrix depends on the desired tissue. Silk biomaterials have come to focus due to their great mechanical properties. As untreated silkworm silk has been found to be quite immunogenic, an alternative could be spider silk. Not only does it own unique mechanical properties, its biocompatibility has been shown already in vivo. In our study, we used native spider dragline silk which is known as the strongest fibre in nature. Methodology/Principal Findings: Steel frames were originally designed and manufactured and woven with spider silk, harvesting dragline silk directly out of the animal. After sterilization, scaffolds were seeded with fibroblasts to analyse cell proliferation and adhesion. Analysis of cell morphology and actin filament alignment clearly revealed adherence. Proliferation was measured by cell count as well as determination of relative fluorescence each after 1, 2, 3, and 5 days. Cell counts for native spider silk were also compared with those for trypsin-digested spider silk. Spider silk specimens displayed less proliferation than collagen-and fibronectin-coated cover slips, enzymatic treatment reduced adhesion and proliferation rates tendentially though not significantly. Nevertheless, proliferation could be proven with high significance (p<0.01). Conclusion/Significance: Native spider silk does not require any modification to its application as a biomaterial that can rival any artificial material in terms of cell growth promoting properties. We could show adhesion mechanics on intracellular level. Additionally, proliferation kinetics were higher than in enzymatically digested controls, indicating that spider silk does not require modification. Recent findings concerning reduction of cell proliferation after exposure could not be met. As biotechnological production of the hierarchical composition of native spider silk fibres is still a challenge, our study has a pioneer role in researching cellular mechanics on native spider silk fibres.	[Kuhbier, Joern W.; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Menger, Bjoern; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, Hannover, Germany; [Brandes, Gudrun] Hannover Med Sch, Ctr Anat, Inst Cell Biol & Electron Microscopy, D-3000 Hannover, Germany; [Guggenheim, Merlin] Univ Zurich Hosp, Dept Surg, Div Reconstruct Surg, CH-8091 Zurich, Switzerland	Hannover Medical School; Leibniz University Hannover; Hannover Medical School; University of Zurich; University Zurich Hospital	Kuhbier, JW (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	joernkuhbier@gmx.de	Vogt, Peter M./AAL-1332-2020; Kasper, Cornelia/AAC-1924-2022	kasper, cornelia/0000-0003-2607-4326	Braukmann-Wittenberg Foundation	Braukmann-Wittenberg Foundation	This study was funded by a grant from the Braukmann-Wittenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a; BRINI E, 2006, BIOMATERIAL BIOMACRO, V7, P3139; Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; JACKSON C, 1995, MACROMOLECULES, V28, P5975, DOI 10.1021/ma00121a042; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0; Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3; Liu CH, 2000, WORLD J GASTROENTERO, V6, P361; MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68; Maheshwari G, 2000, J CELL SCI, V113, P1677; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368; Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e; Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Riekel C, 2004, NATURWISSENSCHAFTEN, V91, P30, DOI 10.1007/s00114-003-0482-8; Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606; Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Sponner A., 2007, PLOS ONE, V10, P1; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 2002, IN VIVO, V16, P229; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; WEN CM, 1990, ANN ALLERGY, V65, P375; Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4; WORK RW, 1982, J ARACHNOL, V10, P1; WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004	54	42	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12032	10.1371/journal.pone.0012032	http://dx.doi.org/10.1371/journal.pone.0012032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711495	Green Published, gold, Green Accepted			2022-12-27	WOS:000280776800014
J	Gu, YZ; Gu, C				Gu, Yuanzheng; Gu, Chen			Dynamics of Kv1 Channel Transport in Axons	PLOS ONE			English	Article							MAMMALIAN CENTRAL NEURONS; K+ CHANNELS; INITIAL SEGMENT; ORGANELLE TRANSPORT; POTASSIUM CHANNELS; ION CHANNELS; PROTEIN EB1; DYNACTIN; TRACKING; MOTOR	Concerted actions of various ion channels that are precisely targeted along axons are crucial for action potential initiation and propagation, and neurotransmitter release. However, the dynamics of channel protein transport in axons remain unknown. Here, using time-lapse imaging, we found fluorescently tagged Kv1.2 voltage-gated K(+) channels (YFP-Kv1.2) moved bi-directionally in discrete puncta along hippocampal axons. Expressing Kv beta 2, a Kv1 accessory subunit, markedly increased the velocity, the travel distance, and the percentage of moving time of these puncta in both anterograde and retrograde directions. Suppressing the Kv beta 2-associated protein, plus-end binding protein EB1 or kinesin II/KIF3A, by siRNA, significantly decreased the velocity of YFP-Kv1.2 moving puncta in both directions. Kv beta 2 mutants with disrupted either Kv1.2-Kv beta 2 binding or Kv beta 2-EB1 binding failed to increase the velocity of YFP-Kv1.2 puncta, confirming a central role of Kv beta 2. Furthermore, fluorescently tagged Kv1.2 and Kv beta 2 co-moved along axons. Surprisingly, when co-moving with Kv1.2 and Kv beta 2, EB1 appeared to travel markedly faster than its plus-end tracking. Finally, using fission yeast S. pombe expressing YFP-fusion proteins as reference standards to calibrate our microscope, we estimated the numbers of YFP-Kv1.2 tetramers in axonal puncta. Taken together, our results suggest that proper amounts of Kv1 channels and their associated proteins are required for efficient transport of Kv1 channel proteins along axons.	[Gu, Yuanzheng] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Gu, YZ (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	gu.49@osu.edu	Gu, Chen/E-3163-2011		Ohio State University; National Multiple Sclerosis Society [TA3012A1]; National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH) [R01NS062720]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Ohio State University startup fund, a Career Transition Fellowship Award from the National Multiple Sclerosis Society (Grant TA3012A1), and a research grant from National Institute of Neurological Disorders and Stroke/National Institutes of Health (NINDS/NIH) (R01NS062720) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Brown M, 2005, CELL METAB, V1, P3, DOI 10.1016/j.cmet.2004.12.007; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Leenders AGM, 2008, J NEUROSCI, V28, P11333, DOI 10.1523/JNEUROSCI.3078-08.2008; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wu JQ, 2008, METHOD CELL BIOL, V89, P253, DOI 10.1016/S0091-679X(08)00609-2; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zhou L, 1998, J NEUROSCI, V18, P7200	34	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11931	10.1371/journal.pone.0011931	http://dx.doi.org/10.1371/journal.pone.0011931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694152	gold, Green Published, Green Submitted			2022-12-27	WOS:000280574300006
J	Miller, AR; Davis, GL; Oden, ZM; Razavi, MR; Fateh, A; Ghazanfari, M; Abdolrahimi, F; Poorazar, S; Sakhaie, F; Olsen, RJ; Bahrmand, AR; Pierce, MC; Graviss, EA; Richards-Kortum, R				Miller, Andrew R.; Davis, Gregory L.; Oden, Z. Maria; Razavi, Mohamad Reza; Fateh, Abolfazl; Ghazanfari, Morteza; Abdolrahimi, Farid; Poorazar, Shahin; Sakhaie, Fatemeh; Olsen, Randall J.; Bahrmand, Ahmad Reza; Pierce, Mark C.; Graviss, Edward A.; Richards-Kortum, Rebecca			Portable, Battery-Operated, Low-Cost, Bright Field and Fluorescence Microscope	PLOS ONE			English	Article							TUBERCULOSIS; DIAGNOSIS	This study describes the design and evaluation of a portable bright-field and fluorescence microscope that can be manufactured for $240 USD. The microscope uses a battery-operated LED-based flashlight as the light source and achieves a resolution of 0.8 mu m at 1000x magnification in fluorescence mode. We tested the diagnostic capability of this new instrument to identify infections caused by the human pathogen, Mycobacterium tuberculosis. Sixty-four direct, decontaminated, and serially diluted smears were prepared from sputa obtained from 19 patients suspected to have M. tuberculosis infection. Slides were stained with auramine orange and evaluated as being positive or negative for M. tuberculosis with both the new portable fluorescence microscope and a laboratory grade fluorescence microscope. Concordant results were obtained in 98.4% of cases. This highly portable, low cost, fluorescence microscope may be a useful diagnostic tool to expand the availability of M. tuberculosis testing at the point-of-care in low resource settings.	[Miller, Andrew R.; Oden, Z. Maria; Pierce, Mark C.; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Razavi, Mohamad Reza; Fateh, Abolfazl; Ghazanfari, Morteza; Abdolrahimi, Farid; Poorazar, Shahin; Sakhaie, Fatemeh; Bahrmand, Ahmad Reza] Inst Pasteur, Dept Mycobacteriol, Tehran, Iran; [Olsen, Randall J.; Bahrmand, Ahmad Reza; Graviss, Edward A.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA	Rice University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; The Methodist Hospital System; The Methodist Hospital - Houston	Miller, AR (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	andymill@gmail.com	Fateh, Abolfazl/K-9507-2017; Razavi, Mohamad Reza/W-3783-2017; Richards-Kortum, Rebecca R/P-4074-2014	Fateh, Abolfazl/0000-0002-2043-8523; Razavi, Mohamad Reza/0000-0002-2204-6267; Richards-Kortum, Rebecca R/0000-0003-2347-9467; Pierce, Mark/0000-0003-4377-9547; Davis, Gregory/0000-0002-5008-1158	Howard Hughes Medical Institute [52005885]	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Support was provided through a grant (grant # 52005885) to Rice University from the Howard Hughes Medical Institute through the Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cambanis A, 2005, TROP MED INT HEALTH, V10, P330, DOI 10.1111/j.1365-3156.2005.01393.x; Hanscheid T, 2008, T ROY SOC TROP MED H, V102, P520, DOI 10.1016/j.trstmh.2008.02.020; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-393; Miller AR, 2010, PROC SPIE, V7556, DOI 10.1117/12.848605; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; *WHO, 2005, GLOB TUB CONTR SURV; *WHO GLOB TUB PROG, 1999, LAB SERV TUB CONTR 2	9	74	74	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11890	10.1371/journal.pone.0011890	http://dx.doi.org/10.1371/journal.pone.0011890			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694194	gold, Green Published			2022-12-27	WOS:000280574300003
J	Butler, AJ; Rees, T; Beesley, P; Bax, NJ				Butler, Alan J.; Rees, Tony; Beesley, Pam; Bax, Nicholas J.			Marine Biodiversity in the Australian Region	PLOS ONE			English	Review							BYCATCH REDUCTION DEVICES; GREAT-BARRIER-REEF; PRAWN TRAWL FISHERY; PORT-PHILLIP BAY; COMMUNITY STRUCTURE; SPATIAL MANAGEMENT; SOUTHERN TASMANIA; CONTINENTAL-SLOPE; DIVERSITY; CONSERVATION	The entire Australian marine jurisdictional area, including offshore and sub-Antarctic islands, is considered in this paper. Most records, however, come from the Exclusive Economic Zone (EEZ) around the continent of Australia itself. The counts of species have been obtained from four primary databases (the Australian Faunal Directory, Codes for Australian Aquatic Biota, Online Zoological Collections of Australian Museums, and the Australian node of the Ocean Biogeographic Information System), but even these are an underestimate of described species. In addition, some partially completed databases for particular taxonomic groups, and specialized databases (for introduced and threatened species) have been used. Experts also provided estimates of the number of known species not yet in the major databases. For only some groups could we obtain an (expert opinion) estimate of undiscovered species. The databases provide patchy information about endemism, levels of threat, and introductions. We conclude that there are about 33,000 marine species (mainly animals) in the major databases, of which 130 are introduced, 58 listed as threatened and an unknown percentage endemic. An estimated 17,000 more named species are either known from the Australian EEZ but not in the present databases, or potentially occur there. It is crudely estimated that there may be as many as 250,000 species (known and yet to be discovered) in the Australian EEZ. For 17 higher taxa, there is sufficient detail for subdivision by Large Marine Domains, for comparison with other National and Regional Implementation Committees of the Census of Marine Life. Taxonomic expertise in Australia is unevenly distributed across taxa, and declining. Comments are given briefly on biodiversity management measures in Australia, including but not limited to marine protected areas.	[Butler, Alan J.; Bax, Nicholas J.] CSIRO Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia; [Butler, Alan J.; Rees, Tony] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Beesley, Pam] Australian Biol Resources Study, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Butler, AJ (corresponding author), CSIRO Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia.	alan.butler@csiro.au	Rees, Tony/K-9837-2015; Bax, Nicholas J/A-2321-2012	Rees, Tony/0000-0003-1887-5211; Bax, Nicholas J/0000-0002-9697-4963	Commonwealth Scientific and Industrial Research Organisation of Australia (CSIRO) Wealth from Oceans National Research Flagship; CSIRO Marine and Atmospheric Research; public-good agency	Commonwealth Scientific and Industrial Research Organisation of Australia (CSIRO) Wealth from Oceans National Research Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Marine and Atmospheric Research(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); public-good agency	The time of Alan Butler and Nic Bax to work on this manuscript was funded by the Commonwealth Scientific and Industrial Research Organisation of Australia (CSIRO) Wealth from Oceans National Research Flagship, a public-good research funding mechanism. There was no external (commercial) client. The work of Tony Rees in maintaining OBIS and CAAB over many years, and in doing the data manipulation for this paper, was funded by CSIRO Marine and Atmospheric Research, a public-good agency. The work by Pam Beesley and other Australian Biological Resources Study (ABRS) staff in supplying data from the Australian Faunal Directory (AFD) was provided through the support of the Australian Government Department of the Environment, Water, Heritage and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARE, 2008, AUSTR FISH STAT 2007; *ABRS, 2003, SURV AUSTR TAX CAP A; *ABRS, 2003, SURV AUSTR TAX CAP B; AIMS, 2008, AIMS IND MAR IND; ALTHAUS F, MARINE ECOL IN PRESS; Althaus F., 2006, BIODIVERSITY SURVEY; BAUDIN N, 1800, J N BAUDIN COMMANDER, V21; Bax N., 2002, TURNING TIDE ERADICA, P26; Bax NJ, 2001, MAR FRESHWATER RES, V52, P451, DOI 10.1071/MF00001; BENNETT I, 1987, DAKINS CLASSIC STUDY; BOUCHET P, 2006, EXPLORATION MARINE B, P33; Brearley A, 2005, E HODGKINS SWANLAND; Brewer D, 1998, FISH RES, V36, P195, DOI 10.1016/S0165-7836(98)00096-4; Brewer D, 2006, FISH RES, V81, P176, DOI 10.1016/j.fishres.2006.07.009; Bulman CM, 2002, MAR FRESHWATER RES, V53, P59, DOI 10.1071/MF01057; Butler A., 2000, STUDY CONSERVATION S; CATON A, 2004, FISHERY STATUS REPOR; Chapman A, 2009, NUMBERS LIVING SPECI; Chapman D, 2006, NUMBERS LIVING SPECI, P61; COLEMAN N, 1978, AUST J MAR FRESH RES, V29, P445; Coleman N, 1997, MAR ECOL PROG SER, V154, P17, DOI 10.3354/meps154017; Commonwealth of Australia, 2005, NAT MAR BIOR AUSTR; Commonwealth of Australia, 1998, AUSTR OC POL, V2; Commonwealth of Australia, 1998, AUSTR OC POL; Commonwealth of Australia, 2006, GUID INT MAR COAST R; Condie SA, 2005, SEA, V14, P1413; Connell S. D., 2007, MARINE ECOLOGY; Constable AJ, 2004, B MAR SCI, V74, P583; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DAVIES CR, 2005, 61 CRC REEF RES CTR, V11; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; DESMOND A, 1991, DARWIN; Edgar G.J., 2008, AUSTR MARINE LIFE PL, V2nd; FLANNERY T, 2004, TERRA AUSTRALIS M FL; Foster S.D., 2009, BIOMETRICS; Furnas M, 2005, MAR POLLUT BULL, V51, P253, DOI 10.1016/j.marpolbul.2004.11.010; Gray JS, 1997, MAR ECOL PROG SER, V159, P97, DOI 10.3354/meps159097; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Harris G., 1996, PORT PHILLIP BAY ENV; HEWITT CL, 2002, NATL INTRO MARINE PE; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; Hobday AJ, 2009, REV-METHODS TECHNOL, V9, P381, DOI 10.1007/978-1-4020-9640-2_23; Hooper J, 2005, COLLATION VALIDATION; IMCRA Technical Group, 1998, INT MAR COAST REG AU; Jeffrey S.W., 1990, P310; Johnson C.R., 2004, P213, DOI 10.1201/9780203970881.ch37; KLOSER RJ, 2008, MAPPING SEAFLOOR HAB, V47, P93; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Last P., 2005, VALIDATION NATL DEME; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Little LR, 2007, ECOL MODEL, V205, P381, DOI 10.1016/j.ecolmodel.2007.03.005; Little LR, 2005, FISHERIES MANAG ECOL, V12, P177, DOI 10.1111/j.1365-2400.2005.00440.x; LYNE V, 1998, LARGE MARINE DOMAINS; LYNE VD, 2008, ANAL AUSTR CONTINENT; MACPHERSON JH, 1966, MEMOIRS NATL MUSEUM, V27, P1; Mapstone BD, 2008, FISH RES, V94, P315, DOI 10.1016/j.fishres.2008.07.013; Marine Biodiversity Decline Working Group, 2008, NAT APPR ADDR MAR BI; Mawson V., 1988, CSIRO SEA 50 YEARS M; McDonald A.D., 2004, EFFECTS LINE FISHING; National Biodiversity Strategy Review Task Group, 2009, AUSTR BIOD CONS STRA; O'Hara T., 2008, BIOREGIONALISATION A; OHARA TD, 2008, BIOREGIONALISATION W; Otway NM, 1996, MAR ENVIRON RES, V41, P45, DOI 10.1016/0141-1136(94)00001-8; Pascoe S, 2009, OCEAN COAST MANAGE, V52, P130, DOI 10.1016/j.ocecoaman.2008.10.009; Pitcher CR, 2000, ICES J MAR SCI, V57, P1359, DOI 10.1006/jmsc.2000.0911; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poore Gary C.B., 2008, Museum Victoria Science Reports, V11, P1; POORE GCB, 1994, DEEP-SEA RES PT I, V41, P677, DOI 10.1016/0967-0637(94)90049-3; POORE GCB, 1979, ESTUAR COAST MAR SCI, V9, P477, DOI 10.1016/0302-3524(79)90019-7; POORE GCB, 1974, AUST J MAR FRESH RES, V25, P371; POORE GCB, 2004, MARINE DECAPOD CRUST, V9; Robertson G, 2008, CCAMLR SCI, V15, P107; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Ross DJ, 2004, MAR BIOL, V144, P747, DOI 10.1007/s00227-003-1223-4; Salini J, 2000, FISH RES, V45, P1, DOI 10.1016/S0165-7836(99)00104-6; SHAPIRO MA, 1975, PRELIMINARY REPORT W; Sliwa Cathryn, 2009, V204, P425; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STEPHENSON W, 1970, ECOL MONOGR, V40, P459, DOI 10.2307/1942340; Stobutzki I, 2003, ICES J MAR SCI, V60, P951, DOI 10.1016/S1054-3139(03)00117-6; TWIDALE CR, 1986, IDEAS ENDEAVOURS NAT, V9; WALLACE C, 1984, LOST AUSTR F PERON, V21; WARD TJ, 2006, COASTS OCEANS THEME; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; WHARTON WJL, 1893, COOKS J HIS FIRST VO; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Williams A, 2001, MAR ECOL PROG SER, V212, P247, DOI 10.3354/meps212247; WILLIAMS A, MAR ECOL PR IN PRESS; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; Wilson B.R., 1987, P43; WILSON D, 2009, FISHERY STATUS REPOR, V9; Wilson J. R, 1996, SYDNEY DEEPWATER OUT, V1-7; WOMERSLEY H. B. S., 1958, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V9, P217; YOUNG JW, 2009, 2004063 FRDC CSIRO M; LARGE MARINE ECOSYST	96	69	73	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11831	10.1371/journal.pone.0011831	http://dx.doi.org/10.1371/journal.pone.0011831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689847	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520400005
J	Gordon, DP; Beaumont, J; MacDiarmid, A; Robertson, DA; Ahyong, ST				Gordon, Dennis P.; Beaumont, Jennifer; MacDiarmid, Alison; Robertson, Donald A.; Ahyong, Shane T.			Marine Biodiversity of Aotearoa New Zealand	PLOS ONE			English	Review							SOUTHERN KERMADEC ARC; HABITAT; SEDIMENT; DISTURBANCE; BIOSECURITY; IMPACTS; RANGE	The marine-biodiversity assessment of New Zealand (Aotearoa as known to Maori) is confined to the 200 nautical-mile boundary of the Exclusive Economic Zone, which, at 4.2 million km(2), is one of the largest in the world. It spans 30 degrees of latitude and includes a high diversity of seafloor relief, including a trench 10 km deep. Much of this region remains unexplored biologically, especially the 50% of the EEZ deeper than 2,000 m. Knowledge of the marine biota is based on more than 200 years of marine exploration in the region. The major oceanographic data repository is the National Institute of Water and Atmospheric Research (NIWA), which is involved in several Census of Marine Life field projects and is the location of the Southwestern Pacific Regional OBIS Node; NIWA is also data manager and custodian for fisheries research data owned by the Ministry of Fisheries. Related data sources cover alien species, environmental measures, and historical information. Museum collections in New Zealand hold more than 800,000 registered lots representing several million specimens. During the past decade, 220 taxonomic specialists (85 marine) from 18 countries have been engaged in a project to review New Zealand's entire biodiversity. The above-mentioned marine information sources, published literature, and reports were scrutinized to give the results summarized here for the first time (current to 2010), including data on endemism and invasive species. There are 17,135 living species in the EEZ. This diversity includes 4,315 known undescribed species in collections. Species diversity for the most intensively studied phylum-level taxa (Porifera, Cnidaria, Mollusca, Brachiopoda, Bryozoa, Kinorhyncha, Echinodermata, Chordata) is more or less equivalent to that in the ERMS (European Register of Marine Species) region, which is 5.5 times larger in area than the New Zealand EEZ. The implication is that, when all other New Zealand phyla are equally well studied, total marine diversity in the EEZ may be expected to equal that in the ERMS region. This equivalence invites testable hypotheses to explain it. There are 177 naturalized alien species in New Zealand coastal waters, mostly in ports and harbours. Marine-taxonomic expertise in New Zealand covers a broad number of taxa but is, proportionately, at or near its lowest level since the Second World War. Nevertheless, collections are well supported by funding and are continually added to. Threats and protection measures concerning New Zealand's marine biodiversity are commented on, along with potential and priorities for future research.	[Gordon, Dennis P.; Beaumont, Jennifer; MacDiarmid, Alison; Robertson, Donald A.; Ahyong, Shane T.] Natl Inst Water & Atmospher Res, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Gordon, DP (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.	d.gordon@niwa.co.nz		Ahyong, Shane/0000-0002-2820-4158	New Zealand Foundation for Research, Science and Technology [C01X0502]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	The New Zealand Foundation for Research, Science and Technology supported the decade-long project to review and inventory New Zealand's biodiversity that provided the data reviewed and analyzed here (Contract No. C01X0502 to Dennis Gordon). The Sloan Foundation supported some of the field work that yielded results or data mentioned in the manuscript, but none of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 1998, AUST J AGR RESOUR EC, V42, P1, DOI 10.1111/1467-8489.00034; AQUARONE MC, 2009, 46 LME; Arnold A, 2004, SHINING SPOTLIGHT BI; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; BAGLEY NW, 2000, NIWA TECH REP, V72, P1; Ballantine WJ, 2008, HYDROBIOLOGIA, V606, P35, DOI 10.1007/s10750-008-9347-7; BEAUMONT J, 2010, MAPPING ENV VALUES N, P1; BEAUMONT J, 2008, MAPPING VALUES NZ CO, V1, P1; Bradford-Grieve J, 2006, SEA, P1451; BRADFORDGRIEVE J, 2008, NZ SCI REV, V65, P84; Campbell Hamish J., 2008, Proceedings of the Royal Society of Victoria, V120, P38; CARTER L, 1986, NEW ZEAL J MAR FRESH, V20, P665, DOI 10.1080/00288330.1986.9516187; Carter Rowan, 2005, New Zealand Natural Sciences, V30, P49; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Chang FH, 2003, J PLANKTON RES, V25, P737, DOI 10.1093/plankt/25.7.737; CHANG FH, 2003, CLIMATE UPDATE, V53, P4; Clark Malcolm, 2003, Journal of Northwest Atlantic Fishery Science, V31, P441; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; CLARK MR, 2001, INTERRIDGE NEWS, V10, P14; COSTELLO MJ, 2001, PATRIMOINES NATURELS, V50, P1; Coutts ADM, 2007, MAR POLLUT BULL, V54, P875, DOI 10.1016/j.marpolbul.2007.03.011; Cranfield HJ, 2003, CONT SHELF RES, V23, P1337, DOI 10.1016/S0278-4343(03)00122-5; CRANFIELD HJ, 1998, NIWA TECHNICAL REPOR, V1, P48; Cryer M, 2002, ECOL APPL, V12, P1824, DOI 10.1890/1051-0761(2002)012[1824:MOMBBT]2.0.CO;2; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; de Ronde CEJ, 2001, EARTH PLANET SC LETT, V193, P359, DOI 10.1016/S0012-821X(01)00534-9; Dodgshun T, 2003, SEAFOOD NZ, V11, P35; FOSTER BA, 1979, NEW ZEAL J MAR FRESH, V13, P143, DOI 10.1080/00288330.1979.9515788; GLASBY GP, 1990, MAR MINING, V9, P403; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon D.P., 2008, VA MUS NAT HIST SPEC, V15, P37; Gordon Dennis P., 2000, Oceanography, V13, P41; GORDON DP, NZ INVENTOR IN PRESS, V2; GORDON DP, 2009, NZ INVENTORY BIODIVE, V1, P9; GORDON DP, NZ INVENTORY B UNPUB, V3; GOULD B, 2008, BIOSECURITY, V85, P18; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GRIFFITHS GA, 1979, NATURE, V282, P61, DOI 10.1038/282061a0; Gust N, 2006, BIOL INVASIONS, V8, P339, DOI 10.1007/s10530-004-8243-y; GUST N, 2001, DESIGN BASELINE SURV; Hamilton A., 1896, DEEP SEA FAUNA NZ EX; HEATH RA, 1985, NEW ZEAL J MAR FRESH, V19, P79, DOI 10.1080/00288330.1985.9516077; Hewitt CD, 2001, 22 CRIMP, P1; Hewitt CL, 2004, NEW ZEAL J MAR FRESH, V38, P429, DOI 10.1080/00288330.2004.9517250; HEWITT CL, 1996, 4 CRIMP, P1; Hicks DM, 2004, J GEOL, V112, P471, DOI 10.1086/421075; HURST RJ, 2000, NIWA TECH REP, V84, P1; HUTCHING G, 2009, MARINE CONSERVATION; INGLIS G, 2006, DUNEDIN HARBOUR PORT; INGLIS G, 2008, PORT TIMARU 2 BASELI; JACKSON JA, 2009, LONG TERM EFFECTS CL, P1; Johnston Emma L., 2009, V204, P133; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Landis CA, 2008, GEOL MAG, V145, P173, DOI 10.1017/S0016756807004268; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; MacDiarmid A.E., 2007, TREASURES SEA NGA TA; Minchin Dan, 2009, V204, P109; NELSON WA, 1997, NZ SCI REV, V54, P58; Orpin AR, 1997, MAR GEOL, V138, P51, DOI 10.1016/S0025-3227(96)00101-6; PEART R, 2010, MANAGING MARINE ENV, P245; Probert P. Keith, 1997, Aquatic Conservation, V7, P27, DOI 10.1002/(SICI)1099-0755(199703)7:1<27::AID-AQC214>3.3.CO;2-0; Putnam G., 1977, Tuatara, V22, P189; Rhodes LL, 2006, NEW ZEAL J MAR FRESH, V40, P211, DOI 10.1080/00288330.2006.9517414; RIDGWAY NM, 1984, NZ OCEANOGRAPHIC I S, V23, P1; Rodriguez L. O., 2000, IMPLEMENTING GTI REC; Rowden A.A., 2002, P1; Russell LK, 2008, BIOL INVASIONS, V10, P103, DOI 10.1007/s10530-007-9113-1; *S PAC REG ENV PRO, 1999, COAST MAN PROF DIR I; SHARPLES J, 1998, SEA, V11, P965; Smith AM, 2009, MAR FRESHWATER RES, V60, P475, DOI 10.1071/MF08321; Snelder TH, 2007, ENVIRON MANAGE, V39, P12, DOI 10.1007/s00267-005-0206-2; Stevens Leigh M., 1996, P321; Thompson R., 1994, 1 40 YEARS NZ OCEANO; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; Thrush SF, 2001, MAR ECOL PROG SER, V223, P277, DOI 10.3354/meps223277; Thrush SF, 1995, MAR ECOL PROG SER, V129, P141, DOI 10.3354/meps129141; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; WILLIAMS R, 2008, SURVEILLANCE, V35, P4; Winston Judith E., 1997, P81; Wotton DM, 2004, NEW ZEAL J MAR FRESH, V38, P553, DOI 10.1080/00288330.2004.9517260; Wright IC, 2006, J VOLCANOL GEOTH RES, V149, P263, DOI 10.1016/j.jvolgeores.2005.03.021; Wright IC, 2002, MAR GEOL, V185, P207, DOI 10.1016/S0025-3227(01)00285-7; WRIGHT IC, 2009, TE ARA ENCY NZ; ZELDIS J, 2009, GLOBAL CHANGE IGBP S	85	66	70	19	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10905	10.1371/journal.pone.0010905	http://dx.doi.org/10.1371/journal.pone.0010905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689846	Green Published, gold			2022-12-27	WOS:000280520400003
J	Pereira, PM; Marques, JP; Soares, AR; Carreto, L; Santos, MAS				Pereira, Patricia M.; Marques, Joao Paulo; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.			MicroRNA Expression Variability in Human Cervical Tissues	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; DOWN-REGULATION; CANCER; GENES; CARCINOMA; PROFILES; SIGNATURES; NEOPLASIA; PATTERNS	MicroRNAs (miRNAs) are short (similar to 22 nt) non-coding regulatory RNAs that control gene expression at the post-transcriptional level. Deregulation of miRNA expression has been discovered in a wide variety of tumours and it is now clear that they contribute to cancer development and progression. Cervical cancer is one of the most common cancers in women worldwide and there is a strong need for a non-invasive, fast and efficient method to diagnose the disease. We investigated miRNA expression profiles in cervical cancer using a microarray platform containing probes for mature miRNAs. We have evaluated miRNA expression profiles of a heterogeneous set of cervical tissues from 25 different patients. This set included 19 normal cervical tissues, 4 squamous cell carcinoma, 5 high-grade squamous intraepithelial lesion (HSIL) and 9 low-grade squamous intraepithelial lesion (LSIL) samples. We observed high variability in miRNA expression especially among normal cervical samples, which prevented us from obtaining a unique miRNA expression signature for this tumour type. However, deregulated miRNAs were identified in malignant and pre-malignant cervical tissues after tackling the high expression variability observed. We were also able to identify putative target genes of relevant candidate miRNAs. Our results show that miRNA expression shows natural variability among human samples, which complicates miRNA data profiling analysis. However, such expression noise can be filtered and does not prevent the identification of deregulated miRNAs that play a role in the malignant transformation of cervical squamous cells. Deregulated miRNAs highlight new candidate gene targets allowing for a better understanding of the molecular mechanism underlying the development of this tumour type.	[Pereira, Patricia M.; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal; [Pereira, Patricia M.; Soares, Ana R.; Carreto, Laura; Santos, Manuel A. S.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Marques, Joao Paulo] Univ Coimbra, Fac Med, CIMAGO, Coimbra, Portugal; [Soares, Ana R.] Ctr Neurosci, Expt Biol & Biomed PhD Program, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra; Universidade de Coimbra	Pereira, PM (corresponding author), Univ Aveiro, Dept Biol, RNA Biol Lab, P-3800 Aveiro, Portugal.	msantos@ua.pt	Soares, Ana RSCM/G-7331-2014; Santos, Manuel/E-6704-2010	Soares, Ana RSCM/0000-0003-4000-7461; Santos, Manuel/0000-0002-0437-1146; Pereira, Patricia/0000-0002-4828-7632	Portuguese Foundation for Science and Technology (FCT); Calouste Gulbenkian Foundation/CIMAGO; FCT/FEDER [PTDC/BIA-BCM/64745/2006]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/64745/2006] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Calouste Gulbenkian Foundation/CIMAGO; FCT/FEDER(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	PMP and ARS are supported by the Portuguese Foundation for Science and Technology (FCT). This project was funded by Calouste Gulbenkian Foundation/CIMAGO and FCT/FEDER Project Ref: PTDC/BIA-BCM/64745/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Alami Y, 1999, BIOCHEM BIOPH RES CO, V257, P738, DOI 10.1006/bbrc.1999.0516; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATESHEN C, 2002, NAT REV CANCER, V2, P777; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cantile M, 2003, EUR J CANCER, V39, P257, DOI 10.1016/S0959-8049(02)00599-3; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; HAKAMA M, 2008, EUR J CANC; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Mutirangura A, 1998, INT J CANCER, V78, P153, DOI 10.1002/(SICI)1097-0215(19981005)78:2<153::AID-IJC5>3.0.CO;2-Y; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Pett MR, 2006, P NATL ACAD SCI USA, V103, P3822, DOI 10.1073/pnas.0600078103; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Stoler MH, 2000, INT J GYNECOL PATHOL, V19, P16, DOI 10.1097/00004347-200001000-00004; Thomison J, 2008, HUM PATHOL, V39, P154, DOI 10.1016/j.humpath.2007.11.002; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	44	139	145	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11780	10.1371/journal.pone.0011780	http://dx.doi.org/10.1371/journal.pone.0011780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668671	Green Published, gold			2022-12-27	WOS:000280297300015
J	Akieda-Asai, S; Zaima, N; Ikegami, K; Kahyo, T; Yao, I; Hatanaka, T; Iemura, S; Sugiyama, R; Yokozeki, T; Eishi, Y; Koike, M; Ikeda, K; Chiba, T; Yamaza, H; Shimokawa, I; Song, SY; Matsuno, A; Mizutani, A; Sawabe, M; Chao, MV; Tanaka, M; Kanaho, Y; Natsume, T; Sugimura, H; Date, Y; McBurney, MW; Guarente, L; Setou, M				Akieda-Asai, Sayaka; Zaima, Nobuhiro; Ikegami, Koji; Kahyo, Tomoaki; Yao, Ikuko; Hatanaka, Takahiro; Iemura, Shun-ichiro; Sugiyama, Rika; Yokozeki, Takeaki; Eishi, Yoshinobu; Koike, Morio; Ikeda, Kyoji; Chiba, Takuya; Yamaza, Haruyoshi; Shimokawa, Isao; Song, Si-Young; Matsuno, Akira; Mizutani, Akiko; Sawabe, Motoji; Chao, Moses V.; Tanaka, Masashi; Kanaho, Yasunori; Natsume, Tohru; Sugimura, Haruhiko; Date, Yukari; McBurney, Michael W.; Guarente, Leonard; Setou, Mitsutoshi			SIRT1 Regulates Thyroid-Stimulating Hormone Release by Enhancing PIP5K gamma Activity through Deacetylation of Specific Lysine Residues in Mammals	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; CALORIE RESTRICTION; INSULIN SENSITIVITY; LONGEVITY PROTEIN; INCREASED DOSAGE; LIFE-SPAN; GH3 CELL; RECEPTOR; THYROTROPIN; MICE	Background: SIRT1, a NAD-dependent deacetylase, has diverse roles in a variety of organs such as regulation of endocrine function and metabolism. However, it remains to be addressed how it regulates hormone release there. Methodology/Principal Findings: Here, we report that SIRT1 is abundantly expressed in pituitary thyrotropes and regulates thyroid hormone secretion. Manipulation of SIRT1 level revealed that SIRT1 positively regulated the exocytosis of TSH-containing granules. Using LC/MS-based interactomics, phosphatidylinositol-4-phosphate 5-kinase (PIP5K) c was identified as a SIRT1 binding partner and deacetylation substrate. SIRT1 deacetylated two specific lysine residues (K265/K268) in PIP5K gamma and enhanced PIP5K gamma enzyme activity. SIRT1-mediated TSH secretion was abolished by PIP5K gamma knockdown. SIRT1 knockdown decreased the levels of deacetylated PIP5K gamma, PI(4,5) P-2, and reduced the secretion of TSH from pituitary cells. These results were also observed in SIRT1-knockout mice. Conclusions/Significance: Our findings indicated that the control of TSH release by the SIRT1-PIP5K gamma pathway is important for regulating the metabolism of the whole body.	[Akieda-Asai, Sayaka; Date, Yukari] Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan; [Akieda-Asai, Sayaka; Zaima, Nobuhiro; Ikegami, Koji; Kahyo, Tomoaki; Yao, Ikuko; Hatanaka, Takahiro; Song, Si-Young; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Zaima, Nobuhiro; Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan; [Kahyo, Tomoaki; Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol, Shizuoka, Japan; [Yao, Ikuko] Kansai Med Univ, Dept Med Chem, Osaka, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Sugiyama, Rika; Yokozeki, Takeaki; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Sugiyama, Rika; Yokozeki, Takeaki; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Ibaraki, Japan; [Eishi, Yoshinobu; Koike, Morio] Tokyo Med & Dent Univ, Dept Human Pathol, Tokyo, Japan; [Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Res Inst, Aichi, Japan; [Chiba, Takuya; Yamaza, Haruyoshi; Shimokawa, Isao] Nagasaki Univ, Grad Sch Biomed Sci, Dept Investigat Pathol, Nagasaki 852, Japan; [Yamaza, Haruyoshi] Kyushu Univ, Sect Pediat Dent, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Matsuno, Akira] Teikyo Univ Chica Med Ctr, Dept Neurosurg, Chiba, Japan; [Mizutani, Akiko] Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan; [Sawabe, Motoji] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Sawabe, Motoji] Tokyo Metropolitan Geriatr Hosp, Bioresource Ctr Geriatr Res, Tokyo 173, Japan; [Sawabe, Motoji] Inst Gerontol, Tokyo, Japan; [Chao, Moses V.] NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY USA; [Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [McBurney, Michael W.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA	University of Miyazaki; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kansai Medical University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tsukuba; Tokyo Medical & Dental University (TMDU); National Center for Geriatrics & Gerontology; Nagasaki University; Kyushu University; Teikyo University; Tokai University; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; New York University; Tokyo Metropolitan Institute of Gerontology; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Massachusetts Institute of Technology (MIT)	Akieda-Asai, S (corresponding author), Miyazaki Univ, Frontier Sci Res Ctr, Miyazaki, Japan.	setou@hama-med.ac.jp	Natsume, Tohru/M-7627-2018; Eishi, Yoshinobu/N-3602-2017; Yamaza, Haruyoshi/AAD-4011-2019	Natsume, Tohru/0000-0002-1510-2582; Eishi, Yoshinobu/0000-0002-0521-1670; Yamaza, Haruyoshi/0000-0003-1138-3943; Chao, Moses/0000-0002-6969-3744	Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research	Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research	This study was supported by the Mitsubishi Kagaku Institute of Life Sciences and WAKATE S for Scientific Research to M. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; Allison SJ, 2009, AGING-US, V1, P316, DOI 10.18632/aging.100028; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Asai S, 2006, ENDOCRINE, V30, P161, DOI 10.1385/ENDO:30:2:161; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blagosklonny MV, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.17; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; Chubb SAP, 2005, J CLIN ENDOCR METAB, V90, P5317, DOI 10.1210/jc.2005-0298; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gary KA, 2003, J PHARMACOL EXP THER, V305, P410, DOI 10.1124/jpet.102.044040; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; ISHII K, 1998, ENG DESIGN AUTOMATIO, V4, P5; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Letinic K, 2009, P NATL ACAD SCI USA, V106, P11342, DOI 10.1073/pnas.0904244106; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Matsuno A, 2005, J HISTOCHEM CYTOCHEM, V53, P1177, DOI 10.1369/jhc.5B6708.2005; Matsuno A, 2008, FOLIA HISTOCHEM CYTO, V46, P419, DOI 10.2478/v10042-008-0069-5; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Renz M, 2000, J BIOL CHEM, V275, P10429, DOI 10.1074/jbc.275.14.10429; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHALLY AV, 1978, ANNU REV BIOCHEM, V47, P89, DOI 10.1146/annurev.bi.47.070178.000513; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shin DJ, 2003, J BIOL CHEM, V278, P34114, DOI 10.1074/jbc.M305417200; Shindler KS, 1996, J HISTOCHEM CYTOCHEM, V44, P1331, DOI 10.1177/44.11.8918908; Stace C, 2008, ADV ENZYME REGUL, V48, P55, DOI 10.1016/j.advenzreg.2007.11.008; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; THOTAKURA NR, 1995, GLYCOBIOLOGY, V5, P3, DOI 10.1093/glycob/5.1.3; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vinciguerra M, 2010, AGING-US, V2, P43; Weiss RE, 1997, ENDOCRINOLOGY, V138, P3624, DOI 10.1210/en.138.9.3624; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	71	36	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11755	10.1371/journal.pone.0011755	http://dx.doi.org/10.1371/journal.pone.0011755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668706	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243800024
J	Watt, K; Waddle, E; Jhaveri, R				Watt, Kevin; Waddle, Erica; Jhaveri, Ravi			Changing Epidemiology of Serious Bacterial Infections in Febrile Infants without Localizing Signs	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI SEPSIS; ANTIMICROBIAL RESISTANCE; PRACTICE GUIDELINES; RISK-FACTORS; MANAGEMENT; CHILDREN; FEVER; ERA; PROPHYLAXIS	Objective: Historically, management of infants with fever without localizing signs (FWLS) has generated much controversy, with attempts to risk stratify based on several criteria. Advances in medical practice may have altered the epidemiology of serious bacterial infections (SBIs) in this population. We conducted this study to test the hypothesis that the rate of SBIs in this patient population has changed over time. Patients and Methods: We performed a retrospective review of all infants meeting FWLS criteria at our institution from 1997-2006. We examined all clinical and outcome data and performed statistical analysis of SBI rates and ampicillin resistance rates. Results: 668 infants met criteria for FWLS. The overall rate of SBIs was 10.8%, with a significant increase from 2002-2006 (52/361, 14.4%) compared to 1997-2001 (20/307, 6.5%) (p = 0.001). This increase was driven by an increase in E. coli urinary tract infections (UTI), particularly in older infants (31-90 days). Conclusions: We observed a significant increase in E. coli UTI among FWLS infants with high rates of ampicillin resistance. The reasons are likely to be multifactorial, but the results themselves emphasize the need to examine urine in all febrile infants,<90days and consider local resistance patterns when choosing empiric antibiotics.	[Watt, Kevin; Waddle, Erica; Jhaveri, Ravi] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Waddle, Erica; Jhaveri, Ravi] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27710 USA	Duke University; Duke University	Watt, K (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	ravi.jhaveri@duke.edu		Jhaveri, Ravi/0000-0001-9921-0419				Alarcon A, 2004, PEDIATR INFECT DIS J, V23, P295, DOI 10.1097/00006454-200404000-00004; BAKER MD, 1993, NEW ENGL J MED, V329, P1437, DOI 10.1056/NEJM199311113292001; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; BASKIN MN, 1992, J PEDIATR-US, V120, P22, DOI 10.1016/S0022-3476(05)80591-8; Belfer RA, 2001, PEDIATR EMERG CARE, V17, P83, DOI 10.1097/00006565-200104000-00001; Bizzarro MJ, 2008, PEDIATRICS, V121, P689, DOI 10.1542/peds.2007-2171; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; Byington CL, 2003, PEDIATRICS, V111, P964, DOI 10.1542/peds.111.5.964; *CDC, 2008, ACT BACT COR SUV REP; *CIRC REF LIB, 2004, INC CIRC STAT; CRAIN EF, 1982, J PEDIATR-US, V101, P686, DOI 10.1016/S0022-3476(82)80291-6; DAGAN R, 1985, J PEDIATR-US, V107, P855, DOI 10.1016/S0022-3476(85)80175-X; Glasgow TS, 2005, PEDIATRICS, V116, P696, DOI 10.1542/peds.2004-2421; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; JASKIEWICZ JA, 1994, PEDIATRICS, V94, P390; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; MARSHALL R, 1979, J PEDIATR-US, V95, P690, DOI 10.1016/S0022-3476(79)80712-X; MCGOWAN JE, 1973, NEW ENGL J MED, V288, P1309, DOI 10.1056/NEJM197306212882501; Pantell RH, 2004, JAMA-J AM MED ASSOC, V291, P1203, DOI 10.1001/jama.291.10.1203; Rentz AC, 2004, ARCH PEDIAT ADOL MED, V158, P556, DOI 10.1001/archpedi.158.6.556; ROBERTS KB, 1983, J PEDIATR-US, V103, P864, DOI 10.1016/S0022-3476(83)80702-1; Sadow KB, 1999, ARCH PEDIAT ADOL MED, V153, P611, DOI 10.1001/archpedi.153.6.611; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; WISWELL TE, 1992, J UROLOGY, V148, P739, DOI 10.1016/S0022-5347(17)36708-3; YOUNG PC, 1995, PEDIATRICS, V95, P623; Zangwill Kenneth M., 1992, Morbidity and Mortality Weekly Report, V41, P25; Zorc JJ, 2005, PEDIATRICS, V116, P644, DOI 10.1542/peds.2004-1825; 2007, MMWR MORB MORTAL WKL, V56, P701; 2005, MMWR MORB MORTAL WKL, V54, P1205	31	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12448	10.1371/journal.pone.0012448	http://dx.doi.org/10.1371/journal.pone.0012448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805983	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500014
J	Cheung, C; Yu, K; Fung, G; Leung, M; Wong, C; Li, Q; Sham, P; Chua, S; McAlonan, G				Cheung, Charlton; Yu, Kevin; Fung, Germaine; Leung, Meikei; Wong, Clive; Li, Qi; Sham, Pak; Chua, Siew; McAlonan, Grainne			Autistic Disorders and Schizophrenia: Related or Remote? An Anatomical Likelihood Estimation	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CHILDHOOD-ONSET SCHIZOPHRENIA; PREPULSE INHIBITION; OBSTETRIC COMPLICATIONS; SPECTRUM DISORDERS; GATING DEFICITS; BRAIN STRUCTURE; FAMILY-HISTORY; BASAL GANGLIA; TEMPORAL-LOBE	Shared genetic and environmental risk factors have been identified for autistic spectrum disorders (ASD) and schizophrenia. Social interaction, communication, emotion processing, sensorimotor gating and executive function are disrupted in both, stimulating debate about whether these are related conditions. Brain imaging studies constitute an informative and expanding resource to determine whether brain structural phenotype of these disorders is distinct or overlapping. We aimed to synthesize existing datasets characterizing ASD and schizophrenia within a common framework, to quantify their structural similarities. In a novel modification of Anatomical Likelihood Estimation (ALE), 313 foci were extracted from 25 voxel-based studies comprising 660 participants (308 ASD, 352 first-episode schizophrenia) and 801 controls. The results revealed that, compared to controls, lower grey matter volumes within limbic-striato-thalamic circuitry were common to ASD and schizophrenia. Unique features of each disorder included lower grey matter volume in amygdala, caudate, frontal and medial gyrus for schizophrenia and putamen for autism. Thus, in terms of brain volumetrics, ASD and schizophrenia have a clear degree of overlap that may reflect shared etiological mechanisms. However, the distinctive neuroanatomy also mapped in each condition raises the question about how this is arrived in the context of common etiological pressures.	[Cheung, Charlton; Yu, Kevin; Fung, Germaine; Leung, Meikei; Wong, Clive; Li, Qi; Sham, Pak; Chua, Siew; McAlonan, Grainne] Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Qi; Sham, Pak; Chua, Siew; McAlonan, Grainne] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak; Chua, Siew; McAlonan, Grainne] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, C (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	McAlonan, Grainne/G-1541-2011	McAlonan, Grainne/0000-0002-4466-2343; Yu, Kevin/0000-0002-2019-8160	ING Asia/Pacific; University of Hong Kong	ING Asia/Pacific; University of Hong Kong(University of Hong Kong)	The autism research programme and neuroimaging group in the Department of Psychiatry is supported by a donation from ING Asia/Pacific and the University of Hong Kong funding to Drs GM McAlonan, SE Chua and Prof PC Sham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; AUKES MF, 2008, BIOL PSYCHIAT; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bonilha L, 2008, BRAIN DEV-JPN, V30, P396, DOI 10.1016/j.braindev.2007.11.006; Bora E, 2009, CURR OPIN PSYCHIATR, V22, P320, DOI 10.1097/YCO.0b013e328329e970; Braff David L, 2005, Dialogues Clin Neurosci, V7, P125; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Cannell JJ, 2008, MED HYPOTHESES, V70, P750, DOI 10.1016/j.mehy.2007.08.016; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Chan R.C.K., 2009, SCHIZOPHR B; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; Chua SE, 2009, PSYCHOL MED, V39, P793, DOI 10.1017/S0033291708004212; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Courchesne E, 1999, NEUROLOGY, V52, P1106, DOI 10.1212/WNL.52.5.1106; COURCHESNE E, 1994, LANCET, V343, P63, DOI 10.1016/S0140-6736(94)90923-7; COURCHESNE E, 1994, NEUROLOGY, V44, P214, DOI 10.1212/WNL.44.2.214; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Craig JS, 2004, SCHIZOPHR RES, V69, P29, DOI 10.1016/S0920-9964(03)00154-3; Craig MC, 2007, BRIT J PSYCHIAT, V191, P224, DOI 10.1192/bjp.bp.106.034603; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Daenen EWPM, 2002, BEHAV BRAIN RES, V136, P571, DOI 10.1016/S0166-4328(02)00223-1; Daniels JL, 2008, PEDIATRICS, V121, pE1357, DOI 10.1542/peds.2007-2296; DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911; DENG MY, 2009, PSYCHOPHARMACOLOGY B; Ebdrup BH, 2010, J PSYCHIATR NEUROSCI, V35, P95, DOI 10.1503/jpn.090049; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Esterberg ML, 2008, SCHIZOPHR RES, V104, P265, DOI 10.1016/j.schres.2008.04.029; Fatemi SH, 1999, MOL PSYCHIATR, V4, P145, DOI 10.1038/sj.mp.4000520; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Geyer MA, 2006, NEUROTOX RES, V10, P211, DOI 10.1007/BF03033358; Ghaziuddin M, 2005, J AUTISM DEV DISORD, V35, P177, DOI 10.1007/s10803-004-1996-4; GILMORE JH, 2010, AM J PSYCHIAT; Goodman Ann B., 1994, Psychiatric Quarterly (New York), V65, P287, DOI 10.1007/BF02354305; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Joyal CC, 2003, BIOL PSYCHIAT, V54, P1302, DOI 10.1016/S0006-3223(03)00597-3; Kasparek T, 2007, PROG NEURO-PSYCHOPH, V31, P151, DOI 10.1016/j.pnpbp.2006.08.011; Ke XY, 2008, NEUROREPORT, V19, P921, DOI 10.1097/WNR.0b013e328300edf3; Killgore WDS, 2009, COGN BEHAV NEUROL, V22, P28, DOI 10.1097/WNN.0b013e318192cc67; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Kumari V, 2008, CORTEX, V44, P1206, DOI 10.1016/j.cortex.2007.11.007; Kumari V, 2007, INT J NEUROPSYCHOPH, V10, P463, DOI 10.1017/S1461145706007139; Kwon H, 2004, DEV MED CHILD NEUROL, V46, P760, DOI 10.1017/S0012162204001306; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; LANCASTER JL, 2007, COMPARISON TALAIRACH; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; LEUNG M, 2009, SCHIZOPHR B; Lipska BK, 1995, PSYCHOPHARMACOLOGY, V122, P35, DOI 10.1007/BF02246439; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Matsumoto H, 1999, SCHIZOPHR RES, V38, P93, DOI 10.1016/S0920-9964(99)00010-9; Matsumoto H, 2001, PSYCHOL MED, V31, P907, DOI 10.1017/S0033291701003944; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MCALONAN GM, 2008, J CHILD PSYCHOL PSYC; McGrath J, 2003, SCHIZOPHR RES, V63, P73, DOI 10.1016/S0920-9964(02)00435-8; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Molina V, 2010, PSYCHIAT RES-NEUROIM, V181, P204, DOI 10.1016/j.pscychresns.2009.09.003; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Purves D, 2001, NAT NEUROSCI, V4, P777, DOI 10.1038/90470; Rausch JL, 2005, J CLIN PSYCHIAT, V66, P1592, DOI 10.4088/JCP.v66n1216; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Salgado-Pineda P, 2003, NEUROIMAGE, V19, P365, DOI 10.1016/S1053-8119(03)00094-6; Schaufelberger MS, 2007, BRIT J PSYCHIAT, V191, pS117, DOI 10.1192/bjp.191.51.s117; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; Sumich A, 2002, AM J PSYCHIAT, V159, P1232, DOI 10.1176/appi.ajp.159.7.1232; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Toal F, 2009, BRIT J PSYCHIAT, V194, P418, DOI 10.1192/bjp.bp.107.049007; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Venkatasubramanian Ganesan, 2010, Indian J Psychiatry, V52, P28, DOI 10.4103/0019-5545.58892; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; Williams DL, 2007, NEUROIMAG CLIN N AM, V17, P495, DOI 10.1016/j.nic.2007.07.007; Witthaus H, 2009, PSYCHIAT RES-NEUROIM, V173, P163, DOI 10.1016/j.pscychresns.2008.08.002; Yoshihara Yujiro, 2008, Ann Gen Psychiatry, V7, P25, DOI 10.1186/1744-859X-7-25	88	136	137	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12233	10.1371/journal.pone.0012233	http://dx.doi.org/10.1371/journal.pone.0012233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	639XY	20805880	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600012
J	Watanabe, TM; Iwane, AH; Tanaka, H; Ikebe, M; Yanagida, T				Watanabe, Tomonobu M.; Iwane, Atsuko H.; Tanaka, Hiroto; Ikebe, Mitsuo; Yanagida, Toshio			Mechanical Characterization of One-Headed Myosin-V Using Optical Tweezers	PLOS ONE			English	Article							MOTOR DOMAIN DETERMINES; HAND-OVER-HAND; MOLECULAR MOTORS; PROCESSIVE MOVEMENT; STEPPING KINETICS; ACTIN-FILAMENT; SINGLE; FORCE; STEPS; BINDING	Class V myosin (myosin-V) is a cargo transporter that moves along an actin filament with large (similar to 36-nm) successive steps. It consists of two heads that each includes a motor domain and a long (23 nm) neck domain. One of the more popular models describing these steps, the hand-over-hand model, assumes the two-headed structure is imperative. However, we previously succeeded in observing successive large steps by one-headed myosin-V upon optimizing the angle of the actomyosin interaction. In addition, it was reported that wild type myosin-VI and myosin-IX, both one-headed myosins, can also generate successive large steps. Here, we describe the mechanical properties (stepsize and stepping kinetics) of successive large steps by one-headed and two-headed myosin-Vs. This study shows that the stepsize and stepping kinetics of one-headed myosin-V are very similar to those of the two-headed one. However, there was a difference with regards to stability against load and the number of multisteps. One-headed myosin-V also showed unidirectional movement that like two-headed myosin-V required 3.5 k(B)T from ATP hydrolysis. This value is also similar to that of smooth muscle myosin-II, a non-processive motor, suggesting the myosin family uses a common mechanism for stepping regardless of the steps being processive or non-processive. In this present paper, we conclude that one-headed myosin-V can produce successive large steps without following the hand-over-hand mechanism.	[Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Soft Biosyst Grp, Labs Nanobiol, Suita, Osaka, Japan; [Tanaka, Hiroto] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Kobe, Hyogo, Japan	Osaka University; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan	Watanabe, TM (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.	Hyanagida@phys1.med.osaka-u.ac.jp	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230; Iwane, Atsuko/0000-0003-2641-2268	National Institutes of Health (NIH) [DC006103, AR048526, AR048898]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) Grants DC006103, AR048526 and AR048898 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; CRAIG SW, 1982, METHOD ENZYMOL, V85, P316; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kitamura Kazuo, 2005, Biophysics (Nagoya-shi), V1, P1, DOI 10.2142/biophysics.1.1; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Park H, 2007, Q REV BIOPHYS, V40, P87, DOI 10.1017/S0033583507004611; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Thompson RF, 2002, ANAT RECORD, V268, P276, DOI 10.1002/ar.10160; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; Yanagida T, 2008, PHILOS T R SOC B, V363, P2123, DOI 10.1098/rstb.2008.2265; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12224	10.1371/journal.pone.0012224	http://dx.doi.org/10.1371/journal.pone.0012224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805877	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600009
J	Woo, YH; Walker, M; Churchill, GA				Woo, Yong H.; Walker, Michael; Churchill, Gary A.			Coordinated Expression Domains in Mammalian Genomes	PLOS ONE			English	Article							GENE-EXPRESSION; ALZHEIMERS-DISEASE; ORGANIZATION; REGIONS; MAP	Background: Gene order in eukaryotic genomes is not random. Genes showing similar expression (coexpression) patterns are often clustered along the genome. The goal of this study is to characterize coexpression clustering in mammalian genomes and to investigate the underlying mechanisms. Methodology/Principal Findings: We detect clustering of coexpressed genes across multiple scales, from neighboring genes to chromosomal domains that span tens of megabases and, in some cases, entire chromosomes. Coexpression domains may be positively or negatively correlated with other domains, within and between chromosomes. We find that long-range expression domains are associated with gene density, which in turn is related to physical organization of the chromosomes within the nucleus. We show that gene expression changes between healthy and diseased tissue samples occur in a gene density-dependent manner. Conclusions/Significance: We demonstrate that coexpression domains exist across multiple scales. We identify potential mechanisms for short-range as well as long-range coexpression domains. We provide evidence that the three-dimensional architecture of the chromosomes may underlie long-range coexpression domains. Chromosome territory reorganization may play a role in common human diseases such as Alzheimer's disease and psoriasis.	[Woo, Yong H.; Walker, Michael; Churchill, Gary A.] Jackson Lab, Ctr Genome Dynam, Bar Harbor, ME 04609 USA	Jackson Laboratory	Woo, YH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	gary.churchill@jax.org	Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284	National Institute of General Medical Sciences Centers of Excellence in Systems Biology [GM076468];  [GM30998]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030998, P50GM076468, R01GM030998] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Centers of Excellence in Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences Centers of Excellence in Systems Biology program, grant #GM076468. Partial support for YW was provided by #GM30998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gandhi MS, 2009, GENE CHROMOSOME CANC, V48, P222, DOI 10.1002/gcc.20639; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Matarazzo MR, 2007, P NATL ACAD SCI USA, V104, P16546, DOI 10.1073/pnas.0702924104; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Zhou Y, 2003, CANCER RES, V63, P5781	30	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12158	10.1371/journal.pone.0012158	http://dx.doi.org/10.1371/journal.pone.0012158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805879	gold, Green Submitted, Green Published			2022-12-27	WOS:000281011600007
J	Al-Daghri, NM; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Sabico, SLB; Chrousos, GP				Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Sabico, Shaun Louie B.; Chrousos, George P.			Decreasing Prevalence of the Full Metabolic Syndrome but a Persistently High Prevalence of Dyslipidemia among Adult Arabs	PLOS ONE			English	Article							DIABETES-MELLITUS; HERITABILITY; POPULATION; POLYMORPHISM; DEFINITIONS; ASSOCIATION; CHOLESTEROL; DISEASE	A decade has passed since metabolic syndrome (MetS) was documented to be highly prevalent in the kingdom of Saudi Arabia. No follow-up epidemiologic study was done. This study aims to fill this gap. In this cross-sectional, observational study, a total of 2850 randomly selected Saudi adults aged 18-55 years were recruited. Subjects' information was generated from a database of more than 10,000 Saudi citizens from the existing Biomarkers Screening in Riyadh Program (RIYADH Cohort), Saudi Arabia. Anthropometrics included body mass index (BMI), blood pressure, as well as waist and hip circumferences. Fasting blood glucose and lipid profile were determined using routine laboratory procedures. The definition of ATP-III (NHANES III) was used for the diagnosis of the full MetS. The overall prevalence of complete MetS was 35.3% [Confidence-Interval (CI) 33.5-37.01]. Age-adjusted prevalence according to the European standard population is 37.0%. Low HDL-cholesterol was the most prevalent of all MetS risk factors, affecting 88.6% (CI 87.5-89.7) and hypertriglyceridemia the second most prevalent, affecting 34% (CI 32.3-35.7) of the subjects. The prevalence of the full MetS decreased from previous estimates but remains high, while dyslipidemia remains extremely high, affecting almost 90% of middle-aged Arabs. Screening for dyslipidemia among Saudi adults is warranted, especially among those most at risk. Scientific inquiry into the molecular causes of these manifestations should be pursued as a first step in the discovery of etiologic therapies.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Sabico, Shaun Louie B.; Chrousos, George P.] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia; [Alkharfy, Khalid M.] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia; [Chrousos, George P.] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet, GR-11527 Athens, Greece	King Saud University; King Saud University; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Al-Daghri, NM (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia.	aldaghri2000@hotmail.com	Al-Daghri, Nasser/G-7736-2011; Sabico, Shaun/C-9086-2011; Al-Daghri, Nasser/A-8360-2011; Al-okail, Majed S/E-5565-2016	Al-Daghri, Nasser/0000-0001-5472-1725; Sabico, Shaun/0000-0002-5248-2350; Al-Daghri, Nasser/0000-0001-5472-1725; Al-okail, Majed S/0000-0001-8147-3499				Al-Daghri N, 2003, DIABETIC MED, V20, P832, DOI 10.1046/j.1464-5491.2003.01044.x; Al-Daghri NM, 2008, DIABETES-METAB RES, V24, P52, DOI 10.1002/dmrr.763; Al-Daghri NM, 2007, SAUDI MED J, V28, P339; Al-Daghri NM, 2009, SAUDI MED J, V30, P267; Al-Daghri NM, 2003, CLIN SCI, V105, P467, DOI 10.1042/CS20030007; Al-Nozha MM, 2005, SAUDI MED J, V26, P1918; ALDAGHRI NM, 2010, EUR J CLIN INVEST; Alfadda AA, 2008, SAUDI MED J, V29, P821; Bassiony MM, 2009, SAUDI MED J, V30, P876; Bayoumi RA, 2007, OBESITY, V15, P551, DOI 10.1038/oby.2007.555; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Cea-Calvo L, 2009, INT J CLIN PRACT, V63, P71, DOI 10.1111/j.1742-1241.2008.01902.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Harzallah F, 2006, DIABETIC MED, V23, P441, DOI 10.1111/j.1464-5491.2006.01866.x; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Khader Y, 2007, J DIABETES COMPLICAT, V21, P214, DOI 10.1016/j.jdiacomp.2005.11.003; LIN JW, 2010, J CLIN ENDOCRINOL ME; NG SW, 2010, OBES REV; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71	22	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12159	10.1371/journal.pone.0012159	http://dx.doi.org/10.1371/journal.pone.0012159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730053	Green Submitted, gold, Green Published			2022-12-27	WOS:000280862200015
J	Kermen, F; Sultan, S; Sacquet, J; Mandairon, N; Didier, A				Kermen, Florence; Sultan, Sebastien; Sacquet, Joelle; Mandairon, Nathalie; Didier, Anne			Consolidation of an Olfactory Memory Trace in the Olfactory Bulb Is Required for Learning-Induced Survival of Adult-Born Neurons and Long-Term Memory	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; RECOGNITION MEMORY; DISCRIMINATION TASK; GENERATED NEURONS; PREFRONTAL CORTEX; ODOR RECOGNITION; SPATIAL MEMORY; GRANULE CELL; C-FOS; NEUROGENESIS	Background: It has recently been proposed that adult-born neurons in the olfactory bulb, whose survival is modulated by learning, support long-term olfactory memory. However, the mechanism used to select which adult-born neurons following learning will participate in the long-term retention of olfactory information is unknown. We addressed this question by investigating the effect of bulbar consolidation of olfactory learning on memory and neurogenesis. Methodology/Principal Findings: Initially, we used a behavioral ecological approach using adult mice to assess the impact of consolidation on neurogenesis. Using learning paradigms in which consolidation time was varied, we showed that a spaced (across days), but not a massed (within day), learning paradigm increased survival of adult-born neurons and allowed long-term retention of the task. Subsequently, we used a pharmacological approach to block consolidation in the olfactory bulb, consisting in intrabulbar infusion of the protein synthesis inhibitor anisomycin, and found impaired learning and no increase in neurogenesis, while basic olfactory processing and the basal rate of adult-born neuron survival remained unaffected. Taken together these data indicate that survival of adult-born neurons during learning depends on consolidation processes taking place in the olfactory bulb. Conclusion/Significance: We can thus propose a model in which consolidation processes in the olfactory bulb determine both survival of adult-born neurons and long-term olfactory memory. The finding that adult-born neuron survival during olfactory learning is governed by consolidation in the olfactory bulb strongly argues in favor of a role for bulbar adult-born neurons in supporting olfactory memory.	[Kermen, Florence; Sultan, Sebastien; Sacquet, Joelle; Mandairon, Nathalie; Didier, Anne] Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kermen, F (corresponding author), Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France.	fkermen@olfac.univ-lyon1.fr	DIDIER, Anne/H-4413-2017; Mandairon, Nathalie/H-4439-2017	DIDIER, Anne/0000-0003-3118-9961; Mandairon, Nathalie/0000-0001-7935-5215; KERMEN, Florence/0000-0002-2247-9636	OSEO-Anvar [E1482.037]; Centre National de Recherche Scientifique (National Center of Scientific Research); University Lyon1; French Ministry for Research	OSEO-Anvar; Centre National de Recherche Scientifique (National Center of Scientific Research); University Lyon1; French Ministry for Research(Ministry of Research, France)	This work was supported by OSEO-Anvar (contract EZUS Lyon1 E1482.037), Centre National de Recherche Scientifique (National Center of Scientific Research), University Lyon1 and the French Ministry for Research (doctoral fellowship to FK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buonviso N, 1998, EUR J NEUROSCI, V10, P2472, DOI 10.1046/j.1460-9568.1998.00266.x; Busto GU, 2009, EUR J NEUROSCI, V29, P1431, DOI 10.1111/j.1460-9568.2009.06689.x; Carballo-Marquez A, 2009, HIPPOCAMPUS, V19, P446, DOI 10.1002/hipo.20530; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Coureaud G, 2009, LEARN MEMORY, V16, P470, DOI 10.1101/lm.1434009; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Elaagouby A, 1996, CHEM SENSES, V21, P159, DOI 10.1093/chemse/21.2.159; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Guerin D, 2008, BEHAV NEUROSCI, V122, P816, DOI 10.1037/a0012522; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; KABA H, 1989, NEUROSCIENCE, V32, P657, DOI 10.1016/0306-4522(89)90287-X; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Keller M, 2005, NEUROSCIENCE, V133, P359, DOI 10.1016/j.neuroscience.2005.02.027; Keller M, 2004, BEHAV NEUROSCI, V118, P1274, DOI 10.1037/0735-7044.118.6.1274; Keverne EB, 1996, J PHYSIOLOGY-PARIS, V90, P399, DOI 10.1016/S0928-4257(97)87929-6; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Litaudon P, 1997, EUR J NEUROSCI, V9, P1593, DOI 10.1111/j.1460-9568.1997.tb01517.x; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandairon N, 2008, NEUROBIOL LEARN MEM, V90, P178, DOI 10.1016/j.nlm.2008.02.008; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; McLean JH, 2005, NEUROSCIENCE, V135, P329, DOI 10.1016/j.neuroscience.2005.06.029; Montag-Sallaz M, 2002, J NEUROBIOL, V52, P61, DOI 10.1002/neu.10069; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; MOULY AM, 1993, BEHAV NEUROSCI, V107, P451, DOI 10.1037/0735-7044.107.3.451; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Petreanu L, 2002, J NEUROSCI, V22, P6106; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Roullet F, 2005, LEARN MEMORY, V12, P307, DOI 10.1101/lm.89605; Roullet F, 2005, BEHAV BRAIN RES, V157, P127, DOI 10.1016/j.bbr.2004.06.017; Salcedo E, 2005, CHEM SENSES, V30, P615, DOI 10.1093/chemse/bji055; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Touzani K, 2007, P NATL ACAD SCI USA, V104, P5632, DOI 10.1073/pnas.0611554104; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Tronel S, 2003, J NEUROSCI, V23, P5472; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Wanisch K, 2008, BEHAV BRAIN RES, V186, P191, DOI 10.1016/j.bbr.2007.08.008	56	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12118	10.1371/journal.pone.0012118	http://dx.doi.org/10.1371/journal.pone.0012118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	638AP	20730099	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200002
J	Reynolds, BF; Powers, SP; Bishop, MA				Reynolds, Brad F.; Powers, Sean P.; Bishop, Mary Anne			Application of Acoustic Telemetry to Assess Residency and Movements of Rockfish and Lingcod at Created and Natural Habitats in Prince William Sound	PLOS ONE			English	Article							OPHIODON-ELONGATUS; ARTIFICIAL REEFS; CONSERVATION; PATTERNS	Loss and/or degradation of nearshore habitats have led to increased efforts to restore or enhance many of these habitats, particularly those that are deemed essential for marine fishes. Copper rockfish (Sebastes caurinus) and lingcod (Ophiodon enlongatus) are dominant members of the typical reef fish community that inhabit rocky and high-relief substrates along the Pacific Northwest. We used acoustic telemetry to document their residency and movements in the nearshore waters of Prince William Sound, Alaska in order to assess use of created reef habitat in an individual-based manner. A total of 57 fish were surgically implanted with acoustic transmitters. Forty-five fish were captured and monitored in three habitats: artificial reef, low-relief natural reef, and patchy high-relief natural reef. Within each habitat, both rockfish and lingcod exhibited long periods of residency with limited movements. Twelve rockfish were captured at the natural reefs and displaced a distance of 4.0 km to the artificial reef. Five of the 12 rockfish returned within 10 d of their release to their initial capture site. Another five of the 12 displaced fish established residency at the artificial reef through the duration of our study. Our results suggest the potential for artificial reefs to provide rockfish habitat in the event of disturbances to natural habitat.	[Reynolds, Brad F.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA; [Reynolds, Brad F.; Powers, Sean P.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Reynolds, Brad F.; Bishop, Mary Anne] Prince William Sound Sci Ctr, Cordova, AK USA	University of South Alabama; Dauphin Island Sea Lab	Reynolds, BF (corresponding author), Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA.	breynolds@pwssc.org	Bizzarro, Joseph/A-2988-2012	Powers, Sean/0000-0002-4770-9944	North Pacific Research Board; Prince William Sound Oil Spill Recovery Institute; Dauphin Island Sea Lab	North Pacific Research Board; Prince William Sound Oil Spill Recovery Institute; Dauphin Island Sea Lab	Funding for this project was provided by grants from the North Pacific Research Board and the Prince William Sound Oil Spill Recovery Institute. The lead author received support from a graduate fellowship provided by the Dauphin Island Sea Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Brown H, 2010, MAR ECOL PROG SER, V403, P205, DOI 10.3354/meps08465; Cass AJ, 1990, CAN SPEC PUBL FISH A, V109, P40; *EXX VALD OIL SPIL, 1999, EXX VALD OIL SPILL R; Gordon David A., 1994, Alaska Fishery Research Bulletin, V1, P140; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; JAGIELO TH, 1990, FISH B-NOAA, V88, P815; Johnson SW, 2003, ENVIRON BIOL FISH, V66, P259, DOI 10.1023/A:1023981908146; Lawton JH, 1996, OIKOS, V76, P3, DOI 10.2307/3545742; Love M, 1996, PROBABLY MORE YOU WA; LOVESTAM G, 1990, AMBIO, V19, P87; Martell SJD, 2000, B MAR SCI, V66, P729; MATTHEWS KR, 1990, CAN J ZOOL, V68, P2243, DOI 10.1139/z90-312; MATTHEWS KR, 1990, FISH B-NOAA, V88, P223; MATTHEWS KR, 1992, FISH B-NOAA, V90, P784; MATTHEWS KR, 1990, ENVIRON BIOL FISH, V29, P161, DOI 10.1007/BF00002217; MEYER S, 2004, SGED40 U AL FAIRB AL; Miller MW, 2002, ICES J MAR SCI, V59, pS27, DOI 10.1006/jmsc.2001.1162; Munk Kristen M., 2001, Alaska Fishery Research Bulletin, V8, P12; PETERSON CH, 2003, MARINE ECOLOGY PROGR, V264, P251; PINCOCK DG, 2008, DOC004691 VEMCO; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Powers SP, 2003, MAR ECOL PROG SER, V264, P265, DOI 10.3354/meps264265; REYNOLDS BF, 2009, THESIS U S AL; Starr RM, 2005, MAR TECHNOL SOC J, V39, P19, DOI 10.4031/002533205787521677; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Thorsteinson LK, 2002, FISHES ALASKA; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	29	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12130	10.1371/journal.pone.0012130	http://dx.doi.org/10.1371/journal.pone.0012130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730090	Green Submitted, gold, Green Published			2022-12-27	WOS:000280862200004
J	Textoris, J; Ban, LH; Capo, C; Raoult, D; Leone, M; Mege, JL				Textoris, Julien; Ban, Leang Heng; Capo, Christian; Raoult, Didier; Leone, Marc; Mege, Jean-Louis			Sex-Related Differences in Gene Expression Following Coxiella burnetii Infection in Mice: Potential Role of Circadian Rhythm	PLOS ONE			English	Article							GENDER-DIFFERENCES; IMMUNE-RESPONSE; DIMORPHISM; RECEPTOR; PATTERN; SEPSIS; LIVER; EPIDEMIOLOGY; ANDROGENS; HEPCIDIN	Background: Q fever, a zoonosis due to Coxiella burnetii infection, exhibits sexual dimorphism; men are affected more frequently and severely than women for a given exposure. Here we explore whether the severity of C. burnetii infection in mice is related to differences in male and female gene expression profiles. Methodology/Principal Findings: Mice were infected with C. burnetii for 24 hours, and gene expression was measured in liver cells using microarrays. Multiclass analysis identified 2,777 probes for which expression was specifically modulated by C. burnetti infection. Only 14% of the modulated genes were sex-independent, and the remaining 86% were differentially expressed in males and females. Castration of males and females showed that sex hormones were responsible for more than 60% of the observed gene modulation, and this reduction was most pronounced in males. Using functional annotation of modulated genes, we identified four clusters enriched in males that were related to cell-cell adhesion, signal transduction, defensins and cytokine/Jak-Stat pathways. Up-regulation of the IL-10 and Stat-3 genes may account for the high susceptibility of men with Q fever to C. burnetii infection and autoantibody production. Two clusters were identified in females, including the circadian rhythm pathway, which consists of positive (Clock, Arntl) and negative (Per) limbs of a feedback loop. We found that Clock and Arntl were down-modulated whereas Per was up-regulated; these changes may be associated with efficient bacterial elimination in females but not in males, in which an exacerbated host response would be prominent. Conclusion: This large-scale study revealed for the first time that circadian rhythm plays a major role in the anti-infectious response of mice, and it provides a new basis for elucidating the role of sexual dimorphism in human infections.	[Textoris, Julien; Ban, Leang Heng; Capo, Christian; Raoult, Didier; Leone, Marc; Mege, Jean-Louis] CNRS, Unite Rech Malad Infect Trop & Emergentes, Fac Med, UMR 6236, Marseille, France; [Textoris, Julien; Ban, Leang Heng; Leone, Marc] Univ Mediterranee, Serv Anesthesie & Reanimat, Hop Nord, Assistance Publ Hop Marseille, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Textoris, J (corresponding author), CNRS, Unite Rech Malad Infect Trop & Emergentes, Fac Med, UMR 6236, Marseille, France.	Jean-Louis.Mege@univmed.fr	MEGE, JEAN-LOUIS/O-6063-2016; Textoris, Julien/H-3317-2019; Leone, Marc/P-4835-2016; RAOULT, Didier/A-8434-2008	Textoris, Julien/0000-0002-3821-9337; Leone, Marc/0000-0002-3097-758X; RAOULT, Didier/0000-0002-0633-5974				Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Basant A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-110; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Bird MD, 2008, CELL IMMUNOL, V252, P57, DOI 10.1016/j.cellimm.2007.09.007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Capo C, 1999, J IMMUNOL, V163, P6078; Ceribelli A, 2007, J THORAC ONCOL, V2, pS15, DOI 10.1097/01.JTO.0000268635.25579.7e; Chappell PE, 2005, J NEUROENDOCRINOL, V17, P119, DOI 10.1111/j.1365-2826.2005.01270.x; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Davidoff AM, 2003, BLOOD, V102, P480, DOI 10.1182/blood-2002-09-2889; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; DELLINGER RP, 2008, CRIT CARE MED, V296, P327; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Ghigo E, 2004, J INFECT DIS, V190, P1767, DOI 10.1086/425041; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; Habbal OA, 2009, INT REV IMMUNOL, V28, P93, DOI 10.1080/08830180802645050; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Hollm-Delgado MG, 2005, EMERG INFECT DIS, V11, P77, DOI 10.3201/eid1101.030651; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Howe D, 2006, CELL MICROBIOL, V8, P496, DOI 10.1111/j.1462-5822.2005.00641.x; Hsieh YC, 2007, CRIT CARE MED, V35, pS621, DOI 10.1097/01.CCM.0000278603.18687.4F; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; Leone M, 2004, J INFECT DIS, V189, P339, DOI 10.1086/380798; Lopez F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004001; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Meghari S, 2006, J INFECT DIS, V194, P365, DOI 10.1086/505227; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mokart D, 2005, BRIT J ANAESTH, V95, P776, DOI 10.1093/bja/aei257; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; PARETSKY D, 1964, J BACTERIOL, V88, P137, DOI 10.1002/path.1700880118; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Pierce CY, 2007, ANAL CHIM ACTA, V583, P23, DOI 10.1016/j.aca.2006.09.065; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sopena N, 2005, CHEST, V127, P213, DOI 10.1378/chest.127.1.213; Theobald S, 2006, T ROY SOC TROP MED H, V100, P299, DOI 10.1016/j.trstmh.2005.05.023; Treister NS, 2005, J DENT RES, V84, P1187, DOI 10.1177/154405910508401218; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106	65	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12190	10.1371/journal.pone.0012190	http://dx.doi.org/10.1371/journal.pone.0012190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730052	gold, Green Published, Green Submitted			2022-12-27	WOS:000280862200027
J	Tsuchiya, M; Piras, V; Giuliani, A; Tomita, M; Selvarajoo, K				Tsuchiya, Masa; Piras, Vincent; Giuliani, Alessandro; Tomita, Masaru; Selvarajoo, Kumar			Collective Dynamics of Specific Gene Ensembles Crucial for Neutrophil Differentiation: The Existence of Genome Vehicles Revealed	PLOS ONE			English	Article							COMPLEX NETWORKS; QUORUM; WAVES	Cell fate decision remarkably generates specific cell differentiation path among the multiple possibilities that can arise through the complex interplay of high-dimensional genome activities. The coordinated action of thousands of genes to switch cell fate decision has indicated the existence of stable attractors guiding the process. However, origins of the intracellular mechanisms that create "cellular attractor'' still remain unknown. Here, we examined the collective behavior of genome-wide expressions for neutrophil differentiation through two different stimuli, dimethyl sulfoxide (DMSO) and all-trans-retinoic acid (atRA). To overcome the difficulties of dealing with single gene expression noises, we grouped genes into ensembles and analyzed their expression dynamics in correlation space defined by Pearson correlation and mutual information. The standard deviation of correlation distributions of gene ensembles reduces when the ensemble size is increased following the inverse square root law, for both ensembles chosen randomly from whole genome and ranked according to expression variances across time. Choosing the ensemble size of 200 genes, we show the two probability distributions of correlations of randomly selected genes for atRA and DMSO responses overlapped after 48 hours, defining the neutrophil attractor. Next, tracking the ranked ensembles' trajectories, we noticed that only certain, not all, fall into the attractor in a fractal-like manner. The removal of these genome elements from the whole genomes, for both atRA and DMSO responses, destroys the attractor providing evidence for the existence of specific genome elements (named "genome vehicle'') responsible for the neutrophil attractor. Notably, within the genome vehicles, genes with low or moderate expression changes, which are often considered noisy and insignificant, are essential components for the creation of the neutrophil attractor. Further investigations along with our findings might provide a comprehensive mechanistic view of cell fate decision.	[Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Tsuchiya, Masa; Piras, Vincent; Tomita, Masaru; Selvarajoo, Kumar] Keio Univ, Sch Media & Governance, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, I-00161 Rome, Italy	Keio University; Keio University; Istituto Superiore di Sanita (ISS)	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; kumar@ttck.keio.ac.jp	Piras, Vincent/K-3203-2012; Giuliani, Alessandro/K-7589-2016	Piras, Vincent/0000-0002-3427-0995; Giuliani, Alessandro/0000-0002-4640-804X; Selvarajoo, Kumar/0000-0002-0314-9666	CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government; Keio University; JASSO (Japan Student Services Organization)	CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government; Keio University; JASSO (Japan Student Services Organization)	This study is funded by the CREST (Core Research of Evolutional Science & Technology) of Japan Science and Technology, Tsuruoka City, Yamagata prefecture government, GCOE (Global Center of Excellence) program of Keio University and JASSO (Japan Student Services Organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BUTTE AJ, 2000, ENTROPY, V2000, P418; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; FARMER JD, 1985, PHYS REV LETT, V55, P351, DOI 10.1103/PhysRevLett.55.351; Forman JE, 1998, ACS SYM SER, V682, P206; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUFFMAN SA, 1993, ORDER; Klein ES, 2000, J BIOL CHEM, V275, P19401, DOI 10.1074/jbc.M002472200; Komarova NL, 2005, B MATH BIOL, V67, P701, DOI 10.1016/j.bulm.2004.09.008; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P1155, DOI 10.1093/nar/25.6.1155; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Steuer R, 2005, STUD CLASS DATA ANAL, P81, DOI 10.1007/3-540-26981-9_11; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; UMBERGER DK, 1985, PHYS REV LETT, V55, P661, DOI 10.1103/PhysRevLett.55.661; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; WADDINGTON CH, 1957, MACMILLAN; YAKUSHEVICH LV, 2007, J BIOSCIENCE, V26, P305	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12116	10.1371/journal.pone.0012116	http://dx.doi.org/10.1371/journal.pone.0012116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725638	gold, Green Published, Green Submitted			2022-12-27	WOS:000280849100029
J	Mocellin, S; Shrager, J; Scolyer, R; Pasquali, S; Verdi, D; Marincola, FM; Briarava, M; Gobbel, R; Rossi, C; Nitti, D				Mocellin, Simone; Shrager, Jeff; Scolyer, Richard; Pasquali, Sandro; Verdi, Daunia; Marincola, Francesco M.; Briarava, Marta; Gobbel, Randy; Rossi, Carlo; Nitti, Donato			Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology	PLOS ONE			English	Article							PERSONALIZED MEDICINE; TRANSLATIONAL RESEARCH; METASTATIC MELANOMA; SYSTEMS BIOLOGY; METAANALYSIS; CHEMOTHERAPY; MANAGEMENT; SIGNATURES; UPDATE; MAP	Background: The efficacy of current anticancer treatments is far from satisfactory and many patients still die of their disease. A general agreement exists on the urgency of developing molecularly targeted therapies, although their implementation in the clinical setting is in its infancy. In fact, despite the wealth of preclinical studies addressing these issues, the difficulty of testing each targeted therapy hypothesis in the clinical arena represents an intrinsic obstacle. As a consequence, we are witnessing a paradoxical situation where most hypotheses about the molecular and cellular biology of cancer remain clinically untested and therefore do not translate into a therapeutic benefit for patients. Objective: To present a computational method aimed to comprehensively exploit the scientific knowledge in order to foster the development of personalized cancer treatment by matching the patient's molecular profile with the available evidence on targeted therapy. Methods: To this aim we focused on melanoma, an increasingly diagnosed malignancy for which the need for novel therapeutic approaches is paradigmatic since no effective treatment is available in the advanced setting. Relevant data were manually extracted from peer-reviewed full-text original articles describing any type of anti-melanoma targeted therapy tested in any type of experimental or clinical model. To this purpose, Medline, Embase, Cancerlit and the Cochrane databases were searched. Results and Conclusions: We created a manually annotated database (Targeted Therapy Database, TTD) where the relevant data are gathered in a formal representation that can be computationally analyzed. Dedicated algorithms were set up for the identification of the prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the molecular profile of individual patients. In this essay we describe the principles and computational algorithms of an original method developed to fully exploit the available knowledge on cancer biology with the ultimate goal of fruitfully driving both preclinical and clinical research on anticancer targeted therapy. In the light of its theoretical nature, the prediction performance of this model must be validated before it can be implemented in the clinical setting.	[Mocellin, Simone; Pasquali, Sandro; Verdi, Daunia; Briarava, Marta; Rossi, Carlo; Nitti, Donato] Univ Padua, Clin Chirurg Gen, Padua, Italy; [Shrager, Jeff; Gobbel, Randy] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy; [Scolyer, Richard] Stanford Univ, Symbol Syst Program, Palo Alto, CA 94304 USA; [Shrager, Jeff; Gobbel, Randy] CollabRx Inc, Palo Alto, CA USA; [Scolyer, Richard] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Scolyer, Richard] Melanoma Inst Australia, Sydney, NSW, Australia; [Scolyer, Richard] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Marincola, Francesco M.] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Francesco M.] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Stanford University; University of Sydney; Melanoma Institute Australia; University of Sydney; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Mocellin, S (corresponding author), Univ Padua, Clin Chirurg Gen, Padua, Italy.	simone.mocellin@unipd.it	MOCELLIN, SIMONE/AID-6338-2022; Gobbel, John R/C-9848-2016; Pasquali, Sandro/L-1790-2016; Scolyer, Richard/AAE-8511-2019; Rossi, Carlo Riccardo r/A-7685-2010	MOCELLIN, SIMONE/0000-0002-9433-8445; Gobbel, John R/0000-0002-5959-7644; Pasquali, Sandro/0000-0003-4815-6293; Scolyer, Richard/0000-0002-8991-0013; Rossi, Carlo Riccardo r/0000-0001-7875-5655; Verdi, Daunia/0000-0003-2282-2163	CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER	CLINICAL CENTER		Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Allgayer H, 2008, ADV MED SCI-POLAND, V53, P130, DOI 10.2478/v10039-008-0025-9; Amin W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-396; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Ely S, 2009, TRANSL RES, V154, P303, DOI 10.1016/j.trsl.2009.08.001; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Ficenec David, 2003, Briefings in Bioinformatics, V4, P260, DOI 10.1093/bib/4.3.260; Frueh FW, 2009, PHARMACOGENOMICS, V10, P1077, DOI [10.2217/pgs.09.62, 10.2217/PGS.09.62]; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Gomah ME, 2010, J MOL DIAGN, V12, P51, DOI 10.2353/jmoldx.2010.090082; Higgins J., 2009, COCHRANE HDB SYSTEMA; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanehisa Minoru, 2009, Genome Inform, V23, P212; Kirkwood JM, 2008, NAT CLIN PRACT ONCOL, V5, P2, DOI 10.1038/ncponc1004; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Krallinger M, 2009, ANN NY ACAD SCI, V1158, P14, DOI 10.1111/j.1749-6632.2008.03750.x; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laubenbacher R, 2009, BBA-REV CANCER, V1796, P129, DOI 10.1016/j.bbcan.2009.06.001; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Macleod MR, 2005, BMJ-BRIT MED J, V331, P110, DOI 10.1136/bmj.331.7508.110-b; McConnell P, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-60; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; Mocellin S, 2010, J NATL CANC I; Mocellin S, 2008, MELANOMA RES, V18, P163, DOI 10.1097/CMR.0b013e328300c50b; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Parkinson DR, 2009, CLIN PHARMACOL THER, V86, P23, DOI 10.1038/clpt.2009.76; Payne Philip R O, 2008, AMIA Annu Symp Proc, P566; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Riley LB, 2009, SURG CLIN N AM, V89, P1, DOI 10.1016/j.suc.2008.09.016; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Sharkey RM, 2006, CA-CANCER J CLIN, V56, P226, DOI 10.3322/canjclin.56.4.226; Stokes TH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S18; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; Tawbi HA, 2007, SEMIN ONCOL, V34, P532, DOI 10.1053/j.seminoncol.2007.09.008; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Wang Qing-hua, 2007, Journal of Ecology and Rural Environment, V23, P81; *WHO, 2004, MORT HLTH STAT CAUS; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; 2010, PHARMGKB PHARMACOGEN	56	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e11965	10.1371/journal.pone.0011965	http://dx.doi.org/10.1371/journal.pone.0011965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706624	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900001
J	Sompallae, R; Callegari, S; Kamranvar, SA; Masucci, MG				Sompallae, Ramakrishna; Callegari, Simone; Kamranvar, Siamak Akbari; Masucci, Maria G.			Transcription Profiling of Epstein-Barr Virus Nuclear Antigen (EBNA)-1 Expressing Cells Suggests Targeting of Chromatin Remodeling Complexes	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; LATENT INFECTION; EBNA-1; DNA; GENE; PROMOTER; ENHANCER; SITES; INACTIVATION; REPLICATION	The Epstein-Barr virus (EBV) encoded nuclear antigen (EBNA)-1 regulates virus replication and transcription, and participates in the remodeling of the cellular environment that accompanies EBV induced B-cell immortalization and malignant transformation. The putative cellular targets of these effects of EBNA-1 are largely unknown. To address this issue we have profiled the transcriptional changes induced by short-and long-term expression of EBNA-1 in the EBV negative B-cell lymphoma BJAB. Three hundred and nineteen cellular genes were regulated in a conditional transfectant shortly after EBNA-1 induction while a ten fold higher number of genes was regulated upon continuous EBNA-1 expression. Promoter analysis of the differentially regulated genes demonstrated a significant enrichment of putative EBNA-1 binding sites suggesting that EBNA-1 may directly influence the transcription of a subset of genes. Gene ontology analysis of forty seven genes that were consistently regulated independently on the time of EBNA-1 expression revealed an unexpected enrichment of genes involved in the maintenance of chromatin architecture. The interaction network of the affected gene products suggests that EBNA-1 may promote a broad rearrangement of the cellular transcription landscape by altering the expression of key components of chromatin remodeling complexes.	[Sompallae, Ramakrishna; Callegari, Simone; Kamranvar, Siamak Akbari; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Sompallae, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809	Swedish Cancer Society; Swedish Medical Research Council; Karolinska Institutet, Stockholm, Sweden; European Community [LSHC-CT-2005-018704]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Stockholm, Sweden; European Community(European Commission)	This study was supported by grants awarded by the Swedish Cancer Society, the Swedish Medical Research Council and Karolinska Institutet, Stockholm, Sweden and by the European Community Integrated Project on Infection and Cancer, INCA, Project no. LSHC-CT-2005-018704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila-Osorio H, 1999, INT J CANCER, V81, P645, DOI 10.1002/(SICI)1097-0215(19990517)81:4<645::AID-IJC22>3.0.CO;2-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Choi YJ, 2009, FEBS LETT, V583, P1292, DOI 10.1016/j.febslet.2009.03.023; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cleynen I, 2008, INT J ONCOL, V32, P289; Cohen AJ, 1996, CANCER RES, V56, P831; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; DRESANG LR, 2009, J VIROL; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; GAHN TA, 1995, J VIROL, V69, P2633, DOI 10.1128/JVI.69.4.2633-2636.1995; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Horner D, 1995, INTERVIROLOGY, V38, P195, DOI 10.1159/000150433; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Kang MS, 2001, P NATL ACAD SCI USA, V98, P15233, DOI 10.1073/pnas.211556598; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kirchmaier AL, 1998, J VIROL, V72, P4657, DOI 10.1128/JVI.72.6.4657-4666.1998; Legagneux V, 2004, BIOL CELL, V96, P201, DOI 10.1016/j.biolcel.2004.01.003; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Murray PG, 2001, J PATHOL, V194, P158, DOI 10.1002/path.873; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; REISMAN D, 1986, MOL CELL BIOL, V6, P3838, DOI 10.1128/MCB.6.11.3838; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ruf IK, 1999, MOL CELL BIOL, V19, P1651; SAMPLE J, 1992, J VIROL, V66, P4654, DOI 10.1128/JVI.66.8.4654-4661.1992; Sansam CG, 2006, CELL CYCLE, V5, P621, DOI 10.4161/cc.5.6.2579; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheu LF, 1996, J PATHOL, V180, P243, DOI 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7; Simon JA, 2009, NAT REV MOL CELL BIO; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; SUGDEN B, 1989, J VIROL, V63, P2644, DOI 10.1128/JVI.63.6.2644-2649.1989; SUNG NS, 1994, MOL CELL BIOL, V14, P7144, DOI 10.1128/MCB.14.11.7144; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P667, DOI 10.1055/s-2007-991534; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wood VHJ, 2007, ONCOGENE, V26, P4135, DOI 10.1038/sj.onc.1210496; WYSOKENSKI DA, 1989, J VIROL, V63, P2657, DOI 10.1128/JVI.63.6.2657-2666.1989; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	54	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12052	10.1371/journal.pone.0012052	http://dx.doi.org/10.1371/journal.pone.0012052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706582	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900014
J	Udwadia, ZF; Pinto, LM; Uplekar, MW				Udwadia, Zarir F.; Pinto, Lancelot M.; Uplekar, Mukund W.			Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; CONTROL PROGRAM; CARE	Setting: Mumbai, India. A study conducted in Mumbai two decades ago revealed the extent of inappropriate tuberculosis (TB) management practices of private practitioners. Over the years, India's national TB programme has made significant progress in TB control. Efforts to engage private practitioners have also been made with several successful documented public-private mix initiatives in place. Objective: To study prescribing practices of private practitioners in the treatment of tuberculosis, two decades after a similar study conducted in the same geographical area revealed dismal results. Methods: Survey questionnaire administered to practicing general practitioners attending a continuing medical education programme. Results: The participating practitioners had never been approached or oriented by the local TB programme. Only 6 of the 106 respondents wrote a prescription with a correct drug regimen. 106 doctors prescribed 63 different drug regimens. There was tendency to over treat with more drugs for longer durations. Only 3 of the 106 respondents could write an appropriate prescription for treatment of multidrug-resistant TB. Conclusions: With a vast majority of private practitioners unable to provide a correct prescription for treating TB and not approached by the national TB programme, little seems to have changed over the years. Strategies to control TB through public sector health services will have little impact if inappropriate management of TB patients in private clinics continues unabated. Large scale implementation of public-private mix approaches should be a top priority for the programme. Ignoring the private sector could worsen the epidemic of multidrug-resistant and extensively drug-resistant forms of TB.	[Udwadia, Zarir F.; Pinto, Lancelot M.] PD Hinduja Natl Hosp & Med Res Ctr, Dept Resp Dis, Mumbai, Maharashtra, India; [Uplekar, Mukund W.] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Udwadia, ZF (corresponding author), PD Hinduja Natl Hosp & Med Res Ctr, Dept Resp Dis, Mumbai, Maharashtra, India.	lance.pinto@gmail.com		Pinto, Lancelot/0000-0002-5418-5448				Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; Almeida D, 2003, CLIN INFECT DIS, V36, pE152, DOI 10.1086/374931; [Anonymous], WHOHTMTB2008394; Chugh Satish, 2008, J Indian Med Assoc, V106, P596; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Global Alliance for TB drug development, 2007, PATHW PAT CHART DYN; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; *IPPS, 2005, NAT FAM HLTH SURV NF, V1; JAIN S, 2007, AM THOR SOC 2007 INT; Kelkar-Khambete A, 2008, INT J TUBERC LUNG D, V12, P87; *MIN HLTH FAM WELF, 2009, TB IND 2009 RNTCP ST; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P705; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Rodrigues C, 2006, INT J TUBERC LUNG D, V10, P1421; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; *WHO, 2009, GLOB TUB CONTR SUV P; *WHO, 2006, ENG ALL CAR PROV TUB; World Health Organization, WHOCDSTB2003313, V313	21	137	137	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12023	10.1371/journal.pone.0012023	http://dx.doi.org/10.1371/journal.pone.0012023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711502	Green Published, Green Submitted, gold			2022-12-27	WOS:000280776800013
J	Bemmo, A; Dias, C; Rose, AAN; Russo, C; Siegel, P; Majewski, J				Bemmo, Amandine; Dias, Christel; Rose, April A. N.; Russo, Caterina; Siegel, Peter; Majewski, Jacek			Exon-Level Transcriptome Profiling in Murine Breast Cancer Reveals Splicing Changes Specific to Tumors with Different Metastatic Abilities	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELL SURVIVAL; VITAMIN-D-RECEPTOR; PROTEIN-KINASE; E-CADHERIN; GENE-EXPRESSION; HOMOZYGOUS DELETIONS; CARCINOMA CELLS; OVARIAN-CANCER; MAMMARY-TUMOR	Background: Breast cancer is the second most frequent type of cancer affecting women. We are increasingly aware that changes in mRNA splicing are associated with various characteristics of cancer. The most deadly aspect of cancer is metastasis, the process by which cancer spreads from the primary tumor to distant organs. However, little is known specifically about the involvement of alternative splicing in the formation of macroscopic metastases. Our study investigates transcript isoform changes that characterize tumors of different abilities to form growing metastases. Methods and Findings: To identify alternative splicing events (ASEs) that are associated with the fully metastatic phenotype in breast cancer, we used Affymetrix Exon Microarrays to profile mRNA isoform variations genome-wide in weakly metastatic (168FARN and 4T07) and highly metastatic (4T1) mammary carcinomas. Statistical analysis identified significant expression changes in 7606 out of 155,994 (4%) exons and in 1725 out of 189,460 (1%) intronic regions, which affect 2623 out of 16,654 (16%) genes. These changes correspond to putative alternative isoforms-several of which are novel-that are differentially expressed between tumors of varying metastatic phenotypes. Gene pathway analysis showed that 1224 of genes expressing alternative isoforms were involved in cell growth, cell interactions, cell proliferation, cell migration and cell death and have been previously linked to cancers and genetic disorders. We chose ten predicted splice variants for RT-PCR validation, eight of which were successfully confirmed (MED24, MFI2, SRRT, CD44, CLK1 and HNRNPH1). These include three novel intron retentions in CD44, a gene in which isoform variations have been previously associated with the metastasis of several cancers. Conclusion: Our findings reveal that various genes are differently spliced and/or expressed in association with the metastatic phenotype of tumor cells. Identification of metastasis-specific isoforms may contribute to the development of improved breast cancer stage identification and targeted therapies.	[Bemmo, Amandine; Dias, Christel; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Rose, April A. N.; Russo, Caterina; Siegel, Peter] McGill Univ, Dept Med, Montreal, PQ, Canada; [Siegel, Peter] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Siegel, Peter] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Bemmo, Amandine; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Bemmo, A (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	amandine.bemmo@mail.mcgill.ca	Rose, April/AAR-8222-2020	Rose, April/0000-0002-9845-4603	Canadian Institutes of Health Research; Genome Quebec; Genome Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Quebec; Genome Canada(Genome Canada)	Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), Genome Quebec (www.genomequebec.com), Genome Canada (www.genomecanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, ID VAL ALT SPLIC EV; Affymetrix, 2005, GUID PROB LOG INT ER; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Aziz KA, 2000, BLOOD, V96, P3161; Barbour AP, 2003, CANCER RES, V63, P887; Bates RC, 2001, CANCER RES, V61, P5275; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindels EMJ, 2000, CANCER RES, V60, P177; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brooks PC, 1996, CANCER METAST REV, V15, P187, DOI 10.1007/BF00437471; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chiba N, 2000, J BIOL CHEM, V275, P10719, DOI 10.1074/jbc.275.15.10719; Corjay MH, 1998, LAB INVEST, V78, P847; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Duchesne S, 2009, ACAD RADIOL, V16, P61, DOI 10.1016/j.acra.2008.05.024; Dutertre M, 2010, CANCER RES, V70, P896, DOI 10.1158/0008-5472.CAN-09-2703; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Faraldo MM, 1998, EMBO J, V17, P2139, DOI 10.1093/emboj/17.8.2139; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fujii K, 2001, J IMMUNOL, V167, P1198, DOI 10.4049/jimmunol.167.3.1198; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Luo J, 1999, CANCER RES, V59, P3552; Marhaba R, 2004, J MOL HISTOL, V35, P211; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; MCCORMICK BA, 1992, PHARMACOL THERAPEUT, V53, P239, DOI 10.1016/0163-7258(92)90011-N; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mori Y, 2002, CANCER RES, V62, P3641; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; Rots NY, 1998, MOL CELL BIOL, V18, P1911, DOI 10.1128/MCB.18.4.1911; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SATO T, 1992, CANCER RES, V52, P1643; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Wallach-Dayan SB, 2008, MOL CANCER THER, V7, P1615, DOI 10.1158/1535-7163.MCT-07-2383; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang S, 1999, MOL CELL BIOL, V19, P7447; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang L, 2004, CANCER BIOL THER, V3, P1283, DOI 10.4161/cbt.3.12.1388	77	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11981	10.1371/journal.pone.0011981	http://dx.doi.org/10.1371/journal.pone.0011981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700505	Green Submitted, Green Published, gold			2022-12-27	WOS:000280687900004
J	Feng, GA; Simpson, JA; Chaluluka, E; Molyneux, ME; Rogerson, SJ				Feng, Gaoqian; Simpson, Julie A.; Chaluluka, Ebbie; Molyneux, Malcolm E.; Rogerson, Stephen J.			Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; INSECTICIDE-TREATED NETS; SULFADOXINE-PYRIMETHAMINE; BLANTYRE; TRANSMISSION; RESISTANCE; MORBIDITY; EFFICACY; ANEMIA; MORTALITY	Background: The World Health Organization recommends insecticidal bednets and intermittent preventive treatment to reduce malaria in pregnancy. Longitudinal data of malaria prevalence and pregnancy outcomes are valuable in gauging the impact of these antimalarial interventions. Methodology/Principal Findings: We recruited 8,131 women delivering in a single Malawian hospital over 9 years. We recorded demographic data, antenatal prescription of intermittent preventive therapy during pregnancy with sulfadoxine-pyrimethamine and bed net use, and examined finger-prick blood for malaria parasites and hemoglobin concentration. In 4,712 women, we examined placental blood for malaria parasites and recorded the infant's birth weight. Peripheral and placental parasitemia prevalence declined from 23.5% to 5.0% and from 25.2% to 6.8% respectively. Smaller declines in prevalence of low birth weight and anemia were observed. Coverage of intermittent preventive treatment and bednets increased. Number of sulfadoxine-pyrimethamine doses received correlated inversely with placental parasitemia (Odds Ratio (95% CI): 0.79 (0.68, 0.91)), maternal anemia (0.81, (0.73, 0.90)) and low birth weight from 1997-2001 (0.63 (0.53, 0.75)), but not from 2002-2006. Bednet use protected from peripheral parasitemia (0.47, (0.37, 0.60)) and placental parasitemia (0.41, (0.31, 0.54)) and low birth weight (0.75 (0.59, 0.95)) but not anemia throughout the study. Compared to women without nets who did not receive 2-dose sulfadoxine-pyrimethamine, women using nets and receiving 2-dose sulfadoxine-pyrimethamine were less likely to have parasitemia or low birth weight babies. Women receiving 2-dose sulfadoxine-pyrimethamine alone had little evidence of protection whereas bednets alone gave intermediate protection. Conclusions/Significance: Increased bednet coverage explains changes in parasitemia and birth weight among pregnant women better than sulfadoxine-pyrimethamine use. High bed net coverage, and sulfadoxine-pyrimethamine resistance, may be contributing to its apparent loss of effectiveness.	[Feng, Gaoqian; Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia; [Simpson, Julie A.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Chaluluka, Ebbie; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England	University of Melbourne; University of Melbourne; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Feng, GA (corresponding author), Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia.	sroger@unimelb.edu.au	Simpson, Julie A/P-7299-2014	Feng, Gaoqian/0000-0002-3605-038X; Simpson, Julie/0000-0002-2660-2013; Rogerson, Stephen/0000-0003-4287-1982	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Data collection was funded by a Wellcome Trust Senior Research fellowship to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2008, WORLD MAL REP 2008; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Gamble C, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003755.PUB2; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Holtz TH, 2004, TROP MED INT HEALTH, V9, P77, DOI 10.1046/j.1365-3156.2003.01170.x; Kalilani L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001166; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kwiek JJ, 2008, MALAWI MED J, V20, P80, DOI 10.4314/mmj.v20i3.10965; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Malenga Grace, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS15, DOI 10.1016/j.trstmh.2009.02.003; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Nebie I, 2008, TROP MED INT HEALTH, V13, P229, DOI 10.1111/j.1365-3156.2007.01994.x; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Nkhoma S, 2007, ACTA TROP, V102, P138, DOI 10.1016/j.actatropica.2007.04.006; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; WHO UNICEF, 2005, WORLD MALARIA REPORT	38	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12012	10.1371/journal.pone.0012012	http://dx.doi.org/10.1371/journal.pone.0012012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700457	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900011
J	Record, CJ; Chaikuad, A; Rellos, P; Das, S; Pike, ACW; Fedorov, O; Marsden, BD; Knapp, S; Lee, WH				Record, Christopher J.; Chaikuad, Apirat; Rellos, Peter; Das, Sanjan; Pike, Ashley C. W.; Fedorov, Oleg; Marsden, Brian D.; Knapp, Stefan; Lee, Wen Hwa			Structural Comparison of Human Mammalian Ste20-Like Kinases	PLOS ONE			English	Article							CASPASE-MEDIATED ACTIVATION; PROTEIN-KINASE; CELL-PROLIFERATION; INDUCED APOPTOSIS; HISTONE H2B; PAK-FAMILY; MST1; CLONING; PATHWAY; PHOSPHORYLATION	Background: The serine/threonine mammalian Ste-20 like kinases (MSTs) are key regulators of apoptosis, cellular proliferation as well as polarization. Deregulation of MSTs has been associated with disease progression in prostate and colorectal cancer. The four human MSTs are regulated differently by C-terminal regions flanking the catalytic domains. Principal Findings: We have determined the crystal structure of kinase domain of MST4 in complex with an ATP-mimetic inhibitor. This is the first structure of an inactive conformation of a member of the MST kinase family. Comparison with active structures of MST3 and MST1 revealed a dimeric association of MST4 suggesting an activation loop exchanged mechanism of MST4 auto-activation. Together with a homology model of MST2 we provide a comparative analysis of the kinase domains for all four members of the human MST family. Significance: The comparative analysis identified new structural features in the MST ATP binding pocket and has also defined the mechanism for autophosphorylation. Both structural features may be further explored for inhibitors design. Enhanced version: This article can also be viewed as an enhanced version (http://plosone.org/enhanced/pone.0011905/) in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.	[Record, Christopher J.; Chaikuad, Apirat; Rellos, Peter; Das, Sanjan; Pike, Ashley C. W.; Fedorov, Oleg; Marsden, Brian D.; Knapp, Stefan; Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford, England; [Marsden, Brian D.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Knapp, Stefan] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England	University of Oxford; University of Oxford; Radcliffe Infirmary; University of Oxford	Record, CJ (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	wenhwa.lee@sgc.ox.ac.uk	Fedorov, Oleg Y./B-6412-2014; Lee, Wen Hwa/GZA-8183-2022; Knapp, Stefan/AAG-2347-2019; Lee, Wen Hwa/G-1250-2013	Fedorov, Oleg Y./0000-0001-9004-1815; Lee, Wen Hwa/0000-0002-4098-5225; Knapp, Stefan/0000-0001-5995-6494; Lee, Wen Hwa/0000-0002-4098-5225; Record, Christopher/0000-0002-9802-2683; Chaikuad, Apirat/0000-0003-1120-2209	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Oxford University Nuffield Department of Medicine	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University Nuffield Department of Medicine	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The authors also thank the Oxford University Nuffield Department of Medicine Summer Internship Program 2009 for CJR's sponsorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Ahn SH, 2005, CELL CYCLE, V4, P780, DOI 10.4161/cc.4.6.1745; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boomer JS, 2005, J CELL BIOCHEM, V95, P34, DOI 10.1002/jcb.20401; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feig LA, 2002, CURR BIOL, V12, pR259, DOI 10.1016/S0960-9822(02)00787-X; Goehring AS, 2003, MOL BIOL CELL, V14, P1501, DOI 10.1091/mbc.E02-06-0348; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hofken T, 2002, EMBO J, V21, P4851, DOI 10.1093/emboj/cdf481; Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kakeya H, 1998, CANCER RES, V58, P4888; Ko TP, 2010, ACTA CRYSTALLOGR D, V66, P145, DOI 10.1107/S0907444909047507; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Lu TJ, 2005, J INORG BIOCHEM, V99, P1306, DOI 10.1016/j.jinorgbio.2005.03.003; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill EE, 2005, CANCER RES, V65, P5485, DOI 10.1158/0008-5472.CAN-05-1453; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Qian ZJ, 2001, J BIOL CHEM, V276, P22439, DOI 10.1074/jbc.M009323200; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sung V, 2003, CANCER RES, V63, P3356; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Teraishi F, 2006, CANCER RES, V66, P6072, DOI 10.1158/0008-5472.CAN-06-0125; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	61	39	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11905	10.1371/journal.pone.0011905	http://dx.doi.org/10.1371/journal.pone.0011905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20730082	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900002
J	Turbill, C; Ruf, T				Turbill, Christopher; Ruf, Thomas			Senescence Is More Important in the Natural Lives of Long- Than Short-Lived Mammals	PLOS ONE			English	Article							LIFE-SPAN; EVOLUTION; POPULATIONS; PREDICTION; SURVIVAL; PATTERNS; GROWTH; LIMITS; RATES; BIRDS	Background: Senescence has been widely detected among mammals, but its importance to fitness in wild populations remains controversial. According to evolutionary theories, senescence occurs at an age when selection is relatively weak, which in mammals can be predicted by adult survival rates. However, a recent analysis of senescence rates found more age-dependent mortalities in natural populations of longer lived mammal species. This has important implications to ageing research and for understanding the ecological relevance of senescence, yet so far these have not been widely appreciated. We re-address this question by comparing the mean and maximum life span of 125 mammal species. Specifically, we test the hypothesis that senescence occurs at a younger age relative to the mean natural life span in longer lived species. Methodology/Principal Findings: We show, using phylogenetically-informed generalised least squares models, a significant log-log relationship between mean life span, as calculated from estimates of adult survival for natural populations, and maximum recorded life span among mammals (R-2 = 0.57, p<0.0001). This provides further support for a key prediction of evolutionary theories of ageing. The slope of this relationship (0.353 +/- 0.052 s.e.m.), however, indicated that mammals with higher survival rates have a mean life span representing a greater fraction of their potential maximum life span: the ratio of maximum to mean life span decreased significantly from >10 in short-lived to similar to 1.5 in long-lived mammal species. Conclusions/Significance: We interpret the ratio of maximum to mean life span to be an index of the likelihood an individual will experience senescence, which largely determines maximum life span. Our results suggest that senescence occurs at an earlier age relative to the mean life span, and therefore is experienced by more individuals and remains under selection pressure, in long-compared to short-lived mammals. A minimum rate of somatic degradation may ultimately limit the natural life span of mammals. Our results also indicate that senescence and modulating factors like oxidative stress are increasingly important to the fitness of longer lived mammals (and vice versa).	[Turbill, Christopher; Ruf, Thomas] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	University of Veterinary Medicine Vienna	Turbill, C (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.	christopher.turbill@fiwi.at		Ruf, Thomas/0000-0002-9235-7079; Turbill, Christopher/0000-0001-9810-7102	Austrian Science Fund (FWF)	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	C.T. was funded by a postdoctoral fellowship from the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOTKIN DB, 1974, AM NAT, V108, P181, DOI 10.1086/282898; Carnes BA, 2003, BIOGERONTOLOGY, V4, P31, DOI 10.1023/A:1022425317536; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; JACKSON DA, 1991, OECOLOGIA, V86, P147, DOI 10.1007/BF00317404; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; MAGALHAES JPD, 2007, GERONTOL A, V62, P149; McCarthy MA, 2008, AM NAT, V172, P216, DOI 10.1086/588074; MEDAVAR PB, 1952, UNSOLVED PROBEM BIOL; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PERON G, 2010, P R SOC LOND B; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; R Core Team, 2020, R LANG ENV STAT COMP; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ricklefs RE, 2010, AGING CELL, V9, P273, DOI 10.1111/j.1474-9726.2009.00542.x; Ruf T, 2000, OIKOS, V90, P413, DOI 10.1034/j.1600-0706.2000.900223.x; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	35	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12019	10.1371/journal.pone.0012019	http://dx.doi.org/10.1371/journal.pone.0012019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700508	Green Published, gold, Green Submitted			2022-12-27	WOS:000280687900015
J	Sogawa, C; Mitsuhata, C; Kumagai-Morioka, K; Sogawa, N; Ohyama, K; Morita, K; Kozai, K; Dohi, T; Kitayama, S				Sogawa, Chiharu; Mitsuhata, Chieko; Kumagai-Morioka, Kei; Sogawa, Norio; Ohyama, Kazumi; Morita, Katsuya; Kozai, Katsuyuki; Dohi, Toshihiro; Kitayama, Shigeo			Expression and Function of Variants of Human Catecholamine Transporters Lacking the Fifth Transmembrane Region Encoded by Exon 6	PLOS ONE			English	Article							HUMAN NOREPINEPHRINE TRANSPORTER; PERIPHERAL-BLOOD LYMPHOCYTES; HUMAN DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; NORADRENALINE TRANSPORTER; C-TERMINUS; SPLICE VARIANTS; PLASMA-MEMBRANE; TRAFFICKING; OLIGOMERIZATION	Background: The transporters for dopamine (DAT) and norepinephrine (NET) are members of the Na(+)- and Cl(-)-dependent neurotransmitter transporter family SLC6. There is a line of evidence that alternative splicing results in several isoforms of neurotransmitter transporters including NET. However, its relevance to the physiology and pathology of the neurotransmitter reuptake system has not been fully elucidated. Methodology/Principal Findings: We found novel isoforms of human DAT and NET produced by alternative splicing in human blood cells (DAT) and placenta (NET), both of which lacked the region encoded by exon 6. RT-PCR analyses showed a difference in expression between the full length (FL) and truncated isoforms in the brain and peripheral tissues, suggesting tissue-specific alternative splicing. Heterologous expression of the FL but not truncated isoforms of DAT and NET in COS-7 cells revealed transport activity. However, immunocytochemistry with confocal microscopy and a cell surface biotinylation assay demonstrated that the truncated as well as FL isoform was expressed at least in part in the plasma membrane at the cell surface, although the truncated DAT was distributed to the cell surface slower than FL DAT. A specific antibody to the C-terminus of DAT labeled the variant but not FL DAT, when cells were not treated with Triton for permeabilization, suggesting the C-terminus of the variant to be located extracellulary. Co-expression of the FL isoform with the truncated isoform in COS-7 cells resulted in a reduced uptake of substrates, indicating a dominant negative effect of the variant. Furthermore, an immunoprecipitation assay revealed physical interaction between the FL and truncated isoforms. Conclusions/Significance: The unique expression and function and the proposed membrane topology of the variants suggest the importance of isoforms of catecholamine transporters in monoaminergic signaling in the brain and peripheral tissues.	[Sogawa, Chiharu; Sogawa, Norio; Kitayama, Shigeo] Okayama Univ, Dept Dent Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Mitsuhata, Chieko; Kozai, Katsuyuki] Hiroshima Univ, Dept Pediat Dent, Grad Sch Biomed Sci, Hiroshima, Japan; [Kumagai-Morioka, Kei; Morita, Katsuya; Dohi, Toshihiro] Hiroshima Univ, Dept Dent Pharmacol, Grad Sch Biomed Sci, Hiroshima, Japan; [Ohyama, Kazumi] Okayama Univ, Sch Dent, RI Res Ctr, Okayama 700, Japan	Okayama University; Hiroshima University; Hiroshima University; Okayama University	Sogawa, C (corresponding author), Okayama Univ, Dept Dent Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	shigeok@md.okayama-u.ac.jp	SOGAWA, Chiharu/B-1994-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Programs from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1993, ANNU REV NEUROSCI, V16, P16; Amenta F, 2001, J NEUROIMMUNOL, V117, P133, DOI 10.1016/S0165-5728(01)00317-4; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Borowsky B, 1998, J BIOL CHEM, V273, P29077, DOI 10.1074/jbc.273.44.29077; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Distelmaier F, 2004, J NEUROCHEM, V91, P537, DOI 10.1111/j.1471-4159.2004.02729.x; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Gu HH, 1996, J BIOL CHEM, V271, P18100, DOI 10.1074/jbc.271.30.18100; Hahn MK, 2003, J NEUROSCI, V23, P4470; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Kawarai T, 1997, GENE, V195, P11, DOI 10.1016/S0378-1119(97)00131-5; KIM DS, 1994, NEURAL PROCESS LETT, V1, P17, DOI 10.1007/BF02312396; Kitayama S, 1996, JPN J PHARMACOL, V72, P195, DOI 10.1254/jjp.72.195; Kitayama S, 2003, EUR J PHARMACOL, V479, P65, DOI 10.1016/j.ejphar.2003.08.057; Kitayama S, 1999, J BIOL CHEM, V274, P10731, DOI 10.1074/jbc.274.16.10731; Kitayama S, 2001, NEUROSCI LETT, V312, P108, DOI 10.1016/S0304-3940(01)02138-3; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; LANGER SZ, 1988, PROG NEURO-PSYCHOPH, V12, P193, DOI 10.1016/0278-5846(88)90037-1; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Masson J, 1999, PHARMACOL REV, V51, P439; Mata S, 2005, J NEUROIMMUNOL, V170, P134, DOI 10.1016/j.jneuroim.2005.08.007; Miller GM, 2001, MOL BRAIN RES, V87, P124, DOI 10.1016/S0169-328X(00)00288-6; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Porzgen P, 1998, BBA-GENE STRUCT EXPR, V1398, P365, DOI 10.1016/S0167-4781(98)00072-4; RAMAMOORTHY S, 1993, BIOCHEMISTRY-US, V32, P1346, DOI 10.1021/bi00056a021; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Sogawa C, 2007, BIOCHEM J, V401, P185, DOI 10.1042/BJ20060495; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Wagner E, 2002, J CELL SCI, V115, P3033; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11945	10.1371/journal.pone.0011945	http://dx.doi.org/10.1371/journal.pone.0011945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700532	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400005
J	Ogura, T; Krosnowski, K; Zhang, LN; Bekkerman, M; Lin, WH				Ogura, Tatsuya; Krosnowski, Kurt; Zhang, Lana; Bekkerman, Mikhael; Lin, Weihong			Chemoreception Regulates Chemical Access to Mouse Vomeronasal Organ: Role of Solitary Chemosensory Cells	PLOS ONE			English	Article							TASTE CELLS; RECEPTOR-CELLS; NERVE-FIBERS; BITTER; CHANNEL; RESPONSES; PROTEINS; TRPM5; COMMUNICATION; LOCALIZATION	Controlling stimulus access to sensory organs allows animals to optimize sensory reception and prevent damage. The vomeronasal organ (VNO) detects pheromones and other semiochemicals to regulate innate social and sexual behaviors. This semiochemical detection generally requires the VNO to draw in chemical fluids, such as bodily secretions, which are complex in composition and can be contaminated. Little is known about whether and how chemical constituents are monitored to regulate the fluid access to the VNO. Using transgenic mice and immunolabeling, we found that solitary chemosensory cells (SCCs) reside densely at the entrance duct of the VNO. In this region, most of the intraepithelial trigeminal fibers innervate the SCCs, indicating that SCCs relay sensory information onto the trigeminal fibers. These SCCs express transient receptor potential channel M5 (TRPM5) and the phospholipase C (PLC) beta 2 signaling pathway. Additionally, the SCCs express choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) for synthesizing and packaging acetylcholine, a potential transmitter. In intracellular Ca2+ imaging, the SCCs responded to various chemical stimuli including high concentrations of odorants and bitter compounds. The responses were suppressed significantly by a PLC inhibitor, suggesting involvement of the PLC pathway. Further, we developed a quantitative dye assay to show that the amount of stimulus fluid that entered the VNOs of behaving mice is inversely correlated to the concentration of odorous and bitter substances in the fluid. Genetic knockout and pharmacological inhibition of TRPM5 resulted in larger amounts of bitter compounds entering the VNOs. Our data uncovered that chemoreception of fluid constituents regulates chemical access to the VNO and plays an important role in limiting the access of non-specific irritating and harmful substances. Our results also provide new insight into the emerging role of SCCs in chemoreception and regulation of physiological actions.	[Ogura, Tatsuya; Krosnowski, Kurt; Zhang, Lana; Bekkerman, Mikhael; Lin, Weihong] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Ogura, T (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	Weihong@umbc.edu		Bekkerman, Michael/0000-0003-2201-6874	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC009269]; American Recovery and Reinvestment Act Administrative Supplement; University of Maryland, Baltimore County; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009269] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Recovery and Reinvestment Act Administrative Supplement; University of Maryland, Baltimore County; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project is supported by National Institutes of Health/National Institute on Deafness and Other Communication Disorders R01DC009269, American Recovery and Reinvestment Act Administrative Supplement, and University of Maryland, Baltimore County start-up funds to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; BRYANT B, 2000, CHEMISTHESIS COMMON, P73; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; ECCLES R, 1982, PHYSIOL BEHAV, V28, P1011, DOI 10.1016/0031-9384(82)90168-8; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Farbman A, 2000, NEUROBIOLOGY TASTE S, P131; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; HALPERN M, 1980, PHYSIOL BEHAV, V24, P367, DOI 10.1016/0031-9384(80)90100-6; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P411; Kardon R, 1995, Curr Opin Ophthalmol, V6, P20, DOI 10.1097/00055735-199512000-00004; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kozlova I, 2005, AM J PHYSIOL-LUNG C, V288, pL874, DOI 10.1152/ajplung.00303.2004; KROSNOWSKI K, 2009, CHEM SENSES IN PRESS, V34; Kuwabara Y, 2007, ENVIRON HEALTH PERSP, V115, P1609, DOI 10.1289/ehp.9848; Liman E. R., 2007, V179, P287; Lin WH, 2008, J NEUROPHYSIOL, V99, P1451, DOI 10.1152/jn.01195.2007; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Lin WH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-114; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Margolskee Robert F., 1993, Current Opinion in Neurobiology, V3, P526, DOI 10.1016/0959-4388(93)90051-Y; Matsuda H, 1996, BRAIN RES, V712, P35; MEREDITH M, 1980, SCIENCE, V207, P1224, DOI 10.1126/science.7355286; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 1997, J NEUROSCI, V17, P3580; Ogura T, 2007, CELL TISSUE RES, V330, P17, DOI 10.1007/s00441-007-0470-y; Ogura T, 2008, CHEM SENSES, V33, pS104; Osculati F, 2007, EUR J HISTOCHEM, V51, P65; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; PORAN NS, 1993, PHYSIOL BEHAV, V53, P959, DOI 10.1016/0031-9384(93)90275-K; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; Robinson R, 2008, PLOS BIOL, V6, DOI 10.1371/journal.pbio.0060039; Rodriguez I, 2009, RESULTS PROBL CELL D, V47, P77, DOI 10.1007/400_2008_8; Sbarbati A, 2003, CELLS TISSUES ORGANS, V175, P51, DOI 10.1159/000073437; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Swaney WT, 2009, BEHAV BRAIN RES, V200, P239, DOI 10.1016/j.bbr.2008.09.039; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001; Wise PM, 2009, ANN NY ACAD SCI, V1170, P206, DOI 10.1111/j.1749-6632.2009.03912.x; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1985, J CHEM ECOL, V11, P1147, DOI 10.1007/BF01024105; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; Zancanaro C, 1999, EUR J NEUROSCI, V11, P4473, DOI 10.1046/j.1460-9568.1999.00912.x; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	63	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11924	10.1371/journal.pone.0011924	http://dx.doi.org/10.1371/journal.pone.0011924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689832	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300033
J	Rosenthal, CR; Kennard, C; Soto, D				Rosenthal, Clive R.; Kennard, Christopher; Soto, David			Visuospatial Sequence Learning without Seeing	PLOS ONE			English	Article							STIMULUS-RESPONSE COMPATIBILITY; SPATIAL-ATTENTION; EYE-MOVEMENTS; IMPLICIT; RECOGNITION; EXPRESSION; EXPLICIT; KNOWLEDGE; SELECTION; CORTEX	Background: The ability to detect and integrate associations between unrelated items that are close in space and time is a key feature of human learning and memory. Learning sequential associations between non-adjacent visual stimuli (higher-order visuospatial dependencies) can occur either with or without awareness (explicit vs. implicit learning) of the products of learning. Existing behavioural and neurocognitive studies of explicit and implicit sequence learning, however, are based on conscious access to the sequence of target locations and, typically, on conditions where the locations for orienting, or motor, responses coincide with the locations of the target sequence. Methodology/Principal Findings: Dichoptic stimuli were presented on a novel sequence learning task using a mirror stereoscope to mask the eye-of-origin of visual input from conscious awareness. We demonstrate that conscious access to the sequence of target locations and responses that coincide with structure of the target sequence are dispensable features when learning higher-order visuospatial associations. Sequence knowledge was expressed in the ability of participants to identify the trained higher-order visuospatial sequence on a recognition test, even though the trained and untrained recognition sequences were identical when viewed at a conscious binocular level, and differed only at the level of the masked sequential associations. Conclusions/Significance: These results demonstrate that unconscious processing can support perceptual learning of higher-order sequential associations through interocular integration of retinotopic-based codes stemming from monocular eye-of-origin information. Furthermore, unlike other forms of perceptual associative learning, visuospatial attention did not need to be directed to the locations of the target sequence. More generally, the results pose a challenge to neural models of learning to account for a previously unknown capacity of the human visual system to support the detection, learning and recognition of higher-order sequential associations under conditions where observers are unable to see the target sequence or perform responses that coincide with structure of the target sequence.	[Rosenthal, Clive R.; Kennard, Christopher] Univ Oxford, Dept Clin Neurol, Oxford, England; [Soto, David] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London, England	University of Oxford; Imperial College London	Rosenthal, CR (corresponding author), Univ Oxford, Dept Clin Neurol, Oxford, England.	clive.rosenthal@clneuro.ox.ac.uk	Soto, David/R-3711-2019	Soto, David/0000-0003-0205-7513	Wellcome Trust [073735]; British Academy [PDF/2007/501]; Medical Research Council [89631]; MRC [G0802212] Funding Source: UKRI; Medical Research Council [G0802212] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); British Academy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants from the Wellcome Trust (073735), British Academy (PDF/2007/501) and Medical Research Council (89631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Boyer M, 2005, PSYCHOL RES-PSYCH FO, V69, P383, DOI 10.1007/s00426-004-0207-4; Conroy MA, 2005, COGN AFFECT BEHAV NE, V5, P14, DOI 10.3758/CABN.5.1.14; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; Craighero L, 2004, CURR BIOL, V14, P331, DOI 10.1016/j.cub.2004.01.054; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Cui J, 2009, VISION RES, V49, P228, DOI 10.1016/j.visres.2008.10.015; Curran T, 1997, PSYCHOL RES-PSYCH FO, V60, P24, DOI 10.1007/BF00419678; de Haan B, 2008, BRAIN RES, V1204, P102, DOI 10.1016/j.brainres.2008.01.105; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Deroost N, 2006, EXP PSYCHOL, V53, P16, DOI 10.1027/1618-3169.53.1.16; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DIENES Z, 1995, J EXP PSYCHOL LEARN, V21, P1322, DOI 10.1037/0278-7393.21.5.1322; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Ergorul C, 2006, J NEUROSCI, V26, P4111, DOI 10.1523/JNEUROSCI.0441-06.2006; Frensch PA, 1999, J EXP PSYCHOL LEARN, V25, P260, DOI 10.1037/0278-7393.25.1.260; Fu QF, 2008, CONSCIOUS COGN, V17, P185, DOI 10.1016/j.concog.2007.01.007; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Grafton ST, 1998, J NEUROSCI, V18, P9420; Grafton ST, 2002, EXP BRAIN RES, V146, P369, DOI 10.1007/s00221-002-1181-y; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hazeltine E, 2002, ATTENTION PERFORM, V19, P673; Helmuth LL, 2000, NEUROPSYCHOLOGIA, V38, P1443, DOI 10.1016/S0028-3932(00)00059-2; Heyes CM, 2002, Q J EXP PSYCHOL-A, V55, P593, DOI 10.1080/02724980143000389; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hoffmann J, 1997, PSYCHOL RES-PSYCH FO, V60, P87, DOI 10.1007/BF00419682; HOWARD JH, 1992, J EXP PSYCHOL LEARN, V18, P1029, DOI 10.1037/0278-7393.18.5.1029; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Jimenez L, 2006, J EXP PSYCHOL LEARN, V32, P475, DOI 10.1037/0278-7393.32.3.475; JIMENEZ L, 2001, Q J EXPT PSYCHOL A, V54, P1105; Keele SW, 2003, PSYCHOL REV, V110, P316, DOI 10.1037/0033-295X.110.2.316; Kinder A, 2003, PSYCHOL REV, V110, P728, DOI 10.1037/0033-295X.110.4.728; Koch I, 2007, HUM MOVEMENT SCI, V26, P257, DOI 10.1016/j.humov.2007.01.004; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Laubrock J, 2010, ATTEN PERCEPT PSYCHO, V72, P683, DOI 10.3758/APP.72.3.683; Manns JR, 2006, HIPPOCAMPUS, V16, P795, DOI 10.1002/hipo.20205; Marcus DJ, 2006, MEM COGNITION, V34, P420, DOI 10.3758/BF03193419; Mayr U, 1996, J EXP PSYCHOL LEARN, V22, P350, DOI 10.1037/0278-7393.22.2.350; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Nattkemper D, 1997, PSYCHOL RES-PSYCH FO, V60, P98, DOI 10.1007/BF00419683; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Norman E, 2006, CONSCIOUS COGN, V15, P723, DOI 10.1016/j.concog.2005.06.003; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Remillard G, 2009, J EXP PSYCHOL LEARN, V35, P528, DOI 10.1037/a0014646; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rosenthal C. R., 2010, COGN NEUR SOC ANN M; Rosenthal CR, 2009, J NEUROSCI, V29, P15115, DOI 10.1523/JNEUROSCI.2603-09.2009; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schumacher EH, 2007, BRAIN RES, V1136, P77, DOI 10.1016/j.brainres.2006.11.081; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Shanks DR, 2006, NEUROPSYCHOPHARMACOL, V31, P1768, DOI 10.1038/sj.npp.1300935; Shanks DR, 1999, J EXP PSYCHOL LEARN, V25, P1435, DOI 10.1037/0278-7393.25.6.1435; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; Shanks DR, 2003, J EXP PSYCHOL LEARN, V29, P248, DOI 10.1037/0278-7393.29.2.248; Shanks DR, 2002, PSYCHON B REV, V9, P362, DOI 10.3758/BF03196294; Shanks DR, 2002, PSYCHOL RES-PSYCH FO, V66, P99, DOI 10.1007/s00426-001-0081-2; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; STADLER M, 1992, J EXPT PSYCHOL LEARN, V18, P819; Su Y, 2009, P NATL ACAD SCI USA, V106, P15990, DOI 10.1073/pnas.0903697106; Tubau E, 2007, J EXP PSYCHOL GEN, V136, P43, DOI 10.1037/0096-3445.136.1.43; Valle-Inclan F, 2003, PSYCHOL RES-PSYCH FO, V67, P240, DOI 10.1007/s00426-003-0131-z; Valle-Inclan F, 2008, PSYCHOPHYSIOLOGY, V45, P279, DOI 10.1111/j.1469-8986.2007.00616.x; Voss JL, 2008, LEARN MEMORY, V15, P454, DOI 10.1101/lm.971208; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; ZHAOPING L, 2008, J VISION, V8, DOI DOI 10.1115/1.2830851; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595	80	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11906	10.1371/journal.pone.0011906	http://dx.doi.org/10.1371/journal.pone.0011906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QZ	20689577	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520300020
J	Chiang, WC; Geel, TM; Altintas, MM; Sever, S; Ruiters, MHJ; Reiser, J				Chiang, Wen Chih; Geel, Tessa M.; Altintas, Mehmet M.; Sever, Sanja; Ruiters, Marcel H. J.; Reiser, Jochen			Establishment of Protein Delivery Systems Targeting Podocytes	PLOS ONE			English	Article							GLOMERULAR PROTEIN; TRPC6	Background: Podocytes are uniquely structured cells that are critical to the kidney filtration barrier. Their anatomic location on the outer side of the glomerular capillaries expose podocytes to large quantities of both plasma and urinary components and thus are reachable for drug delivery. Recent years have made clear that interference with podocyte-specific disease pathways can modulate glomerular function and influence severity and progression of glomerular disease. Methodology/Principal Findings: Here, we describe studies that show efficient transport of proteins into the mammalian cells mouse 3T3 fibroblasts and podocytes, utilizing an approach termed profection. We are using synthetic lipid structures that allow the safe packing of proteins or antibodies resulting in the subsequent delivery of protein into the cell. The uptake of lipid coated protein is facilitated by the intrinsic characteristic of cells such as podocytes to engulf particles that are physiologically retained in the extracellular matrix. Profection of the restriction enzyme MunI in 3T3 mouse fibroblasts caused an increase in DNA degradation. Moreover, purified proteins such as beta-galactosidase and the large GTPase dynamin could be profected into podocytes using two different profection reagents with the success rate of 95-100%. The delivered b-galactosidase enzyme was properly folded and able to cleave its substrate X-gal in podocytes. Diseased podocytes are also potential recipients of protein cargo as we also delivered fluorophore labeled IgG into puromycin treated podocytes. We are currently optimizing our protocol for in vivo profection. Conclusions: Protein transfer is developing as an exciting tool to study and target highly differentiated cells such as podocytes.	[Chiang, Wen Chih; Sever, Sanja; Reiser, Jochen] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chiang, Wen Chih] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Geel, Tessa M.] Univ Groningen, Inst Drug Explorat GUIDE, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Altintas, Mehmet M.; Reiser, Jochen] Univ Miami, Leonard Miller Sch Med, Div Nephrol & Hypertens, Miami, FL USA; [Ruiters, Marcel H. J.] Synvolux Therapeut BV, Groningen, Netherlands	Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University Hospital; University of Groningen; University of Miami	Chiang, WC (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jreiser@med.miami.edu	Altintas, Mehmet Mete/ABI-5904-2020; Altintas, Mehmet Mete/T-5333-2018	Altintas, Mehmet Mete/0000-0002-1871-6985; Chiang, Wen Chih/0000-0002-8844-0988	National Taiwan University Hospital; National Health Research Institute in Taiwan; Nephrology & Hypertension Division of the University of Miami; US National Institutes of Health (NIH) [DK073495, T32DK007540]; National Health Research Institute, Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007540, R01DK073495] Funding Source: NIH RePORTER	National Taiwan University Hospital(National Taiwan University); National Health Research Institute in Taiwan; Nephrology & Hypertension Division of the University of Miami; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	WC was sponsored by National Taiwan University Hospital and National Health Research Institute in Taiwan as well as by Divisional funds of the Nephrology & Hypertension Division of the University of Miami. JR is supported by the US National Institutes of Health (NIH) grant DK073495. MMA was supported by NIH training grant T32DK007540. MHJR is part of a commercial funder for this research. TMG also received materials from Synvolux Therapeutics to perform parts of the described experiments. The funders contributed the study design, data collection and analysis.; Wen Chih Chiang is a recipient of National Health Research Institute Physician Scientist Award, Taiwan. The authors thank Prof. V. Siksnys, Institute of Biotechnology, Vilnius, Lithuania for providing MunI.	Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Geel TM, 2009, EXP CELL RES, V315, P2487, DOI 10.1016/j.yexcr.2009.06.011; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hasegawa U, 2009, J CONTROL RELEASE, V140, P312, DOI 10.1016/j.jconrel.2009.06.025; Hirakura T, 2010, J CONTROL RELEASE, V142, P483, DOI 10.1016/j.jconrel.2009.11.023; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; van der Gun BTF, 2007, J CONTROL RELEASE, V123, P228, DOI 10.1016/j.jconrel.2007.08.014; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	19	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11837	10.1371/journal.pone.0011837	http://dx.doi.org/10.1371/journal.pone.0011837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686602	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520200010
J	Ruffner, MA; Robbins, PD				Ruffner, Melanie A.; Robbins, Paul D.			Dendritic Cells Transduced to Express Interleukin 4 Reduce Diabetes Onset in Both Normoglycemic and Prediabetic Nonobese Diabetic Mice	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NOD MOUSE; T-CELLS; RECOMBINANT ADENOVIRUS; DISEASE-MODELS; GENE-THERAPY; IL-4; CYTOKINES; INSULITIS; RESPONSES	Background: We and others have previously demonstrated that treatment with bone marrow derived DC genetically modified to express IL-4 reduce disease pathology in mouse models of collagen-induced arthritis and delayed-type hypersensitivity. Moreover, treatment of normoglycemic NOD mice with bone marrow derived DC, genetically modified to express interleukin 4 (IL-4), reduces the onset of hyperglycemia in a significant number of animals. However, the mechanism(s) through which DC expressing IL-4 function to prevent autoimmune diabetes and whether this treatment can reverse disease in pre-diabetic NOD mice are unknown. Methodology/Principal Findings: DC were generated from the bone marrow of NOD mice and transduced with adenoviral vectors encoding soluble murine IL-4 (DC/sIL-4), a membrane-bound IL-4 construct, or empty vector control. Female NOD mice were segregated into normoglycemic (<150mg/dL) and prediabetic groups (between 150 and 250 mg/dL) on the basis of blood glucose measurements, and randomized for adoptive transfer of 10(6) DC via a single i.v. injection. A single injection of DC/sIL-4, when administered to normoglycemic 12-week old NOD mice, significantly reduced the number of mice that developed diabetes. Furthermore, DC/sIL-4, but not control DC, decreased the number of mice progressing to diabetes when given to prediabetic NOD mice 12-16 weeks of age. DC/sIL-4 treatment also significantly reduced islet mononuclear infiltration and increased the expression of FoxP3 in the pancreatic lymph nodes of a subset of treated animals. Furthermore, DC/sIL-4 treatment altered the antigen-specific Th2:Th1 cytokine profiles as determined by ELISPOT of splenocytes in treated animals. Conclusions: Adoptive transfer of DC transduced to express IL-4 into both normoglycemic and prediabetic NOD mice is an effective treatment for T1D.	[Ruffner, Melanie A.; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Ruffner, Melanie A.] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ruffner, MA (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu	Ruffner, Melanie/S-3352-2019	Ruffner, Melanie/0000-0002-2943-9944	Juvenile Diabetes Research Foundation [7-2005-1154]; National Institutes of Health (NIH) [F30 DK082217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082217] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Juvenile Diabetes Research Foundation Grant 7-2005-1154 to P.D.R. and National Institutes of Health (NIH) F30 DK082217 Fellowship to M.A.R. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Angelini F, 2005, CLIN EXP IMMUNOL, V142, P341, DOI 10.1111/j.1365-2249.2005.02916.x; Bianco NR, 2009, ARTHRITIS RHEUM-US, V60, P380, DOI 10.1002/art.24229; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Cameron MJ, 1997, J IMMUNOL, V159, P4686; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Feili-Hariri M, 2003, HUM GENE THER, V14, P13, DOI 10.1089/10430340360464679; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Hill NJ, 2003, J IMMUNOL, V170, P1649, DOI 10.4049/jimmunol.170.4.1649; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; Kim SH, 2002, MOL THER, V6, P584, DOI 10.1006/mthe.2002.0712; King C, 2001, NAT MED, V7, P206, DOI 10.1038/84659; Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402; Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001; Ma LL, 2003, DIABETES, V52, P1976, DOI 10.2337/diabetes.52.8.1976; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; Morelli AE, 2000, J VIROL, V74, P9617, DOI 10.1128/JVI.74.20.9617-9628.2000; Papaccio G, 2002, J CELL BIOCHEM, V86, P651, DOI 10.1002/jcb.10250; Perone MJ, 2006, J IMMUNOL, V177, P5278, DOI 10.4049/jimmunol.177.8.5278; Rapoport MJ, 2005, CYTOKINE, V30, P219, DOI 10.1016/j.cyto.2005.01.012; Rehman KK, 2008, MOL THER, V16, P1409, DOI 10.1038/mt.2008.116; Rodacki M, 2006, CLIN DEV IMMUNOL, V13, P101, DOI 10.1080/17402520600877182; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Son YI, 2002, J IMMUNOL METHODS, V262, P145, DOI 10.1016/S0022-1759(02)00013-3; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P	34	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11848	10.1371/journal.pone.0011848	http://dx.doi.org/10.1371/journal.pone.0011848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686610	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200014
J	Johansson, MEV; Gustafsson, JK; Sjoberg, KE; Petersson, J; Holm, L; Sjovall, H; Hansson, GC				Johansson, Malin E. V.; Gustafsson, Jenny K.; Sjoberg, Karolina E.; Petersson, Joel; Holm, Lena; Sjovall, Henrik; Hansson, Gunnar C.			Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model	PLOS ONE			English	Article							BARRIER FUNCTION; MURINE COLITIS; MUCIN; MICE; SODIUM; GLYCOSYLATION; BIOSYNTHESIS; DISEASE; MOUSE; COLON	Background: Protection of the large intestine with its enormous amount of commensal bacteria is a challenge that became easier to understand when we recently could describe that colon has an inner attached mucus layer devoid of bacteria (Johansson et al. (2008) Proc. Natl. Acad. Sci. USA 105, 15064-15069). The bacteria are thus kept at a distance from the epithelial cells and lack of this layer, as in Muc2-null mice, allow bacteria to contact the epithelium. This causes colitis and later on colon cancer, similar to the human disease Ulcerative Colitis, a disease that still lacks a pathogenetic explanation. Dextran Sulfate (DSS) in the drinking water is the most widely used animal model for experimental colitis. In this model, the inflammation is observed after 3-5 days, but early events explaining why DSS causes this has not been described. Principal Findings: When mucus formed on top of colon explant cultures were exposed to 3% DSS, the thickness of the inner mucus layer decreased and became permeable to 2 mm fluorescent beads after 15 min. Both DSS and Dextran readily penetrated the mucus, but Dextran had no effect on thickness or permeability. When DSS was given in the drinking water to mice and the colon was stained for bacteria and the Muc2 mucin, bacteria were shown to penetrate the inner mucus layer and reach the epithelial cells already within 12 hours, long before any infiltration of inflammatory cells. Conclusion: DSS thus causes quick alterations in the inner colon mucus layer that makes it permeable to bacteria. The bacteria that reach the epithelial cells probably trigger an inflammatory reaction. These observations suggest that altered properties or lack of the inner colon mucus layer may be an initial event in the development of colitis.	[Johansson, Malin E. V.; Gustafsson, Jenny K.; Sjoberg, Karolina E.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Gustafsson, Jenny K.; Sjoberg, Karolina E.; Sjovall, Henrik] Univ Gothenburg, Dept Internal Med, Gothenburg, Sweden; [Petersson, Joel; Holm, Lena] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Uppsala University	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C./AAF-7324-2019; Hansson, Gunnar C/A-1236-2009	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Jabbar, Karolina/0000-0001-8994-3280; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council [7461, 8288, 21027, 342-2004-4434]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation [KAW2007.0118]; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); EU; Wilhelm and Martina Lundgren's Foundation; Soderberg's Stiftelser; Swedish Foundation; Mucosal Immunobiology and Vaccine Center (MIVAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); EU(European Commission); Wilhelm and Martina Lundgren's Foundation; Soderberg's Stiftelser; Swedish Foundation; Mucosal Immunobiology and Vaccine Center (MIVAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 8288, 21027, and 342-2004-4434), The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation (KAW2007.0118), IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), EU-FP7 IBDase, Wilhelm and Martina Lundgren's Foundation, Soderberg's Stiftelser, and The Swedish Foundation for Strategic Research - Innate Immunity Program and The Mucosal Immunobiology and Vaccine Center (MIVAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; COOPER HS, 1993, LAB INVEST, V69, P238; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; HANSSON GC, 2010, GUT MICROBES, V1, P10; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; ISAO O, 1990, GASTROENTEROLOGY, V98, P694; Johansson M, 2000, GASTROENTEROLOGY, V119, P1297, DOI 10.1053/gast.2000.19455; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JURJUS AR, 2009, J PHARMACOL TOX MET, V50, P81; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; MARCUS R, 1971, LANCET, V2, P765; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Renes IB, 2002, AM J PHYSIOL-GASTR L, V282, pG382, DOI 10.1152/ajpgi.00229.2001; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Tai EKK, 2007, EXP BIOL MED, V232, P799; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	31	241	256	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12238	10.1371/journal.pone.0012238	http://dx.doi.org/10.1371/journal.pone.0012238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805871	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600014
J	Saito, T; Nakamura, A; Aoki, Y; Yokota, T; Okada, T; Osawa, M; Takeda, S				Saito, Takashi; Nakamura, Akinori; Aoki, Yoshitsugu; Yokota, Toshifumi; Okada, Takashi; Osawa, Makiko; Takeda, Shin'ichi			Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MUSCLE-CELLS; GENE; PROTEIN; EXPRESSION; INDUCTION; MYOBLASTS; TOOL	Background: Antisense oligonucleotide-induced exon skipping is a promising approach for treatment of Duchenne muscular dystrophy (DMD). We have systemically administered an antisense phosphorodiamidate morpholino oligomer (PMO) targeting dystrophin exons 6 and 8 to a dog with canine X-linked muscular dystrophy in Japan (CXMDJ) lacking exon 7 and achieved recovery of dystrophin in skeletal muscle. To date, however, antisense chemical compounds used in DMD animal models have not been directly applied to a DMD patient having the same type of exon deletion. We recently identified a DMD patient with an exon 7 deletion and tried direct translation of the antisense PMO used in dog models to the DMD patient's cells. Methodology/Principal Findings: We converted fibroblasts of CXMDJ and the DMD patient to myotubes by FACS-aided MyoD transduction. Antisense PMOs targeting identical regions of dog and human dystrophin exons 6 and 8 were designed. These antisense PMOs were mixed and administered as a cocktail to either dog or human cells in vitro. In the CXMDJ and human DMD cells, we observed a similar efficacy of skipping of exons 6 and 8 and a similar extent of dystrophin protein recovery. The accompanying skipping of exon 9, which did not alter the reading frame, was different between cells of these two species. Conclusion/Significance: Antisense PMOs, the effectiveness of which has been demonstrated in a dog model, achieved multi-exon skipping of dystrophin gene on the FACS-aided MyoD-transduced fibroblasts from an exon 7-deleted DMD patient, suggesting the feasibility of systemic multi-exon skipping in humans.	[Saito, Takashi; Nakamura, Akinori; Aoki, Yoshitsugu; Okada, Takashi; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Saito, Takashi; Osawa, Makiko] Tokyo Womens Med Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo, Japan; [Yokota, Toshifumi] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	National Center for Neurology & Psychiatry - Japan; Tokyo Women's Medical University; Children's National Health System	Saito, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan.	takeda@ncnp.go.jp		Yokota, Toshifumi/0000-0001-7316-3546; Saito, Takashi/0000-0002-5672-8856; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506; , toshifumi/0000-0001-6672-6742	Ministry of Health, Labour and Welfare of Japan [H19-Translational Research-003, H21-Translational Research-011, H21-Clinical Research-011]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Health and Labour Sciences Research Grants for Translational Research from the Ministry of Health, Labour and Welfare of Japan (H19-Translational Research-003, H21-Translational Research-011, H21-Clinical Research-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Etzion S, 2002, CIRCULATION, V106, pI125, DOI 10.1161/01.cir.0000032888.55215.b8; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; McClorey G, 2006, NEUROMUSCULAR DISORD, V16, P583, DOI 10.1016/j.nmd.2006.05.017; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Mitrpant C, 2009, MOL THER, V17, P1418, DOI 10.1038/mt.2009.49; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Noda T, 2009, BIOCHEM BIOPH RES CO, V382, P473, DOI 10.1016/j.bbrc.2009.03.060; Pramono ZAD, 1996, BIOCHEM BIOPH RES CO, V226, P445, DOI 10.1006/bbrc.1996.1375; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; REISS J, 1994, HUM MOL GENET, V3, P295, DOI 10.1093/hmg/3.2.295; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	35	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12239	10.1371/journal.pone.0012239	http://dx.doi.org/10.1371/journal.pone.0012239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805873	gold, Green Submitted, Green Published			2022-12-27	WOS:000281011600015
J	Sazawal, S; Dhingra, U; Dhingra, P; Hiremath, G; Sarkar, A; Dutta, A; Menon, VP; Black, RE				Sazawal, Sunil; Dhingra, Usha; Dhingra, Pratibha; Hiremath, Girish; Sarkar, Archana; Dutta, Arup; Menon, Venugopal P.; Black, Robert E.			Micronutrient Fortified Milk Improves Iron Status, Anemia and Growth among Children 1-4 Years: A Double Masked, Randomized, Controlled Trial	PLOS ONE			English	Article							PLASMA ZINC CONCENTRATIONS; HOME-FORTIFICATION; YOUNG-CHILDREN; LINEAR GROWTH; EFFICACY; INFANTS; SUPPLEMENTATION; MORBIDITY; FOOD	Background: Multiple micronutrient deficiencies are highly prevalent among preschool children and often lead to anemia and growth faltering. Given the limited success of supplementation and health education programs, fortification of foods could be a viable and sustainable option. We report results from a community based double-masked, randomized trial among children 1-4 years evaluating the effects of micronutrients (especially of zinc and iron) delivered through fortified milk on growth, anemia and iron status markers as part of a four group study design, running two studies simultaneously. Methods and Findings: Enrolled children (n = 633) were randomly allocated to receive either micronutrients fortified milk (MN = 316) or control milk (Co = 317). Intervention of MN milk provided additional 7.8 mg zinc, 9.6 mg iron, 4.2 mu g selenium, 0.27 mg copper, 156 mu g vitamin A, 40.2 mg vitamin C, and 7.5 mg vitamin E per day (three serves) for one year. Anthropometry was recorded at baseline, mid-and end-study. Hematological parameters were estimated at baseline and end-study. Both groups were comparable at baseline. Compliance was over 85% and did not vary between groups. Compared to children consuming Co milk, children consuming MN milk showed significant improvement in weight gain (difference of mean: 0.21 kg/year; 95% confidence interval [CI] 0.12 to 0.31, p < 0.001) and height gain (difference of mean: 0.51 cm/year; 95% CI 0.27 to 0.75, p < 0.001). Mean hemoglobin (Hb) (difference of 13.6 g/L; 95% CI 11.1 to 16.0, p < 0.001) and serum ferritin levels (difference of 7.9 mu g/L; 95% CI 5.4 to 10.5, p < 0.001) also improved. Children in MN group had 88% (odds ratio = 0.12, 95% CI 0.08 to 0.20, p < 0.001) lower risk of iron deficiency anemia. Conclusions/Significance: Milk provides an acceptable and effective vehicle for delivery of specific micronutrients, especially zinc and iron. Micronutrient bundle improved growth and iron status and reduced anemia in children 1-4 years old.	[Sazawal, Sunil; Dhingra, Usha; Hiremath, Girish; Dutta, Arup; Black, Robert E.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Sazawal, Sunil; Dhingra, Pratibha; Sarkar, Archana; Menon, Venugopal P.] Annamalai Univ, Dept Biochem, Ctr Micronutrient Res, Chidambaram, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Annamalai University	Sazawal, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	rblack@jhsph.edu		Menon, Venugopal Padmanabhan/0000-0002-1283-3822; Black, Robert/0000-0001-9926-7984	Fonterra Brands (Singapore) Pte. Ltd.	Fonterra Brands (Singapore) Pte. Ltd.(Fonterra)	The study was supported from the grants of Fonterra Brands (Singapore) Pte. Ltd. The funders did not have any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adu-Afarwuah S, 2008, AM J CLIN NUTR, V87, P929, DOI 10.1093/ajcn/87.4.929; ALLEN LH, 1994, EUR J CLIN NUTR, V48, pS75; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Ash DM, 2003, AM J CLIN NUTR, V77, P891, DOI 10.1093/ajcn/77.4.891; Beinner Mark Anthony, 2003, Food and Nutrition Bulletin, V24, P268; Bhandari N, 2004, J NUTR, V134, P2342; Bhandari N, 2007, J NUTR, V137, P112; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brown KH, 2007, AM J CLIN NUTR, V85, P538, DOI 10.1093/ajcn/85.2.538; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Faber M, 2005, AM J CLIN NUTR, V82, P1032, DOI 10.1093/ajcn/82.5.1032; Fahmida U, 2007, ASIA PAC J CLIN NUTR, V16, P301; GIBSON RS, 2004, ASIA PAC J CLIN NUTR, V13, pS23; HAMBIDGE KM, 1990, J TRACE ELEM ELECT H, V4, P229; Hop LT, 2005, J NUTR, V135, p660S, DOI 10.1093/jn/135.3.660S; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Morley R, 1999, ARCH DIS CHILD, V81, P247, DOI 10.1136/adc.81.3.247; Ramakrishnan U, 2004, J NUTR, V134, P2592, DOI 10.1093/jn/134.10.2592; Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, P191, DOI 10.3945/ajcn.2008.26862; Rivera JA, 2003, J NUTR, V133, p4010S, DOI 10.1093/jn/133.11.4010S; Sazawal S, 2007, BMJ-BRIT MED J, V334, P140, DOI 10.1136/bmj.39035.482396.55; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012164; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Singh Meharban, 2004, Indian Journal of Pediatrics, V71, P59, DOI 10.1007/BF02725658; Smuts CM, 2005, J NUTR, V135, p653S, DOI 10.1093/jn/135.3.653S; Torrejon CS, 2004, NUTRITION, V20, P177, DOI 10.1016/j.nut.2003.10.013; *UNICEF, 2006, 4 UNICEF; Walker CF, 2005, AM J CLIN NUTR, V82, P5, DOI 10.1093/ajcn/82.1.5; Wieringa FT, 2007, J NUTR, V137, P466; World Health Organization, 2006, WHO CHILD GROWTH STA, P312; Zlotkin S, 2003, J NUTR, V133, P1075, DOI 10.1093/jn/133.4.1075	32	64	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12167	10.1371/journal.pone.0012167	http://dx.doi.org/10.1371/journal.pone.0012167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730057	gold, Green Submitted, Green Published			2022-12-27	WOS:000280862200021
J	Pasay, C; Mounsey, K; Stevenson, G; Davis, R; Arlian, L; Morgan, M; Vyszenski-Moher, D; Andrews, K; McCarthy, J				Pasay, Cielo; Mounsey, Kate; Stevenson, Graeme; Davis, Rohan; Arlian, Larry; Morgan, Marjorie; Vyszenski-Moher, DiAnn; Andrews, Kathy; McCarthy, James			Acaricidal Activity of Eugenol Based Compounds against Scabies Mites	PLOS ONE			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS ACARI; CROTAMITON 10-PERCENT CREAM; BUD OIL COMPOUNDS; CHEMICAL-COMPOSITION; SARCOPTES-SCABIEI; IN-VITRO; TYROPHAGUS-PUTRESCENTIAE; PYRETHROID ACARICIDES; DERMANYSSUS-GALLINAE; TETRANYCHUS-URTICAE	Backgound: Human scabies is a debilitating skin disease caused by the "itch mite'' Sarcoptes scabiei. Ordinary scabies is commonly treated with topical creams such as permethrin, while crusted scabies is treated with topical creams in combination with oral ivermectin. Recent reports of acaricide tolerance in scabies endemic communities in Northern Australia have prompted efforts to better understand resistance mechanisms and to identify potential new acaricides. In this study, we screened three essential oils and four pure compounds based on eugenol for acaricidal properties. Methodology/Principal Findings: Contact bioassays were performed using live permethrin-sensitive S. scabiei var suis mites harvested from pigs and permethrin-resistant S. scabiei var canis mites harvested from rabbits. Results of bioassays showed that clove oil was highly toxic against scabies mites. Nutmeg oil had moderate toxicity and ylang ylang oil was the least toxic. Eugenol, a major component of clove oil and its analogues -acetyleugenol and isoeugenol, demonstrated levels of toxicity comparable to benzyl benzoate, the positive control acaricide, killing mites within an hour of contact. Conclusions: The acaricidal properties demonstrated by eugenol and its analogues show promise as leads for future development of alternative topical acaricides to treat scabies.	[Pasay, Cielo; Mounsey, Kate; Andrews, Kathy; McCarthy, James] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia; [Pasay, Cielo; Mounsey, Kate; Andrews, Kathy; McCarthy, James] Univ Queensland, Australian Ctr Int & Trop Hlth, Brisbane, Qld, Australia; [Stevenson, Graeme; Davis, Rohan; Andrews, Kathy] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Arlian, Larry; Morgan, Marjorie; Vyszenski-Moher, DiAnn] Wright State Univ, Dayton, OH 45435 USA	QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; Griffith University; University System of Ohio; Wright State University Dayton	Pasay, C (corresponding author), Univ Queensland, Queensland Inst Med Res, Brisbane, Qld, Australia.	Cielo.Pasay@qimr.edu.au	Stevenson, Graeme/C-2297-2009; Andrews, Katherine/F-9586-2011; Davis, Rohan A/B-1689-2008; McCarthy, James S/C-1681-2009	Andrews, Katherine/0000-0002-1591-8979; Davis, Rohan A/0000-0003-4291-7573; Mounsey, Kate/0000-0003-0579-9424; McCarthy, James/0000-0001-6596-9718	National Health and Medical Research Council, Canberra, ACT [496635]; Queensland Health Smart State Grant (Australia); United States National Institutes of Health; National Institute of Allergy and Infectious Diseases, Bethesda, MD [AI-017252]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017252, R21AI017252] Funding Source: NIH RePORTER	National Health and Medical Research Council, Canberra, ACT(National Health and Medical Research Council (NHMRC) of Australia); Queensland Health Smart State Grant (Australia); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Health and Medical Research Council, Canberra, ACT (Grant 496635)/Queensland Health Smart State Grant (Australia), United States National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD (Grant AI-017252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo CP, 2010, NAT PROD COMMUN, V5, P471; Carapetis JR, 1997, PEDIATR INFECT DIS J, V16, P494, DOI 10.1097/00006454-199705000-00008; Cavalcanti SCH, 2010, BIORESOURCE TECHNOL, V101, P829, DOI 10.1016/j.biortech.2009.08.053; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Choi HY, 2010, J MED ENTOMOL, V47, P387, DOI 10.1603/ME09119; COSKEY RJ, 1979, ARCH DERMATOL, V115, P109, DOI 10.1001/archderm.1979.04010010075035; Currie B J, 2000, Australas J Dermatol, V41, P139, DOI 10.1046/j.1440-0960.2000.00417.x; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Currie J, 2004, ACSMS HEALTH FIT J, V8, P12, DOI 10.1097/00135124-200407000-00005; Damiani N, 2009, PARASITOL RES, V106, P145, DOI 10.1007/s00436-009-1639-y; Elmhalli FH, 2009, EXP APPL ACAROL, V48, P251, DOI 10.1007/s10493-009-9236-4; Fichi G, 2007, EXP PARASITOL, V115, P168, DOI 10.1016/j.exppara.2006.07.005; FRASER J, 1994, MED J AUSTRALIA, V160, P806, DOI 10.5694/j.1326-5377.1994.tb125968.x; George DR, 2010, MED VET ENTOMOL, V24, P1, DOI 10.1111/j.1365-2915.2009.00855.x; George DR, 2009, EXP APPL ACAROL, V48, P43, DOI 10.1007/s10493-008-9225-z; HERNANDEZPEREZ E, 1983, J AM ACAD DERMATOL, V8, P121, DOI 10.1016/S0190-9622(83)80285-0; Ho S. H., 1994, Postharvest Biology and Technology, V4, P179, DOI 10.1016/0925-5214(94)90019-1; Hongratanaworakit T, 2004, PLANTA MED, V70, P632, DOI 10.1055/s-2004-827186; Jeong EY, 2009, PEST MANAG SCI, V65, P327, DOI 10.1002/ps.1684; Jukic M, 2006, CROAT CHEM ACTA, V79, P209; Kim EH, 2003, APPL ENTOMOL ZOOL, V38, P261, DOI 10.1303/aez.2003.261; Kim EH, 2003, J AGR FOOD CHEM, V51, P885, DOI 10.1021/jf0208278; Kim HK, 2008, EXP APPL ACAROL, V44, P1, DOI 10.1007/s10493-008-9129-y; KOLIOPOULUS G, PARASITOL RES   0420; Liu ZL, 2010, MOLECULES, V15, P2600, DOI 10.3390/molecules15042600; Macchioni F, 2002, J AGR FOOD CHEM, V50, P4586, DOI 10.1021/jf020270w; Miresmailli S, 2006, PEST MANAG SCI, V62, P366, DOI 10.1002/ps.1157; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; Mounsey KE, 2008, FUTURE MICROBIOL, V3, P57, DOI 10.2217/17460913.3.1.57; Mounsey KE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-43; Mounsey KE, 2009, ARCH DERMATOL, V145, P840, DOI 10.1001/archdermatol.2009.125; Oladimeji FA, 2000, J ETHNOPHARMACOL, V72, P305, DOI 10.1016/S0378-8741(00)00229-4; Olivero-Verbel J, 2010, PEST MANAG SCI, V66, P664, DOI 10.1002/ps.1927; Pasay C, 2008, MED VET ENTOMOL, V22, P82, DOI 10.1111/j.1365-2915.2008.00716.x; Pasay C, 2006, AM J TROP MED HYG, V74, P649, DOI 10.4269/ajtmh.2006.74.649; Pasay C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000354; Perrucci S., 1994, Parassitologia (Rome), V36, P269; ROTH WI, 1991, J AM ACAD DERMATOL, V24, P502, DOI 10.1016/S0190-9622(08)80078-3; Ribeiro VLS, 2010, BIORESOURCE TECHNOL, V101, P2506, DOI 10.1016/j.biortech.2009.11.016; Stashenko EE, 1996, HRC-J HIGH RES CHROM, V19, P353, DOI 10.1002/jhrc.1240190609; TAPLIN D, 1991, LANCET, V337, P1016, DOI 10.1016/0140-6736(91)92669-S; TAPLIN D, 1990, PEDIATR DERMATOL, V7, P67, DOI 10.1111/j.1525-1470.1990.tb01078.x; Tewary DK, 2006, J PEST SCI, V79, P209, DOI 10.1007/s10340-006-0135-8; Walton SF, 2000, T ROY SOC TROP MED H, V94, P92, DOI 10.1016/S0035-9203(00)90454-1; Walton SF, 2004, ARCH DERMATOL, V140, P563, DOI 10.1001/archderm.140.5.563; Williamson EM, 2007, NAT PROD COMMUN, V2, P1303; Yang YC, 2003, J AGR FOOD CHEM, V51, P4884, DOI 10.1021/jf034225f	48	73	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12079	10.1371/journal.pone.0012079	http://dx.doi.org/10.1371/journal.pone.0012079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711455	gold, Green Published			2022-12-27	WOS:000280849100018
J	Wang, HL; Yan, HP; Fu, A; Han, MJ; Hallahan, D; Han, ZZ				Wang, Hailun; Yan, Heping; Fu, Allie; Han, Miaojun; Hallahan, Dennis; Han, Zhaozhong			TIP-1 Translocation onto the Cell Plasma Membrane Is a Molecular Biomarker of Tumor Response to Ionizing Radiation	PLOS ONE			English	Article							PHAGE-DISPLAY; CANCER-PATIENTS; CYANOVIRIN-N; GROWTH; THERAPY; MARKERS; SURFACE; LUNG	Background: Tumor response to treatment has been generally assessed with anatomic and functional imaging. Recent development of in vivo molecular and cellular imaging showed promise in time-efficient assessment of the therapeutic efficacy of a prescribed regimen. Currently, the in vivo molecular imaging is limited with shortage of biomarkers and probes with sound biological relevance. We have previously shown in tumor-bearing mice that a hexapeptide (HVGGSSV) demonstrated potentials as a molecular imaging probe to distinguish the tumors responding to ionizing radiation (IR) and/or tyrosine kinase inhibitor treatment from those of non-responding tumors. Methodology/Principal Findings: In this study we have studied biological basis of the HVGGSSV peptide binding within the irradiated tumors by use of tumor-bearing mice and cultured cancer cells. The results indicated that Tax interacting protein 1 (TIP-1, also known as Tax1BP3) is a molecular target that enables the selective binding of the HVGGSSV peptide within irradiated xenograft tumors. Optical imaging and immunohistochemical staining indicated that a TIP-1 specific antibody demonstrated similar biodistribution as the peptide in tumor-bearing mice. The TIP-1 antibody blocked the peptide from binding within irradiated tumors. Studies on both of human and mouse lung cancer cells showed that the intracellular TIP-1 relocated to the plasma membrane surface within the first few hours after exposure to IR and before the onset of treatment associated apoptosis and cell death. TIP-1 relocation onto the cell surface is associated with the reduced proliferation and the enhanced susceptibility to the subsequent IR treatment. Conclusions/Significance: This study by use of tumor-bearing mice and cultured cancer cells suggested that imaging of the radiation-inducible TIP-1 translocation onto the cancer cell surface may predict the tumor responsiveness to radiation in a time-efficient manner and thus tailor radiotherapy of cancer.	[Wang, Hailun; Fu, Allie; Han, Miaojun; Han, Zhaozhong] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Wang, Hailun; Han, Zhaozhong] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Yan, Heping; Hallahan, Dennis] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Hallahan, Dennis] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Han, Zhaozhong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Vanderbilt University	Wang, HL (corresponding author), Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA.	dhallahan@wustl.edu; zhaozhong.han@vanderbilt.edu	Wang, Hailun/T-5696-2019	Wang, Hailun/0000-0001-8651-2856	NIH [R01CA127482, P50 CA128323, R01CA112385, R01CA89674, R01CA125757]; NATIONAL CANCER INSTITUTE [R01CA125757, R01CA112385, P50CA128323, R01CA127482, R01CA089674] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NIH grants R01CA127482 (Z Han), P50 CA128323 (Gore), R01CA112385, R01CA89674 and R01CA125757 (DE Hallahan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Besser J, 2007, DEV GROWTH DIFFER, V49, P205, DOI 10.1111/j.1440-169x.2007.00921.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Hallahan D, 1996, CANCER RES, V56, P5150; Hallahan DE, 1998, CANCER RES, V58, P5216; Hampson L, 2004, INT J ONCOL, V25, P1249; Han Z, 2008, NAT MED, V14, P343, DOI 10.1038/nm1691; Han ZZ, 2006, TECHNOL CANCER RES T, V5, P437, DOI 10.1177/153303460600500412; Han ZZ, 2004, PEPTIDES, V25, P551, DOI 10.1016/j.peptides.2004.02.018; Han ZZ, 2004, COMB CHEM HIGH T SCR, V7, P55, DOI 10.2174/138620704772884823; Han ZZ, 2002, BIOCHEM BIOPH RES CO, V292, P1036, DOI 10.1006/bbrc.2002.6741; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Kay BK, 2004, CHEM BIOL, V11, P423, DOI 10.1016/j.chembiol.2004.04.004; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Levashova Z, 2010, J NUCL MED, V51, P959, DOI 10.2967/jnumed.109.072199; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Svensson JP, 2006, PLOS MED, V3, P1904, DOI 10.1371/journal.pmed.0030422; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Tenzer A, 2004, PROTEOMICS, V4, P2796, DOI 10.1002/pmic.200400811; Zhang LL, 2005, CIRCULATION, V112, P1601, DOI 10.1161/CIRCULATIONAHA.104.529537; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	29	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12051	10.1371/journal.pone.0012051	http://dx.doi.org/10.1371/journal.pone.0012051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711449	Green Published, Green Submitted, gold			2022-12-27	WOS:000280849100010
J	Danoviz, ME; Nakamuta, JS; Marques, FLN; dos Santos, L; Alvarenga, EC; dos Santos, AA; Antonio, EL; Schettert, IT; Tucci, PJ; Krieger, JE				Danoviz, Maria E.; Nakamuta, Juliana S.; Marques, Fabio L. N.; dos Santos, Leonardo; Alvarenga, Erica C.; dos Santos, Alexandra A.; Antonio, Ednei L.; Schettert, Isolmar T.; Tucci, Paulo J.; Krieger, Jose E.			Rat Adipose Tissue-Derived Stem Cells Transplantation Attenuates Cardiac Dysfunction Post Infarction and Biopolymers Enhance Cell Retention	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; STROMAL CELLS; FUNCTIONAL IMPROVEMENT; VENTRICULAR-FUNCTION; MUSCLE-CELLS; IN-VITRO; DIFFERENTIATION; SURVIVAL; REPAIR; HEART	Background: Cardiac cell transplantation is compromised by low cell retention and poor graft viability. Here, the effects of co-injecting adipose tissue-derived stem cells (ASCs) with biopolymers on cell cardiac retention, ventricular morphometry and performance were evaluated in a rat model of myocardial infarction (MI). Methodology/Principal Findings: Tc-99m-labeled ASCs (1 x 10(6) cells) isolated from isogenic Lewis rats were injected 24 hours post-MI using fibrin a, collagen (ASC/C), or culture medium (ASC/M) as vehicle, and cell body distribution was assessed 24 hours later by gamma-emission counting of harvested organs. ASC/F and ASC/C groups retained significantly more cells in the myocardium than ASC/M (13.8+/-2.0 and 26.8+/-2.4% vs. 4.8+/-0.7%, respectively). Then, morphometric and direct cardiac functional parameters were evaluated 4 weeks post-MI cell injection. Left ventricle (LV) perimeter and percentage of interstitial collagen in the spare myocardium were significantly attenuated in all ASC-treated groups compared to the non-treated (NT) and control groups (culture medium, fibrin, or collagen alone). Direct hemodynamic assessment under pharmacological stress showed that stroke volume (SV) and left ventricle end-diastolic pressure were preserved in ASC-treated groups regardless of the vehicle used to deliver ASCs. Stroke work (SW), a global index of cardiac function, improved in ASC/M while it normalized when biopolymers were co-injected with ASCs. A positive correlation was observed between cardiac ASCs retention and preservation of SV and improvement in SW post-MI under hemodynamic stress. Conclusions: We provided direct evidence that intramyocardial injection of ASCs mitigates the negative cardiac remodeling and preserves ventricular function post-MI in rats and these beneficial effects can be further enhanced by administrating co-injection of ASCs with biopolymers.	[Danoviz, Maria E.; Nakamuta, Juliana S.; dos Santos, Leonardo; Schettert, Isolmar T.; Krieger, Jose E.] Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil; [Alvarenga, Erica C.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Marques, Fabio L. N.] Univ Sao Paulo, Sch Med, Nucl Med Ctr, Radiopharm Lab, Sao Paulo, Brazil; [dos Santos, Alexandra A.; Antonio, Ednei L.; Tucci, Paulo J.] Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Danoviz, ME (corresponding author), Univ Sao Paulo, Sch Med, Inst Heart, Sao Paulo, Brazil.	krieger@incor.usp.br	Alvarenga, Erika Costa/P-7596-2018; Pereira, Alexandre/HHN-1038-2022; Antonio, Ednei/AGG-9987-2022; Navarro Marques, Fabio Luiz/ABI-7774-2020; dos Santos, Leonardo/B-6509-2013; Krieger, Jose E/C-3117-2011; Schettert, Isolmar/D-1355-2012; Marques, Fabio LN/C-4153-2012; Tucci, Paulo/D-1441-2015	Alvarenga, Erika Costa/0000-0002-9480-9761; Antonio, Ednei/0000-0002-8254-5762; Navarro Marques, Fabio Luiz/0000-0001-7383-926X; dos Santos, Leonardo/0000-0002-4340-6364; Krieger, Jose E/0000-0001-5464-1792; Marques, Fabio LN/0000-0001-7383-926X; Tucci, Paulo/0000-0001-9793-670X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [01/0009-0, 05/54695-3, 04/06784-4]; Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT) [552324/20005-1, 10120104096700]; CNPq [141276/2004-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by grants from the public Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP # 01/0009-0), Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Ministerio da Saude/Departamento Ciencia e Tecnologia (MCT/CNPq/MS/DECIT 552324/20005-1 and 10120104096700). MED and JSN were recipients of fellowships from FAPESP (05/54695-3 and 04/06784-4, respectively), and LS was a recipient of a fellowship from CNPq (141276/2004-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaneze V, 2010, STEM CELLS DEV, V19, P371, DOI 10.1089/scd.2009.0195; Becker C, 2006, INT J CARDIOL, V113, P348, DOI 10.1016/j.ijcard.2005.11.060; Blande IS, 2009, TRANSFUSION, V49, P2680, DOI 10.1111/j.1537-2995.2009.02346.x; Brown RP, 1997, TOXICOL IND HEALTH, V13, P407, DOI 10.1177/074823379701300401; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DOSSANTOS L, 2009, INT J CARDIOL; DOSSANTOS L, 2010, CAN J PHYSL IN PRESS; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LITWIN SE, 1994, CIRCULATION, V89, P345, DOI 10.1161/01.CIR.89.1.345; MADONNA R, 2009, ARTERIOSCLER THROMB; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; Tholpady SS, 2003, ANAT REC PART A, V272A, P398, DOI 10.1002/ar.a.10039; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	79	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12077	10.1371/journal.pone.0012077	http://dx.doi.org/10.1371/journal.pone.0012077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711471	Green Submitted, gold, Green Published			2022-12-27	WOS:000280811900023
J	Kawamura, N; Tabata, H; Sun-Wada, GH; Wada, Y				Kawamura, Nobuyuki; Tabata, Hiroyuki; Sun-Wada, Ge-Hong; Wada, Yoh			Optic Nerve Compression and Retinal Degeneration in Tcirg1 Mutant Mice Lacking the Vacuolar-Type H+-ATPase a3 Subunit	PLOS ONE			English	Article							PROTON PUMP ATPASE; V-ATPASE; OSTEOCLAST DIFFERENTIATION; CILIARY EPITHELIUM; CELL-DEATH; MOUSE; OSTEOPETROSIS; ISOFORMS; ACIDIFICATION; KIDNEY	Background: Vacuolar-type proton transporting ATPase (V-ATPase) is involved in the proper development of visual function. Mutations in the Tcirg1 (also known as Atp6V0a3) locus, which encodes the a3 subunit of V-ATPase, cause severe autosomal recessive osteopetrosis (ARO) in humans. ARO is often associated with impaired vision most likely because of nerve compression at the optic canal. We examined the ocular phenotype of mice deficient in Tcirg1 function. Methodology/Principal Findings: X-ray microtomography showed narrowed foramina in the skull, suggesting that optic nerve compression occurred in the a3-deficient (Tcirg1(-/-)) mice. The retina of the mutant mice had normal architecture, but the number of apoptotic cells was increased at 2-3 wks after birth. In the ocular system, the a3 subunit accumulated in the choriocapillary meshwork in uveal tissues. Two other subunit isoforms a1 and a2 accumulated in the retinal photoreceptor layer. We found that the a4 subunit, whose expression has previously been shown to be restricted to several transporting epithelia, was enriched in pigmented epithelial cells of the retina and ciliary bodies. The expression of a4 in the uveal tissue was below the level of detection in wild-type mice, but it was increased in the mutant choriocapillary meshwork, suggesting that compensation may have occurred among the a subunit isoforms in the mutant tissues. Conclusions: Our findings suggest that a similar etiology of visual impairment is involved in both humans and mice; thus, a3-deficient mice may provide a suitable model for clinical and diagnostic purposes in cases of ARO.	[Kawamura, Nobuyuki; Tabata, Hiroyuki; Sun-Wada, Ge-Hong] Doshisha Womens Coll, Dept Biochem, Fac Pharmaceut Sci, Kyotanabe, Japan; [Wada, Yoh] Osaka Univ, Div Biol Sci, Inst Sci & Ind Res, Ibaraki, Japan	Osaka University	Kawamura, N (corresponding author), Doshisha Womens Coll, Dept Biochem, Fac Pharmaceut Sci, Kyotanabe, Japan.	yohwada@sanken.osaka-u.ac.jp		Kawamura, Nobuyuki/0000-0003-0664-749X	Ministry of Education, Culture, Science and Technology, Japan [20570142, 15079205, 21116002]	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid from Ministry of Education, Culture, Science and Technology, Japan (20570142 to GHSW; 15079205 and 21116002 to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askmyr M, 2009, EXP HEMATOL, V37, P302, DOI 10.1016/j.exphem.2008.10.010; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; DEGUCHI J, 1994, INVEST OPHTH VIS SCI, V35, P568; DICKIE MM, 1967, MOUSE NEWS LETT, V36; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; MAZZOLARI E, 2009, AM J HEMATOL; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; NUCKELS RJ, 2008, INVEST OPHTHALMOL VI; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Pyza E, 2004, J INSECT PHYSIOL, V50, P985, DOI 10.1016/j.jinsphys.2004.08.003; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x; Sun-Wada GH, 2007, CELL TISSUE RES, V329, P239, DOI 10.1007/s00441-007-0421-7; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Sun-Wada GH, 2005, J BIOENERG BIOMEMBR, V37, P415, DOI 10.1007/s10863-005-9482-z; Sun-Wada GH, 2003, J BIOL CHEM, V278, P44843, DOI 10.1074/jbc.M307197200; Tabata H, 2008, CELL TISSUE RES, V332, P447, DOI 10.1007/s00441-008-0597-5; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vidarsson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004471; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Wax MB, 1997, P NATL ACAD SCI USA, V94, P6752, DOI 10.1073/pnas.94.13.6752; Wu Q, 1997, AM J PHYSIOL-CELL PH, V273, pC1700, DOI 10.1152/ajpcell.1997.273.5.C1700; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	35	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12086	10.1371/journal.pone.0012086	http://dx.doi.org/10.1371/journal.pone.0012086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711468	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900026
J	Dumitriu, B; Bhattaram, P; Dy, P; Huang, YSA; Quayum, N; Jensen, J; Lefebvre, V				Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Quayum, Nayeem; Jensen, Jan; Lefebvre, Veronique			Sox6 Is Necessary for Efficient Erythropoiesis in Adult Mice under Physiological and Anemia-Induced Stress Conditions	PLOS ONE			English	Article							RED-BLOOD-CELLS; BCL-X-L; ERYTHROID-DIFFERENTIATION; DEFINITIVE ERYTHROPOIESIS; STAT5A(-/-)5B(-/-) MICE; OXIDATIVE STRESS; GENE; EXPRESSION; GLOBIN; INSIGHTS	Background: Definitive erythropoiesis is a vital process throughout life. Both its basal activity under physiological conditions and its increased activity under anemia-induced stress conditions are highly stimulated by the hormone erythropoietin. The transcription factor Sox6 was previously shown to enhance fetal erythropoiesis together and beyond erythropoietin signaling, but its importance in adulthood and mechanisms of action remain unknown. We used here Sox6 conditional null mice and molecular assays to address these questions. Methodology/Principal Findings: Sox6(fl/fl) ErGFPCre adult mice, which lacked Sox6 in erythroid cells, exhibited compensated anemia, erythroid cell developmental defects, and anisocytotic, short-lived red cells under physiological conditions, proving that Sox6 promotes basal erythropoiesis. Tamoxifen treatment of Sox6(fl/fl) CaggCreER mice induced widespread inactivation of Sox6 in a timely controlled manner and resulted in erythroblast defects before reticulocytosis, demonstrating that impaired erythropoiesis is a primary cause rather than consequence of anemia in the absence of Sox6. Twenty five percent of Sox6(fl/fl) ErGFPCre mice died 4 or 5 days after induction of acute anemia with phenylhydrazine. The others recovered slowly. They promptly increased their erythropoietin level and amplified their erythroid progenitor pool, but then exhibited severe erythroblast and reticulocyte defects. Sox6 is thus essential in the maturation phase of stress erythropoiesis that follows the erythropoietin-dependent amplification phase. Sox6 inactivation resulted in upregulation of embryonic globin genes, but embryonic globin chains remained scarce and apparently inconsequential. Sox6 inactivation also resulted in downregulation of erythroid terminal markers, including the Bcl2l1 gene for the anti-apoptotic factor Bcl-xL, and in vitro assays indicated that Sox6 directly upregulates Bcl2l1 downstream of and beyond erythropoietin signaling. Conclusions/Significance: This study demonstrates that Sox6 is necessary for efficient erythropoiesis in adult mice under both basal and stress conditions. It is primarily involved in enhancing the survival rate and maturation process of erythroid cells and acts at least in part by upregulating Bcl2l1.	[Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Dumitriu, Bogdan; Bhattaram, Pallavi; Dy, Peter; Huang, Yuanshuai; Lefebvre, Veronique] Cleveland Clin, Lerner Res Inst, Orthopaed Res Ctr, Cleveland, OH 44106 USA; [Dumitriu, Bogdan] Cleveland Clin, Lerner Res Inst, Dept Internal Med, Cleveland, OH 44106 USA; [Quayum, Nayeem; Jensen, Jan] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dumitriu, B (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	lefebvv@ccf.org		Jensen, Jan/0000-0003-0657-4032	Roche Foundation for Anemia Research; Cooley's Anemia Foundation; American Heart Association	Roche Foundation for Anemia Research; Cooley's Anemia Foundation; American Heart Association(American Heart Association)	This work was supported by a Roche Foundation for Anemia Research grant to VL and by postdoctoral fellowships from the Cooley's Anemia Foundation and the American Heart Association to BD. Acquisition of the Advia 120 instrument was made possible by a gift from Herbert and Judith Harvey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; BHATTARAM P, 2010, NAT COMMUN IN PRESS; Broudy VC, 1996, BLOOD, V88, P75; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cohen-Barak O, 2007, EXP HEMATOL, V35, P358, DOI 10.1016/j.exphem.2006.11.009; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Hagiwara N, 2005, DEV DYNAM, V234, P301, DOI 10.1002/dvdy.20535; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kim SI, 2007, ONCOGENE, V26, P6777, DOI 10.1038/sj.onc.1210761; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Montel-Hagen A, 2009, CURR OPIN HEMATOL, V16, P165, DOI 10.1097/MOH.0b013e328329905c; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Noordermeer D, 2008, IUBMB LIFE, V60, P824, DOI 10.1002/iub.129; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Quayum N, 2008, EXP DIABETES RES, DOI 10.1155/2008/312060; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; SCHRIER SL, 1994, ANNU REV MED, V45, P211; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Srinoun K, 2009, HAEMATOL-HEMATOL J, V94, P1211, DOI 10.3324/haematol.2009.005827; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Wagner KU, 2000, DEVELOPMENT, V127, P4949; WALFAREN P, 2005, BLOOD, V105, P600; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yi ZH, 2006, PLOS GENET, V2, P129, DOI 10.1371/journal.pgen.0020014; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	55	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12088	10.1371/journal.pone.0012088	http://dx.doi.org/10.1371/journal.pone.0012088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711497	gold, Green Published			2022-12-27	WOS:000280776800020
J	Bollo, M; Paredes, RM; Holstein, D; Zheleznova, N; Camacho, P; Lechleiter, JD				Bollo, Mariana; Paredes, R. Madelaine; Holstein, Deborah; Zheleznova, Nadezhda; Camacho, Patricia; Lechleiter, James D.			Calcineurin Interacts with PERK and Dephosphorylates Calnexin to Relieve ER Stress in Mammals and Frogs	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; KINASE-II; TRANSLATIONAL CONTROL; BINDING PROTEINS; CALCIUM-BINDING; CELL-SURVIVAL; PHOSPHORYLATION; APOPTOSIS; INHIBITION	Background: The accumulation of misfolded proteins within the endoplasmic reticulum (ER) triggers a cellular process known as the Unfolded Protein Response (UPR). One of the earliest responses is the attenuation of protein translation. Little is known about the role that Ca(2+) mobilization plays in the early UPR. Work from our group has shown that cytosolic phosphorylation of calnexin (CLNX) controls Ca(2+) uptake into the ER via the sarco-endoplasmic reticulum Ca(2+)-ATPase (SERCA) 2b. Methodology/Principal Findings: Here, we demonstrate that calcineurin (CN), a Ca(2+) dependent phosphatase, associates with the (PKR)-like ER kinase (PERK), and promotes PERK auto-phosphorylation. This association, in turn, increases the phosphorylation level of eukaryotic initiation factor-2 alpha (eIF2-alpha) and attenuates protein translation. Data supporting these conclusions were obtained from co-immunoprecipitations, pull-down assays, in-vitro kinase assays, siRNA treatments and [(35)S]-methionine incorporation measurements. The interaction of CN with PERK was facilitated at elevated cytosolic Ca(2+) concentrations and involved the cytosolic domain of PERK. CN levels were rapidly increased by ER stressors, which could be blocked by siRNA treatments for CN-A alpha in cultured astrocytes. Downregulation of CN blocked subsequent ER-stress-induced increases in phosphorylated elF2-alpha. CN knockdown in Xenopus oocytes predisposed them to induction of apoptosis. We also found that CLNX was dephosphorylated by CN when Ca(2+) increased. These data were obtained from [gamma(32)P]-CLNX immunoprecipitations and Ca(2+) imaging measurements. CLNX was dephosphorylated when Xenopus oocytes were treated with ER stressors. Dephosphorylation was pharmacologically blocked by treatment with CN inhibitors. Finally, evidence is presented that PERK phosphorylates CN-A at low resting levels of Ca(2+). We further show that phosphorylated CN-A exhibits decreased phosphatase activity, consistent with this regulatory mechanism being shut down as ER homeostasis is re-established. Conclusions/Significance: Our data suggest two new complementary roles for CN in the regulation of the early UPR. First, CN binding to PERK enhances inhibition of protein translation to allow the cell time to recover. The induction of the early UPR, as indicated by increased P-elF2 alpha, is critically dependent on a translational increase in CN-A alpha. Second, CN dephosphorylates CLNX and likely removes inhibition of SERCA2b activity, which would aid the rapid restoration of ER Ca(2+) homeostasis.	[Bollo, Mariana] Inst Invest Med Mercedes & Martin Ferreyra INIMEC, Cordoba, Argentina; [Paredes, R. Madelaine; Holstein, Deborah; Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zheleznova, Nadezhda; Camacho, Patricia] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Bollo, M (corresponding author), Inst Invest Med Mercedes & Martin Ferreyra INIMEC, Cordoba, Argentina.	Lechleiter@uthscsa.edu			National Institutes of Health [R01 GM55372., PO1 AG19316-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by National Institutes of Health (http://www.nih.gov/) R01 GM55372 to Patricia Camacho and NIH PO1 AG19316-06 to Brian Herman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; CAMACHO P, 1993, SCIENCE, V260, P226, DOI 10.1126/science.8385800; Carlberg M, 1996, CARCINOGENESIS, V17, P2589, DOI 10.1093/carcin/17.12.2589; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; EHRLICH BE, 1995, CURR OPIN NEUROBIOL, V5, P304, DOI 10.1016/0959-4388(95)80042-5; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HASHIMOTO Y, 1989, J BIOL CHEM, V264, P16524; HASHIMOTO Y, 1988, P NATL ACAD SCI USA, V85, P7001, DOI 10.1073/pnas.85.18.7001; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Kitamura M, 2010, NEPHROL DIAL TRANSPL, V25, P6, DOI 10.1093/ndt/gfp516; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Ma TS, 1999, CELL CALCIUM, V26, P25, DOI 10.1054/ceca.1999.0049; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Park EK, 2002, MOL CELL BIOL, V22, P3404, DOI 10.1128/MCB.22.10.3404-3414.2002; PERRINO BA, 1995, J BIOL CHEM, V270, P7012; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saelim N, 2007, APOPTOSIS, V12, P1781, DOI 10.1007/s10495-007-0109-1; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; von Ahsen O, 2000, METHOD ENZYMOL, V322, P183; WADA I, 1991, J BIOL CHEM, V266, P19599; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wong HN, 1998, J BIOL CHEM, V273, P17227, DOI 10.1074/jbc.273.27.17227	59	62	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11925	10.1371/journal.pone.0011925	http://dx.doi.org/10.1371/journal.pone.0011925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700529	gold, Green Published, Green Submitted			2022-12-27	WOS:000280605400003
J	Sun, YT; Lodish, HF				Sun, Yutong; Lodish, Harvey F.			Adiponectin Deficiency Promotes Tumor Growth in Mice by Reducing Macrophage Infiltration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; STIMULATES ANGIOGENESIS; ADIPOSE-TISSUE; NUDE-MICE; IDENTIFICATION; EXPRESSION; APOPTOSIS; RECEPTOR; OBESITY	Adiponectin is an adipocyte-derived plasma protein that has been implicated in regulating angiogenesis, but the role of adiponectin in regulating this process is still controversial. In this study, in order to determine whether adiponectin affects tumor growth and tumor induced vascularization, we implanted B16F10 melanoma and Lewis Lung Carcinoma cells subcutaneously into adiponectin knockout and wild-type control mice, and found that adiponectin deficiency markedly promoted the growth of both tumors. Immunohistochemical analyses indicated that adiponectin deficiency reduced macrophage recruitment to the tumor, but did not affect cancer cell mitosis, apoptosis, or tumor-associated angiogenesis. In addition, treatment with recombinant adiponectin did not affect the proliferation of cultured B16F10 tumor cells. Importantly, the restoration of microphage infiltration at an early stage of tumorigenesis by means of co-injection of B16F10 cells and macrophages reversed the increased tumor growth in adiponectin knockout mice. Thus, we conclude that the enhanced tumor growth observed in adiponectin deficient mice is likely due to the reduction of macrophage infiltration rather than enhanced angiogenesis.	[Sun, Yutong; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Sun, YT (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	; Stefanadis, Christodoulos/ABH-2232-2020	Sun, Yutong/0000-0002-9368-2957; Stefanadis, Christodoulos/0000-0001-5974-6454	Susan G. Komen for the Cure; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5R01DK047618-22]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047618] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from Susan G. Komen for the Cure (to Y.S.) and in part by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant 5R01DK047618-22 (to H. F. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Susan G. Komen for the Cure: http://ww5.komen.org/. U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): http://www.niddk.nih.gov/.	Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Arditi JD, 2007, HORM METAB RES, V39, P9, DOI 10.1055/s-2007-956518; Bonnotte B, 2001, J IMMUNOL, V167, P5077, DOI 10.4049/jimmunol.167.9.5077; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fiumara A, 1997, J CLIN ENDOCR METAB, V82, P1615, DOI 10.1210/jc.82.5.1615; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kumar R, 1999, J LEUKOCYTE BIOL, V65, P102, DOI 10.1002/jlb.65.1.102; Lam JBB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004968; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Man K, 2010, CLIN CANCER RES, V16, P967, DOI 10.1158/1078-0432.CCR-09-1487; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Nishihara T, 2008, WORLD J GASTROENTERO, V14, P6473, DOI 10.3748/wjg.14.6473; OHASHI K, ADIPONECTIN PROMOTES, P6153; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	32	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11987	10.1371/journal.pone.0011987	http://dx.doi.org/10.1371/journal.pone.0011987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700533	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400020
J	Cranford, TW; Krysl, P; Amundin, M				Cranford, Ted W.; Krysl, Petr; Amundin, Mats			A New Acoustic Portal into the Odontocete Ear and Vibrational Analysis of the Tympanoperiotic Complex	PLOS ONE			English	Article							SOUND-TRANSMISSION; HEARING; PORPOISE; WHALES	Global concern over the possible deleterious effects of noise on marine organisms was catalyzed when toothed whales stranded and died in the presence of high intensity sound. The lack of knowledge about mechanisms of hearing in toothed whales prompted our group to study the anatomy and build a finite element model to simulate sound reception in odontocetes. The primary auditory pathway in toothed whales is an evolutionary novelty, compensating for the impedance mismatch experienced by whale ancestors as they moved from hearing in air to hearing in water. The mechanism by which high-frequency vibrations pass from the low density fats of the lower jaw into the dense bones of the auditory apparatus is a key to understanding odontocete hearing. Here we identify a new acoustic portal into the ear complex, the tympanoperiotic complex (TPC) and a plausible mechanism by which sound is transduced into the bony components. We reveal the intact anatomic geometry using CT scanning, and test functional preconceptions using finite element modeling and vibrational analysis. We show that the mandibular fat bodies bifurcate posteriorly, attaching to the TPC in two distinct locations. The smaller branch is an inconspicuous, previously undescribed channel, a cone-shaped fat body that fits into a thin-walled bony funnel just anterior to the sigmoid process of the TPC. The TPC also contains regions of thin translucent bone that define zones of differential flexibility, enabling the TPC to bend in response to sound pressure, thus providing a mechanism for vibrations to pass through the ossicular chain. The techniques used to discover the new acoustic portal in toothed whales, provide a means to decipher auditory filtering, beam formation, impedance matching, and transduction. These tools can also be used to address concerns about the potential deleterious effects of high-intensity sound in a broad spectrum of marine organisms, from whales to fish.	[Cranford, Ted W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Amundin, Mats] Kolmarden Wildlife Pk, Dept Res & Educ, Kolmarden, Sweden; [Amundin, Mats] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	California State University System; San Diego State University; University of California System; University of California San Diego; Linkoping University	Cranford, TW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	tcranfor@mail.sdsu.edu		Krysl, Petr/0000-0003-1761-5047	Fleet Industrial Supply Center (FISC) [N00244-08-1-0025]; Chief of Naval Operations Environmental Readiness Division [CNO-N45]; Naval Postgraduate School	Fleet Industrial Supply Center (FISC); Chief of Naval Operations Environmental Readiness Division; Naval Postgraduate School(United States Department of Defense)	Fleet Industrial Supply Center (FISC). Grant# N00244-08-1-0025. The funding flows from the Chief of Naval Operations Environmental Readiness Division (CNO-N45) and the Naval Postgraduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIADIS I, 1987, COMMUN APPL NUMER M, V3, P507, DOI 10.1002/cnm.1630030611; BEKESY GEORG v., 1948, JOUR ACOUSTICAL SOC AMER, V20, P749; Blevins R.D., 2001, FORMULAS NATURAL FRE; BOENNINGHAUS G, 1904, ARCH OTOLOGY, P196; BOENNINGHAUS G, 1904, ZOOL JB A, V19, P189; Bullock T.H., 1971, ORIENTATION NAVIGATI, P373; BULLOCK TH, 1968, Z VERGL PHYSIOL, V59, P117; Cranford T. W, 1988, ANIMAL SONAR PROCESS, P67; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford Ted W., 2003, P27; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; CRANFORD TW, 1992, THESIS U CALIFORNIA; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; deHaan Reysenbach, 1957, ACTA OTO-LARYNGOL, V134, P1; Fahy F, 2007, SOUND STRUCTURAL VIB; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; FLEISCHER G, 1973, 9 P ANN C BIOL SON D, P137; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Hato N, 2003, AUDIOL NEURO-OTOL, V8, P140, DOI 10.1159/000069475; Hemila S, 2001, HEARING RES, V151, P221, DOI 10.1016/S0378-5955(00)00232-X; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; HERZOG H, 1930, Z HALS NASEN OHRENH, V27, P402; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Hinton E., 1976, EARTHQ ENG STRUCT D, V4, P245, DOI [DOI 10.1002/EQE.4290040305, 10.1002/eqe.4290040305]; Hughes T.J. R., 2000, FINITE ELEMENT METHO; KELLOGG WN, 1952, SCIENCE, V116, P250, DOI 10.1126/science.116.3010.250; KELLOGG WN, 1953, J COMP PHYSIOL PSYCH, V46, P446, DOI 10.1037/h0060437; KELLOGG WN, 1953, SCIENCE, V117, P239, DOI 10.1126/science.117.3036.239; Ketten DR, 2000, SPR HDB AUD, V12, P43; Krysl P, 2008, INT J NUMER METH ENG, V76, P1020, DOI 10.1002/nme.2354; Krysl P., 2006, PRAGMATIC INTRO FINI; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; MATHIEU WA, 1991, LISTENING BOOK DISCO; MCBRIDE AF, 1956, DEEP-SEA RES, V3, P153, DOI 10.1016/0146-6313(56)90096-X; MCCORMICK J G, 1970, Journal of the Acoustical Society of America, V48, P1418, DOI 10.1121/1.1912302; MCCORMICK JG, 1980, ANIMAL SONAR SYSTEMS, P449; MCGOWEN MR, 2009, MOL PHYLOG EVOL; MEAD JG, 2009, SMITHSONIAN CONTRIB, V627, P216; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Norris K. S., 1964, P317; Norris K.S., 1972, P251; Norris K. S., 1969, P391; Norris K.S., 1974, PORPOISE WATCHER; Norris K.S., 1968, EVOLUTION ENV, P297; NORRIS KS, 1974, J ACOUST SOC AM, V56, P659, DOI 10.1121/1.1903305; NORRIS KS, 1980, ANIMAL SONAR SYSTEMS, P495; Nummela S, 2004, MAR MAMMAL SCI, V20, P491, DOI 10.1111/j.1748-7692.2004.tb01174.x; Nummela S, 1999, HEARING RES, V133, P61, DOI 10.1016/S0378-5955(99)00053-2; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; Popper A. N., 1980, CETACEAN BEHAV MECH, P1; Ridgway S. H., 2001, Aquatic Mammals, V27, P267; Ridgway S.H, 1983, HEARING OTHER SENSES, P247; Ridgway SH, 1999, MAR MAMMAL SCI, V15, P926, DOI 10.1111/j.1748-7692.1999.tb00861.x; Ridgway SH, 2001, J EXP BIOL, V204, P3829; Roache PJ, 1998, VERIFICATION VALIDAT; Sargent J.R., 1975, BIOCH BIOPHYSICAL PE, V2, P215; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yost WA, 1994, FUNDAMENTALS HEARING	62	47	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11927	10.1371/journal.pone.0011927	http://dx.doi.org/10.1371/journal.pone.0011927			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694149	Green Published, gold			2022-12-27	WOS:000280574300005
J	Nakahara, Y; Kanamori, Y; Kiuchi, M; Kamimura, M				Nakahara, Yuichi; Kanamori, Yasushi; Kiuchi, Makoto; Kamimura, Manabu			Two Hemocyte Lineages Exist in Silkworm Larval Hematopoietic Organ	PLOS ONE			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; PARALYTIC PEPTIDE; LEPIDOPTERAN INSECT; MANDUCA-SEXTA; IN-VITRO; CELL; MOTH; DIFFERENTIATION; HEMOLYMPH; DIVISION	Background: Insects have multiple hemocyte morphotypes with different functions as do vertebrates, however, their hematopoietic lineages are largely unexplored with the exception of Drosophila melanogaster. Methodology/Principal Findings: To study the hematopoietic lineage of the silkworm, Bombyx mori, we investigated in vivo and in vitro differentiation of hemocyte precursors in the hematopoietic organ (HPO) into the four mature hemocyte subsets, namely, plasmatocytes, granulocytes, oenocytoids, and spherulocytes. Five days after implantation of enzymatically-dispersed HPO cells from a GFP-expressing transgenic line into the hemocoel of normal larvae, differentiation into plasmatocytes, granulocytes and oenocytoids, but not spherulocytes, was observed. When the HPO cells were cultured in vitro, plasmatocytes appeared rapidly, and oenocytoids possessing prophenol oxidase activity appeared several days later. HPO cells were also able to differentiate into a small number of granulocytes, but not into spherulocytes. When functionally mature plasmatocytes were cultured in vitro, oenocytoids were observed 10 days later. These results suggest that the hemocyte precursors in HPO first differentiate into plasmatocytes, which further change into oenocytoids. Conclusions/Significance: From these results, we propose that B. mori hemocytes can be divided into two major lineages, a granulocyte lineage and a plasmatocyte-oenocytoid lineage. The origins of the spherulocytes could not be determined in this study. We construct a model for the hematopoietic lineages at the larval stage of B. mori.	[Nakahara, Yuichi; Kanamori, Yasushi; Kiuchi, Makoto; Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan	Nakahara, Y (corresponding author), Teikyo Univ, Sch Med, Dept Biochem, Tokyo 173, Japan.	kamimura@affrc.go.jp			Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan	Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan	This work was supported by the Bio-oriented Technology Research Advancement Institution (BRAIN) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1973, International Journal of Insect Morphology and Embryology, V2, P207, DOI 10.1016/0020-7322(73)90029-9; AKAI H, 1971, J INSECT PHYSIOL, V17, P1665, DOI 10.1016/0022-1910(71)90062-X; ARNOLD JW, 1976, CAN J ZOOL, V54, P1003, DOI 10.1139/z76-112; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; BEAULATON J, 1979, BIOCHIMIE, V61, P157, DOI 10.1016/S0300-9084(79)80064-4; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Gardiner EMM, 2000, ARCH INSECT BIOCHEM, V43, P147, DOI 10.1002/(SICI)1520-6327(200004)43:4&lt;147::AID-ARCH1&gt;3.0.CO;2-J; Gardiner EMM, 1999, J INSECT PHYSIOL, V45, P113, DOI 10.1016/S0022-1910(98)00092-4; Gupta A. P., 1979, INSECT HEMOCYTES DEV, P86; Han SS, 1998, ZOOL SCI, V15, P371, DOI 10.2108/zsj.15.371; HINKS CF, 1977, CAN J ZOOL, V55, P1740, DOI 10.1139/z77-225; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Imamura M, 2006, INSECT BIOCHEM MOLEC, V36, P429, DOI 10.1016/j.ibmb.2006.03.002; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; KURIHARA Y, 1992, APPL ENTOMOL ZOOL, V27, P225, DOI 10.1303/aez.27.225; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ling E, 2005, TISSUE CELL, V37, P101, DOI 10.1016/j.tice.2004.10.007; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; MITSUHASHI J, 1988, APPL ENTOMOL ZOOL, V23, P488, DOI 10.1303/aez.23.488; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, J INSECT PHYSIOL, V49, P907, DOI 10.1016/S0022-1910(03)00149-5; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Nardi JB, 2004, DEV GENES EVOL, V214, P19, DOI 10.1007/s00427-003-0371-3; Nardi JB, 2003, DEV GENES EVOL, V213, P477, DOI 10.1007/s00427-003-0352-6; Nittono Y., 1960, B SERIC EXP STA TOKY, V16, P171; OCHIAI M, 1992, CELL TISSUE RES, V268, P431, DOI 10.1007/BF00319149; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Saito T, 2003, APPL ENTOMOL ZOOL, V38, P583, DOI 10.1303/aez.2003.583; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; TAKADA M, 1971, JPN J ENTOMOL, V39, P385; Wago Haruhisa, 1991, P215; Wang CL, 2010, INSECT SCI, V17, P7, DOI 10.1111/j.1744-7917.2009.01288.x; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Yamashita M, 2001, J INSECT PHYSIOL, V47, P325, DOI 10.1016/S0022-1910(00)00144-X	46	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11816	10.1371/journal.pone.0011816	http://dx.doi.org/10.1371/journal.pone.0011816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676370	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520100007
J	Paulo, AC; Correia-Neves, M; Domingos, T; Murta, AG; Pedrosa, J				Paulo, A. Cristina; Correia-Neves, Margarida; Domingos, Tiago; Murta, Alberto G.; Pedrosa, Jorge			Influenza Infectious Dose May Explain the High Mortality of the Second and Third Wave of 1918-1919 Influenza Pandemic	PLOS ONE			English	Article							SPANISH INFLUENZA; IMMUNE-RESPONSE; A VIRUSES; TRANSMISSION; PATHOGENICITY; HEMAGGLUTININ; IMPACT; DEATH; TIME; SEASONALITY	Background: It is widely accepted that the shift in case-fatality rate between waves during the 1918 influenza pandemic was due to a genetic change in the virus. In animal models, the infectious dose of influenza A virus was associated to the severity of disease which lead us to propose a new hypothesis. We propose that the increase in the case-fatality rate can be explained by the dynamics of disease and by a dose-dependent response mediated by the number of simultaneous contacts a susceptible person has with infectious ones. Methods: We used a compartment model with seasonality, waning of immunity and a Holling type II function, to model simultaneous contacts between a susceptible person and infectious ones. In the model, infected persons having mild or severe illness depend both on the proportion of infectious persons in the population and on the level of simultaneous contacts between a susceptible and infectious persons. We further allowed for a high or low rate of waning immunity and volunteer isolation at different times of the epidemic. Results: In all scenarios, case-fatality rate was low during the first wave (Spring) due to a decrease in the effective reproduction number. The case-fatality rate in the second wave (Autumn) depended on the ratio between the number of severe cases to the number of mild cases since, for each 1000 mild infections only 4 deaths occurred whereas for 1000 severe infections there were 20 deaths. A third wave (late Winter) was dependent on the rate for waning immunity or on the introduction of new susceptible persons in the community. If a group of persons became voluntarily isolated and returned to the community some days latter, new waves occurred. For a fixed number of infected persons the overall case-fatality rate decreased as the number of waves increased. This is explained by the lower proportion of infectious individuals in each wave that prevented an increase in the number of severe infections and thus of the case-fatality rate. Conclusion: The increase on the proportion of infectious persons as a proxy for the increase of the infectious dose a susceptible person is exposed, as the epidemic develops, can explain the shift in case-fatality rate between waves during the 1918 influenza pandemic.	[Paulo, A. Cristina; Correia-Neves, Margarida; Pedrosa, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Domingos, Tiago] Inst Super Tecn, Environm & Energy Sci Area, DEM, Ctr Innovat Technol & Res, Lisbon, Portugal; [Domingos, Tiago] Inst Super Tecn, IN, Ctr Innovat Technol & Res, Lisbon, Portugal; [Murta, Alberto G.] Inst Nacl Recursos Biol IPIMAR, Lisbon, Portugal	Universidade do Minho; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Paulo, AC (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.	cristinapaulo@ecsaude.uminho.pt	Domingos, Tiago/D-4558-2012; Correia-Neves, Margarida/AAH-4636-2020; Pedrosa, Jorge/H-4877-2011; Correia-Neves, Margarida/C-9122-2009	Domingos, Tiago/0000-0002-6194-0405; Correia-Neves, Margarida/0000-0002-2202-5431; Pedrosa, Jorge/0000-0002-8204-4888; Correia-Neves, Margarida/0000-0002-2202-5431; PAULO, Ana Cristina/0000-0002-9249-2609	Faculdade de Ciencias e Tecnologia [PPCDT/AMB/55701/2004]	Faculdade de Ciencias e Tecnologia	TD acknowledges the support of the Faculdade de Ciencias e Tecnologia through grant PPCDT/AMB/55701/2004. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Bell D, 2006, EMERG INFECT DIS, V12, P88; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chang DB, 2007, J THEOR BIOL, V246, P621, DOI 10.1016/j.jtbi.2007.02.004; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; DAVIES JR, 1984, J HYG-CAMBRIDGE, V92, P125, DOI 10.1017/S002217240006410X; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Enserink M, 2007, SCIENCE, V315, P582, DOI 10.1126/science.315.5812.582; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Francis T, 1939, J EXP MED, V69, P283, DOI 10.1084/jem.69.2.283; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; GRILLI EA, 1986, J HYG-CAMBRIDGE, V96, P335, DOI 10.1017/S0022172400066080; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; JA M, 1990, EQUINE VET J, V22, P93; Kawana A, 2007, EMERG INFECT DIS, V13, P590, DOI 10.3201/eid1304.060615; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Klugman KP, 2009, EMERG INFECT DIS, V15, P346, DOI 10.3201/eid1502.081208; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; Mamelund SE, 2006, SOC SCI MED, V62, P923, DOI 10.1016/j.socscimed.2005.06.051; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; McSweeny Kirsten, 2007, N Z Med J, V120, pU2579; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nicas M, 2008, J OCCUP ENVIRON HYG, V5, P347, DOI 10.1080/15459620802003896; Nishiura H, 2008, NEW ZEAL MED J, V121, P18; Oh S, 2000, J VIROL, V74, P5460, DOI 10.1128/JVI.74.12.5460-5469.2000; Oxford JS, 2005, VACCINE, V23, P940, DOI 10.1016/j.vaccine.2004.06.035; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; PAYNE AMM, 1958, P ROY SOC MED, V51, P1009; PINTO CA, 1969, ARCH GES VIRUSFORSCH, V26, P225, DOI 10.1007/BF01242375; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Renshaw E., 1995, MODELLING BIOL POPUL; Richard SA, 2009, EPIDEMIOL INFECT, V137, P1062, DOI 10.1017/S0950268809002088; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Taylor RM, 1941, J EXP MED, V73, P43, DOI 10.1084/jem.73.1.43; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wattrang E, 2003, VIRAL IMMUNOL, V16, P57, DOI 10.1089/088282403763635456; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; White LF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001498; *WHO, 2005, 200529 CDS WHO; YETTER RA, 1980, INFECT IMMUN, V29, P654	61	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11655	10.1371/journal.pone.0011655	http://dx.doi.org/10.1371/journal.pone.0011655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668679	Green Submitted, gold, Green Published			2022-12-27	WOS:000280297300001
J	Fernandes, LP; Annibale, A; Kleinjung, J; Coolen, ACC; Fraternali, F				Fernandes, Luis P.; Annibale, Alessia; Kleinjung, Jens; Coolen, Anthony C. C.; Fraternali, Franca			Protein Networks Reveal Detection Bias and Species Consistency When Analysed by Information-Theoretic Methods	PLOS ONE			English	Article							SCALE-FREE NETWORKS; INTERACTION MAP; INTERACTOME; YEAST; COMPLEXES; IDENTIFICATION; STABILITY; TOPOLOGY	We apply our recently developed information-theoretic measures for the characterisation and comparison of protein-protein interaction networks. These measures are used to quantify topological network features via macroscopic statistical properties. Network differences are assessed based on these macroscopic properties as opposed to microscopic overlap, homology information or motif occurrences. We present the results of a large-scale analysis of protein-protein interaction networks. Precise null models are used in our analyses, allowing for reliable interpretation of the results. By quantifying the methodological biases of the experimental data, we can define an information threshold above which networks may be deemed to comprise consistent macroscopic topological properties, despite their small microscopic overlaps. Based on this rationale, data from yeast-two-hybrid methods are sufficiently consistent to allow for intra-species comparisons (between different experiments) and inter-species comparisons, while data from affinity-purification mass-spectrometry methods show large differences even within intra-species comparisons.	[Fernandes, Luis P.; Coolen, Anthony C. C.; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Annibale, Alessia; Coolen, Anthony C. C.] Kings Coll London, Dept Math, London WC2R 2LS, England; [Kleinjung, Jens] Natl Inst Med Res, MRC, Div Math Biol, London NW7 1AA, England	University of London; King's College London; University of London; King's College London; MRC National Institute for Medical Research	Fernandes, LP (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternali@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Annibale, Alessia/0000-0003-4010-6742; Kleinjung, Jens/0000-0002-7875-5724	Engineering and Physical Sciences Research Council (EPSRC); Medical Research Council (MRC) [U.1175.03.001.00001.01]; Leverhulme Trust [F/07040/AL]; BBSRC [BB/H018409/1] Funding Source: UKRI; EPSRC [EP/E032400/1] Funding Source: UKRI; MRC [MC_U117581331] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H018409/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E032400/1] Funding Source: researchfish; Medical Research Council [MC_U117581331] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), Medical Research Council (MRC) (grant U.1175.03.001.00001.01) and the Leverhulme Trust (grant F/07040/AL to FF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Annibale A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/48/485001; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Cesareni G, 2005, FEBS LETT, V579, P1828, DOI 10.1016/j.febslet.2005.01.064; CLAUDE A, 2006, NATURE, V440, P631; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coolen ACC, 2009, J STAT PHYS, V136, P1035, DOI 10.1007/s10955-009-9821-2; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; DONG J, 2004, NATURE, V430, P88; Dorogovstev S. N., 2003, EVOLUTION NETWORKS B; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Friedel CC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-297; Gallos LK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.248701; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivanic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005815; Ivanic J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000114; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P39; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LEVY ED, 2009, SCI SIGNAL, V25, P193; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milenkovic T, 2008, CANCER INFORM, V6, P257; Narayanan M, 2007, J COMPUT BIOL, V14, P892, DOI 10.1089/cmb.2007.0025; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perez-Vicente Conrad, 2008, J PHYS A, V41; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; R Development Core Team, 2007, R LANG ENV STAT COMP; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramakrishnan SR, 2009, BIOINFORMATICS, V25, P2955, DOI 10.1093/bioinformatics/btp461; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, GENETICA, V136, P259, DOI 10.1007/s10709-009-9359-x; SEIDEL JJ, 1976, P INT C THEOR COMB R, V1, P481; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu XP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000515	67	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12083	10.1371/journal.pone.0012083	http://dx.doi.org/10.1371/journal.pone.0012083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805870	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600006
J	Tong, SL; Wang, XY; Barnett, AG				Tong, Shilu; Wang, Xiao Yu; Barnett, Adrian Gerard			Assessment of Heat-Related Health Impacts in Brisbane, Australia: Comparison of Different Heatwave Definitions	PLOS ONE			English	Article							PUBLIC-HEALTH; MORTALITY; TEMPERATURE; WAVES; SULTRINESS; COLD	Background: There is no global definition of a heatwave because local acclimatisation and adaptation influence the impact of extreme heat. Even at a local level there can be multiple heatwave definitions, based on varying temperature levels or time periods. We investigated the relationship between heatwaves and health outcomes using ten different heatwave definitions in Brisbane, Australia. Methodology/Principal Findings: We used daily data on climate, air pollution, and emergency hospital admissions in Brisbane between January 1996 and December 2005; and mortality between January 1996 and November 2004. Case-crossover analyses were used to assess the relationship between each of the ten heatwave definitions and health outcomes. During heatwaves there was a statistically significant increase in emergency hospital admissions for all ten definitions, with odds ratios ranging from 1.03 to 1.18. A statistically significant increase in the odds ratios of mortality was also found for eight definitions. The size of the heat-related impact varied between definitions. Conclusions/Significance: Even a small change in the heatwave definition had an appreciable effect on the estimated health impact. It is important to identify an appropriate definition of heatwave locally and to understand its health effects in order to develop appropriate public health intervention strategies to prevent and mitigate the impact of heatwaves.	[Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Tong, SL (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au	Barnett, Adrian/I-9850-2012	Barnett, Adrian/0000-0001-6339-0374	Australian Research Council [DP0559655]; NHMRC [553043]	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was partly funded by the Australian Research Council (DP0559655). ST was supported by an NHMRC research fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Barnett AG, 2007, EPIDEMIOLOGY, V18, P369, DOI 10.1097/01.ede.0000257515.34445.a0; BARNETT AG, 2010, ANALYSING SEASONAL H; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kysely J, 2008, INT J BIOMETEOROL, V52, P733, DOI 10.1007/s00484-008-0166-3; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; Ostro BD, 2009, ENVIRON RES, V109, P614, DOI 10.1016/j.envres.2009.03.010; *QLD, 2009, QUEENSL GOV POP HOUS; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; SCHREIBER U, 2006, QUEENSLAND HEATWAVE; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; STEADMAN RG, 1979, J APPL METEOROL, V18, P874, DOI 10.1175/1520-0450(1979)018<0874:TAOSPI>2.0.CO;2	22	111	111	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12155	10.1371/journal.pone.0012155	http://dx.doi.org/10.1371/journal.pone.0012155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730050	gold, Green Published, Green Submitted			2022-12-27	WOS:000280862200014
J	Vang, AG; Ben-Sasson, SZ; Dong, HL; Kream, B; DeNinno, MP; Claffey, MM; Housley, W; Clark, RB; Epstein, PM; Brocke, S				Vang, Amanda G.; Ben-Sasson, Shlomo Z.; Dong, Hongli; Kream, Barbara; DeNinno, Michael P.; Claffey, Michelle M.; Housley, William; Clark, Robert B.; Epstein, Paul M.; Brocke, Stefan			PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PROTEIN-KINASE-A; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CAMP-SPECIFIC PHOSPHODIESTERASE; DIFFERENTIAL EXPRESSION; ADENOSINE RECEPTORS; LEUKOCYTE ADHESION	Background: Abolishing the inhibitory signal of intracellular cAMP by phosphodiesterases (PDEs) is a prerequisite for effector T (Teff) cell function. While PDE4 plays a prominent role, its control of cAMP levels in Teff cells is not exclusive. T cell activation has been shown to induce PDE8, a PDE isoform with 40- to 100-fold greater affinity for cAMP than PDE4. Thus, we postulated that PDE8 is an important regulator of Teff cell functions. Methodology/Principal Findings: We found that Teff cells express PDE8 in vivo. Inhibition of PDE8 by the PDE inhibitor dipyridamole (DP) activates cAMP signaling and suppresses two major integrins involved in Teff cell adhesion. Accordingly, DP as well as the novel PDE8-selective inhibitor PF-4957325-00 suppress firm attachment of Teff cells to endothelial cells. Analysis of downstream signaling shows that DP suppresses proliferation and cytokine expression of Teff cells from Crem(-/-) mice lacking the inducible cAMP early repressor (ICER). Importantly, endothelial cells also express PDE8. DP treatment decreases vascular adhesion molecule and chemokine expression, while upregulating the tight junction molecule claudin-5. In vivo, DP reduces CXCL12 gene expression as determined by in situ probing of the mouse microvasculature by cell-selective laser-capture microdissection. Conclusion/Significance: Collectively, our data identify PDE8 as a novel target for suppression of Teff cell functions, including adhesion to endothelial cells.	[Vang, Amanda G.; Housley, William; Clark, Robert B.; Brocke, Stefan] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Vang, Amanda G.; Dong, Hongli; Epstein, Paul M.; Brocke, Stefan] Univ Connecticut, Ctr Hlth, Dept Pharmacol, Farmington, CT USA; [Ben-Sasson, Shlomo Z.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Dong, Hongli; Epstein, Paul M.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Kream, Barbara; Clark, Robert B.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Kream, Barbara] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA; [DeNinno, Michael P.; Claffey, Michelle M.] Pfizer Global Res & Dev, Groton Labs, Groton, CT USA	University of Connecticut; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Connecticut; University of Connecticut; University of Connecticut; Pfizer	Vang, AG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA.	sbrocke@uchc.edu	Vang, Amana Gratton/AAE-7803-2022; Cote, Rick H/G-3363-2013	Vang, Amana Gratton/0000-0003-4534-7107; Cote, Rick H/0000-0002-1573-6526; Epstein, Paul/0000-0003-0681-8236	Connecticut Breast Health Initiative; Connecticut Department of Public Health; Smart Family Foundation; National Institutes of Health (NIH) [1R56 AI 072533-01 A1]; National Multiple Sclerosis Society [RG 4070-A-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072533] Funding Source: NIH RePORTER	Connecticut Breast Health Initiative; Connecticut Department of Public Health; Smart Family Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional start up funds to S.B., the Connecticut Breast Health Initiative (P.E. and S.B.), the Connecticut Department of Public Health (P.E. and S.B.), the Smart Family Foundation (P.E.), National Institutes of Health (NIH) grant 1R56 AI 072533-01 A1 (R.C.), and National Multiple Sclerosis Society grant RG 4070-A-6 (R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ashikaga T, 1997, BIOCHEM PHARMACOL, V54, P1071, DOI 10.1016/S0006-2952(97)00287-6; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bartolome RA, 2003, MOL BIOL CELL, V14, P54, DOI 10.1091/mbc.E02-05-0275; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Beavo Joseph A., 2007, P3; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bielekova B, 2009, MULT SCLER J, V15, P1206, DOI 10.1177/1352458509345903; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774, DOI 10.1002/jlb.67.6.774; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Chilcoat CD, 2008, J LEUKOCYTE BIOL, V83, P964, DOI 10.1189/jlb.0405192; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; COEUGNIET E, 1976, ACTA MED SCAND, V199, P99; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dong HL, 2006, BIOCHEM BIOPH RES CO, V345, P713, DOI 10.1016/j.bbrc.2006.04.143; Eigler A, 1997, SCAND J IMMUNOL, V45, P132, DOI 10.1046/j.1365-3083.1997.d01-377.x; Ekholm D, 1997, J IMMUNOL, V159, P1520; Fisher DA, 1998, BIOCHEM BIOPH RES CO, V246, P570, DOI 10.1006/bbrc.1998.8684; Ford ML, 2003, J IMMUNOL, V171, P6527, DOI 10.4049/jimmunol.171.12.6527; Frohman EM, 2001, J CLIN IMMUNOL, V21, P61, DOI 10.1023/A:1011016124524; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Giembycz MA, 2008, BRIT J PHARMACOL, V155, P288, DOI 10.1038/bjp.2008.297; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jung S, 1996, J NEUROIMMUNOL, V68, P1, DOI 10.1016/0165-5728(96)00051-3; Kim HH, 2008, ARTERIOSCL THROM VAS, V28, pS39, DOI 10.1161/ATVBAHA.107.160226; Kinnecom K, 2005, BRAIN RES PROTOC, V16, P1, DOI 10.1016/j.brainresprot.2005.08.002; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Layseca-Espinosa E, 2003, J INVEST DERMATOL, V121, P81, DOI 10.1046/j.1523-1747.2003.12301.x; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Moore CS, 2006, J PHARMACOL EXP THER, V319, P63, DOI 10.1124/jpet.106.106096; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Price GM, 2008, MICROVASC RES, V76, P46, DOI 10.1016/j.mvr.2008.02.003; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Sommer N, 1997, J NEUROIMMUNOL, V79, P54, DOI 10.1016/S0165-5728(97)00111-2; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2004, SCIENCE, V305, P212, DOI 10.1126/science.1099896; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Sullivan GW, 2004, J LEUKOCYTE BIOL, V75, P127, DOI 10.1189/jlb.0603300; THOMPSON WJ, 1980, J CYCLIC NUCL PROT, V6, P25; Vastel L., 2007, Cell and Tissue Banking, V8, P205, DOI 10.1007/s10561-006-9030-z; Weyrich AS, 2005, CIRCULATION, V111, P633, DOI 10.1161/01.CIR.0000154607.90506.45; Wunder F, 2009, MOL PHARMACEUT, V6, P326, DOI 10.1021/mp800127n; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhuplatov SB, 2006, BASIC CLIN PHARMACOL, V99, P431, DOI 10.1111/j.1742-7843.2006.pto_516.x	72	48	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12011	10.1371/journal.pone.0012011	http://dx.doi.org/10.1371/journal.pone.0012011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711499	gold, Green Published, Green Submitted			2022-12-27	WOS:000280776800009
J	Sullivan, LA; Carbon, JG; Roland, CL; Toombs, JE; Nyquist-Andersen, M; Kavlie, A; Schlunegger, K; Richardson, JA; Brekken, RA				Sullivan, Laura A.; Carbon, Juliet G.; Roland, Christina L.; Toombs, Jason E.; Nyquist-Andersen, Mari; Kavlie, Anita; Schlunegger, Kyle; Richardson, James A.; Brekken, Rolf A.			r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; IMMUNE CELL INFILTRATION; TUMOR-GROWTH; ANGIOGENESIS; METASTASIS; LYMPHANGIOGENESIS; VASCULATURE; PROGRESSION; INHIBITION	Vascular endothelial growth factor (VEGF) is critical for physiological and pathological angiogenesis. Within the tumor microenvironment, VEGF functions as an endothelial cell survival factor, permeability factor, mitogen, and chemotactic agent. The majority of these functions are mediated by VEGF-induced activation of VEGF receptor 2 (VEGFR2), a high affinity receptor tyrosine kinase expressed by endothelial cells and other cell types in the tumor microenvironment. VEGF can also ligate other cell surface receptors including VEGFR1 and neuropilin-1 and -2. However, the importance of VEGF-induced activation of these receptors in tumorigenesis is still unclear. We report the development and characterization of r84, a fully human monoclonal antibody that binds human and mouse VEGF and selectively blocks VEGF from interacting with VEGFR2 but does not interfere with VEGF: VEGFR1 interaction. Selective blockade of VEGF binding to VEGFR2 by r84 is shown through ELISA, receptor binding assays, receptor activation assays, and cell-based functional assays. Furthermore, we show that r84 has potent anti-tumor activity and does not alter tissue histology or blood and urine chemistry after chronic high dose therapy in mice. In addition, chronic r84 therapy does not induce elevated blood pressure levels in some models. The ability of r84 to specifically block VEGF: VEGFR2 binding provides a valuable tool for the characterization of VEGF receptor pathway activation during tumor progression and highlights the utility and safety of selective blockade of VEGF-induced VEGFR2 signaling in tumors.	[Sullivan, Laura A.; Carbon, Juliet G.; Roland, Christina L.; Toombs, Jason E.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Nyquist-Andersen, Mari; Kavlie, Anita] Affitech AS, Oslo, Norway; [Schlunegger, Kyle] Peregrine Pharmaceut Inc, Tustin, CA USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sullivan, LA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Surg Oncol, Dept Surg, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu			Peregrine Pharmaceuticals; Simmons Comprehensive Cancer Center; Uniting Against Lung Cancer; UT SPORE in lung cancer [P50 CA070907]; Effie Marie Cain Scholarship in Angiogenesis Research; Affitech AS; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Peregrine Pharmaceuticals; Simmons Comprehensive Cancer Center; Uniting Against Lung Cancer; UT SPORE in lung cancer; Effie Marie Cain Scholarship in Angiogenesis Research; Affitech AS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a sponsored research agreement from Peregrine Pharmaceuticals (to R. A. Brekken), institutional funding from the Simmons Comprehensive Cancer Center, the Randall Bridwell Lung Cancer Research Grant from Uniting Against Lung Cancer (to R. A. Brekken, www.UnitingAgainstLungCancer.org), a development award from the UT SPORE in lung cancer (P50 CA070907) (to R. A. Brekken), the Effie Marie Cain Scholarship in Angiogenesis Research (to R. A. Brekken) and Affitech AS (M. Nyquist-Andersen, A. Kavlie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Brekken RA, 1998, CANCER RES, V58, P1952; Brekken RA, 2000, CANCER RES, V60, P5117; Bussolati B, 2001, AM J PATHOL, V159, P993, DOI 10.1016/S0002-9440(10)61775-0; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Dowlati A, 2005, CLIN CANCER RES, V11, P7938, DOI 10.1158/1078-0432.CCR-04-2538; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fong GH, 1999, DEVELOPMENT, V126, P3015; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Huang XM, 1998, BIOCHEM BIOPH RES CO, V252, P643, DOI 10.1006/bbrc.1998.9717; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jayson GC, 2002, J NATL CANCER I, V94, P1484, DOI 10.1093/jnci/94.19.1484; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Vredenburgh JJ, 2009, NEURO-ONCOLOGY, V11, P80, DOI 10.1215/15228517-2008-075; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xu L, 2006, CANCER RES, V66, P3971, DOI 10.1158/0008-5472.CAN-04-3085; Yan L, 2008, CANCER J, V14, P178, DOI 10.1097/PPO.0b013e318172d71a; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	51	31	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12031	10.1371/journal.pone.0012031	http://dx.doi.org/10.1371/journal.pone.0012031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700512	gold, Green Published, Green Submitted			2022-12-27	WOS:000280687900019
J	Shui, G; Guan, XL; Gopalakrishnan, P; Xue, YK; Goh, JSY; Yang, HY; Wenk, MR				Shui, Guanghou; Guan, Xue Li; Gopalakrishnan, Pradeep; Xue, Yangkui; Goh, Joyce Sze Yuin; Yang, Hongyuan; Wenk, Markus R.			Characterization of Substrate Preference for Slc1p and Cst26p in Saccharomyces cerevisiae Using Lipidomic Approaches and an LPAAT Activity Assay	PLOS ONE			English	Article							ACID ACYLTRANSFERASE-BETA; CONGENITAL GENERALIZED LIPODYSTROPHY; MASS-SPECTROMETRY; LYSOPHOSPHOLIPID ACYLTRANSFERASES; PHOSPHATIDIC-ACID; GLOBAL ANALYSIS; BUDDING YEAST; BIOSYNTHESIS; MEMBRANE; IDENTIFICATION	Background: Phosphatidic acid (PA) is a key regulated intermediate and precursor for de novo biosynthesis of all glycerophospholipids. PA can be synthesized through the acylation of lysophosphatidic acid (LPA) by 1-acyl-3-phosphate acyltransferase (also called lysophosphatidic acid acyltransferase, LPAAT). Recent findings have substantiated the essential roles of acyltransferases in various biological functions. Methodologies/Principal Findings: We used a flow-injection-based lipidomic approach with similar to 200 multiple reaction monitoring (MRM) transitions to pre-screen fatty acyl composition of phospholipids in the yeast Saccharomyces cerevisiae mutants. Dramatic changes were observed in fatty acyl composition in some yeast mutants including Slc1p, a well-characterized LPAAT, and Cst26p, a recently characterized phosphatidylinositol stearoyl incorporating 1 protein and putative LPAAT in S. cerevisiae. A comprehensive high-performance liquid chromatography-based multi-stage MRM approach (more than 500 MRM transitions) was developed and further applied to quantify individual phospholipids in both strains to confirm these changes. Our data suggest potential fatty acyl substrates as well as fatty acyls that compensate for defects in both Cst26p and Slc1p mutants. These results were consistent with those from a non-radioactive LPAAT enzymatic assay using C17-LPA and acyl-CoA donors as substrates. Conclusions: We found that Slc1p utilized fatty acid (FA) 18:1 and FA 14:0 as substrates to synthesize corresponding PAs; moreover, it was probably the only acyltransferase responsible for acylation of saturated short-chain fatty acyls (12:0 and 10:0) in S. cerevisiae. We also identified FA 18:0, FA 16:0, FA 14:0 and exogenous FA 17:0 as preferred substrates for Cst26p because transformation with a GFP-tagged CST26 restored the phospholipid profile of a CST26 mutant. Our current findings expand the enzymes and existing scope of acyl-CoA donors for glycerophospholipid biosynthesis.	[Shui, Guanghou; Guan, Xue Li; Gopalakrishnan, Pradeep; Xue, Yangkui; Goh, Joyce Sze Yuin; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	National University of Singapore; National University of Singapore; National University of Singapore; University of New South Wales Sydney	Shui, G (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	bchsgh@nus.edu.sg; bchmrw@nus.edu.sg	Yang, Hongyuan/AAR-1326-2020; Wenk, Markus Rene/D-1441-2014; Guan, Xue Li/D-2935-2014	Yang, Hongyuan/0000-0002-8482-6031; Guan, Xue Li/0000-0002-5189-8178; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [2007-04]; Singapore NMRC [R-183-000-224-213]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore NMRC(National Medical Research Council, Singapore)	This work was supported by the Singapore National Research Foundation under CRP Award No. 2007-04, Singapore NMRC Grant R-183-000-224-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bin Y, 2004, PLANT CELL PHYSIOL, V45, P503, DOI 10.1093/pcp/pch064; Bonham L, 2003, EXPERT OPIN THER TAR, V7, P643; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Diefenbach CSM, 2006, CANCER-AM CANCER SOC, V107, P1511, DOI 10.1002/cncr.22184; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Esch SW, 2007, J LIPID RES, V48, P235, DOI 10.1194/jlr.D600034-JLR200; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gopalacharyulu PV, 2009, MOL BIOSYST, V5, P276, DOI 10.1039/b815347g; Guan XL, 2006, FASEB J, V20, P1152, DOI 10.1096/fj.05-5362com; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; LE GM, 2009, FEBS J, V276, P6412; Lee LHW, 2009, INT J NEUROPSYCHOPH, V12, P953, DOI 10.1017/S146114570900995X; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200	37	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11956	10.1371/journal.pone.0011956	http://dx.doi.org/10.1371/journal.pone.0011956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694142	Green Published, Green Submitted, gold			2022-12-27	WOS:000280574300012
J	Chiang, F; Kuper, H; Lindfield, R; Keenan, T; Seyam, N; Magauran, D; Khalilia, N; Batta, H; Abdeen, Z; Sargent, N				Chiang, Far; Kuper, Hannah; Lindfield, Robert; Keenan, Tiarnan; Seyam, Na'el; Magauran, Denise; Khalilia, Nasrallah; Batta, Habes; Abdeen, Ziad; Sargent, Nicholas			Rapid Assessment of Avoidable Blindness in the Occupied Palestinian Territories	PLOS ONE			English	Article							VISUAL IMPAIRMENT; NATIONAL SURVEY; GLOBAL DATA; PREVALENCE; DISTRICT; EYE	Background: There are no recent data on the prevalence and causes of blindness in the Occupied Palestinian Territories. The aim of our study was to estimate the prevalence and causes of blindness and visual impairment in the population aged 50 years and above in the Occupied Palestinian Territories using the Rapid Assessment of Avoidable Blindness (RAAB) survey method. Methods and Findings: Clusters of 40 people who were 50 years and above were selected with probability proportionate to size using a multistage cluster random sampling method. Participants received a comprehensive ophthalmic examination in their homes, including visual acuity testing by one of three experienced ophthalmologists. The principal cause for visual loss was determined by an experienced ophthalmologist using portable diagnostic instruments. Information about previous cataract surgery, satisfaction with surgery and barriers to cataract surgery were collected. The prevalence of self-reported diabetes was also determined. The prevalence of bilateral blindness (VA<3/60 in the better eye with available correction) was 3.4% (95% CI: 2.7-4.0), 2.0% (95% CI: 1.4-2.5) for severe visual impairment (VA >= 3/60 and <6/60), and 7.4% (95% CI: 6.4-8.3) for visual impairment (VA >= 6/60 and <6/18). Avoidable causes (i.e. cataract, refractive error, aphakia, surgical complications, corneal scarring and phthysis) accounted for 80.0% of bilateral blindness, severe visual impairment (70.7%) and visual impairment (86.2%). Cataract was the main cause of blindness (55.0%). The prevalence of blindness was higher in Gaza (4.9%, 95% CI: 3.7-6.1%) than in the West Bank (2.5%, 95% CI: 1.9-3.1%) and among women (4.3%, 95% CI: 3.3-5.2%) compared to men (2.2%, 95% CI: 1.5-2.9%). Among people who had undergone cataract surgery in the past, only 54.5% of eyes obtained a good outcome (VA >= 6/18), 23.2% had a borderline outcome (VA<6/18 and >= 6/60) and 22.3% had a poor outcome (VA<6/60) with available correction. The prevalence of self-reported diabetes mellitus in >= 50 year age group was 26.4% (95% CI: 24.9-27.9). Conclusions: The prevalence of blindness suggests that significant numbers of people in the Occupied Palestinian Territories exist who do not access eye care - predominantly women and those residing in Gaza. Programmes need to focus on maximizing the use of current services by these excluded groups.	[Chiang, Far; Khalilia, Nasrallah; Batta, Habes; Sargent, Nicholas] St John Eye Hosp, Jerusalem, Israel; [Kuper, Hannah; Lindfield, Robert] London Sch Hyg & Trop Med, London WC1, England; [Keenan, Tiarnan] Manchester Royal Eye Hosp, Manchester M13 9WH, Lancs, England; [Seyam, Na'el] Mil Med Serv, Gaza, Israel; [Magauran, Denise] Epsom & St Helier Univ Hosp NHS Trust, Sutton, Surrey, England; [Abdeen, Ziad] Al Quds Univ, Al Quds Nutr & Hlth Res Inst, Jerusalem, Israel	University of London; London School of Hygiene & Tropical Medicine; Manchester Royal Eye Hospital	Chiang, F (corresponding author), St John Eye Hosp, Jerusalem, Israel.	njsargent@hotmail.com	Abdeen, Ziad/AAC-7889-2019		The Linbury Trust; Palestinian Authority Ministry of Health; National Institute for Health Research [ACF-2008-06-014] Funding Source: researchfish; Fight for Sight [1865/66] Funding Source: researchfish	The Linbury Trust; Palestinian Authority Ministry of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was principally funded by The Linbury Trust (www.linburytrust.org.uk). This funding agency did not take part directly nor influenced the conducting of the study in any way and did not take part in the preparation of the manuscript.; The authors wish to thank all the staff based at the St. John facilities in Jerusalem and Gaza for their contributions as well as the study participants. We would like to thank Anthony Chignell, Steven James and Charles Kanawati for initiating this study, Philip Mann for his assistance with the original proposal, and Assad Yousef Hussein and Jom'a El Jazzar for initiating the study in Gaza. We greatly appreciated the support and permission given by the Palestinian Authority Ministry of Health and local municipalities.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; [Anonymous], 2008, PAL FIG 2007; AVISAR R, 2003, HAREFUAH, V142, P160; Avisar Rahamim, 2003, Harefuah, V142, P94; Avisar R, 2006, ISRAEL MED ASSOC J, V8, P880; Fouad D, 2004, BRIT J OPHTHALMOL, V88, P614, DOI 10.1136/bjo.2003.026997; GOLYCHEV VN, 1991, VESTN OFTALMOL, P63; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Khandekar R, 2002, BRIT J OPHTHALMOL, V86, P957, DOI 10.1136/bjo.86.9.957; LANE SD, 1987, URBAN ANTHROP, V16, P151; Mansour AM, 1997, BRIT J OPHTHALMOL, V81, P905, DOI 10.1136/bjo.81.10.905; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Ngondi J, 2006, PLOS MED, V3, P2424, DOI 10.1371/journal.pmed.0030478; Oye JE, 2006, BRIT J OPHTHALMOL, V90, P538, DOI 10.1136/bjo.2005.082271; *PAL CENTR BUR STA, 2007, PAL FIG 2006; *PAL CENTR BUR STA, 2008, CENS FIN RES GAZ STR; *PAL CENTR BUR STA, 2007, 8 PAL CENTR BUR STAT; Palestinian Central Bureau of Statistics, 2004, ACC HLTH SERV SURV 2; Palestinian Central Bureau of Statistics, 2008, CENS FIN RES W BANK; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; THOMSON IM, 1984, BRIT J OPHTHALMOL, V68, P598, DOI 10.1136/bjo.68.8.598; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; *UN OFF COORD HUM, 2007, HUM IMP W BANK BARR; WADUD Z, 2006, BRIT J OPHTHALMOL; World Health Organization, 1988, COD INSTR WHO PBL EY, P1; World Health Organization, 2005, PREV BLINDN DIAB MEL, P9; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002	30	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11854	10.1371/journal.pone.0011854	http://dx.doi.org/10.1371/journal.pone.0011854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686616	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000280520200019
J	Fujimoto, J; Kadara, H; Men, TY; van Pelt, C; Lotan, D; Lotan, R				Fujimoto, Junya; Kadara, Humam; Men, Taoyan; van Pelt, Carolyn; Lotan, Dafna; Lotan, Reuben			Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout Mice	PLOS ONE			English	Article							CIGARETTE-SMOKE; A/J MICE; EXPRESSION SIGNATURE; GENE-EXPRESSION; GREEN TEA; CANCER; TUMORIGENESIS; MOUSE; MODEL; IDENTIFICATION	Background: Improved understanding of lung cancer development and progression, including insights from studies of animal models, are needed to combat this fatal disease. Previously, we found that mice with a knockout (KO) of G-protein coupled receptor 5A (Gprc5a) develop lung tumors after a long latent period (12 to 24 months). Methodology/Principal Findings: To determine whether a tobacco carcinogen will enhance tumorigenesis in this model, we administered 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) i.p. to 2-months old Gprc5a-KO mice and sacrificed groups (n = 5) of mice at 6, 9, 12, and 18 months later. Compared to control Gprc5a-KO mice, NNK-treated mice developed lung tumors at least 6 months earlier, exhibited 2- to 4-fold increased tumor incidence and multiplicity, and showed a dramatic increase in lesion size. A gene expression signature, NNK-ADC, of differentially expressed genes derived by transcriptome analysis of epithelial cell lines from normal lungs of Gprc5a-KO mice and from NNK-induced adenocarcinoma was highly similar to differential expression patterns observed between normal and tumorigenic human lung cells. The NNK-ADC expression signature also separated both mouse and human adenocarcinomas from adjacent normal lung tissues based on publicly available microarray datasets. A key feature of the signature, up-regulation of Ube2c, Mcm2, and Fen1, was validated in mouse normal lung and adenocarcinoma tissues and cells by immunohistochemistry and western blotting, respectively. Conclusions/Significance: Our findings demonstrate that lung tumorigenesis in the Gprc5a-KO mouse model is augmented by NNK and that gene expression changes induced by tobacco carcinogen(s) may be conserved between mouse and human lung epithelial cells. Further experimentation to prove the reliability of the Gprc5a knockout mouse model for the study of tobacco-induced lung carcinogenesis is warranted.	[Fujimoto, Junya; Kadara, Humam; Men, Taoyan; Lotan, Dafna; Lotan, Reuben] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [van Pelt, Carolyn] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fujimoto, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	rlotan@mdanderson.org			The Samuel Waxman Cancer Research Foundation; Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair; Cancer Center [P30 CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	The Samuel Waxman Cancer Research Foundation; Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from The Samuel Waxman Cancer Research Foundation, the Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair and P30 CA16672 Cancer Center Core Grant (Transgenic Animal Facility, DNA Sequencing, Veterinary Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALANSKY R, INT J CANC, V126, P1047; Bennett CN, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2125; D'Agostini F, 2009, CANCER PREV RES, V2, P546, DOI 10.1158/1940-6207.CAPR-08-0235; DEVEREUX TR, 1993, MOL CARCINOGEN, V8, P177, DOI 10.1002/mc.2940080308; Gabrielson E, 2006, RESPIROLOGY, V11, P533, DOI 10.1111/j.1440-1843.2006.00909.x; HECHT SS, 1989, CARCINOGENESIS, V10, P1901, DOI 10.1093/carcin/10.10.1901; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hollander MC, 2008, NEOPLASIA, V10, P866, DOI 10.1593/neo.08406; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacks Tyler, 2005, Harvey Lect, V101, P1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kadara H, 2009, CANCER PREV RES, V2, P702, DOI 10.1158/1940-6207.CAPR-09-0084; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kassie F, 2008, CANCER PREV RES, V1, P568, DOI 10.1158/1940-6207.CAPR-08-0064; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Lu G, 2006, CANCER RES, V66, P11494, DOI 10.1158/0008-5472.CAN-06-1497; Lu Y, 2006, CANCER RES, V66, P1956, DOI 10.1158/0008-5472.CAN-05-3158; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Okamoto Y, 2003, CANCER RES, V63, P4167; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Sabourin CLK, 1998, EXP LUNG RES, V24, P499, DOI 10.3109/01902149809087383; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Simon R, 2007, CANCER INFORM, V3, P11; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Steiling K, 2008, CANCER PREV RES, V1, P396, DOI 10.1158/1940-6207.CAPR-08-0174; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun SY, 1999, CANCER RES, V59, P2493; Tan DF, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-6; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhang ZQ, 2000, CANCER RES, V60, P901	40	27	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11847	10.1371/journal.pone.0011847	http://dx.doi.org/10.1371/journal.pone.0011847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686609	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200013
J	Rossi, SL; Nistor, G; Wyatt, T; Yin, HZ; Poole, AJ; Weiss, JH; Gardener, MJ; Dijkstra, S; Fischer, DF; Keirstead, HS				Rossi, Sharyn L.; Nistor, Gabriel; Wyatt, Tanya; Yin, Hong Zhen; Poole, Aleksandra J.; Weiss, John H.; Gardener, Matthew J.; Dijkstra, Sipke; Fischer, David F.; Keirstead, Hans S.			Histological and Functional Benefit Following Transplantation of Motor Neuron Progenitors to the Injured Rat Spinal Cord	PLOS ONE			English	Article							SCHWANN-CELL TRANSPLANTATION; NEUROTROPHIC FACTORS; PRECURSOR CELLS; AXONAL GROWTH; RECOVERY; DIFFERENTIATE; MOTONEURONS; CHANNELS; INCREASE	Background: Motor neuron loss is characteristic of cervical spinal cord injury (SCI) and contributes to functional deficit. Methodology/Principal Findings: In order to investigate the amenability of the injured adult spinal cord to motor neuron differentiation, we transplanted spinal cord injured animals with a high purity population of human motor neuron progenitors (hMNP) derived from human embryonic stem cells (hESCs). In vitro, hMNPs displayed characteristic motor neuron-specific markers, a typical electrophysiological profile, functionally innervated human or rodent muscle, and secreted physiologically active growth factors that caused neurite branching and neuronal survival. hMNP transplantation into cervical SCI sites in adult rats resulted in suppression of intracellular signaling pathways associated with SCI pathogenesis, which correlated with greater endogenous neuronal survival and neurite branching. These neurotrophic effects were accompanied by significantly enhanced performance on all parameters of the balance beam task, as compared to controls. Interestingly, hMNP transplantation resulted in survival, differentiation, and site-specific integration of hMNPs distal to the SCI site within ventral horns, but hMNPs near the SCI site reverted to a neuronal progenitor state, suggesting an environmental deficiency for neuronal maturation associated with SCI. Conclusions/Significance: These findings underscore the barriers imposed on neuronal differentiation of transplanted cells by the gliogenic nature of the injured spinal cord, and the physiological relevance of transplant-derived neurotrophic support to functional recovery.	[Rossi, Sharyn L.; Nistor, Gabriel; Wyatt, Tanya; Keirstead, Hans S.] Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Anat & Ne, Irvine, CA 92717 USA; [Yin, Hong Zhen; Weiss, John H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Poole, Aleksandra J.] Calif Stem Cell Inc, Irvine, CA USA; [Gardener, Matthew J.] BioFocus, Saffron Walden, Essex, England; [Dijkstra, Sipke] Galapagos, Leiden, Netherlands; [Fischer, David F.] BioFocus, Leiden, Netherlands	University of California System; University of California Irvine; University of California System; University of California Irvine; Galapagos NV	Rossi, SL (corresponding author), Univ Calif Irvine, Sch Med, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Dept Anat & Ne, Irvine, CA 92717 USA.	hansk@uci.edu	weiss, john/B-4283-2008	weiss, john/0000-0001-9323-7813; Fischer, David/0000-0002-6690-0197; Dijkstra, Sipke/0000-0003-2535-297X	California Institute for Regenerative Medicine [RC1-00345-1]; Families of Spinal Muscular Atrophy [445710-47005]; ALS association; Bill and Joan Jackson Scholars Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036548] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Families of Spinal Muscular Atrophy; ALS association; Bill and Joan Jackson Scholars Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by the California Institute for Regenerative Medicine (RC1-00345-1), Families of Spinal Muscular Atrophy (445710-47005), and the ALS association (TREAT ALS). Sharyn Rossi was supported by the California Institute of Regenerative Medicine Training Grant and the Bill and Joan Jackson Scholars Fund. Tanya Wyatt was supported by the Bill and Joan Jackson Scholars Fund. California Stem Cell, Inc. provided cells and reagents via a material transfer agreement with UCI, however, played no role in the funding of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RM, 1999, ANAL BIOCHEM, V267, P344, DOI 10.1006/abio.1998.3018; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; BRUNK U, 1968, ACTA HISTOCHEM, V31, P345; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kloth V, 2006, BRAIN RES BULL, V70, P68, DOI 10.1016/j.brainresbull.2006.04.006; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; LIEBL DJ, 2001, EXPT NEUROLOGY, V167; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Martin D, 1996, J NEUROSCI RES, V45, P588; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Riley CP, 2004, J MOL HISTOL, V35, P771, DOI 10.1007/s10735-004-0778-9; Rosenbluth J, 1997, EXP NEUROL, V147, P172, DOI 10.1006/exnr.1997.6583; Schaal SM, 2007, CELL TRANSPLANT, V16, P207, DOI 10.3727/000000007783464768; Schallert T, 2002, PHARM CEREBRAL ISCHE, P201; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Shihabuddin Lamya S., 2008, V438, P55, DOI 10.1007/978-1-59745-133-8_6; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Takami T, 2002, J NEUROSCI, V22, P6670; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; TIMM F, 1958, Dtsch Z Gesamte Gerichtl Med, V46, P706, DOI 10.1007/BF00665092; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xiao M, 2007, NEUROBIOL DIS, V26, P363, DOI 10.1016/j.nbd.2007.01.012; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943	45	71	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11852	10.1371/journal.pone.0011852	http://dx.doi.org/10.1371/journal.pone.0011852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686613	gold, Green Published			2022-12-27	WOS:000280520200017
J	Wang, T; Zheng, W; Xu, H; Zhou, JM; Wang, ZY				Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You			Clioquinol Inhibits Zinc-Triggered Caspase Activation in the Hippocampal CA1 Region of a Global Ischemic Gerbil Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; NEURONAL DEATH; TRANSIENT ISCHEMIA; TRANSGENIC MICE; CANCER-CELLS; IN-VITRO; APOPTOSIS; CHELATOR	Background: Excessive release of chelatable zinc from excitatory synaptic vesicles is involved in the pathogenesis of selective neuronal cell death following transient forebrain ischemia. The present study was designed to examine the neuroprotective effect of a membrane-permeable zinc chelator, clioquinol (CQ), in the CA1 region of the gerbil hippocampus after transient global ischemia. Methodology/Principal Findings: The common carotid arteries were occluded bilaterally, and CQ (10 mg/kg, i.p.) was injected into gerbils once a day. The zinc chelating effect of CQ was examined with TSQ fluorescence and autometallography. Neuronal death, the expression levels of caspases and apoptosis inducing factor (AIF) were evaluated using TUNEL, in situ hybridization and Western blotting, respectively. We were able to show for the first time that CQ treatment attenuates the ischemia-induced zinc accumulation in the CA1 pyramidal neurons, accompanied by less neuronal loss in the CA1 field of the hippocampus after ischemia. Furthermore, the expression levels of caspase-3, -9, and AIF were significantly decreased in the hippocampus of CQ-treated gerbils. Conclusions/Significance: The present study indicates that the neuroprotective effect of CQ is related to downregulation of zinc-triggered caspase activation in the hippocampal CA1 region of gerbils with global ischemia.	[Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You] China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China	China Medical University; Ministry of Education, China	Wang, T (corresponding author), China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China.	zhanyouw@hotmail.com		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [30370452, 30770680]; Program for New Century Excellent Talents in University [NCET-04-0288]; Department of Education of Liaoning Province [20060948]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Department of Education of Liaoning Province	The study was supported by the Natural Science Foundation of China (30370452, 30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), and the Research Project for Universities of the Department of Education of Liaoning Province (20060948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; ARAKI T, 1989, ACTA NEUROL SCAND, V80, P548, DOI 10.1111/j.1600-0404.1989.tb03925.x; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Carboni S, 2005, J NEUROCHEM, V92, P1054, DOI 10.1111/j.1471-4159.2004.02925.x; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Gupta S, 2006, BIOL PHARM BULL, V29, P957, DOI 10.1248/bpb.29.957; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Ibach B, 2005, PHARMACOPSYCHIATRY, V38, P178, DOI 10.1055/s-2005-871241; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Park JA, 2000, J NEUROSCI, V20, P9096; Regland B, 2001, DEMENT GERIATR COGN, V12, P408, DOI 10.1159/000051288; Ritchie CW, 2004, EXPERT OPIN INV DRUG, V13, P1585, DOI 10.1517/13543784.13.12.1585; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Strosznajder R, 2006, ACTA NEUROBIOL EXP, V66, P15; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018	42	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11888	10.1371/journal.pone.0011888	http://dx.doi.org/10.1371/journal.pone.0011888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686690	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200047
J	Roberts, T; McGreevy, P; Valenzuela, M				Roberts, Taryn; McGreevy, Paul; Valenzuela, Michael			Human Induced Rotation and Reorganization of the Brain of Domestic Dogs	PLOS ONE			English	Article							OLFACTORY-BULB; MORPHOLOGY; TYPOLOGY; SKULL	Domestic dogs exhibit an extraordinary degree of morphological diversity. Such breed-to-breed variability applies equally to the canine skull, however little is known about whether this translates to systematic differences in cerebral organization. By looking at the paramedian sagittal magnetic resonance image slice of canine brains across a range of animals with different skull shapes (N = 13), we found that the relative reduction in skull length compared to width (measured by Cephalic Index) was significantly correlated to a progressive ventral pitching of the primary longitudinal brain axis (r = 0.83), as well as with a ventral shift in the position of the olfactory lobe (r = 0.81). Furthermore, these findings were independent of estimated brain size or body weight. Since brachycephaly has arisen from generations of highly selective breeding, this study suggests that the remarkable diversity in domesticated dogs' body shape and size appears to also have led to human-induced adaptations in the organization of the canine brain.	[Roberts, Taryn; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Valenzuela, Michael] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Valenzuela, Michael] Univ New S Wales, Brain & Ageing Res Program, Fac Med, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Roberts, T (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	taryn@bell.net; michaelv@unsw.edu.au		McGreevy, Paul/0000-0001-7220-8378; Valenzuela, Michael/0000-0001-7162-6607	University of New South Wales; Natural Sciences and Engineering Research Council of Canada	University of New South Wales; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	MV is supported by a University of New South Wales Vice Chancellor's Fellowship. TR was funded by a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge K, 2005, ANAT REC PART A, V285A, P690, DOI 10.1002/ar.a.20201; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P37, DOI 10.1111/j.1740-8261.2008.01487.x; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; Coppinger Raymond, 1995, P21; CURTIS MA, 2009, PROGR BRAIN RES; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dickie AM, 2001, VET RADIOL ULTRASOUN, V42, P205, DOI 10.1111/j.1740-8261.2001.tb00926.x; Evans HE, 1979, MILLERS ANATOMY DOG; Evans KE, 2006, ANAT HISTOL EMBRYOL, V35, P221, DOI 10.1111/j.1439-0264.2005.00663.x; Flegel T, 2008, VET RADIOL ULTRASOUN, V49, P419, DOI 10.1111/j.1740-8261.2008.00400.x; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; GITTLEMAN JL, 1991, J ZOOL, V225, P253, DOI 10.1111/j.1469-7998.1991.tb03815.x; Goodwin D, 1997, ANIM BEHAV, V53, P297, DOI 10.1006/anbe.1996.0370; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; LIGNEREUX Y, 1991, REV MED VET-TOULOUSE, V142, P469; MARTONCIKOVA M, 2010, ACTA HISTOC IN PRESS; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; MCGREEVY PD, 2010, J VET BEHAV IN PRESS; Myers P., 2022, ANIMAL DIVERSITY WEB; Onar V, 2001, ANAT HISTOL EMBRYOL, V30, P41, DOI 10.1046/j.1439-0264.2001.00292.x; Ostrander EA, 2007, AM SCI, V95, P406, DOI 10.1511/2007.67.3724; REGODON S, 1993, ANN ANAT, V175, P361, DOI 10.1016/S0940-9602(11)80043-9; Schwarz T, 2000, VET RADIOL ULTRASOUN, V41, P220, DOI 10.1111/j.1740-8261.2000.tb01482.x; SEIFERLE E, 1966, ACTA ANAT, V63, P346, DOI 10.1159/000142799; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA	27	67	67	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11946	10.1371/journal.pone.0011946	http://dx.doi.org/10.1371/journal.pone.0011946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668685	Green Published, gold			2022-12-27	WOS:000280297300028
J	Lin, YP; He, P; Wang, QH; Lu, DJ; Li, ZL; Wu, CS; Jiang, N				Lin, Yuping; He, Peng; Wang, Qinhong; Lu, Dajun; Li, Zilong; Wu, Changsheng; Jiang, Ning			The Alcohol Dehydrogenase System in the Xylose-Fermenting Yeast Candida maltosa	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ADH GENES; RESPIRATORY YEAST; MULTIPLE FORMS; MESSENGER-RNA; EVOLUTION; EXPRESSION; PROTEIN; FERMENTATION; PHYLOGENY	Background: The alcohol dehydrogenase (ADH) system plays a critical role in sugar metabolism involving in not only ethanol formation and consumption but also the general "cofactor balance'' mechanism. Candida maltosa is able to ferment glucose as well as xylose to produce a significant amount of ethanol. Here we report the ADH system in C. maltosa composed of three microbial group I ADH genes (CmADH1, CmADH2A and CmADH2B), mainly focusing on its metabolic regulation and physiological function. Methodology/Principal Findings: Genetic analysis indicated that CmADH2A and CmADH2B tandemly located on the chromosome could be derived from tandem gene duplication. In vitro characterization of enzymatic properties revealed that all the three CmADHs had broad substrate specificities. Homo-and heterotetramers of CmADH1 and CmADH2A were demonstrated by zymogram analysis, and their expression profiles and physiological functions were different with respect to carbon sources and growth phases. Fermentation studies of ADH2A-deficient mutant showed that CmADH2A was directly related to NAD regeneration during xylose metabolism since CmADH2A deficiency resulted in a significant accumulation of glycerol. Conclusions/Significance: Our results revealed that CmADH1 was responsible for ethanol formation during glucose metabolism, whereas CmADH2A was glucose-repressed and functioned to convert the accumulated ethanol to acetaldehyde. To our knowledge, this is the first demonstration of function separation and glucose repression of ADH genes in xylose-fermenting yeasts. On the other hand, CmADH1 and CmADH2A were both involved in ethanol formation with NAD regeneration to maintain NADH/NAD ratio in favor of producing xylitol from xylose. In contrast, CmADH2B was expressed at a much lower level than the other two CmADH genes, and its function is to be further confirmed.	[Lin, Yuping; He, Peng; Lu, Dajun; Li, Zilong; Wu, Changsheng; Jiang, Ning] Chinese Acad Sci, Ctr Microbial Biotechnol, Inst Microbiol, Beijing, Peoples R China; [Lin, Yuping; Li, Zilong; Wu, Changsheng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Qinhong] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Lin, YP (corresponding author), Chinese Acad Sci, Ctr Microbial Biotechnol, Inst Microbiol, Beijing, Peoples R China.	wang_qh@tib.cas.cn; Jiangn@sun.im.ac.cn			National High Technology Research and Development Program of China [2006AA020101]; Chinese Academy of Sciences [KSCX2-YW-G-064, KSCX1-YW-11C3, KSCX1-YW-11E]; National Basic Research Program [2007CB707803]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program(National Basic Research Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2006AA020101), the National Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-G-064, KSCX1-YW-11C3 and KSCX1-YW-11E) and the National Basic Research Program (973 Program, 2007CB707803). Q. W. is supported by the Bairenjihhua Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMORE R, 1991, GENE, V109, P89, DOI 10.1016/0378-1119(91)90592-Y; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; Bozzi A, 1997, BBA-PROTEIN STRUCT M, V1339, P133, DOI 10.1016/S0167-4838(96)00225-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brisdelli F, 2004, BIOCHIMIE, V86, P705, DOI 10.1016/j.biochi.2004.08.004; BRUINENBERG PM, 1984, APPL MICROBIOL BIOT, V19, P256, DOI 10.1007/BF00251847; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Cho JY, 1998, APPL ENVIRON MICROB, V64, P1350; Cho JY, 1999, APPL ENVIRON MICROB, V65, P2363; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; CIRIACY M, 1975, MUTAT RES, V29, P315, DOI 10.1016/0165-1218(75)90093-2; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; DENIS CL, 1983, J BIOL CHEM, V258, P1165; DENIS CL, 1981, J MOL BIOL, V148, P355, DOI 10.1016/0022-2836(81)90181-9; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fredlund E, 2006, YEAST, V23, P1137, DOI 10.1002/yea.1428; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P277, DOI 10.1007/s00253-006-0761-3; Guo C, 2006, J APPL MICROBIOL, V101, P1096, DOI 10.1111/j.1365-2672.2006.02994.x; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; INDRATI R, 1991, CAN J MICROBIOL, V37, P803, DOI 10.1139/m91-139; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Mazzoni C, 2006, FEMS YEAST RES, V6, P421, DOI 10.1111/j.1567-1364.2005.00013.x; MAZZONI C, 1992, MOL MICROBIOL, V6, P2279, DOI 10.1111/j.1365-2958.1992.tb01403.x; Park YC, 2006, J IND MICROBIOL BIOT, V33, P1032, DOI 10.1007/s10295-006-0154-8; Passoth V, 1996, APPL BIOCHEM BIOTECH, V57-8, P201, DOI 10.1007/BF02941701; Passoth V, 2003, YEAST, V20, P39, DOI 10.1002/yea.933; PILGRIM D, 1987, MOL CELL BIOL, V7, P294, DOI 10.1128/MCB.7.1.294; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; SALIOLA M, 1991, YEAST, V7, P391, DOI 10.1002/yea.320070409; Saliola M, 2007, FEMS YEAST RES, V7, P693, DOI 10.1111/j.1567-1364.2007.00250.x; Saliola M, 2006, FEMS YEAST RES, V6, P1184, DOI 10.1111/j.1567-1364.2006.00103.x; SHAIN DH, 1992, MOL GEN GENET, V232, P479, DOI 10.1007/BF00266253; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2307, DOI 10.1128/AEM.70.4.2307-2317.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; WIESENFELD M, 1975, BIOCHIM BIOPHYS ACTA, V405, P500, DOI 10.1016/0005-2795(75)90115-4; WILLIAMSON VM, 1980, NATURE, V283, P214, DOI 10.1038/283214a0	47	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11752	10.1371/journal.pone.0011752	http://dx.doi.org/10.1371/journal.pone.0011752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668703	Green Submitted, gold, Green Published			2022-12-27	WOS:000280243800022
J	Firneisz, G; Varga, T; Lengyel, G; Feher, J; Ghyczy, D; Wichmann, B; Selmeci, L; Tulassay, Z; Racz, K; Somogyi, A				Firneisz, Gabor; Varga, Timea; Lengyel, Gabriella; Feher, Janos; Ghyczy, Dora; Wichmann, Barna; Selmeci, Laszlo; Tulassay, Zsolt; Racz, Karoly; Somogyi, Aniko			Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALANINE AMINOTRANSFERASE; IV ACTIVITY; SENSITIVITY; POPULATION; INHIBITION; PREVALENCE; CIRRHOSIS; PROTEIN; COHORT	Background: In a cross-sectional study we studied the fasting serum DPP-4 enzymatic activity (sDPP-4) and the insulin resistance index (HOMA2-IR) in gliptin naive patients with type 2 diabetes and in non-alcoholic fatty liver disease (NAFLD) and in healthy controls (CNTRL). Methods and Findings: sDPP-4 was measured by kinetic assay in 39 NAFLD (F/M: 19/20, mean age: 47.42 yrs) and 82 type 2 diabetes (F/M:48/34, 62.8 yrs) patients and 26 (F/M:14/12, 35.3 yrs) controls. Definition of T2D group as patients with type 2 diabetes but without clinically obvious liver disease created non-overlapping study groups. Diagnosis of NAFLD was based on ultrasonography and the exclusion of other etiololgy. Patients in T2D and NAFLD groups were similarly obese. 75 g CH OGTT in 39 NAFLD patients: 24-NGT, 4-IGT or IFG ("prediabetes''), 11-type 2 diabetes. HOMA2-IR: CNTRL: 1.44; T2D-group: 2.62 (p = 0.046 vs CNTRL, parametric tests); NAFLD(NGTonly): 3.23 (p = 0.0013 vs CNTRL); NAFLD(IFG/IGT/type 2 diabetes): 3.82 (p<0.001 vs CNTRL, p = 0.049 vs 2TD group). sDPP-4 activity was higher in NAFLD both with NGT (mean: 33.08U/L) and abnormal glucose metabolism (30.38U/L) than in CNTRL (25.89U/L, p<0.001 and p = 0.013) or in T2D groups (23.97U/L, p<0.001 and p = 0.004). Correlations in NAFLD among sDPP-4 and ALT: r = 0.4637, p = 0.0038 and gamma GT: r = 0.4991, p = 0.0017 and HOMA2-IR: r = 0.5295, p = 0.0026 and among HOMA2-IR and ALT: r = 0.4340, p = 0.0147 and gamma GT: r = 0.4128, p = 0.0210. Conclusions: The fasting serum DPP-4 activity was not increased in T2D provided that patients with liver disease were intentionally excluded. The high serum DPP-4 activities in NAFLD were correlated with liver tests but not with the fasting plasma glucose or HbA1C supporting that the excess is of hepatic origin and it might contribute to the speedup of metabolic deterioration. The correlation among cGT, ALT and serum DPP-4 activity and also between serum DPP-4 activity and HOMA2-IR in NAFLD strongly suggests that serum DPP-4 activity should be considered as a novel liver disease biomarker.	[Firneisz, Gabor; Varga, Timea; Lengyel, Gabriella; Feher, Janos; Ghyczy, Dora; Wichmann, Barna; Selmeci, Laszlo; Tulassay, Zsolt; Racz, Karoly; Somogyi, Aniko] Semmelweis Univ, Dept Med, H-1085 Budapest, Hungary	Semmelweis University	Firneisz, G (corresponding author), Semmelweis Univ, Dept Med, H-1085 Budapest, Hungary.	firneisz@bel2.sote.hu	Firneisz, Gabor/AAC-9654-2021	Firneisz, Gabor/0000-0002-9123-8131	Hungarian Liver Research Foundation [PD73606 OTKA, ETT-258/2009]; Hungarian Diabetes Association	Hungarian Liver Research Foundation; Hungarian Diabetes Association	This study was supported by the Szekelyhidi Miklos award of the Hungarian Liver Research Foundation, the PD73606 OTKA, the ETT-258/2009 grants and the Hungarian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andrieu T, 2003, J CLIN VIROL, V27, P59, DOI 10.1016/S1386-6532(02)00128-2; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Balaban YH, 2007, ANN HEPATOL, V6, P242, DOI 10.1016/S1665-2681(19)31905-2; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Edgerton DS, 2009, DIABETES, V58, P243, DOI 10.2337/db08-0515; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gautier A, 2010, DIABETOLOGIA, V53, P247, DOI 10.1007/s00125-009-1602-6; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hanley AJG, 2007, DIABETES CARE, V30, P1819, DOI 10.2337/dc07-0086; Ioannou GN, 2003, GASTROENTEROLOGY, V125, P1053, DOI 10.1016/S0016-5085(03)01200-9; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Mentzel S, 1996, J HISTOCHEM CYTOCHEM, V44, P445, DOI 10.1177/44.5.8627002; Pala L, 2005, DIABETOLOGIA, V48, P1168, DOI 10.1007/s00125-005-1749-8; Ryskjaer J, 2006, EUR J ENDOCRINOL, V155, P485, DOI 10.1530/eje.1.02221; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	23	99	109	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12226	10.1371/journal.pone.0012226	http://dx.doi.org/10.1371/journal.pone.0012226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805868	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600010
J	Bate, R; Hess, K				Bate, Roger; Hess, Kimberly			Assessing Website Pharmacy Drug Quality: Safer Than You Think?	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY	Background: Internet-sourced drugs are often considered suspect. The World Health Organization reports that drugs from websites that conceal their physical address are counterfeit in over 50 percent of cases; the U. S. Food and Drug Administration (FDA) works with the National Association of Boards of Pharmacy (NABP) to regularly update a list of websites likely to sell drugs that are illegal or of questionable quality. Methods and Findings: This study examines drug purchasing over the Internet, by comparing the sales of five popular drugs from a selection of websites stratified by NABP or other ratings. The drugs were assessed for price, conditions of purchase, and basic quality. Prices and conditions of purchase varied widely. Some websites advertised single pills while others only permitted the purchase of large quantities. Not all websites delivered the exact drugs ordered, some delivered no drugs at all; many websites shipped from multiple international locations, and from locations that were different from those advertised on the websites. All drug samples were tested against approved U. S. brand formulations using Raman spectrometry. Many (17) websites substituted drugs, often in different formulations from the brands requested. These drugs, some of which were probably generics or perhaps non-bioequivalent copy versions, could not be assessed accurately. Of those drugs that could be assessed, none failed from "approved", "legally compliant" or "not recommended" websites (0 out of 86), whereas 8.6% (3 out of 35) failed from "highly not recommended" and unidentifiable websites. Conclusions: Of those drugs that could be assessed, all except Viagra (R) passed spectrometry testing. Of those that failed, few could be identified either by a country of manufacture listed on the packaging, or by the physical location of the website pharmacy. If confirmed by future studies on other drug samples, then U. S. consumers should be able to reduce their risk by relying on credentialing agencies recommended lists and by using common sense when examining packaging and pills.	[Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA; [Bate, Roger; Hess, Kimberly] Africa Fighting Malaria, Washington, DC USA	American Enterprise Institute for Public Policy Research	Bate, R (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA.	RBate@aei.org			Searle Freedom Trust; Legatum Institute; Legatum Foundation	Searle Freedom Trust; Legatum Institute; Legatum Foundation	The Searle Freedom Trust provided the initial grant and bulk of funding for this project. Subsequent funding was provided by the Legatum Institute and Legatum Foundation. The authors thank their funders for this support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugay DE, 2010, APPL SPECTROSC, V64, P467, DOI 10.1366/000370210791211745; de Veij M, 2007, J RAMAN SPECTROSC, V38, P181, DOI 10.1002/jrs.1621; Deloitte Center for Health Solutions, 2009, 2009 SURV HLTH CAR C; *EUR COMM TAX CUST, 2005, REP COMM CUST ACT CO; Gryniewicz C.M., 2007, AM PHARM REV, V10, P24; *IMH HLTH, 2008, CHANN DISTR US SAL; *KAIS FAM FDN, 2008, PRESCR DRUG TRENDS; LIVINGSTON G, 2009, DAILY REFLECTOR 0603; *MARK MON, 2008, BRANDJ IND; *STAE FOOD DRUG AD, 2009, SDFA ISS 2009 1 SAF; *US FDA, 2007, FDA SAYS CONS CONT; US Government Accountability Office, 2004, INT PHARM SOM POS SA; WITKOWSKI M, 2005, USE RAMAN SPECTROSCO; 2004, WALL STREET J ONLINE, V3	14	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12199	10.1371/journal.pone.0012199	http://dx.doi.org/10.1371/journal.pone.0012199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730049	Green Published, gold			2022-12-27	WOS:000280862200030
J	Yan, H; Venkatesan, K; Beaver, JE; Klitgord, N; Yildirim, MA; Hao, T; Hill, DE; Cusick, ME; Perrimon, N; Roth, FP; Vidal, M				Yan, Han; Venkatesan, Kavitha; Beaver, John E.; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Perrimon, Norbert; Roth, Frederick P.; Vidal, Marc			A Genome-Wide Gene Function Prediction Resource for Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; STRESS-RESPONSE; EXPRESSION; IDENTIFICATION; MICROARRAY; NETWORKS; CELLS; MACHINES; SYSTEM	Predicting gene functions by integrating large-scale biological data remains a challenge for systems biology. Here we present a resource for Drosophila melanogaster gene function predictions. We trained function-specific classifiers to optimize the influence of different biological datasets for each functional category. Our model predicted GO terms and KEGG pathway memberships for Drosophila melanogaster genes with high accuracy, as affirmed by cross-validation, supporting literature evidence, and large-scale RNAi screens. The resulting resource of prioritized associations between Drosophila genes and their potential functions offers a guide for experimental investigations.	[Yan, Han; Venkatesan, Kavitha; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, CCSB, Boston, MA 02115 USA; [Yan, Han; Venkatesan, Kavitha; Klitgord, Niels; Yildirim, Muhammed A.; Hao, Tong; Hill, David E.; Cusick, Michael E.; Perrimon, Norbert; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA; [Yildirim, Muhammed A.] Harvard Univ, Div Engn & Appl Sci, Appl Phys Program, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Beaver, John E.; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard Medical School	Yan, H (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, CCSB, Boston, MA 02115 USA.	frederick_roth@hms.harvard.edu; marc_vidal@dfci.harvard.edu	Roth, Frederick P/H-6308-2011; Yildirim, Muhammed/J-3695-2014; Hill, David E/B-6617-2011; Klitgord, Niels/B-5121-2009	Yildirim, Muhammed/0000-0003-2826-1766; Perrimon, Norbert/0000-0001-7542-472X; Roth, Frederick/0000-0002-6628-649X	National Institutes of Health (NIH) [HG001715, HG004233, HG003224]; Canadian Institute for Advanced Research; Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG001715, R01HG003224, R01HG001715, P50HG004233, U01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH; HG001715, HG004233 and HG003224; http://www.nih.gov/), the Canadian Institute for Advanced Research (http://www2.cifar.ca/), and the Presidential Scholarship from Harvard University (http://www.harvard.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000351; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEAVER J, 2010, BIOINFORMATICS  0521; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brody T, 1999, TRENDS GENET, V15, P333, DOI 10.1016/S0168-9525(99)01775-8; Carney GE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-288; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Deng XX, 2006, GENETICS, V174, P1859, DOI 10.1534/genetics.106.064568; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Deng Xutao, 2008, Int J Bioinform Res Appl, V4, P263, DOI 10.1504/IJBRA.2008.019574; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Estrada B, 2006, PLOS GENET, V2, P160, DOI 10.1371/journal.pgen.0020016; Firth LC, 2007, DEV BIOL, V307, P521, DOI 10.1016/j.ydbio.2007.04.037; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Johansson AM, 2007, EMBO J, V26, P2307, DOI 10.1038/sj.emboj.7601604; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kotsiantis S B, 2007, INFORMATICA, V31, P249, DOI DOI 10.31449/INF.V31I3.148; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee HJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-32; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Maines JZ, 2007, DEVELOPMENT, V134, P1471, DOI 10.1242/dev.02810; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Mezey JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-2; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Obozinski G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s6; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reinke V, 2002, NAT GENET, V32, P541, DOI 10.1038/ng1039; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Tasan M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s8; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tian WD, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s7; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Umemori M, 2009, GENE REGUL SYST BIO, V3, P11; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Weber KE, 2008, GENETICS, V178, P1093, DOI 10.1534/genetics.107.078014; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; WITTEN IH, 2000, DATA MINING PRACTICA, V25; Wu XW, 2006, METH MOL B, V316, P35; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	76	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12139	10.1371/journal.pone.0012139	http://dx.doi.org/10.1371/journal.pone.0012139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711346	gold, Green Published			2022-12-27	WOS:000280859700024
J	Roelandt, P; Pauwelyn, KA; Sancho-Bru, P; Subramanian, K; Ordovas, L; Vanuytsel, K; Geraerts, M; Firpo, M; De Vos, R; Fevery, J; Nevens, F; Hu, WS; Verfaillie, CM				Roelandt, Philip; Pauwelyn, Karen Ann; Sancho-Bru, Pau; Subramanian, Kartik; Ordovas, Laura; Vanuytsel, Kim; Geraerts, Martine; Firpo, Meri; De Vos, Rita; Fevery, Johan; Nevens, Frederik; Hu, Wei-Shou; Verfaillie, Catherine M.			Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; LIVER DEVELOPMENT; MOUSE EMBRYO; EFFICIENT DIFFERENTIATION; TRANSCRIPTION FACTOR; PROGENITOR CELLS; EXPRESSION; TRANSPLANTATION; CULTURES; LINES	Stem cell-derived hepatocytes may be an alternative cell source to treat liver diseases or to be used for pharmacological purposes. We developed a protocol that mimics mammalian liver development, to differentiate cells with pluripotent characteristics to hepatocyte-like cells. The protocol supports the stepwise differentiation of human embryonic stem cells (ESC) to cells with characteristics of primitive streak (PS)/mesendoderm (ME)/definitive endoderm (DE), hepatoblasts, and finally cells with phenotypic and functional characteristics of hepatocytes. Remarkably, the same protocol can also differentiate rat multipotent adult progenitor cells (rMAPCs) to hepatocyte-like cells, even though rMAPC are isolated clonally from cultured rat bone marrow (BM) and have characteristics of primitive endoderm cells. A fraction of rMAPCs can be fated to cells expressing genes consistent with a PS/ME/DE phenotype, preceding the acquisition of phenotypic and functional characteristics of hepatocytes. Although the hepatocyte-like progeny derived from both cell types is mixed, between 10-20% of cells are developmentally consistent with late fetal hepatocytes that have attained synthetic, storage and detoxifying functions near those of adult hepatocytes. This differentiation protocol will be useful for generating hepatocyte-like cells from rodent and human stem cells, and to gain insight into the early stages of liver development.	[Roelandt, Philip; Pauwelyn, Karen Ann; Sancho-Bru, Pau; Ordovas, Laura; Vanuytsel, Kim; Geraerts, Martine; Verfaillie, Catherine M.] Catholic Univ Leuven, Interdept Stem Cell Inst Leuven, Louvain, Belgium; [Roelandt, Philip; Pauwelyn, Karen Ann; Fevery, Johan; Nevens, Frederik] Univ Hosp Leuven, Hepatol Dept, Louvain, Belgium; [Subramanian, Kartik; Firpo, Meri; Hu, Wei-Shou] Univ Minnesota, Stem Cell Inst Minnesota, Minneapolis, MN USA; [Subramanian, Kartik; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [De Vos, Rita] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; KU Leuven; University Hospital Leuven	Roelandt, P (corresponding author), Catholic Univ Leuven, Interdept Stem Cell Inst Leuven, Louvain, Belgium.	Philip.roelandt@med.kuleuven.be; Ka.pauwelyn@gmail.com	Ordovas, Laura/AAA-2959-2019; Bose, Bipasha/H-3265-2019; Verfaillie, Catherine/H-5148-2013; Sancho-Bru, Pau/D-4900-2014	Ordovas, Laura/0000-0003-3982-1263; Bose, Bipasha/0000-0002-2312-9734; Verfaillie, Catherine/0000-0001-7564-4079; Sancho-Bru, Pau/0000-0001-5569-9259; Vanuytsel, Kim/0000-0002-8872-0736	National Institutes of Health [RO1-HL67932, RO1 DK58295, RO1-HL073221, U19-DK61244]; Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders) [G.0667.07, KAN 1.5163.09]; IWT; KULeuven SCIL Center of Excellence Award; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos [2006 BP-A 10104]; Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067932, R01HL073221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058295, U19DK061244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders)(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KULeuven SCIL Center of Excellence Award; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos; Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to C. Verfaillie from the National Institutes of Health (RO1-HL67932, RO1 DK58295, RO1-HL073221 and U19-DK61244), the Alpha 1 Foundation, FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders, www.fwo.be) G.0667.07 Odysseus award, IWT-SBO grant (HepStem), and a KULeuven SCIL Center of Excellence Award. K. Pauwelyn was funded by FWO, BAEF (Belgian American Education Foundation, www.baef.be) and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Sancho-Bru was funded by FWO (KAN 1.5163.09) and Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos (2006 BP-A 10104). P. Roelandt was funded by IWT (Agentschap voor Innovatie door Wetenschap en Technologie - Agency for Innovation by Science and Technology, www.iwt.be) and VVGE. L. Ordovas was funded by Instituto Aragones de Ciencias de la Salud and Gobierno de Aragon. M. Geraerts was funded by FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breyer A, 2006, EXP HEMATOL, V34, P1596, DOI 10.1016/j.exphem.2006.07.013; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cesari F, 2008, NAT REV MOL CELL BIO, V9, P924, DOI 10.1038/nrm2545; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Farquhar MJ, 2008, J VIRAL HEPATITIS, V15, P849, DOI 10.1111/j.1365-2893.2008.01051.x; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Gong ZJ, 1999, HEPATOLOGY, V29, P576, DOI 10.1002/hep.510290238; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Ishii T, 2010, CELL TISSUE RES, V339, P505, DOI 10.1007/s00441-009-0906-7; Gomez-Lechon MJ, 2008, EXPERT OPIN DRUG MET, V4, P837, DOI 10.1517/17425255.4.7.837 ; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Robertson EJ, 2003, PHILOS T R SOC B, V358, P1351, DOI 10.1098/rstb.2003.1332; Roelandt P, 2010, NAT PROTOC, V5, P1324, DOI 10.1038/nprot.2010.80; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sancho-Bru P, 2009, GUT, V58, P594, DOI 10.1136/gut.2008.171116; SANCHOBRU P, 2010, J HEPATOL IN PRESS; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Sekhon SS, 2004, AM J PATHOL, V164, P2229, DOI 10.1016/S0002-9440(10)63779-0; Serls AE, 2005, DEVELOPMENT, V132, P35, DOI 10.1242/dev.01570; SierraSantoyo A, 1996, J APPL TOXICOL, V16, P281, DOI 10.1002/(SICI)1099-1263(199607)16:4<281::AID-JAT344>3.0.CO;2-K; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	53	55	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12101	10.1371/journal.pone.0012101	http://dx.doi.org/10.1371/journal.pone.0012101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711405	Green Submitted, Green Published, gold			2022-12-27	WOS:000280849100023
J	Josseran, L; Fouillet, A; Caillere, N; Brun-Ney, D; Ilef, D; Brucker, G; Medeiros, H; Astagneau, P				Josseran, Loic; Fouillet, Anne; Caillere, Nadege; Brun-Ney, Dominique; Ilef, Daniele; Brucker, Gilles; Medeiros, Helena; Astagneau, Pascal			Assessment of a Syndromic Surveillance System Based on Morbidity Data: Results from the Oscour (R) Network during a Heat Wave	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; TIMELINESS; MORTALITY; FORCES	Background: Syndromic surveillance systems have been developed in recent years and are now increasingly used by stakeholders to quickly answer questions and make important decisions. It is therefore essential to evaluate the quality and utility of such systems. This study was designed to assess a syndromic surveillance system based on emergency departments' (ED) morbidity rates related to the health effects of heat waves. This study uses data collected during the 2006 heat wave in France. Methods: Data recorded from 15 EDs in the Ile-de-France (Paris and surrounding area) from June to August, 2006, were transmitted daily via the Internet to the French Institute for Public Health Surveillance. Items collected included diagnosis (ICD10), outcome, and age. Several aspects of the system have been evaluated (data quality, cost, flexibility, stability, and performance). Periods of heat wave are considered the most suitable time to evaluate the system. Results: Data quality did not vary significantly during the period. Age, gender and outcome were completed in a comprehensive manner. Diagnoses were missing or uninformative for 37.5% of patients. Stability was recorded as being 99.49% for the period overall. The average cost per day over the study period was estimated to be (sic)287. Diagnoses of hyperthermia, malaise, dehydration, hyponatremia were correlated with increased temperatures. Malaise was most sensitive in younger and elderly adults but also the less specific. However, overall syndrome groups were more sensitive with comparable specificity than individual diagnoses. Conclusion: This system satisfactorily detected the health impact of hot days (observed values were higher than expected on more than 90% of days on which a heat alert was issued). Our findings should reassure stakeholders about the reliability of health impact assessments during or following such an event. These evaluations are essential to establish the validity of the results of syndromic surveillance systems.	[Josseran, Loic; Fouillet, Anne; Caillere, Nadege; Ilef, Daniele; Medeiros, Helena] French Inst Publ Hlth Surveillance, Dept Alert Coordinat & Reg, St Maurice, France; [Brun-Ney, Dominique] AP HP, Paris, France; [Brucker, Gilles] GIP Esther, Paris, France; [Astagneau, Pascal] Univ Paris 06, Sch Med, Dept Publ Hlth, Paris, France	Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte	Josseran, L (corresponding author), French Inst Publ Hlth Surveillance, Dept Alert Coordinat & Reg, St Maurice, France.	l.josseran@invs.sante.fr	josseran, loic/F-3190-2019; Alkhalawi, Mohammed j/C-6111-2012; Astagneau, Pascal/AAF-3473-2020	josseran, loic/0000-0002-9021-1818; 	French National Institut for Public Health Surveillance	French National Institut for Public Health Surveillance	This study was funded by the French National Institut for Public Health Surveillance (www.invs.sante.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Chaudet H, 2005, STUD HEALTH TECHNOL, V116, P983; Cooper D L, 2002, Commun Dis Public Health, V5, P127; Curtis AB, 2001, AM J PREV MED, V20, P108, DOI 10.1016/S0749-3797(00)00284-1; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Espino JU, 2004, STUD HEALTH TECHNOL, V107, P1192; Flamand C, 2008, Euro Surveill, V13; German RR, 2000, EPIDEMIOLOGY, V11, P720, DOI 10.1097/00001648-200011000-00020; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Jefferson H, 2008, J PUBLIC HEALTH-UK, V30, P375, DOI 10.1093/pubmed/fdn026; Jones H W, 1945, Bull Med Libr Assoc, V33, P3; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Leonardi G, 2006, SOZ PRAVENTIV MED, V51, P194, DOI 10.1007/s00038-006-5039-0; Meynard JB, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-29; Pascal M, 2006, INT J BIOMETEOROL, V50, P144, DOI 10.1007/s00484-005-0003-x; RAMLOW JM, 1990, PUBLIC HEALTH REP, V105, P283; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Smith G E, 2006, Euro Surveill, V11, P220; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; van den Wijngaard C, 2008, EMERG INFECT DIS, V14, P917, DOI 10.3201/eid1406.071467; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; [No title captured]	28	56	56	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e11984	10.1371/journal.pone.0011984	http://dx.doi.org/10.1371/journal.pone.0011984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711252	Green Published, gold, Green Submitted			2022-12-27	WOS:000280776800001
J	Matsumura, H; Yoshida, K; Luo, SJ; Kimura, E; Fujibe, T; Albertyn, Z; Barrero, RA; Kruger, DH; Kahl, G; Schroth, GP; Terauchi, R				Matsumura, Hideo; Yoshida, Kentaro; Luo, Shujun; Kimura, Eiji; Fujibe, Takahiro; Albertyn, Zayed; Barrero, Roberto A.; Krueger, Detlev H.; Kahl, Guenter; Schroth, Gary P.; Terauchi, Ryohei			High-Throughput SuperSAGE for Digital Gene Expression Analysis of Multiple Samples Using Next Generation Sequencing	PLOS ONE			English	Article							RNA; GENOME; TRANSCRIPTOME; IDENTIFICATION; ARRAYS; SAGE	We established a protocol of the SuperSAGE technology combined with next-generation sequencing, coined "High-Throughput (HT-) SuperSAGE''. SuperSAGE is a method of digital gene expression profiling that allows isolation of 26-bp tag fragments from expressed transcripts. In the present protocol, index (barcode) sequences are employed to discriminate tags from different samples. Such barcodes allow researchers to analyze digital tags from transcriptomes of many samples in a single sequencing run by simply pooling the libraries. Here, we demonstrated that HT-SuperSAGE provided highly sensitive, reproducible and accurate digital gene expression data. By increasing throughput for analysis in HT-SuperSAGE, various applications are foreseen and several examples are provided in the present study, including analyses of laser-microdissected cells, biological replicates and tag extraction using different anchoring enzymes.	[Matsumura, Hideo; Yoshida, Kentaro; Fujibe, Takahiro; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Matsumura, Hideo] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Kimura, Eiji] Iwate Med Univ, Dept Anat, Morioka, Iwate 020, Japan; [Albertyn, Zayed; Barrero, Roberto A.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Krueger, Detlev H.] Univ Hosp Charite, Inst Med Virol, Berlin, Germany; [Kahl, Guenter] Goethe Univ Frankfurt, Bioctr, Frankfurt, Germany	Iwate Biotechnology Research Center; Shinshu University; Illumina; Iwate Medical University; Murdoch University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt	Matsumura, H (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	hideoma@shinshu-u.ac.jp	Terauchi, Ryohei/Y-2992-2019	Terauchi, Ryohei/0000-0002-0095-4651; Matsumura, Hideo/0000-0003-4849-1016; Yoshida, Kentaro/0000-0002-3614-1759; Barrero, Roberto/0000-0002-7735-665X	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [22380009] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (http://brain.naro.affrc.go.jp/tokyo/index_E.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nielsen KL, 2008, NEXT GENERATION SEQU, P229; Pleasance ED, 2003, GENOME RES, V13, P1203, DOI 10.1101/gr.873003; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vilain C, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng024; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	21	85	90	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12010	10.1371/journal.pone.0012010	http://dx.doi.org/10.1371/journal.pone.0012010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700453	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900010
J	Brettschneider, J; Czerwoniak, A; Senel, M; Fang, LB; Kassubek, J; Pinkhardt, E; Lauda, F; Kapfer, T; Jesse, S; Lehmensiek, V; Ludolph, AC; Otto, M; Tumani, H				Brettschneider, Johannes; Czerwoniak, Anne; Senel, Makbule; Fang, Lubin; Kassubek, Jan; Pinkhardt, Elmar; Lauda, Florian; Kapfer, Tamara; Jesse, Sarah; Lehmensiek, Vera; Ludolph, Albert C.; Otto, Markus; Tumani, Hayrettin			The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; B-CELLS; PREDICT CONVERSION; MRI CRITERIA; DIAGNOSIS; PATTERNS; ANTIBODIES; MIGRATION; CONSENSUS	Background: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognostic marker in patients with clinically isolated syndrome (CIS) regarding conversion to MS, and to compare it to Barkhof criteria in magnetic resonance imaging (MRI), oligoclonal bands (OCB) and the polyspecific intrathecal B cell response against measles, rubella and varicella zoster virus (MRZR). Methodology/Principal Findings: CXCL13 was determined in a prospective study over 2 years including 46 patients that remained CIS over follow-up (CIS-CIS), 45 patients that developed MS (CIS-RRMS), and 30 controls using ELISA. CSF CXCL13 was significantly elevated in CIS-RRMS as compared to CIS-CIS and controls (p<0.001). It was significantly elevated in CIS with OCB (p<0.001), positive MRZR (p = 0.04), and gadolinium enhancement in MRI (p = 0.02) and showed a significant correlation with CSF leukocyte count (p<0.001) and QIgG (p<0.001). CXCL13 showed the best positive predictive value (PPV) of all parameters investigated (70%, 95%-CI: 53-84%), which could be further increased by combination with Barkhof criteria in MRI (80%). Conclusions/Significance: Our data indicate the relevance of CXCL13 in CIS to predict conversion to MS. It furthermore shows CXCL13 to be an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell response that manifests itself in OCB and MRZR.	[Brettschneider, Johannes; Czerwoniak, Anne; Senel, Makbule; Fang, Lubin; Kassubek, Jan; Pinkhardt, Elmar; Lauda, Florian; Kapfer, Tamara; Jesse, Sarah; Lehmensiek, Vera; Ludolph, Albert C.; Otto, Markus; Tumani, Hayrettin] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	Ulm University	Brettschneider, J (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	johannes.brettschneider@uni-ulm.de	Kassubek, Jan/F-2774-2015; Otto, Markus/F-4304-2015; Senel, Makbule/AAU-8687-2020; Kassubek, Jan/GPX-0910-2022; Senel, Makbule/AAQ-4635-2021; Kassubek, Jan/O-1740-2019	Kassubek, Jan/0000-0002-7106-9270; Otto, Markus/0000-0003-4273-4267; Kassubek, Jan/0000-0002-7106-9270; Senel, Makbule/0000-0002-2737-7495; Kassubek, Jan/0000-0002-7106-9270	University of Ulm	University of Ulm	This study was funded by the University of Ulm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BOSCA I, 2010, J NEUROIMMUNOL; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Fischer L, 2009, CLIN CANCER RES, V15, P5968, DOI 10.1158/1078-0432.CCR-09-0108; Franciotta D, 2008, J NEUROIMMUNOL, V200, P125, DOI 10.1016/j.jneuroim.2008.06.004; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; JARIUS S, 2008, J NEUROL SCI; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuhle J, 2007, NEW ENGL J MED, V356, P371, DOI 10.1056/NEJMoa063602; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lund Frances E., 2005, V8, P25; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Michalowska-Wender G, 2008, PHARMACOL REP, V60, P549; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Nelson PJ, 2001, IMMUNITY, V14, P377, DOI 10.1016/S1074-7613(01)00118-2; NEWCOMBE RG, 1992, BRIT MED J, V304, P381, DOI 10.1136/bmj.304.6823.381-c; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Reiber H, 2001, CLIN CHEM LAB MED, V39, P324, DOI 10.1515/CCLM.2001.051; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; SENEL M, 2009, J NEUROL NEUROSURG P; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Thrower BW, 2007, NEUROLOGY, V68, pS12, DOI 10.1212/01.wnl.0000277704.56189.85; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	43	96	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11986	10.1371/journal.pone.0011986	http://dx.doi.org/10.1371/journal.pone.0011986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700489	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400019
J	Husemoen, LLN; Jorgensen, T; Borch-Johnsen, K; Hansen, T; Pedersen, O; Linneberg, A				Husemoen, Lise Lotte N.; Jorgensen, Torben; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf; Linneberg, Allan			The Association of Alcohol and Alcohol Metabolizing Gene Variants with Diabetes and Coronary Heart Disease Risk Factors in a White Population	PLOS ONE			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; DRINKING HABITS; BLOOD-PRESSURE; CONSUMPTION; POLYMORPHISM; ADH; GENOTYPE; INSULIN; ALDH2; METAANALYSIS	Background: Epidemiological studies have shown a J- or U-shaped relation between alcohol and type 2 diabetes and coronary heart disease (CHD). The underlying mechanisms are not clear. The aim was to examine the association between alcohol intake and diabetes and intermediate CHD risk factors in relation to selected ADH and ALDH gene variants. Methodology/Principal Findings: Cross-sectional study including 6,405 Northern European men and women aged 30-60 years from the general population of Copenhagen, Denmark. Data were collected with self-administered questionnaires, a physical examination, a 2 hour oral glucose tolerance test, and various blood tests. J shaped associations were observed between alcohol and diabetes, metabolic syndrome (MS), systolic and diastolic blood pressure, triglyceride, total cholesterol, and total homocysteine. Positive associations were observed with insulin sensitivity and HDL cholesterol, and a negative association with insulin release. Only a few of the selected ADH and ALDH gene variants was observed to have an effect. The ADH1c (rs1693482) fast metabolizing CC genotype was associated with an increased risk of impaired glucose tolerance (IGT)/diabetes compared to the CT and TT genotypes. Significant interactions were observed between alcohol and ADH1b (rs1229984) with respect to LDL and between alcohol and ALDH2 (rs886205) with respect to IGT/diabetes. Conclusions/Significance: The selected ADH and ALDH gene variants had only minor effects, and did not seem to markedly modify the health effects of alcohol drinking. The observed statistical significant associations would not be significant, if corrected for multiple testing.	[Husemoen, Lise Lotte N.; Jorgensen, Torben; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Aarhus University; University of Copenhagen; University of Southern Denmark	Husemoen, LLN (corresponding author), Res Ctr Prevent & Hlth, Glostrup, Denmark.	lloh@glo.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018	Pedersen, Oluf/0000-0002-3321-3972; Linneberg, Allan/0000-0002-0994-0184; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830	Danish Diabetes Association; Danish Medi-cal Research Council	Danish Diabetes Association; Danish Medi-cal Research Council(Danish Medical Research Council)	The study was supported by the Danish Diabetes Association (www.diabetes.dk) and Danish Medi-cal Research Council (www.fi.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, DEFINITION DIAGNOS 1; Balkau B, 1999, DIABETIC MED, V16, P442; Beulens JWJ, 2007, DIABETES, V56, P2388, DOI 10.2337/db07-0181; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; BOSRON WF, 1987, ENZYME, V37, P19, DOI 10.1159/000469238; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Chou WY, 1999, ALCOHOL CLIN EXP RES, V23, P963, DOI 10.1111/j.1530-0277.1999.tb04213.x; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Cushman W C, 2001, J Clin Hypertens (Greenwich), V3, P166, DOI 10.1111/j.1524-6175.2001.00443.x; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Djousse L, 2005, AM J CARDIOL, V96, P227, DOI 10.1016/j.amjcard.2005.03.050; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p157S, DOI 10.1097/00000374-200105051-00027; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; Fischer M, 2007, ALCOHOL CLIN EXP RES, V31, P1654, DOI 10.1111/j.1530-0277.2007.00471.x; Gemma Simonetta, 2006, Ann Ist Super Sanita, V42, P8; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Harada S, 1999, ALCOHOL CLIN EXP RES, V23, P958, DOI 10.1111/j.1530-0277.1999.tb04212.x; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; HEMPEL J, 1984, FEBS LETT, V173, P367, DOI 10.1016/0014-5793(84)80807-8; Hines LA, 2005, ATHEROSCLEROSIS, V182, P293, DOI 10.1016/j.atherosclerosis.2005.02.005; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Homann N, 2006, INT J CANCER, V118, P1998, DOI 10.1002/ijc.21583; HSU LC, 1991, J BIOL CHEM, V266, P12257; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Husemoen LLN, 2004, EUR J CLIN NUTR, V58, P1142, DOI 10.1038/sj.ejcn.1601942; Husemoen LLN, 2003, GENET EPIDEMIOL, V24, P322, DOI 10.1002/gepi.10239; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Linneberg A, 2006, CLIN EXP ALLERGY, V36, P714, DOI 10.1111/j.1365-2222.2006.02507.x; Linneberg A, 2010, CLIN EXP ALLERGY, V40, P123, DOI 10.1111/j.1365-2222.2009.03398.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakamura Y, 2002, ATHEROSCLEROSIS, V164, P171, DOI 10.1016/S0021-9150(02)00059-X; OKAYAMA A, 1994, J HUM HYPERTENS, V8, P205; Peterson RJ, 1999, GENOME RES, V9, P844, DOI 10.1101/gr.9.9.844; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; SAVOLAINEN MJ, 1995, CURR OPIN LIPIDOL, V6, P243, DOI 10.1097/00041433-199508000-00009; Sesso HD, 1999, CURR OPIN NEPHROL HY, V8, P353, DOI 10.1097/00041552-199905000-00013; SHERMAN D, 1993, HUM GENET, V92, P477, DOI 10.1007/BF00216454; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith LV, 2007, EUR J EPIDEMIOL, V22, P771, DOI 10.1007/s10654-007-9177-3; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STEWART MJ, 1995, BIOCHEM BIOPH RES CO, V211, P144, DOI 10.1006/bbrc.1995.1789; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; TSURITANI I, 1995, AM J HYPERTENS, V8, P1053, DOI 10.1016/0895-7061(95)00222-B; Whitfield JB, 2003, ALCOHOL CLIN EXP RES, V27, P509, DOI 10.1097/01.ALC.0000057940.57330.70; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Younis J, 2005, ATHEROSCLEROSIS, V180, P225, DOI 10.1016/j.atherosclerosis.2004.12.010	53	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11735	10.1371/journal.pone.0011735	http://dx.doi.org/10.1371/journal.pone.0011735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700531	gold, Green Published, Green Submitted			2022-12-27	WOS:000280605400001
J	Jayachandran, G; Ueda, K; Wang, BB; Roth, JA; Ji, L				Jayachandran, Gitanjali; Ueda, Kentaro; Wang, Bingbing; Roth, Jack A.; Ji, Lin			NPRL2 Sensitizes Human Non-Small Cell Lung Cancer (NSCLC) Cells to Cisplatin Treatment by Regulating Key Components in the DNA Repair Pathway	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; CHK2 PROTEIN-KINASE; S-PHASE CHECKPOINT; HISTONE H2AX; IN-VITRO; DOWNSTREAM EFFECTOR; GENOMIC INSTABILITY; DAMAGE CHECKPOINT	NPRL2, one of the tumor suppressor genes residing in a 120-kb homozygous deletion region of human chromosome band 3p21.3, has a high degree of amino acid sequence homology with the nitrogen permease regulator 2 (NPR2) yeast gene, and mutations of NPRL2 in yeast cells are associated with resistance to cisplatin-mediated cell killing. Previously, we showed that restoration of NPRL2 in NPRL2-negative and cisplatin-resistant cells resensitize lung cancer cells to cisplatin treatment in vitro and in vivo. In this study, we show that sensitization of non-small cell lung cancer (NSCLC) cells to cisplatin by NPRL2 is accomplished through the regulation of key components in the DNA-damage checkpoint pathway. NPRL2 can phosphorylate ataxia telangiectasia mutated (ATM) kinase activated by cisplatin and promote downstream gamma-H2AX formation in vitro and in vivo, which occurs during apoptosis concurrently with the initial appearance of high-molecular-weight DNA fragments. Moreover, this combination treatment results in higher Chk1 and Chk2 kinase activity than does treatment with cisplatin alone and can activate Chk2 in pleural metastases tumor xenograft in mice. Activated Chk1 and Chk2 increase the expression of cell cycle checkpoint proteins, including Cdc25A and Cdc25C, leading to higher levels of G2/M arrest in tumor cells treated with NPRL2 and cisplatin than in tumor cells treated with cisplatin only. Our results therefore suggest that ectopic expression of NPRL2 activates the DNA damage checkpoint pathway in cisplatin-resistant and NPRL2-negative cells; hence, the combination of NPRL2 and cisplatin can resensitize cisplatin nonresponders to cisplatin treatment through the activation of the DNA damage checkpoint pathway, leading to cell arrest in the G2/M phase and induction of apoptosis. The direct implication of this study is that combination treatment with NPRL2 and cisplatin may overcome cisplatin resistance and enhance therapeutic efficacy.	[Jayachandran, Gitanjali; Ueda, Kentaro; Wang, Bingbing; Roth, Jack A.; Ji, Lin] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Roth, Jack A.; Ji, Lin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Ueda, Kentaro] Wakayama Med Univ, Sch Med, Wakayama, Japan	University of Texas System; UTMD Anderson Cancer Center; Wakayama Medical University	Jayachandran, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	lji@mdanderson.org			National Cancer Institute, National Institutes of Health [SPORE P50CA70907, R01CA116322, MMHCC U01CA10535201]; Department of Defense [DAMD17-02-1-0706]; University of Texas M. D. Anderson Cancer Center [CA-16672]; Texas State Legislature; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA116322, P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); University of Texas M. D. Anderson Cancer Center; Texas State Legislature; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from the National Cancer Institute, National Institutes of Health, SPORE P50CA70907, R01CA116322, and MMHCC U01CA10535201; grants from the Department of Defense Lung Cancer Program PROSPECT (DAMD17-02-1-0706); The University of Texas M. D. Anderson Cancer Center Support Core Grant (CA-16672); and a grant from the Tobacco Settlement Funds as appropriated by the Texas State Legislature. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; EVANS DL, 1994, CANCER RES, V54, P1596; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fondon JW, 1998, P NATL ACAD SCI USA, V95, P7514, DOI 10.1073/pnas.95.13.7514; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Henkels KM, 1997, CANCER RES, V57, P4488; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 1999, CANCER RES, V59, P3333; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lerman MI, 2000, CANCER RES, V60, P6116; Lin WC, 2001, GENE DEV, V15, P1833; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Talasz H, 2002, CELL DEATH DIFFER, V9, P27, DOI 10.1038/sj.cdd.4400925; Ueda K, 2006, CANCER RES, V66, P9682, DOI 10.1158/0008-5472.CAN-06-1483; Wistuba II, 2000, CANCER RES, V60, P1949; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	49	28	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11994	10.1371/journal.pone.0011994	http://dx.doi.org/10.1371/journal.pone.0011994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700484	Green Published, gold, Green Submitted			2022-12-27	WOS:000280605400026
J	Sridhar, J; Narmada, SR; Sabarinathan, R; Ou, HY; Deng, ZX; Sekar, K; Rafi, ZA; Rajakumar, K				Sridhar, Jayavel; Narmada, Suryanarayanan Ramkumar; Sabarinathan, Radhakrishnan; Ou, Hong-Yu; Deng, Zixin; Sekar, Kanagaraj; Rafi, Ziauddin Ahamed; Rajakumar, Kumar			sRNAscanner: A Computational Tool for Intergenic Small RNA Detection in Bacterial Genomes	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; ENCODING GENES; SOLUBLE-RNAS; IDENTIFICATION; PREDICTION; TYPHIMURIUM; EXPRESSION; PROTEINS; STRESS	Background: Bacterial non-coding small RNAs (sRNAs) have attracted considerable attention due to their ubiquitous nature and contribution to numerous cellular processes including survival, adaptation and pathogenesis. Existing computational approaches for identifying bacterial sRNAs demonstrate varying levels of success and there remains considerable room for improvement. Methodology/Principal Findings: Here we have proposed a transcriptional signal-based computational method to identify intergenic sRNA transcriptional units (TUs) in completely sequenced bacterial genomes. Our sRNAscanner tool uses position weight matrices derived from experimentally defined E. coli K-12 MG1655 sRNA promoter and rho-independent terminator signals to identify intergenic sRNA TUs through sliding window based genome scans. Analysis of genomes representative of twelve species suggested that sRNAscanner demonstrated equivalent sensitivity to sRNAPredict2, the best performing bioinformatics tool available presently. However, each algorithm yielded substantial numbers of known and uncharacterized hits that were unique to one or the other tool only. sRNAscanner identified 118 novel putative intergenic sRNA genes in Salmonella enterica Typhimurium LT2, none of which were flagged by sRNAPredict2. Candidate sRNA locations were compared with available deep sequencing libraries derived from Hfq-co-immunoprecipitated RNA purified from a second Typhimurium strain (Sittka et al. (2008) PLoS Genetics 4: e1000163). Sixteen potential novel sRNAs computationally predicted and detected in deep sequencing libraries were selected for experimental validation by Northern analysis using total RNA isolated from bacteria grown under eleven different growth conditions. RNA bands of expected sizes were detected in Northern blots for six of the examined candidates. Furthermore, the 5'-ends of these six Northern-supported sRNA candidates were successfully mapped using 5'-RACE analysis. Conclusions/Significance: We have developed, computationally examined and experimentally validated the sRNAscanner algorithm. Data derived from this study has successfully identified six novel S. Typhimurium sRNA genes. In addition, the computational specificity analysis we have undertaken suggests that similar to 40% of sRNAscanner hits with high cumulative sum of scores represent genuine, undiscovered sRNA genes. Collectively, these data strongly support the utility of sRNAscanner and offer a glimpse of its potential to reveal large numbers of sRNA genes that have to date defied identification. sRNAscanner is available from: http://bicmku.in:8081/sRNAscanner or http://cluster.physics.iisc.ernet.in/sRNAscanner/.	[Sridhar, Jayavel; Rafi, Ziauddin Ahamed] Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India; [Narmada, Suryanarayanan Ramkumar; Sabarinathan, Radhakrishnan; Sekar, Kanagaraj] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Sridhar, Jayavel; Rajakumar, Kumar] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Rajakumar, Kumar] Univ Hosp Leicester, NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Ou, Hong-Yu; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Ou, Hong-Yu; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Madurai Kamaraj University; Indian Institute of Science (IISC) - Bangalore; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sridhar, J (corresponding author), Madurai Kamaraj Univ, Sch Biotechnol, Ctr Excellence Bioinformat, Madurai 625021, Tamil Nadu, India.	kr46@le.ac.uk	OU, Hong-Yu/O-5208-2019	OU, Hong-Yu/0000-0001-9439-1660; Sambaturu, Narmada/0000-0002-2570-3699; Sabarinathan, Radhakrishnan/0000-0001-8916-3954	Department of Biotechnology, Government of India; Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University; Commonwealth Scholarship Commission Split-Site Doctoral Award; Shanghai Rising-Star Program [Q7A14028]; National Natural Science Foundation of China [30700013/C010103]; Royal Society-National Natural Science Foundation of China [2007/R3]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University; Commonwealth Scholarship Commission Split-Site Doctoral Award; Shanghai Rising-Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society-National Natural Science Foundation of China(Royal Society of LondonNational Natural Science Foundation of China (NSFC))	This study was supported by project grants from Department of Biotechnology, Government of India to KS. ZAR and JS received financial support from Department of Biotechnology for the Centre of Excellence in Bioinformatics, Madurai Kamaraj University. JS was supported by a Commonwealth Scholarship Commission Split-Site Doctoral Award. HYO was supported by the Shanghai Rising-Star Program (Q7A14028) and National Natural Science Foundation of China grants (30700013/C010103). KR and ZD were supported by a Royal Society-National Natural Science Foundation of China, International Joint Project Grant (2007/R3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Chiapello H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-171; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Douchin V, 2006, J BIOL CHEM, V281, P12253, DOI 10.1074/jbc.M600819200; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; LINU MY, 1997, J BIOL CHEM, V272, P17502; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2009, RNA BIOL, V6, P266, DOI 10.4161/rna.6.3.8332; Sridhar J, 2007, OMICS, V11, P74, DOI 10.1089/omi.2006.0006; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; VOGEL J, 2008, HDB RNA BIOCH 3, P595; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	41	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11970	10.1371/journal.pone.0011970	http://dx.doi.org/10.1371/journal.pone.0011970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700540	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400011
J	Chang, MW; Ayeni, C; Breuer, S; Torbett, BE				Chang, Max W.; Ayeni, Christian; Breuer, Sebastian; Torbett, Bruce E.			Virtual Screening for HIV Protease Inhibitors: A Comparison of AutoDock 4 and Vina	PLOS ONE			English	Article							MOLECULAR DOCKING; LIGAND; RECOGNITION	Background: The AutoDock family of software has been widely used in protein-ligand docking research. This study compares AutoDock 4 and AutoDock Vina in the context of virtual screening by using these programs to select compounds active against HIV protease. Methodology/Principal Findings: Both programs were used to rank the members of two chemical libraries, each containing experimentally verified binders to HIV protease. In the case of the NCI Diversity Set II, both AutoDock 4 and Vina were able to select active compounds significantly better than random (AUC = 0.69 and 0.68, respectively; p<0.001). The binding energy predictions were highly correlated in this case, with r = 0.63 and iota = 0.82. For a set of larger, more flexible compounds from the Directory of Universal Decoys, the binding energy predictions were not correlated, and only Vina was able to rank compounds significantly better than random. Conclusions/Significance: In ranking smaller molecules with few rotatable bonds, AutoDock 4 and Vina were equally capable, though both exhibited a size-related bias in scoring. However, as Vina executes more quickly and is able to more accurately rank larger molecules, researchers should look to it first when undertaking a virtual screen.	[Chang, Max W.; Breuer, Sebastian; Torbett, Bruce E.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ayeni, Christian] Univ Calif Merced, Dept Bioengn, Merced, CA USA	Scripps Research Institute; University of California System; University of California Merced	Chang, MW (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	betorbet@scripps.edu		Torbett, Bruce/0000-0003-4995-1694; Chang, Max/0000-0002-4526-489X	NIH [5T32NSO412119, GM083658, GM48870, AI40882]; CFAR [3 P30 AI036214-13S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040882, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048870, P01GM083658] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from the NIH to M.W.C (5T32NSO412119), B.E.T. (GM083658, GM48870 and AI40882) and CFAR support (3 P30 AI036214-13S1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbault F, 2006, CHEMOMETR INTELL LAB, V82, P269, DOI 10.1016/j.chemolab.2005.05.014; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang MW, 2007, J CHEM INF MODEL, V47, P1258, DOI 10.1021/ci700044s; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; GASTEIGER J, 1990, TETRAHEDRON COMPUT M, V3, P3; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pan YP, 2003, J CHEM INF COMP SCI, V43, P267, DOI 10.1021/ci020055f; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Trott O., 2009, J COMPUT CHEM; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249	22	147	152	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11955	10.1371/journal.pone.0011955	http://dx.doi.org/10.1371/journal.pone.0011955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694138	Green Published, gold, Green Submitted			2022-12-27	WOS:000280574300011
J	Munoz, J; Gomez, A; Green, AJ; Figuerola, J; Amat, F; Rico, C				Munoz, Joaquin; Gomez, Africa; Green, Andy J.; Figuerola, Jordi; Amat, Francisco; Rico, Ciro			Evolutionary Origin and Phylogeography of the Diploid Obligate Parthenogen Artemia parthenogenetica (Branchiopoda: Anostraca)	PLOS ONE			English	Article							BRINE; POPULATIONS; DISPERSAL; COEXISTENCE; DIVERSITY; CRUSTACEA; DISTANCE; SEX	Background: Understanding the evolutionary origin and the phylogeographic patterns of asexual taxa can shed light on the origin and maintenance of sexual reproduction. We assessed the geographic origin, genetic diversity, and phylogeographic history of obligate parthenogen diploid Artemia parthenogenetica populations, a widespread halophilic crustacean. Methodology/Principal Findings: We analysed a partial sequence of the Cytochrome c Oxidase Subunit I mitochondrial gene from an extensive set of localities (including Eurasia, Africa, and Australia), and examined their phylogeographic patterns and the phylogenetic relationships of diploid A. parthenogenetica and its closest sexual relatives. Populations displayed an extremely low level of mitochondrial genetic diversity, with one widespread haplotype shared by over 79% of individuals analysed. Phylogenetic and phylogeographic analyses indicated a multiple and recent evolutionary origin of diploid A. parthenogenetica, and strongly suggested that the geographic origin of parthenogenesis in Artemia was in Central Asia. Our results indicate that the maternal sexual ancestors of diploid A. parthenogenetica were an undescribed species from Kazakhstan and A. urmiana. Conclusions/Significance: We found evidence for multiple origin of parthenogenesis in Central Asia. Our results indicated that, shortly after its origin, diploid A. parthenogenetica populations underwent a rapid range expansion from Central Asia towards the Mediterranean region, and probably to the rest of its current geographic distribution. This contrasts with the restricted geographic distribution, strong genetic structure, and regional endemism of sexual Artemia lineages and other passively dispersed sexual continental aquatic invertebrates. We hypothesize that diploid parthenogens might have reached their current distribution in historical times, with a range expansion possibly facilitated by an increased availability of suitable habitat provided by anthropogenic activities, such as the spread of solar saltworks, aided by their natural dispersal vectors (i.e., waterbirds).	[Munoz, Joaquin; Green, Andy J.; Figuerola, Jordi; Rico, Ciro] Estac Biol Donana CSIC, Dept Wetland Ecol, Seville, Spain; [Gomez, Africa] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Amat, Francisco] CSIC, Inst Acuicultura Torre Sal, Ribera De Cabanes, Castellon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Hull; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Munoz, J (corresponding author), Estac Biol Donana CSIC, Dept Wetland Ecol, Seville, Spain.	quini@ebd.csic.es	Rico, Ciro/K-5725-2015; Figuerola, Jordi/B-7917-2008; Rico, Ciro/P-9750-2019; Green, Andy J/A-5189-2008; Munoz, Joaquin/B-9938-2009; Gomez, A/L-6505-2014	Rico, Ciro/0000-0002-0822-336X; Figuerola, Jordi/0000-0002-4664-9011; Rico, Ciro/0000-0002-0822-336X; Green, Andy J/0000-0002-1268-4951; Munoz, Joaquin/0000-0003-3623-2439; Gomez, A/0000-0002-1297-4502	Spanish Ministerio de Educacion y Ciencia [BOS2003-02846, CGL 2005-02306 BOS, CGL2006-05085/BOS]; NERC [NE/B501298/1]; Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Spanish Ministerio de Educacion y Ciencia(Spanish Government); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the Spanish Ministerio de Educacion y Ciencia (projects BOS2003-02846, CGL 2005-02306 BOS and CGL2006-05085/BOS, including FEDER funds). AG was supported by a NERC Advanced Fellowship (NE/B501298/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzopoulos TJ, 2009, INT REV HYDROBIOL, V94, P560, DOI 10.1002/iroh.200911147; Abatzopoulos TJ, 2002, BIOL J LINN SOC, V75, P333, DOI 10.1111/j.1095-8312.2002.tb02074.x; ABATZOPOULOS TJ, 2002, ARTEMIA BASIC APPL B; ABREUGROBOIS FA, 1987, ARTEMIA RES ITS APPL, V1; Agh N, 2007, INT REV HYDROBIOL, V92, P48, DOI 10.1002/iroh.200610909; Amat Domenech F., 1980, P19; Barata C, 1996, J EXP MAR BIOL ECOL, V196, P313, DOI 10.1016/0022-0981(95)00137-9; Baxevanis AD, 2006, MOL PHYLOGENET EVOL, V40, P724, DOI 10.1016/j.ympev.2006.04.010; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; Bossier P, 2004, AQUACULTURE, V231, P93, DOI 10.1016/j.aquaculture.2003.11.001; BROWNE RA, 1990, EVOLUTION, V44, P1035, DOI 10.1111/j.1558-5646.1990.tb03824.x; Caceres CE, 1997, P NATL ACAD SCI USA, V94, P9171, DOI 10.1073/pnas.94.17.9171; Chaplin JA, 1997, HEREDITY, V78, P57; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GAJARDO G, 2002, BASIC APPL BIOL, P225; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; HARPENDING HC, 1998, TREE, V95, P1961; HONTORIA F, 1992, J PLANKTON RES, V14, P949, DOI 10.1093/plankt/14.7.949; Hou L, 2006, AQUAC RES, V37, P671, DOI 10.1111/j.1365-2109.2006.01480.x; Johnson SG, 2006, EVOLUTION, V60, P1417, DOI 10.1111/j.0014-3820.2006.tb01220.x; Kappas I, 2009, MOL PHYLOGENET EVOL, V52, P192, DOI 10.1016/j.ympev.2009.03.012; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney M, 2006, MOL ECOL, V15, P1743, DOI 10.1111/j.1365-294X.2006.02898.x; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; Ketmaier V, 2008, AQUAT SCI, V70, P65, DOI 10.1007/s00027-007-7028-7; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kurlansky M, 2003, SALT WORLD HIST; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; McMaster K, 2007, HYDROBIOLOGIA, V576, P39, DOI 10.1007/s10750-006-0291-0; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Mills S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-225; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Mura G, 2005, J PLANKTON RES, V27, P895, DOI 10.1093/plankt/fbi063; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Nunes BS, 2006, ENVIRON POLLUT, V144, P453, DOI 10.1016/j.envpol.2005.12.037; Palumbi Stephen R., 1996, P205; PILLA EJS, 1994, HEREDITY, V73, P47, DOI 10.1038/hdy.1994.97; Sanchez MI, 2007, MAR BIOL, V151, P1407, DOI 10.1007/s00227-006-0577-9; Schneider S, 1999, GENETICS, V152, P1079; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schon I, 2007, HYDROBIOLOGIA, V575, P33, DOI 10.1007/s10750-006-0276-z; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Triantaphyllidis GV, 1996, HYDROBIOLOGIA, V335, P97, DOI 10.1007/BF00015271; VANSTAPPEN G, 2002, BIOL AQUATIC ORGANIS, P171; VANSTAPPEN G, 2008, THESIS GHENT U BELGI; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x; ZHANG L, 1992, GENETICA, V85, P211, DOI 10.1007/BF00132273; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161; Zierold T, 2009, FRESHWATER BIOL, V54, P1392, DOI 10.1111/j.1365-2427.2009.02191.x	58	36	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11932	10.1371/journal.pone.0011932	http://dx.doi.org/10.1371/journal.pone.0011932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694140	Green Published, gold, Green Submitted			2022-12-27	WOS:000280574300007
J	Sahlin, P; Jonsson, H				Sahlin, Patrik; Jonsson, Henrik			A Modeling Study on How Cell Division Affects Properties of Epithelial Tissues Under Isotropic Growth	PLOS ONE			English	Article							SHOOT APEX; ARABIDOPSIS; MORPHOGENESIS; EPIDERMIS	Cell proliferation affects both cellular geometry and topology in a growing tissue, and hence rules for cell division are key to understanding multicellular development. Epithelial cell layers have for long times been used to investigate how cell proliferation leads to tissue-scale properties, including organism-independent distributions of cell areas and number of neighbors. We use a cell-based two-dimensional tissue growth model including mechanics to investigate how different cell division rules result in different statistical properties of the cells at the tissue level. We focus on isotropic growth and division rules suggested for plant cells, and compare the models with data from the Arabidopsis shoot. We find that several division rules can lead to the correct distribution of number of neighbors, as seen in recent studies. In addition we find that when also geometrical properties are taken into account other constraints on the cell division rules result. We find that division rules acting in favor of equally sized and symmetrically shaped daughter cells can best describe the statistical tissue properties.	[Sahlin, Patrik; Jonsson, Henrik] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden	Lund University	Sahlin, P (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	henrik@thep.lu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was in part supported by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corson F, 2009, P NATL ACAD SCI USA, V106, P8453, DOI 10.1073/pnas.0812493106; Dumais J, 2007, CURR OPIN PLANT BIOL, V10, P58, DOI 10.1016/j.pbi.2006.11.014; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fischer K, 1998, PLANT J, V15, P119, DOI 10.1046/j.1365-313X.1998.00173.x; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hofmeister W, 1863, JB WISS BOT, V3, P259; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Lewis FT, 1926, ANAT REC, V33, P331, DOI 10.1002/ar.1090330502; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Sahlin P, 2009, L N INST COMP SCI SO, V4, P971; Smith LG, 2001, NAT REV MOL CELL BIO, V2, P33, DOI 10.1038/35048050; Thompson D. W., 1917, GROWTH FORM; von Sachs J, 1878, ARB BOT I WURZBURG, V2, P46	18	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11750	10.1371/journal.pone.0011750	http://dx.doi.org/10.1371/journal.pone.0011750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689588	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520300003
J	Bloemendaal, ALA; Brouwer, EC; Fluit, AC				Bloemendaal, Alexander L. A.; Brouwer, Ellen C.; Fluit, Ad C.			Methicillin Resistance Transfer from Staphylocccus epidermidis to Methicillin-Susceptible Staphylococcus aureus in a Patient during Antibiotic Therapy	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; BIOSYNTHESIS; EMERGENCE	Background: The mecA gene, encoding methicillin resistance in staphylococci, is located on a mobile genetic element called Staphylococcal Cassette Chromosome mec (SCCmec). Horizontal, interspecies transfer of this element could be an important factor in the dissemination of methicillin-resistant S. aureus (MRSA). Previously, we reported the isolation of a closely related methicillin-susceptible Staphylococcus aureus (MSSA), MRSA and potential SCCmec donor Staphylococcus epidermidis isolate from the same patient. Based on fingerprint techniques we hypothesized that the S. epidermidis had transferred SCCmec to the MSSA to become MRSA. The aim of this study was to show that these isolates form an isogenic pair and that interspecies horizontal SCCmec transfer occurred. Methodology/Results: Whole genome sequencing of both isolates was performed and for the MSSA gaps were closed by conventional sequencing. The SCCmec of the S. epidermidis was also sequenced by conventional methods. The results show no difference in nucleotide sequence between the two isolates except for the presence of SCCmec in the MRSA. The SCCmec of the S. epidermidis and the MRSA are identical except for a single nucleotide in the ccrB gene, which results in a valine to alanine substitution. The main difference with the closely related EMRSA-16 is the presence of SaPI2 encoding toxic shock syndrome toxin and exfoliative toxin A in the MSSA-MRSA pair. No transfer of SCCmec from the S. epidermidis to the MSSA could be demonstrated in vitro. Conclusion: The MSSA and MRSA form an isogenic pair except for SCCmec. This strongly supports our hypothesis that the MRSA was derived from the MSSA by interspecies horizontal transfer of SCCmec from S. epidermidis O7.1.	[Bloemendaal, Alexander L. A.; Brouwer, Ellen C.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bloemendaal, Alexander L. A.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bloemendaal, ALA (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	a.c.fluit@umcutrecht.nl			European Union [HEALTH-F3-2008-222718]	European Union(European Commission)	A.C. Fluit was in part supported by European Union FP7 Grant no. HEALTH-F3-2008-222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jansen WTM, 2006, ANTIMICROB AGENTS CH, V50, P2072, DOI 10.1128/AAC.01539-05; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Nishifuji K, 2008, J DERMATOL SCI, V49, P21, DOI 10.1016/j.jdermsci.2007.05.007; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; TENBROEKESMITS NJ, 2010, NUCL ACIDS IN PRESS; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Wielders C, 2001, LANCET, V358, P424; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	18	78	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11841	10.1371/journal.pone.0011841	http://dx.doi.org/10.1371/journal.pone.0011841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686601	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200011
J	Aravena, P; Hurtado, E; Riveros, R; Cardona, JF; Manes, F; Ibanez, A				Aravena, Pia; Hurtado, Esteban; Riveros, Rodrigo; Cardona, Juan Felipe; Manes, Facundo; Ibanez, Agustin			Applauding with Closed Hands: Neural Signature of Action-Sentence Compatibility Effects	PLOS ONE			English	Article							CORTICAL POTENTIALS; MOTOR SYSTEM; ACTION WORDS; ELECTROPHYSIOLOGICAL EVIDENCE; FRONTOTEMPORAL DEGENERATION; ATTENTIONAL PROCESSES; PARKINSONS-DISEASE; VERB COMPREHENSION; FINGER MOVEMENT; LANGUAGE	Background: Behavioral studies have provided evidence for an action-sentence compatibility effect (ACE) that suggests a coupling of motor mechanisms and action-sentence comprehension. When both processes are concurrent, the action sentence primes the actual movement, and simultaneously, the action affects comprehension. The aim of the present study was to investigate brain markers of bidirectional impact of language comprehension and motor processes. Methodology/Principal Findings: Participants listened to sentences describing an action that involved an open hand, a closed hand, or no manual action. Each participant was asked to press a button to indicate his/her understanding of the sentence. Each participant was assigned a hand-shape, either closed or open, which had to be used to activate the button. There were two groups (depending on the assigned hand-shape) and three categories (compatible, incompatible and neutral) defined according to the compatibility between the response and the sentence. ACEs were found in both groups. Brain markers of semantic processing exhibited an N400-like component around the Cz electrode position. This component distinguishes between compatible and incompatible, with a greater negative deflection for incompatible. Motor response elicited a motor potential (MP) and a re-afferent potential (RAP), which are both enhanced in the compatible condition. Conclusions/Significance: The present findings provide the first ACE cortical measurements of semantic processing and the motor response. N400-like effects suggest that incompatibility with motor processes interferes in sentence comprehension in a semantic fashion. Modulation of motor potentials (MP and RAP) revealed a multimodal semantic facilitation of the motor response. Both results provide neural evidence of an action-sentence bidirectional relationship. Our results suggest that ACE is not an epiphenomenal post-sentence comprehension process. In contrast, motor-language integration occurring during the verb onset supports a genuine and ongoing brain motor-language interaction.	[Aravena, Pia; Cardona, Juan Felipe; Manes, Facundo; Ibanez, Agustin] INECO, Lab Expt Psychol & Neurosci, Buenos Aires, Capital Federal, Argentina; [Aravena, Pia; Riveros, Rodrigo; Ibanez, Agustin] Univ Diego Portales, Cognit Neurosci Lab, Santiago, Chile; [Hurtado, Esteban] Pontificia Univ Catolica Chile, Doctoral Program, Sch Psychol, Santiago, Chile; [Manes, Facundo; Ibanez, Agustin] Favaloro Univ, Inst Neurosci, Buenos Aires, Capital Federal, Argentina; [Ibanez, Agustin] Natl Sci & Tech Res Council CONICET, Buenos Aires, Capital Federal, Argentina	University Diego Portales; Pontificia Universidad Catolica de Chile; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Aravena, P (corresponding author), INECO, Lab Expt Psychol & Neurosci, Buenos Aires, Capital Federal, Argentina.	aibanez@neurologiacognitiva.org	Cardona, Juan F./O-9436-2015; Ibanez, Agustin/H-7976-2015; Cardona, Juan Felipe/M-7939-2019	Cardona, Juan F./0000-0001-6795-7753; Ibanez, Agustin/0000-0001-6758-5101; Cardona, Juan Felipe/0000-0001-6795-7753	CONICET (The National Scientific and Technical Research Council); FINECO (Foundation for Research in Cognitive Neurosciences)	CONICET (The National Scientific and Technical Research Council)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FINECO (Foundation for Research in Cognitive Neurosciences)	This research was supported by CONICET (The National Scientific and Technical Research Council) and FINECO (Foundation for Research in Cognitive Neurosciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 2006, CORTEX, V42, P507, DOI 10.1016/S0010-9452(08)70388-5; Arbib MA, 2010, BRAIN LANG, V112, P12, DOI 10.1016/j.bandl.2009.10.001; Badets A, 2010, COGNITION, V115, P46, DOI 10.1016/j.cognition.2009.11.007; Bak TH, 2006, BRAIN, V129, P321, DOI 10.1093/brain/awh701; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barrett AM, 2005, BEHAV BRAIN SCI, V28, P125, DOI 10.1017/S0140525X05220034; BENECKE R, 1985, NEUROSCI LETT, V62, P347, DOI 10.1016/0304-3940(85)90573-7; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Bergen BK, 2005, CONSTR APPROACH LANG, V3, P147; Borghi AM, 2004, MEM COGNITION, V32, P863, DOI 10.3758/BF03196865; Borreggine KL, 2006, COGNITIVE SCI, V30, P1097, DOI 10.1207/s15516709cog0000_91; Botzel K, 1997, EXP BRAIN RES, V114, P352, DOI 10.1007/PL00005643; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; CAPPA SF, 1992, APHASIOLOGY, V6, P359, DOI 10.1080/02687039208248607; Cappa SF, 1997, BRAIN LANG, V56, P55, DOI 10.1006/brln.1997.1737; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Cornejo C, 2009, BRAIN COGNITION, V70, P42, DOI 10.1016/j.bandc.2008.12.005; d'Honincthun P, 2008, CORTEX, V44, P834, DOI 10.1016/j.cortex.2007.04.003; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Davidson, 2001, SUBJECTIVE INTERSUBJ; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; DEECKE L, 1987, CIBA F SYMP, V132, P231; DEVEGA M, GAR WORKSH IN PRESS; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Dirnberger G, 2000, EXP BRAIN RES, V135, P231, DOI 10.1007/s002210000522; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Elman J, 1997, SCIENCE, V276, P1180; Eversheim U, 2001, LEARN MEMORY, V8, P183, DOI 10.1101/lm.39301; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; FISCHLER I, 1979, J VERB LEARN VERB BE, V18, P1, DOI 10.1016/S0022-5371(79)90534-6; FUSTER JM, 2003, CORTEX MIND; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gentilucci M, 1998, EUR J NEUROSCI, V10, P752, DOI 10.1046/j.1460-9568.1998.00060.x; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; GROEBEN N, 2000, QUALITATIVE SOCIAL R, V1; Guerra S, 2009, BRAIN COGNITION, V70, P221, DOI 10.1016/j.bandc.2009.02.004; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2008, BRAIN LANG, V107, P179, DOI 10.1016/j.bandl.2008.09.006; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; HOLCOMB PJ, 1994, BRAIN COGNITION, V24, P259, DOI 10.1006/brcg.1994.1014; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Ibanez A, 2010, NEUROSCI LETT, V471, P48, DOI 10.1016/j.neulet.2010.01.009; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karl A, 2004, PAIN, V110, P90, DOI 10.1016/j.pain.2004.03.013; KARNISKI W, 1993, BRAIN LANG, V44, P58, DOI 10.1006/brln.1993.1005; Kaschak MP, 2005, COGNITION, V94, pB79, DOI 10.1016/j.cognition.2004.06.005; Kelly SD, 2004, BRAIN LANG, V89, P253, DOI 10.1016/S0093-934X(03)00335-3; Kelly SD, 2002, DEV NEUROPSYCHOL, V22, P323, DOI 10.1207/S15326942dn2201_1; Kelly SD, 2007, BRAIN LANG, V101, P222, DOI 10.1016/j.bandl.2006.07.008; Kelly SD, 2010, PSYCHOL SCI, V21, P260, DOI 10.1177/0956797609357327; Kelly SD, 2010, J COGNITIVE NEUROSCI, V22, P683, DOI 10.1162/jocn.2009.21254; KLEIMAN GM, 1980, MEM COGNITION, V8, P336, DOI 10.3758/BF03198273; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kliegl R, 2004, EUR J COGN PSYCHOL, V16, P262, DOI 10.1080/09541440340000213; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2009, PSYCHOPHYSIOLOGY, V46, P179, DOI 10.1111/j.1469-8986.2008.00752.x; Ku YX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000771; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lindeman Robert W, 2006, VIRTUAL REALITY, V9, p[2, 203], DOI [DOI 10.1007/S10055-005-0010-6, 10.1007/s10055-005-0010-6]; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Louwerse M. M., 2008, P 30 ANN C COGN SCI, P1313; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Martin A., 2003, ORG CONCEPTUAL KNOWL; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; MCCARTHY R, 1990, NATURE, V343, P599, DOI 10.1038/343599a0; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neary D, 2000, J NEUROL SCI, V180, P15, DOI 10.1016/S0022-510X(00)00425-1; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; Neville HJ, 1997, BRAIN LANG, V57, P285, DOI 10.1006/brln.1997.1739; OBLESER J, 2008, J COGNITIVE NEUROS S, pS231; Obleser J, 2010, CEREB CORTEX, V20, P633, DOI 10.1093/cercor/bhp128; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; PAPAGNO C, 1993, J NEUROL NEUROSUR PS, V56, P286, DOI 10.1136/jnnp.56.3.286; Peran P, 2009, CORTEX, V45, P960, DOI 10.1016/j.cortex.2009.02.019; PRAAMSTRA P, 1993, COGNITIVE BRAIN RES, V1, P73, DOI 10.1016/0926-6410(93)90013-U; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2008, SYMBOLS EMBODIMENT M, P85, DOI DOI 10.1093/ACPROF:OSO/9780199217274.003.0006; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rhee J, 2001, NEUROCASE, V7, P173, DOI 10.1093/neucas/7.2.173; Richardson D, 2003, COGNITIVE SCI, V31, P733; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; SANMARTIN R, 2010, NEUROIMAGE, V10, P1016; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; SEITZ RJ, 1992, ACTA NEUROL SCAND, V86, P60, DOI 10.1111/j.1600-0404.1992.tb08055.x; Shtyrov Y, 2004, EUR J NEUROSCI, V19, P1083, DOI 10.1111/j.0953-816X.2004.03126.x; Siemionow V, 2000, EXP BRAIN RES, V133, P303, DOI 10.1007/s002210000382; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P1444, DOI 10.1016/S1388-2457(02)00195-5; Smith AL, 2006, BRAIN RES, V1071, P165, DOI 10.1016/j.brainres.2005.11.084; Taylor LJ, 2008, Q J EXP PSYCHOL, V61, P896, DOI 10.1080/17470210701625519; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Toni I, 2008, J PHYSIOL-PARIS, V102, P71, DOI 10.1016/j.jphysparis.2008.03.005; Tops M, 2006, PSYCHON B REV, V13, P229, DOI 10.3758/BF03193835; Tseng M., 2005, P 27 ANN C COGN SCI; Valenstein E., 2003, CLIN NEUROPSYCHOLOGY, P215; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; VAN EM, 2008, J PHYSIOL-PARIS, V102, P95; VAN PC, 1995, PSYCHOPHYSIOLOGY, V32, P511; VAN PC, 2006, BRAIN LANG, V97, P279; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WHEELER K, EMPIRICAL E IN PRESS; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wu YC, 2005, PSYCHOPHYSIOLOGY, V42, P654, DOI 10.1111/j.1469-8986.2005.00356.x; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	132	88	90	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11751	10.1371/journal.pone.0011751	http://dx.doi.org/10.1371/journal.pone.0011751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QX	20676367	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100002
J	Guan, SX; Blanchard, A; Zhang, PH; Zhu, ZY				Guan, Shengxi; Blanchard, Aine; Zhang, Penghua; Zhu, Zhenyu			Alteration of Sequence Specificity of the Type IIS Restriction Endonuclease BtsI	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; DNA RESTRICTION; CLEAVAGE; ENZYMES; VARIANTS; GENES	The Type IIS restriction endonuclease BtsI recognizes and digests at GCAGTG(2/0). It comprises two subunits: BtsIA and BtsIB. The BtsIB subunit contains the recognition domain, one catalytic domain for bottom strand nicking and part of the catalytic domain for the top strand nicking. BtsIA has the rest of the catalytic domain that is responsible for the DNA top strand nicking. BtsIA alone has no activity unless it mixes with BtsIB to reconstitute the BtsI activity. During characterization of the enzyme, we identified a BtsIB mutant R119A found to have a different digestion pattern from the wild type BtsI. After characterization, we found that BtsIB(R119A) is a novel restriction enzyme with a previously unreported recognition sequence CAGTG(2/0), which is named as BtsI-1. Compared with wild type BtsI, BtsI-1 showed different relative activities in NEB restriction enzyme reaction buffers NEB1, NEB2, NEB3 and NEB4 and less star activity. Similar to the wild type BtsIB subunit, the BtsI-1 B subunit alone can act as a bottom nicking enzyme recognizing CAGTG(-/0). This is the first successful case of a specificity change among this restriction endonuclease type.	[Guan, Shengxi; Blanchard, Aine; Zhang, Penghua; Zhu, Zhenyu] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Guan, SX (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	zhuz@neb.com			New England Biolabs	New England Biolabs	New England Biolabs supported the work. As the authors are all employed by New England Biolabs, the funders were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Bellamy SRW, 2005, J MOL BIOL, V348, P641, DOI 10.1016/j.jmb.2005.02.035; Besnier CE, 2001, EMBO REP, V2, P782, DOI 10.1093/embo-reports/kve175; GINGERAS TR, 1978, NUCLEIC ACIDS RES, V5, P4105, DOI 10.1093/nar/5.11.4105; Heiter DF, 2005, J MOL BIOL, V348, P631, DOI 10.1016/j.jmb.2005.02.034; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Jurenaite-Urbanaviciene S, 2007, P NATL ACAD SCI USA, V104, P10358, DOI 10.1073/pnas.0610365104; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rimseliene R, 2003, J MOL BIOL, V327, P383, DOI 10.1016/S0022-2836(03)00142-6; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Xu SY, 2007, NUCLEIC ACIDS RES, V35, P4608, DOI 10.1093/nar/gkm481; Xu Y, 2001, P NATL ACAD SCI USA, V98, P12990, DOI 10.1073/pnas.241215698; Zhang PH, 2010, PROTEIN EXPRES PURIF, V69, P226, DOI 10.1016/j.pep.2009.09.003; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003; Zhu ZY, 2003, J MOL BIOL, V330, P359, DOI 10.1016/S0022-2836(03)00595-3	19	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11787	10.1371/journal.pone.0011787	http://dx.doi.org/10.1371/journal.pone.0011787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668693	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300019
J	Christiansen, B; Muguerza, NB; Petersen, AM; Kveiborg, B; Madsen, CR; Thomas, H; Ihlemann, N; Sorensen, JC; Kober, L; Sorensen, H; Torp-Pedersen, C; Dominguez, H				Christiansen, Buris; Muguerza, Natalia Bellostas; Petersen, Atheline Major; Kveiborg, Britt; Madsen, Christian Rask; Thomas, Hermann; Ihlemann, Nikolaj; Sorensen, Jens Christian; Kober, Lars; Sorensen, Hilmer; Torp-Pedersen, Christian; Dominguez, Helena			Ingestion of Broccoli Sprouts Does Not Improve Endothelial Function in Humans with Hypertension	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR INJURY; CANCER RISK; PART II; BRASSICA; METABOLISM; ISOTHIOCYANATES; POLYMORPHISMS; VASODILATION; DYSFUNCTION	Ingestion of glucosinolates has previously been reported to improve endothelial function in spontaneously hypertensive rats, possibly because of an increase in NO availability in the endothelium due to an attenuation of oxidative stress; in our study we tried to see if this also would be the case in humans suffering from essential hypertension. Methods: 40 hypertensive individuals without diabetes and with normal levels of cholesterol were examined. The participants were randomized either to ingest 10 g dried broccoli sprouts, a natural donor of glucosinolates with high in vitro antioxidative potential, for a 4 week period or to continue their ordinary diet and act as controls. Blood pressure, endothelial function measured by flow mediated dilation (FMD) and blood samples were obtained from the participants every other week and the content of glucosinolates was measured before and after the study. Measurements were blinded to treatment allocation. Results: In the interventional group overall FMD increased from 4% to 5.8% in the interventional group whereas in the control group FMD was stable (4% at baseline and 3.9% at the end of the study). The change in FMD in the interventional group was mainly due to a marked change in FMD in two participants while the other participants did not have marked changes in FMD. The observed differences were not statistically significant. Likewise significant changes in blood pressure or blood samples were not detected between or within groups. Diastolic blood pressure stayed essentially unchanged in both groups, while the systolic blood pressure showed a small non significant decrease (9 mm Hg) in the interventional group from a value of 153 mm Hg at start. Conclusion: Daily ingestion of 10 g dried broccoli sprouts does not improve endothelial function in the presence of hypertension in humans.	[Christiansen, Buris] Copenhagen Univ Hosp, Herlev Hosp, Dept Oncol, Region Hovedstaden, Denmark; [Muguerza, Natalia Bellostas; Sorensen, Jens Christian; Sorensen, Hilmer] Univ Copenhagen, Fac Life Sci, Copenhagen, Denmark; [Petersen, Atheline Major] Odense Univ Hosp, Dept Endocrinol, Region Midt, Denmark; [Kveiborg, Britt] Sygehus Syd, Dept Med, Region Sjaelland, Denmark; [Madsen, Christian Rask; Thomas, Hermann] Joslin Diabet Ctr, Dept Vasc Biol & Complicat, Boston, MA 02215 USA; [Ihlemann, Nikolaj; Kober, Lars; Torp-Pedersen, Christian] Copenhagen Univ Hosp, Gentofte Hosp, Dept Cardiol, Region Hovedstaden, Denmark; [Dominguez, Helena] Copenhagen Univ Hosp, Herlev Hosp, Dept Cardiol, Region Hovedstaden, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Harvard University; Joslin Diabetes Center, Inc.; University of Copenhagen; University of Copenhagen	Christiansen, B (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Oncol, Region Hovedstaden, Denmark.	buris@dadlnet.dk	DOMINGUEZ, Helena/ABC-1905-2021; Torp-Pedersen, Christian/E-5931-2013; Sorensen, Jens Christian/E-4110-2015	DOMINGUEZ, Helena/0000-0002-7089-2636; Sorensen, Jens Christian/0000-0001-6286-3010; Kober, Lars/0000-0002-6635-1466	Danish Heart Association; Beckett foundation	Danish Heart Association; Beckett foundation	This study was supported by grants from the Danish Heart Association (hjerteforeningen.dk) and the Beckett foundation (www.beckett-fonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellostas N, 2007, J SCI FOOD AGR, V87, P1586, DOI 10.1002/jsfa.2896; Bellostas N, 2006, J CHROMATOGR A, V1130, P246, DOI 10.1016/j.chroma.2006.05.079; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Gasper AV, 2007, J NUTR, V137, P1718, DOI 10.1093/jn/137.7.1718; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hambrecht R, 2000, JAMA-J AM MED ASSOC, V283, P3095, DOI 10.1001/jama.283.23.3095; Lampe JW, 2002, J NUTR, V132, P2991, DOI 10.1093/jn/131.10.2991; London SJ, 2000, LANCET, V356, P724, DOI 10.1016/S0140-6736(00)02631-3; Meiselman HJ, 2006, CLIN HEMORHEOL MICRO, V35, P37; Murashima M, 2004, BIOFACTORS, V22, P271, DOI 10.1002/biof.5520220154; Nara Y, 1999, CLIN EXP PHARMACOL P, V26, P536, DOI 10.1046/j.1440-1681.1999.03089.x; Newey VR, 2002, ULTRASOUND MED BIOL, V28, P209, DOI 10.1016/S0301-5629(01)00505-1; Pereira FMV, 2002, J AGR FOOD CHEM, V50, P6239, DOI 10.1021/jf020309x; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Sidhu JS, 2002, HEART, V88, P289, DOI 10.1136/heart.88.3.289; Taneva E, 2006, AM J CARDIOL, V97, P1002, DOI 10.1016/j.amjcard.2005.10.032; Verkerk R, 2008, MOL NUTR FOOD RES; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yamori Y, 1999, CLIN EXP PHARMACOL P, V26, P568, DOI 10.1046/j.1440-1681.1999.03085.x; Zhu CY, 2003, FOOD CHEM TOXICOL, V41, P455, DOI 10.1016/S0278-6915(02)00278-8	28	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12461	10.1371/journal.pone.0012461	http://dx.doi.org/10.1371/journal.pone.0012461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805984	Green Published, Green Submitted, gold			2022-12-27	WOS:000281301500026
J	Drineas, P; Lewis, J; Paschou, P				Drineas, Petros; Lewis, Jamey; Paschou, Peristera			Inferring Geographic Coordinates of Origin for Europeans Using Small Panels of Ancestry Informative Markers	PLOS ONE			English	Article							GENETIC SUBSTRUCTURE; POPULATION-STRUCTURE; ADMIXTURE; DISEASE; GENOME; ASSOCIATION; STRATIFICATION; SELECTION; PATTERNS; LINKAGE	Recent large-scale studies of European populations have demonstrated the existence of population genetic structure within Europe and the potential to accurately infer individual ancestry when information from hundreds of thousands of genetic markers is used. In fact, when genomewide genetic variation of European populations is projected down to a two-dimensional Principal Components Analysis plot, a surprising correlation with actual geographic coordinates of self-reported ancestry has been reported. This substructure can hamper the search of susceptibility genes for common complex disorders leading to spurious correlations. The identification of genetic markers that can correct for population stratification becomes therefore of paramount importance. Analyzing 1,200 individuals from 11 populations genotyped for more than 500,000 SNPs (Population Reference Sample), we present a systematic exploration of the extent to which geographic coordinates of origin within Europe can be predicted, with small panels of SNPs. Markers are selected to correlate with the top principal components of the dataset, as we have previously demonstrated. Performing thorough cross-validation experiments we show that it is indeed possible to predict individual ancestry within Europe down to a few hundred kilometers from actual individual origin, using information from carefully selected panels of 500 or 1,000 SNPs. Furthermore, we show that these panels can be used to correctly assign the HapMap Phase 3 European populations to their geographic origin. The SNPs that we propose can prove extremely useful in a variety of different settings, such as stratification correction or genetic ancestry testing, and the study of the history of European populations.	[Drineas, Petros; Lewis, Jamey] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Paschou, Peristera] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Rensselaer Polytechnic Institute; Democritus University of Thrace	Drineas, P (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	ppaschou@mbg.duth.gr		Paschou, Peristera/0000-0002-9783-1024	National Science Foundation Computing and Communication Foundations (NSF CCF) [0447950, 0824684]; European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF) [235-2009]; two Tourette Syndrome Association (TSA)	National Science Foundation Computing and Communication Foundations (NSF CCF); European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF); two Tourette Syndrome Association (TSA)	This work was supported, in part, by a National Science Foundation Computing and Communication Foundations (NSF CCF) 0447950 CAREER award to PD; an NSF CCF 0824684 award to PD; a European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF) 235-2009 Short-Term Fellowship to PD; and two Tourette Syndrome Association (TSA) Research Grant Awards to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; DEAN M, 1994, AM J HUM GENET, V55, P788; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; WRIGHT S, 1951, ANN EUGENIC, V15, P323	27	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11892	10.1371/journal.pone.0011892	http://dx.doi.org/10.1371/journal.pone.0011892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805874	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600004
J	Olberding, JE; Thouless, MD; Arruda, EM; Garikipati, K				Olberding, Joseph E.; Thouless, Michael D.; Arruda, Ellen M.; Garikipati, Krishna			The Non-Equilibrium Thermodynamics and Kinetics of Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; LIPID-BILAYERS; MOLECULAR-BOND; F-ACTIN; FORCE; INTEGRIN; FIBROBLASTS; ACTIVATION; BINDING	Background: We consider a focal adhesion to be made up of molecular complexes, each consisting of a ligand, an integrin molecule, and associated plaque proteins. Free energy changes drive the binding and unbinding of these complexes and thereby controls the focal adhesion's dynamic modes of growth, treadmilling and resorption. Principal Findings: We have identified a competition among four thermodynamic driving forces for focal adhesion dynamics: (i) the work done during the addition of a single molecular complex of a certain size, (ii) the chemical free energy change associated with the addition of a molecular complex, (iii) the elastic free energy change associated with deformation of focal adhesions and the cell membrane, and (iv) the work done on a molecular conformational change. We have developed a theoretical treatment of focal adhesion dynamics as a nonlinear rate process governed by a classical kinetic model. We also express the rates as being driven by out-of-equilibrium thermodynamic driving forces, and modulated by kinetics. The mechanisms governed by the above four effects allow focal adhesions to exhibit a rich variety of behavior without the need to introduce special constitutive assumptions for their response. For the reaction-limited case growth, treadmilling and resorption are all predicted by a very simple chemo-mechanical model. Treadmilling requires symmetry breaking between the ends of the focal adhesion, and is achieved by driving force (i) above. In contrast, depending on its numerical value (ii) causes symmetric growth, resorption or is neutral, (iii) causes symmetric resorption, and (iv) causes symmetric growth. These findings hold for a range of conditions: temporally-constant force or stress, and for spatially-uniform and non-uniform stress distribution over the FA. The symmetric growth mode dominates for temporally-constant stress, with a reduced treadmilling regime. Significance: In addition to explaining focal adhesion dynamics, this treatment can be coupled with models of cytoskeleton dynamics and contribute to the understanding of cell motility.	[Olberding, Joseph E.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Dept Mech Engn, Michigan Ctr Theoret Phys, Ann Arbor, MI 48109 USA; [Thouless, Michael D.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.] Univ Michigan, Program Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Olberding, JE (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	krishna@umich.edu			University of Michigan; Department of Energy	University of Michigan(University of Michigan System); Department of Energy(United States Department of Energy (DOE))	JEO was supported by a Rackham pre-doctoral fellowship from the University of Michigan. KG was supported by a Presidential Early Career Award for Scientists and Engineers (PECASE) grant from the Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Aroush DRB, 2008, SOFT MATTER, V4, P2410, DOI 10.1039/b804643n; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; De Groot S. R., 1984, NONEQUILIBRIUM THERM; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Deshpande VS, 2008, J MECH PHYS SOLIDS, V56, P1484, DOI 10.1016/j.jmps.2007.08.006; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X; Freund LB, 2009, P NATL ACAD SCI USA, V106, P8818, DOI 10.1073/pnas.0903003106; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 2008, COMMUNICATION; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JUNGBAUER S, 2008, J CELL BIOL, V171, P283; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lin Y, 2008, J MECH PHYS SOLIDS, V56, P241, DOI 10.1016/j.jmps.2007.02.008; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115; Nicolas A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051902; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; OOSAWA F, 1977, BIORHEOLOGY, V14, P11; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Qian J, 2008, LANGMUIR, V24, P1262, DOI 10.1021/la702401b; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shen CJ, 2008, CELL MOL BIOENG, V1, P15, DOI 10.1007/s12195-008-0005-y; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; VINEYARD GH, 1957, J PHYS CHEM SOLIDS, V3, P121, DOI 10.1016/0022-3697(57)90059-8; Wang JZ, 2008, J MECH PHYS SOLIDS, V56, P251, DOI 10.1016/j.jmps.2007.05.011; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	48	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12043	10.1371/journal.pone.0012043	http://dx.doi.org/10.1371/journal.pone.0012043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805876	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600005
J	Udell, JA; Wang, JT; Gladstone, DJ; Tu, JV				Udell, Jacob A.; Wang, Julie T.; Gladstone, David J.; Tu, Jack V.			Anticoagulation after Anterior Myocardial Infarction and the Risk of Stroke	PLOS ONE			English	Article							LEFT-VENTRICULAR THROMBUS; ACUTE CORONARY SYNDROME; LONG-TERM; MURAL THROMBI; ANTIPLATELET THERAPY; CLINICAL-TRIAL; WARFARIN; ASPIRIN; WALL; DYSFUNCTION	Background: Survivors of anterior MI are at increased risk for stroke with predilection to form ventricular thrombus. Commonly patients are discharged on dual antiplatelet therapy. Given the frequency of early coronary reperfusion and risk of bleeding, it remains uncertain whether anticoagulation offers additional utility. We examined the effectiveness of anticoagulation therapy for the prevention of stroke after anterior MI. Methods and Findings: We performed a population-based cohort analysis of 10,383 patients who survived hospitalization for an acute MI in Ontario, Canada from April 1, 1999 to March 31, 2001. The primary outcome was four-year ischemic stroke rates compared between anterior and non-anterior MI patients. Risk factors for stroke were assessed by multivariate Cox proportional-hazards analysis. Warfarin use was determined at discharge and followed for 90 days among a subset of patients aged 66 and older (n = 1483). Among the 10,383 patients studied, 2,942 patients survived hospitalization for an anterior MI and 20% were discharged on anticoagulation therapy. Within 4 years, 169 patients (5.7%) were admitted with an ischemic stroke, half of which occurred within 1-year post-MI. There was no significant difference in stroke rate between anterior and non-anterior MI patients. The use of warfarin up to 90 days was not associated with stroke protection after anterior MI (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.37-1.26). The use of angiotensin-converting-enzyme inhibitors (HR, 0.65; 95% CI, 0.44-0.95) and beta-blockers (HR, 0.60; 95% CI, 0.41-0.87) were associated with a significant decrease in stroke risk. There was no significant difference in bleeding-related hospitalizations in patients who used warfarin for up to 90 days post-MI. Conclusion: Many practitioners still consider a large anterior-wall MI as high risk for potential LV thrombus formation and stroke. Among a cohort of elderly patients who survived an anterior MI there was no benefit from the use of warfarin up to 90 days post-MI to prevent ischemic stroke. Our data suggests that routine anticoagulation of patients with anterior-wall MI may not be indicated. Prospective randomized trials are needed to determine the optimal antithrombin strategy for preventing this common and serious adverse outcome.	[Udell, Jacob A.; Wang, Julie T.; Gladstone, David J.; Tu, Jack V.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Udell, Jacob A.; Gladstone, David J.; Tu, Jack V.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Udell, Jacob A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Brigham & Women's Hospital	Udell, JA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	judell@partners.org		Udell, Jacob/0000-0001-7402-9584; Gladstone, David/0000-0003-0612-5544; Tu, Jack/0000-0003-0111-722X	Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation (HSF); HSF Centre for Stroke Recovery; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto	Canada Research Chair in Health Services Research(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation (HSF)(Heart & Stroke Foundation of Canada); HSF Centre for Stroke Recovery; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto(University of Toronto)	Dr. Tu is supported by a Canada Research Chair in Health Services Research and a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The EFFECT study was funded by a Canadian Institutes of Health Research (CIHR) Team Grant in Cardiovascular Outcomes Research (www.ccort.ca). Dr. Gladstone is supported by a Clinician Scientist Award from the Heart and Stroke Foundation (HSF), the HSF Centre for Stroke Recovery, and the Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P749, DOI 10.1016/S0735-1097(98)00006-0; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; [Anonymous], 1986, Lancet, V2, P57; Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; ASINGER RW, 1981, NEW ENGL J MED, V305, P297, DOI 10.1056/NEJM198108063050601; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; BODENHEIMER MM, 1994, J AM COLL CARDIOL, V24, P61, DOI 10.1016/0735-1097(94)90542-8; Bradshaw PJ, 2006, HEART, V92, P905, DOI 10.1136/hrt.2005.073122; CATTANEO M, 1993, LANCET, V342, P812, DOI 10.1016/0140-6736(93)91581-6; CREGLER LL, 1992, AM HEART J, V123, P1110, DOI 10.1016/0002-8703(92)91069-D; DEVITA C, 1994, LANCET, V343, P1115; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; FRIEDMAN MJ, 1982, AM J MED, V72, P894, DOI 10.1016/0002-9343(82)90848-8; FUSTER V, 1989, NEW ENGL J MED, V320, P392; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Greaves SC, 1997, AM J CARDIOL, V80, P442, DOI 10.1016/S0002-9149(97)00392-5; Herlitz J, 2005, J INTERN MED, V257, P201, DOI 10.1111/j.1365-2796.2004.01433.x; HESS DC, 1993, NEUROL CLIN, V11, P399, DOI 10.1016/S0733-8619(18)30160-9; HJALMARSON A, 1985, EUR HEART J, V6, P199; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Kapral MK, 1999, CAN MED ASSOC J, V161, P989; KEATING EC, 1983, AM J MED, V74, P989, DOI 10.1016/0002-9343(83)90798-2; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403; Kontny F, 1997, J AM COLL CARDIOL, V30, P962, DOI 10.1016/S0735-1097(97)00258-1; KOUVARAS G, 1990, AM HEART J, V119, P73, DOI 10.1016/S0002-8703(05)80084-5; LAMAS GA, 1988, AM J CARDIOL, V62, P31, DOI 10.1016/0002-9149(88)91360-4; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Lopez-Sendon J, 2004, EUR HEART J, V25, P1341, DOI 10.1016/j.ehj.2004.06.002; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; Miller FG, 2008, NEW ENGL J MED, V358, P765, DOI 10.1056/NEJMp0800136; Mooe T, 1997, STROKE, V28, P762, DOI 10.1161/01.STR.28.4.762; Nayak D, 2004, AM J CARDIOL, V93, P1529, DOI 10.1016/j.amjcard.2004.02.066; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pullicino P, 2003, NEW ENGL J MED, V348, P256; REEDER GS, 1981, MAYO CLIN PROC, V56, P77; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Schull MJ, 2005, AM HEART J, V150, P583, DOI 10.1016/j.ahj.2005.03.061; TANNE D, 1995, AM J CARDIOL, V76, P825, DOI 10.1016/S0002-9149(99)80236-7; Topol Eric J, 2003, ACP J Club, V138, P34; TRAMARIN R, 1986, EUR HEART J, V7, P482, DOI 10.1093/oxfordjournals.eurheartj.a062095; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Tu JV, 2004, QUALITY CARDIAC CARE; Tu JV, 2005, 2 I CLIN EV SCI; TURPIE AGG, 1989, NEW ENGL J MED, V320, P352, DOI 10.1056/NEJM198902093200604; VAITKUS PT, 1993, J AM COLL CARDIOL, V22, P1004, DOI 10.1016/0735-1097(93)90409-T; vanDantzig JM, 1996, EUR HEART J, V17, P1640; VECCHIO C, 1991, CIRCULATION, V84, P512, DOI 10.1161/01.CIR.84.2.512; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; WEINREICH DJ, 1984, ANN INTERN MED, V100, P789, DOI 10.7326/0003-4819-100-6-789; WEINTRAUB WS, 1989, AM J CARDIOL, V64, P708, DOI 10.1016/0002-9149(89)90752-2; Witt BJ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.058; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	63	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12150	10.1371/journal.pone.0012150	http://dx.doi.org/10.1371/journal.pone.0012150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730096	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200010
J	Lopez-Ramos, JC; Tomioka, Y; Morimatsu, M; Yamamoto, S; Ozaki, K; Ono, E; Delgado-Garcia, JM				Lopez-Ramos, Juan C.; Tomioka, Yukiko; Morimatsu, Masami; Yamamoto, Sayo; Ozaki, Kinuyo; Ono, Etsuro; Delgado-Garcia, Jose M.			Motor-Coordination-Dependent Learning, More than Others, Is Impaired in Transgenic Mice Expressing Pseudorabies Virus Immediate-Early Protein IE180	PLOS ONE			English	Article							LURCHER MUTANT MICE; ACOUSTIC STARTLE RESPONSE; CEREBELLAR PURKINJE-CELLS; AUJESZKYS-DISEASE VIRUS; LONG-TERM HABITUATION; PREPULSE INHIBITION; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL ROLES; NERVOUS PATHWAY; GENE-EXPRESSION	The cerebellum in transgenic mice expressing pseudorabies virus immediate-early protein IE180 (TgIE96) was substantially diminished in size, and its histoarchitecture was severely disorganized, resulting in severe ataxia. TgIE96 mice can therefore be used as an experimental model to study the involvement of cerebellar circuits in different learning tasks. The performance of three-month-old TgIE96 mice was studied in various behavioral tests, including associative learning (classical eyeblink conditioning), object recognition, spatial orientation (water maze), startle response and prepulse inhibition, and passive avoidance, and compared with that of wild-type mice. Wild-type and TgIE96 mice presented similar reflexively evoked eyeblinks, and acquired classical conditioned eyelid responses with similar learning curves for both trace and delay conditioning paradigms. The two groups of mice also had similar performances during the object recognition test. However, they showed significant differences for the other three tests included in this study. Although both groups of animals were capable of swimming, TgIE96 mice failed to learn the water maze task during the allowed time. The startle response to a severe tone was similar in both control and TgIE96 mice, but the latter were unable to produce a significant prepulse inhibition. TgIE96 mice also presented evident deficits for the proper accomplishment of a passive avoidance test. These results suggest that the cerebellum is not indispensable for the performance of classical eyeblink conditioning and for object recognition tasks, but seems to be necessary for the proper performance of water maze, prepulse inhibition, and passive avoidance tests.	[Lopez-Ramos, Juan C.; Delgado-Garcia, Jose M.] Pablo Olavide Univ, Div Neurosci, Seville, Spain; [Tomioka, Yukiko; Morimatsu, Masami] Hokkaido Univ, Inst Med Genet, Div Dis Model Innovat, Sapporo, Hokkaido, Japan; [Yamamoto, Sayo; Ozaki, Kinuyo; Ono, Etsuro] Kyushu Univ, Sch Med Sci, Ctr Biomed Res, Biomed Labs, Fukuoka 812, Japan	Universidad Pablo de Olavide; Hokkaido University; Kyushu University	Lopez-Ramos, JC (corresponding author), Pablo Olavide Univ, Div Neurosci, Seville, Spain.	etsuro@anim.med.kyushu-u.ac.jp; jmdelgar@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Morimatsu, Masami/A-6698-2012; Ramos, Juan Carlos López/K-9336-2014	Morimatsu, Masami/0000-0003-0740-0157; Lopez Ramos, Juan Carlos/0000-0003-0943-8802	Spanish Ministry of Science and Innovation [BFU2008-00899]; Junta de Andalucia (Spain) [BIO-122, CVI-02487]; Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain)	The research leading to these results has received funding from the Spanish Ministry of Science and Innovation (BFU2008-00899), the Junta de Andalucia (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini MV, 1999, MOL BRAIN RES, V70, P164, DOI 10.1016/S0169-328X(99)00144-8; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Boele HJ, 2010, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.019.2009; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; BROWN SH, 1993, EXP BRAIN RES, V94, P478; CASTON J, 1995, DEV BRAIN RES, V86, P311, DOI 10.1016/0165-3806(95)00037-E; Cendelin J, 2009, CEREBELLUM, V8, P35, DOI 10.1007/s12311-008-0061-9; Chen L, 1996, J NEUROSCI, V16, P2829; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Delgado-Garcia J M, 2002, Cerebellum, V1, P289, DOI 10.1080/147342202320883597; DESPERATI C, 1989, NEUROSCI LETT, V100, P164, DOI 10.1016/0304-3940(89)90678-2; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Gandhi CC, 2000, BEHAV BRAIN RES, V109, P37, DOI 10.1016/S0166-4328(99)00160-6; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; GREEN MR, 1983, CELL, V35, P137, DOI 10.1016/0092-8674(83)90216-7; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2000, J NEUROPHYSIOL, V83, P836, DOI 10.1152/jn.2000.83.2.836; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; Hilber P, 1998, BEHAV GENET, V28, P299, DOI 10.1023/A:1021675514883; Hobbs WE, 2001, J VIROL, V75, P3391, DOI 10.1128/JVI.75.7.3391-3403.2001; IHARA S, 1983, VIROLOGY, V131, P437, DOI 10.1016/0042-6822(83)90510-X; Inman M, 2001, J GEN VIROL, V82, P483, DOI 10.1099/0022-1317-82-3-483; Ioannides AA, 2005, PROG BRAIN RES, V148, P139, DOI 10.1016/S0079-6123(04)48012-1; Kishimoto Y, 2002, EUR J NEUROSCI, V16, P2416, DOI 10.1046/j.1460-9568.2002.02407.x; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; KRITAS SK, 1994, ACTA VET HUNG, V42, P309; KRITAS SK, 1994, VET MICROBIOL, V40, P323, DOI 10.1016/0378-1135(94)90120-1; Krizkova A, 2002, Cesk Fysiol, V51, P169; KUGELBERG E, 1952, BRAIN, V75, P385, DOI 10.1093/brain/75.3.385; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Lalonde R, 2008, NEUROBIOL LEARN MEM, V90, P472, DOI 10.1016/j.nlm.2008.05.004; LALONDE R, 1994, NEUROSCI BIOBEHAV R, V18, P161, DOI 10.1016/0149-7634(94)90022-1; LEATON RN, 1986, SCIENCE, V232, P513, DOI 10.1126/science.3961494; LEATON RN, 1991, BEHAV NEUROSCI, V105, P804, DOI 10.1037/0735-7044.105.6.804; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; Lopez-Ramos JC, 2007, J APPL PHYSIOL, V103, P1479, DOI 10.1152/japplphysiol.00384.2007; Machado CJ, 2009, EMOTION, V9, P147, DOI 10.1037/a0014539; Martin LA, 2003, EUR J NEUROSCI, V18, P2002, DOI 10.1046/j.1460-9568.2003.02921.x; Morcuende S, 2001, NEUROTOX RES, V3, P527, DOI 10.1007/BF03033208; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ogura H, 2001, BEHAV GENET, V31, P317, DOI 10.1023/A:1012235510600; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Porras-Garcia E, 2010, J NEUROPHYSIOL, V104, P346, DOI 10.1152/jn.00180.2010; Roizman B., 2001, FIELDS VIROLOGY, V4th ed., P2399; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; SAWAKI M, 2008, MOL CELL NEUROSCI, V39, P478; SWARTZWELDER HS, 1981, PHYSIOL BEHAV, V26, P323; Taharaguchi S, 2003, VIROLOGY, V307, P243, DOI 10.1016/S0042-6822(02)00062-4; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; Terhune KP, 2005, J NEURO-OPHTHALMOL, V25, P273, DOI 10.1097/01.wno.0000189826.62010.48; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Tomioka Y, 2008, EUR J NEUROSCI, V27, P2115, DOI 10.1111/j.1460-9568.2008.06174.x; Van Alphen AM, 2002, ANN NY ACAD SCI, V978, P413; VANOIRSCHOT JT, 1990, VET MICROBIOL, V23, P85, DOI 10.1016/0378-1135(90)90139-M; Vozeh F, 1998, Cesk Fysiol, V47, P74; Wong ML, 1997, ARCH VIROL, V142, P2099, DOI 10.1007/s007050050228; Woody CD, 1999, BRAIN RES, V836, P79, DOI 10.1016/S0006-8993(99)01613-3; WU L, 1988, VIROLOGY, V167, P318, DOI 10.1016/0042-6822(88)90089-X; YUAN R, 1989, VIROLOGY, V172, P92, DOI 10.1016/0042-6822(89)90110-4	67	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12123	10.1371/journal.pone.0012123	http://dx.doi.org/10.1371/journal.pone.0012123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711341	Green Published, Green Submitted, gold			2022-12-27	WOS:000280859700015
J	Rapaport, F; Leslie, C				Rapaport, Franck; Leslie, Christina			Determining Frequent Patterns of Copy Number Alterations in Cancer	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; ARRAY; GENOME; EXPRESSION; CLASSIFICATION; HYBRIDIZATION; ABERRATIONS	Cancer progression is often driven by an accumulation of genetic changes but also accompanied by increasing genomic instability. These processes lead to a complicated landscape of copy number alterations (CNAs) within individual tumors and great diversity across tumor samples. High resolution array-based comparative genomic hybridization (aCGH) is being used to profile CNAs of ever larger tumor collections, and better computational methods for processing these data sets and identifying potential driver CNAs are needed. Typical studies of aCGH data sets take a pipeline approach, starting with segmentation of profiles, calls of gains and losses, and finally determination of frequent CNAs across samples. A drawback of pipelines is that choices at each step may produce different results, and biases are propagated forward. We present a mathematically robust new method that exploits probe-level correlations in aCGH data to discover subsets of samples that display common CNAs. Our algorithm is related to recent work on maximum-margin clustering. It does not require pre-segmentation of the data and also provides grouping of recurrent CNAs into clusters. We tested our approach on a large cohort of glioblastoma aCGH samples from The Cancer Genome Atlas and recovered almost all CNAs reported in the initial study. We also found additional significant CNAs missed by the original analysis but supported by earlier studies, and we identified significant correlations between CNAs.	[Rapaport, Franck; Leslie, Christina] Sloan Kettering Inst, Computat Biol Program, New York, NY USA	Memorial Sloan Kettering Cancer Center	Rapaport, F (corresponding author), Sloan Kettering Inst, Computat Biol Program, New York, NY USA.	cleslie@cbio.mskcc.org		Rapaport, Franck/0000-0001-6553-2110	National Science Foundation [IIS-0705580]; National Institutes of Health [1-U24-CA143840]; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [0835494] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation grant IIS-0705580 and National Institutes of Health grant 1-U24-CA143840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; BACH F, 2007, ADV NEURAL INFORM PR, V20; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Franchini C, 2006, APOPTOSIS, V11, P2217, DOI 10.1007/s10495-006-0195-5; HASTIE T, 2004, NIPS; HOLMSTROM K, 1999, ADV MODEL OPTIM, V1, P47; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; MAGNANI I, 2005, IDENTIFICATION OLIGO; Mao X, 1999, BRIT J CANCER, V79, P724, DOI 10.1038/sj.bjc.6690116; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Mark HFL, 1999, CANCER GENET CYTOGEN, V108, P26, DOI 10.1016/S0165-4608(98)00104-6; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Nagasaka T, 2007, BRAIN TUMOR PATHOL, V24, P1, DOI 10.1007/s10014-006-0209-6; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; O'Hagan RC, 2003, CANCER RES, V63, P5352; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rapaport F, 2008, BIOINFORMATICS, V24, pI375, DOI 10.1093/bioinformatics/btn188; Rueda OM, 2010, CURR BIOINFORM, V5, P1; Shlens J., 2005, TUTORIAL PRINCIPAL C; SPEICHER MR, 1994, CANCER RES, V54, P3817; Spencer DV, 2007, CANCER GENET CYTOGEN, V179, P82, DOI 10.1016/j.cancergencyto.2007.08.007; Sturm JF, 1999, OPTIM METHOD SOFTW, V11-2, P625, DOI 10.1080/10556789908805766; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Tibshirani R, 2005, J R STAT SOC B, V67, P91, DOI 10.1111/j.1467-9868.2005.00490.x; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; TROLET J, 2009, INVEST OPHTHALMOL VI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; XU L, 2005, ADV NEURAL INFORM PR, V17, P1537; Zhang K., 2007, P 24 INT C MACH LEAR, V227, P1119; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao ZX, 2008, MACROMOL BIOSCI, V8, P25, DOI 10.1002/mabi.200700180	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12028	10.1371/journal.pone.0012028	http://dx.doi.org/10.1371/journal.pone.0012028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711339	Green Published, gold, Green Submitted			2022-12-27	WOS:000280859700002
J	Xu, HL; Balakrishnan, K; Malaterre, J; Beasley, M; Yan, YQ; Essers, J; Appeldoorn, E; Thomaszewski, JM; Vazquez, M; Verschoor, S; Lavin, MF; Bertonchello, I; Ramsay, RG; Mckay, MJ				Xu, Huiling; Balakrishnan, Kuhendra; Malaterre, Jordane; Beasley, Matthew; Yan, Yuqian; Essers, Jeroen; Appeldoorn, Esther; Thomaszewski, Jonathan M.; Vazquez, Melisa; Verschoor, Sandra; Lavin, Martin F.; Bertonchello, Ivan; Ramsay, Robert G.; Mckay, Michael J.			Rad21-Cohesin Haploinsufficiency Impedes DNA Repair and Enhances Gastrointestinal Radiosensitivity in Mice	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; RADIATION-INDUCED APOPTOSIS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; SMALL-INTESTINE; STEM-CELLS; HOMOLOGOUS RECOMBINATION; VERTEBRATE CELLS	Approximately half of cancer-affected patients receive radiotherapy (RT). The doses delivered have been determined upon empirical experience based upon average radiation responses. Ideally higher curative radiation doses might be employed in patients with genuinely normal radiation responses and importantly radiation hypersensitive patients would be spared the consequences of excessive tissue damage if they were indentified before treatment. Rad21 is an integral subunit of the cohesin complex, which regulates chromosome segregation and DNA damage responses in eukaryotes. We show here, by targeted inactivation of this key cohesin component in mice, that Rad21 is a DNA-damage response gene that markedly affects animal and cell survival. Biallelic deletion of Rad21 results in early embryonic death. Rad21 heterozygous mutant cells are defective in homologous recombination (HR)-mediated gene targeting and sister chromatid exchanges. Rad21(+/-) animals exhibited sensitivity considerably greater than control littermates when challenged with whole body irradiation (WBI). Importantly, Rad21(+/-) animals are significantly more sensitive to WBI than Atm heterozygous mutant mice. Since supralethal WBI of mammals most typically leads to death via damage to the gastrointestinal tract (GIT) or the haematopoietic system, we determined the functional status of these organs in the irradiated animals. We found evidence for GIT hypersensitivity of the Rad21 mutants and impaired bone marrow stem cell clonogenic regeneration. These data indicate that Rad21 gene dosage is critical for the ionising radiation (IR) response. Rad21 mutant mice thus represent a new mammalian model for understanding the molecular basis of irradiation effects on normal tissues and have important implications in the understanding of acute radiation toxicity in normal tissues.	[Xu, Huiling; Balakrishnan, Kuhendra; Malaterre, Jordane; Beasley, Matthew; Yan, Yuqian; Vazquez, Melisa; Verschoor, Sandra; Ramsay, Robert G.; Mckay, Michael J.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia; [Xu, Huiling; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Fac Med & Dent Sci, Parkville, Vic 3052, Australia; [Appeldoorn, Esther] Erasmus MC, Dept Cell Biol & Genet, Dept Radiobiol, Dept Vasc Surg, Rotterdam, Netherlands; [Thomaszewski, Jonathan M.; Mckay, Michael J.] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia; [Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Bertonchello, Ivan] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; University of Melbourne	Xu, HL (corresponding author), Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia.	rob.ramsay@petermac.org; michael.mckay@act.gov.au	Ramsay, Robert G/C-3291-2015; Bertoncello, Ivan/B-9235-2008; Lavin, Martin F/F-5961-2014; Yan, Yuqian/AAU-5681-2020; McKay, Michael/ABA-9029-2021	Ramsay, Robert G/0000-0001-5003-0433; Lavin, Martin F/0000-0002-5940-4769; 	NHMRC [400207, 400310]; Cancer Council Victoria [081219]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported in part by NHMRC grants 400207 and 400310 (www.nhmrc.gov.au) and Cancer Council Victoria grant 081219 (www.cancercouncil.com.au/cancercouncil/VIC). RGR is also supported by a NHMRC Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD MC, 1991, EXP HEMATOL, V19, P282; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bremer M, 2003, RADIOTHER ONCOL, V69, P155, DOI 10.1016/j.radonc.2003.08.004; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Geoffroy-Perez B, 2001, INT J CANCER, V93, P288, DOI 10.1002/ijc.1329; GERMAN JAA, 1994, ANAL SISTER CHROMATI; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Heo SJ, 1998, MOL GEN GENET, V257, P149, DOI 10.1007/s004380050634; Hogan B, 1994, MANIPULATING MOUSE E; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Maj JG, 2003, CANCER RES, V63, P4338; McKay MJ, 1996, GENOMICS, V36, P305, DOI 10.1006/geno.1996.0466; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Ramsay RG, 2004, MOL CANCER RES, V2, P354; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Spring K, 2001, CANCER RES, V61, P4561; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; Szuts D, 2005, EXP CELL RES, V311, P240, DOI 10.1016/j.yexcr.2005.09.009; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Thomas P, 2003, MUTAGENESIS, V18, P187, DOI 10.1093/mutage/18.2.187; Thompson Deborah, 2005, Hum Mutat, V25, P594, DOI 10.1002/humu.9344; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; WITHERS HR, 1969, RADIAT RES, V38, P598, DOI 10.2307/3572619; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Xu HL, 2004, EMBO REP, V5, P378, DOI 10.1038/sj.embor.7400121; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884	58	79	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12112	10.1371/journal.pone.0012112	http://dx.doi.org/10.1371/journal.pone.0012112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711430	Green Published, gold			2022-12-27	WOS:000280859700008
J	Wegwitz, F; Kluth, MA; Manz, C; Otto, B; Gruner, K; Heinlein, C; Kuhl, M; Warnecke, G; Schumacher, U; Deppert, W; Tolstonog, GV				Wegwitz, Florian; Kluth, Mark-Andreas; Maenz, Claudia; Otto, Benjamin; Gruner, Katharina; Heinlein, Christina; Kuehl, Marion; Warnecke, Gabriele; Schumacher, Udo; Deppert, Wolfgang; Tolstonog, Genrich V.			Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; STEM-CELLS; BREAST-CANCER; TRANSGENIC MICE; BASAL-LIKE; EXPRESSION; GLAND; DIFFERENTIATION; IDENTIFICATION	Background: In analogy to normal stem cell differentiation, the current cancer stem cell (CSC) model presumes a hierarchical organization and an irreversible differentiation in tumor tissue. Accordingly, CSCs should comprise only a small subset of the tumor cells, which feeds tumor growth. However, some recent findings raised doubts on the general applicability of the CSC model and asked for its refinement. Methodology/Principal Findings: In this study we analyzed the CSC properties of mammary carcinoma cells derived from transgenic (WAP-T) mice. We established a highly tumorigenic WAP-T cell line (G-2 cells) that displays stem-like traits. G-2 cells, as well as their clonal derivates, are closely related to primary tumors regarding histology and gene expression profiles, and reflect heterogeneity regarding their differentiation states. G-2 cultures comprise cell populations in distinct differentiation states identified by co-expression of cytoskeletal proteins (cytokeratins and vimentin), a combination of cell surface markers and a set of transcription factors. Cellular subsets sorted according to expression of CD24a, CD49f, CD61, Epcam, Sca1, and Thy1 cell surface proteins, or metabolic markers (e.g. ALDH activity) are competent to reconstitute the initial cellular composition. Repopulation efficiency greatly varies between individual subsets and is influenced by interactions with the respective complementary G-2 cellular subset. The balance between differentiation states is regulated in part by the transcription factor Sox10, as depletion of Sox10 led to up-regulation of Twist2 and increased the proportion of Thy1-expressing cells representing cells in a self-renewable, reversible, quasi-mesenchymal differentiation state. Conclusions/Significance: G-2 cells constitute a self-reproducing cancer cell system, maintained by bi- and unidirectional conversion of complementary cellular subsets. Our work contributes to the current controversial discussion on the existence and nature of CSC and provides a basis for the incorporation of alternative hypotheses into the CSC model.	[Wegwitz, Florian; Kluth, Mark-Andreas; Maenz, Claudia; Gruner, Katharina; Heinlein, Christina; Kuehl, Marion; Warnecke, Gabriele; Deppert, Wolfgang; Tolstonog, Genrich V.] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumor Virol, D-2000 Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Dept Anat 2, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wegwitz, F (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumor Virol, Martinistr 52, D-2000 Hamburg, Germany.	wolfgang.deppert@hpi.uni-hamburg.de; genrich.tolstonog@hpi.uni-hamburg.de			Deutsche Forschungsgemeinschaft [De 212/23-1-3]; Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen''); VFK Krebsforschung gGmbH; Fonds der Chemischen Industrie; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen'')(Deutsche Krebshilfe); VFK Krebsforschung gGmbH; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	This study was supported by grants from the Deutsche Forschungsgemeinschaft (De 212/23-1-3 to W. D. and G. T.), the Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen'') to W. D. and G. T., the VFK Krebsforschung gGmbH to W. D., and the Fonds der Chemischen Industrie. The Heinrich-Pette-Institute is financially supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bassuk AG, 1998, MOL MED, V4, P392, DOI 10.1007/BF03401746; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dakir ELH, 2008, CARCINOGENESIS, V29, P2377, DOI 10.1093/carcin/bgn190; DEXTER DL, 1978, CANCER RES, V38, P3174; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Gilles C, 1999, J CELL SCI, V112, P4615; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Greenberg JM, 2004, DEV DYNAM, V230, P350, DOI 10.1002/dvdy.20045; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Lander Arthur D., 2009, Journal of Biology (London), V8, P70, DOI 10.1186/jbiol177; LENNON VA, 1978, P NATL ACAD SCI USA, V75, P6093, DOI 10.1073/pnas.75.12.6093; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lotem J, 2006, ONCOGENE, V25, P7663, DOI 10.1038/sj.onc.1209816; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; NOWELL PC, 1986, CANCER RES, V46, P2203; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; RUDLAND PS, 1982, J NATL CANCER I, V68, P799; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schulze-Garg C, 2000, ONCOGENE, V19, P1028, DOI 10.1038/sj.onc.1203281; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Smith GH, 2005, STEM CELL REV, V1, P215, DOI 10.1385/SCR:1:3:215; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tzeng YJ, 1998, ONCOGENE, V16, P2103, DOI 10.1038/sj.onc.1201733; TZENG YJ, 1993, ONCOGENE, V8, P1965; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, WD SCI P COMP ENG, V1, P295, DOI 10.1142/9789812799470_0048; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	80	18	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12103	10.1371/journal.pone.0012103	http://dx.doi.org/10.1371/journal.pone.0012103			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20730114	gold, Green Published, Green Submitted			2022-12-27	WOS:000280849100025
J	Skorupski, P; Chittka, L				Skorupski, Peter; Chittka, Lars			Photoreceptor Spectral Sensitivity in the Bumblebee, Bombus impatiens (Hymenoptera: Apidae)	PLOS ONE			English	Article							COLOR-VISION; INSECTS; OMMATIDIA; BEES	The bumblebee Bombus impatiens is increasingly used as a model in comparative studies of colour vision, or in behavioural studies relying on perceptual discrimination of colour. However, full spectral sensitivity data on the photoreceptor inputs underlying colour vision are not available for B. impatiens. Since most known bee species are trichromatic, with photoreceptor spectral sensitivity peaks in the UV, blue and green regions of the spectrum, data from a related species, where spectral sensitivity measurements have been made, are often applied to B impatiens. Nevertheless, species differences in spectral tuning of equivalent photoreceptor classes may result in peaks that differ by several nm, which may have small but significant effects on colour discrimination ability. We therefore used intracellular recording to measure photoreceptor spectral sensitivity in B. impatiens. Spectral peaks were estimated at 347, 424 and 539 nm for UV, blue and green receptors, respectively, suggesting that this species is a UV-blue-green trichromat. Photoreceptor spectral sensitivity peaks are similar to previous measurements from Bombus terrestris, although there is a significant difference in the peak sensitivity of the blue receptor, which is shifted in the short wave direction by 12-13 nm in B. impatiens compared to B. terrestris.	[Skorupski, Peter; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Skorupski, P (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	p.skorupski@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BERNARD GD, 1978, NATURWISSENSCHAFTEN, V65, P442, DOI 10.1007/BF00405378; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Kelber A, 2006, INVERTEBRATE VISION, P250; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Laughlin SB, 1981, HDB SENSORY PHYSL B, VVII, P133; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P556, DOI 10.1113/jphysiol.1966.sp008002; Palacios AG, 1998, VISUAL NEUROSCI, V15, P319, DOI 10.1017/S0952523898152136; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; Stavenga DG, 2004, J COMP PHYSIOL A, V190, P115, DOI 10.1007/s00359-003-0477-0; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wakakuwa M, 2007, PHOTOCHEM PHOTOBIOL, V83, P27, DOI 10.1562/2006-03-03-IR-831; Worden BD, 2005, J EXP BIOL, V208, P2045, DOI 10.1242/jeb.01582	24	45	48	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12049	10.1371/journal.pone.0012049	http://dx.doi.org/10.1371/journal.pone.0012049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711523	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000280811900012
J	Wang, IJ; Jhuang, MC; Chen, YH; Yeh, LK; Liu, CY; Young, TH				Wang, I-Jong; Jhuang, Min-Chao; Chen, Yu-Hsin; Yeh, Lung-Kun; Liu, Chia-Yang; Young, Tai-Horng			Chitosan Modification of Adenovirus to Modify Transfection Efficiency in Bovine Corneal Epithelial Cells	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; OCULAR DRUG-DELIVERY; POLYMER-COATED ADENOVIRUS; GROWTH-FACTOR RECEPTOR; IN-VITRO; POLYETHYLENE-GLYCOL; NEUTRALIZING ANTIBODIES; ENHANCED TRANSDUCTION; IMMUNE-RESPONSES; VIVO	Background: The purpose of this study is to modulate the transfection efficiency of adenovirus (Ad) on the cornea by the covalent attachment of chitosan on adenoviral capsids via a thioether linkage between chitosan modified with 2-iminothiolane and Ad cross-linked with N-[gamma-maleimidobutyryloxy] succinimide ester (GMBS). Methodology/Principal Findings: Modified Ad was obtained by reaction with the heterobifunctional crosslinking reagent, GMBS, producing maleimide-modified Ad (Ad-GMBS). Then, the chitosan-SH was conjugated to Ad-GMBS via a thioether bond at different ratios of Ad to GMBS to chitosan-SH. The sizes and zeta potentials of unmodified Ad and chitosan-modified Ads were measured, and the morphologies of the virus particles were observed under transmission electron microscope. Primary cultures of bovine corneal epithelial cells were transfected with Ads and chitosan-modified Ads in the absence or presence of anti-adenovirus antibodies. Chitosan modification did not significantly change the particle size of Ad, but the surface charge of Ad increased significantly from -24.3 mV to nearly neutral. Furthermore, primary cultures of bovine corneal epithelial cells were transfected with Ad or chitosan-modified Ad in the absence or presence of anti-Ad antibodies. The transfection efficiency was attenuated gradually with increasing amounts of GMBS. However, incorporation of chitosan partly restored transfection activity and rendered the modified antibody resistant to antibody neutralization. Conclusions/Significance: Chitosan can provide a platform for chemical modification of Ad, which offers potential for further in vivo applications.	[Wang, I-Jong] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan; [Jhuang, Min-Chao; Chen, Yu-Hsin; Young, Tai-Horng] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol & Cell Biol Neurosci & Anat, Cincinnati, OH USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 10764, Taiwan.	thyoung@ntu.edu.tw		Wang, I-Jong/0000-0002-3045-0614; Liu, Chia-yang/0000-0002-8398-5516	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Supported by National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arcasoy SM, 1997, AM J RESP CELL MOL, V17, P422, DOI 10.1165/ajrcmb.17.4.2714; Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Bernkop-Schnurch A, 2003, INT J PHARMACEUT, V260, P229, DOI 10.1016/S0378-5173(03)00271-0; Bonsted A, 2006, J GENE MED, V8, P286, DOI 10.1002/jgm.853; Borchard G, 1996, J CONTROL RELEASE, V39, P131, DOI 10.1016/0168-3659(95)00146-8; Borras T, 1996, INVEST OPHTH VIS SCI, V37, P1282; Borras T, 2001, J GENE MED, V3, P437, DOI 10.1002/jgm.210; BUDENZ DL, 1995, INVEST OPHTH VIS SCI, V36, P2211; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Chillon M, 1998, GENE THER, V5, P995, DOI 10.1038/sj.gt.3300665; Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441; Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972; Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001; Croyle MA, 2001, MOL THER, V4, P22, DOI 10.1006/mthe.2001.0411; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; de Campos AM, 2004, PHARM RES-DORDR, V21, P803, DOI 10.1023/B:PHAM.0000026432.75781.cb; De Campos AM, 2003, EUR J PHARM SCI, V20, P73, DOI 10.1016/S0928-0987(03)00178-7; de Salamanca AE, 2006, INVEST OPHTH VIS SCI, V47, P1416, DOI 10.1167/iovs.05-0495; Diebold Y, 2007, BIOMATERIALS, V28, P1553, DOI 10.1016/j.biomaterials.2006.11.028; Eto Y, 2005, J GENE MED, V7, P604, DOI 10.1002/jgm.699; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Harding SE, 2003, BIOCHEM SOC T, V31, P1036; HELMKE RJ, 1970, APPL MICROBIOL, V20, P986, DOI 10.1128/AEM.20.6.986-988.1970; Kawamata Y, 2002, BIOMATERIALS, V23, P4573, DOI 10.1016/S0142-9612(02)00203-X; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Lanciotti J, 2003, MOL THER, V8, P99, DOI 10.1016/S1525-0016(03)00139-4; MASHHOUR B, 1994, GENE THER, V1, P122; Masuko T, 2005, BIOMACROMOLECULES, V6, P880, DOI 10.1021/bm049352e; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015; O'Neal D, 1998, J LIPID RES, V39, P2086; O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Rosenblatt Mark I., 2004, International Ophthalmology Clinics, V44, P81, DOI 10.1097/00004397-200404430-00010; Stevenson M, 2007, CANCER GENE THER, V14, P335, DOI 10.1038/sj.cgt.7701022; Stevenson M, 2006, GENE THER, V13, P356, DOI 10.1038/sj.gt.3302655; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; TAO WH, 1995, INVEST OPHTH VIS SCI, V36, P2614; Tsubota K, 1998, EXP EYE RES, V67, P531, DOI 10.1006/exer.1998.0557; WILCOX GE, 1969, APPL MICROBIOL, V18, P268, DOI 10.1128/AEM.18.2.268-269.1969	45	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12085	10.1371/journal.pone.0012085	http://dx.doi.org/10.1371/journal.pone.0012085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711466	Green Submitted, Green Published, gold			2022-12-27	WOS:000280811900025
J	Egger, SW; Engelhardt, HR; Britten, KH				Egger, Seth W.; Engelhardt, Heidi R.; Britten, Kenneth H.			Monkey Steering Responses Reveal Rapid Visual-Motor Feedback	PLOS ONE			English	Article							OPTIC FLOW; NEURONAL RESPONSES; EYE-MOVEMENTS; RETINAL FLOW; DIRECTION; PERCEPTION; BEHAVIOR; PURSUIT; SMOOTH; HEAD	The neural mechanisms underlying primate locomotion are largely unknown. While behavioral and theoretical work has provided a number of ideas of how navigation is controlled, progress will require direct physiolgical tests of the underlying mechanisms. In turn, this will require development of appropriate animal models. We trained three monkeys to track a moving visual target in a simple virtual environment, using a joystick to control their direction. The monkeys learned to quickly and accurately turn to the target, and their steering behavior was quite stereotyped and reliable. Monkeys typically responded to abrupt steps of target direction with a biphasic steering movement, exhibiting modest but transient overshoot. Response latencies averaged approximately 300 ms, and monkeys were typically back on target after about 1 s. We also exploited the variability of responses about the mean to explore the time-course of correlation between target direction and steering response. This analysis revealed a broad peak of correlation spanning approximately 400 ms in the recent past, during which steering errors provoke a compensatory response. This suggests a continuous, visual-motor loop controls steering behavior, even during the epoch surrounding transient inputs. Many results from the human literature also suggest that steering is controlled by such a closed loop. The similarity of our results to those in humans suggests the monkey is a very good animal model for human visually guided steering.	[Egger, Seth W.; Engelhardt, Heidi R.; Britten, Kenneth H.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Britten, Kenneth H.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Egger, SW (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	khbritten@ucdavis.edu		/0000-0003-3688-7099	National Institutes of Health, National Eye Institute [EY10562]; Vision Core Center [EY12576]; PI Werner; NATIONAL EYE INSTITUTE [R01EY010562, P30EY012576] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vision Core Center; PI Werner; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health, National Eye Institute. Two grants supported this work: EY10562 to KHB, and a Vision Core Center grant, EY12576, PI Werner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Churchland MM, 2001, J NEUROPHYSIOL, V86, P741, DOI 10.1152/jn.2001.86.2.741; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; Fajen BR, 2003, J EXP PSYCHOL HUMAN, V29, P343, DOI 10.1037/0096-1523.29.2.343; Gibson JJ, 1950, PERCEPTION VISUAL WO; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; Hildreth EC, 2000, J EXP PSYCHOL HUMAN, V26, P1106, DOI 10.1037//0096-1523.26.3.1106; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; Mennie N, 2007, EXP BRAIN RES, V179, P427, DOI 10.1007/s00221-006-0804-0; Page WK, 2008, CEREB CORTEX, V18, P727, DOI 10.1093/cercor/bhm109; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Stone LS, 1997, VISION RES, V37, P573, DOI 10.1016/S0042-6989(96)00204-0; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wilkie R, 2003, J EXP PSYCHOL HUMAN, V29, P363, DOI 10.1037/0096-1523.29.2.363; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wilkie RM, 2006, J EXP PSYCHOL HUMAN, V32, P88, DOI 10.1037/0096-1523.32.1.88; Wilkie RM, 2005, J EXP PSYCHOL HUMAN, V31, P901, DOI 10.1037/0096-1523.31.5.901; Wilkie RM, 2002, CURR BIOL, V12, P2014, DOI 10.1016/S0960-9822(02)01337-4; Zhang T, 2004, NEURON, V42, P993, DOI 10.1016/j.neuron.2004.06.008	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11975	10.1371/journal.pone.0011975	http://dx.doi.org/10.1371/journal.pone.0011975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694144	Green Published, gold			2022-12-27	WOS:000280574300017
J	Jung, O; Jansen, F; Mieth, A; Barbosa-Sicard, E; Pliquett, RU; Babelova, A; Morisseau, C; Hwang, SH; Tsai, C; Hammock, BD; Schaefer, L; Geisslinger, G; Amann, K; Brandes, RP				Jung, Oliver; Jansen, Felix; Mieth, Anja; Barbosa-Sicard, Eduardo; Pliquett, Rainer U.; Babelova, Andrea; Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.; Schaefer, Liliana; Geisslinger, Gerd; Amann, Kerstin; Brandes, Ralf P.			Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE REGULATION; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; GLOMERULAR INJURY; ARACHIDONIC-ACID; KIDNEY; PROTECTION; MASS; GLOMERULONEPHRITIS	Epoxyeicotrienoic acids (EETs) are cytochrome P450-dependent anti-hypertensive and anti-inflammatory derivatives of arachidonic acid, which are highly abundant in the kidney and considered reno-protective. EETs are degraded by the enzyme soluble epoxide hydrolase (sEH) and sEH inhibitors are considered treatment for chronic renal failure (CRF). We determined whether sEH inhibition attenuates the progression of CRF in the 5/6-nephrectomy model (5/6-Nx) in mice. 5/6-Nx mice were treated with a placebo, an ACE-inhibitor (Ramipril, 40 mg/kg), the sEH-inhibitor cAUCB or the CYP-inhibitor fenbendazole for 8 weeks. 5/6-Nx induced hypertension, albuminuria, glomerulosclerosis and tubulo-interstitial damage and these effects were attenuated by Ramipril. In contrast, cAUCB failed to lower the blood pressure and albuminuria was more severe as compared to placebo. Plasma EET-levels were doubled in 5/6 Nx-mice as compared to sham mice receiving placebo. Renal sEH expression was attenuated in 5/6-Nx mice but cAUCB in these animals still further increased the EET-level. cAUCB also increased 5-HETE and 15-HETE, which derive from peroxidation or lipoxygenases. Similar to cAUCB, CYP450 inhibition increased HETEs and promoted albuminuria. Thus, sEH-inhibition failed to elicit protective effects in the 5/6-Nx model and showed a tendency to aggravate the disease. These effects might be consequence of a shift of arachidonic acid metabolism into the lipoxygenase pathway.	[Jung, Oliver; Jansen, Felix; Mieth, Anja; Pliquett, Rainer U.; Babelova, Andrea; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Frankfurt, Germany; [Jung, Oliver; Pliquett, Rainer U.] Klinikum Goethe Univ, Med Klin 3, Frankfurt, Germany; [Barbosa-Sicard, Eduardo] Klinikum Goethe Univ, Inst Vasc Signalling, Frankfurt, Germany; [Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morisseau, Christophe; Hwang, Sung H.; Tsai, Cindy; Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Schaefer, Liliana] Klinikum Goethe Univ, Pharmazentrum Frankfurt, ZAFES, Inst Allgemeine Pharmakol, Frankfurt, Germany; [Geisslinger, Gerd] Klinikum Goethe Univ, Pharmazentrum Frankfurt, ZAFES, Inst Klin Pharmakol, Frankfurt, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of California System; University of California Davis; University of California System; University of California Davis; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Erlangen Nuremberg	Jung, O (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Fachbereich Med, Frankfurt, Germany.	r.brandes@em.uni-frankfurt.de	Pliquett, Rainer U./ABG-1742-2020; Brandes, Ralf P/L-3058-2017; Babelova, Andrea/E-7768-2018	Pliquett, Rainer U./0000-0001-9684-0618; Brandes, Ralf P/0000-0002-8035-0048; Babelova, Andrea/0000-0001-9548-6602; Schaefer, Liliana/0000-0002-3318-3005	Deutsche Forschungsgemeinschaft [BR1839/4-2, SFB 423, Z2]; Exzellenzcluster 147 "Cardio-Pulmonary Systems''; Medical Faculty of the Goethe-University; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); National Institute of Environmental Health Sciences [R01 ER02710]; National Institutes of Health [HL59699]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL059699, R01HL059699] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Exzellenzcluster 147 "Cardio-Pulmonary Systems''; Medical Faculty of the Goethe-University; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Deutsche Forschungsgemeinschaft (BR1839/4-2 and SFB 423, Z2), the Exzellenzcluster 147 "Cardio-Pulmonary Systems'', the Medical Faculty of the Goethe-University, the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF) and the National Institute of Environmental Health Sciences (grant R01 ER02710) and National Institutes of Health HL59699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Capdevila JH, 2001, BIOCHEM BIOPH RES CO, V285, P571, DOI 10.1006/bbrc.2001.5167; Chamberlain RM, 2007, EXP PHYSIOL, V92, P251, DOI 10.1113/expphysiol.2006.034751; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Chiurchiu C, 2005, J AM SOC NEPHROL, V16, pS58, DOI 10.1681/ASN.2004110968; Dimmler A, 2003, DIAGN MOL PATHOL, V12, P108, DOI 10.1097/00019606-200306000-00007; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Fleming I, 2008, TRENDS CARDIOVAS MED, V18, P20, DOI 10.1016/j.tcm.2007.11.002; Fornage M, 2002, HYPERTENSION, V40, P485, DOI 10.1161/01.HYP.0000032278.75806.68; GRIFFIN KA, 1994, J AM SOC NEPHROL, V4, P2023; Guasch A, 1999, KIDNEY INT, V56, P261, DOI 10.1046/j.1523-1755.1999.00537.x; Haas CS, 2003, J AM SOC NEPHROL, V14, P2288, DOI 10.1097/01.ASN.0000082999.46030.FE; Hamad AM, 2004, DRUGS, V64, P2417, DOI 10.2165/00003495-200464210-00004; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; Kim SK, 2003, AUTOMAT CONSTR, V12, P15, DOI 10.1016/S0926-5805(02)00033-X; Kim YS, 2005, J AM SOC NEPHROL, V16, P352, DOI 10.1681/ASN.2004070568; Klahr S, 2003, AM J KIDNEY DIS, V41, pS3, DOI 10.1053/ajkd.2003.50074; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Liu JY, 2010, BIOCHEM PHARMACOL, V79, P880, DOI 10.1016/j.bcp.2009.10.025; Loch D, 2007, CELL BIOCHEM BIOPHYS, V47, P87, DOI 10.1385/CBB:47:1:87; Ma J, 2005, PROSTAG LEUKOTR ESS, V72, P13, DOI 10.1016/j.plefa.2004.06.004; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Moreno C, 2001, AM J HYPERTENS, V14, p90S, DOI 10.1016/S0895-7061(01)02075-1; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Parrish AR, 2009, CELL BIOL TOXICOL, V25, P217, DOI 10.1007/s10565-008-9071-0; Revermann M, 2010, CURR OPIN PHARMACOL, V10, P173, DOI 10.1016/j.coph.2009.12.002; Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099; Revermann M, 2009, J HYPERTENS, V27, P322, DOI 10.1097/HJH.0b013e32831aedfa; Ryan AD, 2010, CURR OPIN PHARMACOL, V10, P166, DOI 10.1016/j.coph.2010.02.005; SHIMAMURA T, 1975, AM J PATHOL, V79, P95; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; VENIANT M, 1994, KIDNEY INT, V46, P421, DOI 10.1038/ki.1994.290; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244	47	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11979	10.1371/journal.pone.0011979	http://dx.doi.org/10.1371/journal.pone.0011979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694143	Green Published, gold, Green Submitted			2022-12-27	WOS:000280574300019
J	Gonzalez, AM; Marcel, TC; Kohutova, Z; Stam, P; van der Linden, CG; Niks, RE				Gonzalez, Ana M.; Marcel, Thierry C.; Kohutova, Zuzana; Stam, Piet; van der Linden, C. Gerard; Niks, Rients E.			Peroxidase Profiling Reveals Genetic Linkage between Peroxidase Gene Clusters and Basal Host and Non-Host Resistance to Rusts and Mildew in Barley	PLOS ONE			English	Article							CLASS-III PEROXIDASES; PUCCINIA-HORDEI; DISEASE RESISTANCE; QUANTITATIVE RESISTANCE; POWDERY MILDEW; CONSENSUS MAP; EXPRESSION; FAMILY; RICE; DIVERSITY	Background: Higher plants possess a large multigene family encoding secreted class III peroxidase (Prx) proteins. Peroxidases appear to be associated with plant disease resistance based on observations of induction during disease challenge and the presence or absence of isozymes in resistant vs susceptible varieties. Despite these associations, there is no evidence that allelic variation of peroxidases directly determines levels of disease resistance. Methodology/Principal Findings: The current study introduces a new strategy called Prx-Profiling. We showed that with this strategy a large number of peroxidase genes can be mapped on the barley genome. In order to obtain an estimate of the total number of Prx clusters we followed a re-sampling procedure, which indicated that the barley genome contains about 40 peroxidase gene clusters. We examined the association between the Prxs mapped and the QTLs for resistance of barley to homologous and heterologous rusts, and to the barley powdery mildew fungus. We report that 61% of the QTLs for partial resistance to P. hordei, 61% of the QTLs for resistance to B. graminis and 47% of the QTLs for non-host resistance to other Puccinia species co-localize with Prx based markers. Conclusions/Significance: We conclude that Prx-Profiling was effective in finding the genetic location of Prx genes on the barley genome. The finding that QTLs for basal resistance to rusts and powdery mildew fungi tend to co-locate with Prx clusters provides a base for exploring the functional role of Prx-related genes in determining natural differences in levels of basal resistance.	[Gonzalez, Ana M.; Marcel, Thierry C.; Kohutova, Zuzana; Stam, Piet; van der Linden, C. Gerard; Niks, Rients E.] Wageningen Univ & Res Ctr WUR, Lab Plant Breeding, Wageningen, Netherlands	Wageningen University & Research	Gonzalez, AM (corresponding author), Mision Biol Galicia CSIC, Plant Genet Resources Dept, Pontevedra, Spain.	Rients.Niks@wur.nl	Niks, Rients/Y-4720-2019; GONZÁLEZ, ANA/D-3944-2014; Marcel, Thierry/ABI-2242-2020	Niks, Rients/0000-0002-3912-3775; GONZÁLEZ, ANA/0000-0002-9952-0860; Marcel, Thierry/0000-0002-7452-4013	Xunta de Galicia [AA-123]; European Union [FOOD-CT-2005-513959]; Czech University of Agriculture	Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Union(European Commission); Czech University of Agriculture	Support for this research was provided by a contract from Xunta de Galicia through the program "Angeles Alvarino'' (number AA-123) to A. M. G (http://www.conselleriaiei.org); from the Bioexploit Integrated Project FOOD-CT-2005-513959 that resides under the 6th framework Programme of the European Union to T. C. M (http://www.bioexploit.net); and by the Czech University of Agriculture to Z.K. (http://www.msc.pef.czu.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghnoum R, 2010, MOL PLANT MICROBE IN, V23, P91, DOI 10.1094/MPMI-23-1-0091; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; COLLINGE DB, 1997, MECH ENV STRESS RESI, P335; Duroux L, 2003, J MOL EVOL, V57, P397, DOI 10.1007/s00239-003-2489-3; Faris JD, 1999, THEOR APPL GENET, V98, P219, DOI 10.1007/s001220051061; Fry S.C., 1986, MOL PHYSL ASPECTS PL, P169; GIESE H, 1994, HEREDITAS, V120, P267, DOI 10.1111/j.1601-5223.1994.00267.x; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jafary H, 2008, GENETICS, V178, P2327, DOI 10.1534/genetics.107.077552; Jafary H, 2006, MOL PLANT MICROBE IN, V19, P1270, DOI 10.1094/MPMI-19-1270; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Johrde A, 2008, MOL PLANT PATHOL, V9, P687, DOI 10.1111/J.1364-3703.2008.00494.X; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kristensen BK, 2001, MOL PLANT PATHOL, V2, P311, DOI 10.1046/j.1464-6722.2001.00079.x; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Mantovani P, 2006, GENOME, V49, P1473, DOI 10.1139/G06-100; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Marcel TC, 2008, NEW PHYTOL, V177, P743, DOI 10.1111/j.1469-8137.2007.02298.x; Marcel TC, 2007, MOL PLANT MICROBE IN, V20, P1604, DOI 10.1094/MPMI-20-12-1604; Mochida K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-72; NIKS RE, 1986, PHYSIOL MOL PLANT P, V28, P309, DOI 10.1016/S0048-4059(86)80073-X; Niks RE, 2009, NEW PHYTOL, V182, P817, DOI 10.1111/j.1469-8137.2009.02849.x; OMANN F, 1994, GENOME, V37, P137, DOI 10.1139/g94-018; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Passardi F, 2007, PHYTOCHEMISTRY, V68, P1605, DOI 10.1016/j.phytochem.2007.04.005; Pecchioni N, 1999, PLANT BREEDING, V118, P29, DOI 10.1046/j.1439-0523.1999.118001029.x; Pflieger S, 2001, MOL BREEDING, V7, P275, DOI 10.1023/A:1011605013259; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Sasaki K, 2004, PLANT CELL PHYSIOL, V45, P1442, DOI 10.1093/pcp/pch165; Shtaya MJY, 2006, EUPHYTICA, V151, P421, DOI 10.1007/s10681-006-9172-x; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THORDALCHRISTENSEN H, 1992, PHYSIOL MOL PLANT P, V40, P395, DOI 10.1016/0885-5765(92)90031-P; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; VALE GP, 1994, PHYSIOL MOL PLANT P, V44, P207, DOI 10.1016/S0885-5765(05)80005-0; van der Linden CG, 2005, REGNUM VEG, V143, P291; van der Linden CG, 2004, THEOR APPL GENET, V109, P384, DOI 10.1007/s00122-004-1642-8; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Vandepoele K, 2005, PLANT PHYSIOL, V137, P31, DOI 10.1104/pp.104.054700; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; VERA P, 1993, MOL PLANT MICROBE IN, V6, P790; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang GX, 2007, J INTEGR PLANT BIOL, V49, P1580, DOI 10.1111/j.1774-7909.2007.00574.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; YOUNG SA, 1995, PLANT PHYSIOL, V107, P1333, DOI 10.1104/pp.107.4.1333; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	57	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10495	10.1371/journal.pone.0010495	http://dx.doi.org/10.1371/journal.pone.0010495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689842	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520400002
J	Griffiths, HJ				Griffiths, Huw J.			Antarctic Marine Biodiversity - What Do We Know About the Distribution of Life in the Southern Ocean?	PLOS ONE			English	Review							CLIMATE-CHANGE; BIOGEOGRAPHY; PHYTOPLANKTON; PRODUCTIVITY; DYNAMICS; FAUNA; WEST	The remote and hostile Southern Ocean is home to a diverse and rich community of life that thrives in an environment dominated by glaciations and strong currents. Marine biological studies in the region date back to the nineteenth century, but despite this long history of research, relatively little is known about the complex interactions between the highly seasonal physical environment and the species that inhabit the Southern Ocean. Oceanographically, the Southern Ocean is a major driver of global ocean circulation and plays a vital role in interacting with the deep water circulation in each of the Pacific, Atlantic, and Indian oceans. The Census of Antarctic Marine Life and the Scientific Committee on Antarctic Research Marine Biodiversity Information Network (SCAR-MarBIN) have strived to coordinate and unify the available scientific expertise and biodiversity data to improve our understanding of Southern Ocean biodiversity. Taxonomic lists for all marine species have been compiled to form the Register of Antarctic Marine Species, which currently includes over 8,200 species. SCAR-MarBIN has brought together over 1 million distribution records for Southern Ocean species, forming a baseline against which future change can be judged. The sample locations and numbers of known species from different regions were mapped and the depth distributions of benthic samples plotted. Our knowledge of the biodiversity of the Southern Ocean is largely determined by the relative inaccessibility of the region. Benthic sampling is largely restricted to the shelf; little is known about the fauna of the deep sea. The location of scientific bases heavily influences the distribution pattern of sample and observation data, and the logistical supply routes are the focus of much of the at-sea and pelagic work. Taxa such as mollusks and echinoderms are well represented within existing datasets with high numbers of georeferenced records. Other taxa, including the species-rich nematodes, are represented by just a handful of digital records.	British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Griffiths, HJ (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	hjg@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X	Alfred P. Sloan Foundation; Natural Environmental Research Council; Census of Antarctic Marine Life team; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Census of Antarctic Marine Life team; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Alfred P. Sloan Foundation and The Natural Environmental Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the Census of Antarctic Marine Life team is gratefully acknowledged, along with that of colleagues from various science disciplines: David Barnes, Katrin Linse, Bruno Danis, Claire Allen, Sally Thorpe, Clause-Dieter Hillenbrand, Victoria Peck, Tom Jordan, Susie Grant, Victoria Wadley, Michael Stoddart, the scientists and crew of the IPY/CAML research vessels, SCAR-MarBIN, and all the RAMS taxonomic editors.	ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Brandl D, 2004, CONTROL ENG, V51, P14; Brandt A, 2007, NATURE, V447, P307, DOI 10.1038/nature05827; Clarke A., 1990, P9; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke A, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000886; Clayton MN, 1997, POLAR BIOL, V17, P141, DOI 10.1007/s003000050116; De Broyer C, 1993, DOCUMENTS TRAVAIL I, V73, P1; De Broyer C, 2010, SCAR MARBIN ANTARCTI; Deacon G., 1984, ANTARCTIC CIRCUMPOLA; ELSAYED SZ, 1988, COMP BIOCHEM PHYS B, V90, P489, DOI 10.1016/0305-0491(88)90287-8; Gloersen P, 1992, NASA SPECIAL PUBLICA, V511; GRANT RA, 2009, POLAR BIOL IN PRESS; Griffiths HJ, 2008, ANTARCT SCI, V20, P213, DOI 10.1017/S0954102008001168; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 2004, ANTARCT SCI, V16, P11, DOI 10.1017/S0954102004001750; HEDGPETH JW, 1969, INTRO ANTARCTIC ZOOG; Hempel G., 1985, P266; Hempel G, 2007, ANTARCT SCI, V19, P195, DOI 10.1017/S0954102007000272; Hillenbrand CD, 2003, MAR GEOL, V193, P253, DOI 10.1016/S0025-3227(02)00659-X; Hosie GW, 2003, PROG OCEANOGR, V58, P263, DOI 10.1016/j.pocean.2003.08.007; Korb RE, 2004, DEEP-SEA RES PT II, V51, P99, DOI 10.1016/j.dsr2.2003.04.002; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Orsi A. H., 2005, HYDROGRAPHIC ATLAS W; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Primo C, 2007, ANTARCT SCI, V19, P321, DOI 10.1017/S0954102007000521; RINTOUL S, 2009, SO OCEAN OBSERVING S; Rintoul SR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028550; Smale DA, 2008, MAR ECOL PROG SER, V355, P85, DOI 10.3354/meps07311; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Tavares M, 2004, ANTARCT SCI, V16, P129, DOI 10.1017/S0954102004001877; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; TREGUER P, 1992, POLAR BIOL, V12, P149; Waller CL, 2006, AUSTRAL ECOL, V31, P656, DOI 10.1111/j.1442-9993.2006.01618.x; WHITEHOUSE MJ, 2009, DEEP SEA 1 IN PRESS	42	190	199	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11683	10.1371/journal.pone.0011683	http://dx.doi.org/10.1371/journal.pone.0011683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689841	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520400004
J	Renaud, V; Godefroy, E; Larrieu, P; Fleury, F; Jotereau, F; Guilloux, Y				Renaud, Virginie; Godefroy, Emmanuelle; Larrieu, Pierre; Fleury, Fabrice; Jotereau, Francine; Guilloux, Yannick			Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; NEWLY SYNTHESIZED PROTEINS; DISULFIDE BONDS; ENDOPLASMIC-RETICULUM; HLA-A2 MELANOMAS; QUALITY-CONTROL; ANTIGEN; BINDING; CELLS; GENE	Background: We previously demonstrated that the matrix metalloproteinase-2 (MMP-2) contained an antigenic peptide recognized by a CD8 T cell clone in the HLA-A*0201 context. The presentation of this peptide on class I molecules by human melanoma cells required a cross-presentation mechanism. Surprisingly, the classical endogenous processing pathway did not process this MMP-2 epitope. Methodology/Principal Findings: By PCR directed mutagenesis we showed that disruption of a single disulfide bond induced MMP-2 epitope presentation. By Pulse-Chase experiment, we demonstrated that disulfide bonds stabilized MMP-2 and impeded its degradation. Finally, using drugs, we documented that mutated MMP-2 epitope presentation used the proteasome and retrotranslocation complex. Conclusions/Significance: These data appear crucial to us since they established the existence of a new inhibitory mechanism for the generation of a T cell epitope. In spite of MMP-2 classified as a self-antigen, the fact that cross-presentation is the only way to present this MMP-2 epitope underlines the importance to target this type of antigen in immunotherapy protocols.	[Renaud, Virginie; Larrieu, Pierre; Jotereau, Francine; Guilloux, Yannick] INSERM, UMR 892, Nantes, France; [Godefroy, Emmanuelle] NYU, Sch Med, Inst Canc, New York, NY USA; [Fleury, Fabrice; Jotereau, Francine; Guilloux, Yannick] Fac Sci & Tech Nantes, Nantes, France; [Fleury, Fabrice] CNRS, Unite Biotechnol Biocatalyse & Bioregulat, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); New York University; Nantes Universite; Centre National de la Recherche Scientifique (CNRS)	Renaud, V (corresponding author), INSERM, UMR 892, Nantes, France.	guilloux@nantes.inserm.fr	Jotereau, Francine/AAU-1735-2020; guilloux, yannick/L-4801-2015; Godefroy, Emmanuelle/AAQ-3082-2020; Jotereau, Francine/L-8668-2015	Jotereau, Francine/0000-0002-2508-4875; Godefroy, Emmanuelle/0000-0002-4981-6639; guilloux, yannick/0000-0003-2352-7238	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer [PL074]; European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network [503306]	Ligue Nationale contre le Cancer and Comite 44; Institut National de la Sante et de la Recherche Medical; Institut National du Cancer(Institut National du Cancer (INCA) France); European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network	This work was supported by grants from the Ligue Nationale contre le Cancer and Comite 44, Institut National de la Sante et de la Recherche Medical, Institut National du Cancer (PL074), and the European Network for the Identification and Validation of Antigens and Biomarkers in Cancer and their Application in Clinical Tumor Immunology Network (503306). V. Renaud was supported by a doctoral fellowship from the Association pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Branza-Nichita N, 2002, BIOCHEM BIOPH RES CO, V296, P470, DOI 10.1016/S0006-291X(02)00907-5; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; COLLINS DS, 1991, J IMMUNOL, V147, P4054; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Godefroy E, 2005, J EXP MED, V202, P61, DOI 10.1084/jem.20042138; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guilloux Y, 1996, J EXP MED, V183, P1173, DOI 10.1084/jem.183.3.1173; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moreau-Aubry A, 2000, J EXP MED, V191, P1617, DOI 10.1084/jem.191.9.1617; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Moses MA, 1997, STEM CELLS, V15, P180, DOI 10.1002/stem.150180; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Sheu BC, 2001, CANCER RES, V61, P237; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VANDERBRUGGEN P, 1992, CURR OPIN IMMUNOL, V4, P608, DOI 10.1016/0952-7915(92)90035-D; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11894	10.1371/journal.pone.0011894	http://dx.doi.org/10.1371/journal.pone.0011894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689590	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300009
J	Morgan, JC; Irving, H; Okedi, LM; Steven, A; Wondji, CS				Morgan, John C.; Irving, Helen; Okedi, Loyce M.; Steven, Andrew; Wondji, Charles S.			Pyrethroid Resistance in an Anopheles funestus Population from Uganda	PLOS ONE			English	Article							AFRICAN MALARIA VECTOR; SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; GAMBIAE; CULICIDAE; DIPTERA; DDT; PERMETHRIN; MOZAMBIQUE; MUTATION	Background: The susceptibility status of Anopheles funestus to insecticides remains largely unknown in most parts of Africa because of the difficulty in rearing field-caught mosquitoes of this malaria vector. Here we report the susceptibility status of the An. funestus population from Tororo district in Uganda and a preliminary characterisation of the putative resistance mechanisms involved. Methodology/Principal Findings: A new forced egg laying technique used in this study significantly increased the numbers of field-caught females laying eggs and generated more than 4000 F-1 adults. WHO bioassays indicated that An. funestus in Tororo is resistant to pyrethroids (62% mortality after 1 h exposure to 0.75% permethrin and 28% mortality to 0.05% deltamethrin). Suspected DDT resistance was also observed with 82% mortality. However this population is fully susceptible to bendiocarb (carbamate), malathion (organophosphate) and dieldrin with 100% mortality observed after exposure to each of these insecticides. Sequencing of a fragment of the sodium channel gene containing the 1014 codon conferring pyrethroid/DDT resistance in An. gambiae did not detect the L1014F kdr mutation but a correlation between haplotypes and resistance phenotype was observed indicating that mutations in other exons may be conferring the knockdown resistance in this species. Biochemical assays suggest that resistance in this population is mediated by metabolic resistance with elevated level of GSTs, P450s and pNPA compared to a susceptible strain of Anopheles gambiae. RT-PCR further confirmed the involvement of P450s with a 12-fold over-expression of CYP6P9b in the Tororo population compared to the fully susceptible laboratory colony FANG. Conclusion: This study represents the first report of pyrethroid/DDT resistance in An. funestus from East Africa. With resistance already reported in southern and West Africa, this indicates that resistance in An. funestus may be more widespread than previously assumed and therefore this should be taken into account for the implementation and management of vector control programs in Africa.	[Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Okedi, Loyce M.] Natl Livestock Resources Res Inst, Tororo, Uganda	Liverpool School of Tropical Medicine; University of Liverpool	Morgan, JC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	c.s.wondji@liverpool.ac.uk	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust [083515/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Research Career Development Fellowship 083515/Z/07/Z to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 1998, WHOCDCMAL98; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; Bashalkhanov S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-84; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Ramphul U, 2009, T R SOC TROP MED HYG; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhaeghen K, 2010, AM J TROP MED HYG, V82, P566, DOI 10.4269/ajtmh.2010.08-0668; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	27	117	119	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11872	10.1371/journal.pone.0011872	http://dx.doi.org/10.1371/journal.pone.0011872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686697	Green Published, gold, Green Accepted			2022-12-27	WOS:000280520200034
J	Scopelliti, PE; Borgonovo, A; Indrieri, M; Giorgetti, L; Bongiorno, G; Carbone, R; Podesta, A; Milani, P				Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Bongiorno, Gero; Carbone, Roberta; Podesta, Alessandro; Milani, Paolo			The Effect of Surface Nanometre-Scale Morphology on Protein Adsorption	PLOS ONE			English	Article							ELECTRICAL DETECTION; NANOSTRUCTURED TIO2; DRUG-DELIVERY; DIFFERENTIATION; NANOTECHNOLOGY; OPPORTUNITIES; NANOMEDICINE; BIOMATERIALS; ENHANCEMENT; TOPOGRAPHY	Background: Protein adsorption is the first of a complex series of events that regulates many phenomena at the nano-bio interface, e. g. cell adhesion and differentiation, in vivo inflammatory responses and protein crystallization. A quantitative understanding of how nanoscale morphology influences protein adsorption is strategic for providing insight into all of these processes, however this understanding has been lacking until now. Methodology/Principal Findings: Here we introduce novel methods for quantitative high-throughput characterization of protein-surface interaction and we apply them in an integrated experimental strategy, to study the adsorption of a panel of proteins on nanostructured surfaces. We show that the increase of nanoscale roughness ( from 15 nm to 30 nm) induces a decrease of protein binding affinity (<= 90%) and a relevant increase in adsorbed proteins (<= 500%) beyond the corresponding increase of specific area. We demonstrate that these effects are caused by protein nucleation on the surface, which is promoted by surface nanoscale pores. Conclusions/Significance: These results show that the adsorption of proteins depends significantly on surface nanostructure and that the relevant morphological parameter regulating the protein adsorption process is the nanometric pore shape. These new findings improve our understanding of the role of nanostructures as a biomaterial design parameter and they have important implications for the general understanding of cell behavior on nanostructured surfaces.	[Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy; [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Indrieri, Marco; Giorgetti, Luca; Podesta, Alessandro; Milani, Paolo] Univ Milan, Dept Phys, Milan, Italy; [Scopelliti, Pasquale Emanuele; Borgonovo, Antonio; Bongiorno, Gero; Milani, Paolo] Fdn Filarete, Milan, Italy; [Giorgetti, Luca] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Carbone, Roberta] Tethis Srl, Milan, Italy	University of Milan; University of Milan; IRCCS European Institute of Oncology (IEO)	Scopelliti, PE (corresponding author), Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy.	paolo.milani@mi.infn.it	Milani, Paolo/AAN-5069-2021; Podestà, Alessandro/E-6568-2010	Podestà, Alessandro/0000-0002-4169-6679	University of Milan	University of Milan	This work was supported by the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Barborini E, 2002, APPL PHYS LETT, V81, P3052, DOI 10.1063/1.1510579; Benesch T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021401; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Giorgetti L, 2008, LANGMUIR, V24, P11637, DOI 10.1021/la801910p; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X; Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617; Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; MANUS JB, 2009, BIOMATERIALS, V30, P5094; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Page AJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.065701; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; PAWLEY J, 2008, HDB BIOL CONFOCAL MI, P635; Podesta A, 2009, J PHYS CHEM C, V113, P18264, DOI 10.1021/jp905930r; Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9; Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923; Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rocker C, 2009, NAT NANOTECHNOL, V4, P577, DOI [10.1038/NNANO.2009.195, 10.1038/nnano.2009.195]; Saridakis E, 2009, TRENDS BIOTECHNOL, V27, P99, DOI 10.1016/j.tibtech.2008.10.008; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Talbot J, 2000, COLLOID SURFACE A, V165, P287, DOI 10.1016/S0927-7757(99)00409-4; Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006; Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	52	193	195	5	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11862	10.1371/journal.pone.0011862	http://dx.doi.org/10.1371/journal.pone.0011862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686681	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200026
J	Bogs, J; Veits, J; Gohrbandt, S; Hundt, J; Stech, O; Breithaupt, A; Teifke, JP; Mettenleiter, TC; Stech, J				Bogs, Jessica; Veits, Jutta; Gohrbandt, Sandra; Hundt, Jana; Stech, Olga; Breithaupt, Angele; Teifke, Jens P.; Mettenleiter, Thomas C.; Stech, Juergen			Highly Pathogenic H5N1 Influenza Viruses Carry Virulence Determinants beyond the Polybasic Hemagglutinin Cleavage Site	PLOS ONE			English	Article							A VIRUSES; GENE REASSORTANTS; STALK-LENGTH; NEURAMINIDASE; EMERGENCE; SEQUENCE; RECOMBINATION; GLYCOSYLATION; CONSTELLATION; PATHOBIOLOGY	Highly pathogenic avian influenza viruses (HPAIV) originate from avirulent precursors but differ from all other influenza viruses by the presence of a polybasic cleavage site in their hemagglutinins (HA) of subtype H5 or H7. In this study, we investigated the ability of a low-pathogenic avian H5N1 strain to transform into an HPAIV. Using reverse genetics, we replaced the monobasic HA cleavage site of the low-pathogenic strain A/Teal/Germany/Wv632/2005 (H5N1) (TG05) by a polybasic motif from an HPAIV (TG05(poly)). To elucidate the virulence potential of all viral genes of HPAIV, we generated two reassortants carrying the HA from the HPAIV A/Swan/Germany/R65/06 (H5N1) (R65) plus the remaining genes from TG05 (TG05-HA(R65)) or in reversed composition the mutated TG05 HA plus the R65 genes (R65-HATG05(poly)). In vitro, TG05(poly) and both reassortants were able to replicate without the addition of trypsin, which is characteristic for HPAIV. Moreover, in contrast to avirulent TG05, the variants TG05(poly), TG05-HA(R65), and R65-HATG05(poly) are pathogenic in chicken to an increasing degree. Whereas the HA cleavage site mutant TG05(poly) led to temporary non-lethal disease in all animals, the reassortant TG05-HA(R65) caused death in 3 of 10 animals. Furthermore, the reassortant R65-HATG05(poly) displayed the highest lethality as 8 of 10 chickens died, resembling "natural" HPAIV strains. Taken together, acquisition of a polybasic HA cleavage site is only one necessary step for evolution of low-pathogenic H5N1 strains into HPAIV. However, these low-pathogenic strains may already have cryptic virulence potential. Moreover, besides the polybasic cleavage site, the additional virulence determinants of H5N1 HPAIV are located within the HA itself and in other viral proteins.	[Bogs, Jessica; Veits, Jutta; Gohrbandt, Sandra; Hundt, Jana; Stech, Olga; Mettenleiter, Thomas C.; Stech, Juergen] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany; [Breithaupt, Angele; Teifke, Jens P.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute	Bogs, J (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany.	juergen.stech@fli.bund.de	Mettenleiter, h. c. Thomas C./U-1016-2019; Breithaupt, Angele/B-6155-2013; Breithaupt, Angele/GON-7227-2022	Breithaupt, Angele/0000-0002-6373-5923; Teifke, Jens/0000-0001-7168-4970; Stech, Juergen/0000-0002-3187-702X	Forschungssofortprogramm Influenza of the German government [FSI 2.44]; European Commission [SSPE-CT-2006-44372 (Innflu)]	Forschungssofortprogramm Influenza of the German government; European Commission(European CommissionEuropean Commission Joint Research Centre)	Forschungssofortprogramm Influenza of the German government (FSI 2.44) and European Commission [SSPE-CT-2006-44372 (Innflu)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 2008, MANUAL DIAGNOSTIC TE; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DESHPANDE KL, 1985, VIROLOGY, V147, P49, DOI 10.1016/0042-6822(85)90226-0; DEWIT E, 2009, J VIROL; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; Garten Wolfgang, 2008, V27, P156; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KAWAOKA Y, 1985, VIROLOGY, V146, P130, DOI 10.1016/0042-6822(85)90059-5; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Klopfleisch R, 2006, VET PATHOL, V43, P463, DOI 10.1354/vp.43-4-463; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Pavlova SP, 2009, VACCINE, V27, P773, DOI 10.1016/j.vaccine.2008.11.033; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perdue ML, 1997, VIRUS RES, V49, P173, DOI 10.1016/S0168-1702(97)01468-8; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; ROHM C, 1995, VIROLOGY, V209, P664, DOI 10.1006/viro.1995.1301; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; SCHAFER W, 1955, Z NATURFORSCH PT B, V10, P81, DOI 10.1515/znb-1955-0205; SCHOLTISSEK C, 1979, VIROLOGY, V95, P492, DOI 10.1016/0042-6822(79)90503-8; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Starick E, 2008, VET MICROBIOL, V128, P243, DOI 10.1016/j.vetmic.2007.10.012; Stech J, 1999, J VIROL, V73, P1878, DOI 10.1128/JVI.73.3.1878-1884.1999; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Stech O, 2009, J VIROL, V83, P5864, DOI 10.1128/JVI.02649-08; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; Zhirnov OP, 2009, VIROLOGY, V394, P57, DOI 10.1016/j.virol.2009.08.013	58	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11826	10.1371/journal.pone.0011826	http://dx.doi.org/10.1371/journal.pone.0011826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676399	Green Submitted, Green Published, gold			2022-12-27	WOS:000280371800021
J	De Paepe, M; De Monte, S; Robert, L; Lindner, AB; Taddei, F				De Paepe, Marianne; De Monte, Silvia; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois			Emergence of Variability in Isogenic Escherichia coli Populations Infected by a Filamentous Virus	PLOS ONE			English	Article							HOST; EVOLUTION; DYNAMICS; REVEALS; GROWTH	The spread of epidemics not only depends on the average number of parasites produced per host, but also on the existence of highly infectious individuals. It is widely accepted that infectiousness depends on genetic and environmental determinants. However, even in clonal populations of host and viruses growing in homogeneous conditions, high variability can exist. Here we show that Escherichia coli cells commonly display high differentials in viral burst size, and address the kinetics of emergence of such variability with the non-lytic filamentous virus M13. By single-cell imaging of a virally-encoded fluorescent reporter, we monitor the viral charge distribution in infected bacterial populations at different time following infection. A mathematical model assuming autocatalytic virus replication and inheritance of bacterial growth rates quantitatively reproduces the experimental distributions, demonstrating that deterministic amplification of small host inhomogeneities is a mechanism sufficient to explain large and highly skewed distributions. This mechanism of amplification is general and may occur whenever a parasite has an initial phase of exponential growth within its host. Moreover, it naturally reproduces the shift towards higher virulence when the host is experimenting poor conditions, as observed commonly in host-parasite systems.	[De Paepe, Marianne; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois] INSERM, U1001, Paris, France; [De Paepe, Marianne; Robert, Lydia; Lindner, Ariel B.; Taddei, Francois] Univ Paris 05, Paris, France; [De Monte, Silvia] Ecole Normale Super, UMR 7625, F-75231 Paris, France; [De Monte, Silvia] Univ Paris 06, UMR 7625, Paris, France; [De Monte, Silvia] CNRS, UMR 7625, Paris, France; [Robert, Lydia] AgroParisTech ENGREF, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech	De Paepe, M (corresponding author), INSERM, U1001, Paris, France.	demonte@biologie.ens.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; De Monte, Silvia/0000-0001-7953-5494; Taddei, Francois/0000-0002-7894-0647; robert, lydia/0000-0002-0715-0322	Agence Nationale de la Recherche; Human Frontier Scientific Program; European Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier Scientific Program(Human Frontier Science Program); European Science Foundation(European Science Foundation (ESF)European Commission)	This project was funded in part by Agence Nationale de la Recherche, Human Frontier Scientific Program and a EURY award from the European Science Foundation to F. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DELBRUCK M, 1945, J BACTERIOL, V50, P131; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Kaltz O, 2003, EVOLUTION, V57, P1535, DOI 10.1111/j.0014-3820.2003.tb00361.x; KOCH AL, 1966, J THEOR BIOL, V12, P276, DOI 10.1016/0022-5193(66)90119-6; Kuo MY, 2000, CAN J MICROBIOL, V46, P841, DOI 10.1139/cjm-46-9-841; LERNER TJ, 1981, VIROLOGY, V115, P282, DOI 10.1016/0042-6822(81)90111-2; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Messenger SL, 1999, P ROY SOC B-BIOL SCI, V266, P397, DOI 10.1098/rspb.1999.0651; Nolan D, 2006, CURR OPIN IMMUNOL, V18, P413, DOI 10.1016/j.coi.2006.05.015; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; RUSSEL M, 2006, BACTERIOPHAGES, P146; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tsuru S, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036015; Zhu Y, 2009, VIROLOGY, V385, P39, DOI 10.1016/j.virol.2008.10.031	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11823	10.1371/journal.pone.0011823	http://dx.doi.org/10.1371/journal.pone.0011823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676396	gold, Green Published, Green Submitted			2022-12-27	WOS:000280371800020
J	Cussans, J; Goulson, D; Sanderson, R; Goffe, L; Darvill, B; Osborne, JL				Cussans, John; Goulson, David; Sanderson, Roy; Goffe, Louis; Darvill, Ben; Osborne, Juliet L.			Two Bee-Pollinated Plant Species Show Higher Seed Production when Grown in Gardens Compared to Arable Farmland	PLOS ONE			English	Article							FORAGING RANGE; POLLEN LIMITATION; LANDSCAPE-SCALE; INSECT VISITS; NEST DENSITY; BUMBLEBEE; CROPS; REPRODUCTION; HYMENOPTERA; EXTINCTION	Background: Insect pollinator abundance, in particular that of bees, has been shown to be high where there is a superabundance of floral resources; for example in association with mass-flowering crops and also in gardens where flowering plants are often densely planted. Since land management affects pollinator numbers, it is also likely to affect the resultant pollination of plants growing in these habitats. We hypothesised that the seed or fruit set of two plant species, typically pollinated by bumblebees and/or honeybees might respond in one of two ways: 1) pollination success could be reduced when growing in a floriferous environment, via competition for pollinators, or 2) pollination success could be enhanced because of increased pollinator abundance in the vicinity. Methodology/Principal Findings: We compared the pollination success of experimental plants of Glechoma hederacea L. and Lotus corniculatus L. growing in gardens and arable farmland. On the farms, the plants were placed either next to a mass-flowering crop (oilseed rape, Brassica napus L. or field beans, Vicia faba L.) or next to a cereal crop (wheat, Triticum spp.). Seed set of G. hederacea and fruit set of L. corniculatus were significantly higher in gardens compared to arable farmland. There was no significant difference in pollination success of G. hederacea when grown next to different crops, but for L. corniculatus, fruit set was higher in the plants growing next to oilseed rape when the crop was in flower. Conclusions/Significance: The results show that pollination services can limit fruit set of wild plants in arable farmland, but there is some evidence that the presence of a flowering crop can facilitate their pollination (depending on species and season). We have also demonstrated that gardens are not only beneficial to pollinators, but also to the process of pollination.	[Cussans, John; Osborne, Juliet L.] Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden, Herts, England; [Goulson, David; Darvill, Ben] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Sanderson, Roy; Goffe, Louis] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Stirling; Newcastle University - UK	Cussans, J (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden, Herts, England.	juliet.osborne@bbsrc.ac.uk	Goulson, David/A-2462-2010; Osborne, Juliet L/I-6776-2012; Cussans, John/AAB-2306-2022; Cussans, John/A-2764-2010	Goulson, David/0000-0003-4421-2876; Goffe, Louis/0000-0002-3623-2458	Biotechnology and Biological Sciences Research Council of the UK [BB/E001491]; Biotechnology and Biological Sciences Research Council [BB/E001491/1, BB/E002757/1] Funding Source: researchfish; BBSRC [BB/E001491/1, BB/E002757/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded as part of Project BB/E001491, funded by the Biotechnology and Biological Sciences Research Council of the UK (URL:http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Darwin C, 1891, EFFECTS CROSS SELF F; *DEFR, 2009, AGR UK; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Frankie GW, 2009, J KANSAS ENTOMOL SOC, V82, P1, DOI 10.2317/JKES708.23.1; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; GOULSON D, J APPL ECOL IN PRESS; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knuth P, 1909, HDB FLOWER POLLINATI, VIII; Knuth P., 1908, HDB FLOWER POLLINATI, VII, DOI 10.1126/science.28.715.345; Knuth P.E.O.W., 1906, HDB FLOWER POLLINATI, VI; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; Moragues E, 2005, BIOL CONSERV, V122, P611, DOI 10.1016/j.biocon.2004.09.015; Nielsen C, 2008, BIOL INVASIONS, V10, P1353, DOI 10.1007/s10530-007-9210-1; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Stelzer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009559; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Thompson K, 1999, CONSERV BIOL, V13, P185, DOI 10.1046/j.1523-1739.1999.97353.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x	38	41	42	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11753	10.1371/journal.pone.0011753	http://dx.doi.org/10.1371/journal.pone.0011753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668704	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000280243800023
J	Bremer, J; O'Connor, T; Tiberi, C; Rehrauer, H; Weis, J; Aguzzi, A				Bremer, Juliane; O'Connor, Tracy; Tiberi, Cinzia; Rehrauer, Hubert; Weis, Joachim; Aguzzi, Adriano			Ablation of Dicer from Murine Schwann Cells Increases Their Proliferation while Blocking Myelination	PLOS ONE			English	Article							DIFFERENTIATION; MORPHOGENESIS; INHIBITION; MECHANISMS; MICRORNA; PATHWAY; MIRNAS	The myelin sheaths that surround the thick axons of the peripheral nervous system are produced by the highly specialized Schwann cells. Differentiation of Schwann cells and myelination occur in discrete steps. Each of these requires coordinated expression of specific proteins in a precise sequence, yet the regulatory mechanisms controlling protein expression during these events are incompletely understood. Here we report that Schwann cell-specific ablation of the enzyme Dicer1, which is required for the production of small non-coding regulatory microRNAs, fully arrests Schwann cell differentiation, resulting in early postnatal lethality. Dicer(-/-) Schwann cells had lost their ability to myelinate, yet were still capable of sorting axons. Both cell death and, paradoxically, proliferation of immature Schwann cells was markedly enhanced, suggesting that their terminal differentiation is triggered by growth-arresting regulatory microRNAs. Using microRNA microarrays, we identified 16 microRNAs that are upregulated upon myelination and whose expression is controlled by Dicer in Schwann cells. This set of microRNAs appears to drive Schwann cell differentiation and myelination of peripheral nerves, thereby fulfilling a crucial function for survival of the organism.	[Bremer, Juliane; O'Connor, Tracy; Tiberi, Cinzia; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Weis, Joachim] Rhein Westfal TH Aachen, Fac Med, Inst Neuropathol, Aachen, Germany; [Rehrauer, Hubert] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital; RWTH Aachen University; University of Zurich	Bremer, J (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/AAH-9487-2020; Bremer, Juliane/E-2298-2012; Weis, Joachim/G-1984-2014; Aguzzi, Adriano/A-3351-2008	Weis, Joachim/0000-0003-3280-6773; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union; Swiss National Foundation; Novartis Foundation; University of Zurich	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); University of Zurich	AA is the recipient of an Advanced Investigator Grant of the European Research Council and of grants by the European Union (PRIORITY and LUPAS), the Swiss National Foundation, and the Novartis Foundation. JB received a Career Development Award of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Ebenezer GJ, 2007, BRAIN, V130, P2703, DOI 10.1093/brain/awm199; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; HEUSS D, 2008, DIAGNOSTIK BEI POLYN; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; KIM HA, 1995, ONCOGENE, V11, P325; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; LEWIS MA, 2010, MICRORNAS MOUSE DEV; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; PANG RT, 2010, CARCINOGENESIS; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	33	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12450	10.1371/journal.pone.0012450	http://dx.doi.org/10.1371/journal.pone.0012450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805985	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000281301500016
J	Poroyko, V; White, JR; Wang, M; Donovan, S; Alverdy, J; Liu, DC; Morowitz, MJ				Poroyko, Valeriy; White, James Robert; Wang, Mei; Donovan, Sharon; Alverdy, John; Liu, Donald C.; Morowitz, Michael J.			Gut Microbial Gene Expression in Mother-Fed and Formula-Fed Piglets	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN PLASMINOGEN; ESCHERICHIA-COLI; NECROTIZING ENTEROCOLITIS; SALMONELLA-TYPHIMURIUM; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; FED INFANTS; HUMAN-MILK; BIFIDOBACTERIUM	Background: Effects of diet on the structure and function of gut microbial communities in newborn infants are poorly understood. High-resolution molecular studies are needed to definitively ascertain whether gut microbial communities are distinct in milk-fed and formula-fed infants. Methodology/Principal Findings: Pyrosequencing-based whole transcriptome shotgun sequencing (RNA-seq) was used to evaluate community wide gut microbial gene expression in 21 day old neonatal piglets fed either with sow's milk (mother fed, MF; n = 4) or with artificial formula (formula fed, FF; n = 4). Microbial DNA and RNA were harvested from cecal contents for each animal. cDNA libraries and 16S rDNA amplicons were sequenced on the Roche 454 GS-FLX Titanium system. Communities were similar at the level of phylum but were dissimilar at the level of genus; Prevotella was the dominant genus within MF samples and Bacteroides was most abundant within FF samples. Screened cDNA sequences were assigned functional annotations by the MG-RAST annotation pipeline and based upon best-BLASTX-hits to the NCBI COG database. Patterns of gene expression were very similar in MF and FF animals. All samples were enriched with transcripts encoding enzymes for carbohydrate and protein metabolism, as well as proteins involved in stress response, binding to host epithelium, and lipopolysaccharide metabolism. Carbohydrate utilization transcripts were generally similar in both groups. The abundance of enzymes involved in several pathways related to amino acid metabolism (e.g., arginine metabolism) and oxidative stress response differed in MF and FF animals. Conclusions/Significance: Abundant transcripts identified in this study likely contribute to a core microbial metatranscriptome in the distal intestine. Although microbial community gene expression was generally similar in the cecal contents of MF and FF neonatal piglets, several differentially abundant gene clusters were identified. Further investigations of gut microbial gene expression will contribute to a better understanding of normal and abnormal enteric microbiology in animals and humans.	[Poroyko, Valeriy; Alverdy, John; Liu, Donald C.; Morowitz, Michael J.] Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; [Liu, Donald C.; Morowitz, Michael J.] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA; [Wang, Mei; Donovan, Sharon] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [White, James Robert] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University System of Maryland; University of Maryland College Park	Poroyko, V (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA.	morowitz@uchicago.edu	Donovan, Sharon/AAY-6787-2020	Donovan, Sharon/0000-0002-9785-4189; Wang, Mei/0000-0003-0379-6633	Surgical Infection Society; March of Dimes Foundation; NIH [R01 HD61929]; Bristol Myers-Squibb; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061929] Funding Source: NIH RePORTER	Surgical Infection Society; March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers-Squibb(Bristol-Myers Squibb); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funding from the Surgical Infection Society (MM) and the March of Dimes Foundation (MM), as well as Bristol Myers-Squibb (SMD) and NIH R01 HD61929 (SMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Amin HJ, 2002, J PEDIATR-US, V140, P425, DOI 10.1067/mpd.2002.123289; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aycicek A, 2006, NUTRITION, V22, P616, DOI 10.1016/j.nut.2005.12.011; Bertolo RF, 2008, J NUTR, V138, p2032S, DOI 10.1093/jn/138.10.2032S; Candela M, 2007, J BACTERIOL, V189, P5929, DOI 10.1128/JB.00159-07; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Friel JK, 2002, PEDIATR RES, V51, P612, DOI 10.1203/00006450-200205000-00012; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GOLDBERG JB, 1993, J BACTERIOL, V175, P1605, DOI 10.1128/JB.175.6.1605-1611.1993; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Houle VM, 1997, PEDIATR RES, V42, P78, DOI 10.1203/00006450-199707000-00013; Houot L, 2010, INFECT IMMUN, V78, P1482, DOI 10.1128/IAI.01356-09; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Klaassens ES, 2007, APPL ENVIRON MICROB, V73, P1388, DOI 10.1128/AEM.01921-06; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; LEY RE, P NATL ACAD SCI, V102, P11070; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; LUNDEQUIST B, 1985, ACTA PAEDIATR SCAND, V74, P45, DOI 10.1111/j.1651-2227.1985.tb10919.x; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morales Y, 2007, SEMIN PERINATOL, V31, P83, DOI 10.1053/j.semperi.2007.02.002; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; PRANGLI AL, 2009, PEDIAT ALLERGY IMMUN; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sanchez B, 2009, J MOL MICROB BIOTECH, V17, P158, DOI 10.1159/000233579; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; SASAJIMA K, 1983, AGR BIOL CHEM TOKYO, V47, P1375, DOI 10.1080/00021369.1983.10858526; SCHUTTE JB, 1992, BRIT J NUTR, V68, P195, DOI 10.1079/BJN19920077; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; SHAH P, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004339.PUB3; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vaillancourt K, 2008, APPL ENVIRON MICROB, V74, P1264, DOI 10.1128/AEM.01585-07; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142	74	78	87	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12459	10.1371/journal.pone.0012459	http://dx.doi.org/10.1371/journal.pone.0012459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805981	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500025
J	Traylor, RN; Bruno, DL; Burgess, T; Wildin, R; Spencer, A; Ganesamoorthy, D; Amor, DJ; Hunter, M; Caplan, M; Rosenfeld, JA; Theisen, A; Torchia, BS; Shaffer, LG; Ballif, BC; Slater, HR				Traylor, Ryan N.; Bruno, Damien L.; Burgess, Trent; Wildin, Robert; Spencer, Anne; Ganesamoorthy, Devika; Amor, David J.; Hunter, Matthew; Caplan, Michael; Rosenfeld, Jill A.; Theisen, Aaron; Torchia, Beth S.; Shaffer, Lisa G.; Ballif, Blake C.; Slater, Howard R.			A Genotype-First Approach for the Molecular and Clinical Characterization of Uncommon De Novo Microdeletion of 20q13.33	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; SUBTELOMERIC DELETION; PERICENTRIC-INVERSION; SOX18; CHROMOSOME-20; MUTATIONS; LOCUS; 20Q; REARRANGEMENTS; TRANSCRIPTION	Background: Subtelomeric deletions of the long arm of chromosome 20 are rare, with only 11 described in the literature. Clinical features of individuals with these microdeletions include severe limb malformations, skeletal abnormalities, growth retardation, developmental and speech delay, mental retardation, seizures and mild, non-specific dysmorphic features. Methodology/Principal Findings: We characterized microdeletions at 20q13.33 in six individuals referred for genetic evaluation of developmental delay, mental retardation, and/or congenital anomalies. A comparison to previously reported cases of 20q13.33 microdeletion shows phenotypic overlap, with clinical features that include mental retardation, developmental delay, speech and language deficits, seizures, and behavior problems such as autistic spectrum disorder. There does not appear to be a clinically recognizable constellation of dysmorphic features among individuals with subtelomeric 20q microdeletions. Conclusions/Significance: Based on genotype-phenotype correlation among individuals in this and previous studies, we discuss several possible candidate genes for specific clinical features, including ARFGAP1, CHRNA4 and KCNQ2 and neurodevelopmental deficits. Deletion of this region may play an important role in cognitive development.	[Traylor, Ryan N.; Rosenfeld, Jill A.; Theisen, Aaron; Torchia, Beth S.; Shaffer, Lisa G.; Ballif, Blake C.] Signature Genom Labs, Spokane, WA USA; [Bruno, Damien L.; Burgess, Trent; Ganesamoorthy, Devika; Amor, David J.; Hunter, Matthew; Slater, Howard R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Bruno, Damien L.; Burgess, Trent; Ganesamoorthy, Devika; Amor, David J.; Slater, Howard R.] Univ Melbourne, Royal Childrens Hosp, Dept Pediat, Parkville, Vic 3052, Australia; [Wildin, Robert; Spencer, Anne] St Lukes Reg Med Ctr, Boise, ID USA; [Caplan, Michael] Univ Chicago, Pritzker Sch Med, Northshore Univ Healthsyst, Chicago, IL 60637 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; NorthShore University Health System; University of Chicago	Traylor, RN (corresponding author), Signature Genom Labs, Spokane, WA USA.	ballif@signaturegenomics.com	Hunter, Matthew/S-7150-2019; Ganesamoorthy, Devika/J-8359-2014; Amor, David J/A-6478-2018; Bruno, Damien L/C-3665-2013	Hunter, Matthew/0000-0002-2475-6545; Ganesamoorthy, Devika/0000-0001-8149-6703; Amor, David J/0000-0001-7191-8511; Hunter, Matthew/0000-0002-7659-1404	Signature Genomic Laboratories, LLC	Signature Genomic Laboratories, LLC	As an employer of RN Traylor, JA Rosenfeld, A Theisen, BS Torchia, LG Shaffer and BC Ballif, Signature Genomic Laboratories, LLC, funded this work in part. Signature Genomic Laboratories had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aldred MA, 2002, AM J MED GENET, V113, P167, DOI 10.1002/ajmg.10751; Ardalan A, 2005, AM J MED GENET A, V138A, P288, DOI 10.1002/ajmg.a.30966; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Bena F, 2007, AM J MED GENET A, V143A, P1894, DOI 10.1002/ajmg.a.31789; Beri-Deixheimer M, 2007, EUR J HUM GENET, V15, P446, DOI 10.1038/sj.ejhg.5201784; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Combi R, 2004, J NEUROL, V251, P923, DOI 10.1007/s00415-004-0541-x; DeScipio C, 2010, AM J MED GENET A, V152A, P373, DOI 10.1002/ajmg.a.33219; Downes M, 2001, TRENDS CARDIOVAS MED, V11, P318, DOI 10.1016/S1050-1738(01)00131-1; FRAISSE J, 1982, SEM HOP PARIS, V58, P1366; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Heron SE, 2007, J MED GENET, V44, P791, DOI 10.1136/jmg.2007.051938; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Kroepfl T, 2008, CLIN GENET, V73, P492, DOI 10.1111/j.1399-0004.2008.00982.x; Nakashima E, 2005, AM J MED GENET A, V132A, P181, DOI 10.1002/ajmg.a.30411; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; PETERSEN MB, 1987, J MED GENET, V24, P93, DOI 10.1136/jmg.24.2.93; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Roberts AE, 2004, AM J MED GENET A, V128A, P352, DOI 10.1002/ajmg.a.30142; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; SHABTAI F, 1993, J MED GENET, V30, P171, DOI 10.1136/jmg.30.2.171; Shaffer LG, 2007, GENET MED, V9, P607, DOI 10.1097/GIM.0b013e3181484b49; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Traylor RN, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-17; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118	30	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12462	10.1371/journal.pone.0012462	http://dx.doi.org/10.1371/journal.pone.0012462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805988	gold, Green Published, Green Submitted			2022-12-27	WOS:000281301500027
J	Schepens, I; Jaunin, F; Begre, N; Laderach, U; Marcus, K; Hashimoto, T; Favre, B; Borradori, L				Schepens, Isabelle; Jaunin, Fabienne; Begre, Nadja; Laederach, Ursula; Marcus, Katrin; Hashimoto, Takashi; Favre, Bertrand; Borradori, Luca			The Protease Inhibitor Alpha-2-Macroglobuline-Like-1 Is the p170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human	PLOS ONE			English	Article							AUTOIMMUNE MULTIORGAN SYNDROME; PLAKIN FAMILY; ALPHA(2)-MACROGLOBULIN; PERIPLAKIN; ANTIBODIES	Background: Paraneoplastic pemphigus (PNP) is a devastating autoimmune blistering disease, involving mucocutaneous and internal organs, and associated with underlying neoplasms. PNP is characterized by the production of autoantibodies targeting proteins of the plakin and cadherin families involved in maintenance of cell architecture and tissue cohesion. Nevertheless, the identity of an antigen of Mr 170,000 (p170), thought to be critical in PNP pathogenesis, has remained unknown. Methodology/Principal Findings: Using an immunoprecipitation and mass spectrometry based approach, we identified p170 as alpha-2-macroglobuline-like-1, a broad range protease inhibitor expressed in stratified epithelia and other tissues damaged in the PNP disease course. We demonstrate that 10 PNP sera recognize alpha-2-macroglobuline-like-1 (A2ML1), while none of the control sera obtained from patients with bullous pemphigoid, pemphigus vulgaris, pemphigus foliaceus and normal subjects does. Conclusions/Significance: Our study unravels a broad range protease inhibitor as a new class of target antigens in a paraneoplastic autoimmune multiorgan syndrome and opens a new challenging investigation avenue for a better understanding of PNP pathogenesis.	[Schepens, Isabelle; Begre, Nadja; Laederach, Ursula; Favre, Bertrand; Borradori, Luca] Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland; [Schepens, Isabelle; Begre, Nadja; Laederach, Ursula; Favre, Bertrand; Borradori, Luca] Univ Bern, Bern, Switzerland; [Jaunin, Fabienne] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland; [Marcus, Katrin] Ruhr Univ Bochum, MPC, Bochum, Germany; [Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan	University of Bern; University Hospital of Bern; University of Bern; University of Geneva; Ruhr University Bochum; Kurume University	Schepens, I (corresponding author), Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland.	isabelle.schepens@insel.ch; luca.borradori@insel.ch	Hashimoto, Takashi/H-6947-2019	Hashimoto, Takashi/0000-0002-0144-3255; Schepens, Isabelle/0000-0002-6718-9608	European Community [HEALTH-F2-2008-200515]; Swiss National Foundation [FNS/SNF 31003A-121966, 31003A-09811]	European Community(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This project was supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant agreement number HEALTH-F2-2008-200515 (http://ec.europa.eu/research/health/medical-research/rare-diseases/projects/pemphigus_en.html)(to L.B.) and the Swiss National Foundation for Scientific Research (FNS/SNF 31003A-121966 and 31003A-09811, to L.B.)(http://www.projectdb.snf.ch/WebForms/Frameset.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Anhalt G J, 1997, Adv Dermatol, V12, P77; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Borradori L, 1998, J INVEST DERMATOL, V111, P338, DOI 10.1046/j.1523-1747.1998.00280.x; Bowen GM, 2000, ARCH DERMATOL, V136, P652, DOI 10.1001/archderm.136.5.652; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Galliano MF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002729; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; HASHIMOTO T, 1995, J INVEST DERMATOL, V104, P829, DOI 10.1111/1523-1747.ep12607012; Heizmann M, 2001, AM J HEMATOL, V66, P142, DOI 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.3.CO;2-S; JACKSON J, 1989, J CLIN INVEST, V83, P698, DOI 10.1172/JCI113934; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACIEJEWSKARODR.H, ARTHRITIS RHEUM, V62, P93; Mahoney MG, 1998, J INVEST DERMATOL, V111, P308, DOI 10.1046/j.1523-1747.1998.00279.x; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Mimouni D, 2002, BRIT J DERMATOL, V147, P725, DOI 10.1046/j.1365-2133.2002.04992.x; Nguyen VT, 2001, ARCH DERMATOL, V137, P193; Niessen CM, 1996, J CELL SCI, V109, P1695; Nikolskaia OV, 2003, BRIT J DERMATOL, V149, P1143, DOI 10.1111/j.1365-2133.2003.05659.x; Nousari HC, 1999, NEW ENGL J MED, V340, P1406, DOI 10.1056/NEJM199905063401805; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; OURSLER JR, 1992, J CLIN INVEST, V89, P1775, DOI 10.1172/JCI115781; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reich K, 1999, BRIT J DERMATOL, V141, P739; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sehgal VN, 2009, INT J DERMATOL, V48, P162, DOI 10.1111/j.1365-4632.2009.03995.x; Wang J, 2005, BRIT J DERMATOL, V153, P558, DOI 10.1111/j.1365-2133.2005.06599.x; Wang LC, 2004, LANCET, V363, P525, DOI 10.1016/S0140-6736(04)15539-6; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhu XJ, 2007, J DERMATOL, V34, P503, DOI 10.1111/j.1346-8138.2007.00322.x	39	67	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12250	10.1371/journal.pone.0012250	http://dx.doi.org/10.1371/journal.pone.0012250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805888	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600022
J	Altorf-van Der Kuil, W; Engberink, MF; Brink, EJ; van Baak, MA; Bakker, SJL; Navis, G; van't Veer, P; Geleijnse, JM				Altorf-van der Kuil, Wieke; Engberink, Marielle F.; Brink, Elizabeth J.; van Baak, Marleen A.; Bakker, Stephan J. L.; Navis, Gerjan; van't Veer, Pieter; Geleijnse, Johanna M.			Dietary Protein and Blood Pressure: A Systematic Review	PLOS ONE			English	Article							DISEASE RISK-FACTORS; VASCULAR ENDOTHELIAL FUNCTION; SYMPATHETIC-NERVOUS-SYSTEM; JAPAN COOPERATIVE RESEARCH; MIDDLE-AGED MEN; CARDIOVASCULAR-DISEASES; WEIGHT-LOSS; POSTMENOPAUSAL WOMEN; CARBOHYDRATE INTAKE; METABOLIC SYNDROME	Background: Elevated blood pressure (BP), which is a major risk factor for cardiovascular disease, is highly prevalent worldwide. Recently, interest has grown in the role of dietary protein in human BP. We performed a systematic review of all published scientific literature on dietary protein, including protein from various sources, in relation to human BP. Methodology/Principal Findings: We performed a MEDLINE search and a manual search to identify English language studies on the association between protein and blood pressure, published before June 2010. A total of 46 papers met the inclusion criteria. Most observational studies showed no association or an inverse association between total dietary protein and BP or incident hypertension. Results of biomarker studies and randomized controlled trials indicated a beneficial effect of protein on BP. This beneficial effect may be mainly driven by plant protein, according to results in observational studies. Data on protein from specific sources (e.g. from fish, dairy, grain, soy, and nut) were scarce. There was some evidence that BP in people with elevated BP and/or older age could be more sensitive to dietary protein. Conclusions/Significance: In conclusion, evidence suggests a small beneficial effect of protein on BP, especially for plant protein. A blood pressure lowering effect of protein may have important public health implications. However, this warrants further investigation in randomized controlled trials. Furthermore, more data are needed on protein from specific sources in relation to BP, and on the protein-BP relation in population subgroups.	[Altorf-van der Kuil, Wieke; Engberink, Marielle F.; Brink, Elizabeth J.; van Baak, Marleen A.; Bakker, Stephan J. L.; Navis, Gerjan; Geleijnse, Johanna M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Altorf-van der Kuil, Wieke; Engberink, Marielle F.; van't Veer, Pieter; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Brink, Elizabeth J.] TNO Qual Life, Human Studies Grp, Zeist, Netherlands; [van Baak, Marleen A.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Bakker, Stephan J. L.; Navis, Gerjan] Univ Med Ctr Groningen, Kidney Ctr, NL-9713 AV Groningen, Netherlands; [Bakker, Stephan J. L.; Navis, Gerjan] Univ Groningen, Groningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Netherlands Organization Applied Science Research; Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; University of Groningen	Altorf-van Der Kuil, W (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	Wieke.Altorf-vanderKuil@wur.nl	Bakker, Stephan J. L./J-4023-2015; Geleijnse, Johanna Marianna M/B-5749-2012	Bakker, Stephan J. L./0000-0003-3356-6791; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; van Baak, Marleen/0000-0003-2592-6363	Top Institute (TI) Food and Nutrition	Top Institute (TI) Food and Nutrition	The current review was supported by Top Institute (TI) Food and Nutrition, which is a public/private partnership that generates vision on scientific breakthroughs in food and nutrition, resulting in the development of innovative products and technologies. Partners are major Dutch Food companies and research organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2006, ARCH MED RES, V37, P778, DOI 10.1016/j.arcmed.2006.01.007; ANDERSON GH, 1986, CAN J PHYSIOL PHARM, V64, P863, DOI 10.1139/y86-149; Anderson JW, 2007, METABOLISM, V56, P280, DOI 10.1016/j.metabol.2006.10.013; [Anonymous], 1998, ZO EET NEDERLAND RES; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 2003, CURR OPIN LIPIDOL, V14, P55, DOI 10.1097/00041433-200302000-00010; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Azadbakht L, 2007, BRIT J NUTR, V98, P807, DOI 10.1017/S0007114507746871; Azadbakht L, 2007, AM J CLIN NUTR, V85, P735, DOI 10.1093/ajcn/85.3.735; Azadbakht L, 2007, DIABETES CARE, V30, P967, DOI 10.2337/dc06-2126; Bingham SA, 2003, J NUTR, V133, p921S, DOI 10.1093/jn/133.3.921S; Brinkworth GD, 2004, DIABETOLOGIA, V47, P1677, DOI 10.1007/s00125-004-1511-7; BRUSSAARD JH, 1981, AM J CLIN NUTR, V34, P2023, DOI 10.1093/ajcn/34.10.2023; Burke V, 2001, HYPERTENSION, V38, P821, DOI 10.1161/hy1001.092614; Chan YH, 2007, AM J CLIN NUTR, V86, P938, DOI 10.1093/ajcn/86.4.938; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cirillo M, 2002, J HUM HYPERTENS, V16, P205, DOI 10.1038/sj.jhh.1001323; DANIELS BS, 1990, AM J PHYSIOL, V258, pR1095, DOI 10.1152/ajpregu.1990.258.5.R1095; DEHAVEN J, 1980, NEW ENGL J MED, V302, P477, DOI 10.1056/NEJM198002283020901; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Ferrara LA, 2006, EUR J CLIN NUTR, V60, P643, DOI 10.1038/sj.ejcn.1602363; GARCIAPALMIERI MR, 1984, HYPERTENSION, V6, P322, DOI 10.1161/01.HYP.6.3.322; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gokce N, 2004, J NUTR, V134, p2807S, DOI 10.1093/jn/134.10.2807S; Harrison RA, 2004, NUTR METAB CARDIOVAS, V14, P344, DOI 10.1016/S0939-4753(04)80024-3; HAVLIK RJ, 1990, PREV MED, V19, P31, DOI 10.1016/0091-7435(90)90004-4; He J, 2005, ANN INTERN MED, V143, P1, DOI 10.7326/0003-4819-143-1-200507050-00004; He J, 1999, CLIN EXP HYPERTENS, V21, P785, DOI 10.3109/10641969909061008; He JA, 1995, J HYPERTENS, V13, P1267, DOI 10.1097/00004872-199511000-00008; HEKMAN PRW, 1990, J CARDIOVASC PHARM, V16, pS12, DOI 10.1097/00005344-199000168-00007; HENDLER R, 1988, AM J CLIN NUTR, V48, P1239, DOI 10.1093/ajcn/48.5.1239; Hodgson JM, 2006, AM J CLIN NUTR, V83, P780, DOI 10.1093/ajcn/83.4.780; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Iseki K, 2003, HYPERTENS RES, V26, P289, DOI 10.1291/hypres.26.289; JOFFRES MR, 1987, AM J CLIN NUTR, V45, P469, DOI 10.1093/ajcn/45.2.469; KESTIN M, 1989, AM J CLIN NUTR, V50, P280, DOI 10.1093/ajcn/50.2.280; KIHARA M, 1984, HYPERTENSION, V6, P736, DOI 10.1161/01.HYP.6.5.736; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; KUCHEL O, 1998, AM J PHYSL REGULATOR, V275; Leidy HJ, 2007, OBESITY, V15, P421, DOI 10.1038/oby.2007.531; Liu K, 1996, CIRCULATION, V93, P60, DOI 10.1161/01.CIR.93.1.60; Liu LJ, 2000, HYPERTENS RES, V23, P151, DOI 10.1291/hypres.23.151; Liu LJ, 2000, HYPERTENS RES, V23, P413, DOI 10.1291/hypres.23.413; Liu LJ, 2002, INT J EPIDEMIOL, V31, P227, DOI 10.1093/ije/31.1.227; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; LONG CL, 1975, METABOLISM, V24, P929, DOI 10.1016/0026-0495(75)90084-0; MARLISS EB, 1979, AM J CLIN NUTR, V32, P1617, DOI 10.1093/ajcn/32.8.1617; Masala G, 2008, J HYPERTENS, V26, P2112, DOI 10.1097/HJH.0b013e32830ef75c; Matthan NR, 2007, AM J CLIN NUTR, V85, P960, DOI 10.1093/ajcn/85.4.960; Meckling KA, 2007, APPL PHYSIOL NUTR ME, V32, P743, DOI 10.1139/H07-059; MORAN JP, 1993, AM J CLIN NUTR, V57, P213, DOI 10.1093/ajcn/57.2.213; Muzio F, 2007, AM J CLIN NUTR, V86, P946, DOI 10.1093/ajcn/86.4.946; Myers VH, 2007, CURR OPIN LIPIDOL, V18, P20, DOI 10.1097/MOL.0b013e328012d911; Obarzanek E, 1996, JAMA-J AM MED ASSOC, V275, P1598, DOI 10.1001/jama.275.20.1598; Palm F, 2009, CURR OPIN NEPHROL HY, V18, P68, DOI 10.1097/MNH.0b013e32831c4cdf; PAPAKONSTANTINO.E, 2010, EUROPEAN J CLIN NUTR; PELLUM LK, 1983, NUTR REP INT, V27, P1277; Pijls LTJ, 1999, NEPHROL DIAL TRANSPL, V14, P1445, DOI 10.1093/ndt/14.6.1445; PRESCOTT SL, 1988, CLIN SCI, V74, P665, DOI 10.1042/cs0740665; REED D, 1985, HYPERTENSION, V7, P405, DOI 10.1161/01.HYP.7.3_Pt_1.405; Ruggenenti P, 2009, HYPERTENSION, V54, P567, DOI 10.1161/HYPERTENSIONAHA.109.132522; SACKS FM, 1984, HYPERTENSION, V6, P199, DOI 10.1161/01.HYP.6.2_Pt_1.199; Sagara M, 2004, J AM COLL NUTR, V23, P85, DOI 10.1080/07315724.2004.10719347; SOWERS JR, 2004, AM J PHYSL HEART CIR, V286; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stamler J, 1996, CIRCULATION, V94, P2417, DOI 10.1161/01.CIR.94.10.2417; Umesawa M, 2009, AM J CLIN NUTR, V90, P377, DOI 10.3945/ajcn.2008.27109; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; Wheeler ML, 2002, DIABETES CARE, V25, P1277, DOI 10.2337/diacare.25.8.1277; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; YAMORI Y, 1990, J CARDIOVASC PHARM, V16, pS43, DOI 10.1097/00005344-199000168-00018; Yang G, 2005, AM J CLIN NUTR, V81, P1012; ZHOU BF, 1994, INT J EPIDEMIOL, V23, P716, DOI 10.1093/ije/23.4.716	77	101	101	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12102	10.1371/journal.pone.0012102	http://dx.doi.org/10.1371/journal.pone.0012102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711407	Green Published, gold			2022-12-27	WOS:000280849100024
J	Dickson, TL; Mitchell, CE				Dickson, Timothy L.; Mitchell, Charles E.			Herbivore and Fungal Pathogen Exclusion Affects the Seed Production of Four Common Grassland Species	PLOS ONE			English	Article							TALLGRASS PRAIRIE; VIRUS-INFECTION; PLANT; COMMUNITY; HOST; POPULATIONS; DISEASE; ESTABLISHMENT; CONSEQUENCES; DIVERSITY	Insect herbivores and fungal pathogens can independently affect plant fitness, and may have interactive effects. However, few studies have experimentally quantified the joint effects of insects and fungal pathogens on seed production in non-agricultural populations. We examined the factorial effects of insect herbivore exclusion (via insecticide) and fungal pathogen exclusion (via fungicide) on the population-level seed production of four common graminoid species (Andropogon gerardii, Schizachyrium scoparium, Poa pratensis, and Carex siccata) over two growing seasons in Minnesota, USA. We detected no interactive effects of herbivores and pathogens on seed production. However, the seed production of all four species was affected by either insecticide or fungicide in at least one year of the study. Insecticide consistently doubled the seed production of the historically most common species in the North American tallgrass prairie, A. gerardii (big bluestem). This is the first report of insect removal increasing seed production in this species. Insecticide increased A. gerardii number of seeds per seed head in one year, and mass per seed in both years, suggesting that consumption of flowers and seed embryos contributed to the effect on seed production. One of the primary insect species consuming A. gerardii flowers and seed embryos was likely the Cecidomyiid midge, Contarinia wattsi. Effects on all other plant species varied among years. Herbivores and pathogens likely reduce the dispersal and colonization ability of plants when they reduce seed output. Therefore, impacts on seed production of competitive dominant species may help to explain their relatively poor colonization abilities. Reduced seed output by dominant graminoids may thereby promote coexistence with subdominant species through competition-colonization tradeoffs.	[Dickson, Timothy L.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Dickson, TL (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.	DicksonTL@gmail.com	Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993	University of Minnesota Graduate School; Land Institute; United States National Science Foundation NSF/DEB [9411972]	University of Minnesota Graduate School(University of Minnesota System); Land Institute; United States National Science Foundation NSF/DEB(National Science Foundation (NSF))	Funding was provided by fellowships from the University of Minnesota Graduate School and the Land Institute to Charles Mitchell, and a United States National Science Foundation grant (NSF/DEB 9411972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Alexander HM, 2000, OECOLOGIA, V122, P346, DOI 10.1007/s004420050040; ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; Blaney CS, 2001, J APPL ECOL, V38, P1104, DOI 10.1046/j.1365-2664.2001.00663.x; Bradley DJ, 2008, ECOL LETT, V11, P461, DOI 10.1111/j.1461-0248.2008.01162.x; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; CALUMPANG SMF, 1993, INT J PEST MANAGE, V39, P161, DOI 10.1080/09670879309371783; CARLSSON U, 1992, OECOLOGIA, V90, P509, DOI 10.1007/BF01875444; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; CARTER MR, 1988, J RANGE MANAGE, V41, P253, DOI 10.2307/3899180; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craine JM, 2003, PLANT ECOL, V165, P85, DOI 10.1023/A:1021414615001; Crawley Michael J., 1997, P401; Daleo P, 2009, J ECOL, V97, P781, DOI 10.1111/j.1365-2745.2009.01508.x; Dickson TL, 2009, RESTOR ECOL, V17, P597, DOI 10.1111/j.1526-100X.2008.00427.x; Eviner VT, 2003, ECOLOGY, V84, P120, DOI 10.1890/0012-9658(2003)084[0120:GPFIAE]2.0.CO;2; Foster BL, 2004, J ECOL, V92, P435, DOI 10.1111/j.0022-0477.2004.00882.x; Foster BL, 2003, J ECOL, V91, P999, DOI 10.1046/j.1365-2745.2003.00830.x; Fournier V, 2006, ECOL APPL, V16, P2382, DOI 10.1890/1051-0761(2006)016[2382:MPEOAS]2.0.CO;2; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Gillings S, 2005, P ROY SOC B-BIOL SCI, V272, P733, DOI 10.1098/rspb.2004.3010; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Hatcher PE, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P133; HATCHER PE, 1995, BIOL REV, V70, P639, DOI 10.1111/j.1469-185X.1995.tb01655.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JAROSZ AM, 1992, OECOLOGIA, V89, P53, DOI 10.1007/BF00319015; JAROSZ AM, 1995, NEW PHYTOL, V129, P371, DOI 10.1111/j.1469-8137.1995.tb04308.x; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Littell RC, 2002, SAS LINEAR MODELS; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Mack R, 1985, STUDIES PLANT DEMOGR, P127; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Mitchell CE, 2003, ECOL LETT, V6, P147, DOI 10.1046/j.1461-0248.2003.00408.x; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Oerke E.C., 1994, CROP PRODUCTION CROP; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; PAUL ND, 1987, J ECOL, V75, P61, DOI 10.2307/2260536; Remold SK, 2002, J ECOL, V90, P967, DOI 10.1046/j.1365-2745.2002.00731.x; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; TURNER CL, 1995, INT J PLANT SCI, V156, P216, DOI 10.1086/297243	45	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12022	10.1371/journal.pone.0012022	http://dx.doi.org/10.1371/journal.pone.0012022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711408	gold, Green Published			2022-12-27	WOS:000280849100006
J	Marionnet, C; Pierrard, C; Lejeune, F; Sok, J; Thomas, M; Bernerd, F				Marionnet, Claire; Pierrard, Cecile; Lejeune, Francois; Sok, Juliette; Thomas, Marie; Bernerd, Francoise			Different Oxidative Stress Response in Keratinocytes and Fibroblasts of Reconstructed Skin Exposed to Non Extreme Daily-Ultraviolet Radiation	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; DERMAL-EPIDERMAL JUNCTION; ANTIOXIDANT DEFENSE; UV-IRRADIATION; REDUCED TOLERANCE; B INJURY; IN-VITRO; METALLOTHIONEIN; EXPRESSION; GENE	Experiments characterizing the biological effects of sun exposure have usually involved solar simulators. However, they addressed the worst case scenario i.e. zenithal sun, rarely found in common outdoor activities. A non-extreme ultraviolet radiation (UV) spectrum referred as "daily UV radiation'' (DUVR) with a higher UVA (320-400 nm) to UVB (280-320 nm) irradiance ratio has therefore been defined. In this study, the biological impact of an acute exposure to low physiological doses of DUVR (corresponding to 10 and 20% of the dose received per day in Paris mid-April) on a 3 dimensional reconstructed skin model, was analysed. In such conditions, epidermal and dermal morphological alterations could only be detected after the highest dose of DUVR. We then focused on oxidative stress response induced by DUVR, by analyzing the modulation of mRNA level of 24 markers in parallel in fibroblasts and keratinocytes. DUVR significantly modulated mRNA levels of these markers in both cell types. A cell type differential response was noticed: it was faster in fibroblasts, with a majority of inductions and high levels of modulation in contrast to keratinocyte response. Our results thus revealed a higher sensitivity in response to oxidative stress of dermal fibroblasts although located deeper in the skin, giving new insights into the skin biological events occurring in everyday UV exposure.	[Marionnet, Claire; Pierrard, Cecile; Lejeune, Francois; Sok, Juliette; Thomas, Marie; Bernerd, Francoise] LOreal Rech, Clichy, France	L'Oreal Group	Marionnet, C (corresponding author), LOreal Rech, Clichy, France.	fbernerd@rd.loreal.com						APPLEGATE LA, 1995, PHOTOCHEM PHOTOBIOL, V61, P285, DOI 10.1111/j.1751-1097.1995.tb03973.x; APPLEGATE LA, 1995, PHOTODERMATOL PHOTO, V11, P95, DOI 10.1111/j.1600-0781.1995.tb00146.x; ATHAR M, 1992, PHARM SKIN; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Black AT, 2008, CARCINOGENESIS, V29, P219, DOI 10.1093/carcin/bgm242; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Christiaens FJ, 2005, PHOTOCHEM PHOTOBIOL, V81, P874, DOI 10.1562/2004-05-14-RA-167R1.1; *COPL, 1994, COPL SUN PROT FACT T; Durchdewald M, 2007, J INVEST DERMATOL, V127, P646, DOI 10.1038/sj.jid.5700585; GILCHREST BA, 1995, PHOTODAMAGE, P97; Godar DE, 2005, PHOTOCHEM PHOTOBIOL, V81, P736, DOI 10.1562/2004-09-07-IR-308R.1; Hanada K, 1998, J INVEST DERMATOL, V111, P582, DOI 10.1046/j.1523-1747.1998.00342.x; Hansen C, 1997, PHOTOCHEM PHOTOBIOL, V65, P550, DOI 10.1111/j.1751-1097.1997.tb08603.x; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Heinloth AN, 2003, RADIAT RES, V160, P273, DOI 10.1667/RR3047; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Kannan S, 2006, CANCER RES, V66, P8421, DOI 10.1158/0008-5472.CAN-06-1181; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Krutmann J, 2006, PROG BIOPHYS MOL BIO, V92, P105, DOI 10.1016/j.pbiomolbio.2006.02.018; Krutmann J, 2005, SKIN AGING, P33; LAVKER RM, 1995, J AM ACAD DERMATOL, V32, P53, DOI 10.1016/0190-9622(95)90184-1; LAVKER RM, 1995, PHOTOCHEM PHOTOBIOL, V62, P348, DOI 10.1111/j.1751-1097.1995.tb05280.x; Leccia MT, 1998, EUR J DERMATOL, V8, P478; Lejeune F, 2008, PHOTODERMATOL PHOTO, V24, P249, DOI 10.1111/j.1600-0781.2008.00370.x; Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Ogawa F, 2006, J INVEST DERMATOL, V126, P1128, DOI 10.1038/sj.jid.5700116; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Seite S, 2006, PHOTODERMATOL PHOTO, V22, P67, DOI 10.1111/j.1600-0781.2006.00209.x; Seite S, 2000, PHOTODERMATOL PHOTO, V16, P3, DOI 10.1034/j.1600-0781.2000.160103.x; Seite S, 1998, PROTECTION SKIN ULTR, P159; Sheehan JM, 2002, PHOTOCH PHOTOBIO SCI, V1, P365, DOI 10.1039/b108291d; SHINDO Y, 1993, J INVEST DERMATOL, V100, P260, DOI 10.1111/1523-1747.ep12469048; Taungjaruwinai WM, 2009, AM J DERMATOPATH, V31, P427, DOI 10.1097/DAD.0b013e3181882c21; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wang WH, 2004, CLIN EXP DERMATOL, V29, P57, DOI 10.1111/j.1365-2230.2004.01424.x; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Young AR, 2007, J INVEST DERMATOL, V127, P975, DOI 10.1038/sj.jid.5700606	50	68	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12059	10.1371/journal.pone.0012059	http://dx.doi.org/10.1371/journal.pone.0012059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706594	Green Submitted, Green Published, gold			2022-12-27	WOS:000280811900016
J	Dyer, MD; Neff, C; Dufford, M; Rivera, CG; Shattuck, D; Bassaganya-Riera, J; Murali, TM; Sobral, BW				Dyer, Matthew D.; Neff, Chris; Dufford, Max; Rivera, Corban G.; Shattuck, Donna; Bassaganya-Riera, Josep; Murali, T. M.; Sobral, Bruno W.			The Human-Bacterial Pathogen Protein Interaction Networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis	PLOS ONE			English	Article							VIRULENCE FACTORS; LETHAL TOXIN; MACROPHAGES; APOPTOSIS; DATABASE; MAP; RESOURCE; INNATE; CELLS; SET	Background: Bacillus anthracis, Francisella tularensis, and Yersinia pestis are bacterial pathogens that can cause anthrax, lethal acute pneumonic disease, and bubonic plague, respectively, and are listed as NIAID Category A priority pathogens for possible use as biological weapons. However, the interactions between human proteins and proteins in these bacteria remain poorly characterized leading to an incomplete understanding of their pathogenesis and mechanisms of immune evasion. Methodology: In this study, we used a high-throughput yeast two-hybrid assay to identify physical interactions between human proteins and proteins from each of these three pathogens. From more than 250,000 screens performed, we identified 3,073 human-B. anthracis, 1,383 human-F. tularensis, and 4,059 human-Y. pestis protein-protein interactions including interactions involving 304 B. anthracis, 52 F. tularensis, and 330 Y. pestis proteins that are uncharacterized. Computational analysis revealed that pathogen proteins preferentially interact with human proteins that are hubs and bottlenecks in the human PPI network. In addition, we computed modules of human-pathogen PPIs that are conserved amongst the three networks. Functionally, such conserved modules reveal commonalities between how the different pathogens interact with crucial host pathways involved in inflammation and immunity. Significance: These data constitute the first extensive protein interaction networks constructed for bacterial pathogens and their human hosts. This study provides novel insights into host-pathogen interactions.	[Dyer, Matthew D.; Bassaganya-Riera, Josep; Sobral, Bruno W.] Virginia Bioinformat Inst, Blacksburg, VA USA; [Neff, Chris; Dufford, Max; Shattuck, Donna] Myriad Genet, Salt Lake City, UT USA; [Rivera, Corban G.; Murali, T. M.] Virginia Polytech Inst & State Univ, Dept Comp Sci, Blacksburg, VA 24061 USA	Myriad Genetics, Inc; Virginia Polytechnic Institute & State University	Dyer, MD (corresponding author), Life Technol, Foster City, CA USA.	murali@cs.vt.edu; sobral@vbi.vt.edu	Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900040C, DHHSN266200400057C]; Myriad, INC.	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Myriad, INC.	This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900040C to Bruno Sobral and contract DHHSN266200400057C to Myriad. Facilities and equipment for doing the experiments was provided by Myriad, INC. Time for CN, MD, and DS was partially funded by Myriad, INC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gilbert D, 2005, BRIEF BIOINFORM, V6, P194, DOI 10.1093/bib/6.2.194; Grande F, 2008, CURR PHARM DESIGN, V14, P385; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Haase R, 2005, J IMMUNOL, V175, P8209, DOI 10.4049/jimmunol.175.12.8209; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Narayanan M, 2007, J COMPUT BIOL, V14, P892, DOI 10.1089/cmb.2007.0025; Pallandre JR, 2007, J IMMUNOL, V179, P7593, DOI 10.4049/jimmunol.179.11.7593; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rivera CG, 2009, LECT N BIOINFORMAT, V5462, P67, DOI 10.1007/978-3-642-00727-9_9; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; STARNBACH MN, 1994, J IMMUNOL, V153, P1603; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tewari K, 2006, P NATL ACAD SCI USA, V103, P16388, DOI 10.1073/pnas.0602565103; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	47	103	104	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12089	10.1371/journal.pone.0012089	http://dx.doi.org/10.1371/journal.pone.0012089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711500	Green Submitted, Green Published, gold			2022-12-27	WOS:000280776800021
J	Lindgren, J; Caldwell, MW; Konishi, T; Chiappe, LM				Lindgren, Johan; Caldwell, Michael W.; Konishi, Takuya; Chiappe, Luis M.			Convergent Evolution in Aquatic Tetrapods: Insights from an Exceptional Fossil Mosasaur	PLOS ONE			English	Article							SQUAMATA; FISH; MELANOSOMES; DINOSAURS; REPTILIA; TISSUE; COLOR; SKIN	Mosasaurs (family Mosasauridae) are a diverse group of secondarily aquatic lizards that radiated into marine environments during the Late Cretaceous (98-65 million years ago). For the most part, they have been considered to be simple anguilliform swimmers - i.e., their propulsive force was generated by means of lateral undulations incorporating the greater part of the body - with unremarkable, dorsoventrally narrow tails and long, lizard-like bodies. Convergence with the specialized fusiform body shape and inferred carangiform locomotory style (in which only a portion of the posterior body participates in the thrust-producing flexure) of ichthyosaurs and metriorhynchid crocodyliform reptiles, along with cetaceans, has so far only been recognized in Plotosaurus, the most highly derived member of the Mosasauridae. Here we report on an exceptionally complete specimen (LACM 128319) of the moderately derived genus Platecarpus that preserves soft tissues and anatomical details (e.g., large portions of integument, a partial body outline, putative skin color markings, a downturned tail, branching bronchial tubes, and probable visceral traces) to an extent that has never been seen previously in any mosasaur. Our study demonstrates that a streamlined body plan and crescent-shaped caudal fin were already well established in Platecarpus, a taxon that preceded Plotosaurus by 20 million years. These new data expand our understanding of convergent evolution among marine reptiles, and provide insights into their evolution's tempo and mode.	[Lindgren, Johan] Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden; [Caldwell, Michael W.; Konishi, Takuya] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Caldwell, Michael W.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA	Lund University; University of Alberta; University of Alberta	Lindgren, J (corresponding author), Lund Univ, Dept Earth & Ecosyst Sci, Lund, Sweden.	johan.lindgren@geol.lu.se	Caldwell, Michael/A-2622-2014	Caldwell, Michael/0000-0002-2377-3925; Chiappe, Luis/0000-0001-9661-0601	Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences; Natural Sciences and Engineering Research Council of Canada; University of Alberta, Faculty of Science, Chair's Research Allowance; Dinosaur Institute of the Natural History Museum of Los Angeles County	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Alberta, Faculty of Science, Chair's Research Allowance(University of Alberta); Dinosaur Institute of the Natural History Museum of Los Angeles County	This research was supported by the Swedish Research Council, the Crafoord Foundation, the Royal Swedish Academy of Sciences, the Natural Sciences and Engineering Research Council of Canada, the University of Alberta, Faculty of Science, Chair's Research Allowance, Alberta Ingenuity Fund (PhD Student Scholarship), and the Dinosaur Institute of the Natural History Museum of Los Angeles County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PA, 1988, PALEOBIOLOGY, V14, P331, DOI 10.1017/S0094837300012082; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; BERTA A, 2006, MARINE MAMMALS EVOLU; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Geist Nicholas R., 2002, Journal of Vertebrate Paleontology, V22, p57A; Green R.F., 1972, P247; Hattin DE., 1982, KANSAS GEOL SURV B, V225, P1; HENRY RW, 1983, ANAT REC, V207, P435, DOI 10.1002/ar.1092070306; Hua Stephane, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V193, P1; Kear BP, 2006, BIOL LETTERS, V2, P113, DOI 10.1098/rsbl.2005.0374; King D., 1999, MONITORS BIOL VARANI; KONISHI T, 1869, J VERTEBR P IN PRESS; Konishi T, 2007, J VERTEBR PALEONTOL, V27, P59, DOI 10.1671/0272-4634(2007)27[59:NSOPPC]2.0.CO;2; Lindgren J, 2007, LETHAIA, V40, P153, DOI 10.1111/j.1502-3931.2007.00009.x; Lindgren J, 2009, BIOL LETTERS, V5, P528, DOI 10.1098/rsbl.2009.0097; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P510, DOI 10.1562/2004-10-19-RA-345.1; Long JH, 1996, J EXP BIOL, V199, P2139; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; Martin JE, 2007, GEOL SOC AM SPEC PAP, V427, P167, DOI 10.1130/2007.2427(12); McGowan Christopher, 2003, pi; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; OSBORN HF, 1899, MEMOIRS AM MUSEUM NA, V1, P167; Pees M, 2009, VET RADIOL ULTRASOUN, V50, P487, DOI 10.1111/j.1740-8261.2009.01569.x; Russell D. A., 1967, PEABODY MUS NAT HIST, V23, P1; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; Schumacher B. A., 2007, 2 MOS M, P41; Smith KT, 2008, J VERTEBR PALEONTOL, V28, P85, DOI 10.1671/0272-4634(2008)28[85:ANASAW]2.0.CO;2; SNOW FH, 1878, T KANSAS ACAD SCI, V6, P54, DOI DOI 10.2307/3623557; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Tsang KW, 2002, J WILDLIFE DIS, V38, P224, DOI 10.7589/0090-3558-38.1.224; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Williston S. W., 1899, KANSAS U Q, V8, P39; WILLISTON SW, 1897, KANSAS U Q, V6, P99; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; YOUNG BA, 2008, FORT HAYS STUDIES, V3, P159; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	40	68	71	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e11998	10.1371/journal.pone.0011998	http://dx.doi.org/10.1371/journal.pone.0011998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711249	gold, Green Submitted, Green Published			2022-12-27	WOS:000280776800002
J	Deu, E; Yang, ZM; Wang, F; Klemba, M; Bogyo, M				Deu, Edgar; Yang, Zhimou; Wang, Flora; Klemba, Michael; Bogyo, Matthew			Use of Activity-Based Probes to Develop High Throughput Screening Assays That Can Be Performed in Complex Cell Extracts	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IDENTIFICATION; PROTEASES; INHIBITORS; DISCOVERY	Background: High throughput screening (HTS) is one of the primary tools used to identify novel enzyme inhibitors. However, its applicability is generally restricted to targets that can either be expressed recombinantly or purified in large quantities. Methodology and Principal Findings: Here, we described a method to use activity-based probes (ABPs) to identify substrates that are sufficiently selective to allow HTS in complex biological samples. Because ABPs label their target enzymes through the formation of a permanent covalent bond, we can correlate labeling of target enzymes in a complex mixture with inhibition of turnover of a substrate in that same mixture. Thus, substrate specificity can be determined and substrates with sufficiently high selectivity for HTS can be identified. In this study, we demonstrate this method by using an ABP for dipeptidyl aminopeptidases to identify (Pro-Arg)(2)-Rhodamine as a specific substrate for DPAP1 in Plasmodium falciparum lysates and Cathepsin C in rat liver extracts. We then used this substrate to develop highly sensitive HTS assays (Z'>0.8) that are suitable for use in screening large collections of small molecules (i.e >300,000) for inhibitors of these proteases. Finally, we demonstrate that it is possible to use broad-spectrum ABPs to identify target-specific substrates. Conclusions: We believe that this approach will have value for many enzymatic systems where access to large amounts of active enzyme is problematic.	[Deu, Edgar; Yang, Zhimou; Bogyo, Matthew] Stanford Sch Med, Dept Pathol, Stanford, CA USA; [Wang, Flora; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Bogyo, Matthew] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; Virginia Polytechnic Institute & State University; Stanford University	Deu, E (corresponding author), Stanford Sch Med, Dept Pathol, Stanford, CA USA.	mbogyo@stanford.edu	Yang, Zhimou/F-1798-2010	Yang, Zhimou/0000-0003-2967-6920; Bogyo, Matthew/0000-0003-3753-4412	NIH [R01 EB005011, R01 AI078947]; Burrough Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burrough Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funding by NIH grants R01 EB005011 and R01 AI078947 and a New Investigator Award in Pathogenesis from the Burrough Wellcome Fund (all to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WF, 2010, MOL BIOTECHNOL, V45, P180, DOI 10.1007/s12033-010-9251-z; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; DEU E, 2010, CHEM BIOL UNPUB; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fonovic M, 2007, CURR PHARM DESIGN, V13, P253, DOI 10.2174/138161207779313623; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; LEYTUS SP, 1983, BIOCHEM J, V209, P299, DOI 10.1042/bj2090299; Liu JX, 1999, BIOORG MED CHEM LETT, V9, P3231; Luciani N, 2001, BIOCHEM J, V356, P813, DOI 10.1042/0264-6021:3560813; Rosse G, 2000, J COMB CHEM, V2, P461, DOI 10.1021/cc000019y; Wakata A, 2010, J AM CHEM SOC, V132, P1578, DOI 10.1021/ja907226n; WANG FKP, 2010, MOL BIOCH PARA UNPUB; Williams KP, 2009, METHODS MOL BIOL, V565, P107, DOI 10.1007/978-1-60327-258-2_5; Yuan F, 2006, J AM CHEM SOC, V128, P5616, DOI 10.1021/ja060835v; Zock JM, 2009, COMB CHEM HIGH T SCR, V12, P870, DOI 10.2174/138620709789383277	19	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11985	10.1371/journal.pone.0011985	http://dx.doi.org/10.1371/journal.pone.0011985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700487	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400018
J	Webb, TJ; Vanden Berghe, E; O'Dor, R				Webb, Thomas J.; Vanden Berghe, Edward; O'Dor, Ron			Biodiversity's Big Wet Secret: The Global Distribution of Marine Biological Records Reveals Chronic Under-Exploration of the Deep Pelagic Ocean	PLOS ONE			English	Article							DIVERSITY; SEA; IMPACTS; FISHES	Background: Understanding the distribution of marine biodiversity is a crucial first step towards the effective and sustainable management of marine ecosystems. Recent efforts to collate location records from marine surveys enable us to assemble a global picture of recorded marine biodiversity. They also effectively highlight gaps in our knowledge of particular marine regions. In particular, the deep pelagic ocean - the largest biome on Earth - is chronically under-represented in global databases of marine biodiversity. Methodology/Principal Findings: We use data from the Ocean Biogeographic Information System to plot the position in the water column of ca 7 million records of marine species occurrences. Records from relatively shallow waters dominate this global picture of recorded marine biodiversity. In addition, standardising the number of records from regions of the ocean differing in depth reveals that regardless of ocean depth, most records come either from surface waters or the sea bed. Midwater biodiversity is drastically under-represented. Conclusions/Significance: The deep pelagic ocean is the largest habitat by volume on Earth, yet it remains biodiversity's big wet secret, as it is hugely under-represented in global databases of marine biological records. Given both its value in the provision of a range of ecosystem services, and its vulnerability to threats including overfishing and climate change, there is a pressing need to increase our knowledge of Earth's largest ecosystem.	[Webb, Thomas J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Vanden Berghe, Edward] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [O'Dor, Ron] Consortium Ocean Leadership, Census Marine Life, Washington, DC USA	University of Sheffield; Rutgers State University New Brunswick	Webb, TJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	t.j.webb@sheffield.ac.uk	Webb, Tom/D-5224-2011	Webb, Tom/0000-0003-3183-8116	Royal Society; Sloan Foundation	Royal Society(Royal Society of London); Sloan Foundation(Alfred P. Sloan Foundation)	This work was made possible by a Royal Society (www.royalsoc.ac.uk) Research Fellowship to TJW, and by support from the Sloan Foundation (www.sloan.org/) to OBIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante C., 2009, NGDC24 NOAA NESDIS; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Berra TM, 1997, ENVIRON BIOL FISH, V50, P1, DOI 10.1023/A:1007354702142; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fornwall Mark, 2000, Oceanography, V13, P31; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Grassle J. Frederick, 2000, Oceanography, V13, P5; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; HOLT RD, 2010, NATURE, V463, P32; Jamieson A. J., 2008, P ROYAL SOC B, V276, P1037, DOI 10.1098/rspb.2008.1670; Kunzig R, 2003, SCIENCE, V302, P991, DOI 10.1126/science.1090808; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; O'Dor R, 2010, ESA PUBLICATION, V306; Osborn KJ, 2009, SCIENCE, V325, P964, DOI 10.1126/science.1172488; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; R Core Team, 2020, R LANG ENV STAT COMP; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Sizling AL, 2009, ECOLOGY, V90, P3575, DOI 10.1890/08-1129.1; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Somerfield PJ, 2009, MAR ECOL PROG SER, V382, P221, DOI 10.3354/meps08045; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Vanden Berghe E, 2009, MAR ECOL PROG SER, V382, P225, DOI 10.3354/meps07826; VANDENBERGE E, 2010, ESA PUBLICATION; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Webb TJ, 2009, BIOL LETTERS, V5, P145, DOI 10.1098/rsbl.2008.0735	30	162	164	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e10223	10.1371/journal.pone.0010223	http://dx.doi.org/10.1371/journal.pone.0010223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689845	Green Published, gold, Green Accepted			2022-12-27	WOS:000280520400001
J	Liu, J; Chen, KP; Wang, JH; Zhang, CY				Liu, Jun; Chen, Keping; Wang, Jian-Hua; Zhang, Chiyu			Molecular Evolution of the Primate Antiviral Restriction Factor Tetherin	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANCIENT ADAPTIVE EVOLUTION; CODON-SUBSTITUTION MODELS; NUCLEOTIDE SUBSTITUTIONS; RETROVIRAL RESTRICTION; POSITIVE SELECTION; INDIVIDUAL SITES; HIV-1 INFECTION; PROTEIN; RELEASE	Background: Tetherin is a recently identified antiviral restriction factor that restricts HIV-1 particle release in the absence of the HIV-1 viral protein U (Vpu). It is reminiscent of APOBEC3G and TRIM5a that also antagonize HIV. APOBEC3G and TRIM5a have been demonstrated to evolve under pervasive positive selection throughout primate evolution, supporting the red-queen hypothesis. Therefore, one naturally presumes that Tetherin also evolves under pervasive positive selection throughout primate evolution and supports the red-queen hypothesis. Here, we performed a detailed evolutionary analysis to address this presumption. Methodology/Principal Findings: Results of non-synonymous and synonymous substitution rates reveal that Tetherin as a whole experiences neutral evolution rather than pervasive positive selection throughout primate evolution, as well as in non-primate mammal evolution. Sliding-window analyses show that the regions of the primate Tetherin that interact with viral proteins are under positive selection or relaxed purifying selection. In particular, the sites identified under positive selection generally focus on these regions, indicating that the main selective pressure acting on the primate Tetherin comes from virus infection. The branch-site model detected positive selection acting on the ancestral branch of the New World Monkey lineage, suggesting an episodic adaptive evolution. The positive selection was also found in duplicated Tetherins in ruminants. Moreover, there is no bias in the alterations of amino acids in the evolution of the primate Tetherin, implying that the primate Tetherin may retain broad spectrum of antiviral activity by maintaining structure stability. Conclusions/Significance: These results conclude that the molecular evolution of Tetherin may be attributed to the host-virus arms race, supporting the Red Queen hypothesis, and Tetherin may be in an intermediate stage in transition from neutral to pervasive adaptive evolution.	[Liu, Jun; Chen, Keping; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	Jiangsu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Liu, J (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857	Jiangsu University	Jiangsu University	The study was supported by the Top-notch personnel Project of Jiangsu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Arnaud F, 2010, J VIROL, V84, P4415, DOI 10.1128/JVI.00029-10; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Feldmann H, 2004, TRENDS MICROBIOL, V12, P433, DOI 10.1016/j.tim.2004.08.009; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gilbert C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000425; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Liu HF, 2005, GENE, V362, P109, DOI 10.1016/j.gene.2005.06.045; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Meslin FX, 2000, REV SCI TECH OIE, V19, P310, DOI 10.20506/rst.19.1.1214; Nei M, 2002, J HERED, V93, P157, DOI 10.1093/jhered/93.3.157; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ortiz M, 2008, GENES IMMUN, V9, P483, DOI 10.1038/gene.2008.40; Ortiz M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-11; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006934; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	62	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11904	10.1371/journal.pone.0011904	http://dx.doi.org/10.1371/journal.pone.0011904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689591	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300019
J	Valecha, N; Phyo, AP; Mayxay, M; Newton, PN; Krudsood, S; Keomany, S; Khanthavong, M; Pongvongsa, T; Ruangveerayuth, R; Uthaisil, C; Ubben, D; Duparc, S; Bacchieri, A; Corsi, M; Rao, BHK; Bhattacharya, PC; Dubhashi, N; Ghosh, SK; Dev, V; Kumar, A; Pukittayakamee, S				Valecha, Neena; Phyo, Aung Pyae; Mayxay, Mayfong; Newton, Paul N.; Krudsood, Srivicha; Keomany, Sommay; Khanthavong, Maniphone; Pongvongsa, Tiengkham; Ruangveerayuth, Ronnatrai; Uthaisil, Chirapong; Ubben, David; Duparc, Stephan; Bacchieri, Antonella; Corsi, Marco; Rao, Bappanad H. K.; Bhattacharya, Prabash C.; Dubhashi, Nagesh; Ghosh, Susanta K.; Dev, Vas; Kumar, Ashwani; Pukittayakamee, Sasithon			An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia	PLOS ONE			English	Article							ANTIMALARIAL-DRUG SUSCEPTIBILITY; RESISTANT PLASMODIUM-FALCIPARUM; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; PLUS MEFLOQUINE; EFFICACY; ARTEMISININ; THAILAND; TRIAL	Background: The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloquine (AS+MQ) in Asia. Methods and Findings: This was an open-label, randomised, non-inferiority, 63-day follow-up study conducted in Thailand, Laos and India. Patients aged 3 months to 65 years with Plasmodium falciparum mono-infection or mixed infection were randomised with an allocation ratio of 2: 1 to a fixed-dose DHA/PQP combination tablet (adults: 40 mg/160 mg; children: 20 mg/320 mg; n = 769) or loose combination of AS+MQ (AS: 50 mg, MQ: 250 mg; n = 381). The cumulative doses of study treatment over the 3 days were of about 6.75 mg/kg of DHA and 54 mg/kg of PQP and about 12 mg/kg of AS and 25 mg/kg of MQ. Doses were rounded up to the nearest half tablet. The primary endpoint was day-63 polymerase chain reaction (PCR) genotype-corrected cure rate. Results were 87.9% for DHA/PQP and 86.6% for AS+MQ in the intention-to-treat (ITT; 97.5% one-sided confidence interval, CI: >-2.87%), and 98.7% and 97.0%, respectively, in the per protocol population (97.5% CI: >-0.39%). No country effect was observed. Kaplan-Meier estimates of proportions of patients with new infections on day 63 (secondary endpoint) were significantly lower for DHA/PQP than AS+MQ: 22.7% versus 30.3% (p=0.0042; ITT). Overall gametocyte prevalence (days 7 to 63; secondary endpoint), measured as person-gametocyte-weeks, was significantly higher for DHA/PQP than AS+MQ (10.15% versus 4.88%; p = 0.003; ITT). Fifteen serious adverse events were reported, 12 (1.6%) in DHA/PQP and three (0.8%) in AS+MQ, among which six (0.8%) were considered related to DHA/PQP and three (0.8%) to AS+MQ. Conclusions: DHA/PQP was a highly efficacious drug for P. falciparum malaria in areas where multidrug parasites are prevalent. The DHA/PQP combination can play an important role in the first-line treatment of uncomplicated falciparum malaria.	[Valecha, Neena] Natl Inst Malaria Res, Delhi, India; [Phyo, Aung Pyae] Shoklo Malaria Res Unit, Tak, Thailand; [Mayxay, Mayfong; Newton, Paul N.] Wellcome Trust Mahosot Hosp Oxford Univ Trop Med, Mahosot Hosp, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies & Res, Viangchan, Laos; [Newton, Paul N.] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Krudsood, Srivicha; Pukittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Keomany, Sommay] Salavan Prov Hosp, Salavan, Laos; [Khanthavong, Maniphone] Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Pongvongsa, Tiengkham] Savannakhet Prov Malaria Stn, Savannakhet, Laos; [Ruangveerayuth, Ronnatrai] Mae Sod Hosp, Tak, Thailand; [Uthaisil, Chirapong] Mae Ramat Hosp, Tak, Thailand; [Ubben, David; Duparc, Stephan] Int Ctr Cointrin, Geneva, Switzerland; [Bacchieri, Antonella; Corsi, Marco] Sigma Tau Ind Farmaceut Riunite, Pomezia, Italy; [Rao, Bappanad H. K.] Wenlock Dist Govt Hosp, Mangalore, India; [Bhattacharya, Prabash C.] Down Town Hosp, Gauhati, India; [Dubhashi, Nagesh] Goa Med Coll & Hosp, Dept Med, Bambolim, India; [Ghosh, Susanta K.] Natl Inst Malaria Res Field Unit, Bangalore, Karnataka, India; [Dev, Vas] Natl Inst Malaria Res Field Unit, Gauhati, India; [Kumar, Ashwani] Natl Inst Malaria Res Field Unit, Panaji, Goa, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Mahidol University; University of Oxford; Mahidol University; Goa Medical College & Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Valecha, N (corresponding author), Natl Inst Malaria Res, Delhi, India.	neenavalecha@gmail.com	Phyo, Aung Pyae/K-2413-2019; Valecha, Neena/B-9830-2011; Duparc, Stephan/AAH-8758-2020; Phyo, Aung Pyae/GYU-6181-2022	Phyo, Aung Pyae/0000-0002-0383-9624; Duparc, Stephan/0000-0002-9649-4847; Phyo, Aung Pyae/0000-0002-0383-9624; Newton, Paul/0000-0002-4608-6431; Kumar, Ashwani/0000-0002-2485-7581	Medicines for Malaria Venture	Medicines for Malaria Venture	The development of DHA-PQP was undertaken by a public-private partnership that operated within a development agreement between the Medicines for Malaria Venture and Sigma Tau. Oxford University also joined the development team as academic partners. Dr Justin Cook was funded by Medicines for Malaria Venture. Role of the funding source: A committee representing members of the DHA-PQP Joint Development Team and study site Principal Investigators developed the protocol. Sigma Tau conducted the study, collected and analysed data. All authors had access to the primary data and take responsibility for data reporting accuracy and completeness. The corresponding author had responsibility for the final decision to submit for publication.	[Anonymous], 2003, ASS MON ANT DRUG EFF; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Ashley EA, 2006, TROP MED INT HEALTH, V11, P1653, DOI 10.1111/j.1365-3156.2006.01724.x; Campbell P, 2006, T ROY SOC TROP MED H, V100, P108, DOI 10.1016/j.trstmh.2005.06.016; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Chaijaroenkul W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-37; CHEN L, 1982, CHINESE MED J-PEKING, V95, P281; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Hatabu Toshimitsu, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P73; HEIN T, 2004, LANCET, V363, P18; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Hutagalung R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-46; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Krudsood S, 2002, AM J TROP MED HYG, V67, P465, DOI 10.4269/ajtmh.2002.67.465; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Mayxay M, 2006, TROP MED INT HEALTH, V11, P1157, DOI 10.1111/j.1365-3156.2006.01671.x; Mayxay M, 2004, CLIN INFECT DIS, V39, P1139, DOI 10.1086/424512; Mayxay M, 2003, T ROY SOC TROP MED H, V97, P343, DOI 10.1016/S0035-9203(03)90165-9; Mayxay M, 2007, AM J TROP MED HYG, V77, P36, DOI 10.4269/ajtmh.2007.77.36; Mayxay M, 2007, AM J TROP MED HYG, V76, P245, DOI 10.4269/ajtmh.2007.76.245; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; RANFORDCARTWRIGHT LC, 1993, PARASITOLOGY, V107, P11, DOI 10.1017/S003118200007935X; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Simpson JA, 2000, ANTIMICROB AGENTS CH, V44, P3414, DOI 10.1128/AAC.44.12.3414-3424.2000; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Stohrer JM, 2004, TROP MED INT HEALTH, V9, P1175, DOI 10.1111/j.1365-3156.2004.01320.x; Tarning J, 2005, ANTIMICROB AGENTS CH, V49, P5127, DOI 10.1128/AAC.49.12.5127-5128.2005; TIEN NT, 2002, J MALARIA PARASITE D, P37; TIP NQ, 2001, J MALARIA PARASITE D, P45; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; VANVUGT M, 1992, ANTIMICROBIAL AGENTS, V42, P135; Verle P, 2000, TROP MED INT HEALTH, V5, P203, DOI 10.1046/j.1365-3156.2000.00542.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; *WHO, 2008, MIN INF CONS RES MOB; *WHO, 2001, WHOCDSRBM2001; WHO, 2006, WHO GUID TREATM MAL; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358; 2002, INT J EPIDEM, V31, P1086	47	61	61	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11880	10.1371/journal.pone.0011880	http://dx.doi.org/10.1371/journal.pone.0011880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689583	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300008
J	Acuna, DE; Parada, V				Acuna, Daniel E.; Parada, Victor			People Efficiently Explore the Solution Space of the Computationally Intractable Traveling Salesman Problem to Find Near-Optimal Tours	PLOS ONE			English	Article							CONVEX-HULL; PHASE-TRANSITIONS; HUMAN-PERFORMANCE; COMPLEXITY; OPTIMIZATION; BACKBONES; ALGORITHM; MODELS	Humans need to solve computationally intractable problems such as visual search, categorization, and simultaneous learning and acting, yet an increasing body of evidence suggests that their solutions to instantiations of these problems are near optimal. Computational complexity advances an explanation to this apparent paradox: (1) only a small portion of instances of such problems are actually hard, and (2) successful heuristics exploit structural properties of the typical instance to selectively improve parts that are likely to be sub-optimal. We hypothesize that these two ideas largely account for the good performance of humans on computationally hard problems. We tested part of this hypothesis by studying the solutions of 28 participants to 28 instances of the Euclidean Traveling Salesman Problem (TSP). Participants were provided feedback on the cost of their solutions and were allowed unlimited solution attempts (trials). We found a significant improvement between the first and last trials and that solutions are significantly different from random tours that follow the convex hull and do not have self-crossings. More importantly, we found that participants modified their current better solutions in such a way that edges belonging to the optimal solution ("good'' edges) were significantly more likely to stay than other edges ("bad'' edges), a hallmark of structural exploitation. We found, however, that more trials harmed the participants' ability to tell good from bad edges, suggesting that after too many trials the participants "ran out of ideas.'' In sum, we provide the first demonstration of significant performance improvement on the TSP under repetition and feedback and evidence that human problem-solving may exploit the structure of hard problems paralleling behavior of state-of-the-art heuristics.	[Acuna, Daniel E.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Acuna, Daniel E.] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN USA; [Parada, Victor] Univ Santiago, Dept Ingn Informat, Santiago, Chile	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidad de Santiago de Chile	Acuna, DE (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	acuna@cs.umn.edu	Parada, Victor/AHD-6455-2022; Parada, Victor/M-5840-2014; Acuna, Daniel/O-8006-2016	Parada, Victor/0000-0002-8649-5694; Acuna, Daniel/0000-0002-7765-1595	National Institutes of Health (NIH) [1R90 DK71500-04]; CONICYT-FIC-World Bank Fellowship [05-DOCFIC-BANCO-01]; Center for Cognitive Sciences of the University of Minnesota; Complex Engineering Systems Institute (ICM) [P-05-004-F]; CONICYT [FBO16]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICYT-FIC-World Bank Fellowship; Center for Cognitive Sciences of the University of Minnesota(University of Minnesota System); Complex Engineering Systems Institute (ICM); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The first author was partially funded by the National Institutes of Health (NIH) Neuro-physical-computational Sciences (NPCS) Graduate Training Fellowship (1R90 DK71500-04), CONICYT-FIC-World Bank Fellowship (05-DOCFIC-BANCO-01) and the Center for Cognitive Sciences of the University of Minnesota. The second author was partially funded by the Complex Engineering Systems Institute (ICM: P-05-004-F, CONICYT: FBO16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achlioptas D, 2005, NATURE, V435, P759, DOI 10.1038/nature03602; Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; ACUNA D, 2008, NEURAL INFORM PROCES; *AD, 2002, AD FLASH TECHN; Agarwala R, 2000, GENOME RES, V10, P350, DOI 10.1101/gr.10.3.350; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; American Psychological Association, 2002, ETH PRINC PSYCH COD; Anderson John R., 2007, CAN HUMAN MIND OCCUR; Anderson John R., 1983, ARCHITECTURE COGNITI; [Anonymous], 1989, GENETIC ALGORITHMS S; Applegate D., 2005, CONCORDE CODE SOLVIN; Bellman Richard, 1960, P S APPL MATH, V10, DOI [10.1090/psapm/010, DOI 10.1090/PSAPM/010]; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; CHEESEMAN P, 1991, P 12 INT JOINT C ART, P331; Dilkina B, 2007, LECT NOTES COMPUT SC, V4741, P256; Downey R.G., 1999, MG COMP SCI; Doya K., 2007, BAYESIAN BRAIN PROBA; DURBIN R, 1987, NATURE, V326, P689, DOI 10.1038/326689a0; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Garey M.R., 1979, COMPUTERS INTRACTABI; Gelman A, 2007, DATA ANAL USING REGR, P301; GEREVINI A, 2002, P 6 INT C AI PLANN S, P12; Gomes CP, 2000, J AUTOM REASONING, V24, P67, DOI 10.1023/A:1006314320276; GOMES CP, 1997, P 14 NAT C ART INT A, P221; Graham SM, 2000, MEM COGNITION, V28, P1191, DOI 10.3758/BF03211820; Haxhimusa Y, 2009, IMAGE VISION COMPUT, V27, P887, DOI 10.1016/j.imavis.2008.06.016; Kilby P, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P175; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; KROLAK P, 1970, P 7 WORKSH DES AUT A, P250; KRUEGER LE, 1990, BEHAV BRAIN SCI, V13, P449, DOI 10.1017/S0140525X00079644; Lee MD, 2000, PERCEPT PSYCHOPHYS, V62, P226, DOI 10.3758/BF03212074; LEVIN LA, 1986, SIAM J COMPUT, V15, P285, DOI 10.1137/0215020; MacGregor JN, 2004, MEM COGNITION, V32, P260, DOI 10.3758/BF03196857; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; Marr D., 1982, VISION COMPUTATIONAL; Ormerod TC, 1999, PERCEPT PSYCHOPHYS, V61, P1227, DOI 10.3758/BF03207625; Pizlo Z, 2006, J PROBL SOLVING, V1, P83, DOI 10.7771/1932-6246.1009; Reinelt G., 1991, ORSA Journal on Computing, V3, P376, DOI 10.1287/ijoc.3.4.376; Schneider J, 1996, COMPUT PHYS COMMUN, V96, P173, DOI 10.1016/0010-4655(96)00062-8; Simon H.A, 1957, MODELS MAN SOCIAL RA; SLANEY J, 2001, P 17 INT JOINT C ART, P254; Spielman DA, 2004, J ACM, V51, P385, DOI 10.1145/990308.990310; Tak S, 2008, J PROBL SOLVING, V2, P4, DOI 10.7771/1932-6246.1028; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; van Rooij I, 2003, MEM COGNITION, V31, P215, DOI 10.3758/BF03194380; van Rooij I, 2008, COGNITIVE SCI, V32, P939, DOI 10.1080/03640210801897856; van Rooij I, 2006, J PROBL SOLVING, V1, P44, DOI 10.7771/1932-6246.1006; Vickers D, 2006, PERCEPT PSYCHOPHYS, V68, P32, DOI 10.3758/BF03193653; WILLIAMS R, 2003, P 18 INT JOINT C ART; WILLIAMS R, 2003, 6 INT C THEOR APPL S, P222; Zhang WX, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P343; Zhang WX, 2004, J ARTIF INTELL RES, V21, P471, DOI 10.1613/jair.1389	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11685	10.1371/journal.pone.0011685	http://dx.doi.org/10.1371/journal.pone.0011685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686597	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200003
J	Boyd, JW; Oldenburg, EW; McMichael, GA				Boyd, James W.; Oldenburg, Eric W.; McMichael, Geoffrey A.			Color Photographic Index of Fall Chinook Salmon Embryonic Development and Accumulated Thermal Units	PLOS ONE			English	Article							TEMPERATURE; FISHES; TIME; EGGS	Background: Knowledge of the relationship between accumulated thermal units and developmental stages of Chinook salmon embryos can be used to determine the approximate date of egg fertilization in natural redds, thus providing insight into oviposition timing of wild salmonids. However, few studies have documented time to different developmental stages of embryonic Chinook salmon and no reference color photographs are available. The objectives of this study were to construct an index relating developmental stages of hatchery-reared fall Chinook salmon embryos to time and temperature (e.g., degree days) and provide high-quality color photographs of each identified developmental stage. Methodology/Principal Findings: Fall Chinook salmon eggs were fertilized in a hatchery environment and sampled approximately every 72 h post-fertilization until 50% hatch. Known embryonic developmental features described for sockeye salmon were used to describe development of Chinook salmon embryos. A thermal sums model was used to describe the relationship between embryonic development rate and water temperature. Mean water temperature was 8.0 degrees C (range; 3.9-11.7 degrees C) during the study period. Nineteen stages of embryonic development were identified for fall Chinook salmon; two stages in the cleavage phase, one stage in the gastrulation phase, and sixteen stages in the organogenesis phase. The thermal sums model used in this study provided similar estimates of fall Chinook salmon embryonic development rate in water temperatures varying from 3.9-11.7 degrees C (mean = 8 degrees C) to those from several other studies rearing embryos in constant 8 degrees C water temperature. Conclusions/Significance: The developmental index provides a reasonable description of timing to known developmental stages of Chinook salmon embryos and was useful in determining developmental stages of wild fall Chinook salmon embryos excavated from redds in the Columbia River. This index should prove useful to other researchers who wish to approximate fertilization dates of Chinook salmon eggs from natural redds, assuming the thermal history of embryos is known.	[Boyd, James W.; Oldenburg, Eric W.; McMichael, Geoffrey A.] Ecol Grp, Richland, WA USA		Boyd, JW (corresponding author), US Forest Serv, Eureka, MT USA.	jboyd03@fs.fed.us			Grant County Public Utility District #2, Washington	Grant County Public Utility District #2, Washington	Grant County Public Utility District #2, Washington funded this research (http://gcpud.org/). The funders had a role in study design, data collection and analysis, and decision to publish.	ALDERDICE DF, 1978, J FISH RES BOARD CAN, V35, P69, DOI 10.1139/f78-010; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; BALLARD WW, 1973, J EXP ZOOL, V184, P7, DOI 10.1002/jez.1401840103; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BLAXTER JHS, 1988, FISH PHYSIOL, V11, P1, DOI DOI 10.1016/S1546-5098(08)60198-3; CHAPMAN DW, 1986, T AM FISH SOC, V115, P537, DOI 10.1577/1548-8659(1986)115<537:EORFOT>2.0.CO;2; CRISP DT, 1981, FRESHWATER BIOL, V11, P361, DOI 10.1111/j.1365-2427.1981.tb01267.x; EMBODY G. G., 1934, TRANS AMER FISH SOC, V64, P281, DOI 10.1577/1548-8659(1934)64[281:ROTTTI]2.0.CO;2; FRY FEJ, 1971, FISH PHYSIOL, V11, P1; Norris T, 1868, AM FISH CULTURE EMBR; Ojanguren AF, 2003, J FISH BIOL, V62, P580, DOI 10.1046/j.1095-8649.2003.00049.x; Pennell W, 2001, FISH HATCHERY MANAGEMENT, SECOND EDITION, P187; Velsen F.J., 1980, CAN SPEC PUBL FISH A, V49, P1; Velsen F. P. J., 1987, CANADIAN DATA REPORT, V626, P67	14	8	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11877	10.1371/journal.pone.0011877	http://dx.doi.org/10.1371/journal.pone.0011877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686709	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520200039
J	Carpintero, R; Gruaz, L; Brandt, KJ; Scanu, A; Faille, D; Combes, V; Grau, GE; Burger, D				Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Scanu, Anna; Faille, Dorothee; Combes, Valery; Grau, Georges E.; Burger, Danielle			HDL Interfere with the Binding of T Cell Microparticles to Human Monocytes to Inhibit Pro-Inflammatory Cytokine Production	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RECEPTOR ANTAGONIST PRODUCTION; ENDOTHELIAL MICROPARTICLES; PLATELET MICROPARTICLES; CONTACT-ACTIVATION; SYNOVIAL TISSUE; LYMPH-NODE; EXPRESSION; IL-1-BETA; ARTHRITIS	Background: Direct cellular contact with stimulated T cells is a potent mechanism that induces cytokine production in human monocytes in the absence of an infectious agent. This mechanism is likely to be relevant to T cell-mediated inflammatory diseases such as rheumatoid arthritis and multiple sclerosis. Microparticles (MP) generated by stimulated T cells (MPT) display similar monocyte activating ability to whole T cells, isolated T cell membranes, or solubilized T cell membranes. We previously demonstrated that high-density lipoproteins (HDL) inhibited T cell contact- and MPT-induced production of IL-1 beta but not of its natural inhibitor, the secreted form of IL-1 receptor antagonist (sIL-1Ra). Methodology/Principal Findings: Labeled MPT were used to assess their interaction with monocytes and T lymphocytes by flow cytometry. Similarly, interactions of labeled HDL with monocytes and MPT were assessed by flow cytometry. In parallel, the MPT-induction of IL-1 beta and sIL-1Ra production in human monocytes and the effect of HDL were assessed in cell cultures. The results show that MPT, but not MP generated by activated endothelial cells, bond monocytes to trigger cytokine production. MPT did not bind T cells. The inhibition of IL-1 beta production by HDL correlated with the inhibition of MPT binding to monocytes. HDL interacted with MPT rather than with monocytes suggesting that they bound the activating factor(s) of T cell surface. Furthermore, prototypical pro-inflammatory cytokines and chemokines such as TNF, IL-6, IL-8, CCL3 and CCL4 displayed a pattern of production induced by MPT and inhibition by HDL similar to IL-1 beta, whereas the production of CCL2, like that of sIL-1Ra, was not inhibited by HDL. Conclusions/Significance: HDL inhibit both MPT binding to monocytes and the MPT-induced production of some but not all cytokines, shedding new light on the mechanism by which HDL display their anti-inflammatory functions.	[Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Burger, Danielle] Univ Geneva, Hans Wilsdorf Lab, Inflammat & Allergy Res Grp, Div Immunol & Allergy,Dept Internal Med,Fac Med, Geneva, Switzerland; [Carpintero, Rakel; Gruaz, Lyssia; Brandt, Karim J.; Burger, Danielle] Univ Geneva, Univ Hosp, Geneva, Switzerland; [Scanu, Anna] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Faille, Dorothee; Combes, Valery; Grau, Georges E.] Univ Sydney, Dept Pathol, Camperdown, NSW, Australia	University of Geneva; University of Geneva; University of Padua; University of Sydney	Carpintero, R (corresponding author), Univ Geneva, Hans Wilsdorf Lab, Inflammat & Allergy Res Grp, Div Immunol & Allergy,Dept Internal Med,Fac Med, Geneva, Switzerland.	danielle.Burger@hcuge.ch	Faille, Dorothée/AFO-5088-2022; Grau, Georges/AGR-7139-2022; Burger, Danielle/A-1996-2008	Faille, Dorothée/0000-0003-4414-739X; Grau, Georges/0000-0002-0442-0462; Brandt, Karim J./0000-0003-1042-5283; SCANU, Anna/0000-0001-6497-5374; Combes, Valery/0000-0003-2178-3596	EU [MPCM LSHP-CT-2006-037749]; Swiss National Science Foundation [320000-116259]; Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation; Basque Government (Spain); National Health and Medical Research Council of Australia; Australian Research Council; Rebecca Cooper Foundation, Sydney, Australia	EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation; Basque Government (Spain)(Basque Government); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Rebecca Cooper Foundation, Sydney, Australia	This work was supported by a grant to project MPCM # LSHP-CT-2006-037749 from the EU, the Swiss National Science Foundation (DB, grant # 320000-116259), the Swiss Society for Multiple Sclerosis (DB), and the Hans Wilsdorf Foundation (DB). RC is a recipient of a postdoctoral fellowship from the Basque Government (Spain). GG and VC are supported by grants from the National Health and Medical Research Council of Australia, the Australian Research Council and the Rebecca Cooper Foundation, Sydney, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Ardoin SP, 2008, MOD RHEUMATOL, V18, P319, DOI 10.1007/s10165-008-0054-z; Banfi C, 2005, PROTEOMICS, V5, P4443, DOI 10.1002/pmic.200402017; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Berckmans RJ, 2005, ARTHRITIS RES THER, V7, pR536, DOI 10.1186/ar1706; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Burger D, 2000, EUR CYTOKINE NETW, V11, P346; Burger D, 2004, J IMMUNOL, V173, P1292, DOI 10.4049/jimmunol.173.2.1292; Burger D, 2004, PROG INFLAM RES, P165; BURGER D, 2007, CONT TARGETED THERAP, P85; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Chizzolini C, 1997, EUR J IMMUNOL, V27, P171, DOI 10.1002/eji.1830270125; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Gruaz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009418; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jimenez JJ, 2005, MULT SCLER J, V11, P310, DOI 10.1191/1352458505ms1184oa; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Jy W, 2004, FRONT BIOSCI-LANDMRK, V9, P3137, DOI 10.2741/1466; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Larkin M, 2001, LANCET, V357, P1679, DOI 10.1016/S0140-6736(00)04867-4; Li YYY, 2008, IMMUNOL LETT, V117, P114, DOI 10.1016/j.imlet.2007.08.013; Messer L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2648; Minagar A, 2001, NEUROLOGY, V56, P1319, DOI 10.1212/WNL.56.10.1319; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; PATERSON PY, 1960, J EXP MED, V111, P119, DOI 10.1084/jem.111.1.119; PEARSON CM, 1964, J EXP MED, V120, P547, DOI 10.1084/jem.120.4.547; Pisetsky DS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2856; Pluskota E, 2008, BLOOD, V112, P2327, DOI 10.1182/blood-2007-12-127183; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Scanu A, 2008, J LEUKOCYTE BIOL, V83, P921, DOI 10.1189/jlb.0807551; Sebbag M, 1997, EUR J IMMUNOL, V27, P624, DOI 10.1002/eji.1830270308; Sheremata WA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-23; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Vey E, 1996, EUR J IMMUNOL, V26, P2404, DOI 10.1002/eji.1830261021	44	33	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11869	10.1371/journal.pone.0011869	http://dx.doi.org/10.1371/journal.pone.0011869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686620	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520200032
J	Zietsch, J; Ziegenhagen, N; Heppner, FL; Reuss, D; von Deimling, A; Holtkamp, N				Zietsch, Jan; Ziegenhagen, Nicolas; Heppner, Frank L.; Reuss, David; von Deimling, Andreas; Holtkamp, Nikola			The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; IN-VITRO; C-KIT; PROGRESSION; SU11248; IMBALANCES; MUTATIONS; IMATINIB; CELLS	Background: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive tumors which originate from Schwann cells and develop in about 10% of neurofibromatosis type 1 (NF1) patients. The five year survival rate is poor and more effective therapies are needed. Sunitinib is a drug targeting receptor tyrosine kinases (RTK) like PDGFR alpha, c-Kit and VEGFR-2. These genes are structurally related and cluster on chromosomal segment 4q12. Methodology/Principal Findings: Here we characterize this region by multiplex ligation-dependent probe amplification (MLPA) in MPNST. Our probe set encompasses the 3 adjacent RTK genes (PDGFRA, KIT, KDR) and 6 flanking genes. We found amplification of several genes within this region in a subset of MPNST and MPNST cell lines. Transcript and protein expression of PDGFRA matched well with its increased copy number suggesting a central role of PDGFRA within the amplicon. Studying the effect of sunitinib on 5 MPNST cell lines revealed that cell line S462 harboring the 4q12 amplicon was extremely sensitive to the drug with an IC50 below 1.0 mu M. Moreover, sunitinib induced apoptosis and prevented PDGFAA induced signaling via PDGFR alpha as determined by western blotting. Co-expression of VEGF and its receptor VEGFR-2 (KDR) was present in MPNST cell lines suggesting an autocrine loop. We show that VEGF triggered signal transduction via the MAPK pathway, which could be blocked by sunitinib. Conclusions/Significance: Since multiple receptors targeted by sunitinib are expressed or over-expressed by MPNST cells sunitinib appears as an attractive drug for treatment of MPNST patients. Presence of the 4q12 amplicon and subsequent over-expression of PDGFRA might serve as predictive markers for efficacy of sunitinib.	[Zietsch, Jan; Ziegenhagen, Nicolas; Heppner, Frank L.; Holtkamp, Nikola] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Reuss, David; von Deimling, Andreas] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Reuss, David; von Deimling, Andreas] Deutsch Krebsforschungszentrum Heidelberg, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Zietsch, J (corresponding author), Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany.	nikola.holtkamp@charite.de	von Deimling, Andreas/F-7774-2013; Heppner, Frank/ABH-8393-2020	von Deimling, Andreas/0000-0002-5863-540X; Heppner, Frank/0000-0001-9816-8917	Bundesministerium fur Bildung und Forschung (BMBF) [01GM0841]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases (grant 01GM0841). URL: http://www.bmbf.de/press/2806.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Angelov L, 1999, CANCER RES, V59, P5536; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Chugh R, 2009, J CLIN ONCOL, V27, P3148, DOI 10.1200/JCO.2008.20.5054; Cichowski K, 2003, GENE DEV, V17, P449, DOI 10.1101/gad.1054703; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hermanson M, 1996, CANCER RES, V56, P164; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Holtkamp N, 2007, NEOPLASIA, V9, P671, DOI 10.1593/neo.07304; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; HOUK BE, 2009, CANC CHEMOTHER PHARM; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Koga T, 2002, J PATHOL, V197, P98, DOI 10.1002/path.1101; Kuchenbauer F, 2005, LEUKEMIA, V19, P2366, DOI 10.1038/sj.leu.2403957; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Nakagawa Y, 2006, ONCOL REP, V15, P297; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Thomas SL, 2007, NEUROCHEM RES, V32, P1129, DOI 10.1007/s11064-007-9279-z; VONDEIMLING A, 1995, BRAIN PATHOL, V5, P153; Wasa J, 2008, CLIN EXP METASTAS, V25, P819, DOI 10.1007/s10585-008-9197-8; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	31	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11858	10.1371/journal.pone.0011858	http://dx.doi.org/10.1371/journal.pone.0011858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686603	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520200022
J	Kamata, M; Liang, M; Liu, S; Nagaoka, Y; Chen, ISY				Kamata, Masakazu; Liang, Min; Liu, Shirley; Nagaoka, Yoshiko; Chen, Irvin S. Y.			Live Cell Monitoring of hiPSC Generation and Differentiation Using Differential Expression of Endogenous microRNAs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LENTIVIRAL VECTORS; GENE-EXPRESSION; TRANSGENE EXPRESSION; IPS CELLS; FIBROBLASTS; INDUCTION; LINES; RETROVIRUSES; CONVERSION	Human induced pluripotent stem cells (hiPSCs) provide new possibilities for regenerative therapies. In order for this potential to be achieved, it is critical to efficiently monitor the differentiation of these hiPSCs into specific lineages. Here, we describe a lentiviral reporter vector sensitive to specific microRNAs ( miRNA) to show that a single vector bearing multiple miRNA target sequences conjugated to different reporters can be used to monitor hiPSC formation and subsequent differentiation from human fetal fibroblasts (HFFs). The reporter vector encodes EGFP conjugated to the targets of human embryonic stem cell (hESC) specific miRNAs (miR-302a and miR-302d) and mCherry conjugated to the targets of differentiated cells specific miRNAs (miR-142-3p, miR-155, and miR-223). The vector was used to track reprogramming of HFF to iPSC. HFFs co-transduced with this reporter vector and vectors encoding 4 reprogramming factors (OCT4, SOX2, KLF4 and cMYC) were mostly positive for EGFP (67%) at an early stage of hiPSC formation. EGFP expression gradually disappeared and mCherry expression increased indicating less miRNAs specific to differentiated cells and expression of miRNAs specific to hESCs. Upon differentiation of the hiPSC into embryoid bodies, a large fraction of these hiPSCs regained EGFP expression and some of those cells became single positive for EGFP. Further differentiation into neural lineages showed distinct structures demarcated by either EGFP or mCherry expression. These findings demonstrate that a miRNA dependent reporter vector can be a useful tool to monitor living cells during reprogramming of hiPSC and subsequent differentiation to lineage specific cells.	[Kamata, Masakazu; Liang, Min; Liu, Shirley; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Nagaoka, Yoshiko] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kamata, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Chen, Irvin/0000-0003-1199-2415; Kamata, Masakazu/0000-0003-0323-3742	California Institute for Regenerative Medicine (CIRM) [RS1-00172-1]; National Institutes of Health (NIH) [AI055281, AI069350, AI028697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069350, P30AI028697] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the California Institute for Regenerative Medicine (CIRM) RS1-00172-1 and by the National Institutes of Health (NIH) AI055281, AI069350, and AI028697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2007, BLOOD, V109, P2797, DOI 10.1182/blood-2006-10-049312; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kamata M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000342; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LIANG M, 2010, J GENE MED IN PRESS; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas S, 2008, HUM MOL GENET, V17, P3411, DOI 10.1093/hmg/ddn235; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai KN, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/917084; VANIN EF, 1994, J VIROL, V68, P4241, DOI 10.1128/JVI.68.7.4241-4250.1994; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	59	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11834	10.1371/journal.pone.0011834	http://dx.doi.org/10.1371/journal.pone.0011834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676373	Green Published, gold			2022-12-27	WOS:000280520100012
J	Leal, E; Villanova, FE				Leal, Elcio; Villanova, Fabiola E.			Diversity of HIV-1 Subtype B: Implications to the Origin of BF Recombinants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; ENVELOPE GLYCOPROTEIN; CELL TURNOVER; V3 REGION; T-CELLS; INFECTION; EVOLUTIONARY; TROPISM; BRAZIL	Background: The HIV-1 subtype B epidemic in Brazil is peculiar because of the high frequency of isolates having the GWGR tetramer at V3 loop region. It has been suggested that GWGR is a distinct variant and less pathogenic than other subtype B isolates. Methodology/Principal Findings: Ninety-four percent of the HIV-1 subtype B worldwide sequences (7689/8131) obtained from the Los Alamos HIV database contain proline at the tetramer of the V3 loop of the env gene (GPGR) and only 0.74% (60/8131) have tryptophan (GWGR). By contrast, 48.4% (161/333) of subtype B isolates from Brazil have proline, 30.6% (102/333) contain tryptophan and 10.5% (35/333) have phenylalanine (F) at the second position of the V3 loop tip. The proportion of tryptophan and phenylalanine in Brazilian isolates is much higher than in worldwide subtype B sequences (chi-square test, p = 0.0001). The combined proportion of proline, tryptophan and phenylalanine (GPGR+GWGR+GFGR) of Brazilian isolates corresponds to 89% of all amino acids in the V3 loop. Phylogenetic analysis revealed that almost all subtype B isolates in Brazil have a common origin regardless of their motif (GWGR, GPGR, GGGR, etc.) at the V3 tetramer. This shared ancestral origin was also observed in CRF28_BF and CRF29_BF in a genome region (free of recombination) derived from parental subtype B. These results imply that tryptophan substitution (e.g., GWGR-to-GxGR), which was previously associated with the change in the coreceptor usage within the host, also occurs at the population level. Conclusions/Significance: Based on the current findings and previous study showing that tryptophan and phenylalanine in the V3 loop are related with coreceptor usage, we propose that tryptophan and phenylalanine in subtype B isolates in Brazil are kept by selective mechanisms due to the distinct coreceptor preferences in target cells of GWGR, GFGR and GFGR viruses.	[Leal, Elcio; Villanova, Fabiola E.] Fed Univ Para, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	Leal, E (corresponding author), Fed Univ Para, BR-66059 Belem, Para, Brazil.	elcioleal@gmail.com	Leal, Elcio/M-5275-2019; VILLANOVA, FABIOLA E/E-7437-2013; Leal, Elcio/J-6236-2016	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/52841-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants no. 07/52841-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; CHOE H, 1996, CELL, V85, P1; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; da Silva J, 2006, GENETICS, V174, P1689, DOI 10.1534/genetics.106.062885; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; Diaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; KUIKEN CL, 1992, J VIROL, V66, P5704; KUIKEN CL, 1999, COMPUTATIONAL EVOLUT; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; LOUWAGIE J, 1994, AIDS RES HUM RETROV, V10, P561, DOI 10.1089/aid.1994.10.561; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Martins LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002651; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Ndung'u T, 2000, VIROLOGY, V278, P390, DOI 10.1006/viro.2000.0583; Peeters M, 1999, Med Trop (Mars), V59, P449; POTTS KE, 1993, AIDS, V7, P1191, DOI 10.1097/00002030-199309000-00007; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Santoro-Lopes G, 2000, AIDS RES HUM RETROV, V16, P953, DOI 10.1089/08892220050058362; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; van Rij RP, 2003, VIROLOGY, V314, P451, DOI 10.1016/S0042-6822(03)00454-9; Vanham G, 2000, AIDS, V14, P2299, DOI 10.1097/00002030-200010200-00011; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11833	10.1371/journal.pone.0011833	http://dx.doi.org/10.1371/journal.pone.0011833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676362	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520100011
J	Koen, EL; Garroway, CJ; Wilson, PJ; Bowman, J				Koen, Erin L.; Garroway, Colin J.; Wilson, Paul J.; Bowman, Jeff			The Effect of Map Boundary on Estimates of Landscape Resistance to Animal Movement	PLOS ONE			English	Article							CIRCUIT-THEORY; GENE FLOW; CORRIDORS; MODELS; SCALE	Background: Artificial boundaries on a map occur when the map extent does not cover the entire area of study; edges on the map do not exist on the ground. These artificial boundaries might bias the results of animal dispersal models by creating artificial barriers to movement for model organisms where there are no barriers for real organisms. Here, we characterize the effects of artificial boundaries on calculations of landscape resistance to movement using circuit theory. We then propose and test a solution to artificially inflated resistance values whereby we place a buffer around the artificial boundary as a substitute for the true, but unknown, habitat. Methodology/Principal Findings: We randomly assigned landscape resistance values to map cells in the buffer in proportion to their occurrence in the known map area. We used circuit theory to estimate landscape resistance to organism movement and gene flow, and compared the output across several scenarios: a habitat-quality map with artificial boundaries and no buffer, a map with a buffer composed of randomized habitat quality data, and a map with a buffer composed of the true habitat quality data. We tested the sensitivity of the randomized buffer to the possibility that the composition of the real but unknown buffer is biased toward high or low quality. We found that artificial boundaries result in an overestimate of landscape resistance. Conclusions/Significance: Artificial map boundaries overestimate resistance values. We recommend the use of a buffer composed of randomized habitat data as a solution to this problem. We found that resistance estimated using the randomized buffer did not differ from estimates using the real data, even when the composition of the real data was varied. Our results may be relevant to those interested in employing Circuitscape software in landscape connectivity and landscape genetics studies.	[Koen, Erin L.; Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada	Trent University; Ministry of Natural Resources & Forestry	Koen, EL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	erinkoen@trentu.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Garroway, Colin/0000-0002-0955-0688	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc.gc.ca) scholarship to ELK and CJG, and a NSERC grant to JB and PJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Bowman J, 2005, FOREST CHRON, V81, P801, DOI 10.5558/tfc81801-6; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dixon JD, 2006, CONSERV BIOL, V20, P155, DOI 10.1111/j.1523-1739.2005.00292.x; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Pascual-Hortal L, 2007, LANDSCAPE URBAN PLAN, V83, P176, DOI 10.1016/j.landurbplan.2007.04.003; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Roberts JH, 2007, T AM FISH SOC, V136, P971, DOI 10.1577/T06-215.1; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; SHAH VB, 2008, P 7 PYTH SCI C PAS 2; Theobald D.M., 2006, CONNECTIVITY CONSERV, P416, DOI DOI 10.1017/CBO9780511754821.019; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05	22	75	76	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11785	10.1371/journal.pone.0011785	http://dx.doi.org/10.1371/journal.pone.0011785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668690	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300017
J	TeKippe, M; Aballay, A				TeKippe, Michael; Aballay, Alejandro			C. elegans Germline-Deficient Mutants Respond to Pathogen Infection Using Shared and Distinct Mechanisms	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; INNATE IMMUNITY; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; TUMOR-GROWTH; LINE; LONGEVITY; BACTERIAL; DAF-16	Reproduction extracts a cost in resources that organisms are then unable to utilize to deal with a multitude of environmental stressors. In the nematode C. elegans, development of the germline shortens the lifespan of the animal and increases its susceptibility to microbial pathogens. Prior studies have demonstrated germline-deficient nematodes to have increased resistance to Gram negative bacteria. We show that germline-deficient strains display increased resistance across a broad range of pathogens including Gram positive and Gram negative bacteria, and the fungal pathogen Cryptococcus neoformans. Furthermore, we show that the FOXO transcription factor DAF-16, which regulates longevity and immunity in C. elegans, appears to be crucial for maintaining longevity in both wild-type and germline-deficient backgrounds. Our studies indicate that germline-deficient mutants glp-1 and glp-4 respond to pathogen infection using common and different mechanisms that involve the activation of DAF-16.	[TeKippe, Michael; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA	Duke University	TeKippe, M (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977, R37GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM070977 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Davies S, 2005, EXP GERONTOL, V40, P784, DOI 10.1016/j.exger.2005.07.009; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Fedorka KM, 2007, P ROY SOC B-BIOL SCI, V274, P1211, DOI 10.1098/rspb.2006.0394; Fedorka KM, 2004, EVOLUTION, V58, P2478; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gami MS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-45; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; ROBERTS TM, 1982, J CELL BIOL, V92, P113, DOI 10.1083/jcb.92.1.113; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; WARD S, 1978, GENETICS, V88, P285; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	48	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11777	10.1371/journal.pone.0011777	http://dx.doi.org/10.1371/journal.pone.0011777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668681	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300012
J	Tran, TH; Nguyen, TD; Nguyen, TT; Ninh, TTV; Tran, NBC; Nguyen, VMH; Tran, TTN; Cao, TT; Pham, VM; Nguyen, TCB; Tran, TDH; Pham, VT; To, SD; Campbell, JI; Stockwell, E; Schultsz, C; Simmons, CP; Glover, C; Lam, W; Marques, F; May, JP; Upton, A; Budhram, R; Dougan, G; Farrar, J; Nguyen, VVC; Dolecek, C				Tran Tinh Hien; Nguyen Thi Dung; Nguyen Thanh Truong; Ninh Thi Thanh Van; Tran Nguyen Bich Chau; Nguyen Van Minh Hoang; Tran Thi Thu Nga; Cao Thu Thuy; Pham Van Minh; Nguyen Thi Cam Binh; Tran Thi Diem Ha; Pham Van Toi; To Song Diep; Campbell, James I.; Stockwell, Elaine; Schultsz, Constance; Simmons, Cameron P.; Glover, Clare; Lam, Winnie; Marques, Filipe; May, James P.; Upton, Anthony; Budhram, Ronald; Dougan, Gordon; Farrar, Jeremy; Nguyen Van Vinh Chau; Dolecek, Christiane			A Randomised Trial Evaluating the Safety and Immunogenicity of the Novel Single Oral Dose Typhoid Vaccine M01ZH09 in Healthy Vietnamese Children	PLOS ONE			English	Article							SALMONELLA PATHOGENICITY ISLAND-2; ENTERICA SEROVAR TYPHI; FEVER; IMMUNIZATION; VOLUNTEERS; BURDEN; SYSTEM; TY21A; AROC; ASIA	Background: The emergence of drug resistant typhoid fever is a major public health problem, especially in Asia. An oral single dose typhoid vaccine would have major advantages. M01ZH09 is a live oral single dose candidate typhoid vaccine containing Salmonella enterica serovar Typhi (Ty2 aroC(-) ssaV(-)) ZH9 with two independently attenuating deletions. Studies in healthy adults demonstrated immunogenicity and an acceptable safety profile. Objectives: We conducted a randomised placebo controlled, single-blind trial to evaluate the safety and immunogenicity of M01ZH09 in healthy Vietnamese children aged 5 to 14 years. Methods: Subjects were randomly assigned to receive either a nominal dose of 5x10(9) CFU of M01ZH09 or placebo and were followed up for 28 days. The primary safety outcome was the proportion of subjects with any adverse event attributed to M01ZH09. The primary immunogenicity endpoint was the proportion of subjects who showed a positive immune response to M01ZH09 in the Salmonella Typhi lipopolysaccharide (LPS) specific serum IgA and IgG ELISA. Principal Findings: One hundred and fifty-one children were enrolled, 101 subjects received M01ZH09 and 50 subjects received placebo. An intention to treat analysis was conducted. There were no serious adverse events and no bacteraemias. In the M01ZH09 group, 26 (26%; 95% CI, 18-5%) of 101 subjects experienced adverse events compared to 11 (22%; 95% CI, 12-36%) of 50 subjects in the placebo group (odds ratio (OR) [95% CI] = 1.23 [0.550-2.747]; p = 0.691). Faecal shedding of S. Typhi (Ty2 aroC(-) ssaV(-)) ZH9 was detected in 51 (51%; 95% CI, 41-61%) of 100 M01ZH09 subjects. No shedding was detected beyond day 3. A positive immune response, defined as 70% increase (1.7 fold change) in LPS specific serum IgG (day 14 or 28) and/or 50% increase (1.5 fold change) in LPS specific serum IgA (day 7 or 14) from baseline was detected in 98 (97%; 95% CI, 92-99%) of 101 M01ZH09 recipients and 8 (16%; 95% CI, 7-29%) of 50 placebo recipients. Twenty-eight (100%; 95% CI, 88-100%) of 28 vaccine recipients who were evaluated in the LPS specific IgA ELISPOT assay showed a positive response compared to none of the 14 placebo recipients tested. Conclusions: This was the first phase II trial of a novel oral candidate typhoid vaccine in children in an endemic country. M01ZH09 had an appropriate safety profile and was immunogenic in children.	[Tran Tinh Hien; Ninh Thi Thanh Van; Tran Nguyen Bich Chau; Nguyen Van Minh Hoang; Tran Thi Thu Nga; Pham Van Minh; Nguyen Thi Cam Binh; Tran Thi Diem Ha; Pham Van Toi; Campbell, James I.; Stockwell, Elaine; Schultsz, Constance; Simmons, Cameron P.; Farrar, Jeremy; Nguyen Van Vinh Chau; Dolecek, Christiane] Hosp Trop Dis, Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Campbell, James I.; Stockwell, Elaine; Schultsz, Constance; Simmons, Cameron P.; Farrar, Jeremy; Dolecek, Christiane] Univ Oxford, Ctr Trop Med, Oxford, England; [Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Ctr Poverty Related Communicable Dis, NL-1105 AZ Amsterdam, Netherlands; [Lam, Winnie; Marques, Filipe; May, James P.; Upton, Anthony; Budhram, Ronald] Emergent Prod Dev UK Ltd, Wokingham, England; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Dolecek, Christiane] London Sch Hyg & Trop Med, London WC1, England	University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine	Tran, TH (corresponding author), Hosp Trop Dis, Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	cdolecek@oucru.org	Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022; Marques, Filipe/A-2698-2012; Marques, Filipe/GYE-2508-2022	Simmons, Cameron P/0000-0002-9039-7392; PHAM VAN, TOI/0000-0002-6496-5464; Farrar, Jeremy/0000-0002-2700-623X	Emergent Product Development UK Ltd., UK; Wellcome Trust, UK [B9RKYTO]	Emergent Product Development UK Ltd., UK; Wellcome Trust, UK(Wellcome Trust)	The trial was sponsored by Emergent Product Development UK Ltd., UK and funded by a Strategic Translational Award from the Wellcome Trust, UK (grant code: B9RKYTO). The funding agency had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The data was subject to a confidentiality agreement between the sponsor and investigator, which established full access to the study data. Prior to publication the manuscript was reviewed by the sponsor but there was no obligation on behalf of the academic authors to modify the publication. The data entry and analysis of data was managed by Statwood (now Quanticate), UK, an independent Clinical Research Organisation. Data was opened to the principal investigators at the time of unblinding. The data was reviewed by an academic author and statistician and the first draft of the manuscript was written by an academic author, who subsequently incorporated revisions from all the authors.	Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Dougan G, 2002, BRIT MED BULL, V62, P113, DOI 10.1093/bmb/62.1.113; Fraser A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub2; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; Kantele A, 1998, INFECT IMMUN, V66, P5630, DOI 10.1128/IAI.66.12.5630-5635.1998; Kirkpatrick BD, 2006, VACCINE, V24, P116, DOI 10.1016/j.vaccine.2005.08.008; Kirkpatrick BD, 2005, J INFECT DIS, V192, P360, DOI 10.1086/431605; Kirkpatrick BD, 2005, CLIN DIAGN LAB IMMUN, V12, P1127, DOI 10.1128/CDLI.12.9.1127-1129.2005; LEVINE M, 2004, MUCOSAL IMMUNIZATION; LEVINE MM, 1987, LANCET, V1, P1049; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2007, CLIN INFECT DIS, V45, pS34, DOI 10.1086/518144; WHO, 2008, TYPH VACC WHO POS PA, V83, P49; *WHO, 2006, JOINT WHO UNICEF STA	19	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11778	10.1371/journal.pone.0011778	http://dx.doi.org/10.1371/journal.pone.0011778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668668	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000280297300013
J	Branco, S; Ree, RH				Branco, Sara; Ree, Richard H.			Serpentine Soils Do Not Limit Mycorrhizal Fungal Diversity	PLOS ONE			English	Article							ECTOMYCORRHIZAL COMMUNITIES; CENOCOCCUM-GEOPHILUM; EVOLUTION; SYSTEMATICS; ADAPTATION; LIFE; DIVERGENCE; TOLERANCE; RADIATION; ECOLOGY	Background: Physiologically stressful environments tend to host depauperate and specialized biological communities. Serpentine soils exemplify this phenomenon by imposing well-known constraints on plants; however, their effect on other organisms is still poorly understood. Methodology/Principal Findings: We used a combination of field and molecular approaches to test the hypothesis that serpentine fungal communities are species-poor and specialized. We conducted surveys of ectomycorrhizal fungal diversity from adjacent serpentine and non-serpentine sites, described fungal communities using nrDNA Internal Transcribed Spacer (ITS) fragment and sequence analyses, and compared their phylogenetic community structure. Although we detected low fungal overlap across the two habitats, we found serpentine soils to support rich fungal communities that include representatives from all major fungal lineages. We failed to detect the phylogenetic signature of endemic clades that would result from specialization and adaptive radiation within this habitat. Conclusions/Significance: Our results indicate that serpentine soils do not constitute an extreme environment for ectomycorrhizal fungi, and raise important questions about the role of symbioses in edaphic tolerance and the maintenance of biodiversity.	[Branco, Sara] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Branco, Sara; Ree, Richard H.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Branco, Sara] Ctr Invest Montanha, Braganca, Portugal	University of Chicago; Field Museum of Natural History (Chicago); Instituto Politecnico de Braganca	Branco, S (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sbranco@uchicago.edu			University of Chicago; Fulbright Commission (Portugal); Fundacao Calouste Gulbenkian (Portugal); Field Museum Women's Board Graduate Fellowship; Pritzker Foundation	University of Chicago(University of Chicago); Fulbright Commission (Portugal); Fundacao Calouste Gulbenkian (Portugal); Field Museum Women's Board Graduate Fellowship; Pritzker Foundation	This study was funded by the University of Chicago Hinds Funds. S. Branco is supported by the Fulbright Commission (Portugal), Fundacao Calouste Gulbenkian (Portugal), and the Field Museum Women's Board Graduate Fellowship. This research was carried out in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR C, 2002, THESIS U TECNICA LIS; Alexander E.B., 2007, SERPENTINE GEOECOLOG; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Avis PG, 2008, NEW PHYTOL, V179, P472, DOI 10.1111/j.1469-8137.2008.02491.x; Avis PG, 2003, NEW PHYTOL, V160, P239, DOI 10.1046/j.1469-8137.2003.00865.x; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Blaudez D, 2000, MYCOL RES, V104, P1366, DOI 10.1017/S0953756200003166; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Branco S, 2009, NORTHEAST NAT, V16, P329, DOI 10.1656/045.016.0524; Brooks R.R., 1987, SERPENTINE ITS VEGET; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; DION P, 2008, MICROBIOLOGY EXTREME, P369; Douhan GW, 2007, CURR GENET, V52, P191, DOI 10.1007/s00294-007-0150-1; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Espeland M, 2008, MOL PHYLOGENET EVOL, V48, P904, DOI 10.1016/j.ympev.2008.06.006; Fitzsimons MS, 2010, PLANT SOIL, V330, P393, DOI 10.1007/s11104-009-0213-9; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hansen K, 2006, MYCOLOGIA, V98, P1029, DOI 10.3852/mycologia.98.6.1029; Harris DJ, 1998, MOL PHYLOGENET EVOL, V10, P37, DOI 10.1006/mpev.1997.0463; Hartley J, 1997, PLANT SOIL, V189, P303, DOI 10.1023/A:1004255006170; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Kruckeberg A. R., 2002, GEOLOGY PLANT LIFE E; KRUCKEBERG AR, 1954, ECOLOGY, V35, P267, DOI 10.2307/1931126; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddison WP., 2008, EVOLUTION, V62, P1103; Malpas J., 1992, ECOLOGY AREAS SERPEN, P7, DOI 10.1007/978-94-011-3722-5_2; MATHENY B, 2006, MOL PHYLLOGENET EVOL, V43, P430; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Miller SL, 2006, MYCOLOGIA, V98, P960, DOI 10.3852/mycologia.98.6.960; Moncalvo JM, 2006, MYCOLOGIA, V98, P937, DOI 10.3852/mycologia.98.6.937; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Moser AM, 2009, PLANT SOIL, V315, P185, DOI 10.1007/s11104-008-9743-9; OKANEN J, 2005, VEGAN COMMUNITY ECOL; Panaccione DG, 2001, MYCOLOGIA, V93, P645, DOI 10.2307/3761819; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parrent JL, 2010, NEW PHYTOL, V185, P882, DOI 10.1111/j.1469-8137.2010.03190.x; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Proctor J, 1999, TRENDS ECOL EVOL, V14, P334, DOI 10.1016/S0169-5347(99)01698-5; Ram HYM, 1997, CURR SCI INDIA, V72, P306; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Sugiyama J, 2006, MYCOLOGIA, V98, P996, DOI 10.3852/mycologia.98.6.996; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walker JF, 2005, MOL ECOL, V14, P829, DOI 10.1111/j.1365-294X.2005.02455.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WILKINSON DM, 1995, OIKOS, V72, P298, DOI 10.2307/3546233; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076; Zwickl D. J, 2006, GENETIC ALGORITHM AP	67	34	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11757	10.1371/journal.pone.0011757	http://dx.doi.org/10.1371/journal.pone.0011757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668696	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243800026
J	Nalam, K; Ahmed, A; Devi, SM; Francalacci, P; Baig, M; Sechi, LA; Hartskeerl, RA; Ahmed, N				Nalam, Kishore; Ahmed, Ahmed; Devi, Sundru Manjulata; Francalacci, Paolo; Baig, Mumtaz; Sechi, Leonardo A.; Hartskeerl, Rudy A.; Ahmed, Niyaz			Genetic Affinities within a Large Global Collection of Pathogenic Leptospira: Implications for Strain Identification and Molecular Epidemiology	PLOS ONE			English	Article							SEQUENCE; NOV.; POPULATIONS; INSIGHTS; SEROVARS	Leptospirosis is an important zoonosis with widespread human health implications. The non-availability of accurate identification methods for the individualization of different Leptospira for outbreak investigations poses bountiful problems in the disease control arena. We harnessed fluorescent amplified fragment length polymorphism analysis (FAFLP) for Leptospira and investigated its utility in establishing genetic relationships among 271 isolates in the context of species level assignments of our global collection of isolates and strains obtained from a diverse array of hosts. In addition, this method was compared to an in-house multilocus sequence typing (MLST) method based on polymorphisms in three housekeeping genes, the rrs locus and two envelope proteins. Phylogenetic relationships were deduced based on bifurcating Neighbor-joining trees as well as median joining network analyses integrating both the FAFLP data and MLST based haplotypes. The phylogenetic relationships were also reproduced through Bayesian analysis of the multilocus sequence polymorphisms. We found FAFLP to be an important method for outbreak investigation and for clustering of isolates based on their geographical descent rather than by genome species types. The FAFLP method was, however, not able to convey much taxonomical utility sufficient to replace the highly tedious serotyping procedures in vogue. MLST, on the other hand, was found to be highly robust and efficient in identifying ancestral relationships and segregating the outbreak associated strains or otherwise according to their genome species status and, therefore, could unambiguously be applied for investigating phylogenetics of Leptospira in the context of taxonomy as well as gene flow. For instance, MLST was more efficient, as compared to FAFLP method, in clustering strains from the Andaman island of India, with their counterparts from mainland India and Sri Lanka, implying that such strains share genetic relationships and that leptospiral strains might be frequently circulating between the islands and the mainland.	[Nalam, Kishore; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands; [Devi, Sundru Manjulata] Cent Food Technol Res Inst, Mysore 570013, Karnataka, India; [Francalacci, Paolo] Univ Sassari, Dept Zool & Evolutionary Genet, I-07100 Sassari, Italy; [Baig, Mumtaz] Govt Vidarbha Inst Sci & Humanities, Amravati, Maharashtra, India; [Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	University of Hyderabad; Food & Agriculture Organization of the United Nations (FAO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); University of Sassari; Government Vidarbha Institute of Science & Humanities; University of Sassari	Nalam, K (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	niyazSL@uohyd.ernet.in	Sundru, Manjulata Devi/AAM-8462-2020; Sechi, Leonardo Antonio/Y-3109-2018; Ahmed, Niyaz/D-2589-2010	Sundru, Manjulata Devi/0000-0002-2744-1629; Ahmed, Niyaz/0000-0001-6425-7583; sechi, leonardo antonio/0000-0003-0566-2049; FRANCALACCI, Paolo/0000-0001-7912-162X	Council for Scientific and Industrial Research (CSIR) of India; EC [ICA4-CT-2001-10086]	Council for Scientific and Industrial Research (CSIR) of India(Council of Scientific & Industrial Research (CSIR) - India); EC(European CommissionEuropean Commission Joint Research Centre)	This study did not receive any designated funding and the work was carried out from the routine laboratory supplies and resources available to the investigators in the form of a core support. Kishore Nalam would like to acknowledge the Junior Research Fellowship of the Council for Scientific and Industrial Research (CSIR) of India. Rudy Hartskeerl would like to acknowledge support from the EC grant ICA4-CT-2001-10086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; BANDELT HJ, 1995, GENETICS, V141, P743; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; KMETY E, 1993, CLASSIFICATION SPECI, P17; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pavon ABI, 2009, METHODS MOL BIOL, V551, P129, DOI 10.1007/978-1-60327-999-4_11; Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vijayachari P, 2008, T ROY SOC TROP MED H, V102, P117, DOI 10.1016/j.trstmh.2007.08.012; Vijayachari P, 2004, J CLIN MICROBIOL, V42, P3575, DOI [10.1128/JCM.42.8.3575-3580.2004, 10.1128/jcm.42.8.3575-3580.2004]	34	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12637	10.1371/journal.pone.0012637	http://dx.doi.org/10.1371/journal.pone.0012637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805987	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500029
J	Offer, SM; Pan-Hammarstrom, Q; Hammarstrom, L; Harris, RS				Offer, Steven M.; Pan-Hammarstrom, Qiang; Hammarstrom, Lennart; Harris, Reuben S.			Unique DNA Repair Gene Variations and Potential Associations with the Primary Antibody Deficiency Syndromes IgAD and CVID	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; CLASS-SWITCH RECOMBINATION; STRAND BREAK REPAIR; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; MUTATIONS; PROTEIN; MECHANISM; COMPLEX; MUTL	Background: Despite considerable effort, the genetic factors responsible for >90% of the antibody deficiency syndromes IgAD and CVID remain elusive. To produce a functionally diverse antibody repertoire B lymphocytes undergo class switch recombination. This process is initiated by AID-catalyzed deamination of cytidine to uridine in switch region DNA. Subsequently, these residues are recognized by the uracil excision enzyme UNG2 or the mismatch repair proteins MutS alpha (MSH2/MSH6) and MutL alpha (PMS2/MLH1). Further processing by ubiquitous DNA repair factors is thought to introduce DNA breaks, ultimately leading to class switch recombination and expression of a different antibody isotype. Methodology/Principal Findings: Defects in AID and UNG2 have been shown to result in the primary immunodeficiency hyper-IgM syndrome, leading us to hypothesize that additional, potentially more subtle, DNA repair gene variations may underlie the clinically related antibody deficiencies syndromes IgAD and CVID. In a survey of twenty-seven candidate DNA metabolism genes, markers in MSH2, RAD50, and RAD52 were associated with IgAD/CVID, prompting further investigation into these pathways. Resequencing identified four rare, non-synonymous alleles associated with IgAD/CVID, two in MLH1, one in RAD50, and one in NBS1. One IgAD patient carried heterozygous non-synonymous mutations in MLH1, MSH2, and NBS1. Functional studies revealed that one of the identified mutations, a premature RAD50 stop codon (Q372X), confers increased sensitivity to ionizing radiation. Conclusions: Our results are consistent with a class switch recombination model in which AID-catalyzed uridines are processed by multiple DNA repair pathways. Genetic defects in these DNA repair pathways may contribute to IgAD and CVID.	[Offer, Steven M.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden	University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska University Hospital	Offer, SM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	Offer, Steven/AAA-3633-2021; Offer, Steven/A-7461-2013; hammarstrom, qiang pan/ABA-4589-2021	Offer, Steven/0000-0002-7513-9678; Offer, Steven/0000-0002-7513-9678; pan-hammarstrom, qiang/0000-0003-1990-8804	National Institutes of Health [U19 AI067152, R21 AI079743, R01 GM80437]; Swedish Cancerfound; University of Minnesota; Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, R21AI079743, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancerfound; University of Minnesota(University of Minnesota System); Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research(Karolinska Institutet); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (U19 AI067152 to L. H., R21 AI079743 and R01 GM80437 to R.H.) and by Swedish Cancerfound (to Q.P.). S.M.O. was also supported in part by a University of Minnesota Graduate School Doctoral Dissertation Fellowship and by the Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research and Education Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Barnetson RA, 2008, HUM MUTAT, V29, P367, DOI 10.1002/humu.20635; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Fuellen G, 2005, PROTEINS, V61, P888, DOI 10.1002/prot.20616; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Liu T, 1999, HUM GENET, V105, P437, DOI 10.1007/s004390051127; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ostergaard JR, 2005, AM J MED GENET A, V139A, P96, DOI 10.1002/ajmg.a.30998; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2008, EUR J IMMUNOL, V38, P327, DOI 10.1002/eji.200737927; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schaffer AA, 2007, CURR OPIN GENET DEV, V17, P201, DOI 10.1016/j.gde.2007.04.002; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Scott RH, 2007, NAT CLIN PRACT ONCOL, V4, P130, DOI 10.1038/ncponc0719; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; WATSON P, 1994, ANTICANCER RES, V14, P1635; Whiteside D, 2002, CANCER RES, V62, P359; Yong PFK, 2008, IMMUNOL ALLERGY CLIN, V28, P691, DOI 10.1016/j.iac.2008.06.003	59	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12260	10.1371/journal.pone.0012260	http://dx.doi.org/10.1371/journal.pone.0012260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805886	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600025
J	Wiemuth, D; Lott, JS; Ly, K; Ke, Y; Teesdale-Spittle, P; Snyder, PM; McDonald, FJ				Wiemuth, Dominik; Lott, J. Shaun; Ly, Kevin; Ke, Ying; Teesdale-Spittle, Paul; Snyder, Peter M.; McDonald, Fiona J.			Interaction of Serum- and Glucocorticoid Regulated Kinase 1 (SGK1) with the WW-Domains of Nedd4-2 Is Required for Epithelial Sodium Channel Regulation	PLOS ONE			English	Article							NA+-CHANNEL; PHOSPHORYLATION; ENAC; ALDOSTERONE; INHIBITION; ISOFORMS; SPECIFICITY; BINDS	Background: The epithelial sodium channel (ENaC) is an integral component of the pathway for Na+ absorption in epithelial cells. The ubiquitin ligases Nedd4 and Nedd4-2 bind to ENaC and decrease its activity. Conversely, Serum- and Glucocorticoid regulated Kinase-1 (SGK1), a downstream mediator of aldosterone, increases ENaC activity. This effect is at least partly mediated by direct interaction between SGK and Nedd4-2. SGK binds both Nedd4 and Nedd4-2, but it is only able to phosphorylate Nedd4-2. Phosphorylation of Nedd4-2 reduces its ability to bind to ENaC, due to the interaction of phosphorylated Nedd4-2 with 14-3-3 proteins, and hence increases ENaC activity. WW-domains in Nedd4-like proteins bind PY-motifs (PPXY) present in ENaC subunits, and SGK also has a PY-motif. Principal Finding: Here we show that single or tandem WW-domains of Nedd4 and Nedd4-2 mediate binding to SGK and that different WW-domains of Nedd4 and Nedd4-2 are involved. Our data also show that WW-domains 2 and 3 of Nedd4-2 mediate the interaction with SGK in a cooperative manner, that activated SGK has increased affinity for the WW-domains of Nedd4-2 in vitro, and a greater stimulatory effect on ENaC Na+ transport compared to wildtype SGK. Further, SGK lacking a PY motif failed to stimulate ENaC activity in the presence of Nedd4-2. Conclusions: Binding of Nedd4-2 WW-domains to SGK is necessary for SGK-induced ENaC activity.	[Wiemuth, Dominik; Ly, Kevin; Ke, Ying; McDonald, Fiona J.] Univ Otago, Dept Physiol, Dunedin, New Zealand; [Lott, J. Shaun] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Teesdale-Spittle, Paul] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Snyder, Peter M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	University of Otago; University of Auckland; Victoria University Wellington; University of Iowa; University of Iowa	Wiemuth, D (corresponding author), Univ Otago, Dept Physiol, Dunedin, New Zealand.	fiona.mcdonald@otago.ac.nz		Lott, Shaun/0000-0003-3660-452X	Marsden Fund Council; Otago Medical Research Foundation; U.S.A. National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256, R01HL058812] Funding Source: NIH RePORTER	Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Otago Medical Research Foundation; U.S.A. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research received funding support from the Marsden Fund Council from government funding administered by the Royal Society of New Zealand (http://marsden.rsnz.org/), the Otago Medical Research Foundation (http://hsframework36.otago.ac.nz/), and the U.S.A. National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Asher C, 2001, BIOCHEM BIOPH RES CO, V286, P1228, DOI 10.1006/bbrc.2001.5508; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Farr TJ, 2000, BIOCHEM J, V345, P503, DOI 10.1042/0264-6021:3450503; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; SHEPPARD DN, 1994, AM J PHYSIOL, V266, pL405, DOI 10.1152/ajplung.1994.266.4.L405; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	34	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12163	10.1371/journal.pone.0012163	http://dx.doi.org/10.1371/journal.pone.0012163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730100	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200018
J	Cinner, JE; Bodin, O				Cinner, Joshua E.; Bodin, Orjan			Livelihood Diversification in Tropical Coastal Communities: A Network-Based Approach to Analyzing 'Livelihood Landscapes'	PLOS ONE			English	Article							ECONOMIC-GROWTH; INCOME DIVERSIFICATION; SOCIAL RESILIENCE; MARINE; DETERMINANTS; CONSERVATION; STRATEGIES; BIODIVERSITY; MANAGEMENT; FISHERIES	Background: Diverse livelihood portfolios are frequently viewed as a critical component of household economies in developing countries. Within the context of natural resources governance in particular, the capacity of individual households to engage in multiple occupations has been shown to influence important issues such as whether fishers would exit a declining fishery, how people react to policy, the types of resource management systems that may be applicable, and other decisions about natural resource use. Methodology/Principal Findings: This paper uses network analysis to provide a novel methodological framework for detailed systemic analysis of household livelihood portfolios. Paying particular attention to the role of natural resource-based occupations such as fisheries, we use network analyses to map occupations and their interrelationships-what we refer to as 'livelihood landscapes'. This network approach allows for the visualization of complex information about dependence on natural resources that can be aggregated at different scales. We then examine how the role of natural resource-based occupations changes along spectra of socioeconomic development and population density in 27 communities in 5 western Indian Ocean countries. Network statistics, including in-and out-degree centrality, the density of the network, and the level of network centralization are compared along a multivariate index of community-level socioeconomic development and a gradient of human population density. The combination of network analyses suggests an increase in household-level specialization with development for most occupational sectors, including fishing and farming, but that at the community-level, economies remained diversified. Conclusions/Significance: The novel modeling approach introduced here provides for various types of livelihood portfolio analyses at different scales of social aggregation. Our livelihood landscapes approach provides insights into communities' dependencies and usages of natural resources, and shows how patterns of occupational interrelationships relate to socioeconomic development and population density. A key question for future analysis is how the reduction of household occupational diversity, but maintenance of community diversity we see with increasing socioeconomic development influences key aspects of societies' vulnerability to environmental change or disasters.	[Cinner, Joshua E.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bodin, Orjan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Bodin, Orjan] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	James Cook University; Stockholm University; Stockholm University	Cinner, JE (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	joshua.cinner@jcu.edu.au	Cinner, Joshua/AAA-6823-2021; Bodin, Örjan/A-5098-2010; Cinner, Joshua e/E-8966-2011	Bodin, Örjan/0000-0002-8218-1153; Cinner, Joshua e/0000-0003-2675-9317	Western Indian Ocean Marine Science Association; Australian Academy of Science; Stockholm Resilience Center; Beijer Institute for Ecological Economics; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Foundation for Strategic Environmental Research (Mistra)	Western Indian Ocean Marine Science Association; Australian Academy of Science; Stockholm Resilience Center; Beijer Institute for Ecological Economics; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Foundation for Strategic Environmental Research (Mistra)	This research was funded by the Western Indian Ocean Marine Science Association and the collaboration supported by the Australian Academy of Science, the Stockholm Resilience Center, and the Beijer Institute for Ecological Economics. The second author received funding from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), and the Foundation for Strategic Environmental Research (Mistra). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulai A, 2001, FOOD POLICY, V26, P437, DOI 10.1016/S0306-9192(01)00013-6; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 2006, TOURISM GLOBAL ENV C; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Barrett CB, 2001, FOOD POLICY, V26, P315, DOI 10.1016/S0306-9192(01)00014-8; Barrett CB, 2001, FOOD POLICY, V26, P367, DOI 10.1016/S0306-9192(01)00017-3; Bene C, 2010, WORLD DEV, V38, P933, DOI 10.1016/j.worlddev.2009.12.010; Berkes F, 2005, ECOSYSTEMS, V8, P967, DOI 10.1007/s10021-005-0140-4; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Borgatti SP, UCINET WINDOWS SOFTW; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Butts CT, 2006, SOC NETWORKS, V28, P283, DOI 10.1016/j.socnet.2005.07.003; CAMPBELL DJ, 1990, FOOD FOODWAYS, V4, P143; Carrier James G., 1989, WAGE TRADE EXCHANGE; Carter MR, 1997, ECON DEV CULT CHANGE, V45, P557, DOI 10.1086/452291; CHIROT D, 1982, ANNU REV SOCIOL, V8, P81, DOI 10.1146/annurev.so.08.080182.000501; Cinner JE, 2007, CORAL REEFS, V26, P1035, DOI 10.1007/s00338-007-0213-2; Cinner JE, 2010, MAR POLICY, V34, P22, DOI 10.1016/j.marpol.2009.04.003; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner J, 2009, ECOL SOC, V14; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; Clausen R, 2008, CONSERV BIOL, V22, P458, DOI 10.1111/j.1523-1739.2007.00851.x; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; Degenne A., 1999, INTRO SOCIAL NETWORK, DOI 10.4135/9781849209373; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Ellis F, 2000, J AGR ECON, V51, P289, DOI 10.1111/j.1477-9552.2000.tb01229.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GROSSMAN GM, 1993, MEXICO-U.S. FREE TRADE AGREEMENT, P13; GROSSMAN GM, 1995, Q J ECON, V110, P353, DOI 10.2307/2118443; Henry G.T., 1990, PRACTICAL SAMPLING, V21; Jansen HGP, 2006, AGR SYST, V88, P92, DOI 10.1016/j.agsy.2005.06.005; Koczberski G, 2005, AGR SYST, V85, P324, DOI 10.1016/j.agsy.2005.06.014; Kuznets S, 1955, AM ECON REV, V45, P1; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Marshall NA, 2007, RURAL SOCIOL, V72, P359, DOI 10.1526/003601107781799254; Marshall NA, 2007, ECOL SOC, V12, DOI 10.5751/es-01940-120101; McClanahan TR, 2009, CONSERV BIOL, V23, P662, DOI 10.1111/j.1523-1739.2008.01154.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; Niehof A, 2004, FOOD POLICY, V29, P321, DOI 10.1016/j.foodpol.2004.07.009; Pender J, 2004, FOOD POLICY, V29, P339, DOI 10.1016/j.foodpol.2004.07.005; POLLNAC RB, 1998, RAPID ASSESSMENT MAN; Pomeroy RS, 2006, MAR POLICY, V30, P786, DOI 10.1016/j.marpol.2006.02.003; Rigg J, 1998, PROG HUM GEOG, V22, P497, DOI 10.1191/030913298667432980; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; Start D., 2005, RURAL TRANSFORMATION; Van Der Kooij A.J., 2007, PREDICTION ACCURACY; VANDERGEEST P, 1988, WORLD DEV, V16, P683, DOI 10.1016/0305-750X(88)90175-1; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769	52	101	104	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11999	10.1371/journal.pone.0011999	http://dx.doi.org/10.1371/journal.pone.0011999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711442	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000280849100004
J	Gannon, PO; Godin-Ethier, J; Hassler, M; Delvoye, N; Aversa, M; Poisson, AO; Peant, B; Fahmy, MA; Saad, F; Lapointe, R; Mes-Masson, AM				Gannon, Philippe O.; Godin-Ethier, Jessica; Hassler, Matthew; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie			Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; L-ARGININE; TESTOSTERONE; INFILTRATION; CATABOLISM; POLYAMINES; RESPONSES; BENIGN; GENE; RNA	Background: Prostate cancer (PCa) is the most frequently diagnosed cancer in North American men. Androgen-deprivation therapy (ADT) accentuates the infiltration of immune cells within the prostate. However, the immunosuppressive pathways regulated by androgens in PCa are not well characterized. Arginase 2 (ARG2) expression by PCa cells leads to a reduced activation of tumor-specific T cells. Our hypothesis was that androgens could regulate the expression of ARG2 by PCa cells. Methodology/Principal Findings: In this report, we demonstrate that both ARG1 and ARG2 are expressed by hormone-sensitive (HS) and hormone-refractory (HR) PCa cell lines, with the LNCaP cells having the highest arginase activity. In prostate tissue samples, ARG2 was more expressed in normal and non-malignant prostatic tissues compared to tumor tissues. Following androgen stimulation of LNCaP cells with 10 nM R1881, both ARG1 and ARG2 were overexpressed. The regulation of arginase expression following androgen stimulation was dependent on the androgen receptor (AR), as a siRNA treatment targeting the AR inhibited both ARG1 and ARG2 overexpression. This observation was correlated in vivo in patients by immunohistochemistry. Patients treated by ADT prior to surgery had lower ARG2 expression in both nonmalignant and malignant tissues. Furthermore, ARG1 and ARG2 were enzymatically active and their decreased expression by siRNA resulted in reduced overall arginase activity and L-arginine metabolism. The decreased ARG1 and ARG2 expression also translated with diminished LNCaP cells cell growth and increased PBMC activation following exposure to LNCaP cells conditioned media. Finally, we found that interleukin-8 (IL-8) was also upregulated following androgen stimulation and that it directly increased the expression of ARG1 and ARG2 in the absence of androgens. Conclusion/Significance: Our data provides the first detailed in vitro and in vivo account of an androgen-regulated immunosuppressive pathway in human PCa through the expression of ARG1, ARG2 and IL-8.	[Gannon, Philippe O.; Godin-Ethier, Jessica; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Gannon, Philippe O.; Godin-Ethier, Jessica; Delvoye, Nathalie; Aversa, Meghan; Poisson, Alexis O.; Peant, Benjamin; Fahmy, Mona Alam; Saad, Fred; Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Hassler, Matthew] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Saad, Fred] Univ Montreal, CHUM, Dept Surg, Montreal, PQ, Canada; [Lapointe, Rejean; Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Gannon, PO (corresponding author), Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.	fred.saad@umontreal.ca; rejean.lapointe@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Peant, Benjamin/0000-0001-5090-0558	Sanofi Aventis; Canadian Uro-Oncology Group/AstraZeneca; Prostate Cancer Research Foundation of Canada; University of Montreal Chair in Prostate Cancer; Fonds de recherche en sante du Quebec (FRSQ); FRSQ; Institut du cancer de Montreal/Canderel; Universite de Montreal	Sanofi Aventis(Sanofi-Aventis); Canadian Uro-Oncology Group/AstraZeneca(AstraZeneca); Prostate Cancer Research Foundation of Canada; University of Montreal Chair in Prostate Cancer; Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Institut du cancer de Montreal/Canderel; Universite de Montreal	The research was supported by a Sanofi Aventis research grant (F.S.), by a Canadian Uro-Oncology Group/AstraZeneca research award (F.S.) and by a grant from the Prostate Cancer Research Foundation of Canada (R.L.). The funders had no role in study design, data collection and analysis, data sharing, decision to publish, or preparation of the manuscript. Furthermore, F.S. holds the University of Montreal Chair in Prostate Cancer. R.L. is supported by a fellowship from the Fonds de recherche en sante du Quebec (FRSQ). P.O.G. is a recipient of a Ph.D. studentship from the FRSQ and received additional support from the Institut du cancer de Montreal/Canderel scholarship and from the Molecular Biology program of the Universite de Montreal.	Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Buga GM, 1998, AM J PHYSIOL-REG I, V275, pR1256, DOI 10.1152/ajpregu.1998.275.4.R1256; Chang SS, 2009, BJU INT, V103, P8, DOI 10.1111/j.1464-410X.2008.08256.x; Diallo JS, 2008, BRIT J CANCER, V99, P1613, DOI 10.1038/sj.bjc.6604730; Diallo JS, 2007, CLIN CANCER RES, V13, P7044, DOI 10.1158/1078-0432.CCR-07-1224; Gannon PO, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-18; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Gopalakrishnan V, 1996, ANAL CHEM, V68, P3520, DOI 10.1021/ac960613n; Grandvaux N, 2005, FEBS J, V272, P3120, DOI 10.1111/j.1742-4658.2005.04726.x; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; HARRIS BE, 1983, CANCER RES, V43, P3008; JEMAL A, 2008, CA-CANCER J CLIN, V96, P58, DOI DOI 10.3322/CA.2007.0010; JIMMUNOL, 1963, J IMMUNOL, V3771, P3777; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; Keskinege A, 2001, CANCER DETECT PREV, V25, P76; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; LEPAGE C, 2006, BRIT J CANCER, V1912, P1; Lessard L, 2007, CELL SIGNAL, V19, P1093, DOI 10.1016/j.cellsig.2006.12.012; Levillain O, 2005, ENDOCRINOLOGY, V146, P950, DOI 10.1210/en.2004-1199; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; MANTEUFFELCYMBOROWSKA M, 1995, INT J BIOCHEM CELL B, V27, P287, DOI 10.1016/1357-2725(94)00070-R; Mercader M, 2001, P NATL ACAD SCI USA, V98, P14565, DOI 10.1073/pnas.251140998; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Montironi R, 1998, J CLIN PATHOL, V51, P5, DOI 10.1136/jcp.51.1.5; Mumenthaler SM, 2008, INT J ONCOL, V32, P357; MUMENTHALER SM, 2008, DISRUPTION ARGINASE; MUNDER M, 1999, REGULATED EXPRESSION, V16, pTH1; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Olszewska A, 2007, FUNGAL GENET BIOL, V44, P1285, DOI 10.1016/j.fgb.2007.07.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRETLOW TG, 1985, CANCER RES, V45, P442; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Singh R, 2000, CANCER RES, V60, P3305; Tate DJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-14; XU QL, 1993, EUR J BIOCHEM, V211, P891, DOI 10.1111/j.1432-1033.1993.tb17622.x; YAMANAKA H, 1975, AM J PHYSIOL, V229, P1102, DOI 10.1152/ajplegacy.1975.229.4.1102	44	35	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12107	10.1371/journal.pone.0012107	http://dx.doi.org/10.1371/journal.pone.0012107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711410	Green Published, Green Submitted, gold			2022-12-27	WOS:000280849100026
J	Ning, K; Fermin, D				Ning, Kang; Fermin, Damian			SAW: A Method to Identify Splicing Events from RNA-Seq Data Based on Splicing Fingerprints	PLOS ONE			English	Article							IDENTIFICATION	Splicing event identification is one of the most important issues in the comprehensive analysis of transcription profile. Recent development of next-generation sequencing technology has generated an extensive profile of alternative splicing. However, while many of these splicing events are between exons that are relatively close on genome sequences, reads generated by RNA-Seq are not limited to alternative splicing between close exons but occur in virtually all splicing events. In this work, a novel method, SAW, was proposed for the identification of all splicing events based on short reads from RNA-Seq. It was observed that short reads not in known gene models are actually absent words from known gene sequences. An efficient method to filter and cluster these short reads by fingerprint fragments of splicing events without aligning short reads to genome sequences was developed. Additionally, the possible splicing sites were also determined without alignment against genome sequences. A consensus sequence was then generated for each short read cluster, which was then aligned to the genome sequences. Results demonstrated that this method could identify more than 90% of the known splicing events with a very low false discovery rate, as well as accurately identify, a number of novel splicing events between distant exons.	[Ning, Kang; Fermin, Damian] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ning, K (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	albertnk@gmail.com	Ning, Kang/ABD-3446-2020	Ning, Kang/0000-0003-3325-5387				Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; Elenitoba-Johnson KSJ, 2006, P NATL ACAD SCI USA, V103, P7402, DOI 10.1073/pnas.0506514103; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mo F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-537; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Trapnell C, 2009, BIOINFORMATICS; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wheeler DJ., 1994, DIGITAL SRC RES REPO	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12047	10.1371/journal.pone.0012047	http://dx.doi.org/10.1371/journal.pone.0012047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706591	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900011
J	Hur, YS; Kim, KD; Paek, SH; Yoo, SH				Hur, Yong Suk; Kim, Ki Deok; Paek, Sun Ha; Yoo, Seung Hyun			Evidence for the Existence of Secretory Granule (Dense-Core Vesicle)-Based Inositol 1,4,5-Trisphosphate-Dependent Ca2+ Signaling System in Astrocytes	PLOS ONE			English	Article							DEPENDENT GLUTAMATE RELEASE; CHROMOGRANIN-SECRETOGRANIN FAMILY; CYTOSOLIC CALCIUM OSCILLATIONS; FIBRILLARY ACIDIC PROTEIN; ADRENAL CHROMAFFIN CELLS; CULTURED ASTROCYTES; RECEPTOR/CA2+ CHANNEL; D-SERINE; HIPPOCAMPAL ASTROCYTES; ENDOPLASMIC-RETICULUM	Background: The gliotransmitters released from astrocytes are deemed to play key roles in the glial cell-neuron communication for normal function of the brain. The gliotransmitters, such as glutamate, ATP, D-serine, neuropeptide Y, are stored in vesicles of astrocytes and secreted following the inositol 1,4,5-trisphosphate (IP3)-induced intracellular Ca2+ releases. Yet studies on the identity of the IP3-dependent intracellular Ca2+ stores remain virtually unexplored. Principal Findings: We have therefore studied the potential existence of the IP3-sensitive intracellular Ca2+ stores in the cytoplasm of astrocytes using human brain tissue samples in contrast to cultured astrocytes that had primarily been used in the past. It was thus found that secretory granule marker proteins chromogranins and secretogranin II localize in the large dense core vesicles of astrocytes, thereby confirming the large dense core vesicles as bona fide secretory granules. Moreover, consistent with the major IP3-dependent intracellular Ca2+ store role of secretory granules in secretory cells, secretory granules of astrocytes also contained all three (types 1, 2, and 3) IP3R isoforms. Significance: Given that the secretory granule marker proteins chromogranins and secretogranin II are high-capacity, low-affinity Ca2+ storage proteins and chromogranins interact with the IP(3)Rs to activate the IP3R/Ca2+ channels, i.e., increase both the mean open time and the open probability of the channels, these results imply that secretory granules of astrocytes function as the IP3-sensitive intracellular Ca2+ store.	[Hur, Yong Suk; Kim, Ki Deok; Yoo, Seung Hyun] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea	Inha University; Seoul National University (SNU)	Hur, YS (corresponding author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.	shyoo@inha.ac.kr	Paek, Sun Ha/J-2760-2012	HUR, YONGSUK/0000-0002-4069-7338	Brain Korea 21 Program of the Republic of Korea	Brain Korea 21 Program of the Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	The present work was funded in part by the Brain Korea 21 Program of the Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Anouar Y, 1996, FEBS LETT, V394, P295, DOI 10.1016/0014-5793(96)00976-3; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; BETTICA A, 1990, J HISTOCHEM CYTOCHEM, V38, P103, DOI 10.1177/38.1.2152935; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; BLONDEL O, 1995, TRENDS NEUROSCI, V18, P157, DOI 10.1016/0166-2236(95)93894-4; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CASEY RP, 1977, BIOCHEMISTRY-US, V16, P972, DOI 10.1021/bi00624a025; Chen XK, 2005, J NEUROSCI, V25, P9236, DOI 10.1523/JNEUROSCI.1640-05.2005; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Fellin Tommaso, 2006, Novartis Found Symp, V276, P208; FISCHERCOLBRIE R, 1990, J BIOL CHEM, V265, P9208; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1993, J NEUROCHEM, V60, P2312, DOI 10.1111/j.1471-4159.1993.tb03520.x; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; GERDES HH, 1989, J BIOL CHEM, V264, P12009; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HELLE KB, 1990, NEUROCHEM INT, V17, P165, DOI 10.1016/0197-0186(90)90139-K; Hua X, 2004, J NEUROSCI RES, V76, P86, DOI 10.1002/jnr.20061; Huh YH, 2007, BIOCHEMISTRY-US, V46, P14032, DOI 10.1021/bi701364p; Huh YH, 2006, BIOCHEMISTRY-US, V45, P1212, DOI 10.1021/bi051594r; Huh YH, 2005, FEBS LETT, V579, P5145, DOI 10.1016/j.febslet.2005.08.025; Huh YH, 2005, FEBS LETT, V579, P2597, DOI 10.1016/j.febslet.2005.03.076; Huh YH, 2005, BIOCHEMISTRY-US, V44, P6122, DOI 10.1021/bi048070w; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886; KENNEDY PGE, 1980, LAB INVEST, V43, P342; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kreft M, 2004, GLIA, V46, P437, DOI 10.1002/glia.20018; Krzan M, 2003, J NEUROSCI, V23, P1580; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; Majo G, 1998, LIFE SCI, V62, P607, DOI 10.1016/S0024-3205(97)01156-9; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; MARUYAMA Y, 1994, CELL CALCIUM, V16, P419, DOI 10.1016/0143-4160(94)90035-3; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; Paco S, 2009, J NEUROCHEM, V110, P143, DOI 10.1111/j.1471-4159.2009.06116.x; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Park HY, 2002, BIOCHEMISTRY-US, V41, P1259, DOI 10.1021/bi0156963; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Potokar M, 2008, GLIA, V56, P135, DOI 10.1002/glia.20597; Quesada I, 2003, BIOPHYS J, V85, P963, DOI 10.1016/S0006-3495(03)74535-4; Ramamoorthy P, 2008, J NEUROSCI, V28, P13815, DOI 10.1523/JNEUROSCI.5361-07.2008; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; SantoDomingo J, 2008, EUR J NEUROSCI, V28, P1265, DOI 10.1111/j.1460-9568.2008.06440.x; SCHIMMEL A, 1992, FEBS LETT, V314, P375, DOI 10.1016/0014-5793(92)81509-K; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Thrower EC, 2003, J BIOL CHEM, V278, P49699, DOI 10.1074/jbc.M309307200; Thrower EC, 2002, J BIOL CHEM, V277, P15801, DOI 10.1074/jbc.M110139200; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; Xie L, 2006, TRAFFIC, V7, P429, DOI 10.1111/j.1600-0854.2006.00401.x; Yoo SH, 2007, BIOCHEMISTRY-US, V46, P14663, DOI 10.1021/bi701339m; Yoo SH, 2010, FASEB J, V24, P653, DOI 10.1096/fj.09-132456; YOO SH, 1995, BIOCHEMISTRY-US, V34, P8680, DOI 10.1021/bi00027a017; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; YOO SH, 1994, J BIOL CHEM, V269, P12001; Yoo SH, 2005, FEBS LETT, V579, P222, DOI 10.1016/j.febslet.2004.11.079; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; Yoo SH, 2002, J BIOL CHEM, V277, P16011, DOI 10.1074/jbc.M105594200; Yoo SH, 2001, J BIOL CHEM, V276, P45806, DOI 10.1074/jbc.M107532200; YOO SH, 1991, J BIOL CHEM, V266, P7740; YOO SH, 1990, J BIOL CHEM, V265, P13446; Yoo SH, 2000, J BIOL CHEM, V275, P15067, DOI 10.1074/jbc.M909391199; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009; Zonta M, 2003, J PHYSIOL-LONDON, V553, P407, DOI 10.1113/jphysiol.2003.046706	94	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11973	10.1371/journal.pone.0011973	http://dx.doi.org/10.1371/journal.pone.0011973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700485	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400013
J	Kuizon, S; DiMaiuta, K; Walus, M; Jenkins, EC; Kuizon, M; Kida, E; Golabek, AA; Espinoza, DO; Pullarkat, RK; Junaid, MA				Kuizon, Salomon; DiMaiuta, Kathleen; Walus, Marius; Jenkins, Edmund C., Jr.; Kuizon, Marisol; Kida, Elizabeth; Golabek, Adam A.; Espinoza, Daniel O.; Pullarkat, Raju K.; Junaid, Mohammed A.			A Critical Tryptophan and Ca2+ in Activation and Catalysis of TPPI, the Enzyme Deficient in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							TRIPEPTIDYL-PEPTIDASE-I; PEPSTATIN-INSENSITIVE PROTEINASE; MOUSE MODEL; SUBUNIT C; CLN2; DIAGNOSIS; ASSAY; PROTEASE; DISEASE; LINCL	Background: Tripeptidyl aminopeptidase I (TPPI) is a crucial lysosomal enzyme that is deficient in the fatal neurodegenerative disorder called classic late-infantile neuronal ceroid lipofuscinosis (LINCL). It is involved in the catabolism of proteins in the lysosomes. Recent X-ray crystallographic studies have provided insights into the structural/functional aspects of TPPI catalysis, and indicated presence of an octahedrally coordinated Ca2+. Methodology: Purified precursor and mature TPPI were used to study inhibition by NBS and EDTA using biochemical and immunological approaches. Site-directed mutagenesis with confocal imaging technique identified a critical W residue in TPPI activity, and the processing of precursor into mature enzyme. Principal Findings: NBS is a potent inhibitor of the purified TPPI. In mammalian TPPI, W542 is critical for tripeptidyl peptidase activity as well as autocatalysis. Transfection studies have indicated that mutants of the TPPI that harbor residues other than W at position 542 have delayed processing, and are retained in the ER rather than transported to lysosomes. EDTA inhibits the autocatalytic processing of the precursor TPPI. Conclusions/Significance: We propose that W542 and Ca2+ are critical for maintaining the proper tertiary structure of the precursor proprotein as well as the mature TPPI. Additionally, Ca2+ is necessary for the autocatalytic processing of the precursor protein into the mature TPPI. We have identified NBS as a potent TPPI inhibitor, which led in delineating a critical role for W542 residue. Studies with such compounds will prove valuable in identifying the critical residues in the TPPI catalysis and its structure-function analysis.	[Kuizon, Salomon; DiMaiuta, Kathleen; Jenkins, Edmund C., Jr.; Kuizon, Marisol; Pullarkat, Raju K.; Junaid, Mohammed A.] New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, Staten Isl, NY 10314 USA; [Walus, Marius; Kida, Elizabeth; Golabek, Adam A.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Espinoza, Daniel O.] New York State Inst Basic Res Dev Disabil, Dept Mol Biol, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities	Kuizon, S (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	mohammed.junaid@omr.state.ny.us		Jenkins, Edmund/0000-0002-6448-090X	New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health [R01 NS047355]	New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by funds from the New York State Office of Mental Retardation and Developmental Disabilities, and the National Institutes of Health Grant R01 NS047355 (to A. A. G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorjay A, 2005, WORLD J GASTROENTERO, V11, P5751, DOI 10.3748/wjg.v11.i37.5751; Autefage H, 2009, J BIOL CHEM, V284, P11507, DOI 10.1074/jbc.M807151200; Boustany R., 1996, HDB CLIN NEUROLOGY, V66, P671; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Elleder M, 2008, ACTA NEUROPATHOL, V116, P119, DOI 10.1007/s00401-008-0349-3; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; FREISHEIM JH, 1969, BIOCHEMISTRY-US, V8, P2271, DOI 10.1021/bi00834a006; GALLAGHER T, 1993, PROTEINS, V16, P205, DOI 10.1002/prot.340160207; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; Golabek AA, 2006, BIOL CHEM, V387, P1091, DOI 10.1515/BC.2006.135; Guhaniyogi J, 2009, J BIOL CHEM, V284, P3985, DOI 10.1074/jbc.M806943200; IPPOLITO JA, 1990, J MOL BIOL, V215, P457, DOI 10.1016/S0022-2836(05)80364-X; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; Junaid MA, 1999, NEUROSCI LETT, V264, P157, DOI 10.1016/S0304-3940(99)00095-6; Junaid MA, 2000, INT J BIOL MARKER, V15, P129, DOI 10.1177/172460080001500201; Junaid MA, 1999, CLIN CHIM ACTA, V281, P169, DOI 10.1016/S0301-2115(98)00333-9; Junaid MA, 2001, ADV GENET, V45, P93, DOI 10.1016/S0065-2660(01)45005-X; KIDA E, J NEUROPATHOL EXP NE, V60, P280; Kleijer WJ, 2001, PRENATAL DIAG, V21, P99, DOI 10.1002/1097-0223(200102)21:2<99::AID-PD988>3.0.CO;2-F; Kurachi Y, 2000, NEUROLOGY, V54, P1676, DOI 10.1212/WNL.54.8.1676; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Liu CG, 1998, GENOMICS, V50, P206, DOI 10.1006/geno.1998.5328; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundblad R.L., 2005, CHEM REAGENTS PROTEI, P247; Mitchison HM, 1999, NEUROBIOL DIS, V6, P321, DOI 10.1006/nbdi.1999.0267; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Pal A, 2009, J BIOL CHEM, V284, P3976, DOI 10.1074/jbc.M806947200; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Ramachandran L.K., 1967, METHOD ENZYMOL, V11, P283; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sleat DE, 2008, MOL GENET METAB, V94, P222, DOI 10.1016/j.ymgme.2008.01.014; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sleat DE, 1998, BIOCHEM J, V334, P547, DOI 10.1042/bj3340547; Sohar I, 1999, J NEUROCHEM, V73, P700, DOI 10.1046/j.1471-4159.1999.0730700.x; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Tsukamoto T, 2006, CANCER-AM CANCER SOC, V106, P1489, DOI 10.1002/cncr.21764; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Young EP, 2000, PRENATAL DIAG, V20, P337; Zeman W., 1970, HDB CLINICAL NEUROLO, P588; Zhong NA, 2000, GENET TEST, V4, P243, DOI 10.1089/10906570050501452; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	54	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11929	10.1371/journal.pone.0011929	http://dx.doi.org/10.1371/journal.pone.0011929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689811	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520500002
J	Schneider, JA; Dandona, R; Pasupneti, S; Lakshmi, V; Liao, CH; Yeldandi, V; Mayer, KH				Schneider, John A.; Dandona, Rakhi; Pasupneti, Shravani; Lakshmi, Vemu; Liao, Chuanhong; Yeldandi, Vijay; Mayer, Kenneth H.			Initial Commitment to Pre-Exposure Prophylaxis and Circumcision for HIV Prevention amongst Indian Truck Drivers	PLOS ONE			English	Article							RISK REDUCTION MODEL; CONDOM USE; ANDHRA-PRADESH; PLANNED BEHAVIOR; YOUNG MEN; ACCEPTABILITY; HEALTH; IMPACT; SEX; HIV/AIDS	Studies of HIV prevention interventions such as pre-exposure prophylaxis (PREP) and circumcision in India are limited. The present study sought to investigate Indian truck-drivers initial commitment to PREP and circumcision utilizing the AIDS Risk Reduction Model. Ninety truck-drivers completed an in-depth qualitative interview and provided a blood sample for HIV and HSV-2 testing. Truck-drivers exhibited low levels of initial commitment towards PREP and even lower for circumcision. However, potential leverage points for increasing commitment were realized in fear of infecting family rather than self, self-perceptions of risk, and for PREP focusing on cultural beliefs towards medication and physicians. Cost was a major barrier to both HIV prevention interventions. Despite these barriers, our findings suggest that the ARRM may be useful in identifying several leverage points that may be used by peers, health care providers and public health field workers to enhance initial commitment to novel HIV prevention interventions in India.	[Schneider, John A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Schneider, John A.; Liao, Chuanhong] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Dandona, Rakhi] Publ Hlth Fdn India, New Delhi, India; [Pasupneti, Shravani] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Lakshmi, Vemu] Nizams Inst Med Sci, Dept Microbiol, Hyderabad, Andhra Pradesh, India; [Yeldandi, Vijay] SHARE India, Hyderabad, Andhra Pradesh, India; [Mayer, Kenneth H.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA	University of Chicago; University of Chicago; Public Health Foundation of India; University of Chicago; Nizam's Institute of Medical Sciences; Brown University; Brown University	Schneider, JA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jschnei1@medicine.bsd.uchicago.edu		Pasupneti, Shravani/0000-0002-7112-601X; Dandona, Rakhi/0000-0003-0926-788X	Lancet International Fellowship; National Center for Research Resources [KL2RR025000]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025000] Funding Source: NIH RePORTER	Lancet International Fellowship; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Lancet International Fellowship and grant KL2RR025000 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHAVI N, 2008, AIDS UNTOLD STORIES; Albarracin D, 2004, AIDS CARE, V16, P700, DOI 10.1080/09540120412331269558; Albarracin D, 2001, PSYCHOL BULL, V127, P142, DOI 10.1037//0033-2909.127.1.142; Amirkhanian YA, 2003, AIDS EDUC PREV, V15, P205, DOI 10.1521/aeap.15.4.205.23832; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2005, NFHS3, VI; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANDURA A, 1997, ESSENCE CONTROL; *BBC N, 2005, HIV IS OUT CONTR IND; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Brecht ML, 2009, J BEHAV HEALTH SER R, V36, P247, DOI 10.1007/s11414-007-9106-y; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107; CATANIA JA, 1994, HEALTH PSYCHOL, V13, P548, DOI 10.1037/0278-6133.13.6.548; Chakraborty K, 2009, SOC PSYCH PSYCH EPID, V44, P482, DOI 10.1007/s00127-008-0468-0; Chandhiok N, 2007, REPROD HEALTH MATTER, V15, P53, DOI 10.1016/S0968-8080(07)29309-7; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Cornman DH, 2007, SOC SCI MED, V64, P1572, DOI 10.1016/j.socscimed.2006.11.011; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Datye V, 2006, HEALTH POLICY PLANN, V21, P343, DOI 10.1093/heapol/czl021; Fauci AS, 2007, CLIN INFECT DIS, V45, pS206, DOI 10.1086/522540; Fochsen G, 2006, QUAL HEALTH RES, V16, P1236, DOI 10.1177/1049732306293776; Gibney L, 2003, SOC SCI MED, V56, P1411, DOI 10.1016/S0277-9536(02)00138-7; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Hoffman S, 2003, AM J PUBLIC HEALTH, V93, P1897, DOI 10.2105/AJPH.93.11.1897; *IPS, 2005, HLTH HIV AIDS CAMP T; Janesick V, 2003, STRATEGIES QUALITATI; Kumar SGP, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-82; Lal A, 1999, J Assoc Physicians India, V47, P224; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; MALOW RM, 1994, AIDS EDUC PREV, V6, P113; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Mazumdar PG, 2007, J BIOSOC SCI, V39, P819, DOI 10.1017/S0021932007002106; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; MISHRA V, 2009, CONCURRENT SEXUAL PA; *NACO, 2007, COND PROM; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; ORNER P, 2004, PAVING PATH CHALLENG; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pandey A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000343766.00573.15; Rao KD, 2006, INT J QUAL HEALTH C, V18, P414, DOI 10.1093/intqhc/mzl049; Rosengarten M, 2009, SOC SCI MED, V69, P1049, DOI 10.1016/j.socscimed.2009.07.039; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Schneider JA, 2009, INT J STD AIDS, V20, P39, DOI 10.1258/ijsa.2008.008163; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Sheeran P, 2001, HEALTH PSYCHOL, V20, P12, DOI 10.1037/0278-6133.20.1.12; SINGH YN, 1993, J ACQUIR IMMUNE DEFI, V6; Singhal A., 2003, COMBATING AIDS COMMU; Steinbrook R, 2008, NEW ENGL J MED, V358, P107, DOI 10.1056/NEJMp0708474; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Strauss A., 1998, BASICS QUALITATIVE R; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Taylor S. J., 1984, INTRO QUALITATIVE RE; *UNAIDS, 2007, AIDS EP UPD; *UNAIDS, 2007, 3 WAV NAT AIDS CONTR; van de Vijver DAMC, 2009, J INFECT DIS, V199, P1310, DOI 10.1086/597804; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	67	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11922	10.1371/journal.pone.0011922	http://dx.doi.org/10.1371/journal.pone.0011922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QZ	20689602	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520300031
J	Boellmann, F; Thomas, RS				Boellmann, Frank; Thomas, Russell S.			The Identification of Protein Kinase C Iota as a Regulator of the Mammalian Heat Shock Response Using Functional Genomic Screens	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HSF1; ACTIVATION; GENE; FACTOR-1; CELLS; REPRESSION; MECHANISM; COMPLEX; HSP70; PHOSPHORYLATION	Background: The heat shock response is widely used as a surrogate of the general protein quality control system within the cell. This system plays a significant role in aging and many protein folding diseases as well as the responses to other physical and chemical stressors. Methods/Principal Findings: In this study, a broad-based functional genomics approach was taken to identify potential regulators of the mammalian heat shock response. In the primary screen, a total of 13724 full-length genes in mammalian expression vectors were individually co-transfected into human embryonic kidney cells together with a human HSP70B promoter driving firefly luciferase. A subset of the full-length genes that showed significant activation in the primary screen were then evaluated for their ability to hyper-activate the HSP70B under heat shock conditions. Based on the results from the secondary assay and gene expression microarray analyses, eight genes were chosen for validation using siRNA knockdown. Of the eight genes, only PRKCI showed a statistically significant reduction in the heat shock response in two independent siRNA duplexes compared to scrambled controls. Knockdown of the PRKCI mRNA was confirmed using quantitative RT-PCR. Additional studies did not show a direct physical interaction between PRKCI and HSF1. Conclusions/Significance: The results suggest that PRKCI is an indirect co-regulator of HSF1 activity and the heat shock response. Given the underlying role of HSF1 in many human diseases and the response to environmental stressors, PRKCI represents a potentially new candidate for gene-environment interactions and therapeutic intervention.	[Boellmann, Frank; Thomas, Russell S.] Hamner Inst Hlth Sci, Ctr Genom Biol & Bioinformat, Res Triangle Pk, NC USA	The Hamner Institutes for Health Sciences	Boellmann, F (corresponding author), Hamner Inst Hlth Sci, Ctr Genom Biol & Bioinformat, Res Triangle Pk, NC USA.	rthomas@thehamner.org		Thomas, Russell/0000-0002-2340-0301	American Chemistry Council	American Chemistry Council	The research was supported through a grant provided by the American Chemistry Council's Long-Range Research Initiative (http://www.americanchemistry.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ding XZ, 1996, J INVEST MED, V44, P144; Ding XZ, 1997, J CLIN INVEST, V99, P136, DOI 10.1172/JCI119124; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Halsey TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r104; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Hung JJ, 1998, J BIOL CHEM, V273, P31924, DOI 10.1074/jbc.273.48.31924; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; RITOSSA F, 1963, DROSOPHILA INFORM SE, V122; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; SCHEDL P, 1978, CELL, V14, P921, DOI 10.1016/0092-8674(78)90346-X; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; STEINKRAUS KA, 2008, AGING CELL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; van de Water B, 2006, TOXICOL LETT, V162, P83, DOI 10.1016/j.toxlet.2005.10.014; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; YAMAMOTO N, 1994, KIDNEY INT, V45, P1093, DOI 10.1038/ki.1994.146; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11850	10.1371/journal.pone.0011850	http://dx.doi.org/10.1371/journal.pone.0011850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686607	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200015
J	Casasanto, D; Jasmin, K				Casasanto, Daniel; Jasmin, Kyle			Good and Bad in the Hands of Politicians: Spontaneous Gestures during Positive and Negative Speech	PLOS ONE			English	Article								Background: According to the body-specificity hypothesis, people with different bodily characteristics should form correspondingly different mental representations, even in highly abstract conceptual domains. In a previous test of this proposal, right- and left-handers were found to associate positive ideas like intelligence, attractiveness, and honesty with their dominant side and negative ideas with their non-dominant side. The goal of the present study was to determine whether 'body-specific' associations of space and valence can be observed beyond the laboratory in spontaneous behavior, and whether these implicit associations have visible consequences. Methodology and Principal Findings: We analyzed speech and gesture (3012 spoken clauses, 1747 gestures) from the final debates of the 2004 and 2008 US presidential elections, which involved two right-handers (Kerry, Bush) and two left-handers (Obama, McCain). Blind, independent coding of speech and gesture allowed objective hypothesis testing. Right- and left-handed candidates showed contrasting associations between gesture and speech. In both of the left-handed candidates, left-hand gestures were associated more strongly with positive-valence clauses and right- hand gestures with negative-valence clauses; the opposite pattern was found in both right- handed candidates. Conclusions: Speakers associate positive messages more strongly with dominant hand gestures and negative messages with non-dominant hand gestures, revealing a hidden link between action and emotion. This pattern cannot be explained by conventions in language or culture, which associate 'good' with 'right' but not with 'left'; rather, results support and extend the body-specificity hypothesis. Furthermore, results suggest that the hand speakers use to gesture may have unexpected (and probably unintended) communicative value, providing the listener with a subtle index of how the speaker feels about the content of the co-occurring speech.	[Casasanto, Daniel; Jasmin, Kyle] Max Planck Inst Psycholinguist, Neurobiol Language Grp, Nijmegen, Netherlands; [Casasanto, Daniel] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Casasanto, Daniel] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	Max Planck Society; Radboud University Nijmegen; The New School	Casasanto, D (corresponding author), Max Planck Inst Psycholinguist, Neurobiol Language Grp, Nijmegen, Netherlands.	casasanto@alum.mit.edu		Jasmin, Kyle/0000-0001-9723-8207	National Research Service [F32MH072502]; Spanish Ministry of Education and Science [SEJ2006-04732/PSIC]; DGI; Consejeria de Innovacion; Ciencia y Empresa; Junta de Andalucia; European Regional Development Fund (ERDF) [P09-SEJ-4772]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH072502] Funding Source: NIH RePORTER	National Research Service; Spanish Ministry of Education and Science(Spanish Government); DGI; Consejeria de Innovacion; Ciencia y Empresa; Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (ERDF)(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Research Service Award #F32MH072502, by a grant from the Spanish Ministry of Education and Science #SEJ2006-04732/PSIC, DGI, and by a grant from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, and the European Regional Development Fund (ERDF), Project P09-SEJ-4772, to D. Casasanto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN G, 1966, CHIRONOMIA TREATISE; Beale I.L., 2020, PSYCHOL LEFT RIGHT; Beilock SL, 2007, PSYCHOL SCI, V18, P51, DOI 10.1111/j.1467-9280.2007.01848.x; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Goldin-Meadow S., 2003, HEARING GESTURE OUR; Hane AA, 2008, DEV PSYCHOL, V44, P1491, DOI 10.1037/a0012855; Kita S., 2001, GESTURE, V1, P73, DOI DOI 10.1075/GEST.1.1.06KIT; Maxwell JS, 2007, PSYCHOL SCI, V18, P1113, DOI 10.1111/j.1467-9280.2007.02033.x; McNeill D., 1992, HAND MIND WHAT GESTU; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Ozyurek A, 2002, J MEM LANG, V46, P688, DOI 10.1006/jmla.2001.2826; QUINTILIANUS MF, 1920, T I ORATORIA; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Willems RM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.039.2009; Willems RM, 2010, PSYCHOL SCI, V21, P67, DOI 10.1177/0956797609354072	16	90	96	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11805	10.1371/journal.pone.0011805	http://dx.doi.org/10.1371/journal.pone.0011805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633QX	20676371	Green Published, gold			2022-12-27	WOS:000280520100003
J	Dimairo, M; MacPherson, P; Bandason, T; Zezai, A; Munyati, SS; Butterworth, AE; Mungofa, S; Rusikaniko, S; Fielding, K; Mason, PR; Corbett, EL				Dimairo, Munyaradzi; MacPherson, Peter; Bandason, Tsitsi; Zezai, Abbas; Munyati, Shungu S.; Butterworth, Anthony E.; Mungofa, Stanley; Rusikaniko, Simba; Fielding, Katherine; Mason, Peter R.; Corbett, Elizabeth L.			The Risk and Timing of Tuberculosis Diagnosed in Smear-Negative TB Suspects: A 12 Month Cohort Study in Harare, Zimbabwe	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RECONSTITUTION INFLAMMATORY SYNDROME; RESOURCE-LIMITED SETTINGS; HIGH-HIV-PREVALENCE; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; IMMUNE RECONSTITUTION; SOUTH-AFRICA; FOLLOW-UP; INFECTION	Background: Cases of smear-negative TB have increased dramatically in high prevalence HIV settings and pose considerable diagnostic and management challenges. Methods and Findings: Between February 2006 and July 2007, a cohort study nested within a cluster-randomised trial of community-based case finding strategies for TB in Harare, Zimbabwe was undertaken. Participants who had negative sputum smears and remained symptomatic of TB were follow-up for one year with standardised investigations including HIV testing, repeat sputum smears, TB culture and chest radiography. Defaulters were actively traced to the community. The objectives were to investigate the incidence and risk factors for TB. TB was diagnosed in 218 (18.2%) participants, of which 39.4% was bacteriologically confirmed. Most cases (84.2%) were diagnosed within 3 months, but TB incidence remained high thereafter (111.3 per 1000 person-years, 95% CI: 86.6 to 146.3). HIV prevalence was 63.3%, and HIV-infected individuals had a 3.5-fold higher risk of tuberculosis than HIV-negative individuals. Conclusion: We found that diagnosis of TB was insensitive and slow, even with early radiography and culture. Until more sensitive and rapid diagnostic tests become widely available, a much more proactive and integrated approach towards prompt initiation of ART, ideally from within TB clinics and without waiting for TB to be excluded, is needed to minimise the risk and consequences of diagnostic delay.	[Dimairo, Munyaradzi; Bandason, Tsitsi; Zezai, Abbas; Munyati, Shungu S.; Mason, Peter R.] Biomed Res & Training Inst, Harare, Zimbabwe; [MacPherson, Peter] Univ Liverpool, Wellcome Trust Trop Ctr, Liverpool L69 3BX, Merseyside, England; [Butterworth, Anthony E.; Corbett, Elizabeth L.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Mungofa, Stanley] Harare City Hlth, Harare, Zimbabwe; [Rusikaniko, Simba] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Fielding, Katherine] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England	Biomedical Research Training Institute; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine	Dimairo, M (corresponding author), Biomed Res & Training Inst, Harare, Zimbabwe.	p.macpherson@liv.ac.uk	MacPherson, Peter/AHD-2477-2022; Dimairo, Munya/U-6905-2019	MacPherson, Peter/0000-0002-0329-9613; Fielding, Katherine/0000-0002-6524-3754; Corbett, Elizabeth/0000-0002-3552-3181; Dimairo, Munyaradzi/0000-0002-9311-6920	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	ELC receives funding from the Wellcome Trust, UK. PM is funded by the Wellcome Trust Clinical PhD programme at the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; CORBETT EL, 2009, LANCET; CRAMPIN AC, 2009, AIDS IN PRESS; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; *FDN INN NEW DIAGN, 2009, RAP SCAL INT MOL DIA; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 1997, INT J TUBERC LUNG D, V1, P346; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2009, CLIN CHEST MED, V30, P797, DOI 10.1016/j.ccm.2009.08.013; MORGAN MA, 1983, J CLIN MICROBIOL, V18, P384, DOI 10.1128/JCM.18.2.384-388.1983; Munyati SS, 2005, CLIN INFECT DIS, V40, P1818, DOI 10.1086/429912; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, GLOB TUB CONTR 2009; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	34	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11849	10.1371/journal.pone.0011849	http://dx.doi.org/10.1371/journal.pone.0011849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676374	Green Published, Green Accepted, gold			2022-12-27	WOS:000280520100019
J	Moharregh-Khiabani, D; Blank, A; Skripuletz, T; Miller, E; Kotsiari, A; Gudi, V; Stangel, M				Moharregh-Khiabani, Darius; Blank, Alexander; Skripuletz, Thomas; Miller, Elvira; Kotsiari, Alexandra; Gudi, Viktoria; Stangel, Martin			Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse	PLOS ONE			English	Article							BRAIN-BARRIER PERMEABILITY; INDUCED DEMYELINATION; MULTIPLE-SCLEROSIS; GLIAL-CELLS; IN-VITRO; RAT; OLIGODENDROCYTES; DIMETHYLFUMARATE; DIFFERENTIATION; NEUROTOXICANT	Background: Fumaric acid esters (FAE) are a group of compounds which are currently under investigation as an oral treatment for relapsing-remitting multiple sclerosis. One of the suggested modes of action is the potential of FAE to exert a neuroprotective effect. Methodology/Principal Findings: We have investigated the impact of monomethylfumarate (MMF) and dimethylfumaric acid (DMF) on de- and remyelination using the toxic cuprizone model where the blood-brain-barrier remains intact and only scattered T-cells and peripheral macrophages are found in the central nervous system (CNS), thus excluding the influence of immunomodulatory effects on peripheral immune cells. FAE showed marginally accelerated remyelination in the corpus callosum compared to controls. However, we found no differences for demyelination and glial reactions in vivo and no cytoprotective effect on oligodendroglial cells in vitro. In contrast, DMF had a significant inhibitory effect on lipopolysaccharide (LPS) induced nitric oxide burst in microglia and induced apoptosis in peripheral blood mononuclear cells (PBMC). Conclusions: These results contribute to the understanding of the mechanism of action of fumaric acids. Our data suggest that fumarates have no or only little direct protective effects on oligodendrocytes in this toxic model and may act rather indirectly via the modulation of immune cells.	[Moharregh-Khiabani, Darius; Blank, Alexander; Skripuletz, Thomas; Miller, Elvira; Kotsiari, Alexandra; Gudi, Viktoria; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Gudi, Viktoria; Stangel, Martin] Ctr Syst Neurosci, Hannover, Germany	Hannover Medical School	Moharregh-Khiabani, D (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	Stangel.Martin@MH-Hannover.de	Stangel, Martin/AAH-5345-2020; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony; Biogen Idec	Georg-Christoph-Lichtenberg Fellowship; State of Lower Saxony(European Commission); Biogen Idec(Biogen)	This study was partly supported by the Georg-Christoph-Lichtenberg Fellowship by the State of Lower Saxony and by Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER DA, 1987, J NEUROL SCI, V78, P125, DOI 10.1016/0022-510X(87)90055-4; Cammer W, 1999, J NEUROL SCI, V168, P116, DOI 10.1016/S0022-510X(99)00181-1; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Heine S, 2006, J NEUROIMMUNOL, V177, P173, DOI 10.1016/j.jneuroim.2006.04.016; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Lindner M, 2008, GLIA, V56, P1104, DOI 10.1002/glia.20682; Lindner M, 2009, NEUROSCI LETT, V453, P120, DOI 10.1016/j.neulet.2009.02.004; Linker Ralf A, 2008, Expert Rev Neurother, V8, P1683, DOI 10.1586/14737175.8.11.1683; Litjens NHR, 2004, EUR J IMMUNOL, V34, P565, DOI 10.1002/eji.200324174; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Norkute A, 2009, J NEUROSCI RES, V87, P1343, DOI 10.1002/jnr.21946; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SKRIPULETZ T, 2009, BRAIN PATHOL; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Stangel M, 2003, J NEUROIMMUNOL, V138, P25, DOI 10.1016/S0165-5728(03)00087-0; Stangel M, 2000, J NEUROIMMUNOL, V103, P195, DOI 10.1016/S0165-5728(99)00241-6; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Treumer F, 2003, J INVEST DERMATOL, V121, P1383, DOI 10.1111/j.1523-1747.2003.12605.x; Wierinckx A, 2005, J NEUROIMMUNOL, V166, P132, DOI 10.1016/j.jneuroim.2005.05.013; Yang MH, 2009, J ETHNOPHARMACOL, V121, P130, DOI 10.1016/j.jep.2008.10.010; Zhu KJ, 2001, J INVEST DERMATOL, V116, P203, DOI 10.1046/j.1523-1747.2001.01159.x	34	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11769	10.1371/journal.pone.0011769	http://dx.doi.org/10.1371/journal.pone.0011769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668697	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800033
J	Foussard, H; Ferrer, P; Valenti, P; Polesello, C; Carreno, S; Payre, F				Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois			LRCH Proteins: A Novel Family of Cytoskeletal Regulators	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; SINGLE-NUCLEOTIDE POLYMORPHISM; STABLE MICROTUBULE FORMATION; F-ACTIN-BINDING; RETROVIRAL INFECTION; KNEE OSTEOARTHRITIS; CELL-DIVISION; DROSOPHILA; MOESIN; GENOME	Background: Comparative genomics has revealed an unexpected level of conservation for gene products across the evolution of animal species. However, the molecular function of only a few proteins has been investigated experimentally, and the role of many animal proteins still remains unknown. Here we report the characterization of a novel family of evolutionary conserved proteins, which display specific features of cytoskeletal scaffolding proteins, referred to as LRCHs. Principal Findings: Taking advantage of the existence of a single LRCH gene in flies, dLRCH, we explored its function in cultured cells, and show that dLRCH act to stabilize the cell cortex during cell division. dLRCH depletion leads to ectopic cortical blebs and alters positioning of the mitotic spindle. We further examined the consequences of dLRCH deletion throughout development and adult life. Although dLRCH is not essential for cell division in vivo, flies lacking dLRCH display a reduced fertility and fitness, particularly when raised at extreme temperatures. Conclusion/Significance: These results support the idea that some cytoskeletal regulators are important to buffer environmental variations and ensure the proper execution of basic cellular processes, such as the control of cell shape, under environmental variations.	[Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois] Univ Toulouse UPS, Ctr Dev Biol, Toulouse, France; [Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Foussard, H (corresponding author), Univ Toulouse UPS, Ctr Dev Biol, Toulouse, France.	payre@cict.fr	Cédric, POLESELLO/ABC-3406-2021	Carreno, Sebastien/0000-0002-5839-2102; Polesello, Cedric/0000-0001-6859-2960; PAYRE, Francois/0000-0002-8144-6711	Fondation pour la Recherche Medicale; Human Frontier Science Program; Canadian Institutes for Health Research [MOP-89877]; Association pour la Recherche contre le Cancer [3832, 1111]; Fondation pour la Recherche Medicale [2005]; Agence Nationale de la Recherche	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	S.C. was initially funded by a Fondation pour la Recherche Medicale (http://www. frm. org/) fellowship and a Human Frontier Science Program (http://www.hfsp.org/) Career Development Award. He is now a Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml) Junior fellow and supported by the Canadian Institutes for Health Research (http://www. cihr. ca/) (grant no: MOP-89877). This work was supported by grants from the Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/) (no 3832, no 1111), Fondation pour la Recherche Medicale (Equipe 2005) and Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) Blanc (Netoshape). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DAINES B, HIGH RESOLUTION MAP; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FRANKEL N, 2010, NATURE; GATTI M, 1991, METHOD CELL BIOL, V35, P543; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Haedicke J, 2008, J VIROL, V82, P4665, DOI 10.1128/JVI.02403-07; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Hindle KL, 2009, PROTEINS, V77, P342, DOI 10.1002/prot.22440; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jiang Q, 2008, J HUM GENET, V53, P42, DOI 10.1007/s10038-007-0216-4; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; LASSERRE R, 2010, EMBO J; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Raynaud-Messina B, 2001, EUR J CELL BIOL, V80, P643, DOI 10.1078/0171-9335-00195; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sjoblom B, 2008, CURR OPIN STRUC BIOL, V18, P702, DOI 10.1016/j.sbi.2008.10.003; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Spector TD, 2006, ARTHRITIS RHEUM-US, V54, P524, DOI 10.1002/art.21624; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761	50	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12257	10.1371/journal.pone.0012257	http://dx.doi.org/10.1371/journal.pone.0012257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805893	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600024
J	Piton, J; Petrella, S; Delarue, M; Andre-Leroux, G; Jarlier, V; Aubry, A; Mayer, C				Piton, Jeremie; Petrella, Stephanie; Delarue, Marc; Andre-Leroux, Gwenaelle; Jarlier, Vincent; Aubry, Alexandra; Mayer, Claudine			Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase	PLOS ONE			English	Article							BREAKAGE-REUNION DOMAIN; CRYSTAL-STRUCTURE; TOPOISOMERASE-IV; FUNCTIONAL-ANALYSIS; II TOPOISOMERASE; CRYSTALLIZATION; MUTATIONS; SEQUENCE; SUBUNITS; STRAINS	Mycobacterium tuberculosis DNA gyrase, an indispensable nanomachine involved in the regulation of DNA topology, is the only type II topoisomerase present in this organism and is hence the sole target for quinolone action, a crucial drug active against multidrug-resistant tuberculosis. To understand at an atomic level the quinolone resistance mechanism, which emerges in extensively drug resistant tuberculosis, we performed combined functional, biophysical and structural studies of the two individual domains constituting the catalytic DNA gyrase reaction core, namely the Toprim and the breakage-reunion domains. This allowed us to produce a model of the catalytic reaction core in complex with DNA and a quinolone molecule, identifying original mechanistic properties of quinolone binding and clarifying the relationships between amino acid mutations and resistance phenotype of M. tuberculosis DNA gyrase. These results are compatible with our previous studies on quinolone resistance. Interestingly, the structure of the entire breakage-reunion domain revealed a new interaction, in which the Quinolone-Binding Pocket (QBP) is blocked by the N-terminal helix of a symmetry-related molecule. This interaction provides useful starting points for designing peptide based inhibitors that target DNA gyrase to prevent its binding to DNA.	[Piton, Jeremie; Delarue, Marc; Mayer, Claudine] Inst Pasteur, Dept Biol Struct & Chim, Unite Dynam Struct Macromol, Paris, France; [Piton, Jeremie; Delarue, Marc; Andre-Leroux, Gwenaelle; Mayer, Claudine] CNRS, URA 2185, Paris, France; [Petrella, Stephanie; Jarlier, Vincent; Aubry, Alexandra] Univ Paris 06, EA1541, Paris, France; [Andre-Leroux, Gwenaelle] Inst Pasteur, Dept Biol Struct & Chim, Unite Biochim Struct, Paris, France; [Mayer, Claudine] Univ Paris Diderot Paris 7, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Piton, J (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Unite Dynam Struct Macromol, Paris, France.	mayer@pasteur.fr	Aubry, Alexandra/F-8783-2014	Aubry, Alexandra/0000-0003-4230-4793; Petrella, Stephanie/0000-0001-6641-5901; Piton, jeremie/0000-0003-4420-5027	Ministere de l'enseignement superieur et de la recherche	Ministere de l'enseignement superieur et de la recherche	J.P. is funded by the "Ministere de l'enseignement superieur et de la recherche.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Aubry A, 2004, ANTIMICROB AGENTS CH, V48, P1281, DOI 10.1128/AAC.48.4.1281-1288.2004; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Carr SB, 2006, ACTA CRYSTALLOGR F, V62, P1164, DOI 10.1107/S1744309106044150; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Costenaro L, 2005, STRUCTURE, V13, P287, DOI 10.1016/j.str.2004.12.011; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; Fu G, 2009, ACTA CRYSTALLOGR F, V65, P350, DOI 10.1107/S1744309109006575; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Heddle J, 2002, ANTIMICROB AGENTS CH, V46, P1805, DOI 10.1128/AAC.46.6.1805-1815.2002; HOOPER CD, 2003, QUINOLONE ANTIMICROB; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Matrat S, 2008, ANTIMICROB AGENTS CH, V52, P2909, DOI 10.1128/AAC.01380-07; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mdluli Khisimuzi, 2007, Infectious Disorders - Drug Targets, V7, P159; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piton J, 2009, ACTA CRYSTALLOGR F, V65, P1182, DOI 10.1107/S1744309109042067; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smith CK, 1996, J MOL BIOL, V263, P237, DOI 10.1006/jmbi.1996.0572; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; van Doorn HR, 2008, INT J TUBERC LUNG D, V12, P736; Veziris N, 2007, EUR J CLIN MICROBIOL, V26, P423, DOI 10.1007/s10096-007-0298-0; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; World Health Organization, 2009, WHOHTMTB2009	56	95	101	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12245	10.1371/journal.pone.0012245	http://dx.doi.org/10.1371/journal.pone.0012245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805881	Green Published, gold			2022-12-27	WOS:000281011600017
J	Smits, SA; Ouverney, CC				Smits, Samuel A.; Ouverney, Cleber C.			jsPhyloSVG: A Javascript Library for Visualizing Interactive and Vector-Based Phylogenetic Trees on the Web	PLOS ONE			English	Article							DISPLAY	Background: Many software packages have been developed to address the need for generating phylogenetic trees intended for print. With an increased use of the web to disseminate scientific literature, there is a need for phylogenetic trees to be viewable across many types of devices and feature some of the interactive elements that are integral to the browsing experience. We propose a novel approach for publishing interactive phylogenetic trees. Methods/Principal Findings: We present a javascript library, jsPhyloSVG, which facilitates constructing interactive phylogenetic trees from raw Newick or phyloXML formats directly within the browser in Scalable Vector Graphics (SVG) format. It is designed to work across all major browsers and renders an alternative format for those browsers that do not support SVG. The library provides tools for building rectangular and circular phylograms with integrated charting. Interactive features may be integrated and made to respond to events such as clicks on any element of the tree, including labels. Conclusions/Significance: jsPhyloSVG is an open-source solution for rendering dynamic phylogenetic trees. It is capable of generating complex and interactive phylogenetic trees across all major browsers without the need for plugins. It is novel in supporting the ability to interpret the tree inference formats directly, exposing the underlying markup to data-mining services. The library source code, extensive documentation and live examples are freely accessible at www.jsphylosvg.com.	[Smits, Samuel A.; Ouverney, Cleber C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	California State University System; San Jose State University	Smits, SA (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	samsmits@gmail.com; cleber.ouverney@sjsu.edu		Ouverney, Cleber/0000-0002-4135-7562	National Institutes of Health (NIH) [1SC3GM0822]; NIH MARC [5T34 GM008253]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008253, SC3GM082291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded in part by National Institutes of Health (NIH) Grant # 1SC3GM0822 and NIH MARC Grant # 5T34 GM008253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; *JAVASCRIPT LIB, 2010, IQUERY WRIT LESS DO; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Palidwor G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-79; Pethica R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008934; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *YAH US INT LIB, YUI 3; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	11	65	65	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12267	10.1371/journal.pone.0012267	http://dx.doi.org/10.1371/journal.pone.0012267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805892	Green Published, Green Submitted, gold			2022-12-27	WOS:000281011600028
J	Bai, WM; Xun, F; Li, Y; Zhang, WH; Li, LH				Bai, Wenming; Xun, Fen; Li, Yang; Zhang, Wenhao; Li, Linghao			Rhizome Severing Increases Root Lifespan of Leymus chinensis in a Typical Steppe of Inner Mongolia	PLOS ONE			English	Article							LONGEVITY; TURNOVER; SURVIVORSHIP; AVAILABILITY; DIAMETER; GROWTH; CARBON; DEPTH	Background: Root lifespan is an important trait that determines plants' ability to acquire and conserve soil resources. There have been several studies investigating characteristics of root lifespan of both woody and herbaceous species. However, most of the studies have focused on non-clonal plants, and there have been little data on root lifespan for clonal plants that occur widely in temperate grasslands. Methodology/Principal Findings: We investigated the effects of rhizome severing on overall root lifespan of Leymus chinensis, a clonal, dominant grass species in the temperate steppe in northern China, in a 2-year field study using modified rhizotron technique. More specifically, we investigated the effects of rhizome severing on root lifespan of roots born in different seasons and distributed at different soil depths. Rhizome severing led to an increase in the overall root lifespan from 81 to 103 days. The increase in root lifespan exhibited spatial and temporal characteristics such that it increased lifespan for roots distributed in the top two soil layers and for roots born in summer and spring, but it had no effect on lifespan of roots in the deep soil layer and born in autumn. We also examined the effect of rhizome severing on carbohydrate and N contents in roots, and found that root carbohydrate and N contents were not affected by rhizome severing. Further, we found that root lifespan of Stipa krylovii and Artemisia frigida, two dominant, non-clonal species in the temperate steppe, was significantly longer (118 d) than that of L. chinensis (81 d), and this value became comparable to that of L. chinensis under rhizome severing (103 d). Conclusions/Significance: We found that root lifespan in dominant, clonal L. chinensis was shorter than for the dominant, non-clonal species of S. krylovii and A. frigida. There was a substantial increase in the root lifespan of L. chinensis in response to severing their rhizomes, and this increase in root lifespan exhibited temporal and spatial characteristics. These findings suggest that the presence of rhizomes is likely to account for the observed short lifespan of clonal plant species in the temperate steppe.	[Bai, Wenming; Xun, Fen; Li, Yang; Zhang, Wenhao; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Xun, Fen; Li, Yang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	llinghao@ibcas.ac.cn	Zhang, Wen-Hao/B-5805-2009	Zhang, Wen-Hao/0000-0003-2708-2221	State Key Basic Research Development Program of China [2010CB833502]; CAS [KZCX2-XB2-01, KSCX-YW-Z-1022]	State Key Basic Research Development Program of China; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This research was supported by a grant of the State Key Basic Research Development Program of China (2010CB833502) and the knowledge innovation program of CAS (KZCX2-XB2-01, KSCX-YW-Z-1022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1985, OECOLOGIA, V66, P317, DOI 10.1007/BF00378292; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Anderson LJ, 2003, NEW PHYTOL, V158, P489, DOI 10.1046/j.1469-8137.2003.00757.x; Baddeley JA, 2005, PLANT SOIL, V276, P15, DOI 10.1007/s11104-005-0263-6; Bai WM, 2008, FUNCT ECOL, V22, P583, DOI 10.1111/j.1365-2435.2008.01403.x; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bates TR, 2002, HORTSCIENCE, V37, P313, DOI 10.21273/HORTSCI.37.2.313; *CHIN AC SCI, 1985, VEG INN MONGL, P516; Eissenstat DM, 2000, NEW PHYTOL, V147, P33, DOI 10.1046/j.1469-8137.2000.00686.x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Farrar JF, 2000, NEW PHYTOL, V147, P43, DOI 10.1046/j.1469-8137.2000.00688.x; Gill RA, 2002, PLANT ECOL, V159, P241, DOI 10.1023/A:1015529507670; HASSID WZ, 1964, METHODS CARBOHYDRATE, V4, P33; HENDRICKS JJ, 1993, TRENDS ECOL EVOL, V8, P174, DOI 10.1016/0169-5347(93)90143-D; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hooker JE, 2000, ROOT METHODS: A HANDBOOK, P273; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Lopez B, 2001, NEW PHYTOL, V151, P437, DOI 10.1046/j.0028-646x.2001.00189.x; Norby RJ, 2000, NEW PHYTOL, V147, P3, DOI 10.1046/j.1469-8137.2000.00676.x; Stewart AM, 2008, OECOLOGIA, V157, P453, DOI 10.1007/s00442-008-1088-9; Van der Krift TAJ, 2002, FUNCT ECOL, V16, P198, DOI 10.1046/j.1365-2435.2002.00611.x; Wang Ya-Ying, 2007, Acta Botanica Yunnanica, V29, P74; [王昱生 Wang Yusheng], 2004, [生态学报, Acta Ecologica Sinica], V24, P900; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Wells CE, 2001, ECOLOGY, V82, P882, DOI 10.1890/0012-9658(2001)082[0882:MDISAA]2.0.CO;2; West JB, 2003, FUNCT ECOL, V17, P20, DOI 10.1046/j.1365-2435.2003.00695.x; Xu WenJing, 2006, Journal of Plant Ecology, V30, P104; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhang GuangHui, 2006, Acta Prataculturae Sinica, V15, P42; ZHU TC, 2004, BIOL ECOLOGICAL STUD, P90	30	13	17	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12125	10.1371/journal.pone.0012125	http://dx.doi.org/10.1371/journal.pone.0012125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711343	Green Published, Green Submitted, gold			2022-12-27	WOS:000280859700017
J	Martinez, D; Heudebert, G; Seas, C; Henostroza, G; Rodriguez, M; Zamudio, C; Centor, RM; Herrera, C; Gotuzzo, E; Estrada, C				Martinez, Dalila; Heudebert, Gustavo; Seas, Carlos; Henostroza, German; Rodriguez, Martin; Zamudio, Carlos; Centor, Robert M.; Herrera, Cesar; Gotuzzo, Eduardo; Estrada, Carlos			Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							METHODOLOGICAL STANDARDS; CONFIDENCE-INTERVALS; TREATMENT FAILURE; MDR-TB; DIAGNOSIS; VALIDATION; CALIFORNIA; INPATIENTS; COUNTRIES; RUSSIA	Background: Multidrug-resistant tuberculosis (MDR-TB), resistance to at least isoniazid and rifampin, is a worldwide problem. Objective: To develop a clinical prediction rule to stratify risk for MDR-TB among patients with pulmonary tuberculosis. Methods: Derivation and internal validation of the rule among adult patients prospectively recruited from 37 health centers (Peru), either a) presenting with a positive acid-fast bacillus smear, or b) had failed therapy or had a relapse within the first 12 months. Results: Among 964 patients, 82 had MDR-TB (prevalence, 8.5%). Variables included were MDR-TB contact within the family, previous tuberculosis, cavitary radiologic pattern, and abnormal lung exam. The area under the receiver-operating curve (AUROC) was 0.76. Selecting a cut-off score of one or greater resulted in a sensitivity of 72.6%, specificity of 62.8%, likelihood ratio (LR) positive of 1.95, and LR negative of 0.44. Similarly, selecting a cut-off score of two or greater resulted in a sensitivity of 60.8%, specificity of 87.5%, LR positive of 4.85, and LR negative of 0.45. Finally, selecting a cut-off score of three or greater resulted in a sensitivity of 45.1%, specificity of 95.3%, LR positive of 9.56, and LR negative of 0.58. Conclusion: A simple clinical prediction rule at presentation can stratify risk for MDR-TB. If further validated, the rule could be used for management decisions in resource-limited areas.	[Martinez, Dalila; Seas, Carlos; Zamudio, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Heudebert, Gustavo; Centor, Robert M.; Estrada, Carlos] Univ Alabama, Div Gen Internal Med, Birmingham, AL USA; [Heudebert, Gustavo; Centor, Robert M.; Estrada, Carlos] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Herrera, Cesar] Minist Hlth, Peruvian TB Program, Lima, Peru; [Henostroza, German; Rodriguez, Martin] Univ Alabama, Div Infect Dis, Birmingham, AL USA	Universidad Peruana Cayetano Heredia; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham	Martinez, D (corresponding author), Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru.	cestrada@uab.edu		Seas, Carlos/0000-0001-7067-9141; Zamudio, Carlos/0000-0001-7479-127X	NIH [1U2RTW007368-01A1]; FOGARTY INTERNATIONAL CENTER [U2RTW007368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding and Support: Peru ICOHRTA Network for AIDS/TB Research Training (NIH Grant 1U2RTW007368-01A1- Fogarty International Center, Dr Gotuzzo, Lima Peru) for funding the training of Dr. Martinez at the School of Public Health at University of Alabama at Birmingham (UAB). http://projectreporter. nih.gov/project_info_description.cfm?aid=7239089&icde=4053480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Villaorduna C, 2008, CLIN INFECT DIS, V47, P487, DOI 10.1086/590010; Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Balabanova Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007129; BENDOV I, 1987, AM REV RESPIR DIS, V135, P1307; Boonsarngsuk V, 2009, SINGAP MED J, V50, P378; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Granich RM, 2005, JAMA-J AM MED ASSOC, V293, P2732, DOI 10.1001/jama.293.22.2732; Haukoos JS, 2005, ACAD EMERG MED, V12, P360, DOI 10.1197/j.aem.2004.11.018; Huyen MNT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-149; JEREB JA, 1995, ARCH INTERN MED, V155, P854, DOI 10.1001/archinte.155.8.854; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Kliiman K, 2009, ANN INTERN MED, V150, P766, DOI 10.7326/0003-4819-150-11-200906020-00004; KOOPMAN PAR, 1984, BIOMETRICS, V40, P513, DOI 10.2307/2531405; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Minime-Lingoupou F, 2010, INT J TUBERC LUNG D, V14, P782; O'Riordan P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003173; Rakoczy KS, 2008, INFECT CONT HOSP EP, V29, P927, DOI 10.1086/590667; Richter Elvira, 2009, Expert Rev Respir Med, V3, P497, DOI 10.1586/ers.09.45; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; Soto A, 2008, BRAZ J INFECT DIS, V12, P128, DOI 10.1590/S1413-86702008000200006; UNAIDS/WHO, 2009, EP FACT SHEET HIV AI; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; Wisnivesky JP, 2005, J GEN INTERN MED, V20, P947, DOI 10.1111/j.1525-1497.2005.0185.x; World Health Organisation, 2009, GLOB TUB CONTR PAT C; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	35	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12082	10.1371/journal.pone.0012082	http://dx.doi.org/10.1371/journal.pone.0012082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711459	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100020
J	Castillo, S; Srithayakumar, V; Meunier, V; Kyle, CJ				Castillo, Sarrah; Srithayakumar, Vythegi; Meunier, Vanessa; Kyle, Christopher J.			Characterization of Major Histocompatibility Complex (MHC) DRB Exon 2 and DRA Exon 3 Fragments in a Primary Terrestrial Rabies Vector (Procyon lotor)	PLOS ONE			English	Article							NATURAL-SELECTION; EVOLUTIONARY RELATIONSHIPS; GENETIC-VARIATION; RACCOON; LOCI; RESISTANCE; DIVERSITY; ECOLOGY; VARIABILITY; SUPERTYPES	The major histocompatibility complex (MHC) presents a unique system to explore links between genetic diversity and pathogens, as diversity within MHC is maintained in part by pathogen driven selection. While the majority of wildlife MHC studies have investigated species that are of conservation concern, here we characterize MHC variation in a common and broadly distributed species, the North American raccoon (Procyon lotor). Raccoons host an array of broadly distributed wildlife diseases (e. g., canine distemper, parvovirus and raccoon rabies virus) and present important human health risks as they persist in high densities and in close proximity to humans and livestock. To further explore how genetic variation influences the spread and maintenance of disease in raccoons we characterized a fragment of MHC class II DRA exon 3 (250bp) and DRB exon 2 (228 bp). MHC DRA was found to be functionally monomorphic in the 32 individuals screened; whereas DRB exon 2 revealed 66 unique alleles among the 246 individuals screened. Between two and four alleles were observed in each individual suggesting we were amplifying a duplicated DRB locus. Nucleotide differences between DRB alleles ranged from 1 to 36 bp (0.4-15.8% divergence) and translated into 1 to 21 (1.3-27.6% divergence) amino acid differences. We detected a significant excess of nonsynonymous substitutions at the peptide binding region (P = 0.005), indicating that DRB exon 2 in raccoons has been influenced by positive selection. These data will form the basis of continued analyses into the spatial and temporal relationship of the raccoon rabies virus and the immunogenetic response in its primary host.	[Castillo, Sarrah; Srithayakumar, Vythegi] Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada; [Meunier, Vanessa; Kyle, Christopher J.] Trent Univ, Dept Forens Sci, Peterborough, ON K9J 7B8, Canada; [Castillo, Sarrah; Srithayakumar, Vythegi; Kyle, Christopher J.] Trent Univ, Nat Resources DNA Profiling & Forens Ctr, Peterborough, ON K9J 7B8, Canada	Trent University; Trent University; Trent University	Castillo, S (corresponding author), Trent Univ, Environm & Life Sci Gradate Program, Peterborough, ON K9J 7B8, Canada.	scastillo@nrdpfc.ca			Natural Sciences and Engineering Research Council of Canada [355850]; Rabies Research Unit of the Ontario Ministry of Natural Resources	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Rabies Research Unit of the Ontario Ministry of Natural Resources	This research was funded through a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to CJK (Grant # 355850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by collaboration funds to CJK from the Rabies Research Unit of the Ontario Ministry of Natural Resources. The Rabies Research Unit also provided samples for this research.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSSON L, 1991, IMMUNOGENETICS, V33, P188, DOI 10.1007/BF01719239; Babik W, 2005, MOL ECOL, V14, P4249, DOI 10.1111/j.1365-294X.2005.02751.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biedrzycka A, 2008, MOL ECOL, V17, P4801, DOI 10.1111/j.1365-294X.2008.03955.x; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Breuer L., 2005, INTRO QUEUEING THEOR; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CAREY AB, 1983, J APPL ECOL, V20, P777, DOI 10.2307/2403126; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Cullingham CI, 2008, MOL ECOL, V17, P4874, DOI 10.1111/j.1365-294X.2008.03956.x; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Doherty P C, 1975, Nature, V256, P50; Gillett R. M., 2009, THESIS TRENT U PETER, P149; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Helgen KM, 2008, J MAMMAL, V89, P282, DOI 10.1644/07-MAMM-A-155R.1; Huchard E, 2006, IMMUNOGENETICS, V58, P805, DOI 10.1007/s00251-006-0156-8; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1994, PHILOS T ROY SOC B, V346, P359, DOI 10.1098/rstb.1994.0153; HUGHES AL, 1995, IMMUNOGENETICS, V42, P233, DOI 10.1007/BF00176440; HUGHES AL, 1990, MOL BIOL EVOL, V7, P491; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; HUGHES AL, 1993, IMMUNOGENETICS, V37, P337, DOI 10.1007/BF00216798; JENKINS SR, 1988, REV INFECT DIS, V10, pS620; Junge RE, 2007, J ZOO WILDLIFE MED, V38, P18, DOI 10.1638/05-123.1; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KENNEDY ML, 1984, J MAMMAL, V65, P195, DOI 10.2307/1381159; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Saitoh K, 2008, GENE, V423, P92, DOI 10.1016/j.gene.2008.06.025; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sun DX, 2004, BIOCHEM GENET, V42, P385, DOI 10.1023/B:BIGI.0000039812.46203.89; Szanto A, 2009, THESIS TRENT U PETER; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wheeler DC, 2008, J AGR BIOL ENVIR ST, V13, P388, DOI 10.1198/108571108X383483; Yuhki N, 1997, J IMMUNOL, V158, P2822; Zeisset I, 2009, MOL ECOL RESOUR, V9, P738, DOI 10.1111/j.1755-0998.2009.02535.x; Zeng CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-315	55	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12066	10.1371/journal.pone.0012066	http://dx.doi.org/10.1371/journal.pone.0012066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706587	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900020
J	Graham, BS; McElrath, MJ; Keefer, MC; Rybczyk, K; Berger, D; Weinhold, KJ; Ottinger, J; Ferarri, G; Montefiori, DC; Stablein, D; Smith, C; Ginsberg, R; Eldridge, J; Duerr, A; Fast, P; Haynes, BF				Graham, Barney S.; McElrath, M. Juliana; Keefer, Michael C.; Rybczyk, Kyle; Berger, David; Weinhold, Kent J.; Ottinger, Janet; Ferarri, Guido; Montefiori, David C.; Stablein, Don; Smith, Carol; Ginsberg, Richard; Eldridge, John; Duerr, Ann; Fast, Pat; Haynes, Barton F.		AIDS Vaccine Evaluation Grp	Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-CELLS; NEUTRALIZING ANTIBODIES; SYNTHETIC PEPTIDES; ENVELOPE PROTEIN; GP120; ADJUVANT; SAFETY; LOOP; RESPONSES	Background: A peptide vaccine was produced containing B and T cell epitopes from the V3 and C4 Envelope domains of 4 subtype B HIV-1 isolates (MN, RF, CanO, & Ev91). The peptide mixture was formulated as an emulsion in incomplete Freund's adjuvant (IFA). Methods: Low-risk, healthy adult subjects were enrolled in a randomized, placebo-controlled dose-escalation study, and selected using criteria specifying that 50% in each study group would be HLA-B7+. Immunizations were scheduled at 0, 1, and 6 months using a total peptide dose of 1 or 4 mg. Adaptive immune responses in 16 vaccine recipients and two placebo recipients after the 2 nd immunization were evaluated using neutralization assays of sera, as well as ELISpot and ICS assays of cryopreserved PBMCs to assess CD4 and CD8 T-cell responses. In addition, Cr-51 release assays were performed on fresh PBMCs following 14-day stimulation with individual vaccine peptide antigens. Results: 24 subjects were enrolled; 18 completed 2 injections. The study was prematurely terminated because 4 vaccinees developed prolonged pain and sterile abscess formation at the injection site-2 after dose 1, and 2 after dose 2. Two other subjects experienced severe systemic reactions consisting of headache, chills, nausea, and myalgia. Both reactions occurred after the second 4 mg dose. The immunogenicity assessments showed that 6/8 vaccinees at each dose level had detectable MN-specific neutralizing (NT) activity, and 2/7 HLA-B7+ vaccinees had classical CD8 CTL activity detected. However, using both ELISpot and ICS, 8/16 vaccinees (5/7 HLA-B7+) and 0/2 controls had detectable vaccine-specific CD8 T-cell responses. Subjects with moderate or severe systemic or local reactions tended to have more frequent T cell responses and higher antibody responses than those with mild or no reactions. Conclusions: The severity of local responses related to the formulation of these four peptides in IFA is clinically unacceptable for continued development. Both HIV-specific antibody and T cell responses were induced and the magnitude of response correlated with the severity of local and systemic reactions. If potent adjuvants are necessary for subunit vaccines to induce broad and durable immune responses, careful, incremental clinical evaluation is warranted to minimize the risk of adverse events.	[Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [McElrath, M. Juliana; Berger, David; Duerr, Ann] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Rybczyk, Kyle] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Weinhold, Kent J.; Ottinger, Janet; Ferarri, Guido; Montefiori, David C.; Haynes, Barton F.] Duke Univ, Sch Med, Durham, NC USA; [Stablein, Don; Smith, Carol] EMMES Corp, Rockville, MD USA; [Eldridge, John] Profectus Biosci Inc, Tarrytown, NY USA; [Fast, Pat] Int AIDS Vaccine Initiat, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Rochester; Vanderbilt University; Duke University; Emmes Corporation; International AIDS Vaccine Initiative	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	Division of AIDS; National Institute of Allergy and Infectious Diseases, University of Rochester [NO1-AI-45208]; National Institute of Allergy and Infectious Diseases, University of Washington at Seattle [NO1-AI-45209]; National Institute of Allergy and Infectious Diseases, Vanderbilt University [NO1-AI-45210]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI045209, ZIAAI005035, N01AI045210, UM1AI069481, N01AI045208] Funding Source: NIH RePORTER	Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, University of Rochester(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, University of Washington at Seattle(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the following National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) contracts: NO1-AI-45208 (University of Rochester), NO1-AI-45209 (University of Washington at Seattle), and NO1-AI-45210 (Vanderbilt University). Scientists from NIAID, Division of AIDS, participated in the study design of the trial. The EMMES Corporation was the data coordinating and statistical center operating under a Division of AIDS-sponsored contract. John Eldridge now works at Profectus Biosciences, Inc., which did not exist at the time of this study and had no role in the design or funding of this work.	AlexanderMiller MA, 1996, INT IMMUNOL, V8, P641, DOI 10.1093/intimm/8.5.641; AUCOUTURIER J, 2006, VACCINE S2, V24; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Bartlett JA, 1998, AIDS, V12, P1291, DOI 10.1097/00002030-199811000-00010; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Gahery-Segard H, 2000, J VIROL, V74, P1694, DOI 10.1128/JVI.74.4.1694-1703.2000; Gorse GJ, 1996, J INFECT DIS, V173, P330, DOI 10.1093/infdis/173.2.330; HART MK, 1990, J IMMUNOL, V145, P2677; HART MK, 1991, P NATL ACAD SCI USA, V88, P9448, DOI 10.1073/pnas.88.21.9448; HAYNES BF, 1993, T ASSOC AM PHYSICIAN, V106, P33; HAYNES BF, 1993, J IMMUNOL, V151, P1646; Lambert JS, 2001, VACCINE, V19, P3033, DOI 10.1016/S0264-410X(01)00051-2; Lehman HK, 2008, J PEDIATR-US, V152, P133, DOI 10.1016/j.jpeds.2007.08.039; Letvin NL, 2001, J VIROL, V75, P4165, DOI 10.1128/JVI.75.9.4165-4175.2001; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Pinto LA, 1999, AIDS, V13, P2003, DOI 10.1097/00002030-199910220-00002; RERKSNGARM S, 2009, N ENGL J MED; SAFRIT JT, 1994, J IMMUNOL, V153, P3822; TRAUGER RJ, 1994, J INFECT DIS, V169, P1256, DOI 10.1093/infdis/169.6.1256; TRAUGER RJ, 1995, J ACQ IMMUN DEF SYND, V10, pS74; Vu HM, 1996, BIOCHEMISTRY-US, V35, P5158, DOI 10.1021/bi952665x; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; YASUTOMI Y, 1993, J IMMUNOL, V151, P5096	24	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e11995	10.1371/journal.pone.0011995	http://dx.doi.org/10.1371/journal.pone.0011995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706632	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900002
J	Blackburn, DC; Bickford, DP; Diesmos, AC; Iskandar, DT; Brown, RM				Blackburn, David C.; Bickford, David P.; Diesmos, Arvin C.; Iskandar, Djoko T.; Brown, Rafe M.			An Ancient Origin for the Enigmatic Flat-Headed Frogs (Bombinatoridae: Barbourula) from the Islands of Southeast Asia	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PALAWAN ISLAND; DISCOGLOSSID FROGS; LARVAL CHARACTERS; GLOBAL PATTERNS; SE ASIA; DIVERSIFICATION; ANURA; MITOCHONDRIAL; PHILIPPINE	Background: The complex history of Southeast Asian islands has long been of interest to biogeographers. Dispersal and vicariance events in the Pleistocene have received the most attention, though recent studies suggest a potentially more ancient history to components of the terrestrial fauna. Among this fauna is the enigmatic archaeobatrachian frog genus Barbourula, which only occurs on the islands of Borneo and Palawan. We utilize this lineage to gain unique insight into the temporal history of lineage diversification in Southeast Asian islands. Methodology/Principal Findings: Using mitochondrial and nuclear genetic data, multiple fossil calibration points, and likelihood and Bayesian methods, we estimate phylogenetic relationships and divergence times for Barbourula. We determine the sensitivity of focal divergence times to specific calibration points by jackknife approach in which each calibration point is excluded from analysis. We find that relevant divergence time estimates are robust to the exclusion of specific calibration points. Barbourula is recovered as a monophyletic lineage nested within a monophyletic Costata. Barbourula diverged from its sister taxon Bombina in the Paleogene and the two species of Barbourula diverged in the Late Miocene. Conclusions/Significance: The divergences within Barbourula and between it and Bombina are surprisingly old and represent the oldest estimates for a cladogenetic event resulting in living taxa endemic to Southeast Asian islands. Moreover, these divergence time estimates are consistent with a new biogeographic scenario: the Palawan Ark Hypothesis. We suggest that components of Palawan's terrestrial fauna might have "rafted'' on emergent portions of the North Palawan Block during its migration from the Asian mainland to its present-day position near Borneo. Further, dispersal from Palawan to Borneo (rather than Borneo to Palawan) may explain the current day disjunct distribution of this ancient lineage.	[Blackburn, David C.; Brown, Rafe M.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Blackburn, David C.; Brown, Rafe M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bickford, David P.] Natl Univ Singapore, Singapore 117548, Singapore; [Diesmos, Arvin C.] Natl Museum Philippines, Manila, Philippines; [Iskandar, Djoko T.] Inst Teknol Bandung, Bandung, Java, Indonesia	University of Kansas; University of Kansas; National University of Singapore; National Museum of the Philippines; Institute Technology of Bandung	Blackburn, DC (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	david.c.blackburn@gmail.com	Blackburn, David/L-3812-2019; Iskasndar, Djoko/AAD-2204-2021; Diesmos, Arvin C./AGG-8542-2022; Bickford, David P/A-5306-2011	Blackburn, David/0000-0002-1810-9886; Iskasndar, Djoko/0000-0002-8923-6081; Bickford, David P/0000-0003-1478-3387	United States National Science Foundation [DEB-0640737, 0743491]; National University of Singapore [154-000-383-133]; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); National University of Singapore(National University of Singapore); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the United States National Science Foundation (http://www.nsf.gov; DEB-0640737 and 0743491 to RMB) and the National University of Singapore (http://www.nus.edu.sg; R-154-000-383-133) to DPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2009, ENCY ISLANDS; ANTUNES MT, 1981, CR ACAD SCI II, V293, P1099; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Bickford D, 2008, CURR BIOL, V18, pR374, DOI 10.1016/j.cub.2008.03.010; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bird P.R., 1993, J SE ASIAN EARTH SCI, V8, P449, DOI DOI 10.1016/0743-9547(93)90045-Q; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Brown RM, 2010, J HERPETOL, V44, P37, DOI 10.1670/08-316.1; Brown RN, 2009, HERPETOL MONOGR, V23, P1; Brown RM, 2002, BIOL J LINN SOC, V76, P393, DOI 10.1111/j.1095-8312.2002.tb01704.x; BROWN RM, 2009, ENCY ISLANDS, P723; Brown W.C., 1982, ADV HERPETOLOGY EVOL, P416; Cannatella D.C., 1985, THESIS U KANSAS LAWR, P404; CLARKE BT, 1987, J NAT HIST, V21, P879, DOI 10.1080/00222938700770531; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; deJong R, 1996, CLADISTICS, V12, P323, DOI 10.1111/j.1096-0031.1996.tb00018.x; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; DICKERSON RE, 1928, MONOGRAPHS BUREAU SC, V2, P1; Drewes, 2004, P CALIFORNIA ACAD SC, V55, P395; DRUMMOND AJ, 2009, BEAST V1 4 2 BAYESIA; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1975, U KANS OCCAS PAP MUS, V42, P1; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; DURKEE EF, 1993, B GEOLOGICAL SOC MAL, V33, P242; Encarnacion J, 1997, LITHOS, V42, P1, DOI 10.1016/S0024-4937(97)00026-1; ERSPAMER V, 1972, BRIT J PHARMACOL, V45, P333, DOI 10.1111/j.1476-5381.1972.tb08087.x; Esselstyn JA, 2004, P BIOL SOC WASH, V117, P271; ESSELSTYN JA, 2010, J BIOGEOGR IN PRESS; Esselstyn JA, 2008, J MAMMAL, V89, P815, DOI 10.1644/07-MAMM-A-285.1; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; ESTES R, 1982, Journal of Vertebrate Paleontology, V2, P9; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; EVANS SE, 1990, PALAEONTOLOGY, V33, P299; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gao KQ, 2001, J VERTEBR PALEONTOL, V21, P460, DOI 10.1671/0272-4634(2001)021[0460:MAFLPC]2.0.CO;2; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1111/j.1096-0031.2003.tb00405.x; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hamilton W., 1979, US GEOLOGICAL SURVEY, V1078, P345; Heaney L.R., 1985, Modern Quaternary Research in Southeast Asia, V9, P127; HEANEY LR, 1986, BIOL J LINN SOC, V28, P127, DOI 10.1111/j.1095-8312.1986.tb01752.x; HEANEY LR, 1991, B AM MUS NAT HIST, P145; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Henrici AC, 1998, J VERTEBR PALEONTOL, V18, P321, DOI 10.1080/02724634.1998.10011060; Henrici AC, 2006, ANN CARNEGIE MUS, V75, P11, DOI 10.2992/0097-4463(2006)75[11:EBANPA]2.0.CO;2; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; HOLLOWAY NH, 1982, AAPG BULL, V66, P1355; Inger R.F, 1954, FIELDIANA, V33, P1; Inger RF, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P445; ISKANDAR DT, 1995, RAFFLES B ZOOL, V43, P309; ISKANDAR DT, 1978, COPEIA, P564; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Jones AW, 2008, BIOL J LINN SOC, V95, P620, DOI 10.1111/j.1095-8312.2008.01073.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LANZA B, 1975, Monitore Zoologico Italiano, V9, P153; LANZA B, 1976, Monitore Zoologico Italiano, V10, P311; Linkem CW, 2010, HERPETOLOGICA, V66, P67, DOI 10.1655/08-074.1; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; Maglia AM, 1998, HERPETOLOGICA, V54, P344; Marivaux L, 2006, ZOOL SCR, V35, P395, DOI 10.1111/j.1463-6409.2006.00235.x; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Milsom J, 2009, J GEOL SOC LONDON, V166, P985, DOI 10.1144/0016-76492009-067; Mitchell AHG., 1986, J SE ASIAN EARTH SCI, V1, P3, DOI DOI 10.1016/0743-9547(86)90003-6; MYERS GS, 1943, COPEIA, P148; Nunome M, 2007, ZOOL SCR, V36, P537, DOI 10.1111/j.1463-6409.2007.00296.x; NYLANDER JAA, 2004, MRMODELTEST V2 3 EVO; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliveros CH, 2010, MOL PHYLOGENET EVOL, V54, P822, DOI 10.1016/j.ympev.2009.12.001; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; PALUMBI SR, 1991, SIMPLE FOOLS G UNPUB; PARK RK, 1979, SEDIMENTARY HIST BAS; Pugener LA, 2003, ZOOL J LINN SOC-LOND, V139, P129, DOI 10.1046/j.1096-3642.2003.00075.x; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Rage J.-C., 2003, CIENCIAS TERRA UNL, V15, P103; RAGE JC, 1989, Z PALAEONTOGRAPHIC A, V206, P1; Rambaut A, 2009, TREEANNOTATOR V1 5 3; Richards CM, 1998, HERPETOL J, V8, P41; Rocek Zbynek, 2000, Amphibian Biology, V4, P1332; Roelants K, 2005, SYST BIOL, V54, P111, DOI 10.1080/10635150590905894; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Saldivar-Sali A., 1981, 2 ASCOPE C EXH MAN P, P99; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; San Mauro D, 2004, GENE, V343, P357, DOI 10.1016/j.gene.2004.10.001; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Savage J.M., 1973, EVOLUTIONARY BIOL AN, P351; Siler CD, 2010, MOL PHYLOGENET EVOL, V55, P699, DOI 10.1016/j.ympev.2010.01.027; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J., 2008, SUMTREES SUMMARIZATI; Taylor B., 1980, Tectonic and geologic evolution of southeast asian seas and islands, P89, DOI 10.1029/GM023p0089; Taylor E. H., 1924, American Museum Novitates, Vno. 121, P1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Uyeda Josef C., 2007, Proceedings of the California Academy of Sciences, V58, P367; Van Bocxlaer I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-131; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Welton LJ, 2009, HERPETOLOGICA, V65, P328, DOI 10.1655/08-057R1.1; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Yuan W, 2000, NATURWISSENSCHAFTEN, V87, P417, DOI 10.1007/s001140050753; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	109	68	73	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12090	10.1371/journal.pone.0012090	http://dx.doi.org/10.1371/journal.pone.0012090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711504	gold, Green Published			2022-12-27	WOS:000280776800022
J	Gkirtzou, K; Tsamardinos, I; Tsakalides, P; Poirazi, P				Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis; Poirazi, Panayiota			MatureBayes: A Probabilistic Algorithm for Identifying the Mature miRNA within Novel Precursors	PLOS ONE			English	Article							MICRORNA PRECURSORS; DIVISION; GENES	Background: MicroRNAs (miRNAs) are small, single stranded RNAs with a key role in post-transcriptional regulation of thousands of genes across numerous species. While several computational methods are currently available for identifying miRNA genes, accurate prediction of the mature miRNA remains a challenge. Existing approaches fall short in predicting the location of mature miRNAs but also in finding the functional strand(s) of miRNA precursors. Methodology/Principal Findings: Here, we present a computational tool that incorporates a Naive Bayes classifier to identify mature miRNA candidates based on sequence and secondary structure information of their miRNA precursors. We take into account both positive (true mature miRNAs) and negative (same-size non-mature miRNA sequences) examples to optimize sensitivity as well as specificity. Our method can accurately predict the start position of experimentally verified mature miRNAs for both human and mouse, achieving a significantly larger (often double) performance accuracy compared with two existing methods. Moreover, the method exhibits a very high generalization performance on miRNAs from two other organisms. More importantly, our method provides direct evidence about the features of miRNA precursors which may determine the location of the mature miRNA. We find that the triplet of positions 7, 8 and 9 from the mature miRNA end towards the closest hairpin have the largest discriminatory power, are relatively conserved in terms of sequence composition (mostly contain a Uracil) and are located within or in very close proximity to the hairpin loop, suggesting the existence of a possible recognition site for Dicer and associated proteins. Conclusions: This work describes a novel algorithm for identifying the start position of mature miRNA(s) produced by miRNA precursors. Our tool has significantly better (often double) performance than two existing approaches and provides new insights about the potential use of specific sequence/structural information as recognition signals for Dicer processing. Web Tool available at: http://mirna.imbb.forth.gr/MatureBayes.html	[Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis] Univ Crete, Dept Comp Sci, Iraklion, Greece; [Gkirtzou, Katerina; Tsamardinos, Ioannis; Tsakalides, Panagiotis] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece; [Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH); Foundation for Research & Technology - Hellas (FORTH)	Gkirtzou, K (corresponding author), Univ Crete, Dept Comp Sci, Iraklion, Greece.	poirazi@imbb.forth.gr	Tsakalides, Panagiotis/O-2063-2015	Tsakalides, Panagiotis/0000-0003-4918-603X; Poirazi, Panayiota/0000-0001-6152-595X	European Community [MTKD-CT-2005-029791]; European Commission [PIOF-GA-2008-219622]	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Marie Curie TOK-DEV ASPIRE grant [MTKD-CT-2005-029791] within the 6th European Community Framework Program (K.G., P.T.) and the Marie Curie Outgoing Fellowship [PIOF-GA-2008-219622] of the European Commission (P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEREZIKOV E, 2006, NAT GENET S1, V38; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gkirtzou K, 2008, IEEE INT C BIOINF BI, P291; HARRY Z, 2004, LECT NOTES COMPUTER, P501; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Kong Yong, 2005, GeoActa, V3, P62; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Mitchell T.M, 2003, MACH LEARN; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Oulas A, 2009, IEEE T INF TECHNOL B, V13, P67, DOI 10.1109/TITB.2008.2007086; PBARTEL D, 2004, CELL, V116, P281; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; TAO M, 2007, THERMODYNAMIC STRUCT; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x	37	89	92	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e11843	10.1371/journal.pone.0011843	http://dx.doi.org/10.1371/journal.pone.0011843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700506	Green Published, Green Submitted, gold			2022-12-27	WOS:000280687900001
J	Neumann-Staubitz, P; Hall, SL; Kuo, J; Jackson, AP				Neumann-Staubitz, Petra; Hall, Stephanie L.; Kuo, Joseph; Jackson, Antony P.			Characterization of a Temperature-Sensitive Vertebrate Clathrin Heavy Chain Mutant as a Tool to Study Clathrin-Dependent Events In Vivo	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; TRANS-GOLGI NETWORK; PROTEIN-TRANSPORT; SACCHAROMYCES-CEREVISIAE; BETA-GLUCURONIDASE; ACTIN; EXPRESSION; MEMBRANE; INTERNALIZATION; TRIMERIZATION	Clathrin and clathrin-dependent events are evolutionary conserved although it is believed that there are differences in the requirement for clathrin in yeast and higher vertebrates. Clathrin is a long-lived protein and thus, with clathrin knockdowns only long-term consequences of clathrin depletion can be studied. Here, we characterize the first vertebrate temperature-sensitive clathrin heavy chain mutant as a tool to investigate responses to rapid clathrin inactivation in higher eukaryotes. Although we created this mutant using a clathrin cryo-electron microscopy model and a yeast temperature-sensitive mutant as a guide, the resulting temperature-sensitive clathrin showed an altered phenotype compared to the corresponding yeast temperature-sensitive clathrin. First, it seemed to form stable triskelions at the non-permissive temperature although endocytosis was impaired under these conditions. Secondly, as a likely consequence of the stable triskelions at the non-permissive temperature, clathrin also localized correctly to its target membranes. Thirdly, we did not observe missorting of the lysosomal enzyme beta-glucuronidase which could indicate that the temperature-sensitive clathrin is still operating at the non-permissive temperature at the Golgi or, that, like in yeast, more than one TGN trafficking pathway exists. Fourthly, in contrast to yeast, actin does not appear to actively compensate in general endocytosis. Thus, there seem to be differences between vertebrates and yeast which can be studied in further detail with this newly created tool.	[Neumann-Staubitz, Petra; Hall, Stephanie L.; Kuo, Joseph; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Neumann-Staubitz, Petra] Georg August Univ Goettingen, Dept Gen Microbiol, Inst Microbiol & Genet, Gottingen, Germany	University of Cambridge; University of Gottingen	Neumann-Staubitz, P (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	pneuman3@gwdg.de		Kuo, Joe/0000-0003-0140-5088; Jackson, Antony Philip/0000-0002-2895-7387	Deutsche Forschungsgemeinschaft DFG (German Research Foundation); Biotechnology and Biological Sciences Research Council [BB/D001242/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft DFG (German Research Foundation)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Deutsche Forschungsgemeinschaft DFG (German Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Baggett JJ, 2001, TRAFFIC, V2, P297, DOI 10.1034/j.1600-0854.2001.002005297.x; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; BROWN WJ, 1984, J CELL BIOL, V99, P320, DOI 10.1083/jcb.99.1.320; BURSTEDDE T, 2006, REV PROTOCOLS DT40 R; Chen CY, 1998, GENETICS, V150, P577; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Duncan MC, 2005, NATURE, V438, P571, DOI 10.1038/438571a; ENNS CA, 1983, J CELL BIOL, V97, P579, DOI 10.1083/jcb.97.2.579; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1994, J BIOL CHEM, V269, P30745; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; GABEL CA, 1984, J CELL BIOL, V99, P296, DOI 10.1083/jcb.99.1.296; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; LEMMON SK, 1991, J CELL BIOL, V112, P65, DOI 10.1083/jcb.112.1.65; LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Medina FA, 2006, CELL CYCLE, V5, P1865, DOI 10.4161/cc.5.16.3132; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MUNN AL, 1991, MOL CELL BIOL, V11, P3868, DOI 10.1128/MCB.11.8.3868; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; PAYNE GS, 1987, MOL CELL BIOL, V7, P3888, DOI 10.1128/MCB.7.11.3888; PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Pishvaee B, 1997, EMBO J, V16, P2227, DOI 10.1093/emboj/16.9.2227; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; RANDALL WC, 1939, PANTING TEMPERATURE, P761; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Royle SJ, 2006, J CELL SCI, V119, P4071, DOI 10.1242/jcs.03192; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Vallejo J, 2005, FASEB J, V19, P586, DOI 10.1096/fj.04-2380fje; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wu XJ, 1998, J CHROMATOGR B, V708, P61, DOI 10.1016/S0378-4347(97)00673-7; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Ybe JA, 2003, TRAFFIC, V4, P850, DOI 10.1046/j.1600-0854.2003.0139.x	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12017	10.1371/journal.pone.0012017	http://dx.doi.org/10.1371/journal.pone.0012017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700507	Green Published, gold, Green Submitted			2022-12-27	WOS:000280687900014
J	Clark, TD; Njama-Meya, D; Nzarubara, B; Maiteki-Sebuguzi, C; Greenhouse, B; Staedke, SG; Kamya, MR; Dorsey, G; Rosenthal, PJ				Clark, Tamara D.; Njama-Meya, Denise; Nzarubara, Bridget; Maiteki-Sebuguzi, Catherine; Greenhouse, Bryan; Staedke, Sarah G.; Kamya, Moses R.; Dorsey, Grant; Rosenthal, Philip J.			Incidence of Malaria and Efficacy of Combination Antimalarial Therapies over 4 Years in an Urban Cohort of Ugandan Children	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; AMODIAQUINE; ARTESUNATE; MORBIDITY; MORTALITY; KAMPALA; AFRICA; BURDEN	Background: Combination therapies are now recommended to treat uncomplicated malaria. We used a longitudinal design to assess the incidence of malaria and compare the efficacies of 3 combination regimens in Kampala, Uganda. Methodology/Principal Findings: Children aged 1-10 years were enrolled from randomly selected households in 2004-05 and 2007, and were followed at least monthly through 2008. Insecticide-treated bednets (ITNs) were provided in 2006. Children were randomized upon their first episode, and then treated for all episodes of uncomplicated malaria with amodiaquine/sulfadoxine-pyrimethamine (AQ/SP), artesunate/amodiaquine (AS/AQ), or artemether/lumefantrine (AL). Risks of parasitological failure were determined for each episode of uncomplicated malaria and clinical parameters were followed. A total of 690 children experienced 1464 episodes of malaria. 96% of these episodes were uncomplicated malaria and treated with study drugs; 94% were due to Plasmodium falciparum. The rank order of treatment efficacy was AL. AS/AQ. AQ/SP. Failure rates increased over time for AQ/SP, but not the artemisinin-based regimens. Over the 4-year course of the study the prevalence of asymptomatic parasitemia decreased from 11.8% to 1.4%, the incidence of malaria decreased from 1.55 to 0.32 per person year, and the prevalence of anemia (hemoglobin <10 gm/dL) decreased from 5.9% to 1.0%. No episodes of severe malaria (based on WHO criteria) and no deaths were seen. Conclusions/Significance: With ready access to combination therapies and distribution of ITNs, responses were excellent for artemisinin-containing regimens, severe malaria was not seen, and the incidence of malaria and prevalence of parasitemia and anemia decreased steadily over time.	[Clark, Tamara D.; Greenhouse, Bryan; Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Njama-Meya, Denise; Nzarubara, Bridget; Maiteki-Sebuguzi, Catherine; Kamya, Moses R.] Makerere Univ, Sch Med, Kampala, Uganda; [Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England	University of California System; University of California San Francisco; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Clark, TD (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	prosenthal@medsfgh.ucsf.edu		Greenhouse, Bryan/0000-0003-0287-9111	National Institutes of Health [AI52142]; Doris Duke Charitable Foundation [2004047]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was received from the National Institutes of Health (AI52142) and the Doris Duke Charitable Foundation (2004047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; Djimde AA, 2003, AM J TROP MED HYG, V69, P558, DOI 10.4269/ajtmh.2003.69.558; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Greenhouse B, 2009, J INFECT DIS, V199, P758, DOI 10.1086/596741; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Nsobya SL, 2004, J INFECT DIS, V189, P2220, DOI 10.1086/421281; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; van den Broek I, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-113; WHO, 2003, ASS MON ANT DRUG EFF; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0; Zwang J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-203	26	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11759	10.1371/journal.pone.0011759	http://dx.doi.org/10.1371/journal.pone.0011759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689585	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000280520300004
J	Tiwary, R; Yu, WP; Li, J; Park, SK; Sanders, BG; Kline, K				Tiwary, Richa; Yu, Weiping; Li, Jing; Park, Sook-Kyung; Sanders, Bob G.; Kline, Kimberly			Role of Endoplasmic Reticulum Stress in alpha-TEA Mediated TRAIL/DR5 Death Receptor Dependent Apoptosis	PLOS ONE			English	Article							MAMMARY-TUMOR BURDEN; VITAMIN-E; CANCER-CELLS; C-JUN; UP-REGULATION; ACTIVATION; PROTEIN; EXPRESSION; JNK; INDUCTION	Background: alpha-TEA (RRR-alpha-tocopherol ether-linked acetic acid analog), a derivative of RRR-alpha-tocopherol (vitamin E) exhibits anticancer actions in vitro and in vivo in variety of cancer types. The objective of this study was to obtain additional insights into the mechanisms involved in alpha-TEA induced apoptosis in human breast cancer cells. Methodology/Principal Findings: alpha-TEA induces endoplasmic reticulum (ER) stress as indicated by increased expression of CCAAT/enhancer binding protein homologous protein (CHOP) as well as by enhanced expression or activation of specific markers of ER stress such as glucose regulated protein (GRP78), phosphorylated alpha subunit of eukaryotic initiation factor 2 (peIF-2 alpha), and spliced XBP-1 mRNA. Knockdown studies using siRNAs to TRAIL, DR5, JNK and CHOP as well as chemical inhibitors of ER stress and caspase-8 showed that: i) alpha-TEA activation of DR5/caspase-8 induces an ER stress mediated JNK/CHOP/DR5 positive amplification loop; ii) alpha-TEA downregulation of c-FLIP (L) protein levels is mediated by JNK/CHOP/DR5 loop via a JNK dependent Itch E3 ligase ubiquitination that further serves to enhance the JNK/CHOP/DR5 amplification loop by preventing c-FLIP's inhibition of caspase-8; and (iii) alpha-TEA downregulation of Bcl-2 is mediated by the ER stress dependent JNK/CHOP/DR5 signaling. Conclusion: Taken together, ER stress plays an important role in alpha-TEA induced apoptosis by enhancing DR5/caspase-8 proapoptotic signaling and suppressing anti-apoptotic factors c-FLIP and Bcl-2 via ER stress mediated JNK/CHOP/DR5/caspase-8 signaling.	[Tiwary, Richa; Yu, Weiping; Li, Jing; Park, Sook-Kyung; Sanders, Bob G.] Univ Texas Austin, Sch Biol Sci C0900, Austin, TX 78712 USA; [Kline, Kimberly] Univ Texas Austin, Dept Nutr Sci A2703, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tiwary, R (corresponding author), Univ Texas Austin, Sch Biol Sci C0900, Austin, TX 78712 USA.	k.kline@mail.utexas.edu			Clayton Foundation for Research; National Institute of Environmental Health Sciences Center [ES007784]; Center for Molecular and Cellular Toxicology at the University of Texas at Austin; NIEHS/NIH [T32 ES07247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247, P30ES007784] Funding Source: NIH RePORTER	Clayton Foundation for Research; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Molecular and Cellular Toxicology at the University of Texas at Austin; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Clayton Foundation for Research, the National Institute of Environmental Health Sciences Center Grant ES007784, the Center for Molecular and Cellular Toxicology at the University of Texas at Austin and a NIEHS/NIH Toxicology Training Grant T32 ES07247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2006, CARCINOGENESIS, V27, P717, DOI 10.1093/carcin/bgi270; Anderson K, 2004, EXP BIOL MED, V229, P1169, DOI 10.1177/153537020422901112; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; HABENER, 1996, MOL CELL BIOL, V16, P1479; Hahn T, 2006, CANCER RES, V66, P9374, DOI 10.1158/0008-5472.CAN-06-2403; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Gutierrez S, 2006, APOPTOSIS, V11, P1101, DOI 10.1007/s10495-006-6984-z; Jia L, 2008, PROSTATE, V68, P427, DOI 10.1002/pros.20716; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kline K, 2007, VITAM HORM, V76, P435, DOI 10.1016/S0083-6729(07)76017-X; Kruyt FAE, 2008, CANCER LETT, V263, P14, DOI 10.1016/j.canlet.2008.02.003; Lawson KA, 2004, EXP BIOL MED, V229, P954, DOI 10.1177/153537020422900913; Lawson KA, 2003, MOL CANCER THER, V2, P437; Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008; Li J, 2008, PROSTATE, V68, P849, DOI 10.1002/pros.20750; Lizaka T, 2007, TOXICOLOGY, V241, P146, DOI 10.1016/j.tox.2007.08.095; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; SEOKHYUN KM, 2008, CANCER RES, V68, P2062; Shetty S, 2002, APOPTOSIS, V7, P413, DOI 10.1023/A:1020031023947; Shun MC, 2004, NUTR CANCER, V48, P95, DOI 10.1207/s15327914nc4801_13; Shun MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/824571; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; THAHN K, 2009, MOL CANCER THER, V8, P1570; Tuma RS, 2009, J NATL CANCER I, V101, P138, DOI 10.1093/jnci/djn507; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Wang J, 2008, HEPATOB PANCREAT DIS, V7, P45; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu WP, 2006, APOPTOSIS, V11, P1813, DOI 10.1007/s10495-006-9234-5; Yu WP, 2009, MOL NUTR FOOD RES, V53, P1573, DOI 10.1002/mnfr.200900011; Yu WP, 2003, CANCER RES, V63, P2483; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	45	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11865	10.1371/journal.pone.0011865	http://dx.doi.org/10.1371/journal.pone.0011865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686688	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200029
J	Marri, PR; Paniscus, M; Weyand, NJ; Rendon, MA; Calton, CM; Hernandez, DR; Higashi, DL; Sodergren, E; Weinstock, GM; Rounsley, SD; So, M				Marri, Pradeep Reddy; Paniscus, Mary; Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; Sodergren, Erica; Weinstock, George M.; Rounsley, Steven D.; So, Magdalene			Genome Sequencing Reveals Widespread Virulence Gene Exchange among Human Neisseria Species	PLOS ONE			English	Article							REPEAT-ENCLOSED ELEMENTS; DNA-SEQUENCE; GONORRHOEAE; MENINGITIDIS; COMMENSAL; STRAIN; TRANSFORMATION; EXPRESSION; IDENTIFICATION; RECOMBINATION	Commensal bacteria comprise a large part of the microbial world, playing important roles in human development, health and disease. However, little is known about the genomic content of commensals or how related they are to their pathogenic counterparts. The genus Neisseria, containing both commensal and pathogenic species, provides an excellent opportunity to study these issues. We undertook a comprehensive sequencing and analysis of human commensal and pathogenic Neisseria genomes. Commensals have an extensive repertoire of virulence alleles, a large fraction of which has been exchanged among Neisseria species. Commensals also have the genetic capacity to donate DNA to, and take up DNA from, other Neisseria. Our findings strongly suggest that commensal Neisseria serve as reservoirs of virulence alleles, and that they engage extensively in genetic exchange.	[Marri, Pradeep Reddy; Paniscus, Mary; Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; Rounsley, Steven D.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA; [Paniscus, Mary] Univ Arizona, Grad Interdisciplinary Program Genet, Tucson, AZ USA; [Weyand, Nathan J.; Rendon, Maria A.; Calton, Christine M.; Hernandez, Diana R.; Higashi, Dustin L.; So, Magdalene] Univ Arizona, Dept Immunol, Tucson, AZ USA; [Rounsley, Steven D.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Calton, Christine M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; Oregon Health & Science University; Washington University (WUSTL)	Marri, PR (corresponding author), Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA.	pradeepm@email.arizona.edu	So, Magdalene/ABB-8918-2020; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Calton, Christine/0000-0002-5189-5006; Rendon, Maria/0000-0001-8971-0567; So, Magdalene/0000-0001-8301-0674	National Institutes of Health (NIH) [R01 AI068033-01, U54HG004968]; BIO5 Institute and College of Medicine, University of Arizona; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068033] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIO5 Institute and College of Medicine, University of Arizona; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH) grant R01 AI068033-01 and by funds from the BIO5 Institute and College of Medicine, University of Arizona, awarded to MS. Additional support was provided by NIH grant U54HG004968 to GMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho EL, 2000, MICROB PATHOGENESIS, V28, P81, DOI 10.1006/mpat.1999.0325; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bauer FJ, 1999, MOL MICROBIOL, V31, P903, DOI 10.1046/j.1365-2958.1999.01230.x; Bennett JS, 2009, INT J MED MICROBIOL, V299, P133, DOI 10.1016/j.ijmm.2008.06.010; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; BERGER U, 1972, MED MICROBIOL IMMUN, V158, P121, DOI 10.1007/BF02120477; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; BOWLER LD, 1994, J BACTERIOL, V176, P333, DOI 10.1128/JB.176.2.333-337.1994; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CATLIN BW, 1960, SCIENCE, V131, P608, DOI 10.1126/science.131.3400.608-a; Cornelissen CN, 2004, IRON TRANSPORT IN BACTERIA, P256; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Glitza IC, 2008, INT J HYG ENVIR HEAL, V211, P263, DOI 10.1016/j.ijheh.2007.05.006; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagen TA, 2006, MOL MICROBIOL, V62, P1144, DOI 10.1111/j.1365-2958.2006.05429.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hill SA, 2009, FEMS MICROBIOL REV, V33, P521, DOI 10.1111/j.1574-6976.2009.00171.x; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Janda WM, 2003, MANUAL CLIN MICROBIO, P585; Jordan PW, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-21; Kaplan JB, 2002, APPL ENVIRON MICROB, V68, P4943, DOI 10.1128/AEM.68.10.4943-4950.2002; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; KNAPP J S, 1988, Clinical Microbiology Reviews, V1, P415; Lee SW, 2005, CELL MICROBIOL, V7, P1271, DOI 10.1111/j.1462-5822.2005.00551.x; Linz B, 2000, MOL MICROBIOL, V36, P1049, DOI 10.1046/j.1365-2958.2000.01932.x; Liu SV, 2002, J BACTERIOL, V184, P6163, DOI 10.1128/JB.184.22.6163-6173.2002; MAIDEN MC, 1998, CLIN INFECT DIS   S1, V27, P1; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; MURALIDHARAN K, 1987, A VAN LEEUW J MICROB, V53, P435, DOI 10.1007/BF00415499; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Qvarnstrom Y, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-11; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saez Nieto J A, 1998, Int Microbiol, V1, P59; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; SEIFERT HS, 1990, J BACTERIOL, V172, P40, DOI 10.1128/JB.172.1.40-46.1990; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Snyder LAS, 2001, J BACTERIOL, V183, P1233, DOI 10.1128/JB.183.4.1233-1241.2001; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tonjum T, 2005, BERGEYS MANUAL SYSTE, P777; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	59	140	144	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11835	10.1371/journal.pone.0011835	http://dx.doi.org/10.1371/journal.pone.0011835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676376	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100013
J	Nalam, RL; Andreu-Vieyra, C; Matzuk, MM				Nalam, Roopa L.; Andreu-Vieyra, Claudia; Matzuk, Martin M.			Absence of Inhibin Alpha and Retinoblastoma Protein Leads to Early Sertoli Cell Dysfunction	PLOS ONE			English	Article							CACHEXIA-LIKE SYNDROME; TUMOR-SUPPRESSOR GENE; HORMONE; SMAD3; MICE; RB; TUMORIGENESIS; INACTIVATION; PROGRESSION	Sertoli cells, the support cells of mammalian spermatogenesis, are regulated by a number of nuclear factors and express retinoblastoma (RB) tumor suppressor protein. We hypothesized that RB is an important mediator of Sertoli cell tumorigenesis in inhibin alpha knockout (Inha KO) mice. In our previous mouse studies, we found that conditional knockout (cKO) of Rb in Sertoli cells caused progressive Sertoli cell dysfunction. Initially, loss of RB had no gross effect on Sertoli cell function as the mice were fertile with normal testis weights at 6 weeks of age, but by 10-14 weeks of age, mutant mice demonstrated severe Sertoli cell dysfunction and infertility. Although double knockout (dKO) of Rb and Inha did not result in exacerbation of the tumorigenic phenotype of Inha-null mice, we found that the dKO mice demonstrate an acceleration of Sertoli cell dysfunction compared to Rb cKO mice. Specifically, in contrast to Rb cKO mice, Inha/Rb dKO mice showed signs of Sertoli cell dysfunction as early as 4 weeks of age. These results demonstrate that RB is not essential for Sertoli cell tumorigenesis in Inha KO mice but that loss of Inha accelerates the infertility phenotype of Rb cKO mice.	[Nalam, Roopa L.; Andreu-Vieyra, Claudia; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Nalam, Roopa L.; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Nalam, RL (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu			National Institutes of Health [CA60651]; Edward J. and Josephine G. Hudson Scholar Fund; NATIONAL CANCER INSTITUTE [R01CA060651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward J. and Josephine G. Hudson Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported by National Institutes of Health grant CA60651 (to M. M. M.) and the Edward J. and Josephine G. Hudson Scholar Fund (to R.L.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra C, 2007, ENDOCRINOLOGY, V148, P3837, DOI 10.1210/en.2006-1590; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Burns KH, 2003, MOL ENDOCRINOL, V17, P2053, DOI 10.1210/me.2003-0038; Burns KH, 2003, MOL ENDOCRINOL, V17, P2039, DOI 10.1210/me.2003-0039; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kumar TR, 1999, MOL ENDOCRINOL, V13, P851, DOI 10.1210/me.13.6.851; Kumar TR, 1996, ENDOCRINOLOGY, V137, P4210, DOI 10.1210/en.137.10.4210; Li QL, 2007, MOL HUM REPROD, V13, P675, DOI 10.1093/molehr/gam055; Li QL, 2007, MOL ENDOCRINOL, V21, P2472, DOI 10.1210/me.2007-0147; Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402; Marino S, 2000, GENE DEV, V14, P994; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Nagaraja AK, 2008, MOL CELL ENDOCRINOL, V294, P19, DOI 10.1016/j.mce.2008.06.019; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; SKINNER MK, 2005, SERTOLI CELL BIOL, pR15; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Vooijs M, 1998, ONCOGENE, V17, P1, DOI 10.1038/sj.onc.1202169; Yan W, 2003, APMIS, V111, P174, DOI 10.1034/j.1600-0463.2003.1110121.x	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11797	10.1371/journal.pone.0011797	http://dx.doi.org/10.1371/journal.pone.0011797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676395	Green Published, gold, Green Submitted			2022-12-27	WOS:000280371800006
J	Gupte, S; Labinskyy, N; Gupte, R; Csiszar, A; Ungvari, Z; Edwards, JG				Gupte, Sachin; Labinskyy, Nazar; Gupte, Rakhee; Csiszar, Anna; Ungvari, Zoltan; Edwards, John G.			Role of NAD(P)H Oxidase in Superoxide Generation and Endothelial Dysfunction in Goto-Kakizaki (GK) Rats as a Model of Nonobese NIDDM	PLOS ONE			English	Article							SPONTANEOUSLY DIABETIC RATS; INCREASED OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; DECREASED SUSCEPTIBILITY; PERIPHERAL NEUROPATHY; METABOLIC SYNDROME; BASEMENT-MEMBRANE; GENE-EXPRESSION	Background: Cardiovascular disease is the leading cause of mortality in diabetics, and it has a complex etiology that operates on several levels. Endothelial dysfunction and increased generation of reactive oxygen species are believed to be an underlying cause of vascular dysfunction and coronary artery disease in diabetes. This impairment is likely the result of decreased bioavailability of nitric oxide (NO) within the vasculature. However, it is unclear whether hyperglycemia per se stimulates NADPH oxidase-derived superoxide generation in vascular tissue. Methods and Results: This study focused on whether NADPH oxidase-derived superoxide is elevated in vasculature tissue evoking endothelial/smooth muscle dysfunction in the hyperglycemic (169+/-4 mg%) Goto-Kakizaki (GK) rat. By dihydroethidine fluorescence staining, we determined that aorta superoxide levels were significantly elevated in 9 month-old GK compared with age matched Wistar (GK; 195+/-6%, Wistar; 100+/-3.5%). Consistent with these findings, 10(-6) mol/L acetylcholine-induced relaxation of the carotid artery was significantly reduced in GK rats compared with age matched Wistar (GK; 41+/-7%, Wistar; 100+/-5%) and measurements in the aorta showed a similar trend (p = .08). In contrast, relaxation to the NO donor SNAP was unaltered in GK compared to Wistar. Endothelial dysfunction was reversed by lowering of superoxide with apocynin, a specific Nox inhibitor. Conclusions: The major findings from this study are that chronic hyperglycemia induces significant vascular dysfunction in both the aorta and small arteries. Hyperglycemic induced increases in NAD(P)H oxidase activity that did not come from an increase in the expression of the NAD(P)H oxidase subunits, but more likely as a result of chronic activation via intracellular signaling pathways.	[Gupte, Sachin; Gupte, Rakhee] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Csiszar, Anna; Ungvari, Zoltan] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Labinskyy, Nazar; Csiszar, Anna; Edwards, John G.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of South Alabama; University of Oklahoma System; University of Oklahoma Health Sciences Center; New York Medical College	Gupte, S (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	j_edwards@nymc.edu	Ungvari, Zoltan/ADU-0095-2022; Ungvari, Zoltan/GZK-8127-2022		National Institutes of Health [HL077256, HL43023, HL085352]; American Heart Association [0435070]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077256, R01HL085352, P01HL043023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health under the following grant numbers: HL077256, HL43023, HL085352; as well by the American Heart Association (Grant#0435070). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; BATH PMW, 1991, ARTERIOSCLER THROMB, V11, P254, DOI 10.1161/01.ATV.11.2.254; Bitar MS, 2005, EUR J PHARMACOL, V511, P53, DOI 10.1016/j.ejphar.2005.01.014; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Cheng ZJ, 2001, HYPERTENSION, V37, P433, DOI 10.1161/01.HYP.37.2.433; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008; Csiszar A, 2007, AM J PATHOL, V170, P388, DOI 10.2353/ajpath.2007.060708; Debin R, 2009, FUND CLIN PHARMACOL, V23, P59, DOI 10.1111/j.1472-8206.2008.00659.x; Ding H, 2007, EUR J PHARMACOL, V561, P121, DOI 10.1016/j.ejphar.2006.12.034; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Ferreira FML, 1999, LIFE SCI, V65, P1013, DOI 10.1016/S0024-3205(99)00332-X; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; GRAHAM KA, CANC BIOL THER, V10; Grijalva J, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-34; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Hainsey T, 2002, MED SCI SPORT EXER, V34, P1249, DOI 10.1097/00005768-200208000-00004; Hilenski L, 2004, ARTERIOSCLER THROMB, V24, P1; Janssen U, 2003, KIDNEY INT, V63, P2162, DOI 10.1046/j.1523-1755.2003.00007.x; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; KITAHARA A, 1978, TOHOKU J EXP MED, V126, P7, DOI 10.1620/tjem.126.7; Kobayashi T, 2004, AM J PHYSIOL-HEART C, V287, pH135, DOI 10.1152/ajpheart.01074.2003; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lin JM, 2001, DIABETES, V50, P2737, DOI 10.2337/diabetes.50.12.2737; Liu S, 2007, FREE RADICAL BIO MED, V42, P852, DOI 10.1016/j.freeradbiomed.2006.12.025; Meininger CJ, 2000, BIOCHEM J, V349, P353, DOI 10.1042/0264-6021:3490353; Movassat J, 1997, DIABETOLOGIA, V40, P916, DOI 10.1007/s001250050768; Murakawa Y, 2002, DIABETES-METAB RES, V18, P473, DOI 10.1002/dmrr.326; Oliveira Paulo J, 2002, Rev Port Cardiol, V21, P759; Oliveira PJ, 2001, BIOSCIENCE REP, V21, P45; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Phillips AO, 2001, AM J KIDNEY DIS, V37, P400, DOI 10.1053/ajkd.2001.21322; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P1; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Rafalski K, 2007, MED SCI SPORT EXER, V39, P75, DOI 10.1249/01.mss.0000240324.08406.3d; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Rajesh M, 2009, J CELL MOL MED, V13, P2330, DOI 10.1111/j.1582-4934.2008.00564.x; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, pH153, DOI 10.1152/ajpheart.01142.2008; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; Ungvari Z, 2003, ARTERIOSCL THROM VAS, V23, P418, DOI 10.1161/01.ATV.0000061735.85377.40; Ungvari Z, 1999, CARDIOVASC RES, V43, P1018, DOI 10.1016/S0008-6363(99)00106-6; Vesely DL, 1999, METABOLISM, V48, P771, DOI 10.1016/S0026-0495(99)90178-6; Wallace KJ, 2004, PHYSIOL GENOMICS, V19, P1, DOI 10.1152/physiolgenomics.00114.2004; Wallis RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002962; Witte K, 2002, NITRIC OXIDE-BIOL CH, V6, P85, DOI 10.1006/niox.2001.0363; YAGIHASHI S, 1979, TOHOKU J EXP MED, V127, P359, DOI 10.1620/tjem.127.359; YAGIHASHI S, 1982, TOHOKU J EXP MED, V138, P39, DOI 10.1620/tjem.138.39; YAGIHASHI S, 1978, DIABETOLOGIA, V15, P309, DOI 10.1007/BF02573824; Yasuda K, 2002, CLIN EXP PHARMACOL P, V29, P1001, DOI 10.1046/j.1440-1681.2002.03757.x; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	56	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11800	10.1371/journal.pone.0011800	http://dx.doi.org/10.1371/journal.pone.0011800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668682	gold, Green Published, Green Submitted			2022-12-27	WOS:000280297300026
J	Wang, GH; Wang, YD; Teng, MX; Zhang, DN; Li, L; Liu, YL				Wang, Guohua; Wang, Yadong; Teng, Mingxiang; Zhang, Denan; Li, Lang; Liu, Yunlong			Signal Transducers and Activators of Transcription-1 (STAT1) Regulates microRNA Transcription in Interferon gamma-Stimulated HeLa Cells	PLOS ONE			English	Article							DNA-BINDING-SITES; CHROMATIN-IMMUNOPRECIPITATION; PROFILING REVEALS; NETWORK MOTIFS; BREAST-CANCER; UP-REGULATION; C-FOS; GENOME; GENES; DATABASE	Background: Constructing and modeling the gene regulatory network is one of the central themes of systems biology. With the growing understanding of the mechanism of microRNA biogenesis and its biological function, establishing a microRNA mediated gene regulatory network is not only desirable but also achievable. Methodology: In this study, we propose a bioinformatics strategy to construct the microRNA-mediated regulatory network using genome-wide binding patterns of transcription factor(s) and RNA polymerase II (RPol II), derived using chromatin immunoprecipitation following next generation sequencing (ChIP-seq) technology. Our strategy includes three key steps, identification of transcription start sites and promoter regions of primary microRNA transcripts using RPol II binding patterns, selection of cooperating transcription factors that collaboratively function with the transcription factors targeted by ChIP-seq assay, and construction of the network that contains regulatory cascades of both transcription factors and microRNAs. Principal Findings: Using CAMDA (Critical Assessment of Massive Data Analysis) 2009 data set that includes ChIP-seq data on RPol II and STAT1 (signal transducers and activators of transcription 1) in HeLa S3 cells in control condition and with interferon gamma stimulation, we first identified promoter regions of 83 microRNAs in HeLa cells. We then identified two potential STAT1 collaborating factors, AP-1 and C/EBP (CCAAT enhancer-binding proteins), and further established eight feedback network elements that may regulate cellular response during interferon gamma stimulation. Conclusions: This study offers a bioinformatics strategy to provide testable hypotheses on the mechanisms of microRNA-mediated transcriptional regulation, based upon genome-wide protein-DNA interaction data derived from ChIP-seq experiments.	[Wang, Guohua; Wang, Yadong; Teng, Mingxiang; Zhang, Denan] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Teng, Mingxiang; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Teng, Mingxiang; Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Dept Med, Div Biostat, Indianapolis, IN USA; [Li, Lang; Liu, Yunlong] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Liu, Yunlong] Indiana Univ, Sch Med, Ctr Med Genom, Indianapolis, IN USA	Harbin Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wang, GH (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn; yunliu@iupui.edu	Zhang, Denan/ABE-7528-2021; Wang, Guohua/GLR-7939-2022	Teng, Mingxiang/0000-0002-8536-8941	U.S. National Institutes of Health [AA017941, CA113001]; China 863 High-Tech Program [2007AA02Z302]; China Natural Science Foundation [60901075, 60973078]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017941] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 863 High-Tech Program(National High Technology Research and Development Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by the U.S. National Institutes of Health grants AA017941 (Y.L.), CA113001 (L.L and Y. L.), China 863 High-Tech Program 2007AA02Z302 (Y.L.), and China Natural Science Foundation 60901075 (G.W.), 60973078 (Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; *AFF, 2001, AFF MICR SUIT US GUI; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; DO H, 2009, J NUTR BIOCH; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Liu YL, 2006, GENOMICS, V88, P452, DOI 10.1016/j.ygeno.2006.04.006; Lo RKH, 2006, CELL SIGNAL, V18, P2143, DOI 10.1016/j.cellsig.2006.04.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG G, PLOS ONE UNPUB; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396	49	55	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11794	10.1371/journal.pone.0011794	http://dx.doi.org/10.1371/journal.pone.0011794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668688	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300022
J	Fordyce, JA				Fordyce, James A.			Interpreting the gamma Statistic in Phylogenetic Diversification Rate Studies: A Rate Decrease Does Not Necessarily Indicate an Early Burst	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; MOLECULAR PHYLOGENIES; BIRDS	Background: Phylogenetic hypotheses are increasingly being used to elucidate historical patterns of diversification rate-variation. Hypothesis testing is often conducted by comparing the observed vector of branching times to a null, pure-birth expectation. A popular method for inferring a decrease in speciation rate, which might suggest an early burst of diversification followed by a decrease in diversification rate is the gamma statistic. Methodology: Using simulations under varying conditions, I examine the sensitivity of gamma to the distribution of the most recent branching times. Using an exploratory data analysis tool for lineages through time plots, tree deviation, I identified trees with a significant gamma statistic that do not appear to have the characteristic early accumulation of lineages consistent with an early, rapid rate of cladogenesis. I further investigated the sensitivity of the gamma statistic to recent diversification by examining the consequences of failing to simulate the full time interval following the most recent cladogenic event. The power of gamma to detect rate decrease at varying times was assessed for simulated trees with an initial high rate of diversification followed by a relatively low rate. Conclusions: The gamma statistic is extraordinarily sensitive to recent diversification rates, and does not necessarily detect early bursts of diversification. This was true for trees of various sizes and completeness of taxon sampling. The gamma statistic had greater power to detect recent diversification rate decreases compared to early bursts of diversification. Caution should be exercised when interpreting the gamma statistic as an indication of early, rapid diversification.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37916 USA	University of Tennessee System; University of Tennessee Knoxville	Fordyce, JA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37916 USA.	jfordyce@utk.edu						Barraclough TG, 2002, MOL BIOL EVOL, V19, P1706, DOI 10.1093/oxfordjournals.molbev.a003993; Dornburg A, 2008, SYST BIOL, V57, P905, DOI 10.1080/10635150802562392; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Jiggins CD, 2006, EVOLUTION, V60, P1454, DOI 10.1111/j.0014-3820.2006.tb01224.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2020, R LANG ENV STAT COMP; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; RAMBAUT AP, 2002, PHYLOGEN V1 0; Weir JT, 2006, EVOLUTION, V60, P842; [No title captured]	15	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11781	10.1371/journal.pone.0011781	http://dx.doi.org/10.1371/journal.pone.0011781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668707	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243800036
J	Suchard, MS; Mayne, E; Green, VA; Shalekoff, S; Donninger, SL; Stevens, WS; Gray, CM; Tiemessen, CT				Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Shalekoff, Sharon; Donninger, Samantha L.; Stevens, Wendy S.; Gray, Clive M.; Tiemessen, Caroline T.			FOXP3 Expression Is Upregulated in CD4(+)T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MESSENGER-RNA EXPRESSION; GROWTH-FACTOR-BETA; T-CELLS; DENDRITIC CELLS; TGF-BETA; PERIPHERAL-BLOOD; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; IMMUNE ACTIVATION	Background: Understanding the role of different classes of T cells during HIV infection is critical to determining which responses correlate with protective immunity. To date, it is unclear whether alterations in regulatory T cell (Treg) function are contributory to progression of HIV infection. Methodology: FOXP3 expression was measured by both qRT-PCR and by flow cytometry in HIV-infected individuals and uninfected controls together with expression of CD25, GITR and CTLA-4. Cultured peripheral blood mononuclear cells were stimulated with anti-CD3 and cell proliferation was assessed by CFSE dilution. Principal Findings: HIV infected individuals had significantly higher frequencies of CD4(+) FOXP3(+) T cells (median of 8.11%; range 1.33%-26.27%) than healthy controls (median 3.72%; range 1.3-7.5%; P = 0.002), despite having lower absolute counts of CD4+ FOXP3+ T cells. There was a significant positive correlation between the frequency of CD4+ FOXP3+ T cells and viral load (rho = 0.593 P = 0.003) and a significant negative correlation with CD4 count (rho = -0.423 P = 0.044). 48% of our patients had CD4 counts below 200 cells/mu l and these patients showed a marked elevation of FOXP3 percentage (median 10% range 4.07%-26.27%). Assessing the mechanism of increased FOXP3 frequency, we found that the high FOXP3 levels noted in HIV infected individuals dropped rapidly in unstimulated culture conditions but could be restimulated by T cell receptor stimulation. This suggests that the high FOXP3 expression in HIV infected patients is likely due to FOXP3 upregulation by individual CD4(+) T cells following antigenic or other stimulation. Conclusions/Significance: FOXP3 expression in the CD4(+) T cell population is a marker of severity of HIV infection and a potential prognostic marker of disease progression.	[Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Stevens, Wendy S.] Univ Witwatersrand, Johannesburg, South Africa; [Green, Victoria A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Suchard, Melinda S.; Mayne, Elizabeth; Green, Victoria A.; Shalekoff, Sharon; Donninger, Samantha L.; Gray, Clive M.; Tiemessen, Caroline T.] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Bath; National Institute for Communicable Diseases (NICD)	Suchard, MS (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	thesuchards@telkomsa.net		Suchard, Melinda Shelley/0000-0002-6978-4654; Gray, Clive/0000-0002-9293-901X; Tiemessen, Caroline/0000-0002-0991-1690; Mayne, Elizabeth/0000-0002-6360-3488	Sarum St Michael Educational Charity, England [309456]; University of Bath Alumni Fund, England; Calne Rotary Club; South African AIDS Vaccine Initiative (SAAVI); Wellcome Trust; National Institutes of Health; Elizabeth Glazer Paediatric AIDS Foundation	Sarum St Michael Educational Charity, England; University of Bath Alumni Fund, England; Calne Rotary Club; South African AIDS Vaccine Initiative (SAAVI); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glazer Paediatric AIDS Foundation	Financial assistance was provided by Sarum St Michael Educational Charity, England (registered charity number 309456,, ssmsarum@waitrose.com, no Web site), the University of Bath Alumni Fund, England (www.alumni.bath.ac.uk), Calne Rotary Club (www.calne.org.uk/community/groups/rotaryclub), the South African AIDS Vaccine Initiative (SAAVI), the Wellcome Trust (http://www.wellcome.ac.uk/Funding/index.htm), the National Institutes of Health and the Elizabeth Glazer Paediatric AIDS Foundation International Leadership Award. CTT is a Wellcome Trust International Senior Research Fellow (076352/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Billerbeck E, 2008, HUM IMMUNOL, V69, P771, DOI 10.1016/j.humimm.2008.07.016; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen W, 2007, CURR MED CHEM, V14, P2245, DOI 10.2174/092986707781696591; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chougnet C, 2006, J LEUKOCYTE BIOL, V80, P994, DOI 10.1189/jlb.0306135; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Firan M, 2006, BLOOD, V107, P619, DOI 10.1182/blood-2005-06-2277; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gazzola L, 2006, AM J RESP CRIT CARE, V174, P356, DOI 10.1164/ajrccm.174.3.356; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Goleva E, 2005, J ALLERGY CLIN IMMUN, V116, P1094, DOI 10.1016/j.jaci.2005.08.051; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hoji A, 2008, AIDS RES HUM RETROV, V24, P1087, DOI 10.1089/aid.2008.0041; Hougardy JM, 2007, MICROBES INFECT, V9, P1325, DOI 10.1016/j.micinf.2007.06.004; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Huehn J, 2005, TRENDS IMMUNOL, V26, P632, DOI 10.1016/j.it.2005.10.001; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Koch SD, 2008, HUM IMMUNOL, V69, P737, DOI 10.1016/j.humimm.2008.08.281; Kolte L, 2009, CLIN EXP IMMUNOL, V155, P44, DOI 10.1111/j.1365-2249.2008.03803.x; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Levy Y, 2006, CURR OPIN HIV AIDS, V1, P69, DOI 10.1097/01.COH.0000194101.89944.a5; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Montes M, 2006, AIDS, V20, P1669, DOI 10.1097/01.aids.0000238415.98194.38; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Qin XJ, 2008, CHINESE MED J-PEKING, V121, P581, DOI 10.1097/00029330-200804010-00002; Rallon NI, 2009, CLIN EXP IMMUNOL, V155, P35, DOI 10.1111/j.1365-2249.2008.03797.x; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Savarino A, 2000, AIDS, V14, P1079, DOI 10.1097/00002030-200006160-00004; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki Nabila, 2008, Curr HIV/AIDS Rep, V5, P20, DOI 10.1007/s11904-008-0004-6; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sharabi A, 2008, J IMMUNOL, V181, P3243, DOI 10.4049/jimmunol.181.5.3243; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vogtenhuber C, 2008, J IMMUNOL, V181, P8767, DOI 10.4049/jimmunol.181.12.8767; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731; Zhang ZN, 2008, JPN J INFECT DIS, V61, P391; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	84	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11762	10.1371/journal.pone.0011762	http://dx.doi.org/10.1371/journal.pone.0011762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668701	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800030
J	Sengupta, A; Lichti, UF; Carlson, BA; Ryscavage, AO; Gladyshev, VN; Yuspa, SH; Hatfield, DL				Sengupta, Aniruddha; Lichti, Ulrike F.; Carlson, Bradley A.; Ryscavage, Andrew O.; Gladyshev, Vadim N.; Yuspa, Stuart H.; Hatfield, Dolph L.			Selenoproteins Are Essential for Proper Keratinocyte Function and Skin Development	PLOS ONE			English	Article							VITAMIN-E; IN-VITRO; SELENIUM DEFICIENCY; STRATUM-CORNEUM; TRANSGENIC MICE; HAIR FOLLICLE; BETA-CAROTENE; GENE TRSP; ANTIOXIDANTS; EXPRESSION	Dietary selenium is known to protect skin against UV-induced damage and cancer and its topical application improves skin surface parameters in humans, while selenium deficiency compromises protective antioxidant enzymes in skin. Furthermore, skin and hair abnormalities in humans and rodents may be caused by selenium deficiency, which are overcome by dietary selenium supplementation. Most important biological functions of selenium are attributed to selenoproteins, proteins containing selenium in the form of the amino acid, selenocysteine (Sec). Sec insertion into proteins depends on Sec tRNA; thus, knocking out the Sec tRNA gene (Trsp) ablates selenoprotein expression. We generated mice with targeted removal of selenoproteins in keratin 14 (K14) expressing cells and their differentiated descendents. The knockout progeny had a runt phenotype, developed skin abnormalities and experienced premature death. Lack of selenoproteins in epidermal cells led to the development of hyperplastic epidermis and aberrant hair follicle morphogenesis, accompanied by progressive alopecia after birth. Further analyses revealed that selenoproteins are essential antioxidants in skin and unveiled their role in keratinocyte growth and viability. This study links severe selenoprotein deficiency to abnormalities in skin and hair and provides genetic evidence for the role of these proteins in keratinocyte function and cutaneous development.	[Sengupta, Aniruddha; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Lichti, Ulrike F.; Ryscavage, Andrew O.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sengupta, A (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.	yuspas@dc37a.nci.nih.gov; hatfield@mail.nih.gov	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Sengupta, Aniruddha/0000-0001-5560-0837; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health, National Cancer Institute; Center for Cancer Research; NIH; NATIONAL CANCER INSTITUTE [ZIABC005445, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research, and in addition, NIH grants awarded to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2000, ENDOCRINOLOGY, V141, P2490, DOI 10.1210/en.141.7.2490; Berger MM, 2007, AM J CLIN NUTR, V85, P1301, DOI 10.1093/ajcn/85.5.1301; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Cross CE, 1998, ENVIRON HEALTH PERSP, V106, P1241, DOI 10.2307/3433992; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Fleming J, 2001, NUTR CANCER, V40, P42, DOI 10.1207/S15327914NC401_9; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs J, 1998, FREE RADICAL BIO MED, V25, P848, DOI 10.1016/S0891-5849(98)00161-0; Gollnick HPM, 1996, EUR J DERMATOL, V6, P200; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Heinrich U, 2006, SKIN PHARMACOL PHYS, V19, P224, DOI 10.1159/000093118; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kanekura T, 2005, CLIN EXP DERMATOL, V30, P346, DOI 10.1111/j.1365-2230.2005.01746.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; McKenzie RC, 2000, CLIN EXP DERMATOL, V25, P631, DOI 10.1046/j.1365-2230.2000.00725.x; Moll R, 1998, Subcell Biochem, V31, P205; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; PENCE BC, 1994, J INVEST DERMATOL, V102, P759, DOI 10.1111/1523-1747.ep12377571; Rafferty TS, 1998, BIOCHEM J, V332, P231, DOI 10.1042/bj3320231; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Richelle M, 2006, BRIT J NUTR, V96, P227, DOI 10.1079/BJN20061817; Rostan EF, 2002, INT J DERMATOL, V41, P606, DOI 10.1046/j.1365-4362.2002.01567.x; Sano T, 2009, J DERMATOL SCI, V53, P77, DOI 10.1016/j.jdermsci.2008.08.001; Sengupta A, 2008, BIOCHEM J, V413, P151, DOI 10.1042/BJ20080277; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Steenvoorden DPT, 1997, J PHOTOCH PHOTOBIO B, V41, P1, DOI 10.1016/S1011-1344(97)00081-X; Thiele JJ, 1997, J INVEST DERMATOL, V108, P753, DOI 10.1111/1523-1747.ep12292144; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032	41	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12249	10.1371/journal.pone.0012249	http://dx.doi.org/10.1371/journal.pone.0012249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805887	gold, Green Published, Green Submitted			2022-12-27	WOS:000281011600021
J	Andreyeva, A; Leshchyns'ka, I; Knepper, M; Betzel, C; Redecke, L; Sytnyk, V; Schachner, M				Andreyeva, Aksana; Leshchyns'ka, Iryna; Knepper, Michael; Betzel, Christian; Redecke, Lars; Sytnyk, Vladimir; Schachner, Melitta			CHL1 Is a Selective Organizer of the Presynaptic Machinery Chaperoning the SNARE Complex	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; ADHESION MOLECULE L1; CLOSE HOMOLOG; MICE DEFICIENT; CALL GENE; ASSOCIATION; BINDING; CSP; PHOSPHORYLATION; OLIGOMERIZATION	Proteins constituting the presynaptic machinery of vesicle release undergo substantial conformational changes during the process of exocytosis. While changes in the conformation make proteins vulnerable to aggregation and degradation, little is known about synaptic chaperones which counteract these processes. We show that the cell adhesion molecule CHL1 directly interacts with and regulates the activity of the synaptic chaperones Hsc70, CSP and alpha SGT. CHL1, Hsc70, CSP and alpha SGT form predominantly CHL1/Hsc70/alpha SGT and CHL1/CSP complexes in synapses. Among the various complexes formed by CHL1, Hsc70, CSP and alpha SGT, SNAP25 and VAMP2 induce chaperone activity only in CHL1/Hsc70/alpha SGT and CHL1/CSP complexes, respectively, indicating a remarkable selectivity of a presynaptic chaperone activity for proteins of the exocytotic machinery. In mice with genetic ablation of CHL1, chaperone activity in synapses is reduced and the machinery for synaptic vesicle exocytosis and, in particular, the SNARE complex is unable to sustain prolonged synaptic activity. Thus, we reveal a novel role for a cell adhesion molecule in selective activation of the presynaptic chaperone machinery.	[Andreyeva, Aksana; Leshchyns'ka, Iryna; Knepper, Michael; Sytnyk, Vladimir; Schachner, Melitta] Univ Hamburg, Zentrum Mol Neurobiol, Hamburg, Germany; [Betzel, Christian; Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Hamburg, Germany; [Leshchyns'ka, Iryna; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Andreyeva, Aksana] Univ Dusseldorf, Inst Neuro & Sensory Physiol, Dusseldorf, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of New South Wales Sydney; Heinrich Heine University Dusseldorf; Shantou University; Rutgers State University New Brunswick	Andreyeva, A (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Hamburg, Germany.	v.sytnyk@unsw.edu.au; Schachner@Biology.Rutgers.Edu	Sytnyk, Vladimir/A-3878-2010; Redecke, Lars/A-5611-2013; Betzel, Christian/G-8105-2018	Betzel, Christian/0000-0002-3879-5019; Sytnyk, Vladimir/0000-0003-1927-2199; Leshchyns'ka, Iryna/0000-0002-2025-5831	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Melitta Schachner is supported by the New Jersey Commission for Spinal Cord Research. This work was supported by the Deutsche Forschungsgemeinschaft (to MS, IL, VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; Aufricht C, 1998, AM J PHYSIOL-RENAL, V274, pF268, DOI 10.1152/ajprenal.1998.274.2.F268; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Evans GJO, 2003, TRAFFIC, V4, P653, DOI 10.1034/j.1600-0854.2003.00127.x; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Georgieva D, 2004, BIOCHEM BIOPH RES CO, V323, P1278, DOI 10.1016/j.bbrc.2004.08.230; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Kolata S, 2008, J NEUROSCI, V28, P13505, DOI 10.1523/JNEUROSCI.2127-08.2008; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morellini F, 2007, MOL CELL NEUROSCI, V34, P121, DOI 10.1016/j.mcn.2006.10.006; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pratte M, 2009, PHYSIOL BEHAV, V97, P394, DOI 10.1016/j.physbeh.2009.03.009; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Smith GB, 2005, J BIOL CHEM, V280, P32669, DOI 10.1074/jbc.M501806200; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; Tobaben S, 2003, J BIOL CHEM, V278, P38376, DOI 10.1074/jbc.M301558200; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsuang Ming T, 2004, World Psychiatry, V3, P73; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514	54	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12018	10.1371/journal.pone.0012018	http://dx.doi.org/10.1371/journal.pone.0012018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711454	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100005
J	Cox, MB; Cairns, MJ; Gandhi, KS; Carroll, AP; Moscovis, S; Stewart, GJ; Broadley, S; Scott, RJ; Booth, DR; Lechner-Scott, J				Cox, Mathew B.; Cairns, Murray J.; Gandhi, Kaushal S.; Carroll, Adam P.; Moscovis, Sophia; Stewart, Graeme J.; Broadley, Simon; Scott, Rodney J.; Booth, David R.; Lechner-Scott, Jeannette		ANZgene Multiple Sclerosis Genetic	MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood	PLOS ONE			English	Article							SCLEROSIS SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; DIFFERENTIATION; RECEPTOR; DISEASE; DICER; RISK	It is well established that Multiple Sclerosis (MS) is an immune mediated disease. Little is known about what drives the differential control of the immune system in MS patients compared to unaffected individuals. MicroRNAs (miRNAs) are small non-coding nucleic acids that are involved in the control of gene expression. Their potential role in T cell activation and neurodegenerative disease has recently been recognised and they are therefore excellent candidates for further studies in MS. We investigated the transcriptome of currently known miRNAs using miRNA microarray analysis in peripheral blood samples of 59 treatment naive MS patients and 37 controls. Of these 59, 18 had a primary progressive, 17 a secondary progressive and 24 a relapsing remitting disease course. In all MS subtypes miR-17 and miR-20a were significantly under-expressed in MS, confirmed by RT-PCR. We demonstrate that these miRNAs modulate T cell activation genes in a knock-in and knock-down T cell model. The same T cell activation genes are also up-regulated in MS whole blood mRNA, suggesting these miRNAs or their analogues may provide useful targets for new therapeutic approaches.	[Cox, Mathew B.; Cairns, Murray J.; Carroll, Adam P.; Moscovis, Sophia; Scott, Rodney J.; Lechner-Scott, Jeannette] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Cairns, Murray J.; Carroll, Adam P.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Gandhi, Kaushal S.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Broadley, Simon] Griffith Univ, Dept Neurol, Gold Coast, Qld, Australia	Hunter Medical Research Institute; University of Newcastle; University of Sydney; Westmead Institute for Medical Research; Griffith University	Cox, MB (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia.	Rodney.scott@newcastle.edu.au	Scott, Rodney J/B-2827-2013; MOSCATO, PABLO ALBERTO/G-7668-2013	Scott, Rodney J/0000-0001-7724-3404; Lechner-Scott, Jeannette/0000-0002-3850-447X; Stankovich, Jim/0000-0001-9344-7749; Cairns, Murray/0000-0003-2490-2538; Field, Judith/0000-0002-7089-0999; Kilpatrick, Trevor/0000-0003-3999-085X	Multiple Sclerosis Research Australia; Australian Research Council [LPO776744]; Macquarie Group Foundation; John Hunter Charitable Trust; University of Newcastle; NSW Health; Henderson Foundation; M.C. Ainsworth Research Fellowship	Multiple Sclerosis Research Australia; Australian Research Council(Australian Research Council); Macquarie Group Foundation; John Hunter Charitable Trust; University of Newcastle; NSW Health; Henderson Foundation; M.C. Ainsworth Research Fellowship	This work was supported by Multiple Sclerosis Research Australia (www.msra.org.au) and the Australian Research Council (www.arc.gov.au under the Linkage Projects Scheme [LPO776744]). MBC is supported by a special grant from Macquarie Group Foundation, the John Hunter Charitable Trust Fund and the University of Newcastle. MJC is supported by the Schizophrenia Research Institute (www.schizophreniaresearcorg.au), utilizing funding from NSW Health, the Henderson Foundation and an M.C. Ainsworth Research Fellowship in Epigenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), 2009, NAT GENET, V41, P824; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEVERIDGE NJ, 2009, CELL SIGNAL, V1845, P17; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; COMI G, 2009, MULT SCLER, V2, pS155; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Corvol JC, 2008, P NATL ACAD SCI USA, V105, P11839, DOI 10.1073/pnas.0805065105; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; GANDHI KS, HUM MOL GENET; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser S.L., 2008, HARRISONS PRINCIPLES; Howe CJ, 2003, ASSAY DRUG DEV TECHN, V1, P537, DOI 10.1089/154065803322302790; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; LINDBERG RLP, 2010, EUROPEAN J IMMUNOLOG, V9999; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; PLOS O, PLOS ONE, P6; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Satoh J, 2008, DIS MARKERS, V25, P27, DOI 10.1155/2008/824640; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Weinshenker BG, 2003, LANCET, V361, P889, DOI 10.1016/S0140-6736(03)12784-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	33	218	230	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12132	10.1371/journal.pone.0012132	http://dx.doi.org/10.1371/journal.pone.0012132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711463	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100032
J	McCormack, AL; Mak, SK; Henderson, JM; Bumcrot, D; Farrer, MJ; Di Monte, DA				McCormack, Alison L.; Mak, Sally K.; Henderson, Jaimie M.; Bumcrot, David; Farrer, Matthew J.; Di Monte, Donato A.			alpha-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; IN-VITRO; MUTATION; DEGRADATION; MECHANISMS; INCLUSIONS; EXPRESSION; AUTOPHAGY; DEMENTIA	The protein alpha-synuclein is involved in the pathogenesis of Parkinson's disease and other neurodegenerative disorders. Its toxic potential appears to be enhanced by increased protein expression, providing a compelling rationale for therapeutic strategies aimed at reducing neuronal alpha-synuclein burden. Here, feasibility and safety of alpha-synuclein suppression were evaluated by treating monkeys with small interfering RNA (siRNA) directed against alpha-synuclein. The siRNA molecule was chemically modified to prevent degradation by exo- and endonucleases and directly infused into the left substantia nigra. Results compared levels of alpha-synuclein mRNA and protein in the infused (left) vs. untreated (right) hemisphere and revealed a significant 40-50% suppression of alpha-synuclein expression. These findings could not be attributable to non-specific effects of siRNA infusion since treatment of a separate set of animals with luciferase-targeting siRNA produced no changes in alpha-synuclein. Infusion with alpha-synuclein siRNA, while lowering alpha-synuclein expression, had no overt adverse consequences. In particular, it did not cause tissue inflammation and did not change (i) the number and phenotype of nigral dopaminergic neurons, and (ii) the concentrations of striatal dopamine and its metabolites. The data represent the first evidence of successful anti-alpha-synuclein intervention in the primate substantia nigra and support further development of RNA interference-based therapeutics.	[McCormack, Alison L.; Di Monte, Donato A.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [McCormack, Alison L.; Di Monte, Donato A.] SRI Int, Menlo Pk, CA 94025 USA; [Mak, Sally K.] Parkinsons Inst, Sunnyvale, CA USA; [Henderson, Jaimie M.] Stanford Univ, Stanford, CA 94305 USA; [Bumcrot, David] Alnylam Pharmaceut, Cambridge, MA USA; [Farrer, Matthew J.] Mayo Clin, Coll Med, Jacksonville, FL 32224 USA	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); SRI International; Stanford University; Mayo Clinic	McCormack, AL (corresponding author), German Ctr Neurodegenerat Dis DZNE, Bonn, Germany.	donato.dimonte@dzne.de		Farrer, Matthew/0000-0003-1159-5321; Di Monte, Donato/0000-0002-8296-836X; Henderson, Jaimie/0000-0002-3276-2267	Michael J. Fox Foundation; Backus Foundation; Phinney Foundation; Parkinson's Disease Foundation	Michael J. Fox Foundation; Backus Foundation; Phinney Foundation; Parkinson's Disease Foundation	This work was supported by grants from the Michael J. Fox Foundation, the Backus Foundation, the Phinney Foundation and the Parkinson's Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; COOKSON MR, 2009, CELL DEATH DIFFER, V4, P9; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; DROPYRIDINE, 1967, J NEUROPATHOL EXP NE, V793, P802; Drury S, 2009, DIAGN MOL PATHOL, V18, P103, DOI 10.1097/PDM.0b013e31817c1ae2; EMMERS R, 1963, BRAIN; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fountaine TM, 2008, EUR J NEUROSCI, V28, P2459, DOI 10.1111/j.1460-9568.2008.06527.x; Gonzalez-Alegre P, 2007, NAT CLIN PRACT NEURO, V3, P394, DOI 10.1038/ncpneuro0551; GORBATYUK OS, 2010, MOL THER; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; LEWIS J, 2008, IN VIVO, V3, P19; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Mak SK, 2009, EXP NEUROL, V220, P359, DOI 10.1016/j.expneurol.2009.09.021; MCCORMACK A, 2008, PATHOLOGIC MODIFICAT, V6, P1; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; PLOS O, PLOS ONE, P7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	37	114	140	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12122	10.1371/journal.pone.0012122	http://dx.doi.org/10.1371/journal.pone.0012122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711464	Green Published, Green Submitted, gold			2022-12-27	WOS:000280849100030
J	Smith, DH; Winters-Digiacinto, P; Mitiku, M; O'Rourke, S; Sinangil, F; Wrin, T; Montefiori, DC; Berman, PW				Smith, Douglas H.; Winters-Digiacinto, Peggy; Mitiku, Misrach; O'Rourke, Sara; Sinangil, Faruk; Wrin, Terri; Montefiori, David C.; Berman, Phillip W.			Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; NEUTRALIZING ANTIBODIES; DOUBLE-BLIND; GUINEA-PIGS; TRIAL; INFECTION; GP120; THAILAND; EFFICACY	Background: Previous clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine. However, the recent RV144 HIV vaccine trial in Thailand showed that a prime/boost immunization strategy involving priming with canarypox vCP1521 followed by boosting with rgp120 could provide significant, although modest, protection from HIV infection. Based on these results, there is renewed interest in the development of rgp120 based antigens for follow up vaccine trials, where this immunization approach can be applied to other cohorts at high risk for HIV infection. Of particular interest are cohorts in Africa, India, and China that are infected with clade C viruses. Methodology/Principal Findings: A panel of 10 clade C rgp120 envelope proteins was expressed in 293 cells, purified by immunoaffinity chromatography, and used to immunize guinea pigs. The resulting sera were collected and analyzed in checkerboard experiments for rgp120 binding, V3 peptide binding, and CD4 blocking activity. Virus neutralization studies were carried out with two different assays and two different panels of clade C viruses. A high degree of cross reactivity against clade C and clade B viruses and viral proteins was observed. Most, but not all of the immunogens tested elicited antibodies that neutralized tier 1 clade B viruses, and some sera neutralized multiple clade C viruses. Immunization with rgp120 from the CN97001 strain of HIV appeared to elicit higher cross neutralizing antibody titers than the other antigens tested. Conclusions/Significance: While all of the clade C antigens tested were immunogenic, some were more effective than others in eliciting virus neutralizing antibodies. Neutralization titers did not correlate with rgp120 binding, V3 peptide binding, or CD4 blocking activity. CN97001 rgp120 elicited the highest level of neutralizing antibodies, and should be considered for further HIV vaccine development studies.	[Smith, Douglas H.; Winters-Digiacinto, Peggy; Mitiku, Misrach; Sinangil, Faruk; Berman, Phillip W.] VaxGen Inc, Brisbane, Qld, Australia; [O'Rourke, Sara; Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Sinangil, Faruk] Global Solut Infect Dis, San Francisco, CA USA; [Wrin, Terri] Monogram Biosci, San Francisco, CA USA; [Montefiori, David C.] Duke Univ, Sch Med, Durham, NC USA	University of California System; University of California Santa Cruz; Duke University	Smith, DH (corresponding author), VaxGen Inc, Brisbane, Qld, Australia.	pwb@soe.ucsc.edu			National Institutes of Health (NIH) [AI046903-01, AI30034]; University of California Santa Cruz; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI046903] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Santa Cruz(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI046903-01 to PWB and AI30034 to DCM, as well as funds provided by the University of California Santa Cruz. DS, MM, PW-D, FS and PB were employees of VaxGen, Inc. when the experiments reported in this publication were carried out and as such, VaxGen is considered by PLoS ONE to have funded and played a role in this research. TW is an employee of Monogram Biosciences, a commercial assay services organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; BERMAN PW, 1994, AIDS, V8, P591, DOI 10.1097/00002030-199405000-00004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V192, P974, DOI 10.1086/432734; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; JGILBERT PB, 2005, J INFECT DIS, V191, P666; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; POWELL MF, 1995, AIDS RES HUM RETROV, V11, P203, DOI 10.1089/aid.1995.11.203; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Tartaglia J, 1998, AIDS RES HUM RETROV, V14, pS291	30	17	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12076	10.1371/journal.pone.0012076	http://dx.doi.org/10.1371/journal.pone.0012076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711452	gold, Green Submitted, Green Published			2022-12-27	WOS:000280849100017
J	Gasc, A; Duryea, MC; Cox, RM; Kern, A; Calsbeek, R				Gasc, Amandine; Duryea, M. C.; Cox, Robert M.; Kern, Andrew; Calsbeek, Ryan			Invasive Predators Deplete Genetic Diversity of Island Lizards	PLOS ONE			English	Article							CONSERVATION; CONSEQUENCES; POPULATIONS; IMPACT; RATS	Invasive species can dramatically impact natural populations, especially those living on islands. Though numerous examples illustrate the ecological impact of invasive predators, no study has examined the genetic consequences for native populations subject to invasion. Here we capitalize on a natural experiment in which a long-term study of the brown anole lizard (Anolis sagrei) was interrupted by rat invasion. An island population that was devastated by rats recovered numerically following rat extermination. However, population genetic analyses at six microsatellite loci suggested a possible loss of genetic diversity due to invasion when compared to an uninvaded island studied over the same time frame. Our results provide partial support for the hypothesis that invasive predators can impact the genetic diversity of resident island populations.	[Gasc, Amandine; Duryea, M. C.; Cox, Robert M.; Kern, Andrew; Calsbeek, Ryan] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Gasc, A (corresponding author), Museum Natl Hist Nat, Dept Syst & Evolut, F-75231 Paris, France.	ryan.calsbeek@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	National Science Foundation [DEB-0816862]	National Science Foundation(National Science Foundation (NSF))	Research was supported by a National Science Foundation grant (DEB-0816862) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Bardeleben C, 2004, MOL ECOL NOTES, V4, P176, DOI 10.1111/j.1471-8286.2004.00602.x; Beaumont MA, 2002, GENETICS, V162, P2025; Calsbeek R, 2008, EVOLUTION, V62, P478, DOI 10.1111/j.1558-5646.2007.00282.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Donlan CJ, 2003, BIOL CONSERV, V114, P29, DOI 10.1016/S0006-3207(02)00401-9; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Eales J, 2010, BIOL INVASIONS, V12, P77, DOI 10.1007/s10530-009-9431-6; Fordham DA, 2010, BIODIVERS CONSERV, V19, P329, DOI 10.1007/s10531-008-9529-7; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Frankham R, 1999, GENET RES, V74, P237, DOI 10.1017/S001667239900405X; Hadfield MG, 2009, BIOL INVASIONS, V11, P1595, DOI 10.1007/s10530-008-9409-9; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Kingsford RT, 2009, CONSERV BIOL, V23, P834, DOI 10.1111/j.1523-1739.2009.01287.x; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Koper N, 2010, BIOL CONSERV, V143, P220, DOI 10.1016/j.biocon.2009.10.006; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Miller KA, 2009, MOL ECOL, V18, P3792, DOI 10.1111/j.1365-294X.2009.04315.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neigel JE, 2010, MOL ECOL, V19, P1073, DOI 10.1111/j.1365-294X.2010.04536.x; Peacock MM, 2009, MOL ECOL, V18, P3603, DOI 10.1111/j.1365-294X.2009.04308.x; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; RAYMOND M, 1994, GENEPOP VER 3 0; Ryan ME, 2009, P NATL ACAD SCI USA, V106, P11166, DOI 10.1073/pnas.0902252106; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Thomson D, 2005, BIOL INVASIONS, V7, P615, DOI 10.1007/s10530-004-5853-3; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229	34	18	18	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12061	10.1371/journal.pone.0012061	http://dx.doi.org/10.1371/journal.pone.0012061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706576	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900017
J	Chang, CH; Berke, JD; Maren, S				Chang, Chun-hui; Berke, Joshua D.; Maren, Stephen			Single-Unit Activity in the Medial Prefrontal Cortex during Immediate and Delayed Extinction of Fear in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; INFRALIMBIC CORTEX; LEARNED FEAR; NEURONS; MEMORY; CONSOLIDATION; INTERNEURONS; EXCITABILITY; MAINTENANCE	Delivering extinction trials minutes after fear conditioning yields only a short-term fear suppression that fully recovers the following day. Because extinction has been reported to increase CS-evoked spike firing and spontaneous bursting in the infralimbic (IL) division of the medial prefrontal cortex (mPFC), we explored the possibility that this immediate extinction deficit is related to altered mPFC function. Single-units were simultaneously recorded in rats from neurons in IL and the prelimbic (PrL) division of the mPFC during an extinction session conducted 10 minutes (immediate) or 24 hours (delayed) after auditory fear conditioning. In contrast to previous reports, IL neurons exhibited CS-evoked responses early in extinction training in both immediate and delayed conditions and these responses decreased in magnitude over the course of extinction training. During the retention test, CS-evoked firing in IL was significantly greater in animals that failed to acquire extinction. Spontaneous bursting during the extinction and test sessions was also different in the immediate and delayed groups. There were no group differences in PrL activity during extinction or retention testing. Alterations in both spontaneous and CS-evoked neuronal activity in the IL may contribute to the immediate extinction deficit.	[Chang, Chun-hui; Berke, Joshua D.; Maren, Stephen] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Berke, Joshua D.; Maren, Stephen] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chang, CH (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	maren@umich.edu	Maren, Stephen/B-6182-2014; Maren, Stephen/A-7091-2009	Maren, Stephen/0000-0002-9342-7411; Maren, Stephen/0000-0002-9342-7411; Chang, Chun-hui/0000-0003-0914-2518	National Institutes of Health [R01MH065961]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a National Institutes of Health grant (R01MH065961) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; Barrett D, 2003, J NEUROSCI, V23, P5740; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Campfield KM, 2001, J TRAUMA STRESS, V14, P327, DOI 10.1023/A:1011117018705; Chang CH, 2009, LEARN MEMORY, V16, P62, DOI 10.1101/lm.1085009; Collins DR, 1999, J NEUROSCI, V19, P836; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Everly G.S., 1999, CRITICAL INCIDENT ST; Garakani A, 2006, MT SINAI J MED, V73, P941; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Garcia R, 2006, LEARN MEMORY, V13, P14, DOI 10.1101/lm.60406; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Gray MJ, 2005, BEHAV MODIF, V29, P189, DOI 10.1177/0145445504270884; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hobin JA, 2003, J NEUROSCI, V23, P8410; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Kim SC, 2010, J NEUROSCI, V30, P832, DOI 10.1523/JNEUROSCI.4145-09.2010; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 2005, NEUROSCIENTIST, V11, P89, DOI 10.1177/1073858404269232; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; McNally Richard J, 2003, Psychol Sci Public Interest, V4, P45, DOI 10.1111/1529-1006.01421; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Norrholm SD, 2008, BEHAV NEUROSCI, V122, P1016, DOI 10.1037/a0012604; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 1996, J NEUROSCI, V16, P3334; Pavlov I.P., 1927, CONDITIONED REFLEXES; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rasmusson AM, 1997, ANN NY ACAD SCI, V821, P332, DOI 10.1111/j.1749-6632.1997.tb48290.x; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Shi WX, 2003, J PHARMACOL EXP THER, V305, P680, DOI 10.1124/jpet.102.046359; Sotres-Bayon F, 2009, CEREB CORTEX, V19, P474, DOI 10.1093/cercor/bhn099; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wiltschko AB, 2010, NEUROPSYCHOPHARMACOL, V35, P1261, DOI 10.1038/npp.2009.226; Woods AM, 2008, LEARN MEMORY, V15, P909, DOI 10.1101/lm.1078508	60	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11971	10.1371/journal.pone.0011971	http://dx.doi.org/10.1371/journal.pone.0011971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700483	gold, Green Published, Green Submitted			2022-12-27	WOS:000280605400012
J	Sinclair, MS; Perea-Martinez, I; Dvoryanchikov, G; Yoshida, M; Nishimori, K; Roper, SD; Chaudhari, N				Sinclair, Michael S.; Perea-Martinez, Isabel; Dvoryanchikov, Gennady; Yoshida, Masahide; Nishimori, Katsuhiko; Roper, Stephen D.; Chaudhari, Nirupa			Oxytocin Signaling in Mouse Taste Buds	PLOS ONE			English	Article							RECEPTOR-CELLS; SUCROSE SOLUTION; SODIUM APPETITE; GENE DELETION; III CELLS; MICE; RAT; BEHAVIOR; SWEET; COMMUNICATION	Background: The neuropeptide, oxytocin (OXT), acts on brain circuits to inhibit food intake. Mutant mice lacking OXT (OXT knockout) overconsume salty and sweet (i.e. sucrose, saccharin) solutions. We asked if OXT might also act on taste buds via its receptor, OXTR. Methodology/Principal Findings: Using RT-PCR, we detected the expression of OXTR in taste buds throughout the oral cavity, but not in adjacent non-taste lingual epithelium. By immunostaining tissues from OXTR-YFP knock-in mice, we found that OXTR is expressed in a subset of Glial-like (Type I) taste cells, and also in cells on the periphery of taste buds. Single-cell RT-PCR confirmed this cell-type assignment. Using Ca2+ imaging, we observed that physiologically appropriate concentrations of OXT evoked [Ca2+](i) mobilization in a subset of taste cells (EC50 similar to 33 nM). OXT-evoked responses were significantly inhibited by the OXTR antagonist, L-371,257. Isolated OXT-responsive taste cells were neither Receptor (Type II) nor Presynaptic (Type III) cells, consistent with our immunofluorescence observations. We also investigated the source of OXT peptide that may act on taste cells. Both RT-PCR and immunostaining suggest that the OXT peptide is not produced in taste buds or in their associated nerves. Finally, we also examined the morphology of taste buds from mice that lack OXTR. Taste buds and their constituent cell types appeared very similar in mice with two, one or no copies of the OXTR gene. Conclusions/Significance: We conclude that OXT elicits Ca2+ signals via OXTR in murine taste buds. OXT-responsive cells are most likely a subset of Glial-like (Type I) taste cells. OXT itself is not produced locally in taste tissue and is likely delivered through the circulation. Loss of OXTR does not grossly alter the morphology of any of the cell types contained in taste buds. Instead, we speculate that OXT-responsive Glial-like (Type I) taste bud cells modulate taste signaling and afferent sensory output. Such modulation would complement central pathways of appetite regulation that employ circulating homeostatic and satiety signals.	[Sinclair, Michael S.; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA; [Perea-Martinez, Isabel; Dvoryanchikov, Gennady; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Yoshida, Masahide; Nishimori, Katsuhiko] Tohoku Univ, Dept Mol & Cell Biol, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	University of Miami; University of Miami; Tohoku University	Sinclair, MS (corresponding author), Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA.	NChaudhari@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Sinclair, Michael/0000-0002-3636-5920; Tilahin, Shimelis/0000-0001-8975-8026	American Heart Association [0815215E]; National Institutes of Health/NIDCD [DC006021, DC006308, DC010073, DC00037]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308, R21DC010073, R01DC006021, R56DC006308] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by American Heart Association Predoctoral Fellowship 0815215E (M. S.) and National Institutes of Health/NIDCD grants DC006021, DC006308, DC010073 (N.C.) and DC00037 (S. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico JA, 2005, AM J PHYSIOL-REG I, V289, pR1798, DOI 10.1152/ajpregu.00558.2005; Amico JA, 2001, AM J PHYSIOL-REG I, V281, pR1368, DOI 10.1152/ajpregu.2001.281.5.R1368; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bigiani A, 2007, J NEUROPHYSIOL, V98, P2483, DOI 10.1152/jn.00716.2007; Billings LB, 2006, BEHAV BRAIN RES, V171, P134, DOI 10.1016/j.bbr.2006.03.028; BLACKBURN RE, 1992, NEUROENDOCRINOLOGY, V56, P255, DOI 10.1159/000126236; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CHAUDHARI N, 2010, J CELL BIOL IN PRESS; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Gilbertson TA, 1998, ANN NY ACAD SCI, V855, P860, DOI 10.1111/j.1749-6632.1998.tb10676.x; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HUANG W, 1995, AM J PHYSIOL-REG I, V268, pR634, DOI 10.1152/ajpregu.1995.268.3.R634; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; KU CY, 1995, ENDOCRINOLOGY, V136, P1509, DOI 10.1210/en.136.4.1509; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Leng G, 2008, PROG BRAIN RES, V170, P137, DOI 10.1016/S0079-6123(08)00413-5; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; Medler KF, 2003, J NEUROSCI, V23, P2608; Miedlar JA, 2007, AM J PHYSIOL-REG I, V293, pR1063, DOI 10.1152/ajpregu.00228.2007; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; OLSON BR, 1991, PEPTIDES, V12, P113, DOI 10.1016/0196-9781(91)90176-P; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Parent AS, 2008, ENDOCRINOLOGY, V149, P1358, DOI 10.1210/en.2007-1054; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Roberts CD, 2009, J PHYSIOL-LONDON, V587, P1657, DOI 10.1113/jphysiol.2009.170555; Sabatier N, 2007, BIOCHEM SOC T, V35, P1247, DOI 10.1042/BST0351247; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sclafani A, 2007, AM J PHYSIOL-REG I, V292, pR1828, DOI 10.1152/ajpregu.00826.2006; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Stricker EM, 1996, REGUL PEPTIDES, V66, P83, DOI 10.1016/S0167-0115(96)00058-4; STRICKER EM, 1987, BEHAV NEUROSCI, V101, P560, DOI 10.1037/0735-7044.101.4.560; Swaab DF, 2004, INT REV CYTOL, V240, P305, DOI 10.1016/S0074-7696(04)40003-5; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; TASAKA K, 1991, OBSTET GYNECOL, V77, P101; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Vila G, 2009, J ENDOCRINOL, V203, P175, DOI 10.1677/JOE-09-0227; WILLIAMS PD, 1995, J MED CHEM, V38, P4634, DOI 10.1021/jm00023a002; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	58	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11980	10.1371/journal.pone.0011980	http://dx.doi.org/10.1371/journal.pone.0011980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700536	Green Submitted, gold, Green Published			2022-12-27	WOS:000280605400016
J	Keary, N; Voss, J; Lehmann, K; Bischof, HJ; Lowel, S				Keary, Nina; Voss, Joe; Lehmann, Konrad; Bischof, Hans-Joachim; Loewel, Siegrid			Optical Imaging of Retinotopic Maps in a Small Songbird, the Zebra Finch	PLOS ONE			English	Article							MACAQUE STRIATE CORTEX; GUTTATA-CASTANOTIS-GOULD; PIGEON COLUMBA-LIVIA; OWL TYTO-ALBA; VISUAL-WULST; FUNCTIONAL-ANATOMY; TAENIOPYGIA-GUTTATA; OCULAR DOMINANCE; AVIAN TELENCEPHALON; RECEPTIVE-FIELDS	Background: The primary visual cortex of mammals is characterised by a retinotopic representation of the visual field. It has therefore been speculated that the visual wulst, the avian homologue of the visual cortex, also contains such a retinotopic map. We examined this for the first time by optical imaging of intrinsic signals in zebra finches, a small songbird with laterally placed eyes. In addition to the visual wulst, we visualised the retinotopic map of the optic tectum which is homologue to the superior colliculus in mammals. Methodology/Principal Findings: For the optic tectum, our results confirmed previous accounts of topography based on anatomical studies and conventional electrophysiology. Within the visual wulst, the retinotopy revealed by our experiments has not been illustrated convincingly before. The frontal part of the visual field (0 degrees +/- 30 degrees azimuth) was not represented in the retinotopic map. The visual field from 30 degrees-60 degrees azimuth showed stronger magnification compared with more lateral regions. Only stimuli within elevations between about 20 degrees and 40 degrees above the horizon elicited neuronal activation. Activation from other elevations was masked by activation of the preferred region. Most interestingly, we observed more than one retinotopic representation of visual space within the visual wulst, which indicates that the avian wulst, like the visual cortex in mammals, may show some compartmentation parallel to the surface in addition to its layered structure. Conclusion/Significance: Our results show the applicability of the optical imaging method also for small songbirds. We obtained a more detailed picture of retinotopic maps in birds, especially on the functional neuronal organisation of the visual wulst. Our findings support the notion of homology of visual wulst and visual cortex by showing that there is a functional correspondence between the two areas but also raise questions based on considerable differences between avian and mammalian retinotopic representations.	[Keary, Nina; Voss, Joe; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany; [Lehmann, Konrad; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	University of Bielefeld; Friedrich Schiller University of Jena	Keary, N (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, Bielefeld, Germany.	nina.keary@uni-bielefeld.de	Lehmann, Konrad/AAJ-1017-2020	Lehmann, Konrad/0000-0001-8215-5804	Human Frontier Science Program (HFSP); Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF); Bielefeld University; Deutsche Forschungsgemeinschaft (DFG) [BI 245/18]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Bielefeld University; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by grants from the Human Frontier Science Program (HFSP) (http://www.hfsp.org/), the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) (http://www.bmbf.de/), Bielefeld University (http://www.uni-bielefeld.de/) and the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp), grant number BI 245/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron J, 2007, EUR J NEUROSCI, V26, P1950, DOI 10.1111/j.1460-9568.2007.05783.x; Basole A, 2006, PROG BRAIN RES, V154, P121, DOI 10.1016/S0079-6123(06)54006-3; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BISCHOF HJ, 1988, J COMP PHYSIOL A, V163, P329, DOI 10.1007/BF00604008; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BREDENKOTTER M, 1990, BRAIN RES, V515, P343, DOI 10.1016/0006-8993(90)90620-Q; Brodmann K, 1909, VERGLEICHENDE LOKALI; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; DENTON CJ, 1981, EXP NEUROL, V74, P482, DOI 10.1016/0014-4886(81)90186-2; Engelage Jurgen, 1993, P137; FROST BJ, 1976, VISION RES, V16, P1229, DOI 10.1016/0042-6989(76)90046-8; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; Gunturkun Onur, 1993, P115; HAMDI FA, 1954, Q J EXP PHYSIOL CMS, V39, P111, DOI 10.1113/expphysiol.1954.sp001053; HOLDEN AL, 1971, J PHYSIOL-LONDON, V214, pP44; HOLDEN AL, 1969, J PHYSIOL-LONDON, V201, pP56; Hubener M, 1997, J NEUROSCI, V17, P9270; HUGHES CP, 1974, BRAIN RES, V80, P365, DOI 10.1016/0006-8993(74)91023-3; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; JASSIKGE.D, 1972, BRAIN RES, V40, P303, DOI 10.1016/0006-8993(72)90136-9; KAAS JH, 1995, BRAIN BEHAV EVOLUT, V46, P187, DOI 10.1159/000113273; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Liu GB, 2003, BRAIN RES, V961, P153, DOI 10.1016/S0006-8993(02)03747-2; LOWEL S, 1988, EXP BRAIN RES, V71, P33; LOWEL S, 1987, EXP BRAIN RES, V68, P661; Manger PR, 2002, EUR J NEUROSCI, V16, P743, DOI 10.1046/j.1460-9568.2002.02119.x; MARTIN GR, 1983, VISION RES, V23, P911, DOI 10.1016/0042-6989(83)90061-5; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Meinertzhagen Ian A., 1993, P1363; MEY J, 1992, J HIRNFORSCH, V33, P673; MICELI D, 1990, BRAIN RES, V518, P317, DOI 10.1016/0006-8993(90)90990-S; MICELI D, 1979, NEURAL MECHANISMS BE, P223; NIXDORF BE, 1982, BRAIN RES, V248, P9, DOI 10.1016/0006-8993(82)91142-8; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; PETTIGREW JD, 1979, PROC R SOC SER B-BIO, V204, P435, DOI 10.1098/rspb.1979.0038; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; PLASS L, 1997, THESIS BIELEFELD U B; Plumbley MD, 1999, NETWORK-COMP NEURAL, V10, P41, DOI 10.1088/0954-898X/10/1/003; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; REVZIN AM, 1970, BRAIN BEHAV EVOLUT, V3, P195; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Rosa MGP, 1997, J NEUROPHYSIOL, V77, P3193, DOI 10.1152/jn.1997.77.6.3193; Schmidt A, 1999, J COMP PHYSIOL A, V185, P69, DOI 10.1007/s003590050367; Schmidt A, 2001, J COMP PHYSIOL A, V187, P913, DOI 10.1007/s00359-001-0264-8; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; SHIMIZU T, 1990, J COMP NEUROL, V300, P346, DOI 10.1002/cne.903000307; SPARKS DL, 1988, BRAIN BEHAV EVOLUT, V31, P49, DOI 10.1159/000116575; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; TOOTELL RBH, 1988, J NEUROSCI, V8, P1569; UHLRICH DJ, 1982, VISION RES, V22, P429, DOI 10.1016/0042-6989(82)90188-2; VANESSEN DC, 1979, ANNU REV NEUROSCI, V2, P227, DOI 10.1146/annurev.ne.02.030179.001303; VOSS J, 2005, THESIS BIELEFELD U B; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; WILSON P, 1980, BRAIN RES, V188, P333, DOI 10.1016/0006-8993(80)90035-9; WILSON P, 1980, BRAIN RES, V188, P319, DOI 10.1016/0006-8993(80)90034-7; WOODS EJ, 1977, EXP BRAIN RES, V27, P347; Wylie DRW, 2009, CAN J EXP PSYCHOL, V63, P328, DOI 10.1037/a0016826	69	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11912	10.1371/journal.pone.0011912	http://dx.doi.org/10.1371/journal.pone.0011912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694137	Green Submitted, Green Published, gold			2022-12-27	WOS:000280574300004
J	Wang, XT; Chorley, BN; Pittman, GS; Kleeberger, SR; Brothers, J; Liu, G; Spira, A; Bell, DA				Wang, Xuting; Chorley, Brian N.; Pittman, Gary S.; Kleeberger, Steven R.; Brothers, John, II; Liu, Gang; Spira, Avrum; Bell, Douglas A.			Genetic Variation and Antioxidant Response Gene Expression in the Bronchial Airway Epithelium of Smokers at Risk for Lung Cancer	PLOS ONE			English	Article							OXIDATIVE STRESS; CIGARETTE-SMOKE; NEGATIVE REGULATION; GENOME; POLYMORPHISMS; NRF2; ACTIVATION; SUSCEPTIBILITY; INDUCTION; EXPOSURE	Prior microarray studies of smokers at high risk for lung cancer have demonstrated that heterogeneity in bronchial airway epithelial cell gene expression response to smoking can serve as an early diagnostic biomarker for lung cancer. As a first step in applying functional genomic analysis to population studies, we have examined the relationship between gene expression variation and genetic variation in a central molecular pathway (NRF2-mediated antioxidant response) associated with smoking exposure and lung cancer. We assessed global gene expression in histologically normal airway epithelial cells obtained at bronchoscopy from smokers who developed lung cancer (SC, n = 20), smokers without lung cancer (SNC, n = 24), and never smokers (NS, n = 8). Functional enrichment analysis showed that the NRF2-mediated, antioxidant response element (ARE)-regulated genes, were significantly lower in SC, when compared with expression levels in SNC. Importantly, we found that the expression of MAFG (a binding partner of NRF2) was correlated with the expression of ARE genes, suggesting MAFG levels may limit target gene induction. Bioinformatically we identified single nucleotide polymorphisms (SNPs) in putative ARE genes and to test the impact of genetic variation, we genotyped these putative regulatory SNPs and other tag SNPs in selected NRF2 pathway genes. Sequencing MAFG locus, we identified 30 novel SNPs and two were associated with either gene expression or lung cancer status among smokers. This work demonstrates an analysis approach that integrates bioinformatics pathway and transcription factor binding site analysis with genotype, gene expression and disease status to identify SNPs that may be associated with individual differences in gene expression and/or cancer status in smokers. These polymorphisms might ultimately contribute to lung cancer risk via their effect on the airway gene expression response to tobacco-smoke exposure.	[Wang, Xuting; Chorley, Brian N.; Pittman, Gary S.; Bell, Douglas A.] NIEHS, Environm Genom Sect, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kleeberger, Steven R.] NIEHS, Environm Genet Sect, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Brothers, John, II; Liu, Gang; Spira, Avrum] Boston Univ, Sect Computat Biomed, Dept Med, Boston, MA 02215 USA; [Brothers, John, II; Liu, Gang; Spira, Avrum] Boston Univ, Ctr Pulm, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Boston University; Boston University	Wang, XT (corresponding author), NIEHS, Environm Genom Sect, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	BELL1@niehs.nih.gov	Kleeberger, Steven R/F-1807-2019; Bell, Douglas A/C-7687-2019	Kleeberger, Steven R/0000-0003-2948-8452; Bell, Douglas A/0000-0001-7700-0840; Wang, Xuting/0000-0001-6781-8008; Liu, Gang/0000-0001-9270-6796; Spira, Avrum/0000-0003-1467-0489	National Institute of Environmental Health Sciences, National Institutes of Health [Z01 ES100475]; National Institute of Health [U01ES016035, R01CA124640]; NATIONAL CANCER INSTITUTE [R01CA124640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100513, ZIAES046008, U01ES016035, Z01ES100475] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health (Z01 ES100475) and grants to Avrum Spira from the National Institute of Health (U01ES016035, R01CA124640).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Churg A, 2005, TOXICOL APPL PHARM, V208, P37, DOI 10.1016/j.taap.2005.01.013; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; FIGUEROA JD, 2008, CARCINOGENESIS; Hubner RH, 2009, MOL MED, V15, P203, DOI 10.2119/molmed.2008.00130; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kiyohara C, 2006, EPIDEMIOLOGY, V17, P89, DOI 10.1097/01.ede.0000187627.70026.23; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Shields P G, 1999, Ann Oncol, V10 Suppl 5, pS7; Siedlinski M, 2008, AM J RESP CRIT CARE, V178, P13, DOI 10.1164/rccm.200711-1749OC; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Steiling K, 2008, CANCER PREV RES, V1, P396, DOI 10.1158/1940-6207.CAPR-08-0174; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Wang SS, 2006, CARCINOGENESIS, V27, P1828, DOI 10.1093/carcin/bgl013; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; *WHO, 2006, FACTS SMOK HLTH; Wu XF, 2004, ONCOGENE, V23, P6500, DOI 10.1038/sj.onc.1207811; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725	42	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11934	10.1371/journal.pone.0011934	http://dx.doi.org/10.1371/journal.pone.0011934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689807	Green Published, gold			2022-12-27	WOS:000280520500003
J	Zhang, WL; Deng, ZL; Chen, LA; Zuo, GW; Luo, Q; Shi, QO; Zhang, BQ; Wagner, ER; Rastegar, F; Kim, SH; Jiang, W; Shen, JK; Huang, EY; Gao, YH; Gao, JL; Zhou, JZ; Luo, JY; Huang, JY; Luo, XJ; Bi, Y; Su, YX; Yang, K; Liu, H; Luu, HH; Haydon, RC; He, TC; He, BC				Zhang, Wenli; Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Wagner, Eric R.; Rastegar, Farbod; Kim, Stephanie H.; Jiang, Wei; Shen, Jikun; Huang, Enyi; Gao, Yanhong; Gao, Jian-Li; Zhou, Jian-Zhong; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; Bi, Yang; Su, Yuxi; Yang, Ke; Liu, Hao; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan; He, Bai-Cheng			Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; COLLAGEN-X PROMOTER; STEM-CELLS; OSTEOBLAST DIFFERENTIATION; NUCLEAR RECEPTORS; RECOMBINANT ADENOVIRUSES; MOUSE; BMP; TISSUE	Background: As one of the least studied bone morphogenetic proteins (BMPs), BMP9 is one of the most osteogenic BMPs. Retinoic acid (RA) signaling is known to play an important role in development, differentiation and bone metabolism. In this study, we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of mesenchymal progenitor cells (MPCs). Methodology/Principal Findings: Both primary MPCs and MPC line are used for BMP9 and RA stimulation. Recombinant adenoviruses are used to deliver BMP9, RAR alpha and RXR alpha into MPCs. The in vitro osteogenic differentiation is monitored by determining the early and late osteogenic markers and matrix mineralization. Mouse perinatal limb explants and in vivo MPC implantation experiments are carried out to assess bone formation. We find that both 9CRA and ATRA effectively induce early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as osteopontin (OPN) and osteocalcin (OC). BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Using mouse perinatal limb explants, we find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at growth plate. Progenitor cell implantation studies reveal that co-expression of BMP9 and RXRa or RARa significantly increases trabecular bone and osteoid matrix formation. Conclusion/Significance: Our results strongly suggest that retinoid signaling may synergize with BMP9 activity in promoting osteogenic differentiation of MPCs. This knowledge should expand our understanding about how BMP9 cross-talks with other signaling pathways. Furthermore, a combination of BMP9 and retinoic acid (or its agonists) may be explored as effective bone regeneration therapeutics to treat large segmental bony defects, non-union fracture, and/or osteoporotic fracture.	[Zhang, Wenli; Shi, Qiong; Zhou, Jian-Zhong; Liu, Hao] Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Wenli; Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Luo, Qing; Shi, Qiong; Zhang, Bing-Qiang; Wagner, Eric R.; Rastegar, Farbod; Kim, Stephanie H.; Jiang, Wei; Shen, Jikun; Huang, Enyi; Gao, Yanhong; Gao, Jian-Li; Zhou, Jian-Zhong; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; Bi, Yang; Su, Yuxi; Yang, Ke; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan; He, Bai-Cheng] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Zhang, Bing-Qiang; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Chinese Minist Educ, Chongqing, Peoples R China; [Deng, Zhong-Liang; Chen, Liang; Zuo, Guo-Wei; Zhang, Bing-Qiang; Luo, Jinyong; Huang, Jiayi; Luo, Xiaoji; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med Designated, Affiliated Hosp, Chongqing, Peoples R China; [Luo, Qing; Bi, Yang; Su, Yuxi; He, Tong-Chuan] Chongqing Med Univ, Childrens Hosp, Pediat Res Inst, Stem Cell Biol & Therapy Lab, Chongqing, Peoples R China; [Huang, Enyi] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China; [Gao, Yanhong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Geriatr, Shanghai 200030, Peoples R China; [Yang, Ke] Third Mil Med Univ, Dept Cell Biol, Chongqing, Peoples R China; [He, Bai-Cheng] Chongqing Med Univ, Dept Pharmacol, Chongqing, Peoples R China	Sichuan University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Shanghai Jiao Tong University; Army Medical University; Chongqing Medical University	Zhang, WL (corresponding author), Sichuan Univ, W China Hosp, Dept Orthopaed Surg, Chengdu 610064, Sichuan, Peoples R China.	tche@surgery.bsd.uchicago.edu; hebaicheng99@yahoo.com	; GAO, JianLi/J-4997-2017	Wagner, Eric/0000-0001-9241-5702; Zhang, Wenli/0000-0002-4989-7950; GAO, JianLi/0000-0002-5977-0021	Brinson Foundation; National Institutes of Health [CA106569, AT004418, AR50142, AR054381]; Ministry of Science and Technology of China [2007AA2z400]; Natural Science Foundation of China [30901530, 30800658, 30772211]; Natural Science Foundation Project of Chongqing Science and Technology Commission [2008BB5396, 2009BB5060]; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054381, K08AR050142] Funding Source: NIH RePORTER	Brinson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by research grants from the Brinson Foundation (TCH), the National Institutes of Health (CA106569, AT004418, AR50142, and AR054381 to TCH, RCH and HHL), The 863 Program of Ministry of Science and Technology of China (#2007AA2z400 to LC, TCH, ZLD), the Natural Science Foundation of China (#30901530 to XL, #30800658 to JL, and #30772211 to ZLD), and the Natural Science Foundation Project of Chongqing Science and Technology Commission #2008BB5396 (LC) and #2009BB5060 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen RS, 2003, CHEM VAPOR DEPOS, V9, P301, DOI 10.1002/cvde.200304153; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cohen AJ, 2006, J CELL BIOCHEM, V99, P269, DOI 10.1002/jcb.20937; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Garattini E, 2004, CURR PHARM DESIGN, V10, P433, DOI 10.2174/1381612043453351; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Hatakeyama S, 1996, BIOCHEM MOL BIOL INT, V38, P1235; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; HE BC, CLIN CANC RES; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mic FA, 2002, DEVELOPMENT, V129, P2271; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Park BH, 2001, CURR OPIN ONCOL, V13, P78, DOI 10.1097/00001622-200101000-00015; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; ROGERS MB, 1992, MOL BIOL CELL, V3, P189, DOI 10.1091/mbc.3.2.189; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sinanan ACM, 2004, BIOTECHNOL APPL BIOC, V40, P25, DOI 10.1042/BA20030185; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Virdi AS, 1998, CELL MOL BIOL, V44, P1237; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wang AX, 2008, BIOCHEM BIOPH RES CO, V375, P435, DOI 10.1016/j.bbrc.2008.08.036; Weston AD, 2000, J CELL BIOL, V148, P679, DOI 10.1083/jcb.148.4.679; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	79	107	119	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11917	10.1371/journal.pone.0011917	http://dx.doi.org/10.1371/journal.pone.0011917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689834	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520300027
J	Beagle, B; Johnson, GVW				Beagle, Brandon; Johnson, Gail V. W.			Differential Modulation of TCF/LEF-1 Activity by the Soluble LRP6-ICD	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMINO-TERMINAL ENHANCER; BETA-CATENIN PATHWAY; TRANSCRIPTIONAL REPRESSION; MEDIATED TRANSCRIPTION; WNT CORECEPTOR; GENE FAMILY; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; GAMMA-SECRETASE	The canonical Wnt/beta-catenin (Wnt) pathway is a master transcriptional regulatory signaling pathway that controls numerous biological processes including proliferation and differentiation. As such, transcriptional activity of the Wnt pathway is tightly regulated and/or modulated by numerous proteins at the level of the membrane, cytosol and/or nucleus. In the nucleus, transcription of Wnt target genes by TCF/LEF-1 is repressed by the long Groucho/TLE co-repressor family. However, a truncated member of the Groucho/TLE family, amino terminal enhancer of Split (AES) can positively modulate TCF/LEF-1 activity by antagonizing long Groucho/TLE members in a dominant negative manner. We have previously shown the soluble intracellular domain of the LRP6 receptor, a receptor required for activation of the Wnt pathway, can positively regulate transcriptional activity within the Wnt pathway. In the current study, we show the soluble LRP6 intracellular domain (LRP6-ICD) can also translocate to the nucleus in CHO and HEK 293T cells and in contrast to cytosolic LRP6-ICD; nuclear LRP6-ICD represses TCF/LEF-1 activity. In agreement with previous reports, we show AES enhances TCF/LEF-1 mediated reporter transcription and further we demonstrate that AES activity is spatially regulated in HEK 293T cells. LRP6-ICD interacts with AES exclusively in the nucleus and represses AES mediated TCF/LEF-1 reporter transcription. These results suggest that LRP6-ICD can differentially modulate Wnt pathway transcriptional activity depending upon its subcellular localization and differential protein-protein interactions.	[Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Rochester, Dept Physiol, Rochester, NY 14642 USA; [Beagle, Brandon; Johnson, Gail V. W.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; University of Rochester; University of Alabama System; University of Alabama Birmingham	Beagle, B (corresponding author), Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [F31 AG030788]; NATIONAL INSTITUTE ON AGING [F31AG030788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health; Contract grant number: F31 AG030788. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Bajoghli B, 2007, DEV GENES EVOL, V217, P613, DOI 10.1007/s00427-007-0167-y; Bardwell L, 2008, CURR BIOL, V18, pR910, DOI 10.1016/j.cub.2008.07.082; Beagle B, 2009, J CELL BIOCHEM, V108, P886, DOI 10.1002/jcb.22318; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Courey AJ, 2001, GENE DEV, V15, P2786; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Katayama R, 2010, J CELL SCI, V123, P23, DOI 10.1242/jcs.058602; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Louie SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004310; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MALLO M, 1995, DEV DYNAM, V204, P338, DOI 10.1002/aja.1002040311; Mallo M, 1995, CELL MOL BIOL RES, V41, P435; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mi KH, 2007, J NEUROCHEM, V101, P517, DOI 10.1111/j.1471-4159.2007.04447.x; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Rave-Harel N, 2005, J BIOL CHEM, V280, P30975, DOI 10.1074/jbc.M502315200; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; SAKAI T, MOL BIOL EVOL, V27, P1097; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tago K, 2000, GENE DEV, V14, P1741; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Tezuka N, 2007, BIOCHEM BIOPH RES CO, V356, P648, DOI 10.1016/j.bbrc.2007.03.019; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yokomizo T, 2008, GENE DEV, V22, P960, DOI 10.1101/gad.1669908; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao JS, 2009, TRENDS BIOTECHNOL, V27, P131, DOI 10.1016/j.tibtech.2008.11.007	60	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11821	10.1371/journal.pone.0011821	http://dx.doi.org/10.1371/journal.pone.0011821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676368	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520100008
J	Delhanty, PJD; Sun, YX; Visser, JA; van Kerkwijk, A; Huisman, M; van IJcken, WFJ; Swagemakers, S; Smith, RG; Themmen, APN; van der Lely, AJ				Delhanty, Patric J. D.; Sun, Yuxiang; Visser, Jenny A.; van Kerkwijk, Anke; Huisman, Martin; van IJcken, Wilfred F. J.; Swagemakers, Sigrid; Smith, Roy G.; Themmen, Axel P. N.; van der Lely, Aart-Jan			Unacylated Ghrelin Rapidly Modulates Lipogenic and Insulin Signaling Pathway Gene Expression in Metabolically Active Tissues of GHSR Deleted Mice	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; DES-ACYL GHRELIN; GLUCOSE-UPTAKE; ENDOTHELIAL LIPASE; LIPID-METABOLISM; DESACYL GHRELIN; SKELETAL-MUSCLE; ADIPOCYTES; SENSITIVITY; OBESITY	Background: There is increasing evidence that unacylated ghrelin (UAG) improves insulin sensitivity and glucose homeostasis; however, the mechanism for this activity is not fully understood since a UAG receptor has not been discovered. Methodology/Principal Findings: To assess potential mechanisms of UAG action in vivo, we examined rapid effects of UAG on genome-wide expression patterns in fat, muscle and liver of growth hormone secretagogue receptor (GHSR)-ablated mice using microarrays. Expression data were analyzed using Ingenuity Pathways Analysis and Gene Set Enrichment Analysis. Regulation of subsets of these genes was verified by quantitative PCR in an independent experiment. UAG acutely regulated clusters of genes involved in glucose and lipid metabolism in all three tissues, consistent with enhancement of insulin sensitivity. Conclusions/Significance: Fat, muscle and liver are central to the control of lipid and glucose homeostasis. UAG rapidly modulates the expression of metabolically important genes in these tissues in GHSR-deleted mice indicating a direct, GHSR-independent, action of UAG to improve insulin sensitivity and metabolic profile.	[Delhanty, Patric J. D.; Visser, Jenny A.; van Kerkwijk, Anke; Huisman, Martin; Themmen, Axel P. N.; van der Lely, Aart-Jan] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Ctr Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Sun, Yuxiang] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Smith, Roy G.] Scripps Res Inst Florida, Dept Metab & Aging, Jupiter, FL USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Baylor University; United States Department of Agriculture (USDA); Baylor College of Medicine; Scripps Research Institute	Delhanty, PJD (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	p.delhanty@erasmusmc.nl	Visser, Jenny A./F-8156-2011; van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301	ZonMW, The Netherlands [91203022]; Alize Pharma SAS, Lyon, France; NATIONAL INSTITUTE ON AGING [R01AG019230] Funding Source: NIH RePORTER	ZonMW, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Alize Pharma SAS, Lyon, France; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Financial support for the study was provided by a Programme Grant from ZonMW, The Netherlands (#91203022) and Alize Pharma SAS, Lyon, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Andrews ZB, 2010, ENDOCRINOLOGY, V151, P2078, DOI 10.1210/en.2009-0850; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BROGLIO F, 2007, 89 END SOC M TOR, P89; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Florian M, 2010, ENDOCRINOLOGY, V151, P482, DOI 10.1210/en.2009-0624; Gauna C, 2004, J CLIN ENDOCR METAB, V89, P5035, DOI 10.1210/jc.2004-0363; Gauna C, 2005, J CLIN ENDOCR METAB, V90, P1055, DOI 10.1210/jc.2004-1069; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Granata R, 2010, J MOL ENDOCRINOL, V45, P9, DOI 10.1677/JME-09-0141; Greco AV, 2002, DIABETES, V51, P144, DOI 10.2337/diabetes.51.1.144; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Heijboer AC, 2006, DIABETOLOGIA, V49, P732, DOI 10.1007/s00125-006-0138-2; Herrema H, 2008, HEPATOLOGY, V47, P1894, DOI 10.1002/hep.22284; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inhoff T, 2008, PEPTIDES, V29, P2159, DOI 10.1016/j.peptides.2008.09.014; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lamarche B, 2007, CURR OPIN LIPIDOL, V18, P298, DOI 10.1097/MOL.0b013e328133857f; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lee ES, 2008, REGUL PEPTIDES, V151, P71, DOI 10.1016/j.regpep.2008.05.001; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Liu JH, 2008, J CLIN ENDOCR METAB, V93, P1980, DOI 10.1210/jc.2007-2235; Mano-Otagiri A, 2009, J ENDOCRINOL, V201, P341, DOI 10.1677/JOE-08-0374; Muccioli G, 2004, EUR J PHARMACOL, V498, P27, DOI 10.1016/j.ejphar.2004.07.066; Palmer DG, 2002, BIOCHEM BIOPH RES CO, V291, P439, DOI 10.1006/bbrc.2002.6467; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qiu GS, 2009, ARTERIOSCL THROM VAS, V29, P84, DOI 10.1161/ATVBAHA.108.176487; Ross DA, 2006, MOL ENDOCRINOL, V20, P698, DOI 10.1210/me.2005-0325; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Scroyen I, 2009, THROMB HAEMOSTASIS, V101, P388, DOI 10.1160/TH08-06-0401; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang WZ, 2008, ENDOCRINOLOGY, V149, P4710, DOI 10.1210/en.2008-0263; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	57	92	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11749	10.1371/journal.pone.0011749	http://dx.doi.org/10.1371/journal.pone.0011749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668691	Green Published, Green Submitted, gold			2022-12-27	WOS:000280297300003
J	Higgs, R; Lazzari, E; Wynne, C; Gabhann, JN; Espinosa, A; Wahren-Herlenius, M; Jefferies, CA				Higgs, Rowan; Lazzari, Elisa; Wynne, Claire; Gabhann, Joan Ni; Espinosa, Alexander; Wahren-Herlenius, Marie; Jefferies, Caroline A.			Self Protection from Anti-Viral Responses-Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors	PLOS ONE			English	Article							INTERFERON-ALPHA INDUCTION; IFN REGULATORY FACTOR-3; INNATE IMMUNE-RESPONSE; TRIM FAMILY PROTEINS; I INTERFERON; GENE-EXPRESSION; MEDIATED DEGRADATION; AUTOANTIGEN RO52; E3 LIGASE; UBIQUITINATION	Ro52 is a member of the TRIM family of single-protein E3 ligases and is also a target for autoantibody production in systemic lupus erythematosus and Sjogren's syndrome. We previously demonstrated a novel function of Ro52 in the ubiquitination and proteasomal degradation of IRF3 following TLR3/4 stimulation. We now present evidence that Ro52 has a similar role in regulating the stability and activity of IRF7. Endogenous immunoprecipitation of Ro52-bound proteins revealed that IRF7 associates with Ro52, an effect which increases following TLR7 and TLR9 stimulation, suggesting that Ro52 interacts with IRF7 post-pathogen recognition. Furthermore, we show that Ro52 ubiquitinates IRF7 in a dose-dependent manner, resulting in a decrease in total IRF7 expression and a subsequent decrease in IFN-alpha production. IRF7 stability was increased in bone marrow-derived macrophages from Ro52-deficient mice stimulated with imiquimod or CpG-B, consistent with a role for Ro52 in the negative regulation of IRF7 signalling. Taken together, these results suggest that Ro52-mediated ubiquitination promotes the degradation of IRF7 following TLR7 and TLR9 stimulation. As Ro52 is known to be IFN-inducible, this system constitutes a negative-feedback loop that acts to protect the host from the prolonged activation of the immune response.	[Higgs, Rowan; Lazzari, Elisa; Wynne, Claire; Gabhann, Joan Ni; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut & RSCI Res Inst, Dublin 2, Ireland; [Espinosa, Alexander; Wahren-Herlenius, Marie] Karolinska Inst, Dept Med, Stockholm, Sweden	Royal College of Surgeons - Ireland; Karolinska Institutet	Higgs, R (corresponding author), Royal Coll Surgeons Ireland, Mol & Cellular Therapeut & RSCI Res Inst, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/O-6394-2019; Jefferies, Caroline/AAI-1543-2021; Wahren-Herlenius, Marie/AAN-6942-2021; Lazzari, Elisa/AAE-6437-2019	Lazzari, Elisa/0000-0001-5299-7525; Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Wahren-Herlenius, Marie/0000-0002-0915-7245; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952; Wynne, Claire/0000-0002-0481-8366	Science Foundation Ireland [05/PICA/B815, 08/IN.1/B2091]; Health Research Board (HRB) in Ireland [PHD/2007/11, RFP/2006/121]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (HRB) in Ireland	This work was supported by funding from Science Foundation Ireland (http://www.sfi.ie/home/index.asp) under grant no. 05/PICA/B815 and 08/IN.1/B2091, and from the Health Research Board (HRB) in Ireland (http://www.hrb.ie/) under Grant No PHD/2007/11 and RFP/2006/121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Bolland S, 2009, J EXP MED, V206, P1647, DOI 10.1084/jem.20091507; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Saira K, 2007, J VIROL, V81, P3077, DOI 10.1128/JVI.02064-06; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wahren-Herlenius M, 1999, IMMUNOL TODAY, V20, P234, DOI 10.1016/S0167-5699(99)01458-9; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	33	92	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11776	10.1371/journal.pone.0011776	http://dx.doi.org/10.1371/journal.pone.0011776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668674	Green Published, gold, Green Submitted			2022-12-27	WOS:000280297300011
J	Guo, JY; Ye, GY; Dong, SZ; Liu, SS				Guo, Jian-Yang; Ye, Gong-Yin; Dong, Sheng-Zhang; Liu, Shu-Sheng			An Invasive Whitefly Feeding on a Virus-Infected Plant Increased Its Egg Production and Realized Fecundity	PLOS ONE			English	Article							LEAF CURL-VIRUS; BEMISIA-TABACI HEMIPTERA; GRAIN APHID HOMOPTERA; NON-B-BIOTYPE; TOMATO; TRANSMISSION; BEGOMOVIRUSES; ALEYRODIDAE; ACQUISITION; GEMINIVIRUS	Background: Plant-pathogenic begomoviruses have a complex association with their insect vectors. The interactions of begomoviruses and reproduction of their vectors are poorly understood. Bemisia tabaci is known to transmit many begomoviruses, and the spread of B. tabaci, especially the B and Q 'biotypes', has been accompanied by the epidemics of begomoviruses. One of these identified disease-causing agents was Tomato yellow leaf curl China virus (TYLCCNV). Methodology/Principal Findings: In this study, we compared the egg production and realized fecundity of two 'biotypes' or putative species of the whitefly B. tabaci, including the alien invasive B and the indigenous ZHJ1 from Zhejiang, China, feeding on either healthy or TYLCCNV-infected tobacco plants. The ovary of the whitefly was composed of 12-22 telotrophic ovarioles. According to the morphology of the oocytes and level of yolk content, oocytes in ovarioles were divided into four developmental phases (I-IV). Significantly higher proportion of immature oocytes (phase II, III) and mature oocytes (phase IV) was observed in ovary of females that fed on TYLCCNV-infected tobacco compared to that on healthy plants. Moreover, there was significant increase of eggs laid of B whitefly that fed on TYLCCNV-infected tobacco plants during the early developmental stages. In contrast, the proportion of oocytes of different developmental phases and eggs laid had no significant differences between ZHJ1 whiteflies feeding on TYLCCNV-infected and non-infected host plants. Conclusions/Significance: The invasive B whitefly benefits from feeding on a begomovirus-infected plant through increased egg production and realized fecundity.	[Guo, Jian-Yang; Ye, Gong-Yin; Liu, Shu-Sheng] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci,Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, Sheng-Zhang] China Jiliang Univ, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; China Jiliang University	Guo, JY (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci,Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	chu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013	Dong, Shengzhang/0000-0002-8218-4688	National Nature Science Foundation of China [30730061]; National Basic Research Programme of China [2009CB119203]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programme of China(National Basic Research Program of China)	Financial support from the National Nature Science Foundation of China (30730061) (http://www.nsfc.gov.cn/Portal0/default124.htm) and the National Basic Research Programme of China (2009CB119203) (http://www.most.gov.cn/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Colvin J, 2004, PLANT PATHOL, V53, P577, DOI 10.1111/j.0032-0862.2004.01062.x; Costa HS, 1996, ANN ENTOMOL SOC AM, V89, P694, DOI 10.1093/aesa/89.5.694; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; FERERES A, 1989, ENVIRON ENTOMOL, V18, P388, DOI 10.1093/ee/18.3.388; GAMEEL O I, 1974, Revue de Zoologie Africaine, V88, P784; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jiu M, 2006, J PHYTOPATHOL, V154, P587, DOI 10.1111/j.1439-0434.2006.01151.x; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Lambiase S, 1997, INT J INSECT MORPHOL, V26, P9, DOI 10.1016/S0020-7322(97)88103-2; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; LI M, 2010, J PEST MANA IN PRESS, V56, DOI DOI 10.1111/J.1744-7917.2010.01354.X; Li ZH, 2005, PHYTOPATHOLOGY, V95, P902, DOI 10.1094/PHYTO-95-0902; Li Zheng-Xi, 2005, Insect Science, V12, P421, DOI 10.1111/j.1744-7917.2005.00053.x; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mann RS, 2008, FLA ENTOMOL, V91, P249, DOI 10.1653/0015-4040(2008)91[249:POBTHA]2.0.CO;2; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; McKenzie CL, 2002, FLA ENTOMOL, V85, P367, DOI 10.1653/0015-4040(2002)085[0367:EOTMVT]2.0.CO;2; McKenzie CL, 2002, ARCH INSECT BIOCHEM, V49, P203, DOI 10.1002/arch.10020; MEHTA P, 1994, J ECON ENTOMOL, V87, P1291, DOI 10.1093/jee/87.5.1291; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Polston JE, 2008, J INSECT SCI, V8, P39; Pyka-Fosciak G, 2008, INT J DEV BIOL, V52, P259, DOI 10.1387/ijdb.072338gp; QUIROZ C, 1991, J ECON ENTOMOL, V84, P1920, DOI 10.1093/jee/84.6.1920; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Sinisterra XH, 2005, J GEN VIROL, V86, P1525, DOI 10.1099/vir.0.80665-0; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Szklarzewicz T, 2001, PROTOPLASMA, V218, P45, DOI 10.1007/BF01288359; SZKLARZEWICZ T, 2008, ACTA ZOOLOGICA, V90, P123; Tang Q., 2007, DPS DATA PROCESSING; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zang Lian-Sheng, 2005, Acta Entomologica Sinica, V48, P742; ZEIDAN M, 1991, J GEN VIROL, V72, P2607, DOI 10.1099/0022-1317-72-11-2607; Zhou XP, 2003, J GEN VIROL, V84, P237, DOI 10.1099/vir.0.18608-0	48	38	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11713	10.1371/journal.pone.0011713	http://dx.doi.org/10.1371/journal.pone.0011713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20676356	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300016
J	Barone, MV; Nanayakkara, M; Paolella, G; Maglio, M; Vitale, V; Troiano, R; Ribecco, MTS; Lania, G; Zanzi, D; Santagata, S; Auricchio, R; Troncone, R; Auricchio, S				Barone, Maria Vittoria; Nanayakkara, Merlin; Paolella, Giovanni; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore			Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation	PLOS ONE			English	Article							CELIAC-DISEASE; INTRAEPITHELIAL LYMPHOCYTES; IMMUNE-RESPONSE; ALPHA-GLIADIN; HRS; PROTEIN; ACTIVATION; CHALLENGE; RECEPTOR; MUCOSA	Background: Celiac Disease (CD) is both a frequent disease (1:100) and an interesting model of a disease induced by food. It consists in an immunogenic reaction to wheat gluten and glutenins that has been found to arise in a specific genetic background; however, this reaction is still only partially understood. Activation of innate immunity by gliadin peptides is an important component of the early events of the disease. In particular the so-called "toxic'' A-gliadin peptide P31-43 induces several pleiotropic effects including Epidermal Growth Factor Receptor (EGFR)-dependent actin remodelling and proliferation in cultured cell lines and in enterocytes from CD patients. These effects are mediated by delayed EGFR degradation and prolonged EGFR activation in endocytic vesicles. In the present study we investigated the effects of gliadin peptides on the trafficking and maturation of endocytic vesicles. Methods/Principal Findings: Both P31-43 and the control P57-68 peptide labelled with fluorochromes were found to enter CaCo-2 cells and interact with the endocytic compartment in pulse and chase, time-lapse, experiments. P31-43 was localised to vesicles carrying early endocytic markers at time points when P57-68-carrying vesicles mature into late endosomes. In time-lapse experiments the trafficking of P31-43-labelled vesicles was delayed, regardless of the cargo they were carrying. Furthermore in celiac enterocytes, from cultured duodenal biopsies, P31-43 trafficking is delayed in early endocytic vesicles. A sequence similarity search revealed that P31-43 is strikingly similar to Hrs, a key molecule regulating endocytic maturation. A-gliadin peptide P31-43 interfered with Hrs correct localisation to early endosomes as revealed by western blot and immunofluorescence microscopy. Conclusions: P31-43 and P57-68 enter cells by endocytosis. Only P31-43 localises at the endocytic membranes and delays vesicle trafficking by interfering with Hrs-mediated maturation to late endosomes in cells and intestinal biopsies. Consequently, in P31-43-treated cells, Receptor Tyrosin Kinase (RTK) activation is extended. This finding may explain the role played by gliadin peptides in inducing proliferation and other effects in enterocytes from CD biopsies.	[Barone, Maria Vittoria; Nanayakkara, Merlin; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Barone, Maria Vittoria; Nanayakkara, Merlin; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Paolella, Giovanni; Ribecco, Maria Teresa Silvia] CEINGE Biotecnol Avanzate, Naples, Italy; [Paolella, Giovanni] Univ Naples Federico II, Dept Biochem, Naples, Italy	University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Barone, MV (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	salauric@unina.it	santagata, sara/AAA-5225-2020; AURICCHIO, RENATA/AAC-7718-2022	santagata, sara/0000-0001-8680-084X; Ribecco, Maria Teresa Silvia/0000-0003-3278-9221; NANAYAKKARA, MERLIN/0000-0002-2569-4606; BARONE, Maria Vittoria/0000-0001-6190-4917	LEGGE	LEGGE	Grant Support: LEGGE (Regional Low) 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; AURICCHIO S, 1982, PEDIATR RES, V16, P1004, DOI 10.1203/00006450-198212000-00006; AURICCHIO S, 1984, BIOCHEM BIOPH RES CO, V121, P428, DOI 10.1016/0006-291X(84)90200-6; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Bouamr F, 2007, J VIROL, V81, P2909, DOI 10.1128/JVI.01413-06; Cantarella C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S12; CAPUTO I, 2010, BBA MOL BAS IN PRESS; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Ciclitira PJ, 1998, DIGEST DIS, V16, P337, DOI 10.1159/000016887; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; FRIIS S, 1992, GUT, V33, P1487, DOI 10.1136/gut.33.11.1487; Giovannini C, 2000, TOXICOLOGY, V145, P63, DOI 10.1016/S0300-483X(99)00223-1; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Lahteenoja H, 2000, AM J GASTROENTEROL, V95, P2880, DOI 10.1016/S0002-9270(00)01049-2; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Maiuri L, 1996, SCAND J GASTROENTERO, V31, P247, DOI 10.3109/00365529609004874; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2001, AM J GASTROENTEROL, V96, P150; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; SAVIDGE TC, 1995, GUT, V36, P321, DOI 10.1136/gut.36.3.321; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Vilasi S, 2010, J MOL RECOGNIT, V23, P322, DOI 10.1002/jmr.987; WRIGHT N, 1973, GUT, V14, P603, DOI 10.1136/gut.14.8.603; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; Zimmer KP, 1998, FASEB J, V12, P1349, DOI 10.1096/fasebj.12.13.1349	50	50	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12246	10.1371/journal.pone.0012246	http://dx.doi.org/10.1371/journal.pone.0012246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805894	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600018
J	Nourissat, G; Diop, A; Maurel, N; Salvat, C; Dumont, S; Pigenet, A; Gosset, M; Houard, X; Berenbaum, F				Nourissat, Geoffroy; Diop, Amadou; Maurel, Nathalie; Salvat, Colette; Dumont, Sylvie; Pigenet, Audrey; Gosset, Marjolaine; Houard, Xavier; Berenbaum, Francis			Mesenchymal Stem Cell Therapy Regenerates the Native Bone-Tendon Junction after Surgical Repair in a Degenerative Rat Model	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; FULL-THICKNESS TEARS; CHONDROGENIC DIFFERENTIATION; SUPRASPINATUS TENDON; GROWTH-FACTORS; CARTILAGE; TISSUE; AUGMENTATION; CHONDROCYTES; DEFECTS	Background: The enthesis, which attaches the tendon to the bone, naturally disappears with aging, thus limiting joint mobility. Surgery is frequently needed but the clinical outcome is often poor due to the decreased natural healing capacity of the elderly. This study explored the benefits of a treatment based on injecting chondrocyte and mesenchymal stem cells (MSC) in a new rat model of degenerative enthesis repair. Methodology: The Achilles' tendon was cut and the enthesis destroyed. The damage was repaired by classical surgery without cell injection (group G1, n = 52) and with chondrocyte (group G2, n = 51) or MSC injection (group G3, n = 39). The healing rate was determined macroscopically 15, 30 and 45 days later. The production and organization of a new enthesis was assessed by histological scoring of collagen II immunostaining, glycoaminoglycan production and the presence of columnar chondrocytes. The biomechanical load required to rupture the bone-tendon junction was determined. Principal Findings: The spontaneous healing rate in the G1 control group was 40%, close to those observed in humans. Cell injection significantly improved healing (69%, p = 0.0028 for G2 and p = 0.006 for G3) and the load-to-failure after 45 days (p<0.05) over controls. A new enthesis was clearly produced in cell-injected G2 and G3 rats, but not in the controls. Only the MSC-injected G3 rats had an organized enthesis with columnar chondrocytes as in a native enthesis 45 days after surgery. Conclusions: Cell therapy is an efficient procedure for reconstructing degenerative entheses. MSC treatment produced better organ regeneration than chondrocyte treatment. The morphological and biomechanical properties were similar to those of a native enthesis.	[Nourissat, Geoffroy; Salvat, Colette; Pigenet, Audrey; Gosset, Marjolaine; Houard, Xavier; Berenbaum, Francis] Univ Paris 06, UR 4, Paris, France; [Diop, Amadou; Maurel, Nathalie] Arts & Metiers ParisTech, Biomech & Bone Remodeling EPBRO, Paris, France; [Dumont, Sylvie] Univ Paris 06, St Antoine Hosp, AP HP, Dept Anatomopathol, Paris, France; [Berenbaum, Francis] Univ Paris 06, St Antoine Hosp, AP HP, Dept Rheumatol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Arts et Metiers Institute of Technology; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Nourissat, G (corresponding author), Univ Paris 06, UR 4, Paris, France.	francis.berenbaum@sat.aphp.fr	Berenbaum, Francis/AAO-5690-2020; Gosset, Marjolaine/ACE-0183-2022	Berenbaum, Francis/0000-0001-8252-7815; Gosset, Marjolaine/0000-0002-4875-7892	SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique)	SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique)	This work was funded by a grant from SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; BEST TM, 1993, J ORTHOP RES, V11, P897, DOI 10.1002/jor.1100110617; Blum EK, 2007, J BIOMECH, V40, P891, DOI 10.1016/j.jbiomech.2006.03.003; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Burkhart SS, 2006, J AM ACAD ORTHOP SUR, V14, P333, DOI 10.5435/00124635-200606000-00003; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Derwin KA, 2007, J SHOULDER ELB SURG, V16, p140S, DOI 10.1016/j.jse.2007.04.002; Funakoshi T, 2006, J SHOULDER ELB SURG, V15, P112, DOI 10.1016/j.jse.2005.05.012; Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/0363546504272689; Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Gerber C, 1999, J BONE JOINT SURG AM, V81A, P1281, DOI 10.2106/00004623-199909000-00009; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goutallier D, 2005, REV CHIR ORTHOP, V91, P109, DOI 10.1016/S0035-1040(05)84287-4; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Gupta R, 2007, J SHOULDER ELB SURG, V16, p149S, DOI 10.1016/j.jse.2007.05.002; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524; Im GI, 2006, TISSUE ENG, V12, P527, DOI 10.1089/ten.2006.12.527; Kim DH, 2006, AM J SPORT MED, V34, P407, DOI 10.1177/0363546505281238; Kovacevic D, 2008, CLIN ORTHOP RELAT R, V466, P622, DOI 10.1007/s11999-007-0112-4; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Liu JH, 2004, ARCH SURG-CHICAGO, V139, P423, DOI 10.1001/archsurg.139.4.423; Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Murrell G A, 1993, Foot Ankle, V14, P400; Park JY, 2008, AM J SPORT MED, V36, P1310, DOI 10.1177/0363546508315039; Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790; Randolph MA, 2003, CLIN PLAST SURG, V30, P519, DOI 10.1016/S0094-1298(03)00070-1; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228; Tytherleigh-Strong G, 2001, CURR OPIN RHEUMATOL, V13, P135, DOI 10.1097/00002281-200103000-00007; Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666; Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049; WOO SL, 1987, INJURY REPAIR MUSCUL, P126; Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835	43	90	97	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12248	10.1371/journal.pone.0012248	http://dx.doi.org/10.1371/journal.pone.0012248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805884	Green Submitted, Green Published, gold			2022-12-27	WOS:000281011600020
J	Xie, JL; Vilchez, I; Mateos, M				Xie, Jialei; Vilchez, Igor; Mateos, Mariana			Spiroplasma Bacteria Enhance Survival of Drosophila hydei Attacked by the Parasitic Wasp Leptopilina heterotoma	PLOS ONE			English	Article							NATURAL-POPULATIONS; SYMBIONT INFECTION; ENDOSYMBIONTS; WOLBACHIA; INSECTS; APHIDS; COLEOPTERA; RESISTANCE; CARDINIUM; DIVERSITY	Background: Maternally-transmitted associations between endosymbiotic bacteria and insects are ubiquitous. While many of these associations are obligate and mutually beneficial, many are facultative, and the mechanism(s) by which these microbes persist in their host lineages remain elusive. Inherited microbes with imperfect transmission are expected to be lost from their host lineages if no other mechanisms increase their persistence (i.e., host reproductive manipulation and/or fitness benefits to host). Indeed numerous facultative heritable endosymbionts are reproductive manipulators. Nevertheless, many do not manipulate reproduction, so they are expected to confer fitness benefits to their hosts, as has been shown in several studies that report defense against natural enemies, tolerance to environmental stress, and increased fecundity. Methodology/Principal Findings: We examined whether larval to adult survival of Drosophila hydei against attack by a common parasitoid wasp (Leptopilina heterotoma), differed between uninfected flies and flies that were artificially infected with Spiroplasma, a heritable endosymbiont of Drosophila hydei that does not appear to manipulate host reproduction. Survival was significantly greater for Spiroplasma-infected flies, and the effect of Spiroplasma infection was most evident during the host's pupal stage. We examined whether or not increased survival of Spiroplasma-infected flies was due to reduced oviposition by the wasp (i.e., pre-oviposition mechanism). The number of wasp eggs per fly larva did not differ significantly between Spiroplasma-free and Spiroplasma-infected fly larvae, suggesting that differential fly survival is due to a post-oviposition mechanism. Conclusions/Significance: Our results suggest that Spiroplasma confers protection to D. hydei against wasp parasitism. This is to our knowledge the first report of a potential defensive mutualism in the genus Spiroplasma. Whether it explains the persistence and high abundance of this strain in natural populations of D. hydei, as well as the widespread distribution of heritable Spiroplasma in Drosophila and other arthropods, remains to be investigated.	[Xie, Jialei; Vilchez, Igor; Mateos, Mariana] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Xie, JL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	mmateos@tamu.edu	Xie, Jialei/J-2516-2019; Mateos, Mariana/B-5235-2008	Xie, Jialei/0000-0001-6208-5749; Mateos, Mariana/0000-0001-5738-0145	National Institutes of Health (NIH) [R03 AI078348]; National Science Foundation (NSF) [DEB 0743782]; Texas AM University; Chinese Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078348] Funding Source: NIH RePORTER; Direct For Biological Sciences [0743782] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Texas AM University; Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health (NIH) grant R03 AI078348 and National Science Foundation (NSF) grant DEB 0743782 to MM and Texas A&M University. The Chinese Scholarship Council provided funding for JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER K, 1990, NETH J ZOOL, V40, P514, DOI 10.1163/156854290X00064; Bi K, 2008, J INVERTEBR PATHOL, V99, P57, DOI 10.1016/j.jip.2008.06.008; Carton Y., 1986, P347; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chiu H, 2002, CELL DEATH DIFFER, V9, P1379, DOI 10.1038/sj.cdd.4401134; COHEN AJ, 1987, ISRAEL J MED SCI, V23, P429; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Enigl M, 2007, EXP APPL ACAROL, V42, P75, DOI 10.1007/s10493-007-9080-3; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; Gasparich GE, 2002, FRONT BIOSCI, V7, pD619, DOI 10.2741/gaspari; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hemerik L, 2003, ENTOMOL EXP APPL, V107, P81, DOI 10.1046/j.1570-7458.2003.00032.x; Henning K, 2006, INT J MED MICROBIOL, V296, P157, DOI 10.1016/j.ijmm.2006.01.012; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Lasalle John, 1993, P1; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Martin OY, 2009, J ARACHNOL, V37, P106, DOI 10.1636/SH08-05.1; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Montenegro H, 2006, J ZOOL SYST EVOL RES, V44, P130, DOI 10.1111/j.1439-0469.2006.00353.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moro CV, 2009, RES MICROBIOL, V160, P63, DOI 10.1016/j.resmic.2008.10.006; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; OTA T, 1979, J HERED, V70, P211, DOI 10.1093/oxfordjournals.jhered.a109235; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; RIZKI TM, 1994, ANN NY ACAD SCI, V712, P178, DOI 10.1111/j.1749-6632.1994.tb33572.x; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schutte C, 2008, EXP APPL ACAROL, V46, P307, DOI 10.1007/s10493-008-9188-0; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thiel A, 2009, ADV PARASIT, V70, P45, DOI 10.1016/S0065-308X(09)70002-8; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Tsuchida T, 2006, APPL ENTOMOL ZOOL, V41, P129, DOI 10.1303/aez.2006.129; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Watts T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005703; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]	51	167	176	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12149	10.1371/journal.pone.0012149	http://dx.doi.org/10.1371/journal.pone.0012149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730104	Green Published, Green Submitted, gold			2022-12-27	WOS:000280862200009
J	Bohbot, JD; Dickens, JC				Bohbot, Jonathan D.; Dickens, Joseph C.			Insect Repellents: Modulators of Mosquito Odorant Receptor Activity	PLOS ONE			English	Article							AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; ALLOSTERIC SITE; DEET; DIPTERA; CULICIDAE; OVIPOSITION; INHIBITION; RESPONSES; SS220	Background: DEET, 2-undecanone (2-U), IR3535 and Picaridin are widely used as insect repellents to prevent interactions between humans and many arthropods including mosquitoes. Their molecular action has only recently been studied, yielding seemingly contradictory theories including odorant-dependent inhibitory and odorant-independent excitatory activities on insect olfactory sensory neurons (OSNs) and odorant receptor proteins (ORs). Methodology/Principal Findings: Here we characterize the action of these repellents on two Aedes aegypti ORs, AaOR2 and AaOR8, individually co-expressed with the common co-receptor AaOR7 in Xenopus oocytes; these ORs are respectively activated by the odors indole (AaOR2) and (R)-(2)-1-octen3-ol (AaOR8), odorants used to locate oviposition sites and host animals. In the absence of odorants, DEET activates AaOR2 but not AaOR8, while 2-U activates AaOR8 but not AaOR2; IR3535 and Picaridin do not activate these ORs. In the presence of odors, DEET strongly inhibits AaOR8 but not AaOR2, while 2-U strongly inhibits AaOR2 but not AaOR8; IR3535 and Picaridin strongly inhibit both ORs. Conclusions/Significance: These data demonstrate that repellents can act as olfactory agonists or antagonists, thus modulating OR activity, bringing concordance to conflicting models.	[Bohbot, Jonathan D.; Dickens, Joseph C.] ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Bohbot, JD (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA.	joseph.dickens@ars.usda.gov	Dickens, Dick/AGY-7295-2022		US Department of Defense through the Armed Forces Pest Management Board (AFPMB)	US Department of Defense through the Armed Forces Pest Management Board (AFPMB)(United States Department of Defense)	This work was supported in part by a grant to J.C.D. from the Deployed War Fighter Protection (DWFP) Research Program, funded by the US Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bissinger BW, 2009, EXP APPL ACAROL, V48, P239, DOI 10.1007/s10493-008-9235-x; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; Debboun M, 2007, INSECT REPELLENTS PR; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; FARRAR RR, 1987, ENTOMOL EXP APPL, V43, P17, DOI 10.1007/BF00350369; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Haas Sebastian, 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P127; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hill SR, 2009, CHEM SENSES, V34, P231, DOI 10.1093/chemse/bjn080; Hoffmann EJ, 2003, J MED ENTOMOL, V40, P607, DOI 10.1603/0022-2585-40.5.607; Hoffmann EJ, 2002, J MED ENTOMOL, V39, P935, DOI 10.1603/0022-2585-39.6.935; Hogenkamp DJ, 2007, J MED CHEM, V50, P3369, DOI 10.1021/jm070083v; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; KUTHIALA A, 1992, J MED ENTOMOL, V29, P639, DOI 10.1093/jmedent/29.4.639; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MCCABE ET, 1954, J ORG CHEM, V19, P493, DOI 10.1021/jo01369a003; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Plettner E, 2010, J AGR FOOD CHEM, V58, P3708, DOI 10.1021/jf904139e; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; SCHRECK CE, 1970, J ECON ENTOMOL, V63, P1576, DOI 10.1093/jee/63.5.1576; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; SUMIKAWA K, 1981, NATURE, V292, P862, DOI 10.1038/292862a0; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; WANG G, 2010, PLOS ONE, V4, pE7032; Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	44	94	104	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12138	10.1371/journal.pone.0012138	http://dx.doi.org/10.1371/journal.pone.0012138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20725637	Green Published, gold, Green Submitted			2022-12-27	WOS:000280849100033
J	Cox, B; Briscoe, J; Ulloa, F				Cox, Barny; Briscoe, James; Ulloa, Fausto			SUMOylation by Pias1 Regulates the Activity of the Hedgehog Dependent Gli Transcription Factors	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC HEDGEHOG; NEGATIVE REGULATOR; NEURAL-TUBE; SPINAL-CORD; SUPPRESSOR; DEGRADATION; MODIFIER; PHOSPHORYLATION; UBIQUITINATION	Background: Hedgehog (Hh) signaling, a vital signaling pathway for the development and homeostasis of vertebrate tissues, is mediated by members of the Gli family of zinc finger transcription factors. Hh signaling increases the transcriptional activity of Gli proteins, at least in part, by inhibiting their proteolytic processing. Conversely, phosphorylation by cAMP-dependent protein kinase (PKA) inhibits Gli transcriptional activity by promoting their ubiquitination and proteolysis. Whether other post-translational modifications contribute to the regulation of Gli protein activity has been unclear. Methodology/Principal Findings: Here we provide evidence that all three Gli proteins are targets of small ubiquitin-related modifier (SUMO)-1 conjugation. Expression of SUMO-1 or the SUMO E3 ligase, Pias1, increased Gli transcriptional activity in cultured cells. Moreover, PKA activity reduced Gli protein SUMOylation. Strikingly, in the embryonic neural tube, the forced expression of Pias1 increased Gli activity and induced the ectopic expression of the Gli dependent gene Nkx2.2. Conversely, a point mutant of Pias1, that lacks ligase activity, blocked the endogenous expression of Nkx2.2. Conclusions/Significance: Together, these findings provide evidence that Pias1-dependent SUMOylation influences Gli protein activity and thereby identifies SUMOylation as a post-translational mechanism that regulates the hedgehog signaling pathway.	[Cox, Barny; Briscoe, James; Ulloa, Fausto] Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Cox, B (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	james.briscoe@nimr.mrc.ac.uk	Ulloa, Fausto/AAB-2787-2019	Briscoe, James/0000-0002-1020-5240	Medical Research Council (United Kingdom); European Molecular Biology Organization; Medical Research Council [MC_U117560541] Funding Source: researchfish; MRC [MC_U117560541] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom). F. U. was supported by an European Molecular Biology Organization Long-Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chari NS, 2007, ADV ANAT PATHOL, V14, P344, DOI 10.1097/PAP.0b013e3180ca8a1d; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PHAM A, 1995, GENETICS, V140, P587; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	55	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11996	10.1371/journal.pone.0011996	http://dx.doi.org/10.1371/journal.pone.0011996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711444	gold, Green Published, Green Submitted			2022-12-27	WOS:000280849100003
J	Nakamura, K; Maki, N; Trinh, A; Trask, HW; Gui, JA; Tomlinson, CR; Tsonis, PA				Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.; Tsonis, Panagiotis A.			miRNAs in Newt Lens Regeneration: Specific Control of Proliferation and Evidence for miRNA Networking	PLOS ONE			English	Article							BREAST-CANCER CELLS; EPITHELIAL-CELLS; MICROARRAY DATA; UP-REGULATION; SELF-RENEWAL; STEM-CELLS; MICRORNA; EXPRESSION; DIFFERENTIATION; GROWTH	Background: Lens regeneration in adult newts occurs via transdifferentiation of the pigment epithelial cells (PECs) of the dorsal iris. The same source of cells from the ventral iris is not able to undergo this process. In an attempt to understand this restriction we have studied in the past expression patterns of miRNAs. Among several miRNAs we have found that mir-148 shows an up-regulation in the ventral iris, while members of the let-7 family showed down-regulation in dorsal iris during dedifferentiation. Methodology/Principal Findings: We have performed gain-and loss-of-function experiments of mir-148 and let-7b in an attempt to delineate their function. We find that up-regulation of mir-148 caused significant decrease in the proliferation rates of ventral PECs only, while up-regulation of let-7b affected proliferation of both dorsal and ventral PECs. Neither miRNA was able to affect lens morphogenesis or induction. To further understand how this effect of miRNA up-regulation is mediated we examined global expression of miRNAs after up-regulation of mir148 and let-7b. Interestingly, we identified a novel level of mirRNA regulation, which might indicate that miRNAs are regulated as a network. Conclusion/Significance: The major conclusion is that different miRNAs can control proliferation in the dorsal or ventral iris possibly by a different mechanism. Of interest is that down-regulation of the let-7 family members has also been documented in other systems undergoing reprogramming, such as in stem cells or oocytes. This might indicate that reprogramming during newt regeneration shares common molecular signatures with reprogramming in stem or germ cells. On the other hand that miRNAs can regulate the levels of other miRNAs is a novel level of regulation, which might provide new insights on their function.	[Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Nakamura, Kenta; Maki, Nobuyasu; Trinh, Albert; Tsonis, Panagiotis A.] Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA; [Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.] Dartmouth Coll, Dept Med, Lebanon, NH 03756 USA; [Trask, Heidi W.; Gui, Jiang; Tomlinson, Craig R.] Dartmouth Coll, Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA	University of Dayton; University of Dayton; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Nakamura, K (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	panagiotis.tsonis@notes.udayton.edu	Tomlinson, Craig/F-1319-2017	Tomlinson, Craig/0000-0003-0923-1449	National Institutes of Health (NIH) [EY10540]; NATIONAL EYE INSTITUTE [R01EY010540] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a National Institutes of Health (NIH) grant EY10540 to PAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Barh D, 2010, CURR ONCOL, V17, P70; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Del Rio-Tsonis K, 2003, DEV DYNAM, V226, P211, DOI 10.1002/dvdy.10224; DILEVA G, 2010, J NATL CANC I; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Faber J, 2008, CANCER CELL, V13, P467, DOI 10.1016/j.ccr.2008.05.013; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Grogg MW, 2005, NATURE, V438, P858, DOI 10.1038/nature04175; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hayashi T, 2002, DIFFERENTIATION, V70, P101, DOI 10.1046/j.1432-0436.2002.700205.x; HU Y, 2010, INT J CANC; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lan FF, 2010, INT J CANC; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; RAMACHANDRAN R, 2009, NEUROREHABILITATION, V23; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; SAWADA K, 1993, JPN J OPHTHALMOL, V37, P355; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Trask HW, 2009, RNA, V15, P1917, DOI 10.1261/rna.1677409; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xia HP, 2010, BIOCHEM BIOPH RES CO, V391, P535, DOI 10.1016/j.bbrc.2009.11.093; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhao Yue, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P526	54	32	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12058	10.1371/journal.pone.0012058	http://dx.doi.org/10.1371/journal.pone.0012058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711456	Green Submitted, gold, Green Published			2022-12-27	WOS:000280849100011
J	Richlan, F; Sturm, D; Schurz, M; Kronbichler, M; Ladurner, G; Wimmer, H				Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Ladurner, Gunther; Wimmer, Heinz			A Common Left Occipito-Temporal Dysfunction in Developmental Dyslexia and Acquired Letter-By-Letter Reading?	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; WHITE-MATTER; BRAIN CONNECTIVITY; CHILDREN; ABNORMALITIES; ORTHOGRAPHY; CORTEX; LENGTH; ENGLISH; FMRI	Background: We used fMRI to examine functional brain abnormalities of German-speaking dyslexics who suffer from slow effortful reading but not from a reading accuracy problem. Similar to acquired cases of letter-by-letter reading, the developmental cases exhibited an abnormal strong effect of length (i.e., number of letters) on response time for words and pseudowords. Results: Corresponding to lesions of left occipito-temporal (OT) regions in acquired cases, we found a dysfunction of this region in our developmental cases who failed to exhibit responsiveness of left OT regions to the length of words and pseudowords. This abnormality in the left OT cortex was accompanied by absent responsiveness to increased sublexical reading demands in phonological inferior frontal gyrus (IFG) regions. Interestingly, there was no abnormality in the left superior temporal cortex which-corresponding to the onological deficit explanation-is considered to be the prime locus of the reading difficulties of developmental dyslexia cases. Conclusions: The present functional imaging results suggest that developmental dyslexia similar to acquired letter-by-letter reading is due to a primary dysfunction of left OT regions.	[Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Wimmer, Heinz] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Richlan, Fabio; Sturm, Denise; Schurz, Matthias; Kronbichler, Martin; Wimmer, Heinz] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria; [Richlan, Fabio; Kronbichler, Martin; Ladurner, Gunther] Paracelsus Private Med Univ, Dept Neurol, Christian Doppler Clin, Salzburg, Austria	Salzburg University; Salzburg University; Paracelsus Private Medical University	Richlan, F (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.	fabio.richlan@sbg.ac.at	Richlan, Fabio/C-6285-2008; Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021	Richlan, Fabio/0000-0001-5373-3425; Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Schurz, Matthias/0000-0002-6344-9943	Austrian Science Foundation [P18832-B02]; European Union	Austrian Science Foundation(Austrian Science Fund (FWF)); European Union(European Commission)	This research was supported by grants of the Austrian Science Foundation (http://www.fwf.ac.at), grant number P18832-B02, and the European Union's 6th Framework Programme (http://ec.europa.eu/research/fp6), project NEURODYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro M, 2003, APPL PSYCHOLINGUIST, V24, P621, DOI 10.1017/S0142716403000316; Baayen R. H., 1993, CELEX LEXICAL DATABA; Barca L, 2006, BRAIN LANG, V98, P347, DOI 10.1016/j.bandl.2006.05.001; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; Bergmann J, 2008, COGN NEUROPSYCHOL, V25, P653, DOI 10.1080/02643290802221404; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Davies R, 2007, ANN DYSLEXIA, V57, P179, DOI 10.1007/s11881-007-0010-1; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 2008, COGN BEHAV NEUROL, V21, P227, DOI 10.1097/WNN.0b013e318190d162; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Eckert MA, 2005, CORTEX, V41, P304, DOI 10.1016/S0010-9452(08)70268-5; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Fiebach CJ, 2007, NEUROIMAGE, V36, P901, DOI 10.1016/j.neuroimage.2007.04.004; Frackowiak R.S.J., 2004, HUMAN BRAIN FUNCTION, V2nd ed, P793, DOI [10.1016/B978-012264841-0/50042-1, DOI 10.1016/B978-012264841-0/50042-1]; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; FRYE RE, 2010, CEREB CORTE IN PRESS; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gonzalez JEJ, 2000, J LEARN DISABIL-US, V33, P44, DOI 10.1177/002221940003300108; Hagtvet BE, 2003, DYSLEXIA DIFFERENT L, P181; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Henry C, 2005, NEUROPSYCHOLOGIA, V43, P1983, DOI 10.1016/j.neuropsychologia.2005.04.007; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Kronbichler M, 2008, HUM BRAIN MAPP, V29, P613, DOI 10.1002/hbm.20425; Kronbichler M, 2007, J COGNITIVE NEUROSCI, V19, P1584, DOI 10.1162/jocn.2007.19.10.1584; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K., 1997, SALZBURGER LESE RECH; Lyytinen H., 2006, HDB ORTHOGRAPHY LITE, P47; Maurer U, 2007, BRAIN, V130, P3200, DOI 10.1093/brain/awm193; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Porpodas C., 2006, HDB ORTHOGRAPHY LITE, P189; Pugh KR, 2008, J COGNITIVE NEUROSCI, V20, P1146, DOI 10.1162/jocn.2008.20079; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Sandak R, 2004, SCI STUD READ, V8, P273, DOI 10.1207/s1532799xssr0803_6; Schurz M, 2010, NEUROIMAGE, V49, P2649, DOI 10.1016/j.neuroimage.2009.10.082; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Sharma P., 2004, FAM BUS REV, V17, P1, DOI DOI 10.1111/J.1741-6248.2004.00001.X; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; Snowling M., 2000, DYSLEXIA; Spinelli D, 2005, DEV NEUROPSYCHOL, V27, P217, DOI 10.1207/s15326942dn2702_2; TEWES U, 1991, HAMBURGERWECHSLER IN; Tsapkini K, 2010, CORTEX, V46, P185, DOI 10.1016/j.cortex.2009.02.025; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; WIMMER H, 2010, CORTEX IN PRESS; YAP R, 1993, READ WRIT, V5, P261, DOI 10.1007/BF01027391; Ziegler JC, 2003, J EXP CHILD PSYCHOL, V86, P169, DOI 10.1016/S0022-0965(03)00139-5; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370; Zoccolotti P, 2005, BRAIN LANG, V93, P369, DOI 10.1016/j.bandl.2004.10.010; Zoccolotti P, 1999, APPL PSYCHOLINGUIST, V20, P191, DOI 10.1017/S0142716499002027	70	69	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12073	10.1371/journal.pone.0012073	http://dx.doi.org/10.1371/journal.pone.0012073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637WJ	20711448	gold, Green Published			2022-12-27	WOS:000280849100016
J	Di Stilio, VS; Kumar, RA; Oddone, AM; Tolkin, TR; Salles, P; McCarty, K				Di Stilio, Veronica S.; Kumar, Rachana A.; Oddone, Alessandra M.; Tolkin, Theadora R.; Salles, Patricia; McCarty, Kacie			Virus-Induced Gene Silencing as a Tool for Comparative Functional Studies in Thalictrum	PLOS ONE			English	Article							MADS-BOX GENES; POPPY ESCHSCHOLZIA-CALIFORNICA; TOBACCO RATTLE VIRUS; CAROTENOID BIOSYNTHESIS; NEW-MODEL; ORTHOLOG; PLANT; DUPLICATION; EVOLUTION; PATTERNS	Perennial woodland herbs in the genus Thalictrum exhibit high diversity of floral morphology, including four breeding and two pollination systems. Their phylogenetic position, in the early-diverging eudicots, makes them especially suitable for exploring the evolution of floral traits and the fate of gene paralogs that may have shaped the radiation of the eudicots. A current limitation in evolution of plant development studies is the lack of genetic tools for conducting functional assays in key taxa spanning the angiosperm phylogeny. We first show that virus-induced gene silencing (VIGS) of a PHYTOENE DESATURASE ortholog (TdPDS) can be achieved in Thalictrum dioicum with an efficiency of 42% and a survival rate of 97%, using tobacco rattle virus (TRV) vectors. The photobleached leaf phenotype of silenced plants significantly correlates with the down-regulation of endogenous TdPDS (P < 0.05), as compared to controls. Floral silencing of PDS was achieved in the faster flowering spring ephemeral T. thalictroides. In its close relative, T. clavatum, silencing of the floral MADS box gene AGAMOUS (AG) resulted in strong homeotic conversions of floral organs. In conclusion, we set forth our optimized protocol for VIGS by vacuum-infiltration of Thalictrum seedlings or dormant tubers as a reference for the research community. The three species reported here span the range of floral morphologies and pollination syndromes present in Thalictrum. The evidence presented on floral silencing of orthologs of the marker gene PDS and the floral homeotic gene AG will enable a comparative approach to the study of the evolution of flower development in this group.	[Di Stilio, Veronica S.; Kumar, Rachana A.; Oddone, Alessandra M.; Tolkin, Theadora R.; Salles, Patricia; McCarty, Kacie] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Di Stilio, VS (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	distilio@u.washington.edu	, Veronica/ABA-5490-2021	, Veronica/0000-0002-6921-3018; Tolkin, Theadora/0000-0003-2174-3885	Royalty Research Fund; University of Washington; National Science Foundation (NSF) [IOS-RIG 0818836]	Royalty Research Fund; University of Washington(University of Washington); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Royalty Research Fund, University of Washington (http://www.washington.edu/research/main.php?page=rrf) and National Science Foundation (NSF) IOS-RIG 0818836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Di Stilio VS, 2009, NEW PHYTOL, V183, P718, DOI 10.1111/j.1469-8137.2009.02945.x; Di Stilio VS, 2005, PLANT J, V41, P755, DOI 10.1111/j.1365-313X.2005.02336.x; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Endress PK, 1995, PLANT SYST EVOL, P47; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Galun E, 2005, IN VITRO CELL DEV-PL, V41, P113, DOI 10.1079/IVP2004619; Gould B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-6; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; HINKLEY D, 2006, THALICTRUM OVERVIEW, P178; Khamidullina EA, 2006, NAT PROD REP, V23, P117, DOI 10.1039/b504014k; Kramer EM, 2007, PLANT CELL, V19, P750, DOI 10.1105/tpc.107.050385; Kramer EM, 2003, INT J PLANT SCI, V164, P1, DOI 10.1086/344694; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Liu Y, 2004, PLANT MOL BIOL, V54, P701, DOI 10.1023/B:PLAN.0000040899.53378.83; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lutskii VI, 2005, CHEM NAT COMPD+, V41, P117, DOI 10.1007/s10600-005-0096-9; Nagamatsu A, 2007, PLANT BIOTECHNOL J, V5, P778, DOI 10.1111/j.1467-7652.2007.00288.x; Orashakova S, 2009, PLANT J, V58, P682, DOI 10.1111/j.1365-313X.2009.03807.x; PELLMYR O, 1995, DIE NATURLICHEN PFLA, P160; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Renner T, 2009, MOL PLANT, V2, P1084, DOI 10.1093/mp/ssp033; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Samanani N, 2002, PHYSIOL PLANTARUM, V116, P79, DOI 10.1034/j.1399-3054.2002.1160110.x; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Spitzer B, 2007, PLANT PHYSIOL, V145, P1241, DOI 10.1104/pp.107.105916; TAMURA M, 1995, DIE NATURLICHEN PFLA, P223; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Wang XY, 2010, MOL BIOL REP, V37, P967, DOI 10.1007/s11033-009-9766-1; Wege S, 2007, ANN BOT-LONDON, V100, P641, DOI 10.1093/aob/mcm118; Weigel D., 2002, ARABIDOPSIS LAB MANU; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x	39	53	69	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12064	10.1371/journal.pone.0012064	http://dx.doi.org/10.1371/journal.pone.0012064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706585	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900019
J	Gob, E; Schmitt, J; Benavente, R; Alsheimer, M				Goeb, Eva; Schmitt, Johannes; Benavente, Ricardo; Alsheimer, Manfred			Mammalian Sperm Head Formation Involves Different Polarization of Two Novel LINC Complexes	PLOS ONE			English	Article							NUCLEAR-MEMBRANE PROTEIN; NEUROMUSCULAR-JUNCTION; ACTIN CYTOSKELETON; EXPRESSION PATTERN; MEIOTIC TELOMERES; DOMAIN PROTEINS; SUN-DOMAIN; RAT TESTIS; LAMIN B3; ENVELOPE	Background: LINC complexes are nuclear envelope bridging protein structures formed by interaction of SUN and KASH proteins. They physically connect the nucleus with the peripheral cytoskeleton and are critically involved in a variety of dynamic processes, such as nuclear anchorage, movement and positioning and meiotic chromosome dynamics. Moreover, they are shown to be essential for maintaining nuclear shape. Findings: Based on detailed expression analysis and biochemical approaches, we show here that during mouse sperm development, a terminal cell differentiation process characterized by profound morphogenic restructuring, two novel distinctive LINC complexes are established. They consist either of spermiogenesis-specific Sun3 and Nesprin1 or Sun1 eta, a novel non-nuclear Sun1 isoform, and Nesprin3. We could find that these two LINC complexes specifically polarize to opposite spermatid poles likely linking to sperm-specific cytoskeletal structures. Although, as shown in co-transfection/immunoprecipitation experiments, SUN proteins appear to arbitrarily interact with various KASH partners, our study demonstrates that they actually are able to confine their binding to form distinct LINC complexes. Conclusions: Formation of the mammalian sperm head involves assembly and different polarization of two novel spermiogenesis-specific LINC complexes. Together, our findings suggest that theses LINC complexes connect the differentiating spermatid nucleus to surrounding cytoskeletal structures to enable its well-directed shaping and elongation, which in turn is a critical parameter for male fertility.	[Goeb, Eva; Schmitt, Johannes; Benavente, Ricardo; Alsheimer, Manfred] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany	University of Wurzburg	Gob, E (corresponding author), Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany.	alsheimer@biozentrum.uni-wuerzburg.de	Benavente, Ricardo/GNW-2855-2022		Deutsche Forschungsgemeinschaft [AI 1090/1-1]; Graduate School of the University of Wurzburg [GK 1048]; Elitenetzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of the University of Wurzburg; Elitenetzwerk Bayern	This work was supported by the Deutsche Forschungsgemeinschaft Grant AI 1090/1-1 (http://www.dfg.de), the Graduate School GK 1048 of the University of Wurzburg (http://www.gk-1048.uni-wuerzburg.de) and the Elitenetzwerk Bayern (https://www.elitenetzwerk.bayern.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelfalk C, 2009, J CELL BIOL, V187, P185, DOI 10.1083/jcb.200808016; Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315; Alsheimer M, 1998, J CELL SCI, V111, P2227; Alsheimer M, 2005, EUR J CELL BIOL, V84, P445, DOI 10.1016/j.ejcb.2004.11.003; Alsheimer M., 2009, V5, P81, DOI 10.1159/000166621; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Clermont Y., 1993, FRONT ENDOCRINOL, P332; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dadoune JP, 2003, MICROSC RES TECHNIQ, V61, P56, DOI 10.1002/jemt.10317; Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Fujita E, 2007, AM J PATHOL, V171, P1800, DOI 10.2353/ajpath.2007.070261; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Guttman JA, 1999, ANAT RECORD, V254, P418, DOI 10.1002/(SICI)1097-0185(19990301)254:3<418::AID-AR13>3.0.CO;2-C; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Johnson KJ, 2004, BIOL REPROD, V70, P303, DOI 10.1095/biolreprod.103.021758; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; LONGO FJ, 1987, J CELL BIOL, V105, P1105, DOI 10.1083/jcb.105.3.1105; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schutz W, 2005, EUR J CELL BIOL, V84, P649, DOI 10.1016/j.ejcb.2005.03.001; Schutz W, 2005, EXP CELL RES, V307, P285, DOI 10.1016/j.yexcr.2005.03.023; SEIFERT GJ, 1992, EUR J CELL BIOL, V59, P138; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Toshimori K, 2003, ARCH HISTOL CYTOL, V66, P383, DOI 10.1679/aohc.66.383; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wiche G, 1998, J CELL SCI, V111, P2477; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhen YY, 2002, J CELL SCI, V115, P3207	68	101	106	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12072	10.1371/journal.pone.0012072	http://dx.doi.org/10.1371/journal.pone.0012072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711465	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900030
J	Burd, NA; West, DWD; Staples, AW; Atherton, PJ; Baker, JM; Moore, DR; Holwerda, AM; Parise, G; Rennie, MJ; Baker, SK; Phillips, SM				Burd, Nicholas A.; West, Daniel W. D.; Staples, Aaron W.; Atherton, Philip J.; Baker, Jeff M.; Moore, Daniel R.; Holwerda, Andrew M.; Parise, Gianni; Rennie, Michael J.; Baker, Steven K.; Phillips, Stuart M.			Low-Load High Volume Resistance Exercise Stimulates Muscle Protein Synthesis More Than High-Load Low Volume Resistance Exercise in Young Men	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; P70 S6 KINASE; LENGTHENING CONTRACTIONS; AMINO-ACIDS; BLOOD-FLOW; PHOSPHORYLATION; MYOFIBRILLAR; INTENSITY; INCREASE; CONSUMPTION	Background: We aimed to determine the effect of resistance exercise intensity (% 1 repetition maximum- 1RM) and volume on muscle protein synthesis, anabolic signaling, and myogenic gene expression. Methodology/Principal Findings: Fifteen men (21 +/- 1 years; BMI = 24.1 +/- 0.8 kg/m(2)) performed 4 sets of unilateral leg extension exercise at different exercise loads and/or volumes: 90% of repetition maximum (1RM) until volitional failure (90FAIL), 30% 1RM work-matched to 90% FAIL (30WM), or 30% 1RM performed until volitional failure (30FAIL). Infusion of [ring-C-13(6)] phenylalanine with biopsies was used to measure rates of mixed (MIX), myofibrillar (MYO), and sarcoplasmic (SARC) protein synthesis at rest, and 4 h and 24 h after exercise. Exercise at 30WM induced a significant increase above rest in MIX (121%) and MYO (87%) protein synthesis at 4 h post-exercise and but at 24 h in the MIX only. The increase in the rate of protein synthesis in MIX and MYO at 4 h post-exercise with 90FAIL and 30FAIL was greater than 30WM, with no difference between these conditions; however, MYO remained elevated (199%) above rest at 24 h only in 30FAIL. There was a significant increase in Akt(Ser473) at 24h in all conditions (P = 0.023) and mTOR(Ser2448) phosphorylation at 4 h post-exercise (P = 0.025). Phosporylation of Erk1/2(Tyr202/204), p70S6K(Thr389), and 4E-BP1(Thr37/46) increased significantly (P<0.05) only in the 30FAIL condition at 4 h post-exercise, whereas, 4E-BP1(Thr37/46) phosphorylation was greater 24 h after exercise than at rest in both 90FAIL (237%) and 30FAIL (312%) conditions. Pax7 mRNA expression increased at 24 h post-exercise (P = 0.02) regardless of condition. The mRNA expression of MyoD and myogenin were consistently elevated in the 30FAIL condition. Conclusions/Significance: These results suggest that low-load high volume resistance exercise is more effective in inducing acute muscle anabolism than high-load low volume or work matched resistance exercise modes.	[Burd, Nicholas A.; West, Daniel W. D.; Staples, Aaron W.; Baker, Jeff M.; Moore, Daniel R.; Holwerda, Andrew M.; Parise, Gianni; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Atherton, Philip J.; Rennie, Michael J.] Univ Nottingham, City Hosp, Sch Grad Entry Med & Hlth, Derby, England; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada; [Baker, Steven K.] McMaster Univ, Michael G DeGroote Sch Med, Dept Neurol, Hamilton, ON, Canada	McMaster University; University of Nottingham; McMaster University; McMaster University	Burd, NA (corresponding author), McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada.	phillis@mcmaster.ca	Phillips, Stuart/B-2343-2009	Phillips, Stuart/0000-0002-1956-4098; Moore, Daniel/0000-0001-5865-4398; Atherton, Philip/0000-0002-7286-046X; Holwerda, Andrew/0000-0002-7926-4863; Burd, Nicholas/0000-0001-5581-3154	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, J APPL PHYSIOL, V100, P1460, DOI 10.1152/japplphysiol.01267.2005; ALWAY SE, 1990, EUR J APPL PHYSIOL O, V60, P346, DOI 10.1007/BF00713497; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V272, pE45, DOI 10.1152/ajpendo.1997.272.1.E45; BURD NA, 2010, J PHYSL; CAMERA DM, 2010, MED SCI SPORTS EXERC; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; Creer A, 2005, J APPL PHYSIOL, V99, P950, DOI 10.1152/japplphysiol.00110.2005; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Cuthbertson DJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE731, DOI 10.1152/ajpendo.00415.2005; Deldicque L, 2008, EUR J APPL PHYSIOL, V104, P57, DOI 10.1007/s00421-008-0786-7; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Eliasson J, 2006, AM J PHYSIOL-ENDOC M, V291, pE1197, DOI 10.1152/ajpendo.00141.2006; FRY CS, J APPL PHYSL; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Glover EI, 2008, AM J PHYSIOL-REG I, V295, pR604, DOI 10.1152/ajpregu.00097.2008; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Hartman JW, 2007, AM J CLIN NUTR, V86, P373, DOI 10.1093/ajcn/86.2.373; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; HEYS SD, 1990, BIOMED ENVIRON MASS, V19, P176, DOI 10.1002/bms.1200190314; HOLM L, 2009, AM J PHYSL ENDOCRINO; Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004; Karlsson HKR, 2004, AM J PHYSIOL-ENDOC M, V287, pE1, DOI 10.1152/ajpendo.00430.2003; Kim PL, 2005, J PHYSIOL-LONDON, V568, P283, DOI 10.1113/jphysiol.2005.093708; KUMAR V, 2009, P PHYSL SOC, V15, pC38; KUMAR V, 2008, J PHYSL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1089, DOI 10.1152/ajpendo.00195.2003; MacDougall J D, 1995, Can J Appl Physiol, V20, P480; Mascher H, 2008, AM J PHYSIOL-ENDOC M, V294, pE43, DOI 10.1152/ajpendo.00504.2007; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Moore DR, 2005, AM J PHYSIOL-ENDOC M, V288, pE1153, DOI 10.1152/ajpendo.00387.2004; Moore DR, 2004, EUR J APPL PHYSIOL, V92, P399, DOI 10.1007/s00421-004-1072-y; Nakshabendi IM, 1995, AM J PHYSIOL-ENDOC M, V269, pE996, DOI 10.1152/ajpendo.1995.269.6.E996; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; PHILLIPS SM, 1997, AM J PHYSIOL, V273, P99; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Takarada Y, 2002, EUR J APPL PHYSIOL, V86, P308, DOI 10.1007/s00421-001-0561-5; VILLAREAL DT, 2010, OBESITY SILVER SPRIN; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; West DWD, 2010, J APPL PHYSIOL, V108, P60, DOI 10.1152/japplphysiol.01147.2009; West DWD, 2009, J PHYSIOL-LONDON, V587, P5239, DOI 10.1113/jphysiol.2009.177220; Wilborn CD, 2009, J STRENGTH COND RES, V23, P2179, DOI 10.1519/JSC.0b013e3181bab493; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673	52	338	347	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12033	10.1371/journal.pone.0012033	http://dx.doi.org/10.1371/journal.pone.0012033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711498	Green Published, Green Submitted, gold			2022-12-27	WOS:000280776800015
J	Poynard, T; Thabut, D; Munteanu, M; Ratziu, V; Benhamou, Y; Deckmyn, O				Poynard, Thierry; Thabut, Dominique; Munteanu, Mona; Ratziu, Vlad; Benhamou, Yves; Deckmyn, Olivier			Hirsch Index and Truth Survival in Clinical Research	PLOS ONE			English	Article							H-INDEX; TRIALS	Background: Factors associated with the survival of truth of clinical conclusions in the medical literature are unknown. We hypothesized that publications with a first author having a higher Hirsch' index value (h-I), which quantifies and predicts an individual's scientific research output, should have a longer half-life. Methods and Results: 474 original articles concerning cirrhosis or hepatitis published from 1945 to 1999 were selected. The survivals of the main conclusions were updated in 2009. The truth survival was assessed by time-dependent methods (Kaplan Meier method and Cox). A conclusion was considered to be true, obsolete or false when three or more observers out of the six stated it to be so. 284 out of 474 conclusions (60%) were still considered true, 90 (19%) were considered obsolete and 100 (21%) false. The median of the h-I was = 24 (range 1-85). Authors with true conclusions had significantly higher h-I (median = 28) than those with obsolete (h-I = 19; P = 0.002) or false conclusions (h-I = 19; P = 0.01). The factors associated (P<0.0001) with h-I were: scientific life (h-I = 33 for. 30 years vs. 16 for, 30 years), -methodological quality score (h-I = 36 for high vs. 20 for low scores), and -positive predictive value combining power, ratio of true to not-true relationships and bias (h-I = 33 for high vs. 20 for low values). In multivariate analysis, the risk ratio of h-I was 1.003 (95% CI, 0.994-1.011), and was not significant (P = 0.56). In a subgroup restricted to 111 articles with a negative conclusion, we observed a significant independent prognostic value of h-I (risk ratio = 1.033; 95% CI, 1.008-1.059; P = 0.009). Using an extrapolation of h-I at the time of article publication there was a significant and independent prognostic value of baseline h-I (risk ratio = 0.027; P = 0.0001). Conclusions: The present study failed to clearly demonstrate that the h-index of authors was a prognostic factor for truth survival. However the h-index was associated with true conclusions, methodological quality of trials and positive predictive values.	[Poynard, Thierry; Thabut, Dominique; Ratziu, Vlad; Benhamou, Yves] Univ Paris 06, AP HP, Grp Hosp Pitie Salpetriere, Liver Ctr,Serv Hepatogastroenterol, Paris, France; [Munteanu, Mona; Deckmyn, Olivier] Biopredictive, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Poynard, T (corresponding author), Univ Paris 06, AP HP, Grp Hosp Pitie Salpetriere, Liver Ctr,Serv Hepatogastroenterol, Paris, France.	tpoynard@teaser.fr	Poynard, Thierry/C-1355-2010	Poynard, Thierry/0000-0002-3726-7230; Munteanu, Mona/0000-0003-4517-2757; Deckmyn, Olivier/0000-0002-1589-9368; Poynard, Thierry/0000-0002-2050-640X	Association de Recherche pour Maladies Virales et Hepatiques (ARMHV)	Association de Recherche pour Maladies Virales et Hepatiques (ARMHV)	Funding source: Association de Recherche pour Maladies Virales et Hepatiques (ARMHV). MM and OD are full employees (Researchers) of Biopredictive. Biopredictive is a startup of Paris University Pierre et Marie Curie (UPMC), which is marketing biomarkers in liver diseases. Thierry Poynard is the founder of this company, the inventor of FibroTest, ActiTest, SteatoTest, AshTest and NashTest. The patents of these biomarkers belong to the French Public organization Assistance Publique Hopitaux de Paris. MM and OD had no role in study design, analysis, decision to publish, or preparation of the manuscript. OD helped in the measurements of Hirsch Index, MM in the evaluation of scientific survival of articles conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin A, 1997, ALIMENT PHARM THER, V11, P215, DOI 10.1046/j.1365-2036.1997.131302000.x; Ball P, 2007, NATURE, V448, P737, DOI 10.1038/448737a; Bernard B, 1997, HEPATOLOGY, V25, P63, DOI 10.1053/jhep.1997.v25.pm0008985266; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Butler L, 2008, ETHICS SCI ENV POLIT, V8, P83, DOI DOI 10.3354/ESEP00077; COLE S, 1989, TRENDS BIOCHEM SCI, V14, P9; Fuller Clifton D, 2009, J Am Coll Radiol, V6, P112, DOI 10.1016/j.jacr.2008.07.004; Hall JC, 1997, LANCET, V350, P1752, DOI 10.1016/S0140-6736(05)63577-5; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Horne R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5356; IGLESIAS JE, 2007, SCIENTOMETRICS, V304, P1; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; JACSON P, 2008, TESTING CALCULATION; Jeang KT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-42; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; LaValley MP, 2002, ANN INTERN MED, V137, P932, DOI 10.7326/0003-4819-137-11-200212030-00016; Opthof T, 2002, CARDIOVASC RES, V56, P339, DOI 10.1016/S0008-6363(02)00712-5; Opthof T, 2009, NETH HEART J, V17, P145, DOI 10.1007/BF03086237; Polanyi M., 1964, SCI FAITH SOC; Poynard T, 2002, ANN INTERN MED, V136, P888, DOI 10.7326/0003-4819-136-12-200206180-00010; POYNARD T, 1988, PRESSE MED, V17, P315; POYNARD T, 2002, ANN INTERN MED, V137, P2002; SACKS HS, 1987, NEW ENGL J MED, V316, P450, DOI 10.1056/NEJM198702193160806; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P408, DOI 10.1002/asi.20284	26	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12044	10.1371/journal.pone.0012044	http://dx.doi.org/10.1371/journal.pone.0012044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700455	Green Published, gold, Green Submitted			2022-12-27	WOS:000280687900022
J	Chen, YL; Li, J; Ai, CL; Duan, YR; Wang, L; Zhang, MM; Hopewell, S				Chen, Yaolong; Li, Jing; Ai, Changlin; Duan, Yurong; Wang, Ling; Zhang, Mingming; Hopewell, Sally			Assessment of the Quality of Reporting in Abstracts of Randomized Controlled Trials Published in Five Leading Chinese Medical Journals	PLOS ONE			English	Article							CONSORT	Background: Clear, transparent and sufficiently detailed abstracts of randomized trials (RCTs), published in journal articles are important because readers will often base their initial assessment of a trial on such information. However, little is known about the quality of reporting in abstracts of RCTs published in medical journals in China. Methods: We identified RCTs abstracts from 5 five leading Chinese medical journals published between 1998 and 2007 and indexed in MEDLINE. We assessed the quality of reporting of these abstracts based on the Consolidated Standards of Reporting Trials (CONSORT) abstract checklist. We also sought to identify whether any differences exist in reporting between the Chinese and English language version of the same abstract. Results: We identified 332 RCT abstracts eligible for examination. Overall, the abstracts we examined reported 0-8 items as designated in the CONSORT checklist. On average, three items were reported per abstract. Details of the interventions (288/332; 87%), the number of participants randomized (216/332; 65%) and study objectives (109/332; 33%) were the top three items reported. Only two RCT abstracts reported details of trial registration, no abstracts reported the method of allocation concealment and only one mentioned specifically who was blinded. In terms of the proportion of RCT abstracts fulfilling a criterion, the absolute difference (percentage points) between the Chinese and English abstracts was 10% (ranging from 0 to 25%) on average, per item. Conclusions: The quality of reporting in abstracts of RCTs published in Chinese medical journals needs to be improved. We hope that the introduction and endorsement of the CONSORT for Abstracts guidelines by journals reporting RCTs will lead to improvements in the quality of reporting.	[Chen, Yaolong; Li, Jing; Ai, Changlin; Duan, Yurong; Wang, Ling; Zhang, Mingming] Sichuan Univ, W China Hosp, Chinese Cochrane Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Yaolong] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Gansu, Peoples R China; [Hopewell, Sally] UK Cochrane Ctr, Oxford, England	Sichuan University; Lanzhou University; Cochrane Centre	Chen, YL (corresponding author), Sichuan Univ, W China Hosp, Chinese Cochrane Ctr, Chengdu, Sichuan, Peoples R China.	chicc86@hotmail.com; shopewell@cochrane.co.uk		Hopewell, Sally/0000-0002-6881-6984; Chen, Yaolong/0000-0002-9841-5233				Barry H C, 2001, J Am Board Fam Pract, V14, P437; Berwanger O, 2009, J CLIN EPIDEMIOL, V62, P387, DOI 10.1016/j.jclinepi.2008.05.013; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; Burns KEA, 2005, CRIT CARE MED, V33, P1937, DOI 10.1097/01.CCM.0000178361.73895.24; [常静 CHANG Jing], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P171; [陈耀龙 CHEN YaoIong], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P312; Du YX, 2006, J PREY MED INF, V22, P162; Dupuy A, 2003, ARCH DERMATOL, V139, P589, DOI 10.1001/archderm.139.5.589; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell S, 2008, J INF SCI, V34, P162, DOI 10.1177/0165551507080415; HU BL, 1997, CHIN J ARTERIOSCLERO, V5, P85; Klassen TP, 2005, J CLIN EPIDEMIOL, V58, P763, DOI 10.1016/j.jclinepi.2004.08.020; LI AR, 1995, CHINESE J INTERNAL M, V34, P65; [刘雅莉 LIU Yali], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P768; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; [沈进 SHEN Jin], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P385; Trakas K, 1997, ANN PHARMACOTHER, V31, P423, DOI 10.1177/106002809703100406; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; ZANG X, 2006, CHIN J EVID BASED ME, V6, P586; Zhang DL, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-22; CHINA INDIA JOIN WHO; 2003, CHIN J EVID BASED ME, V3, P254	25	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11926	10.1371/journal.pone.0011926	http://dx.doi.org/10.1371/journal.pone.0011926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689853	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520400013
J	McCurley, N; Mellman, I				McCurley, Nathanael; Mellman, Ira			Monocyte-Derived Dendritic Cells Exhibit Increased Levels of Lysosomal Proteolysis as Compared to Other Human Dendritic Cell Populations	PLOS ONE			English	Article							PERIPHERAL LYMPHOID ORGANS; IN-VITRO; ANTIGEN; PH; IDENTIFICATION; MATURATION; MICE; VIVO	Background: Fine control of lysosomal degradation for limited processing of internalized antigens is a hallmark of professional antigen presenting cells. Previous work in mice has shown that dendritic cells (DCs) contain lysosomes with remarkably low protease content. Combined with the ability to modulate lysosomal pH during phagocytosis and maturation, murine DCs enhance their production of class II MHC-peptide complexes for presentation to T cells. Methodology/Principal Findings: In this study we extend these findings to human DCs and distinguish between different subsets of DCs based on their ability to preserve internalized antigen. Whereas DCs derived in vitro from CD34+ hematopoietic progenitor cells or isolated from peripheral blood of healthy donors are protease poor, DCs derived in vitro from monocytes (MDDCs) are more similar to macrophages (M Phi s) in protease content. Unlike other DCs, MDDCs also fail to reduce their intralysosomal pH in response to maturation stimuli. Indeed, functional characterization of lysosomal proteolysis indicates that MDDCs are comparable to M Phi s in the rapid degradation of antigen while other human DC subtypes are attenuated in this capacity. Conclusions/Significance: Human DCs are comparable to murine DCs in exhibiting a markedly reduced level of lysosomal proteolysis. However, as an important exception to this, human MDDCs stand apart from all other DCs by a heightened capacity for proteolysis that resembles that of M Phi s. Thus, caution should be exercised when using human MDDCs as a model for DC function and cell biology.	[McCurley, Nathanael; Mellman, Ira] Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06510 USA; [McCurley, Nathanael; Mellman, Ira] Yale Univ, Sch Med, Dept Immunobiol, Ludwig Inst Canc Res, New Haven, CT 06510 USA; [McCurley, Nathanael] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [McCurley, Nathanael] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University; Emory University; Emory University; Roche Holding; Genentech	McCurley, N (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06510 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020		National Institutes of Health [R37AI34098, U19AI057234]; Ludwig Institute for Cancer Research; Genentech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, R37AI034098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to the National Institutes of Health (R37AI34098 and U19AI057234) and the Ludwig Institute for Cancer Research (www.licr.org) for their support of this work and Genentech (www.gene.com) for provision of the publication fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI SY, 1967, BIOCHEM J, V105, P549, DOI 10.1042/bj1050549; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Chow AY, 2005, TRENDS IMMUNOL, V26, P72, DOI 10.1016/j.it.2004.11.008; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Haugland R. P., 2007, HDB FLUORESCENT PROB; INABA K, 1983, P NATL ACAD SCI-BIOL, V80, P6041, DOI 10.1073/pnas.80.19.6041; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Lovy J, 2006, DEV COMP IMMUNOL, V30, P259, DOI 10.1016/j.dci.2005.06.003; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Rumfelt LL, 2002, SCAND J IMMUNOL, V56, P130, DOI 10.1046/j.1365-3083.2002.01116.x; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; TURK B, 1994, BIOCHEMISTRY-US, V33, P14800, DOI 10.1021/bi00253a019; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Werdelin O, 2002, P NATL ACAD SCI USA, V99, P9611, DOI 10.1073/pnas.152345899	33	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11949	10.1371/journal.pone.0011949	http://dx.doi.org/10.1371/journal.pone.0011949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689855	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520400017
J	Fett, ME; Pilsl, A; Paquet, D; van Bebber, F; Haass, C; Tatzelt, J; Schmid, B; Winklhofer, KF				Fett, Mareike E.; Pilsl, Anna; Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Tatzelt, Joerg; Schmid, Bettina; Winklhofer, Konstanze F.			Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; DEFICIENT MICE; MOLECULAR CHAPERONES; INDUCED APOPTOSIS; OXIDATIVE STRESS; UP-REGULATION; HEAT-SHOCK	Background: Mutations in the gene encoding the E3 ubiquitin ligase parkin (PARK2) are responsible for the majority of autosomal recessive parkinsonism. Similarly to other knockout mouse models of PD-associated genes, parkin knockout mice do not show a substantial neuropathological or behavioral phenotype, while loss of parkin in Drosophila melanogaster leads to a severe phenotype, including reduced lifespan, apoptotic flight muscle degeneration and male sterility. In order to study the function of parkin in more detail and to address possible differences in its role in different species, we chose Danio rerio as a different vertebrate model system. Methodology/Principal Findings: We first cloned zebrafish parkin to compare its biochemical and functional aspects with that of human parkin. By using an antisense knockdown strategy we generated a zebrafish model of parkin deficiency (knockdown efficiency between 50% and 60%) and found that the transient knockdown of parkin does not cause morphological or behavioral alterations. Specifically, we did not observe a loss of dopaminergic neurons in parkin-deficient zebrafish. In addition, we established transgenic zebrafish lines stably expressing parkin by using a Gal4/UAS-based bidirectional expression system. While parkin-deficient zebrafish are more vulnerable to proteotoxicity, increased parkin expression protected transgenic zebrafish from cell death induced by proteotoxic stress. Conclusions/Significance: Similarly to human parkin, zebrafish parkin is a stress-responsive protein which protects cells from stress-induced cell death. Our transgenic zebrafish model is a novel tool to characterize the protective capacity of parkin in vivo.	[Fett, Mareike E.; Pilsl, Anna; Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Tatzelt, Joerg; Schmid, Bettina; Winklhofer, Konstanze F.] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Paquet, Dominik; van Bebber, Frauke; Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Fett, ME (corresponding author), Univ Munich, Adolf Butenandt Inst, Munich, Germany.	Konstanze.Winklhofer@med.uni-muenchen.de		Tatzelt, Jorg/0000-0001-5017-5528; Winklhofer, Konstanze/0000-0002-7256-8231; Paquet, Dominik/0000-0003-2065-1639	Deutsche Forschungsgemeinschaft [SFB 596]; German Ministry for Education and Research; Helmholtz Alliance Mental Health in an Ageing Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Mental Health in an Ageing Society	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 596: Molecular Mechanisms of Neurodegeneration), the German Ministry for Education and Research (NGFN plus: Functional Genomics of Parkinson's Disease), and the Helmholtz Alliance Mental Health in an Ageing Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Higashi Y, 2004, J NEUROCHEM, V89, P1490, DOI 10.1111/j.1471-4159.2004.02445.x; Hyun DH, 2005, J NEUROSCI RES, V82, P232, DOI 10.1002/jnr.20638; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Muqit MMK, 2004, J NEUROL NEUROSUR PS, V75, P1762, DOI 10.1136/jnnp.2003.018614; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; PAQUET D, 2009, J CLIN INVEST; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pyati UJ, 2007, SEMIN CANCER BIOL, V17, P154, DOI 10.1016/j.semcancer.2006.11.007; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200; SAINI N, 2010, NEUROBIOL D IN PRESS; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schlehe JS, 2008, J BIOL CHEM, V283, P13771, DOI 10.1074/jbc.M707494200; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Tan EK, 2005, HUM GENET, V118, P484, DOI 10.1007/s00439-005-0038-4; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P533, DOI 10.1089/ars.2006.1522; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Woods IG, 2008, NAT BIOTECHNOL, V26, P650, DOI 10.1038/nbt0608-650; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x	63	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11783	10.1371/journal.pone.0011783	http://dx.doi.org/10.1371/journal.pone.0011783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689587	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300005
J	Hunter, JP; Guatelli-Steinberg, D; Weston, TC; Durner, R; Betsinger, TK				Hunter, John P.; Guatelli-Steinberg, Debbie; Weston, Theresia C.; Durner, Ryan; Betsinger, Tracy K.			Model of Tooth Morphogenesis Predicts Carabelli Cusp Expression, Size, and Symmetry in Humans	PLOS ONE			English	Article							MEASUREMENT ERROR; TRAIT; ASSOCIATIONS; MORPHOLOGY; HYPOCONE; TEETH	Background: The patterning cascade model of tooth morphogenesis accounts for shape development through the interaction of a small number of genes. In the model, gene expression both directs development and is controlled by the shape of developing teeth. Enamel knots (zones of nonproliferating epithelium) mark the future sites of cusps. In order to form, a new enamel knot must escape the inhibitory fields surrounding other enamel knots before crown components become spatially fixed as morphogenesis ceases. Because cusp location on a fully formed tooth reflects enamel knot placement and tooth size is limited by the cessation of morphogenesis, the model predicts that cusp expression varies with intercusp spacing relative to tooth size. Although previous studies in humans have supported the model's implications, here we directly test the model's predictions for the expression, size, and symmetry of Carabelli cusp, a variation present in many human populations. Methodology/Principal Findings: In a dental cast sample of upper first molars (M1s) (187 rights, 189 lefts, and 185 antimeric pairs), we measured tooth area and intercusp distances with a Hirox digital microscope. We assessed Carabelli expression quantitatively as an area in a subsample and qualitatively using two typological schemes in the full sample. As predicted, low relative intercusp distance is associated with Carabelli expression in both right and left samples using either qualitative or quantitative measures. Furthermore, asymmetry in Carabelli area is associated with asymmetry in relative intercusp spacing. Conclusions/Significance: These findings support the model's predictions for Carabelli cusp expression both across and within individuals. By comparing right-left pairs of the same individual, our data show that small variations in developmental timing or spacing of enamel knots can influence cusp pattern independently of genotype. Our findings suggest that during evolution new cusps may first appear as a result of small changes in the spacing of enamel knots relative to crown size.	[Hunter, John P.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Newark, OH USA; [Hunter, John P.] Ohio State Univ, Sch Earth Sci, Newark, OH USA; [Guatelli-Steinberg, Debbie; Weston, Theresia C.; Durner, Ryan] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Betsinger, Tracy K.] SUNY Coll Oneonta, Dept Anthropol, Oneonta, NY 13820 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; State University of New York (SUNY) System	Hunter, JP (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Newark, OH USA.	hunter.360@osu.edu	Hunter, John/A-2573-2013		The Ohio State University Newark	The Ohio State University Newark	The Ohio State University Newark supported this study through a Faculty-Initiated Student Assistantship Grant and a Scholarly Activity Grant for Publications Costs to the senior author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY RC, 1990, SYST ZOOL, V39, P124, DOI 10.2307/2992450; BRABANT H, 1971, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V7, P329, DOI 10.3406/bmsap.1971.2024; Brues A.M., 1977, PEOPLE RACES; Garn S.M., 1971, HUMAN RACES; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; Harris EF, 2007, AM J PHYS ANTHROPOL, V132, P238, DOI 10.1002/ajpa.20503; Hsu JW, 1997, J FORENSIC SCI, V42, P802; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KEENE HJ, 1968, ARCH ORAL BIOL, V13, P1023, DOI 10.1016/0003-9969(68)90018-6; Kondo S, 2006, AM J PHYS ANTHROPOL, V129, P196, DOI 10.1002/ajpa.20271; Korenhof C. A. W., 1960, MORPHOGENETICAL ASPE; Kraus BS, 1965, HUMAN DENTITION BIRT; KURTEN B, 1953, ACTA ZOOL FENN, V73, P1; LOMBARDI AV, 1975, J DENT RES, V54, P239; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MEREDITH HV, 1954, J DENT RES, V33, P435, DOI 10.1177/00220345540330031601; REID C, 1991, AM J PHYS ANTHROPOL, V84, P427, DOI 10.1002/ajpa.1330840407; Reid C, 1995, ASPECTS DENT BIOL PA, P299; ROHLF FJ, 1983, EVOLUTION, V37, P180, DOI 10.1111/j.1558-5646.1983.tb05526.x; SAKAI T, 1971, J ANTHROPOL SOC NIP, V79, P297; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; SASAKI K, 1997, ANTHR SCI, V105; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; SCOTT GR, 1978, J DENT RES, V57, P570, DOI 10.1177/00220345780570040601; SCOTT GR, 1979, J DENT RES, V58, P1403, DOI 10.1177/00220345790580041701; Sokal R.R., 2012, BIOMETRY; Sperber H., 1974, THESIS WITWATERSRAND; Townsend G, 2003, J DENT RES, V82, P350, DOI 10.1177/154405910308200505; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; WOOD BA, 1988, J ANAT, V161, P1; Wright S., 1968, EVOLUTION GENETICS P, P373; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	37	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11844	10.1371/journal.pone.0011844	http://dx.doi.org/10.1371/journal.pone.0011844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20689576	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200012
J	Trisciuoglio, D; Gabellini, C; Desideri, M; Ziparo, E; Zupi, G; Del Bufalo, D				Trisciuoglio, Daniela; Gabellini, Chiara; Desideri, Marianna; Ziparo, Elio; Zupi, Gabriella; Del Bufalo, Donatella			Bcl-2 Regulates HIF-1 alpha Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVITY; INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL-CELLS; TUMOR-GROWTH; OVEREXPRESSION; APOPTOSIS; ANGIOGENESIS; DEGRADATION	Background: Hypoxia-Inducible Factor 1 (HIF-1) is a transcription factor that is a critical mediator of the cellular response to hypoxia. Enhanced levels of HIF-1 alpha, the oxygen-regulated subunit of HIF-1, is often associated with increased tumour angiogenesis, metastasis, therapeutic resistance and poor prognosis. It is in this context that we previously demonstrated that under hypoxia, bcl-2 protein promotes HIF-1/Vascular Endothelial Growth Factor (VEGF)-mediated tumour angiogenesis. Methodology/Principal Findings: By using human melanoma cell lines and their stable or transient derivative bcl-2 overexpressing cells, the current study identified HIF-1 alpha protein stabilization as a key regulator for the induction of HIF-1 by bcl-2 under hypoxia. We also demonstrated that bcl-2-induced accumulation of HIF-1 alpha protein during hypoxia was not due to an increased gene transcription or protein synthesis. In fact, it was related to a modulation of HIF-1 alpha protein expression at a post-translational level, indeed its degradation rate was faster in the control lines than in bcl-2 transfectants. The bcl-2-induced HIF-1 alpha stabilization in response to low oxygen tension conditions was achieved through the impairment of ubiquitin-dependent HIF-1 alpha degradation involving the molecular chaperone HSP90, but it was not dependent on the prolyl hydroxylation of HIF-1 alpha protein. We also showed that bcl-2, HIF-1 alpha and HSP90 proteins form a tri-complex that may contribute to enhancing the stability of the HIF-1 alpha protein in bcl-2 overexpressing clones under hypoxic conditions. Finally, by using genetic and pharmacological approaches we proved that HSP90 is involved in bcl-2-dependent stabilization of HIF-1 alpha protein during hypoxia, and in particular the isoform HSP90 beta is the main player in this phenomenon. Conclusions/Significance: We identified the stabilization of HIF-1 alpha protein as a mechanism through which bcl-2 induces the activation of HIF-1 in hypoxic tumour cells involving the beta isoform of molecular chaperone HSP90.	[Trisciuoglio, Daniela; Gabellini, Chiara; Desideri, Marianna; Zupi, Gabriella; Del Bufalo, Donatella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy; [Gabellini, Chiara; Ziparo, Elio] Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Trisciuoglio, D (corresponding author), Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy.	delbufalo@ifo.it	Gabellini, Chiara/M-2539-2014; Del Bufalo, Donatella/AAC-1594-2021; desideri, marianna/K-5771-2016; trisciuoglio, daniela/AAL-4002-2021; Del Bufalo, Donatella/K-8673-2016; trisciuoglio, Daniela/H-2131-2016	Gabellini, Chiara/0000-0002-5544-1570; Del Bufalo, Donatella/0000-0002-3148-6096; desideri, marianna/0000-0002-4311-9656; Del Bufalo, Donatella/0000-0002-3148-6096; trisciuoglio, Daniela/0000-0002-7007-7914; Ziparo, Elio/0000-0002-8776-3515	Italian Association for Cancer Research [08/30/c/91]; Italian Ministry of Health [08/01/c/48, 08/01/c/1]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the Italian Association for Cancer Research, grant number 08/30/c/91 (D. D. B.) and the Italian Ministry of Health, grant number 08/01/c/48 (D. D. B.) and 08/01/c/1 (G.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bilton R, 2006, TRENDS CELL BIOL, V16, P616, DOI 10.1016/j.tcb.2006.10.002; Biroccio A, 2000, FASEB J, V14, P652, DOI 10.1096/fasebj.14.5.652; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cho HJ, 2007, FEBS LETT, V581, P1542, DOI 10.1016/j.febslet.2007.03.015; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Del Bufalo D, 2003, ONCOGENE, V22, P8441, DOI 10.1038/sj.onc.1206999; Del Bufalo D, 2002, EUR J CANCER, V38, P2455, DOI 10.1016/S0959-8049(02)00391-X; DelBufalo D, 1997, FASEB J, V11, P947, DOI 10.1096/fasebj.11.12.9337147; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Diensthuber M, 2008, J NEURO-ONCOL, V89, P131, DOI 10.1007/s11060-008-9602-9; Feng ZW, 1999, J BIOL CHEM, V274, P30341, DOI 10.1074/jbc.274.43.30341; Giorgini S, 2007, MOL CANCER RES, V5, P761, DOI 10.1158/1541-7786.MCR-07-0088; Gorlach Agnes, 2008, Biochem J, V412, pe17, DOI 10.1042/BJ20080920; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hoetelmans RWM, 2004, DNA CELL BIOL, V23, P351, DOI 10.1089/104454904323145236; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jin ZH, 2006, J BIOL CHEM, V281, P14446, DOI 10.1074/jbc.M511914200; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kuo CC, 2007, J IMMUNOL, V178, P6100, DOI 10.4049/jimmunol.178.10.6100; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; LUO W, 2009, J BIOL CHEM; Massaad CA, 2004, J BIOL CHEM, V279, P54470, DOI 10.1074/jbc.M407659200; Neckers L, 2006, HANDB EXP PHARM, V172, P259; Nor JE, 2001, CANCER RES, V61, P2183; Portier BP, 2006, J BIOL CHEM, V281, P40493, DOI 10.1074/jbc.M606181200; Ricca A, 2000, INT J CANCER, V86, P188, DOI 10.1002/(SICI)1097-0215(20000415)86:2<188::AID-IJC7>3.3.CO;2-N; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sreedhar AS, 2004, FEBS LETT, V562, P11; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Trisciuoglio D, 2005, J CELL PHYSIOL, V205, P414, DOI 10.1002/jcp.20413; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Van U. P., 2008, BIOCHEM J, V412, P477, DOI DOI 10.1042/BJ20080476; Wu X, 2009, BRIT J CANCER, V100, P334, DOI 10.1038/sj.bjc.6604855; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	45	66	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11772	10.1371/journal.pone.0011772	http://dx.doi.org/10.1371/journal.pone.0011772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668552	Green Published, Green Submitted, gold			2022-12-27	WOS:000280371800003
J	Yoshiko, Y; Oizumi, K; Hasegawa, T; Minamizaki, T; Tanne, K; Maeda, N; Aubin, JE				Yoshiko, Yuji; Oizumi, Kiyoshi; Hasegawa, Takuro; Minamizaki, Tomoko; Tanne, Kazuo; Maeda, Norihiko; Aubin, Jane E.			A Subset of Osteoblasts Expressing High Endogenous Levels of PPAR gamma Switches Fate to Adipocytes in the Rat Calvaria Cell Culture Model	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; PEROXISOME-PROLIFERATOR; BONE-MARROW; GENE-TRANSCRIPTION; TRABECULAR BONE; ADIPOSE-TISSUE; IN-VITRO; C/EBP-ALPHA; DIFFERENTIATION	Background: Understanding fate choice and fate switching between the osteoblast lineage (ObL) and adipocyte lineage (AdL) is important to understand both the developmental inter-relationships between osteoblasts and adipocytes and the impact of changes in fate allocation between the two lineages in normal aging and certain diseases. The goal of this study was to determine when during lineage progression ObL cells are susceptible to an AdL fate switch by activation of endogenous peroxisome proliferator-activated receptor (PPAR)gamma. Methodology/Principal Findings: Multiple rat calvaria cells within the ObL developmental hierarchy were isolated by either fractionation on the basis of expression of alkaline phosphatase or retrospective identification of single cell-derived colonies, and treated with BRL-49653 (BRL), a synthetic ligand for PPAR gamma. About 30% of the total single cell-derived colonies expressed adipogenic potential (defined cytochemically) when BRL was present. Profiling of ObL and AdL markers by qRT-PCR on amplified cRNA from over 160 colonies revealed that BRL-dependent adipogenic potential correlated with endogenous PPAR gamma mRNA levels. Unexpectedly, a significant subset of relatively mature ObL cells exhibited osteoadipogenic bipotentiality. Western blotting and immunocytochemistry confirmed that ObL cells co-expressed multiple mesenchymal lineage determinants (runt-related transcription factor 2 (Runx2), PPAR gamma, Sox9 and MyoD which localized in the cytoplasm initially, and only Runx2 translocated to the nucleus during ObL progression. Notably, however, some cells exhibited both PPARc and Runx2 nuclear labeling with concomitant upregulation of expression of their target genes with BRL treatment. Conclusions/Significance: We conclude that not only immature but a subset of relatively mature ObL cells characterized by relatively high levels of endogenous PPARc expression can be switched to the AdL. The fact that some ObL cells maintain capacity for adipogenic fate selection even at relatively mature developmental stages implies an unexpected plasticity with important implications in normal and pathological bone development.	[Yoshiko, Yuji; Minamizaki, Tomoko; Maeda, Norihiko] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan; [Oizumi, Kiyoshi] Daiichi Sankyo Co, Biol Res Labs 3, Tokyo, Japan; [Hasegawa, Takuro; Tanne, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthodont & Craniofacial Dev Biol, Hiroshima, Japan; [Aubin, Jane E.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada	Hiroshima University; Daiichi Sankyo Company Limited; Hiroshima University; University of Toronto	Yoshiko, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan.	yyuji@hiroshima-u.ac.jp		Aubin, Jane E./0000-0002-7268-5235	Ministry of Education, Science, Sports and Culture of Japan [13771074]; Canadian Institutes of Health Research [FRN 83704]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (13771074 to YY) and the Canadian Institutes of Health Research (FRN 83704 to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Aoyagi K, 2003, BIOCHEM BIOPH RES CO, V300, P915, DOI 10.1016/S0006-291X(02)02967-4; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bruedigam C, 2008, FEBS LETT, V582, P1618, DOI 10.1016/j.febslet.2008.04.012; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Fux C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh001; Garcia T, 2002, BONE, V31, P205, DOI 10.1016/S8756-3282(02)00781-0; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hasegawa T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-71; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Johnson TE, 1999, ENDOCRINOLOGY, V140, P3245, DOI 10.1210/en.140.7.3245; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Malaval L, 1999, J CELL BIOCHEM, V74, P616; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Rosen ED, 2000, GENE DEV, V14, P1293; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Sloop KW, 1998, BIOCHEM BIOPH RES CO, V251, P142, DOI 10.1006/bbrc.1998.9432; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tornvig L, 2001, CALCIFIED TISSUE INT, V69, P46, DOI 10.1007/s002230020018; TURKSEN K, 1991, J CELL BIOL, V114, P373, DOI 10.1083/jcb.114.2.373; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang SL, 2006, BONE, V38, P662, DOI 10.1016/j.bone.2005.10.025; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	51	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11782	10.1371/journal.pone.0011782	http://dx.doi.org/10.1371/journal.pone.0011782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668686	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300016
J	Bonsall, MB				Bonsall, Michael B.			Parasite Replication and the Evolutionary Epidemiology of Parasite Virulence	PLOS ONE			English	Article							HOST POPULATION-DYNAMICS; WITHIN-HOST; INCLUSIVE FITNESS; VISCOUS POPULATIONS; MULTIPLE INFECTION; KIN SELECTION; COMPETITION; COOPERATION; PHARAOH; CURSE	Parasite virulence evolution is shaped by both within-host and population-level processes yet the link between these differing scales of infection is often neglected. Population structure and heterogeneity in both parasites and hosts will affect how hosts are exploited by pathogens and the intensity of infection. Here, it is shown how the degree of relatedness among parasites together with epidemiological parameters such as pathogen yield and longevity influence the evolution of virulence. Furthermore, the role of kin competition and the degree of cheating within highly structured parasite populations also influences parasite fitness and infectivity patterns. Understanding how the effects of within-host processes scale up to affect the epidemiology has importance for understanding host-pathogen interactions.	[Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Bonsall, Michael B.] Univ Oxford, St Peters Coll, Oxford, England	University of Oxford; University of Oxford	Bonsall, MB (corresponding author), Univ Oxford, Dept Zool, Math Ecol Res Grp, S Parks Rd, Oxford OX1 3PS, England.	michael.bonsall@zoo.ox.ac.uk		Bonsall, Michael/0000-0003-0250-0423	Royal Society; UK Biotechnology and Biological Sciences Research Council [BB/C005172/1]	Royal Society(Royal Society of London); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the Royal Society and the UK Biotechnology and Biological Sciences Research Council (BB/C005172/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, AM NAT, V172, pE244, DOI 10.1086/592404; ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Andre JB, 2006, J THEOR BIOL, V241, P402, DOI 10.1016/j.jtbi.2005.12.011; ANTIA R, 1994, AM NAT, V144, P457, DOI 10.1086/285686; Binmore K., 2002, CALCULUS CONCEPTS ME; Bonhoeffer S, 1996, P ROY SOC B-BIOL SCI, V263, P715, DOI 10.1098/rspb.1996.0107; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Day T, 2001, EVOLUTION, V55, P2389, DOI 10.1111/j.0014-3820.2001.tb00754.x; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fenton A, 2006, P ROY SOC B-BIOL SCI, V273, P2083, DOI 10.1098/rspb.2006.3552; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gandon S, 1998, P ROY SOC B-BIOL SCI, V265, P1545, DOI 10.1098/rspb.1998.0470; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harrison F, 2008, ISME J, V2, P49, DOI 10.1038/ismej.2007.96; Kamo M, 2004, J THEOR BIOL, V231, P435, DOI 10.1016/j.jtbi.2004.07.005; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; MICHOD RE, 1980, NATURE, V288, P694, DOI 10.1038/288694a0; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Nesse R.M., 1996, WHY WE GET SICK NEW; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Pasztor L, 1996, J EVOLUTION BIOL, V9, P511, DOI 10.1046/j.1420-9101.1996.9040511.x; Porcelli SA, 2008, NATURE, V454, P702, DOI 10.1038/454702a; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Raymond B, 2008, J INVERTEBR PATHOL, V99, P103, DOI 10.1016/j.jip.2008.04.007; Raymond B, 2007, J INVERTEBR PATHOL, V96, P151, DOI 10.1016/j.jip.2007.03.003; Roussett F, 2004, GENETIC STRUCTURE SE; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Taylor PD, 2007, J EVOLUTION BIOL, V20, P301, DOI 10.1111/j.1420-9101.2006.01196.x; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	51	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12440	10.1371/journal.pone.0012440	http://dx.doi.org/10.1371/journal.pone.0012440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805976	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500009
J	Houseley, J; Tollervey, D				Houseley, Jonathan; Tollervey, David			Apparent Non-Canonical Trans-Splicing Is Generated by Reverse Transcriptase In Vitro	PLOS ONE			English	Article							CDNA; GENE	Background: Trans-splicing, the in vivo joining of two independently transcribed RNA molecules, is well characterized in lower eukaryotes, but was long thought absent from metazoans. However, recent bioinformatic analyses of EST sequences suggested widespread trans-splicing in mammals. These apparently spliced transcripts generally lacked canonical splice sites, leading us to question their authenticity. Particularly, the native ability of reverse transcriptase enzymes to template switch during transcription could produce apparently trans-spliced sequences. Principal Findings: Here we report an in vitro system for the analysis of template switching in reverse transcription. Using highly purified RNA substrates, we show the reproducible occurrence of apparent trans-splicing between two RNA molecules. Other reported non-canonical splicing events such as exon shuffling and sense-antisense fusions were also readily detected. The latter caused the production of apparent antisense non-coding RNAs, which are also reported to be abundant in humans. Conclusions: We propose that most reported examples of non-canonical splicing in metazoans arise through template switching by reverse transcriptase during cDNA preparation. We further show that the products of template switching can vary between reverse transcriptases, providing a simple diagnostic for identifying many of these experimental artifacts.	[Houseley, Jonathan; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Houseley, J (corresponding author), Babraham Inst, Dept Dev Genet & Imprinting, Cambridge, England.	jon.houseley@bbsrc.ac.uk; d.tollervey@ed.ac.uk	Houseley, Jon/AAF-7409-2021; Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust; BBSRC [BBS/E/B/0000H247] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H247] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Geiszt M, 2004, J BIOL CHEM, V279, P51661, DOI 10.1074/jbc.M409325200; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Herai RH, 2010, BRIEF BIOINFORM, V11, P198, DOI 10.1093/bib/bbp041; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Niu XL, 2010, J GENET GENOMICS, V37, P85, DOI 10.1016/S1673-8527(09)60028-X; OUHAMMOUCH M, 1992, NUCLEIC ACIDS RES, V20, P5443, DOI 10.1093/nar/20.20.5443; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Sambrook J., 2001, MOL CLONING LAB MANU; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Unneberg P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000254; Zeng XC, 2002, FEBS LETT, V520, P183, DOI 10.1016/S0014-5793(02)02812-0; Zhu SY, 2002, FEBS LETT, V520, P185, DOI 10.1016/S0014-5793(02)02813-2	24	99	102	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12271	10.1371/journal.pone.0012271	http://dx.doi.org/10.1371/journal.pone.0012271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805885	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600029
J	Robinson, RA; Lawson, B; Toms, MP; Peck, KM; Kirkwood, JK; Chantrey, J; Clatworthy, IR; Evans, AD; Hughes, LA; Hutchinson, OC; John, SK; Pennycott, TW; Perkins, MW; Rowley, PS; Simpson, VR; Tyler, KM; Cunningham, AA				Robinson, Robert A.; Lawson, Becki; Toms, Mike P.; Peck, Kirsi M.; Kirkwood, James K.; Chantrey, Julian; Clatworthy, Innes R.; Evans, Andy D.; Hughes, Laura A.; Hutchinson, Oliver C.; John, Shinto K.; Pennycott, Tom W.; Perkins, Matthew W.; Rowley, Peter S.; Simpson, Vic R.; Tyler, Kevin M.; Cunningham, Andrew A.			Emerging Infectious Disease Leads to Rapid Population Declines of Common British Birds	PLOS ONE			English	Article							IN-HOUSE FINCHES; WEST-NILE-VIRUS; TRICHOMONAS-GALLINAE; WILD BIRDS; MYCOPLASMAL CONJUNCTIVITIS; SALMONELLA-ENTERICA; AVIAN WILDLIFE; GREAT-BRITAIN; UNITED-STATES; PARASITE	Emerging infectious diseases are increasingly cited as threats to wildlife, livestock and humans alike. They can threaten geographically isolated or critically endangered wildlife populations; however, relatively few studies have clearly demonstrated the extent to which emerging diseases can impact populations of common wildlife species. Here, we report the impact of an emerging protozoal disease on British populations of greenfinch Carduelis chloris and chaffinch Fringilla coelebs, two of the most common birds in Britain. Morphological and molecular analyses showed this to be due to Trichomonas gallinae. Trichomonosis emerged as a novel fatal disease of finches in Britain in 2005 and rapidly became epidemic within greenfinch, and to a lesser extent chaffinch, populations in 2006. By 2007, breeding populations of greenfinches and chaffinches in the geographic region of highest disease incidence had decreased by 35% and 21% respectively, representing mortality in excess of half a million birds. In contrast, declines were less pronounced or absent in these species in regions where the disease was found in intermediate or low incidence. Also, populations of dunnock Prunella modularis, which similarly feeds in gardens, but in which T. gallinae was rarely recorded, did not decline. This is the first trichomonosis epidemic reported in the scientific literature to negatively impact populations of free-ranging non-columbiform species, and such levels of mortality and decline due to an emerging infectious disease are unprecedented in British wild bird populations. This disease emergence event demonstrates the potential for a protozoan parasite to jump avian host taxonomic groups with dramatic effect over a short time period.	[Robinson, Robert A.; Toms, Mike P.] British Trust Ornithol, Thetford, Norfolk, England; [Lawson, Becki; Hutchinson, Oliver C.; John, Shinto K.; Perkins, Matthew W.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Peck, Kirsi M.; Evans, Andy D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Kirkwood, James K.] Univ Federat Anim Welf, Wheathampstead, England; [Chantrey, Julian; Hughes, Laura A.] Univ Liverpool, Dept Vet Pathol, Wirral, England; [Clatworthy, Innes R.; Rowley, Peter S.] UCL Med Sch, Electron Microscopy Unit, London, England; [Pennycott, Tom W.] Scottish Agr Coll, Dis Surveillance Ctr, Ayr, Scotland; [Simpson, Vic R.] Wildlife Vet Invest Ctr, Truro, England; [Tyler, Kevin M.] Univ E Anglia, Sch Med Hlth Policy & Practice, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	British Trust for Ornithology; Zoological Society of London; Royal Society for Protection of Birds; University of Liverpool; University of London; University College London; Scottish Agricultural College; University of East Anglia	Robinson, RA (corresponding author), British Trust Ornithol, Thetford, Norfolk, England.	becki.lawson@ioz.ac.uk	Tyler, Kevin/AGZ-3926-2022; Robinson, Robert/B-8237-2009; Tyler, Kevin M/B-3857-2010; Cunningham, Andrew A/E-7536-2010	Tyler, Kevin/0000-0002-0647-8158; Robinson, Robert/0000-0003-0504-9906; Tyler, Kevin M/0000-0002-0647-8158; lawson, becki/0000-0003-1706-7140; Toms, Mike/0000-0002-0823-5336	BTO; Joint Nature Conservation Committee (JNCC); Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage,; Royal Society; Birdcare Standards Association; British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods; Cranswick Pet Products; Gardman Ltd.; Royal College of Veterinary Surgeons (RCVS) Trust [000443]; RSPB; John and Pamela Salter Trust [R16982]; Universities Federation for Animal Welfare	BTO; Joint Nature Conservation Committee (JNCC); Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage,; Royal Society(Royal Society of London); Birdcare Standards Association; British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods; Cranswick Pet Products; Gardman Ltd.; Royal College of Veterinary Surgeons (RCVS) Trust; RSPB; John and Pamela Salter Trust; Universities Federation for Animal Welfare	The Bird Breeding Survey (BBS) is organised by the British Trust for Ornithology (BTO) and jointly funded by BTO, the Joint Nature Conservation Committee (JNCC) on behalf of the Council for Nature Conservation and the Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage, and the Royal Society for the Protection of Birds (RSPB). This study received financial support from the following organisations: Birdcare Standards Association (http://www.birdcare.org.uk), the British Veterinary Association Animal Welfare Foundation (http://www.bva-awf.org.uk), CJ Wildbird Foods (http://www.birdfood.co.uk/), Cranswick Pet Products (http://www.cranswickpetproducts.co.uk/), Gardman Ltd. (http://www.gardman.co.uk/), the Royal College of Veterinary Surgeons (RCVS) Trust Small Grants Programme Reference 000443 (http://www.rcvs.org.uk/RCVSTrust), the RSPB (http://www.rspb.org.uk/), the John and Pamela Salter Trust (R16982) and the Universities Federation for Animal Welfare (http://www.ufaw.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bondurant R. H., 1994, P111; Bunbury N, 2008, BIOL CONSERV, V141, P153, DOI 10.1016/j.biocon.2007.09.008; Bunbury N, 2007, J WILDLIFE DIS, V43, P399, DOI 10.7589/0090-3558-43.3.399; Bunbury N, 2005, J CLIN MICROBIOL, V43, P1005, DOI 10.1128/JCM.43.2.1005-1006.2005; Cannon AR, 2005, J APPL ECOL, V42, P659, DOI 10.1111/j.1365-2664.2005.01050.x; Census 2001, 2002, 2001 CENSUS ENGLAND; Cepicka I, 2005, VET PARASITOL, V128, P11, DOI 10.1016/j.vetpar.2004.11.003; Chamberlain DE, 2005, IBIS, V147, P563, DOI 10.1111/j.1474-919x.2005.00430.x; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; da Silva DG, 2007, INFECT GENET EVOL, V7, P433, DOI [10.1016/j.meegid.2006.01.002, 10.1016/j.meegid.2007.01.002]; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Erwin KG, 2000, J WILDLIFE DIS, V36, P551, DOI 10.7589/0090-3558-36.3.551; Forrester Donald J., 2008, P120; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Hall AJ, 2008, J WILDLIFE DIS, V44, P585, DOI 10.7589/0090-3558-44.3.585; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; HOFLE U, 2000, RAPTOR BIOMEDICINE, V3, P4; Holmes P, 2005, VET REC, V157, P455, DOI 10.1136/vr.157.15.455; HUDSON PJ, 1989, PARASITOL TODAY, V5, P283, DOI 10.1016/0169-4758(89)90019-7; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; MESA CP, 1961, AVIAN DIS, V5, P48, DOI 10.2307/1587659; *MET OFF, 2010, MET OFF UK ACT AN MA; NARCISI EM, 1991, AVIAN DIS, V35, P55, DOI 10.2307/1591295; *NAT WILDL HLTH CA, 2002, USGS NAT WILDL HLTH; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Pennycott T, 2005, VET REC, V157, P360, DOI 10.1136/vr.157.12.360; Pennycott TW, 2006, VET REC, V158, P817, DOI 10.1136/vr.158.24.817; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; R Development Core Team, 2007, R LANG ENV STAT COMP; Real J, 2000, J WILDLIFE DIS, V36, P64, DOI 10.7589/0090-3558-36.1.64; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Snow D. W., 1998, BIRDS W PALEARCTIC, V2; SOULSBY EJL, HELMINTHS ARTHROPODS, P583; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; Toms Mike, 2007, British Wildlife, V19, P77; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; [No title captured]	52	154	164	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12215	10.1371/journal.pone.0012215	http://dx.doi.org/10.1371/journal.pone.0012215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805869	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000281011600008
J	Shanware, NP; Zhan, LH; Hutchinson, JA; Kim, SH; Williams, LM; Tibbetts, RS				Shanware, Naval P.; Zhan, Lihong; Hutchinson, John A.; Kim, Sang Hwa; Williams, Leah M.; Tibbetts, Randal S.			Conserved and Distinct Modes of CREB/ATF Transcription Factor Regulation by PP2A/B56 gamma and Genotoxic Stress	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PROTEIN-KINASE CK2; BINDING PROTEIN; DNA-DAMAGE; PHOSPHORYLATION; FAMILY; ELEMENT; ATM; IDENTIFICATION; INHIBITOR	Activating transcription factor 1 (ATF1) and the closely related proteins CREB (cyclic AMP resonse element binding protein) and CREM (cyclic AMP response element modulator) constitute a subfamily of bZIP transcription factors that play critical roles in the regulation of cellular growth, metabolism, and survival. Previous studies demonstrated that CREB is phosphorylated on a cluster of conserved Ser residues, including Ser-111 and Ser-121, in response to DNA damage through the coordinated actions of the ataxia-telangiectasia-mutated (ATM) protein kinase and casein kinases 1 and 2 (CK1/2). Here, we show that DNA damage-induced phosphorylation by ATM is a general feature of CREB and ATF1. ATF1 harbors a conserved ATM/CK cluster that is constitutively and stoichiometrically phosphorylated by CK1 and CK2 in asynchronously growing cells. Exposure to DNA damage further induced ATF1 phosphorylation on Ser-51 by ATM in a manner that required prior phosphorylation of the upstream CK residues. Hyperphosphorylated ATF1 showed a 4-fold reduced affinity for CREB-binding protein. We further show that PP2A, in conjunction with its targeting subunit B56 gamma, antagonized ATM and CK1/2-dependent phosphorylation of CREB and ATF1 in cellulo. Finally, we show that CK sites in CREB are phosphorylated during cellular growth and that phosphorylation of these residues reduces the threshold of DNA damage required for ATM-dependent phosphorylation of the inhibitory Ser-121 residue. These studies define overlapping and distinct modes of CREB and ATF1 regulation by phosphorylation that may ensure concerted changes in gene expression mediated by these factors.	[Shanware, Naval P.] Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; Univ Wisconsin, Mol & Environm & Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shanware, NP (corresponding author), Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NIH [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; American Heart Association; Molecular and Environmental Toxicology training grant [T32ES007015]; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); Molecular and Environmental Toxicology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (CA124722, NS059001), The American Cancer Society, and a Shaw Scientist Award to R. S. T. from the Greater Milwaukee Foundation. N.P.S. was supported by an American Heart Association Predoctoral Fellowship. J.A.H was supported by a Molecular and Environmental Toxicology training grant (T32ES007015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FLINT KJ, 1991, ONCOGENE, V6, P2019; Ghoneim C, 2007, J BIOL CHEM, V282, P15490, DOI 10.1074/jbc.M610586200; Gueven N, 2003, GENE CHROMOSOME CANC, V38, P157, DOI 10.1002/gcc.10261; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaspers S, 2007, J ANDROL, V28, P59, DOI 10.2164/jandrol.106.000976; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MASSON N, 1993, NUCLEIC ACIDS RES, V21, P4166, DOI 10.1093/nar/21.18.4166; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Parker D, 1996, MOL CELL BIOL, V16, P694; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Swingle Mark, 2007, V365, P23; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12173	10.1371/journal.pone.0012173	http://dx.doi.org/10.1371/journal.pone.0012173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730097	Green Published, Green Submitted, gold			2022-12-27	WOS:000280862200024
J	Rose, AAN; Annis, MG; Dong, ZF; Pepin, F; Hallett, M; Park, M; Siegel, PM				Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Pepin, Francois; Hallett, Michael; Park, Morag; Siegel, Peter M.			ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties	PLOS ONE			English	Article							MELANOMA PROTEIN-B; DC-HIL; OSTEOBLAST DIFFERENTIATION; THERAPEUTIC TARGET; AURISTATIN-E; EXPRESSION; OSTEOACTIVIN; GPNMB; IDENTIFICATION; MACROPHAGES	Background: Glycoprotein non-metastatic melanoma protein B (GPNMB)/Osteoactivin (OA) is a transmembrane protein expressed in approximately 40-75% of breast cancers. GPNMB/OA promotes the migration, invasion and metastasis of breast cancer cells; it is commonly expressed in basal/triple-negative breast tumors and is associated with shorter recurrence-free and overall survival times in patients with breast cancer. Thus, GPNMB/OA represents an attractive target for therapeutic intervention in breast cancer; however, little is known about the functions of GPNMB/OA within the primary tumor microenvironment. Methodology/Principal Findings: We have employed mouse and human breast cancer cells to investigate the effects of GPNMB/OA on tumor growth and angiogenesis. GPNMB/OA-expressing tumors display elevated endothelial recruitment and reduced apoptosis when compared to vector control-derived tumors. Primary human breast cancers characterized by high vascular density also display elevated levels of GPNMB/OA when compared to those with low vascular density. Using immunoblot and ELISA assays, we demonstrate the GPNMB/OA ectodomain is shed from the surface of breast cancer cells. Transient siRNA-mediated knockdown studies of known sheddases identified ADAM10 as the protease responsible for GPNMB/OA processing. Finally, we demonstrate that the shed extracellular domain (ECD) of GPNMB/OA can promote endothelial migration in vitro. Conclusions/Significance: GPNMB/OA expression promotes tumor growth, which is associated with enhanced endothelial recruitment. We identify ADAM10 as a sheddase capable of releasing the GPNMB/OA ectodomain from the surface of breast cancer cells, which induces endothelial cell migration. Thus, ectodomain shedding may serve as a novel mechanism by which GPNMB/OA promotes angiogenesis in breast cancer.	[Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Hallett, Michael; Park, Morag; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Rose, April A. N.; Annis, Matthew G.; Dong, Zhifeng; Park, Morag; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Park, Morag; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Pepin, Francois] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; McGill University	Rose, AAN (corresponding author), McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada.	peter.siegel@mcgill.ca	Rose, April/AAR-8222-2020	Rose, April/0000-0002-9845-4603; Hallett, Michael/0000-0001-6738-6786; Annis, Matthew/0000-0002-8776-004X	Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research [MOP-84386]; Canadian Institutes of Health Research [CTP-79857]; McGill University Health Centre Foundation; "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec; Fonds de recherche en sante du Quebec; Canadian Cancer Society	Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University Health Centre Foundation; "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec; Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work is supported by grants from the Canadian Breast Cancer Research Alliance/Canadian Institutes of Health Research (MOP-84386 to P. M. S.) and the Canadian Institutes of Health Research (CTP-79857 to M. P. and P. M. S.). Tissue banking activities at McGill were supported by the McGill University Health Centre Foundation and the "Banque de Tissues et de donnees" of the "Reseau de recherche sur le cancer" of the Fonds de recherche en sante du Quebec (M. P.). A.A.N.R. was supported by a studentship from the Fonds de recherche en sante du Quebec and M. G. A. was supported by a post-doctoral fellowship from the Canadian Institutes of Health Research. M. P. holds the Diane and Sal Guerrera Chair in Cancer Genetics at McGill University and P. M. S. acknowledges support from both the Canadian Cancer Society and the Fonds de recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; ABDELMAGID SM, 2010, J CELL BIOC IN PRESS; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Ghilardi C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-201; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kohga K, 2009, CANCER RES, V69, P8050, DOI 10.1158/0008-5472.CAN-09-0789; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Naumovski L, 2010, CURR OPIN MOL THER, V12, P248; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; PEPIN F, 2010, PNAS IN PRESS; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Rose AAN, 2010, FUTURE ONCOL, V6, P55, DOI 10.2217/FON.09.138; Rucci Nadia, 2010, Front Biosci (Schol Ed), V2, P907; Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; TOMIHARI M, 2010, CANC RES; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Williams MD, 2010, MELANOMA RES, V20, P184, DOI 10.1097/CMR.0b013e3283364a08; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	41	123	125	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12093	10.1371/journal.pone.0012093	http://dx.doi.org/10.1371/journal.pone.0012093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20711474	gold, Green Submitted, Green Published			2022-12-27	WOS:000280811900031
J	Schmidt, KH; Viebranz, E; Doerfler, L; Lester, C; Rubenstein, A				Schmidt, Kristina H.; Viebranz, Emilie; Doerfler, Lillian; Lester, Christina; Rubenstein, Aaron			Formation of Complex and Unstable Chromosomal Translocations in Yeast	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; SACCHAROMYCES-CEREVISIAE HOMOLOG; ROTHMUND-THOMSON-SYNDROME; GENOME INSTABILITY; DNA-REPLICATION; ANAPHASE BRIDGES; RECQ FAMILY; REARRANGEMENTS; SGS1; SUPPRESSION	Genome instability, associated with chromosome breakage syndromes and most human cancers, is still poorly understood. In the yeast Saccharomyces cerevisiae, numerous genes with roles in the preservation of genome integrity have been identified. DNA-damage-checkpoint-deficient yeast cells that lack Sgs1, a RecQ-like DNA helicase related to the human Bloom's-syndrome-associated helicase BLM, show an increased rate of genome instability, and we have previously shown that they accumulate recurring chromosomal translocations between three similar genes, CAN1, LYP1 and ALP1. Here, the chromosomal location, copy number and sequence similarity of the translocation targets ALP1 and LYP1 were altered to gain insight into the formation of complex translocations. Among 844 clones with chromosomal rearrangements, 93 with various types of simple and complex translocations involving CAN1, LYP1 and ALP1 were identified. Breakpoint sequencing and mapping showed that the formation of complex translocation types is strictly dependent on the location of the initiating DNA break and revealed that complex translocations arise via a combination of interchromosomal translocation and template-switching, as well as from unstable dicentric intermediates. Template-switching occurred between sequences on the same chromosome, but was inhibited if the genes were transferred to different chromosomes. Unstable dicentric translocations continuously gave rise to clones with multiple translocations in various combinations, reminiscent of intratumor heterogeneity in human cancers. Base substitutions and evidence of DNA slippage near rearrangement breakpoints revealed that translocation formation can be accompanied by point mutations, and their presence in different translocation types within the same clone provides evidence that some of the different translocation types are derived from each other rather than being formed de novo. These findings provide insight into eukaryotic genome instability, especially the formation of translocations and the sources of intraclonal heterogeneity, both of which are often associated with human cancers.	[Schmidt, Kristina H.; Viebranz, Emilie; Doerfler, Lillian; Lester, Christina; Rubenstein, Aaron] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Schmidt, KH (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	kschmidt@usf.edu			National Institutes of Health [R01 GM081425]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM081425 to K.H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chester N, 2006, MOL CELL BIOL, V26, P6713, DOI 10.1128/MCB.00296-06; Cobb JA, 2002, FEBS LETT, V529, P43, DOI 10.1016/S0014-5793(02)03269-6; Frei C, 2000, GENE DEV, V14, P81; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; HOJO ETS, 1995, MUTAT RES-ENVIR MUTA, V334, P59; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morrow DM, 1997, GENETICS, V147, P371; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Paek AL, 2009, GENE DEV, V23, P2861, DOI 10.1101/gad.1862709; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Schmidt KH, 2006, P NATL ACAD SCI USA, V103, P18196, DOI 10.1073/pnas.0608566103; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Selvarajah S, 2006, CHROMOSOMA, V115, P459, DOI 10.1007/s00412-006-0074-4; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12007	10.1371/journal.pone.0012007	http://dx.doi.org/10.1371/journal.pone.0012007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711256	gold, Green Published, Green Submitted			2022-12-27	WOS:000280776800008
J	Williams, RJ; Anandanadesan, A; Purves, D				Williams, Richard J.; Anandanadesan, Ananthi; Purves, Drew			The Probabilistic Niche Model Reveals the Niche Structure and Role of Body Size in a Complex Food Web	PLOS ONE			English	Article							PREY; STABILITY; PATTERNS	The niche model has been widely used to model the structure of complex food webs, and yet the ecological meaning of the single niche dimension has not been explored. In the niche model, each species has three traits, niche position, diet position and feeding range. Here, a new probabilistic niche model, which allows the maximum likelihood set of trait values to be estimated for each species, is applied to the food web of the Benguela fishery. We also developed the allometric niche model, in which body size is used as the niche dimension. About 80% of the links in the empirical data are predicted by the probabilistic niche model, a significant improvement over recent models. As in the niche model, species are uniformly distributed on the niche axis. Feeding ranges are exponentially distributed, but diet positions are not uniformly distributed below the predator. Species traits are strongly correlated with body size, but the allometric niche model performs significantly worse than the probabilistic niche model. The best-fit parameter set provides a significantly better model of the structure of the Benguela food web than was previously available. The methodology allows the identification of a number of taxa that stand out as outliers either in the model's poor performance at predicting their predators or prey or in their parameter values. While important, body size alone does not explain the structure of the one-dimensional niche.	[Williams, Richard J.; Anandanadesan, Ananthi; Purves, Drew] Microsoft Res, Cambridge, England	Microsoft	Williams, RJ (corresponding author), Microsoft Res, Cambridge, England.	ricw@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2009, ECOL LETT, V12, P652, DOI 10.1111/j.1461-0248.2009.01321.x; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1977, P NATL ACAD SCI USA, V74, P4533, DOI 10.1073/pnas.74.10.4533; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Drossel B, 2004, J THEOR BIOL, V229, P539, DOI 10.1016/j.jtbi.2004.04.033; Dunne J. A, 2006, ECOLOGICAL NETWORKS; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Hilborn Ray, 1997, V28; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Morton RD, 1996, OIKOS, V75, P493, DOI 10.2307/3545891; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; WARREN PH, 1987, OECOLOGIA, V74, P231, DOI 10.1007/BF00379364; Warren Philip H., 1996, P142; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x	36	133	134	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12092	10.1371/journal.pone.0012092	http://dx.doi.org/10.1371/journal.pone.0012092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711506	Green Published, gold			2022-12-27	WOS:000280776800023
J	Liu, L; Mason, RP				Liu, Li; Mason, Ralph P.			Imaging beta-Galactosidase Activity in Human Tumor Xenografts and Transgenic Mice Using a Chemiluminescent Substrate	PLOS ONE			English	Article							LACZ GENE-EXPRESSION; IN-VIVO; REPORTER MOLECULE; SENSITIVE METHOD; TRANSFECTION	Background: Detection of enzyme activity or transgene expression offers potential insight into developmental biology, disease progression, and potentially personalized medicine. Historically, the lacZ gene encoding the enzyme beta-galactosidase has been the most common reporter gene and many chromogenic and fluorogenic substrates are well established, but limited to histology or in vitro assays. We now present a novel approach for in vivo detection of b-galactosidase using optical imaging to detect light emission following administration of the chemiluminescent 1,2-dioxetane substrate Galacto-Light PlusTM. Methodology and Principal Findings: B-gal activity was visualized in stably transfected human MCF7-lacZ tumors growing in mice. LacZ tumors were identified versus contralateral wild type tumors as controls, based on two-to tenfold greater light emission following direct intra tumoral or intravenous administration of reporter substrate. The 1,2-dioxetane substrate is commercially available as a kit for microplate-based assays for beta-gal detection, and we have adapted it for in vivo application. Typically, 100 mu l substrate mixture was administered intravenously and light emission was detected from the lacZ tumor immediately with gradual decrease over the next 20 mins. Imaging was also undertaken in transgenic ROSA26 mice following subcutaneous or intravenous injection of substrate mixture. Conclusion and Significance: Light emission was detectable using standard instrumentation designed for more traditional bioluminescent imaging. Use of 1,2-dioxetane substrates to detect enzyme activity offers a new paradigm for non-invasive biochemistry in vivo.	[Liu, Li; Mason, Ralph P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.	Ralph.Mason@UTSouthwestern.edu	Liu, LI/B-6912-2013; Mason, Ralph/C-8472-2012	Liu, LI/0000-0002-9731-6145; Mason, Ralph/0000-0001-7517-3721	Department of Defense Breast Cancer Initiative [BC022001 DAMD 17-03-1-0343-01]; National Cancer Institute [R21 CA120774, U24 CA126608]; Department of Radiology and Simmons Comprehensive Cancer Center; National Institutes of Health [1S10RR024757]; NATIONAL CANCER INSTITUTE [U24CA126608, R21CA120774] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024757, P41RR002584] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Initiative(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Radiology and Simmons Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by Department of Defense Breast Cancer Initiative grant BC022001 DAMD 17-03-1-0343-01 (RPM) and National Cancer Institute R21 CA120774 (RPM) in conjunction with the Southwestern Small Animal Imaging Research Program (SW-SAIRP), which is supported by National Cancer Institute U24 CA126608, the Department of Radiology and Simmons Comprehensive Cancer Center. The IVIS Spectrum was purchased under a National Institutes of Health Shared Instrumentation Grant 1S10RR024757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Celen S, 2009, BIOORGAN MED CHEM, V17, P5117, DOI 10.1016/j.bmc.2009.05.056; Chang YT, 2007, BIOCONJUGATE CHEM, V18, P1716, DOI 10.1021/bc070019s; Chilvers KF, 2001, J APPL MICROBIOL, V91, P1118, DOI 10.1046/j.1365-2672.2001.01484.x; Contero A, 2009, METHODS MOL BIOL, V574, P37, DOI 10.1007/978-1-60327-321-3_4; CUI W, 2010, MAGN RESON MED; Cui WN, 2004, MAGN RESON MED, V51, P616, DOI 10.1002/mrm.10719; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; James AL, 2000, LETT APPL MICROBIOL, V30, P336, DOI 10.1046/j.1472-765X.2000.00669.x; Kodibagkar VD, 2006, MAGN RESON IMAGING, V24, P959, DOI 10.1016/j.mri.2006.04.003; Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983; Lee KH, 2004, EUR J NUCL MED MOL I, V31, P433, DOI 10.1007/s00259-003-1395-7; Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Liu L, 2007, FASEB J, V21, P2014, DOI 10.1096/fj.06-7366lsf; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Masuda-Nishimura I, 2000, LETT APPL MICROBIOL, V30, P130, DOI 10.1046/j.1472-765X.2000.00683.x; Murakami T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2007947; Olesen CEM, 2000, METHOD ENZYMOL, V326, P175; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; Thorne SH, 2005, P IEEE, V93, P750, DOI 10.1109/JPROC.2005.844261; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; Van Dort ME, 2008, MOL IMAGING, V7, P187, DOI 10.2310/7290.2008.00020; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Yu JX, 2008, NMR BIOMED, V21, P704, DOI 10.1002/nbm.1244; Yu JX, 2004, BIOCONJUGATE CHEM, V15, P1334, DOI 10.1021/bc049936d; Zhang GJ, 2009, ASSAY DRUG DEV TECHN, V7, DOI 10.1089/adt.2009.0195; Zhao DW, 2008, FASEB J, V22, P2445, DOI 10.1096/fj.07-103713; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	35	53	55	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12024	10.1371/journal.pone.0012024	http://dx.doi.org/10.1371/journal.pone.0012024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700459	Green Submitted, gold, Green Published			2022-12-27	WOS:000280687900016
J	Rinderknecht, M; Villa, A; Ballmer-Hofer, K; Neri, D; Detmar, M				Rinderknecht, Matthias; Villa, Alessandra; Ballmer-Hofer, Kurt; Neri, Dario; Detmar, Michael			Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; LYMPH-NODE METASTASIS; TUMOR LYMPHANGIOGENESIS; MELANOMA METASTASIS; CELL PROLIFERATION; FACTOR (VEGF)-C; GASTRIC-CANCER; BINDING; DOMAIN; SPECIFICITY	Vascular endothelial growth factor C (VEGF-C) is a key mediator of lymphangiogenesis, acting via its receptors VEGF-R2 and VEGF-R3. High expression of VEGF-C in tumors correlates with increased lymphatic vessel density, lymphatic vessel invasion, sentinel lymph node metastasis and poor prognosis. Recently, we found that in a chemically induced skin carcinoma model, increased VEGF-C drainage from the tumor enhanced lymphangiogenesis in the sentinel lymph node and facilitated metastatic spread of cancer cells via the lymphatics. Hence, interference with the VEGF-C/VEGF-R3 axis holds promise to block metastatic spread, as recently shown by use of a neutralizing anti-VEGF-R3 antibody and a soluble VEGF-R3 (VEGF-C/D trap). By antibody phage-display, we have developed a human monoclonal antibody fragment (single-chain Fragment variable, scFv) that binds with high specificity and affinity to the fully processed mature form of human VEGF-C. The scFv binds to an epitope on VEGF-C that is important for receptor binding, since binding of the scFv to VEGF-C dose-dependently inhibits the binding of VEGF-C to VEGF-R2 and VEGF-R3 as shown by BIAcore and ELISA analyses. Interestingly, the variable heavy domain (V(H)) of the anti-VEGF-C scFv, which contains a mutation typical for camelid heavy chain-only antibodies, is sufficient for binding VEGF-C. This reduced the size of the potentially VEGF-C-blocking antibody fragment to only 14.6 kDa. Anti-VEGF-C V(H)-based immunoproteins hold promise to block the lymphangiogenic activity of VEGF-C, which would present a significant advance in inhibiting lymphatic-based metastatic spread of certain cancer types.	[Rinderknecht, Matthias; Neri, Dario; Detmar, Michael] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Villa, Alessandra] Swiss Fed Inst Technol, Philochem AG, Zurich, Switzerland; [Ballmer-Hofer, Kurt] Paul Scherrer Inst, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Rinderknecht, M (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Ballmer-Hofer, Kurt/0000-0002-3800-9129	National Institutes of Health [CA69184]; Swiss National Science Foundation [3100A0-108207, 3100A-116507, 2-77633-09]; Austrian Science Foundation [S9408-B11]; Cancer League Zurich; Oncosuisse [OC2 01200-08-2007]; Commission of the European Communities [LSHC-CT-2005-518178]; ETH Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Foundation(Austrian Science Fund (FWF)); Cancer League Zurich; Oncosuisse; Commission of the European Communities(European Commission); ETH Zurich(ETH Zurich); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA69184 (www.nih.gov), Swiss National Science Foundation grant 3100A0-108207 (www.snf.ch), Austrian Science Foundation grant S9408-B11 (www.fwf.ac.at), Cancer League Zurich (www.krebsliga-zh.ch), Oncosuisse (www.oncosuisse.ch) and Commission of the European Communities grant LSHC-CT-2005-518178 (www.cordis.europa.eu) issued to M. D.; Swiss National Science Foundation grant 3100A-116507 and Oncosuisse grant OC2 01200-08-2007 issued to K. B.-H.; and ETH Zurich and Swiss National Science Foundation grant 2-77633-09 issued to D.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Brack SS, 2006, CLIN CANCER RES, V12, P3200, DOI 10.1158/1078-0432.CCR-05-2804; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Jeltsch M, 2006, J BIOL CHEM, V281, P12187, DOI 10.1074/jbc.M511593200; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P1751; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; KONDO R, 1993, J MOL EVOL, V36, P517, DOI 10.1007/BF00556356; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Matsuura M, 2009, AM J PATHOL, V175, P1709, DOI 10.2353/ajpath.2009.081139; Moehler TM, 2003, CRIT REV ONCOL HEMAT, V45, P227, DOI 10.1016/S1040-8428(02)00135-X; Muyldermans S, 1999, J MOL RECOGNIT, V12, P131, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Orlandini M, 2006, J BIOL CHEM, V281, P17961, DOI 10.1074/jbc.M600413200; Rinderknecht M, 2008, J CELL PHYSIOL, V216, P347, DOI 10.1002/jcp.21494; Rinderknecht M, 2009, CANCER METAST BIOL T, V13, P55, DOI 10.1007/978-90-481-2247-9_4; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Scheidegger P, 1999, BIOL CHEM, V380, P1449, DOI 10.1515/BC.1999.187; Schliemann C, 2009, BLOOD, V113, P2275, DOI 10.1182/blood-2008-05-160747; Shimizu K, 2004, CANCER SCI, V95, P328, DOI 10.1111/j.1349-7006.2004.tb03211.x; Shin HY, 2002, PHYSIOL GENOMICS, V11, P245, DOI 10.1152/physiolgenomics.00068.2002; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; Tomanek RJ, 2002, DEV DYNAM, V225, P233, DOI 10.1002/dvdy.10158; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Viti F, 2000, METHOD ENZYMOL, V326, P480; VOGEL F, 1977, J MOL EVOL, V9, P159, DOI 10.1007/BF01732746; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200	46	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11941	10.1371/journal.pone.0011941	http://dx.doi.org/10.1371/journal.pone.0011941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689828	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520400016
J	Gill, JC; Wang, OL; Kakar, S; Martinelli, E; Carroll, RS; Kaiser, UB				Gill, John C.; Wang, Oulu; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.			Reproductive Hormone-Dependent and -Independent Contributions to Developmental Changes in Kisspeptin in GnRH-Deficient Hypogonadal Mice	PLOS ONE			English	Article							KISS1 GENE-EXPRESSION; SEXUAL-DIFFERENTIATION; GONADOTROPIN-SECRETION; HYPOTHALAMUS; NEURONS; ACTIVATION; RECEPTOR; BRAIN; ESTROGEN; FEEDBACK	Kisspeptin is a potent activator of GnRH-induced gonadotropin secretion and is a proposed central regulator of pubertal onset. In mice, there is a neuroanatomical separation of two discrete kisspeptin neuronal populations, which are sexually dimorphic and are believed to make distinct contributions to reproductive physiology. Within these kisspeptin neuron populations, Kiss1 expression is directly regulated by sex hormones, thereby confounding the roles of sex differences and early activational events that drive the establishment of kisspeptin neurons. In order to better understand sex steroid hormone-dependent and -independent effects on the maturation of kisspeptin neurons, hypogonadal (hpg) mice deficient in GnRH and its downstream effectors were used to determine changes in the developmental kisspeptin expression. In hpg mice, sex differences in Kiss1 mRNA levels and kisspeptin immunoreactivity, typically present at 30 days of age, were absent in the anteroventral periventricular nucleus (AVPV). Although immunoreactive kisspeptin increased from 10 to 30 days of age to levels intermediate between wild type (WT) females and males, corresponding increases in Kiss1 mRNA were not detected. In contrast, the hpg arcuate nucleus (ARC) demonstrated a 10-fold increase in Kiss1 mRNA between 10 and 30 days in both females and males, suggesting that the ARC is a significant center for sex steroid-independent pubertal kisspeptin expression. Interestingly, the normal positive feedback response of AVPV kisspeptin neurons to estrogen observed in WT mice was lost in hpg females, suggesting that exposure to reproductive hormones during development may contribute to the establishment of the ovulatory gonadotropin surge mechanism. Overall, these studies suggest that the onset of pubertal kisspeptin expression is not dependent on reproductive hormones, but that gonadal sex steroids critically shape the hypothalamic kisspeptin neuronal subpopulations to make distinct contributions to the activation and control of the reproductive hormone cascade at the time of puberty.	[Gill, John C.; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Gill, John C.; Kakar, Shelley; Martinelli, Enzo; Carroll, Rona S.; Kaiser, Ursula B.] Harvard Reprod Endocrine Sci Ctr, Boston, MA USA; [Wang, Oulu] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Gill, JC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA.	JCGILL@PARTNERS.ORG			Eunice Kennedy Shriver NICHD/NIH [U54 HD28138]; Building Interdisciplinary Research Careers in Women's Health (BIRCWH) [Harvard K12 HD051959]; NIH Office of Research in Women's Health;  [R01 HD61577]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138, K12HD051959] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD061577] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Building Interdisciplinary Research Careers in Women's Health (BIRCWH); NIH Office of Research in Women's Health; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement U54 HD28138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (UBK), by R01 HD61577 (UBK), and by the Harvard K12 HD051959 Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program supported by the NIH Office of Research in Women's Health (JCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; ANDREWS WW, 1981, ENDOCRINOLOGY, V109, P2022, DOI 10.1210/endo-109-6-2022; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Bentsen AH, 2010, PEPTIDES, V31, P275, DOI 10.1016/j.peptides.2009.11.017; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; Clarkson J, 2009, ENDOCRINOLOGY; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; CORE AC, 2002, GNRH MASTER MOL; Fetissov SO, 2005, EUR J NEUROSCI, V22, P3217, DOI 10.1111/j.1460-9568.2005.04513.x; Gonzalez-Martinez D, 2008, ENDOCRINOLOGY, V149, P2333, DOI 10.1210/en.2007-1422; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; HASHIZUME K, 1995, EXP ANIM TOKYO, V44, P241, DOI 10.1538/expanim.44.241; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kauffman AS, 2007, J NEUROSCI, V27, P8826, DOI 10.1523/JNEUROSCI.2099-07.2007; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kauffman AS, 2010, MOL CELL ENDOCRINOL, V324, P51, DOI 10.1016/j.mce.2010.01.017; Kauffman AS, 2009, AM J PHYSIOL-ENDOC M, V297, pE1212, DOI 10.1152/ajpendo.00461.2009; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Lima FB, 2008, BRAIN RES, V1227, P76, DOI 10.1016/j.brainres.2008.05.078; MA YJ, 1994, MOL CELL NEUROSCI, V5, P246, DOI 10.1006/mcne.1994.1029; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; Plant TM, 2004, HUM REPROD UPDATE, V10, P67, DOI 10.1093/humupd/dmh001; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; RAMIREZ DV, 1963, ENDOCRINOLOGY, V72, P452, DOI 10.1210/endo-72-3-452; Rance NE, 2009, PEPTIDES, V30, P111, DOI 10.1016/j.peptides.2008.05.016; Roa J, 2006, ENDOCRINOLOGY, V147, P2864, DOI 10.1210/en.2005-1463; Rometo AM, 2008, J NEUROENDOCRINOL, V20, P1376, DOI 10.1111/j.1365-2826.2008.01796.x; Rometo AM, 2007, J CLIN ENDOCR METAB, V92, P2744, DOI 10.1210/jc.2007-0553; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Takase K, 2009, J NEUROENDOCRINOL, V21, P527, DOI 10.1111/j.1365-2826.2009.01868.x; Wang Y, 2005, BIOL REPROD, V73, P610, DOI 10.1095/biolreprod.105.039602	44	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11911	10.1371/journal.pone.0011911	http://dx.doi.org/10.1371/journal.pone.0011911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689830	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300025
J	Fu, XP; Tao, LH; Rivera, A; Williamson, S; Song, XT; Ahmed, N; Zhang, XL				Fu, Xinping; Tao, Lihua; Rivera, Armando; Williamson, Shana; Song, Xiao-Tong; Ahmed, Nabil; Zhang, Xiaoliu			A Simple and Sensitive Method for Measuring Tumor-Specific T Cell Cytotoxicity	PLOS ONE			English	Article							MEDIATED CYTOTOXICITY; TARGET-CELLS; ASSAY; PIGGYBAC; RECEPTORS	A simple and sensitive method to quantitatively measure the cytolytic effect of tumor-specific T killer cells is highly desirable for basic and clinical studies. Chromium ((51)Cr) release assay has been the "gold standard'' for quantifying cytolytic activities of cytotoxic T lymphocytes (CTLs) against target cells and this method is still being used in many laboratories. However, a major drawback of this method is the use of radioactive materials, which is inconvenient to handle because of environmental safety concerns and expensive due to the short half-life of the isotope. Consequently, several nonradioactive methods have been reported recently. Here we report a new method that we recently developed for quantifying antigen-specific cytolytic activity of CTLs. This method fully exploits the high sensitivity and the relative simplicity of luciferase quantitative assay. We initially expected the released luciferase in the supernatant to be the adequate source for monitoring cell death. However, to our total surprise, incubation of these killer T cells with the tumor cell targets did not result in significant release of luciferase in the culture medium. Instead, we found that the remaining luciferase inside the cells could accurately reflect the overall cell viability.	[Fu, Xinping; Tao, Lihua; Rivera, Armando; Zhang, Xiaoliu] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Williamson, Shana; Zhang, Xiaoliu] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Song, Xiao-Tong; Ahmed, Nabil] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Fu, XP (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	shaunzhang@uh.edu	Song, Xiao-Tong/AAI-8424-2020	Zhang, Shaun/0000-0002-2085-3997	NIH/National Cancer Institute [R01CA106671, R01CA132792]; NATIONAL CANCER INSTITUTE [R01CA132792, R01CA106671] Funding Source: NIH RePORTER	NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/National Cancer Institute grants R01CA106671 and R01CA132792 (to XZ). http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, CANCER RES, V67, P5957, DOI 10.1158/0008-5472.CAN-06-4309; Andre ND, 2004, J CLIN LAB ANAL, V18, P27, DOI 10.1002/jcla.20006; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Ayres FM, 2003, IMMUNOL INVEST, V32, P219, DOI 10.1081/IMM-120025102; Chen K, 2005, J IMMUNOL METHODS, V300, P100, DOI 10.1016/j.jim.2005.02.010; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Hoppner M, 2002, J IMMUNOL METHODS, V267, P157, DOI 10.1016/S0022-1759(02)00167-9; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Nelson DL, 2001, CURR PROTOC IMMUNOL, V7, P27, DOI [10.1002/0471142735.im0727s08, 10.1002/0471142735.IM0727S08, DOI 10.1002/0471142735.IM0727S08]; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; van Baalen CA, 2005, J INFECT DIS, V192, P1183, DOI 10.1086/444546; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028	16	47	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11867	10.1371/journal.pone.0011867	http://dx.doi.org/10.1371/journal.pone.0011867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686618	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520200030
J	Panebra, A; Wang, WC; Malone, MM; Pitter, DRG; Weiss, ST; Hawkins, GA; Liggett, SB				Panebra, Alfredo; Wang, Wayne C.; Malone, Molly M.; Pitter, Demar R. G.; Weiss, Scott T.; Hawkins, Gregory A.; Liggett, Stephen B.			Common ADRB2 Haplotypes Derived from 26 Polymorphic Sites Direct beta(2)-Adrenergic Receptor Expression and Regulation Phenotypes	PLOS ONE			English	Article							HEART-FAILURE; THERAPY; ASTHMA	Background: The beta(2)-adrenergic receptor (beta(2)AR) is expressed on numerous cell-types including airway smooth muscle cells and cardiomyocytes. Drugs (agonists or antagonists) acting at these receptors for treatment of asthma, chronic obstructive pulmonary disease, and heart failure show substantial interindividual variability in response. The ADRB2 gene is polymorphic in noncoding and coding regions, but virtually all ADRB2 association studies have utilized the two common nonsynonymous coding SNPs, often reaching discrepant conclusions. Methodology/Principal Findings: We constructed the 8 common ADRB2 haplotypes derived from 26 polymorphisms in the promoter, 5'UTR, coding, and 3'UTR of the intronless ADRB2 gene. These were cloned into an expression construct lacking a vector-based promoter, so that beta(2)AR expression was driven by its promoter, and steady state expression could be modified by polymorphisms throughout ADRB2 within a haplotype. "Whole-gene'' transfections were performed with COS-7 cells and revealed 4 haplotypes with increased cell surface beta(2)AR protein expression compared to the others. Agonist-promoted downregulation of beta(2)AR protein expression was also haplotype-dependent, and was found to be increased for 2 haplotypes. A phylogenetic tree of the haplotypes was derived and annotated by cellular phenotypes, revealing a pattern potentially driven by expression. Conclusions/Significance: Thus for obstructive lung disease, the initial bronchodilator response from intermittent administration of beta-agonist may be influenced by certain beta(2)AR haplotypes (expression phenotypes), while other haplotypes may influence tachyphylaxis during the response to chronic therapy (downregulation phenotypes). An ideal clinical outcome of high expression and less downregulation was found for two haplotypes. Haplotypes may also affect heart failure antagonist therapy, where beta(2)AR increase inotropy and are anti-apoptotic. The haplotype-specific expression and regulation phenotypes found in this transfection-based system suggest that the density of genetic information in the form of these haplotypes, or haplotype-clusters with similar phenotypes can potentially provide greater discrimination of phenotype in human disease and pharmacogenomic association studies.	[Panebra, Alfredo; Wang, Wayne C.; Malone, Molly M.; Pitter, Demar R. G.; Liggett, Stephen B.] Univ Maryland, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Weiss, Scott T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Hawkins, Gregory A.] Wake Forest Univ, Winston Salem, NC 27109 USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wake Forest University	Panebra, A (corresponding author), Univ Maryland, Cardiopulm Genom Program, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012	Panebra, Alfredo/0000-0002-2520-9746; Liggett, Stephen B./0000-0002-0128-3669	United States National Institutes of Health [HL065899, HL045967]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045967, U01HL065899, R37HL045967, R01HL045967] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by a United States National Institutes of Health grant HL065899 and HL045967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; Dorn GW, 2009, MOL PHARMACOL, V76, P466, DOI 10.1124/mol.109.056572; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; HALL IP, 2006, PHARMACOGENETICS, P91; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; LIGGETT SB, 1996, BETA2 AGONISTS ASTHM, P19; Liggett SB, 2005, RECEPTORS, P339; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Panebra A, 2008, AM J PHYSIOL-LUNG C, V294, pL190, DOI 10.1152/ajplung.00277.2007; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Small KM, 2000, J BIOL CHEM, V275, P23059, DOI 10.1074/jbc.M000796200; Small KM, 2004, P NATL ACAD SCI USA, V101, P13020, DOI 10.1073/pnas.0405074101; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709; van Campen LCMC, 1998, J CARDIOVASC PHARM, V32, pS31, DOI 10.1097/00005344-199806321-00006; Wang WCH, 2009, P NATL ACAD SCI USA, V106, P15007, DOI 10.1073/pnas.0906034106; WORTSMAN J, 1984, AM J MED, V77, P779, DOI 10.1016/0002-9343(84)90512-6	25	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11819	10.1371/journal.pone.0011819	http://dx.doi.org/10.1371/journal.pone.0011819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686604	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200006
J	Cheshenko, N; Trepanier, JB; Segarra, TJ; Fuller, AO; Herold, BC				Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Fuller, A. Oveta; Herold, Betsy C.			HSV Usurps Eukaryotic Initiation Factor 3 Subunit M for Viral Protein Translation: Novel Prevention Target	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TO-CELL SPREAD; HIV-1 ACQUISITION; GLYCOPROTEIN-B; GENITAL HERPES; PORCINE CELLS; C-TERMINUS; ENTRY; RECEPTOR; TYPE-1	Prevention of genital herpes is a global health priority. B5, a recently identified ubiquitous human protein, was proposed as a candidate HSV entry receptor. The current studies explored its role in HSV infection. Viral plaque formation was reduced by similar to 90% in human cells transfected with small interfering RNA targeting B5 or nectin-1, an established entry receptor. However, the mechanisms were distinct. Silencing of nectin-1 prevented intracellular delivery of viral capsids, nuclear transport of a viral tegument protein, and release of calcium stores required for entry. In contrast, B5 silencing had no effect on these markers of entry, but inhibited viral protein translation. Specifically, viral immediate early genes, ICP0 and ICP4, were transcribed, polyadenylated and transported from the nucleus to the cytoplasm, but the viral transcripts did not associate with ribosomes or polysomes in B5-silenced cells. In contrast, immediate early gene viral transcripts were detected in polysome fractions isolated from control cells. These findings are consistent with sequencing studies demonstrating that B5 is eukaryotic initiation factor 3 subunit m (eIF3m). Although B5 silencing altered the polysome profile of cells, silencing had little effect on cellular RNA or protein expression and was not cytotoxic, suggesting that this subunit is not essential for host cellular protein synthesis. Together these results demonstrate that B5 plays a major role in the initiation of HSV protein translation and could provide a novel target for strategies to prevent primary and recurrent herpetic disease.	[Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Cheshenko, Natalia; Trepanier, Janie B.; Segarra, Theodore J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Fuller, A. Oveta] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan	Cheshenko, N (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu	Cheshenko, Natalia/ABF-5896-2021	Herold, Betsy/0000-0001-9974-0786	NIH [AI061679, AI70202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061679, U19AI070202, R01AI061679] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI061679 and AI70202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown OJ, 2007, BIOPHYS J, V93, P1068, DOI 10.1529/biophysj.106.100958; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cheshenko N, 2005, J BIOL CHEM, V280, P31116, DOI 10.1074/jbc.M503518200; Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Cheshenko N, 2002, J GEN VIROL, V83, P2247, DOI 10.1099/0022-1317-83-9-2247; Cheshenko N, 2007, MOL BIOL CELL, V18, P3119, DOI 10.1091/mbc.E07-01-0062; Chew SK, 2009, NATURE, V460, P123, DOI 10.1038/nature08087; Conrad NK, 2008, METHOD ENZYMOL, V449, P317, DOI 10.1016/S0076-6879(08)02415-4; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; GELMAN IH, 1985, P NATL ACAD SCI USA, V82, P5265, DOI 10.1073/pnas.82.16.5265; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Kutluay SB, 2009, J VIROL, V83, P3436, DOI 10.1128/JVI.02349-08; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Perez A, 2005, J VIROL, V79, P7419, DOI 10.1128/JVI.79.12.7419-7430.2005; Perez A, 1998, VIRUS RES, V58, P21, DOI 10.1016/S0168-1702(98)00097-5; Perez-Romero P, 2005, J VIROL, V79, P7431, DOI 10.1128/JVI.79.12.7431-7437.2005; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Roberts Craig, 2005, Herpes, V12, P10; SUBRAMANIAN G, 1995, J GEN VIROL, V76, P2375, DOI 10.1099/0022-1317-76-9-2375; Walsh D, 2006, GENE DEV, V20, P461, DOI 10.1101/gad.1375006; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wilson SS, 2009, EXPERT REV ANTI-INFE, V7, P559, DOI [10.1586/eri.09.34, 10.1586/ERI.09.34]; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	33	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11829	10.1371/journal.pone.0011829	http://dx.doi.org/10.1371/journal.pone.0011829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676407	Green Submitted, Green Published, gold			2022-12-27	WOS:000280371800023
J	Jassal, MS; Nedeltchev, GG; Lee, JH; Choi, SW; Atudorei, V; Sharp, ZD; Deretic, V; Timmins, GS; Bishai, WR				Jassal, Mandeep S.; Nedeltchev, Gueno G.; Lee, Jong-Hee; Choi, Seong Won; Atudorei, Viorel; Sharp, Zachary D.; Deretic, Vojo; Timmins, Graham S.; Bishai, William R.			(13)[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis	PLOS ONE			English	Article							UREASE TEST; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; PULMONARY TUBERCULOSIS; TREATMENT RESPONSE; PYLORI; IDENTIFICATION; THERAPY	Background: Pathogen-specific metabolic pathways may be detected by breath tests based on introduction of stable isotopically-labeled substrates and detection of labeled products in exhaled breath using portable infrared spectrometers. Methodology/Principal Findings: We tested whether mycobacterial urease activity could be utilized in such a breath test format as the basis of a novel biomarker and diagnostic for pulmonary TB. Sensitized New-Zealand White Rabbits underwent bronchoscopic infection with either Mycobacterium bovis or Mycobacterium tuberculosis. Rabbits were treated with 25 mg/kg of isoniazid (INH) approximately 2 months after infection when significant cavitary lung pathology was present. [C-13] urea was instilled directly into the lungs of intubated rabbits at selected time points, exhaled air samples analyzed, and the kinetics of delta(CO2)-C-13 formation were determined. Samples obtained prior to inoculation served as control samples for background (CO2)-C-13 conversion in the rabbit model. (CO2)-C-13, from metabolic conversion of [C-13]-urea by mycobacterial urease activity, was readily detectable in the exhaled breath of infected rabbits within 15 minutes of administration. Analyses showed a rapid increase in the rate of (CO2)-C-13 formation both early in disease and prior to treatment with INH. Following INH treatment, all evaluable rabbits showed a decrease in the rate of (CO2)-C-13 formation. Conclusions/Significance: Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response. Future work will test specificity for M. tuberculosis using lung-targeted dry powder inhalation formulations, combined with co-administering oral urease inhibitors together with a saturating oral dose of unlabeled urea, which would prevent the delta(CO2)-C-13 signal from urease-positive gastrointestinal organisms.	[Jassal, Mandeep S.; Nedeltchev, Gueno G.; Lee, Jong-Hee; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Jassal, Mandeep S.] Johns Hopkins Univ, Sch Med, Div Pediat Pulmonol, Baltimore, MD USA; [Choi, Seong Won; Timmins, Graham S.] Univ New Mexico, Div Pharmaceut Sci, Albuquerque, NM 87131 USA; [Atudorei, Viorel; Sharp, Zachary D.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Deretic, Vojo] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	Johns Hopkins University; Johns Hopkins University; University of New Mexico; University of New Mexico; University of New Mexico	Jassal, MS (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai@jhmi.edu	Lee, JongHee/AAH-4129-2019	Lee, JongHee/0000-0001-9938-1306; timmins, graham/0000-0002-4971-718X; Deretic, Vojo/0000-0002-3624-5208	National Institutes of Health (NIH) [AI36973, AI37856, AI30036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI042999, R01AI030036, R29AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The support of National Institutes of Health (NIH) grants/contracts AI36973, AI37856, AI30036 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; BELL GD, 1987, LANCET, V1, P1367; Buzas GM, 2008, J GASTROENTEROL, V43, P108, DOI 10.1007/s00535-007-2135-8; CANETTI G, 1995, TUBERCLE BACILLUS; COX FR, 1977, J CLIN MICROBIOL, V5, P656; DAMATO JJ, 1982, J CLIN MICROBIOL, V15, P478, DOI 10.1128/JCM.15.3.478-480.1982; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; ELNUJUMI AM, 1991, GUT, V32, P866, DOI 10.1136/gut.32.8.866; Fujimura S, 2002, EUR J GASTROEN HEPAT, V14, P1161, DOI 10.1097/00042737-200210000-00019; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gillespie SH, 2003, INT J TUBERC LUNG D, V7, P684; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; LEVYFREBAULT VV, 1992, INT J SYST BACTERIOL, V42, P315; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Mitchell JP, 2009, EXPERT REV MED DEVIC, V6, P147, DOI 10.1586/17434440.6.2.147; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; MITCHISON DA, 1992, J ANTIMICROB CHEMOTH, V29, P477, DOI 10.1093/jac/29.5.477; MURPHY DB, 1975, J CLIN MICROBIOL, V1, P465, DOI 10.1128/JCM.1.5.465-468.1975; NARDELL EA, 2000, TUBERCULOSIS COMPREH, P215; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; Opekun AR, 2005, CLIN BIOCHEM, V38, P731, DOI 10.1016/j.clinbiochem.2005.05.003; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; ROSENSTEIN IJM, 1984, CRC CR REV MICROBIOL, V11, P1, DOI 10.3109/10408418409105901; Sanaka M, 1999, AM J GASTROENTEROL, V94, P1983, DOI 10.1111/j.1572-0241.1999.1983a.x; Sohngen N. L., 1913, ZBL BAKTERIOL      2, V27, P595; STEADHAM JE, 1979, J CLIN MICROBIOL, V10, P134, DOI 10.1128/JCM.10.2.134-137.1979; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; TODA T, 1961, AM REV RESPIR DIS, V83, P757; Uygun A, 2007, J DIGEST DIS, V8, P211, DOI 10.1111/j.1751-2980.2007.00308.x; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147	41	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12451	10.1371/journal.pone.0012451	http://dx.doi.org/10.1371/journal.pone.0012451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805989	Green Published, gold			2022-12-27	WOS:000281301500017
J	Berretta, R; Moscato, P				Berretta, Regina; Moscato, Pablo			Cancer Biomarker Discovery: The Entropic Hallmark	PLOS ONE			English	Article							METHYLACYL-COA-RACEMASE; NF-KAPPA-B; HUMAN PROSTATE-CANCER; HUMAN-MELANOMA CELLS; COENZYME-A-RACEMASE; ENDOTHELIAL GROWTH-FACTOR; METASTATIC UVEAL MELANOMA; GENE-EXPRESSION PROFILES; PELVIC LYMPH-NODES; SISTER-CHROMATID COHESION	Background: It is a commonly accepted belief that cancer cells modify their transcriptional state during the progression of the disease. We propose that the progression of cancer cells towards malignant phenotypes can be efficiently tracked using high-throughput technologies that follow the gradual changes observed in the gene expression profiles by employing Shannon's mathematical theory of communication. Methods based on Information Theory can then quantify the divergence of cancer cells' transcriptional profiles from those of normally appearing cells of the originating tissues. The relevance of the proposed methods can be evaluated using microarray datasets available in the public domain but the method is in principle applicable to other high-throughput methods. Methodology/Principal Findings: Using melanoma and prostate cancer datasets we illustrate how it is possible to employ Shannon Entropy and the Jensen-Shannon divergence to trace the transcriptional changes progression of the disease. We establish how the variations of these two measures correlate with established biomarkers of cancer progression. The Information Theory measures allow us to identify novel biomarkers for both progressive and relatively more sudden transcriptional changes leading to malignant phenotypes. At the same time, the methodology was able to validate a large number of genes and processes that seem to be implicated in the progression of melanoma and prostate cancer. Conclusions/Significance: We thus present a quantitative guiding rule, a new unifying hallmark of cancer: the cancer cell's transcriptome changes lead to measurable observed transitions of Normalized Shannon Entropy values (as measured by high-througput technologies). At the same time, tumor cells increment their divergence from the normal tissue profile increasing their disorder via creation of states that we might not directly measure. This unifying hallmark allows, via the the Jensen-Shannon divergence, to identify the arrow of time of the processes from the gene expression profiles, and helps to map the phenotypical and molecular hallmarks of specific cancer subtypes. The deep mathematical basis of the approach allows us to suggest that this principle is, hopefully, of general applicability for other diseases.	[Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Berretta, R (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013	Moscato, Pablo/0000-0003-2570-5966; Berretta, Regina/0000-0002-4420-3446	Australian Research Council (ARC) Centre of Excellence in Bioinformatics; Hunter Medical Research Institute; University of Newcastle; ARC [DP0559755, DP0773279]	Australian Research Council (ARC) Centre of Excellence in Bioinformatics(Australian Research Council); Hunter Medical Research Institute; University of Newcastle; ARC(Australian Research Council)	The authors acknowledge the support of the Australian Research Council (ARC) Centre of Excellence in Bioinformatics, Hunter Medical Research Institute, The University of Newcastle, and ARC Discovery Projects DP0559755 (Evolutionary algorithms for problems in functional genomics data analysis) and DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalamian-Matheis M, 2007, ADV EXP MED BIOL, V601, P173; Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Adamsen BL, 2007, INT J ONCOL, V31, P1491; Agalliu I, 2007, BRIT J CANCER, V97, P826, DOI 10.1038/sj.bjc.6603929; Agarwal R, 2006, ANTICANCER RES, V26, P4457; Aghaei M, 2005, CLIN BIOCHEM, V38, P887, DOI 10.1016/j.clinbiochem.2005.05.015; Agre P, 1996, NEPHROLOGIE, V17, P409; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; AGRE P, 1993, AM J PHYSIOL, V265, pF463; AGRE P, 1995, TRANSFUS CLIN BIOL, V2, P303, DOI 10.1016/S1246-7820(05)80096-5; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ALCAIDE JRC, 2006, CLIN TRANSL ONCOL, V8, P148; Alcaraz A, 2001, PROSTATE, V47, P29; Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; ANDREYEV NI, 1969, CORRELATION THEORY S; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; ARBITRARIO JP, 2009, CANC CHEMOTHER PHARM; Armstrong K, 2006, PROSTATE, V66, P1223, DOI 10.1002/pros.20376; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Azzone GF, 1997, HIST PHIL LIFE SCI, V19, P163; Babiker AA, 2005, PROSTATE, V62, P105, DOI 10.1002/pros.20102; Babiker AA, 2002, AM J REPROD IMMUNOL, V47, P183, DOI 10.1034/j.1600-0897.2002.1o023.x; BACHMANN IM, 2008, BMC CANCER, V362, P3; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bahamontes-Rosa N, 2008, TRANSFUSION, V48, P1164, DOI 10.1111/j.1537-2995.2008.01683.x; Bai F, 2006, MOL CELL BIOL, V26, P4564, DOI 10.1128/MCB.00266-06; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Balbin A, 2004, ACTA BIOTHEOR, V52, P173, DOI 10.1023/B:ACBI.0000043441.74099.0c; BALLAL RD, 2009, J BIOL CHEM; Bantis A, 2005, J EXP CLIN CANC RES, V24, P273; Barak V, 2007, ANTICANCER RES, V27, P1897; Bartkova J, 2003, APMIS, V111, P252, DOI 10.1034/j.1600-0463.2003.1110129.x; Bastide C, 2009, EJSO-EUR J SURG ONC, V35, P751, DOI 10.1016/j.ejso.2008.04.007; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz Eric, 2009, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-540-79885-9_4; Ben-Naim A., 2008, FAREWELL ENTROPY STA; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benga G, 2006, CELL MOL BIOL, V52, P10, DOI 10.1170/T744; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; BERTHON P, 1995, BRIT J CANCER, V72, P946, DOI 10.1038/bjc.1995.439; Bettendorf O, 2008, GENE CHROMOSOME CANC, V47, P565, DOI 10.1002/gcc.20560; Bhanot Gyan, 2005, Genome Inform, V16, P233; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; BISHOFF JT, 1995, UROLOGY, V45, P270, DOI 10.1016/0090-4295(95)80017-4; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P621, DOI 10.4161/cbt.4.6.1818; Blandino G, 2004, CELL CYCLE, V3, P886; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Bolander A, 2007, ANTICANCER RES, V27, P3211; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bonetto F, 1998, CHAOS, V8, P823, DOI 10.1063/1.166369; Bonn D, 2002, LANCET ONCOL, V3, P3, DOI 10.1016/S1470-2045(01)00603-9; Boralevi F, 2005, BRIT J DERMATOL, V153, P310, DOI 10.1111/j.1365-2133.2005.06664.x; BORDONI R, 1990, J CELL BIOCHEM, V44, P207, DOI 10.1002/jcb.240440403; Boukamp P, 1999, ONCOGENE, V18, P5638, DOI 10.1038/sj.onc.1202934; Boury-Jamot M, 2006, BBA-BIOMEMBRANES, V1758, P1034, DOI 10.1016/j.bbamem.2006.06.013; Boury-Jamot Mathieu, 2009, Handb Exp Pharmacol, P205, DOI 10.1007/978-3-540-79885-9_10; Brandner J. M., 2007, International Journal of Cosmetic Science, V29, P413, DOI 10.1111/j.1468-2494.2007.00402.x; Brey JJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011305; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Brinck U, 2002, INT J MOL MED, V10, P707; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; BROWN LF, 1994, AM J PATHOL, V145, P610; Brychtova S, 2008, NEOPLASMA, V55, P273; Bu YQ, 2008, ONCOLOGY-BASEL, V74, P198, DOI 10.1159/000151367; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Buhmeida A, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-4; Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Butler JS, 2005, J MOL BIOL, V350, P906, DOI 10.1016/j.jmb.2005.05.060; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Camargo JA, 2008, ACTA BIOTHEOR, V56, P275, DOI 10.1007/s10441-008-9053-x; CANBOLAT O, 1994, J LARYNGOL OTOL, V108, P849, DOI 10.1017/S0022215100128300; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846; Carlsson L, 2006, INT J ANDROL, V29, P331, DOI 10.1111/j.1365-2605.2005.00601.x; Casalini R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2728898; Castro MAA, 2005, J THEOR BIOL, V234, P487, DOI 10.1016/j.jtbi.2004.12.006; CAVES CM, 1990, PHYS REV LETT, V64, P2111, DOI 10.1103/PhysRevLett.64.2111; CAVES CM, 1990, PHYS REV LETT, V65, P1387, DOI 10.1103/PhysRevLett.65.1387; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang PL, 2008, J HISTOCHEM CYTOCHEM, V56, P57, DOI 10.1369/jhc.7A7325.2007; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chekmareva MA, 1997, PROSTATE, V33, P271; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; Chellaiah MA, 1998, DRUG NEWS PERSPECT, V11, P350, DOI 10.1358/dnp.1998.11.6.863656; Chen HN, 2007, BIOPHYS J, V92, P46, DOI 10.1529/biophysj.106.091934; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen WW, 2009, MOL BIOL REP, V36, P423, DOI 10.1007/s11033-007-9196-x; Chen XB, 1999, MOL MED TODAY, V5, P387, DOI 10.1016/S1357-4310(99)01545-2; Cheng L, 2005, J UROLOGY, V174, P2181, DOI 10.1097/01.ju.0000181215.41607.c3; Cheng X, 2004, MOL CELL BIOL, V24, P154, DOI 10.1128/MCB.24.1.154-163.2004; Chetcuti A, 2001, PROSTATE, V47, P132, DOI 10.1002/pros.1056; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Ciavarra RP, 2003, CANCER IMMUNOL IMMUN, V52, P535, DOI 10.1007/s00262-003-0383-x; Ciavarra RP, 2004, J IMMUNOTHER, V27, P13, DOI 10.1097/00002371-200401000-00002; Cimitan M, 2006, EUR J NUCL MED MOL I, V33, P1387, DOI 10.1007/s00259-006-0150-2; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Clarke LE, 2009, J CUTAN PATHOL, V36, P433, DOI 10.1111/j.1600-0560.2008.01077.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011; COSSUROCCA P, 2009, AM J SURG PATHOL; CRAIG AM, 1990, INT J CANCER, V46, P133, DOI 10.1002/ijc.2910460124; Craig M, 2008, J CELL BIOCHEM, V103, P1, DOI 10.1002/jcb.21379; Craven RA, 2004, PROTEOMICS, V4, P3998, DOI 10.1002/pmic.200400870; Crooks GE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.100602; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cybulski C, 2008, EUR J CANCER PREV, V17, P62, DOI 10.1097/CEJ.0b013e32809b4d20; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Darley DJ, 2009, ORG BIOMOL CHEM, V7, P543, DOI 10.1039/b815396e; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; DEMEIS L, 1992, ANN NY ACAD SCI, V671, P19; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; DENHAM JW, 2008, RADIOTHER ONCOL; Denhardt D, 2005, J INVEST DERMATOL, V124, pXVI, DOI 10.1111/j.0022-202X.2005.23708.x; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Di Cesare Sebastian, 2007, J Carcinog, V6, P2, DOI 10.1186/1477-3163-6-2; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; DIMITROV BD, 1993, MED HYPOTHESES, V41, P425, DOI 10.1016/0306-9877(93)90119-B; DING GF, 2009, UROL ONCOL; Dobson Roger, 2008, BMJ, V337, pa705, DOI 10.1136/bmj.a705; Dodin IY, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046602; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Doratiotto S, 2009, HISTOL HISTOPATHOL, V24, P101, DOI 10.14670/HH-24.101; Dotan ZA, 2004, INT J CANCER, V111, P60, DOI 10.1002/ijc.20237; Douglas JA, 2007, CANCER EPIDEM BIOMAR, V16, P1510, DOI 10.1158/1055-9965.EPI-07-0137; Drewa T, 2008, PROSTATE CANCER P D, V11, P88, DOI 10.1038/sj.pcan.4500978; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Duesberg P, 2005, CELL ONCOL, V27, P293; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Duesberg P, 2007, SCI AM, V296, P52, DOI 10.1038/scientificamerican0507-52; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Dumas Marc, 2007, J Drugs Dermatol, V6, ps20; Dundr M, 2002, MOL CELL, V9, P5, DOI 10.1016/S1097-2765(02)00433-1; Dunsmuir WD, 2000, BJU INT, V86, P869, DOI 10.1046/j.1464-410x.2000.00916.x; Dzojic H, 2006, PROSTATE, V66, P831, DOI 10.1002/pros.20344; Ecke TH, 2007, ANTICANCER RES, V27, P4143; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Ehlers JP, 2008, CLIN CANCER RES, V14, P115, DOI 10.1158/1078-0432.CCR-07-1825; Ekdahl KN, 2006, ADV EXP MED BIOL, V586, P107; Eroglu A, 2000, MED ONCOL, V17, P319, DOI 10.1007/BF02782198; Ersoy-Evans S, 2006, J AM ACAD DERMATOL, V55, P157, DOI 10.1016/j.jaad.2005.10.002; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Estler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-478; Fabarius A, 2003, CANCER GENET CYTOGEN, V143, P59, DOI 10.1016/S0165-4608(03)00003-7; Fabbri M, 2008, CURR OPIN INVEST DR, V9, P583; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Feng EH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090602; Feng EH, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.012104; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Finlan LE, 2006, CELL CYCLE, V5, P2489, DOI 10.4161/cc.5.21.3393; Fisch NJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.205004; Flannery E, 2009, CURR DRUG TARGETS, V10, P611, DOI 10.2174/138945009788680383; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fox RJ, 2005, NAT CLIN PRACT NEURO, V1, P16, DOI 10.1038/ncpneuro0041; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fu D, 2007, MOL MEMBR BIOL, V24, P366, DOI 10.1080/09687680701446965; Fujita A, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-106; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2008, CANCER MICROENVIRON, V1, P93, DOI 10.1007/s12307-008-0009-0; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Gade Wayne, 2006, Clin Lab Sci, V19, P70; Gagos S, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-20; Gallagher PG, 2005, CANCER RES, V65, P4134, DOI 10.1158/0008-5472.CAN-04-0415; GALLUZZI L, 2009, MOL ASPECTS MED; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Geirsson A, 2004, J HEART LUNG TRANSPL, V23, P1077, DOI 10.1016/j.healun.2004.07.020; Geirsson A, 2003, TRANSPLANTATION, V76, P387, DOI 10.1097/01.TP.0000073612.04525.46; Geirsson A, 2003, BIOCHEM BIOPH RES CO, V301, P718, DOI 10.1016/S0006-291X(03)00028-7; Geissinger E, 2002, CANCER RES, V62, P4820; Ghani KR, 2005, EUR UROL, V47, P196, DOI 10.1016/j.eururo.2004.07.029; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Gille J, 2007, INT J CANCER, V120, P1899, DOI 10.1002/ijc.22531; Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003; Gilmore BF, 2006, BIOCHEM BIOPH RES CO, V346, P436, DOI 10.1016/j.bbrc.2006.05.175; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; GONCALVES BF, 2009, EXP MOL PATHOL; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Graeven U, 2000, J INVEST DERMATOL, V115, P118, DOI 10.1046/j.1523-1747.2000.00022.x; Gray CP, 2003, CLIN CANCER RES, V9, P2551; Gray CP, 2002, BLOOD, V99, P3326, DOI 10.1182/blood.V99.9.3326; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Gray PJ, 2004, MOL CANCER THER, V3, P641; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Gronberg H, 2001, GENE CHROMOSOME CANC, V30, P299; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Grossmann ME, 2001, J IMMUNOTHER, V24, P237, DOI 10.1097/00002371-200105000-00007; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gumerlock PH, 1997, J NATL CANCER I, V89, P66, DOI 10.1093/jnci/89.1.66; Gunia S, 2009, VIRCHOWS ARCH, V454, P573, DOI 10.1007/s00428-009-0759-1; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; HAINAUT P, 1995, BRIT J CANCER, V71, P227, DOI 10.1038/bjc.1995.48; Halaban R, 2000, J EXP MED, V191, P1005, DOI 10.1084/jem.191.6.1005; HALSEY MA, 2009, J CUTAN PATHOL; Hanada S, 2008, J PATHOL, V216, P75, DOI 10.1002/path.2383; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2009, PROSTATE, V69, P603, DOI 10.1002/pros.20910; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Harant H, 2000, J CELL BIOCHEM, V78, P112, DOI 10.1002/(SICI)1097-4644(20000701)78:1<112::AID-JCB10>3.0.CO;2-7; Haritoglou I, 2009, OPHTHALMOLOGICA, V223, P239, DOI 10.1159/000206139; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hauptmann S, 2002, MED HYPOTHESES, V58, P144, DOI 10.1054/mehy.2001.1477; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Heenen M, 2003, ANN DERMATOL VENER, V130, P1025; Hegele RA, 2007, EXP CELL RES, V313, P2134, DOI 10.1016/j.yexcr.2007.03.023; Herrmann JL, 1997, EXP CELL RES, V237, P101, DOI 10.1006/excr.1997.3737; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ho SM, 2006, ANN NY ACAD SCI, V1089, P177, DOI 10.1196/annals.1386.005; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Hoffmann KH, 2003, J NON-EQUIL THERMODY, V28, P233, DOI 10.1515/JNETDY.2003.015; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Horsburgh S, 2005, PROSTATE, V65, P124, DOI 10.1002/pros.20278; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Huang CZ, 2008, J DERMATOL SCI, V52, P130, DOI 10.1016/j.jdermsci.2008.05.006; Huang XY, 2008, MOL CANCER THER, V7, P1624, DOI 10.1158/1535-7163.MCT-07-2134; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Hugel A, 1999, BRIT J CANCER, V79, P551, DOI 10.1038/sj.bjc.6690087; Hussein N G, 1998, J Egypt Public Health Assoc, V73, P97; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Inoue A, 2008, BIOL CELL, V100, P523, DOI 10.1042/BC20070142; ISAACS WB, 1995, CANCER SURV, V23, P19; ISHIBASHI K, 2008, CLIN EXP NEPHROL; Ishitani K, 2003, BIOCHEM BIOPH RES CO, V306, P660, DOI 10.1016/S0006-291X(03)01021-0; Ishiyama T, 2007, CANCER SCI, V98, P50, DOI 10.1111/j.1349-7006.2006.00346.x; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Ismail M, 2009, BRIT J CANCER, V100, P1889, DOI 10.1038/sj.bjc.6605093; Ito Y, 2005, PATHOBIOLOGY, V72, P186, DOI 10.1159/000086788; Itzhaki O, 2008, EXP GERONTOL, V43, P164, DOI 10.1016/j.exger.2007.12.007; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; JAMASPISHVILI T, 2009, PROSTATE CANC PROSTA; Jang A, 1997, CLIN EXP METASTAS, V15, P469, DOI 10.1023/A:1018470709523; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jhavar S, 2009, PROSTATE CANCER P D, V12, P143, DOI 10.1038/pcan.2008.47; JHAVAR S, 2008, PROSTATE CANC PROSTA; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang Z, 2004, AM J CLIN PATHOL, V122, P275, DOI 10.1309/EJUYUQPEX1MG68MK; Jiang Z, 2004, ADV ANAT PATHOL, V11, P316, DOI 10.1097/01.pap.0000146924.14246.be; Jiang Z, 2005, AM J CLIN PATHOL, V123, P231, DOI 10.1309/1G1NK9DBGFNB792L; Jiang Z, 2003, HUM PATHOL, V34, P792, DOI 10.1016/S0046-8177(03)00268-5; Jiang Z, 2004, HISTOPATHOLOGY, V45, P218, DOI 10.1111/j.1365-2559.2004.01930.x; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Johnson J, 2005, J INVEST DERMATOL, V125, P857, DOI 10.1111/j.0022-202X.2004.23920.x; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kadkol SS, 2006, INVEST OPHTH VIS SCI, V47, P802, DOI 10.1167/iovs.05-0422; Kaic G, 2009, DIAGN CYTOPATHOL, V37, P803, DOI 10.1002/dc.21103; Kalcioglu M Tayyar, 2004, Kulak Burun Bogaz Ihtis Derg, V12, P16; Kami K, 2009, J MOL BIOL, V386, P531, DOI 10.1016/j.jmb.2008.12.054; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Karaivanov M, 2007, J MOL HISTOL, V38, P1, DOI 10.1007/s10735-006-9070-5; Karakiewicz PI, 2006, EUR UROL, V50, P218, DOI 10.1016/j.eururo.2006.05.009; Karam JA, 2008, CLIN CANCER RES, V14, P1418, DOI 10.1158/1078-0432.CCR-07-0901; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Kasuno K, 2007, CELL DEATH DIFFER, V14, P1414, DOI 10.1038/sj.cdd.4402131; KATAGIRI Y, 1995, ANN NY ACAD SCI, V760, P371, DOI 10.1111/j.1749-6632.1995.tb44660.x; Katagiri YU, 1996, J CELL BIOCHEM, V62, P123, DOI 10.1002/(SICI)1097-4644(199607)62:1<123::AID-JCB13>3.0.CO;2-O; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Katoh M, 2007, INT J MOL MED, V20, P405; Kaufmann WK, 2008, J INVEST DERMATOL, V128, P175, DOI 10.1038/sj.jid.5700935; Kehinde EO, 2008, CAN J UROL, V15, P3967; Kida H, 2005, J MEMBRANE BIOL, V208, P55, DOI 10.1007/s00232-005-0819-7; Kikuchi E, 2003, CANCER RES, V63, P107; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Klimek R, 2001, NEUROENDOCRINOL LETT, V22, P413; KLIMEK R, 1990, EUR J OBSTET GYN R B, V36, P229, DOI 10.1016/0028-2243(90)90202-C; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Ko YJ, 2008, PROTEINS, V70, P1442, DOI 10.1002/prot.21696; Koivisto P, 1997, PROSTATE CANCER P D, V1, P21, DOI 10.1038/sj.pcan.4500200; KOLLARA A, 2009, J STEROID BIOCH MOL; KONG SL, 2009, VIRUS RES; Konig PH, 2006, J PHYS CHEM A, V110, P548, DOI 10.1021/jp052328q; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Korabiowska M, 2000, ANTICANCER RES, V20, P2791; Koynova DK, 2007, MELANOMA RES, V17, P37, DOI 10.1097/CMR.0b013e3280141617; Kozuka Yuji, 2005, Nihon Rinsho, V63, P231; Krause FS, 2005, ANTICANCER RES, V25, P1783; Kristiansen G, 2008, BRIT J CANCER, V99, P939, DOI 10.1038/sj.bjc.6604614; KRISTIANSEN G, 2009, PATHOLOGE; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kroepfl I, 2006, BJU INT, V97, P985, DOI 10.1111/j.1464-410X.2006.06129.x; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Kuchel PW, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T741; Kuefer R, 2002, AM J PATHOL, V161, P841, DOI 10.1016/S0002-9440(10)64244-7; Kulesz-Martin M, 2005, J INVEST DERM SYMP P, V10, P142, DOI 10.1111/j.1087-0024.2005.200405.x; Kumagai K, 2006, INVEST OPHTH VIS SCI, V47, P2300, DOI 10.1167/iovs.05-0810; Kumanov A, 2007, FOLIA HISTOCHEM CYTO, V45, P75; Kumar-Sinha C, 2004, AM J PATHOL, V164, P787, DOI 10.1016/S0002-9440(10)63167-7; Kunju LP, 2005, HISTOPATHOLOGY, V47, P587, DOI 10.1111/j.1365-2559.2005.02281.x; Kusumi T, 2008, PATHOL INT, V58, P687, DOI 10.1111/j.1440-1827.2008.02294.x; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Kwon O, 2006, CARCINOGENESIS, V27, P2258, DOI 10.1093/carcin/bgl097; KYLE S, 2008, BR J RADIOL, V81; Lacal PM, 2005, INT J ONCOL, V27, P1625; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Landreville S, 2008, FUTURE ONCOL, V4, P629, DOI 10.2217/14796694.4.5.629; LANDSBERG PT, 1984, PHYS LETT A, V102, P171, DOI 10.1016/0375-9601(84)90934-4; Langer F, 2007, THROMB HAEMOSTASIS, V97, P464, DOI 10.1160/TH06-09-0523; Langner C, 2006, VIRCHOWS ARCH, V448, P325, DOI 10.1007/s00428-005-0129-6; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapteva N, 2007, CANCER RES, V67, P10528, DOI 10.1158/0008-5472.CAN-07-0833; Laski ME, 2006, SEMIN NEPHROL, V26, P189, DOI 10.1016/j.semnephrol.2006.03.002; Leav I, 2003, HUM PATHOL, V34, P228, DOI 10.1053/hupa.2003.42; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; LEFF HS, 1990, MAXWELLS DEMON; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lessard L, 2007, CELL SIGNAL, V19, P1093, DOI 10.1016/j.cellsig.2006.12.012; Levin AM, 2007, PROSTATE, V67, P1507, DOI 10.1002/pros.20642; Lewis TB, 2005, CANCER-AM CANCER SOC, V104, P1678, DOI 10.1002/cncr.21372; Li HZ, 2007, INT J ONCOL, V31, P537; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Licchesi JDF, 2008, CLIN CANCER RES, V14, P2570, DOI 10.1158/1078-0432.CCR-07-2033; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; Lin EY, 1999, PLAST RECONSTR SURG, V104, P1666, DOI 10.1097/00006534-199911000-00009; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Lin SH, 2004, ONCOGENE, V23, P2499, DOI 10.1038/sj.onc.1207343; Linden J, 2006, AM J PHYSIOL-CELL PH, V291, pC405, DOI 10.1152/ajpcell.00242.2006; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Lisovsky M, 2006, HUM PATHOL, V37, P1601, DOI 10.1016/j.humpath.2006.06.009; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Liu Ai-jun, 2007, Journal of Zhejiang University-Science B, V8, P853, DOI 10.1631/jzus.2007.B0853; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Liu YL, 2007, HUM PATHOL, V38, P171, DOI 10.1016/j.humpath.2006.07.015; Liu YJ, 2007, P NATL ACAD SCI USA, V104, P12560, DOI 10.1073/pnas.0705313104; Liu Ying-na, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P417; LIZCANO JM, 1990, J NEUR TR S, P323; Lloyd MD, 2008, FEBS J, V275, P1089, DOI 10.1111/j.1742-4658.2008.06290.x; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; LU Q, 2008, PROSTATE; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lundqvist A, 2005, J IMMUNOTHER, V28, P229, DOI 10.1097/01.cji.0000158854.15664.c2; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Luo J, 2002, CANCER RES, V62, P2220; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maeda Norikazu, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-79885-9_12; Magi-Galluzzi C, 2003, AM J SURG PATHOL, V27, P1128, DOI 10.1097/00000478-200308000-00010; Magi-Galluzzi C, 2007, CANCER-AM CANCER SOC, V110, P1248, DOI 10.1002/cncr.22897; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; MAKAROV DV, 2008, ANN REV MED; MAKOVETS S, 2009, NAT CELL BIOL; Malmstrom PU, 2005, ACTA ONCOL, V44, P593, DOI 10.1080/02841860510029626; Mandelin J, 2009, CANCER-AM CANCER SOC, V115, P1753, DOI 10.1002/cncr.24170; Mangahas CR, 2005, J INVEST DERMATOL, V125, P307, DOI 10.1111/j.0022-202X.2005.23820.x; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; Maraldo D, 2007, ANAL CHEM, V79, P7683, DOI 10.1021/ac070895z; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marinescu Ioana, 1991, Revue Roumaine de Physiologie, V28, P45; MARKO M, 2009, EXP CELL RES; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Martens MB, 2006, MODERN PATHOL, V19, P287, DOI 10.1038/modpathol.3800531; Martin MT, 2003, PHYS LETT A, V311, P126, DOI 10.1016/S0375-9601(03)00491-2; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2009, BIOESSAYS, V31, P51, DOI 10.1002/bies.080099; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mavis CK, 2009, PROSTATE, V69, P1312, DOI 10.1002/pros.20976; Mazzucchelli R, 2007, VIRCHOWS ARCH, V450, P371, DOI 10.1007/s00428-007-0367-x; McCrohan AM, 2006, CANCER-AM CANCER SOC, V106, P2743, DOI 10.1002/cncr.21938; McDonnell TJ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-1; McGrath JA, 1999, J DERMATOL SCI, V20, P85, DOI 10.1016/S0923-1811(99)00015-8; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; McGrath John A, 2005, Australas J Dermatol, V46, P221, DOI 10.1111/j.1440-0960.2005.00188.x; McGrath John A., 1999, Journal of Dermatology (Tokyo), V26, P764; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; Meeker AK, 2002, CANCER RES, V62, P6405; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Mellado M, 2001, CURR BIOL, V11, P691, DOI 10.1016/S0960-9822(01)00199-3; Mendes Alexandre, 2008, V141, P131; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Middleman BR, 2002, MODERN PATHOL, V15, P532, DOI 10.1038/modpathol.3880559; Mirtti T, 2009, APMIS, V117, P151, DOI 10.1111/j.1600-0463.2008.00002.x; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mitra A, 2008, BRIT J CANCER, V98, P502, DOI 10.1038/sj.bjc.6604132; Miyake H, 2007, BJU INT, V99, P315, DOI 10.1111/j.1464-410X.2006.06622.x; MIZUTANI K, 2009, J CELL BIOCH; Mobley JA, 2003, CANCER EPIDEM BIOMAR, V12, P775; Mockenhaupt M, 2003, INT J MOL MED, V12, P597; Moghaddami M, 2002, IMMUNOL CELL BIOL, V80, P370, DOI 10.1046/j.1440-1711.2002.01100.x; Moghaddami M, 2001, UROLOGY, V57, P573, DOI 10.1016/S0090-4295(00)01005-0; Molinie V, 2006, HUM PATHOL, V37, P698, DOI 10.1016/j.humpath.2006.01.012; Molinie V, 2005, PROG UROL, V15, P611; Molinie V, 2004, MODERN PATHOL, V17, P1180, DOI 10.1038/modpathol.3800197; Molinie V, 2004, ANN PATHOL, V24, P6; Molinie V, 2007, Actas Urol Esp, V31, P1009; Molinie V, 2008, ANN PATHOL, V28, P417, DOI 10.1016/j.annpat.2008.05.004; Moll I, 1997, J INVEST DERMATOL, V108, P139, DOI 10.1111/1523-1747.ep12332388; Mora, 1999, Cancer Control, V6, P587; Mordaka Pawel Mateusz, 2007, Postepy Biochem, V53, P84; Moro L, 2005, J BIOL CHEM, V280, P22482, DOI 10.1074/jbc.M414091200; Moro L, 2008, CANCER SCI, V99, P553, DOI 10.1111/j.1349-7006.2007.00719.x; Morohashi S, 2007, INT J MOL MED, V20, P139; MORRISON ME, 1993, J EXP MED, V177, P1135, DOI 10.1084/jem.177.4.1135; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mubiru JN, 2007, PROSTATE, V67, P1421, DOI 10.1002/pros.20622; Mubiru JN, 2005, PROSTATE, V65, P117, DOI 10.1002/pros.20277; Mubiru JN, 2004, GENE, V327, P89, DOI 10.1016/j.gene.2003.11.009; Mukherjee R, 2005, PROSTATE, V64, P101, DOI 10.1002/pros.20211; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Muller-Tidow C, 2004, LUNG CANCER, V45, pS145, DOI 10.1016/j.lungcan.2004.07.000; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Murugaiyan G, 2006, J IMMUNOL, V177, P6642, DOI 10.4049/jimmunol.177.10.6642; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Narod SA, 2008, BRIT J CANCER, V99, P371, DOI 10.1038/sj.bjc.6604453; Nassar A, 2005, APPL IMMUNOHISTO M M, V13, P252, DOI 10.1097/00129039-200509000-00007; Nastiuk KL, 1999, PROSTATE, V40, P172; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nessler-Menardi C, 2000, PROSTATE, V45, P124, DOI 10.1002/1097-0045(20001001)45:2<124::AID-PROS6>3.0.CO;2-7; Nessling M, 1999, CYTOGENET CELL GENET, V87, P286, DOI 10.1159/000015451; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Nunez C, 2008, HISTOPATHOLOGY, V53, P166, DOI 10.1111/j.1365-2559.2008.03092.x; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Ohyama Y, 2004, J BONE MINER RES, V19, P1706, DOI 10.1359/jbmr.2004.19.10.1706; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Olgac S, 2006, MODERN PATHOL, V19, P218, DOI 10.1038/modpathol.3800520; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Onaitis Mark, 2002, Surg Oncol Clin N Am, V11, P645, DOI 10.1016/S1055-3207(02)00027-3; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Ostrander EA, 2008, CANCER EPIDEM BIOMAR, V17, P1843, DOI 10.1158/1055-9965.EPI-08-0556; Ostrer H, 2000, SEMIN REPROD MED, V18, P41, DOI 10.1055/s-2000-13474; OUAZIA D, 2009, ANAL BIOCH; Ouyang B, 2009, J UROLOGY, V181, P2508, DOI 10.1016/j.juro.2009.01.110; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; Oyama T, 2005, ARCH PATHOL LAB MED, V129, P1004; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Palapattu GS, 2004, J UROLOGY, V172, P1860, DOI 10.1097/01.ju.0000139886.25848.4a; Palmer DH, 2004, ONCOL REP, V12, P679; Panigrahi AK, 2009, CRIT REV ONCOL HEMAT; Parisi M, 1997, BIOPHYS CHEM, V68, P255, DOI 10.1016/S0301-4622(97)00069-0; Park JJ, 2000, CANCER RES, V60, P5946; Park TJ, 2009, EXP CELL RES, V315, P3152, DOI 10.1016/j.yexcr.2009.07.009; Parrondo JMR, 2001, CHAOS, V11, P725, DOI 10.1063/1.1388006; Pasini L, 2009, EXPERT OPIN THER TAR, V13, P93, DOI 10.1517/14728220802607363 ; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Peehl DM, 2008, J UROLOGY, V180, P2206, DOI 10.1016/j.juro.2008.07.019; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Pequeux C, 1999, Rev Med Liege, V54, P867; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Petitjean Audrey, 2006, Bull Cancer, V93, pE126; Petrovic MM, 2006, FOLIA BIOL-PRAGUE, V52, P173; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Pettus JA, 2008, J ENDOUROL, V22, P1021, DOI 10.1089/end.2007.0129; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Phillips JL, 2001, CANCER RES, V61, P8143; Pilch H, 2000, CANCER, V88, P1370, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1370::AID-CNCR14>3.0.CO;2-8; Pinzon-Charry A, 2005, NEOPLASIA, V7, P1112, DOI 10.1593/neo.05442; Pirtskhalaishvili G, 2000, BRIT J CANCER, V83, P506, DOI 10.1054/bjoc.2000.1289; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; PRICKETT TD, 2009, NAT GENET; Prislei S, 2008, MOL CANCER THER, V7, P233, DOI 10.1158/1535-7163.MCT-07-0390; Pronk CJ, 2008, CELL CYCLE, V7, P706, DOI 10.4161/cc.7.6.5565; Puebla-Mora Ana Graciela, 2006, Ann Diagn Pathol, V10, P205, DOI 10.1016/j.anndiagpath.2005.09.021; Quan HT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180402; Rabiau N, 2009, IN VIVO, V23, P387; Radosavljevic R, 2005, Acta Chir Iugosl, V52, P109; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Rajesh C, 2009, PROTEOMICS, V9, P4071, DOI 10.1002/pmic.200800977; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Rangaswami H, 2007, ONCOL REP, V18, P909; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Rangel J, 2008, CANCER-AM CANCER SOC, V112, P144, DOI 10.1002/cncr.23147; Rankin S, 2005, CELL CYCLE, V4, P1039, DOI 10.4161/cc.4.8.1926; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Rashid Mizanur, 2002, Hokkaido Journal of Medical Science, V77, P341; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reiniger IW, 2007, AM J OPHTHALMOL, V143, P705, DOI 10.1016/j.ajo.2006.11.040; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Ren H, 2009, ANIM GENET, V40, P499, DOI 10.1111/j.1365-2052.2009.01868.x; Rettig MB, 2008, MOL CANCER THER, V7, P2662, DOI 10.1158/1535-7163.MCT-08-0136; Ribeiro GRH, 2004, J DERMATOL SCI, V36, P79, DOI 10.1016/j.jdermsci.2004.08.003; RICHMOND A, 1988, J CELL BIOCHEM, V36, P185, DOI 10.1002/jcb.240360209; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Ritchie W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000011; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; Roche JB, 2008, PROG UROL, V18, P586, DOI 10.1016/j.purol.2008.05.003; Roder Martin Andreas, 2008, Ugeskr Laeger, V170, P2554; Roesch A, 2006, MODERN PATHOL, V19, P1378, DOI 10.1038/modpathol.3800663; Rogers CG, 2004, CANCER, V101, P2549, DOI 10.1002/cncr.20637; Rogers CG, 2004, J UROLOGY, V172, P1501, DOI 10.1097/01.ju.0000137659.53129.14; Rokhlin OW, 1997, CANCER RES, V57, P1758; Rosen EM, 2005, ENDOCR-RELAT CANCER, V12, P533, DOI 10.1677/erc.1.00972; Rosen EM, 2001, CANCER INVEST, V19, P396, DOI 10.1081/CNV-100103134; Rosner MR, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-1; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; RoyBurman P, 1997, MOL MED TODAY, V3, P476, DOI 10.1016/S1357-4310(97)01126-X; RUAN K, 2009, CANC LETT; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Rubin MA, 2005, CANCER EPIDEM BIOMAR, V14, P1424, DOI 10.1158/1055-9965.EPI-04-0801; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9; Rudzki Z, 1997, J CLIN PATHOL-MOL PA, V50, P57, DOI 10.1136/mp.50.2.57; Ruiz-Ederra J, 2009, INVEST OPHTH VIS SCI, V50, P2132, DOI 10.1167/iovs.08-3033; Russo G, 2008, J MED VIROL, V80, P2100, DOI 10.1002/jmv.21312; Rustin P, 2007, Ernst Schering Found Symp Proc, P1; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saad F, 2008, BJU INT, V101, P1071, DOI 10.1111/j.1464-410X.2007.07364.x; Saffin JM, 2005, P NATL ACAD SCI USA, V102, P11302, DOI 10.1073/pnas.0500964102; Sakai I, 2006, UROL INT, V76, P227, DOI 10.1159/000091624; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Samaratunga H, 2007, PATHOLOGY, V39, P476, DOI 10.1080/00313020701570004; Santinelli A, 2007, AM J CLIN PATHOL, V128, P657, DOI 10.1309/P065G467FKKUJDE5; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Sasaki YTF, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-227; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Satoh S, 2000, INT J ONCOL, V17, P707; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Sbisa E, 2006, CELL CYCLE, V5, P205, DOI 10.4161/cc.5.2.2361; Scadden D, 2009, MOL CELL, V35, P395, DOI 10.1016/j.molcel.2009.08.005; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schlechte H, 1998, EUR UROL, V34, P433, DOI 10.1159/000019778; Schlomm T, 2005, INT J ONCOL, V27, P713; SCHLOMM T, 2008, EUR UROL; Schmidt A, 2005, EUR J CELL BIOL, V84, P189, DOI 10.1016/j.ejcb.2004.12.020; SCHMIT TL, 2009, J INVEST DERMATOL; Schmit TL, 2009, CELL CYCLE, V8, P2697, DOI 10.4161/cc.8.17.9413; Schoder H, 2007, EUR UROL, V52, P310, DOI 10.1016/j.eururo.2007.03.026; Schostak M, 2006, CANCER DETECT PREV, V30, P449, DOI 10.1016/j.cdp.2006.07.010; Schultz J, 2009, MOL CARCINOGEN, V48, P14, DOI 10.1002/mc.20452; Schumacher MC, 2006, EUR UROL, V50, P272, DOI 10.1016/j.eururo.2006.01.061; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Shapiro A, 2008, ANTICANCER RES, V28, P3909; SHATTUCK RL, 1994, MOL CELL BIOL, V14, P791, DOI 10.1128/MCB.14.1.791; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shen-Ong GL, 2003, CANCER RES, V63, P3296; Sheng HM, 2009, CURR MED CHEM, V16, P1561, DOI 10.2174/092986709788186255; Sheridan T, 2007, AM J SURG PATHOL, V31, P1351, DOI 10.1097/PAS.0b013e3180536678; Shih Ie-Ming, 1994, In Vivo (Attiki), V8, P113; Shilo K, 2007, ARCH PATHOL LAB MED, V131, P1555; Shimizu T, 2005, ONCOL REP, V14, P441; SHOSKES DA, 1993, CAN J SURG, V36, P33; SIMPSON KL, 1994, IMMUNOLOGY, V81, P452; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Singh RP, 2006, MOL CARCINOGEN, V45, P436, DOI 10.1002/mc.20223; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Sircar K, 2006, CLIN CANCER RES, V12, P4178, DOI 10.1158/1078-0432.CCR-06-0328; Skamrov AV, 2004, J MOL CELL CARDIOL, V37, P717, DOI 10.1016/j.yjmcc.2004.06.006; Skinnider BF, 2004, AM J SURG PATHOL, V28, P701, DOI 10.1097/01.pas.0000126759.43227.d9; Sleeman JE, 2004, PHILOS T R SOC A, V362, P2775, DOI 10.1098/rsta.2004.1463; Slijepcevic P, 2006, DNA REPAIR, V5, P1299, DOI 10.1016/j.dnarep.2006.05.038; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Soikkeli J, 2007, J PATHOL, V213, P180, DOI 10.1002/path.2229; Son DJ, 2007, MOL CANCER THER, V6, P675, DOI 10.1158/1535-7163.MCT-06-0328; SOTOMAYOR P, 2008, PROSTATE; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; SPIRKL W, 1995, PHYS REV E, V52, P3485, DOI 10.1103/PhysRevE.52.3485; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Sreekumar A, 2004, JNCI-J NATL CANCER I, V96, P834, DOI 10.1093/jnci/djh145; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Steijlen PM, 2004, J INVEST DERMATOL, V122, P1321, DOI 10.1111/j.0022-202X.2003.22302.x; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Stewart J, 2007, J CLIN PATHOL, V60, P773, DOI 10.1136/jcp.2006.040808; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Struewing JP, 1998, CURRENT TOPICS ON BRCA1, P71, DOI 10.3233/BD-1998-101-209; Sturgis CD, 2006, ACTA CYTOL, V50, P335, DOI 10.1159/000325965; Sturm RA, 2005, J INVEST DERMATOL, V124, pxiv, DOI 10.1111/j.0022-202X.2005.23741.x; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sun T, 2008, CANCER LETT, V263, P35, DOI 10.1016/j.canlet.2007.12.015; SUN Y, 2008, BREAST CANC RES TREA; Sung MT, 2007, HUM PATHOL, V38, P332, DOI 10.1016/j.humpath.2006.08.016; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takahara K, 2009, ANTICANCER RES, V29, P2497; Takahashi S, 2002, PROSTATE, V50, P154, DOI 10.1002/pros.10044; Takahashi S, 2006, PROSTATE, V66, P211, DOI 10.1002/pros.20336; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takeda Taizo, 2009, Handb Exp Pharmacol, P171, DOI 10.1007/978-3-540-79885-9_8; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tan EY, 2004, AM J PATHOL, V165, P319, DOI 10.1016/S0002-9440(10)63299-3; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tang XY, 2006, HUM PATHOL, V37, P1186, DOI 10.1016/j.humpath.2006.04.019; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Tas F, 2006, MELANOMA RES, V16, P405, DOI 10.1097/01.cmr.0000222598.27438.82; Tasken Kristin Austlid, 2005, Tidsskr Nor Laegeforen, V125, P3279; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; TETTELBACH W, 1993, J CUTAN PATHOL, V20, P259, DOI 10.1111/j.1600-0560.1993.tb00653.x; THOMAS HG, 1988, ARCH BIOCHEM BIOPHYS, V260, P719, DOI 10.1016/0003-9861(88)90501-2; Thomsen MK, 2008, DIFFERENTIATION, V76, P728, DOI 10.1111/j.1432-0436.2008.00293.x; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Thornburg Todd, 2006, Future Oncol, V2, P213, DOI 10.2217/14796694.2.2.213; Tischkowitz M, 2003, LANCET, V362, P80, DOI 10.1016/S0140-6736(03)13823-8; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tokunaga K, 2006, GENES CELLS, V11, P305, DOI 10.1111/j.1365-2443.2006.00936.x; Tomkova K, 2008, NEOPLASMA, V55, P177; Tourkova IL, 2002, J LEUKOCYTE BIOL, V72, P1037; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Tretiakova MS, 2004, AM J SURG PATHOL, V28, P69, DOI 10.1097/00000478-200401000-00007; TRIBUS M, 1961, THERMOSTATISTICS THE; Trpkov K, 2009, AM J CLIN PATHOL, V132, P211, DOI 10.1309/AJCPGFJP83IXZEUR; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Truong CD, 2008, INT J CLIN EXP PATHO, V1, P518; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; TSENG JJ, 2009, MOL HUM REPROD; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; Tycko B, 2003, ANN NY ACAD SCI, V983, P43, DOI 10.1111/j.1749-6632.2003.tb05961.x; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE794, DOI 10.1152/ajpendo.00174.2002; Urbanucci A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-219; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134; Van den Oord JJ, 1998, BRIT J DERMATOL, V138, P615; van Golen KL, 2008, J CELL BIOCHEM, V104, P1587, DOI 10.1002/jcb.21652; Vanguri VK, 2006, APPL IMMUNOHISTO M M, V14, P365, DOI 10.1097/00129039-200609000-00018; Varma M, 2005, HISTOPATHOLOGY, V47, P1, DOI 10.1111/j.1365-2559.2005.02188.x; Venkataraman G, 2007, PROSTATE, V67, P1524, DOI 10.1002/pros.20629; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Verdoucq L, 2008, BIOCHEM J, V415, P409, DOI 10.1042/BJ20080275; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Verschooten L., 2006, International Journal of Cosmetic Science, V28, P1, DOI 10.1111/j.1467-2494.2006.00299.x; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; VONFIGURA G, 2009, J MOL MED; Vu HY, 2008, ARCH BIOCHEM BIOPHYS, V475, P156, DOI 10.1016/j.abb.2008.04.026; Vukovic B, 2007, CYTOGENET GENOME RES, V116, P1, DOI 10.1159/000097411; Vykhovanets EV, 2008, PROSTATE, V68, P34, DOI 10.1002/pros.20666; Wahl JK, 2005, J CELL BIOCHEM, V96, P390, DOI 10.1002/jcb.20514; Walden PD, 1998, EXP CELL RES, V245, P19, DOI 10.1006/excr.1998.4237; Walter-Yohrling J, 2003, CANCER RES, V63, P8939; Wang D, 2008, SEMIN RADIAT ONCOL, V18, P35, DOI 10.1016/j.semradonc.2007.09.005; Wang DZ, 2001, J BIOL CHEM, V276, P3650, DOI 10.1074/jbc.M006115200; Wang DZ, 2000, ONCOGENE, V19, P4647, DOI 10.1038/sj.onc.1203820; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang JB, 2007, INT J UROL, V14, P1088, DOI 10.1111/j.1442-2042.2007.01901.x; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang WL, 2008, AM J SURG PATHOL, V32A, P851, DOI 10.1097/PAS.0b013e31815a0508; Wang XQ, 2008, CLIN CANCER RES, V14, P6813, DOI 10.1158/1078-0432.CCR-08-0626; Wang Y, 2007, J NUTR, V137, p1509S, DOI 10.1093/jn/137.6.1509S; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Watanabe M, 1998, ONCOLOGY-BASEL, V55, P569, DOI 10.1159/000011914; Watanabe T, 2009, J PHYSIOL SCI, V59, P113, DOI 10.1007/s12576-008-0017-3; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weckermann D, 2006, BJU INT, V97, P1173, DOI 10.1111/j.1464-410X.2006.06166.x; Weichert W, 2006, CANCER SCI, V97, P271, DOI 10.1111/j.1349-7006.2006.00170.x; Weichert W, 2005, VIRCHOWS ARCH, V446, P442, DOI 10.1007/s00428-005-1212-8; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644; Weinberg RA, 2007, BIOL CANC; WEINSTEIN RS, 1987, CIBA F SYMP, V125, P240; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; WEN J, 2009, SCAND J UROL NEPHROL, P1; Went PT, 2006, PATHOLOGY, V38, P426, DOI 10.1080/00313020600922470; Wertz IE, 1996, HUM PATHOL, V27, P573, DOI 10.1016/S0046-8177(96)90164-1; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wessagowit V, 2005, ACTA DERM-VENEREOL, V85, P386, DOI 10.1080/00015550510011763; Whittock NV, 2000, EXP DERMATOL, V9, P323, DOI 10.1034/j.1600-0625.2000.009005323.x; Whittock NV, 2000, J INVEST DERMATOL, V115, P368, DOI 10.1046/j.1523-1747.2000.00082.x; Wierzbicki AS, 2007, BIOCHEM SOC T, V35, P881, DOI 10.1042/BST0350881; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Winfield HL, 2007, ARCH DERMATOL, V143, P1076, DOI 10.1001/archderm.143.8.1076; Winnepenninckx V, 2006, MODERN PATHOL, V19, P1170, DOI 10.1038/modpathol.3800627; Winter A, 2009, AKTUEL UROL, V40, P294, DOI 10.1055/s-0028-1098914; Witkiewicz AK, 2005, CANCER EPIDEM BIOMAR, V14, P1418, DOI 10.1158/1055-9965.EPI-04-0607; Wodarz D, 2008, MED HYPOTHESES, V70, P128, DOI 10.1016/j.mehy.2007.03.040; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Wu CL, 2004, HUM PATHOL, V35, P1008, DOI 10.1016/j.humpath.2004.03.019; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Wu Y, 2009, J HUAZHONG U SCI-MED, V29, P246, DOI 10.1007/s11596-009-0223-0; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Xu CL, 2005, PROSTATE, V62, P224, DOI 10.1002/pros.20134; Xu JF, 2005, PROSTATE, V63, P209, DOI 10.1002/pros.20233; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Yamada K, 2006, CANCER SCI, V97, P106, DOI 10.1111/j.1349-7006.2006.00147.x; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang JM, 2001, CANCER RES, V61, P4901; Yang JM, 2001, CANCER RES, V61, P8150; Yang M, 2009, BRAIN RES, V1290, P121, DOI 10.1016/j.brainres.2009.07.018; Yang XMJ, 2003, UROLOGY, V62, P282, DOI 10.1016/S0090-4295(03)00259-0; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yasui Masato, 2009, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-540-79885-9_15; Yeh SY, 2000, P NATL ACAD SCI USA, V97, P11256, DOI 10.1073/pnas.190353897; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yu Tao, 2007, Zhonghua Nan Ke Xue, V13, P222; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zehentner BK, 2006, MOL DIAGN THER, V10, P397, DOI 10.1007/BF03256217; Zerbini LF, 2005, CELL CYCLE, V4, P1247, DOI 10.4161/cc.4.9.1966; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177; Zha S, 2005, MOL CANCER RES, V3, P110, DOI 10.1158/1541-7786.MCR-04-0178; Zha S, 2003, CANCER RES, V63, P7365; Zhang Hui-Hen, 2007, Chinese Journal of Pathology, V36, P742; Zhang J, 2009, ANIMAL, V3, P1, DOI [10.1017/S1751731108003054, 10.1109/ISDRS.2009.5378133]; Zhang X, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000334; Zheng JZ, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041109; Zheng Li, 2006, Hum Mutat, V27, P1062, DOI 10.1002/humu.9457; Zheng SQL, 2002, CANCER RES, V62, P6485; Zhou M, 2002, AM J SURG PATHOL, V26, P926, DOI 10.1097/00000478-200207000-00012; Zhou M, 2004, AM J SURG PATHOL, V28, P239, DOI 10.1097/00000478-200402000-00012; Zhou M, 2003, AM J SURG PATHOL, V27, P772, DOI 10.1097/00000478-200306000-00007; Zhou Q, 2008, J HUAZHONG U SCI-MED, V28, P22, DOI 10.1007/s11596-008-0106-9; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x; Zielie PJ, 2004, J UROLOGY, V172, P1130, DOI 10.1097/01.ju.0000133560.87118.4d; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	808	33	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12262	10.1371/journal.pone.0012262	http://dx.doi.org/10.1371/journal.pone.0012262			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805891	gold, Green Published			2022-12-27	WOS:000281011600026
J	Pitcher, BJ; Harcourt, RG; Charrier, I				Pitcher, Benjamin J.; Harcourt, Robert G.; Charrier, Isabelle			Rapid Onset of Maternal Vocal Recognition in a Colonially Breeding Mammal, the Australian Sea Lion	PLOS ONE			English	Article							PARENT-OFFSPRING RECOGNITION; AMERICAN FUR-SEAL; NEWBORN GOAT KIDS; ACOUSTIC RECOGNITION; MOTHER; PUPS; DISCRIMINATION; SIGNATURE; SWALLOWS; INFANTS	Background: In many gregarious mammals, mothers and offspring have developed the abilities to recognise each other using acoustic signals. Such capacity may develop at different rates after birth/parturition, varying between species and between the participants, i.e., mothers and young. Differences in selective pressures between species, and between mothers and offspring, are likely to drive the timing of the onset of mother-young recognition. We tested the ability of Australian sea lion mothers to identify their offspring by vocalisation, and examined the onset of this behaviour in these females. We hypothesise that a rapid onset of recognition may reflect an adaptation to a colonial lifestyle. Principal Findings: In a playback study maternal responses to own pup and non-filial vocalisations were compared at 12, 24 and every subsequent 24 hours until the females' first departure post-partum. Mothers showed a clear ability to recognise their pup's voice by 48 hours of age. At 24 hours mothers called more, at 48 hours they called sooner and at 72 hours they looked sooner in response to their own pup's vocalisations compared to those of non-filial pups. Conclusions: We demonstrate that Australian sea lion females can vocally identify offspring within two days of birth and before mothers leave to forage post-partum. We suggest that this rapid onset is a result of selection pressures imposed by a colonial lifestyle and may be seen in other colonial vertebrates. This is the first demonstration of the timing of the onset of maternal vocal recognition in a pinniped species.	[Pitcher, Benjamin J.; Harcourt, Robert G.] Macquarie Univ, Marine Mammal Res Grp, Grad Sch Environm, Sydney, NSW 2109, Australia; [Pitcher, Benjamin J.; Charrier, Isabelle] Univ Paris 11, Ctr Neurosci Paris Sud, Equipe Commun Acoust, UMR 8195, Orsay, France; [Pitcher, Benjamin J.; Charrier, Isabelle] CNRS, F-91405 Orsay, France	Macquarie University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Pitcher, BJ (corresponding author), Macquarie Univ, Marine Mammal Res Grp, Grad Sch Environm, Sydney, NSW 2109, Australia.	ben.pitcher@mq.edu.au	Pitcher, Benjamin/A-9631-2012	Pitcher, Benjamin/0000-0002-8580-0343; CHARRIER, Isabelle/0000-0003-4873-2342; Harcourt, Robert/0000-0003-4666-2934	Macquarie University; Centre National de la Recherche Scientifique (CNRS), France; Region Ile-de-France	Macquarie University; Centre National de la Recherche Scientifique (CNRS), France(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France)	Funding and research equipment for this study was provided by Macquarie University and Centre National de la Recherche Scientifique (CNRS), France. Region Ile-de-France provided a cotutelle travel grant to allow B Pitcher to travel to Paris where this paper was written. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; BALCOMBE JP, 1990, ANIM BEHAV, V39, P960, DOI 10.1016/S0003-3472(05)80961-3; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; BIRKHEAD TR, 1978, ANIM BEHAV, V26, P321, DOI 10.1016/0003-3472(78)90050-7; Bradbury Jack W., 1998, pi; Charrier I, 2003, BIOL J LINN SOC, V80, P305, DOI 10.1046/j.1095-8312.2003.00239.x; Charrier I, 2002, J EXP BIOL, V205, P603; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; Charrier I, 2006, J MAMMAL, V87, P929, DOI 10.1644/05-MAMM-A-344R3.1; Charrier I, 2010, ANIM COGN, V13, P471, DOI 10.1007/s10071-009-0298-9; Charrier I, 2009, ANIM BEHAV, V78, P1127, DOI 10.1016/j.anbehav.2009.07.032; DAVIES S. J. J. F., 1962, AUSTRALIAN JOUR ZOOL, V10, P171, DOI 10.1071/ZO9620171; FORMBY D, 1967, DEV MED CHILD NEUROL, V9, P293; GALES NJ, 1994, J ZOOL, V234, P353, DOI 10.1111/j.1469-7998.1994.tb04853.x; Goldsworthy S. D., 2009, UPDATE REPORT UNDERS; HARCOURT R, 1992, J ZOOL, V226, P259, DOI 10.1111/j.1469-7998.1992.tb03838.x; HARCOURT R, 1992, CAN J ZOOL, V70, P320, DOI 10.1139/z92-048; Hayes LD, 2004, ETHOL ECOL EVOL, V16, P145; Hepper PG., 1991, KIN RECOGNITION; HIGGINS LV, 1993, CAN J ZOOL, V71, P2047, DOI 10.1139/z93-290; HOLMES WG, 1984, J COMP PSYCHOL, V98, P246, DOI 10.1037/0735-7036.98.3.246; Insley SJ, 2001, ANIM BEHAV, V61, P129, DOI 10.1006/anbe.2000.1569; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; King JE., 1983, SEALS WORLD BRIT MUS; Kober M, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-13; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P79; MEDVIN MB, 1986, ANIM BEHAV, V34, P1627, DOI 10.1016/S0003-3472(86)80251-2; MEDVIN MB, 1993, ANIM BEHAV, V45, P841, DOI 10.1006/anbe.1993.1105; PETRINOVICH L, 1974, Zeitschrift fuer Tierpsychologie, V34, P308; Pitcher BJ, 2009, NATURWISSENSCHAFTEN, V96, P901, DOI 10.1007/s00114-009-0546-5; PITCHER BJ, 2010, BIOL LETT, DOI DOI 10.1098/RSBL2010.0569; Poindron P, 2003, DEV PSYCHOBIOL, V43, P82, DOI 10.1002/dev.10123; POINDRON P, 1980, ADV STUD BEHAV, V11, P75; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; Sebe F, 2007, DEV PSYCHOBIOL, V49, P375, DOI 10.1002/dev.20218; SIEBER OJ, 1986, BEHAVIOUR, V96, P130, DOI 10.1163/156853986X00252; STODDARD PK, 1983, AUK, V100, P795, DOI 10.1093/auk/100.4.795; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Terrazas A, 2003, DEV PSYCHOBIOL, V43, P311, DOI 10.1002/dev.10139; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; TRILLMICH F, 1981, BEHAVIOUR, V78, P21, DOI 10.1163/156853981X00248; TRIVERS RL, 1974, AM ZOOL, V14, P249; Valanne EH, 1967, EXPERIENTIA, V23, P768, DOI 10.1007/BF02154167; [No title captured], DOI DOI 10.1163/156853981X00347	48	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12195	10.1371/journal.pone.0012195	http://dx.doi.org/10.1371/journal.pone.0012195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730045	Green Published, gold			2022-12-27	WOS:000280862200029
J	Bergholz, R; Staks, T; Ruther, K				Bergholz, Richard; Staks, Thomas; Ruether, Klaus			Effects of the AMPA Antagonist ZK 200775 on Visual Function: A Randomized Controlled Trial	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR SUBUNITS; ACUTE ISCHEMIC-STROKE; MOUSE RETINA; VERTEBRATE RETINA; PRIMATE RETINA; RODENT RETINA; BIPOLAR CELLS; RAT RETINA; B-WAVE; LOCALIZATION	Background: ZK 200775 is an antagonist at the alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor and had earned attention as a possible neuroprotective agent in cerebral ischemia. Probands receiving the agent within phase I trials reported on an alteration of visual perception. In this trial, the effects of ZK 200775 on the visual system were analyzed in detail. Methodology: In a randomised controlled trial we examined eyes and vision before and after the intravenous administration of two different doses of ZK 200775 and placebo. There were 3 groups of 6 probands each: Group 1 recieved 0.03 mg/kg/h, group 2 0.75 mg/kg/h of ZK 200775, the control group received 0.9% sodium chloride solution. Probands were healthy males aged between 57 and 69 years. The following methods were applied: clinical examination, visual acuity, ophthalmoscopy, colour vision, rod absolute threshold, central visual field, pattern-reversal visual evoked potentials (pVEP), ON-OFF and full-field electroretinogram (ERG). Principal Findings: No effect of ZK 200775 was seen on eye position or motility, stereopsis, pupillary function or central visual field testing. Visual acuity and dark vision deteriorated significantly in both treated groups. Color vision was most remarkably impaired. The dark-adapted ERG revealed a reduction of oscillatory potentials (OP) and partly of the a- and b-wave, furthermore an alteration of b-wave morphology and an insignificantly elevated b/a-ratio. Cone-ERG modalities showed decreased amplitudes and delayed implicit times. In the ON- OFF ERG the ON-answer amplitudes increased whereas the peak times of the OFF-answer were reduced. The pattern VEP exhibited lower amplitudes and prolonged peak times. Conclusions: The AMPA receptor blockade led to a strong impairment of typical OFF-pathway functions like color vision and the cone ERG. On the other hand the ON- pathway as measured by dark vision and the scotopic ERG was affected as well. This further elucidates the interdependence of both pathways.	[Bergholz, Richard; Ruether, Klaus] Charite Univ Med Berlin, Dept Ophthalmol, Berlin, Germany; [Staks, Thomas] Bayer Schering Pharma AG, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals	Bergholz, R (corresponding author), Charite Univ Med Berlin, Dept Ophthalmol, Campus Virchow Klinikum, Berlin, Germany.	richard.bergholz@charite.de		Bergholz, Richard/0000-0001-7352-7653	Bayer HealthCare AG	Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	This trial has been funded by Bayer Schering AG (http:// www. bayerhealthcare. com/ scripts/ pages/ en/ index. php). The funder participated in the study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The costs of the trial amounted to approximately 200,000 Euros. Thomas Staks declares the following: There are no financial arrangements with Bayer HealthCare AG and its affiliated companies whereby the value of the compensation could be influenced by the outcome of the study. There are no proprietary interests (i. e. any property or other financial interests, including but not limited to, patents, trademarks, copyrights or licensing arrangements) in the tested product which is the subject of the study. There is no equity interest in Bayer HealthCare AG and its affiliated companies. This would include any ownership interest, stock options, or other financial interest whose value cannot be readily determined through reference of public prices. There is no equity interest in a publicly held company that exceeds US $ 50,000 in value during the clinical study or within one (1) year following completion of the study. There are no significant payments of other sorts, which are payments that have a cumulative monetary value of US $ 25,000 or more made by Bayer HealthCare AG and its affiliated companies during the clinical study or within one (1) year following completion of the study, excluding the costs of conducting the study or other clinical studies. This could include grants to fund ongoing research, compensation in the form of equipment or retainers for ongoing consultation or honoraria.	Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; Awatramani G, 2001, VISUAL NEUROSCI, V18, P147, DOI 10.1017/S0952523801181149; Bach M, 2000, OPHTHALMOLOGE, V97, P898, DOI 10.1007/s003470070018; Brandstatter JH, 2002, CURR EYE RES, V25, P327, DOI 10.1076/ceyr.25.6.327.14235; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Calkins DJ, 2005, VISUAL NEUROSCI, V22, P469, DOI 10.1017/S0952523805224082; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CONNAUGHTON V, 2003, WEBVISION GLUTAMATE; Dong CJ, 2000, VISION RES, V40, P579, DOI 10.1016/S0042-6989(99)00203-5; Elting JW, 2002, STROKE, V33, P2813, DOI 10.1161/01.STR.0000043823.37955.FB; Grunder T, 2000, INVEST OPHTH VIS SCI, V41, P3600; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hack I, 2001, EUR J NEUROSCI, V13, P15, DOI 10.1046/j.1460-9568.2001.01357.x; Harvey DM, 2002, VISUAL NEUROSCI, V19, P681, DOI 10.1017/S0952523802195137; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Hughes TE, 1997, VISUAL NEUROSCI, V14, P103, DOI 10.1017/S0952523800008804; Kamphuis W, 2003, J COMP NEUROL, V455, P172, DOI 10.1002/cne.10469; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Matsui K, 1998, J NEUROSCI, V18, P4500; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; PENG YW, 1995, NEUROSCIENCE, V66, P483, DOI 10.1016/0306-4522(94)00569-Q; Qin P, 1996, BRAIN RES, V710, P303, DOI 10.1016/0006-8993(95)01476-4; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; Walters MR, 2005, CEREBROVASC DIS, V20, P304, DOI 10.1159/000087929; Zhang CX, 1996, NEUROREPORT, V8, P335, DOI 10.1097/00001756-199612200-00066; Zhang J, 2004, J COMP NEUROL, V470, P1, DOI 10.1002/cne.10967; 1999, AR35 SCHER RES; 1999, AG99 SCHER RES; 1999, AO12 SCHER RES	32	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12111	10.1371/journal.pone.0012111	http://dx.doi.org/10.1371/journal.pone.0012111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711429	Green Published, gold, Green Submitted			2022-12-27	WOS:000280859700007
J	Coureuil, M; Ugolin, N; Tavernier, M; Chevillard, S; Barroca, V; Fouchet, P; Allemand, I				Coureuil, Mathieu; Ugolin, Nicolas; Tavernier, Marie; Chevillard, Sylvie; Barroca, Vilma; Fouchet, Pierre; Allemand, Isabelle			Puma and Trail/Dr5 Pathways Control Radiation-Induced Apoptosis in Distinct Populations of Testicular Progenitors	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; BH3-ONLY PROTEINS PUMA; BCL-2 FAMILY-MEMBERS; GERM-CELLS; IN-VIVO; DIFFERENTIATING SPERMATOGONIA; MOUSE TESTIS; P53; MICE; GENE	Spermatogonia-stem cells and progenitors of adult spermatogenesis-are killed through a p53-regulated apoptotic process after gamma-irradiation but the death effectors are still poorly characterized. Our data demonstrate that both intrinsic and extrinsic apoptotic pathways are involved, and especially that spermatogonia can be split into two main populations, according to apoptotic effectors. Following irradiation both Dr5 and Puma genes are upregulated in the alpha(6)-integrin-positive Side Population (SP) fraction, which is highly enriched in spermatogonia. Flow cytometric analysis confirms an increased number of Dr5-expressing SP cells, and Puma-beta isoform accumulates in alpha(6)-integrin positive cellular extracts, enriched in spermatogonia. Trail-/- or Puma-/- spermatogonia display a reduced sensitivity to radiation-induced apoptosis. The TUNEL kinetics strongly suggest that the extrinsic and intrinsic pathways, via Trail/Dr5 and Puma respectively, could be engaged in distinct subpopulations of spermatogonia. Indeed flow cytometric studies show that Dr5 receptor is constitutively present on more than half of the undifferentiated progenitors (Kit(-) alpha(+)(6) SP) and half of the differentiated ones (Kit(+) a(6)(+) SP). In addition after irradiation, Puma is not detected in the Dr5-positive cellular fraction isolated by immunomagnetic purification, while Puma is present in the Dr5-negative cell extracts. In conclusion, adult testicular progenitors are divided into distinct sub-populations by apoptotic effectors, independently of progenitor types (immature Kit-negative versus mature Kit-positive), underscoring differential radiosensitivities characterizing the stem cell/progenitors compartment.	[Coureuil, Mathieu; Tavernier, Marie; Barroca, Vilma; Fouchet, Pierre; Allemand, Isabelle] Univ Paris 07, CEA, INSERM,Inst Cellular & Mol Radiobiol, Lab Gametogenesis Apoptosis & Genotox,U967, Fontenay Aux Roses, France; [Ugolin, Nicolas; Chevillard, Sylvie] CEA, Expt Cancerol Lab, Inst Cellular & Mol Radiobiol, Fontenay Aux Roses, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Coureuil, M (corresponding author), Univ Paris 05, INSERM, Fac Med, U1002, Paris, France.	isabelle.allemand@cea.fr	Coureuil, Mathieu/D-4793-2017	Coureuil, Mathieu/0000-0001-7655-9685; Chevillard, Sylvie/0000-0001-5889-4041; allemand, isabelle/0000-0002-8861-7632; Fouchet, Pierre/0000-0003-0891-079X	Electricite de France; Association pour la Recherche contre le Cancer [5796]	Electricite de France; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	The authors' work was supported by Electricite de France, and by the Association pour la Recherche contre le Cancer (Grant 5796 and a PhD studentship to M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Akhtar RS, 2006, J NEUROSCI, V26, P7257, DOI 10.1523/JNEUROSCI.0196-06.2006; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Braghiroli L, 1998, BIOL REPROD, V59, P111, DOI 10.1095/biolreprod59.1.111; Brunetti G, 2007, ANN NY ACAD SCI, V1116, P316, DOI 10.1196/annals.1402.011; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Coultas L, 2005, EMBO J, V24, P3963, DOI 10.1038/sj.emboj.7600857; Coureui M, 2006, CELL DEATH DIFFER, V13, P1927, DOI 10.1038/sj.cdd.4401887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Hasegawa M, 1998, RADIAT RES, V149, P263, DOI 10.2307/3579959; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; McKee CM, 2006, APOPTOSIS, V11, P2237, DOI 10.1007/s10495-006-0288-1; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Flaherty J, 2006, APOPTOSIS, V11, P2103, DOI 10.1007/s10495-006-0196-4; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Ravi R, 2002, CANCER RES, V62, P1583; Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zauli G, 2006, CYTOKINE GROWTH F R, V17, P245, DOI 10.1016/j.cytogfr.2006.04.002	41	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12134	10.1371/journal.pone.0012134	http://dx.doi.org/10.1371/journal.pone.0012134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711434	gold, Green Published, Green Submitted			2022-12-27	WOS:000280859700021
J	Zhu, H; Yue, JY; Pan, Z; Wu, H; Cheng, Y; Lu, HM; Ren, XC; Yao, M; Shen, ZY; Yang, JM				Zhu, Hua; Yue, Jingyin; Pan, Zui; Wu, Hao; Cheng, Yan; Lu, Huimei; Ren, Xingcong; Yao, Ming; Shen, Zhiyuan; Yang, Jin-Ming			Involvement of Caveolin-1 in Repair of DNA Damage through Both Homologous Recombination and Non-Homologous End Joining	PLOS ONE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; POOR-PROGNOSIS; BASAL-LIKE; FREE SURVIVAL; UP-REGULATION; SHEAR-STRESS; LUNG-CANCER; CARCINOMA; OVEREXPRESSION	Background: Caveolin-1 (Cav-1), the major component of caveolae, is a 21-24 kDa integral membrane protein that interacts with a number of signaling molecules. By acting as a scaffolding protein, Cav-1 plays crucial roles in the regulation of various physiologic and patho-physiologic processes including oncogenic transformation and tumorigenesis, and tumor invasion and metastasis. Methodology/Principal Findings: In the present study we sought to explore the role of Cav-1 in response to DNA damage and the mechanism involved. We found that the level of Cav-1 was up-regulated rapidly in cells treated with ionizing radiation. The up-regulation of Cav-1 following DNA damage occurred only in cells expressing endogenous Cav-1, and was associated with the activation of DNA damage response pathways. Furthermore, we demonstrated that the expression of Cav-1 protected cells against DNA damage through modulating the activities of both the homologous recombination (HR) and non-homologous end joining (NHEJ) repair systems, as evidenced by the inhibitory effects of the Cav-1-targeted siRNA on cell survival, HR frequency, phosphorylation of DNA-dependent protein kinase (DNA-PK), and nuclear translocation of epidermal growth factor receptor (EGFR) following DNA damage, and by the stimulatory effect of the forced expression of Cav-1 on NHEJ frequency. Conclusion/Significance: Our results indicate that Cav-1 may play a critical role in sensing genotoxic stress and in orchestrating the response of cells to DNA damage through regulating the important molecules involved in maintaining genomic integrity.	[Zhu, Hua; Wu, Hao; Yao, Ming] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Penn State Univ, Penn State Hershey Canc Inst, Coll Med, Hershey, PA USA; [Cheng, Yan; Ren, Xingcong; Yang, Jin-Ming] Milton S Hershey Med Ctr, Hershey, PA USA; [Yue, Jingyin; Lu, Huimei; Shen, Zhiyuan] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ USA; [Pan, Zui] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhu, H (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA.	zhuhu2@umdnj.edu; jyang2@hmc.psu.edu	Zhu, Hua/G-4409-2010	Shen, Zhiyuan/0000-0003-2834-0309; Zhu, Hua/0000-0001-7136-7326; Pan, Zui/0000-0003-4105-901X	National Cancer Institute [CA109371, CA066077, CA137738]; NATIONAL CANCER INSTITUTE [R21CA109371, R01CA066077] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Cancer Institute CA109371 (Yang), CA066077 (Yang) and CA137738 (Shen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2006, J VET SCI, V7, P309, DOI 10.4142/jvs.2006.7.4.309; Aldred MA, 2003, CANCER RES, V63, P2864; Ando T, 2007, ONCOL REP, V18, P601; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; Bender FC, 2000, CANCER RES, V60, P5870; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Campbell L, 2003, BRIT J CANCER, V89, P1909, DOI 10.1038/sj.bjc.6601359; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Frank PG, 2006, J CLIN INVEST, V116, P1222, DOI 10.1172/JCI28509; Glait C, 2006, EXP CELL RES, V312, P3899, DOI 10.1016/j.yexcr.2006.08.016; Glait C, 2006, FEBS LETT, V580, P5268, DOI 10.1016/j.febslet.2006.08.071; Hayashi K, 2001, CANCER RES, V61, P2361; HEHLGANS S, 2009, RADIOTHER ONCOL; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li TH, 2006, AM J PATHOL, V168, P1998, DOI 10.2353/ajpath.2006.051089; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Patel HH, 2007, FASEB J, V21, P1565, DOI 10.1096/fj.06-7719com; Patlolla JMR, 2004, ONCOL REP, V11, P957; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Ravid D, 2006, ADV ENZYME REGUL, V46, P163, DOI 10.1016/j.advenzreg.2006.01.022; Pinilla SMR, 2006, BREAST CANCER RES TR, V99, P85, DOI 10.1007/s10549-006-9184-1; Sagara Y, 2004, BRIT J CANCER, V91, P959, DOI 10.1038/sj.bjc.6602029; Satoh T, 2003, CANCER-AM CANCER SOC, V97, P1225, DOI 10.1002/cncr.11198; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shatz M, 2004, LEUKEMIA RES, V28, P907, DOI 10.1016/j.leukres.2004.03.013; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Tanase CP, 2008, EXPERT REV MOL DIAGN, V8, P395, DOI 10.1586/14737159.8.4.395; Wang Y, 2008, BIOCHEM BIOPH RES CO, V370, P201, DOI 10.1016/j.bbrc.2008.03.031; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Wu P, 2008, BIOCHEM BIOPH RES CO, V376, P215, DOI 10.1016/j.bbrc.2008.08.146; Zhu H, 2004, FEBS LETT, V576, P369, DOI 10.1016/j.febslet.2004.09.041; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007; Zhu H, 2008, J PHARMACOL SCI, V106, P287, DOI 10.1254/jphs.FP0071192	56	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12055	10.1371/journal.pone.0012055	http://dx.doi.org/10.1371/journal.pone.0012055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700465	Green Published, gold, Green Submitted			2022-12-27	WOS:000280687900024
J	Hendriksen, H; Prins, J; Olivier, B; Oosting, RS				Hendriksen, Hendrikus; Prins, Jolanda; Olivier, Berend; Oosting, Ronald S.			Environmental Enrichment Induces Behavioral Recovery and Enhanced Hippocampal Cell Proliferation in an Antidepressant-Resistant Animal Model for PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DENTATE GYRUS; NEUROTROPHIC FACTORS; PHYSICAL-ACTIVITY; MEMORY DEFICITS; MOUSE MODEL; NEUROGENESIS; DEPRESSION; EXERCISE; RATS	Background: Post traumatic stress disorder (PTSD) can be considered the result of a failure to recover after a traumatic experience. Here we studied possible protective and therapeutic aspects of environmental enrichment (with and without a running wheel) in Sprague Dawley rats exposed to an inescapable foot shock procedure (IFS). Methodology/Principal Findings: IFS induced long-lasting contextual and non-contextual anxiety, modeling some aspects of PTSD. Even 10 weeks after IFS the rats showed reduced locomotion in an open field. The antidepressants imipramine and escitalopram did not improve anxiogenic behavior following IFS. Also the histone deacetylase (HDAC) inhibitor sodium butyrate did not alleviate the IFS induced immobility. While environmental enrichment (EE) starting two weeks before IFS did not protect the animals from the behavioral effects of the shocks, exposure to EE either immediately after the shock or one week later induced complete recovery three weeks after IFS. In the next set of experiments a running wheel was added to the EE to enable voluntary exercise (EE/VE). This also led to reduced anxiety. Importantly, this behavioral recovery was not due to a loss of memory for the traumatic experience. The behavioral recovery correlated with an increase in cell proliferation in hippocampus, a decrease in the tissue levels of noradrenalin and increased turnover of 5-HT in prefrontal cortex and hippocampus. Conclusions/Significance: This animal study shows the importance of (physical) exercise in the treatment of psychiatric diseases, including post-traumatic stress disorder and points out the possible role of EE in studying the mechanism of recovery from anxiety disorders.	[Hendriksen, Hendrikus; Prins, Jolanda; Olivier, Berend; Oosting, Ronald S.] Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	Utrecht University	Hendriksen, H (corresponding author), Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.	h.hendriksen@uu.nl		Hendriksen, Hendrikus/0000-0001-8526-6526				Arkin Sharon, 2007, Am J Alzheimers Dis Other Demen, V22, P62, DOI 10.1177/1533317506295377; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; Baker DG, 2009, EXPERT OPIN EMERG DR, V14, P251, DOI 10.1517/14728210902972494; Barf TA, 1996, J MED CHEM, V39, P4717, DOI 10.1021/jm9604890; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; BIJLSMA EY, 2009, BEHAV BRAIN RES; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Bremner J Douglas, 2008, Prog Brain Res, V167, P171; Breuer ME, 2007, BIOL PSYCHIAT, V61, P990, DOI 10.1016/j.biopsych.2006.08.032; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; Cohen Judith A, 2005, J Trauma Dissociation, V6, P109, DOI 10.1300/J229v06n02_10; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Davis LL, 2006, CNS DRUGS, V20, P465, DOI 10.2165/00023210-200620060-00003; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fischer FR, 2007, J SPINAL CORD MED, V30, P147, DOI 10.1080/10790268.2007.11753926; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Marchetti C, 2010, BIOL PSYCHIAT, V67, P146, DOI 10.1016/j.biopsych.2009.09.017; MARLATT MW, 2010, BRAIN RES; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Moraska A, 2001, AM J PHYSIOL-REG I, V281, pR484, DOI 10.1152/ajpregu.2001.281.2.R484; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; PERRATON LG, 2009, J EVAL CLIN PRACT; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; Rodriguez-Romaguera J, 2009, BIOL PSYCHIAT, V65, P887, DOI 10.1016/j.biopsych.2009.01.009; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; SCHLOESSER RJ, 2010, MOL PSYCHIAT; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V52, P945, DOI 10.1016/0031-9384(92)90375-C; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V51, P787, DOI 10.1016/0031-9384(92)90117-K; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Wolff M, 2008, HIPPOCAMPUS, V18, P996, DOI 10.1002/hipo.20457; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Yoo MJ, 2007, J MICROBIOL BIOTECHN, V17, P2033	56	53	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11943	10.1371/journal.pone.0011943	http://dx.doi.org/10.1371/journal.pone.0011943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700523	Green Published, gold, Green Submitted			2022-12-27	WOS:000280605400004
J	Rotblat, B; Belanis, L; Liang, H; Haklai, R; Elad-Zefadia, G; Hancock, JF; Kloog, Y; Plowman, SJ				Rotblat, Barak; Belanis, Liron; Liang, Hong; Haklai, Roni; Elad-Zefadia, Galit; Hancock, John F.; Kloog, Yoel; Plowman, Sarah J.			H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output	PLOS ONE			English	Article							K-RAS; PLASMA-MEMBRANE; LIVE CELLS; ASSOCIATION; GALECTIN-1; ACTIVATION; PROTEINS; GTP; LOCALIZATION; DYNAMICS	H-Ras is a binary switch that is activated by multiple co-factors and triggers several key cellular pathways one of which is MAPK. The specificity and magnitude of downstream activation is achieved by the spatio-temporal organization of the active H-Ras in the plasma membrane. Upon activation, the GTP bound H-Ras binds to Galectin-1 (Gal-1) and becomes transiently immobilized in short-lived nanoclusters on the plasma membrane from which the signal is propagated to Raf. In the current study we show that stabilizing the H-Ras-Gal-1 interaction, using bimolecular fluorescence complementation (BiFC), leads to prolonged immobilization of H-Ras. GTP in the plasma membrane which was measured by fluorescence recovery after photobleaching (FRAP), and increased signal out-put to the MAPK module. EM measurements of Raf recruitment to the H-Ras. GTP nanoclusters demonstrated that the enhanced signaling observed in the BiFC stabilized HRas. GTP nanocluster was attributed to increased H-Ras immobilization rather than to an increase in Raf recruitment. Taken together these data demonstrate that the magnitude of the signal output from a GTP-bound H-Ras nanocluster is proportional to its stability.	[Rotblat, Barak; Belanis, Liron; Haklai, Roni; Elad-Zefadia, Galit; Kloog, Yoel] Tel Aviv Univ, Dept Neurobiol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Liang, Hong; Hancock, John F.; Plowman, Sarah J.] Univ Texas Hlth Sci Center Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA	Tel Aviv University; University of Texas System; University of Texas Health Science Center Houston	Rotblat, B (corresponding author), Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.	John.F.Hancock@uth.tmc.edu; kloog@post.tau.ac.il; Sarah.J.Plowman@uth.tmc.edu	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Hancock, John/0000-0003-0542-4710	Binational Science Foundation, BSF [2005344]; Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs; National Institute of General Medical Sciences [R01GM066717]; International Human Frontier Science Program Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	Binational Science Foundation, BSF(US-Israel Binational Science Foundation); Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by awards from the Binational Science Foundation, BSF Grant 2005344 (YK), the Prajs-Drimmer Institute for the Development of Anti-Degenerative Disease Drugs and the National Institute of General Medical Sciences, R01GM066717 (JFH). BR is supported by The International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lommerse PHM, 2006, BIOPHYS J, V91, P1090, DOI 10.1529/biophysj.105.079053; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; PETERSON NO, 1986, METHOD ENZYMOL, V30, P454; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615	24	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11991	10.1371/journal.pone.0011991	http://dx.doi.org/10.1371/journal.pone.0011991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700538	Green Published, Green Submitted, gold			2022-12-27	WOS:000280605400023
J	Michaud, F; Coulombe, F; Gaudreault, E; Paquet-Bouchard, C; Rola-Pleszczynski, M; Gosselin, J				Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Rola-Pleszczynski, Marek; Gosselin, Jean			Epstein-Barr Virus Interferes with the Amplification of IFN alpha Secretion by Activating Suppressor of Cytokine Signaling 3 in Primary Human Monocytes	PLOS ONE			English	Article							REGULATORY FACTOR-7; INDUCED APOPTOSIS; INDUCTION; TRANSCRIPTION; INHIBITION; GENE; PROTEIN; CELLS; EBV; INFECTIONS	Background: Epstein-Barr virus is recognized to cause lymphoproliferative disorders and is also associated with cancer. Evidence suggests that monocytes are likely to be involved in EBV pathogenesis, especially due to a number of cellular functions altered in EBV-infected monocytes, a process that may affect efficient host defense. Because type I interferons (IFNs) are crucial mediators of host defense against viruses, we investigated the effect of EBV infection on the IFN alpha pathway in primary human monocytes. Methodology/Principal Findings: Infection of monocytes with EBV induced IFN alpha secretion but inhibited the positive feedback loop for the amplification of IFN alpha . We showed that EBV infection induced the expression of suppressor of cytokine signaling 3 (SOCS3) and, to a lesser extent, SOCS1, two proteins known to interfere with the amplification of IFN alpha secretion mediated by the JAK/STAT signal transduction pathway. EBV infection correlated with a blockage in the activation of JAK/STAT pathway members and affected the level of phosphorylated IFN regulatory factor 7 (IRF7). Depletion of SOCS3, but not SOCS1, by small interfering RNA (siRNA) abrogated the inhibitory effect of EBV on JAK/STAT pathway activation and significantly restored IFN alpha secretion. Finally, transfection of monocytes with the viral protein Zta caused the upregulation of SOCS3, an event that could not be recapitulated with mutated Zta. Conclusions/Significance: We propose that EBV protein Zta activates SOCS3 protein as an immune escape mechanism that both suppresses optimal IFN alpha secretion by human monocytes and favors a state of type I IFN irresponsiveness in these cells. This immunomodulatory effect is important to better understand the aspects of the immune response to EBV.	[Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Gosselin, Jean] Univ Laval, CHUQ Res Ctr CHUL, Innate Immunol Lab, Quebec City, PQ, Canada; [Michaud, Francois; Coulombe, Francois; Gaudreault, Eric; Paquet-Bouchard, Carine; Gosselin, Jean] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Rola-Pleszczynski, Marek] Univ Sherbrooke, Fac Med, Dept Pediat, Div Immunol, Sherbrooke, PQ, Canada	Laval University; Laval University; University of Sherbrooke	Michaud, F (corresponding author), Univ Laval, CHUQ Res Ctr CHUL, Innate Immunol Lab, Quebec City, PQ, Canada.	jean.gosselin@crchul.ulaval.ca			Canadian Institutes of Health Research; Fondation Dr. Georges Phenix	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Dr. Georges Phenix	This project was supported by a grant from the Canadian Institutes of Health Research to JG. EG is a recipient of a studentship from Fondation Dr. Georges Phenix. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; AMAN P, 1990, EMBO J, V9, P147, DOI 10.1002/j.1460-2075.1990.tb08090.x; BENTZ G, 2001, VIROLOGY, V3, P7; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Cohen JI, 1999, J VIROL, V73, P7627, DOI 10.1128/JVI.73.9.7627-7632.1999; Du ZM, 2005, P NATL ACAD SCI USA, V102, P10267, DOI 10.1073/pnas.0408854102; GOSSELIN J, 1991, EUR J IMMUNOL, V21, P203, DOI 10.1002/eji.1830210130; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Ichikawa T, 2002, BIOCHEM BIOPH RES CO, V294, P414, DOI 10.1016/S0006-291X(02)00502-8; Jabs WJ, 2002, BLOOD, V99, P1512, DOI 10.1182/blood.V99.5.1512; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; Kasahara Y, 2002, CRIT REV ONCOL HEMAT, V44, P283, DOI 10.1016/S1040-8428(02)00119-1; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Larochelle B, 1998, BLOOD, V92, P291, DOI 10.1182/blood.V92.1.291.413k34_291_299; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; MAHOT S, 2003, J GEN VIROL, V974, pEB1; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Ruvolo V, 2003, J VIROL, V77, P3690, DOI 10.1128/JVI.77.6.3690-3701.2003; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Savard M, 2000, J VIROL, V74, P2612, DOI 10.1128/JVI.74.6.2612-2619.2000; Savard M, 2000, J IMMUNOL, V164, P6467, DOI 10.4049/jimmunol.164.12.6467; Savard M, 2006, VIRUS RES, V119, P134, DOI 10.1016/j.virusres.2006.02.008; Shah KM, 2009, ONCOGENE, V28, P3903, DOI 10.1038/onc.2009.249; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; STRAUS SE, 1993, ANN INTERN MED, V118, P45, DOI 10.7326/0003-4819-118-1-199301010-00009; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Tardif M, 2002, J BIOL CHEM, V277, P24148, DOI 10.1074/jbc.M109036200; Tugizov S, 2007, J VIROL, V81, P5484, DOI 10.1128/JVI.00171-07; Vuong BQ, 2004, MOL CELL BIOL, V24, P9092, DOI 10.1128/MCB.24.20.9092-9101.2004; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Yasukawa H, 2003, J CLIN INVEST, V111, P469, DOI 10.1172/JCI200316491; Yokota S, 2005, VIROLOGY, V338, P173, DOI 10.1016/j.virol.2005.04.028; Yokota S, 2004, J VIROL, V78, P6282, DOI 10.1128/JVI.78.12.6282-6286.2004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	47	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11908	10.1371/journal.pone.0011908	http://dx.doi.org/10.1371/journal.pone.0011908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689596	Green Submitted, gold, Green Published			2022-12-27	WOS:000280520300022
J	Chen, N; Yu, JD; Qian, H; Ge, RJ; Wang, JH				Chen, Na; Yu, Jiandong; Qian, Hao; Ge, Rongjing; Wang, Jin-Hui			Axons Amplify Somatic Incomplete Spikes into Uniform Amplitudes in Mouse Cortical Pyramidal Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; THRESHOLD POTENTIALS; REFRACTORY PERIODS; DENDRITIC SPIKES; SODIUM-CHANNELS; PROPAGATION; CELL; PLASTICITY; NERVE; SITE	Background: Action potentials are the essential unit of neuronal encoding. Somatic sequential spikes in the central nervous system appear various in amplitudes. To be effective neuronal codes, these spikes should be propagated to axonal terminals where they activate the synapses and drive postsynaptic neurons. It remains unclear whether these effective neuronal codes are based on spike timing orders and/or amplitudes. Methodology/Principal Findings: We investigated this fundamental issue by simultaneously recording the axon versus soma of identical neurons and presynaptic vs. postsynaptic neurons in the cortical slices. The axons enable somatic spikes in low amplitude be enlarged, which activate synaptic transmission in consistent patterns. This facilitation in the propagation of sequential spikes through the axons is mechanistically founded by the short refractory periods, large currents and high opening probability of axonal voltage-gated sodium channels. Conclusion/Significance: An amplification of somatic incomplete spikes into axonal complete ones makes sequential spikes to activate consistent synaptic transmission. Therefore, neuronal encoding is likely based on spike timing order, instead of graded analogues.	[Chen, Na; Yu, Jiandong; Qian, Hao; Ge, Rongjing; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, N (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jhw@ibp.ac.cn		QIAN, HAO/0000-0001-5771-5865	National Award for Outstanding Young Scientist [30325021]; Natural Science Foundation China (NSFC) [30621130077, 30870517, 30990261, 30700204]; National Basic Research Program [2006CB500804]; CAS Program [KSCX2-YWR-39]	National Award for Outstanding Young Scientist; Natural Science Foundation China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); CAS Program	This study is supported by the National Award for Outstanding Young Scientist (30325021), Natural Science Foundation China (NSFC 30621130077, 30870517 and 30990261), National Basic Research Program (2006CB500804), CAS Program in Knowledge Innovation (KSCX2-YWR-39) to JHW, as well as NSFC (30700204) to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Websites:http://www.nsfc.gov.cn/Portal0/default124.htm for NSFC; http://www.973.gov.cn/ for National Basic Research Program.	ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; BROCK LG, 1953, J PHYSIOL-LONDON, V122, P429, DOI 10.1113/jphysiol.1953.sp005013; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P281, DOI 10.1016/j.bbrc.2006.05.120; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; DAYAN P, 2001, MODEL NEURON, V1, P1; EDWARDS C, 1958, J PHYSIOL-LONDON, V143, P138, DOI 10.1113/jphysiol.1958.sp006049; Epsztein J, 2010, SCIENCE, V327, P474, DOI 10.1126/science.1182773; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Goldman L, 1995, BIOPHYS J, V69, P2364, DOI 10.1016/S0006-3495(95)80105-0; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Hanson JE, 2004, J NEUROSCI, V24, P329, DOI 10.1523/JNEUROSCI.3937-03.2004; HILLE B, 2001, VOLTAGE GATED CALCIU, P95; HILLE B, 2001, CLASSIC BIOPHYSICS S, P25; Hodgkin AL, 1937, J PHYSIOL-LONDON, V90, P183, DOI 10.1113/jphysiol.1937.sp003507; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; MacKenzie PJ, 1996, NEURON, V16, P783, DOI 10.1016/S0896-6273(00)80098-7; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Rieke F, 1998, SPIKES EXPLORING NEU, P1; Roberts CB, 2008, ENDOCRINOLOGY, V149, P3355, DOI 10.1210/en.2008-0152; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P432; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	46	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11868	10.1371/journal.pone.0011868	http://dx.doi.org/10.1371/journal.pone.0011868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686619	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200031
J	McKenna, DD; Farrell, BD				McKenna, Duane D.; Farrell, Brian D.			9-Genes Reinforce the Phylogeny of Holometabola and Yield Alternate Views on the Phylogenetic Placement of Strepsiptera	PLOS ONE			English	Article							HOST-PARASITOID ASSOCIATIONS; MOLECULAR PHYLOGENETICS; FELSENSTEIN ZONE; INSECT ORDERS; GENES; EVOLUTION; COLEOPTERA; PARSIMONY; SUBORDERS; INFERENCE	Background: The extraordinary morphology, reproductive and developmental biology, and behavioral ecology of twisted wing parasites (order Strepsiptera) have puzzled biologists for centuries. Even today, the phylogenetic position of these enigmatic "insects from outer space'' [1] remains uncertain and contentious. Recent authors have argued for the placement of Strepsiptera within or as a close relative of beetles (order Coleoptera), as sister group of flies (order Diptera), or even outside of Holometabola. Methodology/Principal Findings: Here, we combine data from several recent studies with new data (for a total of 9 nuclear genes and similar to 13 kb of aligned data for 34 taxa), to help clarify the phylogenetic placement of Strepsiptera. Our results unequivocally support the monophyly of Neuropteroidea (= Neuropterida + Coleoptera) + Strepsiptera, but recover Strepsiptera either derived from within polyphagan beetles (order Coleoptera), or in a position sister to Neuropterida. All other supra-ordinal- and ordinal-level relationships recovered with strong nodal support were consistent with most other recent studies. Conclusions/Significance: These results, coupled with the recent proposed placement of Strepsiptera sister to Coleoptera, suggest that while the phylogenetic neighborhood of Strepsiptera has been identified, unequivocal placement to a specific branch within Neuropteroidea will require additional study.	[McKenna, Duane D.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Farrell, Brian D.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Memphis; Harvard University	McKenna, DD (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	dmckenna@memphis.edu			National Science Foundation [DEB-0531768]	National Science Foundation(National Science Foundation (NSF))	This paper is based in part upon work supported by the National Science Foundation under Grant No. DEB-0531768. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutel RG, 2006, SYST ENTOMOL, V31, P202, DOI 10.1111/j.1365-3113.2006.00341.x; Beutel RG, 2000, CLADISTICS, V16, P103, DOI 10.1111/j.1096-0031.2000.tb00350.x; Bonneton F, 2006, INSECT MOL BIOL, V15, P351, DOI 10.1111/j.1365-2583.2006.00654.x; BOVING A. G., 1931, Entomologica Americana, V11, P1; Bravo F, 2009, CLADISTICS, V25, P614, DOI 10.1111/j.1096-0031.2009.00264.x; Buschbeck E, 1999, SCIENCE, V286, P1178, DOI 10.1126/science.286.5442.1178; Buschbeck EK, 2003, J COMP PHYSIOL A, V189, P617, DOI 10.1007/s00359-003-0443-x; CARMEAN D, 1995, NATURE, V373, P666, DOI 10.1038/373666b0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalwatzis N, 1996, ANN ENTOMOL SOC AM, V89, P788, DOI 10.1093/aesa/89.6.788; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; Crowson RA, 1981, BIOL COLEOPTERA; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Friedrich F, 2010, CLADISTICS, V26, P579, DOI 10.1111/j.1096-0031.2010.00305.x; Grimaldi David, 2005, pi; Handlirsch A., 1903, SITZ AK WISS WIEN, V112, P716; Hayward DC, 2005, DEV GENES EVOL, V215, P213, DOI 10.1007/s00427-004-0461-x; Hennig W., 1981, INSECT PHYLOGENY; Huelsenbeck John P., 2001, Tijdschrift voor Entomologie, V144, P165; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Hwang UW, 1998, MOL PHYLOGENET EVOL, V9, P470, DOI 10.1006/mpev.1998.0518; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 1998, INT J INSECT MORPHOL, V27, P39, DOI 10.1016/S0020-7322(97)00031-7; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; KATOH K, 2008, RECENT DEV MAFFT MUL; KINZELBACH R, 1990, American Entomologist, V36, P292; Kinzelbach RK, 1978, TIERWELT DEUTSCHLAND, V65, P166; Kirby W, 1815, T LINNEAN SOC LONDON, V11, P86, DOI [10.1111/j.1096-3642.1813.tb00040.x, DOI 10.1111/J.1096-3642.1813.TB00040.X]; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; KRISTENSEN N P, 1975, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V13, P1; Kristensen N.P., 1991, P125; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; LATREILLE PA, 1809, GENERA CRUST INSECT, V4, P388; Lawrence J.F., 1995, P779; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; McKenna DD, 2005, MOL PHYLOGENET EVOL, V37, P117, DOI 10.1016/j.ympev.2005.06.011; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McKenna Duane D., 2009, P278; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Pierce W. D, 1909, B US NATL MUSEUM, V66, P1; PIERCE WD, 1904, SOME HYPERMETAMORPHI, V4, P15; Pohl H, 2005, CLADISTICS, V21, P328, DOI 10.1111/j.1096-0031.2005.00074.x; Pohl H, 2004, ARTHROPOD STRUCT DEV, V33, P31, DOI 10.1016/j.asd.2003.10.001; Pohl H, 2002, ZOOL SCR, V31, P123, DOI 10.1046/j.0300-3256.2001.00078.x; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Proffitt F, 2005, SCIENCE, V307, P343, DOI 10.1126/science.307.5708.343; RASNITSYN AP, 2002, HIST INSECTS, P157, DOI DOI 10.1007/0-306-47577-4; Rokas A, 1999, INSECT MOL BIOL, V8, P527, DOI 10.1046/j.1365-2583.1999.00149.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSS HH, 1982, TXB ENTOMOLOGY, P4; Rossi P, 1793, B SOC PHILOMATHIQUE, V1, P49; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; SWOFFORD DL, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 2002, ZOOL SCR, V31, P3, DOI 10.1046/j.0300-3256.2001.00093.x; WHITING MF, 1994, NATURE, V368, P696, DOI 10.1038/368696a0; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Whiting MF, 1995, J NEW YORK ENTOMOL S, V103, P1; Whiting Michael F., 2005, P3; Wiegmann Brian M., 2009, P260; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zwickl DJ., 2006, THESIS; [No title captured]	77	58	60	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11887	10.1371/journal.pone.0011887	http://dx.doi.org/10.1371/journal.pone.0011887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686704	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200046
J	Wilson, ET; Wong, J; Gribble, PL				Wilson, Elizabeth T.; Wong, Jeremy; Gribble, Paul L.			Mapping Proprioception across a 2D Horizontal Workspace	PLOS ONE			English	Article								Relatively few studies have been reported that document how proprioception varies across the workspace of the human arm. Here we examined proprioceptive function across a horizontal planar workspace, using a new method that avoids active movement and interactions with other sensory modalities. We systematically mapped both proprioceptive acuity (sensitivity to hand position change) and bias (perceived location of the hand), across a horizontal-plane 2D workspace. Proprioception of both the left and right arms was tested at nine workspace locations and in 2 orthogonal directions (left-right and forwards-backwards). Subjects made repeated judgments about the position of their hand with respect to a remembered proprioceptive reference position, while grasping the handle of a robotic linkage that passively moved their hand to each judgement location. To rule out the possibility that the memory component of the proprioceptive testing procedure may have influenced our results, we repeated the procedure in a second experiment using a persistent visual reference position. Both methods resulted in qualitatively similar findings. Proprioception is not uniform across the workspace. Acuity was greater for limb configurations in which the hand was closer to the body, and was greater in a forward-backward direction than in a left-right direction. A robust difference in proprioceptive bias was observed across both experiments. At all workspace locations, the left hand was perceived to be to the left of its actual position, and the right hand was perceived to be to the right of its actual position. Finally, bias was smaller for hand positions closer to the body. The results of this study provide a systematic map of proprioceptive acuity and bias across the workspace of the limb that may be used to augment computational models of sensory-motor control, and to inform clinical assessment of sensory function in patients with sensory-motor deficits.	[Wilson, Elizabeth T.; Wong, Jeremy; Gribble, Paul L.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Wilson, Elizabeth T.; Wong, Jeremy] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Gribble, Paul L.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Wilson, ET (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	paul@gribblelab.org		Gribble, Paul/0000-0002-1368-032X	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. E.W. was supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Bergenheim M, 2000, EXP BRAIN RES, V134, P301, DOI 10.1007/s002210000471; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Brown LE, 2003, EXP BRAIN RES, V153, P266, DOI 10.1007/s00221-003-1601-7; CARSON RG, 1990, NEUROPSYCHOLOGIA, V28, P103; Chapman CD, 2001, BRAIN COGNITION, V46, P62, DOI 10.1016/S0278-2626(01)80035-X; Chieffi S, 2004, EXP BRAIN RES, V158, P421, DOI 10.1007/s00221-004-1916-z; CHOKRON S, 2004, BRAIN COGNITION, V55, P4; CROWE A, 1987, PERCEPT MOTOR SKILL, V64, P46; DARLING WG, 1991, EXP BRAIN RES, V85, P405; DARLING WG, 1993, EXP BRAIN RES, V93, P534; Desmurget M, 2000, EXP BRAIN RES, V134, P77; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; FUENTES CT, J NEUROPHYSIOL, V103, P71; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7; Goble DJ, 2006, EXP BRAIN RES, V168, P307, DOI 10.1007/s00221-005-0280-y; GORDON J, 1995, J NEUROPHYSIOL, V73, P60; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; HALL LA, 1983, J PHYSL, V335, P33; Henriques DYP, 2003, EXP BRAIN RES, V150, P95, DOI 10.1007/s00221-003-1402-z; Herrmann U, 1998, J NEUROSCI, V18, P8402; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; JONES KE, 2001, J PHYSL, V536, P47; LAUFER Y, 1998, PERCEPT MOTOR SKILL, V86, P91; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P820; PAILLARD J, NEUROPSYCHOLOGY SPAT, P55; ROLL JP, 2000, EXP BRAIN RES, V134, P21; ROSSETTI Y, 1994, EXP BRAIN RES, V99, P131; ROTHWELL JC, 1982, BRAIN 3, V105, P42; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; SANES JN, 1984, P NATL ACAD SCI USA, V81, P82; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SITTIG AC, 1985, EXP BRAIN RES, V60, P53; Slinger RT, 1906, BRAIN, V29, P1, DOI 10.1093/brain/29.1.1; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; VANSTRIEN JW, 1992, NED TIJDSCHR PSYCHOL, V47, P92; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; WANN JP, 1992, EXP BRAIN RES, V91, P162; WRISBERG CA, 1985, J MOTOR BEHAV, V17, P54	45	85	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11851	10.1371/journal.pone.0011851	http://dx.doi.org/10.1371/journal.pone.0011851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686612	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200016
J	Kamps, AR; Pruitt, MM; Herriges, JC; Coffman, CR				Kamps, Angela R.; Pruitt, Margaret M.; Herriges, John C.; Coffman, Clark R.			An Evolutionarily Conserved Arginine Is Essential for Tre1 G Protein-Coupled Receptor Function During Germ Cell Migration in Drosophila melanogaster	PLOS ONE			English	Article							ALPHA(1B)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVITY; STRUCTURE PREDICTION; CHEMOKINE RECEPTORS; ARG-TYR; ACTIVATION; DISRUPTION; CXCR4; MODEL; DEATH	Background: G protein-coupled receptors (GPCRs) play central roles in mediating cellular responses to environmental signals leading to changes in cell physiology and behaviors, including cell migration. Numerous clinical pathologies including metastasis, an invasive form of cell migration, have been linked to abnormal GPCR signaling. While the structures of some GPCRs have been defined, the in vivo roles of conserved amino acid residues and their relationships to receptor function are not fully understood. Trapped in endoderm 1 (Tre1) is an orphan receptor of the rhodopsin class that is necessary for primordial germ cell migration in Drosophila melanogaster embryos. In this study, we employ molecular genetic approaches to identify residues in Tre1 that are critical to its functions in germ cell migration. Methodology/Principal Findings: First, we show that the previously reported scattershot mutation is an allele of tre1. The scattershot allele results in an in-frame deletion of 8 amino acids at the junction of the third transmembrane domain and the second intracellular loop of Tre1 that dramatically impairs the function of this GPCR in germ cell migration. To further refine the molecular basis for this phenotype, we assayed the effects of single amino acid substitutions in transgenic animals and determined that the arginine within the evolutionarily conserved E/N/DRY motif is critical for receptor function in mediating germ cell migration within an intact developing embryo. Conclusions/Significance: These structure-function studies of GPCR signaling in native contexts will inform future studies into the basic biology of this large and clinically important family of receptors.	[Kamps, Angela R.; Pruitt, Margaret M.; Herriges, John C.; Coffman, Clark R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University	Kamps, AR (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	ccoffman@iastate.edu			National Science Foundation [IOB-0235332]; Roy J. Carver Charitable Trust [08-3185]; Center for Integrated Animal Genomics at Iowa State University; Iowa Agriculture and Home Economics Experiment Station	National Science Foundation(National Science Foundation (NSF)); Roy J. Carver Charitable Trust; Center for Integrated Animal Genomics at Iowa State University; Iowa Agriculture and Home Economics Experiment Station	This work was supported by grants from the National Science Foundation (IOB-0235332), the Roy J. Carver Charitable Trust (08-3185), the Center for Integrated Animal Genomics at Iowa State University, and the Iowa Agriculture and Home Economics Experiment Station. URLs: http://www.nsf.gov/; http://www.carvertrust.org/; http://www.ciag.iastate.edu/; http://www.iahees.iastate.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berchiche YA, 2007, J BIOL CHEM, V282, P5111, DOI 10.1074/jbc.C600270200; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; BURNETT C, 2005, THESIS U COLL LONDON; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Coffman CR, 2003, ANN NY ACAD SCI, V995, P117, DOI 10.1111/j.1749-6632.2003.tb03215.x; Coffman CR, 2002, GENETICS, V162, P273; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GLOOR GB, 1993, GENETICS, V135, P81; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; HAY B, 1988, DEVELOPMENT, V103, P625; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holmes AL, 1998, GENETICS, V148, P1189; Johansen KM, 2004, METH MOL B, V247, P215; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; Kamps AR, 2005, ANN NY ACAD SCI, V1049, P17, DOI 10.1196/annals.1334.003; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; KUNWAR PS, 2008, J CELL BIOL; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Rosenkilde MM, 2005, MOL PHARMACOL, V68, P11, DOI 10.1124/mol.105.011239; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Scheer A, 2000, MOL PHARMACOL, V57, P219; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; Sonnenblick BP, 1941, P NATL ACAD SCI USA, V27, P484, DOI 10.1073/pnas.27.10.484; SONNENBLICK BP, 1950, EARLY EMBRYOLOGY DRO; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; YAMADA Y, 2007, THESIS IOWA STATE U; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	57	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11839	10.1371/journal.pone.0011839	http://dx.doi.org/10.1371/journal.pone.0011839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676220	Green Submitted, Green Published, gold			2022-12-27	WOS:000280520100015
J	Kiank, C; Zeden, JP; Drude, S; Domanska, G; Fusch, G; Otten, W; Schuett, C				Kiank, Cornelia; Zeden, Jan-Philip; Drude, Solveig; Domanska, Grazyna; Fusch, Gerhard; Otten, Winfried; Schuett, Christine			Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-GAMMA; DENDRITIC CELLS; KYNURENIC ACID; INDUCTION; BARRIER; DEPRESSION; RESPONSES; SUSCEPTIBILITY	It is increasingly recognized that psychological stress influences inflammatory responses and mood. Here, we investigated whether psychological stress ( combined acoustic and restraint stress) activates the tryptophan (Trp) catabolizing enzyme indoleamine 2,3-dioxygenase 1(IDO1) and thereby alters the immune homeostasis and behavior in mice. We measured IDO1 mRNA expression and plasma levels of Trp catabolites after a single 2-h stress session and in repeatedly stressed (4.5-days stress, 2-h twice a day) naive BALB/c mice. A role of cytokines in acute stress-induced IDO1 activation was studied after IFN gamma and TNF alpha blockade and in IDO1(-/-) mice. RU486 and 1-Methyl-L-tryptophan (1-MT) were used to study role of glucocorticoids and IDO1 on Trp depletion in altering the immune and behavioral response in repeatedly stressed animals. Clinical relevance was addressed by analyzing IDO1 activity in patients expecting abdominal surgery. Acute stress increased the IDO1 mRNA expression in brain, lung, spleen and Peyer's patches (max. 14.1 +/- 4.9-fold in brain 6-h after stress) and resulted in a transient depletion of Trp (-25.2 +/- 6.6%) and serotonin (-27.3 +/- 4.6%) from the plasma measured 6-h after stress while kynurenine levels increased 6-h later (11.2 +/- 9.3%). IDO1 mRNA up-regulation was blocked by anti-TNF alpha and anti-IFN gamma treatment. Continuous IDO1 blockade by 1-MT but not RU486 treatment normalized the anti-bacterial defense and attenuated increased IL-10 inducibility in splenocytes after repeated stress as it reduced the loss of body weight and behavioral alterations. Moreover, kynurenic acid which remained increased in 1-MT treated repeatedly stressed mice was identified to reduce the TNFa inducibility of splenocytes in vitro and in vivo. Thus, psychological stress stimulates cytokine-driven IDO1 activation and Trp depletion which seems to have a central role for developing stress-induced immunosuppression and behavioral alteration. Since patients showed Trp catabolism already prior to surgery, IDO is also a possible target enzyme for humans modulating immune homeostasis and mood.	[Kiank, Cornelia; Zeden, Jan-Philip; Drude, Solveig; Domanska, Grazyna; Schuett, Christine] Ernst Moritz Arndt Univ Greifswald, Dept Immunol, DFG Grad Sch GK840, Greifswald, Germany; [Fusch, Gerhard] Ernst Moritz Arndt Univ Greifswald, Dept Pediat, Greifswald, Germany; [Otten, Winfried] Res Inst Biol Farm Anim FBN, Res Unit Behav Physiol, Dummerstorf, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Forschungsinstitut fur Nutztierbiologie (FBN)	Kiank, C (corresponding author), Univ Calif Los Angeles, Dept Med, Ctr Neurobiol Stress, CURE Digest Dis Res Ctr,GLA VA HS, Los Angeles, CA 90024 USA.	ckiank@mednet.ucla.edu	Fusch, Gerhard/ABG-1096-2021; Otten, Winfried/V-8376-2019	Fusch, Gerhard/0000-0003-4026-3211; Otten, Winfried/0000-0002-5613-5356	Deutsche Forschungsgemeinschaft (DFG) [GRK-840, B1, C1]; Fonds der Chemischen Industrie; Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany	Grant support: Deutsche Forschungsgemeinschaft (DFG, GRK-840, projects B1, C1); Fonds der Chemischen Industrie (C.S.); Alfried Krupp von Bohlen and Halbach Stiftung, Essen, Germany (C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau F, 2007, J PHYSIOL-LONDON, V580, P347, DOI 10.1113/jphysiol.2006.120907; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Calcagni E, 2006, ANN NY ACAD SCI, V1069, P62, DOI 10.1196/annals.1351.006; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Dai XC, 2010, J HISTOCHEM CYTOCHEM, V58, P17, DOI 10.1369/jhc.2009.953604; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demaude J, 2006, GUT, V55, P655, DOI 10.1136/gut.2005.078675; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; KIANK C, 2009, BRAIN BEHAV IMMUN, V23, pS42; Kiank C, 2008, BRAIN BEHAV IMMUN, V22, P1173, DOI 10.1016/j.bbi.2008.05.003; Kiank C, 2007, SHOCK, V27, P305, DOI 10.1097/01.shk.0000239754.82711.c0; Kim WS, 2010, KOREAN J ANESTHESIOL, V58, P328, DOI 10.4097/kjae.2010.58.4.328; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Kuc D, 2008, AMINO ACIDS, V35, P503, DOI 10.1007/s00726-007-0631-z; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Logters TT, 2009, SHOCK, V32, P29, DOI 10.1097/SHK.0b013e31819714fa; MacKenzie CR, 2003, ADV EXP MED BIOL, V527, P67; Mazzon E, 2002, GUT, V51, P507, DOI 10.1136/gut.51.4.507; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Muller A, 2009, J CELL MOL MED, V13, P1125, DOI 10.1111/j.1582-4934.2008.00542.x; Muller Norbert, 2006, Expert Rev Neurother, V6, P1017, DOI 10.1586/14737175.6.7.1017; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; OLESEN J, 2006, J NEUROL NEUROSUR S1, V77, P1; Paluszkiewicz P, 2009, AMINO ACIDS, V37, P637, DOI 10.1007/s00726-008-0183-x; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Robinson OJ, 2009, PSYCHOPHARMACOLOGY, V205, P227, DOI 10.1007/s00213-009-1533-4; Russo S, 2009, WORLD J BIOL PSYCHIA, V10, P258, DOI [10.1080/15622970701513764, 10.3109/15622970701513764]; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Schmidt MV, 2008, ANN NY ACAD SCI, V1148, P174, DOI 10.1196/annals.1410.017; Tattevin P, 2010, J INFECT DIS, V201, P956, DOI 10.1086/650996; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Valenzuela-Millan J, 2010, CIR CIR, V78, P147; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YX, 2010, BRAIN BEHAV IMMUN, V24, P201, DOI 10.1016/j.bbi.2009.06.152; Weighardt H, 2002, ANN SURG, V235, P560, DOI 10.1097/00000658-200204000-00015; World Health Organization, 2010, MENT HLTH DEPR	54	73	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11825	10.1371/journal.pone.0011825	http://dx.doi.org/10.1371/journal.pone.0011825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20689575	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520100009
J	Zhang, LL; Blackman, BE; Schonemann, MD; Zogovic-Kapsalis, T; Pan, XY; Tagliaferri, M; Harris, HA; Cohen, I; Pera, RAR; Mellon, SH; Weiner, RI; Leitman, DC				Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Pan, Xiaoyu; Tagliaferri, Mary; Harris, Heather A.; Cohen, Isaac; Pera, Renee A. Reijo; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.			Estrogen Receptor beta-Selective Agonists Stimulate Calcium Oscillations in Human and Mouse Embryonic Stem Cell-Derived Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; BREAST-CANCER; HYPOTHALAMIC NEURONS; HORMONE NEURONS; ER-ALPHA; HIPPOCAMPAL-NEURONS; COUPLED RECEPTOR; BASAL FOREBRAIN	Estrogens are used extensively to treat hot flashes in menopausal women. Some of the beneficial effects of estrogens in hormone therapy on the brain might be due to nongenomic effects in neurons such as the rapid stimulation of calcium oscillations. Most studies have examined the nongenomic effects of estrogen receptors (ER) in primary neurons or brain slices from the rodent brain. However, these cells can not be maintained continuously in culture because neurons are post-mitotic. Neurons derived from embryonic stem cells could be a potential continuous, cell-based model to study nongenomic actions of estrogens in neurons if they are responsive to estrogens after differentiation. In this study ER-subtype specific estrogens were used to examine the role of ER alpha and ER beta on calcium oscillations in neurons derived from human (hES) and mouse embryonic stem cells. Unlike the undifferentiated hES cells the differentiated cells expressed neuronal markers, ER beta, but not ER alpha. The non-selective ER agonist 17 beta-estradiol (E(2)) rapidly increased [Ca(2+)]i oscillations and synchronizations within a few minutes. No change in calcium oscillations was observed with the selective ER alpha agonist 4,4',4 ''-(4-Propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT). In contrast, the selective ER beta agonists, 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN), MF101, and 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3 benzoxazol-5-ol (ERB-041; WAY-202041) stimulated calcium oscillations similar to E2. The ER beta agonists also increased calcium oscillations and phosphorylated PKC, AKT and ERK1/2 in neurons derived from mouse ES cells, which was inhibited by nifedipine demonstrating that ER beta activates L-type voltage gated calcium channels to regulate neuronal activity. Our results demonstrate that ER beta signaling regulates nongenomic pathways in neurons derived from ES cells, and suggest that these cells might be useful to study the nongenomic mechanisms of estrogenic compounds.	[Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Zhang, Lili; Blackman, Brigitte E.; Schonemann, Marcus D.; Zogovic-Kapsalis, Tatjana; Mellon, Synthia H.; Weiner, Richard I.; Leitman, Dale C.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Pan, Xiaoyu] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA USA; [Harris, Heather A.] Wyeth Ayerst Res, Womens Hlth & Musculoskeletal Biol, Collegeville, PA USA; [Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Ctr Human Embryon Stem Cell Res & Educ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Pfizer; Stanford University; University of California System; University of California Berkeley	Zhang, LL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	dale@leitmanlab.com		Reijo Pera, Renee/0000-0002-6487-1329	National Center for Complementary and Alternative Medicine [AT002173]; Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002173] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant from the National Center for Complementary and Alternative Medicine (AT002173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D. C. L. has received financial support for research from Bionovo, Inc. D. C. L. conceived and designed the experiments, analyzed the data and wrote the paper.	Abe H, 2008, ENDOCRINOLOGY, V149, P1155, DOI 10.1210/en.2007-0942; Abraham IM, 2003, J NEUROSCI, V23, P5771; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Barragan M, 2002, BLOOD, V99, P2969, DOI 10.1182/blood.V99.8.2969; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Beyer C, 1999, ANAT EMBRYOL, V199, P379, DOI 10.1007/s004290050236; Beyer C, 1998, EUR J NEUROSCI, V10, P255, DOI 10.1046/j.1460-9568.1998.00045.x; Blurton-Jones M, 2002, J COMP NEUROL, V452, P276, DOI 10.1002/cne.10393; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CHEN Q, ENDOCRINOLOGY, V151, P281; Chu ZG, 2009, J NEUROSCI, V29, P5616, DOI 10.1523/JNEUROSCI.0352-09.2009; Constantin S, 2009, ENDOCRINOLOGY, V150, P1400, DOI 10.1210/en.2008-0979; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Fried G, 2004, EUR J NEUROSCI, V20, P2345, DOI 10.1111/j.1460-9568.2004.03693.x; FUESHKO S, 1994, DEV BIOL, V166, P331, DOI 10.1006/dbio.1994.1319; GITZEN JF, 1987, PSYCHONEUROENDOCRINO, V12, P3; Gorosito SV, 2008, J NEUROSCI RES, V86, P145, DOI 10.1002/jnr.21466; GRADY D, 2009, MENOPAUSE; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; JORDAN VC, 1975, EUR J CANCER, V11, P205, DOI 10.1016/0014-2964(75)90119-X; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; KELLY MJ, 1977, EXP BRAIN RES, V30, P43; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUMOTO A, 1981, J COMP NEUROL, V197, P197, DOI 10.1002/cne.901970203; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MERRIAM GR, 1982, AM J PHYSIOL, V243, pE310, DOI 10.1152/ajpendo.1982.243.4.E310; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Moore JP, 2002, J NEUROSCI, V22, P8932; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Navarro CE, 2003, MOL ENDOCRINOL, V17, P1792, DOI 10.1210/me.2003-0040; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; O'Neill EE, 2008, BRAIN RES, V1222, P1, DOI 10.1016/j.brainres.2008.05.036; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Opas EE, 2006, MATURITAS, V53, P210, DOI 10.1016/j.maturitas.2005.04.006; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Powell CE, 2001, J STEROID BIOCHEM, V77, P97, DOI 10.1016/S0960-0760(01)00040-1; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2008, STEROIDS, V73, P985, DOI 10.1016/j.steroids.2007.11.008; Qiu J, 2006, J NEUROSCI, V26, P5649, DOI 10.1523/JNEUROSCI.0327-06.2006; Rao SP, 2007, GLIA, V55, P1680, DOI 10.1002/glia.20564; Rao SP, 2006, GLIA, V53, P817, DOI 10.1002/glia.20341; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roy D, 1999, ENDOCRINOLOGY, V140, P5045, DOI 10.1210/en.140.11.5045; Sakamoto H, 2007, ENDOCRINOLOGY, V148, P5842, DOI 10.1210/en.2007-0436; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Sheldahl LC, 2008, NEUROSCIENCE, V153, P751, DOI 10.1016/j.neuroscience.2008.02.035; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Szego EM, 2006, J NEUROSCI, V26, P4104, DOI 10.1523/JNEUROSCI.0222-06.2006; Temple JL, 2005, ENDOCRINOLOGY, V146, P558, DOI 10.1210/en.2004-1117; TERASAWA E, 1993, ENDOCRINOLOGY, V133, P2379, DOI 10.1210/en.133.5.2379; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vida B, 2008, J NEUROENDOCRINOL, V20, P1270, DOI 10.1111/j.1365-2826.2008.01787.x; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yoshida H, 2004, NEUROENDOCRINOLOGY, V80, P2, DOI 10.1159/000080519; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2009, ENDOCRINOLOGY, V150, P770, DOI 10.1210/en.2008-0715	89	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11791	10.1371/journal.pone.0011791	http://dx.doi.org/10.1371/journal.pone.0011791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668547	gold, Green Submitted, Green Published			2022-12-27	WOS:000280371800005
J	Castle, JC; Armour, CD; Lower, M; Haynor, D; Biery, M; Bouzek, H; Chen, RH; Jackson, S; Johnson, JM; Rohl, CA; Raymond, CK				Castle, John C.; Armour, Christopher D.; Loewer, Martin; Haynor, David; Biery, Matthew; Bouzek, Heather; Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.; Raymond, Christopher K.			Digital Genome-Wide ncRNA Expression, Including SnoRNAs, across 11 Human Tissues Using PolyA-Neutral Amplification	PLOS ONE			English	Article							NONCODING RNA; TELOMERE MAINTENANCE; PRADER-WILLI; GENE; IDENTIFICATION; TRANSCRIPTS	Non-coding RNAs (ncRNAs) are an essential class of molecular species that have been difficult to monitor on high throughput platforms due to frequent lack of polyadenylation. Using a polyadenylation-neutral amplification protocol and next-generation sequencing, we explore ncRNA expression in eleven human tissues. ncRNAs 7SL, U2, 7SK, and HBII-52 are expressed at levels far exceeding mRNAs. C/D and H/ACA box snoRNAs are associated with rRNA methylation and pseudouridylation, respectively: spleen expresses both, hypothalamus expresses mainly C/D box snoRNAs, and testes show enriched expression of both H/ACA box snoRNAs and RNA telomerase TERC. Within the snoRNA 14q cluster, 14q(I-6) is expressed at much higher levels than other cluster members. More reads align to mitochondrial than nuclear tRNAs. Many lincRNAs are actively transcribed, particularly those overlapping known ncRNAs. Within the Prader-Willi syndrome loci, the snoRNA HBII-85 (group I) cluster is highly expressed in hypothalamus, greater than in other tissues and greater than group II or III. Additionally, within the disease locus we find novel transcription across a 400,000 nt span in ovaries. This genome-wide polyA-neutral expression compendium demonstrates the richness of ncRNA expression, their high expression patterns, their function-specific expression patterns, and is publicly available.	[Castle, John C.; Loewer, Martin] Inst Translat Oncol & Immunol, Mainz, Germany; [Armour, Christopher D.; Biery, Matthew; Raymond, Christopher K.] Nugen Inc, Seattle, WA USA; [Haynor, David; Bouzek, Heather] Univ Washington, Seattle, WA 98195 USA; [Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.] Merck Res Labs, Boston, MA USA; [Castle, John C.; Armour, Christopher D.; Haynor, David; Biery, Matthew; Bouzek, Heather; Chen, Ronghua; Jackson, Stuart; Johnson, Jason M.; Rohl, Carol A.; Raymond, Christopher K.] Rosetta Inpharmat, Seattle, WA USA	University of Washington; University of Washington Seattle; Merck & Company; Merck & Company	Castle, JC (corresponding author), Inst Translat Oncol & Immunol, Mainz, Germany.	castle@uni-mainz.de; carmour@nugeninc.com	Rohl, Carol/I-2589-2012	Rohl, Carol/0000-0002-9229-3917; Biery, Matthew/0000-0003-3315-982X	Rosetta Inpharmatics LLC; Merck Co., Inc.	Rosetta Inpharmatics LLC; Merck Co., Inc.(Merck & Company)	Most authors previously worked for Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc. Rosetta/Merck paid employee salaries and funded the original research. Merck employees have reviewed the manuscript and approved the data release. Further analysis was done by JCC at TRON, a not-for-profit institute.	AGARWAL S, 2010, NATURE; Armour CD, 2009, NAT METHODS, V6, P647, DOI [10.1038/NMETH.1360, 10.1038/nmeth.1360]; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; CASTLE JC, 2010, BMC GENOMIC IN PRESS; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Charette M, 2000, IUBMB LIFE, V49, P341; Christov CP, 2008, BRIT J CANCER, V98, P981, DOI 10.1038/sj.bjc.6604254; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LEIBOVITCH MP, 1991, BIOCHEM BIOPH RES CO, V180, P1241, DOI 10.1016/S0006-291X(05)81329-4; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; LI H, 2009, BWA BURROWS WHEELER; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206	35	87	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11779	10.1371/journal.pone.0011779	http://dx.doi.org/10.1371/journal.pone.0011779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668672	Green Submitted, Green Published, gold			2022-12-27	WOS:000280297300014
J	Hu, C; Zhang, R; Wang, CR; Yu, WH; Lu, JY; Ma, XJ; Wang, J; Jiang, F; Tang, SS; Bao, YQ; Xiang, KS; Jia, WP				Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Wang, Jie; Jiang, Feng; Tang, Shanshan; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping			Effects of GCK, GCKR, G6PC2 and MTNR1B Variants on Glucose Metabolism and Insulin Secretion	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; PANCREATIC BETA-CELL; TYPE-2 DIABETES RISK; CHINESE POPULATION; COMMON VARIANT; HOMEOSTASIS; MELATONIN; ASSOCIATION; DEFINITION; RESISTANCE	Background: Single nucleotide polymorphisms (SNPs) from GCK, GCKR, G6PC2 and MTNR1B were found to modulate the fasting glucose levels. The current study aimed to replicate this association in the Chinese population and further analyze their effects on biphasic insulin secretion. Methods/Principal Findings: SNPs from GCK, GCKR, G6PC2 and MTNR1B were genotyped in the Shanghai Chinese, including 3,410 type 2 diabetes patients and 3,412 controls. The controls were extensively phenotyped for the traits related to glucose metabolism and insulin secretion. We replicated the association between GCK rs1799884, G6PC2 rs16856187 and MTNR1B rs10830963 and fasting glucose in our samples (p = 0.0003 similar to 2.06x10(-8)). GCK rs1799884 and G6PC2 rs16856187 showed association to HOMA-beta, insulinogenic index and both first-and second-phases insulin secretion (p = 0.0030 similar to 0.0396). MTNR1B rs10830963 was associated to HOMA-beta, insulinogenic index and first-phase insulin secretion (p = 0.0102 similar to 0.0426), but not second-phase insulin secretion (p = 0.9933). Combined effect analyses showed individuals carrying more risk allele for high fasting glucose tended to have a higher glucose levels at both fasting and 2 h during OGTTs (p = 1.76x10(-13) and 0.0009, respectively), as well as lower HOMA-beta, insulinogenic index and both first-and second-phases insulin secretion (p = 0.0321 similar to 1.1x10(-7)). Conclusions/Significance: We showed that SNPs from GCK, G6PC2 and MTNR1B modulated the fasting glucose levels in the normoglycaemic population while SNPs from G6PC2 and GCKR was associated with type 2 diabetes. Moreover, we found GCK and G6PC2 genetic variants were associated to both first-and second-phases insulin secretion while MTNR1B genetic variant was associated with first-phase insulin secretion, but not second-phase insulin secretion.	[Hu, Cheng; Wang, Jie; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Jiang, Feng; Tang, Shanshan; Xiang, Kunsan; Jia, Weiping] Shanghai Diabet Inst, Shanghai, Peoples R China; [Hu, Cheng; Zhang, Rong; Wang, Congrong; Yu, Weihui; Lu, Jingyi; Ma, Xiaojing; Wang, Jie; Jiang, Feng; Tang, Shanshan; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China	Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	王, 从容/HDM-0959-2022; Jia, Weiping/B-7483-2012; Hu, Cheng/C-3346-2008	王, 从容/0000-0002-8645-1114; Hu, Cheng/0000-0003-4314-2386	Shanghai Municipal Education Commission and Shanghai Education Development Foundation [09CG07]; National Natural Science Foundation of China [30630061, 30800617]; National 973 Program [2006CB503901]; National 863 Program [2006AA02A409]; Shanghai Rising-Star Program [09QA1404400]; Shanghai Municipality for Basic Research [08dj1400601]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Shanghai Municipal Hospitals [SHDC12007316]	Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); National 863 Program(National High Technology Research and Development Program of China); Shanghai Rising-Star Program; Shanghai Municipality for Basic Research; Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Municipal Hospitals	This work was supported by the "Chen Guang'' project (09CG07) from Shanghai Municipal Education Commission and Shanghai Education Development Foundation, National Natural Science Foundation of China (30630061 and 30800617), National 973 Program (2006CB503901), National 863 Program (2006AA02A409), Shanghai Rising-Star Program (09QA1404400), major program of Shanghai Municipality for Basic Research (08dj1400601), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200) and Shanghai Municipal Hospitals' Project of Chronic Disease Prevention and Treatment (SHDC12007316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Peschke E, 2006, J PINEAL RES, V40, P184, DOI 10.1111/j.1600-079X.2005.00297.x; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zhang SC, 2009, OBESITY, V17, P1581, DOI 10.1038/oby.2009.125	29	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11761	10.1371/journal.pone.0011761	http://dx.doi.org/10.1371/journal.pone.0011761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668700	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243800029
J	Su, TT				Su, Tin Tin			The Effect of a DNA Damaging Agent on Embryonic Cell Cycles of the Cnidarian Hydractinia echinata	PLOS ONE			English	Article							SEA-URCHIN EMBRYOS; MIDBLASTULA TRANSITION; CHECKPOINT; CAFFEINE; REPLICATION; INHIBITION; APOPTOSIS; XENOPUS; REPAIR; ATM	The onset of gastrulation at the Mid-Blastula Transition can accompany profound changes in embryonic cell cycles including the introduction of gap phases and the transition from maternal to zygotic control. Studies in Xenopus and Drosophila embryos have also found that cell cycles respond to DNA damage differently before and after MBT (or its equivalent, MZT, in Drosophila). DNA checkpoints are absent in Xenopus cleavage cycles but are acquired during MBT. Drosophila cleavage nuclei enter an abortive mitosis in the presence of DNA damage whereas post-MZT cells delay the entry into mitosis. Despite attributes that render them workhorses of embryonic cell cycle studies, Xenopus and Drosophila are hardly representative of diverse animal forms that exist. To investigate developmental changes in DNA damage responses in a distant phylum, I studied the effect of an alkylating agent, Methyl Methanesulfonate (MMS), on embryos of Hydractinia echinata. Hydractinia embryos are found to differ from Xenopus embryos in the ability to respond to a DNA damaging agent in early cleavage but are similar to Xenopus and Drosophila embryos in acquiring stronger DNA damage responses and greater resistance to killing by MMS after the onset of gastrulation. This represents the first study of DNA damage responses in the phylum Cnidaria.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Su, TT (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	tin.su@colorado.edu			Laura and Arthur Colwin Endowed Summer Research Fellowship; Woods Hole Marine Biology Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087276] Funding Source: NIH RePORTER	Laura and Arthur Colwin Endowed Summer Research Fellowship; Woods Hole Marine Biology Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a Laura and Arthur Colwin Endowed Summer Research Fellowship, Woods Hole Marine Biology Lab, to T. T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Byrum C.A., 2004, P33; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Duncan T, 2004, CURR BIOL, V14, pR305, DOI 10.1016/j.cub.2004.03.050; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Epel D, 2003, EVOL DEV, V5, P83, DOI 10.1046/j.1525-142X.2003.03013.x; Frank U, 2001, BIOESSAYS, V23, P963, DOI 10.1002/bies.1137; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Halanych KM, 2001, AM ZOOL, V41, P629, DOI 10.1668/0003-1569(2001)041[0629:ABROMP]2.0.CO;2; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Le Bouffant R, 2007, CELL MOL LIFE SCI, V64, P1723, DOI 10.1007/s00018-007-7173-0; Le Bouffant R, 2008, EXP CELL RES, V314, P961, DOI 10.1016/j.yexcr.2007.12.014; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Patel R, 1997, ZYGOTE, V5, P127, DOI 10.1017/S0967199400003804; Peng AM, 2008, CELL CYCLE, V7, P3, DOI 10.4161/cc.7.1.5157; PLICKERT G, 1988, DEVELOPMENT, V103, P795; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Su TT, 2000, CURR BIOL, V10, P119, DOI 10.1016/S0960-9822(00)00300-6; Su TT, 2001, CURR BIOL, V11, P8, DOI 10.1016/S0960-9822(00)00042-7; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11760	10.1371/journal.pone.0011760	http://dx.doi.org/10.1371/journal.pone.0011760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668699	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800028
J	Sazawal, S; Dhingra, U; Hiremath, G; Sarkar, A; Dhingra, P; Dutta, A; Verma, P; Menon, VP; Black, RE				Sazawal, Sunil; Dhingra, Usha; Hiremath, Girish; Sarkar, Archana; Dhingra, Pratibha; Dutta, Arup; Verma, Priti; Menon, Venugopal P.; Black, Robert E.			Prebiotic and Probiotic Fortified Milk in Prevention of Morbidities among Children: Community-Based, Randomized, Double-Blind, Controlled Trial	PLOS ONE			English	Article							BIFIDOBACTERIUM-LACTIS HN019; LONG-TERM CONSUMPTION; ANTIBIOTIC-ASSOCIATED DIARRHEA; PERSISTENT DIARRHEA; DIETARY CONSUMPTION; LACTOBACILLUS GG; INFANT FORMULA; YOUNG-CHILDREN; CARE-CENTERS; METAANALYSIS	Background: Recent reviews suggest common infectious diseases continue to be a major cause of death among preschool children in developing countries. Identification of feasible strategies to combat this disease burden is an important public health need. We evaluated the efficacy of adding prebiotic oligosaccharide and probiotic Bifidobacterium lactis HN019 to milk, in preventing diarrhea, respiratory infections and severe illnesses, in children aged 1-4 years as part of a four group study design, running two studies simultaneously. Methods and Findings: In a community based double-masked, randomized controlled trial, children 1-3 years of age, willing to participate, were randomly allocated to receive either control milk (Co; n = 312) or the same milk fortified with 2.4 g/day of prebiotic oligosaccharide and 1.9x10(7) colony forming unit (c.f.u)/day of probiotic Bifidobacterium lactis HN019 (PP; n = 312). Children were followed up for 1 year providing data for 1-4 years. Biweekly household surveillance was conducted to gather information on compliance and morbidity. Both study groups were comparable at baseline; compliance to intervention was similar. Overall, there was no effect of prebiotic and probiotic on diarrhea (6% reduction, 95% Confidence Interval [CI]: 21 to 12%; p = 0.08). Incidence of dysentery episodes was reduced by 21% (95% CI: 0 to 38%; p = 0.05). Incidence of pneumonia was reduced by 24% (95% CI: 0 to 42%; p = 0.05) and severe acute lower respiratory infection (ALRI) by 35% (95% CI: 0 to 58%; p = 0.05). Compared to children in Co group, children in PP group had 16% (95% CI: 5 to 26%, p = 0.004) and 5% (95% CI: 0 to 10%; p = 0.05) reduction in days with severe illness and high fever respectively. Conclusions/Significance: Milk can be a good medium for delivery of prebiotic and probiotic and resulted in significant reduction of dysentery, respiratory morbidity and febrile illness. Overall, impact of diarrhea was not significant. These findings need confirmation in other settings.	[Sazawal, Sunil; Dhingra, Usha; Hiremath, Girish; Dutta, Arup; Black, Robert E.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Sazawal, Sunil; Sarkar, Archana; Dhingra, Pratibha; Verma, Priti; Menon, Venugopal P.] Annamalai Univ, Dept Biochem, Ctr Micronutrient Res, Chidambaram, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Annamalai University	Sazawal, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	rblack@jhsph.edu		Menon, Venugopal Padmanabhan/0000-0002-1283-3822; Black, Robert/0000-0001-9926-7984	Fonterra Brands (Singapore) Pte Ltd.	Fonterra Brands (Singapore) Pte Ltd.(Fonterra)	Fonterra Brands (Singapore) Pte Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunachalam K, 2000, EUR J CLIN NUTR, V54, P263, DOI 10.1038/sj.ejcn.1600938; AXELSON LT, 1989, MICROB ECOL HEALTH D, V8, P131; Basu S, 2007, J CLIN GASTROENTEROL, V41, P756, DOI 10.1097/01.mcg.0000248009.47526.ea; BHAN MK, 1989, B WORLD HEALTH ORGAN, V67, P281; Binns CW, 2007, ACTA PAEDIATR, V96, P1646, DOI 10.1111/j.1651-2227.2007.00508.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Chiang BL, 2000, EUR J CLIN NUTR, V54, P849, DOI 10.1038/sj.ejcn.1601093; Chouraqui JP, 2004, J PEDIATR GASTR NUTR, V38, P288, DOI 10.1097/00005176-200403000-00011; Coconnier MH, 1997, ANTIMICROB AGENTS CH, V41, P1046, DOI 10.1128/AAC.41.5.1046; Contreras G, 1983, COMPEND INVEST CLIN, V3, P114; Gill HS, 2000, BRIT J NUTR, V83, P167, DOI 10.1017/S0007114500000210; Gill HS, 2001, AM J CLIN NUTR, V74, P833; Guandalini S, 2008, J CLIN GASTROENTEROL, V42, pS53, DOI 10.1097/MCG.0b013e3181674087; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mastretta E, 2002, J PEDIATR GASTR NUTR, V35, P527, DOI 10.1097/00005176-200210000-00013; McNabb B, 2008, CURR OPIN PULM MED, V14, P168, DOI 10.1097/MCP.0b013e3282f76443; Oberhelman RA, 1999, J PEDIATR-US, V134, P15, DOI 10.1016/S0022-3476(99)70366-5; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Roberfroid MB, 2001, AM J CLIN NUTR, V73, p406S, DOI 10.1093/ajcn/73.2.406s; Rohde CL, 2009, NUTR CLIN PRACT, V24, P33, DOI 10.1177/0884533608329297; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Saavedra JM, 2004, AM J CLIN NUTR, V79, P261; Sanz JMC, 2006, NUTR HOSP, V21, P547; Sazawal S, 1998, PEDIATRICS, V102, P1, DOI 10.1542/peds.102.1.1; Sazawal S, 2007, BMJ-BRIT MED J, V334, P140, DOI 10.1136/bmj.39035.482396.55; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Sazawal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012167; Shu Q, 2001, MED MICROBIOL IMMUN, V189, P147, DOI 10.1007/s430-001-8021-9; Shu Q, 2001, J PEDIATR GASTR NUTR, V33, P171, DOI 10.1097/00005176-200108000-00014; SILVA M, 1987, ANTIMICROB AGENTS CH, V31, P1231, DOI 10.1128/AAC.31.8.1231; Szajewska H, 2007, ALIMENT PHARM THER, V25, P257, DOI 10.1111/j.1365-2036.2006.03202.x; Szajewska H, 2001, J PEDIATR GASTR NUTR, V33, pS17, DOI 10.1097/00005176-200110002-00004; Szajewska H, 2006, J PEDIATR-US, V149, P367, DOI 10.1016/j.jpeds.2006.04.053; Szajewska Hania, 2005, Paediatr Drugs, V7, P111, DOI 10.2165/00148581-200507020-00004; Thibault H, 2004, J PEDIATR GASTR NUTR, V39, P147, DOI 10.1097/00005176-200408000-00004; United Nations General Assembly 56th session, 2001, UN GEN ASS 56 SESS; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Weizman Z, 2005, PEDIATRICS, V115, P5, DOI 10.1542/peds.2004-1815; World Health Organization, 2006, WHO CHILD GROWTH STA, P312	46	77	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12164	10.1371/journal.pone.0012164	http://dx.doi.org/10.1371/journal.pone.0012164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730056	Green Published, gold			2022-12-27	WOS:000280862200019
J	Gatenby, RA; Frieden, BR				Gatenby, Robert A.; Frieden, B. Roy			Coulomb Interactions between Cytoplasmic Electric Fields and Phosphorylated Messenger Proteins Optimize Information Flow in Cells	PLOS ONE			English	Article							DYNAMICS; MEMBRANE	Background: Normal membrane (CM) to the nucleus. Movement of messenger proteins in the cytoplasm is thought to be dependent on random walk. However, Brownian motion will disperse messenger proteins throughout the cytosol resulting in slow and highly variable transit times. We propose that a critical component of information transfer is an intracellular electric field generated by distribution of charge on the nuclear membrane (NM). While the latter has been demonstrated experimentally for decades, the role of the consequent electric field has been assumed to be minimal due to a Debye length of about 1 nanometer that results from screening by intracellular Cl- and K+. We propose inclusion of these inorganic ions in the Debye-Huckel equation is incorrect because nuclear pores allow transit through the membrane at a rate far faster than the time to thermodynamic equilibrium. In our model, only the charged, mobile messenger proteins contribute to the Debye length. Findings: Using this revised model and published data, we estimate the NM possesses a Debye-Huckel length of a few microns and find this is consistent with recent measurement using intracellular nano-voltmeters. We demonstrate the field will accelerate isolated messenger proteins toward the nucleus through Coulomb interactions with negative charges added by phosphorylation. We calculate transit times as short as 0.01 sec. When large numbers of phosphorylated messenger proteins are generated by increasing concentrations of extracellular ligands, we demonstrate they generate a self-screening environment that regionally attenuates the cytoplasmic field, slowing movement but permitting greater cross talk among pathways. Preliminary experimental results with phosphorylated RAF are consistent with model predictions. Conclusion: This work demonstrates that previously unrecognized Coulomb interactions between phosphorylated messenger proteins and intracellular electric fields will optimize information transfer from the CM to the NM in cells.	[Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA; [Gatenby, Robert A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Integrated Math Oncol, Tampa, FL 33682 USA; [Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Arizona	Gatenby, RA (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA.	robert.gatenby@moffitt.org			National Cancer Institute (NCI) [1U54CA143970-01]; NATIONAL CANCER INSTITUTE [U54CA143970] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Cancer Institute (NCI) under grant 1U54CA143970-01. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Born M, 2005, PRINCIPLES OPTICS, V7th edn; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Bray D, 2008, CELL MOVEMENTS MOL M; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Castilho L., 2008, ANIMAL CELL TECHNOLO, VVolume 39; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; DUNCAN R, 1982, CLIN CHEM, V28, P749; FRIEDEN BR, 2001, PROBABILITY STAT OPT; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gatenby RA, 2004, MUTAT RES-FUND MOL M, V568, P259, DOI 10.1016/j.mrfmmm.2004.04.018; Gatenby RA, 2002, CANCER RES, V62, P3675; GATENBY RA, 2007, EXPLORATORY DATA ANA, P74; Gatenby RA, 2007, B MATH BIOL, V69, P635, DOI 10.1007/s11538-006-9141-5; JOHNSON HA, 1970, SCIENCE, V168, P1545, DOI 10.1126/science.168.3939.1545; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Krammer BE, 1996, BIOELECTROCH BIOENER, V40, P67, DOI 10.1016/0302-4598(95)01895-6; LOEWENSTEIN WR, 1963, J GEN PHYSIOL, V46, P1123, DOI 10.1085/jgp.46.6.1123; LOEWENSTEIN WR, 1962, NATURE, V195, P462, DOI 10.1038/195462a0; LUO L, 2006, DIAGNOSTIC PATHOLOGY, V1, P1; Narzi D, 2008, J MOL BIOL, V382, P978, DOI 10.1016/j.jmb.2008.07.061; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12084	10.1371/journal.pone.0012084	http://dx.doi.org/10.1371/journal.pone.0012084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711447	Green Submitted, gold, Green Published			2022-12-27	WOS:000280849100021
J	Canderan, G; Gruarin, P; Montagna, D; Fontana, R; Melloni, G; Traversari, C; Dellabona, P; Casorati, G				Canderan, Glenda; Gruarin, Paola; Montagna, Daniela; Fontana, Raffaella; Melloni, Giulio; Traversari, Catia; Dellabona, Paolo; Casorati, Giulia			An Efficient Strategy to Induce and Maintain In Vitro Human T Cells Specific for Autologous Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							TCR GENE-TRANSFER/; HUMAN MELANOMAS; TUMOR-ANTIGEN; LYMPHOCYTES-T; CANCER; IMMUNOTHERAPY; REPERTOIRE; EXPRESSION; VECTOR; MAINTENANCE	Background: The efficient expansion in vitro of cytolytic CD8(+) T cells (CTLs) specific for autologous tumors is crucial both for basic and translational aspects of tumor immunology. We investigated strategies to generate CTLs specific for autologous Non-Small Cell Lung Carcinoma (NSCLC), the most frequent tumor in mankind, using circulating lymphocytes. Principal Findings: Classic Mixed Lymphocyte Tumor Cultures with NSCLC cells consistently failed to induce tumor-specific CTLs. Cross-presentation in vitro of irradiated NSCLC cells by autologous dendritic cells, by contrast, induced specific CTL lines from which we obtained a high number of tumor-specific T cell clones (TCCs). The TCCs displayed a limited TCR diversity, suggesting an origin from few tumor-specific T cell precursors, while their TCR molecular fingerprints were detected in the patient's tumor infiltrating lymphocytes, implying a role in the spontaneous anti-tumor response. Grafting NSCLC-specific TCR into primary allogeneic T cells by lentiviral vectors expressing human V-mouse C chimeric TCR alpha/beta chains overcame the growth limits of these TCCs. The resulting, rapidly expanding CD4(+) and CD8(+) T cell lines stably expressed the grafted chimeric TCR and specifically recognized the original NSCLC. Conclusions: This study defines a strategy to efficiently induce and propagate in vitro T cells specific for NSCLC starting from autologous peripheral blood lymphocytes.	[Canderan, Glenda; Gruarin, Paola; Dellabona, Paolo; Casorati, Giulia] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Montagna, Daniela] Univ Pavia, Dept Pediat, Immunol Lab, I-27100 Pavia, Italy; [Fontana, Raffaella] Ist Sci San Raffaele, Div Mol Oncol, Canc Gene Therapy Unit, I-20132 Milan, Italy; [Melloni, Giulio] Ist Sci San Raffaele, Dept Thorac Surg, I-20132 Milan, Italy; [Traversari, Catia] MolMed SPA, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Canderan, G (corresponding author), VGTI FL, Port St Lucie, FL USA.	dellabona.paolo@hsr.it; casorati.giulia@hsr.it	Dellabona, Paolo/G-5416-2012; Canderan, Glenda/V-3421-2019; Montagna, Daniela/AAK-9380-2020; Casorati, Giulia/J-7141-2018	Dellabona, Paolo/0000-0002-1414-633X; MONTAGNA, DANIELA/0000-0002-1533-579X; Casorati, Giulia/0000-0002-5102-4112	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of Health; Fondazione Cariplo	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Fondazione Cariplo, and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further, MolMed S.P.A. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2008, J IMMUNOTHER, V31, P1, DOI 10.1097/CJI.0b013e31815c193f; ANICHINI A, 1986, J EXP MED, V163, P215, DOI 10.1084/jem.163.1.215; Berard F, 2000, J EXP MED, V192, P1535, DOI 10.1084/jem.192.11.1535; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dorrschuck A, 2004, BLOOD, V104, P2591, DOI 10.1182/blood-2004-02-0459; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Flamand L, 1998, P NATL ACAD SCI USA, V95, P3111, DOI 10.1073/pnas.95.6.3111; FOSSATI G, 1984, INT J CANCER, V33, P591, DOI 10.1002/ijc.2910330508; GENEVEE C, 1992, EUR J IMMUNOL, V22, P1261, DOI 10.1002/eji.1830220522; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; Hart DP, 2008, GENE THER, V15, P625, DOI 10.1038/sj.gt.3303078; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoffmann TK, 2000, CANCER RES, V60, P3542; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957; KNUTH A, 1984, P NATL ACAD SCI-BIOL, V81, P3511, DOI 10.1073/pnas.81.11.3511; Levitsky V, 1998, J IMMUNOL, V161, P594; Mami-Chouaib F, 2002, IMMUNOL REV, V188, P114, DOI 10.1034/j.1600-065X.2002.18810.x; MAVILIO F, 1994, BLOOD, V83, P1988; Montagna D, 2001, BLOOD, V98, P3359, DOI 10.1182/blood.V98.12.3359; Montagna D, 2006, BLOOD, V108, P3843, DOI 10.1182/blood-2006-05-021535; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; MUKHERJI B, 1983, J EXP MED, V158, P240, DOI 10.1084/jem.158.1.240; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Stauss HJ, 2007, MOL THER, V15, P1744, DOI 10.1038/sj.mt.6300216; Tabi Z, 2001, J IMMUNOL, V166, P5695, DOI 10.4049/jimmunol.166.9.5695; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANKY F, 1982, J EXP MED, V155, P83, DOI 10.1084/jem.155.1.83; Vavassori M, 1996, J IMMUNOL, V157, P5739; VOSE BM, 1983, CANCER IMMUNOL IMMUN, P227; Wack A, 1996, J IMMUNOL METHODS, V196, P181, DOI 10.1016/0022-1759(96)00114-7; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12014	10.1371/journal.pone.0012014	http://dx.doi.org/10.1371/journal.pone.0012014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711505	Green Published, gold			2022-12-27	WOS:000280776800010
J	Brown, K; Legros, S; Artus, J; Doss, MX; Khanin, R; Hadjantonakis, AK; Foley, A				Brown, Kemar; Legros, Stephanie; Artus, Jerome; Doss, Michael Xavier; Khanin, Raya; Hadjantonakis, Anna-Katerina; Foley, Ann			A Comparative Analysis of Extra-Embryonic Endoderm Cell Lines	PLOS ONE			English	Article							ANTERIOR NEURAL PLATE; EMBRYONIC STEM-CELLS; VISCERAL-ENDODERM; PRIMITIVE STREAK; MOUSE EMBRYO; PARIETAL ENDODERM; HEART INDUCTION; GENE-EXPRESSION; PLASMINOGEN-ACTIVATOR; PREGASTRULA EPIBLAST	Prior to gastrulation in the mouse, all endodermal cells arise from the primitive endoderm of the blastocyst stage embryo. Primitive endoderm and its derivatives are generally referred to as extra-embryonic endoderm (ExEn) because the majority of these cells contribute to extra-embryonic lineages encompassing the visceral endoderm (VE) and the parietal endoderm (PE). During gastrulation, the definitive endoderm (DE) forms by ingression of cells from the epiblast. The DE comprises most of the cells of the gut and its accessory organs. Despite their different origins and fates, there is a surprising amount of overlap in marker expression between the ExEn and DE, making it difficult to distinguish between these cell types by marker analysis. This is significant for two main reasons. First, because endodermal organs, such as the liver and pancreas, play important physiological roles in adult animals, much experimental effort has been directed in recent years toward the establishment of protocols for the efficient derivation of endodermal cell types in vitro. Conversely, factors secreted by the VE play pivotal roles that cannot be attributed to the DE in early axis formation, heart formation and the patterning of the anterior nervous system. Thus, efforts in both of these areas have been hampered by a lack of markers that clearly distinguish between ExEn and DE. To further understand the ExEn we have undertaken a comparative analysis of three ExEn-like cell lines (END2, PYS2 and XEN). PYS2 cells are derived from embryonal carcinomas (EC) of 129 strain mice and have been characterized as parietal endoderm-like [1], END2 cells are derived from P19 ECs and described as visceral endoderm-like, while XEN cells are derived from blastocyst stage embryos and are described as primitive endoderm-like. Our analysis suggests that none of these cell lines represent a bona fide single in vivo lineage. Both PYS2 and XEN cells represent mixed populations expressing markers for several ExEn lineages. Conversely END2 cells, which were previously characterized as VE-like, fail to express many markers that are widely expressed in the VE, but instead express markers for only a subset of the VE, the anterior visceral endoderm. In addition END2 cells also express markers for the PE. We extended these observations with microarray analysis which was used to probe and refine previously published data sets of genes proposed to distinguish between DE and VE. Finally, genome-wide pathway analysis revealed that SMAD-independent TGFbeta signaling through a TAK1/p38/JNK or TAK1/NLK pathway may represent one mode of intracellular signaling shared by all three of these lines, and suggests that factors downstream of these pathways may mediate some functions of the ExEn. These studies represent the first step in the development of XEN cells as a powerful molecular genetic tool to study the endodermal signals that mediate the important developmental functions of the extra-embryonic endoderm. Our data refine our current knowledge of markers that distinguish various subtypes of endoderm. In addition, pathway analysis suggests that the ExEn may mediate some of its functions through a non-classical MAP Kinase signaling pathway downstream of TAK1.	[Brown, Kemar; Legros, Stephanie; Doss, Michael Xavier; Foley, Ann] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA; [Artus, Jerome; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Khanin, Raya] Sloan Kettering Inst, Computat Biol Program, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Brown, K (corresponding author), Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY USA.	acf2002@med.cornell.edu	Jesudoss, Michael Xavier Doss/D-1983-2015	Jesudoss, Michael Xavier Doss/0000-0001-6339-9782; Artus, Jerome/0000-0003-3423-8634; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	American Heart Association [0930056N]; Beverly and Raymond Sackler; National Institutes of Health [RO1-HD052115, RO1-DK084391]; NYSTEM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Beverly and Raymond Sackler; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for the Foley laboratory is provided by the American Heart Association (0930056N) and funding from Beverly and Raymond Sackler. A.-K. Hadjantonakis laboratory is supported by the National Institutes of Health (RO1-HD052115 and RO1-DK084391) and NYSTEM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acampora D, 1998, DEVELOPMENT, V125, P5091; ANTIN PB, 1994, DEV DYNAM, V200, P144, DOI 10.1002/aja.1002000206; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AZAR Y, 1981, J EMBRYOL EXP MORPH, V61, P133; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Biben C, 1998, DEV BIOL, V194, P135, DOI 10.1006/dbio.1997.8812; Chazaud C, 2006, DEVELOPMENT, V133, P3379, DOI 10.1242/dev.02523; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng LY, 1997, EXP CELL RES, V230, P187, DOI 10.1006/excr.1996.3407; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; COSTA RH, 1990, P NATL ACAD SCI USA, V87, P6589, DOI 10.1073/pnas.87.17.6589; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; FULLILOVE SL, 1970, J EXP ZOOL, V175, P323, DOI 10.1002/jez.1401750306; GANNON M, 1995, DEVELOPMENT, V121, P2439; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; HAMA T, 1985, DEV GROWTH DIFFER, V27, P419; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inman KE, 2006, GENE EXPR PATTERNS, V6, P783, DOI 10.1016/j.modgep.2006.01.010; JACOBSON AG, 1968, J EXP ZOOL, V167, P79, DOI 10.1002/jez.1401670106; JACOBSON AG, 1960, DEV BIOL, V2, P138, DOI 10.1016/0012-1606(60)90003-8; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kimura C, 2000, DEV BIOL, V225, P304, DOI 10.1006/dbio.2000.9835; Knoetgen H, 1999, DEVELOPMENT, V126, P815; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; LEHMAN JM, 1974, J CELL PHYSIOL, V84, P13, DOI 10.1002/jcp.1040840103; MAROTTI KR, 1982, DEV BIOL, V90, P154, DOI 10.1016/0012-1606(82)90220-2; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; Matsui H, 2008, DEV GROWTH DIFFER, V50, P143, DOI [10.1111/j.1440-169x.2008.00987.x, 10.1111/j.1440-169X.2008.00987.x]; MERCOLA D, 1992, GENE REGULATION ANTI, P329; MITRANI E, 1983, J EMBRYOL EXP MORPH, V75, P21; MONZEN K, 1999, MOL CELLULAR BIOL, V19; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; MUMMERY CL, 1985, DEV BIOL, V109, P402, DOI 10.1016/0012-1606(85)90466-X; NASCONE N, 1995, DEVELOPMENT, V121, P515; Nijmeijer RM, 2009, STEM CELL RES, V3, P170, DOI 10.1016/j.scr.2009.06.003; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Rhinn M, 1998, DEVELOPMENT, V125, P845; Rudy-Reil D, 2004, CIRC RES, V94, pE107, DOI 10.1161/01.RES.0000134852.12783.6e; SATER AK, 1989, DEVELOPMENT, V105, P821; SATER AK, 1990, DEV BIOL, V140, P328, DOI 10.1016/0012-1606(90)90083-U; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Schneider VA, 1999, CURR BIOL, V9, P800, DOI 10.1016/S0960-9822(99)80363-7; Shawlot W, 1998, P NATL ACAD SCI USA, V95, P6198, DOI 10.1073/pnas.95.11.6198; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Uchimura T, 2009, GENESIS, V47, P374, DOI 10.1002/dvg.20511; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561	78	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12016	10.1371/journal.pone.0012016	http://dx.doi.org/10.1371/journal.pone.0012016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20711519	Green Submitted, Green Published, gold			2022-12-27	WOS:000280687900013
J	Glaser, RL; Meola, MA				Glaser, Robert L.; Meola, Mark A.			The Native Wolbachia Endosymbionts of Drosophila melanogaster and Culex quinquefasciatus Increase Host Resistance to West Nile Virus Infection	PLOS ONE			English	Article							PARTIAL CYTOPLASMIC INCOMPATIBILITY; AMERICAN MOSQUITOS DIPTERA; VECTOR COMPETENCE; STATISTICAL-ANALYSIS; GENE-SEQUENCES; CULICIDAE; DENSITY; CALIFORNIA; SYMBIONT; STRAINS	Background: The bacterial endosymbiont Wolbachia pipientis has been shown to increase host resistance to viral infection in native Drosophila hosts and in the normally Wolbachia-free heterologous host Aedes aegypti when infected by Wolbachia from Drosophila melanogaster or Aedes albopictus. Wolbachia infection has not yet been demonstrated to increase viral resistance in a native Wolbachia-mosquito host system. Methodology/Principal Findings: In this study, we investigated Wolbachia-induced resistance to West Nile virus (WNV; Flaviviridae) by measuring infection susceptibility in Wolbachia-infected and Wolbachia-free D. melanogaster and Culex quinquefasciatus, a natural mosquito vector of WNV. Wolbachia infection of D. melanogaster induces strong resistance to WNV infection. Wolbachia-infected flies had a 500-fold higher ID50 for WNV and produced 100,000-fold lower virus titers compared to flies lacking Wolbachia. The resistance phenotype was transmitted as a maternal, cytoplasmic factor and was fully reverted in flies cured of Wolbachia. Wolbachia infection had much less effect on the susceptibility of D. melanogaster to Chikungunya (Togaviridae) and La Crosse (Bunyaviridae) viruses. Wolbachia also induces resistance to WNV infection in Cx. quinquefasciatus. While Wolbachia had no effect on the overall rate of peroral infection by WNV, Wolbachia-infected mosquitoes produced lower virus titers and had 2 to 3-fold lower rates of virus transmission compared to mosquitoes lacking Wolbachia. Conclusions/Significance: This is the first demonstration that Wolbachia can increase resistance to arbovirus infection resulting in decreased virus transmission in a native Wolbachia-mosquito system. The results suggest that Wolbachia reduces vector competence in Cx. quinquefasciatus, and potentially in other Wolbachia-infected mosquito vectors.	[Glaser, Robert L.; Meola, Mark A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Glaser, Robert L.] SUNY Albany, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Glaser, RL (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	glaser@wadsworth.org			National Institute of Allergy and Infectious Diseases [AI076258]; New York State Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076258] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York State Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by funding from the National Institute of Allergy and Infectious Diseases (AI076258) and the New York State Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN THG, 1977, MOSQ NEWS, V37, P130; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BOUCHON D, 1998, P R SOC LOND B, V265; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; Echaubard P, 2010, HEREDITY, V104, P15, DOI 10.1038/hdy.2009.100; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Fry AJ, 2002, EVOLUTION, V56, P1976, DOI 10.1111/j.0014-3820.2002.tb00123.x; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; HANNOUN C, 1971, ARTHROPOD CELL CULTU, P227; Harcombe W, 2004, J INVERTEBR PATHOL, V87, P45, DOI 10.1016/j.jip.2004.07.003; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hertig M, 1924, J MED RES, V44, P329; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1998, GENETICS, V148, P221; HOFFMANN AA, 1988, ENTOMOL EXP APPL, V48, P61, DOI 10.1007/BF00343386; HOLDEN PR, 1993, GENET RES, V62, P23, DOI 10.1017/S0016672300031529; Hurst GDD, 2001, HEREDITY, V87, P220, DOI 10.1046/j.1365-2540.2001.00917.x; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Iturbe-Ormaetxe I, 2007, CURR OPIN MICROBIOL, V10, P221, DOI 10.1016/j.mib.2007.05.002; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Panteleev DY, 2007, RUSS J GENET+, V43, P1066, DOI 10.1134/S1022795407090153; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Rasgon JL, 2003, GENETICS, V165, P2029; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	72	244	267	9	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11977	10.1371/journal.pone.0011977	http://dx.doi.org/10.1371/journal.pone.0011977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700535	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400015
J	Xia, JH; Feng, F; Lin, G; Wang, CM; Yue, GH				Xia, Jun Hong; Feng, Felicia; Lin, Grace; Wang, Chun Ming; Yue, Gen Hua			A First Generation BAC-Based Physical Map of the Asian Seabass (Lates calcarifer)	PLOS ONE			English	Article							GENOME DUPLICATION; RESTRICTION FRAGMENTS; FINGERPRINT ANALYSIS; GROWTH TRAITS; LINKAGE MAP; EVOLUTION; CLONES; BARRAMUNDI	Background: The Asian seabass (Lates calcarifer) is an important marine foodfish species in Southeast Asia and Australia. Genetic improvement of this species has been achieved to some extent through selective breeding programs since 1990s. Several genomic tools such as DNA markers, a linkage map, cDNA and BAC libraries have been developed to assist selective breeding. A physical map is still lacking, although it is essential for positional cloning of genes located in quantitative trait loci (QTL) and assembly of whole genome sequences. Methodology/Principal Findings: A genome-wide physical map of the Asian seabass was constructed by restriction fingerprinting of 38,208 BAC clones with SNaPshot HICF FPC technique. A total of 30,454 were assembled into 2,865 contigs. The physical length of the assembled contigs summed up to 665 Mb. Analyses of some contigs using different methods demonstrated the reliability of the assembly. Conclusions/Significance: The present physical map is the first physical map for Asian seabass. This physical map will facilitate the fine mapping of QTL for economically important traits and the positional cloning of genes located in QTL. It will also be useful for the whole genome sequencing and assembly. Detailed information about BAC-contigs and BAC clones are available upon request.	[Xia, Jun Hong; Feng, Felicia; Lin, Grace; Wang, Chun Ming; Yue, Gen Hua] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Xia, JH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015; Lin, Grace XL/F-9883-2011	Yue, GH/0000-0002-3537-2248; Lin, Grace XL/0000-0003-0867-3827	Ministry of National Development	Ministry of National Development	This study is funded by Ministry of National Development for the project: "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carey G, 1999, CYTOBIOS, V100, P137; Chang YL, 2001, GENETICS, V159, P1231; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Froese R., 2014, FISHBASE; GARDNER RC, 1982, DNA-J MOLEC CELL BIO, V1, P109, DOI 10.1089/dna.1.1982.1.109; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Hardie DC, 2004, CAN J FISH AQUAT SCI, V61, P1636, DOI 10.1139/F04-106; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; LARSON H, 1999, ORDER PERCIFORMES SU, P2429; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MEKSEM K, 2005, HDB GENOME MAPPING G, P285; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nelson WM, 2005, PLANT PHYSIOL, V139, P27, DOI 10.1104/pp.105.061978; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Quiniou SMA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-40; Ren CW, 2003, GENOME RES, V13, P2754, DOI 10.1101/gr.1499303; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SODERLUND C, 2000, GENOME RES, V11, P934; Tao QZ, 2001, GENETICS, V158, P1711; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Xu ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni037; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053	40	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11974	10.1371/journal.pone.0011974	http://dx.doi.org/10.1371/journal.pone.0011974			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700486	Green Submitted, Green Published, gold			2022-12-27	WOS:000280605400014
J	de Morree, A; Hulsik, DL; Impagliazzo, A; van Haagen, HHHBM; de Galan, P; van Remoortere, A; 't Hoen, PAC; van Ommen, GB; Frants, RR; van der Maarel, SM				de Morree, Antoine; Hulsik, David Lutje; Impagliazzo, Antonietta; van Haagen, Herman H. H. B. M.; de Galan, Paula; van Remoortere, Alexandra; 't Hoen, Peter A. C.; van Ommen, Gertjan B.; Frants, Rune R.; van der Maarel, Silvere M.			Calpain 3 Is a Rapid-Action, Unidirectional Proteolytic Switch Central to Muscle Remodeling	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; SUBCELLULAR-LOCALIZATION; PROTEIN COMPLEX; IN-VIVO; P94; PREDICTION; MUTATION; PATHWAY; SPECIFICITY; AUTOLYSIS	Calpain 3 (CAPN3) is a cysteine protease that when mutated causes Limb Girdle Muscular Dystrophy 2A. It is thereby the only described Calpain family member that genetically causes a disease. Due to its inherent instability little is known of its substrates or its mechanism of activity and pathogenicity. In this investigation we define a primary sequence motif underlying CAPN3 substrate cleavage. This motif can transform non-related proteins into substrates, and identifies >300 new putative CAPN3 targets. Bioinformatic analyses of these targets demonstrate a critical role in muscle cytoskeletal remodeling and identify novel CAPN3 functions. Among the new CAPN3 substrates are three E3 SUMO ligases of the Protein Inhibitor of Activated Stats (PIAS) family. CAPN3 can cleave PIAS proteins and negatively regulates PIAS3 sumoylase activity. Consequently, SUMO2 is deregulated in patient muscle tissue. Our study thus uncovers unexpected crosstalk between CAPN3 proteolysis and protein sumoylation, with strong implications for muscle remodeling.	[de Morree, Antoine; Impagliazzo, Antonietta; van Haagen, Herman H. H. B. M.; de Galan, Paula; 't Hoen, Peter A. C.; van Ommen, Gertjan B.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Ctr Human Genet, Leiden, Netherlands; [Hulsik, David Lutje] Univ Utrecht, Dept Cellular Architecture & Dynam, Inst Biomembranes, Utrecht, Netherlands; [van Remoortere, Alexandra] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Morree, A (corresponding author), Leiden Univ, Med Ctr, Ctr Human Genet, Leiden, Netherlands.	maarel@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; van der Maarel, Silvere/X-3631-2018	Hoen, Peter A 't/0000-0003-4450-3112; van der Maarel, Silvere/0000-0001-8103-711X; de Morree, Antoine/0000-0002-8316-4531	Dutch Prinses Beatrix Fonds	Dutch Prinses Beatrix Fonds	This work was supported by a grant from the Dutch Prinses Beatrix Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dargelos E, 2002, J BIOTECHNOL, V96, P271, DOI 10.1016/S0168-1656(02)00052-4; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; GARNHAM C, 2009, BIOCHEMISTRY; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Krahn M, 2006, CLIN GENET, V69, P444, DOI 10.1111/j.1399-0004.2006.00603.x; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; MURPHY RM, 2009, J BIOL CHEM; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; SAKAI K, 1987, J BIOCHEM-TOKYO, V101, P911, DOI 10.1093/oxfordjournals.jbchem.a121959; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Sigrist CJA, 2005, BIOINFORMATICS, V21, P4060, DOI 10.1093/bioinformatics/bti614; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; STUELSATZ P, 2010, J BIOL CHEM; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11940	10.1371/journal.pone.0011940	http://dx.doi.org/10.1371/journal.pone.0011940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694146	Green Published, gold, Green Submitted			2022-12-27	WOS:000280574300008
J	Miloslavich, P; Diaz, JM; Klein, E; Jose Alvarado, J; Diaz, C; Gobin, J; Escobar-Briones, E; Cruz-Motta, JJ; Weil, E; Cortes, J; Bastidas, AC; Robertson, R; Zapata, F; Martin, A; Castillo, J; Kazandjian, A; Ortiz, M				Miloslavich, Patricia; Manuel Diaz, Juan; Klein, Eduardo; Jose Alvarado, Juan; Diaz, Cristina; Gobin, Judith; Escobar-Briones, Elva; Jose Cruz-Motta, Juan; Weil, Ernesto; Cortes, Jorge; Carolina Bastidas, Ana; Robertson, Ross; Zapata, Fernando; Martin, Alberto; Castillo, Julio; Kazandjian, Aniuska; Ortiz, Manuel			Marine Biodiversity in the Caribbean: Regional Estimates and Distribution Patterns	PLOS ONE			English	Review							CORAL GENUS MADRACIS; SHALLOW-WATER; ECHINODERMS ECHINODERMATA; VENEZUELA BASIN; CAYOS-COCHINOS; PHASE-SHIFTS; ROCKY SHORES; MONTASTRAEA-ANNULARIS; COMMUNITY STRUCTURE; ALGAL ASSEMBLAGES	This paper provides an analysis of the distribution patterns of marine biodiversity and summarizes the major activities of the Census of Marine Life program in the Caribbean region. The coastal Caribbean region is a large marine ecosystem (LME) characterized by coral reefs, mangroves, and seagrasses, but including other environments, such as sandy beaches and rocky shores. These tropical ecosystems incorporate a high diversity of associated flora and fauna, and the nations that border the Caribbean collectively encompass a major global marine biodiversity hot spot. We analyze the state of knowledge of marine biodiversity based on the geographic distribution of georeferenced species records and regional taxonomic lists. A total of 12,046 marine species are reported in this paper for the Caribbean region. These include representatives from 31 animal phyla, two plant phyla, one group of Chromista, and three groups of Protoctista. Sampling effort has been greatest in shallow, nearshore waters, where there is relatively good coverage of species records; offshore and deep environments have been less studied. Additionally, we found that the currently accepted classification of marine ecoregions of the Caribbean did not apply for the benthic distributions of five relatively well known taxonomic groups. Coastal species richness tends to concentrate along the Antillean arc (Cuba to the southernmost Antilles) and the northern coast of South America (Venezuela -Colombia), while no pattern can be observed in the deep sea with the available data. Several factors make it impossible to determine the extent to which these distribution patterns accurately reflect the true situation for marine biodiversity in general: (1) highly localized concentrations of collecting effort and a lack of collecting in many areas and ecosystems, (2) high variability among collecting methods, (3) limited taxonomic expertise for many groups, and (4) differing levels of activity in the study of different taxa.	[Miloslavich, Patricia; Klein, Eduardo; Jose Cruz-Motta, Juan; Martin, Alberto] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela; [Miloslavich, Patricia; Klein, Eduardo; Jose Cruz-Motta, Juan; Martin, Alberto; Castillo, Julio; Kazandjian, Aniuska] Univ Simon Bolivar, Ctr Biodiversidad Marina, Caracas, Venezuela; [Manuel Diaz, Juan; Castillo, Julio] Univ Nacl Colombia, Bogota, Colombia; [Jose Alvarado, Juan; Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Jose, Costa Rica; [Diaz, Cristina] Museo Mar, Margarita, Venezuela; [Gobin, Judith] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Lajas, PR USA; [Carolina Bastidas, Ana; Kazandjian, Aniuska] Univ Simon Bolivar, Dept Biol Organismos, Caracas, Venezuela; [Robertson, Ross] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Zapata, Fernando] Univ Valle, Dept Biol, Cali, Colombia; [Ortiz, Manuel] Univ La Habana, Ctr Invest Marinas, Havana, Cuba	Simon Bolivar University; Simon Bolivar University; Universidad Nacional de Colombia; Universidad Costa Rica; University West Indies Mona Jamaica; University West Indies Saint Augustine; Universidad Nacional Autonoma de Mexico; University of Puerto Rico; University of Puerto Rico Mayaguez; Simon Bolivar University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad del Valle; Universidad de la Habana	Miloslavich, P (corresponding author), Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Venezuela.	pmilos@usb.ve	Cortés, Jorge/AAC-9782-2020; Weil, Ernesto/AAI-3591-2020; Alvarado, Juan/A-4002-2012; Weil, Ernesto/ABF-1290-2020	Cortés, Jorge/0000-0001-7004-8649; Weil, Ernesto/0000-0001-5275-1584; Alvarado, Juan Jose/0000-0002-2620-9115; Escobar Briones, Elva/0000-0002-8485-7495; Klein, Eduardo/0000-0003-2935-7065; Cruz Motta, Juan Jose/0000-0001-6117-9014; Miloslavich, Patricia/0000-0001-5409-1401	Alfred P. Sloan Foundation; Centro de Biodiversidad Marina CBM; Decanato de Investigacion y Desarrollo of the Universidad Simon Bolivar; Smithsonian Marine Sciences Network	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Centro de Biodiversidad Marina CBM; Decanato de Investigacion y Desarrollo of the Universidad Simon Bolivar; Smithsonian Marine Sciences Network	The Alfred P. Sloan Foundation, the Centro de Biodiversidad Marina CBM and the Decanato de Investigacion y Desarrollo of the Universidad Simon Bolivar provided funds for this work. The Smithsonian Marine Sciences Network provided financial support of the fish work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Perez M, 2005, REV BIOL TROP, V53, P29; Acero A., 1985, P 5 INT COR REEF C, V5, P433; Agard J. R. B., 2007, CARIBBEAN SEA ECOSYS; ALCOLADO P, 2003, SCIENCE, P53; Alcolado Pedro M., 2002, Avicennia, V15, P53; Alonso D., 2008, PRIORIDADES CONSERVA, p20p.; Alvarado JJ, 2008, REV BIOL TROP, V56, P37; Alvarado J. J., 2009, MARINE BIODIVERSITY, P392; ALVIZU A, 2006, COMPOSICION ABUNDANC; Amaro M. E., 2005, DEMOSPONGIAE PORIFER; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrade CA, 2000, J GEOPHYS RES-OCEANS, V105, P26191, DOI 10.1029/2000JC000300; Andrefouet S, 2005, CORAL REEFS, V24, P31, DOI 10.1007/s00338-004-0444-4; [Anonymous], 1953, ZOOGEOGRAPHY SEA; [Anonymous], 2007, REV INVESTIG MAR; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; ARRIVILLAGA A, 2003, 2 I INC AMB U RAF LA; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; BAK R P M, 1975, Bijdragen tot de Dierkunde, V45, P181; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Ballantine David L., 2008, V1, P375, DOI 10.1007/978-1-4020-6847-8_9; Banaszak AT, 2006, J EXP MAR BIOL ECOL, V337, P131, DOI 10.1016/j.jembe.2006.06.014; BARNARD J. LAURENS, 1954, ALLAN HANCOCK ATLANTIC EXPED, V7, P1; BECK M, 2003, MARINE ECOREGIONAL P; Benavides-Serrato M, 2005, REV BIOL TROP, V53, P171; Benavides-Serrato M., 2006, THESIS U PUERTO RICO; BENAVIDESSERRAT.M, 2000, THESIS U BOGOTA JORG; Bernecker Andrea, 2009, V86, P109, DOI 10.1007/978-1-4020-8278-8_5; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; BILLINGHURST Z, 1997, P 8 INT COR REEF S, V2, P1291; Bone D., 2003, BIODIVERSIDAD VENEZU, VI, P264; Borrero-Perez GH, 2008, REV BIOL TROP, V56, P169; Borrero-Pérez Giomar Helena, 2002, Bol. Invest. Mar. Cost., V31, P133; BORREROPE R, 2002, BIOTA COLOMBIANA, V3, P141; Botsford Louis W., 2005, P375; Bouchon, 2008, STATUS CORAL REEFS W, V2008, P265; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Brattstrom H, 1999, SARSIA, V84, P319, DOI 10.1080/00364827.1999.10807343; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Briggs KB, 1996, J MAR RES, V54, P705, DOI 10.1357/0022240963213736; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; BURKE K, 1984, GEOL SOC AM MEM, V162, P31; Burke L., 2004, REEFS RISK CARIBBEAN; Bussing W. A., 2009, MARINE BIODIVERSITY, p[453, 412]; Cairns SD, 1982, SMITHSON CONTRIB MAR, V21, P271; Camacho-Garcia Y. E., 2009, MARINE BIODIVERSITY, p[371, 330]; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Caycedo I.E., 1981, Anales del Instituto de Investigaciones Marinas de Punta de Betin, V11, P39; Caycedo I.E., 1978, ANN INSTITUT INVERTE, V10, P149, DOI [10.25268/bimc.invemar.1978.10.0.512, DOI 10.25268/BIMC.INVEMAR.1978.10.0.512]; CERVIGON F, 2000, PECES ARCHIPIELGO RO; Cervigon F, 1992, GUIA CAMPO ESPECIES; CERVIGON F, 1991, PECES MARINOS VENEZU, V2; Cervigon F., 1994, PECES MARINOS VENEZU, V3; Cervigon F., 1991, PECES MARINOS VENEZU, V1; Cervigon F., 1966, PECES MARINOS VENEZU, V1; Cervigon F, 1996, PECES MARINOS VENEZU, VIV; Chauvaud S, 2001, OCEANOL ACTA, V24, pS3; CHESHER R H, 1972, Bulletin of the Biological Society of Washington, V2, P139; CIAVATTI G, 1989, ANN I OCEANOGR PARIS, V65, P127; CIPRIANI R, 2008, EARLY HUMAN IMPACT M, P95; Clark AM, 1992, STARFISHES ATLANTIC; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke L L, 2001, JOP, V2, P263; CONOLLY JR, 1967, J SEDIMENT PETROL, V37, P44; COOMANS HE, 1963, ANN REP AM MALAC UNI, V30, P9; Corredor J. E., 2004, EOS T AM GEOPHYS UN, V85, P197, DOI DOI 10.1029/2004EO200001; CORTES J, 2009, MARINE BIODIVERSITY, P93; Cortes Jorge, 2009, V86, P119, DOI 10.1007/978-1-4020-8278-8_6; COSEL RV, 1982, MITT DEUSCH MALAK GE, V3, P26; COSEL RV, 1976, MITTEILUNGEN I COLOM, V8, P83; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Cruz-Motta JJ, 2007, CIENC MAR, V33, P133, DOI 10.7773/cm.v33i2.1113; de Laubenfels M. W., 1936, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V30, P1; De LAUBENFELS M. W., 1934, SMITHSONIAN MISC COLL, V91, P1; De Weerdt Wallie H., 2000, Beaufortia, V50, P1; Dean H. K., 2009, MARINE BIODIVERSITY, p[181, 122]; Dean HK, 2001, REV BIOL TROP, V49, P85; Deichmann E., 1963, Studies on the Fauna of Curacao, V14, P100; Deichmann E, 1926, STUD NAT HIST U IOWA, V11, P9; DEICHMANN ELISABETH, 1930, BULL MUS COMP ZOOL, V71, P41; DEICHMANN ELIZABETH, 1940, MEM SOC CUBANA HIST NAT, V14, P183; del Valle Garcia R., 2008, Revista de Biologia Tropical, V56, P19; DEROA EZ, 1967, VENEZUELA ACTA BIOL, V5, P267; DEVANEY DM, 1974, B MAR SCI, V24, P122; DEWEERDT WH, 1991, P BIOL SOC WASH, V104, P189; Diaz ES, 2003, BOUNDR ELEMENT, V4, P203; Diaz J. M., 2003, PRADERAS PASTOS MARI, V10; Diaz JM, 1994, MOLUSCOS CARIBE COLO; Diaz JM, 2000, AREAS CORALINAS COLO, V5; Diaz Juan M., 1995, Caribbean Journal of Science, V31, P104; Diaz Juan Manuel, 2000, Biota Colombiana, V1, P195; Díaz M Juan Manuel, 2003, Bol. Invest. Mar. Cost., V32, P57; Diaz MC, 2005, CARIBB J SCI, V41, P465; DIAZ MC, 1991, SYSTEMATIC REVISIO 1, P134; DIAZ YJ, 2008, CATALOGO CRUSTACEOS; DIAZ YJ, 2001, THESIS U S BOLIVAR; DIAZ YJ, 2008, ANFI  PODOS VENEZUEL; Diaz Yusbelly J., 2005, Organisms Diversity & Evolution Electronic Supplement, V10, P1; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; Diekmann OE, 2002, MAR ECOL PROG SER, V227, P221, DOI 10.3354/meps227221; Diekmann OE, 2001, MAR BIOL, V139, P221; DOWNEY ME, 1973, SMITHSON CONTRIB ZOO, V126, P158; Ercilla G, 1998, J GEOL SOC LONDON, V155, P929, DOI 10.1144/gsjgs.155.6.0929; ESPINOSA J., 1995, RESENAS MALACOLOGICA, VIX, P1; Etnoyer PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010668; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2004, ECOL APPL, V14, P1448, DOI 10.1890/03-5320; *FAO, 2007, 830 FAO; FARMER CT, 1993, J GEOPHYS RES-OCEANS, V98, P2279, DOI 10.1029/92JC02764; Fautin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011914; FLORES C, 1970, Boletin del Instituto Oceanografico Universidad de Oriente Cumana, V9, P3; Fonseca AC, 2003, LATIN AMERICAN CORAL REEFS, P159, DOI 10.1016/B978-044451388-5/50008-4; FONSECA AC, 2000, EVALUACION ECOLOGICA; Fontaine A., 1953, Natural History Notes Natural History Society of Jamaica, VNos. 62-63, P29; Fontaine A., 1953, Natural History Notes Natural History Society of Jamaica, VNo. 60, P197; FONTAINE A, 1953, NAT HIST NOTES NAT H, V56, P170; Foster J. M., 2009, MARINE BIODIVERSITY, p[265, 212]; Franklin MJ, 2008, AGR HIST REV, V56, P215; Garcia RD, 2005, REV BIOL TROP, V53, P9; Garcia-Salgado M, 2008, STATUS CORAL REEFS W, P253; Garcuia-Ruios C.I., 2003, QUITONES PUERTO RICO; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GASCA R, 2009, MARINE BIODIVERSITY, P217; GEOGHEGAN T, 2001, CHARACTERIZATION CAR; Gilbes F, 2004, INT J REMOTE SENS, V25, P1449, DOI 10.1080/01431160310001592427; Gomez P., 2002, ESPONJAS MARINAS GOL; GOMEZ P, 1992, DIVERSIDAD BIOL RESE, P23; Gomez P, 2006, P BIOL SOC WASH, V119, P339, DOI 10.2988/0006-324X(2006)119[339:YCNGAS]2.0.CO;2; González G Dunia N, 2002, Bol. Invest. Mar. Cost., V31, P85; Good TP, 2004, B MAR SCI, V74, P459; GOODBODY I, 2007, INTRO CARIBBEAN SEA; GORDON AL, 1967, J GEOPHYS RES, V72, P6207, DOI 10.1029/JZ072i024p06207; GORDON D, 2001, MARINE BIODIVERSITY, V108, P1; Gracia Adriana, 2004, Iberus, V22, P43; GROBERDUNSMORE R, 2008, SILV SPRING MD P SPE; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Guerra-García José M., 2006, Bol. Invest. Mar. Cost., V35, P149; Guzman HM, 2003, LATIN AMERICAN CORAL REEFS, P241, DOI 10.1016/B978-044451388-5/50012-6; Guzman HM, 1998, REV BIOL TROP, V46, P75; GYORY J, 2008, CARIBBEAN CURRENT OC; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hasbun CR, 2002, REV BIOL TROP, V50, P669; Hechtel G. J., 1969, Postilla, V132, P1; HECHTEL GEORGE JOHN, 1965, PEABODY MUS NATUR HIST YALE UNIV BULL, V20, P1; Hendler G, 2005, CARIBB J SCI, V41, P583; Hendler G., 1988, P411; HENDLER G, 1988, B MAR SCI, V42, P265; Hendler G, 2000, ATOLL RES B, V479, P274; Hendler G., 1995, ECHINODERMS FLORIDA; Hendler Gordon, 1995, Contributions in Science (Los Angeles), V458, P1; HERNAN, 2007, HIDROBIOLOGICA, V17, P25; HERRERAMORENO A, 2004, SANTO DOMINGO, V29, P506; Hess D.F., 1994, Monographiae Biologicae, V71, P139; Hochberg F. G., 2009, MARINE BIODIVERSITY, p[399, 379]; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoetjes PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010769; HOTCHKISS FHC, 1982, ATLANTIC BARRIER REE, P387; HUGGINS A, 2007, BIODIVERSITY CONSERV; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson Jeremy B. C., 1996, P234; Jackson T.A., 2002, T 15 CAR GEOL C; Kaehler S, 1998, MAR ECOL PROG SER, V172, P61, DOI 10.3354/meps172061; Kaehler S, 1996, MAR BIOL, V125, P177, DOI 10.1007/BF00350772; Kemp DW, 2006, J EXP MAR BIOL ECOL, V335, P266, DOI 10.1016/j.jembe.2006.03.017; Kendall M.S., 2001, BENTHIC HABITATS PUE; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; Klein E., 2008, PRIORIDADES PDVSA CO; Knowlton N, 2010, LIFE WORLDS OCEANS D, P65; KOBLUK DR, 1989, B MAR SCI, V44, P1207; Laguarda-Figueras A, 2005, REV BIOL TROP, V53, P109; Laguarda-Figueras Alfredo, 2002, Avicennia, V15, P1; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LALANA R, 2004, REV INVEST MAR, V21, P3; Lalana Rogelio, 2005, Revista Biologia (Havana), V19, P50; Lehnert H, 1998, B MAR SCI, V62, P181; Lehnert Helmut, 1996, Beaufortia, V46, P53; Lehnert Helmut, 1993, Acta Biologica Benrodis, V5, P35; Lehnert Helmut, 1999, Beaufortia, V49, P141; Lehnert Helmut, 1998, Beaufortia, V48, P71; Lessios HA, 1998, REV BIOL TROP, V46, P95; Littler D. S., 2000, CARIBBEAN REEF PLANT; Littler MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010677; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Lodeiros C., 1999, CATALOGO MOLUSCOS MA; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Lu HP, 2007, BASIC APPL ECOL, V8, P1, DOI 10.1016/j.baae.2006.06.004; LUBCHENCO J, 1984, J EXP MAR BIOL ECOL, V78, P23, DOI 10.1016/0022-0981(84)90069-8; Lubchenco J., 1986, COMMUNITY ECOLOGY, P537; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; MACURDA DB, 1982, ATLANTIC BARRIER REE, P413; MAGANACUBILLO J, 2009, BIVALVES SPECIES LIS, P348; MARTIN A, 2007, CAALOGO ANFIPODOS CR; Martinez A, 1975, B I OCEANOGR VENEZUE, V14, P187; Martinez M. A., 1991, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V26, P153; Martinez M. Aida, 1991, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V28, P105; MATTHEWS JE, 1985, MAR GEOL, V68, P1, DOI 10.1016/0025-3227(85)90003-9; McCain J.C, 1968, B US NATL MUS, V278, P1, DOI 10.5479/si.03629236.278; MCCLINTOCK JB, 1990, MAR BIOL, V105, P175, DOI 10.1007/BF01344284; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McKenna SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010749; MCNALLY KL, 1994, J PHYCOL, V30, P316, DOI 10.1111/j.0022-3646.1994.00316.x; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MENGE BA, 1985, OECOLOGIA, V65, P394, DOI 10.1007/BF00378915; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; Meschede M, 1998, TECTONOPHYSICS, V296, P269, DOI 10.1016/S0040-1951(98)00157-7; MESCHEDE M, 2002, T 15 CAR GEOL C U W, P1; Meyer D.L., 1976, Mitteilungen Inst Colombo-Aleman Invest Cient Punta Betin, V8, P141; MEYER DL, 1978, B MAR SCI, V28, P412; MILLER JE, 1984, MEMORIES HOURGLASS 1, V7; MILOSLAVICH P, 2007, P FIN REP GULF MEX C, P24; Miloslavich P, 2005, CARIBBEAN MARINE BIO; Miloslavich Patricia, 2003, Gayana (Concepc.), V67, P275; Moore D.R., 1974, Bulletin Am malac Union, V39, P17; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; MULLERKARGER FE, 1994, CONT SHELF RES, V14, P199, DOI 10.1016/0278-4343(94)90013-2; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norse EA., 1993, GLOBAL MARINE BIOLOG; Nunez SG, 1999, CIENC MAR, V25, P629, DOI 10.7773/cm.v25i4.722; ORTIZ M, 1983, Revista de Investigaciones Marinas, V4, P23; Ortiz M., 2004, CLAVE GRAFICA IDENTI; ORTIZ M, 2001, ILLUSTRATED KEY IDEN; Ortiz Manuel, 1997, Boletin de Investigaciones Marinas y Costeras, V26, P71; Osman R, 2007, P FIN REP GULF MEX C; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pauls S. M., 2003, BIODIVERSIDAD VENEZU, VI, P210; Pawson David L., 2001, Bulletin of the Biological Society of Washington, V10, P311; Perez A, 2007, ESTUDIO COMUNIDADES, P76; PERKINS T, 1975, FLORIDA MARINE RES P, V14; PETUCH E J, 1982, Proceedings of the Biological Society of Washington, V95, P774; Phelan T., 1970, Smithson. Contr. Zool., VNo. 40, P1; PINDELL J, 2000, EVOLUTION NO PORTION; PINDELL JL, 1988, TECTONOPHYSICS, V155, P121, DOI 10.1016/0040-1951(88)90262-4; PINDELL JL, 1991, T 12 CAR GEOL C; PINDELL JL, 2000, AAPG EXPLORER    OCT, P34; Posada JM, 2007, P GULF CARIB FISH I, V59, P23; PRALH HV, 1985, COLOMBIA CORALES ARR; Pujos M, 1997, OCEANOL ACTA, V20, P799; Pulitzer-Finali G., 1987, Annali del Museo Civico di Storia Naturale "Giacomo Doria", V86, P65; RAFFUCCI FAG, 2007, NOMENCLATURA ORGANIS, V3; RAMIREZVILLAROE.P, 2001, CORALES VENEZUELA PO; Randall JE, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2173.1.3; Reyes J, 2005, ERLANGEN EARTH C SER, P309, DOI 10.1007/3-540-27673-4_15; Reyes Javier, 2000, Biota Colombiana, V1, P164; Richards W.J., 1990, P44; RICHARDSON MD, 1995, DEEP-SEA RES PT I, V42, P351, DOI 10.1016/0967-0637(95)00007-S; RICHARDSON MD, 1987, DEEP-SEA RES, V34, P145, DOI 10.1016/0198-0149(87)90079-3; RICHARDSON MD, 1985, MAR GEOL, V68, P243, DOI 10.1016/0025-3227(85)90015-5; Rilov G, 2009, BIOL INVASIONS MARIN, V204; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rodriguez-Sevilla L., 2009, MARINE BIODIVERSITY, p[333, 243]; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rutzler Klaus, 2000, Atoll Research Bulletin, V476, P229; Ryan J, 2003, LATIN AMERICAN CORAL REEFS, P203, DOI 10.1016/B978-044451388-5/50010-2; Salazar-Vallejo Sergio I., 1996, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V67, P11; Salazar-Vallejo SI, 2000, INTERCIENCIA, V25, P7; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Schwabe E., 2009, MARINE BIODIVERSITY, p[323, 240]; SERAFY DK, 1970, B MAR SCI, V20, P662; Shoemaker C. R., 1935, NEW YORK ACADEMY SCI, V15, P229; Shoemaker Clarence R., 1948, SMITHSONIAN MISC COLL, V110, P1; SMITH ML, 2002, FAO SPECIES IDENTIFI, V5, P1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steiner G, 2004, ZOOSYSTEMA, V26, P549; STEINER S.C.C., 2003, ATOLL RES B, V498, P1; STOCK JH, 1985, BIJDR DIERKD, V55, P331, DOI 10.1163/26660644-05502011; Suarez A.M., 1974, Ciencias La Habana Invest Mar, VNo. 6, P1; Sullivan Sealey K., 1999, SETTING GEOGRAPHIC P; TAYLOR W. R., 1960, MARINE ALGAE E TROPI; Thacker RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009622; THOMAS MLH, 1992, B MAR SCI, V50, P133; THOMAS MLH, 1985, B MAR SCI, V37, P857; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Toller W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009207; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; van Soest R.W.M., 1978, STUDIES FAUNA CURAC, P1; van Soest R.W.M., 1984, UITGAVEN NATUURWETEN, V66, P1; Van Soest RWM, 2009, ZOOTAXA, P1; van Soest RWM, 1980, STUD FAUNA CURACAO, V62, P1; VANSOEST RWM, 1988, STUD FAUNA CURACAO, V70, P1; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Victor Benjamin C., 2010, Journal of the Ocean Science Foundation, V3, P1; VINK DLN, 1985, REV SUISSE ZOOL, V92, P525, DOI 10.5962/bhl.part.81894; VOKES H.E., 1983, DISTRIBUTION SHALLOW; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wallenstein FFMM, 2006, HELGOLAND MAR RES, V60, P196, DOI 10.1007/s10152-006-0035-6; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; WEHRTMANN I, 2009, MONOGRAPHIAE BIOL, V86; Weil E, 2003, LATIN AMERICAN CORAL REEFS, P303, DOI 10.1016/B978-044451388-5/50014-X; Weil E, 2008, P 11 INT COR REEF S, V1, P202; Weil E, 2006, REV BIOL TROP, V54, P423; WELLS JW, 1973, B MAR SCI, V23, P16; Werding Bernd, 2003, Memoirs of Museum Victoria, V60, P79; Wilcox TP, 1998, MOL PHYLOGENET EVOL, V10, P436, DOI 10.1006/mpev.1998.0546; WILKIE M, 2003, 63 FAO FOR RES; Wilkinson C., 2004, STATUS CORAL REEFS W, V1; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; Woods SP, 2005, NEUROPSYCHOLOGY, V19, P35, DOI 10.1037/0894-4105.19.1.35; Zea S., 1987, ESPONJAS CARIBE COLO; Zea Sven, 1993, Caribbean Journal of Science, V29, P75; [No title captured]	311	217	244	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11916	10.1371/journal.pone.0011916	http://dx.doi.org/10.1371/journal.pone.0011916			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689856	gold, Green Published			2022-12-27	WOS:000280520400012
J	Friedman, EB; Sun, Y; Moore, JT; Hung, HT; Meng, QC; Perera, P; Joiner, WJ; Thomas, SA; Eckenhoff, RG; Sehgal, A; Kelz, MB				Friedman, Eliot B.; Sun, Yi; Moore, Jason T.; Hung, Hsiao-Tung; Meng, Qing Cheng; Perera, Priyan; Joiner, William J.; Thomas, Steven A.; Eckenhoff, Roderic G.; Sehgal, Amita; Kelz, Max B.			A Conserved Behavioral State Barrier Impedes Transitions between Anesthetic-Induced Unconsciousness and Wakefulness: Evidence for Neural Inertia	PLOS ONE			English	Article							GENERAL-ANESTHETICS; DROSOPHILA-MELANOGASTER; SLEEP; HALOTHANE; BRAIN; ELECTROENCEPHALOGRAM; NOREPINEPHRINE; NARCOLEPSY; AROUSAL; WAKING	One major unanswered question in neuroscience is how the brain transitions between conscious and unconscious states. General anesthetics offer a controllable means to study these transitions. Induction of anesthesia is commonly attributed to drug-induced global modulation of neuronal function, while emergence from anesthesia has been thought to occur passively, paralleling elimination of the anesthetic from its sites in the central nervous system (CNS). If this were true, then CNS anesthetic concentrations on induction and emergence would be indistinguishable. By generating anesthetic dose-response data in both insects and mammals, we demonstrate that the forward and reverse paths through which anesthetic-induced unconsciousness arises and dissipates are not identical. Instead they exhibit hysteresis that is not fully explained by pharmacokinetics as previously thought. Single gene mutations that affect sleep-wake states are shown to collapse or widen anesthetic hysteresis without obvious confounding effects on volatile anesthetic uptake, distribution, or metabolism. We propose a fundamental and biologically conserved concept of neural inertia, a tendency of the CNS to resist behavioral state transitions between conscious and unconscious states. We demonstrate that such a barrier separates wakeful and anesthetized states for multiple anesthetics in both flies and mice, and argue that it contributes to the hysteresis observed when the brain transitions between conscious and unconscious states.	[Friedman, Eliot B.; Hung, Hsiao-Tung] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sun, Yi; Moore, Jason T.; Meng, Qing Cheng; Perera, Priyan; Eckenhoff, Roderic G.; Kelz, Max B.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Joiner, William J.; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Thomas, Steven A.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Moore, Jason T.; Kelz, Max B.] Univ Penn, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Hung, Hsiao-Tung; Sehgal, Amita; Kelz, Max B.] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; [Friedman, Eliot B.; Kelz, Max B.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Friedman, EB (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kelzma@uphs.upenn.edu	Kelz, Max/E-4054-2010	Kelz, Max/0000-0002-2803-6078; Eckenhoff, Roderic/0000-0002-5581-746X	American Recovery and Reinvestment Act (ARRA) [K08 GM077357]; Foundation for Anesthesia Education and Research; University of Pennsylvania's Institute for Translational Medicine and Therapeutics; R.W. Johnson Foundation; Parker B. Francis Fellowship; University of Pennsylvania Department of Anesthesiology and Critical Care;  [R01 GM088156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM077357, R01GM088156] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA); Foundation for Anesthesia Education and Research; University of Pennsylvania's Institute for Translational Medicine and Therapeutics; R.W. Johnson Foundation; Parker B. Francis Fellowship; University of Pennsylvania Department of Anesthesiology and Critical Care; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K08 GM077357, the American Recovery and Reinvestment Act (ARRA) funds through grant K08 GM077357, R01 GM088156, The Foundation for Anesthesia Education and Research (www.faer.org), University of Pennsylvania's Institute for Translational Medicine and Therapeutics (www.itmat.upenn.edu), the Harold Amos Medical Faculty Development Program from the R.W. Johnson Foundation (www.amfdp.org), the Parker B. Francis Fellowship program (www.francisfellowships.org), and the University of Pennsylvania Department of Anesthesiology and Critical Care (www.uphs.upenn.edu/dripps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2009, ANESTHESIOLOGY, V110, P766, DOI 10.1097/ALN.0b013e31819c461c; ALLADA R, 1993, ANESTH ANALG, V77, P19; Berridge CW, 1996, J NEUROSCI, V16, P6999; Berridge CW, 2001, BEHAV NEUROSCI, V115, P165, DOI 10.1037//0735-7044.115.1.165; Bruhn J, 2000, ANESTHESIOLOGY, V93, P981, DOI 10.1097/00000542-200010000-00018; Burrow B, 2005, J CLIN ANESTH, V17, P21, DOI 10.1016/j.jclinane.2004.03.007; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; CAMPBELL JL, 2009, J NEUROGENET, P1; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Correa AM, 1998, AM J PHYSIOL-CELL PH, V275, pC1009, DOI 10.1152/ajpcell.1998.275.4.C1009; Eckenhoff MF, 1998, J PHARMACOL EXP THER, V285, P371; Fort P, 2009, EUR J NEUROSCI, V29, P1741, DOI 10.1111/j.1460-9568.2009.06722.x; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gamo S, 2002, CURR DRUG TARGETS, V3, P31, DOI 10.2174/1389450023348118; Gompf H, 2009, ANESTHESIOLOGY, V111, P1001, DOI 10.1097/ALN.0b013e3181b764b3; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jonson B, 1999, THORAX, V54, P82, DOI 10.1136/thx.54.1.82; Keifer JC, 1996, ANESTHESIOLOGY, V84, P945, DOI 10.1097/00000542-199604000-00023; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kreuer S, 2004, ANESTH ANALG, V98, P692, DOI 10.1213/01.ANE.0000103182.78466.EF; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Lighton JRB, 2005, CURR BIOL, V15, pR965, DOI 10.1016/j.cub.2005.11.020; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; MCCORMICK DA, 1991, PROG BRAIN RES, V88, P293; McKay IDH, 2006, ANESTH ANALG, V102, P91, DOI 10.1213/01.ane.0000184825.65124.24; Mesa A, 2000, ANESTHESIOLOGY, V92, P1194, DOI 10.1097/00000542-200004000-00040; MILLER RD, 1968, ANESTHESIOLOGY, V29, P1153, DOI 10.1097/00000542-196811000-00012; MUELLER RA, 1975, ANESTHESIOLOGY, V42, P143, DOI 10.1097/00000542-197502000-00006; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; Ouyang M, 2004, J NEUROPHYSIOL, V92, P2071, DOI 10.1152/jn.00226.2004; ROIZEN MF, 1978, ANESTHESIOLOGY, V49, P252, DOI 10.1097/00000542-197810000-00005; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; SHADWICK RE, 1990, J APPL PHYSIOL, V68, P1033, DOI 10.1152/jappl.1990.68.3.1033; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Steyn-Ross DA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011918; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; Sun Yi, 2006, BMC Anesthesiol, V6, P13, DOI 10.1186/1471-2253-6-13; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Thomas SA, 1998, J NEUROCHEM, V70, P2468; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; TINKLENBERG JA, 1991, ANN NY ACAD SCI, V625, P532, DOI 10.1111/j.1749-6632.1991.tb33884.x; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; Walcourt A, 2001, ANESTH ANALG, V92, P535, DOI 10.1213/00000539-200102000-00047; Weber B, 2009, ANESTHESIOLOGY, V110, P313, DOI 10.1097/ALN.0b013e3181942df2	53	154	158	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11903	10.1371/journal.pone.0011903	http://dx.doi.org/10.1371/journal.pone.0011903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689589	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520300018
J	Bhattacharjee, RN; Banerjee, B; Akira, S; Hande, MP				Bhattacharjee, Rabindra N.; Banerjee, Birendranath; Akira, Shizuo; Hande, M. Prakash			Telomere-Mediated Chromosomal Instability Triggers TLR4 Induced Inflammation and Death in Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE; CYTOGENETIC DAMAGE; CANCER DEVELOPMENT; CELLS; LENGTH; PERSISTENCE; INDUCTION; STRESS	Background: Telomeres are essential to maintain chromosomal stability. Cells derived from mice lacking telomerase RNA component (mTERC(-/-) mice) display elevated telomere-mediated chromosome instability. Age-dependent telomere shortening and associated chromosome instability reduce the capacity to respond to cellular stress occurring during inflammation and cancer. Inflammation is one of the important risk factors in cancer progression. Controlled innate immune responses mediated by Toll-like receptors (TLR) are required for host defense against infection. Our aim was to understand the role of chromosome/genome instability in the initiation and maintenance of inflammation. Methodology/Principal Findings: We examined the function of TLR4 in telomerase deficient mTERC(-/-) mice harbouring chromosome instability which did not develop any overt immunological disorder in pathogen-free condition or any form of cancers at this stage. Chromosome instability was measured in metaphase spreads prepared from wildtype (mTERC(+/+)), mTERC(+/-) and mTERC(-/-) mouse splenocytes. Peritoneal and/or bone marrow-derived macrophages were used to examine the responses of TLR4 by their ability to produce inflammatory mediators TNF alpha and IL6. Our results demonstrate that TLR4 is highly up-regulated in the immune cells derived from telomerase-null (mTERC(-/-)) mice and lipopolysaccharide, a natural ligand for TLR4 stabilises NF-kappa B binding to its promoter by down-regulating ATF-3 in mTERC(-/-) macrophages. Conclusions/Significance: Our findings implied that background chromosome instability in the cellular level stabilises the action of TLR4-induced NF-kappa B action and sensitises cells to produce excess pro-inflammatory mediators. Chromosome/genomic instability data raises optimism for controlling inflammation by non-toxic TLR antagonists among high-risk groups.	[Bhattacharjee, Rabindra N.; Akira, Shizuo] Osaka Univ, Exploratory Res Adv Technol ERATO, Akira Innate Immun Project, Osaka, Japan; [Bhattacharjee, Rabindra N.; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Japan; [Bhattacharjee, Rabindra N.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Banerjee, Birendranath; Hande, M. Prakash] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Akira, Shizuo] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Osaka University; Western University (University of Western Ontario); National University of Singapore; Osaka University	Bhattacharjee, RN (corresponding author), Osaka Univ, Exploratory Res Adv Technol ERATO, Akira Innate Immun Project, Osaka, Japan.	rbhatta4@uwo.ca; phsmph@nus.edu.sg	Akira, Shizuo/C-3134-2009; Hande, M. Prakash/B-1645-2008	Hande, M. Prakash/0000-0002-4511-6256	Academic Research Fund, Ministry of Education, Singapore [T206B3108]; Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology; Osaka University	Academic Research Fund, Ministry of Education, Singapore(National University of SingaporeMinistry of Education, Singapore); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University	MPH acknowledges the support from Academic Research Fund, Ministry of Education, Singapore (T206B3108) for funding. This work was supported in part by Exploratory Research for Advanced Technology of Japan Science and Technology Agency, grants of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and from the 21st Century Center of Excellence Program of Osaka University to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; BLACKBURN EH, 1991, TRENDS BIOCHEM SCI, V16, P378, DOI 10.1016/0968-0004(91)90155-O; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; di Fagagna FD, 1999, NAT GENET, V23, P76; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech Michael, 2008, V410, P185; Forst B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010374; Guachalla LM, 2009, AGING-US, V1, P303, DOI 10.18632/aging.100030; Hande MP, 1996, INT J RADIAT BIOL, V70, P375, DOI 10.1080/095530096144842; Hande MP, 1997, MUTAGENESIS, V12, P125; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lou ZJ, 2009, AGING-US, V1, P608, DOI 10.18632/aging.100066; Newman JPA, 2008, J CELL PHYSIOL, V214, P796, DOI 10.1002/jcp.21276; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Wiemann SU, 2005, ONCOGENE, V24, P1501, DOI 10.1038/sj.onc.1208308	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11873	10.1371/journal.pone.0011873	http://dx.doi.org/10.1371/journal.pone.0011873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686699	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200035
J	Hu, YM; Shamaei-Tousi, A; Liu, YJ; Coates, A				Hu, Yanmin; Shamaei-Tousi, Alireza; Liu, Yingjun; Coates, Anthony			A New Approach for the Discovery of Antibiotics by Targeting Non-Multiplying Bacteria: A Novel Topical Antibiotic for Staphylococcal Infections	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; RNA-POLYMERASE; MYCOBACTERIUM-TUBERCULOSIS; STATIONARY-PHASE; AUREUS; MUTATIONS; DRUGS; DECOLONIZATION; CHEMOTHERAPY; PREVALENCE	In a clinical infection, multiplying and non-multiplying bacteria co-exist. Antibiotics kill multiplying bacteria, but they are very inefficient at killing non-multipliers which leads to slow or partial death of the total target population of microbes in an infected tissue. This prolongs the duration of therapy, increases the emergence of resistance and so contributes to the short life span of antibiotics after they reach the market. Targeting non-multiplying bacteria from the onset of an antibiotic development program is a new concept. This paper describes the proof of principle for this concept, which has resulted in the development of the first antibiotic using this approach. The antibiotic, called HT61, is a small quinolone-derived compound with a molecular mass of about 400 Daltons, and is active against non-multiplying bacteria, including methicillin sensitive and resistant, as well as Panton-Valentine leukocidin-carrying Staphylococcus aureus. It also kills mupirocin resistant MRSA. The mechanism of action of the drug is depolarisation of the cell membrane and destruction of the cell wall. The speed of kill is within two hours. In comparison to the conventional antibiotics, HT61 kills non-multiplying cells more effectively, 6 logs versus less than one log for major marketed antibiotics. HT61 kills methicillin sensitive and resistant S. aureus in the murine skin bacterial colonization and infection models. No resistant phenotype was produced during 50 serial cultures over a one year period. The antibiotic caused no adverse affects after application to the skin of minipigs. Targeting non-multiplying bacteria using this method should be able to yield many new classes of antibiotic. These antibiotics may be able to reduce the rate of emergence of resistance, shorten the duration of therapy, and reduce relapse rates.	[Hu, Yanmin; Coates, Anthony] Univ London, Ctr Infect, Div Cellular & Mol Med, London, England; [Hu, Yanmin; Shamaei-Tousi, Alireza; Liu, Yingjun; Coates, Anthony] Helperby Therapeut Grp Plc, London, England	University of London	Hu, YM (corresponding author), Univ London, Ctr Infect, Div Cellular & Mol Med, London, England.	acoates@sgul.ac.uk		Coates, Anthony/0000-0001-8052-3175; Hu, Yanmin/0000-0003-0630-5342	Helperby Therapeutics (UK); Helperby Therapeutics	Helperby Therapeutics (UK); Helperby Therapeutics	This work was funded by a grant from Helperby Therapeutics (UK). Helperby Therapeutics also financially supported YM. The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allsop A, 1998, CLIN INFECT DIS, V27, pS141; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P918, DOI 10.1128/AAC.00766-08; BRADLEY SF, 1995, INFECT CONT HOSP EP, V16, P354; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; CAPOBIANCO JO, 1989, ANTIMICROB AGENTS CH, V33, P156, DOI 10.1128/AAC.33.2.156; CASEWELL MW, 1985, J ANTIMICROB CHEMOTH, V15, P523, DOI 10.1093/jac/15.5.523; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Coates ARM, 2008, TRENDS PHARMACOL SCI, V29, P143, DOI 10.1016/j.tips.2007.12.001; Coates Anthony R M, 2006, Drugs R D, V7, P133, DOI 10.2165/00126839-200607030-00001; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Del Pozo JL, 2006, INT J ARTIF ORGANS, V29, P379, DOI 10.1177/039139880602900407; DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drusano GL, 2009, ANTIMICROB AGENTS CH, V53, P2266, DOI 10.1128/AAC.01680-08; ELLNER JJ, 1979, MEDICINE, V58, P145, DOI 10.1097/00005792-197903000-00003; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Hair PI, 2007, DRUGS, V67, P1483, DOI 10.2165/00003495-200767100-00008; Hu YM, 2003, ANTIMICROB AGENTS CH, V47, P653, DOI 10.1128/AAC.47.2.653-657.2003; Hurdle JG, 2005, J ANTIMICROB CHEMOTH, V56, P1166, DOI 10.1093/jac/dki387; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; LEVIN ME, 1993, MOL MICROBIOL, V8, P277, DOI 10.1111/j.1365-2958.1993.tb01572.x; MARKS J, 1990, J CLIN PATHOL, V43, P774, DOI 10.1136/jcp.43.9.774; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; McLeod GI, 1996, J BACTERIOL, V178, P3683, DOI 10.1128/jb.178.13.3683-3688.1996; MITCHISON DA, 1979, CHEST, V76, P771, DOI 10.1378/chest.76.6_Supplement.771; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Mitchison DA, 2004, SEMIN RESP CRIT CARE, V25, P307, DOI 10.1055/s-2004-829503; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; Moellering RC, 1998, CLIN INFECT DIS, V27, pS135; Schmitz FJ, 1998, J ANTIMICROB CHEMOTH, V42, P489, DOI 10.1093/jac/42.4.489; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; STEWART MH, 1992, APPL ENVIRON MICROB, V58, P2649, DOI 10.1128/AEM.58.8.2649-2653.1992; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Walker ES, 2003, INFECT CONT HOSP EP, V24, P342, DOI 10.1086/502218; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; WILLIAMS DL, 1994, ANTIMICROB AGENTS CH, V38, P2380, DOI 10.1128/AAC.38.10.2380; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; YAMADA T, 1985, ANTIMICROB AGENTS CH, V27, P921, DOI 10.1128/AAC.27.6.921; Yang JA, 2006, J KOREAN MED SCI, V21, P827, DOI 10.3346/jkms.2006.21.5.827; Yates RR, 1999, CHEST, V115, p24S, DOI 10.1378/chest.115.suppl_1.24S; Zappia G, 2007, MINI-REV MED CHEM, V7, P389, DOI 10.2174/138955707780363783; Zegans ME, 2002, DNA CELL BIOL, V21, P415, DOI 10.1089/10445490260099700; ZIERSKI M, 1973, PNEUMONOLOGIE, V150, P1, DOI 10.1007/BF02097148	51	47	52	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11818	10.1371/journal.pone.0011818	http://dx.doi.org/10.1371/journal.pone.0011818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676403	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000280371800018
J	Rivero, O; Reif, A; Sanjuan, J; Molto, MD; Kittel-Schneider, S; Najera, C; Topner, T; Lesch, KP				Rivero, Olga; Reif, Andreas; Sanjuan, Julio; Molto, Maria D.; Kittel-Schneider, Sarah; Najera, Carmen; Toepner, Theresia; Lesch, Klaus-Peter			Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A Case-Control Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JOUBERT-SYNDROME; CEREBELLAR DEVELOPMENT; BIPOLAR-DISORDER; CHROMOSOME 6Q23; SUSCEPTIBILITY; LOCUS; METAANALYSIS; EXPRESSION; MUTATIONS	Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys) function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany. Methodology/Principal Findings: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (280 patients with psychotic disorders; 348 controls) and Germany (247 patients with schizophrenic disorders; 360 controls). Allelic, genotypic and haplotype frequencies were compared between cases and controls in both samples separately, as well as in the combined sample. The effect of genotype on several psychopathological measures (BPRS, KGV, PANSS) assessed in a Spanish subsample was also evaluated. We found several significant associations in the Spanish sample. Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). Moreover, several other risk and protective haplotypes were detected (0.006<p<0.036). Joint analysis also supported the association of rs7750586 and rs911507 with the risk for schizophrenia. The analysis of clinical measures also revealed an effect on symptom severity (minimum P value = 0.0037). Conclusions/Significance: Our data support, in agreement with previous reports, an effect of AHI1 variation on the susceptibility to schizophrenia in central and southern European populations.	[Rivero, Olga; Reif, Andreas; Kittel-Schneider, Sarah; Toepner, Theresia; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany; [Rivero, Olga; Molto, Maria D.; Najera, Carmen] Univ Valencia, Dept Genet, Valencia, Spain; [Rivero, Olga; Sanjuan, Julio; Molto, Maria D.; Najera, Carmen] Ctr Biomed Res Network Mental Hlth CIBERSAM, Valencia, Spain; [Sanjuan, Julio] Univ Valencia, Dept Med, Teaching Unit Psychiat, Valencia, Spain	University of Wurzburg; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia	Rivero, O (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany.	RiveroMar_O@klinik.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Rivero, Olga/AAA-8059-2020	Lesch, Klaus-Peter/0000-0001-8348-153X; Molto, Maria Dolores/0000-0001-5219-2022; Rivero, Olga/0000-0002-2664-4053; Kittel-Schneider, Sarah/0000-0003-3057-6150	Spanish Ministry of Health: Instituto de Salud Carlos III [FIS02/0018]; Red de Genotipacion y Psiquiatria Genetica-ISCIII [G03/184]; Red de Enfermedades Mentales (REM-TAP Network); CIBER de Salud Mental (CIBERSAM); Deutsche Forschungsgemeinschaft [RE1632/1-5]; Bundesministerium fur Bildung und Forschung (IZKF Wurzburg) [01KS9603]; European Comission [LSHM-CT-2003-503474]	Spanish Ministry of Health: Instituto de Salud Carlos III(Instituto de Salud Carlos IIISpanish Government); Red de Genotipacion y Psiquiatria Genetica-ISCIII; Red de Enfermedades Mentales (REM-TAP Network); CIBER de Salud Mental (CIBERSAM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (IZKF Wurzburg)(Federal Ministry of Education & Research (BMBF)); European Comission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Spanish Ministry of Health: Instituto de Salud Carlos III, FIS02/0018 (to OR, JS, and CN), Red de Genotipacion y Psiquiatria Genetica-ISCIII G03/184 (to OR, JS, MDM and CN), Red de Enfermedades Mentales (REM-TAP Network) and CIBER de Salud Mental (CIBERSAM) (to OR, JS, MDM and CN). Furthermore, this work was supported by the Deutsche Forschungsgemeinschaft (Grant RE1632/1-5 to AR, Clinical Research Unit - KFO 125 to AR and KPL; SFB 581 to KPL, SFB TRR 58 to AR and KPL), Bundesministerium fur Bildung und Forschung (IZKF Wurzburg, 01KS9603, to KPL; IZKF N-27-N, to AR) and the European Comission (NEWMOOD LSHM-CT-2003-503474, to KPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2006, 20065 MRC BIOST UN; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hirayasu Y, 2007, NEUROPATHOLOGY, V27, P601, DOI 10.1111/j.1440-1789.2007.00827.x; Horrobin DF, 1998, MED HYPOTHESES, V50, P269, DOI 10.1016/S0306-9877(98)90000-7; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; JABLENSKY A, 2003, SCHIZOPHRENIA; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kohn Y, 2005, MOL PSYCHIATR, V10, P1062, DOI 10.1038/sj.mp.4001738; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Langefeld Carl D., 2007, V404, P431, DOI 10.1007/978-1-59745-530-5_21; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levi A, 2005, EUR J HUM GENET, V13, P763, DOI 10.1038/sj.ejhg.5201406; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Selch S, 2007, BIOL PSYCHIAT, V61, P1211, DOI 10.1016/j.biopsych.2006.08.030; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; TORRI F, 2010, FASEB J IN PRESS; White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457	49	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12254	10.1371/journal.pone.0012254	http://dx.doi.org/10.1371/journal.pone.0012254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805890	Green Published, gold, Green Submitted			2022-12-27	WOS:000281011600023
J	Gasparini, C; Simmons, LW; Beveridge, M; Evans, JP				Gasparini, Clelia; Simmons, Leigh W.; Beveridge, Maxine; Evans, Jonathan P.			Sperm Swimming Velocity Predicts Competitive Fertilization Success in the Green Swordtail Xiphophorus helleri	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; GUPPY POECILIA-RETICULATA; CRYPTIC FEMALE CHOICE; INBREEDING AVOIDANCE; MULTIPLE PATERNITY; TRINIDADIAN GUPPY; EVOLUTION; TRAITS; SIZE; PREFERENCE	Sperm competition is expected to favour the evolution of traits that influence the performance of sperm when they compete to fertilize a female's eggs. While there is considerable evidence that selection favours increases in sperm numbers, much less is known about how sperm quality contributes towards competitive fertilization success. Here, we determine whether variation in sperm quality influences competitive fertilization success in the green swordtail Xiphophorus helleri, a highly promiscuous livebearing fish. We use artificial insemination as a method of controlled sperm delivery and show that sperm swimming velocity is the primary determinant of fertilization success when ejaculates from two males compete to fertilize a female's eggs. By contrast, we found no evidence that sperm length had any effect on siring success. We also found no evidence that pre- and postcopulatory sexual traits were phenotypically integrated in this species, suggesting that the previous observation that reproductive skew favours males with high mating rates is unlikely to be due to any direct association between sperm quality and male sexual ornamentation.	[Gasparini, Clelia] Univ Padua, Dipartimento Biol, Padua, Italy; [Simmons, Leigh W.; Beveridge, Maxine; Evans, Jonathan P.] Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Padua; University of Western Australia	Gasparini, C (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	jonevans@cyllene.uwa.edu.au	Evans, Jonathan/A-1992-2011; Gasparini, Clelia/F-2159-2011; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council [DP0663574]; University of Padova	Australian Research Council(Australian Research Council); University of Padova	Funded by the Australian Research Council (DP0663574) and an institutional grant from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; [Anonymous], ECOLOGY EVOLUTION PO; Arnqvist Goran, 2005, pUnpaginated; BASOLO A L, 1990, Animal Behaviour, V40, P332, DOI 10.1016/S0003-3472(05)80928-5; Benson KE, 2006, ANIM BEHAV, V71, P129, DOI 10.1016/j.anbehav.2005.05.004; BILLARD R, 1990, CONTROLS SPERM MOTIL; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Byrne PG, 2003, P ROY SOC B-BIOL SCI, V270, P2079, DOI 10.1098/rspb.2003.2433; CLARK E, 1950, SCIENCE, V112, P722, DOI 10.1126/science.112.2920.722; Crawley M.J., 1993, GLIM ECOLOGISTS; Danielsson I, 2001, P ROY SOC B-BIOL SCI, V268, P77, DOI 10.1098/rspb.2000.1332; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Elgee KE, 2010, J EVOLUTION BIOL, V23, P1331, DOI 10.1111/j.1420-9101.2010.01996.x; Evans JP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1167, DOI 10.1007/s00265-008-0545-0; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia-Gonzalez F, 2007, EVOLUTION, V61, P816, DOI 10.1111/j.1558-5646.2007.00084.x; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Liljedal S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1805, DOI 10.1007/s00265-008-0609-1; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pilastro A, 2004, EVOLUTION, V58, P665, DOI 10.1111/j.0014-3820.2004.tb01690.x; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Rios-Cardenas O, 2010, ECOLOGY EVOLUTION PO; Rosenthal GG, 1996, ANIM BEHAV, V51, P811, DOI 10.1006/anbe.1996.0085; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Seckinger J, 2002, MOL ECOL NOTES, V2, P4, DOI 10.1046/j.1471-8286.2002.00124.x; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tatarenkov A, 2008, MOL ECOL, V17, P4522, DOI 10.1111/j.1365-294X.2008.03936.x; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Vladic TV, 2002, BIOL REPROD, V66, P98, DOI 10.1095/biolreprod66.1.98; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Yue GH, 2004, MOL ECOL NOTES, V4, P474, DOI 10.1111/j.1471-8286.2004.00675.x	48	103	104	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12146	10.1371/journal.pone.0012146	http://dx.doi.org/10.1371/journal.pone.0012146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730092	Green Published, gold, Green Submitted			2022-12-27	WOS:000280862200007
J	Paskaleva, EE; Xue, J; Lee, DYW; Shekhtman, A; Canki, M				Paskaleva, Elena E.; Xue, Jing; Lee, David Y-W.; Shekhtman, Alexander; Canki, Mario			Palmitic Acid Analogs Exhibit Nanomolar Binding Affinity for the HIV-1 CD4 Receptor and Nanomolar Inhibition of gp120-to-CD4 Fusion	PLOS ONE			English	Article							PROTEINS; DOCKING	Background: We recently reported that palmitic acid (PA) is a novel and efficient CD4 fusion inhibitor to HIV-1 entry and infection. In the present report, based on in silico modeling of the novel CD4 pocket that binds PA, we describe discovery of highly potent PA analogs with increased CD4 receptor binding affinities (K-d) and gp120-to-CD4 inhibition constants (K-i). The PA analogs were selected to satisfy Lipinski's rule of drug-likeness, increased solubility, and to avoid potential cytotoxicity. Principal Findings: PA analog 2-bromopalmitate (2-BP) was most efficacious with K-d similar to 74 nM and K-i similar to 122 nM, ascorbyl palmitate (6-AP) exhibited slightly higher K-d similar to 140 nM and K-i similar to 354 nM, and sucrose palmitate (SP) was least efficacious binding to CD4 with K-d similar to 364 nM and inhibiting gp120-to-CD4 binding with K-i similar to 1486 nM. Importantly, PA and its analogs specifically bound to the CD4 receptor with the one to one stoichiometry. Significance: Considering observed differences between K-i and K-d values indicates clear and rational direction for improving inhibition efficacy to HIV-1 entry and infection. Taken together this report introduces a novel class of natural small molecules fusion inhibitors with nanomolar efficacy of CD4 receptor binding and inhibition of HIV-1 entry.	[Paskaleva, Elena E.; Canki, Mario] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Xue, Jing; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Lee, David Y-W.] Harvard Univ, Sch Med, McLean Hosp, Mailman Res Ctr, Belmont, MA 02178 USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; McLean Hospital	Paskaleva, EE (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	cankim@mail.amc.edu		Paskaleva, Elena/0000-0002-4291-9969; Shekhtman, Alexander/0000-0003-2649-2675	NIH [AT003371]; American Diabetes Association [1-06-CD-23, 1R01GM085006]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant number AT003371 to MC and American Diabetes Association Career Development Award number 1-06-CD-23 and 1R01GM085006 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Bhal SK, 2007, MOL PHARMACEUT, V4, P556, DOI 10.1021/mp0700209; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dong SL, 2008, J PHYS CHEM B, V112, P9371, DOI 10.1021/jp801216e; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Goodsell D.S, 2009, CSH PROTOC; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; Lee DYW, 2009, AIDS RES HUM RETROV, V25, P1231, DOI 10.1089/aid.2009.0019; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Paskaleva Elena E, 2006, AIDS Res Ther, V3, P15, DOI 10.1186/1742-6405-3-15; Paskaleva EE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-8; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14	15	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12168	10.1371/journal.pone.0012168	http://dx.doi.org/10.1371/journal.pone.0012168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730055	Green Published, Green Submitted, gold			2022-12-27	WOS:000280862200022
J	Gurung, RL; Lim, SN; Khaw, AK; Soon, JFF; Shenoy, K; Ali, SM; Jayapal, M; Sethu, S; Baskar, R; Hande, MP				Gurung, Resham Lal; Lim, Shi Ni; Khaw, Aik Kia; Soon, Jasmine Fen Fen; Shenoy, Kirthan; Ali, Safiyya Mohamed; Jayapal, Manikandan; Sethu, Swaminathan; Baskar, Rajamanickam; Hande, M. Prakash			Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DENSELY IONIZING-RADIATION; MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; HUMAN CANCER; INHIBITION; EXPOSURE; LENGTH; DEATH; PKCS	Background: A major concern of cancer chemotherapy is the side effects caused by the non-specific targeting of both normal and cancerous cells by therapeutic drugs. Much emphasis has been placed on discovering new compounds that target tumour cells more efficiently and selectively with minimal toxic effects on normal cells. Methodology/Principal Findings: The cytotoxic effect of thymoquinone, a component derived from the plant Nigella sativa, was tested on human glioblastoma and normal cells. Our findings demonstrated that glioblastoma cells were more sensitive to thymoquinone-induced antiproliferative effects. Thymoquinone induced DNA damage, cell cycle arrest and apoptosis in the glioblastoma cells. It was also observed that thymoquinone facilitated telomere attrition by inhibiting the activity of telomerase. In addition to these, we investigated the role of DNA-PKcs on thymoquinone mediated changes in telomere length. Telomeres in glioblastoma cells with DNA-PKcs were more sensitive to thymoquinone mediated effects as compared to those cells deficient in DNA-PKcs. Conclusions/Significance: Our results indicate that thymoquinone induces DNA damage, telomere attrition by inhibiting telomerase and cell death in glioblastoma cells. Telomere shortening was found to be dependent on the status of DNA-PKcs. Collectively, these data suggest that thymoquinone could be useful as a potential chemotherapeutic agent in the management for brain tumours.	[Gurung, Resham Lal; Lim, Shi Ni; Khaw, Aik Kia; Soon, Jasmine Fen Fen; Shenoy, Kirthan; Ali, Safiyya Mohamed; Jayapal, Manikandan; Sethu, Swaminathan; Hande, M. Prakash] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Baskar, Rajamanickam] Natl Canc Ctr, Dept Radiat Oncol, Div Cellular & Mol Res, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS)	Gurung, RL (corresponding author), Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	phsmph@nus.edu.sg	Hande, M. Prakash/B-1645-2008; Sethu, Swaminathan/R-8577-2019; Jayapal, Manikandan/H-9847-2012	Hande, M. Prakash/0000-0002-4511-6256; J, manikandan/0000-0001-6744-8852; Sethu, Swaminathan/0000-0001-9210-2554	Ministry of Education, Singapore [T206B3108, WBS: 185-000-153-112]; National Medical Research Council, Ministry of Health, Singapore [NMRC/EDG/0052/2009, WBS: R-185-000-192-275]	Ministry of Education, Singapore(Ministry of Education, Singapore); National Medical Research Council, Ministry of Health, Singapore(National Medical Research Council, Singapore)	This work was supported by the grants from Academic Research Fund, Ministry of Education, Singapore (T206B3108; WBS: 185-000-153-112) and National Medical Research Council, Ministry of Health, Singapore (NMRC/EDG/0052/2009; WBS: R-185-000-192-275). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal BB, 2008, PLANTA MED, V74, P1560, DOI 10.1055/s-2008-1074578; Bailey SM, 2004, DNA REPAIR, V3, P225, DOI 10.1016/j.dnarep.2003.10.013; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Chen GG, 2005, J CELL PHYSIOL, V203, P127, DOI 10.1002/jcp.20230; de Lange T, 1999, SCIENCE, V283, P947, DOI 10.1126/science.283.5404.947; di Fagagna FD, 1999, NAT GENET, V23, P76; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Falchetti ML, 2000, INT J CANCER, V88, P895, DOI 10.1002/1097-0215(20001215)88:6<895::AID-IJC9>3.0.CO;2-V; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Hande MP, 2005, GENE CHROMOSOME CANC, V44, P1, DOI 10.1002/gcc.20217; Hande MP, 2004, CYTOGENET GENOME RES, V104, P116, DOI 10.1159/000077475; Hande MP, 2003, AM J HUM GENET, V72, P1162, DOI 10.1086/375041; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hande P, 1999, GENOMICS, V56, P221, DOI 10.1006/geno.1998.5668; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Holgersson A, 2005, INT J RADIAT ONCOL, V61, P915, DOI 10.1016/j.ijrobp.2004.10.036; Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8; Kondo Y, 1998, ONCOGENE, V16, P2243, DOI 10.1038/sj.onc.1201754; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; LALUNISTURNER MJ, 1993, RADIAT RES, V134, P349; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Padhye Subhash, 2008, Cancer Ther, V6, P495; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shay JW, 2005, CANCER CELL, V7, P1, DOI 10.1016/j.ccr.2004.12.012; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shiraishi S, 2002, CANCER-AM CANCER SOC, V95, P249, DOI 10.1002/cncr.10677; Shoieb AM, 2003, INT J ONCOL, V22, P107; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Virsik-Kopp P, 2003, INT J RADIAT BIOL, V79, P61, DOI 10.1080/0955300021000038644; Vuorela P, 2004, CURR MED CHEM, V11, P1375, DOI 10.2174/0929867043365116; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Worthen DR, 1998, ANTICANCER RES, V18, P1527; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	41	111	113	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12124	10.1371/journal.pone.0012124	http://dx.doi.org/10.1371/journal.pone.0012124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711342	gold, Green Submitted, Green Published			2022-12-27	WOS:000280859700016
J	Morillo-Huesca, M; Clemente-Ruiz, M; Andujar, E; Prado, F				Morillo-Huesca, Macarena; Clemente-Ruiz, Marta; Andujar, Eloisa; Prado, Felix			The SWR1 Histone Replacement Complex Causes Genetic Instability and Genome-Wide Transcription Misregulation in the Absence of H2A.Z	PLOS ONE			English	Article							VARIANT H2A.Z; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CHECKPOINT ACTIVATION; DNA; YEAST; INO80; RECRUITMENT; EXCHANGE; ADAPTATION	The SWR1 complex replaces the canonical histone H2A with the variant H2A.Z (Htz1 in yeast) at specific chromatin regions. This dynamic alteration in nucleosome structure provides a molecular mechanism to regulate transcription, gene silencing, chromosome segregation and DNA repair. Here we show that genetic instability, sensitivity to drugs impairing different cellular processes and genome-wide transcriptional misregulation in htz1 Delta can be partially or totally suppressed if SWR1 is not formed (swr1 Delta), if it forms but cannot bind to chromatin (swc2 Delta) or if it binds to chromatin but lacks histone replacement activity (swc5 Delta and the ATPase-dead swr1-K727G). These results suggest that in htz1 Delta the nucleosome remodelling activity of SWR1 affects chromatin integrity because of an attempt to replace H2A with Htz1 in the absence of the latter. This would impair transcription and, either directly or indirectly, other cellular processes. Specifically, we show that in htz1 Delta, the SWR1 complex causes an accumulation of recombinogenic DNA damage by a mechanism dependent on phosphorylation of H2A at Ser129, a modification that occurs in response to DNA damage, suggesting that the SWR1 complex impairs the repair of spontaneous DNA damage in htz1 Delta. In addition, SWR1 causes DSBs sensitivity in htz1 Delta; consistently, in the absence of Htz1 the SWR1 complex bound near an endonuclease HO-induced DSB at the mating-type (MAT) locus impairs DSB-induced checkpoint activation. Our results support a stepwise mechanism for the replacement of H2A with Htz1 and demonstrate that a tight control of this mechanism is essential to regulate chromatin dynamics but also to prevent the deleterious consequences of an incomplete nucleosome remodelling.	[Morillo-Huesca, Macarena; Clemente-Ruiz, Marta; Prado, Felix] CABIMER CSIC, Dept Mol Biol, Seville, Spain; [Andujar, Eloisa] CABIMER CSIC, Genom Unit, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Morillo-Huesca, M (corresponding author), CABIMER CSIC, Dept Mol Biol, Seville, Spain.	felix.prado@cabimer.es	Morillo-Huesca, Macarena/H-5144-2015; Prado, Felix/G-7700-2015	Morillo-Huesca, Macarena/0000-0002-2914-4871; Prado, Felix/0000-0001-9805-782X; Andujar, Eloisa/0000-0002-8434-5078	Spanish Ministry of Education and Science [BFU2006-08336]; Junta de Andalucia [P07-CVI-032000]; Spanish Research Council (CSIC)	Spanish Ministry of Education and Science(Spanish Government); Junta de Andalucia(Junta de Andalucia); Spanish Research Council (CSIC)	The research was funded by the Spanish Ministry of Education and Science (BFU2006-08336 grant) and the Junta de Andalucia (P07-CVI-032000). M.C-R. was a recipient of a pre-doctoral training grant from the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Amberg DC., 2005, METHODS YEAST GENETI; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hecht A, 1999, METHOD ENZYMOL, V304, P399; HORIKAWA I, 1995, BIOCHEM BIOPH RES CO, V208, P999, DOI 10.1006/bbrc.1995.1433; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2005, GENE, V363, P183, DOI 10.1016/j.gene.2005.09.007; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; NAUMOV G, 1992, YEAST, V8, P599, DOI 10.1002/yea.320080804; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; PRADO F, 1995, GENETICS, V139, P109; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schmid M, 2004, MOL CELL, V16, P147, DOI 10.1016/j.molcel.2004.09.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zhang CJ, 2005, FLUID PHASE EQUILIBR, V231, P1, DOI 10.1016/j.fluid.2005.03.018; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	57	75	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12143	10.1371/journal.pone.0012143	http://dx.doi.org/10.1371/journal.pone.0012143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711347	gold, Green Submitted, Green Published			2022-12-27	WOS:000280859700025
J	Kunin, M; Dmitrieva, NI; Gallazzini, M; Shen, RF; Wang, GH; Burg, MB; Ferraris, JD				Kunin, Margarita; Dmitrieva, Natalia I.; Gallazzini, Morgan; Shen, Rong-Fong; Wang, Guanghui; Burg, Maurice B.; Ferraris, Joan D.			Mediator of DNA Damage Checkpoint 1 (MDC1) Contributes to High NaCl-Induced Activation of the Osmoprotective Transcription Factor TonEBP/OREBP	PLOS ONE			English	Article							ENHANCER-BINDING PROTEIN; STIMULATES TRANSCRIPTION; NUCLEAR-LOCALIZATION; INDUCIBLE KINASE; PHOSPHORYLATION; ATM; TRANSACTIVATION; TONEBP/NFAT5; INDUCTION; BREAKS	Background: Hypertonicity, such as induced by high NaCl, increases the activity of the transcription factor TonEBP/OREBP whose target genes increase osmoprotective organic osmolytes and heat shock proteins. Methodology: We used mass spectrometry to analyze proteins that coimmunoprecipitate with TonEBP/OREBP in order to identify ones that might contribute to its high NaCl-induced activation. Principal Findings: We identified 20 unique peptides from Mediator of DNA Damage Checkpoint 1 (MDC1) with high probability. The identification was confirmed by Western analysis. We used small interfering RNA knockdown of MDC1 to characterize its osmotic function. Knocking down MDC1 reduces high NaCl-induced increases in TonEBP/OREBP transcriptional and transactivating activity, but has no significant effect on its nuclear localization. We confirm six previously known phosphorylation sites in MDC1, but do not find evidence that high NaCl increases phosphorylation of MDC1. It is suggestive that MDC1 acts as a DNA damage response protein since hypertonicity reversibly increases DNA breaks, and other DNA damage response proteins, like ATM, also associate with TonEBP/OREBP and contribute to its activation by hypertonicity. Conclusions/Significance: MDC1 associates with TonEBP/OREBP and contributes to high NaCl-induced increase of that factor's transcriptional activity.	[Kunin, Margarita; Dmitrieva, Natalia I.; Gallazzini, Morgan; Burg, Maurice B.; Ferraris, Joan D.] NHLBI, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA; [Shen, Rong-Fong; Wang, Guanghui] NHLBI, Prote Core Facil, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kunin, M (corresponding author), Chaim Sheba Med Ctr, Dept Hypertens & Nephrol, IL-52621 Tel Hashomer, Israel.	maurice_burg@nih.gov	Dmitrieva, Natalia/A-2924-2013; Gallazzini, Morgan/E-5465-2011; Dmitrieva, Natalia/Q-9175-2019	Dmitrieva, Natalia/0000-0001-8074-6950; Gallazzini, Morgan/0000-0002-7185-7162; Dmitrieva, Natalia/0000-0001-8074-6950; Kunin, Margarita/0000-0003-4889-0420	National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006134, ZICHL005903, ZIAHL001283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000576] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Colla E, 2006, BIOCHEM J, V393, P411, DOI 10.1042/BJ20051082; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Dmitrieva NI, 2008, AM J PHYSIOL-RENAL, V295, pF1678, DOI 10.1152/ajprenal.90424.2008; Dmitrieva NI, 2005, AM J PHYSIOL-RENAL, V289, pF2, DOI 10.1152/ajprenal.00041.2005; Dmitrieva NI, 2005, P NATL ACAD SCI USA, V102, P10730, DOI 10.1073/pnas.0504870102; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dmitrieva NI, 2003, AM J PHYSIOL-RENAL, V285, pF266, DOI 10.1152/ajprenal.00060.2003; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Ferraris JD, 2007, METHOD ENZYMOL, V428, P279, DOI 10.1016/S0076-6879(07)28016-4; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lou Zhenkun, 2004, Methods Mol Biol, V281, P179; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mochan TA, 2003, CANCER RES, V63, P8586; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rauchman MI, 1997, AM J PHYSIOL-RENAL, V273, pF9, DOI 10.1152/ajprenal.1997.273.1.F9; SPYCHER C, 2008, CELL BIOL, V181, P227; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhou XM, 2006, AM J PHYSIOL-RENAL, V290, pF1169, DOI 10.1152/ajprenal.00378.2005	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12108	10.1371/journal.pone.0012108	http://dx.doi.org/10.1371/journal.pone.0012108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711462	Green Submitted, Green Published, gold			2022-12-27	WOS:000280849100027
J	Cassey, P; Portugal, SJ; Maurer, G; Ewen, JG; Boulton, RL; Hauber, ME; Blackburn, TM				Cassey, Phillip; Portugal, Steven J.; Maurer, Golo; Ewen, John G.; Boulton, Rebecca L.; Hauber, Mark E.; Blackburn, Tim M.			Variability in Avian Eggshell Colour: A Comparative Study of Museum Eggshells	PLOS ONE			English	Article							EGG-COLOR; SEXUAL SELECTION; PHYLOGENETIC ANALYSIS; VISUAL PIGMENTS; CUCULUS-CANORUS; EVOLUTION; VISION; CUCKOO; BIRDS; PATTERNS	Background: The exceptional diversity of coloration found in avian eggshells has long fascinated biologists and inspired a broad range of adaptive hypotheses to explain its evolution. Three main impediments to understanding the variability of eggshell appearance are: (1) the reliable quantification of the variation in eggshell colours; (2) its perception by birds themselves, and (3) its relation to avian phylogeny. Here we use an extensive museum collection to address these problems directly, and to test how diversity in eggshell coloration is distributed among different phylogenetic levels of the class Aves. Methodology and Results: Spectrophotometric data on eggshell coloration were collected from a taxonomically representative sample of 251 bird species to determine the change in reflectance across different wavelengths and the taxonomic level where the variation resides. As many hypotheses for the evolution of eggshell coloration assume that egg colours provide a communication signal for an avian receiver, we also modelled reflectance spectra of shell coloration for the avian visual system. We found that a majority of species have eggs with similar background colour (long wavelengths) but that striking differences are just as likely to occur between congeners as between members of different families. The region of greatest variability in eggshell colour among closely related species coincided with the medium-wavelength sensitive region around 500 nm. Conclusions: The majority of bird species share similar background eggshell colours, while the greatest variability among species aligns with differences along a red-brown to blue axis that most likely corresponds with variation in the presence and concentration of two tetrapyrrole pigments responsible for eggshell coloration. Additionally, our results confirm previous findings of temporal changes in museum collections, and this will be of particular concern for studies testing intraspecific hypotheses relating temporal patterns to adaptation of eggshell colour. We suggest that future studies investigating the phylogenetic association between the composition and concentration of eggshell pigments, and between the evolutionary drivers and functional impacts of eggshell colour variability will be most rewarding.	[Cassey, Phillip; Portugal, Steven J.; Maurer, Golo; Boulton, Rebecca L.] Univ Birmingham, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England; [Ewen, John G.; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hauber, Mark E.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA	University of Birmingham; Zoological Society of London; City University of New York (CUNY) System; Hunter College (CUNY)	Cassey, P (corresponding author), Univ Birmingham, Sch Biosci, Ctr Ornithol, Birmingham, W Midlands, England.	p.cassey@bham.ac.uk	Blackburn, Tim/AAC-3144-2019; Blackburn, Tim M/A-7685-2011	Blackburn, Tim/0000-0003-0152-2663; Cassey, Phillip/0000-0002-2626-0172; Portugal, Steven/0000-0002-2438-2352	Human Frontier Science Program [RGY0069/2007-C]; Leverhulme Trust [F/00 094/AX]	Human Frontier Science Program(Human Frontier Science Program); Leverhulme Trust(Leverhulme Trust)	The work was funded by a Human Frontier Science Program (http://www.hfsp.org/) young investigators' grant (RGY0069/2007-C) and a Leverhulme Trust (http://www.leverhulme.ac.uk/) project grant (F/00 094/AX) to PC and MEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Aviles JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P475, DOI 10.1007/s00265-006-0275-0; BAKKEN GS, 1978, SCIENCE, V200, P321, DOI 10.1126/science.200.4339.321; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; BENNETT PM, 2002, EVOLUTIONARY ECOLOGY; BIRKHEAD TR, 1978, ANIM BEHAV, V26, P321, DOI 10.1016/0003-3472(78)90050-7; BLACKBURN DG, 1986, AM NAT, V128, P165, DOI 10.1086/284552; Burley R., 1989, AVIAN EGG CHEM BIOL; Cassey P, 2009, IBIS, V151, P689, DOI 10.1111/j.1474-919X.2009.00953.x; Cherry MI, 2001, P ROY SOC B-BIOL SCI, V268, P565, DOI 10.1098/rspb.2000.1414; COLLIAS EC, 1993, AUK, V110, P683, DOI 10.2307/4088624; Cott H. B, 1957, ADAPTIVE COLORATION; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2004, EVOLUTION, V58, P2558; Fischer H, 1923, H-S Z PHYSIOL CHEM, V131, P241, DOI 10.1515/bchm2.1923.131.4-6.241; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Gosler Andrew G., 2006, British Birds, V99, P338; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hanley D, 2010, AUK, V127, P453, DOI 10.1525/auk.2009.09090; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Ishikawa S, 2010, FEBS LETT, V584, P770, DOI 10.1016/j.febslet.2009.12.041; Jones CD, 2004, VISION RES, V44, P83, DOI 10.1016/j.visres.2003.08.014; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kilner RM, 2006, BIOL REV, V81, P383, DOI 10.1017/S1464793106007044; Knox Alan G., 1992, Bulletin of the British Ornithologists' Club, V112A, P169; LACK DAVID, 1958, IBIS, V100, P145; Lahti DC, 2008, AUK, V125, P796, DOI 10.1525/auk.2008.07033; Langmore NE, 2009, ANIM BEHAV, V78, P461, DOI 10.1016/j.anbehav.2009.06.003; Lemberg R, 1934, BIOCHEM J, V28, P978, DOI 10.1042/bj0280978; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Magige FJ, 2008, J ORNITHOL, V149, P323, DOI 10.1007/s10336-008-0273-2; Martin W, 2008, AUST J AGR RESOUR EC, V52, P1, DOI 10.1111/j.1467-8489.2008.00404.x; MCALDOWIE AM, 1886, J ANATOMY PHYSL, V20, P225; Milgrom LR, 1997, NATURE, V390, P136; Montgomerie R., 2006, BIRD COLORATION, P90; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; POOLE HK, 1966, P SOC EXP BIOL MED, V122, P596; PURCELL R, 2008, EGG NEST; Reynolds SJ, 2009, ANIM BEHAV, V78, P209, DOI 10.1016/j.anbehav.2009.03.003; Schlaepfer Kurt, 2009, Vogelwelt, V130, P99; Shen YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008838; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sibley CG, 1990, DISTRIBUTION TAXONOM; Soler JJ, 2005, EVOLUTION, V59, P636; Solomon SE, 1997, EGG EGGSHELL QUALITY, V1st; Starling M, 2006, P ROY SOC B-BIOL SCI, V273, P1929, DOI 10.1098/rspb.2006.3490; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Stokke BG, 2002, EVOLUTION, V56, P199; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; TINBERGEN N., 1962, BEHAVIOUR, V19, P74, DOI 10.1163/156853961X00213; Underwood TJ., 2002, AVIAN INCUBATION BEH, P280; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Wallace AR, 1889, DARWINISM; Walters M., 1994, BIRDS EGGS; WALTERS M, 2006, HIST BIOL, V18, P141; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Wellman-Labadie O, 2008, COMP BIOCHEM PHYS B, V149, P640, DOI 10.1016/j.cbpb.2008.01.001; [No title captured]	72	48	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2010	5	8							e12054	10.1371/journal.pone.0012054	http://dx.doi.org/10.1371/journal.pone.0012054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636XC	20711258	Green Submitted, Green Published, gold			2022-12-27	WOS:000280776800018
J	Yao, JR; Wang, CL; Walsh, SA; Hu, SM; Sawatzke, AB; Dang, D; Segar, JL; Ponto, LLB; Sunderland, JJ; Norris, AW				Yao, Jianrong; Wang, Chunlin; Walsh, Susan A.; Hu, Shanming; Sawatzke, Alexander B.; Dang, Diana; Segar, Jeffrey L.; Ponto, Laura L. B.; Sunderland, John J.; Norris, Andrew W.			Localized Fetomaternal Hyperglycemia: Spatial and Kinetic Definition by Positron Emission Tomography	PLOS ONE			English	Article							FETAL-GROWTH; BLOOD-FLOW; MATERNAL METABOLISM; ADULT-RATS; GLUCOSE; RESISTANCE; SECRETION; INFUSION; EXPOSURE; POTENCY	Background: Complex but common maternal diseases such as diabetes and obesity contribute to adverse fetal outcomes. Understanding of the mechanisms involved is hampered by difficulty in isolating individual elements of complex maternal states in vivo. We approached this problem in the context of maternal diabetes and sought an approach to expose the developing fetus in vivo to isolated hyperglycemia in the pregnant rat. Methodology and Principal Findings: We hypothesized that glucose infused into the arterial supply of one uterine horn would more highly expose fetuses in the ipsilateral versus contralateral uterine horn. To test this, the glucose tracer [F-18] fluorodeoxyglucose (FDG) was infused via the left uterine artery. Regional glucose uptake into maternal tissues and fetuses was quantified using positron emission tomography (PET). Upon infusion, FDG accumulation began in the left-sided placentae, subsequently spreading to the fetuses. Over two hours after completion of the infusion, FDG accumulation was significantly greater in left compared to right uterine horn fetuses, favoring the left by 1.9 +/- 0.1 and 2.8 +/- 0.3 fold under fasted and hyperinsulinemic conditions (p<10(-11) n = 32-35 and p<10(-12) n = 27-45) respectively. By contrast, centrally administered [H-3]-2-deoxyglucose accumulated equally between the fetuses of the two uterine horns. Induction of significant hyperglycemia (10(3) mg/dL) localized to the left uterine artery was sustained for at least 48 hours while maternal euglycemia was maintained. Conclusions and Significance: This approach exposes selected fetuses to localized hyperglycemia in vivo, minimizing exposure of the mother and thus secondary effects. Additionally, a set of less exposed internal control fetuses are maintained for comparison, allowing direct study of the in vivo fetal effects of isolated hyperglycemia. Broadly, this approach can be extended to study a variety of maternal-sided perturbations suspected to directly affect fetal health.	[Yao, Jianrong; Wang, Chunlin; Hu, Shanming; Sawatzke, Alexander B.; Dang, Diana; Segar, Jeffrey L.; Norris, Andrew W.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Walsh, Susan A.; Ponto, Laura L. B.; Sunderland, John J.] Univ Iowa, Carver Coll Med, Small Anim Imaging Core, Iowa City, IA USA; [Ponto, Laura L. B.; Sunderland, John J.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Yao, JR (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.	andrew-norris@uiowa.edu	Norris, Andrew W/O-5499-2018	Norris, Andrew W/0000-0001-8396-9543; Sunderland, John/0000-0002-0891-1234; Walsh, Susan/0000-0002-6632-5583; Segar, Jeffrey/0000-0001-7311-8948; Ponto, Laura/0000-0003-1197-6714	American Diabetes Association [1-08-RA-142]; National Institutes of Health (NIH) [R01-DK081548, P30 CA086862]; Burlington Care for Kids; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081548] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burlington Care for Kids; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Diabetes Association's Amaranth Diabetes Fund 1-08-RA-142 ( to A.W.N.), National Institutes of Health (NIH) R01-DK081548 (to A.W.N.), NIH P30 CA086862 (cancer center support grant for the University of Iowa Small Animal Imaging Core), and the Burlington Care for Kids fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON RN, 1976, BIOCHEM J, V156, P233, DOI 10.1042/bj1560233; Bertuzzi A, 1997, BRIT J NUTR, V78, P143, DOI 10.1079/BJN19970126; BIHOREAU MT, 1986, DIABETES, V35, P979, DOI 10.2337/diabetes.35.9.979; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BRUCE N, 1979, BIOL REPROD, V21, P229, DOI 10.1095/biolreprod21.1.229; BUCHANAN TA, 1994, DIABETES, V43, P656, DOI 10.2337/diabetes.43.5.656; BUCHANAN TA, 2000, DIABETES MELLITUS FU, P852; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; DASTON GP, 1989, TERATOLOGY, V40, P555, DOI 10.1002/tera.1420400603; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; EVEN MD, 1994, J REPROD FERTIL, V102, P245; Fauque P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009218; Finnell RH, 2002, ANNU REV PHARMACOL, V42, P181, DOI 10.1146/annurev.pharmtox.42.083001.110955; FLAKE AW, 1986, J PEDIATR SURG, V21, P481, DOI 10.1016/S0022-3468(86)80216-0; FRASER I, 1984, J LEUKOCYTE BIOL, V36, P647, DOI 10.1002/jlb.36.5.647; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; GAUGUIER D, 1991, DIABETES, V40, P109, DOI 10.2337/diab.40.2.S109; Greene EC, 1935, T AM PHILOS SOC, V27, P370; HIRANO T, 1990, DIABETES RES CLIN PR, V9, P231, DOI 10.1016/0168-8227(90)90050-4; Holemans K, 2003, J SOC GYNECOL INVEST, V10, P392, DOI 10.1016/S1071-5576(03)00134-5; KHERA KS, 1987, CRIT REV TOXICOL, V17, P345, DOI 10.3109/10408448709029326; LASUNCION MA, 1983, BIOL NEONATE, V44, P85; Loeken MR, 2008, DIABETES, V57, P3187, DOI 10.2337/db08-1201; Maayan-Metzger A, 2009, NEONATOLOGY, V96, P80, DOI 10.1159/000203337; Massa HM, 1997, BIOL REPROD, V57, P43, DOI 10.1095/biolreprod57.1.43; MAYER M, 1992, CHEMOSPHERE, V25, P1195, DOI 10.1016/0045-6535(92)90129-F; MOORE DCP, 1989, TERATOLOGY, V40, P237, DOI 10.1002/tera.1420400305; Oakes ND, 1999, J LIPID RES, V40, P1155; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; RIZZO T, 1991, NEW ENGL J MED, V325, P911, DOI 10.1056/NEJM199109263251303; SADLER TW, 1989, DIABETES, V38, P70, DOI 10.2337/diabetes.38.1.70; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Schmatz M, 2010, J PERINATOL, V30, P441, DOI 10.1038/jp.2009.182; SCHNEIDEREIT M, 1985, LAB ANIM, V19, P240, DOI 10.1258/002367785780893674; Scialli AR, 2010, REPROD TOXICOL, V29, P247, DOI 10.1016/j.reprotox.2009.10.010; Segar EM, 2009, CLIN SCI, V117, P129, DOI 10.1042/CS20080550; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; Weiss SJ, 2007, J CHILD PSYCHOL PSYC, V48, P773, DOI 10.1111/j.1469-7610.2007.01745.x; Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061; Zawiejska A, 2008, J PHYSIOL PHARMACOL, V59, P5	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2010	5	8							e12027	10.1371/journal.pone.0012027	http://dx.doi.org/10.1371/journal.pone.0012027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635WK	20700464	Green Submitted, Green Published, gold			2022-12-27	WOS:000280687900018
J	Stieren, E; Werchan, WP; El Ayadi, A; Li, FZ; Boehning, D				Stieren, Emily; Werchan, Walter P.; El Ayadi, Amina; Li, Fuzhen; Boehning, Darren			FAD Mutations in Amyloid Precursor Protein Do Not Directly Perturb Intracellular Calcium Homeostasis	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-PROTEIN; MUTANT PRESENILIN-1; MISSENSE MUTATION; APP GENE; IN-VIVO; A-BETA; CA2+; ENTRY; MICE	Disturbances in intracellular calcium homeostasis are likely prominent and causative factors leading to neuronal cell death in Alzheimer's disease (AD). Familial AD (FAD) is early-onset and exhibits autosomal dominant inheritance. FAD-linked mutations have been found in the genes encoding the presenilins and amyloid precursor protein (APP). Several studies have shown that mutated presenilin proteins can directly affect calcium release from intracellular stores independently of A beta production. Although less well established, there is also evidence that APP may directly modulate intracellular calcium homeostasis. Here, we directly examined whether overexpression of FAD-linked APP mutants alters intracellular calcium dynamics. In contrast to previous studies, we found that overexpression of mutant APP has no effects on basal cytosolic calcium, ER calcium store size or agonist-induced calcium release and subsequent entry. Thus, we conclude that mutated APP associated with FAD has no direct effect on intracellular calcium homeostasis independently of A beta production.	[Stieren, Emily; Werchan, Walter P.; El Ayadi, Amina; Li, Fuzhen; Boehning, Darren] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA; [Boehning, Darren] Univ Texas Galveston, Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Boehning, D (corresponding author), Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77550 USA.	dfboehni@utmb.edu	; Boehning, Darren/I-8539-2015	El Ayadi, Amina/0000-0002-3657-0633; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [R21AG031948, F30AG030878]; Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL INSTITUTE ON AGING [F30AG030878, R21AG031948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean C. and William D. Willis Neuroscience Research Endowment; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (www.nih.gov) grants R21AG031948 (D. Boehning) and F30AG030878 (E. Stieren) and funds provided by the Jean C. and William D. Willis Neuroscience Research Endowment (E. Stieren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; De Strooper B, 2000, J CELL SCI, V113, P1857; Duyckaerts C, 1997, NEUROBIOL AGING, V18, pS33, DOI 10.1016/S0197-4580(97)00067-5; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; KAMINO K, 1992, AM J HUM GENET, V51, P998; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Leissring MA, 1999, J NEUROCHEM, V72, P1061, DOI 10.1046/j.1471-4159.1999.0721061.x; Leissring MA, 1999, J BIOL CHEM, V274, P32535, DOI 10.1074/jbc.274.46.32535; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Rojas G, 2008, EXP NEUROL, V209, P234, DOI 10.1016/j.expneurol.2007.09.024; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2005, ARCH NEUROL-CHICAGO, V62, P192, DOI 10.1001/archneur.62.2.192; Solovyova N, 2002, CELL CALCIUM, V32, P49, DOI 10.1016/S0143-4160(02)00094-5; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2010	5	8							e11992	10.1371/journal.pone.0011992	http://dx.doi.org/10.1371/journal.pone.0011992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634SK	20700539	Green Published, gold, Green Submitted			2022-12-27	WOS:000280605400024
J	Saleem, RA; Long-O'Donnell, R; Dilworth, DJ; Armstrong, AM; Jamakhandi, AP; Wan, Y; Knijnenburg, TA; Niemisto, A; Boyle, J; Rachubinski, RA; Shmulevich, I; Aitchison, JD				Saleem, Ramsey A.; Long-O'Donnell, Rose; Dilworth, David J.; Armstrong, Abraham M.; Jamakhandi, Arvind P.; Wan, Yakun; Knijnenburg, Theo A.; Niemisto, Antti; Boyle, John; Rachubinski, Richard A.; Shmulevich, Ilya; Aitchison, John D.			Genome-Wide Analysis of Effectors of Peroxisome Biogenesis	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; PROTEIN FAMILY; FATTY-ACID; IMPORT; UBIQUITINATION; RECEPTOR; MATRIX; PEX5P; INHERITANCE	Peroxisomes are intracellular organelles that house a number of diverse metabolic processes, notably those required for beta-oxidation of fatty acids. Peroxisomes biogenesis can be induced by the presence of peroxisome proliferators, including fatty acids, which activate complex cellular programs that underlie the induction process. Here, we used multi-parameter quantitative phenotype analyses of an arrayed mutant collection of yeast cells induced to proliferate peroxisomes, to establish a comprehensive inventory of genes required for peroxisome induction and function. The assays employed include growth in the presence of fatty acids, and confocal imaging and flow cytometry through the induction process. In addition to the classical phenotypes associated with loss of peroxisomal functions, these studies identified 169 genes required for robust signaling, transcription, normal peroxisomal development and morphologies, and transmission of peroxisomes to daughter cells. These gene products are localized throughout the cell, and many have indirect connections to peroxisome function. By integration with extant data sets, we present a total of 211 genes linked to peroxisome biogenesis and highlight the complex networks through which information flows during peroxisome biogenesis and function.	[Saleem, Ramsey A.; Long-O'Donnell, Rose; Dilworth, David J.; Armstrong, Abraham M.; Jamakhandi, Arvind P.; Wan, Yakun; Knijnenburg, Theo A.; Niemisto, Antti; Boyle, John; Shmulevich, Ilya; Aitchison, John D.] Inst Syst Biol, Seattle, WA USA; [Rachubinski, Richard A.] Univ Alberta, Dept Cell Biol, Fac Med & Dent, Edmonton, AB, Canada; [Niemisto, Antti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland	Institute for Systems Biology (ISB); University of Alberta; Tampere University	Saleem, RA (corresponding author), Inst Syst Biol, Seattle, WA USA.	jaitchis@systemsbiology.org		Boyle, John/0000-0002-5378-5361	U.S. National Institutes of Health [GM075152, GM076547, RR022220]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; Academy of Finland [121830]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075152, P50GM076547] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; Academy of Finland(Academy of Finland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM075152, GM076547 and RR022220 from the U.S. National Institutes of Health. We also thank the Luxembourg Centre for Systems Biomedicine and the University of Luxembourg for support. AN is supported by the Academy of Finland (application number 121830, Postdoctoral Researcher's Project 2008-2010; application number 213462, Finnish Programme for Centres of Excellence in Research 2006-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu M, 2005, J CELL BIOL, V169, P765, DOI 10.1083/jcb.200503083; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; KOLLING R, 1994, YEAST, V10, P1211, DOI 10.1002/yea.320100909; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Ma C, 2009, MOL BIOL CELL, V20, P3680, DOI 10.1091/mbc.E09-01-0037; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Mrsa V, 1999, YEAST, V15, P813, DOI 10.1002/(SICI)1097-0061(199907)15:10A<813::AID-YEA421>3.0.CO;2-Y; NAVARRO B, 1994, BIOCHEM BIOPH RES CO, V202, P960, DOI 10.1006/bbrc.1994.2023; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; NIEMISTO A, 2007, C P IEEE ENG MED BIO, P5559; Niemisto Antti, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2353; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Purdue PE, 1998, J CELL BIOL, V143, P1859; Ratushny AV, 2008, BIOPHYS J, V95, P3715, DOI 10.1529/biophysj.108.134064; RATUSHNY AV, 2008, BIOPHYS J; RODEL G, 1987, MOL GEN GENET, V206, P45, DOI 10.1007/BF00326534; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; Saleem RA, 2006, BBA-MOL CELL RES, V1763, P1541, DOI 10.1016/j.bbamcr.2006.09.005; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Simon E., 1892, Histoire naturelle des araignees, V1, P1; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith JJ, 2009, CURR OPIN CELL BIOL, V21, P119, DOI 10.1016/j.ceb.2009.01.009; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wolinski H, 2009, J PROTEOME RES, V8, P20, DOI 10.1021/pr800782n	54	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11953	10.1371/journal.pone.0011953	http://dx.doi.org/10.1371/journal.pone.0011953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694151	Green Submitted, gold, Green Published			2022-12-27	WOS:000280574300009
J	Xie, J; Qureshi, AA; Li, YH; Han, JL				Xie, Jing; Qureshi, Abrar A.; Li, Yunhui; Han, Jiali			ABO Blood Group and Incidence of Skin Cancer	PLOS ONE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; PHENOTYPIC CHARACTERISTICS; SUN EXPOSURE; RISK-FACTORS; ANTIGENS; EXPRESSION	Background: Previous studies have examined the association between ABO blood group and the risk of some malignancies. However, no prospective cohort study to date has examined the association between ABO blood group and the risk of skin cancer. Methodology/Principal Findings: Using two large cohorts in the US, we examined ABO blood type and incidence of skin cancer, including melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC). We followed up study participants (70,650 female nurses and 24,820 male health professionals) on their diagnosis of incident skin cancer from cohort baseline (1976 in women and 1986 in men) until 2006. Study participants reported their blood type in 1996 in both cohorts. During the follow-up, 685 participants developed melanoma, 1,533 developed SCC and 19,860 developed BCC. We used Cox proportional hazards models to calculate the hazard ratios (HR) and 95% confidence intervals (CI) of each type of skin cancer. We observed that non-O blood group (A, AB, and B combined) was significantly associated with a decreased risk of non-melanoma skin cancer overall. Compared to participants with blood group O, participants with non-O blood group had a 14% decreased risk of developing SCC (multivariable HR: 0.86; 95% CI: 0.78, 0.95) and a 4% decreased risk of developing BCC (multivariable HR: 0.96; 95% CI: 0.93, 0.99). The decreased risk of melanoma for non-O blood group was not statistically significant (multivariable HR: 0.91; 95% CI: 0.78, 1.05). Conclusion/Significance: In two large independent populations, non-O blood group was associated with a decreased risk of skin cancer. The association was statistically significant for non-melanoma skin cancer. Additional studies are needed to confirm these associations and to define the mechanisms by which ABO blood type or closely linked genetic variants may influence skin cancer risk.	[Xie, Jing; Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Xie, Jing; Qureshi, Abrar A.; Han, Jiali] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp,Clin Res Program, Boston, MA 02115 USA; [Qureshi, Abrar A.; Li, Yunhui; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Xie, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jiali.han@channing.harvard.edu			National Cancer Institute [CA087969, CA055075, CA122838]; NATIONAL CANCER INSTITUTE [R01CA122838, P01CA087969] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by the National Cancer Institute (CA087969, CA055075, and CA122838).	AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; American Cancer Society, 2022, CANC FACTS FIGURES 2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; GHAZIZADEH M, 1983, UROL RES, V11, P267, DOI 10.1007/BF00256344; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Hunter D J, 1992, Ann Epidemiol, V2, P231, DOI 10.1016/1047-2797(92)90055-U; Hussein MR, 2005, J CUTAN PATHOL, V32, P191, DOI 10.1111/j.0303-6987.2005.00281.x; Le Pendu J, 2001, APMIS, V109, P9; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Nakagoe T, 2001, J GASTROEN HEPATOL, V16, P176, DOI 10.1046/j.1440-1746.2001.02425.x; Naldi L, 2005, CANCER CAUSE CONTROL, V16, P893, DOI 10.1007/s10552-005-2300-4; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Nozoe T, 2004, DIS ESOPHAGUS, V17, P146, DOI 10.1111/j.1442-2050.2004.00392.x; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; TURSEN U, 2005, DERMATOLOGY ONLINE J, V11; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020	17	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2010	5	8							e11972	10.1371/journal.pone.0011972	http://dx.doi.org/10.1371/journal.pone.0011972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634IM	20694147	Green Published, Green Submitted, gold			2022-12-27	WOS:000280574300016
J	Graf, M; Cellerino, A; Englert, C				Graf, Michael; Cellerino, Alessandro; Englert, Christoph			Gender Separation Increases Somatic Growth in Females but Does Not Affect Lifespan in Nothobranchius furzeri	PLOS ONE			English	Article							CALLOSOBRUCHUS-MACULATUS; HISTORY EVOLUTION; AGING RESEARCH; MODEL SYSTEM; FRUIT-FLIES; REPRODUCTION; COST; LONGEVITY; MORTALITY; VERTEBRATE	According to life history theory, physiological and ecological traits and parameters influence an individual's life history and thus, ultimately, its lifespan. Mating and reproduction are costly activities, and in a variety of model organisms, a negative correlation of longevity and reproductive effort has been demonstrated. We are employing the annual killifish Nothobranchius furzeri as a vertebrate model for ageing. N. furzeri is the vertebrate displaying the shortest known lifespan in captivity with particular strains living only three to four months under optimal laboratory conditions. The animals show explosive growth, early sexual maturation and age-dependent physiological and behavioural decline. Here, we have used N. furzeri to investigate a potential reproduction-longevity trade-off in both sexes by means of gender separation. Though female reproductive effort and offspring investment were significantly reduced after separation, as investigated by analysis of clutch size, eggs in the ovaries and ovary mass, the energetic surplus was not reallocated towards somatic maintenance. In fact, a significant extension of lifespan could not be observed in either sex. This is despite the fact that separated females, but not males, grew significantly larger and heavier than the respective controls. Therefore, it remains elusive whether lifespan of an annual species evolved in periodically vanishing habitats can be prolonged on the cost of reproduction at all.	[Graf, Michael; Cellerino, Alessandro; Englert, Christoph] FLI, Leibniz Inst Age Res, Jena, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Englert, C (corresponding author), FLI, Leibniz Inst Age Res, Jena, Germany.	cenglert@fli-leibniz.de	Cellerino, Alessandro/AAB-4398-2020; Cellerino, Alessandro/M-9380-2013; Cellerino, Alessandro/AAJ-7453-2020	Cellerino, Alessandro/0000-0003-3834-0097; Cellerino, Alessandro/0000-0003-3834-0097; Cellerino, Alessandro/0000-0003-3834-0097; Englert, Christoph/0000-0002-5931-3189	Leibniz Institute for Age Research	Leibniz Institute for Age Research	This work was supported by the host institution, namely the Leibniz Institute for Age Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Borski RJ, 1996, ENDOCRINOLOGY, V137, P3253, DOI 10.1210/en.137.8.3253; Carey JR, 2002, EXP GERONTOL, V37, P507, DOI 10.1016/S0531-5565(01)00230-3; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Erdfelder E., 2004, ALLGEMEINE PSYCHOL D, P148; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; HIRSHFIELD MF, 1980, ECOLOGY, V61, P282, DOI 10.2307/1935187; Holmes DJ, 2001, EXP GERONTOL, V36, P869, DOI 10.1016/S0531-5565(00)00247-3; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; NEUMANN W, 2008, PRACHTGRUNDKARPFLING, P16; PARTRIDGE L, 1988, SCIENCE, V241, P1449, DOI 10.1126/science.241.4872.1449; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; RAGLAND SS, 1973, EXP GERONTOL, V8, P135, DOI 10.1016/0531-5565(73)90003-X; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Reinhardt K, 1999, J INSECT BEHAV, V12, P283, DOI 10.1023/A:1020854403805; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1983, ECOLOGY, V64, P862, DOI 10.2307/1937209; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ricklefs RE, 2007, ECOL LETT, V10, P867, DOI 10.1111/j.1461-0248.2007.01085.x; Roff Derek A., 1992; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; TATAR M, 1993, EVOLUTION, V47, P1302, DOI [10.1111/j.1558-5646.1993.tb02156.x, 10.2307/2410149]; Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039; Terzibasi E, 2009, AGING CELL, V8, P88, DOI 10.1111/j.1474-9726.2009.00455.x; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Vezina F, 2005, J EXP BIOL, V208, P2533, DOI 10.1242/jeb.01675; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	35	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11958	10.1371/journal.pone.0011958	http://dx.doi.org/10.1371/journal.pone.0011958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689818	gold, Green Published			2022-12-27	WOS:000280520500012
J	Tsao, D; Minton, AP; Dokholyan, NV				Tsao, Douglas; Minton, Allen P.; Dokholyan, Nikolay V.			A Didactic Model of Macromolecular Crowding Effects on Protein Folding	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; COARSE-GRAINED STRATEGY; EXCLUDED-VOLUME; PHYSIOLOGICAL CONSEQUENCES; CONCENTRATED-SOLUTIONS; BINDING STABILITY; THERMODYNAMICS; AGGREGATION; SIMULATIONS; CONFINEMENT	A didactic model is presented to illustrate how the effect of macromolecular crowding on protein folding and association is modeled using current analytical theory and discrete molecular dynamics. While analytical treatments of crowding may consider the effect as a potential of average force acting to compress a polypeptide chain into a compact state, the use of simulations enables the presence of crowding reagents to be treated explicitly. Using an analytically solvable toy model for protein folding, an approximate statistical thermodynamic method is directly compared to simulation in order to gauge the effectiveness of current analytical crowding descriptions. Both methodologies are in quantitative agreement under most conditions, indication that both current theory and simulation methods are capable of recapitulating aspects of protein folding even by utilizing a simplistic protein model.	[Tsao, Douglas] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA; [Minton, Allen P.] NIDDKD, Sect Phys Biochem, Lab Biochem & Genet, NIH,US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Tsao, D (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA.	dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Minton, Allen/0000-0001-8459-1247	National Institutes of Health [R01GM080742]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grant R01GM080742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; BOUBLIK T, 1974, MOL PHYS, V27, P1415, DOI 10.1080/00268977400101191; Cheung JK, 2005, BIOPHYS J, V89, P2372, DOI 10.1529/biophysj.105.062067; Cheung MS, 2007, J PHYS CHEM B, V111, P8250, DOI 10.1021/jp068201y; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; COTTER MA, 1977, J CHEM PHYS, V66, P1098, DOI 10.1063/1.434044; Davis CH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051921; Ding F, 2005, TRENDS BIOTECHNOL, V23, P450, DOI 10.1016/j.tibtech.2005.07.001; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dokholyan NV, 2000, J MOL BIOL, V296, P1183, DOI 10.1006/jmbi.1999.3534; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Ferreon ACM, 2004, BIOCHEMISTRY-US, V43, P13357, DOI 10.1021/bi048666j; Goldenberg DP, 2003, J MOL BIOL, V326, P1615, DOI 10.1016/S0022-2836(03)00033-0; HAN JN, 1993, BIOPHYS J, V65, P1155, DOI 10.1016/S0006-3495(93)81145-7; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Homouz D, 2009, J MOL BIOL, V391, P933, DOI 10.1016/j.jmb.2009.06.073; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; Kinjo AR, 2003, BIOPHYS J, V85, P3521, DOI 10.1016/S0006-3495(03)74772-9; Kudlay A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118101; LEBOWITZ JL, 1965, J CHEM PHYS, V43, P774, DOI 10.1063/1.1696842; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; MINTON AP, 2000, BIOPHYS J IN PRESS; Mittal J, 2010, BIOPHYS J, V98, P315, DOI 10.1016/j.bpj.2009.10.009; Pincus DL, 2009, J PHYS CHEM B, V113, P359, DOI 10.1021/jp807755b; Qin SB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031919; Qin SB, 2009, BIOPHYS J, V97, P12, DOI 10.1016/j.bpj.2009.03.066; REISS H, 1959, J CHEM PHYS, V31, P369, DOI 10.1063/1.1730361; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rivera E, 2009, BIOPHYS J, V96, P4552, DOI 10.1016/j.bpj.2009.03.039; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; Sharma S, 2008, FRONT BIOSCI-LANDMRK, V13, P4795, DOI 10.2741/3039; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Shen VK, 2006, BIOPHYS J, V90, P1949, DOI 10.1529/biophysj.105.076497; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Tsao D, 2010, PHYS CHEM CHEM PHYS, V12, P3491, DOI 10.1039/b924236h; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2004, J MOL RECOGNIT, V17, P368, DOI 10.1002/jmr.711; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; Zhou YQ, 1997, J CHEM PHYS, V107, P10691, DOI 10.1063/1.474186; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	53	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11936	10.1371/journal.pone.0011936	http://dx.doi.org/10.1371/journal.pone.0011936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689808	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520500004
J	Danovaro, R; Company, JB; Corinaldesi, C; D'Onghia, G; Galil, B; Gambi, C; Gooday, AJ; Lampadariou, N; Luna, GM; Morigi, C; Olu, K; Polymenakou, P; Ramirez-Llodra, E; Sabbatini, A; Sarda, F; Sibuet, M; Tselepides, A				Danovaro, Roberto; Batista Company, Joan; Corinaldesi, Cinzia; D'Onghia, Gianfranco; Galil, Bella; Gambi, Cristina; Gooday, Andrew J.; Lampadariou, Nikolaos; Luna, Gian Marco; Morigi, Caterina; Olu, Karine; Polymenakou, Paraskevi; Ramirez-Llodra, Eva; Sabbatini, Anna; Sarda, Francesc; Sibuet, Myriam; Tselepides, Anastasios			Deep-Sea Biodiversity in the Mediterranean Sea: The Known, the Unknown, and the Unknowable	PLOS ONE			English	Review							ARISTEUS-ANTENNATUS RISSO; COLD-SEEP COMMUNITIES; CONTINENTAL-SHELF; IONIAN SEA; POPULATION-STRUCTURE; DECAPOD CRUSTACEANS; SUBMARINE CANYONS; SPECIES-DIVERSITY; FISH ASSEMBLAGES; AEGEAN SEA	Deep-sea ecosystems represent the largest biome of the global biosphere, but knowledge of their biodiversity is still scant. The Mediterranean basin has been proposed as a hot spot of terrestrial and coastal marine biodiversity but has been supposed to be impoverished of deep-sea species richness. We summarized all available information on benthic biodiversity (Prokaryotes, Foraminifera, Meiofauna, Macrofauna, and Megafauna) in different deep-sea ecosystems of the Mediterranean Sea (200 to more than 4,000 m depth), including open slopes, deep basins, canyons, cold seeps, seamounts, deep-water corals and deep-hypersaline anoxic basins and analyzed overall longitudinal and bathymetric patterns. We show that in contrast to what was expected from the sharp decrease in organic carbon fluxes and reduced faunal abundance, the deep-sea biodiversity of both the eastern and the western basins of the Mediterranean Sea is similarly high. All of the biodiversity components, except Bacteria and Archaea, displayed a decreasing pattern with increasing water depth, but to a different extent for each component. Unlike patterns observed for faunal abundance, highest negative values of the slopes of the biodiversity patterns were observed for Meiofauna, followed by Macrofauna and Megafauna. Comparison of the biodiversity associated with open slopes, deep basins, canyons, and deep-water corals showed that the deep basins were the least diverse. Rarefaction curves allowed us to estimate the expected number of species for each benthic component in different bathymetric ranges. A large fraction of exclusive species was associated with each specific habitat or ecosystem. Thus, each deep-sea ecosystem contributes significantly to overall biodiversity. From theoretical extrapolations we estimate that the overall deep-sea Mediterranean biodiversity (excluding prokaryotes) reaches approximately 2805 species of which about 66% is still undiscovered. Among the biotic components investigated (Prokaryotes excluded), most of the unknown species are within the phylum Nematoda, followed by Foraminifera, but an important fraction of macrofaunal and megafaunal species also remains unknown. Data reported here provide new insights into the patterns of biodiversity in the deep-sea Mediterranean and new clues for future investigations aimed at identifying the factors controlling and threatening deep-sea biodiversity.	[Danovaro, Roberto; Corinaldesi, Cinzia; Gambi, Cristina; Luna, Gian Marco; Sabbatini, Anna] Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy; [Batista Company, Joan; Ramirez-Llodra, Eva; Sarda, Francesc] CSIC, Inst Ciencias Mar, Barcelona, Spain; [D'Onghia, Gianfranco] Univ Bari, Dept Anim & Environm Biol, Bari, Italy; [Galil, Bella] Natl Inst Oceanog, IL-31080 Haifa, Israel; [Gooday, Andrew J.] Natl Oceanog Ctr, Southampton, Hants, England; [Lampadariou, Nikolaos; Polymenakou, Paraskevi] Hellen Ctr Marine Res, Iraklion, Greece; [Morigi, Caterina] Geol Survey Denmark & Greenland, Stratig Dept, Copenhagen, Denmark; [Olu, Karine] IFREMER, Ctr Brest, Dept Etude Ecosyst Profonds, Plouzane, France; [Sibuet, Myriam] Inst Oceanog, Paris, France; [Tselepides, Anastasios] Univ Piraeus, Dept Maritime Studies, Piraeus, France	Marche Polytechnic University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universita degli Studi di Bari Aldo Moro; Israel Oceanographic & Limnological Research Institute; NERC National Oceanography Centre; Hellenic Centre for Marine Research; Geological Survey Of Denmark & Greenland; Ifremer	Danovaro, R (corresponding author), Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy.	r.danovaro@univpm.it	Sarda, Francisco/L-6229-2014; Luna, Gian Marco/AAY-5262-2020; Morigi, Caterina/L-3883-2016; Company, Joan B./K-7274-2014; Gooday, Andrew/AAH-8991-2021; Tselepides, Anastasios/AAO-3965-2021; Morigi, Caterina/B-3316-2012; Gooday, Andrew/ABB-4267-2020; Polymenakou, Paraskevi/AAW-5313-2020; Luna, Gian Marco/G-9129-2012; Lampadariou, Nikolaos/H-1201-2011	Sarda, Francisco/0000-0001-7905-4148; Morigi, Caterina/0000-0003-1340-9932; Company, Joan B./0000-0002-5878-7155; Morigi, Caterina/0000-0003-1340-9932; Gooday, Andrew/0000-0002-5661-7371; Polymenakou, Paraskevi/0000-0002-9787-7372; Lampadariou, Nikolaos/0000-0003-2171-7150; Tselepides, Anastasios/0000-0002-7880-9091; Olu, Karine/0000-0002-4906-4131; D'Onghia, Gianfranco/0000-0003-0952-9472; LUNA, GIAN MARCO/0000-0002-8303-3400; Ramirez-Llodra, Eva/0000-0003-0137-1906; Gambi, Cristina/0000-0001-6160-6004; SABBATINI, ANNA/0000-0003-4577-5339	EU; European Science Foundation; UK Natural Environment Research Council; Total Foundation; Alfred P. Sloan Foundation; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish	EU(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Total Foundation(Total SA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was partially supported by the HERMES and HERMIONE IP Projects from EU and BIOFUN from European Science Foundation, the Oceans 2025 Strategic Research Program of the UK Natural Environment Research Council, Total Foundation, the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELLO P, 1988, MAR BIOL, V98, P39, DOI 10.1007/BF00392657; ABELLO P, 1992, MAR BIOL, V114, P109; Acosta J, 2003, GEOMORPHOLOGY, V49, P177, DOI 10.1016/S0169-555X(02)00168-X; Alvarez-Perez G, 2005, ERLANGEN EARTH C SER, P207, DOI 10.1007/3-540-27673-4_10; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1995, MOL ECOL, V4, P543, DOI 10.1111/j.1365-294X.1995.tb00255.x; Anderson TR, 2006, ENDEAVOUR, V30, P131, DOI 10.1016/j.endeavour.2006.10.003; AZOUZ A, 1973, SALAMMBO, V2, P473; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Basso D, 2004, SCI MAR, V68, P53, DOI 10.3989/scimar.2004.68s353; Bayon G, 2009, MAR GEOL, V261, P92, DOI 10.1016/j.margeo.2008.10.008; BELLANSANTINI D, 1990, PROG OCEANOGR, V24, P275, DOI 10.1016/0079-6611(90)90037-3; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; Bianchelli S, 2008, CHEM ECOL, V24, P101, DOI 10.1080/02757540801963386; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; BIZON G, 1984, PETROLE TECHNIQUES, V301, P84; BLAKE JA, 1994, DEEP-SEA RES PT II, V41, P835, DOI 10.1016/0967-0645(94)90051-5; Bogi C, 2004, B MALACOLOGICO, V39, P79; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; BOUCHET P, 1992, DEEP-SEA RES, V39, P169, DOI 10.1016/0198-0149(92)90103-Z; Bourcier M, 1973, TETHYS, V4, P811; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhring SI, 2006, LIMNOL OCEANOGR, V51, P157; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Capezzuto F, 2010, CHEM ECOL, V26, P199, DOI 10.1080/02757541003639188; CARTES JE, 1992, J NAT HIST, V26, P1305, DOI 10.1080/00222939200770741; Cartes JE, 1999, J NAT HIST, V33, P1133, DOI 10.1080/002229399299978; Cartes JE, 1998, PROG OCEANOGR, V41, P111, DOI 10.1016/S0079-6611(98)00018-4; Charlou JL, 2003, DEEP-SEA RES PT I, V50, P941, DOI 10.1016/S0967-0637(03)00093-1; Christiansen B., 1989, Senckenbergiana Maritima, V20, P187; CITA MB, 1978, OCEANOL ACTA, V1, P445; Coleman DF, 2001, GEO-MAR LETT, V21, P162, DOI 10.1007/s003670100079; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Company JB, 2004, SCI MAR, V68, P73, DOI 10.3989/scimar.2004.68s373; Company JB, 2003, MAR ECOL PROG SER, V261, P201, DOI 10.3354/meps261201; Company JB, 2001, MAR BIOL, V139, P61; Company JB, 1997, MAR ECOL PROG SER, V148, P49, DOI 10.3354/meps148049; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Corselli C, 1996, MAR GEOL, V132, P227, DOI 10.1016/0025-3227(95)00163-8; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; D'Onghia G, 2006, MAR BIOL, V149, P435, DOI 10.1007/s00227-005-0231-y; D'Onghia G, 2005, FISH RES, V76, P22, DOI 10.1016/j.fishres.2005.05.007; D'Onghia G, 1999, MAR ECOL PROG SER, V184, P189, DOI 10.3354/meps184189; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2004, SCI MAR, V68, P171, DOI 10.3989/scimar.2004.68s3171; D'Onghia G, 2004, SCI MAR, V68, P87, DOI 10.3989/scimar.2004.68s387; D'Onghia G, 2004, SCI MAR, V68, P163, DOI 10.3989/scimar.2004.68s3163; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; D'Onghia G, 2009, FISH RES, V95, P236, DOI 10.1016/j.fishres.2008.09.025; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; Dando PR, 1999, PROG OCEANOGR, V44, P333, DOI 10.1016/S0079-6611(99)00032-4; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Danovaro R, 2004, ECOL LETT, V7, P821, DOI 10.1111/j.1461-0248.2004.00634.x; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; Danovaro R, 2009, OCEANOGRAPHY, V22, P16, DOI 10.5670/oceanog.2009.02; De Rijk S, 1999, J FORAMIN RES, V29, P93, DOI 10.2113/gsjfr.29.2.93; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; De Stigter N. C, 1996, GEOL ULTRIECTIN, V144, P254; DEBOVEE F, 1990, CONT SHELF RES, V10, P1123, DOI 10.1016/0278-4343(90)90077-Y; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Dinet A., 1976, ACTA ADRIAT, V18, P83; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Duperron S, 2007, FEMS MICROBIOL ECOL, V59, P64, DOI 10.1111/j.1574-6941.2006.00194.x; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Dupre S, 2007, DEEP-SEA RES PT I, V54, P1146, DOI 10.1016/j.dsr.2007.03.007; ELEFTHERIOU A, 1996, FOOD CHAINS AEGEAN S; EMIG CC, 2004, CARNETS GEOL; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Fishelson L, 2001, COPEIA, P556; Fontanier C, 2008, DEEP-SEA RES PT I, V55, P1532, DOI 10.1016/j.dsr.2008.07.003; Fontanier C, 2005, DEEP-SEA RES PT I, V52, P1189, DOI 10.1016/j.dsr.2005.01.006; Forbes E., 1844, REPORT BRIT ASS ADV, V13, P130; FREDRIKSSON G, 1985, ANIM REPROD SCI, V8, P109, DOI 10.1016/0378-4320(85)90077-6; Freiwald A., 2004, COLD WATER CORAL REE, V22; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Gage J. D., 1991, DEEP SEA BIOL NATURA; GAGE JD, 1993, NATURE, V365, P609, DOI 10.1038/365609a0; Gage John D., 2003, P313; Galgani F, 1996, MAR ECOL PROG SER, V142, P225, DOI 10.3354/meps142225; GALGANI F, 1995, MAR POLLUT BULL, V30, P713, DOI 10.1016/0025-326X(95)00055-R; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; Galil Bella S., 1994, Senckenbergiana Maritima, V25, P41; GALIL BS, 1995, MAR POLLUT BULL, V30, P22, DOI 10.1016/0025-326X(94)00103-G; Galil BS, 2004, SCI MAR, V68, P63, DOI 10.3989/scimar.2004.68s363; GALIL BS, 1993, CRUSTACEANA, V64, P48, DOI 10.1163/156854093X00054; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; Geistdoerfer P., 1972, Bulletin Mus Natn Hist Nat Paris (Zool), V19, P101; GILAT E, 1984, FISH RES, V2, P257, DOI 10.1016/0165-7836(84)90029-8; Gili JM, 1999, ZOOL J LINN SOC-LOND, V125, P313, DOI 10.1006/zjls.1997.0107; Gili JM, 2000, DEEP-SEA RES PT I, V47, P1513, DOI 10.1016/S0967-0637(99)00119-3; GOLANI D, 1987, ISRAEL J ZOOL, V34, P23; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; Gooday AJ, 1998, DEEP-SEA RES PT II, V45, P165, DOI 10.1016/S0967-0645(97)00041-6; Goren M, 2002, CYBIUM, V26, P150; Goren M, 1997, ISRAEL J ZOOL, V43, P197; GOREN M, 2006, J MAR BIOL ASSOC UK, V2, P1; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; GREENE CH, 1988, SCIENCE, V241, P359, DOI 10.1126/science.241.4863.359; Gremare A, 2002, MAR ECOL PROG SER, V234, P85, DOI 10.3354/meps234085; Guidi-Guilvard LD, 2002, DEEP-SEA RES PT II, V49, P2183, DOI 10.1016/S0967-0645(02)00034-6; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; Harrold C, 1998, LIMNOL OCEANOGR, V43, P669, DOI 10.4319/lo.1998.43.4.0669; Hausmann K, 2002, DEEP-SEA RES PT I, V49, P1959, DOI 10.1016/S0967-0637(02)00095-X; Heijs SK, 2008, FEMS MICROBIOL ECOL, V64, P362, DOI 10.1111/j.1574-6941.2008.00463.x; Heinz P, 2001, J FORAMIN RES, V31, P210, DOI 10.2113/31.3.210; Hogslund S, 2008, J EXP MAR BIOL ECOL, V359, P85, DOI 10.1016/j.jembe.2008.02.015; Holthuis L.B., 1978, Annales du Museum d'Histoire Naturelle de Nice, V5, P37; Hovland Martin, 2008, P1; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; HSU KJ, 1972, SCI AM, V227, P27; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Huguen C, 2009, MAR GEOL, V261, P138, DOI 10.1016/j.margeo.2009.02.005; Husebo A, 2002, HYDROBIOLOGIA, V471, P91, DOI 10.1023/A:1016549203368; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Jannink N. T., 2001, GEOLOGICA ULTRAIECTI, V203; Janssen R., 1989, Senckenbergiana Maritima, V20, P265; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Jorissen FJ, 1995, MAR MICROPALEONTOL, V26, P3, DOI 10.1016/0377-8398(95)00047-X; JORRISEN FJ, 1988, UTRECHT MICROPALEONT, V37, P1; Karakassis I, 1997, MAR ECOL PROG SER, V160, P185, DOI 10.3354/meps160185; Kellogg CA, 2004, MAR ECOL PROG SER, V273, P81, DOI 10.3354/meps273081; Klausewitz W., 1989, Senckenbergiana Maritima, V20, P251; KOUTSOUBAS D, 1992, Bollettino Malacologico, V28, P69; Koutsoubas Drosos, 2000, Senckenbergiana Maritima, V30, P85; Krieger KJ, 2002, HYDROBIOLOGIA, V471, P83, DOI 10.1023/A:1016597119297; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Kroncke I, 2003, MAR ECOL-P S Z N I, V24, P193, DOI 10.1046/j.0173-9565.2003.00825.x; Lambshead PJD, 2000, MAR ECOL PROG SER, V194, P159, DOI 10.3354/meps194159; Lambshead PJD, 2002, MAR ECOL PROG SER, V236, P129, DOI 10.3354/meps236129; Lampadariou N, 2006, PROG OCEANOGR, V69, P19, DOI 10.1016/j.pocean.2006.02.013; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; LAUBIER L, 1993, NFR DELLA CROCE S ME, P397; Lauro FM, 2008, EXTREMOPHILES, V12, P15, DOI 10.1007/s00792-006-0059-5; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LEVIN LA, 2000, DEEP SEA RES 2, V189, P226; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Li L, 1999, MAR BIOTECHNOL, V1, P391, DOI 10.1007/PL00011793; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Luna GM, 2009, CURR MICROBIOL, V59, P356, DOI 10.1007/s00284-009-9445-4; Luna GM, 2004, ENVIRON MICROBIOL, V6, P745, DOI 10.1111/j.1462-2920.2004.00611.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maiorano P, 1998, J NAT HIST, V32, P1609, DOI 10.1080/00222939800771141; Maiorano P, 2002, MAR BIOL, V141, P527, DOI 10.1007/s00227-002-0851-4; Margalef R, 1997, SCI MAR, V61, P109; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; MASSIOTTA R, 1976, SPECIAL PUBLICATION, V1, P251; MASSUTI E, 1995, DEEP-SEA RES PT I, V42, P307, DOI 10.1016/0967-0637(95)00003-O; Massuti E, 2004, SCI MAR, V68, P101, DOI 10.3989/scimar.2004.68s3101; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Matarrese A, 1998, ITAL J ZOOL, V65, P203, DOI 10.1080/11250009809386814; Maynou F, 2000, J MAR BIOL ASSOC UK, V80, P789, DOI 10.1017/S0025315400002769; McClain CR, 2005, OIKOS, V109, P555, DOI 10.1111/j.0030-1299.2005.13529.x; MoralesNin B, 1996, J FISH BIOL, V48, P1097, DOI 10.1006/jfbi.1996.0113; Moranta J, 2004, SCI MAR, V68, P141, DOI 10.3989/scimar.2004.68s3141; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Mortensen P.B., 2006, PROC 10 INT CORAL RE, V1868, P1849; Murray J. W., 1991, ECOLOGY PALAEOECOLOG; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Mytilineou C, 2005, BELG J ZOOL, V135, P229; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Orejas C, 2008, CORAL REEFS, V27, P255, DOI 10.1007/s00338-007-0350-7; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; PARISI E, 1981, Rivista Italiana di Paleontologia e Stratigrafia, V87, P293; Peres J. M., 1958, Ann Inst Oceanogr Paris NS, V34, P213; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; PERES JM, 1985, EKY ENV W MEDITERRAN, P198; Politou CY, 2008, J NAT HIST, V42, P661, DOI 10.1080/00222930701835613; Politou CY, 2005, BELG J ZOOL, V135, P235; Polymenakou PN, 2009, SYST APPL MICROBIOL, V32, P17, DOI 10.1016/j.syapm.2008.09.006; Polymenakou PN, 2005, MICROB ECOL, V50, P447, DOI 10.1007/s00248-005-0005-6; Polymenakou PN, 2005, MICROB ECOL, V49, P367, DOI 10.1007/s00248-004-0274-5; Priede IG, 2000, OCEANOGR MAR BIOL, V38, P357; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Puig P, 2003, MAR GEOL, V193, P129, DOI 10.1016/S0025-3227(02)00641-2; Puig P, 2000, DEEP-SEA RES PT I, V47, P343, DOI 10.1016/S0967-0637(99)00062-X; Pusceddu A, 2009, DEEP-SEA RES PT II, V56, P755, DOI 10.1016/j.dsr2.2008.10.012; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Ramirez-Llodra E, 2008, MAR BIOL, V153, P297, DOI 10.1007/s00227-007-0805-y; Ramirez-Llodra E, 2007, MAR ECOL-EVOL PERSP, V28, P470, DOI 10.1111/j.1439-0485.2007.00207.x; RAMIREZLLODRA E, 2009, MEGABENTHIC DIVERSIT, P1; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Relini G., 1998, Biologia Marina Mediterranea, V5, P3; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Reyss D., 1964, Bulletin de l'Institut Oceanographique Monaco, V63, P1; Richter TO, 2009, DEEP-SEA RES PT I, V56, P267, DOI 10.1016/j.dsr.2008.09.006; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; RISSO A, 1816, HIST NATURELLE CRUST; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Roether W, 2007, PROG OCEANOGR, V74, P540, DOI 10.1016/j.pocean.2007.03.001; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Rosso A, 2010, DEEP-SEA RES PT II, V57, P360, DOI 10.1016/j.dsr2.2009.08.024; Rotllant G, 2002, SCI MAR, V66, P157, DOI 10.3989/scimar.2002.66n2157; Rotllant G, 2006, DEEP-SEA RES PT I, V53, P1895, DOI 10.1016/j.dsr.2006.09.004; RUCABADO J, 1991, INFORMES TECNICOS SC, V165, P1; Salas C, 2002, DEEP-SEA RES PT I, V49, P991, DOI 10.1016/S0967-0637(02)00010-9; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SARDA F, 1994, MAR BIOL, V120, P211, DOI 10.1007/BF00349681; Sarda F, 1998, FISHERIES SCI, V64, P492, DOI 10.2331/fishsci.64.492; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sarda F, 2004, SCI MAR, V68, P117, DOI 10.3989/scimar.2004.68s3117; Sarda F, 2009, PROG OCEANOGR, V82, P227, DOI 10.1016/j.pocean.2009.07.001; Sarda F, 2009, REV FISH BIOL FISHER, V19, P329, DOI 10.1007/s11160-009-9105-6; SARDA F, 1994, FISH B-NOAA, V92, P599; Sarda F, 1997, MAR FRESHWATER RES, V48, P73, DOI 10.1071/MF95043; SARDA F, 2004, MONOGRAPHS SCI MAR, V63, P204; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Schmiedl G, 2000, MAR MICROPALEONTOL, V40, P167, DOI 10.1016/S0377-8398(00)00038-4; Schonberg CHL, 2007, J MAR BIOL ASSOC UK, V87, P1459, DOI 10.1017/S0025315407058249; SELLI R, 1985, GEOLOGICAL EVOLUTION, P131; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SIBUET M, 1979, SARSIA, V64, P85, DOI 10.1080/00364827.1979.10411367; Sibuet M., 2002, OCEAN MARGIN SYSTEMS, P235, DOI DOI 10.1007/978-3-662-05127-6_15; Sion L, 2004, SCI MAR, V68, P153, DOI 10.3989/scimar.2004.68s3153; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; SOETAERT K, 1991, MAR ECOL PROG SER, V75, P275, DOI 10.3354/meps075275; Sorbe JC, 2002, CRUSTACEANA, V75, P957, DOI 10.1163/15685400260569607; SOUTHWARD E, LAMELLIBRACHIA ANAXI; Stanley D. J, 1985, GEOLOGICAL EVOLUTION; STEFANESCU C, 1993, DEEP-SEA RES PT I, V40, P695, DOI 10.1016/0967-0637(93)90066-C; STEFANESCU C, 1994, J MAR BIOL ASSOC UK, V74, P499, DOI 10.1017/S0025315400047627; STEFANESCU C, 1992, MAR ECOL PROG SER, V81, P205, DOI 10.3354/meps081205; STURANY R, 1896, DENKSCHRIFTEN KAI MN, V63; Taviani M, 2005, ERLANGEN EARTH C SER, P137, DOI 10.1007/3-540-27673-4_7; Taviani M, 2005, FACIES, V50, P409, DOI 10.1007/s10347-004-0039-0; TCHUKHTCHIN VD, 1964, T SEVASTOPOL BIOL ST, V17, P48; Tecchio S, 2011, SCI MAR, V75, P341, DOI 10.3989/scimar.2011.75n2341; Tosti L, 2006, CHEM ECOL, V22, P335, DOI 10.1080/02757540600812016; Trincardi F, 2007, MAR GEOL, V246, P208, DOI 10.1016/j.margeo.2007.01.013; Tselepides A, 2000, PROG OCEANOGR, V46, P401, DOI 10.1016/S0079-6611(00)00027-6; Tselepides A, 2004, DEEP-SEA RES PT I, V51, P833; TSELEPIDES A, 1992, NATO ADV SCI I C-MAT, V360, P139; Tudela S, 2003, CRUSTACEANA, V76, P217, DOI 10.1163/156854003321824567; Tunesi L., 2001, P 1 INT S DEEP SEA C, P76; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Tyler P. A., 2002, OCEAN MARGIN SYSTEMS, P339; UCHUPI E, 1989, DEEP-SEA RES, V36, P1443, DOI 10.1016/0198-0149(89)90094-0; Unger MA, 2008, MAR POLLUT BULL, V56, P1498, DOI 10.1016/j.marpolbul.2008.04.018; Urakawa H, 1999, MICROBIOL-UK, V145, P3305, DOI 10.1099/00221287-145-11-3305; Vafidis D, 1997, ISRAEL J ZOOL, V43, P55; Vamvakas C.-N. E ., 1970, Tethys, V2, P89; van der Wielen PWJJ, 2007, ENVIRON MICROBIOL, V9, P1335, DOI 10.1111/j.1462-2920.2006.01210.x; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Van der Zwaan GJ, 1999, EARTH-SCI REV, V46, P213, DOI 10.1016/S0012-8252(99)00011-2; VANHARTEN D, 1987, MAR GEOL, V75, P263, DOI 10.1016/0025-3227(87)90108-3; VANNEY JR, 1985, GEOLOGICAL EVOLUTION, P3; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; VETTER EW, 1994, NATURE, V372, P47, DOI 10.1038/372047a0; Vetter EW, 1999, MAR ECOL PROG SER, V186, P137, DOI 10.3354/meps186137; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9; Vivier M. H, 1978, TETHYS, V8, P307; Wezel F.C., 1985, GEOLOGICAL EVOLUTION, P153; WRIGHT RC, 1981, AAPG BULL, V65, P1009; WWF/IUCN, 2004, MED DEEP SEA EC OV T; YACOBI YZ, 1995, J MARINE SYST, V6, P179, DOI 10.1016/0924-7963(94)00028-A; Yakimov MM, 2007, ISME J, V1, P743, DOI 10.1038/ismej.2007.83; Yakimov MM, 2007, ORIGINS LIFE EVOL B, V37, P177, DOI 10.1007/s11084-006-9021-x; Yakimov MM, 2009, DEEP-SEA RES PT II, V56, P748, DOI 10.1016/j.dsr2.2008.07.024; Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005; Zabala Mikel., 1993, Scientia Marina, V57, P65; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x; Zibrowius H, 2005, ERLANGEN EARTH C SER, P807, DOI 10.1007/3-540-27673-4_42; Zibrowius H, 1980, MEMOIRES I OCEANOGRA, V11, P1; Zibrowius H., 2003, WHITE CORAL COMMUNIT; Zitter TAC, 2008, DEEP-SEA RES PT I, V55, P552, DOI 10.1016/j.dsr.2008.01.002; Zitter TAC, 2005, DEEP-SEA RES PT I, V52, P457, DOI 10.1016/j.dsr.2004.10.005; ZUGMAYER E, 1911, MONACO, V35, P174; Zuniga D, 2009, PROG OCEANOGR, V82, P239, DOI 10.1016/j.pocean.2009.07.002	286	247	250	2	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11832	10.1371/journal.pone.0011832	http://dx.doi.org/10.1371/journal.pone.0011832			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689848	Green Published, Green Accepted, gold			2022-12-27	WOS:000280520400006
J	Fujikura, K; Lindsay, D; Kitazato, H; Nishida, S; Shirayama, Y				Fujikura, Katsunori; Lindsay, Dhugal; Kitazato, Hiroshi; Nishida, Shuhei; Shirayama, Yoshihisa			Marine Biodiversity in Japanese Waters	PLOS ONE			English	Review								To understand marine biodiversity in Japanese waters, we have compiled information on the marine biota in Japanese waters, including the number of described species (species richness), the history of marine biology research in Japan, the state of knowledge, the number of endemic species, the number of identified but undescribed species, the number of known introduced species, and the number of taxonomic experts and identification guides, with consideration of the general ocean environmental background, such as the physical and geological settings. A total of 33,629 species have been reported to occur in Japanese waters. The state of knowledge was extremely variable, with taxa containing many inconspicuous, smaller species tending to be less well known. The total number of identified but undescribed species was at least 121,913. The total number of described species combined with the number of identified but undescribed species reached 155,542. This is the best estimate of the total number of species in Japanese waters and indicates that more than 70% of Japan's marine biodiversity remains un-described. The number of species reported as introduced into Japanese waters was 39. This is the first attempt to estimate species richness for all marine species in Japanese waters. Although its marine biota can be considered relatively well known, at least within the Asian-Pacific region, considering the vast number of different marine environments such as coral reefs, ocean trenches, ice-bound waters, methane seeps, and hydrothermal vents, much work remains to be done. We expect global change to have a tremendous impact on marine biodiversity and ecosystems. Japan is in a particularly suitable geographic situation and has a lot of facilities for conducting marine science research. Japan has an important responsibility to contribute to our understanding of life in the oceans.	[Fujikura, Katsunori; Lindsay, Dhugal; Kitazato, Hiroshi] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Kanagawa, Japan; [Nishida, Shuhei] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo; Kyoto University	Fujikura, K (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Kanagawa, Japan.	fujikura@jamstec.go.jp			Alfred P. Sloan Foundation; Japan Agency for Marine-Earth Science and Technology	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Japan Agency for Marine-Earth Science and Technology	This work was funded as part of a grant from the Alfred P. Sloan Foundation and the Japan Agency for Marine-Earth Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Baba K., 1949, OPISTHOBRANCHIA SAGA; Chihara M., 1997, ILLUSTRATED GUIDE MA; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Desbruyeres D, 2006, HDB DEEP SEA HYDROTH, V18, P544; Eguchi M., 1968, HYDROCORALS SCLERACT; Fujikura K., 2008, DEEP SEA LIFE BIOL O; Fukuda Hiroshi, 2004, Japanese Journal of Benthology, V59, P68; Hayami I, 1996, AM MALACOL BULL, V12, P59; Hayashi R., 1973, SEA STARS SAGAMI BAY; Irimura S., 1982, BRITTLE STARS SAGAMI; Iwasaki Keiji, 2004, Japanese Journal of Benthology, V59, P22; KAJIHARA H, 2004, SEIBUTSUKAGAKU, V55, P71; Kitamura Minoru, 2003, Plankton Biology and Ecology, V50, P43; Kojima S, 2002, J OCEANOGR, V58, P343, DOI 10.1023/A:1015869927288; Kuroda T, 1971, SEA SHELLS SAGAMI BA; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; LINDSAY D, 2009, KAIYO MONTHLY, V53, P417; MATSUURA K, 2004, SEIBUTSUKAGAKU, V55, P79; Miyake S, 1978, CRUSTACEAN ANOMURA S; Nakamura K., 1987, SEA SPIDERS SAGAMI B; Nishi Eijiroh, 2004, Japanese Journal of Benthology, V59, P83; NISHIMURA S, 1981, CHIKYU UMI SEIMEI; OKIYAMA M, 1985, NIHON KAIYO SEIBUTSU; Okoshi Kenji, 2004, Japanese Journal of Benthology, V59, P74; Otani Michio, 2004, Japanese Journal of Benthology, V59, P45; Sakai T., 1965, CRABS SAGAMI BAY; Shigei M, 1986, SEA URCHINS SAGAMI B; SU JL, 1990, OCEANOGR MAR BIOL, V28, P11; TAKISHITA K, 2008, DEEP SEA LIFE BIOL O, P204; TANIDA S, 1989, DEMOSPONGIAE SAGAMI; The Oceanographic Society of Japan, 1985, COAST OC JAP ISL; Tokioka T., 1953, ASCIDIANS SAGAMI BAY; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; YONEKURA N, 2001, REGIONAL GEOMORPHOLO	36	77	83	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2010	5	8							e11836	10.1371/journal.pone.0011836	http://dx.doi.org/10.1371/journal.pone.0011836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RA	20689840	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520400007
J	Huang, T; Wang, P; Ye, ZQ; Xu, H; He, ZS; Feng, KY; Hu, LL; Cui, WR; Wang, K; Dong, XO; Xie, L; Kong, XY; Cai, YD; Li, YX				Huang, Tao; Wang, Ping; Ye, Zhi-Qiang; Xu, Heng; He, Zhisong; Feng, Kai-Yan; Hu, LeLe; Cui, WeiRen; Wang, Kai; Dong, Xiao; Xie, Lu; Kong, Xiangyin; Cai, Yu-Dong; Li, Yixue			Prediction of Deleterious Non-Synonymous SNPs Based on Protein Interaction Network and Hybrid Properties	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENE-EXPRESSION PROFILES; EVOLUTIONARY INFORMATION; DATABASE; SEQUENCE; DISEASE; ATTRIBUTES; MUTATIONS; SIFT	Non-synonymous SNPs (nsSNPs), also known as Single Amino acid Polymorphisms (SAPs) account for the majority of human inherited diseases. It is important to distinguish the deleterious SAPs from neutral ones. Most traditional computational methods to classify SAPs are based on sequential or structural features. However, these features cannot fully explain the association between a SAP and the observed pathophysiological phenotype. We believe the better rationale for deleterious SAP prediction should be: If a SAP lies in the protein with important functions and it can change the protein sequence and structure severely, it is more likely related to disease. So we established a method to predict deleterious SAPs based on both protein interaction network and traditional hybrid properties. Each SAP is represented by 472 features that include sequential features, structural features and network features. Maximum Relevance Minimum Redundancy (mRMR) method and Incremental Feature Selection (IFS) were applied to obtain the optimal feature set and the prediction model was Nearest Neighbor Algorithm (NNA). In jackknife cross-validation, 83.27% of SAPs were correctly predicted when the optimized 263 features were used. The optimized predictor with 263 features was also tested in an independent dataset and the accuracy was still 80.00%. In contrast, SIFT, a widely used predictor of deleterious SAPs based on sequential features, has a prediction accuracy of 71.05% on the same dataset. In our study, network features were found to be most important for accurate prediction and can significantly improve the prediction performance. Our results suggest that the protein interaction context could provide important clues to help better illustrate SAP's functional association. This research will facilitate the post genome-wide association studies.	[Huang, Tao; Ye, Zhi-Qiang; Dong, Xiao; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Ye, Zhi-Qiang; Feng, Kai-Yan; Dong, Xiao; Xie, Lu; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wang, Ping; Xu, Heng; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Wang, Ping; Xu, Heng; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Hu, LeLe; Wang, Kai; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [He, Zhisong; Cui, WeiRen] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn; yxli@sibs.ac.cn	Ye, Zhi-Qiang/N-8513-2014; Xu, Heng/AAS-3465-2021	Ye, Zhi-Qiang/0000-0002-8822-6148; Xu, Heng/0000-0002-7748-2621; WANG, kai/0000-0002-6194-0480; cai, yudong/0000-0001-5664-7979	National High Technology Research and Development Program of China [2006AA02Z330]; National Basic Research Program of China [2004CB518603, 2010CB529206]; National Natural Science Foundation of China [30800641]; Chinese Academy of Sciences [KSCX1-YW-R-74]; China Postdoctoral Science Foundation [20090460669]; SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences)	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences)	This work was supported by the National High Technology Research and Development Program of China (2006AA02Z330), the National Basic Research Program of China (2004CB518603, 2010CB529206), the National Natural Science Foundation of China (30800641), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-74), the China Postdoctoral Science Foundation (20090460669) and the SA-SIBS (Sanofi-Aventis - Shanghai Institutes for Biological Sciences) Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Care MA, 2007, BIOINFORMATICS, V23, P664, DOI 10.1093/bioinformatics/btl649; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Herrgard S, 2003, PROTEINS, V53, P806, DOI 10.1002/prot.10458; Hu J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-297; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones D, 2008, NAT REV DRUG DISCOV, V7, P874, DOI 10.1038/nrd2748; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kohavi R., 1997, ARTIFICIAL INTELLIGE; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	40	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11900	10.1371/journal.pone.0011900	http://dx.doi.org/10.1371/journal.pone.0011900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689580	gold, Green Published, Green Submitted			2022-12-27	WOS:000280520300015
J	Marguet, P; Tanouchi, Y; Spitz, E; Smith, C; You, LC				Marguet, Philippe; Tanouchi, Yu; Spitz, Eric; Smith, Cameron; You, Lingchong			Oscillations by Minimal Bacterial Suicide Circuits Reveal Hidden Facets of Host-Circuit Physiology	PLOS ONE			English	Article							PROGRAMMED POPULATION-CONTROL; ACYL-HOMOSERINE LACTONES; ESCHERICHIA-COLI K-12; AMP RECEPTOR PROTEIN; COPY NUMBER CONTROL; VIBRIO-FISCHERI; PLASMID REPLICATION; CYCLIC-AMP; GENE-E; BIOLOGY	Synthetic biology seeks to enable programmed control of cellular behavior though engineered biological systems. These systems typically consist of synthetic circuits that function inside, and interact with, complex host cells possessing preexisting metabolic and regulatory networks. Nevertheless, while designing systems, a simple well-defined interface between the synthetic gene circuit and the host is frequently assumed. We describe the generation of robust but unexpected oscillations in the densities of bacterium Escherichia coli populations by simple synthetic suicide circuits containing quorum components and a lysis gene. Contrary to design expectations, oscillations required neither the quorum sensing genes (luxR and luxI) nor known regulatory elements in the P-luxI promoter. Instead, oscillations were likely due to density-dependent plasmid amplification that established a population-level negative feedback. A mathematical model based on this mechanism captures the key characteristics of oscillations, and model predictions regarding perturbations to plasmid amplification were experimentally validated. Our results underscore the importance of plasmid copy number and potential impact of "hidden interactions'' on the behavior of engineered gene circuits - a major challenge for standardizing biological parts. As synthetic biology grows as a discipline, increasing value may be derived from tools that enable the assessment of parts in their final context.	[Marguet, Philippe] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Tanouchi, Yu; Spitz, Eric; Smith, Cameron; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [You, Lingchong] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Marguet, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	you@duke.edu	Smith, Cameron/B-7683-2011	Smith, Cameron/0000-0002-6347-7506	David and Lucile Packard Foundation; NIH	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by the David and Lucile Packard Foundation and the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JC, 2005, J MOL BIOL; Andrianantoandro E., 2006, MOL SYSTEMS BIOL; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Atlung T, 1999, PLASMID, V41, P110, DOI 10.1006/plas.1998.1386; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Balbas Paulina, 2004, Methods Mol Biol, V267, P77; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; BREMER H, 1986, J THEOR BIOL, V123, P453, DOI 10.1016/S0022-5193(86)80213-2; BRENDEL V, 1993, J MOL BIOL, V229, P860, DOI 10.1006/jmbi.1993.1092; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; CASHEL M, 1996, MOL BIOL, P1458; Chin JW, 2006, CURR OPIN STRUC BIOL, V16, P551, DOI 10.1016/j.sbi.2006.06.011; CLEWELL DB, 1972, J BACTERIOL, V110, P667, DOI 10.1128/JB.110.2.667-676.1972; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; DUNLAP PV, 1988, J BACTERIOL, V170, P4040, DOI 10.1128/jb.170.9.4040-4046.1988; DUNLAP PV, 1992, J BIOLUM CHEMILUM, V7, P203, DOI 10.1002/bio.1170070307; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; FRENKEL L, 1986, DNA CELL BIOL, V544, P322; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; GALLANT J, 1972, J BIOL CHEM, V247, P6055; HECKER M, 1983, MOL GEN GENET, V190, P355, DOI 10.1007/BF00330665; HENRICH B, 1982, MOL GEN GENET, V185, P493, DOI 10.1007/BF00334146; KEASLING JD, 1989, J THEOR BIOL, V141, P447, DOI 10.1016/S0022-5193(89)80230-9; LAGOSKY PA, 1980, J BACTERIOL, V144, P499, DOI 10.1128/JB.144.2.499-508.1980; MARATEA D, 1985, GENE, V40, P39, DOI 10.1016/0378-1119(85)90022-8; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Mileyko Y, 2008, P NATL ACAD SCI USA, V105, P16659, DOI 10.1073/pnas.0806239105; PAULSSON J, 2001, Q REV BIOPHYS, V1, P59; Sayut DJ, 2006, ACS CHEM BIOL, V1, P692, DOI 10.1021/cb6004245; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; SEO JH, 1985, BIOTECHNOL BIOENG, V27, P156, DOI 10.1002/bit.260270209; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; STRICKER J, 2008, NATURE; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Teich A, 1998, J BIOTECHNOL, V64, P197, DOI 10.1016/S0168-1656(98)00108-4; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Wang ZJ, 2006, MICROBIOL-SGM, V152, P3467, DOI 10.1099/mic.0.29134-0; Wang ZJ, 2002, PLASMID, V47, P69, DOI 10.1006/plas.2001.1562; Weiss LE, 2008, BIOTECHNOL BIOENG, V100, P1251, DOI 10.1002/bit.21862; WU K, 2009, MOL MICROBIOL; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	57	47	48	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11909	10.1371/journal.pone.0011909	http://dx.doi.org/10.1371/journal.pone.0011909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689598	gold, Green Published			2022-12-27	WOS:000280520300023
J	McVicar, CM; Colhoun, LM; Abrahams, JL; Kitson, CL; Hamilton, R; Medina, RJ; Durga, D; Gardiner, TA; Rudd, PM; Stitt, AW				McVicar, Carmel M.; Colhoun, Liza M.; Abrahams, Jodie L.; Kitson, Claire L.; Hamilton, Ross; Medina, Reinhold J.; Durga, Dash; Gardiner, Tom A.; Rudd, Pauline M.; Stitt, Alan W.			Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; MYOCARDIAL-INFARCTION; RETINAL NEOVASCULARIZATION; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; TISSUE PROTECTION; EPO; DEGENERATION; MACROPHAGES; INHIBITION	Background: Erythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to promote pathological angiogenesis in some clinical scenarios. In the current study we have assessed the angiogenic potential of three ESAs; epoetin delta, darbepoetin alfa and epoetin beta using in vitro and in vivo models. Methodology/Principal Findings: The epoetins induced angiogenesis in human microvascular endothelial cells at high doses, although darbepoetin alfa was pro-angiogenic at low-doses (1-20 IU/ml). ESA-induced angiogenesis was VEGF-mediated. In a mouse model of ischaemia-induced retinopathy, all ESAs induced generation of reticulocytes but only epoetin beta exacerbated pathological (pre-retinal) neovascularisation in comparison to controls (p<0.05). Only epoetin delta induced a significant revascularisation response which enhanced normality of the vasculature (p<0.05). This was associated with mobilisation of haematopoietic stem cells and their localisation to the retinal vasculature. Darbepoetin alfa also increased the number of active microglia in the ischaemic retina relative to other ESAs (p<0.05). Darbepoetin alfa induced retinal TNF alpha and VEGF mRNA expression which were up to 4 fold higher than with epoetin delta (p<0.001). Conclusions: This study has implications for treatment of patients as there are clear differences in the angiogenic potential of the different ESAs.	[McVicar, Carmel M.; Colhoun, Liza M.; Kitson, Claire L.; Hamilton, Ross; Medina, Reinhold J.; Durga, Dash; Gardiner, Tom A.; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Abrahams, Jodie L.; Rudd, Pauline M.] Univ Coll Dublin, Dublin Oxford Glycobiol Lab, Natl Inst Bioproc Res & Training, Conway Inst, Dublin 2, Ireland	Queens University Belfast; University College Dublin	McVicar, CM (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	a.stitt@qub.ac.uk	Stitt, Alan/A-9842-2009; Wilson, Matthew H/K-3193-2013; Medina, Reinhold J/A-7949-2015; Hamilton, Ross/B-3659-2013	Stitt, Alan/0000-0002-8647-9918; Medina, Reinhold J/0000-0003-4351-7010; Gardiner, Tom/0000-0003-4907-2630; Abrahams, Jodie/0000-0002-2988-7843; Hamilton, Ross/0000-0001-9794-8452	Shire (Hampshire, UK); Fight for Sight [1688]	Shire (Hampshire, UK); Fight for Sight	Part of this research was funded by a grant from Shire (Hampshire, UK) and Fight for Sight grant no. 1688. AWS and PR have received travel funding from Shire. The funders agreed to the study design. They had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RK, 2008, J IMMUNOL, V180, P5423, DOI 10.4049/jimmunol.180.8.5423; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; *DAHANCA, 2006, INT AN DAHANCA 10; Davies M, 2006, MOL VIS, V12, P467; Ferrario M, 2007, EUR HEART J, V28, P1805, DOI 10.1093/eurheartj/ehm065; Frei U, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-5; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gassmann M, 2003, ADV EXP MED BIOL, V543, P323; Gebarowska D, 2002, AM J PATHOL, V160, P307, DOI 10.1016/S0002-9440(10)64374-X; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Hernandez C, 2006, DIABETES CARE, V29, P2028, DOI 10.2337/dc06-0556; Hirata A, 2006, J AM COLL CARDIOL, V48, P176, DOI 10.1016/j.jacc.2006.04.008; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Janmaat ML, 2010, BLOOD, V115, P1453, DOI 10.1182/blood-2009-07-230870; Jelkmann W, 2004, ANN HEMATOL, V83, P673, DOI 10.1007/s00277-004-0911-6; Kettenmann H, 2006, NAT NEUROSCI, V9, P1463, DOI 10.1038/nn1206-1463; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lappin TR, 2007, ONCOLOGIST, V12, P362, DOI 10.1634/theoncologist.12-4-362; Li WY, 2010, OPHTHAL SURG LAS IM, V41, P18, DOI 10.3928/15428877-20091230-03; LI Y, 2006, J CEREB BLOOD FLOW M; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Nishiya D, 2006, J PHARMACOL SCI, V101, P31, DOI 10.1254/jphs.FP0050966; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Scott SD, 2002, PHARMACOTHERAPY, V22, p160S, DOI 10.1592/phco.22.14.160S.33398; Simpson D, 2000, MOL VIS, V6, P178; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; Westenbrink BD, 2008, CARDIOVASC DRUG THER, V22, P265, DOI 10.1007/s10557-008-6094-y; Yu YP, 2005, NEUROSCI LETT, V387, P5, DOI 10.1016/j.neulet.2005.07.008	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11870	10.1371/journal.pone.0011870	http://dx.doi.org/10.1371/journal.pone.0011870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686695	gold, Green Submitted, Green Published			2022-12-27	WOS:000280520200033
J	Jurczyk, A; Pino, SC; O'Sullivan-Murphy, B; Addorio, M; Lidstone, EA; Diiorio, P; Lipson, KL; Standley, C; Fogarty, K; Lifshitz, L; Urano, F; Mordes, JP; Greiner, DL; Rossini, AA; Bortell, R				Jurczyk, Agata; Pino, Steven C.; O'Sullivan-Murphy, Bryan; Addorio, Martha; Lidstone, Erich A.; Diiorio, Philip; Lipson, Kathryn L.; Standley, Clive; Fogarty, Kevin; Lifshitz, Lawrence; Urano, Fumihiko; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita			A Novel Role for the Centrosomal Protein, Pericentrin, in Regulation of Insulin Secretory Vesicle Docking in Mouse Pancreatic beta-cells	PLOS ONE			English	Article							GAMMA-TUBULIN; MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; EXOCYTOSIS; COMPLEX; FUSION; MUTATIONS; MEMBRANE; GRANULES; KENDRIN	The centrosome is important for microtubule organization and cell cycle progression in animal cells. Recently, mutations in the centrosomal protein, pericentrin, have been linked to human microcephalic osteodysplastic primordial dwarfism (MOPD II), a rare genetic disease characterized by severe growth retardation and early onset of type 2 diabetes among other clinical manifestations. While the link between centrosomal and cell cycle defects may account for growth deficiencies, the mechanism linking pericentrin mutations with dysregulated glucose homeostasis and pre-pubertal onset of diabetes is unknown. In this report we observed abundant expression of pericentrin in quiescent pancreatic beta-cells of normal animals which led us to hypothesize that pericentrin may have a critical function in beta-cells distinct from its known role in regulating cell cycle progression. In addition to the typical centrosome localization, pericentrin was also enriched with secretory vesicles in the cytoplasm. Pericentrin overexpression in beta-cells resulted in aggregation of insulin-containing secretory vesicles with cytoplasmic, but not centrosomal, pericentriolar material and an increase in total levels of intracellular insulin. RNAi-mediated silencing of pericentrin in secretory beta-cells caused dysregulated secretory vesicle hypersecretion of insulin into the media. Together, these data suggest that pericentrin may regulate the intracellular distribution and secretion of insulin. Mice transplanted with pericentrin-depleted islets exhibited abnormal fasting hypoglycemia and inability to regulate blood glucose normally during a glucose challenge, which is consistent with our in vitro data. This previously unrecognized function for a centrosomal protein to mediate vesicle docking in secretory endocrine cells emphasizes the adaptability of these scaffolding proteins to regulate diverse cellular processes and identifies a novel target for modulating regulated protein secretion in disorders such as diabetes.	[Jurczyk, Agata; Pino, Steven C.; O'Sullivan-Murphy, Bryan; Addorio, Martha; Lidstone, Erich A.; Diiorio, Philip; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Lidstone, Erich A.] Western New England Coll, Dept Phys & Biol Sci, Springfield, MA USA; [Standley, Clive; Fogarty, Kevin; Lifshitz, Lawrence] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Urano, Fumihiko; Greiner, Dale L.; Rossini, Aldo A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Western New England University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jurczyk, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Rita.Bortell@umassmed.edu	Urano, Fumihiko/AAF-4492-2020	O'Sullivan-Murphy, Bryan/0000-0002-1426-5013	National Institutes of Health [AI46629, DK53006, DK49106, DK25306]; Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation; Iacocca Foundation; Helmsley Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053006, R01DK049106, R01DK067493, P30DK032520, R37DK025306, R01DK025306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Iacocca Foundation; Helmsley Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AI46629, DK53006, DK49106 and DK25306, the Beta Cell Biology Consortium, and grants from the Juvenile Diabetes Research Foundation, the Iacocca Foundation, and the Helmsley Foundation. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 from the National Institute of Diabetes and Digestive and Kidney Diseases were used; RB is a member of the UMass DERC (DK32520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma N, 2002, ENDOCR J, V49, P449, DOI 10.1507/endocrj.49.449; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; ENDOHYAMAGAMI S, DEV BIOL; FARSHORI PQ, 1994, J SUBMICR CYTOL PATH, V26, P137; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hayat M.A., 1986, BASIC TECHNIQUES TRA, V1st ed.; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kuemmel D, 2008, CURR PROTEIN PEPT SC, V9, P197, DOI 10.2174/138920308783955252; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu QQ, 2001, J CELL SCI, V114, P797; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; PARKER DC, 1995, P NATL ACAD SCI USA, V92, P9560, DOI 10.1073/pnas.92.21.9560; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Varadi A, 2003, BIOCHEM BIOPH RES CO, V311, P272, DOI 10.1016/j.bbrc.2003.09.208; WILLEMS M, 2009, J MED GENET; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11812	10.1371/journal.pone.0011812	http://dx.doi.org/10.1371/journal.pone.0011812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676397	gold, Green Published			2022-12-27	WOS:000280371800014
J	Scambi, C; La Verde, V; De Franceschi, L; Barausse, G; Poli, F; Benedetti, F; Sorio, M; Deriu, F; Roncada, P; Bortolami, O; Turrini, F; Caramaschi, P; Stranieri, C; Bambara, LM; Biasi, D				Scambi, Cinzia; La Verde, Valentina; De Franceschi, Lucia; Barausse, Giovanni; Poli, Fabio; Benedetti, Fabio; Sorio, Marco; Deriu, Francesca; Roncada, Paola; Bortolami, Oscar; Turrini, Francesco; Caramaschi, Paola; Stranieri, Chiara; Bambara, Lisa M.; Biasi, Domenico			Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; REGULATOR FACTOR-H; AMYLOID-A PROTEIN; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; HOST-DISEASE; B-CELLS; EXPRESSION; AUTOIMMUNITY; INFECTION	Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow transplantation (BMT) for haematological disorders. Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD. Methodology: Serum was obtained from patients with SSc and ScGVHD, patients without ScGVHD who received BMT for haematological disorders and healthy controls. Bi-dimensional electrophoresis (2D) was carried out to generate maps of serum proteins from patients and controls. The 2D maps underwent image analysis and differently expressed proteins were identified. Immuno-blot analysis and ELISA assay were used to validate the proteomic data. Hemolytic assay with sheep erythrocytes was performed to evaluate the capacity of Factor H (FH) to control complement activation on the cellular surface. FH binding to endothelial cells (ECs) was also analysed in order to assess possible dysfunctions of this protein. Principal Findings: Fourteen differentially expressed proteins were identified. We detected pneumococcal antibody crossreacting with double stranded DNA in serum of all bone marrow transplanted patients with ScGVHD. We documented higher levels of FH in serum of SSc and ScGVHD patients compared healthy controls and increased sheep erythrocytes lysis after incubation with serum of diffuse SSc patients. In addition, we observed that FH binding to ECs was reduced when we used serum from these patients. Conclusions: The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state. We also found a defective function of Factor H, possibly associated with ECs damage.	[Scambi, Cinzia; La Verde, Valentina; Barausse, Giovanni; Poli, Fabio; Caramaschi, Paola; Stranieri, Chiara; Bambara, Lisa M.; Biasi, Domenico] Univ Verona, Rheumatol Sect, Dept Clin & Expt Med, I-37100 Verona, Italy; [De Franceschi, Lucia] Univ Verona, Sect Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy; [Benedetti, Fabio; Sorio, Marco] Univ Verona, Sect Haematol, Dept Clin & Expt Med, I-37100 Verona, Italy; [Deriu, Francesca] Univ Milan, Dept Vet Pathol Hyg & Publ Hlth DIPAV, Milan, Italy; [Roncada, Paola] Univ Milan, Sect Prote, Ist Sperimentale Italiano L Spallanzani, Milan, Italy; [Bortolami, Oscar] Univ Verona, Unit Epidemiol & Med Stat, Dept Med & Publ Hlth, I-37100 Verona, Italy; [Turrini, Francesco] Univ Turin, Med Chem Sect, Dept Genet Biol & Med Chem, Turin, Italy	University of Verona; University of Verona; University of Verona; University of Milan; IRCCS Lazzaro Spallanzani; University of Milan; University of Verona; University of Turin	Scambi, C (corresponding author), Univ Verona, Rheumatol Sect, Dept Clin & Expt Med, I-37100 Verona, Italy.	cinzia.scambi@univr.it	DE FRANCESCHI, Lucia/AAB-8652-2022; Bortolami, Oscar/E-9219-2016; Roncada, Paola/C-5263-2013; Roncada, Paola/AAJ-6168-2020; Bortolami, Oscar/H-6559-2019; Stranieri, Chiara/GWV-1749-2022	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Bortolami, Oscar/0000-0002-4346-9672; Roncada, Paola/0000-0002-0114-5872; Roncada, Paola/0000-0002-0114-5872; Bortolami, Oscar/0000-0002-4346-9672; 	MIUR (Ministero Ricerca Universitaria)	MIUR (Ministero Ricerca Universitaria)(Ministry of Education, Universities and Research (MIUR))	This work was supported by MIUR (Ministero Ricerca Universitaria) ex 60% for Lisa Maria Bambara. The funder (MIUR) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akesson A, 2003, CLIN EXP RHEUMATOL, V21, pS5; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bell SA, 1996, BRIT J DERMATOL, V134, P848; Blaum BS, 2010, J AM CHEM SOC, V132, P6374, DOI 10.1021/ja1000517; BRANDWEIN SR, 1984, ANN RHEUM DIS, V43, P586, DOI 10.1136/ard.43.4.586; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Ferri C, 1999, CLIN EXP RHEUMATOL, V17, P718; FRIEDMAN CR, 2000, CAMPYLOBACTER, V1, P121; Friese MA, 2003, CLIN EXP IMMUNOL, V132, P485, DOI 10.1046/j.1365-2249.2003.02173.x; Griffiths MR, 2009, J IMMUNOL, V182, P4368, DOI 10.4049/jimmunol.0800205; Hamamdzic D, 2002, CURR OPIN RHEUMATOL, V14, P694, DOI 10.1097/00002281-200211000-00011; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2004, HISTOL HISTOPATHOL, V19, P251, DOI 10.14670/HH-19.251; Jozsi M, 2007, MOL IMMUNOL, V44, P2697, DOI 10.1016/j.molimm.2006.12.001; Kahaleh MB, 1999, AUTOIMMUNITY, V31, P195, DOI 10.3109/08916939908994064; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Molina V, 2005, AUTOIMMUNITY, V38, P235, DOI 10.1080/08916930500050277; Nakiri Y, 2007, CLIN RHEUMATOL, V26, P1721, DOI 10.1007/s10067-007-0665-3; Nietert PJ, 2000, CURR OPIN RHEUMATOL, V12, P520, DOI 10.1097/00002281-200011000-00008; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Penas PF, 2002, ARCH DERMATOL, V138, P924, DOI 10.1001/archderm.138.7.924; SAMMALKORPI KT, 1990, ANN MED, V22, P397, DOI 10.3109/07853899009147277; Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Sato S, 2004, MOL IMMUNOL, V41, P1123, DOI 10.1016/j.molimm.2004.06.025; Schlaf G, 2001, MOL IMMUNOL, V38, P231, DOI 10.1016/S0161-5890(01)00045-1; Schmidt Bela, 1995, Pathol Oncol Res, V1, P54; SENALDI G, 1989, ARTHRITIS RHEUM, V32, P1262, DOI 10.1002/anr.1780321011; Shainkin-Kestenbaum R, 1996, Biomed Pept Proteins Nucleic Acids, V2, P79; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Vaillant P, 1996, Monaldi Arch Chest Dis, V51, P145; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Vaziri-Sani F, 2006, KIDNEY INT, V69, P981, DOI 10.1038/sj.ki.5000155; VENNEKER GT, 1994, LAB INVEST, V70, P830; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Wilkins M. R., 1997, PROTEOME RES NEW FRO; Yamamoto T, 1999, J RHEUMATOL, V26, P609; YANG YQ, 1994, J BIOL CHEM, V269, P20110; Youinou P, 2007, AUTOIMMUN REV, V7, P149, DOI 10.1016/j.autrev.2007.02.016	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12162	10.1371/journal.pone.0012162	http://dx.doi.org/10.1371/journal.pone.0012162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730046	Green Submitted, Green Published, gold			2022-12-27	WOS:000280862200017
J	Menn, B; Bach, S; Blevins, TL; Campbell, M; Meijer, L; Timsit, S				Menn, Benedicte; Bach, Stephane; Blevins, Teri L.; Campbell, Mark; Meijer, Laurent; Timsit, Serge			Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; PROTEIN-KINASES; ROSCOVITINE; ACTIVATION; PHARMACOKINETICS; MACHINERY; NEURONS; INJURY	Background: Although quite challenging, neuroprotective therapies in ischemic stroke remain an interesting strategy to counter mechanisms of ischemic injury and reduce brain tissue damage. Among potential neuroprotective drug, cyclin-dependent kinases (CDK) inhibitors represent interesting therapeutic candidates. Increasing evidence indisputably links cell cycle CDKs and CDK5 to the pathogenesis of stroke. Although recent studies have demonstrated promising neuroprotective efficacies of pharmacological CDK inhibitors in related animal models, none of them were however clinically relevant to human treatment. Methodology/Principal Findings: In the present study, we report that systemic delivery of (S)-roscovitine, a well known inhibitor of mitotic CDKs and CDK5, was neuroprotective in a dose-dependent manner in two models of focal ischemia, as recommended by STAIR guidelines. We show that (S)-roscovitine was able to cross the blood brain barrier. (S)-roscovitine significant in vivo positive effect remained when the compound was systemically administered 2 hrs after the insult. Moreover, we validate one of (S)-roscovitine in vivo target after ischemia. Cerebral increase of CDK5/p25 activity was observed 3 hrs after the insult and prevented by systemic (S)-roscovitine administration. Our results show therefore that roscovitine protects in vivo neurons possibly through CDK5 dependent mechanisms. Conclusions/Significance: Altogether, our data bring new evidences for the further development of pharmacological CDK inhibitors in stroke therapy.	[Menn, Benedicte] Neurokin SA, Inst Neurobiol Med, Marseille, France; [Bach, Stephane; Meijer, Laurent] CNRS, Stn Biol Roscoff, USR3151, Roscoff, France; [Blevins, Teri L.; Campbell, Mark] MDS Pharma Serv, Efficacy Pharmacol, Bothell, WA USA; [Timsit, Serge] CHRU Brest, Fac Med & Sci St Brest, Dept Neurol, Brest, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHU Brest; Universite de Bretagne Occidentale	Menn, B (corresponding author), Neurokin SA, Inst Neurobiol Med, Marseille, France.	serge.timsit@chu-brest.fr	BACH, Stéphane/ABD-5865-2020; MEIJER, Laurent/ABE-7465-2021	, laurent/0000-0003-3511-4916; Timsit, Serge/0000-0003-0346-8576	French Ministry of the ANVAR; PRO-KINASE [LSHB-CT-2004-503467]; Association France Alzheimer; Neurokin S.A.	French Ministry of the ANVAR; PRO-KINASE; Association France Alzheimer; Neurokin S.A.	This study was supported by the French Ministry of the ANVAR (ST), the EEC grant from the PRO-KINASE Research Project (LSHB-CT-2004-503467; ST and LM) and the "Association France Alzheimer'' (LM). BM is Neurokin S. A. employee. TLB and MC are MDS PS employees. MDS PS was not a funder of the work and was used as a CRO to perform an external validation of our data as recommended by STAIR guidelines. MDS PS received payment from Neurokin S.A. for its service. ANVAR, the PRO-KINASE Research Project, and the "Association France Alzheimer'' had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neurokin S. A. was a funder of this work and had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P557, DOI 10.1080/10408440802014287; Chavez JC, 2009, STROKE, V40, pE558, DOI 10.1161/STROKEAHA.109.559914; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Frade JM, 2000, J CELL SCI, V113, P1139; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Guegan C, 1998, EXP NEUROL, V154, P371, DOI 10.1006/exnr.1998.6913; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Padmanabhan J, 2007, DEV NEUROBIOL, V67, P818, DOI 10.1002/dneu.20394; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Sallam H, 2008, PHARMACOL RES, V58, P32, DOI 10.1016/j.phrs.2008.05.010; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Strickley RG, 2004, PHARM RES-DORDR, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Timsit S, 1999, EUR J NEUROSCI, V11, P263, DOI 10.1046/j.1460-9568.1999.00434.x; Timsit Serge, 2007, Biotechnology Journal, V2, P958, DOI 10.1002/biot.200700072; Vita M, 2005, EUR J PHARM SCI, V25, P91, DOI 10.1016/j.ejps.2005.02.001; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wen Y, 2007, BBA-MOL BASIS DIS, V1772, P473, DOI 10.1016/j.bbadis.2006.10.011; Zhang M, 2004, AM J PATHOL, V165, P843, DOI 10.1016/S0002-9440(10)63347-0; Zhang Q, 2009, GLIA, V57, P908, DOI 10.1002/glia.20816	44	72	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12117	10.1371/journal.pone.0012117	http://dx.doi.org/10.1371/journal.pone.0012117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711428	Green Published, Green Submitted, gold			2022-12-27	WOS:000280859700011
J	Thangamani, S; Higgs, S; Ziegler, S; Vanlandingham, D; Tesh, R; Wikel, S				Thangamani, Saravanan; Higgs, Stephen; Ziegler, Sarah; Vanlandingham, Dana; Tesh, Robert; Wikel, Stephen			Host Immune Response to Mosquito-Transmitted Chikungunya Virus Differs from That Elicited by Needle Inoculated Virus	PLOS ONE			English	Article							SALIVARY-GLAND EXTRACTS; VECTOR-BORNE DISEASES; TOLL-LIKE RECEPTOR-3; AEDES-AEGYPTI; INFECTION; PROTEIN; MODULATION; MICE; TRANSMISSION; ENCEPHALITIS	Background: Mosquito-borne diseases are a worldwide public health threat. Mosquitoes transmit viruses or parasites during feeding, along with salivary proteins that modulate host responses to facilitate both blood feeding and pathogen transmission. Understanding these earliest events in mosquito transmission of arboviruses by mosquitoes is essential for development and assessment of rational vaccine and treatment strategies. In this report, we compared host immune responses to chikungunya virus (CHIKV) transmission by (1) mosquito bite, or (2) by needle inoculation. Methods and Findings: Differential cytokine expression was measured using quantitative real-time RT-PCR, at sites of uninfected mosquito bites, CHIKV-infected mosquito bites, and needle-inoculated CHIKV. Both uninfected and CHIKV infected mosquitoes polarized host cytokine response to a T(H)2 profile. Compared to uninfected mosquito bites, expression of IL-4 induced by CHIKV-infected mosquitoes were 150 fold and 527.1 fold higher at 3 hours post feeding (hpf) and 6 hpf, respectively. A significant suppression of T(H)1 cytokines and TLR-3 was also observed. These significant differences may result from variation in the composition of uninfected and CHIKV-infected mosquito saliva. Needle injected CHIKV induced a robust interferon-c, no detectable IL-4, and a significant up-regulation of TLR-3. Conclusions: This report describes the first analysis of cutaneous cytokines in mice bitten by CHIKV-infected mosquitoes. Our data demonstrate contrasting immune activation in the response to CHIKV infection by mosquito bite or needle inoculation. The significant role of mosquito saliva in these earliest events of CHIKV transmission and infection are highlighted.	[Thangamani, Saravanan; Higgs, Stephen; Ziegler, Sarah; Vanlandingham, Dana; Tesh, Robert; Wikel, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Thangamani, Saravanan; Higgs, Stephen; Vanlandingham, Dana; Tesh, Robert; Wikel, Stephen] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Ziegler, Sarah] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thangamani, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	sathanga@utmb.edu	Thangamani, Saravanan/E-7371-2010	Thangamani, Saravanan/0000-0002-4269-5993	United States Army [0310075]; National Institutes of Health (NIH) [AI062735, N01-AI25489, N01-AI30027, AI R21 AI073389]; Sealy Center for Vaccine Development, UTMB, Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073389, N01AI025489, R01AI062735] Funding Source: NIH RePORTER	United States Army(United States Department of DefenseUnited States Army); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development, UTMB, Galveston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by United States Army Medical Research and Materiel Command Award 0310075 and National Institutes of Health (NIH) Grant AI062735 to SW. This study was also supported in part by NIH contract N01-AI25489 and N01-AI30027 to RT, and NIH grant AI R21 AI073389 to SH. SZ is funded by the Sealy Center for Vaccine Development, UTMB, Galveston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; GIRARD YA, J MED ENTOMOL, V47, P421; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Higgs S, 1996, BIOTECHNIQUES, V21, P660; Hochedez P., 2007, EURO SURVEILL, V12; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Lim PL, 2009, J TRAVEL MED, V16, P289, DOI 10.1111/j.1708-8305.2009.00313.x; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x; Osorio JE, 1996, AM J TROP MED HYG, V54, P338, DOI 10.4269/ajtmh.1996.54.338; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pfeffer M., 2006, EUROSURVEILLANCE, V11; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Qureshi ST, 2003, GENES IMMUN, V4, P87, DOI 10.1038/sj.gene.6363937; RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6; RIBEIRO JMC, 1984, J EXP BIOL, V108, P1; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; Thangamani S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-34; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x	39	66	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12137	10.1371/journal.pone.0012137	http://dx.doi.org/10.1371/journal.pone.0012137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20711354	gold, Green Published, Green Submitted			2022-12-27	WOS:000280859700023
J	Villumsen, S; Pedersen, R; Krogfelt, KA; Jensen, JS				Villumsen, Steen; Pedersen, Rebecca; Krogfelt, Karen Angeliki; Jensen, Jorgen Skov			Expanding the Diagnostic Use of PCR in Leptospirosis: Improved Method for DNA Extraction from Blood Cultures	PLOS ONE			English	Article							PATHOGENIC LEPTOSPIRA; TAQMAN ASSAY; DISEASE	Background: Leptospirosis is a neglected zoonosis of ubiquitous distribution. Symptoms are often non-specific and may range from flu-like symptoms to multi-organ failure. Diagnosis can only be made by specific diagnostic tests like serology and PCR. In non-endemic countries, leptospirosis is often not suspected before antibiotic treatment has been initiated and consequently, relevant samples for diagnostic PCR are difficult to obtain. Blood cultures are obtained from most hospitalized patients before antibiotic therapy and incubated for at least five days, thus providing an important source of blood for PCR diagnosis. However, blood cultures contain inhibitors of PCR that are not readily removed by most DNA-extraction methods, primarily sodium polyanetholesulfonate (SPS). Methodology/Principal Findings: In this study, two improved DNA extraction methods for use with blood cultures are presented and found to be superior in recovering DNA of Leptospira interrogans when compared with three previously described methods. The improved methods were easy and robust in use with all tested brands of blood culture media. Applied to 96 blood cultures obtained from 36 patients suspected of leptospirosis, all seven patients with positive convalescence serology were found positive by PCR if at least one anaerobic and one aerobic blood culture, sampled before antibiotic therapy were tested. Conclusions/Significance: This study suggests that a specific and early diagnosis can be obtained in most cases of severe leptospirosis for up to five days after initiation of antimicrobial therapy, if PCR is applied to blood cultures already sampled as a routine procedure in most septic patients.	[Villumsen, Steen; Pedersen, Rebecca; Krogfelt, Karen Angeliki; Jensen, Jorgen Skov] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Villumsen, S (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	jsj@ssi.dk	Krogfelt, Karen Angeliki/P-2430-2018; Jensen, Jørgen/I-2917-2012; Jensen, Jørgen Skov/H-5159-2019; Krogfelt, Karen Angeliki A/O-8145-2016	Jensen, Jørgen Skov/0000-0002-7464-7435; Krogfelt, Karen Angeliki A/0000-0001-7536-3453	Statens Serum Institut, Copenhagen, Denmark	Statens Serum Institut, Copenhagen, Denmark	This study was financed by Statens Serum Institut, Copenhagen, Denmark, only. No external funders supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling HH, 2009, EMERG INFECT DIS, V15, P1805, DOI 10.3201/eid1511.091157; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Fonseca CD, 2006, J INFECTION, V52, P15, DOI 10.1016/j.jinf.2005.02.022; Fredricks DN, 1998, J CLIN MICROBIOL, V36, P2810, DOI 10.1128/JCM.36.10.2810-2816.1998; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hartskeerl RA, 2006, INT COURSE LAB METHO; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Miller BC, 2000, J MICROBIOL METH, V42, P139, DOI 10.1016/S0167-7012(00)00174-3; Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13	14	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12095	10.1371/journal.pone.0012095	http://dx.doi.org/10.1371/journal.pone.0012095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711446	Green Submitted, Green Published, gold			2022-12-27	WOS:000280849100022
J	Noguchi, Y; Nishikata, N; Shikata, N; Kimura, Y; Aleman, JO; Young, JD; Koyama, N; Kelleher, JK; Takahashi, M; Stephanopoulos, G				Noguchi, Yasushi; Nishikata, Natsumi; Shikata, Nahoko; Kimura, Yoshiko; Aleman, Jose O.; Young, Jamey D.; Koyama, Naoto; Kelleher, Joanne K.; Takahashi, Michio; Stephanopoulos, Gregory			Ketogenic Essential Amino Acids Modulate Lipid Synthetic Pathways and Prevent Hepatic Steatosis in Mice	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; REGULATES FOOD-INTAKE; FATTY LIVER-DISEASE; UNCOUPLING PROTEIN-3; ENERGY-EXPENDITURE; IMPROVES GLUCOSE; DE-NOVO; MUSCLE; RAT	Background: Although dietary ketogenic essential amino acid (KAA) content modifies accumulation of hepatic lipids, the molecular interactions between KAAs and lipid metabolism are yet to be fully elucidated. Methodology/Principal Findings: We designed a diet with a high ratio (E/N) of essential amino acids (EAAs) to non-EAAs by partially replacing dietary protein with 5 major free KAAs (Leu, Ile, Val, Lys and Thr) without altering carbohydrate and fat content. This high-KAA diet was assessed for its preventive effects on diet-induced hepatic steatosis and whole-animal insulin resistance. C57B6 mice were fed with a high-fat diet, and hyperinsulinemic ob/ob mice were fed with a high-fat or high-sucrose diet. The high-KAA diet improved hepatic steatosis with decreased de novo lipogensis (DNL) fluxes as well as reduced expressions of lipogenic genes. In C57B6 mice, the high-KAA diet lowered postprandial insulin secretion and improved glucose tolerance, in association with restored expression of muscle insulin signaling proteins repressed by the high-fat diet. Lipotoxic metabolites and their synthetic fluxes were also evaluated with reference to insulin resistance. The high-KAA diet lowered muscle and liver ceramides, both by reducing dietary lipid incorporation into muscular ceramides and preventing incorporation of DNL-derived fatty acids into hepatic ceramides. Conclusion: Our results indicate that dietary KAA intake improves hepatic steatosis and insulin resistance by modulating lipid synthetic pathways.	[Noguchi, Yasushi; Aleman, Jose O.; Young, Jamey D.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kelleher, Joanne K.] Massachusetts Gen Hosp, Shriners Burn Hosp, Boston, MA 02114 USA; [Noguchi, Yasushi; Nishikata, Natsumi; Shikata, Nahoko; Kimura, Yoshiko; Koyama, Naoto; Takahashi, Michio] Ajinomoto Co Inc, Res Inst Hlth Fundamentals, Kanagawa, Japan	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Ajinomoto Co Inc	Noguchi, Y (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Young, Jamey/A-5857-2012	Aleman, Jose/0000-0003-3753-6717; Koyama, Naoto/0000-0003-2005-915X	National Institutes of Health (NIH) Bioengineering Research Partnership [DK58533]; NIH Metabolomics Roadmap Initiative [DK070291]; NIH [DK072856]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072856, R01DK058533, R33DK070291] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Bioengineering Research Partnership(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Metabolomics Roadmap Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) Bioengineering Research Partnership Grant DK58533 and NIH Metabolomics Roadmap Initiative DK070291. J.D.Y. was supported by NIH grant DK072856. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Bernstein AM, 2007, J AM DIET ASSOC, V107, P644, DOI 10.1016/j.jada.2007.01.002; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Eisenstein J, 2002, NUTR REV, V60, P189, DOI 10.1301/00296640260184264; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hasty AH, 1999, J LIPID RES, V40, P1529; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Krebs M, 2005, EUR J CLIN INVEST, V35, P351, DOI 10.1111/j.1365-2362.2005.01506.x; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; PELLETT P L, 1984, American Journal of Clinical Nutrition, V40, P718, DOI 10.1093/ajcn/40.3.718; PENG Y, 1973, J NUTR, V103, P608, DOI 10.1093/jn/103.4.608; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; RAO PBR, 1960, J NUTR, V71, P327, DOI 10.1093/jn/71.3.327; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; SINGAL SA, 1953, J BIOL CHEM, V200, P867; Solerte SB, 2004, AM J CARDIOL, V93, p23A, DOI 10.1016/i.amjcard.2003.11.006; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Tilg H, 2005, NAT CLIN PRACT GASTR, V2, P148, DOI 10.1038/ncpgasthep0116; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vieu C, 2002, J LIPID RES, V43, P510; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; WILLIAMS JN, 1963, NATURE, V200, P472, DOI 10.1038/200472a0; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	49	44	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12057	10.1371/journal.pone.0012057	http://dx.doi.org/10.1371/journal.pone.0012057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706589	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900015
J	Rohwer, N; Dame, C; Haugstetter, A; Wiedenmann, B; Detjen, K; Schmitt, CA; Cramer, T				Rohwer, Nadine; Dame, Christof; Haugstetter, Anja; Wiedenmann, Bertram; Detjen, Katharina; Schmitt, Clemens A.; Cramer, Thorsten			Hypoxia-Inducible Factor 1 alpha Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-kappa B	PLOS ONE			English	Article							CELL CARCINOMA; FACTOR-I; CHEMORESISTANCE; INHIBITION; FACTOR-1-ALPHA; RESISTANCE; SENESCENCE; PATHWAY; OVEREXPRESSION; CONTRIBUTES	Background: Reduced chemosensitivity of solid cancer cells represents a pivotal obstacle in clinical oncology. Hence, the molecular characterization of pathways regulating chemosensitivity is a central prerequisite to improve cancer therapy. The hypoxia-inducible factor HIF-1 alpha has been linked to chemosensitivity while the underlying molecular mechanisms remain largely elusive. Therefore, we comprehensively analysed HIF-1 alpha's role in determining chemosensitivity focussing on responsible molecular pathways. Methodology and Principal Findings: RNA interference was applied to inactivate HIF-1 alpha or p53 in the human gastric cancer cell lines AGS and MKN28. The chemotherapeutic agents 5-fluorouracil and cisplatin were used and chemosensitivity was assessed by cell proliferation assays as well as determination of cell cycle distribution and apoptosis. Expression of p53 and p53 target proteins was analyzed by western blot. NF-kappa B activity was characterized by means of electrophoretic mobility shift assay. Inactivation of HIF-1 alpha in gastric cancer cells resulted in robust elevation of chemosensitivity. Accordingly, HIF-1 alpha-competent cells displayed a significant reduction of chemotherapy-induced senescence and apoptosis. Remarkably, this phenotype was completely absent in p53 mutant cells while inactivation of p53 per se did not affect chemosensitivity. HIF-1 alpha markedly suppressed chemotherapy-induced activation of p53 and p21 as well as the retinoblastoma protein, eventually resulting in cell cycle arrest. Reduced formation of reactive oxygen species in HIF-1 alpha-competent cells was identified as the molecular mechanism of HIF-1 alpha-mediated inhibition of p53. Furthermore, loss of HIF-1 alpha abrogated, in a p53-dependent manner, chemotherapy-induced DNA-binding of NF-kappa B and expression of anti-apoptotic NF-kappa B target genes. Accordingly, reconstitution of the NF-kappa B subunit p65 reversed the increased chemosensitivity of HIF-1 alpha-deficient cells. Conclusion and Significance: In summary, we identified HIF-1 alpha as a potent regulator of p53 and NF-kappa B activity under conditions of genotoxic stress. We conclude that p53 mutations in human tumors hold the potential to confound the efficacy of HIF-1-inhibitors in cancer therapy.	[Rohwer, Nadine; Wiedenmann, Bertram; Detjen, Katharina; Cramer, Thorsten] Charite Univ Med Berlin, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany; [Dame, Christof] Charite Univ Med Berlin, Klin Neonatol, Berlin, Germany; [Rohwer, Nadine] Free Univ Berlin, Fachbereich Biol, Berlin, Germany; [Haugstetter, Anja; Schmitt, Clemens A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Rohwer, Nadine; Haugstetter, Anja; Detjen, Katharina; Schmitt, Clemens A.; Cramer, Thorsten] Charite Univ Med Berlin, Mol Krebsforschungszentrum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohwer, N (corresponding author), Charite Univ Med Berlin, Med Klin Schwerpunkt Hepatol & Gastroenterol, Campus Virchow Klinikum, Berlin, Germany.	thorsten.cramer@charite.de	Schmitt, Clemens A/S-9479-2017; Cramer, Thorsten/S-2479-2016	Schmitt, Clemens A/0000-0002-4731-2226; Cramer, Thorsten/0000-0002-6462-239X; Rohwer, Nadine/0000-0001-6170-1327; Wiedenmann, Bertram/0000-0002-7890-2552	Deutsche Forschungsgemeinschaft [CR 133/2-1, 133/2-2, 133/2-3, Graduiertenkolleg 276/4]; Berliner Krebsgesellschaft e.V. [CRFF200804]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Berliner Krebsgesellschaft e.V.	This study was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) to TC (CR 133/2-1, 133/2-2 and 133/2-3), and NR (Graduiertenkolleg 276/4 - "Signalerkennung und - umsetzung''). TC was also supported by a grant from the Berliner Krebsgesellschaft e.V. (http://www.berliner-krebsgesellschaft.de, CRFF200804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Birner P, 2000, CANCER RES, V60, P4693; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Cramer T, 2008, CELL SIGNAL, V20, P60, DOI 10.1016/j.cellsig.2007.08.016; Culmsee C, 2003, J NEUROSCI, V23, P8586; Cusack JC, 2001, CANCER RES, V61, P3535; Cusack JC, 2000, CANCER RES, V60, P2323; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Gatti L, 2005, METH MOLEC MED, V111, P127; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hammond EM, 2006, CLIN CANCER RES, V12, P5007, DOI 10.1158/1078-0432.CCR-06-0613; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu L, 2007, MOL CELL BIOCHEM, V303, P151, DOI 10.1007/s11010-007-9467-9; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Nakamura J, 2009, ONCOL REP, V22, P693, DOI 10.3892/or_00000489; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Plath T, 2000, J CELL BIOL, V150, P1467, DOI 10.1083/jcb.150.6.1467; Ravi R, 1998, CANCER RES, V58, P4531; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tormos KV, 2010, J CELL MOL MED, V14, P795, DOI 10.1111/j.1582-4934.2010.01031.x; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhong H, 1999, CANCER RES, V59, P5830	55	97	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12038	10.1371/journal.pone.0012038	http://dx.doi.org/10.1371/journal.pone.0012038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706634	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000280811900006
J	Pond, SK; Delport, W; Muse, SV; Scheffler, K				Pond, Sergei Kosakovsky; Delport, Wayne; Muse, Spencer V.; Scheffler, Konrad			Correcting the Bias of Empirical Frequency Parameter Estimators in Codon Models	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; SEQUENCE EVOLUTION; PROTEIN; RATES	Markov models of codon substitution are powerful inferential tools for studying biological processes such as natural selection and preferences in amino acid substitution. The equilibrium character distributions of these models are almost always estimated using nucleotide frequencies observed in a sequence alignment, primarily as a matter of historical convention. In this note, we demonstrate that a popular class of such estimators are biased, and that this bias has an adverse effect on goodness of fit and estimates of substitution rates. We propose a "corrected" empirical estimator that begins with observed nucleotide counts, but accounts for the nucleotide composition of stop codons. We show via simulation that the corrected estimates outperform the de facto standard F3 x 4 estimates not just by providing better estimates of the frequencies themselves, but also by leading to improved estimation of other parameters in the evolutionary models. On a curated collection of 856 sequence alignments, our estimators show a significant improvement in goodness of fit compared to the F3 x 4 approach. Maximum likelihood estimation of the frequency parameters appears to be warranted in many cases, albeit at a greater computational cost. Our results demonstrate that there is little justification, either statistical or computational, for continued use of the F3 x 4-style estimators.	[Pond, Sergei Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Delport, Wayne] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Muse, Spencer V.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Scheffler, Konrad] Univ Stellenbosch, Div Comp Sci, Dept Math Sci, ZA-7600 Stellenbosch, South Africa	University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; North Carolina State University; Stellenbosch University	Pond, SK (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	spond@ucsd.edu	Delport, Wayne/C-1744-2008; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Scheffler, Konrad/0000-0002-6041-8367	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative [NSF-0714991]; National Institutes of Health [AI47745]; University of California, San Diego Center for AIDS Research/NIAID [AI36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047745, R21AI047745, P30AI036214, R56AI047745] Funding Source: NIH RePORTER	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative through Grant NSF-0714991, the National Institutes of Health, AI47745 and by a University of California, San Diego Center for AIDS Research/NIAID Developmental Award to S. L. K. P. (AI36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; LACERDA M, 2010, MOL BIOL EVOL; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seoighe C, 2007, MOL BIOL EVOL, V24, P1025, DOI 10.1093/molbev/msm021; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087	13	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11230	10.1371/journal.pone.0011230	http://dx.doi.org/10.1371/journal.pone.0011230			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689581	Green Published, gold			2022-12-27	WOS:000280520300001
J	Robbins, D; Gu, X; Shi, RH; Liu, JF; Wang, F; Ponville, J; McCord, JM; Zhao, YF				Robbins, Delira; Gu, Xin; Shi, Runhua; Liu, Jianfeng; Wang, Fei; Ponville, Jacqulyne; McCord, Joe M.; Zhao, Yunfeng			The Chemopreventive Effects of Protandim: Modulation of p53 Mitochondrial Translocation and Apoptosis during Skin Carcinogenesis	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; IMMUNODEFICIENT MICE; CANCER-CELLS; 12-O-TETRADECANOYLPHORBOL-13-ACETATE; PATHWAY; MODEL; COMBINATION; ACTIVATION; EXTRACT; MOUSE	Protandim, a well defined dietary combination of 5 well-established medicinal plants, is known to induce endogenous antioxidant enzymes, such as manganese superoxide dismutase (MnSOD). Our previous studies have shown through the induction of various antioxidant enzymes, products of oxidative damage can be decreased. In addition, we have shown that tumor multiplicity and incidence can be decreased through the dietary administration of Protandim in the two-stage skin carcinogenesis mouse model. It has been demonstrated that cell proliferation is accommodated by cell death during DMBA/TPA treatment in the two-stage skin carcinogenesis model. Therefore, we investigated the effects of the Protandim diet on apoptosis; and proposed a novel mechanism of chemoprevention utilized by the Protandim dietary combination. Interestingly, Protandim suppressed DMBA/TPA induced cutaneous apoptosis. Recently, more attention has been focused on transcription-independent mechanisms of the tumor suppressor, p53, that mediate apoptosis. It is known that cytoplasmic p53 rapidly translocates to the mitochondria in response to pro-apoptotic stress. Our results showed that Protandim suppressed the mitochondrial translocation of p53 and mitochondrial outer membrane proteins such as Bax. We examined the levels of p53 and MnSOD expression/activity in murine skin JB6 promotion sensitive (P+) and promotion-resistant (P-) epidermal cells. Interestingly, p53 was induced only in P+ cells, not P- cells; whereas MnSOD is highly expressed in P- cells when compared to P+ cells. In addition, wild-type p53 was transfected into JB6 P-cells. We found that the introduction of wild-type p53 promoted transformation in JB6 P- cells. Our results suggest that suppression of p53 and induction of MnSOD may play an important role in the tumor suppressive activity of Protandim.	[Robbins, Delira; Zhao, Yunfeng] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Gu, Xin] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71105 USA; [Wang, Fei] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Ponville, Jacqulyne] Nicholls State Univ, Dept Chem, Thibodaux, LA 70310 USA; [McCord, Joe M.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [McCord, Joe M.] Hlth Sci Ctr, Aurora, CO USA; [Shi, Runhua] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Jilin University; University of Louisiana System; Nicholls State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Robbins, D (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	yzhao1@lsuhsc.edu	McCord, Joe/GWU-8607-2022	Robichaux, Jacqulyne/0000-0001-8812-7054				Avila GE, 2005, J PHARMACOL EXP THER, V315, P170, DOI 10.1124/jpet.105.087585; BOWDEN GT, 1995, MOL MECH INVOLVED SK, P99; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Chaurasia SS, 2000, PHARMACOL RES, V41, P663, DOI 10.1006/phrs.1999.0634; Chen J, 2006, APOPTOSIS, V11, P943, DOI 10.1007/s10495-006-6715-5; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; Manna SK, 1999, J IMMUNOL, V163, P6800; MARCHENKO ND, 2005, J BIOL CHEM, V280, P19166; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Pani G, 2004, CURR MED CHEM, V11, P1299, DOI 10.2174/0929867043365297; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; POLYAK K, 1997, NATURE, V389, P237; Potapovich AI, 2003, BIOCHEMISTRY-MOSCOW+, V68, P514, DOI 10.1023/A:1023947424341; Tang XW, 2007, J CLIN INVEST, V117, P3753, DOI 10.1172/JCI32481; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Zhang XP, 2007, CLIN CANCER RES, V13, P7181, DOI 10.1158/1078-0432.CCR-07-1133; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zhao Yunfeng, 2003, Methods Mol Biol, V218, P177; Zheng X, 2006, CLIN CANCER RES, V12, P3444, DOI 10.1158/1078-0432.CCR-05-2823	26	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2010	5	7							e11902	10.1371/journal.pone.0011902	http://dx.doi.org/10.1371/journal.pone.0011902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QZ	20689586	Green Published, gold			2022-12-27	WOS:000280520300017
J	Lai, XH; Shirley, RL; Crosa, L; Kanistanon, D; Tempel, R; Ernst, RK; Gallagher, LA; Manoil, C; Heffron, F				Lai, Xin-He; Shirley, Renee L.; Crosa, Lidia; Kanistanon, Duangjit; Tempel, Rebecca; Ernst, Robert K.; Gallagher, Larry A.; Manoil, Colin; Heffron, Fred			Mutations of Francisella novicida that Alter the Mechanism of Its Phagocytosis by Murine Macrophages	PLOS ONE			English	Article							TULARENSIS SUBSP NOVICIDA; BRUCELLA-ABORTUS; IN-VITRO; VIRULENCE DETERMINANTS; NONPHAGOCYTIC CELLS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; HOST-CELLS; O-ANTIGENS; WILD-TYPE	Infection with the bacterial pathogen Francisella tularensis tularensis (F. tularensis) causes tularemia, a serious and debilitating disease. Francisella tularensis novicida strain U112 (abbreviated F. novicida), which is closely related to F. tularensis, is pathogenic for mice but not for man, making it an ideal model system for tularemia. Intracellular pathogens like Francisella inhibit the innate immune response, thereby avoiding immune recognition and death of the infected cell. Because activation of inflammatory pathways may lead to cell death, we reasoned that we could identify bacterial genes involved in inhibiting inflammation by isolating mutants that killed infected cells faster than the wild-type parent. We screened a comprehensive transposon library of F. novicida for mutant strains that increased the rate of cell death following infection in J774 macrophage-like cells, as compared to wild-type F. novicida. Mutations in 28 genes were identified as being hypercytotoxic to both J774 and primary macrophages of which 12 were less virulent in a mouse infection model. Surprisingly, we found that F. novicida with mutations in four genes (lpcC, manB, manC and kdtA) were taken up by and killed macrophages at a much higher rate than the parent strain, even upon treatment with cytochalasin D (cytD), a classic inhibitor of macrophage phagocytosis. At least 10-fold more mutant bacteria were internalized by macrophages as compared to the parent strain if the bacteria were first fixed with formaldehyde, suggesting a surface structure is required for the high phagocytosis rate. However, bacteria were required to be viable for macrophage toxicity. The four mutant strains do not make a complete LPS but instead have an exposed lipid A. Interestingly, other mutations that result in an exposed LPS core were not taken up at increased frequency nor did they kill host cells more than the parent. These results suggest an alternative, more efficient macrophage uptake mechanism for Francisella that requires exposure of a specific bacterial surface structure(s) but results in increased cell death following internalization of live bacteria.	[Lai, Xin-He; Crosa, Lidia; Tempel, Rebecca; Heffron, Fred] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Lai, Xin-He; Shirley, Renee L.] Virogenomics Inc, Tigard, OR USA; [Kanistanon, Duangjit; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Gallagher, Larry A.; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Oregon Health & Science University; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle	Lai, XH (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	laixinhe@gmail.com; heffronf@ohsu.edu	Gallagher, Larry/L-1605-2013	Ernst, Robert/0000-0001-5016-8694	Virogenomics;  [U54 AI05714]	Virogenomics; 	Funded in part by grant U54 AI05714; Xin-He Lai and Renee Shirley were both partially funded by Virogenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their role in the work was solely based on determining if the genes described in the paper could be used in vaccines-work that is not described in this paper.	ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Brissette CA, 1999, ORAL MICROBIOL IMMUN, V14, P137, DOI 10.1034/j.1399-302X.1999.140301.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; CHANG CM, 1975, IMMUNOCHEMISTRY, V12, P19, DOI 10.1016/0019-2791(75)90045-2; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Guo H, 2008, CURR TOP MED CHEM, V8, P141; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Kanipes MI, 2003, J BIOL CHEM, V278, P16356, DOI 10.1074/jbc.M301255200; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Ludu JS, 2008, FEMS MICROBIOL LETT, V278, P86, DOI 10.1111/j.1574-6968.2007.00979.x; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; McLendon MK, 2007, INFECT IMMUN, V75, P5518, DOI 10.1128/IAI.01288-06; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Pei J, 2008, INFECT IMMUN, V76, P30, DOI 10.1128/IAI.00379-07; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Platz GJ, 2010, INFECT IMMUN, V78, P1022, DOI 10.1128/IAI.00992-09; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHRAMM N, 1995, INFECT IMMUN, V63, P324, DOI 10.1128/IAI.63.1.324-332.1995; Sjostedt A. B., 2005, BERGEYS MANUAL SYS B, VII, P199; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; WICK MJ, 1994, INFECT IMMUN, V62, P4542, DOI 10.1128/IAI.62.10.4542-4548.1994; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	48	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11857	10.1371/journal.pone.0011857	http://dx.doi.org/10.1371/journal.pone.0011857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686600	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200021
J	Levin, TC; Glazer, AM; Pachter, L; Brem, RB; Eisen, MB				Levin, Tera C.; Glazer, Andrew M.; Pachter, Lior; Brem, Rachel B.; Eisen, Michael B.			Exploring the Genetic Basis of Variation in Gene Predictions with a Synthetic Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFICATION	Identifying DNA polymorphisms that affect molecular processes like transcription, splicing, or translation typically requires genotyping and experimentally characterizing tissue from large numbers of individuals, which remains expensive and time consuming. Here we introduce an alternative strategy: a "synthetic association study'' in which we computationally predict molecular phenotypes on artificial genomes containing randomly sampled combinations of polymorphic alleles, and perform a classical association study to identify genotypes underlying variation in these computationally predicted annotations. We applied this method to characterize the effects on gene structure of 32,792 single-nucleotide polymorphisms between two strains of the antibiotic producing fungus Penicilium chrysogenum. Although these SNPs represent only 0.1 percent of the nucleotides in the genome, they collectively altered 1.8 percent of predicted gene models between these strains. To determine which SNPs or combinations of SNPs were responsible for this variation, we predicted protein-coding genes in 500 intermediate genomes, each identical except for randomly chosen alleles at each SNP position. Of 30,468 gene models in the genome, 557 varied across these 500 genomes. 226 of these polymorphic gene models (40%) were perfectly correlated with individual SNPs, all of which were within or immediately proximal to the affected gene. The genetic architectures of the other 321 were more complex, with several examples of SNP epistasis that would have been difficult to predict a priori. We expect that many of the SNPs that affect computational gene structure reflect a biologically unrealistic sensitivity of the gene prediction algorithm to sequence changes, and we propose that genome annotation algorithms could be improved by minimizing their sensitivity to natural polymorphisms. However, many of the SNPs we identified are likely to affect transcript structure in vivo, and the synthetic association study approach can be easily generalized to any computed genome annotation to uncover relationships between genotype and important molecular phenotypes.	[Levin, Tera C.; Glazer, Andrew M.; Pachter, Lior; Brem, Rachel B.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Levin, TC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Pachter, Lior/0000-0002-9164-6231; Glazer, Andrew/0000-0002-3938-4713; Levin, Tera/0000-0001-7883-8522; Eisen, Michael/0000-0002-7528-738X				Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chi KR, 2009, NATURE, V461, P712, DOI 10.1038/461712a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; HERSBACH GJM, 1984, DRUGS PHARM SCI, V22, P45; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	18	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11645	10.1371/journal.pone.0011645	http://dx.doi.org/10.1371/journal.pone.0011645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686598	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000280520200001
J	Swindell, WR; Johnston, A; Gudjonsson, JE				Swindell, William R.; Johnston, Andrew; Gudjonsson, Johann E.			Transcriptional Profiles of Leukocyte Populations Provide a Tool for Interpreting Gene Expression Patterns Associated with High Fat Diet in Mice	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION EFFICIENCY; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; INDUCED OBESITY; HEPATIC STEATOSIS; INBRED STRAINS; MACROPHAGE INFILTRATION; LY-6C(HI) MONOCYTES; CALORIC RESTRICTION; LIVER INFLAMMATION	Background: Microarray experiments in mice have shown that high fat diet can lead to elevated expression of genes that are disproportionately associated with immune functions. These effects of high fat (atherogenic) diet may be due to infiltration of tissues by leukocytes in coordination with inflammatory processes. Methodology/Principal Findings: The Novartis strain-diet-sex microarray database (GSE10493) was used to evaluate the hepatic effects of high fat diet (4 weeks) in 12 mouse strains and both genders. We develop and apply an algorithm that identifies "signature transcripts'' for many different leukocyte populations (e.g., T cells, B cells, macrophages) and uses this information to derive an in silico "inflammation profile''. Inflammation profiles highlighted monocytes, macrophages and dendritic cells as key drivers of gene expression patterns associated with high fat diet in liver. In some strains (e.g., NZB/BINJ, B6), we estimate that 50-60% of transcripts elevated by high fat diet might be due to hepatic infiltration by these cell types. Interestingly, DBA mice appeared to exhibit resistance to localized hepatic inflammation associated with atherogenic diet. A common characteristic of infiltrating cell populations was elevated expression of genes encoding components of the toll-like receptor signaling pathway (e.g., Irf5 and Myd88). Conclusions/Significance: High fat diet promotes infiltration of hepatic tissue by leukocytes, leading to elevated expression of immune-associated transcripts. The intensity of this effect is genetically controlled and sensitive to both strain and gender. The algorithm developed in this paper provides a framework for computational analysis of tissue remodeling processes and can be usefully applied to any in vivo setting in which inflammatory processes play a prominent role.	[Swindell, William R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Johnston, Andrew; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA	Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Swindell, WR (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	wswindell@genetics.med.harvard.edu	Johnston, Andrew/I-7904-2014	Johnston, Andrew/0000-0002-1313-9402	National Institutes of Health (NIH) [T32-AR007197]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant T32-AR007197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bigorgne AE, 2008, GASTROENTEROLOGY, V134, P1459, DOI 10.1053/j.gastro.2008.02.055; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Carter CP, 1997, J NUTR, V127, P1344, DOI 10.1093/jn/127.7.1344; Coenen KR, 2009, DIABETOLOGIA, V52, P318, DOI 10.1007/s00125-008-1221-7; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Florez H, 2006, DIABETES RES CLIN PR, V71, P92, DOI 10.1016/j.diabres.2005.05.003; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; KIRK EA, 1995, J LIPID RES, V36, P1522; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Lalor Patricia F, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004155; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Lundman P, 2007, NUTR METAB CARDIOVAS, V17, P195, DOI 10.1016/j.numecd.2005.11.009; McNeill E, 2010, CLIN SCI, V118, P641, DOI 10.1042/CS20090488; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rull A, 2009, CYTOKINE, V48, P273, DOI 10.1016/j.cyto.2009.08.006; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Stienstra R, 2007, ENDOCRINOLOGY, V148, P2753, DOI 10.1210/en.2007-0014; Stokes KY, 2003, CIRCULATION, V107, P2140, DOI 10.1161/01.CIR.0000062687.80186.A0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Wang DQH, 2001, J LIPID RES, V42, P1820; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Zhu MZ, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-43	59	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11861	10.1371/journal.pone.0011861	http://dx.doi.org/10.1371/journal.pone.0011861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686622	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520200025
J	Innamorato, NG; Jazwa, A; Rojo, AI; Garcia, C; Fernandez-Ruiz, J; Grochot-Przeczek, A; Stachurska, A; Jozkowicz, A; Dulak, J; Cuadrado, A				Innamorato, Nadia G.; Jazwa, Agnieszka; Rojo, Ana I.; Garcia, Concepcion; Fernandez-Ruiz, Javier; Grochot-Przeczek, Anna; Stachurska, Anna; Jozkowicz, Alicja; Dulak, Jozef; Cuadrado, Antonio			Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; THERAPEUTIC TARGET; SUBSTANTIA-NIGRA; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS; ALPHA-SYNUCLEIN; CARBON-MONOXIDE; COMPLEX I; IRON	Background: The transcription factor Nrf2 (NF-E2-related factor 2) and its target gene products, including heme oxygenase-1 (HO-1), elicit an antioxidant response that may have therapeutic value for Parkinson's disease (PD). However, HO-1 protein levels are increased in dopaminergic neurons of Parkinson's disease (PD) patients, suggesting its participation in free-iron deposition, oxidative stress and neurotoxicity. Before targeting Nrf2 for PD therapy it is imperative to determine if HO-1 is neurotoxic or neuroprotective in the basal ganglia. Methodology: We addressed this question by comparing neuronal damage and gliosis in Nrf2- or HO-1-knockout mice submitted to intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for five consecutive days. Nrf2- knockout mice showed exacerbated gliosis and dopaminergic nigrostriatal degeneration, as determined by immunohistochemical staining of tyrosine hydroxylase in striatum (STR) and substantia nigra (SN) and by HPLC determination of striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC). On the other hand, the severity of gliosis and dopaminergic degeneration in HO-1-null mice was neither increased nor reduced. Regarding free-iron deposition, both Nrf2- and HO-1-deficient mice exhibited similar number of deposits as determined by Perl's staining, therefore indicating that these proteins do not contribute significantly to iron accumulation or clearance in MPTP-induced Parkinsonism. Conclusions: These results suggest that HO-1 does not protect or enhance the sensitivity to neuronal death in Parkinson's disease and that pharmacological or genetic intervention on Nrf2 may provide a neuroprotective benefit as add on therapy with current symptomatic protocols.	[Innamorato, Nadia G.; Jazwa, Agnieszka; Rojo, Ana I.; Garcia, Concepcion; Fernandez-Ruiz, Javier; Cuadrado, Antonio] Inst Invest Sanitaria La Paz IdiPaz, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Innamorato, Nadia G.; Rojo, Ana I.; Cuadrado, Antonio] UAM, Dept Bioquim, Madrid, Spain; [Innamorato, Nadia G.; Rojo, Ana I.; Cuadrado, Antonio] UAM, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain; [Jazwa, Agnieszka; Grochot-Przeczek, Anna; Stachurska, Anna; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Garcia, Concepcion; Fernandez-Ruiz, Javier] UCM, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, Fac Med, Madrid, Spain	CIBERNED; Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Jagiellonian University; Complutense University of Madrid	Innamorato, NG (corresponding author), Inst Invest Sanitaria La Paz IdiPaz, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	jozef.dulak@uj.edu.pl; antonio.cuadrado@uam.es	Jazwa-Kusior, Agnieszka/Q-1092-2017; Garcia, Concepcion M C/H-9138-2015; Rojo, Ana I/AAA-5203-2019	Garcia, Concepcion M C/0000-0003-2482-1148; Rojo, Ana I/0000-0002-0312-5867; Cuadrado, Antonio/0000-0002-4039-7140; Cuadrado, Antonio/0000-0002-3444-9012; Grochot-Przeczek, Anna/0000-0003-0533-7254	Spanish Ministry of Science and Innovation [SAF2007-62646]; European Union [POIG.02.01.00-12-064/08, 02.02.00-00-014/08]; Universidad Autonoma of Madrid	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Universidad Autonoma of Madrid	This work was supported by grant SAF2007-62646 from the Spanish Ministry of Science and Innovation. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 and 02.02.00-00-014/08). N.I. is recipient of a FPU fellowship of Universidad Autonoma of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Castellani R, 1996, BRAIN RES, V737, P195, DOI 10.1016/0006-8993(96)00729-9; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gille G, 2004, ANN NY ACAD SCI, V1018, P533, DOI 10.1196/annals.1296.066; Glinka Y, 1996, J NEUROCHEM, V66, P2004; Grunblatt E, 2001, J NEUROCHEM, V78, P1, DOI 10.1046/j.1471-4159.2001.00397.x; Grunblatt E, 1999, MOVEMENT DISORD, V14, P612, DOI 10.1002/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hirsch EC, 1998, MOVEMENT DISORD, V13, P39; Hu XM, 2008, J IMMUNOL, V181, P7194, DOI 10.4049/jimmunol.181.10.7194; Huang E, 2005, J NEUROSCI RES, V80, P268, DOI 10.1002/jnr.20444; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li MH, 2006, FREE RADICAL BIO MED, V41, P1079, DOI 10.1016/j.freeradbiomed.2006.06.010; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MOCHIZUKI H, 1994, NEUROSCI LETT, V168, P251, DOI 10.1016/0304-3940(94)90462-6; MORRIS CM, 1994, NEURODEGENERATION, V3, P277; Mundel S, 2002, NEUROCHEM RES, V27, P1231, DOI 10.1023/A:1020989812576; Olivares D, 2009, INT J MOL SCI, V10, P1226, DOI 10.3390/ijms10031226; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rojo AI, 2006, EUR J NEUROSCI, V24, P1874, DOI 10.1111/j.1460-9568.2006.05060.x; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Samoylenko A, 2008, ANTIOXID REDOX SIGN, V10, P1163, DOI 10.1089/ars.2007.1968; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Snyder AM, 2009, BBA-GEN SUBJECTS, V1790, P606, DOI 10.1016/j.bbagen.2008.08.005; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Tsuchihashi SI, 2006, J IMMUNOL, V177, P4749, DOI 10.4049/jimmunol.177.7.4749; Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; YOUDIM MBH, 1993, MOVEMENT DISORD, V8, P1, DOI 10.1002/mds.870080102; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017	54	106	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11838	10.1371/journal.pone.0011838	http://dx.doi.org/10.1371/journal.pone.0011838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676377	gold, Green Published			2022-12-27	WOS:000280520100014
J	Yang, Q; Vernet, M; Orssaud, C; Bonfils, P; Londero, A; Kapoula, Z				Yang, Qing; Vernet, Marine; Orssaud, Christophe; Bonfils, Pierre; Londero, Alain; Kapoula, Zoi			Central Crosstalk for Somatic Tinnitus: Abnormal Vergence Eye Movements	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; CONVERGENCE INSUFFICIENCY; SUPERIOR COLLICULUS; BINOCULAR CONTROL; ADAPTIVE-CHANGES; SACCADES; PRIMATE; NEURONS; CORTEX; ACCOMMODATION	Background: Frequent oulomotricity problems with orthoptic testing were reported in patients with tinnitus. This study examines with objective recordings vergence eye movements in patients with somatic tinnitus patients with ability to modify their subjective tinnitus percept by various movements, such as jaw, neck, eye movements or skin pressure. Methods: Vergence eye movements were recorded with the Eyelink II video system in 15 (23-63 years) control adults and 19 (36-62 years) subjects with somatic tinnitus. Findings: 1) Accuracy of divergence but not of convergence was lower in subjects with somatic tinnitus than in control subjects. 2) Vergence duration was longer and peak velocity was lower in subjects with somatic tinnitus than in control subjects. 3) The number of embedded saccades and the amplitude of saccades coinciding with the peak velocity of vergence were higher for tinnitus subjects. Yet, saccades did not increase peak velocity of vergence for tinnitus subjects, but they did so for controls. 4) In contrast, there was no significant difference of vergence latency between these two groups. Interpretation: The results suggest dysfunction of vergence areas involving cortical-brainstem-cerebellar circuits. We hypothesize that central auditory dysfunction related to tinnitus percept could trigger mild cerebellar-brainstem dysfunction or that tinnitus and vergence dysfunction could both be manifestations of mild cortical-brainstem-cerebellar syndrome reflecting abnormal cross-modality interactions between vergence eye movements and auditory signals.	[Yang, Qing; Vernet, Marine; Kapoula, Zoi] Hop Europeen Georges Pompidou, Grp IRIS, CNRS, Serv Ophtalmol ORL Stomatol, Paris, France; [Orssaud, Christophe] Hop Europeen Georges Pompidou, Serv Ophtalmol, Paris, France; [Bonfils, Pierre; Londero, Alain] Univ Paris 05, Serv ORL & Chirurg Cervico Faciale, Hop Europeen Georges Pompidou, Fac Med Paris Descartes, Paris, France; [Bonfils, Pierre; Londero, Alain] Lab CNRS, UMR 7060, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Yang, Q (corresponding author), Hop Europeen Georges Pompidou, Grp IRIS, CNRS, Serv Ophtalmol ORL Stomatol, Paris, France.	qing.yang@egp.aphp.fr	Orssaud, Christophe/ACM-6549-2022	Lauwereyns, Jan/0000-0003-0551-2550; Vernet, Marine/0000-0001-7331-3567				Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Busettini C, 2005, J NEUROPHYSIOL, V94, P2295, DOI 10.1152/jn.01336.2004; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115, DOI 10.1152/jn.1995.73.5.2115; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Jozefowicz-Korczynska Magdalena, 2002, Int Tinnitus J, V8, P100; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kapoula Z, 2001, NEUROREPORT, V12, P4041, DOI 10.1097/00001756-200112210-00037; KAPOULA Z, 2009, AURIS NASUS LARYNX; LEIGH RJ, 2006, NEUROLOGY E IN PRESS; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mezzalira Raquel, 2007, Int Tinnitus J, V13, P152; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Richter HO, 2004, EUR J NEUROSCI, V20, P2722, DOI 10.1111/j.1460-9568.2004.03743.x; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, INVEST OPHTH VIS SCI, V42, P1479; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; TONNDORF J, 1981, J LARYNGOL OTOL, P18; Tzelepi A, 2004, EXP BRAIN RES, V155, P439, DOI 10.1007/s00221-003-1741-9; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Walton MMG, 2003, J NEUROPHYSIOL, V90, P1124, DOI 10.1152/jn.00877.2002; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624; ZEE DS, 1989, REV NEUROL, V145, P613	38	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2010	5	7							e11845	10.1371/journal.pone.0011845	http://dx.doi.org/10.1371/journal.pone.0011845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QX	20676372	Green Published, Green Submitted, gold			2022-12-27	WOS:000280520100017
J	Hsu, JL; Yu, LS; Sullivan, E; Bowman, M; Mistlberger, RE; Tecott, LH				Hsu, Jennifer L.; Yu, Lisa; Sullivan, Elinor; Bowman, Melodi; Mistlberger, Ralph E.; Tecott, Laurence H.			Enhanced Food Anticipatory Activity Associated with Enhanced Activation of Extrahypothalamic Neural Pathways in Serotonin(2C) Receptor Null Mutant Mice	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ENTRAINABLE CIRCADIAN-RHYTHMS; CONSTITUTIVE ACTIVITY; FEEDING SCHEDULES; GENE-EXPRESSION; LIMBIC SYSTEM; IN-VIVO; C-FOS; RATS; CLOCK	The ability to entrain circadian rhythms to food availability is important for survival. Food-entrained circadian rhythms are characterized by increased locomotor activity in anticipation of food availability (food anticipatory activity). However, the molecular components and neural circuitry underlying the regulation of food anticipatory activity remain unclear. Here we show that serotonin(2C) receptor (5-HT2CR) null mutant mice subjected to a daytime restricted feeding schedule exhibit enhanced food anticipatory activity compared to wild-type littermates, without phenotypic differences in the impact of restricted feeding on food consumption, body weight loss, or blood glucose levels. Moreover, we show that the enhanced food anticipatory activity in 5-HT2CR null mutant mice develops independent of external light cues and persists during two days of total food deprivation, indicating that food anticipatory activity in 5-HT2CR null mutant mice reflects the locomotor output of a food-entrainable oscillator. Whereas restricted feeding induces c-fos expression to a similar extent in hypothalamic nuclei of wild-type and null mutant animals, it produces enhanced expression in the nucleus accumbens and other extrahypothalamic regions of null mutant mice relative to wild-type subjects. These data suggest that 5-HT2CRs gate food anticipatory activity through mechanisms involving extrahypothalamic neural pathways.	[Hsu, Jennifer L.] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Yu, Lisa; Bowman, Melodi; Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Sullivan, Elinor] Oregon Natl Primate Res Ctr, Dept Neurosci, Beaverton, OR USA; [Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon National Primate Research Center; Simon Fraser University	Hsu, JL (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	larry.tecott@ucsf.edu		Sullivan, Elinor/0000-0003-2630-8890; Bowman, Melodi/0000-0002-5975-7329	Bristol Myers Squib Foundation	Bristol Myers Squib Foundation	This work was supported by the Bristol Myers Squib Foundation Freedom to Discover Award (LHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLAH L, 2009, J NEUROSCIENCE; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Albrecht U, 2006, J PHYSIOL-PARIS, V100, P243, DOI 10.1016/j.jphysparis.2007.05.004; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Berthoud HR, 2004, PHYSIOL BEHAV, V81, P781, DOI 10.1016/j.physbeh.2004.04.034; BOULOS Z, 1980, BEHAV BRAIN RES, V1, P39, DOI 10.1016/S0166-4328(80)80049-0; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; De Deurwaerdere P, 2004, J NEUROSCI, V24, P3235, DOI 10.1523/JNEUROSCI.0112-04.2004; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Lax P, 1999, CHRONOBIOL INT, V16, P281, DOI 10.3109/07420529909116858; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; Mistlberger RE, 2003, BRAIN RES, V980, P161, DOI 10.1016/S0006-8993(03)02755-0; MISTLBERGER RE, 1993, PHYSIOL BEHAV, V53, P509, DOI 10.1016/0031-9384(93)90145-6; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Navailles S, 2006, J NEUROCHEM, V99, P1311, DOI 10.1111/j.1471-4159.2006.04188.x; Nonogaki K, 2003, DIABETES, V52, P315, DOI 10.2337/diabetes.52.2.315; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Rocha BA, 2002, J NEUROSCI, V22, P10039; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SHIBATA S, 1995, PHARMACOL BIOCHEM BE, V51, P541, DOI 10.1016/0091-3057(95)90577-8; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11802	10.1371/journal.pone.0011802	http://dx.doi.org/10.1371/journal.pone.0011802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668550	gold, Green Published, Green Submitted			2022-12-27	WOS:000280371800008
J	Oesch, NW; Taylor, WR				Oesch, Nicholas W.; Taylor, W. Rowland			Tetrodotoxin-Resistant Sodium Channels Contribute to Directional Responses in Starburst Amacrine Cells	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; RECEPTIVE-FIELD PROPERTIES; DORSAL-ROOT GANGLIA; RABBIT RETINA; ACTION-POTENTIALS; NA+ CHANNELS; MOUSE RETINA; SELECTIVITY; INHIBITION; CURRENTS	The biophysical mechanisms that give rise to direction selectivity in the retina remain uncertain. Current evidence suggests that the directional signal first arises within the dendrites of starburst amacrine cells (SBACs). Two models have been proposed to explain this phenomenon, one based on mutual inhibitory interactions between SBACs, and the other positing an intrinsic dendritic mechanism requiring a voltage-gradient depolarizing towards the dendritic tips. We tested these models by recording current and voltage responses to visual stimuli in SBACs. In agreement with previous work, we found that the excitatory currents in the SBACs were directional, and remained directional when GABA receptors were blocked. Contrary to the mutual-inhibitory model, stimuli that produce strong directional signals in ganglion cells failed to reveal a significant inhibitory input to SBACs. Suppression of the tonic excitatory conductance, proposed to generate the dendritic voltage-gradient required for the dendrite autonomous model, failed to eliminate the directional signal in SBACs. However, selective block of tetrodotoxin-resistant sodium channels did reduce the strength of the directional excitatory signal in the SBACs. These results indicate that current models of direction-selectivity in the SBACs are inadequate, and suggest that voltage-gated excitatory channels, specifically tetrodotoxin-resistant sodium channels, are important elements in directional signaling. This is the first physiological evidence that tetrodotoxin-resistant sodium channels play a role in retinal information processing.	[Oesch, Nicholas W.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA; [Taylor, W. Rowland] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Oesch, NW (corresponding author), Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA.	oeschn@ninds.nih.gov		Oesch, Nicholas/0000-0001-6972-0741; Taylor, William/0000-0002-6806-3249	National Institutes of Health [EY014888]; NATIONAL EYE INSTITUTE [R01EY014888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY014888 (WRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chiao CC, 2002, J NEUROSCI, V22, P10509; Cohen ED, 2001, VISUAL NEUROSCI, V18, P799, DOI 10.1017/S0952523801185135; COHEN ED, 1995, P NATL ACAD SCI USA, V92, P1127, DOI 10.1073/pnas.92.4.1127; Cook PB, 1998, J NEUROSCI, V18, P2301; Cummins TR, 1997, J NEUROSCI, V17, P3503; DODT HU, 2002, SCI STKE, pPL2; ELLIAS SA, 1980, BRAIN RES, V196, P365, DOI 10.1016/0006-8993(80)90401-1; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; JENSEN RJ, 1995, VISUAL NEUROSCI, V12, P177, DOI 10.1017/S0952523800007409; JENSEN RJ, 1995, J NEUROPHYSIOL, V74, P12, DOI 10.1152/jn.1995.74.1.12; Kaneda M, 2007, J NEUROPHYSIOL, V97, P4225, DOI 10.1152/jn.01022.2006; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Leffler A, 2005, PFLUG ARCH EUR J PHY, V451, P454, DOI 10.1007/s00424-005-1463-x; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; O'Brien BJ, 2008, J COMP NEUROL, V508, P940, DOI 10.1002/cne.21701; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POZNANSKI RR, 1992, B MATH BIOL, V54, P905; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Taylor WR, 2002, J NEUROSCI, V22, P7712; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1994, J NEUROSCI, V14, P6301; Velte TJ, 1997, VISUAL NEUROSCI, V14, P1073, DOI 10.1017/S0952523800011780; Weiser T, 2002, MOL PHARMACOL, V62, P433, DOI 10.1124/mol.62.3.433; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	50	40	40	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12447	10.1371/journal.pone.0012447	http://dx.doi.org/10.1371/journal.pone.0012447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805982	Green Published, gold, Green Submitted			2022-12-27	WOS:000281301500013
J	Raghu, H; Lakka, SS; Gondi, CS; Mohanam, S; Dinh, DH; Gujrati, M; Rao, JS				Raghu, Hari; Lakka, Sajani S.; Gondi, Christopher S.; Mohanam, Sanjeeva; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			Suppression of uPA and uPAR Attenuates Angiogenin Mediated Angiogenesis in Endothelial and Glioblastoma Cell Lines	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; RIBOSOMAL-RNA TRANSCRIPTION; DOWN-REGULATION; SPARC EXPRESSION; GENE-EXPRESSION; TUMOR-GROWTH; INHIBITS ANGIOGENESIS; UROKINASE RECEPTOR; INDUCED MIGRATION; GASTRIC-CANCER	Background: In our earlier reports, we showed that downregulation of uPA and uPAR inhibited glioma tumor angiogenesis in SNB19 cells, and intraperitoneal injection of a hairpin shRNA expressing plasmid targeting uPA and uPAR inhibited angiogenesis in nude mice. The exact mechanism by which inhibition of angiogenesis takes place is not clearly understood. Methodology/Principal Findings: In the present study, we have attempted to investigate the mechanism by which uPA/uPAR downregulation by shRNA inhibits angiogenesis in endothelial and glioblastoma cell lines. uPA/uPAR downregulation by shRNA in U87 MG and U87 SPARC co-cultures with endothelial cells inhibited angiogenesis as assessed by in vitro angiogenesis assay and in vivo dorsal skin-fold chamber model in nude mice. Protein antibody array analysis of co-cultures of U87 and U87 SPARC cells with endothelial cells treated with pU2 (shRNA against uPA and uPAR) showed decreased angiogenin secretion and angiopoietin-1 as well as several other pro-angiogenic molecules. Therefore, we investigated the role of angiogenin and found that nuclear translocation, ribonucleolytic and 45S rRNA synthesis, which are all critical for angiogenic function of angiogenin, were significantly inhibited in endothelial cells transfected with uPA, uPAR and uPA/uPAR when compared with controls. Moreover, uPA and uPAR downregulation significantly inhibited the phosphorylation of Tie-2 receptor and also down regulated FKHR activation in the nucleus of endothelial cells via the GRB2/AKT/BAD pathway. Treatment of endothelial cells with ruPA increased angiogenin secretion and angiogenin expression as determined by ELISA and western blotting in a dose-dependent manner. The amino terminal fragment of uPA down regulated ruPA-induced angiogenin in endothelial cells, thereby suggesting that uPA plays a critical role in positively regulating angiogenin in glioblastoma cells. Conclusions/Significance: Taken together, our results suggest that uPA/uPAR downregulation suppresses angiogenesis in endothelial cells induced by glioblastoma cell lines partially by downregulation of angiogenin and by inhibition of the angiopoietin-1/AKT/FKHR pathway.	[Raghu, Hari; Lakka, Sajani S.; Gondi, Christopher S.; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Raghu, H (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu		Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health (NIH) [CA 75557]; NATIONAL CANCER INSTITUTE [R01CA075557] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health (NIH), CA 75557 (to J.S.R.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Golembieski WA, 2002, J NEURO-ONCOL, V60, P213, DOI 10.1023/A:1021167211131; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gondi CS, 2004, CANCER RES, V64, P4069, DOI 10.1158/0008-5472.CAN-04-1243; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hanahan D, 1996, EUR J CANCER, V32A, P2386, DOI 10.1016/S0959-8049(96)00401-7; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim CK, 2007, CANCER SCI, V98, P253, DOI 10.1111/j.1349-7006.2006.00378.x; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kunigal S, 2006, INT J ONCOL, V29, P1349; LEUNIG M, 1992, CANCER RES, V52, P6553; Liotta LA, 1996, J CLIN INVEST, V97, P273, DOI 10.1172/JCI118412; Marron MB, 2000, ADV EXP MED BIOL, V476, P35; Mohan PM, 1999, CLIN EXP METASTAS, V17, P617, DOI 10.1023/A:1006779902978; Mohanam S, 2002, ONCOGENE, V21, P7824, DOI 10.1038/sj.onc.1205893; Mohanam S, 2001, CLIN CANCER RES, V7, P2519; Mohanam Sanjeeva, 1999, Frontiers in Bioscience, V4, pD178, DOI 10.2741/Mohanam; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Ou XL, 2009, WORLD J GASTROENTERO, V15, P5432, DOI 10.3748/wjg.15.5432; Papapetropoulos A, 1999, LAB INVEST, V79, P213; PYKE C, 1991, AM J PATHOL, V138, P1059; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sakai N, 2001, HUM PATHOL, V32, P1064, DOI 10.1053/hupa.2001.28244; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Subramanian R, 2006, INT J ONCOL, V28, P831; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wiedlocha Antoni, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P299; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com	50	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12458	10.1371/journal.pone.0012458	http://dx.doi.org/10.1371/journal.pone.0012458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805979	Green Submitted, Green Published, gold			2022-12-27	WOS:000281301500024
J	Ceesay, SJ; Casals-Pascual, C; Nwakanma, DC; Walther, M; Gomez-Escobar, N; Fulford, AJC; Takem, EN; Nogaro, S; Bojang, KA; Corrah, T; Jaye, MC; Taal, MA; Sonko, AAJ; Conway, DJ				Ceesay, Serign J.; Casals-Pascual, Climent; Nwakanma, Davis C.; Walther, Michael; Gomez-Escobar, Natalia; Fulford, Anthony J. C.; Takem, Ebako N.; Nogaro, Sarah; Bojang, Kalifa A.; Corrah, Tumani; Jaye, Momodou Cherno; Taal, Makie Abdoulie; Sonko, Aja Adam Jagne; Conway, David J.			Continued Decline of Malaria in The Gambia with Implications for Elimination	PLOS ONE			English	Article							GUINEA-BISSAU; SOUTH-AFRICA; WEST-AFRICA; TRANSMISSION; MORBIDITY; MORTALITY; CHILDREN; ERADICATION; COMBINATION; PROSPECTS	Background: A substantial decline in malaria was reported to have occurred over several years until 2007 in the western part of The Gambia, encouraging consideration of future elimination in this previously highly endemic region. Scale up of interventions has since increased with support from the Global Fund and other donors. Methodology/Principal Findings: We continued to examine laboratory records at four health facilities previously studied and investigated six additional facilities for a 7 year period, adding data from 243,707 slide examinations, to determine trends throughout the country until the end of 2009. We actively detected infections in a community cohort of 800 children living in rural villages throughout the 2008 malaria season, and assayed serological changes in another rural population between 2006 and 2009. Proportions of malaria positive slides declined significantly at all of the 10 health facilities between 2003 (annual mean across all sites, 38.7%) and 2009 (annual mean, 7.9%). Statistical modelling of trends confirmed significant seasonality and decline over time at each facility. Slide positivity was lowest in 2009 at all sites, except two where lowest levels were observed in 2006. Mapping households of cases presenting at the latter sites in 2007-2009 indicated that these were not restricted to a few residual foci. Only 2.8% (22/800) of a rural cohort of children had a malaria episode in the 2008 season, and there was substantial serological decline between 2006 and 2009 in a separate rural area. Conclusions: Malaria has continued to decline in The Gambia, as indicated by a downward trend in slide positivity at health facilities, and unprecedented low incidence and seroprevalence in community surveys. We recommend intensification of control interventions for several years to further reduce incidence, prior to considering an elimination programme.	[Ceesay, Serign J.; Casals-Pascual, Climent; Nwakanma, Davis C.; Walther, Michael; Gomez-Escobar, Natalia; Fulford, Anthony J. C.; Takem, Ebako N.; Nogaro, Sarah; Bojang, Kalifa A.; Corrah, Tumani; Conway, David J.] MRC Labs, Banjul, Gambia; [Casals-Pascual, Climent] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Fulford, Anthony J. C.; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Jaye, Momodou Cherno] Royal Victoria Teaching Hosp, Natl Hlth Lab Serv, Banjul, Gambia; [Taal, Makie Abdoulie] Natl Publ Hlth Labs, Banjul, Gambia; [Sonko, Aja Adam Jagne] Natl Malaria Control Programme, Banjul, Gambia	MRC Laboratory Molecular Biology; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Ceesay, SJ (corresponding author), MRC Labs, Banjul, Gambia.	dconway@mrc.gm	Casals-Pascual, Climent/N-7692-2018	Casals-Pascual, Climent/0000-0002-0867-8954; Conway, David/0000-0002-8711-3037; Nwakanma, Davis/0000-0002-6706-6069; Bojang, Kalifa/0000-0001-7506-0938	UK Medical Research Council (MRC); Medical Research Council [MC_U190097907, MC_U190074193, MC_U190088482, G0701885] Funding Source: researchfish; MRC [MC_U190097907, MC_U190088482, G0701885, MC_U190074193] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support for the research was provided by the UK Medical Research Council (MRC) (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; *ALL PART PARL GRO, 2010, 6 ALL PART PARL GROU; [Anonymous], 2009, WHO WORLD MAL REP 20; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; BISOFFI Z, 2008, EURO SURVEILL, V13; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x; Gerritsen AAM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-162; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; *MICS, 2007, GAMB MULT IND CLUST, P1; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; PAMPANA E, 1963, TXB MALARIA ERADICAT, P508; RAMROTH H, 2009, GLOB HLTH ACTION, V2, DOI DOI 10.3402/GHA.V3402I3400.1909; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; WHO, 2008, GLOB MAL CONTR EL RE	35	100	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12242	10.1371/journal.pone.0012242	http://dx.doi.org/10.1371/journal.pone.0012242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805878	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000281011600016
J	Hall, CHT; Kassel, R; Tacke, RS; Hahn, YS				Hall, Caroline H. T.; Kassel, Rachel; Tacke, Robert S.; Hahn, Young S.			HCV+ Hepatocytes Induce Human Regulatory CD4(+) T Cells through the Production of TGF-beta	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; ANTIVIRAL THERAPY; LIVER-DISEASE; INFECTION; EXPRESSION; LYMPHOCYTES; TGF-BETA-1; EXPANSION; CORE; TRANSFORMING-GROWTH-FACTOR-BETA-1	Background: Hepatitis C Virus (HCV) is remarkably efficient at establishing persistent infection and is associated with the development of chronic liver disease. Impaired T cell responses facilitate and maintain persistent HCV infection. Importantly, CD4(+) regulatory T cells (Tregs) act by dampening antiviral T cell responses in HCV infection. The mechanism for induction and/or expansion of Tregs in HCV is unknown. Methodology/Principal Findings: HCV-expressing hepatocytes were used to determine if hepatocytes are able to induce Tregs. The infected liver environment was modeled by establishing the co-culture of the human hepatoma cell line, Huh7.5, containing the full-length genome of HCV genotype 1a (Huh7.5-FL) with activated CD4(+) T cells. The production of IFN-gamma was diminished following co-culture with Huh7.5-FL as compared to controls. Notably, CD4(+) T cells in contact with Huh7.5-FL expressed an increased level of the Treg markers, CD25, Foxp3, CTLA-4 and LAP, and were able to suppress the proliferation of effector T cells. Importantly, HCV+ hepatocytes upregulated the production of TGF-beta and blockade of TGF-beta abrogated Treg phenotype and function. Conclusions/Significance: These results demonstrate that HCV infected hepatocytes are capable of directly inducing Tregs development and may contribute to impaired host T cell responses.	[Hall, Caroline H. T.; Kassel, Rachel; Tacke, Robert S.; Hahn, Young S.] Univ Virginia, Dept Microbiol, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Hahn, Young S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Hall, CHT (corresponding author), Univ Virginia, Dept Microbiol, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu		Hall, Caroline/0000-0002-7100-3423	National Institutes of Health [5-T32-AI007496, 5-T32-AI007046, 5-T32-GM007267, R01AI057591, U19AI066328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, T32AI007046, R01AI057591, U19AI066328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following National Institutes of Health grants: 5-T32-AI007496 to CHTH and RST, 5-T32-AI007046 to CHTH and RK, 5-T32-GM007267 to RK, R01AI057591, U19AI066328 to YSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Correia MP, 2009, J IMMUNOL, V182, P6149, DOI 10.4049/jimmunol.0802470; Cottrez F, 2001, J IMMUNOL, V167, P773, DOI 10.4049/jimmunol.167.2.773; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Fan TM, 2008, MOL IMMUNOL, V45, P2937, DOI 10.1016/j.molimm.2008.01.019; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; KAKUMU S, 1992, J CLIN PATHOL, V45, P408, DOI 10.1136/jcp.45.5.408; Kimura T, 2006, J INFECT DIS, V193, P1371, DOI 10.1086/503436; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Leroy V, 2002, EUR J GASTROEN HEPAT, V14, P485, DOI 10.1097/00042737-200205000-00004; LIN W, GASTROENTEROLOGY, V138, P2509; MAEDA H, 1995, J IMMUNOL, V155, P4926; Marek B, 2005, J CLIN PHARM THER, V30, P271, DOI 10.1111/j.1365-2710.2005.00644.x; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Pellicano R, 2000, J HEPATOL, V33, P648, DOI 10.1034/j.1600-0641.2000.033004648.x; Perrella A, 2006, GUT, V55, P1370, DOI 10.1136/gut.2006.099887; ROWELL DL, 1997, AM J PHYSIOL, V273, P322; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Tarantino G, 2008, INT J IMMUNOPATH PH, V21, P1007, DOI 10.1177/039463200802100426; Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Wiedmann M, 2000, HEPATOLOGY, V31, P230, DOI 10.1002/hep.510310134; Yakoob J, 2003, EUR J GASTROEN HEPAT, V15, P701, DOI 10.1097/00042737-200306000-00019; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004	44	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12154	10.1371/journal.pone.0012154	http://dx.doi.org/10.1371/journal.pone.0012154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730048	Green Submitted, Green Published, gold			2022-12-27	WOS:000280862200013
J	Adiba, S; Nizak, C; van Baalen, M; Denamur, E; Depaulis, F				Adiba, Sandrine; Nizak, Clement; van Baalen, Minus; Denamur, Erick; Depaulis, Frantz			From Grazing Resistance to Pathogenesis: The Coincidental Evolution of Virulence Factors	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; ENTAMOEBA-HISTOLYTICA; HOST MODEL; DICTYOSTELIUM-DISCOIDEUM; ACANTHAMOEBA-POLYPHAGA; LEGIONELLA-PNEUMOPHILA; DIFFERENTIAL DETECTION; BACTERIAL PATHOGENS; PHYLOGENETIC GROUP	To many pathogenic bacteria, human hosts are an evolutionary dead end. This begs the question what evolutionary forces have shaped their virulence traits. Why are these bacteria so virulent? The coincidental evolution hypothesis suggests that such virulence factors result from adaptation to other ecological niches. In particular, virulence traits in bacteria might result from selective pressure exerted by protozoan predator. Thus, grazing resistance may be an evolutionarily exaptation for bacterial pathogenicity. This hypothesis was tested by subjecting a well characterized collection of 31 Escherichia coli strains (human commensal or extra-intestinal pathogenic) to grazing by the social haploid amoeba Dictyostelium discoideum. We then assessed how resistance to grazing correlates with some bacterial traits, such as the presence of virulence genes. Whatever the relative population size (bacteria/amoeba) for a non-pathogenic bacteria strain, D. discoideum was able to phagocytise, digest and grow. In contrast, a pathogenic bacterium strain killed D. discoideum above a certain bacteria/amoeba population size. A plating assay was then carried out using the E. coli collection faced to the grazing of D. discoideum. E. coli strains carrying virulence genes such as iroN, irp2, fyuA involved in iron uptake, belonging to the B2 phylogenetic group and being virulent in a mouse model of septicaemia were resistant to the grazing from D. discoideum. Experimental proof of the key role of the irp gene in the grazing resistance was evidenced with a mutant strain lacking this gene. Such determinant of virulence may well be originally selected and (or) further maintained for their role in natural habitat: resistance to digestion by free-living protozoa, rather than for virulence per se.	[Adiba, Sandrine; van Baalen, Minus] Univ Paris, CNRS, Ecol Lab, Univ Paris 06,UMR7625, Paris, France; [Nizak, Clement] CNRS, Spectrometrie Phys Lab, UMR5588, Grenoble, France; [Denamur, Erick] Univ Paris Diderot, Paris, France; [Denamur, Erick] INSERM, U722, Paris, France; [Adiba, Sandrine; van Baalen, Minus; Depaulis, Frantz] Ecole Normale Super, CNRS, Ecol Lab, UMR7625, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Adiba, S (corresponding author), Univ Paris, CNRS, Ecol Lab, Univ Paris 06,UMR7625, Paris, France.	sadiba@snv.jussieu.fr	Nizak, Clement/L-1334-2013; Nizak, Clement/HGV-1085-2022; van Baalen, Minus/J-9285-2012	Nizak, Clement/0000-0002-4591-8240; Nizak, Clement/0000-0002-4591-8240; van Baalen, Minus/0000-0002-3713-5967; Depaulis, Frantz/0000-0001-5761-2751; ADIBA, SANDRINE/0000-0003-4308-2870	Fondation pour la Recherche Medicale; ANR Biodiversity	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR Biodiversity(French National Research Agency (ANR))	E. D. was partially supported by the Fondation pour la Recherche Medicale and F. D. by the ANR Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; ANDERSON RM, 1982, POPULATION BIOL INFE; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; BRYANT RJ, 1982, APPL ENVIRON MICROB, V43, P747, DOI 10.1128/AEM.43.4.747-752.1982; BURNS D, 2000, INFECT IMMUN, V68, P2939; Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; CLARHOLM M, 1981, MICROBIAL ECOL, V7, P343, DOI 10.1007/BF02341429; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; DESJARDINS P, 1995, J MOL EVOL, V41, P440, DOI 10.1007/BF00160315; Diard M, 2007, MICROBES INFECT, V9, P214, DOI 10.1016/j.micinf.2006.11.009; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; FAUST MA, 1976, WATER RES, V10, P619, DOI 10.1016/0043-1354(76)90143-3; Fotedar R, 2007, J CLIN MICROBIOL, V45, P1035, DOI 10.1128/JCM.02144-06; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Froquet R, 2007, APPL ENVIRON MICROB, V73, P5657, DOI 10.1128/AEM.00908-07; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; HABTE M, 1977, ARCH MICROBIOL, V113, P181, DOI 10.1007/BF00492022; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Jung SY, 2007, INT J PARASITOL, V37, P417, DOI 10.1016/j.ijpara.2006.10.012; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; LEVIN BR, 1990, PARASITOLOGY, V100, pS103, DOI 10.1017/S0031182000073054; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Noegel AA, 2000, J CELL SCI, V113, P759; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; RIVERA F, 1986, ENVIRON RES, V39, P364, DOI 10.1016/S0013-9351(86)80062-7; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Rupper A, 2001, BBA-GEN SUBJECTS, V1525, P205, DOI 10.1016/S0304-4165(01)00106-4; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; SMITH HW, 1965, J PATHOL BACTERIOL, V89, P95, DOI 10.1002/path.1700890112; Solo-Gabriele HM, 2000, APPL ENVIRON MICROB, V66, P230, DOI 10.1128/AEM.66.1.230-237.2000; Solomon JM, 2000, TRENDS MICROBIOL, V8, P478, DOI 10.1016/S0966-842X(00)01852-7; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Steinert M, 2000, NATURWISSENSCHAFTEN, V87, P1, DOI 10.1007/s001140050001; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Troll H, 1997, J CLIN MICROBIOL, V35, P1701, DOI 10.1128/JCM.35.7.1701-1705.1997; van Baalen M, 2001, OIKOS, V95, P211, DOI 10.1034/j.1600-0706.2001.950203.x; VANDONSEL DJ, 1971, WATER RES, V5, P1079, DOI 10.1016/0043-1354(71)90040-6; VANDONSEL DJ, 1967, APPL MICROBIOL, V15, P1362, DOI 10.1128/AEM.15.6.1362-1370.1967; WEEKERS PHH, 1993, APPL ENVIRON MICROB, V59, P2317, DOI 10.1128/AEM.59.7.2317-2319.1993; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101	74	80	82	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e11882	10.1371/journal.pone.0011882	http://dx.doi.org/10.1371/journal.pone.0011882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20711443	Green Published, gold			2022-12-27	WOS:000280849100001
J	Catterson, JH; Knowles-Barley, S; James, K; Heck, MMS; Harmar, AJ; Hartley, PS				Catterson, James H.; Knowles-Barley, Seymour; James, Katherine; Heck, Margarete M. S.; Harmar, Anthony J.; Hartley, Paul S.			Dietary Modulation of Drosophila Sleep-Wake Behaviour	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; AMINO-ACIDS; LIFE-SPAN; MELANOGASTER; DOPAMINE; AROUSAL; GENES; DEPRIVATION; MAINTENANCE	Background: A complex relationship exists between diet and sleep but despite its impact on human health, this relationship remains uncharacterized and poorly understood. Drosophila melanogaster is an important model for the study of metabolism and behaviour, however the effect of diet upon Drosophila sleep remains largely unaddressed. Methodology/Principal Findings: Using automated behavioural monitoring, a capillary feeding assay and pharmacological treatments, we examined the effect of dietary yeast and sucrose upon Drosophila sleep-wake behaviour for three consecutive days. We found that dietary yeast deconsolidated the sleep-wake behaviour of flies by promoting arousal from sleep in males and shortening periods of locomotor activity in females. We also demonstrate that arousal from nocturnal sleep exhibits a significant ultradian rhythmicity with a periodicity of 85 minutes. Increasing the dietary sucrose concentration from 5% to 35% had no effect on total sucrose ingestion per day nor any affect on arousal, however it did lengthen the time that males and females remained active. Higher dietary sucrose led to reduced total sleep by male but not female flies. Locomotor activity was reduced by feeding flies Metformin, a drug that inhibits oxidative phosphorylation, however Metformin did not affect any aspects of sleep. Conclusions: We conclude that arousal from sleep is under ultradian control and regulated in a sex-dependent manner by dietary yeast and that dietary sucrose regulates the length of time that flies sustain periods of wakefulness. These findings highlight Drosophila as an important model with which to understand how diet impacts upon sleep and wakefulness in mammals and humans.	[Catterson, James H.; James, Katherine; Heck, Margarete M. S.; Harmar, Anthony J.; Hartley, Paul S.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Knowles-Barley, Seymour] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Catterson, JH (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	P.S.Hartley@ed.ac.uk		Hartley, Paul/0000-0003-2782-0490; Catterson, James/0000-0003-4231-0114; Harmar, Anthony/0000-0002-3838-9264	Medical Research Council [G9719726]; British Heart Foundation; Tuberous Sclerosis Association; Wellcome Trust; MRC [G9719726] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Tuberous Sclerosis Association; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council program grant (G9719726) awarded to AJH; the British Heart Foundation and the Tuberous Sclerosis Association support PSH, JHC and KJ. MH is supported by a Wellcome Trust University Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaghi A, 2007, AM J CLIN NUTR, V85, P426, DOI 10.1093/ajcn/85.2.426; Afaghi A, 2008, NUTR NEUROSCI, V11, P146, DOI 10.1179/147683008X301540; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; CONNOLLY KJ, 1966, NATURE, V209, P224, DOI 10.1038/209224a0; CROCKER A, NEURON, V65, P670; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; DOWSE HB, 1989, BEHAV GENET, V19, P529, DOI 10.1007/BF01066252; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; ERIKSSON E, 1980, J NEURAL TRANSM, V48, P305, DOI 10.1007/BF01250665; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gruntenko NE, 2005, J INSECT PHYSIOL, V51, P959, DOI 10.1016/j.jinsphys.2005.04.010; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; HARDELAND R, 1971, AM NAT, V105, P198, DOI 10.1086/282717; Hazel MH, 2003, J EXP BIOL, V206, P79, DOI 10.1242/jeb.00058; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; ISHIMOTO H, GENETICS; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Power JM, 1995, J BIOL RHYTHM, V10, P267, DOI 10.1177/074873049501000309; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; Rontoyanni VG, 2007, NUTRITION, V23, P773, DOI 10.1016/j.nut.2007.07.005; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; ShannahoffKhalsa DS, 1996, AM J PHYSIOL-REG I, V270, pR873, DOI 10.1152/ajpregu.1996.270.4.R873; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Tuomilehto H, 2009, DIABETES CARE, V32, P1965, DOI 10.2337/dc08-1980; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; WU X, 2008, BONE; Wurtman RJ, 2003, AM J CLIN NUTR, V77, P128, DOI 10.1093/ajcn/77.1.128; WURTMAN RJ, 1975, AM J CLIN NUTR, V28, P638, DOI 10.1093/ajcn/28.6.638; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	50	54	55	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12062	10.1371/journal.pone.0012062	http://dx.doi.org/10.1371/journal.pone.0012062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20706579	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000280811900018
J	Bernal-Mizrachi, E; Cras-Meneur, C; Ye, BR; Johnson, JD; Permutt, MA				Bernal-Mizrachi, Ernesto; Cras-Meneur, Corentin; Ye, Bo Ra; Johnson, James D.; Permutt, M. Alan			Transgenic Overexpression of Active Calcineurin in beta-Cells Results in Decreased beta-Cell Mass and Hyperglycemia	PLOS ONE			English	Article							STIMULATED INSULIN-RELEASE; HUMAN PANCREATIC-ISLETS; KINESIN HEAVY-CHAIN; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CHRONIC EXPOSURE; GENE-EXPRESSION; GLUCOSE; APOPTOSIS; TRANSCRIPTION	Background: Glucose modulates beta-cell mass and function through an initial depolarization and Ca2+ influx, which then triggers a number of growth regulating signaling pathways. One of the most important downstream effectors in Ca2+ signaling is the calcium/Calmodulin activated serine threonine phosphatase, calcineurin. Recent evidence suggests that calcineurin/NFAT is essential for beta-cell proliferation, and that in its absence loss of beta-cells results in diabetes. We hypothesized that in contrast, activation of calcineurin might result in expansion of beta-cell mass and resistance to diabetes. Methodology/Principal Findings: To determine the role of activation of calcineurin signaling in the regulation of pancreatic beta-cell mass and proliferation, we created mice that expressed a constitutively active form of calcineurin under the insulin gene promoter (caCn(RIP)). To our surprise, these mice exhibited glucose intolerance. In vitro studies demonstrated that while the second phase of Insulin secretion is enhanced, the overall insulin secretory response was conserved. Islet morphometric studies demonstrated decreased beta-cell mass suggesting that this was a major component responsible for altered Insulin secretion and glucose intolerance in caCn(RIP) mice. The reduced beta-cell mass was accompanied by decreased proliferation and enhanced apoptosis. Conclusions: Our studies identify calcineurin as an important factor in controlling glucose homeostasis and indicate that chronic depolarization leading to increased calcineurin activity may contribute, along with other genetic and environmental factors, to beta-cell dysfunction and diabetes.	[Bernal-Mizrachi, Ernesto; Cras-Meneur, Corentin; Ye, Bo Ra] Univ Michigan, Div Metab, Brehm Ctr Type Diabet 1, Ann Arbor, MI 48109 USA; [Johnson, James D.] Univ British Columbia, Dept Surg, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1W5, Canada; [Permutt, M. Alan] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO USA	University of Michigan System; University of Michigan; University of British Columbia; Washington University (WUSTL)	Bernal-Mizrachi, E (corresponding author), Univ Michigan, Div Metab, Brehm Ctr Type Diabet 1, Ann Arbor, MI 48109 USA.	ebernal@umich.edu	Cras-Méneur, Corentin/A-2628-2008; Cras-Meneur, Corentin/K-7728-2019	Cras-Méneur, Corentin/0000-0001-8921-8927; Cras-Meneur, Corentin/0000-0001-8921-8927; Johnson, James/0000-0002-7523-9433	National Institutes of Health [R01DK073716-01, R37DK16746, P60-DK020579-31]; American Diabetes Association; Juvenile Diabetes Research Foundation; Canadian Institutes for Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK016746, R37DK016746, P60DK020579, R01DK084236, R01DK073716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK073716-01 (E. B. M.), R37DK16746 (M. A. P.) and a Career Development Award from the American Diabetes Association (E. B. M.). J.D.J is supported by grants from the Juvenile Diabetes Research Foundation and the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support of the Radioimmunoassay, Mouse Genetic core and beta-cell Morphology Cores of The Washington University Diabetes Research & Training Center (NIH grant P60-DK020579-31). We also thank the Morphology core from Washington University Digestive Diseases Research Core Center (DDRCC) for histology sections (5P30 DK052574). We would like to acknowledge John Williams and Grzegorz Tadeusz Gurda for providing adenoviruses.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bernal-Mizrachi E, 2003, DIABETES-METAB RES, V19, P32, DOI 10.1002/dmrr.331; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cousin SP, 1999, BIOCHEM J, V344, P649, DOI 10.1042/0264-6021:3440649; DAWSON VL, 1993, P NATL ACAD SCI USA, V90, P3256, DOI 10.1073/pnas.90.8.3256; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANKLIN JL, 1994, ANN NY ACAD SCI, V747, P195; Girish V, 2004, Indian J Cancer, V41, P47; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HEROLD KC, 1993, TRANSPLANTATION, V55, P186, DOI 10.1097/00007890-199301000-00035; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; KAISER N, 1991, ENDOCRINOLOGY, V129, P2067, DOI 10.1210/endo-129-4-2067; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; KINCAID RL, 1986, BIOCHEM BIOPH RES CO, V140, P320, DOI 10.1016/0006-291X(86)91093-4; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; LEAHY JL, 1986, J CLIN INVEST, V77, P908, DOI 10.1172/JCI112389; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Marshak S, 1999, DIABETES, V48, P1230, DOI 10.2337/diabetes.48.6.1230; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; Persaud SJ, 1996, BIOCHEM J, V313, P119, DOI 10.1042/bj3130119; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Redmon JB, 1996, J CLIN INVEST, V98, P2786, DOI 10.1172/JCI119105; ROBERTSON RP, 1989, DIABETES, V38, P1501, DOI 10.2337/diabetes.38.12.1501; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; UNGER RH, 1985, DIABETOLOGIA, V28, P119; van Duijnhoven EM, 2001, J AM SOC NEPHROL, V12, P583, DOI 10.1681/ASN.V123583; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339	52	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11969	10.1371/journal.pone.0011969	http://dx.doi.org/10.1371/journal.pone.0011969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689817	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520500013
J	Hsu, CL; Neilsen, CV; Bryce, PJ				Hsu, Chia-Lin; Neilsen, Colleen V.; Bryce, Paul J.			IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent Inflammation	PLOS ONE			English	Article							HUMAN BASOPHILS; FAMILY-MEMBER; CYTOKINE; RECEPTOR; INTERLEUKIN-33; ST2; ACTIVATION; PHOSPHORYLATION; RECRUITMENT; MATURATION	Background: IL-33 is a recently characterized IL-1 family cytokine and found to be expressed in inflammatory diseases, including severe asthma and inflammatory bowl disease. Recombinant IL-33 has been shown to enhance Th2-associated immune responses and potently increase mast cell proliferation and cytokine production. While IL-33 is constitutively expressed in endothelial and epithelial cells, where it may function as a transcriptional regulator, cellular sources of IL-33 and its role in inflammation remain unclear. Methodology/Principal Findings: Here, we identify mast cells as IL-33 producing cells. IgE/antigen activation of bone marrow-derived mast cells or a murine mast cell line (MC/9) significantly enhanced IL-33. Conversely, recombinant IL-33 directly activated mast cells to produce several cytokines including IL-4, IL-5 and IL-6 but not IL-33. We show that expression of IL-33 in response to IgE-activation required calcium and that ionomycin was sufficient to induce IL-33. In vivo, peritoneal mast cells expressed IL-33 and IL-33 levels were significantly lower within the skin of mast cell deficient mice, compared to littermate controls. Local activation of mast cells promotes edema, followed by the recruitment of inflammatory cells. We demonstrate using passive cutaneous anaphylaxis, a mast cell-dependent model, that deficiency in ST2 or antibody blockage of ST2 or IL-33 ablated the late phase inflammatory response but that the immediate phase response was unaffected. IL-33 levels in the skin were significantly elevated only during the late phase. Conclusions/Significance: Our findings demonstrate that mast cells produce IL-33 after IgE-mediated activation and that the IL-33/ST2 pathway is critical for the progression of IgE-dependent inflammation.	[Hsu, Chia-Lin; Neilsen, Colleen V.; Bryce, Paul J.] Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hsu, CL (corresponding author), Northwestern Univ, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-bryce@northwestern.edu			National Institute of Allergy and Infectious Diseases [R01AI076456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076456] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from grant R01AI076456 from the National Institute of Allergy and Infectious Diseases to PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; BELTRAN CJ, 2009, INFLAMM BOWEL DIS; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hogaboam G, 1998, J IMMUNOL, V160, P6166; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kaneko M, 2000, J ALLERGY CLIN IMMUN, V105, P1202, DOI 10.1067/mai.2000.106731; Kang NI, 2008, INT ARCH ALLERGY IMM, V147, P315, DOI 10.1159/000144039; Kim SJ, 2007, LIFE SCI, V81, P863, DOI 10.1016/j.lfs.2007.06.027; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Lorentz A, 2000, J IMMUNOL, V164, P43, DOI 10.4049/jimmunol.164.1.43; Lorentz A, 2001, IMMUNOL REV, V179, P57, DOI 10.1034/j.1600-065X.2001.790106.x; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Matsuda A, 2009, INVEST OPHTH VIS SCI, V50, P4646, DOI 10.1167/iovs.08-3365; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; Mazzoni A, 2006, J IMMUNOL, V177, P3577, DOI 10.4049/jimmunol.177.6.3577; McCurdy JD, 2001, J LEUKOCYTE BIOL, V70, P977; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Okayama Y, 2001, J IMMUNOL, V166, P4705, DOI 10.4049/jimmunol.166.7.4705; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Robinson DS, 2002, IMMUNITY, V16, P755, DOI 10.1016/S1074-7613(02)00331-X; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081	55	187	197	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11944	10.1371/journal.pone.0011944	http://dx.doi.org/10.1371/journal.pone.0011944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689814	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520500008
J	Szucs, A; Berton, F; Nowotny, T; Sanna, P; Francesconi, W				Szucs, Attila; Berton, Fulvia; Nowotny, Thomas; Sanna, Pietro; Francesconi, Walter			Consistency and Diversity of Spike Dynamics in the Neurons of Bed Nucleus of Stria Terminalis of the Rat: A Dynamic Clamp Study	PLOS ONE			English	Article							CORTICAL-NEURONS; INHIBITORY INTERNEURONS; SYNAPTIC CONDUCTANCE; NEOCORTICAL NEURONS; IN-VIVO; PRECISION; INPUTS; ORGANIZATION; RELIABILITY; INTEGRATION	Neurons display a high degree of variability and diversity in the expression and regulation of their voltage-dependent ionic channels. Under low level of synaptic background a number of physiologically distinct cell types can be identified in most brain areas that display different responses to standard forms of intracellular current stimulation. Nevertheless, it is not well understood how biophysically different neurons process synaptic inputs in natural conditions, i.e., when experiencing intense synaptic bombardment in vivo. While distinct cell types might process synaptic inputs into different patterns of action potentials representing specific "motifs'' of network activity, standard methods of electrophysiology are not well suited to resolve such questions. In the current paper we performed dynamic clamp experiments with simulated synaptic inputs that were presented to three types of neurons in the juxtacapsular bed nucleus of stria terminalis (jcBNST) of the rat. Our analysis on the temporal structure of firing showed that the three types of jcBNST neurons did not produce qualitatively different spike responses under identical patterns of input. However, we observed consistent, cell type dependent variations in the fine structure of firing, at the level of single spikes. At the millisecond resolution structure of firing we found high degree of diversity across the entire spectrum of neurons irrespective of their type. Additionally, we identified a new cell type with intrinsic oscillatory properties that produced a rhythmic and regular firing under synaptic stimulation that distinguishes it from the previously described jcBNST cell types. Our findings suggest a sophisticated, cell type dependent regulation of spike dynamics of neurons when experiencing a complex synaptic background. The high degree of their dynamical diversity has implications to their cooperative dynamics and synchronization.	[Szucs, Attila] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Berton, Fulvia; Sanna, Pietro; Francesconi, Walter] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Nowotny, Thomas] Univ Sussex, Sch Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Szucs, Attila] Hungarian Acad Sci, Balaton Limnol Res Inst, Dept Expt Zool, H-8237 Tihany, Hungary; [Berton, Fulvia] Univ Pisa, Dept Biol, Pisa, Italy	University of California System; University of California San Diego; Scripps Research Institute; University of Sussex; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; University of Pisa	Szucs, A (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	aszucs@ucsd.edu	Nowotny, Thomas/C-3883-2012	Nowotny, Thomas/0000-0002-4451-915X	National Institutes of Health [RC1AA019195, AA016587, AA017371, DA013821]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017371, RC1AA019195, R01AA016587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institutes of Health (Grants RC1AA019195, AA016587, AA017371 and DA013821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Aradi I, 2004, J NEUROPHYSIOL, V91, P2849, DOI 10.1152/jn.00916.2003; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dong HW, 2000, BRAIN RES, V859, P1, DOI 10.1016/S0006-8993(99)02246-5; Dumon EC, 2008, NEUROSCIENCE, V153, P232, DOI 10.1016/j.neuroscience.2008.01.039; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Francesconi W, 2009, PROG NEURO-PSYCHOPH, V33, P1347, DOI 10.1016/j.pnpbp.2009.08.003; Francesconi W, 2009, J NEUROSCI, V29, P5389, DOI 10.1523/JNEUROSCI.5129-08.2009; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HEIMER L, 1991, BASAL FOREBRAIN ANAT, V295, P1; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Piwkowska Z, 2008, J NEUROSCI METH, V169, P302, DOI 10.1016/j.jneumeth.2007.11.010; Sanna PP, 2000, P NATL ACAD SCI USA, V97, P8653, DOI 10.1073/pnas.140219097; Schreiber S, 2004, J NEUROPHYSIOL, V91, P194, DOI 10.1152/jn.00556.2003; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Szucs A, 2004, NEUROSCIENCE, V126, P1063, DOI 10.1016/j.neuroscience.2004.04.015; Tateno T, 2009, J NEUROPHYSIOL, V101, P1056, DOI 10.1152/jn.91057.2008; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Xu-Friedman MA, 2005, J NEUROPHYSIOL, V94, P2512, DOI 10.1152/jn.01307.2004; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2010	5	8							e11920	10.1371/journal.pone.0011920	http://dx.doi.org/10.1371/journal.pone.0011920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633RB	20689810	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000280520500001
J	Taha, R; Seidman, E; Mailhot, G; Boudreau, F; Gendron, FP; Beaulieu, JF; Menard, D; Delvin, E; Amre, D; Levy, E				Taha, Rame; Seidman, Ernest; Mailhot, Genevieve; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Delvin, Edgard; Amre, Devendra; Levy, Emile			Oxidative Stress and Mitochondrial Functions in the Intestinal Caco-2/15 Cell Line	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEDIATED LIPID-PEROXIDATION; ULCERATIVE-COLITIS; COMPLEX-III; SPECTROPHOTOMETRIC ASSAY; CHOLESTEROL ABSORPTION; TRANSCRIPTION FACTORS; REGULATORY ENZYMES; RESPIRATORY-CHAIN; MAMMALIAN-CELLS	Background: Although mitochondrial dysfunction and oxidative stress are central mechanisms in various pathological conditions, they have not been extensively studied in the gastrointestinal tract, which is known to be constantly exposed to luminal oxidants from ingested foods. Key among these is the simultaneous consumption of iron salts and ascorbic acid, which can cause oxidative damage to biomolecules. Methodology/Principal Findings: The objective of the present work was to evaluate how iron-ascorbate (FE/ASC)-mediated lipid peroxidation affects mitochondrion functioning in Caco-2/15 cells. Our results show that treatment of Caco-2/15 cells with FE/ASC (0.2 mM/2 mM) (1) increased malondialdehyde levels assessed by HPLC; (2) reduced ATP production noted by luminescence assay; (3) provoked dysregulation of mitochondrial calcium homeostasis as evidenced by confocal fluorescence microscopy; (4) upregulated the protein expression of cytochrome C and apoptotic inducing factor, indicating exaggerated apoptosis; (5) affected mitochondrial respiratory chain complexes I, II, III and IV; (6) elicited mtDNA lesions as illustrated by the raised levels of 8-OHdG; (7) lowered DNA glycosylase, one of the first lines of defense against 8-OHdG mutagenicity; and (8) altered the gene expression and protein mass of mitochondrial transcription factors (mtTFA, mtTFB1, mtTFB2) without any effects on RNA Polymerase. The presence of the powerful antioxidant BHT (50 mM) prevented the occurrence of oxidative stress and most of the mitochondrial abnormalities. Conclusions/Significance: Collectively, our findings indicate that acute exposure of Caco-2/15 cells to FE/ASC-catalyzed peroxidation produces harmful effects on mitochondrial functions and DNA integrity, which are abrogated by the powerful exogenous BHT antioxidant. Functional derangements of mitochondria may have implications in oxidative stress-related disorders such as inflammatory bowel diseases.	[Taha, Rame; Mailhot, Genevieve; Levy, Emile] Univ Montreal, Dept Nutr, Res Ctr, CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Seidman, Ernest] McGill Univ, Res Inst, Montreal, PQ, Canada; [Seidman, Ernest; Boudreau, Francois; Gendron, Fernand-Pierre; Beaulieu, Jean-Francois; Menard, Daniel; Levy, Emile] Univ Sherbrooke, Dept Anat & Cellular Biol, Fac Med & Hlth Sci, Canadian Inst Hlth Res Team Digest Epithelium, Sherbrooke, PQ J1K 2R1, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, Res Ctr, CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Amre, Devendra] Univ Montreal, Dept Pediat, Res Ctr, CHU St Justine, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Taha, R (corresponding author), Univ Montreal, Dept Nutr, Res Ctr, CHU St Justine, Montreal, PQ H3C 3J7, Canada.	emile.levy@recherche-ste-justine.qc.ca	Mailhot, Genevieve/AAB-8928-2020; Menard, Daniel/AAL-7821-2021; AMRE, DEVENDRA K/D-4988-2015; Mailhot, Genevieve/AAL-1310-2020; Gendron, Fernand-Pierre/AAN-2965-2021	Mailhot, Genevieve/0000-0002-2673-6492; 	Canadian Institutes of Health Research [CTP-82942]; J.A. DeSeve Research Chair in Nutrition; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); J.A. DeSeve Research Chair in Nutrition; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by a Canadian Institutes of Health Research team grant (CTP-82942), the J.A. DeSeve Research Chair in Nutrition (EL) and the Fonds de la Recherche en Sante du Quebec(RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Ahluwalia N, 2010, J NUTR, V140, P812, DOI 10.3945/jn.109.110353; Anders MW, 2006, EXPERT OPIN DRUG MET, V2, P71, DOI 10.1517/17425255.2.1.71; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; BABBS CF, 1992, FREE RADICAL BIO MED, V13, P169, DOI 10.1016/0891-5849(92)90079-V; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brunet S, 2000, FREE RADICAL BIO MED, V28, P46, DOI 10.1016/S0891-5849(99)00197-5; CAMMISOTTO PG, 2010, INT J CELL BIOL; CHANCE B, 1979, PHYSIOL REV, V527, P605; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Courtois F, 2003, AM J CLIN NUTR, V77, P744, DOI 10.1093/ajcn/77.3.744; Courtois F, 2002, J NUTR, V132, P1289, DOI 10.1093/jn/132.6.1289; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Deng XK, 2006, TOXICOL SCI, V91, P59, DOI 10.1093/toxsci/kfj114; Ding XH, 2005, CANCER SCI, V96, P157, DOI 10.1111/j.1349-7006.2005.00024.x; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; FERRARI R, 1990, CIRCULATION, V81, P201, DOI 10.1161/01.CIR.81.1.201; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Gasche C, 2004, GUT, V53, P1190, DOI 10.1136/gut.2003.035758; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P692, DOI 10.1093/oxfordjournals.aje.a117698; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; JOURDHEUIL D, 1993, AM J PHYSIOL, V264, pG1009, DOI 10.1152/ajpgi.1993.264.6.G1009; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kanki T, 2004, ANN NY ACAD SCI, V1011, P61, DOI 10.1196/annals.1293.007; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; Kruidenier L, 2002, ALIMENT PHARM THER, V16, P1997, DOI 10.1046/j.1365-2036.2002.01378.x; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Leblond F, 2009, AM J PHYSIOL-GASTR L, V296, pG805, DOI 10.1152/ajpgi.90424.2008; Levy E, 2000, AM J CLIN NUTR, V71, P807, DOI 10.1093/ajcn/71.3.807; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Levy E, 2007, LIFE SCI, V80, P1472, DOI 10.1016/j.lfs.2007.01.017; Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427; Mailhot G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010446; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Marcil V, 2006, CARDIOVASC RES, V72, P473, DOI 10.1016/j.cardiores.2006.08.024; MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V270, P672, DOI 10.1016/0003-9861(89)90550-X; Mazalli MR, 2009, J AGR FOOD CHEM, V57, P5028, DOI 10.1021/jf901187j; Montoudis A, 2008, J LIPID RES, V49, P961, DOI 10.1194/jlr.M700363-JLR200; Nishikawa M, 2005, BRIT J CANCER, V93, P331, DOI 10.1038/sj.bjc.6602664; Okuda T, 2006, J PHARM SCI-US, V95, P2256, DOI 10.1002/jps.20712; Ozment CP, 2009, BBA-GEN SUBJECTS, V1790, P694, DOI 10.1016/j.bbagen.2008.09.010; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; PARKS DA, 1989, GUT, V30, P293, DOI 10.1136/gut.30.3.293; PARKS DA, 1988, AM J PHYSIOL, V254, pG768, DOI 10.1152/ajpgi.1988.254.5.G768; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pravda J, 2005, WORLD J GASTROENTERO, V11, P2371, DOI 10.3748/wjg.v11.i16.2371; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; Ravid Z, 2008, AM J PHYSIOL-GASTR L, V295, pG873, DOI 10.1152/ajpgi.90376.2008; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sanchez S, 2002, DIGEST DIS SCI, V47, P1389, DOI 10.1023/A:1015395103160; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Trudel K, 2005, J CELL BIOCHEM, V96, P404, DOI 10.1002/jcb.20542; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang RJ, 2006, J PHARMACOL EXP THER, V318, P45, DOI 10.1124/jpet.105.099903; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zhang WJ, 2010, EXP BIOL MED, V235, P633, DOI 10.1258/ebm.2009.009229	71	34	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11817	10.1371/journal.pone.0011817	http://dx.doi.org/10.1371/journal.pone.0011817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20676402	Green Published, gold, Green Submitted			2022-12-27	WOS:000280371800017
J	Wang, HJ; Jin, YL; Reddy, MVPL; Podolsky, R; Liu, SY; Yang, P; Bode, B; Reed, JC; Steed, RD; Anderson, SW; Steed, L; Hopkins, D; Huang, YH; She, JX				Wang, Hongjie; Jin, Yulan; Reddy, M. V. Prasad Linga; Podolsky, Robert; Liu, Siyang; Yang, Ping; Bode, Bruce; Reed, John Chip; Steed, R. Dennis; Anderson, Stephen W.; Steed, Leigh; Hopkins, Diane; Huang, Yihua; She, Jin-Xiong			Genetically Dependent ERBB3 Expression Modulates Antigen Presenting Cell Function and Type 1 Diabetes Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CANCER; LOCI; POLYMORPHISMS; METAANALYSIS; FAMILY	Type 1 diabetes (T1D) is an autoimmune disease resulting from the complex interaction between multiple susceptibility genes, environmental factors and the immune system. Over 40 T1D susceptibility regions have been suggested by recent genome-wide association studies; however, the specific genes and their role in the disease remain elusive. The objective of this study is to identify the susceptibility gene(s) in the 12q13 region and investigate the functional link to the disease pathogenesis. A total of 19 SNPs in the 12q13 region were analyzed by the TaqMan assay for 1,434 T1D patients and 1,865 controls. Thirteen of the SNPs are associated with T1D (best p = 4 x 10(-11)), thus providing confirmatory evidence for at least one susceptibility gene in this region. To identify candidate genes, expression of six genes in the region was analyzed by real-time RT-PCR for PBMCs from 192 T1D patients and 192 controls. SNP genotypes in the 12q13 region are the main factors that determine ERBB3 mRNA levels in PBMCs. The protective genotypes for T1D are associated with higher ERBB3 mRNA level (p < 10(-10)). Furthermore, ERBB3 protein is expressed on the surface of CD11c(+) cells (dendritic cells and monocytes) in peripheral blood after stimulation with LPS, polyI:C or CpG. Subjects with protective genotypes have significantly higher percentages of ERBB3(+) monocytes and dendritic cells (p = 1.1 x 10(-9)); and the percentages of ERBB3(+) cells positively correlate with the ability of APC to stimulate T cell proliferation (R-2 = 0.90, p < 0.0001). Our results indicate that ERBB3 plays a critical role in determining APC function and potentially T1D pathogenesis.	[Wang, Hongjie; Jin, Yulan; Reddy, M. V. Prasad Linga; Podolsky, Robert; Liu, Siyang; Yang, Ping; Steed, Leigh; Hopkins, Diane; Huang, Yihua; She, Jin-Xiong] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Podolsky, Robert] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Reed, John Chip; Steed, R. Dennis] SE Endocrine & Diabet, Atlanta, GA USA; [Anderson, Stephen W.] Pediat Endocrine Associates, Atlanta, GA USA; [She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wang, HJ (corresponding author), Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@mail.mcg.edu	REDDY, M.V. PRASAD LINGA/H-6330-2012; Podolsky, Robert/GRY-0740-2022		National Institutes of Health [2RO1HD37800, 4R33DK069878, 4R33HD050196]; Juvenile Diabetes Research Foundation International [JDRF 1-2004-661]; Georgia Research Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037800, R33HD050196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK069878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Georgia Research Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly supported by grants from the National Institutes of Health (2RO1HD37800, 4R33DK069878, 4R33HD050196) and Juvenile Diabetes Research Foundation International (JDRF 1-2004-661) (JXS). JXS is an eminent scholar supported by the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awata T, 2009, J CLIN ENDOCR METAB, V94, P231, DOI 10.1210/jc.2008-0718; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Fruman DA, 2007, BIOCHEM SOC T, V35, P177, DOI 10.1042/BST0350177; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Kritzik MR, 2000, J ENDOCRINOL, V165, P67, DOI 10.1677/joe.0.1650067; Lin SH, 2008, CLIN CANCER RES, V14, P3729, DOI 10.1158/1078-0432.CCR-08-0472; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	33	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2010	5	7							e11789	10.1371/journal.pone.0011789	http://dx.doi.org/10.1371/journal.pone.0011789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630TN	20668683	Green Published, gold, Green Submitted			2022-12-27	WOS:000280297300020
J	Morandi, F; Ferretti, E; Bocca, P; Prigione, I; Raffaghello, L; Pistoia, V				Morandi, Fabio; Ferretti, Elisa; Bocca, Paola; Prigione, Ignazia; Raffaghello, Lizzia; Pistoia, Vito			A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; G MOLECULES; TH17 CELLS; B-CELLS; DIFFERENTIAL EXPRESSION; TYROSINE-PHOSPHATASE; HELPER-CELLS; ANTIGEN; LYMPHOCYTES; RESPONSES	Background: In recent years, many immunoregulatory functions have been ascribed to soluble HLA-G (sHLA-G). Since chemotaxis is crucial for an efficient immune response, we have investigated for the first time the effects of sHLA-G on chemokine receptor expression and function in different human T cell populations. Methodology/Principal Findings: T cell populations isolated from peripheral blood were stimulated in the presence or absence of sHLA-G. Chemokine receptors expression was evaluated by flow cytometry. sHLA-G downregulated expression of i) CCR2, CXCR3 and CXCR5 in CD4(+) T cells, ii) CXCR3 in CD8(+) T cells, iii) CXCR3 in Th1 clones iv) CXCR3 in TCR V delta 2 gamma 9 T cells, and upregulated CXCR4 expression in TCR V delta 2 gamma 9 T cells. sHLA-G inhibited in vitro chemotaxis of i) CD4(+) T cells towards CCL2, CCL8, CXCL10 and CXCL11, ii) CD8+ T cells towards CXCL10 and CXCL11, iii) Th1 clones towards CXCL10, and iv) TCR V delta 2 gamma 9 T cells towards CXCL10 and CXCL11. Downregulation of CXCR3 expression on CD4+ T cells by sHLA-G was partially reverted by adding a blocking antibody against ILT2/CD85j, a receptor for sHLA-G, suggesting that sHLA-G downregulated chemokine receptor expression mainly through the interaction with ILT2/CD85j. Follicular helper T cells (T(FH)) were isolated from human tonsils and stimulated as described above. sHLA-G impaired CXCR5 expression in T(FH) and chemotaxis of the latter cells towards CXCL13. Moreover, sHLA-G expression was detected in tonsils by immunohistochemistry, suggesting a role of sHLA-G in local control of T(FH) cell chemotaxis. Intracellular pathways were investigated by Western Blot analysis on total extracts from CD4+ T cells. Phosphorylation of Stat5, p70 s6k, beta-arrestin and SHP2 was modulated by sHLA-G treatment. Conclusions/Significance: Our data demonstrated that sHLA-G impairs expression and functionality of different chemokine receptors in T cells. These findings delineate a novel mechanism whereby sHLA-G modulates T cell recruitment in physiological and pathological conditions.	[Morandi, Fabio; Ferretti, Elisa; Bocca, Paola; Prigione, Ignazia; Raffaghello, Lizzia; Pistoia, Vito] G Gaslini Childrens Hosp, Lab Oncol, Genoa, Italy		Morandi, F (corresponding author), G Gaslini Childrens Hosp, Lab Oncol, Genoa, Italy.	fabiomorandi@ospedale-gaslini.ge.it	Bocca, Paola/AAB-3381-2021; Prigione, Ignazia/K-3011-2016; Morandi, Fabio/I-1185-2012	Bocca, Paola/0000-0002-7498-209X; Prigione, Ignazia/0000-0002-0877-6255; Raffaghello, Lizzia/0000-0003-2357-0607; Morandi, Fabio/0000-0002-2849-7595	Ministero della Salute, Progetti di Ricerca Corrente	Ministero della Salute, Progetti di Ricerca Corrente(Ministry of Health, Italy)	This work has been supported by grants from "Ministero della Salute, Progetti di Ricerca Corrente". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Annunziato F, 1999, MICROBES INFECT, V1, P103, DOI 10.1016/S1286-4579(99)80021-5; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Berencsi K, 2007, CANCER IMMUNOL IMMUN, V56, P359, DOI 10.1007/s00262-006-0190-2; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Carosella ED, 1999, CELL MOL LIFE SCI, V55, P327, DOI 10.1007/s000180050295; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Chen ZW, 2005, CLIN IMMUNOL, V116, P202, DOI 10.1016/j.clim.2005.04.005; Ciprandi G, 2008, ALLERGY, V63, P1335, DOI 10.1111/j.1398-9995.2008.01741.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Corcione A, 2004, CLIN CANCER RES, V10, P964, DOI 10.1158/1078-0432.CCR-1182-3; Costa P, 2001, AIDS, V15, P965, DOI 10.1097/00002030-200105250-00004; Decker T, 2003, BLOOD, V101, P278, DOI 10.1182/blood-2002-01-0189; Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919; FORSTER R, 1994, BLOOD, V84, P830; FUJII T, 1994, J IMMUNOL, V153, P5516; Garcia G, 2007, ALLERGY, V62, P170, DOI 10.1111/j.1398-9995.2006.01216.x; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Gros F, 2008, EUR J IMMUNOL, V38, P742, DOI 10.1002/eji.200736918; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; KIRSZENBAUM M, 1994, P NATL ACAD SCI USA, V91, P4209, DOI 10.1073/pnas.91.10.4209; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Menier C, 2008, LEUKEMIA, V22, P578, DOI 10.1038/sj.leu.2405050; MORETTA L, 1991, IMMUNOL REV, V120, P117; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Nakajima H, 2003, J IMMUNOL, V171, P6611, DOI 10.4049/jimmunol.171.12.6611; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pistoia V, 2007, SEMIN CANCER BIOL, V17, P469, DOI 10.1016/j.semcancer.2007.07.004; Prigione I, 2006, MICROBES INFECT, V8, P552, DOI 10.1016/j.micinf.2005.08.008; PRIGIONE I, 2009, INTERFERONGAMMA IL 1; Prigione I, 2009, STEM CELLS, V27, P693, DOI 10.1634/stemcells.2008-0687; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sebti Y, 2003, HUM IMMUNOL, V64, P1093, DOI 10.1016/j.humimm.2003.08.345; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sorensen TL, 2002, MULT SCLER J, V8, P104, DOI 10.1191/1352458502ms781oa; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Winter D, 2007, J IMMUNOL, V179, P4272, DOI 10.4049/jimmunol.179.6.4272; Wischhusell J, 2007, SEMIN CANCER BIOL, V17, P459, DOI 10.1016/j.semcancer.2007.07.005; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	61	36	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11763	10.1371/journal.pone.0011763	http://dx.doi.org/10.1371/journal.pone.0011763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668702	Green Submitted, Green Published, gold			2022-12-27	WOS:000280243800031
J	Ward-Paige, C; Flemming, JM; Lotze, HK				Ward-Paige, Christine; Flemming, Joanna Mills; Lotze, Heike K.			Overestimating Fish Counts by Non-Instantaneous Visual Censuses: Consequences for Population and Community Descriptions	PLOS ONE			English	Article							SIZE-STRUCTURE; REEF; SHARKS; DENSITY; BIOMASS; CARCHARIAS; ABUNDANCE; TRANSECT; IDENTIFICATION; FISHERIES	Background: Increasingly, underwater visual censuses (UVC) are used to assess fish populations. Several studies have demonstrated the effectiveness of protected areas for increasing fish abundance or provided insight into the natural abundance and structure of reef fish communities in remote areas. Recently, high apex predator densities (>100,000 individuals.km(-2)) and biomasses (>4 tonnes.ha(-1)) have been reported for some remote islands suggesting the occurrence of inverted trophic biomass pyramids. However, few studies have critically evaluated the methods used for sampling conspicuous and highly mobile fish such as sharks. Ideally, UVC are done instantaneously, however, researchers often count animals that enter the survey area after the survey has started, thus performing non-instantaneous UVC. Methodology/Principal Findings: We developed a simulation model to evaluate counts obtained by divers deploying non-instantaneous belt-transect and stationary-point-count techniques. We assessed how fish speed and survey procedure (visibility, diver speed, survey time and dimensions) affect observed fish counts. Results indicate that the bias caused by fish speed alone is huge, while survey procedures had varying effects. Because the fastest fishes tend to be the largest, the bias would have significant implications on their biomass contribution. Therefore, caution is needed when describing abundance, biomass, and community structure based on non-instantaneous UVC, especially for highly mobile species such as sharks. Conclusions/Significance: Based on our results, we urge that published literature state explicitly whether instantaneous counts were made and that survey procedures be accounted for when non-instantaneous counts are used. Using published density and biomass values of communities that include sharks we explore the effect of this bias and suggest that further investigation may be needed to determine pristine shark abundances and the existence of inverted biomass pyramids. Because such studies are used to make important management and conservation decisions, incorrect estimates of animal abundance and biomass have serious and significant implications.	[Ward-Paige, Christine; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Ward-Paige, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Mills Flemming, Joanna/0000-0002-3517-3089; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; Lenfest Ocean Program; Pew Charitable Trusts; RAM	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lenfest Ocean Program; Pew Charitable Trusts; RAM	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada to R. A. Myers, H. K. Lotze, J. Mills Flemming, by the Lenfest Ocean Program and The Pew Charitable Trusts with grants to R. A. Myers and H. K. Lotze. These funders did not play a role in conducting the study or in preparing the manuscript.; We thank W. Blanchard for helping to write the simulation AnimDens, C. Minto for initial simulation discussion, and B. Worm, D. Tittensor, H. Whitehead, L. Lucifora, V. Garcia and C. Mora for discussions and valuable comments on the manuscript. We thank RAM for the support and encouragement he always provided.	Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Ault JS, 2006, B MAR SCI, V78, P633; Bansemer CS, 2008, MAR FRESHWATER RES, V59, P322, DOI 10.1071/MF07184; BOHNSACK JA, 1986, NMFSSEFC215 NOAA; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Buck KR, 1996, AQUAT MICROB ECOL, V10, P283; Buray N, 2009, CYBIUM, V33, P21; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eggleston DB, 2004, B MAR SCI, V75, P175; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; GRAY J, 1971, HOW FISHES SWIM, P228; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; GUTMAN M, 1990, J RANGE MANAGE, V43, P535, DOI 10.2307/4002359; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heupel MR, 2007, PAC SCI, V61, P383, DOI 10.2984/1534-6188(2007)61[383:EAORSA]2.0.CO;2; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Johansen JL, 2007, MAR FRESHWATER RES, V58, P233, DOI 10.1071/MF06136; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; PIONTKOVSKI SA, 1995, MAR ECOL PROG SER, V117, P219, DOI 10.3354/meps117219; *R CDT, 2005, R LANG ENV STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; WEBB PW, 1982, FISH B-NOAA, V80, P803	46	137	138	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11722	10.1371/journal.pone.0011722	http://dx.doi.org/10.1371/journal.pone.0011722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661304	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300022
J	Kiebala, M; Polesskaya, O; Yao, ZQ; Perry, SW; Maggirwar, SB				Kiebala, Michelle; Polesskaya, Oksana; Yao, Zhenqiang; Perry, Seth W.; Maggirwar, Sanjay B.			Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 ASSOCIATED DEMENTIA; UP-REGULATES EXPRESSION; TYPE-1 GENE-EXPRESSION; HUMAN FETAL MICROGLIA; TNF-ALPHA; TRANSCRIPTION FACTORS; CHEMOKINE EXPRESSION; RECEPTOR ACTIVATION; NEURONAL INJURY	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorder (HAND) is likely neuroinflammatory in origin, believed to be triggered by inflammatory and oxidative stress responses to cytokines and HIV protein gene products such as the HIV transactivator of transcription (Tat). Here we demonstrate increased messenger RNA for nuclear factor- kappa B (NF-kappa B) family member, transcription factor RelB, in the brain of doxycycline-induced Tat transgenic mice, and increased RelB synthesis in Tat-exposed microglial cells. Since genetic ablation of RelB in mice leads to multi-organ inflammation, we hypothesized that Tat-induced, newly synthesized RelB inhibits cytokine production by microglial cells, possibly through the formation of transcriptionally inactive RelB/RelA complexes. Indeed, tumor necrosis factor-alpha (TNF alpha) production in monocytes isolated from RelB deficient mice was significantly higher than in monocytes isolated from RelB expressing controls. Moreover, RelB overexpression in microglial cells inhibited Tat-induced TNF alpha synthesis in a manner that involved transcriptional repression of the TNF alpha promoter, and increased phosphorylation of RelA at serine 276, a prerequisite for increased RelB/RelA protein interactions. The Rel-homology-domain within RelB was necessary for this interaction. Overexpression of RelA itself, in turn, significantly increased TNF alpha promoter activity, an effect that was completely blocked by RelB overexpression. We conclude that RelB regulates TNF alpha cytokine synthesis by competitive interference binding with RelA, which leads to downregulation of TNF alpha production. Moreover, because Tat activates both RelB and TNF alpha in microglia, and because Tat induces inflammatory TNF alpha synthesis via NF-kappa B, we posit that RelB serves as a cryoprotective, anti-inflammatory, counter-regulatory mechanism for pathogenic NF-kappa B activation. These findings identify a novel regulatory pathway for controlling HIV-induced microglial activation and cytokine production that may have important therapeutic implications for the management of HAND.	[Kiebala, Michelle; Polesskaya, Oksana; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yao, Zhenqiang] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Perry, Seth W.] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu	Polesskaya, Oksana/AAX-9283-2021; Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019; Perry, Seth W/0000-0002-1503-6634; Xu, Hongxi/0000-0001-6238-4511	National Institutes of Health [RO1 NS054578, RO1 NS066801, R21 MH084718, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801, R01NS054578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM); R21 MH084718 (to SWP); T32 AI49105 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; *BIO RAD LAB I LIF, B BIO RAD LAB I LIF, V2890; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bossi P, 1998, CLIN INFECT DIS, V26, P1072, DOI 10.1086/520301; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; CARDENAS V, 2009, J NEUROVIROL, P1; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guillemard E, 2004, VIROLOGY, V329, P371, DOI 10.1016/j.virol.2004.08.030; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; HOWARD OMZ, 1993, P NATL ACAD SCI USA, V90, P2335, DOI 10.1073/pnas.90.6.2335; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Letendre Scott L, 2009, Top HIV Med, V17, P46; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; MAJOR EO, 2009, ANN REV MED; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MULLEROEHRING EM, 2009, NEUROPSYCHOLOGIA; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; NGUYEN TP, 2009, AM J PATHOL; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oberdorfer P, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/348507; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Quiterio S, 2003, BIOMED PHARMACOTHER, V57, P49, DOI 10.1016/S0753-3322(02)00332-3; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; RUBEN S, 1989, J VIROL, V63, P1; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shatrov VA, 1997, EUR CYTOKINE NETW, V8, P37; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Wohlschlaeger J, 2009, CLIN NEUROL NEUROSUR, V111, P422, DOI 10.1016/j.clineuro.2008.12.006; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	109	279	330	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11875	10.1371/journal.pone.0011875	http://dx.doi.org/10.1371/journal.pone.0011875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686703	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200037
